{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "ac895a31-b163-43a4-b39d-bd091055986d",
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[12], line 57\u001b[0m\n\u001b[1;32m     53\u001b[0m client \u001b[38;5;241m=\u001b[39m instructor\u001b[38;5;241m.\u001b[39mfrom_openai(base_client, mode\u001b[38;5;241m=\u001b[39minstructor\u001b[38;5;241m.\u001b[39mMode\u001b[38;5;241m.\u001b[39mJSON)\n\u001b[1;32m     55\u001b[0m \u001b[38;5;66;03m# ============================\u001b[39;00m\n\u001b[1;32m     56\u001b[0m \u001b[38;5;66;03m# ==== Custom JSON Encoder ===\u001b[39;00m\n\u001b[0;32m---> 57\u001b[0m resp \u001b[38;5;241m=\u001b[39m base_client\u001b[38;5;241m.\u001b[39mchat\u001b[38;5;241m.\u001b[39mcompletions\u001b[38;5;241m.\u001b[39mcreate(\n\u001b[1;32m     58\u001b[0m             model\u001b[38;5;241m=\u001b[39mVLLM_MODEL,\n\u001b[1;32m     59\u001b[0m             messages\u001b[38;5;241m=\u001b[39m[\n\u001b[1;32m     60\u001b[0m                 {\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mrole\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124msystem\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcontent\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mhi\u001b[39m\u001b[38;5;124m\"\u001b[39m},\n\u001b[1;32m     61\u001b[0m                 {\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mrole\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124muser\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcontent\u001b[39m\u001b[38;5;124m\"\u001b[39m:\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mhello\u001b[39m\u001b[38;5;124m\"\u001b[39m}\n\u001b[1;32m     62\u001b[0m             ],\n\u001b[1;32m     63\u001b[0m             max_tokens\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m500\u001b[39m,\n\u001b[1;32m     64\u001b[0m             temperature\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m0\u001b[39m,\n\u001b[1;32m     65\u001b[0m         )\n\u001b[1;32m     66\u001b[0m resp\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/openai/_utils/_utils.py:286\u001b[0m, in \u001b[0;36mrequired_args.<locals>.inner.<locals>.wrapper\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    284\u001b[0m             msg \u001b[38;5;241m=\u001b[39m \u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mMissing required argument: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mquote(missing[\u001b[38;5;241m0\u001b[39m])\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    285\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mTypeError\u001b[39;00m(msg)\n\u001b[0;32m--> 286\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m func(\u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/openai/resources/chat/completions/completions.py:1192\u001b[0m, in \u001b[0;36mCompletions.create\u001b[0;34m(self, messages, model, audio, frequency_penalty, function_call, functions, logit_bias, logprobs, max_completion_tokens, max_tokens, metadata, modalities, n, parallel_tool_calls, prediction, presence_penalty, prompt_cache_key, prompt_cache_retention, reasoning_effort, response_format, safety_identifier, seed, service_tier, stop, store, stream, stream_options, temperature, tool_choice, tools, top_logprobs, top_p, user, verbosity, web_search_options, extra_headers, extra_query, extra_body, timeout)\u001b[0m\n\u001b[1;32m   1145\u001b[0m \u001b[38;5;129m@required_args\u001b[39m([\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmessages\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmodel\u001b[39m\u001b[38;5;124m\"\u001b[39m], [\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmessages\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmodel\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mstream\u001b[39m\u001b[38;5;124m\"\u001b[39m])\n\u001b[1;32m   1146\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21mcreate\u001b[39m(\n\u001b[1;32m   1147\u001b[0m     \u001b[38;5;28mself\u001b[39m,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m   1189\u001b[0m     timeout: \u001b[38;5;28mfloat\u001b[39m \u001b[38;5;241m|\u001b[39m httpx\u001b[38;5;241m.\u001b[39mTimeout \u001b[38;5;241m|\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;241m|\u001b[39m NotGiven \u001b[38;5;241m=\u001b[39m not_given,\n\u001b[1;32m   1190\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m ChatCompletion \u001b[38;5;241m|\u001b[39m Stream[ChatCompletionChunk]:\n\u001b[1;32m   1191\u001b[0m     validate_response_format(response_format)\n\u001b[0;32m-> 1192\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_post(\n\u001b[1;32m   1193\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m/chat/completions\u001b[39m\u001b[38;5;124m\"\u001b[39m,\n\u001b[1;32m   1194\u001b[0m         body\u001b[38;5;241m=\u001b[39mmaybe_transform(\n\u001b[1;32m   1195\u001b[0m             {\n\u001b[1;32m   1196\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmessages\u001b[39m\u001b[38;5;124m\"\u001b[39m: messages,\n\u001b[1;32m   1197\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmodel\u001b[39m\u001b[38;5;124m\"\u001b[39m: model,\n\u001b[1;32m   1198\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124maudio\u001b[39m\u001b[38;5;124m\"\u001b[39m: audio,\n\u001b[1;32m   1199\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mfrequency_penalty\u001b[39m\u001b[38;5;124m\"\u001b[39m: frequency_penalty,\n\u001b[1;32m   1200\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mfunction_call\u001b[39m\u001b[38;5;124m\"\u001b[39m: function_call,\n\u001b[1;32m   1201\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mfunctions\u001b[39m\u001b[38;5;124m\"\u001b[39m: functions,\n\u001b[1;32m   1202\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mlogit_bias\u001b[39m\u001b[38;5;124m\"\u001b[39m: logit_bias,\n\u001b[1;32m   1203\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mlogprobs\u001b[39m\u001b[38;5;124m\"\u001b[39m: logprobs,\n\u001b[1;32m   1204\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmax_completion_tokens\u001b[39m\u001b[38;5;124m\"\u001b[39m: max_completion_tokens,\n\u001b[1;32m   1205\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmax_tokens\u001b[39m\u001b[38;5;124m\"\u001b[39m: max_tokens,\n\u001b[1;32m   1206\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmetadata\u001b[39m\u001b[38;5;124m\"\u001b[39m: metadata,\n\u001b[1;32m   1207\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmodalities\u001b[39m\u001b[38;5;124m\"\u001b[39m: modalities,\n\u001b[1;32m   1208\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mn\u001b[39m\u001b[38;5;124m\"\u001b[39m: n,\n\u001b[1;32m   1209\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mparallel_tool_calls\u001b[39m\u001b[38;5;124m\"\u001b[39m: parallel_tool_calls,\n\u001b[1;32m   1210\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mprediction\u001b[39m\u001b[38;5;124m\"\u001b[39m: prediction,\n\u001b[1;32m   1211\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpresence_penalty\u001b[39m\u001b[38;5;124m\"\u001b[39m: presence_penalty,\n\u001b[1;32m   1212\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mprompt_cache_key\u001b[39m\u001b[38;5;124m\"\u001b[39m: prompt_cache_key,\n\u001b[1;32m   1213\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mprompt_cache_retention\u001b[39m\u001b[38;5;124m\"\u001b[39m: prompt_cache_retention,\n\u001b[1;32m   1214\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mreasoning_effort\u001b[39m\u001b[38;5;124m\"\u001b[39m: reasoning_effort,\n\u001b[1;32m   1215\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mresponse_format\u001b[39m\u001b[38;5;124m\"\u001b[39m: response_format,\n\u001b[1;32m   1216\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124msafety_identifier\u001b[39m\u001b[38;5;124m\"\u001b[39m: safety_identifier,\n\u001b[1;32m   1217\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mseed\u001b[39m\u001b[38;5;124m\"\u001b[39m: seed,\n\u001b[1;32m   1218\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mservice_tier\u001b[39m\u001b[38;5;124m\"\u001b[39m: service_tier,\n\u001b[1;32m   1219\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mstop\u001b[39m\u001b[38;5;124m\"\u001b[39m: stop,\n\u001b[1;32m   1220\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mstore\u001b[39m\u001b[38;5;124m\"\u001b[39m: store,\n\u001b[1;32m   1221\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mstream\u001b[39m\u001b[38;5;124m\"\u001b[39m: stream,\n\u001b[1;32m   1222\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mstream_options\u001b[39m\u001b[38;5;124m\"\u001b[39m: stream_options,\n\u001b[1;32m   1223\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtemperature\u001b[39m\u001b[38;5;124m\"\u001b[39m: temperature,\n\u001b[1;32m   1224\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtool_choice\u001b[39m\u001b[38;5;124m\"\u001b[39m: tool_choice,\n\u001b[1;32m   1225\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtools\u001b[39m\u001b[38;5;124m\"\u001b[39m: tools,\n\u001b[1;32m   1226\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtop_logprobs\u001b[39m\u001b[38;5;124m\"\u001b[39m: top_logprobs,\n\u001b[1;32m   1227\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtop_p\u001b[39m\u001b[38;5;124m\"\u001b[39m: top_p,\n\u001b[1;32m   1228\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124muser\u001b[39m\u001b[38;5;124m\"\u001b[39m: user,\n\u001b[1;32m   1229\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mverbosity\u001b[39m\u001b[38;5;124m\"\u001b[39m: verbosity,\n\u001b[1;32m   1230\u001b[0m                 \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mweb_search_options\u001b[39m\u001b[38;5;124m\"\u001b[39m: web_search_options,\n\u001b[1;32m   1231\u001b[0m             },\n\u001b[1;32m   1232\u001b[0m             completion_create_params\u001b[38;5;241m.\u001b[39mCompletionCreateParamsStreaming\n\u001b[1;32m   1233\u001b[0m             \u001b[38;5;28;01mif\u001b[39;00m stream\n\u001b[1;32m   1234\u001b[0m             \u001b[38;5;28;01melse\u001b[39;00m completion_create_params\u001b[38;5;241m.\u001b[39mCompletionCreateParamsNonStreaming,\n\u001b[1;32m   1235\u001b[0m         ),\n\u001b[1;32m   1236\u001b[0m         options\u001b[38;5;241m=\u001b[39mmake_request_options(\n\u001b[1;32m   1237\u001b[0m             extra_headers\u001b[38;5;241m=\u001b[39mextra_headers, extra_query\u001b[38;5;241m=\u001b[39mextra_query, extra_body\u001b[38;5;241m=\u001b[39mextra_body, timeout\u001b[38;5;241m=\u001b[39mtimeout\n\u001b[1;32m   1238\u001b[0m         ),\n\u001b[1;32m   1239\u001b[0m         cast_to\u001b[38;5;241m=\u001b[39mChatCompletion,\n\u001b[1;32m   1240\u001b[0m         stream\u001b[38;5;241m=\u001b[39mstream \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[1;32m   1241\u001b[0m         stream_cls\u001b[38;5;241m=\u001b[39mStream[ChatCompletionChunk],\n\u001b[1;32m   1242\u001b[0m     )\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/openai/_base_client.py:1259\u001b[0m, in \u001b[0;36mSyncAPIClient.post\u001b[0;34m(self, path, cast_to, body, options, files, stream, stream_cls)\u001b[0m\n\u001b[1;32m   1245\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21mpost\u001b[39m(\n\u001b[1;32m   1246\u001b[0m     \u001b[38;5;28mself\u001b[39m,\n\u001b[1;32m   1247\u001b[0m     path: \u001b[38;5;28mstr\u001b[39m,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m   1254\u001b[0m     stream_cls: \u001b[38;5;28mtype\u001b[39m[_StreamT] \u001b[38;5;241m|\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[1;32m   1255\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m ResponseT \u001b[38;5;241m|\u001b[39m _StreamT:\n\u001b[1;32m   1256\u001b[0m     opts \u001b[38;5;241m=\u001b[39m FinalRequestOptions\u001b[38;5;241m.\u001b[39mconstruct(\n\u001b[1;32m   1257\u001b[0m         method\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpost\u001b[39m\u001b[38;5;124m\"\u001b[39m, url\u001b[38;5;241m=\u001b[39mpath, json_data\u001b[38;5;241m=\u001b[39mbody, files\u001b[38;5;241m=\u001b[39mto_httpx_files(files), \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39moptions\n\u001b[1;32m   1258\u001b[0m     )\n\u001b[0;32m-> 1259\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m cast(ResponseT, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mrequest(cast_to, opts, stream\u001b[38;5;241m=\u001b[39mstream, stream_cls\u001b[38;5;241m=\u001b[39mstream_cls))\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/openai/_base_client.py:982\u001b[0m, in \u001b[0;36mSyncAPIClient.request\u001b[0;34m(self, cast_to, options, stream, stream_cls)\u001b[0m\n\u001b[1;32m    980\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    981\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 982\u001b[0m     response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_client\u001b[38;5;241m.\u001b[39msend(\n\u001b[1;32m    983\u001b[0m         request,\n\u001b[1;32m    984\u001b[0m         stream\u001b[38;5;241m=\u001b[39mstream \u001b[38;5;129;01mor\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_should_stream_response_body(request\u001b[38;5;241m=\u001b[39mrequest),\n\u001b[1;32m    985\u001b[0m         \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs,\n\u001b[1;32m    986\u001b[0m     )\n\u001b[1;32m    987\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m httpx\u001b[38;5;241m.\u001b[39mTimeoutException \u001b[38;5;28;01mas\u001b[39;00m err:\n\u001b[1;32m    988\u001b[0m     log\u001b[38;5;241m.\u001b[39mdebug(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mEncountered httpx.TimeoutException\u001b[39m\u001b[38;5;124m\"\u001b[39m, exc_info\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpx/_client.py:914\u001b[0m, in \u001b[0;36mClient.send\u001b[0;34m(self, request, stream, auth, follow_redirects)\u001b[0m\n\u001b[1;32m    910\u001b[0m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_set_timeout(request)\n\u001b[1;32m    912\u001b[0m auth \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_build_request_auth(request, auth)\n\u001b[0;32m--> 914\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_send_handling_auth(\n\u001b[1;32m    915\u001b[0m     request,\n\u001b[1;32m    916\u001b[0m     auth\u001b[38;5;241m=\u001b[39mauth,\n\u001b[1;32m    917\u001b[0m     follow_redirects\u001b[38;5;241m=\u001b[39mfollow_redirects,\n\u001b[1;32m    918\u001b[0m     history\u001b[38;5;241m=\u001b[39m[],\n\u001b[1;32m    919\u001b[0m )\n\u001b[1;32m    920\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    921\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m stream:\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpx/_client.py:942\u001b[0m, in \u001b[0;36mClient._send_handling_auth\u001b[0;34m(self, request, auth, follow_redirects, history)\u001b[0m\n\u001b[1;32m    939\u001b[0m request \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mnext\u001b[39m(auth_flow)\n\u001b[1;32m    941\u001b[0m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[0;32m--> 942\u001b[0m     response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_send_handling_redirects(\n\u001b[1;32m    943\u001b[0m         request,\n\u001b[1;32m    944\u001b[0m         follow_redirects\u001b[38;5;241m=\u001b[39mfollow_redirects,\n\u001b[1;32m    945\u001b[0m         history\u001b[38;5;241m=\u001b[39mhistory,\n\u001b[1;32m    946\u001b[0m     )\n\u001b[1;32m    947\u001b[0m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    948\u001b[0m         \u001b[38;5;28;01mtry\u001b[39;00m:\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpx/_client.py:979\u001b[0m, in \u001b[0;36mClient._send_handling_redirects\u001b[0;34m(self, request, follow_redirects, history)\u001b[0m\n\u001b[1;32m    976\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m hook \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_event_hooks[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mrequest\u001b[39m\u001b[38;5;124m\"\u001b[39m]:\n\u001b[1;32m    977\u001b[0m     hook(request)\n\u001b[0;32m--> 979\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_send_single_request(request)\n\u001b[1;32m    980\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    981\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m hook \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_event_hooks[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mresponse\u001b[39m\u001b[38;5;124m\"\u001b[39m]:\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpx/_client.py:1014\u001b[0m, in \u001b[0;36mClient._send_single_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m   1009\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\n\u001b[1;32m   1010\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mAttempted to send an async request with a sync Client instance.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m   1011\u001b[0m     )\n\u001b[1;32m   1013\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m request_context(request\u001b[38;5;241m=\u001b[39mrequest):\n\u001b[0;32m-> 1014\u001b[0m     response \u001b[38;5;241m=\u001b[39m transport\u001b[38;5;241m.\u001b[39mhandle_request(request)\n\u001b[1;32m   1016\u001b[0m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(response\u001b[38;5;241m.\u001b[39mstream, SyncByteStream)\n\u001b[1;32m   1018\u001b[0m response\u001b[38;5;241m.\u001b[39mrequest \u001b[38;5;241m=\u001b[39m request\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpx/_transports/default.py:250\u001b[0m, in \u001b[0;36mHTTPTransport.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    237\u001b[0m req \u001b[38;5;241m=\u001b[39m httpcore\u001b[38;5;241m.\u001b[39mRequest(\n\u001b[1;32m    238\u001b[0m     method\u001b[38;5;241m=\u001b[39mrequest\u001b[38;5;241m.\u001b[39mmethod,\n\u001b[1;32m    239\u001b[0m     url\u001b[38;5;241m=\u001b[39mhttpcore\u001b[38;5;241m.\u001b[39mURL(\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    247\u001b[0m     extensions\u001b[38;5;241m=\u001b[39mrequest\u001b[38;5;241m.\u001b[39mextensions,\n\u001b[1;32m    248\u001b[0m )\n\u001b[1;32m    249\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m map_httpcore_exceptions():\n\u001b[0;32m--> 250\u001b[0m     resp \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_pool\u001b[38;5;241m.\u001b[39mhandle_request(req)\n\u001b[1;32m    252\u001b[0m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(resp\u001b[38;5;241m.\u001b[39mstream, typing\u001b[38;5;241m.\u001b[39mIterable)\n\u001b[1;32m    254\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m Response(\n\u001b[1;32m    255\u001b[0m     status_code\u001b[38;5;241m=\u001b[39mresp\u001b[38;5;241m.\u001b[39mstatus,\n\u001b[1;32m    256\u001b[0m     headers\u001b[38;5;241m=\u001b[39mresp\u001b[38;5;241m.\u001b[39mheaders,\n\u001b[1;32m    257\u001b[0m     stream\u001b[38;5;241m=\u001b[39mResponseStream(resp\u001b[38;5;241m.\u001b[39mstream),\n\u001b[1;32m    258\u001b[0m     extensions\u001b[38;5;241m=\u001b[39mresp\u001b[38;5;241m.\u001b[39mextensions,\n\u001b[1;32m    259\u001b[0m )\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/connection_pool.py:268\u001b[0m, in \u001b[0;36mConnectionPool.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    266\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m ShieldCancellation():\n\u001b[1;32m    267\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mresponse_closed(status)\n\u001b[0;32m--> 268\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exc\n\u001b[1;32m    269\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m    270\u001b[0m     \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/connection_pool.py:251\u001b[0m, in \u001b[0;36mConnectionPool.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    248\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m exc\n\u001b[1;32m    250\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 251\u001b[0m     response \u001b[38;5;241m=\u001b[39m connection\u001b[38;5;241m.\u001b[39mhandle_request(request)\n\u001b[1;32m    252\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m ConnectionNotAvailable:\n\u001b[1;32m    253\u001b[0m     \u001b[38;5;66;03m# The ConnectionNotAvailable exception is a special case, that\u001b[39;00m\n\u001b[1;32m    254\u001b[0m     \u001b[38;5;66;03m# indicates we need to retry the request on a new connection.\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    258\u001b[0m     \u001b[38;5;66;03m# might end up as an HTTP/2 connection, but which actually ends\u001b[39;00m\n\u001b[1;32m    259\u001b[0m     \u001b[38;5;66;03m# up as HTTP/1.1.\u001b[39;00m\n\u001b[1;32m    260\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_pool_lock:\n\u001b[1;32m    261\u001b[0m         \u001b[38;5;66;03m# Maintain our position in the request queue, but reset the\u001b[39;00m\n\u001b[1;32m    262\u001b[0m         \u001b[38;5;66;03m# status so that the request becomes queued again.\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/connection.py:103\u001b[0m, in \u001b[0;36mHTTPConnection.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    100\u001b[0m     \u001b[38;5;28;01melif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_connection\u001b[38;5;241m.\u001b[39mis_available():\n\u001b[1;32m    101\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m ConnectionNotAvailable()\n\u001b[0;32m--> 103\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_connection\u001b[38;5;241m.\u001b[39mhandle_request(request)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/http11.py:133\u001b[0m, in \u001b[0;36mHTTP11Connection.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    131\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m Trace(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mresponse_closed\u001b[39m\u001b[38;5;124m\"\u001b[39m, logger, request) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[1;32m    132\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_response_closed()\n\u001b[0;32m--> 133\u001b[0m \u001b[38;5;28;01mraise\u001b[39;00m exc\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/http11.py:111\u001b[0m, in \u001b[0;36mHTTP11Connection.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    101\u001b[0m     \u001b[38;5;28;01mpass\u001b[39;00m\n\u001b[1;32m    103\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m Trace(\n\u001b[1;32m    104\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mreceive_response_headers\u001b[39m\u001b[38;5;124m\"\u001b[39m, logger, request, kwargs\n\u001b[1;32m    105\u001b[0m ) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[1;32m    106\u001b[0m     (\n\u001b[1;32m    107\u001b[0m         http_version,\n\u001b[1;32m    108\u001b[0m         status,\n\u001b[1;32m    109\u001b[0m         reason_phrase,\n\u001b[1;32m    110\u001b[0m         headers,\n\u001b[0;32m--> 111\u001b[0m     ) \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_receive_response_headers(\u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)\n\u001b[1;32m    112\u001b[0m     trace\u001b[38;5;241m.\u001b[39mreturn_value \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m    113\u001b[0m         http_version,\n\u001b[1;32m    114\u001b[0m         status,\n\u001b[1;32m    115\u001b[0m         reason_phrase,\n\u001b[1;32m    116\u001b[0m         headers,\n\u001b[1;32m    117\u001b[0m     )\n\u001b[1;32m    119\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m Response(\n\u001b[1;32m    120\u001b[0m     status\u001b[38;5;241m=\u001b[39mstatus,\n\u001b[1;32m    121\u001b[0m     headers\u001b[38;5;241m=\u001b[39mheaders,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    127\u001b[0m     },\n\u001b[1;32m    128\u001b[0m )\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/http11.py:176\u001b[0m, in \u001b[0;36mHTTP11Connection._receive_response_headers\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    173\u001b[0m timeout \u001b[38;5;241m=\u001b[39m timeouts\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mread\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[1;32m    175\u001b[0m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[0;32m--> 176\u001b[0m     event \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_receive_event(timeout\u001b[38;5;241m=\u001b[39mtimeout)\n\u001b[1;32m    177\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(event, h11\u001b[38;5;241m.\u001b[39mResponse):\n\u001b[1;32m    178\u001b[0m         \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_sync/http11.py:212\u001b[0m, in \u001b[0;36mHTTP11Connection._receive_event\u001b[0;34m(self, timeout)\u001b[0m\n\u001b[1;32m    209\u001b[0m     event \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_h11_state\u001b[38;5;241m.\u001b[39mnext_event()\n\u001b[1;32m    211\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m event \u001b[38;5;129;01mis\u001b[39;00m h11\u001b[38;5;241m.\u001b[39mNEED_DATA:\n\u001b[0;32m--> 212\u001b[0m     data \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_network_stream\u001b[38;5;241m.\u001b[39mread(\n\u001b[1;32m    213\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mREAD_NUM_BYTES, timeout\u001b[38;5;241m=\u001b[39mtimeout\n\u001b[1;32m    214\u001b[0m     )\n\u001b[1;32m    216\u001b[0m     \u001b[38;5;66;03m# If we feed this case through h11 we'll raise an exception like:\u001b[39;00m\n\u001b[1;32m    217\u001b[0m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[1;32m    218\u001b[0m     \u001b[38;5;66;03m#     httpcore.RemoteProtocolError: can't handle event type\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    222\u001b[0m     \u001b[38;5;66;03m# perspective. Instead we handle this case distinctly and treat\u001b[39;00m\n\u001b[1;32m    223\u001b[0m     \u001b[38;5;66;03m# it as a ConnectError.\u001b[39;00m\n\u001b[1;32m    224\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m data \u001b[38;5;241m==\u001b[39m \u001b[38;5;124mb\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_h11_state\u001b[38;5;241m.\u001b[39mtheir_state \u001b[38;5;241m==\u001b[39m h11\u001b[38;5;241m.\u001b[39mSEND_RESPONSE:\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/httpcore/_backends/sync.py:126\u001b[0m, in \u001b[0;36mSyncStream.read\u001b[0;34m(self, max_bytes, timeout)\u001b[0m\n\u001b[1;32m    124\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m map_exceptions(exc_map):\n\u001b[1;32m    125\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_sock\u001b[38;5;241m.\u001b[39msettimeout(timeout)\n\u001b[0;32m--> 126\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_sock\u001b[38;5;241m.\u001b[39mrecv(max_bytes)\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from tqdm import tqdm\n",
    "from openai import OpenAI\n",
    "import tiktoken\n",
    "import instructor\n",
    "from pydantic import BaseModel, Field, model_validator\n",
    "from typing import Literal, Any\n",
    "\n",
    "class CausalAnalysis(BaseModel):\n",
    "    relationship: Literal[\"Causal\", \"Not causal\"] = Field(\n",
    "        ..., \n",
    "        description=\"Classify the relationship. Value must be exactly 'Causal' or 'Not causal'.\"\n",
    "    )\n",
    "    score: float = Field(\n",
    "        ..., \n",
    "        ge=0.0, \n",
    "        le=1.0, \n",
    "        description=\"Confidence score (0.0 to 1.0).\"\n",
    "    )\n",
    "   \n",
    "\n",
    "    @model_validator(mode='before')\n",
    "    @classmethod\n",
    "    def robust_validator(cls, data: Any) -> Any:\n",
    "        if isinstance(data, list):\n",
    "            return {\"relationship\": \"Not causal\", \"score\": 0.0, \"reasoning\": \"\"}\n",
    "            \n",
    "        if isinstance(data, dict):\n",
    "            # Unwrap \"data\" or \"result\" wrappers\n",
    "            if \"data\" in data and isinstance(data[\"data\"], dict):\n",
    "                data = data[\"data\"]\n",
    "            elif \"result\" in data and isinstance(data[\"result\"], dict):\n",
    "                data = data[\"result\"]\n",
    "                \n",
    "        return data\n",
    "# ============================\n",
    "# ==== vLLM CONFIG ===========\n",
    "# ============================\n",
    "\n",
    "VLLM_ENDPOINT = \"http://localhost:8000/v1\"\n",
    "VLLM_API_KEY = \"token-abc123\"\n",
    "VLLM_MODEL = \"Henrychur/MMed-Llama-3-8B\"\n",
    "\n",
    "base_client = OpenAI(\n",
    "    base_url=VLLM_ENDPOINT,\n",
    "    api_key=VLLM_API_KEY\n",
    ")\n",
    "\n",
    "client = instructor.from_openai(base_client, mode=instructor.Mode.JSON)\n",
    "\n",
    "# ============================\n",
    "# ==== Custom JSON Encoder ===\n",
    "resp = base_client.chat.completions.create(\n",
    "            model=VLLM_MODEL,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"hi\"},\n",
    "                {\"role\": \"user\", \"content\":\"hello\"}\n",
    "            ],\n",
    "            max_tokens=500,\n",
    "            temperature=0,\n",
    "        )\n",
    "resp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "67d78a7d-c5f3-4c83-9121-242e2cd14b92",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "--- Loading Data from /data/users/nency/truth_discovery/CSTD_code_to_submit/cred doc casuality with preds.csv ---\n",
      "--- Processing 5267 rows with ['Opus_4_5', 'Sonnet_4_5', 'Opus_4'] ---\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 0/5267 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error 403 for global.anthropic.claude-opus-4-5-20251101-v1:0: {\"message\":\"Model access is denied due to INVALID_PAYMENT_INSTRUMENT:A valid payment instrument must be provided.. Your AWS Marketplace subscription for this model cannot be completed at this time. If you recently fixed this issue, try again after 5 minutes.\"}\n",
      "Request Failed for global.anthropic.claude-sonnet-4-5-20250929-v1:0: list index out of range\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 1/5267 [00:06<8:53:18,  6.08s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error 400 for us.anthropic.claude-opus-4-20250215-v1:0: {\"message\":\"The provided model identifier is invalid.\"}\n",
      "Error 403 for global.anthropic.claude-opus-4-5-20251101-v1:0: {\"message\":\"Model access is denied due to INVALID_PAYMENT_INSTRUMENT:A valid payment instrument must be provided.. Your AWS Marketplace subscription for this model cannot be completed at this time. If you recently fixed this issue, try again after 5 minutes.\"}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 2/5267 [00:11<8:03:00,  5.50s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error 400 for us.anthropic.claude-opus-4-20250215-v1:0: {\"message\":\"The provided model identifier is invalid.\"}\n",
      "Error 403 for global.anthropic.claude-opus-4-5-20251101-v1:0: {\"message\":\"Model access is denied due to INVALID_PAYMENT_INSTRUMENT:A valid payment instrument must be provided.. Your AWS Marketplace subscription for this model cannot be completed at this time. If you recently fixed this issue, try again after 5 minutes.\"}\n",
      "Request Failed for global.anthropic.claude-sonnet-4-5-20250929-v1:0: Extra data: line 7 column 1 (char 50)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 3/5267 [00:16<8:07:01,  5.55s/it]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error 400 for us.anthropic.claude-opus-4-20250215-v1:0: {\"message\":\"The provided model identifier is invalid.\"}\n",
      "Error 403 for global.anthropic.claude-opus-4-5-20251101-v1:0: {\"message\":\"Model access is denied due to INVALID_PAYMENT_INSTRUMENT:A valid payment instrument must be provided.. Your AWS Marketplace subscription for this model cannot be completed at this time. If you recently fixed this issue, try again after 5 minutes.\"}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "  0%|          | 3/5267 [00:18<8:47:12,  6.01s/it]\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[1], line 159\u001b[0m\n\u001b[1;32m    156\u001b[0m     \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;130;01m\\n\u001b[39;00m\u001b[38;5;124mCompleted! Saved to: \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mOUTPUT_FILE\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m    158\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;18m__name__\u001b[39m \u001b[38;5;241m==\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m__main__\u001b[39m\u001b[38;5;124m\"\u001b[39m:\n\u001b[0;32m--> 159\u001b[0m     main()\n",
      "Cell \u001b[0;32mIn[1], line 131\u001b[0m, in \u001b[0;36mmain\u001b[0;34m()\u001b[0m\n\u001b[1;32m    129\u001b[0m \u001b[38;5;66;03m# 1. Query all 3 models\u001b[39;00m\n\u001b[1;32m    130\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m model_name, model_id \u001b[38;5;129;01min\u001b[39;00m MODELS\u001b[38;5;241m.\u001b[39mitems():\n\u001b[0;32m--> 131\u001b[0m     pred, score \u001b[38;5;241m=\u001b[39m invoke_model_requests(model_id, sentence)\n\u001b[1;32m    133\u001b[0m     row_data[\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mmodel_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m_Prediction\u001b[39m\u001b[38;5;124m\"\u001b[39m] \u001b[38;5;241m=\u001b[39m pred\n\u001b[1;32m    134\u001b[0m     row_data[\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m{\u001b[39;00mmodel_name\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m_Score\u001b[39m\u001b[38;5;124m\"\u001b[39m] \u001b[38;5;241m=\u001b[39m score\n",
      "Cell \u001b[0;32mIn[1], line 62\u001b[0m, in \u001b[0;36minvoke_model_requests\u001b[0;34m(model_id, text)\u001b[0m\n\u001b[1;32m     53\u001b[0m payload \u001b[38;5;241m=\u001b[39m {\n\u001b[1;32m     54\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124manthropic_version\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mbedrock-2023-05-31\u001b[39m\u001b[38;5;124m\"\u001b[39m,\n\u001b[1;32m     55\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmax_tokens\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;241m1024\u001b[39m,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     58\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtemperature\u001b[39m\u001b[38;5;124m\"\u001b[39m: \u001b[38;5;241m0.0\u001b[39m \u001b[38;5;66;03m# Deterministic for reproducibility\u001b[39;00m\n\u001b[1;32m     59\u001b[0m }\n\u001b[1;32m     61\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m---> 62\u001b[0m     response \u001b[38;5;241m=\u001b[39m requests\u001b[38;5;241m.\u001b[39mpost(url, headers\u001b[38;5;241m=\u001b[39mheaders, json\u001b[38;5;241m=\u001b[39mpayload, timeout\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m60\u001b[39m)\n\u001b[1;32m     64\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m response\u001b[38;5;241m.\u001b[39mstatus_code \u001b[38;5;241m==\u001b[39m \u001b[38;5;241m200\u001b[39m:\n\u001b[1;32m     65\u001b[0m         response_body \u001b[38;5;241m=\u001b[39m response\u001b[38;5;241m.\u001b[39mjson()\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/requests/api.py:115\u001b[0m, in \u001b[0;36mpost\u001b[0;34m(url, data, json, **kwargs)\u001b[0m\n\u001b[1;32m    103\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21mpost\u001b[39m(url, data\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m, json\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[1;32m    104\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124mr\u001b[39m\u001b[38;5;124;03m\"\"\"Sends a POST request.\u001b[39;00m\n\u001b[1;32m    105\u001b[0m \n\u001b[1;32m    106\u001b[0m \u001b[38;5;124;03m    :param url: URL for the new :class:`Request` object.\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    112\u001b[0m \u001b[38;5;124;03m    :rtype: requests.Response\u001b[39;00m\n\u001b[1;32m    113\u001b[0m \u001b[38;5;124;03m    \"\"\"\u001b[39;00m\n\u001b[0;32m--> 115\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m request(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mpost\u001b[39m\u001b[38;5;124m\"\u001b[39m, url, data\u001b[38;5;241m=\u001b[39mdata, json\u001b[38;5;241m=\u001b[39mjson, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/requests/api.py:59\u001b[0m, in \u001b[0;36mrequest\u001b[0;34m(method, url, **kwargs)\u001b[0m\n\u001b[1;32m     55\u001b[0m \u001b[38;5;66;03m# By using the 'with' statement we are sure the session is closed, thus we\u001b[39;00m\n\u001b[1;32m     56\u001b[0m \u001b[38;5;66;03m# avoid leaving sockets open which can trigger a ResourceWarning in some\u001b[39;00m\n\u001b[1;32m     57\u001b[0m \u001b[38;5;66;03m# cases, and look like a memory leak in others.\u001b[39;00m\n\u001b[1;32m     58\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m sessions\u001b[38;5;241m.\u001b[39mSession() \u001b[38;5;28;01mas\u001b[39;00m session:\n\u001b[0;32m---> 59\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m session\u001b[38;5;241m.\u001b[39mrequest(method\u001b[38;5;241m=\u001b[39mmethod, url\u001b[38;5;241m=\u001b[39murl, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/requests/sessions.py:589\u001b[0m, in \u001b[0;36mSession.request\u001b[0;34m(self, method, url, params, data, headers, cookies, files, auth, timeout, allow_redirects, proxies, hooks, stream, verify, cert, json)\u001b[0m\n\u001b[1;32m    584\u001b[0m send_kwargs \u001b[38;5;241m=\u001b[39m {\n\u001b[1;32m    585\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtimeout\u001b[39m\u001b[38;5;124m\"\u001b[39m: timeout,\n\u001b[1;32m    586\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mallow_redirects\u001b[39m\u001b[38;5;124m\"\u001b[39m: allow_redirects,\n\u001b[1;32m    587\u001b[0m }\n\u001b[1;32m    588\u001b[0m send_kwargs\u001b[38;5;241m.\u001b[39mupdate(settings)\n\u001b[0;32m--> 589\u001b[0m resp \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39msend(prep, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39msend_kwargs)\n\u001b[1;32m    591\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m resp\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/requests/sessions.py:703\u001b[0m, in \u001b[0;36mSession.send\u001b[0;34m(self, request, **kwargs)\u001b[0m\n\u001b[1;32m    700\u001b[0m start \u001b[38;5;241m=\u001b[39m preferred_clock()\n\u001b[1;32m    702\u001b[0m \u001b[38;5;66;03m# Send the request\u001b[39;00m\n\u001b[0;32m--> 703\u001b[0m r \u001b[38;5;241m=\u001b[39m adapter\u001b[38;5;241m.\u001b[39msend(request, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs)\n\u001b[1;32m    705\u001b[0m \u001b[38;5;66;03m# Total elapsed time of the request (approximately)\u001b[39;00m\n\u001b[1;32m    706\u001b[0m elapsed \u001b[38;5;241m=\u001b[39m preferred_clock() \u001b[38;5;241m-\u001b[39m start\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/requests/adapters.py:667\u001b[0m, in \u001b[0;36mHTTPAdapter.send\u001b[0;34m(self, request, stream, timeout, verify, cert, proxies)\u001b[0m\n\u001b[1;32m    664\u001b[0m     timeout \u001b[38;5;241m=\u001b[39m TimeoutSauce(connect\u001b[38;5;241m=\u001b[39mtimeout, read\u001b[38;5;241m=\u001b[39mtimeout)\n\u001b[1;32m    666\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 667\u001b[0m     resp \u001b[38;5;241m=\u001b[39m conn\u001b[38;5;241m.\u001b[39murlopen(\n\u001b[1;32m    668\u001b[0m         method\u001b[38;5;241m=\u001b[39mrequest\u001b[38;5;241m.\u001b[39mmethod,\n\u001b[1;32m    669\u001b[0m         url\u001b[38;5;241m=\u001b[39murl,\n\u001b[1;32m    670\u001b[0m         body\u001b[38;5;241m=\u001b[39mrequest\u001b[38;5;241m.\u001b[39mbody,\n\u001b[1;32m    671\u001b[0m         headers\u001b[38;5;241m=\u001b[39mrequest\u001b[38;5;241m.\u001b[39mheaders,\n\u001b[1;32m    672\u001b[0m         redirect\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[1;32m    673\u001b[0m         assert_same_host\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[1;32m    674\u001b[0m         preload_content\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[1;32m    675\u001b[0m         decode_content\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mFalse\u001b[39;00m,\n\u001b[1;32m    676\u001b[0m         retries\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mmax_retries,\n\u001b[1;32m    677\u001b[0m         timeout\u001b[38;5;241m=\u001b[39mtimeout,\n\u001b[1;32m    678\u001b[0m         chunked\u001b[38;5;241m=\u001b[39mchunked,\n\u001b[1;32m    679\u001b[0m     )\n\u001b[1;32m    681\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m (ProtocolError, \u001b[38;5;167;01mOSError\u001b[39;00m) \u001b[38;5;28;01mas\u001b[39;00m err:\n\u001b[1;32m    682\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mConnectionError\u001b[39;00m(err, request\u001b[38;5;241m=\u001b[39mrequest)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/urllib3/connectionpool.py:789\u001b[0m, in \u001b[0;36mHTTPConnectionPool.urlopen\u001b[0;34m(self, method, url, body, headers, retries, redirect, assert_same_host, timeout, pool_timeout, release_conn, chunked, body_pos, preload_content, decode_content, **response_kw)\u001b[0m\n\u001b[1;32m    786\u001b[0m response_conn \u001b[38;5;241m=\u001b[39m conn \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m release_conn \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    788\u001b[0m \u001b[38;5;66;03m# Make the request on the HTTPConnection object\u001b[39;00m\n\u001b[0;32m--> 789\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_make_request(\n\u001b[1;32m    790\u001b[0m     conn,\n\u001b[1;32m    791\u001b[0m     method,\n\u001b[1;32m    792\u001b[0m     url,\n\u001b[1;32m    793\u001b[0m     timeout\u001b[38;5;241m=\u001b[39mtimeout_obj,\n\u001b[1;32m    794\u001b[0m     body\u001b[38;5;241m=\u001b[39mbody,\n\u001b[1;32m    795\u001b[0m     headers\u001b[38;5;241m=\u001b[39mheaders,\n\u001b[1;32m    796\u001b[0m     chunked\u001b[38;5;241m=\u001b[39mchunked,\n\u001b[1;32m    797\u001b[0m     retries\u001b[38;5;241m=\u001b[39mretries,\n\u001b[1;32m    798\u001b[0m     response_conn\u001b[38;5;241m=\u001b[39mresponse_conn,\n\u001b[1;32m    799\u001b[0m     preload_content\u001b[38;5;241m=\u001b[39mpreload_content,\n\u001b[1;32m    800\u001b[0m     decode_content\u001b[38;5;241m=\u001b[39mdecode_content,\n\u001b[1;32m    801\u001b[0m     \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mresponse_kw,\n\u001b[1;32m    802\u001b[0m )\n\u001b[1;32m    804\u001b[0m \u001b[38;5;66;03m# Everything went great!\u001b[39;00m\n\u001b[1;32m    805\u001b[0m clean_exit \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mTrue\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/urllib3/connectionpool.py:466\u001b[0m, in \u001b[0;36mHTTPConnectionPool._make_request\u001b[0;34m(self, conn, method, url, body, headers, retries, timeout, chunked, response_conn, preload_content, decode_content, enforce_content_length)\u001b[0m\n\u001b[1;32m    463\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    464\u001b[0m     \u001b[38;5;66;03m# Trigger any extra validation we need to do.\u001b[39;00m\n\u001b[1;32m    465\u001b[0m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 466\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_validate_conn(conn)\n\u001b[1;32m    467\u001b[0m     \u001b[38;5;28;01mexcept\u001b[39;00m (SocketTimeout, BaseSSLError) \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[1;32m    468\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_raise_timeout(err\u001b[38;5;241m=\u001b[39me, url\u001b[38;5;241m=\u001b[39murl, timeout_value\u001b[38;5;241m=\u001b[39mconn\u001b[38;5;241m.\u001b[39mtimeout)\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/urllib3/connectionpool.py:1095\u001b[0m, in \u001b[0;36mHTTPSConnectionPool._validate_conn\u001b[0;34m(self, conn)\u001b[0m\n\u001b[1;32m   1093\u001b[0m \u001b[38;5;66;03m# Force connect early to allow us to validate the connection.\u001b[39;00m\n\u001b[1;32m   1094\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m conn\u001b[38;5;241m.\u001b[39mis_closed:\n\u001b[0;32m-> 1095\u001b[0m     conn\u001b[38;5;241m.\u001b[39mconnect()\n\u001b[1;32m   1097\u001b[0m \u001b[38;5;66;03m# TODO revise this, see https://github.com/urllib3/urllib3/issues/2791\u001b[39;00m\n\u001b[1;32m   1098\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m conn\u001b[38;5;241m.\u001b[39mis_verified \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m conn\u001b[38;5;241m.\u001b[39mproxy_is_verified:\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/urllib3/connection.py:693\u001b[0m, in \u001b[0;36mHTTPSConnection.connect\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    691\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    692\u001b[0m     sock: socket\u001b[38;5;241m.\u001b[39msocket \u001b[38;5;241m|\u001b[39m ssl\u001b[38;5;241m.\u001b[39mSSLSocket\n\u001b[0;32m--> 693\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39msock \u001b[38;5;241m=\u001b[39m sock \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_new_conn()\n\u001b[1;32m    694\u001b[0m     server_hostname: \u001b[38;5;28mstr\u001b[39m \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mhost\n\u001b[1;32m    695\u001b[0m     tls_in_tls \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mFalse\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/urllib3/connection.py:199\u001b[0m, in \u001b[0;36mHTTPConnection._new_conn\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    194\u001b[0m \u001b[38;5;250m\u001b[39m\u001b[38;5;124;03m\"\"\"Establish a socket connection and set nodelay settings on it.\u001b[39;00m\n\u001b[1;32m    195\u001b[0m \n\u001b[1;32m    196\u001b[0m \u001b[38;5;124;03m:return: New socket connection.\u001b[39;00m\n\u001b[1;32m    197\u001b[0m \u001b[38;5;124;03m\"\"\"\u001b[39;00m\n\u001b[1;32m    198\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m--> 199\u001b[0m     sock \u001b[38;5;241m=\u001b[39m connection\u001b[38;5;241m.\u001b[39mcreate_connection(\n\u001b[1;32m    200\u001b[0m         (\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_dns_host, \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mport),\n\u001b[1;32m    201\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mtimeout,\n\u001b[1;32m    202\u001b[0m         source_address\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39msource_address,\n\u001b[1;32m    203\u001b[0m         socket_options\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39msocket_options,\n\u001b[1;32m    204\u001b[0m     )\n\u001b[1;32m    205\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m socket\u001b[38;5;241m.\u001b[39mgaierror \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[1;32m    206\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m NameResolutionError(\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mhost, \u001b[38;5;28mself\u001b[39m, e) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01me\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/lib/python3.12/site-packages/urllib3/util/connection.py:73\u001b[0m, in \u001b[0;36mcreate_connection\u001b[0;34m(address, timeout, source_address, socket_options)\u001b[0m\n\u001b[1;32m     71\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m source_address:\n\u001b[1;32m     72\u001b[0m     sock\u001b[38;5;241m.\u001b[39mbind(source_address)\n\u001b[0;32m---> 73\u001b[0m sock\u001b[38;5;241m.\u001b[39mconnect(sa)\n\u001b[1;32m     74\u001b[0m \u001b[38;5;66;03m# Break explicitly a reference cycle\u001b[39;00m\n\u001b[1;32m     75\u001b[0m err \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import requests\n",
    "import json\n",
    "import time\n",
    "from statistics import mean\n",
    "from tqdm import tqdm  # pip install tqdm\n",
    "\n",
    "# --- CONFIGURATION ---\n",
    "INPUT_FILE = '/data/users/nency/truth_discovery/CSTD_code_to_submit/cred doc casuality with preds.csv'\n",
    "OUTPUT_FILE = '/data/users/nency/truth_discovery/CSTD_code_to_submit/cred_doc_causality_voting_results.csv'\n",
    "\n",
    "# Use the API Key structure you confirmed works\n",
    "BEDROCK_API_KEY = \"ABSKQmVkcm9ja0FQSUtleS16ZjlhLWF0LTM0NDQ0MzcyMzc5MjpyQlo3TEE5bVJITjUxZ2EyNmZBU2V6a2RlTHlmSW5jSXRKcjhCcDNaUUgyMVc5WWwyQVFqV003YXVLRT0=\"\n",
    "REGION_NAME = \"us-west-2\"\n",
    "\n",
    "# --- MODEL IDENTIFIERS (2026 Catalog) ---\n",
    "# Using standard patterns for the models you requested\n",
    "MODELS = {\n",
    "    \"Opus_4_5\": \"global.anthropic.claude-opus-4-5-20251101-v1:0\",   # Your provided ID\n",
    "    \"Sonnet_4_5\": \"global.anthropic.claude-sonnet-4-5-20250929-v1:0\", # Standard format for Sonnet 4.5\n",
    "    \"Opus_4\": \"us.anthropic.claude-opus-4-20250215-v1:0\"              # Standard format for Opus 4\n",
    "}\n",
    "\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between @DiseaseTgt and the @GeneSrc.\n",
    "Predict it causal if it is explicitly mentioned in the text. Do not use your pre-acquired knowledge. Associations are not causal relations. \n",
    "\n",
    "Respond ONLY with valid JSON in this exact format:\n",
    "{\n",
    "  \"relationship\": \"Causal\" or \"Not causal\",\n",
    "  \"score\": <float between 0.0 and 1.0 representing causal strength>\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "def invoke_model_requests(model_id, text):\n",
    "    \"\"\"\n",
    "    Invokes Bedrock using the 'requests' method you validated.\n",
    "    \"\"\"\n",
    "    url = f\"https://bedrock-runtime.{REGION_NAME}.amazonaws.com/model/{model_id}/invoke\"\n",
    "\n",
    "    headers = {\n",
    "        \"content-type\": \"application/json\",\n",
    "        \"accept\": \"application/json\",\n",
    "        \"Authorization\": f\"Bearer {BEDROCK_API_KEY}\" \n",
    "    }\n",
    "\n",
    "    # Prepare payload with System Prompt\n",
    "    user_message = {\n",
    "        \"role\": \"user\",\n",
    "        \"content\": text\n",
    "    }\n",
    "\n",
    "    # Note: 'system' parameter is supported in newer Anthropic Bedrock API versions\n",
    "    payload = {\n",
    "        \"anthropic_version\": \"bedrock-2023-05-31\",\n",
    "        \"max_tokens\": 1024,\n",
    "        \"system\": SYSTEM_PROMPT, \n",
    "        \"messages\": [user_message],\n",
    "        \"temperature\": 0.0 # Deterministic for reproducibility\n",
    "    }\n",
    "\n",
    "    try:\n",
    "        response = requests.post(url, headers=headers, json=payload, timeout=60)\n",
    "        \n",
    "        if response.status_code == 200:\n",
    "            response_body = response.json()\n",
    "            raw_text = response_body['content'][0]['text'].strip()\n",
    "            \n",
    "            # Sanitize JSON string (remove markdown wrappers if present)\n",
    "            clean_json = raw_text.replace(\"```json\", \"\").replace(\"```\", \"\").strip()\n",
    "            \n",
    "            data = json.loads(clean_json)\n",
    "            return data.get(\"relationship\"), float(data.get(\"score\", 0.0))\n",
    "            \n",
    "        else:\n",
    "            print(f\"Error {response.status_code} for {model_id}: {response.text}\")\n",
    "            return \"Error\", 0.0\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"Request Failed for {model_id}: {e}\")\n",
    "        return \"Error\", 0.0\n",
    "\n",
    "def process_voting(results_dict):\n",
    "    \"\"\"\n",
    "    Determines the winner based on majority vote and calculates average score of winners.\n",
    "    \"\"\"\n",
    "    votes = {\"Causal\": 0, \"Not causal\": 0}\n",
    "    scores = {\"Causal\": [], \"Not causal\": []}\n",
    "\n",
    "    # Tally votes\n",
    "    for model, (rel, score) in results_dict.items():\n",
    "        if rel in votes:\n",
    "            votes[rel] += 1\n",
    "            scores[rel].append(score)\n",
    "    \n",
    "    # Decide Winner\n",
    "    if votes[\"Causal\"] > votes[\"Not causal\"]:\n",
    "        final_decision = \"Causal\"\n",
    "    elif votes[\"Not causal\"] > votes[\"Causal\"]:\n",
    "        final_decision = \"Not causal\"\n",
    "    else:\n",
    "        # Tie (rare with 3 models unless errors occur)\n",
    "        final_decision = \"Ambiguous\"\n",
    "\n",
    "    # Average Score of the Winning Class ONLY\n",
    "    if final_decision in scores and scores[final_decision]:\n",
    "        final_prob = mean(scores[final_decision])\n",
    "    else:\n",
    "        final_prob = 0.0\n",
    "        \n",
    "    return final_decision, final_prob\n",
    "\n",
    "def main():\n",
    "    print(f\"--- Loading Data from {INPUT_FILE} ---\")\n",
    "    df = pd.read_csv(INPUT_FILE)\n",
    "\n",
    "    if 'sentence' not in df.columns:\n",
    "        raise ValueError(\"CSV must contain a 'sentence' column\")\n",
    "\n",
    "    results_list = []\n",
    "\n",
    "    print(f\"--- Processing {len(df)} rows with {list(MODELS.keys())} ---\")\n",
    "    \n",
    "    for index, row in tqdm(df.iterrows(), total=len(df)):\n",
    "        sentence = row['sentence']\n",
    "        \n",
    "        row_data = {\"sentence\": sentence}\n",
    "        model_predictions = {}\n",
    "\n",
    "        # 1. Query all 3 models\n",
    "        for model_name, model_id in MODELS.items():\n",
    "            pred, score = invoke_model_requests(model_id, sentence)\n",
    "            \n",
    "            row_data[f\"{model_name}_Prediction\"] = pred\n",
    "            row_data[f\"{model_name}_Score\"] = score\n",
    "            \n",
    "            if pred != \"Error\":\n",
    "                model_predictions[model_name] = (pred, score)\n",
    "\n",
    "        # 2. Perform Voting\n",
    "        if model_predictions:\n",
    "            final_pred, final_score = process_voting(model_predictions)\n",
    "        else:\n",
    "            final_pred, final_score = (\"Error\", 0.0)\n",
    "\n",
    "        row_data[\"Final_Consensus_Prediction\"] = final_pred\n",
    "        row_data[\"Final_Probability_Score\"] = round(final_score, 4)\n",
    "        \n",
    "        results_list.append(row_data)\n",
    "        \n",
    "        # Optional: slight delay to be gentle on the endpoint\n",
    "        # time.sleep(0.2) \n",
    "\n",
    "    # 3. Save Results\n",
    "    final_df = pd.DataFrame(results_list)\n",
    "    final_df.to_csv(OUTPUT_FILE, index=False)\n",
    "    print(f\"\\nCompleted! Saved to: {OUTPUT_FILE}\")\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "5a7f3376-8023-4a9e-b78a-78e0f5284cfc",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sending request to https://bedrock-runtime.us-west-2.amazonaws.com/model/global.anthropic.claude-opus-4-5-20251101-v1:0/invoke...\n",
      "Error 403: {\"message\":\"Model access is denied due to INVALID_PAYMENT_INSTRUMENT:A valid payment instrument must be provided.. Your AWS Marketplace subscription for this model cannot be completed at this time. If you recently fixed this issue, try again after 2 minutes.\"}\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "pd.read_csv('/data/users/nency/truth_discovery/CSTD_code_to_submit/cred doc casuality with preds.csv')\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between @DiseaseTgt and the @GeneSrc.\n",
    "Predict it causal if it is explicitly mentioned in the text. Do not use your pre-acquired knowledge. Associations are not causal relations. \n",
    "\n",
    "Respond ONLY with valid JSON in this exact format:\n",
    "{\n",
    "  \"relationship\": \"Causal\" or \"Not causal\",\n",
    "  \"score\": <float between 0 and 1>\n",
    "}\n",
    "\"\"\"\n",
    "import requests\n",
    "import json\n",
    "\n",
    "# --- CONFIGURATION ---\n",
    "BEDROCK_API_KEY = \"ABSKQmVkcm9ja0FQSUtleS16ZjlhLWF0LTM0NDQ0MzcyMzc5MjpyQlo3TEE5bVJITjUxZ2EyNmZBU2V6a2RlTHlmSW5jSXRKcjhCcDNaUUgyMVc5WWwyQVFqV003YXVLRT0=\"\n",
    "REGION_NAME = \"us-west-2\"\n",
    "MODEL_ID = \"global.anthropic.claude-opus-4-5-20251101-v1:0\"\n",
    "\n",
    "def invoke_opus_via_api_key():\n",
    "    # Construct the endpoint URL\n",
    "    url = f\"https://bedrock-runtime.{REGION_NAME}.amazonaws.com/model/{MODEL_ID}/invoke\"\n",
    "\n",
    "    headers = {\n",
    "        \"content-type\": \"application/json\",\n",
    "        \"accept\": \"application/json\",\n",
    "        # The specific header for Bedrock API Keys may vary by implementation type,\n",
    "        # but 'Authorization' or 'x-api-key' are standard. \n",
    "        # For Bedrock's specific API Key feature:\n",
    "        \"Authorization\": f\"Bearer {BEDROCK_API_KEY}\" \n",
    "    }\n",
    "\n",
    "    payload = {\n",
    "        \"anthropic_version\": \"bedrock-2023-05-31\",\n",
    "        \"max_tokens\": 1024,\n",
    "        \"messages\": [\n",
    "            {\n",
    "                \"role\": \"user\",\n",
    "                \"content\": \"Hello Opus 4.5, are you online?\"\n",
    "            }\n",
    "        ]\n",
    "    }\n",
    "\n",
    "    try:\n",
    "        print(f\"Sending request to {url}...\")\n",
    "        response = requests.post(url, headers=headers, json=payload)\n",
    "        \n",
    "        if response.status_code == 200:\n",
    "            response_body = response.json()\n",
    "            print(\"\\n--- Response ---\")\n",
    "            print(response_body['content'][0]['text'])\n",
    "        else:\n",
    "            print(f\"Error {response.status_code}: {response.text}\")\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"Request Failed: {e}\")\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    invoke_opus_via_api_key()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6199ddf7-be44-48b9-a6ac-27512f4380f3",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.read_csv( \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\",sep='\\t')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "f9bc772d-64a6-4024-bfdb-1d4da52555d6",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found ground truth label column: 'label'\n",
      "- Text: \"CBP binding transcriptional repressor produced PS1/epsilon-cleavage @ GeneSrc $ inhibited PS1 @ DiseaseTgt $ mutations . Presenilin1 ( PS1 ) , protein implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , forms complexes @ GeneSrc $ , transmembrane protein important neuronal synaptic functions . , show PS1-dependent gamma-secretase protease activity promotes epsilon-like cleavage @ GeneSrc $ produce intracellular domain peptide , @ GeneSrc $ . NMDA receptor agonists stimulate @ GeneSrc $ production suggesting receptor regulates epsilon-cleavage @ GeneSrc $ . @ GeneSrc $ binds transcription factor CBP promotes proteasomal degradation , inhibiting CRE-dependent transactivation . Thus , PS1-dependent epsilon-cleavage product @ GeneSrc $ functions potent repressor CBP/CREB-mediated transcription . Importantly , PS1 mutations associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) gamma-secretase dominant-negative mutation inhibit @ GeneSrc $ production upregulate CREB-mediated transcription indicating @ DiseaseTgt $ mutations cause gain transcriptional function inhibiting production transcriptional repressor @ GeneSrc $ . data raise possibility @ DiseaseTgt $ mutation-induced transcriptional abnormalities maybe causally related dementia associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9425102291380946)\n",
      "- Text: \"Mosaic overgrowth fibroadipose hyperplasia caused somatic activating mutations PIK3CA . phosphatidylinositol 3-kinase ( PI3K ) -AKT signaling pathway critical cellular growth metabolism . Correspondingly , loss function PTEN , negative regulator PI3 K , activating mutations AKT1 , AKT2 @ GeneSrc $ found distinct disorders featuring overgrowth hypoglycemia . performed exome sequencing DNA unaffected affected cells individual unclassified syndrome congenital progressive segmental overgrowth fibrous adipose tissue bone identified @ DiseaseTgt $ mutation encoding p. His1047Leu PIK3CA , gene encodes p110alpha catalytic subunit PI3 K , affected cells . Sequencing PIK3CA ten additional individuals overlapping syndromes identified either p. His1047Leu alteration second @ DiseaseTgt $ alteration , p. His1047Arg , nine cases . Affected dermal fibroblasts showed enhanced basal epidermal growth factor ( EGF ) -stimulated phosphatidylinositol 3,4,5-trisphosphate ( PIP ( 3 ) ) generation concomitant activation downstream signaling relative unaffected counterparts . findings characterize distinct overgrowth syndrome , biochemically demonstrate activation PI3 K signaling thereby identify rational therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0111907488023481)\n",
      "- Text: \"De novo somatic mutations components @ GeneSrc $ pathway cause hemimegalencephaly . De novo somatic mutations focal areas well documented diseases @ DiseaseTgt $ rarely reported malformation developing brain . Hemimegalencephaly ( HME ) characterized overgrowth either one two cerebral hemispheres . molecular etiology HME remains mystery . intractable epilepsy associated HME relieved surgical treatment hemispherectomy , allowing sampling diseased tissue . Exome sequencing mass spectrometry analysis paired brain-blood samples individuals HME ( n = 20 cases ) identified de novo somatic mutations 30 % affected individuals PIK3CA , @ GeneSrc $ MTOR genes . recurrent PIK3CA c.1633G > mutation found four separate cases . Identified mutations present 8 - 40 % sequenced alleles various brain regions associated increased neuronal S6 protein phosphorylation brains affected individuals , indicating aberrant activation mammalian target rapamycin ( mTOR ) signaling . Thus HME probably genetically mosaic disease caused gain function phosphatidylinositol 3-kinase @ GeneSrc $ signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0249537626785812)\n",
      "- Text: \"Akt activation localisation correlate @ DiseaseTgt $ invasion oncogene expression thyroid cancer . INTRODUCTION : Akt activation involved pathogenesis inherited thyroid cancer Cowden 's syndrome @ DiseaseTgt $ . cell culture , Akt regulates thyroid cell growth survival ; recent data suggest Akt also regulates cell motility non-thyroid cell lines . therefore sought evaluate role Akt thyroid cancer progression . METHODS : evaluated 46 thyroid cancer , 20 thyroid follicular adenoma , adjacent normal tissues samples immunohistochemistry activated Akt ( pAkt ) , Akt 1 , 2 , 3 , p27 expression . Immunoblots performed 14 samples . RESULTS : Akt activation identified 10/10 @ DiseaseTgt $ , 26/26 papillary cancers , 2/10 follicular variant papillary cancers , 4/66 normal tissue samples 2/10 typical benign follicular adenomas . Immunoactive pAkt greatest regions capsular invasion ; localised nucleus @ DiseaseTgt $ cytoplasm papillary cancers , except invasive regions papillary cancers localised compartments . Immunoactive Akt 1 , Akt 2 @ GeneSrc $ , correlated pAkt localisation , nuclear pAkt associated cytoplasmic expression p27 . vitro studies using human thyroid cancer cells demonstrated nuclear translocation Akt 1 pAkt associated cytoplasmic p27 cell invasion migration . Cell migration localisation Akt 1 , pAkt , p27 inhibited PI3 kinase , MEK inhibition . DISCUSSION : data suggest important role nuclear activation Akt 1 thyroid cancer progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008160928043103)\n",
      "- Text: \"MicroRNA-125b novel negative regulator p53 . p53 transcription factor key @ DiseaseTgt $ suppressor central regulator stress response . ensure robust precise response cellular signals , p53 gene expression must tightly regulated transcriptional post-translational levels . Computational predictions suggest several microRNAs involved post-transcriptional regulation p53 . demonstrate @ GeneSrc $ , brain-enriched microRNA , bona fide negative regulator p53 zebrafish humans . @ GeneSrc $ down-regulation p53 strictly dependent binding @ GeneSrc $ microRNA response element 3 ' untranslated region p53 mRNA . Overexpression @ GeneSrc $ represses endogenous level p53 protein suppresses apoptosis human neuroblastoma cells human lung fibroblast cells . contrast , knockdown @ GeneSrc $ elevates level p53 protein induces apoptosis human lung fibroblasts zebrafish brain . phenotype rescued significantly either ablation endogenous p53 function ectopic expression @ GeneSrc $ zebrafish . Interestingly , @ GeneSrc $ down-regulated zebrafish embryos treated gamma-irradiation camptothecin , corresponding rapid increase p53 protein response DNA damage . Ectopic expression @ GeneSrc $ suppresses increase p53 stress-induced apoptosis . Together , study demonstrates @ GeneSrc $ important negative regulator p53 p53-induced apoptosis development stress response .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001857187389627)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 @ GeneSrc $ family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha hMSH2 interacted ligand-dependent manner , whereas ER beta hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 hMSH3/hMSH6 interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded ER alpha , ER beta . results suggest hMSH2 may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.89636782663617e-06)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits Akt phosphatase PP2a well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired PP2a phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic @ GeneSrc $ cell cycle inhibitor p27 ( kip1 ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0222443241437077)\n",
      "- Text: \"Activation FoxO LRRK2 induces expression proapoptotic proteins alters survival postmitotic dopaminergic neuron Drosophila . Missense mutations leucine-rich repeat kinase 2 ( LRRK2 ) /Dardarin gene , product encodes kinase multiple domains , known cause autosomal dominant late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . current study , report gene product LRRK2 directly phosphorylates forkhead box transcription factor FoxO1 enhances transcriptional activity . pathway found conserved Drosophila , Drosophila LRRK2 homolog ( dLRRK ) enhanced neuronal toxicity FoxO . Importantly , FoxO mutants resistant LRRK2/dLRRK-induced phosphorylation suppressed neurotoxicity . Moreover , determined FoxO targets hid @ GeneSrc $ Drosophila human , respectively , responsible LRRK2/dLRRK-mediated cell death . data suggest cell death molecules regulated FoxO key factors neurodegeneration LRRK2-linked @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002106217769731)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( @ GeneSrc $ ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha hMSH2 interacted ligand-dependent manner , whereas ER beta hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 hMSH3/hMSH6 interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded ER alpha , ER beta . results suggest hMSH2 may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0014846753603501)\n",
      "- Text: \"Genome-wide association study identifies common variants four loci genetic risk factors @ DiseaseTgt $ . identify susceptibility variants @ DiseaseTgt $ ( @ DiseaseTgt $ ) , performed genome-wide association study ( GWAS ) two replication studies total 2,011 cases 18,381 controls Japan . identified new susceptibility locus 1q32 ( P = 1.52 x 10 ( -12 ) ) designated @ GeneSrc $ , also identified BST1 4p15 second new risk locus ( P = 3.94 x 10 ( -9 ) ) . also detected strong associations SNCA 4q22 ( P = 7.35 x 10 ( -17 ) ) LRRK2 12q12 ( P = 2.72 x 10 ( -8 ) ) , implicated autosomal dominant forms parkinsonism . comparing results GWAS performed individuals European ancestry , identified @ GeneSrc $ , SNCA LRRK2 shared risk loci @ DiseaseTgt $ BST1 MAPT loci showing population differences . results identify two new @ DiseaseTgt $ susceptibility loci , show involvement autosomal dominant parkinsonism loci typical @ DiseaseTgt $ suggest population differences contribute genetic heterogeneity @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0381281862805348)\n",
      "- Text: \"Genome-wide association study reveals genetic risk underlying @ DiseaseTgt $ . performed genome-wide association study ( GWAS ) 1,713 individuals European ancestry @ DiseaseTgt $ ( @ DiseaseTgt $ ) 3,978 controls . replication 3,361 cases 4,573 controls , observed two strong association signals , one gene encoding alpha-synuclein ( SNCA ; rs2736990 , = 1.23 , P = 2.24 x 10 ( -16 ) ) another MAPT locus ( rs393152 , = 0.77 , P = 1.95 x 10 ( -16 ) ) . exchanged data colleagues performing GWAS Japanese @ DiseaseTgt $ cases . Association @ DiseaseTgt $ SNCA replicated Japanese GWAS , confirming major risk locus across populations . replicated effect new locus detected Japanese cohort ( @ GeneSrc $ , rs823128 , = 0.66 , P = 7.29 x 10 ( -8 ) ) provide supporting evidence common variation around LRRK2 modulates risk @ DiseaseTgt $ ( rs1491923 , = 1.14 , P = 1.55 x 10 ( -5 ) ) . data demonstrate unequivocal role common genetic variants etiology typical @ DiseaseTgt $ suggest population-specific genetic heterogeneity disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.006797376398833)\n",
      "- Text: \"CRD-BP mediates stabilization @ GeneSrc $ c-myc mRNA response beta-catenin signalling . Although constitutive activation beta-catenin/Tcf signalling implicated development human cancers , mechanisms beta-catenin/Tcf pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show beta-catenin stabilizes mRNA encoding F-box protein @ GeneSrc $ , identify RNA-binding protein CRD-BP ( coding region determinant-binding protein ) previously unknown target beta-catenin/Tcf transcription factor . CRD-BP binds coding region @ GeneSrc $ mRNA . Overexpression CRD-BP stabilizes @ GeneSrc $ mRNA elevates @ GeneSrc $ levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein ( SCF ) ( betaTrCP ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB beta-catenin . CRD-BP essential induction @ GeneSrc $ c-Myc beta-catenin signalling @ DiseaseTgt $ cells . High levels CRD-BP found primary human @ DiseaseTgt $ exhibiting active beta-catenin/Tcf signalling implicates CRD-BP induction upregulation @ GeneSrc $ , activation dimeric transcription factor NF-kappaB suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0671405983003587)\n",
      "- Text: \"LRRK2 regulates mitochondrial dynamics function direct interaction @ GeneSrc $ . leucine-rich repeat kinase 2 ( LRRK2 ) mutations common cause autosomal-dominant Parkinson disease ( @ DiseaseTgt $ ) . Mitochondrial dysfunction represents critical event pathogenesis @ DiseaseTgt $ . demonstrated wild-type ( WT ) LRRK2 expression caused mitochondrial fragmentation along increased mitochondrial dynamin-like protein ( @ GeneSrc $ , also known @ GeneSrc $ ) , fission protein , exacerbated expression @ DiseaseTgt $ mutants ( R1441C G2019S ) SH-SY5Y differentiated primary cortical neurons . also found LRRK2 interacted @ GeneSrc $ , @ GeneSrc $ interaction enhanced @ DiseaseTgt $ mutations probably results increased mitochondrial @ GeneSrc $ levels . Co-expression dominant-negative @ GeneSrc $ K38A WT Mfn2 blocked LRRK2-induced mitochondrial fragmentation , mitochondrial dysfunction neuronal toxicity . Importantly , mitochondrial fragmentation dysfunction observed cells expressing either GTP-binding deficient mutant LRRK2 K1347A kinase-dead mutant D1994A minimal interaction @ GeneSrc $ increase mitochondrial @ GeneSrc $ level . concluded LRRK2 regulates mitochondrial dynamics increasing mitochondrial @ GeneSrc $ direct interaction @ GeneSrc $ , LRRK2 kinase activity plays critical role process .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1811151014083043)\n",
      "- Text: \"human long non-coding @ GeneSrc $ p53 repressor response DNA damage . well known upon stress , level @ DiseaseTgt $ suppressor p53 remarkably elevated . However , despite extensive studies , underlying mechanism involving important inter-players stress-induced p53 regulation still fully understood . present evidence human @ GeneSrc $ ( @ GeneSrc $ ) strong negative regulator p53 . Unlike MDM2 causes p53 degradation ubiquitin-proteasome pathway , @ GeneSrc $ suppresses p53 translation direct interaction heterogeneous nuclear ribonucleoprotein ( hnRNP ) . Importantly , 28-base @ GeneSrc $ sequence carrying hnRNP binding motifs essential sufficient p53 repression . show @ GeneSrc $ inhibits p53-mediated cell cycle arrest apoptosis . Finally , demonstrate @ GeneSrc $ autoregulatory feedback loop p53 transcriptionally induces @ GeneSrc $ expression . Together , results suggest @ GeneSrc $ I-p53 axis may constitute additional surveillance network cell better respond various stresses .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0229407586976771)\n",
      "- Text: \"Altered splicing @ GeneSrc $ causes X-linked parkinsonism spasticity ( @ GeneSrc $ ) . report novel gene @ DiseaseTgt $ . X-linked parkinsonism spasticity ( @ GeneSrc $ ) presents either typical adult onset @ DiseaseTgt $ earlier onset spasticity followed parkinsonism . previously mapped @ GeneSrc $ gene 28 Mb region Xp11.2-X13.3 . Exome sequencing one affected individual identified five rare variants region , none missense , nonsense frame shift . Using patient-derived cells , tested effect variants expression/splicing relevant genes . synonymous variant @ GeneSrc $ , c.345C > ( p. S115S ) , markedly increased exon 4 skipping , resulting overexpression minor splice isoform produces protein internal deletion 32 amino acids 50 % total pool , concomitant reduction isoforms containing exon 4 . @ GeneSrc $ essential accessory component vacuolar ATPase required lysosomal degradative functions autophagy , pathway frequently affected @ DiseaseTgt $ . Reduction full-size @ GeneSrc $ transcript @ GeneSrc $ cells decreased level @ GeneSrc $ protein @ GeneSrc $ brain may compromise V-ATPase function , seen siRNA knockdown HEK293 cells , may ultimately responsible pathology . Another synonymous mutation exon , c.321C > ( p. D107D ) , similar molecular defect exon inclusion causes X-linked mental retardation Hedera type ( @ GeneSrc $ ) . Mutations @ GeneSrc $ @ GeneSrc $ alter binding sites different splicing factors , may explain marked differences age onset manifestations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0268116647422735)\n",
      "- Text: \"PKB/Akt mediates cell-cycle progression phosphorylation p27 ( Kip1 ) threonine 157 modulation cellular localization . shown novel mechanism Akt-mediated regulation CDK inhibitor p27 ( kip1 ) . Blockade HER2/neu @ DiseaseTgt $ cells inhibits Akt kinase activity upregulates nuclear levels CDK inhibitor ( Kip1 ) . Recombinant Akt Akt precipitated @ DiseaseTgt $ cells phosphorylated wild-type p27 vitro . p27 contains Akt consensus RXRXXT ( 157 ) within nuclear localization motif . Active ( myristoylated ) Akt phosphorylated wild-type p27 vivo unable phosphorylate T157A-p27 mutant . Wild-type p27 localized cytosol nucleus , whereas T157A-p27 localized exclusively nucleus resistant nuclear exclusion Akt . T157A-p27 effective wild-type p27 inhibiting cyclin @ GeneSrc $ activity cell proliferation ; effects rescued active Akt . Expression Ser ( 473 ) phospho Akt primary human breast cancers statistically correlated expression p27 @ DiseaseTgt $ cytosol . data indicate Akt may contribute @ DiseaseTgt $ proliferation phosphorylation cytosolic retention p27 , thus relieving @ GeneSrc $ p27-induced inhibition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0033655276155587)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human colon cancers . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered colon cancers retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer @ DiseaseTgt $ . accumulation beta-catenin activates genes responsive transcription factors TCF/LEF family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF colon-cancer cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , @ GeneSrc $ . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001037124233566)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human @ DiseaseTgt $ . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered @ DiseaseTgt $ retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer gastric hepatocellular carcinomas . accumulation beta-catenin activates genes responsive transcription factors TCF/LEF family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF @ DiseaseTgt $ cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , @ GeneSrc $ . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0619819797123004)\n",
      "- Text: \"Investigation germline PTEN , p53 , p16 ( INK4A ) /p14 ( ARF ) , @ GeneSrc $ alterations familial glioma . Epidemiological studies suggest familial aggregations glioma may due inherited predisposition . Many genes involved @ DiseaseTgt $ frequently altered corresponding sporadic forms . investigated several genes known altered sporadic gliomas potential contribution familial glioma . Fifteen glioma patients family history brain tumors identified Mayo Clinic Department Neurology ( nine diffuse astrocytomas , two oligodendrogliomas , two mixed oligoastrocytomas , one pilocytic astrocytoma , one pineal glioma ) . Eleven propositi one first degree relative glioma . Lymphocyte DNA derived patients analyzed polymerase chain reaction ( PCR ) direct sequencing PTEN , p53 , p16 ( INK4A ) /p14 ( ARF ) , @ GeneSrc $ genes . addition , fluorescence situ hybridization ( FISH ) performed EBV-transformed lymphocytes affected individual detect germline copy number p16 ( INK4A ) /p14 ( ARF ) @ DiseaseTgt $ suppressor region . p53 germline point mutation identified one family findings Li-Fraumeni syndrome , hemizygous germline deletion p16 ( INK4A ) /p14 ( ARF ) @ DiseaseTgt $ suppressor region demonstrated FISH family history astrocytoma melanoma . Thus , whereas germ-line mutations PTEN , p53 , p16 ( INK4A ) /p14 ( ARF ) , @ GeneSrc $ common events familial glioma , outside @ DiseaseTgt $ , point mutations p53 hemizygous deletions rearrangements p16 ( INK4A ) /p14 ( ARF ) @ DiseaseTgt $ suppressor region may account subset familial glioma cases . Collectively , data lend genetic support heritable nature cases glioma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.173037567777251)\n",
      "- Text: \"Interfering apoptosis : Ca ( 2+ ) -binding protein ALG-2 @ DiseaseTgt $ gene @ GeneSrc $ . Two apoptosis-linked genes , named ALG-2 @ GeneSrc $ , identified means functional selection strategy . ALG-2 codes Ca ( 2+ ) -binding protein required cell receptor- , Fas- , glucocorticoid-induced cell death . @ GeneSrc $ , partial complementary DNA homologous familial @ DiseaseTgt $ gene STM2 , rescues cell hybridoma cell receptor- Fas-induced apoptosis . findings suggest ALG-2 may mediate Ca ( 2+ ) -regulated signals along death pathway cell death may play role @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3715409194007989)\n",
      "- Text: \"Low cholesterol stimulates nonamyloidogenic pathway effect alpha -secretase @ GeneSrc $ . Biochemical , epidemiological , genetic findings demonstrate link cholesterol levels , processing amyloid precursor protein ( APP ) , @ DiseaseTgt $ . present report , identify alpha-secretase @ GeneSrc $ ( disintegrin metalloprotease ) major target cholesterol effects APP metabolism . Treatment various peripheral neural cell lines either cholesterol-extracting agent methyl-beta-cyclodextrin hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin resulted drastic increase secreted alpha-secretase cleaved soluble APP . strong stimulatory effect range obtained phorbol esters increased cells overexpressing @ GeneSrc $ . cells overexpressing APP , increase alpha-secretase activity resulted decreased secretion Abeta peptides . Several mechanisms elucidated basis enhanced alpha-secretase activity : increased membrane fluidity impaired internalization APP responsible effect observed methyl-beta-cyclodextrin ; treatment lovastatin resulted higher expression alpha-secretase @ GeneSrc $ . results demonstrate cholesterol reduction promotes nonamyloidogenic alpha-secretase pathway formation neuroprotective alpha-secretase cleaved soluble APP several mechanisms suggest approaches prevention therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3081300807344253)\n",
      "- Text: \"Putative function ADAM9 , @ GeneSrc $ , ADAM17 APP alpha-secretase . putative alpha-secretase cleaves amyloid precursor protein ( APP ) @ DiseaseTgt $ middle amyloid beta peptide ( Abeta ) domain . generally thought alpha-secretase pathway mitigates Abeta formation normal brain . Several studies suggested ADAM9 , @ GeneSrc $ , ADAM17 candidate alpha-secretases belonging ADAM ( disintegrin metalloprotease ) family , membrane-anchored cell surface proteins . comparative study ADAM9 , @ GeneSrc $ , ADAM17 , examined physiological role ADAMs expressing ADAMs COS-7 cells , `` constitutive `` `` regulated `` alpha-secretase activities ADAMs determined . tried suppress expression ADAMs human glioblastoma A172 cells , contain large amounts endogenous alpha-secretase , lipofection double-stranded RNA ( dsRNA ) encoding ADAMs . results indicate ADAM9 , @ GeneSrc $ , ADAM17 catalyze alpha-secretory cleavage therefore act alpha-secretases A172 cells . first report suggest endogenous alpha-secretase composed several ADAM enzymes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001287359085377)\n",
      "- Text: \"Combined kinase inhibition modulates parkin inactivation . Mutations parkin gene cause autosomal-recessive , juvenile-onset parkinsonism , parkin dysfunction may also play role pathogenesis sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although precise function remains largely unknown , parkin seems play neuroprotective role . Several studies indicate changes parkin solubility induced post-translational modifications , S-nitrosylation dopamine modification , comprise one mechanism parkin inactivation associated disease . Protein phosphorylation events recently linked molecular mechanism ( ) underlying @ DiseaseTgt $ , role post-translational modification parkin function remained unclear . report compound phosphorylation parkin casein kinase @ GeneSrc $ ( @ GeneSrc $ ) decreases parkin solubility , leading aggregation inactivation . Combined kinase inhibition partially reverses aggregative properties several pathogenic point mutants cultured cells . Enhanced parkin phosphorylation detected distinct brain areas individuals sporadic @ DiseaseTgt $ correlates increases levels p25 , activator @ GeneSrc $ . findings indicate casein kinase @ GeneSrc $ may represent novel combinatorial therapeutic targets treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.24845998701717)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ oncogene regulates beta-catenin activity . Aberrant activation canonical WNT/beta-catenin pathway occurs almost @ DiseaseTgt $ contributes growth , invasion survival . Although dysregulated beta-catenin activity drives colon tumorigenesis , genetic perturbations required elaborate full malignant transformation . identify genes modulate beta-catenin activity essential @ DiseaseTgt $ cell proliferation , conducted two loss-of-function screens human @ DiseaseTgt $ cells compared genes identified screens analysis copy number alterations @ DiseaseTgt $ specimens . One genes , @ GeneSrc $ , encodes member mediator complex , located 13q12.13 , region recurrent copy number gain substantial fraction @ DiseaseTgt $ . show suppression @ GeneSrc $ expression inhibits proliferation @ DiseaseTgt $ cells characterized high levels @ GeneSrc $ beta-catenin hyperactivity . @ GeneSrc $ kinase activity necessary beta-catenin-driven transformation expression several beta-catenin transcriptional targets . Together observations suggest therapeutic interventions targeting @ GeneSrc $ may confer clinical benefit beta-catenin-driven malignancies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0206409166756172)\n",
      "- Text: \"E2F1 represses beta-catenin transcription antagonized pRB @ GeneSrc $ . E2F1 transcription factor promote proliferation apoptosis activated , key downstream target retinoblastoma tumour suppressor protein ( pRB ) . show E2F1 potent specific inhibitor beta-catenin/T-cell factor ( TCF ) -dependent transcription , function contributes E2F1-induced apoptosis . E2F1 deregulation suppresses beta-catenin activity adenomatous polyposis coli ( APC ) /glycogen synthase kinase-3 ( GSK3 ) -independent manner , reducing expression key beta-catenin targets including c-MYC . interaction explains @ DiseaseTgt $ , depend beta-catenin transcription abnormal proliferation , keep RB1 intact . Remarkably , E2F1 activity also repressed @ GeneSrc $ ( @ GeneSrc $ ) , colorectal oncoprotein . Elevated levels @ GeneSrc $ protect beta-catenin/TCF-dependent transcription inhibition E2F1 . Thus , retaining RB1 amplifying @ GeneSrc $ , @ DiseaseTgt $ cells select conditions collectively suppress E2F1 enhance activity beta-catenin .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0840537844753773)\n",
      "- Text: \"@ GeneSrc $ , potential mediator p53 @ DiseaseTgt $ suppression . ability p53 activate transcription specific sequences suggests genes induced p53 may mediate biological role @ DiseaseTgt $ suppressor . Using subtractive hybridization approach , identified gene , named @ GeneSrc $ , whose induction associated wild-type mutant p53 gene expression human brain tumor cell line . @ GeneSrc $ gene localized chromosome 6p21.2 , sequence , structure , activation p53 conserved rodents . Introduction @ GeneSrc $ cDNA suppressed growth human brain , lung , colon tumor cells culture . Using yeast enhancer trap , p53-binding site identified 2.4 kb upstream @ GeneSrc $ coding sequences . @ GeneSrc $ promoter , including p53-binding site , conferred p53-dependent inducibility upon heterologous reporter gene . studies define gene whose expression directly induced p53 could important mediator p53-dependent @ DiseaseTgt $ growth suppression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5187635533423897)\n",
      "- Text: \"CKIalpha ablation highlights critical role p53 invasiveness control . mature gut renews continuously rapidly throughout adult life , often damage-inflicting micro-environment . major driving force self-renewal intestinal epithelium Wnt-mediated signalling pathway , Wnt signalling frequently hyperactivated colorectal cancer . show casein kinase Ialpha ( CKIalpha ) , component beta-catenin-destruction complex , critical regulator Wnt signalling pathway . Inducing ablation Csnk1a1 ( gene encoding CKIalpha ) gut triggers massive Wnt activation , surprisingly without causing tumorigenesis . CKIalpha-deficient epithelium shows many features human colorectal tumours addition Wnt activation , particular induction DNA damage response cellular senescence , thought provide barrier malignant transformation . epithelial DNA damage response mice accompanied substantial activation p53 , suggesting p53 pathway may counteract pro-tumorigenic effects Wnt hyperactivation . Notably , transition benign adenomas invasive colorectal cancer humans typically linked p53 inactivation , underscoring importance p53 safeguard malignant progression ; however , mechanism p53-mediated @ DiseaseTgt $ suppression unknown . show maintenance intestinal homeostasis CKIalpha-deficient gut requires p53-mediated growth control , combined ablation Csnk1a1 either p53 target gene @ GeneSrc $ ( also known @ GeneSrc $ , @ GeneSrc $ , @ GeneSrc $ @ GeneSrc $ ) triggered high-grade dysplasia extensive proliferation . Unexpectedly , ablations also induced non-proliferating cells invade villous lamina propria rapidly , producing invasive @ DiseaseTgt $ throughout small bowel . Furthermore , p53-deficient gut , loss heterozygosity gene encoding CKIalpha caused highly invasive carcinoma , indicating CKIalpha functions @ DiseaseTgt $ suppressor p53 inactivated . identified set genes ( p53-suppressed invasiveness signature , PSIS ) activated loss p53 CKIalpha probably accounts brisk induction invasiveness . PSIS transcription tumour invasion suppressed @ GeneSrc $ , independently cell cycle control . Restraining tissue invasion suppressing PSIS expression thus novel @ DiseaseTgt $ function wild-type p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0135953162632732)\n",
      "- Text: \"Serine starvation induces stress p53-dependent metabolic remodelling @ DiseaseTgt $ cells . @ DiseaseTgt $ cells acquire distinct metabolic adaptations survive stress associated @ DiseaseTgt $ growth satisfy anabolic demands proliferation . @ DiseaseTgt $ suppressor protein p53 ( also known TP53 ) influences range cellular metabolic processes , including glycolysis , oxidative phosphorylation , glutaminolysis anti-oxidant response . contrast role promoting apoptosis DNA-damaging stress , p53 promote cell survival metabolic stress , function may contribute @ DiseaseTgt $ suppression also @ DiseaseTgt $ functions p53 . show human @ DiseaseTgt $ cells rapidly use exogenous serine serine deprivation triggered activation serine synthesis pathway rapidly suppressed aerobic glycolysis , resulting increased flux tricarboxylic acid cycle . Transient @ GeneSrc $ ( also known @ GeneSrc $ ) activation cell-cycle arrest promoted cell survival efficiently channelling depleted serine stores glutathione synthesis , thus preserving cellular anti-oxidant capacity . Cells lacking p53 failed complete response serine depletion , resulting oxidative stress , reduced viability severely impaired proliferation . role p53 supporting @ DiseaseTgt $ cell proliferation serine starvation translated vivo model , indicating serine depletion potential role treatment p53-deficient @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6214352653421961)\n",
      "- Text: \"model p53-induced apoptosis . inactivation p53 gene large proportion human @ DiseaseTgt $ inspired intense search encoded protein 's physiological biological properties . Expression p53 induces either stable growth arrest programmed cell death ( apoptosis ) . human colorectal cancers , growth arrest dependent transcriptional induction protein @ GeneSrc $ , mechanisms underlying development p53-dependent apoptosis largely unknown . well documented biochemical property p53 ability activate transcription genes , examined detail transcripts induced p53 expression onset apoptosis . 7,202 transcripts identified , 14 ( 0.19 % ) found markedly increased p53-expressing cells compared control cells . Strikingly , many genes predicted encode proteins could generate respond oxidative stress , including one implicated apoptosis plant meristems . observations stimulated additional biochemical pharmacological experiments suggesting p53 results apoptosis three-step process : ( 1 ) transcriptional induction redox-related genes ; ( 2 ) formation reactive oxygen species ; ( 3 ) oxidative degradation mitochondrial components , culminating cell death .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.9165142953663247e-05)\n",
      "- Text: \"Myc suppression @ GeneSrc $ ) Cdk inhibitor influences outcome p53 response DNA damage . Activation @ DiseaseTgt $ suppressor p53 DNA damage induces either cell cycle arrest apoptotic cell death . cytostatic effect p53 mediated transcriptional activation cyclin-dependent kinase ( CDK ) inhibitor @ GeneSrc $ ) , whereas apoptotic effect mediated transcriptional activation mediators including PUMA PIG3 ( ref . 2 ) . determines choice cytostasis apoptosis clear . show transcription factor Myc principal determinant choice . Myc directly recruited @ GeneSrc $ ) promoter DNA-binding protein Miz-1 . interaction blocks @ GeneSrc $ ) induction p53 activators . result Myc switches , cytostatic apoptotic , p53-dependent response colon cancer cells DNA damage . Myc modify ability p53 bind @ GeneSrc $ ) PUMA promoters , selectively inhibits bound p53 activating @ GeneSrc $ ) transcription . inhibiting @ GeneSrc $ ) expression Myc favours initiation apoptosis , thereby influencing outcome p53 response favour cell death .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0447076665628607)\n",
      "- Text: \"DREAM RB cooperate induce gene repression cell-cycle arrest response p53 activation . human @ DiseaseTgt $ acquire mutations causing defects p53 signaling pathway . @ DiseaseTgt $ suppressor p53 becomes activated response genotoxic stress essential arresting cell cycle facilitate DNA repair initiate apoptosis . p53-induced cell cycle-arrest mediated expression CDK inhibitor @ GeneSrc $ , prevents phosphorylation inactivation pocket proteins RB , p130 , p107 . hypophosphorylated state , pocket proteins bind E2F factors forming RB-E2F DREAM transcriptional repressor complexes . , analyze influence RB DREAM p53-induced gene repression cell-cycle arrest . show abrogation DREAM function knockout DREAM component LIN37 results reduced repression cell-cycle genes . identify genes repressed p53-DREAM pathway describe set genes downregulated p53 independent LIN37/DREAM . strikingly , p53-dependent repression cell-cycle genes completely abrogated LIN37-/- ; RB-/- cells leading loss G1/S checkpoint . Taken together , show DREAM RB key factors p53 signaling pathway downregulate large number cell-cycle genes arrest cell cycle G1/S transition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0373078273199538)\n",
      "- Text: \"Wip1 , novel human protein phosphatase induced response ionizing radiation p53-dependent manner . Exposure mammalian cells ionizing radiation ( IR ) induces complex array cellular responses including cell cycle arrest and/or apoptosis . IR-induced G1 arrest shown depend presence @ DiseaseTgt $ suppressor p53 , acts transcriptional activator several genes . p53 also plays role induction apoptosis response DNA damage , pathway activated transcription-dependent -independent mechanisms . report identification novel transcript whose expression induced response IR p53-dependent manner , shows homology type 2C protein phosphatases . named novel gene , wip1 . vitro , recombinant Wip1 displayed characteristics type 2C phosphatase , including Mg2 + dependence relative insensitivity okadaic acid . Studies performed several cell lines revealed wip1 accumulation following IR correlates presence wild-type p53 . accumulation wip1 mRNA following IR rapid transient , protein localized nucleus . Similar @ GeneSrc $ , ectopic expression wip1 human cells suppressed colony formation . results suggest Wip1 might contribute growth inhibitory pathways activated response DNA damage p53-dependent manner .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.1589350983066095e-06)\n",
      "- Text: \"beta-catenin/TCF-4 complex imposes crypt progenitor phenotype @ DiseaseTgt $ cells . transactivation TCF target genes induced Wnt pathway mutations constitutes primary transforming event @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show disruption beta-catenin/TCF-4 activity @ DiseaseTgt $ cells induces rapid G1 arrest blocks genetic program physiologically active proliferative compartment colon crypts . Coincidently , intestinal differentiation program induced . TCF-4 target gene c-MYC plays central role switch direct repression @ GeneSrc $ ) promoter . Following disruption beta-catenin/TCF-4 activity , decreased expression c-MYC releases @ GeneSrc $ ) transcription , turn mediates G1 arrest differentiation . Thus , beta-catenin/TCF-4 complex constitutes master switch controls proliferation versus differentiation healthy malignant intestinal epithelial cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1000182742508521)\n",
      "- Text: \"Somatic KRAS mutations associated human nonmalignant syndrome autoimmunity abnormal leukocyte homeostasis . Somatic gain-of-function mutations members RAS subfamily small guanosine triphosphatases found > 30 % human @ DiseaseTgt $ . recently described syndrome chronic nonmalignant lymphadenopathy , splenomegaly , autoimmunity associated mutation NRAS affecting hematopoietic cells , initially classified disease variant autoimmune lymphoproliferative syndrome . , demonstrate somatic mutations related KRAS gene also associated nonmalignant syndrome autoimmunity breakdown leukocyte homeostasis . activating KRAS mutation impaired cytokine withdrawal-induced T-cell apoptosis suppression proapoptotic protein BCL-2 interacting mediator cell death facilitated proliferation @ GeneSrc $ ) down-regulation . defects could corrected vitro mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 phosphatidyl inositol-3 kinase inhibition . suggest use term RAS-associated autoimmune leukoproliferative disease differentiate disorder autoimmune lymphoproliferative syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004962760486473)\n",
      "- Text: \"PKB/Akt mediates cell-cycle progression phosphorylation @ GeneSrc $ ) threonine 157 modulation cellular localization . shown novel mechanism Akt-mediated regulation CDK inhibitor @ GeneSrc $ ) . Blockade HER2/neu @ DiseaseTgt $ cells inhibits Akt kinase activity upregulates nuclear levels CDK inhibitor ( @ GeneSrc $ ) . Recombinant Akt Akt precipitated @ DiseaseTgt $ cells phosphorylated wild-type p27 vitro . p27 contains Akt consensus RXRXXT ( 157 ) within nuclear localization motif . Active ( myristoylated ) Akt phosphorylated wild-type p27 vivo unable phosphorylate T157A-p27 mutant . Wild-type p27 localized cytosol nucleus , whereas T157A-p27 localized exclusively nucleus resistant nuclear exclusion Akt . T157A-p27 effective wild-type p27 inhibiting cyclin E/CDK2 activity cell proliferation ; effects rescued active Akt . Expression Ser ( 473 ) phospho Akt primary human breast cancers statistically correlated expression p27 @ DiseaseTgt $ cytosol . data indicate Akt may contribute @ DiseaseTgt $ proliferation phosphorylation cytosolic retention p27 , thus relieving CDK2 p27-induced inhibition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2557319401205192)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits Akt phosphatase PP2a well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired PP2a phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor @ GeneSrc $ ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1124054002179531)\n",
      "- Text: \"Cytoplasmic relocalization inhibition cyclin-dependent kinase inhibitor @ GeneSrc $ PKB/Akt-mediated phosphorylation breast cancer . cyclin-dependent kinase inhibitor @ GeneSrc $ putative @ DiseaseTgt $ suppressor human @ DiseaseTgt $ . mechanism underlying @ GeneSrc $ deregulation human @ DiseaseTgt $ , however , poorly understood . demonstrate serine/threonine kinase Akt regulates cell proliferation breast cancer cells preventing @ GeneSrc $ growth arrest . Threonine 157 ( T157 ) , maps within nuclear localization signal @ GeneSrc $ , predicted Akt-phosphorylation site . Akt-induced T157 phosphorylation causes retention @ GeneSrc $ cytoplasm , precluding @ GeneSrc $ G1 arrest . Conversely , @ GeneSrc $ mutant accumulates cell nuclei Akt affect @ GeneSrc $ cell cycle arrest . Lastly , T157-phosphorylated @ GeneSrc $ accumulates cytoplasm primary human breast cancer cells coincident Akt activation . Thus , cytoplasmic relocalization @ GeneSrc $ , secondary Akt-mediated phosphorylation , novel mechanism whereby growth inhibitory properties @ GeneSrc $ functionally inactivated proliferation breast cancer cells sustained .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0399410409208872)\n",
      "- Text: \"@ GeneSrc $ promotes Hdm2-mediated degradation @ DiseaseTgt $ suppressor p53 . TP53 gene ( encoding p53 @ DiseaseTgt $ suppressor ) rarely mutated , although frequently inactivated , medulloblastoma ependymoma . Recent work mouse models showed loss p53 accelerated development medulloblastoma . mechanism underlying p53 inactivation human brain tumors completely understood . show ubiquitination factor E4B ( @ GeneSrc $ ) , E3 E4 ubiquitin ligase , physically interacts p53 Hdm2 ( also known Mdm2 mice ) . @ GeneSrc $ promotes p53 polyubiquitination degradation inhibits p53-dependent transactivation apoptosis . Notably , silencing @ GeneSrc $ expression impairs xenotransplanted @ DiseaseTgt $ growth p53-dependent manner overexpression @ GeneSrc $ correlates decreased expression p53 @ DiseaseTgt $ . also show @ GeneSrc $ overexpression often associated amplification gene human brain tumors . data indicate amplification overexpression @ GeneSrc $ represent previously undescribed molecular mechanisms inactivation p53 brain tumors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8381927093070576)\n",
      "- Text: \"Transcriptional map 170-kb region chromosome 11p15.5 : identification mutational analysis BWR1A gene reveals presence mutations @ DiseaseTgt $ samples . Chromosome region 11p15.5 harbors unidentified genes involved @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome . genetic analysis 170-kb region 11p15.5 loci D11S601 D11S679 resulted identification six transcriptional units . Three genes , hNAP2 , @ GeneSrc $ , KVLQT1 , well characterized , whereas three genes novel . three additional genes designated BWR1A , BWR1B , BWR1C . Full-length cDNAs three genes cloned nucleotide sequences determined . work progress , BWR1C cDNA described IPL [ Qian , N. , Franck , D. , O'Keefe , D. , Dao , D. , Zhao , L. , Yuan , L. , Wang , Q. , Keating , M. , Walsh , C. & Tycko , B . ( 1997 ) Hum . Mol . Genet . 6 , 2021 - 2029 ] . cloning mapping genes together fine mapping three known genes indicates transcriptional map region likely complete . region frequently altered @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome , carried mutational analysis @ DiseaseTgt $ cell lines Beckwith-Wiedemann syndrome samples resulted identification genetic alterations BWR1A gene : insertion introduced stop codon breast cancer cell line BT549 point mutation rhabdomyosarcoma cell line TE125-T . results indicate BWR1A may play role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.3023671748779206e-05)\n",
      "- Text: \"Somatic mutation TSSC5 , novel imprinted gene human chromosome 11p15.5 . previously reported isolation 2.5 Mb @ DiseaseTgt $ subchromosomal transferable fragment ( STF ) 11p15.5 identification nine known genes four novel genes within STF . report isolation fifth novel cDNA , tumor-suppressing STF cDNA 5 , designated TSSC5 , located within STF . TSSC5 encodes predicted protein 424 amino acids . Sequence analysis suggests TSSC5 membrane protein 10 transmembrane segments , located two imprinted genes , @ GeneSrc $ TSSC3 . Northern blot hybridization revealed 1.6-kb transcript multiple adult tissues fetal liver kidney , consistent potential role embryonal tumors . also found TSSC5 imprinted preferential expression maternal chromosome . Reverse transcription-PCR analysis TSSC5 revealed frequent occurrence aberrant RNA splicing , deleted exons 4 , 5 , 6 Wilms ' tumors . Mutational analysis TSSC5 direct DNA sequencing exons revealed base substitution G1120A Wilms ' tumor , matched normal kidney , patient 's mother , changed Arg codon 309 Gln . G1120A substitution thus represents either rare polymorphism @ DiseaseTgt $ mutation , mutant allele maternal origin preferentially expressed patient 's tissue . second base substitution , C892 , found lung cancer , changing Ser codon 233 Phe . substitution absent matched normal tissue thus represented somatic mutation . also found loss heterozygosity lung cancer , suggesting TSSC5 may conventional @ DiseaseTgt $ suppressor gene adult human lung imprinted @ DiseaseTgt $ suppressor gene fetal kidney .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.17806478345141)\n",
      "- Text: \"Hereditary TP53 codon 292 somatic P16INK4A codon 94 mutations Li-Fraumeni syndrome family . Li-Fraumeni syndrome autosomal dominant disorder characterized various types @ DiseaseTgt $ childhood adult cases . Although hereditary TP53 mutation rare different human @ DiseaseTgt $ , frequently reported Li-Fraumeni syndrome . hand , hereditary mutations TP57KIP2 , P15INK4B , P16INK4A , affect cell cycle similar TP53 , observed types @ DiseaseTgt $ . Turkish family diagnosis Li-Fraumeni syndrome , analyzed mutation pattern TP53 , @ GeneSrc $ , P15INK4B , P16INK4A peripheral blood , loss heterozygosity ( homo/hemizygous deletion ) pattern TP53 P15INK4B/P16INK4A two @ DiseaseTgt $ tissues . propositus seminoma , daughter medulloblastoma , one healthy cousins , TP53 codon 292 missense point mutation ( AAA -- > ATA ; Lys -- > Ile ) peripheral blood cells . @ DiseaseTgt $ tissue obtained propositus seminoma revealed loss heterozygosity TP53 gene . analyses @ DiseaseTgt $ tissues propositus daughter , P16INK4A codon 94 missense point mutation ( GCG -- > GAG ; Ala -- > Glu ) observed hereditary TP53 mutation . P16INK4A codon 94 mutation observed family novel mutation Li-Fraumeni syndrome . gene alteration TP53 , @ GeneSrc $ , P15INK4B , P16INK4A observed . Existence P16INK4A mutation hereditary TP53 mutation without loss heterozygosity TP53 gene ( seminoma/medulloblastoma ) may evidence common mechanism involved tumorogenesis . gene alterations TP53 P16INK4A genes may used @ DiseaseTgt $ markers family .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0037024043522978)\n",
      "- Text: \"Integrative clinical genomics @ DiseaseTgt $ . Metastasis primary cause @ DiseaseTgt $ deaths . Although @ DiseaseTgt $ Genome Atlas sequenced primary @ DiseaseTgt $ types obtained surgical resections , much less comprehensive molecular analysis available clinically acquired @ DiseaseTgt $ . perform whole-exome -transcriptome sequencing 500 adult patients metastatic @ DiseaseTgt $ diverse lineage biopsy site . prevalent genes somatically altered @ DiseaseTgt $ included TP53 , @ GeneSrc $ , PTEN , PIK3CA , RB1 . Putative pathogenic germline variants present 12.2 % cases 75 % related defects DNA repair . RNA sequencing complemented DNA sequencing identify gene fusions , pathway activation , immune profiling . results show integrative sequence analysis provides clinically relevant , multi-dimensional view complex molecular landscape microenvironment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0503664044028772)\n",
      "- Text: \"Altered expression Rb p53 uveal melanomas following plaque radiotherapy . PURPOSE : examine expression proteins Rb p53 @ DiseaseTgt $ suppressor pathways uveal melanomas following plaque radiotherapy . METHODS : Immunohistochemistry cell culture studies . Immunohistochemistry Rb , @ GeneSrc $ , cyclin D1 , p53 , HDM2 , Bcl-2 performed twelve eyes containing posterior uveal melanomas enucleated following plaque radiotherapy . Cell culture studies performed three cases . RESULTS : irradiated eyes enucleated radiation complications ( five cases ) , local @ DiseaseTgt $ recurrence ( three cases ) , reasons ( four cases ) . histopathologic examination , cases showed evidence @ DiseaseTgt $ cell loss . However , residual @ DiseaseTgt $ cells present cases , including clinically regressed . Residual cells three clinically regressed cases cultured demonstrated minimal cell division , marked cell death , extensive chromosomal damage . Strong p53 staining observed six cases ( 50 % ) significantly associated recent radiotherapy ( P = .04 ) . Abnormal cytoplasmic staining Rb observed four cases ( 33 % ) . CONCLUSIONS : Plaque radiotherapy uveal melanomas induces DNA damage , inhibits cell division , promotes cell death . changes may due , least part , induction p53 , activates genes involved cell cycle arrest apoptosis . Plaque radiotherapy also cause alterations expression Rb , significance finding require study .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0472352055572006)\n",
      "- Text: \"Hereditary TP53 codon 292 somatic @ GeneSrc $ codon 94 mutations Li-Fraumeni syndrome family . Li-Fraumeni syndrome autosomal dominant disorder characterized various types @ DiseaseTgt $ childhood adult cases . Although hereditary TP53 mutation rare different human @ DiseaseTgt $ , frequently reported Li-Fraumeni syndrome . hand , hereditary mutations TP57KIP2 , P15INK4B , @ GeneSrc $ , affect cell cycle similar TP53 , observed types @ DiseaseTgt $ . Turkish family diagnosis Li-Fraumeni syndrome , analyzed mutation pattern TP53 , P57KIP2 , P15INK4B , @ GeneSrc $ peripheral blood , loss heterozygosity ( homo/hemizygous deletion ) pattern TP53 @ GeneSrc $ two @ DiseaseTgt $ tissues . propositus seminoma , daughter medulloblastoma , one healthy cousins , TP53 codon 292 missense point mutation ( AAA -- > ATA ; Lys -- > Ile ) peripheral blood cells . @ DiseaseTgt $ tissue obtained propositus seminoma revealed loss heterozygosity TP53 gene . analyses @ DiseaseTgt $ tissues propositus daughter , @ GeneSrc $ codon 94 missense point mutation ( GCG -- > GAG ; Ala -- > Glu ) observed hereditary TP53 mutation . @ GeneSrc $ codon 94 mutation observed family novel mutation Li-Fraumeni syndrome . gene alteration TP53 , P57KIP2 , P15INK4B , @ GeneSrc $ observed . Existence @ GeneSrc $ mutation hereditary TP53 mutation without loss heterozygosity TP53 gene ( seminoma/medulloblastoma ) may evidence common mechanism involved tumorogenesis . gene alterations TP53 @ GeneSrc $ genes may used @ DiseaseTgt $ markers family .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.016361127408767)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , @ GeneSrc $ ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , @ GeneSrc $ important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007236510378664)\n",
      "- Text: \"Investigation germline PTEN , p53 , @ GeneSrc $ ) , CDK4 alterations familial glioma . Epidemiological studies suggest familial aggregations glioma may due inherited predisposition . Many genes involved @ DiseaseTgt $ frequently altered corresponding sporadic forms . investigated several genes known altered sporadic gliomas potential contribution familial glioma . Fifteen glioma patients family history brain tumors identified Mayo Clinic Department Neurology ( nine diffuse astrocytomas , two oligodendrogliomas , two mixed oligoastrocytomas , one pilocytic astrocytoma , one pineal glioma ) . Eleven propositi one first degree relative glioma . Lymphocyte DNA derived patients analyzed polymerase chain reaction ( PCR ) direct sequencing PTEN , p53 , @ GeneSrc $ ) , CDK4 genes . addition , fluorescence situ hybridization ( FISH ) performed EBV-transformed lymphocytes affected individual detect germline copy number @ GeneSrc $ ) @ DiseaseTgt $ suppressor region . p53 germline point mutation identified one family findings Li-Fraumeni syndrome , hemizygous germline deletion @ GeneSrc $ ) @ DiseaseTgt $ suppressor region demonstrated FISH family history astrocytoma melanoma . Thus , whereas germ-line mutations PTEN , p53 , @ GeneSrc $ ) , CDK4 common events familial glioma , outside @ DiseaseTgt $ , point mutations p53 hemizygous deletions rearrangements @ GeneSrc $ ) @ DiseaseTgt $ suppressor region may account subset familial glioma cases . Collectively , data lend genetic support heritable nature cases glioma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0380876554374214)\n",
      "- Text: \"p53 Pten control neural glioma stem/progenitor cell renewal differentiation . Glioblastoma ( GBM ) highly lethal brain tumour presenting one two subtypes distinct clinical histories molecular profiles . primary GBM subtype presents acutely high-grade disease typically harbours mutations EGFR , PTEN @ GeneSrc $ ( also known @ GeneSrc $ ) , secondary GBM subtype evolves slow progression low-grade disease classically possesses PDGF TP53 events . show concomitant central nervous system ( CNS ) -specific deletion p53 Pten mouse CNS generates penetrant acute-onset high-grade malignant glioma phenotype notable clinical , pathological molecular resemblance primary GBM humans . genetic observation prompted TP53 PTEN mutational analysis human primary GBM , demonstrating unexpectedly frequent inactivating mutations TP53 well expected PTEN mutations . Integrated transcriptomic profiling , silico promoter analysis functional studies murine neural stem cells ( NSCs ) established dual , singular , inactivation p53 Pten promotes undifferentiated state high renewal potential drives increased Myc protein levels associated signature . Functional studies validated increased Myc activity potent contributor impaired differentiation enhanced renewal NSCs doubly null p53 Pten ( p53 ( -/- ) Pten ( -/- ) ) well @ DiseaseTgt $ neurospheres ( TNSs ) derived model . Myc also serves maintain robust tumorigenic potential p53 ( -/- ) Pten ( -/- ) TNSs . murine modelling studies , together confirmatory transcriptomic/promoter studies human primary GBM , validate pathogenetic role common @ DiseaseTgt $ suppressor mutation profile human primary GBM establish Myc important target cooperative actions p53 Pten regulation normal malignant stem/progenitor cell differentiation , self-renewal tumorigenic potential .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012358027158442)\n",
      "- Text: \"CpG island methylator phenotype @ DiseaseTgt $ . Aberrant methylation promoter region CpG islands associated transcriptional inactivation tumor-suppressor genes neoplasia . understand global patterns CpG island methylation @ DiseaseTgt $ , used recently developed technique called methylated CpG island amplification examine 30 newly cloned differentially methylated DNA sequences . 30 clones , 19 ( 63 % ) progressively methylated age-dependent manner normal colon , 7 ( 23 % ) methylated cancer-specific manner , 4 ( 13 % ) methylated cell lines . Thus , majority CpG islands methylated @ DiseaseTgt $ also methylated subset normal colonic cells process aging . contrast , methylation cancer-specific clones found exclusively subset @ DiseaseTgt $ , appear display CpG island methylator phenotype ( CIMP ) . CIMP+ tumors also high incidence @ GeneSrc $ THBS1 methylation , include majority sporadic @ DiseaseTgt $ microsatellite instability related hMLH1 methylation . thus define pathway @ DiseaseTgt $ appears responsible majority sporadic tumors mismatch repair deficiency .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9477053356702204)\n",
      "- Text: \"Hereditary TP53 codon 292 somatic P16INK4A codon 94 mutations Li-Fraumeni syndrome family . Li-Fraumeni syndrome autosomal dominant disorder characterized various types @ DiseaseTgt $ childhood adult cases . Although hereditary TP53 mutation rare different human @ DiseaseTgt $ , frequently reported Li-Fraumeni syndrome . hand , hereditary mutations TP57KIP2 , @ GeneSrc $ , P16INK4A , affect cell cycle similar TP53 , observed types @ DiseaseTgt $ . Turkish family diagnosis Li-Fraumeni syndrome , analyzed mutation pattern TP53 , P57KIP2 , @ GeneSrc $ , P16INK4A peripheral blood , loss heterozygosity ( homo/hemizygous deletion ) pattern TP53 @ GeneSrc $ two @ DiseaseTgt $ tissues . propositus seminoma , daughter medulloblastoma , one healthy cousins , TP53 codon 292 missense point mutation ( AAA -- > ATA ; Lys -- > Ile ) peripheral blood cells . @ DiseaseTgt $ tissue obtained propositus seminoma revealed loss heterozygosity TP53 gene . analyses @ DiseaseTgt $ tissues propositus daughter , P16INK4A codon 94 missense point mutation ( GCG -- > GAG ; Ala -- > Glu ) observed hereditary TP53 mutation . P16INK4A codon 94 mutation observed family novel mutation Li-Fraumeni syndrome . gene alteration TP53 , P57KIP2 , @ GeneSrc $ , P16INK4A observed . Existence P16INK4A mutation hereditary TP53 mutation without loss heterozygosity TP53 gene ( seminoma/medulloblastoma ) may evidence common mechanism involved tumorogenesis . gene alterations TP53 P16INK4A genes may used @ DiseaseTgt $ markers family .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.02333445398804)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) @ GeneSrc $ ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.886009884535532e-05)\n",
      "- Text: \"Common variants @ GeneSrc $ , MS4A6A/MS4A4E , EPHA1 , CD33 CD2AP associated @ DiseaseTgt $ . sought identify new susceptibility loci @ DiseaseTgt $ staged association study ( GERAD+ ) testing suggestive loci reported @ DiseaseTgt $ Genetic Consortium ( ADGC ) companion paper . undertook combined analysis four genome-wide association datasets ( stage 1 ) identified ten newly associated variants P < = 1 x 10 ( -5 ) . tested variants association independent sample ( stage 2 ) . Three SNPs two loci replicated showed evidence association sample ( stage 3 ) . Meta-analyses data provided compelling evidence @ GeneSrc $ ( rs3764650 , meta P = 4.5 x 10 ( -17 ) ; including ADGC data , meta P = 5.0 x 10 ( -21 ) ) MS4A gene cluster ( rs610932 , meta P = 1.8 x 10 ( -14 ) ; including ADGC data , meta P = 1.2 x 10 ( -16 ) ) new @ DiseaseTgt $ susceptibility loci . also found independent evidence association three loci reported ADGC , , combined , showed genome-wide significance : CD2AP ( GERAD+ , P = 8.0 x 10 ( -4 ) ; including ADGC data , meta P = 8.6 x 10 ( -9 ) ) , CD33 ( GERAD+ , P = 2.2 x 10 ( -4 ) ; including ADGC data , meta P = 1.6 x 10 ( -9 ) ) EPHA1 ( GERAD+ , P = 3.4 x 10 ( -4 ) ; including ADGC data , meta P = 6.0 x 10 ( -10 ) ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0334587916779265)\n",
      "- Text: \"Roc domain leucine-rich repeat kinase 2 sufficient interaction microtubules . Mutations leucine-rich repeat kinase 2 ( LRRK2 ) gene leading cause genetically inherited @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although multidomain protein shown GTPase kinase activities Roc MAPKKK domains , respectively , protein-protein interactions pathways involved LRRK2-mediated signaling remain elusive . Utilizing combination protein pull-down assays , mass spectrometry , Western blotting , immunofluorescence microscopy , study identifies describes interaction LRRK2 microtubules . Roc GTPase-like domain LRRK2 sufficient interaction @ GeneSrc $ heterodimers . interaction occurs guanine nucleotide-independent manner , suggesting tubulin might effector LRRK2 GTPase domain . R1441C pathogenic mutation , located within Roc domain , retains interaction @ GeneSrc $ heterodimers , suggesting disruption interaction likely mechanism whereby R1441C mutation leads disease . subcellular level , endogenous LRRK2 protein found colocalize @ GeneSrc $ primary hippocampal neurons . findings significant link LRRK2 microtubules , structural component cell critically involved pathogenesis several neurodegenerative diseases , including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0064616828809326)\n",
      "- Text: \"alpha-Synuclein aggregates interfere Parkin solubility distribution : role pathogenesis @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) belongs heterogeneous group neurodegenerative disorders movement alterations , cognitive impairment , alpha-synuclein accumulation cortical subcortical regions . Jointly , disorders denominated Lewy body disease . Mutations parkin gene common cause familial parkinsonism , growing number studies shown stress factors associated sporadic @ DiseaseTgt $ promote parkin accumulation insoluble fraction . alpha-Synuclein parkin accumulation mutations genes associated familial @ DiseaseTgt $ . investigate whether alpha-synuclein accumulation might involved pathogenesis disorders interfering parkin solubility , synuclein-transfected neuronal cells transduced lentiviral vectors expressing parkin . Challenging neurons proteasome inhibitors amyloid-beta resulted accumulation insoluble parkin , lesser extent , @ GeneSrc $ . Similarly neurons brains patients Lewy body disease , co-transduced cells alpha-synuclein parkin colocalized co-immunoprecipitated . effects resulted decreased parkin @ GeneSrc $ ubiquitination , accumulation insoluble parkin , cytoskeletal alterations reduced neurite outgrowth . Taken together , accumulation alpha-synuclein might contribute pathogenesis @ DiseaseTgt $ Lewy body diseases promoting alterations parkin tubulin solubility , turn might compromise neural function damaging neuronal cytoskeleton . studies provide new perspective potential nature pathogenic alpha-synuclein parkin interactions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7540656989699108)\n",
      "- Text: \"GSK-3alpha regulates production @ DiseaseTgt $ amyloid-beta peptides . @ DiseaseTgt $ associated increased production aggregation amyloid-beta ( Abeta ) peptides . Abeta peptides derived amyloid precursor protein ( APP ) sequential proteolysis , catalysed aspartyl protease BACE , followed presenilin-dependent gamma-secretase cleavage . Presenilin interacts nicastrin , @ GeneSrc $ PEN-2 ( ref . 6 ) , required gamma-secretase function . Presenilins also interact alpha-catenin , beta-catenin glycogen synthase kinase-3beta ( GSK-3beta ) , functional role proteins gamma-secretase activity established . show therapeutic concentrations lithium , GSK-3 inhibitor , block production Abeta peptides interfering APP cleavage gamma-secretase step , inhibit Notch processing . Importantly , lithium also blocks accumulation Abeta peptides brains mice overproduce APP . target lithium setting GSK-3alpha , required maximal processing APP . Since GSK-3 also phosphorylates tau protein , principal component neurofibrillary tangles , inhibition GSK-3alpha offers new approach reduce formation amyloid plaques neurofibrillary tangles , two pathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.036616203795903)\n",
      "- Text: \"@ GeneSrc $ haploinsufficiency causes dopamine neuron vulnerability alpha-synuclein accumulation mice . @ GeneSrc $ ( @ GeneSrc $ ) phosphoinositide phosphatase dual SAC1 5'-phosphatase enzymatic activities regulating phospholipid signaling . brain-enriched isoform shown participate synaptic vesicle ( SV ) recycling . recently , recessive human mutations identified two phosphatase domains SYNJ1 , including R258Q , R459P R839C , linked rare forms early-onset Parkinsonism . demonstrate @ GeneSrc $ heterozygous deletion ( @ GeneSrc $ ) , associated impaired 5'-phosphatase activity , also leads @ DiseaseTgt $ @ DiseaseTgt $ pathologies mice . report male @ GeneSrc $ mice display age-dependent motor function abnormalities well alpha-synuclein accumulation , impaired autophagy dopaminergic terminal degeneration . @ GeneSrc $ mice contain elevated 5'-phosphatase substrate , PI ( 4,5 ) P2 , particularly midbrain neurons . Moreover , pharmacological elevation membrane PI ( 4,5 ) P2 cultured neurons impairs SV endocytosis , specifically midbrain neurons , exacerbates SV trafficking defects @ GeneSrc $ midbrain neurons . demonstrate down-regulation @ GeneSrc $ transcript subset sporadic @ DiseaseTgt $ brains , implicating potential role @ GeneSrc $ deficiency decline dopaminergic function aging .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0621682287402203)\n",
      "- Text: \"Akt1 regulates pathological angiogenesis , vascular maturation permeability vivo . Akt kinases control essential cellular functions , including proliferation , apoptosis , metabolism transcription , proposed promising targets treatment angiogenesis-dependent pathologies , @ DiseaseTgt $ ischemic injury . precise roles neovascularization remain elusive . show Akt1 predominant isoform vascular cells describe unexpected consequences Akt1 knockout vascular integrity pathological angiogenesis . Angiogenic responses three distinct vivo models enhanced Akt1 ( -/- ) mice ; enhanced responses associated impairment blood vessel maturation increased vascular permeability . Although impaired vascular maturation Akt1 ( -/- ) mice may attributed reduced activation endothelial nitric oxide synthase ( eNOS ) , major phenotypic changes vascular permeability angiogenesis linked reduced expression two endogenous vascular regulators , thrombospondins 1 ( TSP-1 ) 2 ( @ GeneSrc $ ) . Re-expression TSP-1 @ GeneSrc $ mice transplanted wild-type bone marrow corrected angiogenic abnormalities Akt1 ( -/- ) mice . findings establish crucial role Akt-thrombospondin axis angiogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.72586939986631e-07)\n",
      "- Text: \"Expansion @ DiseaseTgt $ SNCA-Rep1 allele upregulates human alpha-synuclein transgenic mouse brain . Alpha-synuclein ( SNCA ) gene implicated development rare forms familial Parkinson disease ( @ DiseaseTgt $ ) . Recently , shown increase SNCA copy numbers leads elevated levels wild-type SNCA-mRNA protein sufficient cause early-onset , familial @ DiseaseTgt $ . critical question concerning molecular pathogenesis @ DiseaseTgt $ contributory role , , played SNCA gene sporadic @ DiseaseTgt $ . expansion SNCA-Rep1 , upstream , polymorphic microsatellite SNCA gene , associated elevated risk sporadic @ DiseaseTgt $ . However , whether SNCA-Rep1 causal variant underlying mechanism effect mediated remained elusive . report effects three distinct SNCA-Rep1 variants brains 72 mice transgenic entire human SNCA locus . Human SNCA-mRNA protein levels increased 1.7- 1.25-fold , respectively , homozygotes expanded , @ DiseaseTgt $ risk-conferring allele compared homozygotes shorter , protective allele . adjusting total SNCA-protein concentration ( endogenous mouse transgenic human ) expressed brain , expanded risk allele contributed 2.6-fold SNCA steady-state shorter allele . Furthermore , targeted deletion @ GeneSrc $ resulted lowest human SNCA-mRNA protein concentrations murine brain . contrast , Rep1 effect observed blood lysates mice . results demonstrate Rep1 regulates human SNCA expression enhancing transcription adult nervous system suggest homozygosity expanded Rep1 allele may mimic locus multiplication , thereby elevating @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0091643026666669)\n",
      "- Text: \"Colonic polyposis caused mTOR-mediated chromosomal instability Apc+/Delta716 Cdx2+/- compound mutant mice . mammalian homeobox transcription factor @ GeneSrc $ key roles intestinal development differentiation . Heterozygous Cdx2 mice develop one two benign hamartomas proximal colon , whereas heterozygous Apc ( Delta716 ) mice develop numerous adenomatous polyps , mostly small intestine . show colonic polyp number six times higher Apc+/Delta716 Cdx2+/- compound mutant mice . Levels APC CDX2 significantly lower distal colon , caused high anaphase bridge index ( ABI ) associated higher frequency loss heterozygosity ( LOH ) Apc . cultured rat intestinal epithelial human @ DiseaseTgt $ cell lines , suppression CDX2 antisense RNA caused marked increases ABI chromosomal aberrations . mediated stimulation mTOR pathway , causing translational deregulation G1-S acceleration , associated low levels p27 activation cyclin E-Cdk2 . obtained similar results colonic mucosa Apc+/Delta716 ) Cdx2+/- compound mutant mice . Forced activation mTOR upstream regulator Akt also increased ABI @ DiseaseTgt $ cells . High ABI cell lines suppressed mTOR inhibitors LY294002 rapamycin . results suggest reduced expression CDX2 important colon tumorigenesis mTOR-mediated chromosomal instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0497840917552189)\n",
      "- Text: \"Parkin mediates proteasome-dependent protein degradation rupture outer mitochondrial membrane . Upon mitochondrial depolarization , Parkin , @ DiseaseTgt $ E3 ubiquitin ligase , translocates cytosol mitochondria promotes degradation mitophagy , selective type autophagy . , report addition mitophagy , Parkin mediates proteasome-dependent degradation outer membrane proteins Tom20 , @ GeneSrc $ , Tom70 , Omp25 depolarized mitochondria . contrast , degradation inner membrane matrix proteins largely depends mitophagy . Furthermore , Parkin induces rupture outer membrane depolarized mitochondria , also depends proteasomal activity . Upon induction mitochondrial depolarization , proteasomes recruited mitochondria perinuclear region . Neither proteasome-dependent degradation outer membrane proteins outer membrane rupture required mitophagy . results suggest Parkin regulates degradation outer inner mitochondrial membrane proteins differently proteasome- mitophagy-dependent pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.5762965774908657e-07)\n",
      "- Text: \"@ GeneSrc $ required p53 activity . @ DiseaseTgt $ suppressor protein p53 transcription factor frequently mutated human @ DiseaseTgt $ . response DNA damage , p53 protein stabilized activated post-translational modifications enable induce either apoptosis cell cycle arrest . Using novel yeast p53 dissociator assay , identify @ GeneSrc $ , part histone acetyltransferase complexes , important cofactor p53 activity . p53 @ GeneSrc $ physically interact human cells . interaction enhanced dramatically DNA damage due phosphorylation event ( ) p53 N-terminus . Proper @ GeneSrc $ function essential full transcriptional activity p53 p53-mediated apoptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3373792185601017)\n",
      "- Text: \"leukemic fusion gene AML1-MDS1-EVI1 suppresses @ GeneSrc $ @ DiseaseTgt $ activation Calreticulin . leukemic fusion gene AML1-MDS1-EVI1 ( AME ) encodes chimeric transcription factor results ( 3,21 ) ( q26 ; q22 ) translocation seen patients @ DiseaseTgt $ , therapy-related myelodysplastic syndrome , chronic myeloid leukemia blast crisis . myeloid transcription factor @ GeneSrc $ crucial normal granulopoiesis . , found conditional expression AME suppresses @ GeneSrc $ protein 90.8 % DNA-binding activity 93.9 % . contrast , @ GeneSrc $ mRNA levels remained unchanged . addition , detected differences @ GeneSrc $ mRNA levels leukemic blasts patients carrying AME translocation ( n = 8 ) compared @ DiseaseTgt $ patients normal karyotype ( n = 9 ) . @ GeneSrc $ protein binding activity , however , reduced significantly ( 100 % 92.1 % , respectively ) AME patient samples . Furthermore , observed calreticulin ( CRT ) , putative inhibitor @ GeneSrc $ translation , strongly activated induction AME cell-line system ( 14.8-fold ) AME patient samples ( 12.2-fold ) . Moreover , inhibition CRT small interfering RNA powerfully restored @ GeneSrc $ levels . results identify @ GeneSrc $ key target leukemic fusion protein AME suggest modulation @ GeneSrc $ CRT may represent mechanism involved differentiation block AME leukemias .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3578655610902677)\n",
      "- Text: \"Dominant-negative mutations @ GeneSrc $ , encoding @ GeneSrc $ ( @ GeneSrc $ ) , @ DiseaseTgt $ . transcription factor @ GeneSrc $ ( @ GeneSrc $ ; encoded gene @ GeneSrc $ ) crucial differentiation granulocytes . Conditional expression @ GeneSrc $ triggers neutrophilic differentiation , mature granulocytes observed Cebpa-mutant mice . identify heterozygous mutations @ GeneSrc $ ten patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) . found five mutations amino terminus truncate full-length protein , affect 30-kD protein initiated downstream . mutant proteins block wild-type @ GeneSrc $ DNA binding transactivation granulocyte target genes dominant-negative manner , fails induce granulocytic differentiation . first report @ GeneSrc $ mutations human neoplasia , mutations likely induce differentiation block found @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4746923996666087)\n",
      "- Text: \"AML1-ETO downregulates granulocytic differentiation factor @ GeneSrc $ ( 8 ; 21 ) myeloid leukemia . transcription factor @ GeneSrc $ , @ GeneSrc $ , encoded @ GeneSrc $ gene , crucial differentiation granulocytes . Conditional expression C/EBPalpha triggers neutrophilic differentiation , Cebpa knockout mice exhibit early block maturation . Dominant-negative mutations @ GeneSrc $ found patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) , @ DiseaseTgt $ ( 8 ; 21 ) translocation gives rise fusion gene RUNX1-CBF2T1 ( also known AML1-ETO ) encoding AML1-ETO fusion protein . RUNX1-CBF2T1 @ DiseaseTgt $ blasts eight-fold lower @ GeneSrc $ RNA levels undetectable @ GeneSrc $ protein levels compared subgroups @ DiseaseTgt $ patients . Conditional expression RUNX1-CBF2T1 U937 cells downregulated @ GeneSrc $ mRNA , protein DNA binding activity . AML1-ETO appears suppress @ GeneSrc $ expression indirectly inhibiting positive autoregulation @ GeneSrc $ promoter . Conditional expression @ GeneSrc $ AML1-ETO-positive Kasumi-1 cells results neutrophilic differentiation . suggest restoring @ GeneSrc $ expression therapeutic implications RUNX1-CBF2T1-positive leukemias .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9458037956001908)\n",
      "- Text: \"Mutations @ GeneSrc $ @ DiseaseTgt $ FAB types @ DiseaseTgt $ . @ GeneSrc $ encodes transcription factor @ GeneSrc $ specifically up-regulated granulocytic differentiation . gene mutated approximately 20 % patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) FAB type M2 occurs absence ( 8 ; 21 ) . much way specific translocations associated particular @ DiseaseTgt $ FAB type , identification non-random associations gene mutation karyotype FAB type may helpful elucidating molecular basis certain forms leukemia . confirm initial findings , 99 patients @ DiseaseTgt $ M2 screened @ GeneSrc $ mutations use PCR-single-strand conformational polymorphism sequencing approach . Nine @ GeneSrc $ mutations identified eight patients . mutations clustered toward COOH terminal protein occurred exclusively intermediate cytogenetic risk group ( 8/64 , 12.5 % ) . Two patients biallelic mutation , one homozygous 1137Ins ( 57 bp ) another two @ GeneSrc $ mutations , 1096Ins ( 27 bp ) 363Ins ( GGCC ) , observed . evidence deletion region six mutated samples analyzed fluorescence situ hybridization BAC clone spanning @ GeneSrc $ locus . @ GeneSrc $ mutation status demonstrated prognostic importance patient group , although may reflect selection size @ DiseaseTgt $ population studied . conclusion , mutation @ GeneSrc $ recurrent finding @ DiseaseTgt $ appears specific intermediate cytogenetic risk group patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0202469049580505)\n",
      "- Text: \"Mutation @ GeneSrc $ @ DiseaseTgt $ . describe family three members affected @ DiseaseTgt $ ( @ DiseaseTgt $ ) identical , 212delC mutation @ GeneSrc $ , gene encoding granulocytic differentiation factor @ GeneSrc $ . Unaffected family members mutation . Latent periods 10 , 18 , 30 years elapsed onset overt leukemia three patients . One second @ GeneSrc $ mutation , time diagnosis . three patients currently well , abnormalities bone marrow . @ GeneSrc $ mutation apparently primary event development @ DiseaseTgt $ family .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7838862532624059)\n",
      "- Text: \"transcriptionally [ correction transcriptively ] active complex APP Fe65 histone acetyltransferase @ GeneSrc $ . Amyloid-beta precursor protein ( APP ) , widely expressed cell-surface protein , cleaved transmembrane region gamma-secretase . gamma-Cleavage APP produces extracellular amyloid beta-peptide @ DiseaseTgt $ releases intracellular tail fragment unknown physiological function . demonstrate cytoplasmic tail APP forms multimeric complex nuclear adaptor protein Fe65 histone acetyltransferase @ GeneSrc $ . complex potently stimulates transcription via heterologous Gal4- LexA-DNA binding domains , suggesting release cytoplasmic tail APP gamma-cleavage may function gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.1984035716776015e-05)\n",
      "- Text: \"Acetylation p53 DNA-binding domain regulates apoptosis induction . ability p53 induce apoptosis plays important role @ DiseaseTgt $ suppression . , describe previously unknown posttranslational modification DNA-binding domain p53 . modification , acetylation lysine 120 ( K120 ) , occurs rapidly DNA damage catalyzed MYST family acetyltransferases hMOF @ GeneSrc $ . Mutation K120 arginine , occurs human @ DiseaseTgt $ , debilitates K120 acetylation diminishes p53-mediated apoptosis without affecting cell-cycle arrest . K120R mutation selectively blocks transcription proapoptotic target genes BAX PUMA nonapoptotic targets p21 hMDM2 remain unaffected . Consistent , depletion hMOF and/or @ GeneSrc $ inhibits ability p53 activate BAX PUMA transcription . Furthermore , acetyllysine 120 ( acetyl-K120 ) form p53 specifically accumulates proapoptotic target genes . data suggest K120 acetylation may help distinguish cell-cycle arrest apoptotic functions p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017414325532618)\n",
      "- Text: \"@ GeneSrc $ acetylation p53 modulates decision cell-cycle arrest apoptosis . Upon DNA damage types stress , p53 induces either cell-cycle arrest apoptosis depending cellular context . However , molecular mechanisms govern choice cell-cycle arrest apoptosis well understood . , show @ GeneSrc $ required cell growth arrest apoptosis mediated p53 also induces acetylation specifically lysine 120 ( K120 ) within DNA-binding domain . Interestingly , modification crucial p53-dependent apoptosis dispensable mediated growth arrest . K120 recurrent site p53 mutation human @ DiseaseTgt $ , corresponding acetylation-defective @ DiseaseTgt $ mutant ( K120R ) abrogates p53-mediated apoptosis , growth arrest . Thus , study demonstrates @ GeneSrc $ acetylation p53 K120 modulates decision cell-cycle arrest apoptosis , reveals DNA-binding core domain important target p53 regulation posttranslational modifications .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9119143463054972)\n",
      "- Text: \"Oxidant stress evoked pacemaking dopaminergic neurons attenuated DJ-1 . @ DiseaseTgt $ pervasive , ageing-related neurodegenerative disease cardinal motor symptoms reflect loss small group neurons , dopaminergic neurons substantia nigra pars compacta ( SNc ) . Mitochondrial oxidant stress widely viewed responsible loss , particular neurons stressed mystery . show , using transgenic mice expressed redox-sensitive variant green fluorescent protein targeted mitochondrial matrix , engagement plasma membrane L-type calcium channels normal autonomous pacemaking created oxidant stress specific vulnerable SNc dopaminergic neurons . oxidant stress engaged defences induced transient , mild mitochondrial depolarization uncoupling . mild uncoupling affected deletion @ GeneSrc $ , component permeability transition pore , attenuated genipin purine nucleotides , antagonists cloned uncoupling proteins . Knocking DJ-1 ( also known PARK7 humans Park7 mice ) , gene associated early-onset form @ DiseaseTgt $ , downregulated expression two uncoupling proteins ( UCP4 ( SLC25A27 ) UCP5 ( SLC25A14 ) ) , compromised calcium-induced uncoupling increased oxidation matrix proteins specifically SNc dopaminergic neurons . drugs approved human use antagonize calcium entry L-type channels , results point novel neuroprotective strategy idiopathic familial forms @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1068013442260446)\n",
      "- Text: \"@ GeneSrc $ mediates stabilization betaTrCP1 c-myc mRNA response beta-catenin signalling . Although constitutive activation beta-catenin/Tcf signalling implicated development human cancers , mechanisms beta-catenin/Tcf pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show beta-catenin stabilizes mRNA encoding F-box protein betaTrCP1 , identify RNA-binding protein @ GeneSrc $ ( coding region determinant-binding protein ) previously unknown target beta-catenin/Tcf transcription factor . @ GeneSrc $ binds coding region betaTrCP1 mRNA . Overexpression @ GeneSrc $ stabilizes betaTrCP1 mRNA elevates betaTrCP1 levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein ( SCF ) ( betaTrCP ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB beta-catenin . @ GeneSrc $ essential induction betaTrCP1 c-Myc beta-catenin signalling @ DiseaseTgt $ cells . High levels @ GeneSrc $ found primary human @ DiseaseTgt $ exhibiting active beta-catenin/Tcf signalling implicates @ GeneSrc $ induction upregulation betaTrCP1 , activation dimeric transcription factor NF-kappaB suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3799148970027743)\n",
      "- Text: \"@ GeneSrc $ modulates generation amyloid beta-peptide . pathogenic event common forms @ DiseaseTgt $ abnormal accumulation amyloid beta-peptide ( Abeta ) . provide strong evidence intracellular cholesterol compartmentation modulates generation Abeta . Using genetic , biochemical metabolic approaches , found cholesteryl-ester levels directly correlated Abeta production . @ GeneSrc $ ( @ GeneSrc $ ) , enzyme catalyses formation cholesteryl esters , modulates generation Abeta tight control equilibrium free cholesterol cholesteryl esters . also show pharmacological inhibitors @ GeneSrc $ , developed treatment atherosclerosis , potent modulators Abeta generation , indicating potential use treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2201744601739316)\n",
      "- Text: \"ACAT inhibitor CP-113,818 markedly reduces amyloid pathology mouse model @ DiseaseTgt $ . Amyloid beta-peptide ( Abeta ) accumulation specific brain regions pathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . previously reported well-characterized @ GeneSrc $ ( @ GeneSrc $ ) inhibitor , CP-113,818 , inhibits Abeta production cell-based experiments . , assessed efficacy CP-113,818 reducing @ DiseaseTgt $ pathology brains transgenic mice expressing human APP ( 751 ) containing London ( V717I ) Swedish ( K670M/N671L ) mutations . Two months treatment CP-113,818 reduced accumulation amyloid plaques 88 % -99 % membrane/insoluble Abeta levels 83 % -96 % , also decreasing brain cholesteryl-esters 86 % . Additionally , soluble Abeta ( 42 ) reduced 34 % brain homogenates . Spatial learning slightly improved correlated decreased Abeta levels . nontransgenic littermates , CP-113,818 also reduced ectodomain shedding endogenous APP brain . results suggest @ GeneSrc $ inhibition may effective prevention treatment @ DiseaseTgt $ inhibiting generation Abeta peptide .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0822278809480198)\n",
      "- Text: \"PKB/Akt phosphorylates @ GeneSrc $ , impairs nuclear import @ GeneSrc $ opposes @ GeneSrc $ G1 arrest . Mechanisms linking mitogenic growth inhibitory cytokine signaling cell cycle fully elucidated either @ DiseaseTgt $ normal cells . show activation protein kinase B ( PKB ) /Akt , contributes resistance antiproliferative signals breast cancer progression part impairing nuclear import action @ GeneSrc $ . Akt transfection caused cytoplasmic @ GeneSrc $ accumulation resistance cytokine-mediated G1 arrest . nuclear localization signal @ GeneSrc $ contains Akt consensus site threonine 157 , @ GeneSrc $ phosphorylation Akt impaired nuclear import vitro . Akt phosphorylated wild-type @ GeneSrc $ p27T157A . cells transfected constitutively active Akt ( T308DS473D ) ( PKB ( DD ) ) , p27WT mislocalized cytoplasm , p27T157A nuclear . cells activated Akt , p27WT failed cause G1 arrest , antiproliferative effect p27T157A impaired . Cytoplasmic @ GeneSrc $ seen 41 % ( 52 128 ) primary human breast cancers conjunction Akt activation correlated poor patient prognosis . Thus , show novel mechanism whereby Akt impairs @ GeneSrc $ function associated aggressive phenotype human breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1285367989655937)\n",
      "- Text: \"PKB/Akt mediates cell-cycle progression phosphorylation @ GeneSrc $ ) threonine 157 modulation cellular localization . shown novel mechanism Akt-mediated regulation CDK inhibitor @ GeneSrc $ ) . Blockade HER2/neu @ DiseaseTgt $ cells inhibits Akt kinase activity upregulates nuclear levels CDK inhibitor ( Kip1 ) . Recombinant Akt Akt precipitated @ DiseaseTgt $ cells phosphorylated wild-type @ GeneSrc $ vitro . @ GeneSrc $ contains Akt consensus RXRXXT ( 157 ) within nuclear localization motif . Active ( myristoylated ) Akt phosphorylated wild-type @ GeneSrc $ vivo unable phosphorylate @ GeneSrc $ mutant . Wild-type @ GeneSrc $ localized cytosol nucleus , whereas @ GeneSrc $ localized exclusively nucleus resistant nuclear exclusion Akt . @ GeneSrc $ effective wild-type @ GeneSrc $ inhibiting cyclin E/CDK2 activity cell proliferation ; effects rescued active Akt . Expression Ser ( 473 ) phospho Akt primary human breast cancers statistically correlated expression @ GeneSrc $ @ DiseaseTgt $ cytosol . data indicate Akt may contribute @ DiseaseTgt $ proliferation phosphorylation cytosolic retention @ GeneSrc $ , thus relieving CDK2 @ GeneSrc $ inhibition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.785686562948378)\n",
      "- Text: \"Akt activation localisation correlate @ DiseaseTgt $ invasion oncogene expression thyroid cancer . INTRODUCTION : Akt activation involved pathogenesis inherited thyroid cancer Cowden 's syndrome @ DiseaseTgt $ . cell culture , Akt regulates thyroid cell growth survival ; recent data suggest Akt also regulates cell motility non-thyroid cell lines . therefore sought evaluate role Akt thyroid cancer progression . METHODS : evaluated 46 thyroid cancer , 20 thyroid follicular adenoma , adjacent normal tissues samples immunohistochemistry activated Akt ( pAkt ) , Akt 1 , 2 , 3 , @ GeneSrc $ expression . Immunoblots performed 14 samples . RESULTS : Akt activation identified 10/10 @ DiseaseTgt $ , 26/26 papillary cancers , 2/10 follicular variant papillary cancers , 4/66 normal tissue samples 2/10 typical benign follicular adenomas . Immunoactive pAkt greatest regions capsular invasion ; localised nucleus @ DiseaseTgt $ cytoplasm papillary cancers , except invasive regions papillary cancers localised compartments . Immunoactive Akt 1 , Akt 2 Akt 3 , correlated pAkt localisation , nuclear pAkt associated cytoplasmic expression @ GeneSrc $ . vitro studies using human thyroid cancer cells demonstrated nuclear translocation Akt 1 pAkt associated cytoplasmic @ GeneSrc $ cell invasion migration . Cell migration localisation Akt 1 , pAkt , @ GeneSrc $ inhibited PI3 kinase , MEK inhibition . DISCUSSION : data suggest important role nuclear activation Akt 1 thyroid cancer progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0311084933584242)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits Akt phosphatase PP2a well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired PP2a phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor @ GeneSrc $ ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1124054002179531)\n",
      "- Text: \"Reciprocal regulation p53 malic enzymes modulates metabolism senescence . Cellular senescence protects multicellular organisms @ DiseaseTgt $ contributes ageing . pre-eminent @ DiseaseTgt $ suppressor p53 important role induction maintenance senescence , carries function remains poorly understood . addition , although increasing evidence supports idea metabolic changes underlie many cell-fate decisions p53-mediated @ DiseaseTgt $ suppression , connections metabolic enzymes senescence established . describe new mechanism p53 links functions . show p53 represses expression tricarboxylic-acid-cycle-associated malic enzymes ME1 @ GeneSrc $ human mouse cells . malic enzymes important NADPH production , lipogenesis glutamine metabolism , ME2 profound effect . inhibition malic enzymes , p53 regulates cell metabolism proliferation . Downregulation ME1 ME2 reciprocally activates p53 distinct MDM2- AMP-activated protein kinase-mediated mechanisms feed-forward manner , bolstering pathway enhancing p53 activation . Downregulation ME1 ME2 also modulates outcome p53 activation , leading strong induction senescence , apoptosis , whereas enforced expression either malic enzyme suppresses senescence . findings define physiological functions malic enzymes , demonstrate positive-feedback mechanism sustains p53 activation , reveal connection metabolism senescence mediated p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001092103098185)\n",
      "- Text: \"H50Q mutation enhances alpha-synuclein aggregation , secretion , toxicity . last two decades , identification missense mutations alpha-synuclein ( alpha-Syn ) gene SNCA families inherited Parkinson disease ( @ DiseaseTgt $ ) reinforced central role alpha-Syn @ DiseaseTgt $ pathogenesis . Recently , new missense mutation ( H50Q ) alpha-Syn described patients familial form @ DiseaseTgt $ dementia . investigated effects novel mutation biophysical properties alpha-Syn consequences cellular function . found H50Q mutation affected neither structure free membrane-bound alpha-Syn monomer , interaction metals , capacity phosphorylated vitro . However , compared wild-type ( WT ) protein , H50Q mutation accelerated alpha-Syn fibrillization vitro . cell-based models , H50Q mutation affect alpha-Syn subcellular localization ability phosphorylated @ GeneSrc $ GRK6 . Interestingly , H50Q increased alpha-Syn secretion SHSY5Y cells culture medium induced mitochondrial fragmentation hippocampal neurons . Although transient overexpression WT H50Q induce toxicity , species induced significant cell death added culture medium hippocampal neurons . Strikingly , H50Q exhibited toxicity , suggesting H50Q-related enhancement alpha-Syn aggregation secretion may play role extracellular toxicity mutant . Together , results provide novel insight mechanism newly described @ DiseaseTgt $ mutation may contribute pathogenesis @ DiseaseTgt $ related disorders .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0091504912914935)\n",
      "- Text: \"Interplay p53 DNA-repair protein @ GeneSrc $ tumorigenesis , genomic stability development . @ GeneSrc $ non-homologous end-joining protein employed DNA double strand break repair V ( ) J recombination . mice , @ GeneSrc $ causes pleiotropic phenotype , includes embryonic lethality massive neuronal apoptosis . DNA damage repaired , activation cell cycle checkpoint protein p53 lead apoptosis . show p53-deficiency rescues several aspects @ GeneSrc $ phenotype , including embryonic lethality , neuronal apoptosis , impaired cellular proliferation . However , significant rescue impaired V ( ) J recombination lymphocyte development . Although p53-deficiency allowed postnatal survival @ GeneSrc $ mice , routinely succumbed pro-B-cell lymphomas chromosomal translocations linking amplified c-myc oncogene IgH locus sequences . Moreover , even @ GeneSrc $ embryonic fibroblasts exhibited marked genomic instability including chromosomal translocations . findings support crucial role non-homologous end-joining pathway caretaker mammalian genome , role required normal development suppression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0330802467366106)\n",
      "- Text: \"Akt1 regulates pathological angiogenesis , vascular maturation permeability vivo . Akt kinases control essential cellular functions , including proliferation , apoptosis , metabolism transcription , proposed promising targets treatment angiogenesis-dependent pathologies , @ DiseaseTgt $ ischemic injury . precise roles neovascularization remain elusive . show Akt1 predominant isoform vascular cells describe unexpected consequences Akt1 knockout vascular integrity pathological angiogenesis . Angiogenic responses three distinct vivo models enhanced Akt1 ( -/- ) mice ; enhanced responses associated impairment blood vessel maturation increased vascular permeability . Although impaired vascular maturation Akt1 ( -/- ) mice may attributed reduced activation endothelial nitric oxide synthase ( eNOS ) , major phenotypic changes vascular permeability angiogenesis linked reduced expression two endogenous vascular regulators , thrombospondins 1 ( TSP-1 ) 2 ( TSP-2 ) . Re-expression @ GeneSrc $ TSP-2 mice transplanted wild-type bone marrow corrected angiogenic abnormalities Akt1 ( -/- ) mice . findings establish crucial role Akt-thrombospondin axis angiogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Akt1 regulates pathological angiogenesis , vascular maturation permeability vivo . Akt kinases control essential cellular functions , including proliferation , apoptosis , metabolism transcription , proposed promising targets treatment angiogenesis-dependent pathologies , @ DiseaseTgt $ ischemic injury . precise roles neovascularization remain elusive . show Akt1 predominant isoform vascular cells describe unexpected consequences Akt1 knockout vascular integrity pathological angiogenesis . Angiogenic responses three distinct vivo models enhanced Akt1 ( -/- ) mice ; enhanced responses associated impairment blood vessel maturation increased vascular permeability . Although impaired vascular maturation Akt1 ( -/- ) mice may attributed reduced activation endothelial nitric oxide synthase ( eNOS ) , major phenotypic changes vascular permeability angiogenesis linked reduced expression two endogenous vascular regulators , thrombospondins 1 ( @ GeneSrc $ ( TSP-2 ) . Re-expression TSP-1 TSP-2 mice transplanted wild-type bone marrow corrected angiogenic abnormalities Akt1 ( -/- ) mice . findings establish crucial role Akt-thrombospondin axis angiogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.109859750192729e-06)\n",
      "- Text: \"Identification 46 novel SNPs 130-kb region containing myocardial infarction susceptibility gene chromosomal band 6p21 . identified total 187 single-nucleotide polymorphisms ( SNPs ) 11 gene loci 130-kb region chromosome 6p21 containing gene strongly associated @ DiseaseTgt $ ( MI ) . comparing data SNPs deposited dbSNP database National Center Biotechnology Information , 46 SNPs ( 24.6 % ) considered novel : four identified @ GeneSrc $ locus , 14 MICB locus , nine BAT1 locus , one ATP6V1G2 locus , six NFKBIL1 locus , one LTA locus , one TNF locus , five LST1 locus , four LY117a locus , one AIF-1 locus . SNP map presented provide useful resource examining relationships genotypes susceptibility MI phenotype , also scanning complex diseases mapped local segment chromosome 6 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.90678803245418e-07)\n",
      "- Text: \"@ GeneSrc $ expression decreases @ DiseaseTgt $ brain function dementia . OBJECTIVES : explore mechanisms altered @ GeneSrc $ ( @ GeneSrc $ ) expression may influence @ DiseaseTgt $ ( @ DiseaseTgt $ ) amyloid neuropathology test hypothesis promotion @ GeneSrc $ expression neurons might developed novel therapeutic strategy @ DiseaseTgt $ . DESIGN : Case-control . Patients Human postmortem brain ( hippocampal formation ) samples @ DiseaseTgt $ cases age-matched @ DiseaseTgt $ cases . RESULTS : Using genome-wide complementary DNA microarray analysis , found @ GeneSrc $ messenger RNA expression significantly decreased function progression clinical dementia @ DiseaseTgt $ brain . Following confirmatory real-time polymerase chain reaction assay , continued explore role @ GeneSrc $ clinical dementia found @ GeneSrc $ protein content negatively associated @ DiseaseTgt $ neuritic plaque pathology beta-amyloid ( Abeta ) ( X-42 ) contents . Moreover , found predicted elevation amyloidogenic Abeta ( 1 - 42 ) Abeta ( 1 - 40 ) peptide accumulation embryonic cortico-hippocampal neurons derived Tg2576 @ DiseaseTgt $ mice hyperglycemic conditions ( glucose level , 182 - 273 mg/dL ) coincided dose-dependent attenuation @ GeneSrc $ expression . importantly , found reconstitution exogenous @ GeneSrc $ expression Tg2576 neurons attenuated hyperglycemic-mediated beta-amyloidogenesis mechanisms involving promotion `` nonamyloidogenic `` alpha-secretase processing amyloid precursor protein attenuation forkheadlike transcription factor 1 ( FoxO3a ) expression . CONCLUSION : Therapeutic preservation neuronal @ GeneSrc $ expression promotes nonamyloidogenic processing amyloid precursor protein precluding generation amyloidogenic Abeta peptides .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0970113253053514)\n",
      "- Text: \"Mutations LRRK2 increase phosphorylation @ GeneSrc $ exacerbating oxidative stress-induced neuronal death . Mutations leucine rich repeat kinase 2 ( LRRK2 ) gene responsible autosomal dominant sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) , possibly exerting effects via toxic gain function . common p. G2019S mutation ( rs34637584 : > G ) responsible 30 - 40 % @ DiseaseTgt $ cases ethnic populations . , show LRRK2 interacts human @ GeneSrc $ ( @ GeneSrc $ ) , mitochondrial member antioxidant family thioredoxin ( Trx ) peroxidases . Importantly , mutations LRRK2 kinase domain significantly increased phosphorylation @ GeneSrc $ compared wild-type . increase @ GeneSrc $ phosphorylation associated decreased peroxidase activity increased death LRRK2-expressing LRRK2-depleted vector-transfected neuronal cells . LRRK2 mutants stimulated mitochondrial factors involved apoptosis induced production reactive oxygen species ( ROS ) oxidative modification macromolecules . Furthermore , immunoblot immunohistochemical analysis postmortem human @ DiseaseTgt $ patients carrying p. G2019S mutation showed marked increase phosphorylated @ GeneSrc $ ( @ GeneSrc $ ) relative normal brain . showed LRRK2 mutations increase inhibition endogenous peroxidase phosphorylation promoting dysregulation mitochondrial function oxidative damage . findings provide mechanistic link enhanced kinase activity @ DiseaseTgt $ LRRK2 neuronal cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8269584564526957)\n",
      "- Text: \"Intracellular secreted Alzheimer beta-amyloid species generated distinct mechanisms cultured hippocampal neurons . Cerebral plaques containing beta-amyloid ( beta A4 ) represent invariant pathological feature @ DiseaseTgt $ ( @ DiseaseTgt $ ) . beta A4 proteolytically generated parent molecule , amyloid precursor protein ( APP ) . non-neuronal cells beta A4 shown secreted via pH-sensitive endocytosis-dependent pathway , process , occurring brain , considered play important role @ DiseaseTgt $ . neurons mechanisms beta A4 production known . analyzed mechanisms expressing human APP mutant versions hippocampal neurons using Semliki forest virus system . show cells initially generate two pools beta A4 , extracellular intracellular , extracellular pool produced via pH-sensitive endocytosis-dependent pathway . Thus , hippocampal neurons able utilize alternate pathway produce intracellular beta A4 . also show common feature two types APP mutations ( `` Swedish `` `` London `` ) implicated early-onset @ DiseaseTgt $ increased production C-terminally elongated beta A4 ( @ GeneSrc $ ) , intra- extracellularly . Since neurons cells produce substantial levels intracellular beta A4 also main victims @ DiseaseTgt $ , findings may provide important link beta A4 neurodegeneration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0162812203822872)\n",
      "- Text: \"Akt-mediated regulation autophagy tumorigenesis Beclin 1 phosphorylation . Aberrant signaling class phosphatidylinositol 3-kinase ( PI3K ) -Akt axis frequent human @ DiseaseTgt $ . , show Beclin 1 , essential autophagy @ DiseaseTgt $ suppressor protein , target protein kinase Akt . Expression Beclin 1 mutant resistant Akt-mediated phosphorylation increased autophagy , reduced anchorage-independent growth , inhibited Akt-driven tumorigenesis . Akt-mediated phosphorylation Beclin 1 enhanced interactions @ GeneSrc $ vimentin intermediate filament proteins , vimentin depletion increased autophagy inhibited Akt-driven transformation . Thus , Akt-mediated phosphorylation Beclin 1 functions autophagy inhibition , oncogenesis , formation autophagy-inhibitory Beclin @ GeneSrc $ intermediate filament complex . findings broad implications understanding role Akt signaling intermediate filament proteins autophagy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0081670268785097)\n",
      "- Text: \"Conservation synteny genome pufferfish ( Fugu rubripes ) region human chromosome 14 ( 14q24.3 ) associated @ DiseaseTgt $ ( AD3 locus ) genome pufferfish ( Fugu rubripes ) ( 400 Mb ) approximately 7.5 times smaller human genome , similar gene repertoire man . regions two genomes exhibited conservation gene order ( i.e . , syntenic ) , possible reduce dramatically effort required identification candidate genes human disease loci sequencing syntenic regions compact Fugu genome . demonstrated three genes ( dihydrolipoamide succinyltransferase , @ GeneSrc $ , S20i15 ) , linked FOS @ DiseaseTgt $ focus ( AD3 ) human chromosome 14 , homologues Fugu genome adjacent Fugu cFOS . relative gene order cFOS , @ GeneSrc $ , S20i15 genomes , Fugu three genes lay within 12.4-kb region , compared > 600 kb human AD3 locus . results demonstrate conservation synteny genomes Fugu man highlight utility approach sequence-based identification genes human disease loci .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001854832084219)\n",
      "- Text: \"Systematic rare variant analyses identify @ GeneSrc $ susceptibility gene familial @ DiseaseTgt $ . Despite substantial progress , causal variants identified minority familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases , leaving high-risk pathogenic variants unidentified1,2 . identify variants , uniformly processed exome sequencing data 2,184 index familial @ DiseaseTgt $ cases 69,775 controls . Exome-wide analyses converged @ GeneSrc $ novel @ DiseaseTgt $ gene identifying c.213C > G/p . S71R high-risk variant presenting ~0.7 % familial @ DiseaseTgt $ cases observed 0.004 % controls ( odds ratio 65.5 ) . variant confirmed cases via Sanger sequencing segregated @ DiseaseTgt $ three families . @ GeneSrc $ encodes small GTPase known interact LRRK2 ( refs . 3,4 ) . Functional analyses showed @ GeneSrc $ S71R increases LRRK2 kinase activity , indicated increased autophosphorylation LRRK2 S1292 . results implicate mutant @ GeneSrc $ key pathological mechanism @ DiseaseTgt $ kinase activity5 - 7-and thus provide novel insights mechanistic connections RAB family biology , LRRK2 @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7278703265448511)\n",
      "- Text: \"@ GeneSrc $ Ser71Arg autosomal dominant @ DiseaseTgt $ : linkage , association , functional analyses . BACKGROUND : @ DiseaseTgt $ progressive neurodegenerative disorder multifactorial causes , among genetic risk factors play part . RAB GTPases regulators substrates LRRK2 , variants LRRK2 gene important risk factors @ DiseaseTgt $ . aimed explore genetic variability RAB GTPases within cases familial @ DiseaseTgt $ . METHODS : whole-exome sequencing probands families Canada Tunisia @ DiseaseTgt $ without genetic cause , recruited Centre Applied Neurogenetics ( Vancouver , BC , Canada ) , international consortium includes people @ DiseaseTgt $ 36 sites 24 countries . 61 RAB GTPases genetically screened , candidate variants genotyped relatives probands assess disease segregation linkage analysis . Genotyping also done assess variant frequencies individuals @ DiseaseTgt $ controls , matched age sex , also Centre Applied Neurogenetics unrelated probands . participants aged 18 years older . sequencing genotyping findings validated case-control association analyses using bioinformatic data obtained publicly available clinicogenomic databases ( AMP-PD , GP2 , 100 000 Genomes Project ) private German clinical diagnostic database ( University Tubingen ) . Clinical pathological findings summarised haplotypes determined . In-vitro studies done investigate protein interactions enzyme activities . FINDINGS : June 1 , 2010 , May 31 , 2017 , 130 probands Canada Tunisia ( 47 [ 36 % ] female 83 [ 64 % ] male ; mean age 72 7 years [ SD 11 7 ; range 38 - 96 ] ; 109 White European ancestry , 18 north African , two east Asian , one Hispanic ] underwent whole-exome sequencing . 15 variants RAB GTPase genes identified , @ GeneSrc $ variant c.213C > G ( Ser71Arg ) cosegregated autosomal dominant @ DiseaseTgt $ three families ( nine affected individuals ; non-parametric linkage Z score=1 95 ; p=0 03 ) . 2604 unrelated individuals @ DiseaseTgt $ 344 matched controls additionally genotyped , five people originating five countries ( Canada , Italy , Poland , Turkey , Tunisia ) identified @ GeneSrc $ variant . database searches , 6043 individuals @ DiseaseTgt $ 62 549 controls included , another eight individuals identified @ GeneSrc $ variant four countries ( Canada , Germany , UK , USA ) . Overall , association @ GeneSrc $ c.213C > G ( Ser71Arg ) @ DiseaseTgt $ significant ( odds ratio [ ] 13 17 , 95 % CI 2 15 - 87 23 ; p=0 0055 ; I2=99 96 % ) . people variant , @ DiseaseTgt $ presented age 54 6 years ( SD 12 75 , range 31 - 81 , n=16 ) , two-thirds family history parkinsonism . @ GeneSrc $ Ser71Arg heterozygotes shared common haplotype , although penetrance incomplete . Findings one individual autopsy showed sparse neurofibrillary tangle pathology midbrain thalamus , without Lewy body pathology . functional studies , @ GeneSrc $ Arg71 activated LRRK2 kinase level greater @ GeneSrc $ Ser71 . INTERPRETATION : @ GeneSrc $ Ser71Arg novel genetic risk factor @ DiseaseTgt $ , reduced penetrance . variant found individuals @ DiseaseTgt $ multiple ethnic groups , haplotype . In-vitro assays show @ GeneSrc $ Arg71 activates LRRK2 kinase , indicates genetically distinct causes familial parkinsonism share mechanism . discovery @ GeneSrc $ Ser71Arg also suggests several genetically inherited causes @ DiseaseTgt $ originated control intracellular immunity . shared aetiology considered future translational research , global epidemiology @ GeneSrc $ Ser71Arg needs assessed inform genetic counselling . FUNDING : National Institutes Health , Canada Excellence Research Chairs program , Aligning Science Across @ DiseaseTgt $ , Michael J Fox Foundation @ DiseaseTgt $ Research , UK Medical Research Council .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.292009678301538)\n",
      "- Text: \"Ultraviolet radiation accelerates @ GeneSrc $ melanomagenesis targeting TP53 . Cutaneous melanoma epidemiologically linked ultraviolet radiation ( UVR ) , molecular mechanisms UVR drives melanomagenesis remain unclear . common somatic mutation melanoma V600E substitution @ GeneSrc $ , early event . investigate UVR accelerates oncogenic @ GeneSrc $ melanomagenesis , used @ GeneSrc $ ) mouse model . mice expressing @ GeneSrc $ ) melanocytes , single dose UVR mimicked mild sunburn humans induced clonal expansion melanocytes , repeated doses UVR increased melanoma burden . show sunscreen ( UVA superior , UVB sun protection factor ( SPF ) 50 ) delayed onset UVR-driven melanoma , provided partial protection . UVR-exposed @ DiseaseTgt $ showed increased numbers single nucleotide variants observed mutations ( H39Y , S124F , R245C , R270C , C272 G ) Trp53 @ DiseaseTgt $ suppressor approximately 40 % cases . TP53 accepted UVR target human non-melanoma skin cancer , thought major role melanoma . However , show , mice , mutant Trp53 accelerated @ GeneSrc $ melanomagenesis , TP53 mutations linked evidence UVR-induced DNA damage human melanoma . Thus , provide mechanistic insight epidemiological data linking UVR acquired naevi humans . Furthermore , identify TP53/Trp53 UVR-target gene cooperates @ GeneSrc $ ) induce melanoma , providing molecular insight UVR accelerates melanomagenesis . study validates public health campaigns promote sunscreen protection individuals risk melanoma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1026569380738571)\n",
      "- Text: \"MLH3 : DNA mismatch repair gene associated mammalian microsatellite instability . DNA mismatch repair important role maintaining genomic integrity association hereditary non-polyposis colon cancer ( HNPCC ) . identify new human mismatch repair proteins , probed nuclear extracts conserved carboxy-terminal MLH1 interaction domain . describe cloning complete genomic sequence MLH3 , encodes new DNA mismatch repair protein interacts MLH1 . MLH3 similar mismatch repair proteins yeast , plants , worms bacteria known mammalian protein , suggesting conserved sequence may confer unique functions mice humans . Cells culture stably expressing dominant-negative MLH3 protein exhibit microsatellite instability . Mlh3 highly expressed gastrointestinal epithelium physically maps mouse complex trait locus colon cancer susceptibility ( @ GeneSrc $ ) . Although unable identify mutation protein-coding region Mlh3 susceptible mouse strain , colon tumours congenic @ GeneSrc $ mice exhibit microsatellite instability . Functional redundancy among Mlh3 , Pms1 Pms2 may explain neither Pms1 Pms2 mutant mice develop @ DiseaseTgt $ , PMS1 PMS2 mutations rarely found HNPCC families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001657972879039)\n",
      "- Text: \"Apolipoprotein E4 allele predictor cholinergic deficits treatment outcome @ DiseaseTgt $ . Apolipoprotein E ( apoE ) critical modulation cholesterol phospholipid transport cells different types . Human apoE polymorphic protein three common alleles , APO epsilon 2 , APO epsilon 3 , APO epsilon 4 . ApoE4 associated sporadic late-onset familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Gene dose shown effect risk developing @ DiseaseTgt $ , age onset , accumulation senile plaques brain , reduction @ GeneSrc $ ( @ GeneSrc $ ) activity hippocampus @ DiseaseTgt $ subjects . characterize possible impact apoE4 allele cholinergic markers @ DiseaseTgt $ , examined effect apoE4 allele copy number pre- postsynaptic markers cholinergic activity . ApoE4 allele copy number showed inverse relationship residual brain @ GeneSrc $ activity nicotinic receptor binding sites hippocampal formation temporal cortex @ DiseaseTgt $ subjects . @ DiseaseTgt $ cases lacking apoE4 allele showed @ GeneSrc $ activities close within age-matched normal control values . effect apoE4 allele cholinomimetic drug responsiveness assessed next group ( n = 40 ) @ DiseaseTgt $ patients completed double-blind , 30-week clinical trial cholinesterase inhibitor tacrine . Results showed > 80 % apoE4-negative @ DiseaseTgt $ patients showed marked improvement 30 weeks measured @ DiseaseTgt $ assessment scale ( ADAS ) , whereas 60 % apoE4 carriers ADAS scores worse compared baseline . results strongly support concept apoE4 plays crucial role cholinergic dysfunction associated @ DiseaseTgt $ may prognostic indicator poor response therapy acetylcholinesterase inhibitors @ DiseaseTgt $ patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0804272162864013)\n",
      "- Text: \"Impact APOE genotype neuropathologic neurochemical markers @ DiseaseTgt $ . BACKGROUND : APOE epsilon4 allele emerged major genetic factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , presence associated increase beta-amyloid senile plaques ( SPs ) neuritic plaques ( NPs ) . Whether affects neurofibrillary tangle ( NFT ) accumulation cholinergic losses @ DiseaseTgt $ remains controversial . contrast , epsilon2 allele reported decrease risk @ DiseaseTgt $ . However , effect neuropathologic neurochemical markers disease unclear . OBJECTIVE : investigate relationship APOE genotype pathologic severity cholinergic dysfunction @ DiseaseTgt $ . METHODS : autopsy series 296 patients @ DiseaseTgt $ , APOE genotype determined blood postmortem brain tissue . NPs NFTs counted midfrontal ( MF ) , inferior parietal ( IP ) , superior temporal ( ST ) cortices hippocampus . @ GeneSrc $ ( @ GeneSrc $ ) activity assessed MF , IP , ST cortices . RESULTS : Compared patients epsilon4 alleles , epsilon4 carriers ( patients either one two epsilon4 alleles ) differ significantly regard pathologic neurochemical measures , except increased ST NPs . However , cases stratified three groups according number epsilon4 alleles , patients two epsilon4 alleles significantly NPs NFTs neocortical regions either one epsilon4 alleles . association epsilon4/4 genotype neocortical pathologic severity remained significant even adjusting age onset age death . contrast , significant group differences regard neocortical @ GeneSrc $ activity . pathologic neurochemical measures compared patients epsilon2 allele without , strong relationship emerged epsilon2 allele decreased NPs neocortical regions . CONCLUSIONS : epsilon4 allele predict cholinergic decline @ DiseaseTgt $ . Although presence single epsilon4 allele appears effect , presence two epsilon4 alleles important determinant NP NFT accumulation . putative protective role epsilon2 allele @ DiseaseTgt $ may mediated reduced plaque burden .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0040124522794901)\n",
      "- Text: \"@ GeneSrc $ inhibitor CP-113,818 markedly reduces amyloid pathology mouse model @ DiseaseTgt $ . Amyloid beta-peptide ( Abeta ) accumulation specific brain regions pathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . previously reported well-characterized acyl-coenzyme : cholesterol acyltransferase ( ACAT ) inhibitor , CP-113,818 , inhibits Abeta production cell-based experiments . , assessed efficacy CP-113,818 reducing @ DiseaseTgt $ pathology brains transgenic mice expressing human APP ( 751 ) containing London ( V717I ) Swedish ( K670M/N671L ) mutations . Two months treatment CP-113,818 reduced accumulation amyloid plaques 88 % -99 % membrane/insoluble Abeta levels 83 % -96 % , also decreasing brain cholesteryl-esters 86 % . Additionally , soluble Abeta ( 42 ) reduced 34 % brain homogenates . Spatial learning slightly improved correlated decreased Abeta levels . nontransgenic littermates , CP-113,818 also reduced ectodomain shedding endogenous APP brain . results suggest ACAT inhibition may effective prevention treatment @ DiseaseTgt $ inhibiting generation Abeta peptide .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035646817514796)\n",
      "- Text: \"HIF-1 antagonizes p53-mediated apoptosis secreted neuronal tyrosinase . Hypoxia-inducible factor ( HIF ) transcription factor regulates fundamental cellular processes response changes oxygen concentration . HIFalpha protein levels increased solid @ DiseaseTgt $ correlate patient prognosis . link HIF apoptosis , major determinant @ DiseaseTgt $ progression treatment outcome , poorly understood . show Caenorhabditis elegans HIF-1 protects DNA-damage-induced germ cell apoptosis antagonizing function @ GeneSrc $ , homologue @ DiseaseTgt $ p53 . antiapoptotic property HIF-1 mediated means transcriptional upregulation tyrosinase family member TYR-2 ASJ sensory neurons . TYR-2 secreted ASJ sensory neurons antagonize CEP-1-dependent germline apoptosis . Knock TYR-2 homologue TRP2 ( also called DCT ) human melanoma cells similarly increases apoptosis , indicating evolutionarily conserved function . findings identify novel link hypoxia programmed cell death , provide paradigm HIF-1 dictating apoptotic cell fate distance .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0103785042764359)\n",
      "- Text: \"interaction hnRNP family member @ GeneSrc $ p53 . @ GeneSrc $ , @ GeneSrc $ , member heterogeneous nuclear ribonucleoprotein ( hnRNP ) family , originally isolated basis ability bind adenovirus 5 early region1B55 K protein . , demonstrated @ GeneSrc $ interacts mutant wild-type p53 human cells pull-down assays using @ GeneSrc $ . interaction confirmed co-immunoprecipitation studies pull-down experiments vitro translated @ GeneSrc $ GST-p53 . binding site @ GeneSrc $ mapped C-terminal region p53 . reciprocal experiments , shown several regions @ GeneSrc $ bound p53 although probable major site interaction located amino acids 395 732 @ GeneSrc $ . reporter assays , @ GeneSrc $ inhibited p53 transcriptional activity although efficiently Ad5E1B55 K protein . Transfection @ GeneSrc $ human @ DiseaseTgt $ cells affected cellular response UV radiation , , although p53 expression induced , little change level p53-inducible genes could observed .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0014477729919785)\n",
      "- Text: \"Methylation profile TP53 regulatory pathway mtDNA alterations breast cancer patients lacking TP53 mutations . present study investigated promoter hypermethylation TP53 regulatory pathways providing potential link epigenetic changes mitochondrial DNA ( mtDNA ) alterations breast cancer patients lacking TP53 mutation . possibility using @ DiseaseTgt $ alterations serum samples blood-based test also explored . Triple-matched samples ( cancerous tissues , matched adjacent normal tissues serum samples ) breast cancer patients screened TP53 mutations , promoter methylation profile @ GeneSrc $ ) , MDM2 , TP53 PTEN genes analyzed well mtDNA alterations , including D-loop mutations mtDNA content . studied cohort , mutation found TP53 ( DNA-binding domain ) . Comparison @ GeneSrc $ ) PTEN methylation patterns showed significant hypermethylation levels @ DiseaseTgt $ tissues ( P < 0.05 < 0.01 , respectively ) whereas TP53 @ DiseaseTgt $ suppressor gene hypermethylated ( P < 0.511 ) . proportion PTEN methylation significantly higher serum normal tissues significant correlation @ DiseaseTgt $ tissues ( P < 0.05 ) . mtDNA analysis revealed 36.36 % somatic 90.91 % germline mutations D-loop region also significant mtDNA depletion @ DiseaseTgt $ tissues ( P < 0.01 ) . addition , mtDNA content matched serum significantly lower normal tissues ( P < 0.05 ) . data provide insight management therapeutic approach based reversal epigenetic silencing crucial genes involved regulatory pathways @ DiseaseTgt $ suppressor TP53 . Additionally , release significant aberrant methylated PTEN matched serum samples might represent promising biomarker breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.009459177125874)\n",
      "- Text: \"PPM1D dephosphorylates @ GeneSrc $ p53 abrogates cell cycle checkpoints . ATM ( ataxia-telangiectasia mutated ) ATR ( ataxia-telangiectasia Rad3-related ) kinases respond DNA damage phosphorylating cellular target proteins activate DNA repair pathways cell cycle checkpoints order maintain genomic integrity . show oncogenic p53-induced serine/threonine phosphatase , PPM1D ( Wip1 ) , dephosphorylates two ATM/ATR targets , @ GeneSrc $ p53 . PPM1D binds @ GeneSrc $ dephosphorylates ATR-targeted phospho-Ser 345 , leading decreased @ GeneSrc $ kinase activity . PPM1D also dephosphorylates p53 phospho-Ser 15 . PPM1D dephosphorylations correlated reduced cellular intra-S G2/M checkpoint activity response DNA damage induced ultraviolet ionizing radiation . Thus , primary function PPM1D may reverse p53 @ GeneSrc $ DNA damage cell cycle checkpoint responses return cell homeostatic state following completion DNA repair . homeostatic functions may partially responsible oncogenic effects PPM1D amplified overexpressed human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0084710441195322)\n",
      "- Text: \"Accumulation parkin substrate , FAF1 , plays key role dopaminergic neurodegeneration . study reports physical functional interplay Fas-associated factor 1 ( FAF1 ) , death-promoting protein , parkin , key susceptibility protein @ DiseaseTgt $ ( @ DiseaseTgt $ ) . found parkin acts E3 ubiquitin ligase ubiquitinate @ GeneSrc $ vitro cellular level , identifying @ GeneSrc $ direct substrate parkin . loss parkin function due @ DiseaseTgt $ mutations found disrupt ubiquitination degradation @ GeneSrc $ , resulting elevated @ GeneSrc $ expression SH-SY5Y cells . Moreover , @ GeneSrc $ cell death abolished wild-type parkin , @ DiseaseTgt $ parkin mutants , implying parkin antagonizes death potential @ GeneSrc $ . led us investigate whether FAF1 participates pathogenesis @ DiseaseTgt $ . address , used gene trap mutagenesis approach generate mutant mice diminished levels FAF1 ( Faf1 ( gt/gt ) ) . Using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) -treated mouse model @ DiseaseTgt $ , found FAF1 accumulated substantia nigra pars compacta ( SNc ) MPTP-treated @ DiseaseTgt $ mice , MPTP-induced dopaminergic cell loss SNc significantly attenuated Faf1 ( gt/gt ) mice versus Faf1 ( +/+ ) mice . MPTP-induced reduction locomotor activity also lessened Faf1 ( gt/gt ) mice versus Faf1 ( +/+ ) mice . Furthermore , found FAF1 deficiency blocked @ DiseaseTgt $ biochemical events , including caspase activation , ROS generation , JNK activation cell death . Taken together , results suggest new role FAF1 : positive modulator @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8824964485453656)\n",
      "- Text: \"Pink1 Parkinson mutations , @ GeneSrc $ chaperones Parkin influence maturation subcellular distribution Pink1 . Mutations ubiquitously expressed gene PTEN-induced kinase 1 ( Pink1 ) cause autosomal recessive @ DiseaseTgt $ . Pink1 encodes putative serine/threonine kinase N-terminal mitochondrial targeting sequence . mechanism leads selective degeneration dopaminergic neurons via Pink1 mutations unknown . full-length pre-protein ( 66 kDa ) N-terminally truncated mature form ( 55 kDa ) described human brain . , report endogenous 66 kDa 55 kDa Pink1 forms cultured cells exclusive mitochondria also occur cytosolic microsome-rich fractions . Pink1 66 kDa predominant isoform cultured cells . Using unbiased analyses immunoisolated Pink1 complexes mass spectrometry , co-immunoprecipitation Hsp90 inhibitor studies , identify Pink1 novel @ GeneSrc $ client kinase . chaperone system influences subcellular distribution 66/55 kDa protein ratio Pink1 . @ DiseaseTgt $ Pink1 mutations decrease whereas Parkin expression increases Pink1 66/55 kDa protein ratio , biochemically linking Pink1 Parkin highlighting potential relevance ratio @ DiseaseTgt $ pathogenesis . Finally , document influence Parkin Pink1 subcellular distribution , providing evidence common pathogenic pathway recessive @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.446834840474941)\n",
      "- Text: \"Interplay p53 DNA-repair protein XRCC4 tumorigenesis , genomic stability development . XRCC4 non-homologous end-joining protein employed DNA double strand break repair V ( ) J recombination . mice , XRCC4-deficiency causes pleiotropic phenotype , includes embryonic lethality massive neuronal apoptosis . DNA damage repaired , activation cell cycle checkpoint protein p53 lead apoptosis . show p53-deficiency rescues several aspects XRCC4-deficient phenotype , including embryonic lethality , neuronal apoptosis , impaired cellular proliferation . However , significant rescue impaired V ( ) J recombination lymphocyte development . Although p53-deficiency allowed postnatal survival XRCC4-deficient mice , routinely succumbed pro-B-cell lymphomas chromosomal translocations linking amplified c-myc oncogene @ GeneSrc $ locus sequences . Moreover , even XRCC4-deficient embryonic fibroblasts exhibited marked genomic instability including chromosomal translocations . findings support crucial role non-homologous end-joining pathway caretaker mammalian genome , role required normal development suppression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.8773690719621226e-06)\n",
      "- Text: \"Unrepaired DNA breaks p53-deficient cells lead oncogenic gene amplification subsequent translocations . Amplification large genomic regions associated complex translocations ( complicons ) basis @ DiseaseTgt $ progression drug resistance . show pro-B lymphomas mice deficient p53 nonhomologous end-joining ( NHEJ ) contain complicons coamplify c-myc ( chromosome 15 ) @ GeneSrc $ ( chromosome 12 ) sequences . carry translocated ( 12 ; 15 ) chromosome , coamplified sequences located within separate complicon often involves third chromosome . Complicon formation initiated recombination RAG1/2-catalyzed @ GeneSrc $ locus double-strand breaks sequences downstream c-myc , generating dicentric ( 15 ; 12 ) chromosome amplification intermediate . recombination event employs microhomology-based end-joining repair pathway , opposed classic NHEJ homologous recombination . findings suggest general model oncogenic complicon formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0021611422752474)\n",
      "- Text: \"coding-independent function gene pseudogene mRNAs regulates @ DiseaseTgt $ biology . canonical role messenger RNA ( mRNA ) deliver protein-coding information sites protein synthesis . However , given microRNAs bind RNAs , hypothesized RNAs could possess regulatory role relies ability compete microRNA binding , independently protein-coding function . model protein-coding-independent role RNAs , describe functional relationship mRNAs produced PTEN @ DiseaseTgt $ suppressor gene pseudogene @ GeneSrc $ critical consequences interaction . find @ GeneSrc $ biologically active regulate cellular levels PTEN exert growth-suppressive role . also show @ GeneSrc $ locus selectively lost human @ DiseaseTgt $ . extended analysis @ DiseaseTgt $ genes possess pseudogenes , oncogenic KRAS . also demonstrate transcripts protein-coding genes PTEN biologically active . findings attribute novel biological role expressed pseudogenes , regulate coding gene expression , reveal non-coding function mRNAs .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4935608472020524)\n",
      "- Text: \"Genetic mapping third Li-Fraumeni syndrome predisposition locus human chromosome 1q23 . Li-Fraumeni syndrome ( LFS ) clinically genetically heterogeneous inherited cancer syndrome . cases ( approximately 70 % ) identified characterized date associated dominantly inherited germ line mutations @ DiseaseTgt $ suppressor gene TP53 ( p53 ) chromosome 17p13.1 . subset non-p53 patients LFS , @ GeneSrc $ chromosome 22q11 identified another predisposing locus . Studying series non-p53 LFS kindred , shown additional genetic heterogeneity LFS kindred inherited predisposition loci p53 @ GeneSrc $ . Using genome-wide scan linkage complementing parametric nonparametric analysis methods , identified linkage region approximately 4 cM chromosome 1q23 , genomic region previously implicated disease . Identification ofa third predisposing gene underlying mutation ( ) provide insight genetic events predispose genesis diverse @ DiseaseTgt $ associated LFS variants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1282711747798609)\n",
      "- Text: \"DNA damage response candidate @ DiseaseTgt $ barrier early human tumorigenesis . evolution @ DiseaseTgt $ , incipient @ DiseaseTgt $ experiences ' oncogenic stress ' , evokes counter-response eliminate hazardous cells . However , nature stress remains elusive , inducible @ DiseaseTgt $ barrier elicits growth arrest cell death . show clinical specimens different stages human tumours urinary bladder , breast , lung colon , early precursor lesions ( normal tissues ) commonly express markers activated DNA damage response . include phosphorylated kinases ATM @ GeneSrc $ , phosphorylated histone H2AX p53 . Similar checkpoint responses induced cultured cells upon expression different oncogenes deregulate DNA replication . Together genetic analyses , including genome-wide assessment allelic imbalances , data indicate early tumorigenesis ( genomic instability malignant conversion ) , human cells activate ATR/ATM-regulated DNA damage response network delays prevents @ DiseaseTgt $ . Mutations compromising checkpoint , including defects @ GeneSrc $ pathway , might allow cell proliferation , survival , increased genomic instability @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.877531001543499)\n",
      "- Text: \"Activation DNA damage checkpoint genomic instability human precancerous lesions . DNA damage checkpoint genes , p53 , frequently mutated human @ DiseaseTgt $ , selective pressure inactivation remains elusive . analysed panel human lung hyperplasias , retained wild-type p53 genes signs gross chromosomal instability , found signs DNA damage response , including histone H2AX @ GeneSrc $ phosphorylation , p53 accumulation , focal staining p53 binding protein 1 ( 53BP1 ) apoptosis . Progression @ DiseaseTgt $ associated p53 53BP1 inactivation decreased apoptosis . DNA damage response also observed dysplastic nevi human skin xenografts , hyperplasia induced overexpression growth factors . lung experimentally-induced skin hyperplasias showed allelic imbalance loci prone DNA double-strand break formation DNA replication compromised ( common fragile sites ) . propose , earliest stages , @ DiseaseTgt $ development associated DNA replication stress , leads DNA double-strand breaks , genomic instability selective pressure p53 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2178546152692922)\n",
      "- Text: \"Collaborative analysis alpha-synuclein gene promoter variability @ DiseaseTgt $ . CONTEXT : Identification replication susceptibility genes @ DiseaseTgt $ population level hampered small studies potential biases . Alpha-synuclein ( SNCA ) one promising susceptibility genes , large-scale studies lacking . OBJECTIVE : determine whether allele-length variability dinucleotide repeat sequence ( @ GeneSrc $ ) SNCA gene promoter associated @ DiseaseTgt $ susceptibility , whether SNCA promoter haplotypes associated @ DiseaseTgt $ , whether @ GeneSrc $ variability modifies age onset . DESIGN , SETTING , PARTICIPANTS : performed collaborative analysis individual-level data SNCA @ GeneSrc $ flanking markers patients @ DiseaseTgt $ controls . Study site recruitment , data collection , analyses performed April 5 , 2004 , December 31 , 2005 . Eighteen participating sites global genetics consortium provided clinical data . Genotyping performed SNCA @ GeneSrc $ , -770 , -116 markers individual sites ; however , site also provided 20 DNA samples regenotyping centrally . MAIN OUTCOME MEASURES : Measures included estimations Hardy-Weinberg equilibrium controls ; test heterogeneity ; analyses association single variants haplotypes ; survival analyses age onset . RESULTS : 18 sites , 11 met stringent criteria concordance Hardy-Weinberg equilibrium low genotyping error rate . 11 sites provided complete data 2692 cases 2652 controls . heterogeneity across studies ( P > .60 ) . SNCA @ GeneSrc $ alleles differed frequency cases controls ( P < .001 ) . Genotypes defined 263 base-pair allele associated @ DiseaseTgt $ ( odds ratio , 1.43 ; 95 % confidence interval , 1.22 - 1.69 ; P < .001 trend ) . Multilocus haplotypes differed frequency cases controls ( global score statistic , P < .001 ) . Two-loci haplotypes associated @ DiseaseTgt $ included @ GeneSrc $ one loci . However , genotypes defined @ GeneSrc $ alleles modify age onset ( P = .55 ) . CONCLUSION : large-scale collaborative analysis demonstrates SNCA @ GeneSrc $ allele-length variability associated increased risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1845491373304514)\n",
      "- Text: \"Expansion @ DiseaseTgt $ SNCA-Rep1 allele upregulates human alpha-synuclein transgenic mouse brain . Alpha-synuclein ( SNCA ) gene implicated development rare forms familial Parkinson disease ( @ DiseaseTgt $ ) . Recently , shown increase SNCA copy numbers leads elevated levels wild-type SNCA-mRNA protein sufficient cause early-onset , familial @ DiseaseTgt $ . critical question concerning molecular pathogenesis @ DiseaseTgt $ contributory role , , played SNCA gene sporadic @ DiseaseTgt $ . expansion SNCA-Rep1 , upstream , polymorphic microsatellite SNCA gene , associated elevated risk sporadic @ DiseaseTgt $ . However , whether SNCA-Rep1 causal variant underlying mechanism effect mediated remained elusive . report effects three distinct SNCA-Rep1 variants brains 72 mice transgenic entire human SNCA locus . Human SNCA-mRNA protein levels increased 1.7- 1.25-fold , respectively , homozygotes expanded , @ DiseaseTgt $ risk-conferring allele compared homozygotes shorter , protective allele . adjusting total SNCA-protein concentration ( endogenous mouse transgenic human ) expressed brain , expanded risk allele contributed 2.6-fold SNCA steady-state shorter allele . Furthermore , targeted deletion Rep1 resulted lowest human SNCA-mRNA protein concentrations murine brain . contrast , @ GeneSrc $ effect observed blood lysates mice . results demonstrate @ GeneSrc $ regulates human SNCA expression enhancing transcription adult nervous system suggest homozygosity expanded @ GeneSrc $ allele may mimic locus multiplication , thereby elevating @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0655136835215895)\n",
      "- Text: \"Somatic PIK3CA Mutations Sporadic Cerebral Cavernous Malformations . BACKGROUND : Cerebral cavernous malformations ( CCMs ) common sporadic inherited vascular malformations central nervous system . Although familial CCMs linked loss-of-function mutations KRIT1 ( CCM1 ) , CCM2 , @ GeneSrc $ ( @ GeneSrc $ ) , genetic cause sporadic CCMs , representing 80 % cases , remains incompletely understood . METHODS : developed two mouse models harboring mutations identified human meningiomas use prostaglandin D2 synthase ( PGDS ) promoter . performed targeted DNA sequencing surgically resected CCMs patients confirmed findings droplet digital polymerase-chain-reaction analysis . RESULTS : found mice expressing one two common genetic drivers meningioma - Pik3ca H1047R AKT1 E17 K - PGDS-positive cells , spectrum typical CCMs develops ( 22 % 11 % mice , respectively ) instead meningiomas , prompted us analyze tissue samples sporadic CCMs 88 patients . detected somatic activating PIK3CA AKT1 mutations 39 % 1 % , respectively , lesion tissue patients . 10 % lesions harbored mutations CCM genes . analyzed lesions induced activating mutations Pik3ca H1074R AKT1 E17 K mice identified PGDS-expressing pericyte probable cell origin . CONCLUSIONS : tissue samples sporadic CCMs , mutations PIK3CA represented greater extent mutations gene . contribution somatic mutations genes cause familial CCMs comparatively small . ( Funded Fondation ARC pour la Recherche contre le @ DiseaseTgt $ others . ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008426879584501)\n",
      "- Text: \"@ GeneSrc $ regulates farnesyl-electrostatic switch K-Ras promotes association Bcl-XL mitochondria induces apoptosis . K-Ras associates plasma membrane ( PM ) farnesylation functions conjunction adjacent polybasic sequence . show phosphorylation @ GeneSrc $ ( @ GeneSrc $ ) S181 within polybasic region promotes rapid dissociation K-Ras PM association intracellular membranes , including outer membrane mitochondria phospho-K-Ras interacts Bcl-XL . @ GeneSrc $ agonists promote apoptosis cells transformed oncogenic K-Ras S181-dependent manner . K-Ras phosphomimetic residue position 181 induces apoptosis via pathway requires Bcl-XL . @ GeneSrc $ agonist bryostatin-1 inhibited growth vitro vivo cells transformed oncogenic K-Ras S181-dependent fashion . data demonstrate location function K-Ras regulated directly @ GeneSrc $ suggest approach therapy K-Ras-dependent @ DiseaseTgt $ agents stimulate phosphorylation S181 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0040025207304529)\n",
      "- Text: \"Genetic association APOE * 4 allele Lewy bodies @ DiseaseTgt $ . OBJECTIVE : explore association APOE * 4 pathologically confirmed cases Lewy body ( LB ) variant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . METHODS : use alpha-synuclein ( @ GeneSrc $ ) immunohistochemistry , LBs detected 74 131 ( 56.5 % ) @ DiseaseTgt $ + LB cases ; remaining 57 cases ( 43.5 % ) LBs . RESULTS : differences gender age Caucasian subjects @ DiseaseTgt $ + LB @ DiseaseTgt $ alone control subjects . APOE * 4 allele frequency highest @ DiseaseTgt $ + LB group ( 47.3 % ; 95 % CI = 37.8 57.0 % ) , intermediate @ DiseaseTgt $ group ( 35.1 % ; 95 % CI = 25.3 46.3 % ) , lowest control group ( 14.2 % ; 95 % CI = 10.5 18.9 % ) . use logistic regression analysis , odds @ DiseaseTgt $ + LB vs @ DiseaseTgt $ alone 2.1-fold ( 95 % CI = 1.0 4.5 , p = 0.055 ) greater persons APOE * 4 allele without APOE * 4 allele . CONCLUSION : APOE * 4 allele associated presence concomitant Lewy bodies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0738330062152326)\n",
      "- Text: \"formation highly soluble oligomers alpha-synuclein regulated fatty acids enhanced @ DiseaseTgt $ . Accumulation misfolded proteins insoluble aggregates occurs several neurodegenerative diseases . @ DiseaseTgt $ ( @ DiseaseTgt $ ) dementia Lewy bodies ( DLB ) , alpha-synuclein ( @ GeneSrc $ ) accumulates insoluble inclusions . identify soluble @ GeneSrc $ oligomers precede insoluble aggregates , probed cytosols mesencephalic neuronal ( MES ) cells , normal @ GeneSrc $ mouse brains , normal , @ DiseaseTgt $ , DLB human brains . contained highly soluble oligomers @ GeneSrc $ whose detection enhanced delipidation . Exposure living MES neurons polyunsaturated fatty acids ( PUFAs ) increased @ GeneSrc $ oligomer levels , whereas saturated FAs decreased . PUFAs directly promoted oligomerization recombinant alphaS . Transgenic mice accumulated soluble oligomers age . @ DiseaseTgt $ DLB brains elevated amounts soluble , lipid-dependent oligomers . conclude @ GeneSrc $ interacts PUFAs vivo promote formation highly soluble oligomers precede insoluble @ GeneSrc $ aggregates associated neurodegeneration .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9532322326414988)\n",
      "- Text: \"@ GeneSrc $ mutations parkinsonism-dementia-amyotrophic lateral sclerosis complex . @ GeneSrc $ gene mutations found cause early-onset @ DiseaseTgt $ . report family southern Italy three brothers affected early-onset parkinsonism , dementia , amyotrophic lateral sclerosis . Molecular analysis @ GeneSrc $ gene two living patients showed novel homozygous mutation exon 7 ( E163 K ) new homozygous mutation ( g.168_185dup ) promoter region gene . mutations cosegregated disease detected heterozygous state patients ' mother healthy siblings . findings expand spectrum clinical presentations associated mutations @ GeneSrc $ gene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5101622006327389)\n",
      "- Text: \"Reduced anti-oxidative stress activities @ GeneSrc $ mutants found @ DiseaseTgt $ patients . @ GeneSrc $ multi-functional protein plays roles transcriptional regulation anti-oxidative stress , loss function thought result onset @ DiseaseTgt $ . previously reported L166P , mutant @ GeneSrc $ found @ DiseaseTgt $ patients , activity prevent hydrogen peroxide ( H2O2 ) -induced cell death . study , analyzed mutants @ GeneSrc $ found @ DiseaseTgt $ patients , including M26I , R98Q , D149A , well L166P . first found mutants made heterodimers wild-type @ GeneSrc $ , mutants except L166P made homodimers . found M26I L166P , derived homozygous mutations @ GeneSrc $ gene , unstable stabilities recovered , part , presence proteasome inhibitor , MG132 . NIH3T3 cell lines stably expressing mutants @ GeneSrc $ showed cell lines L166P C106S , mutant protease activity ( - ) @ GeneSrc $ , activity scavenge even endogenously producing reactive oxygen species . cell lines also showed mutants reduced activities eliminate exogenously added H2O2 activities , except D149A , parallel preventing H2O2-induced cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8881988237215522)\n",
      "- Text: \"Mutational analysis DJ-1 Drosophila implicates functional inactivation oxidative damage aging . Inherited mutations PARK7 , gene encoding DJ-1 , associated loss protein function early-onset parkinsonism . Like human @ GeneSrc $ ( hDJ-1 ) , Drosophila DJ-1b protects oxidative insult modified oxidation . demonstrate hDJ-1 rescues flies mutant DJ-1b , conserved cysteine residue fly protein ( C104 , analogous C106 hDJ-1 ) critical biological antioxidant function vivo . Targeted mutagenesis suggests modification DJ-1b residue inactivates protective activity protein oxidative stress . studies show @ GeneSrc $ modification increases dramatically age flies , mice , humans , aged flies showing strikingly increased susceptibility oxidative stress markedly enhanced DJ-1b modification upon oxidative challenge . Overoxidation DJ-1 age exposure oxidative toxins may lead inactivation DJ-1 function , suggesting role susceptibility sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017498212286139)\n",
      "- Text: \"@ GeneSrc $ , cancer- @ DiseaseTgt $ protein , stabilizes antioxidant transcriptional master regulator Nrf2 . @ GeneSrc $ , cancer- @ DiseaseTgt $ @ DiseaseTgt $ protein , protects cells toxic stresses . However , functional basis protection remained elusive . found loss @ GeneSrc $ leads deficits NQO1 [ NAD ( P ) H quinone oxidoreductase 1 ] , detoxification enzyme . deficit attributed loss Nrf2 ( nuclear factor erythroid 2-related factor ) , master regulator antioxidant transcriptional responses . @ GeneSrc $ stabilizes Nrf2 preventing association inhibitor protein , Keap1 , Nrf2 's subsequent ubiquitination . Without intact @ GeneSrc $ , Nrf2 protein unstable , transcriptional responses thereby decreased basally induction . effect @ GeneSrc $ Nrf2 present transformed lines primary cells across human mouse species . @ GeneSrc $ 's effect Nrf2 subsequent effects antioxidant responses may explain @ GeneSrc $ affects etiology cancer @ DiseaseTgt $ , seemingly disparate disorders . Furthermore , @ GeneSrc $ functional axis presents therapeutic target cancer treatment justifies @ GeneSrc $ tumor biomarker .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4221886980713095)\n",
      "- Text: \"Association @ GeneSrc $ parkin mediated pathogenic @ GeneSrc $ mutations oxidative stress . identification rare monogenic forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) provided tremendous insight molecular pathogenesis disorder . Heritable mutations alpha-synuclein , parkin , @ GeneSrc $ PINK1 cause familial forms @ DiseaseTgt $ . common sporadic form @ DiseaseTgt $ , oxidative stress derangements mitochondrial complex-I function considered play prominent role disease pathogenesis . However , relationship @ GeneSrc $ @ DiseaseTgt $ genes oxidative stress explored . , show pathogenic mutant forms @ GeneSrc $ specifically differentially associate parkin , E3 ubiquitin ligase . Chemical cross-linking shows pathogenic @ GeneSrc $ mutants exhibit impairments homo-dimer formation , suggesting parkin may bind monomeric @ GeneSrc $ . Parkin fails specifically ubiquitinate enhance degradation L166P M26I mutant @ GeneSrc $ , instead promotes stability cultured cells . interaction parkin L166P @ GeneSrc $ may involve larger protein complex contains CHIP Hsp70 , perhaps accounting lack parkin-mediated ubiquitination . Oxidative stress also promotes interaction @ GeneSrc $ parkin , result ubiquitination degradation @ GeneSrc $ . Parkin-mediated alterations @ GeneSrc $ protein stability may pathogenically relevant @ GeneSrc $ levels dramatically increased detergent-insoluble fraction sporadic @ DiseaseTgt $ brains , reduced insoluble fraction parkin-linked autosomal recessive juvenile-onset @ DiseaseTgt $ brains . data potentially link @ GeneSrc $ parkin common molecular pathway multiple levels may important implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9911656349664872)\n",
      "- Text: \"Association PINK1 @ GeneSrc $ confers digenic inheritance early-onset @ DiseaseTgt $ . Mutations genes encoding @ GeneSrc $ pten-induced kinase 1 ( PINK1 ) independently linked autosomal recessive early-onset familial forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . report identification family @ DiseaseTgt $ patients harboring novel heterozygous missense mutations PINK1 @ GeneSrc $ genes encoding DJ-1A39S PINK1P399L , respectively . transfected cells , @ GeneSrc $ interacts PINK1 . PINK1P399L less stable wild-type protein degraded via ubiquitin-mediated proteasomal pathway . Expression wild-type @ GeneSrc $ increased steady-state levels PINK1 , whereas expression DJ-1A39S reduced steady-state levels PINK1 . Furthermore , co-expression wild-type @ GeneSrc $ PINK1 suppresses neurotoxin 1-methyl-4-phenylpyridinium ( MPP ( + ) ) -induced death dopaminergic SH-SY5Y cells . contrast , co-expression @ DiseaseTgt $ DJ-1A39S PINK1P399L significantly potentiated susceptibility SH-SY5Y cells MPP ( + ) -induced cell death . study reports first case autosomal recessive @ DiseaseTgt $ digenic inheritance demonstrates @ GeneSrc $ PINK1 physically associate collaborate protect cells stress via complex formation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8348333209375411)\n",
      "- Text: \"heterozygous effect PINK1 mutations @ DiseaseTgt $ ? OBJECTIVE : investigate significance PINK1 mutations sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . METHODS : determined frequency PINK1 mutations direct sequencing large series @ DiseaseTgt $ patients apparently sporadic disease ( n = 768 ) . RESULTS : Twelve heterozygous mutations identified , nine @ DiseaseTgt $ patients three control subjects . INTERPRETATION : Given difficulty interpreting pathogenic significance heterozygous mutations already reported parkin @ GeneSrc $ , first determined frequency heterozygous PINK1 mutations general population sequencing large number control subjects ( n = 768 ) , subsequently assessed functional significance examining effects stress-induced alterations mitochondrial membrane potential ( DeltaPsim ) . demonstrate enrichment heterozygous mutations sporadic @ DiseaseTgt $ patients compared matched control subjects ( 1.2 % @ DiseaseTgt $ vs 0.4 % control subjects ) . Furthermore , show adversely affect DeltaPsim similar way familial G309D mutation . Although remains difficult conclusively demonstrate pathogenicity heterozygous mutations , results study previously reported subclinical nigrostriatal dysfunction carriers heterozygous PINK1 mutations suggest possibility heterozygous mutations significant risk factor development later onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0650971670933694)\n",
      "- Text: \"Parkin , PINK1 , @ GeneSrc $ form ubiquitin E3 ligase complex promoting unfolded protein degradation . Mutations PARKIN , pten-induced putative kinase 1 ( PINK1 ) , @ GeneSrc $ individually linked autosomal recessive early-onset familial forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although mutations genes lead disease state , functional relationships respective disease-associated mutations cause @ DiseaseTgt $ largely unknown . , show Parkin , PINK1 , @ GeneSrc $ formed complex ( termed PPD complex ) promote ubiquitination degradation Parkin substrates , including Parkin Synphilin-1 neuroblastoma cells human brain lysates . Genetic ablation either Pink1 @ GeneSrc $ resulted reduced ubiquitination endogenous Parkin well decreased degradation increased accumulation aberrantly expressed Parkin substrates . Expression PINK1 enhanced Parkin-mediated degradation heat shock-induced misfolded protein . contrast , @ DiseaseTgt $ Parkin PINK1 mutations showed reduced ability promote degradation Parkin substrates . study identified functional ubiquitin E3 ligase complex consisting @ DiseaseTgt $ Parkin , PINK1 , @ GeneSrc $ promote degradation un-/misfolded proteins suggests @ DiseaseTgt $ mutations impair E3 ligase activity complex , may constitute mechanism underlying @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999994502536924)\n",
      "- Text: \"role pathogenic @ GeneSrc $ mutations @ DiseaseTgt $ . Mutations @ GeneSrc $ ( @ GeneSrc $ ) reported two consanguineous families young-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . study aims confirm presence pathogenic @ GeneSrc $ mutations determine contribution young-onset typical later onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . entire open reading frame @ GeneSrc $ gene screened direct sequencing 185 unrelated @ DiseaseTgt $ patients separate cohort 190 pathologically proven cases @ DiseaseTgt $ . Ethnically matched controls screened mutations identified . report low frequency pathogenic @ GeneSrc $ mutations cohort patients . One homozygous missense mutation one heterozygous mutation found two @ DiseaseTgt $ samples . addition , several variants found coding sequence gene , likely represent polymorphisms . one case , polymorphism population specific . reported 14Kbp deletion found samples controls . confirm presence pathogenic @ GeneSrc $ mutations @ DiseaseTgt $ estimate frequency approximately 1 % . mutations found cohort later onset sporadic pathologically confirmed cases , suggesting @ GeneSrc $ mutations may rarely contribute cause typical sporadic form disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9690519472144604)\n",
      "- Text: \"@ DiseaseTgt $ protein @ GeneSrc $ binds metals protects metal-induced cytotoxicity . progressive loss motor control due reduction dopamine-producing neurons substantia nigra pars compacta decreased striatal dopamine levels classically described features @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Neuronal damage also progresses regions brain , additional non-motor dysfunctions common . Accumulation environmental toxins , pesticides metals , suggested risk factors development typical late onset @ DiseaseTgt $ , although genetic factors seem substantial early onset cases . Mutations @ GeneSrc $ known cause form recessive early onset @ DiseaseTgt $ , highlighting important functional role @ GeneSrc $ early disease prevention . study identifies human @ GeneSrc $ metal-binding protein able evidently bind copper well toxic mercury ions vitro . study characterizes cytoprotective function @ GeneSrc $ @ DiseaseTgt $ variants @ GeneSrc $ respect induced metal cytotoxicity . results show expression @ GeneSrc $ enhances cells ' protective mechanisms induced metal toxicity protection lost @ GeneSrc $ @ DiseaseTgt $ mutations A104 D149A . study also shows oxidation site-mutated @ GeneSrc $ C106A retains ability protect cells . also show concomitant addition dopamine exposure sensitizes cells metal-induced cytotoxicity . also confirm redox-active dopamine adducts enhance metal-catalyzed oxidation intracellular proteins vivo use live cell imaging redox-sensitive S3roGFP . study indicates even small genetic alteration sensitize cells metal-induced cell death , finding may revive interest exogenous factors etiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.427842726976205)\n",
      "- Text: \"@ GeneSrc $ induces thioredoxin 1 expression Nrf2 pathway . @ GeneSrc $ , linked recessively inherited @ DiseaseTgt $ mutated , multi-functional protein anti-oxidant transcription regulatory activities . However , mechanism ( ) @ GeneSrc $ genes regulates provide neuroprotection fully understood . , show wild-type @ GeneSrc $ induces expression thioredoxin 1 ( Trx1 ) , protein disulfide oxidoreductase , whereas pathogenic mutant isoforms L166P M26I . Conversely , @ GeneSrc $ knockdown SH-SY5Y cells DJ-1 knockout mice result significant decrease Trx1 protein mRNA expression levels . importance Trx1 cytoprotective function @ GeneSrc $ confirmed using pharmacological inhibitor Trx reductase , 1-chloro-2,4-dinitrobenzene , Trx1 siRNA . approaches result partial loss @ GeneSrc $ protection . Additionally , knockdown Trx1 significantly abrogates @ GeneSrc $ , hydrogen peroxide-induced activation pro-survival factor AKT . Promoter analysis human Trx1 gene identified antioxidant response element ( ) required @ GeneSrc $ induction Trx1 expression . transcription factor Nuclear factor erythroid-2 related factor 2 ( Nrf2 ) , critical inducer ARE-mediated expression , regulated @ GeneSrc $ . Overexpression @ GeneSrc $ results increased Nrf2 protein levels , promotes translocation nucleus enhances recruitment onto site Trx1 promoter . , Nrf2 knockdown abolishes @ GeneSrc $ Trx1 induction cytoprotection hydrogen peroxide , indicating critical role Nrf2 carrying protective functions @ GeneSrc $ oxidative stress . findings provide new mechanism support antioxidant function @ GeneSrc $ increasing Trx1 expression via Nrf2-mediated transcriptional induction .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.936397530827668)\n",
      "- Text: \"@ DiseaseTgt $ protein @ GeneSrc $ converts zymogen protease carboxyl-terminal cleavage . Mutations @ GeneSrc $ cause recessively transmitted early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , oxidative damage @ GeneSrc $ associated pathogenesis late-onset sporadic @ DiseaseTgt $ . precise biochemical function @ GeneSrc $ remains elusive . , report @ GeneSrc $ synthesized latent protease zymogen low-intrinsic proteolytic activity . @ GeneSrc $ protease zymogen activated removal 15-amino acid peptide C terminus . activated @ GeneSrc $ functions cysteine protease Cys-106 His-126 catalytic diad . show endogenous @ GeneSrc $ dopaminergic cells undergoes C-terminal cleavage response mild oxidative stress , suggesting @ GeneSrc $ protease activation occurs redox-dependent manner . Moreover , find C-terminally cleaved form @ GeneSrc $ activated protease function exhibits enhanced cytoprotective action oxidative stress-induced apoptosis . cytoprotective action @ GeneSrc $ abolished C106A H126A mutations . findings support role @ GeneSrc $ protease cellular defense oxidative stress important implications understanding treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9922677259552946)\n",
      "- Text: \"Clinicogenetic study PINK1 mutations autosomal recessive early-onset parkinsonism . authors performed PINK1 mutation analysis 51 families autosomal recessive Parkinson disease ( ARPD ) . found two novel PINK1 mutations : one homozygous deletion ( 13516 - 18118del ) homozygous missense mutation ( C388R ) . Clinically , patients deletion dementia . Thus , early-onset @ DiseaseTgt $ dementia may considered PINK1-linked parkinsonism . Furthermore , patients PINK1 mutations form 8.9 % parkin- @ GeneSrc $ ARPD families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008584868943433)\n",
      "- Text: \"@ DiseaseTgt $ @ GeneSrc $ protein transcriptional co-activator protects neuronal apoptosis . Mutations @ GeneSrc $ gene cause early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , although role @ GeneSrc $ degeneration dopaminergic neurons unresolved . show major interacting-proteins @ GeneSrc $ dopaminergic neuronal cells nuclear proteins p54nrb pyrimidine tract-binding protein-associated splicing factor ( PSF ) , two multifunctional regulators transcription RNA metabolism . @ DiseaseTgt $ @ GeneSrc $ mutants exhibit decreased nuclear distribution increased mitochondrial localization , resulting diminished co-localization co-activator p54nrb repressor PSF . Unlike pathogenic @ GeneSrc $ mutants , wild-type @ GeneSrc $ acts inhibit transcriptional silencing activity PSF . addition , transcriptional silencer PSF induces neuronal apoptosis , reversed wild-type @ GeneSrc $ lesser extent @ DiseaseTgt $ @ GeneSrc $ mutants . @ GeneSrc $ small interfering RNA sensitizes cells PSF-induced apoptosis . @ GeneSrc $ p54nrb block oxidative stress mutant alpha-synuclein-induced cell death . Thus , @ GeneSrc $ neuroprotective transcriptional co-activator may act concert p54nrb PSF regulate expression neuroprotective genetic program . Mutations impair transcriptional co-activator function @ GeneSrc $ render dopaminergic neurons vulnerable apoptosis may contribute pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9556223061548084)\n",
      "- Text: \"Interaction @ GeneSrc $ Daxx inhibits apoptosis signal-regulating kinase 1 activity cell death . Investigations cellular molecular biology genes cause inherited forms @ DiseaseTgt $ , well downstream pathways trigger , shed considerable light understanding fundamental determinants life death dopaminergic neurons . Homozygous deletion missense mutation @ GeneSrc $ results autosomal recessively inherited @ DiseaseTgt $ , suggesting wild-type @ GeneSrc $ favorable role maintaining neurons . , show @ GeneSrc $ protects oxidative stress-induced cell death , relatively modest ability quench reactive oxygen species insufficient account robust cytoprotective effect . elucidate mechanism cell-preserving function , screened death protein Daxx @ GeneSrc $ partner . demonstrate wild-type @ GeneSrc $ sequesters Daxx nucleus , prevents gaining access cytoplasm , binding activating effector kinase apoptosis signal-regulating kinase 1 , therefore , triggering ensuing death pathway . steps impaired disease-causing L166P mutant isoform @ GeneSrc $ . findings suggest regulated sequestration Daxx nucleus keeping apoptosis signal-regulating kinase 1 activation check critical mechanism @ GeneSrc $ exerts cytoprotective function .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.450517079385496)\n",
      "- Text: \"Mutations @ GeneSrc $ gene associated autosomal recessive early-onset parkinsonism . @ GeneSrc $ gene encodes ubiquitous , highly conserved protein . , show @ GeneSrc $ mutations associated @ GeneSrc $ , monogenic form human parkinsonism . function @ GeneSrc $ protein remains unknown , evidence suggests involvement oxidative stress response . findings indicate loss @ GeneSrc $ function leads neurodegeneration . Elucidating physiological role @ GeneSrc $ protein may promote understanding mechanisms brain neuronal maintenance pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8562015024558725)\n",
      "- Text: \"Loss @ DiseaseTgt $ gene @ GeneSrc $ perturbs mitochondrial dynamics . Growing evidence highlights role mitochondrial dysfunction oxidative stress underlying contributors @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathogenesis . @ GeneSrc $ ( @ GeneSrc $ ) recently identified recessive familial @ DiseaseTgt $ gene . loss leads increased susceptibility neurons oxidative stress death . However , mechanism action fully understood . Presently , report @ GeneSrc $ deficiency cell lines , cultured neurons , mouse brain lymphoblast cells derived @ GeneSrc $ patients display aberrant mitochondrial morphology . also show @ GeneSrc $ mitochondrial defects contribute oxidative stress-induced sensitivity cell death since reversal fragmented mitochondrial phenotype abrogates neuronal cell death . Reactive oxygen species ( ROS ) appear play critical role observed defects , ROS scavengers rescue phenotype mitochondria isolated @ GeneSrc $ deficient animals produce ROS compared control . Importantly , aberrant mitochondrial phenotype rescued expression Pink1 Parkin , two @ DiseaseTgt $ genes involved regulating mitochondrial dynamics quality control . Finally , show @ GeneSrc $ deficiency leads altered autophagy murine human cells . findings define mechanism @ GeneSrc $ mitochondrial defects contribute increased sensitivity oxidative stress-induced cell death previously reported .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0965948834713627)\n",
      "- Text: \"Analysis PARK genes Korean cohort early-onset @ DiseaseTgt $ . Mutations five PARK genes ( SNCA , PARKIN , @ GeneSrc $ , PINK1 , LRRK2 ) well-established genetic causes @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Recently , G2385R substitution LRRK2 determined susceptibility allele Asian @ DiseaseTgt $ . objective study determine frequency mutations PARK genes Korean early-onset @ DiseaseTgt $ ( EOPD ) cohort . authors sequenced 35 exons SNCA , PARKIN , @ GeneSrc $ , PINK1 , LRRK2 72 unrelated EOPD ( age-at-onset < or=50 ) recruited ten movement disorders clinics South Korea . Gene dosage change aforementioned genes studied using multiple ligation-dependent probe amplification . found four patients PARKIN mutations , homozygous deletion exon 4 , compound heterozygous deletion exon 2 exon 4 , heterozygous deletion exon 4 , heterozygous nonsense mutation ( Q40X ) . Four patients PINK1 mutations ; compound heterozygous mutation ( N367S K520RfsX522 ) three heterozygous mutations ( G32R , R279H , F385L ) . missense mutation SNCA ( A53 ) found familial @ DiseaseTgt $ autosomal dominant inheritance . Nine patients ( 12.5 % ) heterozygous G2385R polymorphism LRRK2 , whereas none G2019S mutation . However , mutations detected @ GeneSrc $ UCHL1 series . identified genetic variants PARKIN , PINK1 , LRRK2 , SNCA cause genetic risk factors @ DiseaseTgt $ 25 % Korean EOPD , mutation PARKIN common genetic cause .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0484561050106567)\n",
      "- Text: \"T313 PINK1 mutation extended highly consanguineous Saudi family early-onset @ DiseaseTgt $ . BACKGROUND : date , 5 well-confirmed genes @ DiseaseTgt $ ( @ DiseaseTgt $ ) identified , including 3 autosomal recessive genes : PTEN-induced putative kinase 1 ( PINK1 ) , parkin , @ GeneSrc $ . Almost nothing known genetics @ DiseaseTgt $ Saudi Arabia ; however , consanguineous families , infrequent population , could important evaluation known @ DiseaseTgt $ genes search new @ DiseaseTgt $ factors future . OBJECTIVE : investigate known recessive @ DiseaseTgt $ genes 5 consanguineous Saudi families @ DiseaseTgt $ . DESIGN : entire open frame well untranslated region 5 ' 3 ' intron-exon boundaries PINK1 , parkin , @ GeneSrc $ genes sequenced 5 probands Saudi families . RESULTS : Four 5 probands tested negative PINK1 , parkin , @ GeneSrc $ mutations . However , large Saudi family @ DiseaseTgt $ least 3 consanguineous marriages first cousins , detected threonine methionine substitution codon 313 ( T313 ) PINK1 mutation affected kinase domain . Manifestations disease family included early onset ( age , 28 - 38 years ) , tremulous movement , slow progression , diurnal fluctuations , bradykinesia , good response levodopa therapy , mild dyskinesias . neurologist blinded genetic status clinically evaluated 15 family members , older 20 years , diagnosed @ DiseaseTgt $ individuals later found homozygous T313 mutation . None 13 heterozygotes demonstrated sign @ DiseaseTgt $ . CONCLUSION : homozygous T313 mutation responsible @ DiseaseTgt $ large Saudi family . However , heterozygous T313 mutation act @ DiseaseTgt $ susceptibility factor , contrast several reports mutations affecting 1 PINK1 allele discovered sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6774792854289653)\n",
      "- Text: \"Leucine-rich repeat kinase 2 ( LRRK2 ) interacts parkin , mutant LRRK2 induces neuronal degeneration . @ DiseaseTgt $ ( @ DiseaseTgt $ ) disorder movement , cognition , emotion , characterized pathologically neuronal degeneration Lewy bodies , cytoplasmic inclusion bodies containing deposits aggregated proteins . @ DiseaseTgt $ cases appear sporadic , genetic forms disease , caused mutations alpha-synuclein , parkin , genes , helped elucidate pathogenesis . Mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause autosomal-dominant Parkinsonism clinical features @ DiseaseTgt $ pleomorphic pathology including deposits aggregated protein . study expression interactions LRRK2 , synthesized cDNAs generated expression constructs coding human WT mutant LRRK2 proteins . Expression full-length LRRK2 cells culture suggests protein predominately cytoplasmic , endogenous protein subcellular fractionation . Using coimmunoprecipitation , find LRRK2 , expressed cells culture , interacts parkin alpha-synuclein , @ GeneSrc $ , tau . small proportion cells overexpressing LRRK2 contain protein aggregates , proportion greatly increased coexpression parkin . addition , parkin increases ubiquitination aggregated protein . Also , mutant LRRK2 causes neuronal degeneration SH-SY5Y cells primary neurons . cell model may useful studies @ DiseaseTgt $ cellular pathogenesis therapeutics . findings suggest gain-of-function mechanism pathogenesis LRRK2-linked @ DiseaseTgt $ suggest LRRK2 may involved pathogenic pathway @ DiseaseTgt $ proteins parkin , may help illuminate familial sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.030248758367076)\n",
      "- Text: \"1.1-A resolution crystal structure @ GeneSrc $ , protein mutated autosomal recessive early onset @ DiseaseTgt $ . Mutations @ GeneSrc $ , human gene homologues organisms kingdoms life , shown associated autosomal recessive , early onset @ DiseaseTgt $ ( @ GeneSrc $ ) . report three-dimensional structure @ GeneSrc $ protein , determined resolution 1.1 x-ray crystallography . chain fold @ GeneSrc $ resembles bacterial protein , PfpI , annotated cysteine protease , domain bacterial catalase whose role activity enzyme uncertain . contrast PfpI , hexameric protein whose oligomeric structure essential putative proteolytic activity , @ GeneSrc $ dimer completely different intersubunit contacts . proposed catalytic triad PfpI absent corresponding region structure @ GeneSrc $ , biochemical assays fail detect protease activity purified @ GeneSrc $ . highly conserved cysteine residue , catalytically essential homologues @ GeneSrc $ , shows extreme sensitivity radiation damage may subject forms oxidative modification well . structure suggests loss function caused @ DiseaseTgt $ mutation L166P @ GeneSrc $ due destabilization dimer interface . Taken together , crystal structure human @ GeneSrc $ plus observations suggest possible involvement protein cellular oxidative stress response general etiology neurodegenerative diseases .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9406822096592394)\n",
      "- Text: \"Oxidant stress evoked pacemaking dopaminergic neurons attenuated DJ-1 . @ DiseaseTgt $ pervasive , ageing-related neurodegenerative disease cardinal motor symptoms reflect loss small group neurons , dopaminergic neurons substantia nigra pars compacta ( SNc ) . Mitochondrial oxidant stress widely viewed responsible loss , particular neurons stressed mystery . show , using transgenic mice expressed redox-sensitive variant green fluorescent protein targeted mitochondrial matrix , engagement plasma membrane L-type calcium channels normal autonomous pacemaking created oxidant stress specific vulnerable SNc dopaminergic neurons . oxidant stress engaged defences induced transient , mild mitochondrial depolarization uncoupling . mild uncoupling affected deletion cyclophilin , component permeability transition pore , attenuated genipin purine nucleotides , antagonists cloned uncoupling proteins . Knocking DJ-1 ( also known @ GeneSrc $ humans Park7 mice ) , gene associated early-onset form @ DiseaseTgt $ , downregulated expression two uncoupling proteins ( UCP4 ( SLC25A27 ) UCP5 ( SLC25A14 ) ) , compromised calcium-induced uncoupling increased oxidation matrix proteins specifically SNc dopaminergic neurons . drugs approved human use antagonize calcium entry L-type channels , results point novel neuroprotective strategy idiopathic familial forms @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0036900772351754)\n",
      "- Text: \"LRRK2 gene @ DiseaseTgt $ : mutation analysis case control association study . BACKGROUND : addition four well-confirmed genes linked early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( SNCA , PARKIN , @ GeneSrc $ , PINK1 ) , mutations leucine-rich repeat kinase 2 gene ( LRRK2 ) recently identified families autosomal dominant late-onset @ DiseaseTgt $ . OBJECTIVE : perform mutation analysis LRRK2 probands families showing dominant inheritance @ DiseaseTgt $ conduct case control association study test hypothesis common coding variations might associated increased susceptibility @ DiseaseTgt $ . METHODS : 51 LRRK2 coding exons sequenced 23 probands mutation frequencies evaluated 180 neurologically normal control subjects . association study authors genotyped four coding LRRK2 polymorphisms 250 normal control subjects 121 patients @ DiseaseTgt $ ( predominantly white patients Canadian origin ) , 84 % age onset 50 years 42 % positive family history . RESULTS : authors identified three probands heterozygous LRRK2 mutations : two known G2019S substitution one proband novel I1371V substitution . Mutation analysis large family demonstrated complete segregation G2019S @ DiseaseTgt $ . However , association @ DiseaseTgt $ four polymorphisms allelic genotypic levels ( p > 0.17 ) . Furthermore , authors detect modifying effect genotype APOE genotypes upon age onset @ DiseaseTgt $ group ( p > 0.20 ) . CONCLUSIONS : results support prior suggestion LRRK2 mutations cause @ DiseaseTgt $ . disease families reported presents phenotype indistinguishable typical @ DiseaseTgt $ . three families demonstrate variable age onset explained APOE genotypes . common coding variations LRRK2 gene neither constitute strong @ DiseaseTgt $ risk factors modify age onset ; however , possibility modest risk effect remains assessed large datasets .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9044431828678636)\n",
      "- Text: \"DJ-1 deficient mice demonstrate similar vulnerability pathogenic Ala53Thr human alpha-syn toxicity . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative movement disorder . pathological hallmark @ DiseaseTgt $ presence intraneuronal inclusions composed fibrillized alpha-synuclein ( alpha-syn ) affected brain regions . Mutations gene , PARK7 , encodes @ GeneSrc $ , cause autosomal recessive early-onset @ DiseaseTgt $ . Although @ GeneSrc $ shown involved diverse biological processes , several vitro studies suggest inhibit formation protect effects alpha-syn aggregation . previously established characterized transgenic mice expressing pathogenic Ala53Thr human alpha-syn ( M83 mice ) develop extensive alpha-syn pathologies neuroaxis resulting severe motor impairments eventual fatality . current study , crossbred M83 mice DJ-1 null background ( M83-DJnull mice ) efforts determine effects lack DJ-1 mice . Animals assessed compared survival rate , distribution alpha-syn inclusions , biochemical properties alpha-syn protein , demise function nigral dopaminergic neurons , extent gliosis neuroaxis . M83 M83-DJnull mice displayed similar onset disease pathological changes , none analyses assess changes pathogenesis revealed significant differences M83 M83-DJnull mice . findings suggest DJ-1 may function directly modulate alpha-syn DJ-1 appear play role protecting deleterious effects expressing pathogenic Ala53Thr alpha-syn vivo . possible alpha-syn DJ-1 mutations may lead @ DiseaseTgt $ via independent mechanisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6113971648377593)\n",
      "- Text: \"Mitochondrial localization @ DiseaseTgt $ related protein @ GeneSrc $ : implications pathogenesis . homozygous ( L166P , M26I , deletion ) heterozygous mutations ( D149A , A104 ) @ GeneSrc $ gene identified @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients . biochemical function subcellular localization @ GeneSrc $ protein clarified . date localization @ GeneSrc $ protein largely described studies over-expressing tagged @ GeneSrc $ protein vitro . known whether subcellular localization over-expressed @ GeneSrc $ protein identical endogenously expressed @ GeneSrc $ protein vitro vivo . clarify subcellular localization function @ GeneSrc $ , generated three highly specific antibodies @ GeneSrc $ protein investigated subcellular localization endogenous @ GeneSrc $ protein mouse brain tissues human neuroblastoma cells . found @ GeneSrc $ widely distributed highly expressed brain . cell fractionation immunogold electron microscopy , identified endogenous pool @ GeneSrc $ mitochondrial matrix inter-membrane space . investigate whether pathogenic mutations might prevent distribution @ GeneSrc $ mitochondria , generated human neuroblastoma cells stably transfected wild-type ( WT ) mutant ( M26I , L166P , A104 , D149A ) @ GeneSrc $ performed mitochondrial fractionation confocal co-localization imaging studies . compared WT mutants , L166P mutant exhibits largely reduced protein level . However , pathogenic mutations alter distribution @ GeneSrc $ mitochondria . Thus , @ GeneSrc $ integral mitochondrial protein may important functions regulating mitochondrial physiology . findings @ GeneSrc $ 's mitochondrial localization may important implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3667746249303001)\n",
      "- Text: \"@ DiseaseTgt $ protein @ GeneSrc $ counteracts mitochondrial impairment induced tumour suppressor protein p53 enhancing endoplasmic reticulum-mitochondria tethering . @ GeneSrc $ first identified oncogene . recently , mutations gene found causative autosomal recessive familial @ DiseaseTgt $ . Numerous studies support @ GeneSrc $ role protection oxidative stress maintenance mitochondria structure ; however , mechanism protective function remains largely unknown . investigated whether mitochondrial Ca ( 2 + ) homeostasis , key parameter cell physiology , could target @ GeneSrc $ action . , show @ GeneSrc $ modulates mitochondrial Ca ( 2 + ) transients induced upon cell stimulation 1,4,5-inositol-tris-phosphate agonist favouring endoplasmic reticulum ( ER ) -mitochondria tethering . reduction @ GeneSrc $ levels results mitochondria fragmentation decreased mitochondrial Ca ( 2 + ) uptake stimulated cells . functionally couple effects well-recognized cytoprotective role @ GeneSrc $ , investigated action respect tumour suppressor p53 . p53 overexpression HeLa cells impairs ability accumulate Ca ( 2 + ) mitochondrial matrix , causes alteration mitochondrial morphology reduces ER-mitochondria contact sites . Mitochondrial impairments independent Drp1 activation , since co-expression dominant negative mutant Drp1 failed abolish . @ GeneSrc $ overexpression prevents alterations re-establishing ER-mitochondria tethering . Similarly , co-expression pro-fusion protein Mitofusin 2 blocks effects induced p53 mitochondria , confirming modulation ER-mitochondria contact sites critical mitochondria integrity . Thus , impairment ER-mitochondria communication , consequence @ GeneSrc $ loss-of-function , may detrimental mitochondria-related processes basis mitochondrial dysfunction observed @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3994912110482382)\n",
      "- Text: \"Novel homozygous p. E64D mutation @ GeneSrc $ early onset @ DiseaseTgt $ ( @ GeneSrc $ ) . Mutations parkin gene identified common cause autosomal recessive inherited Parkinson disease ( @ DiseaseTgt $ ) associated early disease manifestation . However , based linkage data , mutations genes contribute genetic heterogeneity early-onset @ DiseaseTgt $ ( EOPD ) . Recently , two mutations @ GeneSrc $ gene described second cause autosomal recessive EOPD ( @ GeneSrc $ ) . Analyzing @ GeneSrc $ gene 104 EOPD patients , identified third mutation , c.192G > C ( p. E64D ) , associated EOPD patient Turkish ancestry characterized functional significance amino acid substitution . patient , substantial reduction dopamine uptake transporter ( DAT ) binding found striatum using [ ( 18 ) F ] FP-CIT PET , indicating serious loss presynaptic dopaminergic afferents . sister , homozygous E64D , clinically unaffected showed reduced dopamine uptake compared clinically unaffected brother , heterozygous E64D . demonstrate crystallography E64D mutation alter structure @ GeneSrc $ protein , however observe tendency towards decreased levels mutant protein overexpressed HEK293 COS7 cells . Using immunocytochemistry contrast homogenous nuclear cytoplasmic staining HEK293 cells overexpressing wild-type @ GeneSrc $ , 5 % cells expressing E64D 80 % cells expressing recently described L166P mutation displayed predominant nuclear localization mutant @ GeneSrc $ protein .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4369640396266445)\n",
      "- Text: \"Identification novel homozygous mutation Arg459Pro SYNJ1 gene Indian family autosomal recessive juvenile Parkinsonism . BACKGROUND : novel homozygous missense mutation ( c.773 G > , p. Arg258Gln ) Synaptojanin 1 ( SYNJ1 , 21q22.2 ) recently reported two Italian one Iranian consanguineous families autosomal recessive juvenile Parkinsonism ( ARJP ) . Contribution synaptic gene related Parkinsonism phenotypes populations still remains unidentified . METHODS : ARJP family two affected siblings characterized frequent tremor bradykinesia rigidity recruited study . siblings showed intense dyskinesia dystonia administration Syndopa . family analyzed mutations exon dosage variations PARKIN , PINK1 @ GeneSrc $ . , whole exome sequencing performed two affected one unaffected sibling family . RESULTS : identified novel homozygous mutation ( c.1376C > G , p. Arg459Pro ) SYNJ1 segregating family . p. Arg459Pro mutation observed 285 additional @ DiseaseTgt $ ( @ DiseaseTgt $ ) samples ( 32 familial , 81 early onset 172 late onset ) screened PCR-Sanger-sequencing . also absent dbSNP , 1000 Genomes , ExAC , NHLBI-ESP database > 250 ethnically matched exomes available laboratory . arginine residue highly conserved across species predicted damaging several silico tools . previous mutation p. Arg258Gln , p. Arg459Pro also present Sac 1 domain SYNJ1 wherein p. Arg258Gln mutation already described impair phosphatase activity . CONCLUSIONS : report another novel mutation SYNJ1 Indian consanguineous ARJP family . Finding additional mutation gene supports involvement SYNJ1 @ DiseaseTgt $ pathogenesis across different ethnicities .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016666752018203)\n",
      "- Text: \"TRAF6 promotes atypical ubiquitination mutant @ GeneSrc $ alpha-synuclein localized Lewy bodies sporadic @ DiseaseTgt $ brains . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disorder characterized loss dopaminergic neurons Substantia Nigra formation ubiquitin- alpha-synuclein ( aSYN ) -positive cytoplasmic inclusions called Lewy bodies ( LBs ) . Although @ DiseaseTgt $ cases sporadic , families genetic mutations found . Mutations @ GeneSrc $ associated autosomal recessive early-onset @ DiseaseTgt $ , missense mutations duplications aSYN ( PARK1 , PARK4 ) linked dominant forms disease . study , identify E3 ubiquitin ligase tumor necrosis factor-receptor associated factor 6 ( TRAF6 ) common player genetic sporadic cases . TRAF6 binds misfolded mutant @ GeneSrc $ aSYN . proteins substrates TRAF6 ligase activity vivo . Interestingly , rather conventional K63 assembly , TRAF6 promotes atypical ubiquitin linkage formation @ DiseaseTgt $ targets share K6- , K27- K29- mediated ubiquitination . Importantly , TRAF6 stimulates accumulation insoluble polyubiquitinated mutant @ GeneSrc $ cytoplasmic aggregates . human post-mortem brains @ DiseaseTgt $ patients , TRAF6 protein colocalizes aSYN LBs . results reveal novel role TRAF6 atypical ubiquitination @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.849359473363442)\n",
      "- Text: \"Rare heterozygous parkin variants French early-onset @ DiseaseTgt $ patients controls . BACKGROUND : Mutations parkin gene cause autosomal recessive early-onset parkinsonism . effect single heterozygous mutations parkin still unclear . aim study evaluate frequency exonic parkin variants case-control study . METHODS : parkin gene screened point mutations exon rearrangements 172 French patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) 170 controls population . Patients single parkin variants also screened PINK1 , @ GeneSrc $ LRRK2 exon 41 mutations . RESULTS : 10 exonic sequence variations identified , including 3 known polymorphisms 7 rare heterozygous variants , 2 novel . significantly rare heterozygous variants patients ( n = 10 ) early-onset @ DiseaseTgt $ controls ( n = 2 ) . Screening PINK1 , @ GeneSrc $ LRRK2 exon 41 10 patients heterozygous parkin failed identify second causative mutation . CONCLUSION : results suggest single parkin mutations increase risk early-onset @ DiseaseTgt $ , possibility second parkin mutation excluded .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.112261839969)\n",
      "- Text: \"DJ-1L166P mutant protein associated early onset @ DiseaseTgt $ unstable forms higher-order protein complexes . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative disorder involves selective degeneration midbrain dopaminergic neurons . Recently @ GeneSrc $ mutations linked autosomal-recessive early-onset Parkinsonism two European families . using gel filtration assays physiological conditions demonstrate @ GeneSrc $ protein forms dimeric structure . Conversely , DJ-1L166P mutant protein shows different elution profile compared DJ-1WT overexpression cellular systems lymphoblasts cells , suggesting might form higher order protein structures . Furthermore observed level DJ-1L166P mutant protein patient 's lymphoblasts low compared wild-type protein . excluded potential transcriptional impairment performing quantitative RT-PCR patient 's material . Pulse-chase experiments transfected COS-1 cells cycloheximide treatment control patient lymphoblasts indicated mutant protein rapidly degraded . rapid turnover structural changes DJ-1L166P mutant protein might crucial disease pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.133312453904249)\n",
      "- Text: \"@ DiseaseTgt $ gene @ GeneSrc $ also key regulator stroke-induced damage . Recent evidence indicated common mechanisms play roles among multiple neurological diseases . However , specifics pathways completely understood . Stroke caused interruption blood flow brain , cumulative evidence supports critical role oxidative stress ensuing neuronal death process . @ GeneSrc $ ( @ GeneSrc $ ) identified gene linked early-onset familial @ DiseaseTgt $ . Currently , work also shows @ GeneSrc $ central death Vitro Vivo models stroke . Loss @ GeneSrc $ increases sensitivity excitotoxicity ischemia , whereas expression @ GeneSrc $ reverse sensitivity indeed provide protection . Importantly , @ GeneSrc $ expression decreases markers oxidative stress stroke insult Vivo , suggesting @ GeneSrc $ protects alleviation oxidative stress . Consistent finding , demonstrate essential role oxidation-sensitive cysteine-106 residue neuroprotective activity @ GeneSrc $ stroke . work provides important example gene seemingly specific one disease , case @ DiseaseTgt $ , also appears central neuropathological conditions stroke . also highlights important commonalities among differing neuropathologies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022904936128555)\n",
      "- Text: \"Gleevec inhibits beta-amyloid production Notch cleavage . Amyloid-beta ( Abeta ) peptides , consisting mainly 40 42 aa ( Abeta40 Abeta42 , respectively ) , metabolites amyloid precursor protein believed major pathological determinants @ DiseaseTgt $ . proteolytic cleavages form Abeta N C termini catalyzed beta-secretase gamma-secretase , respectively . demonstrate gamma-secretase generation Abeta N2a cell-free system ATP dependent . addition , Abl kinase inhibitor imatinib mesylate ( Gleevec , STI571 ) , targets ATP-binding site @ GeneSrc $ several tyrosine kinases , potently reduces Abeta production N2a cell-free system intact N2a cells . STI571 related compound , inhibitor 2 , also reduce Abeta production rat primary neuronal cultures vivo guinea pig brain . STI571 inhibit gamma-secretase-catalyzed S3 cleavage Notch-1 . Furthermore , production Abeta inhibition STI571 demonstrated occur similar extents @ GeneSrc $ WT mouse fibroblasts , indicating effect STI571 Abeta production involve Abl kinase . efficacy STI571 reducing Abeta without affecting Notch-1 cleavage may prove useful basis developing novel therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.054079384683828e-05)\n",
      "- Text: \"Alpha7 nicotinic receptor up-regulation cholinergic basal forebrain neurons @ DiseaseTgt $ . BACKGROUND : Dysfunction basocortical cholinergic projection neurons nucleus basalis ( NB ) correlates cognitive deficits @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Nucleus basalis neurons receive cholinergic inputs express nicotinic acetylcholine receptors ( nAChRs ) muscarinic AChRs ( mAChRs ) , may regulate NB neuron activity @ DiseaseTgt $ . Although alterations AChRs occur @ DiseaseTgt $ cortex , little information detailing whether defects @ GeneSrc $ mAChR gene expression occur cholinergic NB neurons disease progression . OBJECTIVE : determine whether @ GeneSrc $ mAChR gene expression altered cholinergic NB neurons progression @ DiseaseTgt $ . DESIGN : Individual NB neurons subjects diagnosed ante mortem cognitive impairment ( NCI ) , mild cognitive impairment ( MCI ) , mild moderate @ DiseaseTgt $ analyzed single-cell AChR expression profiling via custom-designed microarrays . SETTING : Academic research . PARTICIPANTS : Participants members Rush Religious Orders Study cohort . MAIN OUTCOME MEASURES : Real-time quantitative polymerase chain reaction performed validate microarray findings . RESULTS : Cholinergic NB neurons displayed statistically significant up-regulation alpha7 nAChR messenger RNA expression subjects mild moderate @ DiseaseTgt $ compared NCI MCI ( P < .001 ) . differences found @ GeneSrc $ mAChR subtypes across cohort . Expression levels alpha7 nAChRs inversely associated Global Cognitive Score Mini-Mental State Examination performance . CONCLUSIONS : Up-regulation alpha7 nAChRs may signal compensatory response maintain basocortical cholinergic activity @ DiseaseTgt $ progression . Alternatively , putative competitive interactions receptor beta-amyloid may provide pathogenic mechanism NB dysfunction . Increasing NB alpha7 nAChR expression may serve marker progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022315644359604)\n",
      "- Text: \"@ GeneSrc $ interacts p53 modulate transactivation potential . @ GeneSrc $ gene discovered target Egr1 transcription factor participates cell growth regulation upregulation p21 cell cycle delay G2/M phase . report @ GeneSrc $ able bind p53 @ DiseaseTgt $ suppressor protein , specifically interacting C terminal tetramerization domain p53 . characterized interaction determination binding kinetics using nanoporous optical interferometry demonstrated interaction capable enhancing transcriptional activity p53-dependent gene targets . results suggest mechanistic role @ GeneSrc $ co-regulator p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0448667936324704)\n",
      "- Text: \"Accelerated plaque accumulation , associative learning deficits , up-regulation @ GeneSrc $ protein transgenic mice co-expressing mutant human presenilin 1 amyloid precursor proteins . @ DiseaseTgt $ mutations presenilin 1 2 amyloid precursor protein result elevated beta-amyloid , beta-amyloid accumulation , plaque formation brains affected individuals . crossing presenilin 1 transgenic mice carrying A246E mutation plaque-producing amyloid precursor protein K670N/M671L transgenic mice ( Tg2576 ) , show co-expression mutant transgenes results acceleration amyloid accumulation associative learning deficits . 5 months age detectable plaque pathology , amyloid precursor protein transgenic animals impaired contextual fear learning following two pairings conditioned unconditioned stimuli appear normal following robust five-pairing training . 9 months age beta-amyloid deposition evident , mice impaired following two-pairing five-pairing protocols . Mice carrying transgenes impaired contextual fear conditioning either age . transgenic animal groups performed well controls cued fear conditioning , indicating contextual fear learning deficits hippocampus-specific . associative learning impairments coincident elevated alpha 7 nicotinic acetylcholine receptor protein dentate gyrus . findings provide two robust rapid assays beta-amyloid-associated effects performed young animals : impaired contextual fear learning up-regulation alpha 7 nicotinic receptors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003875446092722)\n",
      "- Text: \"Specific inhibition CBP/beta-catenin interaction rescues defects neuronal differentiation caused presenilin-1 mutation . @ GeneSrc $ signaling shown promote self-renewal variety tissue stem cells , including neuronal stem cells hematopoietic stem cells . However , activation @ GeneSrc $ pathway promoted inhibition pathway prevented differentiation neuronal precursor cells . clear explanation differential effects @ GeneSrc $ activation neuronal precursors available present . Presenilin-1 ( PS-1 ) polytopic protein comprised six eight transmembrane domains . PS-1 , part gamma-secretase complex , required intramembrane proteolysis amyloid precursor protein ( APP ) Notch . Additionally , interactions beta-catenin , PS-1 associated modulation @ GeneSrc $ signaling . @ DiseaseTgt $ PS-1 mutant , PS-1 ( L286V ) , causes dramatic increase cell factor ( TCF ) /beta-catenin transcription PC-12 cells , prevents normal nerve growth factor ( NGF ) -induced neuronal differentiation neurite outgrowth . Selective inhibition TCF/beta-catenin/cAMP-response element-binding protein ( CREB ) -binding protein ( CBP ) -mediated transcription , TCF/beta-catenin/p300 , recently described small molecule antagonist ICG-001 corrects defects neuronal differentiation , highlighting importance @ GeneSrc $ signaling process . propose increased TCF/beta-catenin/CBP-mediated transcription , well failure switch TCF/beta-catenin/p300-mediated transcription , play important role decreasing neuronal differentiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0059921096341965)\n",
      "- Text: \"@ GeneSrc $ inflammasome activation drives tau pathology . @ DiseaseTgt $ characterized accumulation amyloid-beta plaques , aggregation hyperphosphorylated tau neurofibrillary tangles neuroinflammation , together resulting neurodegeneration cognitive decline1 . @ GeneSrc $ inflammasome assembles inside microglia activation , leading increased cleavage activity caspase-1 downstream interleukin-1beta release2 . Although @ GeneSrc $ inflammasome shown essential development progression amyloid-beta pathology mice3 , precise effect tau pathology remains unknown . show loss @ GeneSrc $ inflammasome function reduced tau hyperphosphorylation aggregation regulating tau kinases phosphatases . Tau activated @ GeneSrc $ inflammasome intracerebral injection fibrillar amyloid-beta-containing brain homogenates induced tau pathology @ GeneSrc $ manner . data identify important role microglia @ GeneSrc $ inflammasome activation pathogenesis tauopathies support amyloid-cascade hypothesis @ DiseaseTgt $ , demonstrating neurofibrillary tangles develop downstream amyloid-beta-induced microglial activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1965314095291364)\n",
      "- Text: \"Fyn kinase regulates misfolded alpha-synuclein uptake @ GeneSrc $ inflammasome activation microglia . Persistent microglia-mediated neuroinflammation major pathophysiological contributor progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) , cell-signaling mechanisms governing chronic neuroinflammation well understood . , show Fyn kinase , conjunction class B scavenger receptor CD36 , regulates microglial uptake aggregated human alpha-synuclein ( alphaSyn ) , major component @ DiseaseTgt $ . alphaSyn effectively mediate LPS-independent priming activation microglial @ GeneSrc $ inflammasome . Fyn kinase regulates processes ; mediates PKCdelta-dependent NF-kappaB-p65 nuclear translocation , leading inflammasome priming , facilitates alphaSyn import microglia , contributing generation mitochondrial reactive oxygen species consequently inflammasome activation . vivo experiments using A53 viral-alphaSyn overexpression mouse models well human @ DiseaseTgt $ neuropathological results confirm role Fyn @ GeneSrc $ inflammasome activation . Collectively , study identifies novel Fyn-mediated signaling mechanism amplifies neuroinflammation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0383740092405834)\n",
      "- Text: \"disintegrin-metalloproteinase prevents amyloid plaque formation hippocampal defects @ DiseaseTgt $ mouse model . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized excessive deposition amyloid beta-peptides ( beta peptides ) brain . nonamyloidogenic pathway , amyloid precursor protein ( APP ) cleaved alpha-secretase within beta peptide sequence . Proteinases ADAM family ( adisintegrin metalloproteinase ) main candidates physiologically relevant alpha-secretases , early lethality knockout animals prevented detailed analysis neuronal cells . overcome restriction , generated transgenic mice overexpress either @ GeneSrc $ catalytically inactive @ GeneSrc $ mutant . report show moderate neuronal overexpression @ GeneSrc $ mice transgenic human APP ( [ V717I ] ) increased secretion neurotrophic soluble alpha-secretase-released N-terminal APP domain ( APPs alpha ) , reduced formation beta peptides , prevented deposition plaques . Functionally , impaired long-term potentiation cognitive deficits alleviated . Expression mutant catalytically inactive @ GeneSrc $ led enhancement number size amyloid plaques brains double-transgenic mice . results provide first vivo evidence proteinase ADAM family alpha-secretase APP , reveal activation @ GeneSrc $ promising therapeutic target , support hypothesis decrease alpha-secretase activity contributes development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6365662828825862)\n",
      "- Text: \"Proteomics analysis identifies ribosome associated coiled-coil domain-containing protein-124 novel interaction partner Nucleophosmin-1 . @ GeneSrc $ ( @ GeneSrc $ ) conserved eukaryotic ribosome-associated RNA-binding protein involved resuming ribosome activity stress-related translational shutdown . @ GeneSrc $ protein also detected cellular localizations devoid ribosomes , centrosome , cytokinetic midbody , translation-independent cellular function currently unknown . using unbiased LC-MS/MS-based proteomics approach human embryonic kidney ( HEK293 ) cells , identified novel @ GeneSrc $ partners mapped cellular organization interacting proteins , subset known involved nucleoli biogenesis function . identified novel interaction cancer-associated multifunctional nucleolar marker nucleophosmin ( Npm1 ) @ GeneSrc $ , characterized interaction HEK293 ( human embryonic kidney ) U2OS ( osteosarcoma ) cells . expected , types cells , Npm1 @ GeneSrc $ proteins colocalized within nucleolus assayed immunocytochemical methods , monitoring localization green fluorescent protein-tagged @ GeneSrc $ . nucleolar localization @ GeneSrc $ impaired Npm1 translocates nucleolus nucleoplasm response treatment DNA-intercalator Topo2 inhibitor chemotherapeutic drug doxorubicin . Npm1 critically involved maintaining genomic stability mediating various DNA-repair pathways , over-expression Npm1 specific NPM1 mutations previously associated proliferative diseases , @ DiseaseTgt $ , anaplastic large-cell lymphoma , solid cancers originating different tissues . Identification @ GeneSrc $ novel interaction partner Nmp1 within frame molecular mechanisms involving nucleolar stress-sensing DNA-damage response expected provide novel insights biology cancers associated aberrations NPM1 . article protected copyright . rights reserved .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009092069014732)\n",
      "- Text: \"Activation @ GeneSrc $ stimulates gamma-secretase activity accelerates amyloid plaque formation . Amyloid plaque hallmark primary cause @ DiseaseTgt $ . Mutations presenilin-1 , gamma-secretase catalytic subunit , affect amyloid-beta ( Abeta ) production @ DiseaseTgt $ pathogenesis . However , largely unknown whether gamma-secretase activity amyloid plaque formation regulated environmental factors stress , mediated receptors including @ GeneSrc $ ( @ GeneSrc $ ) . report activation @ GeneSrc $ enhanced gamma-secretase activity thus Abeta production . enhancement involved association @ GeneSrc $ presenilin-1 required agonist-induced endocytosis @ GeneSrc $ subsequent trafficking gamma-secretase late endosomes lysosomes , Abeta production elevated . Similar effects observed activation delta-opioid receptor . Furthermore , chronic treatment @ GeneSrc $ agonists increased cerebral amyloid plaques @ DiseaseTgt $ mouse model . Thus , @ GeneSrc $ activation stimulate gamma-secretase activity amyloid plaque formation , suggests abnormal activation @ GeneSrc $ might contribute Abeta accumulation @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5714203167099715)\n",
      "- Text: \"Modulation oestrogen receptor signalling association activated @ GeneSrc $ . Environmental contaminants affect wide variety biological events many species . Dioxins typical environmental contaminants exert adverse oestrogen-related effects . Although anti-oestrogenic actions well described , dioxins also induce endometriosis oestrogen-dependent @ DiseaseTgt $ , implying possible oestrogenic effects . However , molecular mechanism underlying oestrogen-related actions dioxins remains largely unknown . heterodimer @ GeneSrc $ ( @ GeneSrc $ ) Arnt , basic helix-loop-helix/PAS-family transcription factors , mediates toxic effects dioxins . show agonist-activated @ GeneSrc $ heterodimer directly associates oestrogen receptors ER-alpha ER-beta . association results recruitment unliganded ER co-activator p300 oestrogen-responsive gene promoters , leading activation transcription oestrogenic effects . function liganded ER attenuated . Oestrogenic actions @ GeneSrc $ agonists detected wild-type ovariectomized mouse uteri , absent @ GeneSrc $ ER-alpha-/- ovariectomized mice . findings suggest novel mechanism ER-mediated oestrogen signalling modulated co-regulatory-like function activated @ GeneSrc $ , giving rise adverse oestrogen-related actions dioxin-type environmental contaminants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0628281501437887)\n",
      "- Text: \"Combined activation Ras @ GeneSrc $ neural progenitors induces glioblastoma formation mice . Gliomas common primary malignant brain tumours classified four clinical grades , aggressive @ DiseaseTgt $ grade 4 astrocytomas ( also known glioblastoma multiforme ; GBM ) . Frequent genetic alterations GBMs ( refs 2 - 5 ) result stimulation common signal transduction pathways involving Ras , @ GeneSrc $ proteins . known pathways , , sufficient induce GBM formation . transfer , tissue-specific manner , genes encoding activated forms Ras @ GeneSrc $ astrocytes neural progenitors mice . found although neither activated Ras @ GeneSrc $ alone sufficient induce GBM formation , combination activated Ras @ GeneSrc $ induces high-grade gliomas histological features human GBMs . @ DiseaseTgt $ appear arise gene transfer neural progenitors , transfer differentiated astrocytes . Increased activity RAS found many human GBMs ( ref . 11 ) , show Akt activity increased @ DiseaseTgt $ , implying combined activation two pathways accurately models biology disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9967895869596004)\n",
      "- Text: \"Postzygotic HRAS KRAS mutations cause nevus sebaceous Schimmelpenning syndrome . Nevus sebaceous common congenital cutaneous malformation . Affected individuals may develop benign malignant secondary @ DiseaseTgt $ nevi life . Schimmelpenning syndrome characterized association nevus sebaceous extracutaneous abnormalities . report 65 sebaceous nevi studied , 62 ( 95 % ) mutations HRAS gene 3 ( 5 % ) mutations KRAS gene . HRAS c.37G > C mutation , results p. Gly13Arg substitution , present 91 % lesions . Nonlesional tissues 18 individuals wild-type sequence , confirming genetic mosaicism . HRAS c.37G > C mutation also found 8 8 associated secondary @ DiseaseTgt $ . Mosaicism HRAS c.37G > C KRAS c.35G > mutations found two individuals Schimmelpenning syndrome . Functional analysis HRAS c.37G > C mutant cells showed constitutive activation MAPK @ GeneSrc $ signaling pathways . results indicate nevus sebaceous Schimmelpenning syndrome caused postzygotic HRAS KRAS mutations . mutations may predispose individuals development secondary @ DiseaseTgt $ nevus sebaceous .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001742631424011)\n",
      "- Text: \"@ GeneSrc $ regulates pathological angiogenesis , vascular maturation permeability vivo . @ GeneSrc $ kinases control essential cellular functions , including proliferation , apoptosis , metabolism transcription , proposed promising targets treatment angiogenesis-dependent pathologies , @ DiseaseTgt $ ischemic injury . precise roles neovascularization remain elusive . show @ GeneSrc $ predominant isoform vascular cells describe unexpected consequences @ GeneSrc $ knockout vascular integrity pathological angiogenesis . Angiogenic responses three distinct vivo models enhanced @ GeneSrc $ ) mice ; enhanced responses associated impairment blood vessel maturation increased vascular permeability . Although impaired vascular maturation @ GeneSrc $ ) mice may attributed reduced activation endothelial nitric oxide synthase ( eNOS ) , major phenotypic changes vascular permeability angiogenesis linked reduced expression two endogenous vascular regulators , thrombospondins 1 ( TSP-1 ) 2 ( TSP-2 ) . Re-expression TSP-1 TSP-2 mice transplanted wild-type bone marrow corrected angiogenic abnormalities @ GeneSrc $ ) mice . findings establish crucial role @ GeneSrc $ axis angiogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0634480197397719)\n",
      "- Text: \"deficiency @ GeneSrc $ sufficient suppress @ DiseaseTgt $ development Pten+/- mice . @ DiseaseTgt $ suppressor PTEN frequently inactivated human @ DiseaseTgt $ . major downstream effector PTEN Akt , hyperactivated via PTEN inactivation . known , however , whether diminished @ GeneSrc $ activity sufficient inhibit tumorigenesis initiated Pten deficiency . showed deficiency @ GeneSrc $ sufficient dramatically inhibit @ DiseaseTgt $ development Pten+/- mice . @ GeneSrc $ deficiency profound effect endometrium prostate neoplasia , two types human @ DiseaseTgt $ , PTEN frequently mutated , also affected thyroid adrenal medulla tumors intestinal polyps . Even haplodeficiency @ GeneSrc $ sufficient markedly attenuate development high-grade prostate intraepithelial neoplasia ( PIN ) endometrial carcinoma . results significant implications @ DiseaseTgt $ therapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8473752763750197)\n",
      "- Text: \"mouse model Proteus syndrome . Proteus syndrome mosaic , progressive overgrowth disorder caused somatic activating variant c.49 G > p. ( E17 K ) @ GeneSrc $ . presentation affected individuals variable , diversity tissues demonstrating abnormalities . Common manifestations include skin bony overgrowth , vascular malformations ( VMs ) , cysts @ DiseaseTgt $ . used two methods create mouse models endogenously-regulated mosaic expression Proteus syndrome variant . Variant allele fractions ( VAFs ) ranged 0 % 50 % across numerous tissues 44 Proteus syndrome mice . Mice phenotypically heterogeneous lesions rarely observed 12 months age . VMs frequent finding total 69 found 29 44 Proteus syndrome mice . Twenty-eight cysts ectasia , frequently biliary , seen 22 44 Proteus syndrome mice . Varying levels mammary hyperplasia seen 10 16 female Proteus syndrome mice localized regions hyperplasia stromal expansion noted several additional animals . Interestingly , 27 31 Proteus syndrome animals non-zero blood VAF contrast human disorder rarely seen peripheral blood . Identification variant-positive cells green fluorescent protein ( GFP ) staining chimeric Proteus syndrome mice showed lesions , hyperplastic cells predominantly GFP/Akt1E17K-positive showed increased pAKT signal compared GFP-negative cells . However , hyperplastic mammary epithelium mixture GFP/Akt1E17K-positive negative cells GFP/Akt1E17K-negative cells also increased pAKT signal suggesting variant-positive cells induce lesion formation non-cell autonomous manner .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0640028393028143)\n",
      "- Text: \"Cell-cycle-regulated activation Akt kinase phosphorylation carboxyl terminus . Akt , also known protein kinase B , plays key roles cell proliferation , survival metabolism . Akt hyperactivation contributes many pathophysiological conditions , including human @ DiseaseTgt $ , closely associated poor prognosis chemo- radiotherapeutic resistance . Phosphorylation Akt S473 ( ref . 5 ) T308 ( ref . 6 ) activates Akt . However , remains unclear whether mechanisms account full Akt activation , whether Akt hyperactivation linked misregulated cell cycle progression , another @ DiseaseTgt $ hallmark . report Akt activity fluctuates across cell cycle , mirroring cyclin expression . Mechanistically , phosphorylation S477 T479 Akt extreme carboxy terminus cyclin-dependent kinase 2 ( Cdk2 ) /cyclin mTORC2 , distinct physiological conditions , promotes Akt activation facilitating , functionally compensating , S473 phosphorylation . Furthermore , deletion cyclin A2 allele mouse olfactory bulb leads reduced S477/T479 phosphorylation elevated cellular apoptosis . Notably , cyclin A2-deletion-induced cellular apoptosis mouse embryonic stem cells partly rescued @ GeneSrc $ , supporting physiological role cyclin A2 governing @ GeneSrc $ activation . Together , results study show Akt S477/T479 phosphorylation essential layer Akt activation mechanism regulate physiological functions , thereby providing new mechanistic link aberrant cell cycle progression Akt hyperactivation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003793733590464)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits @ GeneSrc $ phosphatase PP2a well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired PP2a phosphatase activity towards @ GeneSrc $ , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor p27 ( kip1 ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0397363965412406)\n",
      "- Text: \"Survival signalling @ GeneSrc $ eIF4E oncogenesis @ DiseaseTgt $ therapy . Evading apoptosis considered hallmark @ DiseaseTgt $ , mutations apoptotic regulators invariably accompany tumorigenesis . Many chemotherapeutic agents induce apoptosis , disruption apoptosis @ DiseaseTgt $ evolution promote drug resistance . example , @ GeneSrc $ apoptotic regulator activated many @ DiseaseTgt $ may promote drug resistance vitro . Nevertheless , @ GeneSrc $ disables apoptosis contribution clinical drug resistance unclear . Using murine lymphoma model , show @ GeneSrc $ promotes tumorigenesis drug resistance disrupting apoptosis , disruption @ GeneSrc $ signalling using mTOR inhibitor rapamycin reverses chemoresistance lymphomas expressing @ GeneSrc $ , apoptotic defects . eIF4E , translational regulator acts downstream @ GeneSrc $ mTOR , recapitulates @ GeneSrc $ 's action tumorigenesis drug resistance , unable confer sensitivity rapamycin chemotherapy . results establish @ GeneSrc $ signalling mTOR eIF4E important mechanism oncogenesis drug resistance vivo , reveal targeting apoptotic programmes restore drug sensitivity genotype-dependent manner .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3518946992061585)\n",
      "- Text: \"regulated interaction UIM protein Eps15 implicates parkin EGF receptor trafficking @ GeneSrc $ signalling . Mutations parkin gene responsible common familial form @ DiseaseTgt $ . parkin encodes E3 ubiquitin ligase , defects proteasome-mediated protein degradation believed central role pathogenesis @ DiseaseTgt $ . , report novel role parkin proteasome-independent ubiquitination pathway . identified regulated interaction parkin Eps15 , adaptor protein involved epidermal growth factor ( EGF ) receptor ( EGFR ) endocytosis trafficking . Treatment cells EGF stimulates parkin binding Eps15 EGFR promotes parkin-mediated ubiquitination Eps15 . Binding parkin ubiquitin-like ( Ubl ) domain Eps15 ubiquitin-interacting motifs ( UIMs ) required parkin-mediated Eps15 ubiquitination . Furthermore , EGFR endocytosis degradation accelerated parkin-deficient cells , EGFR signalling via phosphoinositide 3-kinase ( @ GeneSrc $ pathway reduced parkin knockout mouse brain . propose ubiquitinating Eps15 , parkin interferes ability Eps15 UIMs bind ubiquitinated EGFR , thereby delaying EGFR internalization degradation , promoting @ GeneSrc $ signalling . Considering role @ GeneSrc $ neuronal survival , results broad new implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016192322861377)\n",
      "- Text: \"( 10 ; 11 ) ( p13 ; q14 ) U937 cell line results fusion AF10 gene CALM , encoding new member @ GeneSrc $ clathrin assembly protein family . translocation ( 10 ; 11 ) ( p13 ; q14 ) recurring chromosomal abnormality observed patients acute lymphoblastic leukemia well @ DiseaseTgt $ . recently reported monocytic cell line U937 ( 10 ; 11 ) ( p13 ; q14 ) translocation . Using combination positional cloning candidate gene approach , cloned breakpoint able show AF10 fused novel gene named CALM ( Clathrin Assembly Lymphoid Myeloid leukemia gene ) located 11q14 . AF10 , putative transcription factor , recently cloned one fusion partners MLL . CALM high homology N-terminal third murine @ GeneSrc $ gene one clathrin assembly proteins . N-terminal region @ GeneSrc $ shown bind clathrin high-affinity binding site phosphoinositols . identification CALM/AF10 fusion gene widely used U937 cell line contribute understanding malignant phenotype line .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.186989716607483e-06)\n",
      "- Text: \"Defining stem cell dynamics models intestinal @ DiseaseTgt $ initiation . @ DiseaseTgt $ disease cells accumulate genetic aberrations believed confer clonal advantage cells surrounding tissue . However , quantitative benefit frequently occurring mutations @ DiseaseTgt $ development remains unknown . quantified competitive advantage @ GeneSrc $ loss , Kras activation , P53 mutations mouse intestine . findings indicate fate conferred mutations deterministic , many mutated stem cells replaced wild-type stem cells biased , still stochastic events . Furthermore , P53 mutations display condition-dependent advantage , especially colitis-affected intestines , clones harboring mutations gene favored . work confirms previously theoretical notion tissue architecture intestine suppresses accumulation mutated lineages .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012203488562608)\n",
      "- Text: \"Intestinal polyposis mice dominant stable mutation beta-catenin gene . Ectopic expression certain Wnt genes mouse mammary tissue tumorigenic , mutations stabilize beta-catenin found various human cancers including @ DiseaseTgt $ . determine role stabilized beta-catenin intestinal tumorigenesis mice , constructed embryonic stem ( ES ) cell-mediated homologous recombination , mutant beta-catenin allele whose exon 3 sandwiched loxP sequences . germline heterozygotes crossed mice expressing Cre recombinase intestines , serines threonine encoded exon 3 phosphorylated glycogen synthase kinase 3beta ( GSK3beta ) deleted offspring intestines , caused adenomatous intestinal polyps resembling @ GeneSrc $ ) knockout mice . nascent microadenomas also found colon . results present experimental genetic evidence activation Wnt signaling pathway cause intestinal colonic tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.00038657241619)\n",
      "- Text: \"Colonic polyposis caused mTOR-mediated chromosomal instability @ GeneSrc $ Cdx2+/- compound mutant mice . mammalian homeobox transcription factor CDX2 key roles intestinal development differentiation . Heterozygous Cdx2 mice develop one two benign hamartomas proximal colon , whereas heterozygous @ GeneSrc $ ) mice develop numerous adenomatous polyps , mostly small intestine . show colonic polyp number six times higher @ GeneSrc $ Cdx2+/- compound mutant mice . Levels APC CDX2 significantly lower distal colon , caused high anaphase bridge index ( ABI ) associated higher frequency loss heterozygosity ( LOH ) @ GeneSrc $ . cultured rat intestinal epithelial human @ DiseaseTgt $ cell lines , suppression CDX2 antisense RNA caused marked increases ABI chromosomal aberrations . mediated stimulation mTOR pathway , causing translational deregulation G1-S acceleration , associated low levels p27 activation cyclin E-Cdk2 . obtained similar results colonic mucosa @ GeneSrc $ ) Cdx2+/- compound mutant mice . Forced activation mTOR upstream regulator Akt also increased ABI @ DiseaseTgt $ cells . High ABI cell lines suppressed mTOR inhibitors LY294002 rapamycin . results suggest reduced expression CDX2 important colon tumorigenesis mTOR-mediated chromosomal instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0833959207074054)\n",
      "- Text: \"target-selected Apc-mutant rat kindred enhances modeling familial human @ DiseaseTgt $ . Progress toward understanding management human @ DiseaseTgt $ significantly advanced appropriate experimental platforms become available . investigated whether rat model carrying knockout allele gatekeeper gene Adenomatous polyposis coli ( Apc ) recapitulates @ DiseaseTgt $ human closely existing murine models . established mutagen-induced nonsense allele rat Apc gene inbred F344/NTac ( F344 ) genetic background . Carriers mutant allele develop multiple neoplasms distribution colon small intestine closely simulates found human familial adenomatous polyposis patients . distinguish phenotype predominantly small intestinal phenotype found @ GeneSrc $ mouse strains , strain designated polyposis rat colon ( Pirc ) kindred . Pirc rat kindred provides several unique favorable features study @ DiseaseTgt $ . Tumor-bearing Pirc rats live least 17 months , carrying significant colonic tumor burden . tumors imaged micro computed tomography scanning classical endoscopy , enabling longitudinal studies tumor genotype phenotype function response chemopreventive therapeutic regimes . metacentric character rat karyotype , like human unlike acrocentric mouse , enabled us demonstrate loss wild-type Apc allele tumors involve chromosome loss . believe Pirc rat kindred address many current gaps modeling human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.026635379156094)\n",
      "- Text: \"Cyclooxygenase-2 overexpression tumor formation blocked sulindac murine model familial adenomatous polyposis . Inducible cyclooxygenase ( Cox-2 ) , also known prostaglandin H synthase 2 ( PGH-2 ) key enzyme formation prostaglandins thromboxanes . Cox-2 product immediate-early gene expressed response growth factors , tumor promoters , cytokines . Overexpression Cox-2 associated human @ DiseaseTgt $ suppression apoptosis cultured epithelia ] cells , activity reversed nonsteroidal anti-inflammatory drug , sulindac sulfide . address relationship Cox-2 , apoptosis , tumor development vivo , studied C57BL/6J-Min/+ ( Min ) mice , strain containing fully penetrant dominant mutation @ GeneSrc $ gene , leading development gastrointestinal adenomas 110 days age . Min mice fed AIN-76A chow diet given sulindac ( 0.5 + /- 0.1 mg/day ) drinking water . Control Min mice homozygous C57BL/6J-+/+ normal littermates lacking @ GeneSrc $ mutation ( + /+ ) fed AIN-76A diet given tap water drink . 110 days age , mice sacrificed , intestinal tracts examined . Control Min mice 11.9 + /- 7.8 tumors per mouse compared 0.1 + /- 0.1 tumors sulindac-treated Min mice . expected , + /+ littermates macroscopic tumors . Examination histologically normal-appearing small bowel Min animals revealed increased amounts Cox-2 prostaglandin E ( 2 ) compared + /+ littermates . Using two different situ techniques , terminal transferase-mediated dUTP nick end labeling direct immunoperoxidase method , Min animals also demonstrated 27 - 47 % decrease enterocyte apoptosis compared + /+ animals . Treatment sulindac inhibited tumor formation decreased small bowel Cox-2 prostaglandin E ( 2 ) baseline restored normal levels apoptosis . data suggest overexpression Cox-2 associated tumorigenesis gastrointestinal epithelium , inhibited sulindac administration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.60703542556316e-05)\n",
      "- Text: \"Genetic identification Mom-1 , major modifier locus affecting Min-induced intestinal neoplasia mouse . Mutations human APC gene caused various familial @ DiseaseTgt $ . Multiple intestinal neoplasia ( Min ) mouse provides excellent model familial @ DiseaseTgt $ : carries mutant mouse @ GeneSrc $ gene develops many intestinal adenomas . , analyze tumor phenotype dramatically modified genetic background . report genetic mapping locus strongly modifies tumor number Min/+ animals . gene , Mom-1 ( Modifier Min-1 ) , maps distal chromosome 4 controls 50 % genetic variation tumor number two intraspecific backcrosses . mapping supported LOD score exceeding 14 . Interestingly , Mom-1 lies region synteny conservation human chromosome 1p35 - 36 , region frequent somatic loss heterozygosity variety human tumors , including colon tumors . results provide evidence major modifier affecting expression inherited cancer syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0065423592645704)\n",
      "- Text: \"targeted chain-termination mutation mouse @ GeneSrc $ gene results multiple intestinal tumors . Germ-line mutations human adenomatous polyposis coli ( APC ) gene result familial adenomatous polyposis , autosomal dominant disorder characterized early onset multiple adenomatous polyps large bowel high likelihood developing @ DiseaseTgt $ . understand role APC intestinal tumor formation , introduced chain-termination mutation 15th exon mouse @ GeneSrc $ gene employed modify endogenous gene homologous recombination embryonic stem cells . Mice heterozygous @ GeneSrc $ gene modification progressively develop intestinal tumors manner similar observed patients familial adenomatous polyposis mice carry mutation called multiple intestinal neoplasia ( Min ) . results indicate @ GeneSrc $ gene modification critical event initiation intestinal tumor formation results autosomal dominant predisposition toward development spontaneous colonic intestinal tumors mice .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003261219541664)\n",
      "- Text: \"Mutations APC tumour suppressor gene cause chromosomal instability . Two forms genetic instability described @ DiseaseTgt $ : microsatellite instability chromosomal instability . Microsatellite instability results mutations mismatch repair genes ; chromosomal instability hallmark many @ DiseaseTgt $ , although completely understood molecular level . truncations Adenomatous Polyposis Coli ( @ GeneSrc $ ) gene found @ DiseaseTgt $ , thought mutations @ GeneSrc $ might responsible chromosomal instability . test hypothesis , examined mouse embryonic stem ( ES ) cells homozygous Min ( multiple intestinal neoplasia ) Apc1638 alleles . show @ GeneSrc $ mutant ES cells display extensive chromosome spindle aberrations , providing genetic evidence role @ GeneSrc $ chromosome segregation . Consistent , @ GeneSrc $ accumulates kinetochore mitosis . @ GeneSrc $ mutant cells form mitotic spindles abundance microtubules inefficiently connect kinetochores . phenotype recapitulated induced expression 253-amino-acid carboxy-terminal fragment @ GeneSrc $ microsatellite unstable @ DiseaseTgt $ cells . conclude loss @ GeneSrc $ sequences lie C-terminal beta-catenin regulatory domain contributes chromosomal instability @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8687389399029136)\n",
      "- Text: \"Mapping multiple intestinal neoplasia ( Min ) proximal chromosome 18 mouse . Min ( multiple intestinal neoplasia ) mutation mouse mapped analyzing inheritance restriction fragment length polymorphisms simple sequence length polymorphisms progeny two intraspecific crosses segregating Min mutation . Min , mutant allele @ GeneSrc $ , mouse homolog human APC ( adenomatous polyposis coli ) gene , maps proximal chromosome 18 . synteny @ GeneSrc $ Mcc , mouse homolog human MCC ( mutated @ DiseaseTgt $ ) gene , conserved mouse human , although gene order @ GeneSrc $ Mcc interval different APC MCC interval .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1226728238432519)\n",
      "- Text: \"Suppression intestinal polyps Msh2-deficient non-Msh2-deficient multiple intestinal neoplasia mice specific cyclooxygenase-2 inhibitor dual cyclooxygenase-1/2 inhibitor . Epidemiological studies suggest nonsteroidal anti-inflammatory agents decrease risk @ DiseaseTgt $ . believed mediated , least part , inhibition cyclooxygenase ( COX ) activity . two COX isoenzymes , namely constitutively expressed COX-1 inducible COX-2 . COX-2 overexpressed adenomas @ DiseaseTgt $ , COX-2-specific inhibitors shown inhibit intestinal polyps @ GeneSrc $ ) mice effectively dual COX-1/COX-2 inhibitors sulindac . Various @ GeneSrc $ knockout mice , including multiple intestinal neoplasia ( Min ) mouse @ GeneSrc $ ) mouse , limited lack large numbers colonic adenomas aberrant crypt foci , putative precursors large-bowel polyps cancers . DNA mismatch-repair-deficient Min mouse model ( @ GeneSrc $ ) genetic features familial adenomatous polyposis hereditary nonpolyposis colorectal cancer , importantly , rapidly develops numerous small- large-bowel adenomas , well colonic aberrant crypt foci . purpose study determine effects COX inhibitors intestinal adenomas colonic aberrant crypt foci accelerated polyposis , mismatch-repair-deficient Min mouse model , addition standard Min mouse model . Weanling @ GeneSrc $ Min mice fed diets containing drug , sulindac , specific COX-2 inhibitor ( MF-tricyclic ) . @ GeneSrc $ Min mice sacrificed 4 weeks 5 months diet , respectively . @ GeneSrc $ mice treated MF-tricyclic significantly fewer small-bowel polyps ( mean + /- SD , 178 + /- 29 ) compared mice sulindac ( 278 + /- 80 ) , control diet ( 341 + /- 43 ; P < 0.001 ) . difference numbers large-bowel polyps aberrant crypt foci mice three groups . MF-tricyclic also effective reducing small- large-bowel polyps Min mice . Western analysis demonstrated COX-2 expression large- small-bowel polyps mice genotypes . study demonstrates specific COX-2 inhibitor effective preventing small-bowel polyps mismatch-repair-deficient Min mice small- large-bowel polyps standard Min mice . Therefore , specific COX-2 inhibitors may useful chemopreventive therapeutic agents humans risk colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002972856261732)\n",
      "- Text: \"Subcellular localization @ GeneSrc $ protein : immunoelectron microscopic study association @ GeneSrc $ protein catenin . Mutations @ GeneSrc $ gene linked development sporadic @ DiseaseTgt $ well familial adenomatous polyposis . Recently , @ GeneSrc $ protein reported associated catenins , proteins bind cell adhesion molecule E-cadherin . present study , examined distribution localization @ GeneSrc $ protein alpha -catenin normal mouse intestine light immunoelectron microscopy using specific antibodies . @ GeneSrc $ protein found localized microvilli apical lateral cytoplasm epithelial cells , whereas alpha-catenin detected lateral cytoplasm . Double-labeling immunoelectron microscopy showed colocalization @ GeneSrc $ protein alpha-catenin lateral cytoplasm , especially along lateral plasma membrane , although certain portion @ GeneSrc $ protein region distributed independently alpha-catenin . results suggest portion @ GeneSrc $ protein localized lateral cytoplasm intestinal epithelial cells functions cooperation catenins , whereas @ GeneSrc $ protein microvilli apical cytoplasm functions independent catenins .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4838747671691434)\n",
      "- Text: \"Suppression intestinal polyposis @ GeneSrc $ delta716 knockout mice inhibition cyclooxygenase 2 ( COX-2 ) . Two cyclooxygenase isozymes catalyze conversion arachidonic acid prostaglandin H2 : constitutive COX-1 inducible COX-2 . assess role COX-2 @ DiseaseTgt $ tumorigenisis , determined effects COX-2 gene ( Ptgs2 ) knockouts novel COX-2 inhibitor @ GeneSrc $ delta716 knockout mice , model human familial adenomatous polyposis . Ptgs2 null mutation reduced number size intestinal polyps dramatically . Furthermore , treating @ GeneSrc $ delta716 mice novel COX-2 inhibitor reduced polyp number significantly sulindac , inhibits isoenzymes . results provide direct genetic evidence COX-2 plays key role tumorigenesis indicate COX-2-selective inhibitors novel class therapeutic agents @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006850762658949)\n",
      "- Text: \"Colonic tumorigenesis BubR1+/-ApcMin/+ compound mutant mice linked premature separation sister chromatids enhanced genomic instability . Faithful chromosome segregation essential maintenance genetic stability cell division least partly monitored spindle checkpoint , surveillance mechanism preventing cell prematurely entering anaphase . @ GeneSrc $ ( @ GeneSrc $ ) gene also plays important role regulating genomic stability , mutations @ GeneSrc $ cause aneuploidy . show whereas @ GeneSrc $ ) mice developed many adenomatous polyps , mostly small intestine , 3 mo age ; @ GeneSrc $ ) compound mutant mice developed 10 times colonic tumors @ GeneSrc $ ) mice . colonic tumors @ GeneSrc $ ) mice higher grades observed @ GeneSrc $ ) mice . Consistently , @ GeneSrc $ ) murine embryonic fibroblasts ( MEFs ) contained beta-catenin proliferated faster rate WT BubR1 ( +/- ) MEFs . Moreover , @ GeneSrc $ ) MEFs slipped mitosis presence nocodazole exhibited higher rate genomic instability WT BubR1 ( +/- ) @ GeneSrc $ ) MEFs , accompanied premature separation sister chromatids . Together , studies suggest BubR1 @ GeneSrc $ functionally interact regulating metaphase-anaphase transition , deregulation may play key role genomic instability development progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013101102336724)\n",
      "- Text: \"Myc deletion rescues @ GeneSrc $ deficiency small intestine . @ GeneSrc $ gene encodes adenomatous polyposis coli tumour suppressor protein , germline mutation characterizes familial adenomatous polyposis ( FAP ) , autosomal intestinal cancer syndrome . Inactivation @ GeneSrc $ also recognized key early event development @ DiseaseTgt $ , loss results constitutive activity beta-catenin-Tcf4 transcription complex . proto-oncogene c-MYC identified target Wnt pathway @ DiseaseTgt $ cells vitro , normal crypts vivo intestinal epithelial cells acutely transformed vivo deletion @ GeneSrc $ gene ; however , significance unclear . Therefore , elucidate role Myc intestine @ GeneSrc $ loss , simultaneously deleted @ GeneSrc $ Myc adult murine small intestine . show loss Myc rescued phenotypes perturbed differentiation , migration , proliferation apoptosis , occur deletion @ GeneSrc $ . Remarkably , rescue occurred presence high levels nuclear beta-catenin . Array analysis revealed Myc required majority Wnt target gene activation following @ GeneSrc $ loss . data establish Myc critical mediator early stages neoplasia following @ GeneSrc $ loss .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3789218492096154)\n",
      "- Text: \"Multiple intestinal neoplasia caused mutation murine homolog @ GeneSrc $ gene . Germ-line mutations @ GeneSrc $ gene responsible familial adenomatous polyposis ( FAP ) , autosomal dominantly inherited disease humans . Patients FAP develop multiple @ DiseaseTgt $ . Recently , mouse lineage exhibits autosomal dominantly inherited predisposition multiple intestinal neoplasia ( Min ) described . Linkage analysis showed murine homolog @ GeneSrc $ gene ( mApc ) tightly linked Min locus . Sequence comparison mApc normal Min-affected mice identified nonsense mutation , cosegregated Min phenotype . mutation analogous found FAP kindreds sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9556662583623958)\n",
      "- Text: \"Intestinal tumorigenesis compound mutant mice Dpc4 ( Smad4 ) @ GeneSrc $ genes . DPC4 ( SMAD4 ) gene plays key role TGFbeta signaling pathway . inactivated mouse homolog Dpc4 ( Smad4 ) . homozygous mutants embryonic lethal , whereas heterozygotes showed abnormality . introduced Dpc4 mutation @ GeneSrc $ ) knockout mice , model human familial adenomatous polyposis . @ GeneSrc $ Dpc4 located chromosome 18 , constructed compound heterozygotes carrying mutations chromosome meiotic recombination . mice , intestinal polyps developed malignant tumors simple @ GeneSrc $ ) heterozygotes , showing extensive stromal cell proliferation , submucosal invasion , cell type heterogeneity , vivo transplantability . results indicate mutations DPC4 ( SMAD4 ) play significant role malignant progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0092887040763507)\n",
      "- Text: \"Chemoprevention @ DiseaseTgt $ targeting APC-deficient cells apoptosis . Cancer chemoprevention uses natural , synthetic , biological substances reverse , suppress , prevent either initial phase carcinogenesis progression neoplastic cells cancer . holds promise overcoming problems associated treatment late-stage cancers . However , broad application chemoprevention compromised present limited effectiveness potential toxicity . overcome challenges , developed new chemoprevention approach specifically targets premalignant tumour cells apoptosis . show deficiency adenomatous polyposis coli ( APC ) gene subsequent activation beta-catenin lead repression cellular caspase-8 inhibitor c-FLIP ( also known CFLAR ) expression activation c-Myc , all-trans-retinyl acetate ( RAc ) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand ( TRAIL ) death receptors suppresses decoy receptors . Thus , combination TRAIL RAc induces apoptosis APC-deficient premalignant cells without affecting normal cells vitro . addition , show short-term non-continuous TRAIL RAc treatment induce apoptosis specifically intestinal polyps , strongly inhibit tumour growth , prolong survival multiple intestinal neoplasms @ GeneSrc $ ( @ GeneSrc $ ) ) mice . approach , demonstrate TRAIL RAc induce significant cell death human colon polyps , providing potentially selective approach @ DiseaseTgt $ chemoprevention targeting APC-deficient cells apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0038649102729487)\n",
      "- Text: \"DCC constrains tumour progression via dependence receptor activity . role deleted colorectal carcinoma ( DCC ) tumour suppressor matter debate past 15 years . DCC gene expression lost markedly reduced majority advanced @ DiseaseTgt $ , functioning dependence receptor , DCC shown induce apoptosis unless engaged ligand , netrin-1 ( ref . 2 ) . However , far animal model supported view DCC loss-of-function causally implicated predisposing aggressive cancer development . investigate role DCC-induced apoptosis control tumour progression , created mouse model pro-apoptotic activity DCC genetically silenced . Although loss DCC-induced apoptosis mouse model associated major disorganization intestines , leads spontaneous intestinal neoplasia relatively low frequency . Loss DCC-induced apoptosis also associated increase number aggressiveness intestinal tumours predisposing @ GeneSrc $ mutant context , resulting development highly invasive adenocarcinomas . results demonstrate DCC functions tumour suppressor via ability trigger tumour cell apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.34990061630441e-05)\n",
      "- Text: \"p53 status determines role autophagy pancreatic tumour development . Macroautophagy ( hereafter referred autophagy ) process organelles termed autophagosomes deliver cytoplasmic constituents lysosomes degradation . Autophagy major role cellular homeostasis implicated various forms human disease . role autophagy @ DiseaseTgt $ seems complex , reports indicating pro-tumorigenic @ DiseaseTgt $ roles . show , humanized genetically-modified mouse model pancreatic ductal adenocarcinoma ( PDAC ) , autophagy 's role @ DiseaseTgt $ development intrinsically connected status @ DiseaseTgt $ suppressor p53 . Mice pancreases containing activated oncogenic allele Kras ( also called Ki-Ras ) -- common mutational event PDAC -- develop small number pre-cancerous lesions stochastically develop PDAC time . However , mice also lacking essential autophagy genes @ GeneSrc $ Atg7 accumulate low-grade , pre-malignant pancreatic intraepithelial neoplasia lesions , progression high-grade pancreatic intraepithelial neoplasias PDAC blocked . marked contrast , mice containing oncogenic Kras lacking p53 , loss autophagy longer blocks @ DiseaseTgt $ progression , actually accelerates @ DiseaseTgt $ onset , metabolic analysis revealing enhanced glucose uptake enrichment anabolic pathways , fuel @ DiseaseTgt $ growth . findings provide considerable insight role autophagy @ DiseaseTgt $ important implications autophagy inhibition @ DiseaseTgt $ therapy . regard , also show treatment mice autophagy inhibitor hydroxychloroquine , currently used several clinical trials , significantly accelerates @ DiseaseTgt $ formation mice containing oncogenic Kras lacking p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.982810606126004)\n",
      "- Text: \"Amyloid precursor proteins inhibit heme oxygenase activity augment neurotoxicity @ DiseaseTgt $ . Amyloid precursor protein ( APP ) generates beta-amyloid peptide , postulated participate neurotoxicity @ DiseaseTgt $ . report APP @ GeneSrc $ bind heme oxygenase ( HO ) , enzyme whose product , bilirubin , antioxidant neuroprotective . binding APP inhibits HO activity , APP mutations linked familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) provides substantially greater inhibition HO activity wild-type APP . Cortical cultures transgenic mice expressing Swedish mutant APP greatly reduced bilirubin levels , establishing mutant APP inhibits HO activity vivo . Oxidative neurotoxicity markedly greater cerebral cortical cultures APP Swedish mutant transgenic mice wild-type cultures . findings indicate augmented neurotoxicity caused APP-HO interactions may contribute neuronal cell death @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9795501637795804)\n",
      "- Text: \"Presenilin-dependent transcriptional control Abeta-degrading enzyme neprilysin intracellular domains betaAPP @ GeneSrc $ . Amyloid beta-peptide ( Abeta ) , plays central role @ DiseaseTgt $ , generated presenilin-dependent gamma-secretase cleavage beta-amyloid precursor protein ( betaAPP ) . report presenilins ( PS1 PS2 ) also regulate Abeta degradation . Presenilin-deficient cells fail degrade Abeta drastic reductions transcription , expression , activity neprilysin , key Abeta-degrading enzyme . Neprilysin activity expression also lowered gamma-secretase inhibitors PS1/PS2 deficiency mouse brain . Neprilysin activity restored transient expression PS1 PS2 expression amyloid intracellular domain ( AICD ) , cogenerated Abeta , gamma-secretase cleavage betaAPP . Neprilysin gene promoters transactivated AICDs APP-like proteins ( APP , @ GeneSrc $ , APLP2 ) , Abeta gamma-secretase cleavage products Notch , N- E- cadherins . presenilin-dependent regulation neprilysin , mediated AICDs , provides physiological means modulate Abeta levels varying levels gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003727776001097)\n",
      "- Text: \"Presenilin-dependent transcriptional control Abeta-degrading enzyme neprilysin intracellular domains betaAPP APLP . Amyloid beta-peptide ( Abeta ) , plays central role @ DiseaseTgt $ , generated presenilin-dependent gamma-secretase cleavage beta-amyloid precursor protein ( betaAPP ) . report presenilins ( PS1 PS2 ) also regulate Abeta degradation . Presenilin-deficient cells fail degrade Abeta drastic reductions transcription , expression , activity neprilysin , key Abeta-degrading enzyme . Neprilysin activity expression also lowered gamma-secretase inhibitors PS1/PS2 deficiency mouse brain . Neprilysin activity restored transient expression PS1 PS2 expression amyloid intracellular domain ( AICD ) , cogenerated Abeta , gamma-secretase cleavage betaAPP . Neprilysin gene promoters transactivated AICDs APP-like proteins ( APP , APLP1 , @ GeneSrc $ ) , Abeta gamma-secretase cleavage products Notch , N- E- cadherins . presenilin-dependent regulation neprilysin , mediated AICDs , provides physiological means modulate Abeta levels varying levels gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.384999287340063e-07)\n",
      "- Text: \"@ GeneSrc $ therapeutics rapidly clear beta-amyloid reverse deficits @ DiseaseTgt $ mouse models . @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated impaired clearance beta-amyloid ( Abeta ) brain , process normally facilitated @ GeneSrc $ ( @ GeneSrc $ ) . @ GeneSrc $ expression transcriptionally induced action nuclear receptors peroxisome proliferator-activated receptor gamma liver X receptors coordination retinoid X receptors ( RXRs ) . Oral administration RXR agonist bexarotene mouse model @ DiseaseTgt $ resulted enhanced clearance soluble Abeta within hours @ GeneSrc $ manner . Abeta plaque area reduced 50 % within 72 hours . Furthermore , bexarotene stimulated rapid reversal cognitive , social , olfactory deficits improved neural circuit function . Thus , RXR activation stimulates physiological Abeta clearance mechanisms , resulting rapid reversal broad range Abeta-induced deficits .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1320529693910503)\n",
      "- Text: \"Neurodegeneration central nervous system apoE-deficient mice . @ GeneSrc $ ( apoE ) involved development regeneration central nervous system ( CNS ) . ApoE may also necessary maintain integrity synapto-dendritic complexity . analyzed synaptic alterations CNS apoE-deficient ( knockout ) mice aging process . apoE-deficient homozygous mice , age-dependent 15 40 % loss synaptophysin-immunoreactive nerve terminals microtubule-associated protein 2-immunoreactive dendrites neocortex hippocampus , compared controls . Dendritic alterations observed early 4 months age . Ultrastructural analysis revealed extensive dendritic vacuolization disruption endomembrane system cytoskeleton apoE-deficient homozygous mice . immunocytochemical studies neuronal cytoskeleton showed apoE-deficient mice decrease immunoreactivity alpha beta tubulin ( kinesin ) cell bodies processes . results support contention apoE might play important role maintaining stability synapto-dendritic apparatus altered deficient functioning molecule could underlie synaptic cytoskeletal alterations @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.07443430346857e-05)\n",
      "- Text: \"@ GeneSrc $ essential amyloid deposition APP ( V717F ) transgenic mouse model @ DiseaseTgt $ . quantified amount amyloid beta-peptide ( Abeta ) immunoreactivity well amyloid deposits large cohort transgenic mice overexpressing V717F human amyloid precursor protein ( APP ( V717F+/- ) TG mice ) , one , two mouse @ GeneSrc $ ( @ GeneSrc $ ) alleles various ages . Remarkably , amyloid deposits found brain region APP ( V717F+/- ) @ GeneSrc $ ) TG mice old 22 mo age , whereas age-matched APP ( V717F + /- ) @ GeneSrc $ ) @ GeneSrc $ ) TG mice display abundant amyloid deposition . amount Abeta immunoreactivity hippocampus also markedly reduced @ GeneSrc $ gene dose-dependent manner ( @ GeneSrc $ ) > @ GeneSrc $ ) > > @ GeneSrc $ ) ) , Abeta immunoreactivity detected cerebral cortex APP ( V717F+/- ) @ GeneSrc $ ) TG mice time points examined . absence apolipoprotein E protein ( @ GeneSrc $ ) dramatically reduced amount Abeta ( 1 - 40 ) Abeta ( 1 - 42 ) immunoreactive deposits well resulting astrogliosis microgliosis normally observed APP ( V717F ) TG mice . @ GeneSrc $ immunoreactivity detected subset Abeta immunoreactive deposits virtually thioflavine-S-fluorescent amyloid deposits . absence @ GeneSrc $ alters neither transcription translation APP ( V717F ) transgene processing Abeta peptide ( ) , postulate @ GeneSrc $ promotes deposition fibrillization Abeta , ultimately affecting clearance protease-resistant @ GeneSrc $ aggregates . @ GeneSrc $ appears play essential role amyloid deposition brain , one neuropathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006192641870327)\n",
      "- Text: \"@ GeneSrc $ isoform-dependent amyloid deposition neuritic degeneration mouse model @ DiseaseTgt $ . @ GeneSrc $ ( apoE ) alleles determine age-adjusted relative risk ( epsilon4 > epsilon3 ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . ApoE may affect @ DiseaseTgt $ pathogenesis promoting deposition amyloid-beta ( Abeta ) peptide conversion fibrillar form . determine effect apoE Abeta deposition @ DiseaseTgt $ pathology , compared APP ( V717F ) transgenic ( TG ) mice expressing mouse , human , apoE ( apoE ( -/- ) ) . severe , plaque-associated neuritic dystrophy developed APP ( V717F ) TG mice expressing mouse human apoE . Though significant levels Abeta deposition also occurred APP ( V717F ) TG , apoE ( -/- ) mice , neuritic degeneration virtually absent . Expression apoE3 apoE4 APP ( V717F ) TG , apoE ( -/- ) mice resulted fibrillar Abeta deposits neuritic plaques 15 months age substantially ( > 10-fold ) fibrillar deposits observed apoE4-expressing APP ( V717F ) TG mice . data demonstrate critical isoform-specific role apoE neuritic plaque formation , pathological hallmark @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1069232953666081)\n",
      "- Text: \"Gene delivery human apolipoprotein E alters brain Abeta burden mouse model @ DiseaseTgt $ . @ GeneSrc $ ( apoE ) alleles important genetic risk factors @ DiseaseTgt $ ( @ DiseaseTgt $ ) , epsilon4 allele increasing epsilon2 allele decreasing risk developing @ DiseaseTgt $ . ApoE shown influence brain amyloid-beta peptide ( Abeta ) amyloid burden , humans transgenic mice . show direct intracerebral administration lentiviral vectors expressing three common human apoE isoforms differentially alters hippocampal Abeta amyloid burden PDAPP mouse model @ DiseaseTgt $ . Expression apoE4 absence mouse apoE increases hippocampal Abeta ( 1 - 42 ) levels amyloid burden . contrast , expression apoE2 , even presence mouse apoE , markedly reduces hippocampal Abeta burden . data demonstrate rapid apoE isoform-dependent effects brain Abeta burden mouse model @ DiseaseTgt $ . Gene delivery apoE2 may prevent reduce brain Abeta burden subsequent development neuritic plaques .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001408946913747)\n",
      "- Text: \"@ GeneSrc $ allele-dependent pathogenesis : model age-related retinal degeneration . Age-related macular degeneration ( AMD ) late-onset , multifactorial , neurodegenerative disease retina leading cause irreversible vision loss elderly Western world . describe murine model combines three known AMD risk factors : advanced age , high fat cholesterol-rich ( HF-C ) diet , apolipoprotein E ( apoE ) genotype . Eyes aged , targeted replacement mice expressing human apoE2 , apoE3 , apoE4 maintained HF-C diet show apoE isoform-dependent pathologies differential severity . ApoE4 mice severely affected . develop constellation changes mimic pathology associated human AMD . alterations include diffuse sub-retinal pigment epithelial deposits , drusenoid deposits , thickened Bruch 's membrane , atrophy , hypopigmentation , hyperpigmentation retinal pigment epithelium . extreme cases , apoE4 mice also develop marked choroidal neovascularization , hallmark exudative AMD . Neither age HF-C diet alone sufficient elicit changes . document choroidal neovascularization AMD-like ocular pathologies animal model exploits known AMD risk factors . model additionally attractive complicated invasive experimental intervention . findings model implicate human apoE E4 allele susceptibility gene AMD support hypothesis common pathogenic mechanisms may underlie AMD @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.946390155761384e-05)\n",
      "- Text: \"Sense antisense transcripts @ GeneSrc $ gene normal @ GeneSrc $ knockout mice , expression spinal cord injury corresponding human transcripts . apolipoprotein E ( ApoE ) gene linked maladies hypercholesterolemia , CNS injury disease . study , present evidence , addition known transcript ( ApoE S1 ) translates ApoE , three additional transcripts mice . Two transcripts , ApoE S2 ApoE S3 , predicted transmembrane proteins , transcribed sense strand . ApoE AS1 transcribed antisense strand complementary exon 4 ApoE S1 . open reading frame ApoE AS1 conserved human mouse . antisense transcript falls within region human epsilon 4 allele linked familial onset form @ DiseaseTgt $ . also demonstrate expression ApoE S3 ApoE AS1 ApoE knockout mice , ApoE S1 ApoE S2 get transcribed . previously identified ApoE S1 upregulated mice spinal cord injury . study , show spinal cord-injured C57BL/6 mice , ApoE S1 @ GeneSrc $ S3 transcripts 10-fold upregulated antisense ApoE AS1 100-fold upregulated compared normal levels . data suggest alternate transcripts involved molecular pathogenesis CNS disease perhaps ApoE expression general , show ApoE S2 AS1 also transcribed human .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.1181733376781976e-06)\n",
      "- Text: \"Activation estrogen receptor alpha increases estrogen receptor beta decreases @ GeneSrc $ expression hippocampus vitro vivo . Previous evidence indicates , carriers apolipoprotein E4 ( ApoE4 ) , estrogen therapy increased risk late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , whereas individuals carrying ApoE2/3 , estrogen therapy reduced risk @ DiseaseTgt $ [ Cauley JA , Zmuda JM , Yaffe K , Kuller LH , Ferrell , Wisniewski SR , Cummings SR ( 1999 ) J Bone Miner Res 14:1175 - 1181 ; Yaffe K , Haan , Byers , Tangen C , Kuller L ( 2000 ) Neurology 54:1949 - 1954 ] . Estrogen mechanisms action mediated two estrogen receptors ( ERs ) , ERalpha ERbeta . study , determined relationship ER subtype estrogen regulation ApoE expression HT-22 cells ectopically transfected ERalpha ERbeta , primary cultured rat hippocampal neurons vitro rat hippocampus vivo molecular biological pharmacological analyses . Results analyses demonstrated activation ERalpha either 17beta-estradiol specific-agonist , propylpyrazole triol , up-regulated ApoE mRNA protein expression . contrast , ERbeta-selective agonist , diarylpropionitrile , down-regulated ApoE mRNA protein expression . results demonstrate , vitro vivo , ApoE expression differentially regulated depending activation ER subtypes . data suggest use ER-selective ligands could provide therapeutic benefit reduce risk @ DiseaseTgt $ increasing ApoE expression ApoE2/3 allele carriers decreasing ApoE expression ApoE4 allele carriers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.109575692750504e-05)\n",
      "- Text: \"novel @ GeneSrc $ interaction inhibitor rescues altered thrombosis cognitive decline @ DiseaseTgt $ mice . Many @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients suffer cerebrovascular abnormalities altered cerebral blood flow cerebral microinfarcts . Recently , fibrinogen identified strong cerebrovascular risk factor @ DiseaseTgt $ , specifically binds beta-amyloid ( @ GeneSrc $ ) , thereby altering fibrin clot structure delaying clot degradation . determine @ GeneSrc $ interaction could targeted potential new treatment @ DiseaseTgt $ , designed high-throughput screen identified RU-505 effective inhibitor @ GeneSrc $ interaction . RU-505 restored @ GeneSrc $ altered fibrin clot formation degradation vitro inhibited vessel occlusion @ DiseaseTgt $ transgenic mice . Furthermore , long-term treatment RU-505 significantly reduced vascular amyloid deposition microgliosis cortex improved cognitive impairment mouse models @ DiseaseTgt $ . studies suggest inhibitors targeting @ GeneSrc $ interaction show promise therapy treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2481244693019164)\n",
      "- Text: \"ApoE-directed therapeutics rapidly clear beta-amyloid reverse deficits @ DiseaseTgt $ mouse models . @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated impaired clearance beta-amyloid ( @ GeneSrc $ ) brain , process normally facilitated apolipoprotein E ( apoE ) . ApoE expression transcriptionally induced action nuclear receptors peroxisome proliferator-activated receptor gamma liver X receptors coordination retinoid X receptors ( RXRs ) . Oral administration RXR agonist bexarotene mouse model @ DiseaseTgt $ resulted enhanced clearance soluble @ GeneSrc $ within hours apoE-dependent manner . @ GeneSrc $ plaque area reduced 50 % within 72 hours . Furthermore , bexarotene stimulated rapid reversal cognitive , social , olfactory deficits improved neural circuit function . Thus , RXR activation stimulates physiological @ GeneSrc $ clearance mechanisms , resulting rapid reversal broad range @ GeneSrc $ deficits .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0639248567551433)\n",
      "- Text: \"Comment `` ApoE-directed therapeutics rapidly clear beta-amyloid reverse deficits @ DiseaseTgt $ mouse models `` . Cramer et al . ( Reports , 23 March 2012 , p. 1503 ; published online 9 February 2012 ) demonstrated mouse model @ DiseaseTgt $ ( @ DiseaseTgt $ ) treatment APP/PS1DeltaE9 mice bexarotene decreased @ GeneSrc $ pathology ameliorated memory deficits . confirm reversal memory deficits APP/PS1DeltaE9 mice expressing human APOE3 APOE4 levels nontransgenic controls significant decrease interstitial fluid @ GeneSrc $ , effects amyloid deposition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009045812184513)\n",
      "- Text: \"Complement microglia mediate early synapse loss @ DiseaseTgt $ mouse models . Synapse loss @ DiseaseTgt $ ( @ DiseaseTgt $ ) correlates cognitive decline . Involvement microglia complement @ DiseaseTgt $ attributed neuroinflammation , prominent late disease . show mouse models complement microglia mediate synaptic loss early @ DiseaseTgt $ . C1q , initiating protein classical complement cascade , increased associated synapses overt plaque deposition . Inhibition C1q , C3 , microglial complement receptor CR3 reduces number phagocytic microglia , well extent early synapse loss . C1q necessary toxic effects soluble beta-amyloid ( @ GeneSrc $ ) oligomers synapses hippocampal long-term potentiation . Finally , microglia adult brains engulf synaptic material CR3-dependent process exposed soluble @ GeneSrc $ oligomers . Together , findings suggest complement-dependent pathway microglia prune excess synapses development inappropriately activated mediate synapse loss @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0849758593587154)\n",
      "- Text: \"Becn1 mutation mediates hyperactive autophagic sequestration amyloid oligomers improved cognition @ DiseaseTgt $ . Impairment autophagy pathway observed pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , neurodegenerative disorder characterized abnormal deposition extracellular intracellular amyloid beta ( @ GeneSrc $ ) peptides . Yet role autophagy @ GeneSrc $ production @ DiseaseTgt $ progression complex . study whether increased basal autophagy plays beneficial role @ GeneSrc $ clearance cognitive improvement , developed novel genetic model hyperactivate autophagy vivo . found knock-in point mutation F121A essential autophagy gene Beclin 1/Becn1 mice significantly reduces interaction BECN1 inhibitor BCL2 , thus leads constitutively active autophagy even non-autophagy-inducing conditions multiple tissues , including brain . Becn1F121A-mediated autophagy hyperactivation significantly decreases amyloid accumulation , prevents cognitive decline , restores survival @ DiseaseTgt $ mouse models . Using immunoisolation method , found biochemically @ GeneSrc $ oligomers autophagic substrates sequestered inside autophagosomes brain autophagy-hyperactive @ DiseaseTgt $ mice . addition genetic activation autophagy Becn1 gain-of-function , also found ML246 , small-molecule autophagy inducer , well voluntary exercise , physiological autophagy inducer , exert similar Becn1-dependent protective effects @ GeneSrc $ removal memory @ DiseaseTgt $ mice . Taken together , results demonstrate genetically disrupting BECN1-BCL2 binding hyperactivates autophagy vivo , sequestrates amyloid oligomers prevents @ DiseaseTgt $ progression . study establishes new approaches activate autophagy brain , reveals important function Becn1-mediated autophagy hyperactivation prevention @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0300460057426413)\n",
      "- Text: \"Glutaminyl cyclase inhibition attenuates pyroglutamate @ GeneSrc $ @ DiseaseTgt $ pathology . abundance , resistance proteolysis , rapid aggregation neurotoxicity , N-terminally truncated , particular , pyroglutamate ( pE ) -modified @ GeneSrc $ peptides suggested important initiation pathological cascades resulting development @ DiseaseTgt $ . found N-terminal pE-formation catalyzed glutaminyl cyclase vivo . Glutaminyl cyclase expression upregulated cortices individuals @ DiseaseTgt $ correlated appearance pE-modified @ GeneSrc $ . Oral application glutaminyl cyclase inhibitor resulted reduced Abeta ( 3 ( pE ) -42 ) burden two different transgenic mouse models @ DiseaseTgt $ new Drosophila model . Treatment mice accompanied reductions @ GeneSrc $ , diminished plaque formation gliosis improved performance context memory spatial learning tests . observations consistent hypothesis Abeta ( 3 ( pE ) -42 ) acts seed @ GeneSrc $ aggregation self-aggregation co-aggregation Abeta ( 1 - 40/42 ) . Therefore , Abeta ( 3 ( pE ) -40/42 ) peptides seem represent @ GeneSrc $ forms exceptional potency disturbing neuronal function . reduction brain pE-Abeta inhibition glutaminyl cyclase offers new therapeutic option treatment @ DiseaseTgt $ provides implications amyloidoses , familial Danish dementia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0161957348793918)\n",
      "- Text: \"Comment `` ApoE-directed therapeutics rapidly clear beta-amyloid reverse deficits @ DiseaseTgt $ mouse models `` . Cramer et al . ( Reports , 23 March 2012 , p. 1503 ; published online 9 February 2012 ) reported bexarotene rapidly reduces beta-amyloid ( @ GeneSrc $ ) levels plaque burden two mouse models @ GeneSrc $ deposition @ DiseaseTgt $ ( @ DiseaseTgt $ ) . report , although bexarotene reduces soluble Abeta40 levels one mouse models , drug impact plaque burden three strains exhibit Abeta amyloidosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0235231472798133)\n",
      "- Text: \"vicious cycle beta amyloid-dependent neuronal hyperactivation . beta-amyloid @ GeneSrc $ neuronal hyperactivity believed contribute circuit dysfunction characterizes early stages @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although experimental evidence support hypothesis continues accrue , underlying pathological mechanisms well understood . experiment , used mouse models Abeta-amyloidosis show hyperactivation initiated suppression glutamate reuptake . Hyperactivity occurred neurons preexisting baseline activity , whereas inactive neurons generally resistant @ GeneSrc $ hyperactivation . @ GeneSrc $ @ DiseaseTgt $ brain extracts purified @ GeneSrc $ dimers able sustain vicious cycle . findings suggest cellular mechanism @ GeneSrc $ neuronal dysfunction active plaque formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0962725767515202)\n",
      "- Text: \"Alzheimer 's beta peptide induces neurodegeneration apoptotic cell death transgenic mice . test whether hypothesis @ DiseaseTgt $ peptide neurotoxic , introduced transgene mice direct expression peptide neurons . show transgene expressed brain regions severely affected @ DiseaseTgt $ resulting extensive neuronal degeneration . Morphological biochemical evidence indicates eventual death cells occurs apoptosis . Coincident cell degeneration cell death presence striking reactive gliosis . 50 % transgenic mice die 12 months age , half normal life span control mice . data show @ GeneSrc $ neurotoxic vivo suggest apoptosis may responsible accompanying neuronal loss , principal underlying cellular feature @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5265829771371296)\n",
      "- Text: \"Alzheimer-type neuropathology transgenic mice overexpressing V717F @ GeneSrc $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common cause progressive intellectual failure aged humans . @ DiseaseTgt $ brains contain numerous amyloid plaques surrounded dystrophic neurites , show profound synaptic loss , neurofibrillary tangle formation gliosis . amyloid plaques composed amyloid beta-peptide ( beta ) , 40 - 42-amino-acid fragment beta-amyloid precursor protein ( APP ) . primary pathogenic role APP/A beta suggested missense mutations APP tightly linked autosomal dominant forms @ DiseaseTgt $ . major obstacle elucidating treating @ DiseaseTgt $ lack animal model . Animals transgenic APP previously failed show extensive @ DiseaseTgt $ neuropathology , report production transgenic mice express high levels human mutant APP ( valine residue 717 substituted phenylalanine ) progressively develop many pathological hallmarks @ DiseaseTgt $ , including numerous extracellular thioflavin S-positive @ GeneSrc $ deposits , neuritic plaques , synaptic loss , astrocytosis microgliosis . mice support primary role @ GeneSrc $ genesis @ DiseaseTgt $ could provide preclinical model testing therapeutic drugs .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9883941069523214)\n",
      "- Text: \"Correlative memory deficits , @ GeneSrc $ elevation , amyloid plaques transgenic mice . Transgenic mice overexpressing 695-amino acid isoform human @ DiseaseTgt $ beta-amyloid ( Abeta ) precursor protein containing Lys670 -- > Asn , Met671 -- > Leu mutation normal learning memory spatial reference alternation tasks 3 months age showed impairment 9 10 months age . fivefold increase Abeta ( 1 - 40 ) 14-fold increase Abeta ( 1 - 42/43 ) accompanied appearance behavioral deficits . Numerous @ GeneSrc $ plaques stained Congo red dye present cortical limbic structures mice elevated amounts @ GeneSrc $ . correlative appearance behavioral , biochemical , pathological abnormalities reminiscent @ DiseaseTgt $ transgenic mice suggests new opportunities exploring pathophysiology neurobiology disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029281378478002)\n",
      "- Text: \"@ DiseaseTgt $ presenilin 1 variants elevate Abeta1 - 42/1 - 40 ratio vitro vivo . Mutations presenilin 1 ( PS1 ) presenilin 2 genes cosegregate majority early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . document Abeta1 - 42 ( 43 ) /Abeta1 - 40 ratio conditioned media independent N2a cell lines expressing three @ DiseaseTgt $ PS1 variants uniformly elevated relative cells expressing similar levels wild-type PS1 . Similarly , Abeta1 - 42 ( 43 ) /Abeta1 - 40 ratio elevated brains young transgenic animals coexpressing chimeric @ GeneSrc $ ( APP ) @ DiseaseTgt $ PS1 variant compared brains transgenic mice expressing APP alone transgenic mice coexpressing wild-type human PS1 APP . studies provide compelling support view one mechanism mutant PS1 cause @ DiseaseTgt $ increasing extracellular concentration @ GeneSrc $ peptides terminating 42 ( 43 ) , species foster @ GeneSrc $ deposition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5)\n",
      "- Text: \"Mutant presenilins @ DiseaseTgt $ increase production 42-residue amyloid beta-protein transfected cells transgenic mice . mechanism mutations presenilin ( PS ) genes cause aggressive form early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) unknown , fibroblasts mutation carriers secrete increased levels amyloidogenic beta 42 peptide , main component @ DiseaseTgt $ plaques . established transfected cell transgenic mouse models coexpress human PS amyloid beta-protein precursor ( APP ) genes analyzed quantitatively effects PS expression APP processing . models , expression wild-type PS genes alter APP levels , alpha- beta-secretase activity @ GeneSrc $ production . transfected cells , PS1 PS2 mutations caused highly significant increase beta 42 secretion mutant clones . Likewise , mutant wildtype PS1 transgenic mice showed significant overproduction beta 42 brain , effect detectable early 2 - 4 months age . Different PS mutations differential effects @ GeneSrc $ generation . extent beta 42 increase correlate presenilin expression levels . data demonstrate presenilin mutations cause dominant gain function may induce @ DiseaseTgt $ enhancing beta 42 production , thus promoting cerebral beta-amyloidosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9424604216186326)\n",
      "- Text: \"Amyloidogenic role cytokine TGF-beta1 transgenic mice @ DiseaseTgt $ . Deposition amyoid-beta peptide central nervous system hallmark @ DiseaseTgt $ possible cause neurodegeneration . factors initiate promote deposition amyloid-beta peptide known . transforming growth factor TGF-beta1 plays central role response brain injury , increased TGF-beta1 found central nervous system patients @ DiseaseTgt $ . report TGF-beta1 induces amyloid-beta deposition cerebral blood vessels meninges aged transgenic mice overexpressing cytokine astrocytes . Co-expression TGF-beta1 transgenic mice overexpressing @ GeneSrc $ , develop @ DiseaseTgt $ like pathology , accelerated deposition amyloid-beta peptide . TGF-beta1 messenger RNA present post-mortem brain tissue @ DiseaseTgt $ patients controls , levels correlating strongly amyloid-beta deposition damaged cerebral blood vessels patients cerebral amyloid angiopathy . results indicate overexpression TGF-beta1 may initiate promote amyloidogenesis @ DiseaseTgt $ experimental models may risk factor developing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0104067319066419)\n",
      "- Text: \"Two @ GeneSrc $ transgenic mouse models @ DiseaseTgt $ pathology . Mutations @ GeneSrc $ ( APP ) gene cause early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) affecting formation @ GeneSrc $ peptide , major constituent @ DiseaseTgt $ plaques . expressed human APP751 containing mutations brains transgenic mice . Two transgenic mouse lines develop pathological features reminiscent @ DiseaseTgt $ . degree pathology depends expression levels specific mutations . 2-fold overexpression human APP Swedish double mutation positions 670/671 combined V717I mutation causes beta deposition neocortex hippocampus 18-month-old transgenic mice . deposits mostly diffuse type ; however , congophilic plaques detected . mice 7-fold overexpression human APP harboring Swedish mutation alone , typical plaques appear 6 months , increase age Congo Red-positive first detection . congophilic plaques accompanied neuritic changes dystrophic cholinergic fibers . Furthermore , inflammatory processes indicated massive glial reaction apparent . notably , plaques immunoreactive hyperphosphorylated tau , reminiscent early tau pathology . immunoreactivity exclusively found congophilic senile plaques lines . higher expressing line , elevated tau phosphorylation demonstrated biochemically 6-month-old animals increases age . mice resemble major features @ DiseaseTgt $ pathology suggest central role beta pathogenesis disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6875278290275234)\n",
      "- Text: \"Deficiency presenilin-1 inhibits normal cleavage @ GeneSrc $ . Point mutations presenilin-1 gene ( PS1 ) major cause @ DiseaseTgt $ . result selective increase production amyloidogenic peptide amyloid-beta ( 1 - 42 ) proteolytic processing @ GeneSrc $ ( APP ) . investigate whether PS1 also involved normal APP processing neuronal cultures derived PS1-deficient mouse embryos . Cleavage alpha- beta-secretase extracellular domain APP affected absence PS1 , whereas cleavage gamma-secretase transmembrane domain APP prevented , causing carboxyl-terminal fragments APP accumulate fivefold drop production amyloid peptide . Pulse-chase experiments indicated PS1 deficiency specifically decreased turnover membrane-associated fragments APP . regulation cholesterol metabolism proteolysis membrane-bound transcription factor , PS1 appears facilitate proteolytic activity cleaves integral membrane domain APP . results indicate mutations PS1 manifest clinically cause gain function inhibition PS1 activity potential target anti-amyloidogenic therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3359794446070745)\n",
      "- Text: \"@ DiseaseTgt $ PS1 variant rescues developmental abnormalities PS1-deficient embryos . Mutations presenilin 1 ( PS1 ) cosegregate approximately 25 % early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . variety vitro vivo paradigms established one mechanism PS1 variants cause @ DiseaseTgt $ elevating production highly amyloidogenic Abeta1 - 42/43 peptides . PS1 homologous sel-12 , C. elegans protein facilitates signaling mediated Notch/lin-12 family receptors . Wild-type human PS1 complements egg-laying defect C. elegans lacking sel-12 , @ DiseaseTgt $ PS1 variants exhibit reduced rescue activity . data suggested mutant PS1 may cause disease result reduction PS1 function . test function @ DiseaseTgt $ PS1 mammals , examined ability A246E PS1 variant complement embryonic lethality axial skeletal defects mice lacking PS1 . Finally , examine influence reduced PS1 levels @ GeneSrc $ production , quantified Abeta1 - 42/43 peptide levels PS1 heterozygous null mice ( PS1 [ +/- ] mice ) . report human wild-type A246E PS1 efficiently rescue phenotypes observed PS1 ( -/- ) embryos , findings consistent view @ DiseaseTgt $ PS1 mutants retain sufficient normal function mammalian embryonic development . Moreover , levels Abeta1 - 42/43 Abeta1 - 40 peptides PS1 ( +/- ) control mice indistinguishable . Collectively , data lead us conclude mutant PS1 causes @ DiseaseTgt $ loss normal PS1 function influencing @ GeneSrc $ ( APP ) processing manner elevates Abeta1 - 42/43 production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5)\n",
      "- Text: \"Expression human apolipoprotein E reduces amyloid-beta deposition mouse model @ DiseaseTgt $ . epsilon4 allele apolipoprotein E ( apo E ) associated increased risk developing @ DiseaseTgt $ ( @ DiseaseTgt $ ) . may due interactions apo E amyloid-beta protein ( @ GeneSrc $ ) . assess effects human apo E isoforms @ GeneSrc $ deposition vivo , bred apo E3 apo E4 hemizygous ( + /- ) transgenic mice expressing apo E astrocytes mice homozygous ( + /+ ) mutant @ GeneSrc $ ( APPV717F ) transgene develop age-dependent @ DiseaseTgt $ . mice mouse apo E null ( -/- ) background . nine months age , APPV717F+/- , apo E-/- mice developed @ GeneSrc $ deposition , , reported previously , quantity @ GeneSrc $ deposits significantly less seen APPV717F+/- mice expressing mouse apo E. contrast effects mouse apo E , similar levels human apo E3 apo E4 markedly suppressed early @ GeneSrc $ deposition nine months age APPV717F+/- transgenic mice , even compared mice lacking apo E. findings suggest human apo E isoforms decrease @ GeneSrc $ aggregation increase Abeta clearance relative environment mouse apo E apo E present . results may important implications understanding mechanisms underlying link apo E @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1827521247187207)\n",
      "- Text: \"Two transmembrane aspartates presenilin-1 required presenilin endoproteolysis gamma-secretase activity . Accumulation amyloid-beta protein ( @ GeneSrc $ ) cerebral cortex early invariant event pathogenesis @ DiseaseTgt $ . final step generation @ GeneSrc $ @ GeneSrc $ apparently intramembranous proteolysis elusive gamma-secretase ( ) . common cause familial @ DiseaseTgt $ mutation genes encoding presenilins 1 2 , alters gamma-secretase activity increase production highly amyloidogenic Abeta42 isoform . Moreover , deletion presenilin-1 mice greatly reduces gamma-secretase activity , indicating presenilin-1 mediates proteolytic event . report mutation either two conserved transmembrane ( TM ) aspartate residues presenilin-1 , Asp 257 ( TM6 ) Asp 385 ( TM7 ) , substantially reduces @ GeneSrc $ production increases amounts carboxy-terminal fragments @ GeneSrc $ substrates gamma-secretase . observed effects three different cell lines well cell-free microsomes . Either Asp -- > Ala mutations also prevented normal endoproteolysis presenilin-1 TM6 -- > TM7 cytoplasmic loop . functional presenilin-1 variant ( carrying deletion exon 9 ) associated familial @ DiseaseTgt $ require cleavage , Asp 385 -- > Ala mutation still inhibited gamma-secretase activity . results indicate two transmembrane aspartate residues critical presenilin-1 endoproteolysis gamma-secretase activity , suggest presenilin 1 either unique diaspartyl cofactor gamma-secretase gamma-secretase , autoactivated intramembranous aspartyl protease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1261215313183271)\n",
      "- Text: \"Immunization amyloid-beta attenuates @ DiseaseTgt $ pathology PDAPP mouse . Amyloid-beta peptide ( @ GeneSrc $ ) seems central role neuropathology @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Familial forms disease linked mutations amyloid precursor protein ( APP ) presenilin genes . Disease-linked mutations genes result increased production 42-amino-acid form peptide ( Abeta42 ) , predominant form found amyloid plaques @ DiseaseTgt $ . PDAPP transgenic mouse , overexpresses mutant human APP ( amino acid position 717 phenylalanine instead normal valine ) , progressively develops many neuropathological hallmarks @ DiseaseTgt $ age- brain-region-dependent manner . present study , transgenic animals immunized Abeta42 , either onset @ DiseaseTgt $ neuropathologies ( 6 weeks age ) older age ( 11 months ) , amyloid-beta deposition several subsequent neuropathological changes well established . report immunization young animals essentially prevented development beta-amyloid-plaque formation , neuritic dystrophy astrogliosis . Treatment older animals also markedly reduced extent progression @ DiseaseTgt $ neuropathologies . results raise possibility immunization amyloid-beta may effective preventing treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6492296238275618)\n",
      "- Text: \"Presenilin 2 deficiency causes mild pulmonary phenotype changes @ GeneSrc $ processing enhances embryonic lethal phenotype presenilin 1 deficiency . Mutations homologous presenilin 1 ( PS1 ) presenilin 2 ( PS2 ) genes cause common aggressive form familial @ DiseaseTgt $ . Although PS1 function dysfunction extensively studied , little known function PS2 vivo . delineate relationships PS2 PS1 activities whether PS2 mutations involve gain loss function , generated PS2 homozygous deficient ( -/- ) PS1/PS2 double homozygous deficient mice . contrast PS1 ( -/- ) mice , PS2 ( -/- ) mice viable fertile develop mild pulmonary fibrosis hemorrhage age . Absence PS2 detectably alter processing @ GeneSrc $ little effect physiologically important apoptotic processes , indicating @ DiseaseTgt $ mutations PS2 , PS1 , result gain function . Although PS1 ( +/- ) PS2 ( -/- ) mice survive relatively good health , complete deletion PS2 PS1 genes causes phenotype closely resembling full Notch-1 deficiency . results demonstrate vivo PS1 PS2 partially overlapping functions PS1 essential PS2 redundant normal Notch signaling mammalian embryological development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2193154200796276)\n",
      "- Text: \"Apolipoprotein E essential amyloid deposition APP ( V717F ) transgenic mouse model @ DiseaseTgt $ . quantified amount amyloid beta-peptide ( @ GeneSrc $ ) immunoreactivity well amyloid deposits large cohort transgenic mice overexpressing V717F human amyloid precursor protein ( APP ( V717F+/- ) TG mice ) , one , two mouse apolipoprotein E ( Apoe ) alleles various ages . Remarkably , amyloid deposits found brain region APP ( V717F+/- ) Apoe ( -/- ) TG mice old 22 mo age , whereas age-matched APP ( V717F + /- ) Apoe ( +/- ) Apoe ( +/+ ) TG mice display abundant amyloid deposition . amount @ GeneSrc $ immunoreactivity hippocampus also markedly reduced Apoe gene dose-dependent manner ( Apoe ( +/+ ) > Apoe ( +/- ) > > Apoe ( -/- ) ) , @ GeneSrc $ immunoreactivity detected cerebral cortex APP ( V717F+/- ) Apoe ( -/- ) TG mice time points examined . absence apolipoprotein E protein ( apoE ) dramatically reduced amount Abeta ( 1 - 40 ) Abeta ( 1 - 42 ) immunoreactive deposits well resulting astrogliosis microgliosis normally observed APP ( V717F ) TG mice . ApoE immunoreactivity detected subset @ GeneSrc $ immunoreactive deposits virtually thioflavine-S-fluorescent amyloid deposits . absence apoE alters neither transcription translation APP ( V717F ) transgene processing @ GeneSrc $ peptide ( ) , postulate apoE promotes deposition fibrillization @ GeneSrc $ , ultimately affecting clearance protease-resistant @ GeneSrc $ aggregates . ApoE appears play essential role amyloid deposition brain , one neuropathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.004201204318194)\n",
      "- Text: \"Apolipoprotein E isoform-dependent amyloid deposition neuritic degeneration mouse model @ DiseaseTgt $ . Apolipoprotein E ( apoE ) alleles determine age-adjusted relative risk ( epsilon4 > epsilon3 ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . ApoE may affect @ DiseaseTgt $ pathogenesis promoting deposition amyloid-beta ( @ GeneSrc $ ) peptide conversion fibrillar form . determine effect apoE @ GeneSrc $ deposition @ DiseaseTgt $ pathology , compared APP ( V717F ) transgenic ( TG ) mice expressing mouse , human , apoE ( apoE ( -/- ) ) . severe , plaque-associated neuritic dystrophy developed APP ( V717F ) TG mice expressing mouse human apoE . Though significant levels @ GeneSrc $ deposition also occurred APP ( V717F ) TG , apoE ( -/- ) mice , neuritic degeneration virtually absent . Expression apoE3 apoE4 APP ( V717F ) TG , apoE ( -/- ) mice resulted fibrillar @ GeneSrc $ deposits neuritic plaques 15 months age substantially ( > 10-fold ) fibrillar deposits observed apoE4-expressing APP ( V717F ) TG mice . data demonstrate critical isoform-specific role apoE neuritic plaque formation , pathological hallmark @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0326204352031363)\n",
      "- Text: \"@ GeneSrc $ peptide immunization reduces behavioural impairment plaques model @ DiseaseTgt $ . Much evidence indicates abnormal processing extracellular deposition amyloid-beta peptide ( @ GeneSrc $ ) , proteolytic derivative @ GeneSrc $ ( @ GeneSrc $ ) , central pathogenesis @ DiseaseTgt $ ( reviewed ref . 1 ) . PDAPP transgenic mouse model @ DiseaseTgt $ , immunization @ GeneSrc $ causes marked reduction burden brain amyloid . Evidence @ GeneSrc $ immunization also reduces cognitive dysfunction murine models @ DiseaseTgt $ would support hypothesis abnormal @ GeneSrc $ processing essential pathogenesis @ DiseaseTgt $ , would encourage development strategies directed ' amyloid cascade ' . show @ GeneSrc $ immunization reduces deposition cerebral fibrillar @ GeneSrc $ cognitive dysfunction TgCRND8 murine model @ DiseaseTgt $ without , however , altering total levels @ GeneSrc $ brain . implies either approximately 50 % reduction dense-cored @ GeneSrc $ plaques sufficient affect cognition , vaccination may modulate activity/abundance small subpopulation especially toxic @ GeneSrc $ species .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0981928358619176)\n",
      "- Text: \"@ GeneSrc $ peptide vaccination prevents memory loss animal model @ DiseaseTgt $ . Vaccinations amyloid-beta peptide ( @ GeneSrc $ ) dramatically reduce amyloid deposition transgenic mouse model @ DiseaseTgt $ . determine vaccinations deleterious beneficial functional consequences , tested eight months @ GeneSrc $ vaccination different transgenic model @ DiseaseTgt $ mice develop learning deficits amyloid accumulates . show vaccination @ GeneSrc $ protects transgenic mice learning age-related memory deficits normally occur mouse model @ DiseaseTgt $ . testing potential deleterious effects vaccine , mice performed superbly radial-arm water-maze test working memory . Later , age untreated transgenic mice show memory deficits , @ GeneSrc $ transgenic mice showed cognitive performance superior control transgenic mice , ultimately , performed well nontransgenic mice . @ GeneSrc $ mice also partial reduction amyloid burden end study . therapeutic approach may thus prevent , possibly , treat @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0109649092412637)\n",
      "- Text: \"Axonal transport @ GeneSrc $ mediated direct binding kinesin light chain subunit kinesin-I . analyzed mechanism axonal transport @ GeneSrc $ ( APP ) , plays major role development @ DiseaseTgt $ . Coimmunoprecipitation , sucrose gradient , direct vitro binding demonstrated APP forms complex microtubule motor , conventional kinesin ( kinesin-I ) , binding directly TPR domain kinesin light chain ( KLC ) subunit . estimated apparent Kd binding 15 - 20 nM , binding stoichiometry two APP per KLC . addition , association APP microtubules axonal transport APP greatly decreased gene-targeted mouse mutant neuronally enriched KLC1 gene . propose one normal functions APP may membrane cargo receptor kinesin-I KLC important kinesin-I-driven transport APP axons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005116069901333)\n",
      "- Text: \"Amyloid precursor proteins inhibit heme oxygenase activity augment neurotoxicity @ DiseaseTgt $ . @ GeneSrc $ ( APP ) generates beta-amyloid peptide , postulated participate neurotoxicity @ DiseaseTgt $ . report APP APLP bind heme oxygenase ( HO ) , enzyme whose product , bilirubin , antioxidant neuroprotective . binding APP inhibits HO activity , APP mutations linked familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) provides substantially greater inhibition HO activity wild-type APP . Cortical cultures transgenic mice expressing Swedish mutant APP greatly reduced bilirubin levels , establishing mutant APP inhibits HO activity vivo . Oxidative neurotoxicity markedly greater cerebral cortical cultures APP Swedish mutant transgenic mice wild-type cultures . findings indicate augmented neurotoxicity caused APP-HO interactions may contribute neuronal cell death @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9667787065166314)\n",
      "- Text: \"TGF-beta1 promotes microglial amyloid-beta clearance reduces plaque burden transgenic mice . Abnormal accumulation amyloid-beta peptide ( Abeta ) brain appears crucial pathogenesis forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , underlying mechanisms sporadic forms @ DiseaseTgt $ remain unknown . Transforming growth factor beta1 ( TGF-beta1 ) , key regulator brain 's responses injury inflammation , implicated @ GeneSrc $ deposition vivo . demonstrate modest increase astroglial TGF-beta1 production aged transgenic mice expressing human beta-amyloid precursor protein ( hAPP ) results three-fold reduction number parenchymal amyloid plaques , 50 % reduction overall Abeta load hippocampus neocortex , decrease number dystrophic neurites . mice expressing hAPP TGF-beta1 , @ GeneSrc $ accumulated substantially cerebral blood vessels , parenchymal plaques . human cases @ DiseaseTgt $ , Abeta immunoreactivity associated parenchymal plaques inversely correlated Abeta blood vessels cortical TGF-beta1 mRNA levels . reduction parenchymal plaques hAPP/TGF-beta1 mice associated strong activation microglia increase inflammatory mediators . Recombinant TGF-beta1 stimulated @ GeneSrc $ clearance microglial cell cultures . results demonstrate TGF-beta1 important modifier amyloid deposition vivo indicate TGF-beta1 might promote microglial processes inhibit accumulation Abeta brain parenchyma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.012514548451829)\n",
      "- Text: \"Metabolic regulation brain @ GeneSrc $ neprilysin . Amyloid beta peptide ( @ GeneSrc $ ) , pathogenic agent @ DiseaseTgt $ ( @ DiseaseTgt $ ) , physiological metabolite brain . examined role neprilysin , candidate @ GeneSrc $ peptidase , metabolism using neprilysin gene-disrupted mice . Neprilysin deficiency resulted defects degradation exogenously administered @ GeneSrc $ metabolic suppression endogenous @ GeneSrc $ levels gene dose-dependent manner . regional levels @ GeneSrc $ neprilysin-deficient mouse brain distinct order hippocampus , cortex , thalamus/striatum , cerebellum , hippocampus highest level cerebellum lowest , correlating vulnerability Abeta deposition brains humans @ DiseaseTgt $ . observations suggest even partial down-regulation neprilysin activity , could caused aging , contribute @ DiseaseTgt $ development promoting @ GeneSrc $ accumulation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008412559071326)\n",
      "- Text: \"BACE knockout mice healthy despite lacking primary beta-secretase activity brain : implications @ DiseaseTgt $ therapeutics . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disorder characterized accumulation amyloid plaques neurofibrillary tangles brain . major components plaque , beta-amyloid peptides ( Abetas ) , produced @ GeneSrc $ ( APP ) activity beta- gamma-secretases . beta-secretase activity cleaves APP define N-terminus Abeta1-x peptides , therefore , long- sought therapeutic target treatment @ DiseaseTgt $ . gene encoding beta-secretase beta-site APP cleaving enzyme ( BACE ) identified recently . However , known whether BACE primary beta-secretase mammalian brain whether inhibition beta-secretase might effects mammals would preclude utility therapeutic target . work described herein , generated two lines BACE knockout mice characterized pathology , beta-secretase activity @ GeneSrc $ production . mice appeared develop normally showed consistent phenotypic differences wild-type littermates , including overall normal tissue morphology brain histochemistry , normal blood urine chemistries , normal blood-cell composition , overt behavioral neuromuscular effects . Brain primary cortical cultures BACE knockout mice showed detectable beta-secretase activity , primary cortical cultures BACE knockout mice produced much less @ GeneSrc $ APP . findings BACE primary beta-secretase activity brain loss beta-secretase activity produces profound phenotypic defects concomitant reduction beta-amyloid peptide clearly indicate BACE excellent therapeutic target treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5269106842111029)\n",
      "- Text: \"Treatment copper-zinc chelator markedly rapidly inhibits beta-amyloid accumulation @ DiseaseTgt $ transgenic mice . Inhibition neocortical beta-amyloid ( @ GeneSrc $ ) accumulation may essential effective therapeutic intervention @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Cu Zn enriched @ GeneSrc $ deposits @ DiseaseTgt $ , solubilized Cu/Zn-selective chelators vitro . report 49 % decrease brain @ GeneSrc $ deposition ( -375 microg/g wet weight , p = 0.0001 ) blinded study APP2576 transgenic mice treated orally 9 weeks clioquinol , antibiotic bioavailable Cu/Zn chelator . accompanied modest increase soluble @ GeneSrc $ ( 1.45 % total cerebral @ GeneSrc $ ) ; APP , synaptophysin , GFAP levels unaffected . General health body weight parameters significantly stable treated animals . results support targeting interactions Cu Zn @ GeneSrc $ novel therapy prevention treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0021581756090766)\n",
      "- Text: \"Loss presenilin 1 associated enhanced beta-catenin signaling skin tumorigenesis . Presenilin 1 ( PS1 ) required proteolytic processing Notch @ GeneSrc $ ( APP ) , molecules play pivotal roles cell-fate determination development @ DiseaseTgt $ pathogenesis , respectively . addition , PS1 interacts beta-catenin promotes turnover independent mechanisms . Consistent activity , report PS1 important controlling epidermal cell proliferation vivo . PS1 knockout mice rescued neuronal expression human PS1 transgene develop spontaneous skin cancers . PS1-null keratinocytes exhibit higher cytosolic beta-catenin beta-catenin/lymphoid enhancer factor-1/T cell factor ( beta-catenin/LEF ) -mediated signaling . effect reversed reintroducing wild-type PS1 , PS1 mutant active Notch processing defective beta-catenin binding . Nuclear beta-catenin protein detected tumors . Elevated beta-catenin/LEF signaling correlated activation downstream target cyclin D1 accelerated entry G ( 1 ) phase cell cycle . report demonstrates function PS1 adult tissues , analysis suggests deregulation beta-catenin pathway contributes skin tumor phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.3018360023220104e-05)\n",
      "- Text: \"Enhanced neurofibrillary degeneration transgenic mice expressing mutant tau APP . JNPL3 transgenic mice expressing mutant tau protein , develop neurofibrillary tangles progressive motor disturbance , crossed Tg2576 transgenic mice expressing mutant @ GeneSrc $ ( APP ) , thus modulating @ GeneSrc $ ( beta-amyloid peptide ) environment . resulting double mutant ( tau/APP ) progeny Tg2576 parental strain developed @ GeneSrc $ deposits age ; however , relative JNPL3 mice , double mutants exhibited neurofibrillary tangle pathology substantially enhanced limbic system olfactory cortex . results indicate either APP @ GeneSrc $ influences formation neurofibrillary tangles . interaction @ GeneSrc $ tau pathologies mice supports hypothesis similar interaction occurs @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3179063733298696)\n",
      "- Text: \"subset NSAIDs lower amyloidogenic Abeta42 independently cyclooxygenase activity . Epidemiological studies documented reduced prevalence @ DiseaseTgt $ among users nonsteroidal anti-inflammatory drugs ( NSAIDs ) . proposed NSAIDs exert beneficial effects part reducing neurotoxic inflammatory responses brain , although mechanism proved . report NSAIDs ibuprofen , indomethacin sulindac sulphide preferentially decrease highly amyloidogenic Abeta42 peptide ( 42-residue isoform amyloid-beta peptide ) produced variety cultured cells much 80 % . effect seen NSAIDs seems mediated inhibition cyclooxygenase ( COX ) activity , principal pharmacological target NSAIDs . Furthermore , short-term administration ibuprofen mice produce mutant @ GeneSrc $ ( APP ) lowered brain levels Abeta42 . cultured cells , decrease Abeta42 secretion accompanied increase Abeta ( 1 - 38 ) isoform , indicating NSAIDs subtly alter gamma-secretase activity without significantly perturbing APP processing pathways Notch cleavage . findings suggest NSAIDs directly affect amyloid pathology brain reducing Abeta42 peptide levels independently COX activity Abeta42-lowering activity could optimized selectively target pathogenic Abeta42 species .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.669031451578535e-05)\n",
      "- Text: \"Brain plasma amyloid-beta efflux : measure brain amyloid burden mouse model @ DiseaseTgt $ . deposition amyloid-beta ( @ GeneSrc $ ) peptides amyloid plaques precedes cognitive dysfunction @ DiseaseTgt $ ( @ DiseaseTgt $ ) years . Biomarkers indicative brain amyloid burden could useful identifying individuals high risk developing @ DiseaseTgt $ . @ DiseaseTgt $ humans , baseline plasma Abeta levels transgenic mouse model @ DiseaseTgt $ correlate brain amyloid burden . However , peripheral administration monoclonal antibody Abeta ( m266 ) , observed rapid increase plasma @ GeneSrc $ magnitude increase highly correlated amyloid burden hippocampus cortex . method may useful quantifying brain amyloid burden patients risk diagnosed @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006367259895996)\n",
      "- Text: \"Accelerated plaque accumulation , associative learning deficits , up-regulation alpha 7 nicotinic receptor protein transgenic mice co-expressing mutant human presenilin 1 amyloid precursor proteins . @ DiseaseTgt $ mutations presenilin 1 2 @ GeneSrc $ result elevated beta-amyloid , beta-amyloid accumulation , plaque formation brains affected individuals . crossing presenilin 1 transgenic mice carrying A246E mutation plaque-producing @ GeneSrc $ K670N/M671L transgenic mice ( Tg2576 ) , show co-expression mutant transgenes results acceleration amyloid accumulation associative learning deficits . 5 months age detectable plaque pathology , @ GeneSrc $ transgenic animals impaired contextual fear learning following two pairings conditioned unconditioned stimuli appear normal following robust five-pairing training . 9 months age beta-amyloid deposition evident , mice impaired following two-pairing five-pairing protocols . Mice carrying transgenes impaired contextual fear conditioning either age . transgenic animal groups performed well controls cued fear conditioning , indicating contextual fear learning deficits hippocampus-specific . associative learning impairments coincident elevated alpha 7 nicotinic acetylcholine receptor protein dentate gyrus . findings provide two robust rapid assays beta-amyloid-associated effects performed young animals : impaired contextual fear learning up-regulation alpha 7 nicotinic receptors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035592994468305)\n",
      "- Text: \"Immunization reverses memory deficits without reducing brain @ GeneSrc $ burden @ DiseaseTgt $ model . previously shown chronic treatment monoclonal antibody m266 , specific amyloid beta-peptide ( @ GeneSrc $ ) , increases plasma concentrations @ GeneSrc $ reduces @ GeneSrc $ burden PDAPP transgenic mouse model @ DiseaseTgt $ ( @ DiseaseTgt $ ) . report administration m266 PDAPP mice rapidly reverse memory deficits object recognition task holeboard learning memory task , without altering brain @ GeneSrc $ burden . also found @ GeneSrc $ complex present plasma cerebrospinal fluid m266-treated mice . data indicate passive immunization @ GeneSrc $ monoclonal antibody rapidly reverse memory impairment certain learning memory tasks PDAPP mouse model @ DiseaseTgt $ , owing perhaps enhanced peripheral clearance ( ) sequestration soluble brain @ GeneSrc $ species .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0068595199610617)\n",
      "- Text: \"Inclusion body myositis-like phenotype induced transgenic overexpression @ GeneSrc $ skeletal muscle . Inclusion body myositis ( IBM ) , common age-related muscle disease elderly population , incurable disorder leading severe disability . Sporadic IBM unknown etiology , although affected muscle fibers characterized many pathobiochemical alterations traditionally associated neurodegenerative brain disorders @ DiseaseTgt $ . Accumulation amyloid-beta peptide , derived proteolysis larger amyloid-beta precursor protein ( @ GeneSrc $ ) , seems early pathological event @ DiseaseTgt $ also IBM , latter , predominantly occurs intracellularly within affected myofibers . elucidate possible role @ GeneSrc $ mismetabolism pathogenesis IBM , transgenic mice derived selectively targeted @ GeneSrc $ overexpression skeletal muscle using muscle creatine kinase promoter . report older ( > 10 months ) transgenic mice exhibit intracellular immunoreactivity @ GeneSrc $ proteolytic derivatives skeletal muscle . transgenic model , selective overexpression @ GeneSrc $ leads development subset histopathological clinical features characteristic IBM , including centric nuclei , inflammation , deficiencies motor performance . results consistent pathogenic role @ GeneSrc $ mismetabolism human IBM .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0248446665195463)\n",
      "- Text: \"Presenilins required beta 42 production early secretory pathway . Presenilins 1 2 ( PS1/PS2 ) suggested gamma-secretases responsible proteolytic cleavage @ GeneSrc $ ( APP ) form amyloid-beta ( @ GeneSrc $ ) , protein implicated development @ DiseaseTgt $ . examined whether presenilins required generation multiple @ GeneSrc $ species analyzing production several forms secreted intracellular @ GeneSrc $ mouse cells lacking PS1 , PS2 proteins . Although @ GeneSrc $ species abolished PS1/PS2 ( -/- ) cells , production intracellular beta 42 generated endoplasmic reticulum/intermediate compartment unaffected absence proteins , either singly combination . results indicate production pool @ GeneSrc $ occurs independently PS1/PS2 , therefore , another gamma-secretase activity must responsible cleavage APP within early secretory compartments .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4705548405741876)\n",
      "- Text: \"Insulin-degrading enzyme regulates levels insulin , amyloid beta-protein , @ GeneSrc $ intracellular domain vivo . Two substrates insulin-degrading enzyme ( IDE ) , amyloid beta-protein ( Abeta ) insulin , critically important pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) type 2 diabetes mellitus ( DM2 ) , respectively . previously identified IDE principal regulator Abeta levels neuronal microglial cells . small chromosomal region containing mutant IDE allele associated hyperinsulinemia glucose intolerance rat model DM2 . Human genetic studies implicated IDE region chromosome 10 @ DiseaseTgt $ DM2 . establish whether IDE hypofunction decreases @ GeneSrc $ insulin degradation vivo chronically increases levels , characterized mice homozygous deletions IDE gene ( IDE -- ) . IDE deficiency resulted > 50 % decrease @ GeneSrc $ degradation brain membrane fractions primary neuronal cultures similar deficit insulin degradation liver . IDE -- mice showed increased cerebral accumulation endogenous @ GeneSrc $ , hallmark @ DiseaseTgt $ , hyperinsulinemia glucose intolerance , hallmarks DM2 . Moreover , mice elevated levels intracellular signaling domain @ GeneSrc $ , recently found degraded IDE vitro . Together emerging genetic evidence , vivo findings suggest IDE hypofunction may underlie contribute forms @ DiseaseTgt $ DM2 provide mechanism recently recognized association among hyperinsulinemia , diabetes , @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.215738549751105)\n",
      "- Text: \"GSK-3alpha regulates production @ DiseaseTgt $ amyloid-beta peptides . @ DiseaseTgt $ associated increased production aggregation amyloid-beta ( @ GeneSrc $ ) peptides . @ GeneSrc $ peptides derived @ GeneSrc $ ( APP ) sequential proteolysis , catalysed aspartyl protease BACE , followed presenilin-dependent gamma-secretase cleavage . Presenilin interacts nicastrin , APH-1 PEN-2 ( ref . 6 ) , required gamma-secretase function . Presenilins also interact alpha-catenin , beta-catenin glycogen synthase kinase-3beta ( GSK-3beta ) , functional role proteins gamma-secretase activity established . show therapeutic concentrations lithium , GSK-3 inhibitor , block production @ GeneSrc $ peptides interfering APP cleavage gamma-secretase step , inhibit Notch processing . Importantly , lithium also blocks accumulation @ GeneSrc $ peptides brains mice overproduce APP . target lithium setting GSK-3alpha , required maximal processing APP . Since GSK-3 also phosphorylates tau protein , principal component neurofibrillary tangles , inhibition GSK-3alpha offers new approach reduce formation amyloid plaques neurofibrillary tangles , two pathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.335769292492205)\n",
      "- Text: \"Genetic background regulates @ GeneSrc $ processing beta-amyloid deposition mouse . @ DiseaseTgt $ ( @ DiseaseTgt $ ) multigenic neurodegenerative disorder characterized distinct neuropathological hallmarks including deposits @ GeneSrc $ peptide . @ GeneSrc $ 39- 43-amino acid peptide derived proteolytic processing @ GeneSrc $ ( APP ) . increasing evidence suggests altered APP processing @ GeneSrc $ metabolism common feature @ DiseaseTgt $ , relationship levels @ GeneSrc $ various APP products onset @ DiseaseTgt $ remains unclear . undertaken screen characterize genetic factors modify APP processing , @ GeneSrc $ metabolism @ GeneSrc $ deposition genomic-based yeast artificial chromosome ( YAC ) transgenic mouse model @ DiseaseTgt $ . mutant human APP YAC transgene transferred three inbred mouse strains . Despite similar levels holo-APP expression congenic strains , levels APP C-terminal fragments well brain plasma @ GeneSrc $ young animals varied genetic background . Furthermore , demonstrate age-dependent @ GeneSrc $ deposition APP YAC transgenic model dramatically altered depending congenic strain examined . studies demonstrate APP processing , @ GeneSrc $ metabolism @ GeneSrc $ deposition regulated genetic background analysis phenotypes mice provide new insights factors regulate @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8852394271594606)\n",
      "- Text: \"Gleevec inhibits beta-amyloid production Notch cleavage . Amyloid-beta ( @ GeneSrc $ ) peptides , consisting mainly 40 42 aa ( Abeta40 Abeta42 , respectively ) , metabolites @ GeneSrc $ believed major pathological determinants @ DiseaseTgt $ . proteolytic cleavages form @ GeneSrc $ N C termini catalyzed beta-secretase gamma-secretase , respectively . demonstrate gamma-secretase generation @ GeneSrc $ N2a cell-free system ATP dependent . addition , Abl kinase inhibitor imatinib mesylate ( Gleevec , STI571 ) , targets ATP-binding site Abl several tyrosine kinases , potently reduces @ GeneSrc $ production N2a cell-free system intact N2a cells . STI571 related compound , inhibitor 2 , also reduce Abeta production rat primary neuronal cultures vivo guinea pig brain . STI571 inhibit gamma-secretase-catalyzed S3 cleavage Notch-1 . Furthermore , production @ GeneSrc $ inhibition STI571 demonstrated occur similar extents Abl-/- WT mouse fibroblasts , indicating effect STI571 @ GeneSrc $ production involve Abl kinase . efficacy STI571 reducing @ GeneSrc $ without affecting Notch-1 cleavage may prove useful basis developing novel therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6021222029842536)\n",
      "- Text: \"Nonsteroidal anti-inflammatory drugs lower amyloidogenic Abeta42 inhibiting Rho . subset nonsteroidal anti-inflammatory drugs ( NSAIDs ) shown preferentially reduce secretion highly amyloidogenic , 42-residue amyloid-beta peptide Abeta42 . found Rho effector , Rho-associated kinase , preferentially regulated amount Abeta42 produced vitro NSAIDs effective Rho inhibitors lowered Abeta42 . Administration Y-27632 , selective Rock inhibitor , also preferentially lowered brain levels Abeta42 transgenic mouse model @ DiseaseTgt $ . Thus , Rho-Rock pathway may regulate @ GeneSrc $ processing , subset NSAIDs reduce Abeta42 inhibition Rho activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.170824123339586e-05)\n",
      "- Text: \"Enhanced proteolysis beta-amyloid APP transgenic mice prevents plaque formation , secondary pathology , premature death . Converging evidence suggests accumulation cerebral amyloid beta-protein ( @ GeneSrc $ ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) reflects imbalance production degradation self-aggregating peptide . Upregulation proteases degrade @ GeneSrc $ thus represents novel therapeutic approach lowering steady-state @ GeneSrc $ levels , consequences sustained upregulation vivo studied . show transgenic overexpression insulin-degrading enzyme ( IDE ) neprilysin ( NEP ) neurons significantly reduces brain @ GeneSrc $ levels , retards completely prevents amyloid plaque formation associated cytopathology , rescues premature lethality present @ GeneSrc $ ( APP ) transgenic mice . findings demonstrate chronic upregulation @ GeneSrc $ proteases represents efficacious therapeutic approach combating @ DiseaseTgt $ pathology vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2747615148133643)\n",
      "- Text: \"BACE1 deficiency rescues memory deficits cholinergic dysfunction mouse model @ DiseaseTgt $ . beta-site APP cleaving enzyme 1 ( BACE1 ) beta-secretase enzyme required generating pathogenic beta-amyloid ( @ GeneSrc $ ) peptides @ DiseaseTgt $ ( @ DiseaseTgt $ ) . BACE1 knockout mice lack @ GeneSrc $ phenotypically normal , suggesting therapeutic inhibition BACE1 may free mechanism-based side effects . However , direct evidence BACE1 inhibition would improve cognition lacking . show BACE1 null mice engineered overexpress human APP ( BACE1 ( -/- ) .Tg2576 ( + ) ) rescued @ GeneSrc $ hippocampal memory deficits . Moreover , impaired hippocampal cholinergic regulation neuronal excitability found Tg2576 @ DiseaseTgt $ model ameliorated BACE1 ( -/- ) .Tg2576 ( + ) bigenic mice . behavioral electrophysiological rescue deficits BACE1 ( -/- ) .Tg2576 ( + ) mice correlated dramatic reduction cerebral Abeta40 Abeta42 levels occurs amyloid deposition Tg2576 mice . gene-based approach demonstrates lower @ GeneSrc $ levels beneficial @ DiseaseTgt $ memory impairments , validating BACE1 therapeutic target @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0119763694268604)\n",
      "- Text: \"Gene expression profiles transcripts @ GeneSrc $ transgenic mice : up-regulation mitochondrial metabolism apoptotic genes early cellular change @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) progressive neurodegenerative disease characterized impairment cognitive functions beta amyloid ( @ GeneSrc $ ) plaques cerebral cortex hippocampus . objective determine genes critical cellular changes @ DiseaseTgt $ progression , particular emphasis changes early disease progression . investigated established @ GeneSrc $ ( APP ) transgenic mouse model ( Tg2576 mouse model ) gene expression profiles three stages disease progression : long ( 2 months age ) , immediately ( 5 months ) ( 18 months ) appearance @ GeneSrc $ plaques . Using cDNA microarray techniques , measured mRNA levels 11 283 cDNA clones cerebral cortex Tg2576 mice age-matched wild-type ( WT ) mice three time points . gene expression analysis revealed genes related mitochondrial energy metabolism apoptosis up-regulated 2-month-old Tg2576 mice genes up-regulated 5 18 months age . microarray results confirmed using northern blot analysis . Results situ hybridization mitochondrial genes-ATPase-6 , heat-shock protein 86 programmed cell death gene 8-suggest granule cells hippocampal dentate gyrus pyramidal neurons hippocampus cerebral cortex up-regulated Tg2576 mice compared WT mice . Results double-labeling situ hybridization suggest Tg2576 mice selective , over-expressed neurons mitochondrial gene ATPase-6 undergo oxidative damage . results , therefore , suggest mitochondrial energy metabolism impaired expression mutant APP and/or @ GeneSrc $ , up-regulation mitochondrial genes compensatory response . findings important implications understanding mechanism @ GeneSrc $ toxicity @ DiseaseTgt $ developing therapeutic strategies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010049022656882)\n",
      "- Text: \"Partial loss presenilins causes seborrheic keratosis autoimmune disease mice . Presenilin ( PS1 ) ( PS2 ) centers gamma-secretase release @ GeneSrc $ APP @ DiseaseTgt $ ( @ DiseaseTgt $ ) . cleave signaling proteins like Notch downregulate beta-catenin modulate Wnt signaling . Inactivation PS1 PS1 PS2 causes prenatally lethal ' Notch phenotype , ' hampered investigation PS function adulthood seriously . thus turned towards PS1+/-PS2-/- mice carry severe reduction PS alleles compatible survival , analyze consequences impaired PS function especially adulthood . ' partial deficient ' mice , PS1 protein concentration considerably lowered , functionally reflected reduced gamma-secretase activity impaired beta-catenin downregulation . phenotype normal approximately 6 months , majority mice develop autoimmune disease characterized dermatitis , glomerulonephritis , keratitis vasculitis , seen human systemic lupus erythematosus . Besides B-cell dominated infiltrates , observe hypergammaglobulinemia immune complex deposits several tissues , high-titer nuclear autoantibodies increased CD4+/CD8 + ratio . mice develop benign skin hyperplasia similar human seborrheic keratosis opposed malignant keratocarcinomata observed skin-specific PS1 ' full ' knockouts . partial reduction PS function PS1+/-PS2-/- mice causes novel phenotype adulthood unrelated developmental defects full knockouts . PS1+/-PS2+/- mice remain healthy , points towards sharply defined minimum PS function . Skin immune system appear especially sensitive targets impaired PS function may need careful monitoring gamma-secretase inhibitors envisaged treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3095608740861489)\n",
      "- Text: \"disintegrin-metalloproteinase prevents amyloid plaque formation hippocampal defects @ DiseaseTgt $ mouse model . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized excessive deposition amyloid beta-peptides ( beta peptides ) brain . nonamyloidogenic pathway , @ GeneSrc $ ( APP ) cleaved alpha-secretase within @ GeneSrc $ peptide sequence . Proteinases ADAM family ( adisintegrin metalloproteinase ) main candidates physiologically relevant alpha-secretases , early lethality knockout animals prevented detailed analysis neuronal cells . overcome restriction , generated transgenic mice overexpress either ADAM10 catalytically inactive ADAM10 mutant . report show moderate neuronal overexpression ADAM10 mice transgenic human APP ( [ V717I ] ) increased secretion neurotrophic soluble alpha-secretase-released N-terminal APP domain ( APPs alpha ) , reduced formation beta peptides , prevented deposition plaques . Functionally , impaired long-term potentiation cognitive deficits alleviated . Expression mutant catalytically inactive ADAM10 led enhancement number size amyloid plaques brains double-transgenic mice . results provide first vivo evidence proteinase ADAM family alpha-secretase APP , reveal activation ADAM10 promising therapeutic target , support hypothesis decrease alpha-secretase activity contributes development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4273543144158404)\n",
      "- Text: \"Identification loci determining susceptibility lethal effects amyloid precursor protein transgene overexpression . Phenotypes produced expression human amyloid precursor protein ( APP ) transgenes vary depending genetic background mouse . FVB/N mice overexpressing human APP695 develop central nervous system disorder die prematurely , precluding development Abeta peptide amyloid plaques . 129S6 mice resistant lethal effects APP overexpression , allowing sufficient levels @ GeneSrc $ expression development amyloid plaques age-dependent memory deficits . identify genes determine susceptibility resistance APP analyzed crosses involving FVB/NCr 129S6.Tg2576 mice overexpress ' Swedish ' mutant ( K670N , M671L ) APP695 . APP transgene-positive FVB129S6F1 ( F1 ) mice resistant lethal effects APP overexpression , FVBxF1 backcross F2 intercross offspring produced . Analysis age death quantitative trait revealed significant linkage loci proximal chromosome 14 chromosome 9 ; 129S6 alleles protect lethal effects APP . Within chromosome 14 interval segments homologous regions human chromosome 10 linked late onset @ DiseaseTgt $ levels Abeta peptide plasma . However , analysis plasma Abeta peptide concentrations 6 weeks backcross offspring produced significant linkage . Similarly , elevation human Abeta peptide concentrations expression mutant presenilin transgenes increase proportion mice dying prematurely , suggesting early death reflects effects APP fragments Abeta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017821563973312)\n",
      "- Text: \"Reduced beta-amyloid production increased inflammatory responses presenilin conditional knock-out mice . Mutations presenilins ( PS ) 1 2 major cause familial @ DiseaseTgt $ . Conditional double knock-out mice lacking presenilins postnatal forebrain ( PS cDKO mice ) exhibit memory synaptic plasticity impairments followed progressive neurodegeneration cerebral cortex . investigate molecular events may underlie observed phenotypes identify additional neuropathological markers PS cDKO brain . Enzyme-linked immunosorbent assay analysis showed reduced levels toxic beta-amyloid ( @ GeneSrc $ ) peptides cerebral cortex PS cDKO mice . Interestingly , reduction Abeta40 Abeta42 peptides similar PS1 conditional knock-out PS cDKO mice . examined gene expression profile oligonucleotide microarrays PS cDKO cerebral cortex found high number genes differentially expressed , notably group up-regulated inflammatory genes . Quantitative real-time reverse transcription PCR Western analyses confirmed elevated levels glial fibrillary acidic protein , complement component C1q , cathepsin , up-regulation associated inflammatory responses various neurodegenerative processes . Immunohistochemical analysis revealed increase complement component C1q confined hippocampal formation , whereas glial fibrillary acidic protein cathepsin up-regulated throughout entire neocortex hippocampus . addition , strong microglial activation occurs hippocampus deeper cortical layers PS cDKO mice . results indicate memory impairment neurodegeneration PS cDKO mice caused @ GeneSrc $ accumulation loss PS function leads differential up-regulation inflammatory markers cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0100538976978824)\n",
      "- Text: \"ACAT inhibitor CP-113,818 markedly reduces amyloid pathology mouse model @ DiseaseTgt $ . Amyloid beta-peptide ( @ GeneSrc $ ) accumulation specific brain regions pathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . previously reported well-characterized acyl-coenzyme : cholesterol acyltransferase ( ACAT ) inhibitor , CP-113,818 , inhibits @ GeneSrc $ production cell-based experiments . , assessed efficacy CP-113,818 reducing @ DiseaseTgt $ pathology brains transgenic mice expressing human APP ( 751 ) containing London ( V717I ) Swedish ( K670M/N671L ) mutations . Two months treatment CP-113,818 reduced accumulation amyloid plaques 88 % -99 % membrane/insoluble @ GeneSrc $ levels 83 % -96 % , also decreasing brain cholesteryl-esters 86 % . Additionally , soluble Abeta ( 42 ) reduced 34 % brain homogenates . Spatial learning slightly improved correlated decreased Abeta levels . nontransgenic littermates , CP-113,818 also reduced ectodomain shedding endogenous APP brain . results suggest ACAT inhibition may effective prevention treatment @ DiseaseTgt $ inhibiting generation @ GeneSrc $ peptide .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0142338328556021)\n",
      "- Text: \"Elevated amyloid beta protein ( Abeta42 ) late onset @ DiseaseTgt $ associated single nucleotide polymorphisms urokinase-type plasminogen activator gene . Plasma amyloid beta protein ( Abeta42 ) levels late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) linked region chromosome 10q . PLAU gene within region encodes urokinase-type plasminogen activator , converts plasminogen plasmin . @ GeneSrc $ aggregates induce PLAU expression thereby increasing plasmin , degrades aggregated non-aggregated forms @ GeneSrc $ . evaluated single nucleotide polymorphisms ( SNPs ) PLAU association Abeta42 @ DiseaseTgt $ . PLAU SNP compound genotypes composed haplotype pairs showed significant association @ DiseaseTgt $ three independent case-control series . PLAU SNP haplotypes associated significantly plasma Abeta42 10 extended @ DiseaseTgt $ families . One SNPs analyzed missense C/T polymorphism exon 6 PLAU ( PLAU_1=rs2227564 ) , causes proline leucine change ( P141L ) . analyzed PLAU_1 association @ DiseaseTgt $ six case-control series 24 extended @ DiseaseTgt $ families . CT TT PLAU_1 genotypes showed association ( P=0.05 ) overall estimated odds ratio 1.2 ( 1.0 - 1.5 ) . CT TT genotypes PLAU_1 also associated significant age-dependent elevation plasma Abeta42 24 extended @ DiseaseTgt $ families ( P=0.0006 ) . knockout mice lacking PLAU gene , plasma -- brain -- Abeta42 well Abeta40 significantly elevated , also age-dependent manner . PLAU_1 associations independent associations found among plasma Abeta42 , @ DiseaseTgt $ variants IDE VR22 region . results provide strong evidence PLAU nearby gene involved development @ DiseaseTgt $ . PLAU_1 plausible pathogenic mutation could act increasing Abeta42 , additional biological experiments required show definitively .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0555491389044882)\n",
      "- Text: \"Gene delivery human apolipoprotein E alters brain @ GeneSrc $ burden mouse model @ DiseaseTgt $ . Apolipoprotein E ( apoE ) alleles important genetic risk factors @ DiseaseTgt $ ( @ DiseaseTgt $ ) , epsilon4 allele increasing epsilon2 allele decreasing risk developing @ DiseaseTgt $ . ApoE shown influence brain amyloid-beta peptide ( Abeta ) amyloid burden , humans transgenic mice . show direct intracerebral administration lentiviral vectors expressing three common human apoE isoforms differentially alters hippocampal @ GeneSrc $ amyloid burden PDAPP mouse model @ DiseaseTgt $ . Expression apoE4 absence mouse apoE increases hippocampal Abeta ( 1 - 42 ) levels amyloid burden . contrast , expression apoE2 , even presence mouse apoE , markedly reduces hippocampal @ GeneSrc $ burden . data demonstrate rapid apoE isoform-dependent effects brain @ GeneSrc $ burden mouse model @ DiseaseTgt $ . Gene delivery apoE2 may prevent reduce brain @ GeneSrc $ burden subsequent development neuritic plaques .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002103074972122)\n",
      "- Text: \"Environmental enrichment reduces @ GeneSrc $ levels amyloid deposition transgenic mice . Cerebral deposition beta-amyloid ( Abeta ) peptides invariant pathological hallmark brains patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) transgenic mice coexpressing familial @ DiseaseTgt $ APP PS1 variants . report exposure transgenic mice `` enriched environment `` results pronounced reductions cerebral @ GeneSrc $ levels amyloid deposits , compared animals raised `` standard housing `` conditions . enzymatic activity @ GeneSrc $ endopeptidase , neprilysin , elevated brains `` enriched `` mice inversely correlated amyloid burden . Moreover , DNA microarray analysis revealed selective upregulation levels transcripts encoded genes associated learning memory , vasculogenesis , neurogenesis , cell survival pathways , @ GeneSrc $ sequestration , prostaglandin synthesis . studies provide evidence environmental enrichment leads reductions steady-state levels cerebral @ GeneSrc $ peptides amyloid deposition selective upregulation levels specific transcripts brains transgenic mice .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4096157239926045)\n",
      "- Text: \"Presenilin-dependent transcriptional control @ GeneSrc $ enzyme neprilysin intracellular domains @ GeneSrc $ APLP . Amyloid beta-peptide ( @ GeneSrc $ ) , plays central role @ DiseaseTgt $ , generated presenilin-dependent gamma-secretase cleavage @ GeneSrc $ ( @ GeneSrc $ ) . report presenilins ( PS1 PS2 ) also regulate @ GeneSrc $ degradation . Presenilin-deficient cells fail degrade @ GeneSrc $ drastic reductions transcription , expression , activity neprilysin , key @ GeneSrc $ enzyme . Neprilysin activity expression also lowered gamma-secretase inhibitors PS1/PS2 deficiency mouse brain . Neprilysin activity restored transient expression PS1 PS2 expression amyloid intracellular domain ( AICD ) , cogenerated @ GeneSrc $ , gamma-secretase cleavage @ GeneSrc $ . Neprilysin gene promoters transactivated AICDs APP-like proteins ( APP , APLP1 , APLP2 ) , @ GeneSrc $ gamma-secretase cleavage products Notch , N- E- cadherins . presenilin-dependent regulation neprilysin , mediated AICDs , provides physiological means modulate @ GeneSrc $ levels varying levels gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0348727531425632)\n",
      "- Text: \"Abeta42 essential parenchymal vascular amyloid deposition mice . Considerable circumstantial evidence suggests Abeta42 initiating molecule @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathogenesis . However , absolute requirement Abeta42 amyloid deposition never demonstrated vivo . addressed developing transgenic models express Abeta1 - 40 Abeta1 - 42 absence human amyloid beta protein precursor ( APP ) overexpression . Mice expressing high levels Abeta1 - 40 develop overt amyloid pathology . contrast , mice expressing lower levels Abeta1 - 42 accumulate insoluble Abeta1 - 42 develop compact amyloid plaques , congophilic amyloid angiopathy ( CAA ) , diffuse @ GeneSrc $ deposits . mice expressing Abeta1 - 42 crossed mutant APP ( Tg2576 ) mice , also massive increase amyloid deposition . data establish Abeta1 - 42 essential amyloid deposition parenchyma also vessels .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001975854104471)\n",
      "- Text: \"Brain estrogen deficiency accelerates @ GeneSrc $ plaque formation @ DiseaseTgt $ animal model . Much evidence indicates women higher risk developing @ DiseaseTgt $ ( @ DiseaseTgt $ ) men . reason gender difference unclear . hypothesize estrogen deficiency brains women @ DiseaseTgt $ may key risk factor . rapidly acquired postmortem brains women @ DiseaseTgt $ , found greatly reduced estrogen levels compared age- gender-matched normal control subjects ; @ DiseaseTgt $ control subjects comparably low levels serum estrogen . examined onset severity @ DiseaseTgt $ pathology associated estrogen depletion using gene-based approach , crossing estrogen-synthesizing enzyme aromatase gene knockout mice APP23 transgenic mice , mouse model @ DiseaseTgt $ , produce estrogen-deficient APP23 mice . Compared APP23 transgenic control mice , estrogen-deficient APP23 mice exhibited greatly reduced brain estrogen early-onset increased beta amyloid peptide ( @ GeneSrc $ ) deposition . mice also exhibited increased @ GeneSrc $ production , microglia cultures prepared brains mice impaired @ GeneSrc $ clearance/degradation . contrast , ovariectomized APP23 mice exhibited plaque pathology similar observed APP23 transgenic control mice . results indicate estrogen depletion brain may significant risk factor developing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0212329903374434)\n",
      "- Text: \"specific amyloid-beta protein assembly brain impairs memory . Memory function often declines age , believed deteriorate initially changes synaptic function rather loss neurons . individuals go develop @ DiseaseTgt $ neurodegeneration . use Tg2576 mice , express human amyloid-beta precursor protein ( APP ) variant linked @ DiseaseTgt $ , investigate cause memory decline absence neurodegeneration amyloid-beta protein amyloidosis . Young Tg2576 mice ( < 6 months old ) normal memory lack neuropathology , middle-aged mice ( 6 - 14 months old ) develop memory deficits without neuronal loss , old mice ( > 14 months old ) form abundant neuritic plaques containing amyloid-beta ( refs 3 - 6 ) . found memory deficits middle-aged Tg2576 mice caused extracellular accumulation 56-kDa soluble amyloid-beta assembly , term Abeta * 56 ( @ GeneSrc $ star 56 ) . Abeta * 56 purified brains impaired Tg2576 mice disrupts memory administered young rats . propose Abeta * 56 impairs memory independently plaques neuronal loss , may contribute cognitive deficits associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.948975294016688e-05)\n",
      "- Text: \"prolyl isomerase Pin1 regulates @ GeneSrc $ processing amyloid-beta production . Neuropathological hallmarks @ DiseaseTgt $ neurofibrillary tangles composed tau neuritic plaques comprising amyloid-beta peptides ( Abeta ) derived @ GeneSrc $ ( APP ) , exact relationship remains elusive . Phosphorylation tau APP certain serine threonine residues preceding proline affects tangle formation Abeta production vitro . Phosphorylated Ser/Thr-Pro motifs peptides exist cis trans conformations , conversion catalysed Pin1 prolyl isomerase . Pin1 proposed regulate protein function accelerating conformational changes , activity never visualized biological pathological significance Pin1 substrate conformations unknown . Notably , Pin1 downregulated and/or inhibited oxidation @ DiseaseTgt $ neurons , Pin1 knockout causes tauopathy neurodegeneration , Pin1 promoter polymorphisms appear associate reduced Pin1 levels increased risk late-onset @ DiseaseTgt $ . However , role Pin1 APP processing Abeta production unknown . show Pin1 profound effects APP processing Abeta production . find Pin1 binds phosphorylated Thr 668-Pro motif APP accelerates isomerization 1,000-fold , regulating APP intracellular domain two conformations , visualized NMR . Whereas Pin1 overexpression reduces Abeta secretion cell cultures , knockout Pin1 increases secretion . Pin1 knockout alone combination overexpression mutant APP mice increases amyloidogenic APP processing selectively elevates insoluble Abeta42 ( major toxic species ) brains age-dependent manner , Abeta42 prominently localized multivesicular bodies neurons , shown @ DiseaseTgt $ plaque pathology . Thus , Pin1-catalysed prolyl isomerization novel mechanism regulate APP processing Abeta production , deregulation may link tangle plaque pathologies . findings provide new insight pathogenesis treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0154952032745205)\n",
      "- Text: \"PKCepsilon increases endothelin converting enzyme activity reduces amyloid plaque pathology transgenic mice . Deposition plaques containing amyloid beta ( @ GeneSrc $ ) peptides neuropathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate neuronal overexpression epsilon isozyme PKC decreases @ GeneSrc $ levels , plaque burden , plaque-associated neuritic dystrophy reactive astrocytosis transgenic mice expressing @ DiseaseTgt $ forms human amyloid precursor protein ( APP ) . Compared APP singly transgenic mice , APP/PKCepsilon doubly transgenic mice decreased @ GeneSrc $ levels showed evidence altered cleavage APP . Instead , PKCepsilon overexpression selectively increased activity endothelin-converting enzyme , degrades @ GeneSrc $ . activities @ GeneSrc $ enzymes , insulin degrading enzyme neprilysin , unchanged . results indicate increased neuronal PKCepsilon activity promote @ GeneSrc $ clearance reduce @ DiseaseTgt $ neuropathology increased endothelin-converting enzyme activity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6477891765117785)\n",
      "- Text: \"synthase 2 ( NOS2 ) deletion promotes multiple pathologies mouse model @ DiseaseTgt $ . @ DiseaseTgt $ characterized two primary pathological features : amyloid plaques neurofibrillary tangles . interconnection amyloid tau aggregates intense interest , mouse models yet reveal direct interrelationship . show may key factor connects amyloid tau pathologies . Genetic removal synthase 2 mice expressing mutated @ GeneSrc $ results pathological hyperphosphorylation mouse tau , redistribution somatodendritic compartment cortical hippocampal neurons , aggregate formation . Lack synthase 2 @ GeneSrc $ Swedish mutant mouse increased insoluble beta-amyloid peptide levels , neuronal degeneration , caspase-3 activation , tau cleavage , suggesting acts junction point beta-amyloid peptides , caspase activation , tau aggregation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0167751841103265)\n",
      "- Text: \"Antiamyloidogenic neuroprotective functions cathepsin B : implications @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) may result accumulation amyloid-beta ( @ GeneSrc $ ) peptides brain . cysteine protease cathepsin B ( CatB ) associated amyloid plaques @ DiseaseTgt $ brains suspected increase @ GeneSrc $ production . , demonstrate CatB actually reduces levels @ GeneSrc $ peptides , especially aggregation-prone species Abeta1 - 42 , proteolytic cleavage . Genetic inactivation CatB mice neuronal expression familial @ DiseaseTgt $ human amyloid precursor protein ( hAPP ) increased relative abundance Abeta1 - 42 , worsening plaque deposition @ DiseaseTgt $ pathologies . Lentivirus-mediated expression CatB aged hAPP mice reduced preexisting amyloid deposits , even thioflavin S-positive plaques . cell-free conditions , CatB effectively cleaved Abeta1 - 42 , generating C-terminally truncated @ GeneSrc $ peptides less amyloidogenic . Thus , CatB likely fulfills antiamyloidogenic neuroprotective functions . Insufficient CatB activity might promote @ DiseaseTgt $ ; increasing CatB activity could counteract neuropathology disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6483370946671865)\n",
      "- Text: \"Exogenous induction cerebral beta-amyloidogenesis governed agent host . Protein aggregation established pathogenic mechanism @ DiseaseTgt $ , little known initiation process vivo . Intracerebral injection dilute , amyloid-beta ( Abeta ) -containing brain extracts humans @ DiseaseTgt $ @ GeneSrc $ ( APP ) transgenic mice induced cerebral beta-amyloidosis associated pathology APP transgenic mice time- concentration-dependent manner . seeding activity brain extracts reduced abolished Abeta immunodepletion , protein denaturation , @ GeneSrc $ immunization host . phenotype exogenously induced amyloidosis depended host source agent , suggesting existence polymorphic @ GeneSrc $ strains varying biological activities reminiscent prion strains .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1435178906855921)\n",
      "- Text: \"Deficiency neuronal TGF-beta signaling promotes neurodegeneration @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized progressive neurodegeneration cerebral accumulation beta-amyloid peptide ( Abeta ) , unknown makes neurons susceptible degeneration . report TGF-beta type II receptor ( TbetaRII ) mainly expressed neurons , TbetaRII levels reduced human @ DiseaseTgt $ brain correlate pathological hallmarks disease . Reducing neuronal TGF-beta signaling mice resulted age-dependent neurodegeneration promoted @ GeneSrc $ accumulation dendritic loss mouse model @ DiseaseTgt $ . cultured cells , reduced TGF-beta signaling caused neuronal degeneration resulted increased levels secreted @ GeneSrc $ beta-secretase-cleaved soluble amyloid precursor protein . results show reduced neuronal TGF-beta signaling increases age-dependent neurodegeneration @ DiseaseTgt $ vivo . Increasing neuronal TGF-beta signaling may thus reduce neurodegeneration beneficial @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1342993628710347)\n",
      "- Text: \"Activation beta2-adrenergic receptor stimulates gamma-secretase activity accelerates amyloid plaque formation . Amyloid plaque hallmark primary cause @ DiseaseTgt $ . Mutations presenilin-1 , gamma-secretase catalytic subunit , affect amyloid-beta ( @ GeneSrc $ ) production @ DiseaseTgt $ pathogenesis . However , largely unknown whether gamma-secretase activity amyloid plaque formation regulated environmental factors stress , mediated receptors including beta ( 2 ) -adrenergic receptor ( beta ( 2 ) -AR ) . report activation beta ( 2 ) -AR enhanced gamma-secretase activity thus @ GeneSrc $ production . enhancement involved association beta ( 2 ) -AR presenilin-1 required agonist-induced endocytosis beta ( 2 ) -AR subsequent trafficking gamma-secretase late endosomes lysosomes , @ GeneSrc $ production elevated . Similar effects observed activation delta-opioid receptor . Furthermore , chronic treatment beta ( 2 ) -AR agonists increased cerebral amyloid plaques @ DiseaseTgt $ mouse model . Thus , beta ( 2 ) -AR activation stimulate gamma-secretase activity amyloid plaque formation , suggests abnormal activation beta ( 2 ) -AR might contribute @ GeneSrc $ accumulation @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003012583299136)\n",
      "- Text: \"Ccr2 deficiency impairs microglial accumulation accelerates progression @ DiseaseTgt $ . Microglia principal immune cells brain . @ DiseaseTgt $ , brain mononuclear phagocytes recruited blood accumulate senile plaques . However , role microglia @ DiseaseTgt $ resolved . Microglia may neuroprotective phagocytosing amyloid-beta ( @ GeneSrc $ ) , activation secretion neurotoxins may also cause neurodegeneration . Ccr2 chemokine receptor expressed microglia , mediates accumulation mononuclear phagocytes sites inflammation . show Ccr2 deficiency accelerates early disease progression markedly impairs microglial accumulation transgenic mouse model @ DiseaseTgt $ ( Tg2576 ) . @ DiseaseTgt $ mice deficient Ccr2 accumulated @ GeneSrc $ earlier died prematurely , manner correlated Ccr2 gene dosage , indicating absence early microglial accumulation leads decreased @ GeneSrc $ clearance increased mortality . Thus , Ccr2-dependent microglial accumulation plays protective role early stages @ DiseaseTgt $ promoting @ GeneSrc $ clearance .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5354832942467374)\n",
      "- Text: \"Tau deficiency induces parkinsonism dementia impairing APP-mediated iron export . microtubule-associated protein tau risk alleles Alzheimer 's disease @ DiseaseTgt $ mutations cause brain degenerative diseases termed tauopathies . Aggregated tau forms neurofibrillary tangles pathologies , little certain function tau mode involvement pathogenesis . Neuronal iron accumulation observed pathologically cortex Alzheimer 's disease , substantia nigra ( SN ) @ DiseaseTgt $ various brain regions tauopathies . report tau-knockout mice develop age-dependent brain atrophy , iron accumulation SN neuronal loss , concomitant cognitive deficits parkinsonism . changes prevented oral treatment moderate iron chelator , clioquinol . @ GeneSrc $ ( APP ) ferroxidase activity couples surface ferroportin export iron , activity inhibited Alzheimer 's disease , thereby causing neuronal iron accumulation . primary neuronal culture , found loss tau also causes iron retention , decreasing surface trafficking APP . Soluble tau levels fall affected brain regions Alzheimer 's disease tauopathies , found similar decrease soluble tau SN @ DiseaseTgt $ 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) mouse model . data suggest loss soluble tau could contribute toxic neuronal iron accumulation Alzheimer 's disease , @ DiseaseTgt $ tauopathies , rescued pharmacologically .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010822543036521)\n",
      "- Text: \"Modulation oestrogen receptor signalling association activated dioxin receptor . Environmental contaminants affect wide variety biological events many species . Dioxins typical environmental contaminants exert adverse oestrogen-related effects . Although anti-oestrogenic actions well described , dioxins also induce endometriosis oestrogen-dependent @ DiseaseTgt $ , implying possible oestrogenic effects . However , molecular mechanism underlying oestrogen-related actions dioxins remains largely unknown . heterodimer dioxin receptor ( AhR ) @ GeneSrc $ , basic helix-loop-helix/PAS-family transcription factors , mediates toxic effects dioxins . show agonist-activated @ GeneSrc $ heterodimer directly associates oestrogen receptors ER-alpha ER-beta . association results recruitment unliganded ER co-activator p300 oestrogen-responsive gene promoters , leading activation transcription oestrogenic effects . function liganded ER attenuated . Oestrogenic actions AhR agonists detected wild-type ovariectomized mouse uteri , absent AhR-/- ER-alpha-/- ovariectomized mice . findings suggest novel mechanism ER-mediated oestrogen signalling modulated co-regulatory-like function activated @ GeneSrc $ , giving rise adverse oestrogen-related actions dioxin-type environmental contaminants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039657653252613)\n",
      "- Text: \"Replication @ GeneSrc $ , CR1 , PICALM associations @ DiseaseTgt $ . OBJECTIVE : test replication association variants @ GeneSrc $ , CR1 , PICALM genes @ DiseaseTgt $ . DESIGN : Follow-up case-control association study . SETTING : Mayo Clinics Jacksonville , Florida , Rochester , Minnesota . PARTICIPANTS : Community-based patients European descent late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) controls without dementia seen Mayo clinics , autopsy-confirmed cases controls whose pathology evaluated Mayo Clinic Jacksonville . Additional samples obtained National Cell Repository @ DiseaseTgt $ ( NCRAD ) . total 1829 @ DiseaseTgt $ cases 2576 controls analyzed . INTERVENTIONS : significant single-nucleotide polymorphisms @ GeneSrc $ ( rs11136000 ) , CR1 ( rs3818361 ) , PICALM ( rs3851179 ) tested allelic association @ DiseaseTgt $ . Main Outcome Measure Clinical pathology-confirmed diagnosis @ DiseaseTgt $ . RESULTS : Odds ratios @ GeneSrc $ , CR1 , PICALM 0.82 , 1.15 , 0.80 , respectively , comparable direction magnitude originally reported . P values 8.6 x 10 ( -5 ) , .014 , 1.3 x 10 ( -5 ) , respectively ; remain significant even Bonferroni correction 3 single-nucleotide polymorphisms tested . CONCLUSION : results show near-perfect replication provide first additional evidence @ GeneSrc $ , CR1 , PICALM associated risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9644028246241544)\n",
      "- Text: \"CR1 associated amyloid plaque burden age-related cognitive decline . OBJECTIVE : Recently , genome-wide association studies identified 3 new susceptibility loci @ DiseaseTgt $ ( @ DiseaseTgt $ ) , @ GeneSrc $ , CR1 , PICALM . leveraged available neuropsychological autopsy data 2 cohort studies investigate whether loci associated cognitive decline @ DiseaseTgt $ neuropathology . METHODS : Religious Orders Study ( ROS ) Rush Memory Aging Project ( MAP ) longitudinal studies enroll nondemented subjects include annual clinical evaluations brain donation death . evaluated CR1 ( rs6656401 ) , @ GeneSrc $ ( rs11136000 ) , PICALM ( rs7110631 ) 1,666 subjects . evaluated associations genotypes rate change cognitive function well @ DiseaseTgt $ pathology . Lastly , used pathway analysis determine whether relationships single nucleotide polymorphisms cognitive decline mediated @ DiseaseTgt $ pathology . RESULTS : Among study cohort , mean years follow-up 7.8 ROS 4.3 MAP . CR1 locus associated global cognitive decline ( p = 0.011 ) global @ DiseaseTgt $ pathology ( p = 0.025 ) . specifically , locus affects deposition neuritic amyloid plaque ( p = 0.009 ) . mediation analysis , controlling amyloid pathology strongly attenuated effect CR1 locus cognitive decline . INTERPRETATION : found common variation CR1 locus broad impact cognition effect largely mediated individual 's amyloid plaque burden . therefore highlight 1 functional consequence CR1 susceptibility allele generalize role locus cognitive aging general population .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0138533759602249)\n",
      "- Text: \"Genome-wide association study identifies variants @ GeneSrc $ PICALM associated @ DiseaseTgt $ . undertook two-stage genome-wide association study ( GWAS ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) involving 16,000 individuals , powerful @ DiseaseTgt $ GWAS date . stage 1 ( 3,941 cases 7,848 controls ) , replicated established association apolipoprotein E ( APOE ) locus ( significant SNP , rs2075650 , P = 1.8 x 10 ( -157 ) ) observed genome-wide significant association SNPs two loci previously associated disease : @ GeneSrc $ ( also known @ GeneSrc $ ) gene ( rs11136000 , P = 1.4 x 10 ( -9 ) ) 5 ' PICALM gene ( rs3851179 , P = 1.9 x 10 ( -8 ) ) . associations replicated stage 2 ( 2,023 cases 2,340 controls ) , producing compelling evidence association @ DiseaseTgt $ combined dataset ( rs11136000 , P = 8.5 x 10 ( -10 ) , odds ratio = 0.86 ; rs3851179 , P = 1.3 x 10 ( -9 ) , odds ratio = 0.86 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.028376222032268)\n",
      "- Text: \"Meta-analysis confirms CR1 , @ GeneSrc $ , PICALM @ DiseaseTgt $ risk loci reveals interactions APOE genotypes . OBJECTIVES : determine whether genotypes @ GeneSrc $ , PICALM , CR1 confer risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) whether risk @ DiseaseTgt $ associated genes influenced apolipoprotein E ( APOE ) genotypes . DESIGN : Association study @ DiseaseTgt $ @ GeneSrc $ , PICALM , CR1 , APOE genotypes . SETTING : Academic research institutions United States , Canada , Israel . PARTICIPANTS : Seven thousand seventy cases @ DiseaseTgt $ , 3055 autopsies , 8169 elderly cognitively normal controls , 1092 autopsies , 12 different studies , including white , African American , Israeli-Arab , Caribbean Hispanic individuals . RESULTS : Unadjusted , @ GeneSrc $ ( odds ratio [ ] , 0.91 ; 95 % confidence interval [ CI ] , 0.85 - 0.96 single-nucleotide polymorphism [ SNP ] rs11136000 ) , CR1 ( , 1.14 ; 95 % CI , 1.07 - 1.22 ; SNP rs3818361 ) , PICALM ( , 0.89 ; 95 % CI , 0.84 - 0.94 , SNP rs3851179 ) associated @ DiseaseTgt $ white individuals . None significantly associated @ DiseaseTgt $ ethnic groups . APOE epsilon4 significantly associated @ DiseaseTgt $ ( ORs , 1.80 - 9.05 ) 1 small white cohort Arab cohort . Adjusting age , sex , presence least 1 APOE epsilon4 allele greatly reduced evidence association PICALM CR1 @ GeneSrc $ . Models main SNP effect , presence absence APOE epsilon4 , interaction term showed significant interaction presence absence APOE epsilon4 PICALM . CONCLUSIONS : confirm completely independent data set CR1 , @ GeneSrc $ , PICALM @ DiseaseTgt $ susceptibility loci European ancestry populations . Genotypes PICALM confer risk predominantly APOE epsilon4-positive subjects . Thus , APOE PICALM synergistically interact .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2562019963149284)\n",
      "- Text: \"Genome-wide association study identifies variants @ GeneSrc $ CR1 associated @ DiseaseTgt $ . gene encoding apolipoprotein E ( APOE ) chromosome 19 confirmed susceptibility locus late-onset @ DiseaseTgt $ . identify risk loci , conducted large genome-wide association study 2,032 individuals France @ DiseaseTgt $ ( cases ) 5,328 controls . Markers outside APOE suggestive evidence association ( P < 10 ( -5 ) ) examined collections Belgium , Finland , Italy Spain totaling 3,978 @ DiseaseTgt $ cases 3,297 controls . Two loci gave replicated evidence association : one within @ GeneSrc $ ( also called @ GeneSrc $ ) , encoding @ GeneSrc $ @ GeneSrc $ , chromosome 8 ( rs11136000 , = 0.86 , 95 % CI 0.81 - 0.90 , P = 7.5 x 10 ( -9 ) combined data ) within CR1 , encoding complement component ( 3b/4b ) receptor 1 , chromosome 1 ( rs6656401 , = 1.21 , 95 % CI 1.14 - 1.29 , P = 3.7 x 10 ( -9 ) combined data ) . Previous biological studies support roles @ GeneSrc $ CR1 clearance beta amyloid ( Abeta ) peptide , principal constituent amyloid plaques , one major brain lesions individuals @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0132542999593146)\n",
      "- Text: \"@ DiseaseTgt $ chemoprevention antioxidant tempol acts partially via p53 @ DiseaseTgt $ suppressor . previously demonstrated nitroxide antioxidant tempol ( 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl ) increased latency tumorigenesis doubled ( 100 % ) lifespan @ GeneSrc $ mice , mouse model ataxia telangiectasia , displays accelerated oxidative damage stress . Tempol treatment @ DiseaseTgt $ p53-deficient mice resulted small significant ( 25 % ) increase lifespan prolonging latency tumorigenesis , demonstrating existing oxidative stress damage necessary chemopreventative effects tempol . However , relatively small effect latency p53-deficient mice finding tempol-mediated resistance oxidative insult p53-dependent suggested direct role p53 chemopreventative effects tempol . Surprisingly , tempol treatment specifically increased serine 18 phosphorylation p53 ( gamma-H2AX ) p21 expression primary thymocytes vitro p53-dependent fashion . Inhibition phosphoinositide 3-kinase ( PI3 K ) family members suggested SMG-1 responsible tempol-mediated enhancement p53 serine 18 phosphorylation . data suggest chemopreventative effect tempol solely due reduction oxidative stress damage may also related redox-mediated signaling functions include p53 pathway activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0490574859174585)\n",
      "- Text: \"Declining p53 function aging process : possible mechanism increased @ DiseaseTgt $ incidence older populations . @ DiseaseTgt $ disease aging . accumulation mutations individual cells lifetime thought reason . work , explored additional hypothesis : could p53 function decline age , would contribute enhanced mutation frequency tumorigenesis aging process ? efficiency p53 response gamma-irradiation found decline significantly various tissues aging mice several inbred strains , including lower p53 transcriptional activity p53-dependent apoptosis . decline resulted decreased stabilization p53 protein stress . function @ GeneSrc $ ATM ) kinase declined significantly age , may responsible decline p53 response radiation . Declining p53 responses stresses also observed cultured splenocytes aging mice . Interestingly , time onset decreased p53 response correlated life span mice ; mice live longer delay onset decreased p53 activity time . results suggest enhanced fixation mutations older individuals declining fidelity p53-mediated apoptosis senescence response stress , suggest plausible explanation correlation tumorigenesis aging process .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0894097562715013)\n",
      "- Text: \"Trp53 deficiency protects acute intestinal inflammation . p53 protein important @ DiseaseTgt $ suppressor activity also additional immunological functions , whose nature extent beginning recognized . article , show p53 novel inflammation-promoting action intestinal tract , loss p53 upstream activating kinase , @ GeneSrc $ , protects acute intestinal inflammation murine models . Mechanistically , deficiency p53 leads increased survival epithelial cells lamina propria macrophages , higher IL-6 expression owing enhanced glucose-dependent NF-kappaB activation , increased mucosal STAT3 activation . Blockade loss IL-6 signaling reverses protective effects p53 deficiency . Conversely , IL-6 treatment protects acute colitis manner dependent STAT3 signaling induction cytoprotective factors epithelial cells . Together , results indicate p53 promotes inflammation intestinal tract suppression epithelium-protective factors , thus significantly expanding spectrum physiological immunological p53 activities unrelated @ DiseaseTgt $ formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039282568173176)\n",
      "- Text: \"Wip1 phosphatase modulates @ GeneSrc $ signaling pathways . Deletion Ppm1d , gene encoding Wip1 phosphatase , renders cells resistant transformation mice resistant @ DiseaseTgt $ development . , report deficiency Wip1 resulted activation @ GeneSrc $ ( @ GeneSrc $ ) kinase . turn , overexpression Wip1 sufficient reduce activation @ GeneSrc $ signaling cascade DNA damage . Wip1 dephosphorylated @ GeneSrc $ Ser1981 , site critical @ GeneSrc $ monomerization activation , critical resetting @ GeneSrc $ phosphorylation cells repaired damaged DNA . propose Wip1 phosphatase integral component @ GeneSrc $ signaling pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016130384514531)\n",
      "- Text: \"APOE * 4-associated @ DiseaseTgt $ risk modified @ GeneSrc $ polymorphism . Genetic studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) , devastating neurodegenerative disorder , identified apolipoprotein E ( APOE ) gene strong susceptibility marker @ DiseaseTgt $ . E * 4 allele APOE major risk factor @ DiseaseTgt $ regardless age onset family history . However , observation APOE * 4 allele neither necessary sufficient expression @ DiseaseTgt $ emphasizes involvement environmental genetic elements , either conjunction APOE * 4 alone , increase individual 's risk developing @ DiseaseTgt $ . Among candidate genes may affect risk multifactorial disease gene coding @ GeneSrc $ ( ACT ) . Like APOE protein , ACT binds beta-amyloid peptide ( beta P ) high affinity filamentous deposits found @ DiseaseTgt $ brain serves strong stimulatory factor polymerization beta P amyloid filaments . @ DiseaseTgt $ brains , ACT expression enhanced , particularly areas develop amyloid plaques , suggesting ACT may play important role pathogenesis @ DiseaseTgt $ . show common polymorphism signal peptide ACT confers significant risk @ DiseaseTgt $ . Furthermore , APOE * 4 gene dosage effect associated @ DiseaseTgt $ risk significantly modified ACT polymorphism . also identified unique combination ACT/AA APOE 4/4 genotypes potential susceptibility marker @ DiseaseTgt $ , frequency 1/17 @ DiseaseTgt $ group compared 1/313 general population control . data show ACT behaves modifier gene alters @ DiseaseTgt $ risk conventionally associated APOE * 4 allele .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6181627068302292)\n",
      "- Text: \"Genomic structure , chromosome mapping expression analysis human AXIN2 gene . Conductin Wnt signalling protein serves negative regulator beta-catenin stability . previously isolated human homolog ( AXIN2 ) murine @ GeneSrc $ gene shown mutated @ DiseaseTgt $ ( @ DiseaseTgt $ ) defective mismatch repair ( MMR ) . report detailed genomic structure gene analysis cDNA genomic clones . gene spans > = 25 kb containing ten exons ranging 96 bp 904 bp . splice donor acceptor sites conform GT/AG rule . FISH ( Fluorescence situ Hybridization ) analysis localized gene human chromosome band 17q24 showed exists single copy human genome . Northern blot analysis different human organs demonstrated AXIN2 gene highly expressed human thymus , prostate , testis , small intestine ovarian tissues expressed lower level colon . data reported provides framework analysis important Wnt signalling protein vertebrate development tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0851646239582441)\n",
      "- Text: \"Hepatic IGFBP1 prosurvival factor binds @ GeneSrc $ , protects liver apoptosis , antagonizes proapoptotic actions p53 mitochondria . Liver generally refractory apoptosis induced p53 @ DiseaseTgt $ suppressor protein , molecular basis remains poorly understood . show p53 transcriptional activation leads enhanced expression hepatic IGFBP1 ( insulin-like growth factor-binding protein-1 ) . Exhibiting previously unanticipated role , portion intracellular IGFBP1 protein localizes mitochondria binds proapoptotic protein @ GeneSrc $ hinders @ GeneSrc $ activation apoptosis induction . Interestingly , many cells tissues p53 also direct apoptotic function mitochondria includes @ GeneSrc $ binding activation . IGFBP1 complex @ GeneSrc $ , formation proapoptotic @ GeneSrc $ complex apoptosis induction impaired , cultured cells liver . contrast , livers IGFBP1-deficient mice exhibit spontaneous apoptosis accompanied p53 mitochondrial accumulation evidence @ GeneSrc $ oligomerization . data support importance @ GeneSrc $ mediator p53 's mitochondrial function . results also identify IGFBP1 negative regulator @ GeneSrc $ pathway apoptosis , whose expression integrates transcriptional mitochondrial functions p53 @ DiseaseTgt $ suppressor protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1125096937449014)\n",
      "- Text: \"Becn1 mutation mediates hyperactive autophagic sequestration amyloid oligomers improved cognition @ DiseaseTgt $ . Impairment autophagy pathway observed pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , neurodegenerative disorder characterized abnormal deposition extracellular intracellular amyloid beta ( Abeta ) peptides . Yet role autophagy Abeta production @ DiseaseTgt $ progression complex . study whether increased basal autophagy plays beneficial role Abeta clearance cognitive improvement , developed novel genetic model hyperactivate autophagy vivo . found knock-in point mutation F121A essential autophagy gene Beclin 1/Becn1 mice significantly reduces interaction BECN1 inhibitor @ GeneSrc $ , thus leads constitutively active autophagy even non-autophagy-inducing conditions multiple tissues , including brain . Becn1F121A-mediated autophagy hyperactivation significantly decreases amyloid accumulation , prevents cognitive decline , restores survival @ DiseaseTgt $ mouse models . Using immunoisolation method , found biochemically Abeta oligomers autophagic substrates sequestered inside autophagosomes brain autophagy-hyperactive @ DiseaseTgt $ mice . addition genetic activation autophagy Becn1 gain-of-function , also found ML246 , small-molecule autophagy inducer , well voluntary exercise , physiological autophagy inducer , exert similar Becn1-dependent protective effects Abeta removal memory @ DiseaseTgt $ mice . Taken together , results demonstrate genetically disrupting @ GeneSrc $ binding hyperactivates autophagy vivo , sequestrates amyloid oligomers prevents @ DiseaseTgt $ progression . study establishes new approaches activate autophagy brain , reveals important function Becn1-mediated autophagy hyperactivation prevention @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004659134155674)\n",
      "- Text: \"senescence program controlled p53 p16INK4a contributes outcome @ DiseaseTgt $ therapy . p53 INK4a/ARF mutations promote tumorigenesis drug resistance , part , disabling apoptosis . show primary murine lymphomas also respond chemotherapy engaging senescence program controlled p53 p16 ( INK4a ) . Hence , @ DiseaseTgt $ p53 INK4a/ARF mutations-but lacking ARF alone-respond poorly cyclophosphamide therapy vivo . Moreover , @ DiseaseTgt $ harboring @ GeneSrc $ apoptotic block undergo drug-induced cytostasis involving accumulation p53 , p16 ( INK4a ) , senescence markers , typically acquire p53 INK4a mutations upon progression terminal stage . Finally , mice bearing @ DiseaseTgt $ capable drug-induced senescence much better prognosis following chemotherapy harboring @ DiseaseTgt $ senescence defects . Therefore , cellular senescence contributes treatment outcome vivo .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9829920503523628)\n",
      "- Text: \"Dissecting p53 @ DiseaseTgt $ suppressor functions vivo . Although p53 @ DiseaseTgt $ suppressor acts plethora processes influence cellular proliferation survival , remains unclear p53 functions essential @ DiseaseTgt $ suppression , consequence , selected @ DiseaseTgt $ development . Using mouse model harboring primary , genetically modified myc-driven lymphomas , show disruption apoptosis downstream p53 @ GeneSrc $ dominant-negative caspase 9 confers-like p53 loss-a selective advantage , completely alleviates pressure inactivate p53 lymphomagenesis . Despite p53-null-like aggressive phenotype , apoptosis-defective lymphomas retain intact p53 genes display checkpoint defects gross aneuploidy characteristic p53 mutant @ DiseaseTgt $ . Therefore , apoptosis p53 function selected lymphoma development , whereas defective cell-cycle checkpoints aneuploidy mere byproducts p53 loss .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3010334117000278)\n",
      "- Text: \"Point mutations juxtamembrane domain FLT3 define new class activating mutations @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) , two clusters activating mutations known FMS-like tyrosine kinase-3 ( FLT3 ) gene : FLT3-internal tandem duplications ( FLT3-ITDs ) juxtamembrane ( JM ) domain 20 % 25 % patients , FLT3 point mutations tyrosine-kinase domain ( FLT3-TKD ) 7 % 10 % patients , respectively . , characterized new class activating point mutations ( PMs ) cluster 16-amino acid stretch juxtamembrane domain FLT3 ( FLT3-JM-PMs ) . Expression 4 FLT3-JM-PMs interleukin-3 ( IL-3 ) -dependent Ba/F3 cells led factor-independent growth , hyperresponsiveness FLT3 ligand , resistance apoptotic cell death . FLT3-JM-PM receptors autophosphorylated showed higher constitutive dimerization rate compared FLT3-wild-type ( WT ) receptor . molecular mechanism , could show activation STAT5 up-regulation @ GeneSrc $ FLT3-JM-PMs . FLT3 inhibitor PKC412 abrogated factor-independent growth FLT3-JM-PM-expressing cells . Compared FLT3-ITD FLT3-TKD mutants , FLT3-JM-PMs showed weaker transforming potential related lower autophosphorylation receptor downstream target STAT5 . Mapping FLT3-JM-PMs crystal structure FLT3 showed mutations reduce stability autoinhibitory JM domain , provides structural basis transforming capacity new class gain-of-function mutations FLT3 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3080190276597699)\n",
      "- Text: \"Neuroprotective effects brain-derived neurotrophic factor rodent primate models @ DiseaseTgt $ . Profound neuronal dysfunction entorhinal cortex contributes early loss short-term memory @ DiseaseTgt $ . show broad neuroprotective effects entorhinal @ GeneSrc $ ( @ GeneSrc $ ) administration several animal models @ DiseaseTgt $ , extension therapeutic benefits degenerating hippocampus . amyloid-transgenic mice , @ GeneSrc $ gene delivery , administered disease onset , reverses synapse loss , partially normalizes aberrant gene expression , improves cell signaling restores learning memory . outcomes occur independently effects amyloid plaque load . aged rats , BDNF infusion reverses cognitive decline , improves age-related perturbations gene expression restores cell signaling . adult rats primates , BDNF prevents lesion-induced death entorhinal cortical neurons . aged primates , BDNF reverses neuronal atrophy ameliorates age-related cognitive impairment . Collectively , findings indicate BDNF exerts substantial protective effects crucial neuronal circuitry involved @ DiseaseTgt $ , acting amyloid-independent mechanisms . BDNF therapeutic delivery merits exploration potential therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0215909907066393)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors alphaCaMKII . Furthermore , loss presenilins causes reduced expression CBP CREB/CBP target genes , c-fos @ GeneSrc $ . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels Cdk5 activator p25 hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0047735960476372)\n",
      "- Text: \"Systematic rare variant analyses identify RAB32 susceptibility gene familial @ DiseaseTgt $ . Despite substantial progress , causal variants identified minority familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases , leaving high-risk pathogenic variants unidentified1,2 . identify variants , uniformly processed exome sequencing data 2,184 index familial @ DiseaseTgt $ cases 69,775 controls . Exome-wide analyses converged RAB32 novel @ DiseaseTgt $ gene identifying c.213C > G/p . S71R high-risk variant presenting ~0.7 % familial @ DiseaseTgt $ cases observed 0.004 % controls ( odds ratio 65.5 ) . variant confirmed cases via Sanger sequencing segregated @ DiseaseTgt $ three families . RAB32 encodes small GTPase known interact @ GeneSrc $ ( refs . 3,4 ) . Functional analyses showed RAB32 S71R increases @ GeneSrc $ kinase activity , indicated increased autophosphorylation @ GeneSrc $ S1292 . results implicate mutant RAB32 key pathological mechanism @ GeneSrc $ kinase activity5 - 7-and thus provide novel insights mechanistic connections RAB family biology , @ GeneSrc $ @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7659851736371086)\n",
      "- Text: \"Clinical features @ DiseaseTgt $ patients homozygous @ GeneSrc $ G2019S mutations . BACKGROUND : G2019S mutation common pathogenic substitution @ GeneSrc $ ( @ GeneSrc $ ) gene , recently identified familial sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . OBJECTIVES : report clinical characteristics @ DiseaseTgt $ patients homozygous @ GeneSrc $ 6055G > ( G2019S ) mutations compare previously published descriptions heterozygous patients . DESIGN : Descriptive clinical report international consortium studies . Subjects Patients familial PD homozygous @ GeneSrc $ mutations included 23 Tunisians , 2 Algerians , 2 US patients , 1 Canadian , 1 Moroccan . RESULTS : observable differences homozygote heterozygote phenotypes . CONCLUSIONS : @ DiseaseTgt $ related @ GeneSrc $ characterized typical clinical features , similarities patients homozygous heterozygous mutations support gene dosage effect .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9913873078296066)\n",
      "- Text: \"@ GeneSrc $ expression linked dopamine-innervated areas . OBJECTIVE : @ GeneSrc $ ( @ GeneSrc $ ) linked @ DiseaseTgt $ . study explores expression @ GeneSrc $ human rodent brain tissue . METHODS : analyzed @ GeneSrc $ gene activity cellular level using situ hybridization . RESULTS : found high strikingly specific expression @ GeneSrc $ mRNA rodent striatum parts cortex signals dopamine neurons . human tissue , @ GeneSrc $ mRNA found corresponding brain areas caudatus putamen lower levels dopamine neurons also devoid @ GeneSrc $ mRNA . Expression levels striatal tissue differ @ DiseaseTgt $ patients control subjects . INTERPRETATION : Unlike genes far linked @ DiseaseTgt $ , results demonstrate @ GeneSrc $ expression particularly high brain dopaminoceptive areas .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0220762096811915)\n",
      "- Text: \"Leucine-Rich Repeat Kinase 2 interacts Parkin , DJ-1 PINK-1 Drosophila melanogaster model @ DiseaseTgt $ . Mutations @ GeneSrc $ gene common genetic cause familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , physiological pathological functions unknown . Therefore , generated several independent Drosophila lines carrying WT mutant human @ GeneSrc $ ( mutations kinase , COR LRR domains , resp . ) . Ectopic expression WT mutant @ GeneSrc $ dopaminergic neurons caused significant loss accompanied complex age-dependent changes locomotor activity . Overall , ubiquitous expression @ GeneSrc $ increased lifespan fertility flies . However , flies sensitive rotenone . LRRK2 expression eye exacerbated retinal degeneration . Importantly , double transgenic flies , various indices eye dopaminergic survival modified complex fashion concomitant expression PINK1 , DJ-1 Parkin . evidence suggests genetic interaction @ DiseaseTgt $ genes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6244458141382486)\n",
      "- Text: \"Genotype-phenotype correlations GBA mutations @ DiseaseTgt $ risk onset . BACKGROUND : Mutations GBA @ GeneSrc $ genes implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , particularly Ashkenazi Jews . METHODS : Israeli Ashkenazi cohort 420 patients @ DiseaseTgt $ , 333 elderly controls , 3,805 young controls screened eight GBA mutations , associated mild ( N370S , R496H ) severe ( 84GG , IVS2 + 1 , V394L , D409H , L444P , RecTL ) Gaucher disease . Patients @ DiseaseTgt $ elderly controls also genotyped @ GeneSrc $ G2019S . RESULTS : GBA carrier frequency 17.9 % patients @ DiseaseTgt $ compared 4.2 % elderly 6.35 % young controls . proportion severe mutation carriers among @ DiseaseTgt $ patient GBA carriers 29 % compared 7 % among young controls . Severe mild GBA mutations increased risk developing @ DiseaseTgt $ 13.6- 2.2-fold , affected average age @ DiseaseTgt $ onset ( AAO ) , 55.7 57.9 years , compared 60.7 years patients without known GBA @ GeneSrc $ mutations . CONCLUSIONS : data demonstrate genotype-phenotype correlations different GBA mutations @ DiseaseTgt $ ( @ DiseaseTgt $ ) risk AAO Ashkenazi Jews . Additionally , earlier AAO observed @ GeneSrc $ G2019S carrier @ DiseaseTgt $ patients . Finally , data demonstrate surprisingly high frequency , one third patient population , carried mutation GBA @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9838137307531628)\n",
      "- Text: \"Evaluation @ GeneSrc $ G2019S penetrance : relevance genetic counseling @ DiseaseTgt $ . report results family-based study @ GeneSrc $ G2019S penetrance @ DiseaseTgt $ . studied 19 families identified analysis unrelated consecutive patients . cumulative incidence disease 15 % 60 years , 21 % 70 years , 32 % 80 years . study provides accurate estimates G2019S penetrance minimizing selection bias .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1531403057481592)\n",
      "- Text: \"@ DiseaseTgt $ mutations @ GeneSrc $ augment kinase activity . Mutations @ GeneSrc $ gene ( LRRK2 ) cause late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) clinical appearance indistinguishable @ DiseaseTgt $ . Initial studies suggest LRRK2 mutations common yet identified determinant @ DiseaseTgt $ susceptibility , transmitted autosomal-dominant mode inheritance . Herein , characterize LRRK2 gene transcript human brain subclone predominant ORF . Exogenously expressed LRRK2 protein migrates approximately 280 kDa present largely cytoplasm also associates mitochondrial outer membrane . Familial-linked mutations G2019S R1441C obvious effect protein steady-state levels , turnover , localization . However , vitro kinase assays using full-length recombinant LRRK2 reveal increase activity caused familial-linked mutations autophosphorylation phosphorylation generic substrate . results suggest gain-of-function mechanism LRRK2-linked disease central role kinase activity development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1005493033079351)\n",
      "- Text: \"Genome-wide association study identifies common variants four loci genetic risk factors @ DiseaseTgt $ . identify susceptibility variants @ DiseaseTgt $ ( @ DiseaseTgt $ ) , performed genome-wide association study ( GWAS ) two replication studies total 2,011 cases 18,381 controls Japan . identified new susceptibility locus 1q32 ( P = 1.52 x 10 ( -12 ) ) designated PARK16 , also identified BST1 4p15 second new risk locus ( P = 3.94 x 10 ( -9 ) ) . also detected strong associations SNCA 4q22 ( P = 7.35 x 10 ( -17 ) ) @ GeneSrc $ 12q12 ( P = 2.72 x 10 ( -8 ) ) , implicated autosomal dominant forms parkinsonism . comparing results GWAS performed individuals European ancestry , identified PARK16 , SNCA @ GeneSrc $ shared risk loci @ DiseaseTgt $ BST1 MAPT loci showing population differences . results identify two new @ DiseaseTgt $ susceptibility loci , show involvement autosomal dominant parkinsonism loci typical @ DiseaseTgt $ suggest population differences contribute genetic heterogeneity @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0118469077148076)\n",
      "- Text: \"Analysis @ GeneSrc $ R1628P risk factor @ DiseaseTgt $ . Common genetic variants increase risk @ DiseaseTgt $ may differentiate patient subgroups influence future individualized therapeutic strategies . Herein show evidence @ GeneSrc $ ( @ GeneSrc $ ) c.4883G > C ( R1628P ) risk factor ethnic Chinese populations . study 1,986 individuals 3 independent centers Taiwan Singapore demonstrates @ GeneSrc $ R1628P increases risk @ DiseaseTgt $ ( odds ratio , 1.84 ; 95 % confidence interval , 1.20 - 2.83 ; p = 0.006 ) . Haplotype analysis suggests ancestral founder carriers approximately 2,500 years ago . findings support importance @ GeneSrc $ variants sporadic @ DiseaseTgt $ . Ann Neurol 2008 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3129383220591521)\n",
      "- Text: \"Physiological pathological roles LRRK2 nuclear envelope integrity . Mutations @ GeneSrc $ cause @ DiseaseTgt $ , mechanisms involved @ GeneSrc $ toxicity @ DiseaseTgt $ yet fully understood . found LRRK2 translocates nucleus binding seven absentia homolog ( SIAH-1 ) , nucleus directly interacts lamin A/C , independent kinase activity . LRRK2 knockdown caused nuclear lamina abnormalities nuclear disruption . @ GeneSrc $ disease mutations mostly abolish interaction lamin A/C , similar @ GeneSrc $ knockdown , cause disorganization lamin A/C leakage nuclear proteins . Dopaminergic neurons LRRK2 G2019S transgenic LRRK2 -/- mice display decreased circularity nuclear lamina leakage nuclear protein 53BP1 cytosol . Dopaminergic nigral cortical neurons @ GeneSrc $ G2019S idiopathic @ DiseaseTgt $ patients exhibit abnormalities nuclear lamina . data indicate LRRK2 plays essential role maintaining nuclear envelope integrity . Disruption function disease mutations suggests novel phosphorylation-independent loss-of-function mechanism may synergize neurotoxic effects caused LRRK2 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0905250027285852)\n",
      "- Text: \"Structure ROC domain Parkinson 's disease-associated leucine-rich repeat kinase 2 reveals dimeric GTPase . Mutations @ GeneSrc $ ( @ GeneSrc $ ) common cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ contains Ras complex proteins ( ROC ) domain may act GTPase regulate protein kinase activity . structure ROC mechanism ( ) regulates kinase activity known . , report crystal structure @ GeneSrc $ ROC domain complex GDP-Mg ( 2 + ) 2.0-A resolution . structure displays dimeric fold generated extensive domain-swapping , resulting pair active sites constructed essential functional groups contributed monomers . Two @ DiseaseTgt $ pathogenic residues , R1441 I1371 , located interface two monomers provide exquisite interactions stabilize ROC dimer . structure demonstrates loss stabilizing forces ROC dimer likely related decreased GTPase activity resulting mutations sites . data suggest ROC domain may regulate @ GeneSrc $ kinase activity dimer , possibly via C-terminal ROC ( COR ) domain molecular hinge . structure @ GeneSrc $ ROC domain also represents signature previously undescribed class GTPases complex proteins results may provide unique molecular target therapeutics @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7172566490128793)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ . OBJECTIVES : review molecular genetics functional biology @ GeneSrc $ ( @ GeneSrc $ ) parkinsonism summarize opportunities challenges develop interventions @ DiseaseTgt $ ( @ DiseaseTgt $ ) based genetic insight . DATA SOURCES : Publications cited focused @ GeneSrc $ biology 2004 March 2009 . STUDY SELECTION : Literature selected based original contributions , seminal observations , thoughtful reviews . DATA EXTRACTION : Unless stated otherwise , data primarily abstracted peer-reviewed literature appearing PubMed . DATA SYNTHESIS : Genetic mutations predispose @ DiseaseTgt $ diagnostically useful early atypical presentations . molecular pathways identified suggest therapeutic interventions @ GeneSrc $ idiopathic @ DiseaseTgt $ rationale opportunity develop physiologically relevant biomarkers experimental models test . CONCLUSIONS : affected asymptomatic @ GeneSrc $ carriers provide opportunity define natural history @ DiseaseTgt $ . includes frequency , penetrance , rate motor symptoms , nonmotor comorbidities , associated biomarkers .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5718710900899758)\n",
      "- Text: \"@ GeneSrc $ mutations Spanish patients @ DiseaseTgt $ : frequency , clinical features , incomplete penetrance . BACKGROUND : Several pathogenic mutations @ GeneSrc $ gene implicated familial sporadic cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) . R1441 G mutation frequent Spanish patients Basque ethnicity @ DiseaseTgt $ , G2019S mutation common mutation found several populations worldwide . OBJECTIVES : determine frequency @ GeneSrc $ G2019S R1441 G mutations @ DiseaseTgt $ patients non-Basque northeast region Spain ( Catalonia ) , characterize family history clinical features . DESIGN : screened patients presence @ GeneSrc $ R1441 G G2019S mutations . @ GeneSrc $ mutations detected restriction endonuclease digestion , samples abnormal electrophoresis pattern sequenced identify exact nucleotide change . clinical features family history patients @ GeneSrc $ mutations studied detail . SETTING : northeast region Spain . Patients Three hundred two patients @ DiseaseTgt $ . MAIN OUTCOME MEASURES : Onset age , clinical features , family history @ DiseaseTgt $ @ GeneSrc $ mutations . RESULTS : R1441 G mutation present 0.7 % total @ DiseaseTgt $ cases . G2019S mutation found 6.4 % familial 3.4 % sporadic cases . Additionally , found 1 patient R1441C mutation . Age onset ranged 33 78 years . Clinical features different classic @ DiseaseTgt $ , except 1 patient presented monosymptomatic leg rest tremor 8 years ' duration . addition , 91-year-old unaffected relative patient G2019S mutation found mutation carrier . CONCLUSIONS : G2019S mutation frequency @ DiseaseTgt $ patients northeast Spain similar reported European regions . R1441 G mutation uncommon Catalonia . presence aged unaffected G2019S mutation carrier supports previously described occurrence incomplete penetrance @ DiseaseTgt $ patients @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3796630877661886)\n",
      "- Text: \"Common variants @ GeneSrc $ associated sporadic @ DiseaseTgt $ . Multiple mutations gene leucine-rich repeat kinase ( @ GeneSrc $ ) cause autosomal dominant late-onset parkinsonism ( @ GeneSrc $ ) . Gly2019Ser mutation appears common different populations . investigate whether novel gene influences non-Mendelian sporadic form @ DiseaseTgt $ , genotyped 121 single nucleotide polymorphisms comprehensively covering entire @ GeneSrc $ gene region set 340 @ DiseaseTgt $ patients 680 matched control subjects Germany . association could demonstrated . therefore evidence existence common variant @ GeneSrc $ strong influence @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0139134814012398)\n",
      "- Text: \"Increased Phospho-AKT Blood Cells @ GeneSrc $ G2019S Mutation Carriers . purpose study investigate whether differential phosphorylation states blood markers identify patients @ GeneSrc $ @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assessed @ GeneSrc $ P-Ser-473-AKT levels peripheral blood cells patients G2019S @ GeneSrc $ @ DiseaseTgt $ ( @ DiseaseTgt $ , n = 31 ) , G2019S @ GeneSrc $ non-manifesting carriers ( L2NMC , n = 26 ) , @ DiseaseTgt $ ( @ DiseaseTgt $ , n = 25 ) , controls ( n = 40 , total n = 122 ) . found differences @ GeneSrc $ groups detected specific increase P-Ser-473-AKT levels G2019S carriers , either @ DiseaseTgt $ L2NMC , absent @ DiseaseTgt $ . Although insensitive @ GeneSrc $ inhibition , study identifies P-Ser-473-AKT endogenous candidate biomarker peripheral inflammation G2019S carriers using accessible blood cells . ANN NEUROL 2022 ; 92:888 - 894 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1998664918139024)\n",
      "- Text: \"@ GeneSrc $ mutations Crete : R1441H associated @ DiseaseTgt $ evolving PSP .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0289522764852527)\n",
      "- Text: \"common @ GeneSrc $ G2019S mutation related dyskinesias North African @ DiseaseTgt $ ?\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0038308837216037)\n",
      "- Text: \"Cloning gene containing mutations cause @ GeneSrc $ @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ; OMIM # 168600 ) second common neurodegenerative disorder Western world presents progressive movement disorder . hallmark pathological features @ DiseaseTgt $ loss dopaminergic neurons substantia nigra neuronal intracellular Lewy body inclusions . Parkinsonism typically sporadic nature ; however , several rare familial forms linked genetic loci , identification causal mutations provided insight disease process . @ GeneSrc $ , identified 2002 Funayama colleagues , appears common cause familial @ DiseaseTgt $ . describe cloning novel gene contains missense mutations segregating @ GeneSrc $ @ DiseaseTgt $ five families England Spain . tremor observed @ DiseaseTgt $ number families Basque descent , named protein @ GeneSrc $ , derived Basque word dardara , meaning tremor .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2385616668562094)\n",
      "- Text: \"Drosophila model @ GeneSrc $ parkinsonism . Mutations leucine-rich repeat kinase ( @ GeneSrc $ ) gene cause late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pleiomorphic pathology . Previously , others found expression mutant @ GeneSrc $ causes neuronal degeneration cell culture . used GAL4/UAS system generate transgenic Drosophila expressing either wild-type human @ GeneSrc $ @ GeneSrc $ , common mutation associated @ DiseaseTgt $ . Expression either wild-type human @ GeneSrc $ @ GeneSrc $ photoreceptor cells caused retinal degeneration . Expression @ GeneSrc $ @ GeneSrc $ neurons produced adult-onset selective loss dopaminergic neurons , locomotor dysfunction , early mortality . Expression mutant @ GeneSrc $ caused severe parkinsonism-like phenotype expression equivalent levels wild-type @ GeneSrc $ . Treatment l-DOPA improved mutant @ GeneSrc $ locomotor impairment prevent loss tyrosine hydroxylase-positive neurons . knowledge , first vivo '' gain-of-function `` model recapitulates several key features @ GeneSrc $ human parkinsonism . flies may provide useful model studying @ GeneSrc $ pathogenesis future therapeutic screens @ DiseaseTgt $ intervention .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1609864582641959)\n",
      "- Text: \"Clinical features @ GeneSrc $ @ DiseaseTgt $ central Norway . Several pathogenic mutations @ GeneSrc $ ( @ GeneSrc $ ; @ GeneSrc $ ) gene recently identified familial sporadic parkinsonism . screened 435 Norwegian patients diagnosed @ DiseaseTgt $ 519 control subjects presence 7 @ GeneSrc $ mutations . Nine patients seven families found heterozygote carriers @ GeneSrc $ 6055G > ( G2019S ) mutation . Twelve 28 first-degree relatives also carried mutation , 1 @ DiseaseTgt $ . clinical features included asymmetric resting tremor , bradykinesia , rigidity good response levodopa could distinguished @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7815585862670708)\n",
      "- Text: \"Mutations @ GeneSrc $ increase phosphorylation peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene responsible autosomal dominant sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) , possibly exerting effects via toxic gain function . common p. G2019S mutation ( rs34637584 : > G ) responsible 30 - 40 % @ DiseaseTgt $ cases ethnic populations . , show @ GeneSrc $ interacts human peroxiredoxin 3 ( PRDX3 ) , mitochondrial member antioxidant family thioredoxin ( Trx ) peroxidases . Importantly , mutations @ GeneSrc $ kinase domain significantly increased phosphorylation PRDX3 compared wild-type . increase PRDX3 phosphorylation associated decreased peroxidase activity increased death @ GeneSrc $ @ GeneSrc $ vector-transfected neuronal cells . @ GeneSrc $ mutants stimulated mitochondrial factors involved apoptosis induced production reactive oxygen species ( ROS ) oxidative modification macromolecules . Furthermore , immunoblot immunohistochemical analysis postmortem human @ DiseaseTgt $ patients carrying p. G2019S mutation showed marked increase phosphorylated PRDX3 ( p-PRDX3 ) relative normal brain . showed @ GeneSrc $ mutations increase inhibition endogenous peroxidase phosphorylation promoting dysregulation mitochondrial function oxidative damage . findings provide mechanistic link enhanced kinase activity @ DiseaseTgt $ @ GeneSrc $ neuronal cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3714495705756029)\n",
      "- Text: \"Mutations @ GeneSrc $ cause autosomal-dominant parkinsonism pleomorphic pathology . previously linked families autosomal-dominant , late-onset parkinsonism chromosome 12p11.2-q13.1 ( @ GeneSrc $ ) . high-resolution recombination mapping candidate gene sequencing 46 families , found six disease-segregating mutations ( five missense one putative splice site mutation ) gene encoding large , multifunctional protein , @ GeneSrc $ ( @ GeneSrc $ ) . belongs ROCO protein family includes protein kinase domain MAPKKK class several major functional domains . Within affected carriers families , six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied strikingly diverse pathologies . include abnormalities consistent @ DiseaseTgt $ , diffuse Lewy body disease , nigral degeneration without distinctive histopathology , progressive supranuclear palsy-like pathology . Clinical diagnoses Parkinsonism dementia amyotrophy , associated pathologies , also noted . Hence , @ GeneSrc $ may central pathogenesis several major neurodegenerative disorders associated parkinsonism .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3641556220463889)\n",
      "- Text: \"Localization @ GeneSrc $ membranous vesicular structures mammalian brain . OBJECTIVE : @ GeneSrc $ gene responsible late-onset @ DiseaseTgt $ encodes large novel protein unknown biological function termed @ GeneSrc $ ( @ GeneSrc $ ) . studies herein explore localization @ GeneSrc $ mammalian brain . METHODS : Polyclonal antibodies generated amino carboxy termini @ GeneSrc $ used examine biochemical , subcellular , immunohistochemical distribution @ GeneSrc $ . RESULTS : LRRK2 detected rat brain approximate 280kDa protein Western blot analysis . Subcellular fractionation demonstrates presence LRRK2 microsomal , synaptic vesicle-enriched synaptosomal cytosolic fractions rat brain , well mitochondrial outer membrane . Immunohistochemical analysis rat human brain tissue primary rat cortical neurons , LRRK2-specific antibodies , shows widespread neuronal-specific labeling localized exclusively punctate structures within perikarya , dendrites , axons . Confocal colocalization analysis primary cortical neurons shows partial yet significant overlap LRRK2 immunoreactivity markers specific mitochondria lysosomes . Furthermore , ultrastructural analysis rodent basal ganglia detects @ GeneSrc $ immunoreactivity associated membranous vesicular intracellular structures , including lysosomes , endosomes , transport vesicles , mitochondria . INTERPRETATION : association @ GeneSrc $ variety membrane vesicular structures , membrane-bound organelles , microtubules suggests affinity @ GeneSrc $ lipids lipid-associated proteins may suggest potential role biogenesis and/or regulation vesicular membranous intracellular structures within mammalian brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0134968040783649)\n",
      "- Text: \"@ GeneSrc $ mutations @ DiseaseTgt $ . determine frequency @ GeneSrc $ mutations @ DiseaseTgt $ ( @ DiseaseTgt $ ) , authors studied 786 @ DiseaseTgt $ probands , 32 affected siblings , 1,044 unaffected siblings , 278 unrelated controls . authors designed allelic discrimination assays nine @ GeneSrc $ mutations identified six probands @ DiseaseTgt $ , one affected sibling , one unaffected sibling , one unrelated control . Thus @ GeneSrc $ mutations rarely cause idiopathic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9113453684267256)\n",
      "- Text: \"Clinical positron emission tomography @ DiseaseTgt $ caused @ GeneSrc $ . recently identified mutations gene @ GeneSrc $ ( @ GeneSrc $ ) , cause autosomal dominant @ DiseaseTgt $ . , describe two families autosomal dominant @ DiseaseTgt $ caused @ GeneSrc $ G2019S mutation . present clinical description patients , including 6- ( 18 ) F-fluoro-L-dopa positron emission tomography discuss potential implications mutation , alters conserved residue domain required kinase activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.999993323769558)\n",
      "- Text: \"Inhibitors @ GeneSrc $ protect models @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) mutations common cause @ DiseaseTgt $ . identify inhibitors @ GeneSrc $ kinase protective vitro vivo models @ GeneSrc $ neurodegeneration . results establish @ GeneSrc $ degeneration neurons vivo kinase dependent @ GeneSrc $ kinase inhibition provides potential new neuroprotective paradigm treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1377925646069707)\n",
      "- Text: \"familial Parkinsonism gene @ GeneSrc $ regulates neurite process morphology . Mutations @ GeneSrc $ underlie autosomal-dominant , inherited form @ DiseaseTgt $ ( @ DiseaseTgt $ ) mimics clinical features common `` sporadic `` form @ DiseaseTgt $ . @ GeneSrc $ protein includes putative GTPase , protein kinase , WD40 repeat , leucine-rich repeat ( LRR ) domains unknown function . show @ DiseaseTgt $ @ GeneSrc $ mutations display disinhibited kinase activity induce progressive reduction neurite length branching primary neuronal cultures intact rodent CNS . contrast , @ GeneSrc $ deficiency leads increased neurite length branching . Neurons express @ DiseaseTgt $ @ GeneSrc $ mutations additionally harbor prominent phospho-tau-positive inclusions lysosomal characteristics ultimately undergo apoptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9972574348190074)\n",
      "- Text: \"Autosomal dominant dopa-responsive parkinsonism multigenerational Swiss family . AIM : describe large family autosomal dominant parkinsonism . BACKGROUND : Seven genes directly implicated autosomally inherited parkinsonism . However , several multigenerational large families known identifiable mutation . MATERIAL METHODS : Family members evaluated clinically , history chart review . Genetic investigation included SCA2 , SCA3 , UCHL1 , SNCA , @ GeneSrc $ , PINK1 , PRKN , PGRN , FMR1 premutation , MAPT . proband underwent brain fluorodopa PET ( FD-PET ) scan , one autopsy available . RESULTS : Eleven patients diagnosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , nine women . Mean age onset 52 tremor-predominant dopa-responsive parkinsonism . Disease progression slow severe motor fluctuations occurred . One patient required subthalamic nucleus deep-brain stimulation good motor outcome . One patient mental retardation , schizophrenia became demented , another patient demented . Three patients also two unaffected subjects mild learning difficulties . genetic tests yielded negative results . FD-PET showed marked asymmetric striatal tracer uptake deficiency , consistent @ DiseaseTgt $ . Pathological examination demonstrated Lewy bodies immunostaining negative alpha-synuclein . CONCLUSION : Apart younger age onset female predominance , phenotype indistinguishable @ DiseaseTgt $ , including FD-PET scan results . known genetic causes autosomal dominant @ DiseaseTgt $ excluded , family harbors novel genetic defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1009307972442989)\n",
      "- Text: \"@ GeneSrc $ regulates autophagic activity localizes specific membrane microdomains novel human genomic reporter cellular model . @ GeneSrc $ ( @ GeneSrc $ ) mutations common genetic cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) although @ GeneSrc $ function remains unclear . report new role @ GeneSrc $ regulating autophagy describe recruitment @ GeneSrc $ endosomal-autophagic pathway specific membrane subdomains . Using novel human genomic reporter cellular model , found @ GeneSrc $ locate membrane microdomains neck caveolae , microvilli/filopodia intraluminal vesicles multivesicular bodies ( MVBs ) . human brain cultured human cells @ GeneSrc $ present cytoplasmic puncta corresponding MVBs autophagic vacuoles ( AVs ) . Expression common R1441C mutation genomic DNA construct caused impaired autophagic balance evident accumulation MVBs large AVs containing incompletely degraded material increased levels p62 . Furthermore , R1441C mutation induced formation skein-like abnormal MVBs . Conversely , @ GeneSrc $ siRNA knockdown increased autophagic activity prevented cell death caused inhibition autophagy starvation conditions . work necessitated developing new , efficient recombineering strategy , termed Sequential insertion Target ovErlapping Primers ( STEP ) seamlessly fuse green fluorescent protein-derivative YPet human @ GeneSrc $ protein @ GeneSrc $ genomic locus carried bacterial artificial chromosome . Taken together data demonstrate functional involvement @ GeneSrc $ endosomal-autophagic pathway recruitment specific membrane microdomains physiological human gene expression model suggesting novel function important @ DiseaseTgt $ protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0449894914265618)\n",
      "- Text: \"@ GeneSrc $ G2019S families @ DiseaseTgt $ originated Europe Middle East : evidence two distinct founding events beginning two millennia ago . @ GeneSrc $ ( @ GeneSrc $ ) G2019S mutation common genetic determinant @ DiseaseTgt $ ( @ DiseaseTgt $ ) identified date . accounts 1 % -7 % @ DiseaseTgt $ patients European origin 20 % -40 % Ashkenazi Jews North African Arabs @ DiseaseTgt $ . Previous studies concluded patients populations shared common Middle Eastern founder lived 13th century . tested hypothesis genotyping 25 microsatellite single-nucleotide-polymorphism markers 22 families G2019S observed two distinct haplotypes . Haplotype 1 present 19 families Ashkenazi Jewish European ancestry , whereas haplotype 2 occurred three European American families . Using maximum-likelihood method , estimated families haplotype 1 shared common ancestor 2,250 ( 95 % confidence interval 1,650 - 3,120 ) years ago , whereas haplotype 2 appeared share recent founder . data suggest two separate founding events G2019S populations , beginning time coincides Jewish Diasporas .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4077868963019961)\n",
      "- Text: \"PINK1 mutations parkinsonism . BACKGROUND : PINK1 loss-of-function causes recessive , early-onset parkinsonism . Tunisia high rate consanguineous marriage PINK1 carrier frequency disease prevalence yet assessed . OBJECTIVES : frequency PINK1 mutations familial parkinsonism , community-based patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( non-familial @ DiseaseTgt $ ) , control subjects determined . Demographic clinical characteristics individuals PINK1 homozygous heterozygous variants , without PINK1 mutations , compared . METHODS : total 92 kindreds ( 208 affected 340 unaffected subjects ) , 240 nonfamilial @ DiseaseTgt $ , 368 control participants recruited Institut National de Neurologie , Tunis . Clinical examinations included Hoehn & Yahr , UPDRS , Epworth scales . PINK1 sequencing dosage analysis performed familial index patients , variants identified screened subjects . Parkin @ GeneSrc $ genes also examined . RESULTS : Four PINK1 homozygous mutations , three novel ( Q129X , Q129fsX157 , G440E , one previously reported ; Q456X ) , segregate parkinsonism 46 individuals 14 92 families ( 15 % ) . Six 240 patients nonfamilial @ DiseaseTgt $ found either homozygous Q456X Q129X ( 2.5 % ) substitutions . patients familial disease , PINK1 homozygotes younger disease onset ( 36 + /- 12 years ) noncarriers ( 57 + /- 15 years ) often akinetic-rigid presentation examination slow progression . CONCLUSIONS : Segregation PINK1 mutations parkinsonism within families , frequency estimates within population controls , suggested four PINK1 mutations pathogenic . Several PINK1 sequence variants potentially benign evidence PINK1 heterozygosity increases susceptibility @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0137572738618743)\n",
      "- Text: \"Identification haplotype analysis @ GeneSrc $ G2019S Japanese patients @ DiseaseTgt $ . @ GeneSrc $ G2019S common known cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients European origin , little known distribution populations . authors identified two 586 Japanese patients @ DiseaseTgt $ heterozygous mutation shared haplotype distinct observed Europeans . suggests G2019S originated separate founders Europe Japan widely dispersed previously recognized .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0738339957885437)\n",
      "- Text: \"interrupted SCA2 CAG repeat expansions responsible parkinsonism ? BACKGROUND : Autosomal dominant parkinsonism ( ADP ) caused large percentage familial sporadic cases mutations @ GeneSrc $ gene , particularly G2019S . also caused mutations genes associated autosomal dominant cerebellar ataxia ( ADCA ) , notably CAG/CAA repeat expansions SCA2 . METHODS : screened 164 families ADP expansions SCA2 , 3 , 17 genes G2019S mutation @ GeneSrc $ . SCA2 CAG/CAA repeat expansion sequenced determine structure . phenotypes patients ADP caused SCA2 , @ GeneSrc $ , unknown mutations compared , well SCA2 patients interrupted uninterrupted expansions size . RESULTS : Three French ADP families SCA2 mutations . expansions ranged 37 39 repeats interrupted stable upon transmission . patients ( n = 9 ) levodopa-responsive parkinsonism without cerebellar signs . significantly symmetric signs less rigidity ADP caused G2019S mutation @ GeneSrc $ unknown mutations . Interestingly , two sisters carrying SCA2 G2019S @ GeneSrc $ mutations markedly earlier onset mother SCA2 . contrast , similar-sized uninterrupted repeats associated ADCA cerebellar ataxia constant associated rarely one mild @ DiseaseTgt $ signs . CONCLUSION : results suggest configuration SCA2 CAG/CAA repeat expansions plays important role phenotype variability . Uninterrupted SCA2 repeat expansions found families autosomal dominant cerebellar ataxia result somatic mosaicism produce large hairpin RNAs , may interact double-stranded RNA-binding proteins . characteristics modified interruption SCA2 repeat expansion found families autosomal dominant parkinsonism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0028038974043603)\n",
      "- Text: \"@ GeneSrc $ haplotype analyses European North African families @ DiseaseTgt $ : common founder G2019S mutation dating 13th century .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0238605341929205)\n",
      "- Text: \"@ GeneSrc $ R1441G-related @ DiseaseTgt $ : evidence common founding event seventh century Northern Spain . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene together represent common genetic determinant @ DiseaseTgt $ ( @ DiseaseTgt $ ) identified date . vast majority patients @ GeneSrc $ @ DiseaseTgt $ reported literature carry one three pathogenic substitutions : G2019S , R1441C , R1441 G . G2019S R1441C geographically widespread , R1441 G prevalent Basque Country rare outside Northern Spain . sought better understand processes shaped current distribution R1441 G . performed haplotype analysis 29 unrelated @ DiseaseTgt $ patients heterozygous R1441 G 85 wild-type controls using 20 markers spanned 15.1 Mb across @ GeneSrc $ region . Nine patients Basque origin 20 non-Basques . inferred haplotypes using Bayesian approach utilized maximum-likelihood method estimate age recent common ancestor . Significant incomplete allele sharing observed distance 6.0 Mb single , rare ten-marker haplotype 5.8 Mb length seen mutation carriers . estimate recent common ancestor lived 1,350 ( 95 % CI , 1,020 - 1,740 ) years ago approximately seventh century . hypothesize R1441 G originated Basque population dispersion mutation occurred short-range gene flow largely limited nearby regions Spain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0597525563786808)\n",
      "- Text: \"common missense variant @ GeneSrc $ gene , Gly2385Arg , associated @ DiseaseTgt $ risk Taiwan . Mutations @ GeneSrc $ gene cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Whether @ GeneSrc $ variants influence susceptibility commoner , sporadic forms @ DiseaseTgt $ remains largely unknown . Data particularly limited concerning Asian population . search novel , biologically relevant variants , sequenced @ GeneSrc $ coding region Taiwanese patients @ DiseaseTgt $ . Four newly identified variants another variant recently found Taiwanese @ DiseaseTgt $ family tested association disease sample 608 @ DiseaseTgt $ cases 373 ethnically matched controls . Heterozygosity Gly2385Arg variant significantly frequent among @ DiseaseTgt $ patients controls ( nominal p value=0.004 , corrected multiple comparisons=0.012 , gender- age-adjusted odds ratio=2.24 , 95 % C.I . : 1.29 - 3.88 ) ; variant uniformly distributed across genders age strata . Two novel variants , Met1869Val Glu1874Stop , found one @ DiseaseTgt $ case ; pathogenic role remains , therefore , uncertain . remaining two novel variants ( Ala419Val Pro755Leu ) present similar frequency cases controls , therefore , interpreted disease-unrelated polymorphisms . findings suggest @ GeneSrc $ Gly2385Arg first identified , functionally relevant variant , acts common risk factor sporadic @ DiseaseTgt $ population Chinese ethnicity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0749287192366132)\n",
      "- Text: \"Identification novel @ GeneSrc $ mutation linked autosomal dominant parkinsonism : evidence common founder across European populations . Autosomal dominant parkinsonism attributed pathogenic amino acid substitutions @ GeneSrc $ ( @ GeneSrc $ ) . sequencing multiplex families consistent @ GeneSrc $ assignment , identified novel heterozygous @ GeneSrc $ mutation . referral sample 248 affected probands families autosomal dominant parkinsonism subsequently assessed ; 7 ( 2.8 % ) found carry heterozygous @ GeneSrc $ 6055G -- > transition ( G2019S ) . seven patients originate United States , Norway , Ireland , Poland . samples patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) populations , screening identified six patients @ GeneSrc $ G2019S ; mutations found matched control individuals . Subsequently , 42 family members 13 probands examined ; 22 @ GeneSrc $ G2019S substitution , 7 diagnosis @ DiseaseTgt $ . note , patients share ancestral haplotype indicative common founder , , within families , @ GeneSrc $ G2019S segregates disease ( multipoint LOD score 2.41 ) . Penetrance age dependent , increasing 17 % age 50 years 85 % age 70 years . summary , study demonstrates @ GeneSrc $ G2019S accounts parkinsonism several families within Europe North America . work highlights fact proportion clinically typical , late-onset @ DiseaseTgt $ cases genetic basis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8116618876048306)\n",
      "- Text: \"Progressive degeneration human neural stem cells caused pathogenic @ GeneSrc $ . Nuclear-architecture defects shown correlate manifestation number human diseases well ageing . therefore plausible diseases whose manifestations correlate ageing might connected appearance nuclear aberrations time . decided evaluate nuclear organization context ageing-associated disorders focusing @ GeneSrc $ ( @ GeneSrc $ ) dominant mutation ( G2019S ; glycine-to-serine substitution amino acid 2019 ) , associated familial sporadic @ DiseaseTgt $ well impairment adult neurogenesis mice . report generation induced pluripotent stem cells ( iPSCs ) derived @ DiseaseTgt $ patients implications @ GeneSrc $ ) mutation human neural-stem-cell ( NSC ) populations . Mutant NSCs showed increased susceptibility proteasomal stress well passage-dependent deficiencies nuclear-envelope organization , clonal expansion neuronal differentiation . Disease phenotypes rescued targeted correction @ GeneSrc $ ) mutation wild-type counterpart @ DiseaseTgt $ iPSCs recapitulated targeted knock-in @ GeneSrc $ ) mutation human embryonic stem cells . Analysis human brain tissue showed nuclear-envelope impairment clinically diagnosed @ DiseaseTgt $ patients . Together , results identify nucleus previously unknown cellular organelle @ DiseaseTgt $ pathology may help open new avenues @ DiseaseTgt $ diagnoses well potential development therapeutics targeting fundamental cell structure .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8147725929038786)\n",
      "- Text: \"@ DiseaseTgt $ causing LRRK2 mutation I2020 associated increased kinase activity . Mutations @ GeneSrc $ gene ( LRRK2 ) recently identified families autosomal dominant late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . LRRK2 protein consists multiple domains belongs Roco family , novel group Ras/GTPase superfamily . Besides GTPase ( Roc ) domain , contains predicted kinase domain , homology MAP kinase kinase kinases . Using cell fractionation immunofluorescence microscopy , show LRRK2 localized cytoplasm associated cellular membrane structures . purified LRRK2 protein demonstrates autokinase activity . disease-associated I2020 mutant shows significant increase autophosphorylation approximately 40 % comparison wild-type protein vitro . suggests pathology @ DiseaseTgt $ caused I2020 mutation associated increase rather loss LRRK2 kinase activity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9633538333618976)\n",
      "- Text: \"@ GeneSrc $ Gly2385Arg variant associated @ DiseaseTgt $ : genetic functional evidence . Evidence @ GeneSrc $ haplotypes associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) risk recently found Chinese population Singapore , common @ GeneSrc $ missense variant , Gly2385Arg , independently detected putative risk factor @ DiseaseTgt $ Chinese population Taiwan . test association Gly2385Arg variant large case-control sample Chinese ethnicity Singapore , perform functional studies wild type Gly2385Arg @ GeneSrc $ protein human cell lines . case-control study involving 989 Chinese subjects , frequency heterozygous Gly2385Arg genotype higher @ DiseaseTgt $ compared controls ( 7.3 vs. 3.6 % , odds ratio = 2.1 , 95 % CI : 1.1 - 3.9 , P = 0.014 ) ; values yield estimated population attributable risk ( PAR ) approximately 4 % . multivariate logistic regression analysis disease group ( @ DiseaseTgt $ vs. controls ) dependent variable genotype independent factor adjustments made effect age gender , heterozygous Gly2385Arg genotype remained associated increased risk @ DiseaseTgt $ compared wild type genotype ( odds ratio = 2.67 , 95 % CI : 1.43 - 4.99 , P = 0.002 ) . glycine position 2385 candidate site N-myristoylation , Gly2385Arg variant replaces hydrophobic glycine hydrophilic arginine , increases net positive charge @ GeneSrc $ WD40 domain . transfection studies , demonstrated wild type Gly2385Arg variant @ GeneSrc $ protein localize cytoplasm form aggregates . However , condition oxidative stress , Gly2385Arg variant toxic associated higher rate apoptosis . study lends support contention Gly2385Arg common risk factor @ DiseaseTgt $ Chinese population . bioinformatics in-vitro studies also suggest Gly2385Arg variant biologically relevant might act pro-apoptotic mechanisms .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.061842651854422)\n",
      "- Text: \"RAB32 Ser71Arg autosomal dominant @ DiseaseTgt $ : linkage , association , functional analyses . BACKGROUND : @ DiseaseTgt $ progressive neurodegenerative disorder multifactorial causes , among genetic risk factors play part . RAB GTPases regulators substrates @ GeneSrc $ , variants @ GeneSrc $ gene important risk factors @ DiseaseTgt $ . aimed explore genetic variability RAB GTPases within cases familial @ DiseaseTgt $ . METHODS : whole-exome sequencing probands families Canada Tunisia @ DiseaseTgt $ without genetic cause , recruited Centre Applied Neurogenetics ( Vancouver , BC , Canada ) , international consortium includes people @ DiseaseTgt $ 36 sites 24 countries . 61 RAB GTPases genetically screened , candidate variants genotyped relatives probands assess disease segregation linkage analysis . Genotyping also done assess variant frequencies individuals @ DiseaseTgt $ controls , matched age sex , also Centre Applied Neurogenetics unrelated probands . participants aged 18 years older . sequencing genotyping findings validated case-control association analyses using bioinformatic data obtained publicly available clinicogenomic databases ( AMP-PD , GP2 , 100 000 Genomes Project ) private German clinical diagnostic database ( University Tubingen ) . Clinical pathological findings summarised haplotypes determined . In-vitro studies done investigate protein interactions enzyme activities . FINDINGS : June 1 , 2010 , May 31 , 2017 , 130 probands Canada Tunisia ( 47 [ 36 % ] female 83 [ 64 % ] male ; mean age 72 7 years [ SD 11 7 ; range 38 - 96 ] ; 109 White European ancestry , 18 north African , two east Asian , one Hispanic ] underwent whole-exome sequencing . 15 variants RAB GTPase genes identified , RAB32 variant c.213C > G ( Ser71Arg ) cosegregated autosomal dominant @ DiseaseTgt $ three families ( nine affected individuals ; non-parametric linkage Z score=1 95 ; p=0 03 ) . 2604 unrelated individuals @ DiseaseTgt $ 344 matched controls additionally genotyped , five people originating five countries ( Canada , Italy , Poland , Turkey , Tunisia ) identified RAB32 variant . database searches , 6043 individuals @ DiseaseTgt $ 62 549 controls included , another eight individuals identified RAB32 variant four countries ( Canada , Germany , UK , USA ) . Overall , association RAB32 c.213C > G ( Ser71Arg ) @ DiseaseTgt $ significant ( odds ratio [ ] 13 17 , 95 % CI 2 15 - 87 23 ; p=0 0055 ; I2=99 96 % ) . people variant , @ DiseaseTgt $ presented age 54 6 years ( SD 12 75 , range 31 - 81 , n=16 ) , two-thirds family history parkinsonism . RAB32 Ser71Arg heterozygotes shared common haplotype , although penetrance incomplete . Findings one individual autopsy showed sparse neurofibrillary tangle pathology midbrain thalamus , without Lewy body pathology . functional studies , RAB32 Arg71 activated @ GeneSrc $ kinase level greater RAB32 Ser71 . INTERPRETATION : RAB32 Ser71Arg novel genetic risk factor @ DiseaseTgt $ , reduced penetrance . variant found individuals @ DiseaseTgt $ multiple ethnic groups , haplotype . In-vitro assays show RAB32 Arg71 activates @ GeneSrc $ kinase , indicates genetically distinct causes familial parkinsonism share mechanism . discovery RAB32 Ser71Arg also suggests several genetically inherited causes @ DiseaseTgt $ originated control intracellular immunity . shared aetiology considered future translational research , global epidemiology RAB32 Ser71Arg needs assessed inform genetic counselling . FUNDING : National Institutes Health , Canada Excellence Research Chairs program , Aligning Science Across @ DiseaseTgt $ , Michael J Fox Foundation @ DiseaseTgt $ Research , UK Medical Research Council .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6126619968053869)\n",
      "- Text: \"Ashkenazi @ DiseaseTgt $ patients @ GeneSrc $ G2019S mutation share common founder dating second fifth centuries . @ GeneSrc $ G2019S mutation major genetic determinant @ DiseaseTgt $ ( @ DiseaseTgt $ ) across world occurs elevated frequency Ashkenazi Jews . determined @ GeneSrc $ haplotypes 77 G2019S carriers , mostly Ashkenazi Jews , 50 noncarrier Ashkenazi @ DiseaseTgt $ patients , using 16 genetic markers . single haplotype detected mutation carriers , indicating individuals share common founder . Using maximum-likelihood method , estimate Ashkenazi Jews G2019S share common ancestor lived approximately 1,830 ( 95 % CI 1,560 - 2,160 ) years ago , around second century , second Jewish Diaspora .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.007160481174116)\n",
      "- Text: \"Comprehensive evaluation common genetic variation within @ GeneSrc $ reveals evidence association sporadic @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) complex neurodegenerative disorder whose aetiologies largely unknown . date , mutations six genes found causal rare familial forms disease common variation within least three associated common sporadic forms @ DiseaseTgt $ . @ GeneSrc $ recently identified familial @ DiseaseTgt $ gene , although role sporadic disease unknown . study , performed first comprehensive evaluation common genetic variation within @ GeneSrc $ investigated contribution risk sporadic @ DiseaseTgt $ . first characterized linkage disequilibrium within @ GeneSrc $ using panel densely spaced SNPs across gene . identified subset tagging-SNPs ( tSNP ) capture majority common variation within @ GeneSrc $ . single tSNP tSNP haplotype analyses , using large epidemiologically matched sporadic case-control series comprising 932 individuals , yielded significant evidence disease association . identified haplotype dramatically increases disease risk present two copies ( OR=5.5 , 95 % CI=2.1 - 14.0 , P=0.0001 ) . Thus , provide first evidence common genetic variation within @ GeneSrc $ contributes risk sporadic @ DiseaseTgt $ Chinese population .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4903464876425261)\n",
      "- Text: \"Genetics @ DiseaseTgt $ . PURPOSE REVIEW : @ DiseaseTgt $ second common neurodegenerative disorder affects 2 % population age 60 years . Due increasing proportion elderly individuals developed countries , @ DiseaseTgt $ related neurodegenerative disorders represent growing burden health care system . majority cases , cause disease still unknown , elucidation remains one major challenges neurosciences . Recent findings rare genetic forms @ DiseaseTgt $ allowed development novel animal models , providing basis better understanding molecular pathogenesis disease , setting stage development novel treatment strategies . RECENT FINDINGS : Several novel genes monogenic forms @ DiseaseTgt $ , PINK-1 autosomal-recessive early-onset variant , @ GeneSrc $ relatively common late-onset autosomal-dominant form recently discovered , several novel animal models generated basis genes found earlier . SUMMARY : combination genetic , pathologic molecular findings provide increasing evidence pathways identified cloning different disease genes interacting different levels share several major pathogenic mechanisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6849459900789945)\n",
      "- Text: \"G2019S @ GeneSrc $ mutation French North African families @ DiseaseTgt $ . Mutations @ GeneSrc $ recently identified autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) , including G2019S mutation . evaluate frequency , analyzed 198 probands @ DiseaseTgt $ , mostly France North Africa . Surprisingly , frequency North African families ( 7/17 , 41 % ) greater Europe ( 5/174 , 2.9 % ) . clinical features 21 patients , including 1 homozygous mutation , typical @ DiseaseTgt $ , lower Mini-Mental State Examination scores . also 15 unaffected mutation carriers , aged 32 74 years . @ GeneSrc $ mutations appear common cause @ DiseaseTgt $ , particularly North Africa .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9770586121983408)\n",
      "- Text: \"@ GeneSrc $ R1628P increases risk @ DiseaseTgt $ : replication evidence . showed frequency @ GeneSrc $ variant ( c.4883 G > C , R1628P ) higher @ DiseaseTgt $ ( @ DiseaseTgt $ ) compared controls ( 8.4 vs. 3.4 % , P = 0.046 , 2.5 , 95 % CI 1.1 - 5.6 ) . multivariate logistic regression ( adjustments made effect age , age onset , gender ) , heterozygous R1628P genotype associated increased risk @ DiseaseTgt $ compared controls ( 3.3 , 95 % CI 1.4- 7.9 , P = 0.007 ) . provided independent confirmation R1628P variant increases risk @ DiseaseTgt $ among Chinese .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022342670356804)\n",
      "- Text: \"@ GeneSrc $ mutation cause parkinsonism original @ GeneSrc $ family . detected missense mutation kinase domain @ GeneSrc $ gene members @ DiseaseTgt $ Japanese family ( Sagamihara family ) served basis original defining @ GeneSrc $ @ DiseaseTgt $ locus . results Sagamihara family , combination unique pathological features characterized pure nigral degeneration without Lewy bodies , provided us valuable information elucidating protein structure-pathogenesis relationship gene product @ GeneSrc $ . detect mutation known mutations @ GeneSrc $ gene Japanese patients sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1582874434580939)\n",
      "- Text: \"@ GeneSrc $ pathogenic substitutions @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) mutations implicated autosomal dominant parkinsonism , consistent typical levodopa-responsive @ DiseaseTgt $ . gene maps chromosome 12q12 encodes large , multifunctional protein . identify novel @ GeneSrc $ mutations , sequenced 100 affected probands family history parkinsonism . Semiquantitative analysis also performed probands identify @ GeneSrc $ genomic multiplication deletion . kindreds , referred movement disorder clinics many parts Europe , Asia , North America , parkinsonism segregates autosomal dominant trait . 51 exons @ GeneSrc $ gene analyzed frequency novel sequence variants assessed within controls . segregation mutations disease examined larger , multiplex families . study identified 26 coding variants , including 15 nonsynonymous amino acid substitutions three affect codon ( R1441C , R1441 G , R1441H ) . Seven coding changes seem pathogenic , segregate disease identified within controls . multiplications deletions identified .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4064568493957759)\n",
      "- Text: \"Mutations GIGYF2 ( TNRC15 ) gene PARK11 locus familial @ DiseaseTgt $ . genetic basis association PARK11 region chromosome 2 familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) unknown . study examined GIGYF2 ( Grb10-Interacting GYF Protein-2 ) ( TNRC15 ) gene , contains PARK11 microsatellite marker highest linkage score ( D2S206 , LOD 5.14 ) . 27 coding exons GIGYF2 gene sequenced 123 Italian 126 French patients familial PD , plus 131 Italian 96 French controls . total seven different GIGYF2 missense mutations resulting single amino acid substitutions present 12 unrelated @ DiseaseTgt $ index patients ( 4.8 % ) controls . Three amino acid insertions deletions found four index patients absent controls . Specific exon sequencing showed ten sequence changes absent 91 controls . four families amino acid substitutions least one @ DiseaseTgt $ case available , GIGYF2 mutations ( Asn56Ser , Thr112Ala , Asp606Glu ) segregated @ DiseaseTgt $ . , however , two unaffected carriers one family , suggesting age-dependent incomplete penetrance . One index case ( @ DiseaseTgt $ onset age 33 ) inherited GIGYF2 mutation ( Ile278Val ) affected father ( @ DiseaseTgt $ onset age 66 ) previously described @ DiseaseTgt $ mutation @ GeneSrc $ gene ( Ile1371Val ) affected mother ( @ DiseaseTgt $ onset age 61 ) . earlier onset severe clinical course index patient suggest additive effects GIGYF2 @ GeneSrc $ mutations . data strongly support GIGYF2 PARK11 gene causal role familial PD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2416914331160474)\n",
      "- Text: \"@ GeneSrc $ phosphorylates brain tubulin-beta isoforms modulates microtubule stability -- point convergence @ DiseaseTgt $ ? Autosomal dominant mutations @ GeneSrc $ ( @ GeneSrc $ ) common genetic cause late-onset @ DiseaseTgt $ . prevalent @ GeneSrc $ ) mutation repeatedly shown enhance kinase activity neurotoxicity , however , molecular mechanisms leading neurodegeneration remain poorly defined . show recombinant human @ GeneSrc $ preferentially phosphorylates tubulin-beta purified bovine brain phosphorylation three-fold enhanced @ GeneSrc $ ) mutation . tandem mass spectrometry , Thr107 identified phosphorylation site highly conserved tubulin-beta family members also tubulin-beta genes different species . @ GeneSrc $ co-immunoprecipitated tubulin-beta wild-type mouse brain @ GeneSrc $ over-expressing , non-neuronal human embryonic kidney 293 cells . However , effect @ GeneSrc $ tubulin phosphorylation assembly detectable mouse brain samples . vitro co-incubation bovine brain tubulins @ GeneSrc $ increased microtubule stability presence microtubule-associated proteins may explain reduction neurite length @ GeneSrc $ neurons culture . findings suggest @ GeneSrc $ neurodegeneration @ DiseaseTgt $ brains may partly mediated increased phosphorylation tubulin-beta constraining microtubule dynamics .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2859719611788933)\n",
      "- Text: \"Frequency @ GeneSrc $ mutations early- late-onset @ DiseaseTgt $ . OBJECTIVE : evaluate frequency leucine-rich repeat kinase gene ( @ GeneSrc $ ) mutations single nucleotide polymorphisms ( SNPs ) early-onset @ DiseaseTgt $ ( EOPD ) late-onset @ DiseaseTgt $ ( LOPD ) . METHODS : genotyped five previously reported @ GeneSrc $ mutations ( G2019S , L1114L , I1122V , R1441C , Y1699C ) 17 coding SNPs haplotype analysis 504 cases @ DiseaseTgt $ 314 controls enrolled Genetic Epidemiology @ DiseaseTgt $ Study . Cases controls recruited without knowledge family history @ DiseaseTgt $ cases oversampled < = 50 age onset ( AAO ) category . RESULTS : @ GeneSrc $ G2019S mutation present 28 cases @ DiseaseTgt $ ( 5.6 % ) two controls ( 0.6 % ) ( chi ( 2 ) = 13.25 ; p < 0.01 ; odds ratio 9.18 , 95 % CI : 2.17 38.8 ) . mutations L1114L , I1122V , R1441C , Y1699C identified . frequency @ GeneSrc $ G2019S mutation 4.9 % 245 cases AAO < = 50 years vs 6.2 % 259 cases AAO > 50 ( p = 0.56 ) . cases @ DiseaseTgt $ G2019S mutation shared disease-associated haplotype . frequency @ GeneSrc $ G2019S mutation higher subset 181 cases reporting four Jewish grandparents ( 9.9 % ) cases ( 3.1 % ) ( p < 0.01 ) . Age-specific penetrance age 80 24 % similar Jewish non-Jewish cases . CONCLUSIONS : G2019S mutation risk factor early- late-onset @ DiseaseTgt $ confirms previous report greater frequency G2019S mutation Jewish non-Jewish cases @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9005796694830335)\n",
      "- Text: \"@ GeneSrc $ impairs PINK1/Parkin-dependent mitophagy via kinase activity : pathologic insights @ DiseaseTgt $ . Mutations @ GeneSrc $ , encoding @ GeneSrc $ ( @ GeneSrc $ ) , leading cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . frequent mutations , G2019S substitution , increases kinase activity , remains unclear causes @ DiseaseTgt $ . Recent studies suggest @ GeneSrc $ modulates mitochondrial homeostasis . Mitochondrial dysfunction plays key role pathogenesis @ DiseaseTgt $ forms linked PARK2 PINK1 , encoding cytosolic E3 ubiquitin-protein ligase Parkin mitochondrial kinase PINK1 , jointly regulate mitophagy . explored role @ GeneSrc $ kinase activity PINK1/Parkin-dependent mitophagy . @ GeneSrc $ increased mitochondrial aggregation attenuated mitochondrial clearance cells coexpressing Parkin exposed protonophore carbonylcyanide m-chlorophenylhydrazone . Forster resonance energy transfer imaging microscopy showed @ GeneSrc $ impaired interactions Parkin Drp1 mitochondrial targets early mitophagy . inhibition @ GeneSrc $ kinase activity ' kinase-dead ' @ GeneSrc $ mutation pharmacological inhibitor ( @ GeneSrc $ ) restored interactions . monitoring mitophagy human primary fibroblasts novel dual-fluorescence mtRosella reporter new hypothermic shock paradigm revealed similar defects @ DiseaseTgt $ patients G2019S @ GeneSrc $ substitution PARK2 mutations relative healthy subjects . defect restored @ GeneSrc $ treatment @ GeneSrc $ patients . results suggest @ DiseaseTgt $ forms due @ GeneSrc $ PARK2 mutations involve pathogenic mechanisms converging PINK1/Parkin-dependent mitophagy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9753078966615588)\n",
      "- Text: \"Analysis PARK genes Korean cohort early-onset @ DiseaseTgt $ . Mutations five PARK genes ( SNCA , PARKIN , DJ-1 , PINK1 , @ GeneSrc $ ) well-established genetic causes @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Recently , G2385R substitution @ GeneSrc $ determined susceptibility allele Asian @ DiseaseTgt $ . objective study determine frequency mutations PARK genes Korean early-onset @ DiseaseTgt $ ( EOPD ) cohort . authors sequenced 35 exons SNCA , PARKIN , DJ-1 , PINK1 , @ GeneSrc $ 72 unrelated EOPD ( age-at-onset < or=50 ) recruited ten movement disorders clinics South Korea . Gene dosage change aforementioned genes studied using multiple ligation-dependent probe amplification . found four patients PARKIN mutations , homozygous deletion exon 4 , compound heterozygous deletion exon 2 exon 4 , heterozygous deletion exon 4 , heterozygous nonsense mutation ( Q40X ) . Four patients PINK1 mutations ; compound heterozygous mutation ( N367S K520RfsX522 ) three heterozygous mutations ( G32R , R279H , F385L ) . missense mutation SNCA ( A53 ) found familial @ DiseaseTgt $ autosomal dominant inheritance . Nine patients ( 12.5 % ) heterozygous G2385R polymorphism @ GeneSrc $ , whereas none G2019S mutation . However , mutations detected DJ-1 UCHL1 series . identified genetic variants PARKIN , PINK1 , @ GeneSrc $ , SNCA cause genetic risk factors @ DiseaseTgt $ 25 % Korean EOPD , mutation PARKIN common genetic cause .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.040858642403225)\n",
      "- Text: \"@ GeneSrc $ ( @ GeneSrc $ ) interacts parkin , mutant @ GeneSrc $ induces neuronal degeneration . @ DiseaseTgt $ ( @ DiseaseTgt $ ) disorder movement , cognition , emotion , characterized pathologically neuronal degeneration Lewy bodies , cytoplasmic inclusion bodies containing deposits aggregated proteins . @ DiseaseTgt $ cases appear sporadic , genetic forms disease , caused mutations alpha-synuclein , parkin , genes , helped elucidate pathogenesis . Mutations @ GeneSrc $ ( @ GeneSrc $ ) cause autosomal-dominant Parkinsonism clinical features @ DiseaseTgt $ pleomorphic pathology including deposits aggregated protein . study expression interactions @ GeneSrc $ , synthesized cDNAs generated expression constructs coding human WT mutant @ GeneSrc $ proteins . Expression full-length @ GeneSrc $ cells culture suggests protein predominately cytoplasmic , endogenous protein subcellular fractionation . Using coimmunoprecipitation , find @ GeneSrc $ , expressed cells culture , interacts parkin alpha-synuclein , DJ-1 , tau . small proportion cells overexpressing @ GeneSrc $ contain protein aggregates , proportion greatly increased coexpression parkin . addition , parkin increases ubiquitination aggregated protein . Also , mutant @ GeneSrc $ causes neuronal degeneration SH-SY5Y cells primary neurons . cell model may useful studies @ DiseaseTgt $ cellular pathogenesis therapeutics . findings suggest gain-of-function mechanism pathogenesis @ GeneSrc $ @ DiseaseTgt $ suggest @ GeneSrc $ may involved pathogenic pathway @ DiseaseTgt $ proteins parkin , may help illuminate familial sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3768854323966727)\n",
      "- Text: \"@ GeneSrc $ interacts vacuolar-type H+-ATPase pump a1 subunit regulate lysosomal function . Lysosomal dysfunction lies centre cellular mechanisms underlying @ DiseaseTgt $ although precise underlying mechanisms remain unknown . investigated role @ GeneSrc $ ( @ GeneSrc $ ) lysosome biology autophagy pathway primary neurons expressing human @ GeneSrc $ LRKK2-R1441C mutant human wild-type ( @ GeneSrc $ ) genomic locus . expression @ GeneSrc $ @ GeneSrc $ inhibited autophagosome production , whereas @ GeneSrc $ induced decrease autophagosome/lysosome fusion increased lysosomal pH . vivo data cortex substantia nigra pars compacta aged @ GeneSrc $ transgenic animals revealed alterations autophagosome puncta number reflecting phenotypes seen vitro . Using two selective potent @ GeneSrc $ kinase inhibitors , MLi-2 PF-06447475 , demonstrated @ GeneSrc $ decrease autolysosome maturation dependent @ GeneSrc $ kinase activity . showed @ GeneSrc $ @ GeneSrc $ bind a1 subunit vATPase , abolished @ GeneSrc $ mutation , leading decrease a1 protein cellular mislocalization . Modulation lysosomal zinc increased vATPase a1 protein levels rescued @ GeneSrc $ cellular phenotypes . work defines novel interaction @ GeneSrc $ protein vATPase a1 subunit demonstrates mode action drugs may rescue lysosomal dysfunction . results demonstrate importance @ GeneSrc $ lysosomal biology , well critical role lysosome @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1734193646326565)\n",
      "- Text: \"Multiple @ GeneSrc $ variants modulate risk @ DiseaseTgt $ : Chinese multicenter study . others found two polymorphic @ GeneSrc $ ( @ GeneSrc $ ) variants ( rs34778348 : G > ; p. G2385R rs33949390 : G > C ; p. R1628P ) associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) among Chinese patients , common worldwide rs34637584 : G > ; p. G2019S mutation , absent . Focusing exclusively Han Chinese , first sequenced coding regions young onset familial @ DiseaseTgt $ patients identified 59 variants . examined variants 250 patients 250 control subjects . Among 17 polymorphic variants , five demonstrated different frequency cases versus controls considered larger sample 1,363 patients 1,251 control subjects . relative risk individual p. G2385R p. R1628P 1.9 , reduced 1.5 - 1.6 individual also carries rs7133914 : G > C ; p. R1398H rs7308720 : C > : p. N551 K . risk carrier p. R1628P largely negated individual also carries p. R1398H p. N551 K . dopaminergic neuronal lines , p. R1398H significantly lower kinase activity , whereas p. G2385R p. R1628P showed higher kinase activity wild type . provided first evidence multiple @ GeneSrc $ variants exert individual effect together modulate risk @ DiseaseTgt $ among Chinese .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0071316023554291)\n",
      "- Text: \"Mutations @ GeneSrc $ Roc-COR tandem domain link @ DiseaseTgt $ Wnt signalling pathways . Mutations @ GeneSrc $ , encoding @ GeneSrc $ , common known cause @ DiseaseTgt $ . @ GeneSrc $ Roc-COR tandem domain exhibits GTPase activity controlling @ GeneSrc $ kinase activity via intramolecular process . report interaction @ GeneSrc $ dishevelled family phosphoproteins ( DVL1 - 3 ) , key regulators Wnt ( Wingless/Int ) signalling pathways important axon guidance , synapse formation neuronal maintenance . Interestingly , DVLs interact mediate activation small GTPases structural similarity @ GeneSrc $ Roc domain . @ GeneSrc $ Roc-COR domain DVL1 DEP domain necessary sufficient @ GeneSrc $ interaction . Co-expression DVL1 increased @ GeneSrc $ steady-state protein levels , effect dependent DEP domain . Strikingly , @ GeneSrc $ - 3 interactions disrupted familial @ GeneSrc $ mutation Y1699C , whereas pathogenic mutations residues R1441 R1728 strengthened @ GeneSrc $ interactions . Co-expression DVL1 @ GeneSrc $ mammalian cells resulted redistribution @ GeneSrc $ typical cytoplasmic DVL1 aggregates HEK293 SH-SY5Y cells co-localization neurites growth cones differentiated dopaminergic SH-SY5Y cells . first report modulation key @ GeneSrc $ protein interaction @ GeneSrc $ Roc-COR domain mutations segregating @ DiseaseTgt $ . Since DVL1 DEP domain known involved regulation small GTPases , propose : ( ) DVLs may influence @ GeneSrc $ GTPase activity , ( ii ) Roc-COR domain mutations modulating @ GeneSrc $ interactions indirectly influence kinase activity . findings also link @ GeneSrc $ Wnt signalling pathways , suggesting novel pathogenic mechanisms new targets genetic analysis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1959759269040317)\n",
      "- Text: \"@ DiseaseTgt $ @ GeneSrc $ protein mutation I2020 stabilizes active state conformation leading increased kinase activity . effect @ GeneSrc $ ( @ GeneSrc $ ) mutation I2020 kinase activity controversial , increased decreased effects reported . conducted steady-state pre-steady-state kinetic studies LRRKtide analog LRRKtide ( ) . phosphorylation differs rate-limiting steps : product release rate-limiting LRRKtide phosphoryl transfer rate-limiting LRRKtide ( ) . result , observed I2020 mutant active wild type ( WT ) @ GeneSrc $ LRRKtide ( ) phosphorylation , whereas less active WT LRRKtide phosphorylation . pre-steady-state kinetic data suggest ( ) I2020 mutant accelerates rates phosphoryl transfer reactions 3 - 7-fold ; ( ii ) increase masked rate-limiting product release step LRRKtide phosphorylation ; ( iii ) observed lower activity mutant LRRKtide phosphorylation consequence instability : concentration active form mutant 3-fold lower WT . I2020 mutant dramatically low KATP therefore leads resistance ATP competitive inhibitors . Two well known DFG-out type II inhibitors also weaker toward mutant inhibit mutant unexpected ATP competitive mechanism . I2020 residue lies next DYG motif activation loop @ GeneSrc $ kinase domain . modeling metadynamic simulations suggest I2020 mutant stabilizes DYG-in active conformation creates unusual allosteric pocket bind type II inhibitors ATP competitive fashion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0252031944549661)\n",
      "- Text: \"@ DiseaseTgt $ mutations LRRK2 link enhanced GTP-binding kinase activities neuronal toxicity . Mutations @ GeneSrc $ gene ( LRRK2 ) cause late-onset @ DiseaseTgt $ indistinguishable @ DiseaseTgt $ . mechanisms whereby missense alterations LRRK2 gene initiate neurodegeneration remain unknown . , demonstrate seven 10 suspected familial-linked mutations result increased kinase activity . Functional disease-associated mutations conserved residues reveal critical link intrinsic guanosine triphosphatase ( GTPase ) activity downstream kinase activity . LRRK2 kinase activity requires GTPase activity , whereas GTPase activity functions independently kinase activity . LRRK2 kinase GTPase activity required neurotoxicity potentiate peroxide-induced cell death , although LRRK2 function canonical MAP-kinase-kinase-kinase . results suggest link LRRK2 kinase activity pathogenic mechanisms relating neurodegeneration , supporting gain-of-function role LRRK2 mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7435390189264511)\n",
      "- Text: \"@ GeneSrc $ regulates mitochondrial dynamics function direct interaction DLP1 . @ GeneSrc $ ( @ GeneSrc $ ) mutations common cause autosomal-dominant Parkinson disease ( @ DiseaseTgt $ ) . Mitochondrial dysfunction represents critical event pathogenesis @ DiseaseTgt $ . demonstrated wild-type ( WT ) @ GeneSrc $ expression caused mitochondrial fragmentation along increased mitochondrial dynamin-like protein ( DLP1 , also known DRP1 ) , fission protein , exacerbated expression @ DiseaseTgt $ mutants ( R1441C G2019S ) SH-SY5Y differentiated primary cortical neurons . also found @ GeneSrc $ interacted DLP1 , @ GeneSrc $ interaction enhanced @ DiseaseTgt $ mutations probably results increased mitochondrial DLP1 levels . Co-expression dominant-negative DLP1 K38A WT Mfn2 blocked @ GeneSrc $ mitochondrial fragmentation , mitochondrial dysfunction neuronal toxicity . Importantly , mitochondrial fragmentation dysfunction observed cells expressing either GTP-binding deficient mutant @ GeneSrc $ K1347A kinase-dead mutant D1994A minimal interaction DLP1 increase mitochondrial DLP1 level . concluded @ GeneSrc $ regulates mitochondrial dynamics increasing mitochondrial DLP1 direct interaction DLP1 , @ GeneSrc $ kinase activity plays critical role process .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5831328841916593)\n",
      "- Text: \"Mitochondrial impairment patients @ DiseaseTgt $ G2019S mutation @ GeneSrc $ . OBJECTIVE : @ GeneSrc $ ) mutation common identifiable cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) , underlying mechanisms leading neuronal cell death remain largely unclear . Impaired mitochondrial function morphology described different vivo vitro model systems early-onset @ DiseaseTgt $ ( EOPD ) well EOPD patient tissue . aim study assess mitochondrial function morphology @ GeneSrc $ ) mutant patient tissue determine whether impaired mitochondrial function morphology shared features early-onset late-onset @ DiseaseTgt $ . METHODS : Skin biopsies taken 5 patients @ DiseaseTgt $ @ GeneSrc $ ) mutation . Assessment mitochondrial membrane potential intracellular ATP levels well substrate-linked mitochondrial ATP production assays carried 3 independent cell preparations per patient . Results compared 5 age-matched controls . Mitochondrial elongation interconnectivity assessed using previously published methods . RESULTS : mitochondrial membrane potential total intracellular ATP levels decreased G2019S mutation carriers . Subsequently undertaken mitochondrial ATP production assays suggested observed reduction least partially due impaired mitochondrial function . Mitochondrial elongation interconnectivity increased @ GeneSrc $ ) patient cohort . CONCLUSION : results provide evidence impaired mitochondrial function morphology @ GeneSrc $ ) mutant patient tissue . studies required determine whether impaired mitochondrial function due increased @ GeneSrc $ kinase activity mechanisms @ GeneSrc $ haploinsufficiency .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4111205930718278)\n",
      "- Text: \"Genetic clinical identification @ DiseaseTgt $ patients @ GeneSrc $ G2019S mutation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1107532144030822)\n",
      "- Text: \"Motor phenotype @ GeneSrc $ G2019S carriers early-onset @ DiseaseTgt $ . OBJECTIVE : determine motor phenotype @ GeneSrc $ G2019S mutation carriers . @ GeneSrc $ mutation carriers previously reported manifest tremor dominant motor phenotype , associated slower motor progression less cognitive impairment compared postural instability gait difficulty ( PIGD ) phenotype . DESIGN : Cross-sectional observational study . SETTING : Thirteen movement disorders centers . PARTICIPANTS : Nine hundred twenty-five early-onset @ DiseaseTgt $ cases defined age onset younger 51 years . MAIN OUTCOME MEASURES : @ GeneSrc $ mutation status @ DiseaseTgt $ motor phenotype : tremor dominant PIGD . Demographic information , family history @ DiseaseTgt $ , Unified @ DiseaseTgt $ Rating Scale score collected participants . DNA samples genotyped @ GeneSrc $ mutations ( G2019S , I2020 , R1441C , Y1699C ) . Logistic regression used examine associations G2019S mutation status motor phenotype adjusting disease duration , Ashkenazi Jewish ancestry , levodopa dose , family history @ DiseaseTgt $ . RESULTS : Thirty-four cases ( 3.7 % ) ( 14 previously reported ) G2019S carriers . mutations found . Carriers likely Ashkenazi Jewish ( 55.9 % vs 11.9 % ; P < .001 ) significantly differ demographic disease characteristics . Carriers lower tremor score ( P = .03 ) likely PIGD phenotype ( 92.3 % vs 58.9 % ; P = .003 ) . association G2019S mutation PIGD phenotype remained controlling disease duration Ashkenazi Jewish ancestry ( odds ratio , 17.7 ; P < .001 ) . CONCLUSION : Early-onset @ DiseaseTgt $ G2019S @ GeneSrc $ carriers likely manifest PIGD phenotype , may implications disease course .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5234588534329823)\n",
      "- Text: \"LRRK2 gene @ DiseaseTgt $ : mutation analysis case control association study . BACKGROUND : addition four well-confirmed genes linked early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( SNCA , PARKIN , DJ-1 , PINK1 ) , mutations @ GeneSrc $ gene ( LRRK2 ) recently identified families autosomal dominant late-onset @ DiseaseTgt $ . OBJECTIVE : perform mutation analysis LRRK2 probands families showing dominant inheritance @ DiseaseTgt $ conduct case control association study test hypothesis common coding variations might associated increased susceptibility @ DiseaseTgt $ . METHODS : 51 LRRK2 coding exons sequenced 23 probands mutation frequencies evaluated 180 neurologically normal control subjects . association study authors genotyped four coding LRRK2 polymorphisms 250 normal control subjects 121 patients @ DiseaseTgt $ ( predominantly white patients Canadian origin ) , 84 % age onset 50 years 42 % positive family history . RESULTS : authors identified three probands heterozygous LRRK2 mutations : two known G2019S substitution one proband novel I1371V substitution . Mutation analysis large family demonstrated complete segregation G2019S @ DiseaseTgt $ . However , association @ DiseaseTgt $ four polymorphisms allelic genotypic levels ( p > 0.17 ) . Furthermore , authors detect modifying effect genotype APOE genotypes upon age onset @ DiseaseTgt $ group ( p > 0.20 ) . CONCLUSIONS : results support prior suggestion LRRK2 mutations cause @ DiseaseTgt $ . disease families reported presents phenotype indistinguishable typical @ DiseaseTgt $ . three families demonstrate variable age onset explained APOE genotypes . common coding variations LRRK2 gene neither constitute strong @ DiseaseTgt $ risk factors modify age onset ; however , possibility modest risk effect remains assessed large datasets .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9672236752821496)\n",
      "- Text: \"Genome-wide association study reveals genetic risk underlying @ DiseaseTgt $ . performed genome-wide association study ( GWAS ) 1,713 individuals European ancestry @ DiseaseTgt $ ( @ DiseaseTgt $ ) 3,978 controls . replication 3,361 cases 4,573 controls , observed two strong association signals , one gene encoding alpha-synuclein ( SNCA ; rs2736990 , = 1.23 , P = 2.24 x 10 ( -16 ) ) another MAPT locus ( rs393152 , = 0.77 , P = 1.95 x 10 ( -16 ) ) . exchanged data colleagues performing GWAS Japanese @ DiseaseTgt $ cases . Association @ DiseaseTgt $ SNCA replicated Japanese GWAS , confirming major risk locus across populations . replicated effect new locus detected Japanese cohort ( PARK16 , rs823128 , = 0.66 , P = 7.29 x 10 ( -8 ) ) provide supporting evidence common variation around @ GeneSrc $ modulates risk @ DiseaseTgt $ ( rs1491923 , = 1.14 , P = 1.55 x 10 ( -5 ) ) . data demonstrate unequivocal role common genetic variants etiology typical @ DiseaseTgt $ suggest population-specific genetic heterogeneity disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0052787149594106)\n",
      "- Text: \"Roc domain @ GeneSrc $ sufficient interaction microtubules . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene leading cause genetically inherited @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although multidomain protein shown GTPase kinase activities Roc MAPKKK domains , respectively , protein-protein interactions pathways involved @ GeneSrc $ signaling remain elusive . Utilizing combination protein pull-down assays , mass spectrometry , Western blotting , immunofluorescence microscopy , study identifies describes interaction @ GeneSrc $ microtubules . Roc GTPase-like domain @ GeneSrc $ sufficient interaction alpha/beta-tubulin heterodimers . interaction occurs guanine nucleotide-independent manner , suggesting tubulin might effector @ GeneSrc $ GTPase domain . R1441C pathogenic mutation , located within Roc domain , retains interaction alpha/beta-tubulin heterodimers , suggesting disruption interaction likely mechanism whereby R1441C mutation leads disease . subcellular level , endogenous @ GeneSrc $ protein found colocalize alpha/beta-tubulin primary hippocampal neurons . findings significant link @ GeneSrc $ microtubules , structural component cell critically involved pathogenesis several neurodegenerative diseases , including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5721770691086331)\n",
      "- Text: \"@ GeneSrc $ G2019S mutation Ashkenazi Jews @ DiseaseTgt $ : gender effect ? BACKGROUND : Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene common genetic determinant @ DiseaseTgt $ ( @ DiseaseTgt $ ) identified date , implicated familial sporadic forms disease . G2019S change @ GeneSrc $ exon 41 associated disease varying frequencies Asian , European , North American , North African populations , particularly prevalent among Ashkenazi Jews . METHODS : assessed occurrence @ GeneSrc $ G2019S , I2012 , I2020 , R1441G/C/H mutations cohort Jewish Israeli patients @ DiseaseTgt $ , determined @ GeneSrc $ haplotypes 76 G2019S-carriers detected 50 noncarrier Ashkenazi patients , using six microsatellite markers span entire gene . RESULTS : G2019S mutation identified among patients @ DiseaseTgt $ , 14.8 % Ashkenazi 2.7 % non-Ashkenazi patients , 26 % 10.6 % Ashkenazi familial apparently sporadic cases . carrier frequencies Ashkenazi non-Ashkenazi control samples 2.4 % 0.4 % . common shared haplotype detected non-Ashkenazi half-Ashkenazi carriers full-Ashkenazi carriers tested , except two . Women patients positive family history @ DiseaseTgt $ significantly over-represented among G2019S mutation carriers . Age disease onset similar carriers noncarriers . CONCLUSIONS : data suggest @ GeneSrc $ G2019S mutation plays important role causality familial sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) Israel gender affects frequency among patients . Although testing symptomatic patients may help establish diagnosis @ DiseaseTgt $ , value screening asymptomatic individuals remains questionable penetrance age-dependent risk mutation accurately assessed , specific disease prevention modifying interventions become available .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9673073141967822)\n",
      "- Text: \"@ GeneSrc $ G2019S R1441 G mutations associated @ DiseaseTgt $ common Basque Country , relative prevalence determined ethnicity . Mutations @ GeneSrc $ gene frequent cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) described , prevalence varies populations . Patients , 418 , @ DiseaseTgt $ 138 unrelated controls Basque Country screened @ GeneSrc $ G2019S R1441 G mutations . patients , 3.82 % heterozygous carriers G2019S 13.15 % R1441 G . G2019S frequency higher non-Basque population ( 6.0 % ) , R1441 G common Basque origin population ( 22.4 % ) . conclusion G2019S R1441 G mutations ' frequency varies markedly Basque non-Basque origin population reinforcing importance ethnicity consideration establishing mutation prevalence .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0903622604941219)\n",
      "- Text: \"@ GeneSrc $ Arg1628Pro variant risk factor @ DiseaseTgt $ Chinese population . c. G4883C variant @ GeneSrc $ ( @ GeneSrc $ ) gene ( protein effect : Arg1628Pro ) recently proposed second risk factor sporadic @ DiseaseTgt $ Han Chinese population ( Gly2385Arg variant ) . paper , analyze Arg1628Pro variant associated haplotype large sample 1,337 Han subjects ( 834 patients 543 controls ) ascertained single referral center Taiwan . sample , Arg1628Pro allele frequent among patients ( 3.8 % ) among controls ( 1.8 % ; p = 0.004 , 2.13 , 95 % CI 1.29 - 3.52 ) . Sixty heterozygous two homozygous carriers Arg1628Pro variant identified among patients , one also carrier @ GeneSrc $ Gly2385Arg variant . also show carriers Arg1628Pro variant share common , extended haplotype , suggesting founder effect . @ DiseaseTgt $ onset age similar patients carried Arg1628Pro variant carry . data support contention Arg1628Pro variant second risk factor @ DiseaseTgt $ Han Chinese population . Adding estimated effects Arg1628Pro ( population attributable risk [ PAR ] approximately 4 % ) Gly2385Arg variants ( PAR approximately 6 % ) yields total PAR approximately 10 % .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1809237955642887)\n",
      "- Text: \"Comprehensive analysis @ GeneSrc $ publicly available @ DiseaseTgt $ cases neurologically normal controls . Mutation @ GeneSrc $ , encoding @ GeneSrc $ , common known genetic cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . large size gene relative ease common mutations screened means although 50 @ GeneSrc $ screening papers published , analyzed entire coding sequence . Furthermore , comprehensive sequence-based analysis performed control samples . , present sequencing coding exons series 275 @ DiseaseTgt $ cases 275 neurologically normal controls analysis @ GeneSrc $ locus whole gene multiplications deletions . also present case-control SNP association results using 74 SNPs genotyped across @ GeneSrc $ . identified six novel disease-associated missense mutations , including two altered residue protein . data analysis previously reported disease-segregating mutations shows majority disease-causing mutations lie C-terminal half protein .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8543683257115727)\n",
      "- Text: \"clinic-based study @ GeneSrc $ gene @ DiseaseTgt $ yields new mutations . Referral-based studies indicate mutation ( G2019S ) exon 41 @ GeneSrc $ gene might common cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . authors sequenced @ GeneSrc $ ( @ GeneSrc $ ) exons 31 , 35 , 41 371 consecutively recruited patients @ DiseaseTgt $ found mutations six ( 1.6 % ) subjects , including two heterozygous new putative pathogenic variants ( R1441H , IVS31 + 3A -- > G ) . data confirm important contribution @ GeneSrc $ @ DiseaseTgt $ susceptibility clinic-based population .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1694765773312855)\n",
      "- Text: \"Rare heterozygous parkin variants French early-onset @ DiseaseTgt $ patients controls . BACKGROUND : Mutations parkin gene cause autosomal recessive early-onset parkinsonism . effect single heterozygous mutations parkin still unclear . aim study evaluate frequency exonic parkin variants case-control study . METHODS : parkin gene screened point mutations exon rearrangements 172 French patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) 170 controls population . Patients single parkin variants also screened PINK1 , DJ-1 @ GeneSrc $ exon 41 mutations . RESULTS : 10 exonic sequence variations identified , including 3 known polymorphisms 7 rare heterozygous variants , 2 novel . significantly rare heterozygous variants patients ( n = 10 ) early-onset @ DiseaseTgt $ controls ( n = 2 ) . Screening PINK1 , DJ-1 @ GeneSrc $ exon 41 10 patients heterozygous parkin failed identify second causative mutation . CONCLUSION : results suggest single parkin mutations increase risk early-onset @ DiseaseTgt $ , possibility second parkin mutation excluded .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0614210637565475)\n",
      "- Text: \"LRRK2 exon 41 mutations sporadic @ DiseaseTgt $ Europeans . BACKGROUND : Mutations @ GeneSrc $ gene ( LRRK2 ) , particularly G2019S mutation exon 41 , detected familial sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases . OBJECTIVES : assess frequency LRRK2 exon 41 mutations series sporadic @ DiseaseTgt $ cases Europe determine clinical features LRRK2 mutation carriers . DESIGN : analyzed European cases sporadic @ DiseaseTgt $ presence LRRK2 exon 41 mutations . mutations screened denaturing high-performance liquid chromatography , abnormal chromatograph traces investigated direct sequencing determine exact nature variants . Early-onset sporadic @ DiseaseTgt $ cases also screened parkin mutations . haplotypes associated G2019S mutation determined . clinical characteristics patients carrying LRRK2 mutations detailed . SETTING : French Network Study @ DiseaseTgt $ Genetics . Patients Three hundred twenty patients apparently sporadic @ DiseaseTgt $ Europe . MAIN OUTCOME MEASURES : Results genetic analyses . RESULTS : found G2019S mutation 6 patients identified 2 new variants ( Y2006H T2031S ) 1 patient . clinical features similar typical @ DiseaseTgt $ . G2019S mutation carriers shared common haplotype . CONCLUSIONS : G2019S mutation almost frequent sporadic cases ( 1.9 % ) previously reported familial cases ( 2.9 % ) Europe occurs common founder . identified 2 novel variants . Although phenotype LRRK2 mutation carriers closely resembles typical @ DiseaseTgt $ , age onset younger ( 29 years 1 patient ) previously described , 3 patients improved deep brain stimulation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.08348772093)\n",
      "- Text: \"crucial role adipose tissue p53 regulation insulin resistance . Various stimuli , telomere dysfunction oxidative stress , induce irreversible cell growth arrest , termed ' cellular senescence ' . response controlled @ DiseaseTgt $ suppressor proteins p53 pRb . also evidence senescent cells promote changes related aging age-related diseases . show p53 expression adipose tissue crucially involved development insulin resistance , underlies age-related cardiovascular metabolic disorders . found excessive calorie intake led accumulation oxidative stress adipose tissue mice type 2 diabetes-like disease promoted senescence-like changes , increased activity senescence-associated @ GeneSrc $ , increased expression p53 increased production proinflammatory cytokines . Inhibition p53 activity adipose tissue markedly ameliorated senescence-like changes , decreased expression proinflammatory cytokines improved insulin resistance mice type 2 diabetes-like disease . Conversely , upregulation p53 adipose tissue caused inflammatory response led insulin resistance . Adipose tissue individuals diabetes also showed senescence-like features . results show previously unappreciated role adipose tissue p53 expression regulation insulin resistance suggest cellular aging signals adipose tissue could new target treatment diabetes ( pages 996 - 967 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.401966959300432e-07)\n",
      "- Text: \"BID regulation p53 contributes chemosensitivity . role p53 protein ( encoded TP53 ) @ DiseaseTgt $ suppression relies partly ability p53 regulate transcription genes important cell-cycle arrest apoptosis . apoptotic pathway mediated p53 fully understood . show BID , member pro-apoptotic Bcl-2 family proteins , regulated p53 . @ GeneSrc $ mRNA increased p53-dependent manner vitro vivo , strong expression splenic red pulp colonic epithelium gamma-irradiated mice . human mouse @ GeneSrc $ genomic loci contain p53-binding DNA response elements bind p53 mediate p53-dependent transactivation reporter gene . addition , @ GeneSrc $ mouse embryonic fibroblasts resistant wild-type fibroblasts DNA damaging agent adriamycin nucleotide analogue 5-fluorouracil , stabilize endogenous p53 . results indicate @ GeneSrc $ p53-responsive ' chemosensitivity gene ' may enhance cell death response chemotherapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017122115999755)\n",
      "- Text: \"Long-term haematopoietic reconstitution Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream @ GeneSrc $ - -p16Ink4a , p19Arf Trp53 ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype c-kit+Sca-1+Flt3+CD150-CD48-Lin- , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0524786633086529)\n",
      "- Text: \"Prevention @ GeneSrc $ mammary tumorigenesis mice progesterone antagonist . Women mutations breast cancer susceptibility gene BRCA1 predisposed breast ovarian cancers . BRCA1 protein suppresses @ DiseaseTgt $ development specifically ovarian hormone-sensitive tissues remains unclear . demonstrate mammary glands nulliparous @ GeneSrc $ mice accumulate lateral branches undergo extensive alveologenesis , phenotype occurs pregnancy wild-type mice . Progesterone receptors , estrogen receptors , overexpressed mutant mammary epithelial cells defect degradation proteasome pathway . Treatment @ GeneSrc $ mice progesterone antagonist mifepristone ( RU 486 ) prevented mammary tumorigenesis . findings reveal tissue-specific function @ GeneSrc $ protein raise possibility antiprogesterone treatment may useful breast cancer prevention individuals @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.682827760586492e-05)\n",
      "- Text: \"Fusion novel gene , BTL , ETV6 @ DiseaseTgt $ ( 4 ; 12 ) ( q11-q12 ; p13 ) . ETV6 gene ( also known TEL ) main target chromosomal translocations affecting chromosome band 12p13 . rearrangements fuse ETV6 wide variety partner genes myeloid lymphoid malignancies . report 4 new cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) immature myeloblasts ( French-American-British [ FAB ] -M0 ) ( 4 ; 12 ) ( q11-q12 ; p13 ) . cases , ETV6 found recombined new gene , homologous mouse @ GeneSrc $ gene . gene named BTL ( Brx-like Translocated Leukemia ) . Reverse transcriptase-polymerase chain reaction ( RT-PCR ) experiments indicate expression BTL-ETV6 transcript , reciprocal ETV6-BTL transcript , common finding leukemias . contrast majority ETV6 fusions , complete helix-loop-helix ( HLH ) ETS DNA binding domains ETV6 present predicted BTL-ETV6 fusion protein , chimeric gene transcribed BTL promoter .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0408890012568094)\n",
      "- Text: \"Colonic tumorigenesis @ GeneSrc $ compound mutant mice linked premature separation sister chromatids enhanced genomic instability . Faithful chromosome segregation essential maintenance genetic stability cell division least partly monitored spindle checkpoint , surveillance mechanism preventing cell prematurely entering anaphase . adenomatous polyposis coli ( Apc ) gene also plays important role regulating genomic stability , mutations Apc cause aneuploidy . show whereas Apc ( Min ) ( /+ ) mice developed many adenomatous polyps , mostly small intestine , 3 mo age ; @ GeneSrc $ ) compound mutant mice developed 10 times colonic tumors Apc ( Min ) ( /+ ) mice . colonic tumors @ GeneSrc $ ) mice higher grades observed Apc ( Min ) ( /+ ) mice . Consistently , @ GeneSrc $ ) murine embryonic fibroblasts ( MEFs ) contained beta-catenin proliferated faster rate WT @ GeneSrc $ ) MEFs . Moreover , @ GeneSrc $ ) MEFs slipped mitosis presence nocodazole exhibited higher rate genomic instability WT @ GeneSrc $ ) Apc ( Min ) ( /+ ) MEFs , accompanied premature separation sister chromatids . Together , studies suggest @ GeneSrc $ Apc functionally interact regulating metaphase-anaphase transition , deregulation may play key role genomic instability development progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022107174467222)\n",
      "- Text: \"Complement microglia mediate early synapse loss @ DiseaseTgt $ mouse models . Synapse loss @ DiseaseTgt $ ( @ DiseaseTgt $ ) correlates cognitive decline . Involvement microglia complement @ DiseaseTgt $ attributed neuroinflammation , prominent late disease . show mouse models complement microglia mediate synaptic loss early @ DiseaseTgt $ . @ GeneSrc $ , initiating protein classical complement cascade , increased associated synapses overt plaque deposition . Inhibition @ GeneSrc $ , C3 , microglial complement receptor CR3 reduces number phagocytic microglia , well extent early synapse loss . @ GeneSrc $ necessary toxic effects soluble beta-amyloid ( Abeta ) oligomers synapses hippocampal long-term potentiation . Finally , microglia adult brains engulf synaptic material CR3-dependent process exposed soluble Abeta oligomers . Together , findings suggest complement-dependent pathway microglia prune excess synapses development inappropriately activated mediate synapse loss @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2632684082972895)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors @ GeneSrc $ . Furthermore , loss presenilins causes reduced expression CBP CREB/CBP target genes , c-fos BDNF . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels Cdk5 activator p25 hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000128425774348)\n",
      "- Text: \"synthase 2 ( NOS2 ) deletion promotes multiple pathologies mouse model @ DiseaseTgt $ . @ DiseaseTgt $ characterized two primary pathological features : amyloid plaques neurofibrillary tangles . interconnection amyloid tau aggregates intense interest , mouse models yet reveal direct interrelationship . show may key factor connects amyloid tau pathologies . Genetic removal synthase 2 mice expressing mutated amyloid precursor protein results pathological hyperphosphorylation mouse tau , redistribution somatodendritic compartment cortical hippocampal neurons , aggregate formation . Lack synthase 2 amyloid precursor protein Swedish mutant mouse increased insoluble beta-amyloid peptide levels , neuronal degeneration , @ GeneSrc $ activation , tau cleavage , suggesting acts junction point beta-amyloid peptides , caspase activation , tau aggregation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004249236252384)\n",
      "- Text: \"Synphilin-1 attenuates neuronal degeneration A53 alpha-synuclein transgenic mouse model . Genetic alterations alpha-synuclein cause autosomal dominant familial Parkinsonism may contribute sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Synphilin-1 alpha-synuclein-interacting protein , implications @ DiseaseTgt $ pathogenesis related protein aggregation . Currently , vivo role synphilin-1 alpha-synuclein-linked pathogenesis fully understood . Using mouse prion protein promoter , generated synphilin-1 transgenic mice , display @ DiseaseTgt $ phenotypes . However , synphilin-1/A53 alpha-synuclein double-transgenic mice survived longer A53 alpha-synuclein single-transgenic mice . attenuated A53 alpha-synuclein-induced motor abnormalities decreased astroglial reaction neuronal degeneration brains double-transgenic mice . Overexpression synphilin-1 decreased @ GeneSrc $ activation , increased beclin-1 LC3 II expression promoted formation aggresome-like structures , suggesting synphilin-1 alters multiple cellular pathways protect neuronal degeneration . studies demonstrate synphilin-1 diminish severity alpha-synucleinopathy play neuroprotective role A53 alpha-synuclein toxicity vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.038323493352708e-05)\n",
      "- Text: \"Alpha-synuclein lowers p53-dependent apoptotic response neuronal cells . Abolishment 6-hydroxydopamine implication @ DiseaseTgt $ . examined influence alpha-synuclein responsiveness TSM1 neuronal cells apoptotic stimulus . show alpha-synuclein drastically lowers basal staurosporine-stimulated @ GeneSrc $ immunoreactivity activity . accompanied lower DNA fragmentation reduced number terminal deoxynucleotide transferase-mediated dUTP nick end labeling ( TUNEL ) -positive neurons . Interestingly , alpha-synuclein also diminishes p53 expression transcriptional activity . demonstrate antiapoptotic phenotype displayed alpha-synuclein fully reversed @ DiseaseTgt $ dopamine derivative 6-hydroxydopamine . Thus , 6-hydroxydopamine fully abolishes alpha-synuclein-mediated reduction @ GeneSrc $ activity reverses associated decrease p53 expression . 6-Hydroxydopamine triggers thioflavin T-positive deposits alpha-synuclein , mock-transfected TSM1 neurons , drastically increases alpha-synuclein immunoreactivity . Altogether , suggest alpha-synuclein lowers p53-dependent @ GeneSrc $ activation TSM1 response apoptotic stimuli propose natural toxin 6-hydroxydopamine abolishes antiapoptotic phenotype triggering alpha-synuclein aggregation , thereby likely contributing @ DiseaseTgt $ neuropathology .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0178155737294354)\n",
      "- Text: \"DCC gene product induces apoptosis mechanism requiring receptor proteolysis . development colonic carcinoma associated mutation specific set genes . One , DCC ( deleted @ DiseaseTgt $ ) , candidate tumour-suppressor gene , encodes receptor netrin-1 , molecule involved axon guidance . Loss DCC expression tumours restricted colon carcinoma , , although increase frequency tumour formation DCC hemizygous mice , reestablishment DCC expression suppresses tumorigenicity . However , mechanism action DCC unknown . show DCC induces apoptosis absence ligand binding , blocks apoptosis engaged netrin-1 . Furthermore , DCC caspase substrate , mutation site @ GeneSrc $ cleaves DCC suppresses pro-apoptotic effect DCC completely . results indicate DCC may function tumour-suppressor protein inducing apoptosis settings ligand unavailable ( example , metastasis tumour growth beyond local blood supply ) functional caspase cascades mechanism requires cleavage DCC Asp 1,290 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000111872066762)\n",
      "- Text: \"Dissecting p53 @ DiseaseTgt $ suppressor functions vivo . Although p53 @ DiseaseTgt $ suppressor acts plethora processes influence cellular proliferation survival , remains unclear p53 functions essential @ DiseaseTgt $ suppression , consequence , selected @ DiseaseTgt $ development . Using mouse model harboring primary , genetically modified myc-driven lymphomas , show disruption apoptosis downstream p53 Bcl2 dominant-negative @ GeneSrc $ confers-like p53 loss-a selective advantage , completely alleviates pressure inactivate p53 lymphomagenesis . Despite p53-null-like aggressive phenotype , apoptosis-defective lymphomas retain intact p53 genes display checkpoint defects gross aneuploidy characteristic p53 mutant @ DiseaseTgt $ . Therefore , apoptosis p53 function selected lymphoma development , whereas defective cell-cycle checkpoints aneuploidy mere byproducts p53 loss .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3472500237092702)\n",
      "- Text: \"Destabilization beta-catenin mutations presenilin-1 potentiates neuronal apoptosis . Mutations presenilin-1 gene major cause familial early-onset @ DiseaseTgt $ . Presenilin-1 associate members catenin family signalling proteins , significance association unknown . show presenilin-1 forms complex beta-catenin vivo increases beta-catenin stability . Pathogenic mutations presenilin-1 gene reduce ability presenilin-1 stabilize @ GeneSrc $ , lead increased degradation @ GeneSrc $ brains transgenic mice . Moreover , beta-catenin levels markedly reduced brains @ DiseaseTgt $ patients presenilin-1 mutations . Loss beta-catenin signalling increases neuronal vulnerability apoptosis induced amyloid-beta protein . Thus , mutations presenilin-1 may increase neuronal apoptosis altering stability beta-catenin , predisposing individuals early-onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.050198699181663)\n",
      "- Text: \"Loss presenilin 1 associated enhanced @ GeneSrc $ signaling skin tumorigenesis . Presenilin 1 ( PS1 ) required proteolytic processing Notch beta-amyloid precursor protein ( APP ) , molecules play pivotal roles cell-fate determination development @ DiseaseTgt $ pathogenesis , respectively . addition , PS1 interacts beta-catenin promotes turnover independent mechanisms . Consistent activity , report PS1 important controlling epidermal cell proliferation vivo . PS1 knockout mice rescued neuronal expression human PS1 transgene develop spontaneous skin cancers . PS1-null keratinocytes exhibit higher cytosolic @ GeneSrc $ @ GeneSrc $ enhancer factor-1/T cell factor @ GeneSrc $ signaling . effect reversed reintroducing wild-type PS1 , PS1 mutant active Notch processing defective beta-catenin binding . Nuclear beta-catenin protein detected tumors . Elevated @ GeneSrc $ signaling correlated activation downstream target cyclin D1 accelerated entry G ( 1 ) phase cell cycle . report demonstrates function PS1 adult tissues , analysis suggests deregulation beta-catenin pathway contributes skin tumor phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.224544218788152e-05)\n",
      "- Text: \"GSK-3alpha regulates production @ DiseaseTgt $ amyloid-beta peptides . @ DiseaseTgt $ associated increased production aggregation amyloid-beta ( Abeta ) peptides . Abeta peptides derived amyloid precursor protein ( APP ) sequential proteolysis , catalysed aspartyl protease BACE , followed presenilin-dependent gamma-secretase cleavage . Presenilin interacts nicastrin , APH-1 PEN-2 ( ref . 6 ) , required gamma-secretase function . Presenilins also interact alpha-catenin , @ GeneSrc $ glycogen synthase kinase-3beta ( GSK-3beta ) , functional role proteins gamma-secretase activity established . show therapeutic concentrations lithium , GSK-3 inhibitor , block production Abeta peptides interfering APP cleavage gamma-secretase step , inhibit Notch processing . Importantly , lithium also blocks accumulation Abeta peptides brains mice overproduce APP . target lithium setting GSK-3alpha , required maximal processing APP . Since GSK-3 also phosphorylates tau protein , principal component neurofibrillary tangles , inhibition GSK-3alpha offers new approach reduce formation amyloid plaques neurofibrillary tangles , two pathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039570561805457)\n",
      "- Text: \"Partial loss presenilins causes seborrheic keratosis autoimmune disease mice . Presenilin ( PS1 ) ( PS2 ) centers gamma-secretase release Abeta APP @ DiseaseTgt $ ( @ DiseaseTgt $ ) . cleave signaling proteins like Notch downregulate @ GeneSrc $ modulate Wnt signaling . Inactivation PS1 PS1 PS2 causes prenatally lethal ' Notch phenotype , ' hampered investigation PS function adulthood seriously . thus turned towards PS1+/-PS2-/- mice carry severe reduction PS alleles compatible survival , analyze consequences impaired PS function especially adulthood . ' partial deficient ' mice , PS1 protein concentration considerably lowered , functionally reflected reduced gamma-secretase activity impaired @ GeneSrc $ downregulation . phenotype normal approximately 6 months , majority mice develop autoimmune disease characterized dermatitis , glomerulonephritis , keratitis vasculitis , seen human systemic lupus erythematosus . Besides B-cell dominated infiltrates , observe hypergammaglobulinemia immune complex deposits several tissues , high-titer nuclear autoantibodies increased CD4+/CD8 + ratio . mice develop benign skin hyperplasia similar human seborrheic keratosis opposed malignant keratocarcinomata observed skin-specific PS1 ' full ' knockouts . partial reduction PS function PS1+/-PS2-/- mice causes novel phenotype adulthood unrelated developmental defects full knockouts . PS1+/-PS2+/- mice remain healthy , points towards sharply defined minimum PS function . Skin immune system appear especially sensitive targets impaired PS function may need careful monitoring gamma-secretase inhibitors envisaged treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7436696381189808)\n",
      "- Text: \"common human skin tumour caused activating mutations beta-catenin . WNT signalling orchestrates number developmental programs . response stimulus , cytoplasmic beta-catenin ( encoded CTNNB1 ) stabilized , enabling downstream transcriptional activation members LEF/TCF family . One target genes beta-catenin/TCF encodes c-MYC , explaining constitutive activation WNT pathway lead cancer , particularly colon . @ DiseaseTgt $ arise mutations gene encoding adenomatous polyposis coli ( APC ) , protein required ubiquitin-mediated degradation beta-catenin , small percentage colon cancers harbour beta-catenin-stabilizing mutations . Recently , discovered transgenic mice expressing activated @ GeneSrc $ predisposed developing skin tumours resembling pilomatricomas . Given skin adult mice also exhibits signs de novo hair-follicle morphogenesis , wondered whether human pilomatricomas might originate hair matrix cells whether might possess beta-catenin-stabilizing mutations . , explore cell origin aetiology common human skin tumour . found nuclear LEF-1 dividing tumour cells , providing biochemical evidence pilomatricomas derived hair matrix cells . least 75 % tumours possess mutations affecting amino-terminal segment , normally involved phosphorylation-dependent , ubiquitin-mediated degradation protein . percentage CTNNB1 mutations greater human tumours examined thus far , directly implicates beta-catenin/LEF misregulation major cause hair matrix cell tumorigenesis humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0023452125868689)\n",
      "- Text: \"@ GeneSrc $ TCF mediate cell positioning intestinal epithelium controlling expression EphB/ephrinB . small intestine , progeny stem cells migrate precise patterns . Absorptive , enteroendocrine , goblet cells migrate toward villus Paneth cells occupy bottom crypts . show @ GeneSrc $ TCF inversely control expression EphB2/EphB3 receptors ligand ephrin-B1 @ DiseaseTgt $ along crypt-villus axis . Disruption EphB2 EphB3 genes reveals gene products restrict cell intermingling allocate cell populations within intestinal epithelium . EphB2/EphB3 null mice , proliferative differentiated populations intermingle . adult EphB3 ( -/- ) mice , Paneth cells follow downward migratory path , scatter along crypt villus . conclude intestinal epithelium @ GeneSrc $ TCF couple proliferation differentiation sorting cell populations EphB/ephrin-B system .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.607991477616721e-05)\n",
      "- Text: \"Intestinal polyposis mice dominant stable mutation @ GeneSrc $ gene . Ectopic expression certain Wnt genes mouse mammary tissue tumorigenic , mutations stabilize beta-catenin found various human cancers including @ DiseaseTgt $ . determine role stabilized @ GeneSrc $ intestinal tumorigenesis mice , constructed embryonic stem ( ES ) cell-mediated homologous recombination , mutant @ GeneSrc $ allele whose exon 3 sandwiched loxP sequences . germline heterozygotes crossed mice expressing Cre recombinase intestines , serines threonine encoded exon 3 phosphorylated glycogen synthase kinase 3beta ( GSK3beta ) deleted offspring intestines , caused adenomatous intestinal polyps resembling Apc ( Delta716 ) knockout mice . nascent microadenomas also found colon . results present experimental genetic evidence activation Wnt signaling pathway cause intestinal colonic tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0590401783733336)\n",
      "- Text: \"Myeloid translocation gene family members associate T-cell factors ( TCFs ) influence TCF-dependent transcription . Canonical Wnt signaling mediated molecular `` switch `` regulates transcriptional properties T-cell factor ( TCF ) family DNA-binding proteins . Members myeloid translocation gene ( MTG ) family transcriptional corepressors frequently disrupted chromosomal translocations acute myeloid leukemia , whereas MTG16 may inactivated 40 % breast cancer MTG8 candidate cancer gene @ DiseaseTgt $ . Genetic studies imply corepressor family may function stem cells . Given mice lacking Myeloid Translocation Gene Related-1 ( Mtgr1 ) fail maintain secretory lineage small intestine , surveyed transcription factors might recruit Mtgr1 intestinal stem cells progenitor cells found MTG family members associate specifically TCF4 . Coexpression @ GeneSrc $ disrupted association corepressors TCF4 . Furthermore , expressed Xenopus embryos , MTG family members inhibited axis formation impaired ability beta-catenin XLef-1 induce axis duplication , indicating MTG family members act downstream @ GeneSrc $ . Moreover , found c-Myc , transcriptional target Wnt pathway , overexpressed small intestines mice lacking Mtgr1 , thus linking inactivation Mtgr1 activation potent oncogene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8819463522793511)\n",
      "- Text: \"Mutations APC tumour suppressor gene cause chromosomal instability . Two forms genetic instability described @ DiseaseTgt $ : microsatellite instability chromosomal instability . Microsatellite instability results mutations mismatch repair genes ; chromosomal instability hallmark many @ DiseaseTgt $ , although completely understood molecular level . truncations Adenomatous Polyposis Coli ( APC ) gene found @ DiseaseTgt $ , thought mutations APC might responsible chromosomal instability . test hypothesis , examined mouse embryonic stem ( ES ) cells homozygous Min ( multiple intestinal neoplasia ) Apc1638 alleles . show Apc mutant ES cells display extensive chromosome spindle aberrations , providing genetic evidence role APC chromosome segregation . Consistent , APC accumulates kinetochore mitosis . Apc mutant cells form mitotic spindles abundance microtubules inefficiently connect kinetochores . phenotype recapitulated induced expression 253-amino-acid carboxy-terminal fragment APC microsatellite unstable @ DiseaseTgt $ cells . conclude loss APC sequences lie C-terminal @ GeneSrc $ regulatory domain contributes chromosomal instability @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.019235212759042)\n",
      "- Text: \"Colonic tumorigenesis BubR1+/-ApcMin/+ compound mutant mice linked premature separation sister chromatids enhanced genomic instability . Faithful chromosome segregation essential maintenance genetic stability cell division least partly monitored spindle checkpoint , surveillance mechanism preventing cell prematurely entering anaphase . adenomatous polyposis coli ( Apc ) gene also plays important role regulating genomic stability , mutations Apc cause aneuploidy . show whereas Apc ( Min ) ( /+ ) mice developed many adenomatous polyps , mostly small intestine , 3 mo age ; BubR1 ( +/- ) Apc ( Min ) ( /+ ) compound mutant mice developed 10 times colonic tumors Apc ( Min ) ( /+ ) mice . colonic tumors BubR1 ( +/- ) Apc ( Min ) ( /+ ) mice higher grades observed Apc ( Min ) ( /+ ) mice . Consistently , BubR1 ( +/- ) Apc ( Min ) ( /+ ) murine embryonic fibroblasts ( MEFs ) contained @ GeneSrc $ proliferated faster rate WT BubR1 ( +/- ) MEFs . Moreover , BubR1 ( +/- ) Apc ( Min ) ( /+ ) MEFs slipped mitosis presence nocodazole exhibited higher rate genomic instability WT BubR1 ( +/- ) Apc ( Min ) ( /+ ) MEFs , accompanied premature separation sister chromatids . Together , studies suggest BubR1 Apc functionally interact regulating metaphase-anaphase transition , deregulation may play key role genomic instability development progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.55013812091506e-06)\n",
      "- Text: \"Myc deletion rescues Apc deficiency small intestine . APC gene encodes adenomatous polyposis coli tumour suppressor protein , germline mutation characterizes familial adenomatous polyposis ( FAP ) , autosomal intestinal cancer syndrome . Inactivation APC also recognized key early event development @ DiseaseTgt $ , loss results constitutive activity @ GeneSrc $ transcription complex . proto-oncogene c-MYC identified target Wnt pathway @ DiseaseTgt $ cells vitro , normal crypts vivo intestinal epithelial cells acutely transformed vivo deletion APC gene ; however , significance unclear . Therefore , elucidate role Myc intestine Apc loss , simultaneously deleted Apc Myc adult murine small intestine . show loss Myc rescued phenotypes perturbed differentiation , migration , proliferation apoptosis , occur deletion Apc . Remarkably , rescue occurred presence high levels nuclear @ GeneSrc $ . Array analysis revealed Myc required majority Wnt target gene activation following Apc loss . data establish Myc critical mediator early stages neoplasia following Apc loss .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0386657962136313)\n",
      "- Text: \"@ GeneSrc $ , expressed ( 12 ; 21 ) human acute lymphocytic leukemia , induces @ DiseaseTgt $ mice . TEL-AML1 expressed ( 12 ; 21 ) chromosomal translocation inB-precursor acute lymphocytic leukemia ( ) . Creation TEL-AML1fusion disrupts one copy TEL AML1 genes , loss TEL @ GeneSrc $ also associated cases @ DiseaseTgt $ without TEL-AML1 . determine whether @ GeneSrc $ contribute leukemogenesis , transduced marrow C57BL/6 mice retroviral vector expressing @ GeneSrc $ control vector . Transduced cells introduced irradiated syngeneic recipients . Two 9 @ GeneSrc $ mice developed ( one T-lineage one B-precursor ) , whereas 0 20 control mice developed leukemia . B-precursor retransplantable expressed @ GeneSrc $ . similarly transduced marrow C57BL/6 mice lacking overlapping p16 ( INK4a ) p19 ( ARF ) genes transplanted cells wild-type recipients . control mice died , six eight @ GeneSrc $ mice died leukemia . Overall , findings indicate @ GeneSrc $ contributes leukemogenesis may cooperate loss p16 ( INK4a ) p14 ( ARF ) transform lymphoid progenitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0176908508424255)\n",
      "- Text: \"Myeloid translocation gene family members associate T-cell factors ( TCFs ) influence TCF-dependent transcription . Canonical Wnt signaling mediated molecular `` switch `` regulates transcriptional properties T-cell factor ( TCF ) family DNA-binding proteins . Members myeloid translocation gene ( MTG ) family transcriptional corepressors frequently disrupted chromosomal translocations acute myeloid leukemia , whereas MTG16 may inactivated 40 % breast cancer @ GeneSrc $ candidate cancer gene @ DiseaseTgt $ . Genetic studies imply corepressor family may function stem cells . Given mice lacking Myeloid Translocation Gene Related-1 ( Mtgr1 ) fail maintain secretory lineage small intestine , surveyed transcription factors might recruit Mtgr1 intestinal stem cells progenitor cells found MTG family members associate specifically TCF4 . Coexpression beta-catenin disrupted association corepressors TCF4 . Furthermore , expressed Xenopus embryos , MTG family members inhibited axis formation impaired ability beta-catenin XLef-1 induce axis duplication , indicating MTG family members act downstream beta-catenin . Moreover , found c-Myc , transcriptional target Wnt pathway , overexpressed small intestines mice lacking Mtgr1 , thus linking inactivation Mtgr1 activation potent oncogene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000199104454459)\n",
      "- Text: \"Myeloid translocation gene family members associate T-cell factors ( TCFs ) influence TCF-dependent transcription . Canonical Wnt signaling mediated molecular `` switch `` regulates transcriptional properties T-cell factor ( TCF ) family DNA-binding proteins . Members myeloid translocation gene ( MTG ) family transcriptional corepressors frequently disrupted chromosomal translocations acute myeloid leukemia , whereas MTG16 may inactivated 40 % breast cancer MTG8 candidate cancer gene @ DiseaseTgt $ . Genetic studies imply corepressor family may function stem cells . Given mice lacking @ GeneSrc $ ( @ GeneSrc $ ) fail maintain secretory lineage small intestine , surveyed transcription factors might recruit @ GeneSrc $ intestinal stem cells progenitor cells found MTG family members associate specifically TCF4 . Coexpression beta-catenin disrupted association corepressors TCF4 . Furthermore , expressed Xenopus embryos , MTG family members inhibited axis formation impaired ability beta-catenin XLef-1 induce axis duplication , indicating MTG family members act downstream beta-catenin . Moreover , found c-Myc , transcriptional target Wnt pathway , overexpressed small intestines mice lacking @ GeneSrc $ , thus linking inactivation @ GeneSrc $ activation potent oncogene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0303838747409565)\n",
      "- Text: \"rare truncating mutation ADH1C ( G78Stop ) shows significant association @ DiseaseTgt $ large international sample . BACKGROUND : Alcohol dehydrogenases ( ADHs ) may involved pathogenesis neurodegenerative disorders multiple roles detoxification pathways retinoic acid synthesis . previous study , significant association @ GeneSrc $ class IV allele @ DiseaseTgt $ ( @ DiseaseTgt $ ) found Swedish sample . PATIENTS : previously associated single-nucleotide polymorphism plus 12 polymorphisms @ GeneSrc $ cluster human chromosome 4q23 screened association extension original sample included 123 Swedish @ DiseaseTgt $ patients 127 geographically matched control subjects . rare nonsense single-nucleotide polymorphism ADH1C ( G78stop , rs283413 ) identified 3 patients controls . obtain sufficient power detect possible association rare variant disease , screened large international sample 1076 @ DiseaseTgt $ patients European ancestry 940 matched controls . RESULTS : previously identified association @ GeneSrc $ class IV allele remained significant ( P < .02 ) extended Swedish study . Furthermore , international collaboration , G78stop mutation ADH1C found 22 ( 2.0 % ) @ DiseaseTgt $ patients 6 controls ( 0.6 % ) . association statistically significant ( chi ( 2 ) ( 1 ) = 7.5 ; 2-sided P = .007 ; odds ratio , 3.25 [ 95 % confidence interval , 1.31 - 8.05 ] ) . addition , G78stop mutation identified 4 ( 10.0 % ) 40 Caucasian index cases @ DiseaseTgt $ mainly hereditary forms disorder . CONCLUSION : Findings presented herein provide evidence mutations genes encoding ADHs genetic risk factors @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0342057232545112)\n",
      "- Text: \"Cell-cycle-regulated activation Akt kinase phosphorylation carboxyl terminus . Akt , also known protein kinase B , plays key roles cell proliferation , survival metabolism . Akt hyperactivation contributes many pathophysiological conditions , including human @ DiseaseTgt $ , closely associated poor prognosis chemo- radiotherapeutic resistance . Phosphorylation Akt S473 ( ref . 5 ) T308 ( ref . 6 ) activates Akt . However , remains unclear whether mechanisms account full Akt activation , whether Akt hyperactivation linked misregulated cell cycle progression , another @ DiseaseTgt $ hallmark . report Akt activity fluctuates across cell cycle , mirroring cyclin expression . Mechanistically , phosphorylation S477 T479 Akt extreme carboxy terminus cyclin-dependent kinase 2 @ GeneSrc $ mTORC2 , distinct physiological conditions , promotes Akt activation facilitating , functionally compensating , S473 phosphorylation . Furthermore , deletion @ GeneSrc $ allele mouse olfactory bulb leads reduced S477/T479 phosphorylation elevated cellular apoptosis . Notably , @ GeneSrc $ cellular apoptosis mouse embryonic stem cells partly rescued S477D/T479E-Akt1 , supporting physiological role @ GeneSrc $ governing Akt activation . Together , results study show Akt S477/T479 phosphorylation essential layer Akt activation mechanism regulate physiological functions , thereby providing new mechanistic link aberrant cell cycle progression Akt hyperactivation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0606841381155701)\n",
      "- Text: \"Loss presenilin 1 associated enhanced beta-catenin signaling skin tumorigenesis . Presenilin 1 ( PS1 ) required proteolytic processing Notch beta-amyloid precursor protein ( APP ) , molecules play pivotal roles cell-fate determination development @ DiseaseTgt $ pathogenesis , respectively . addition , PS1 interacts beta-catenin promotes turnover independent mechanisms . Consistent activity , report PS1 important controlling epidermal cell proliferation vivo . PS1 knockout mice rescued neuronal expression human PS1 transgene develop spontaneous skin cancers . PS1-null keratinocytes exhibit higher cytosolic beta-catenin beta-catenin/lymphoid enhancer factor-1/T cell factor ( beta-catenin/LEF ) -mediated signaling . effect reversed reintroducing wild-type PS1 , PS1 mutant active Notch processing defective beta-catenin binding . Nuclear beta-catenin protein detected tumors . Elevated beta-catenin/LEF signaling correlated activation downstream target @ GeneSrc $ accelerated entry G ( 1 ) phase cell cycle . report demonstrates function PS1 adult tissues , analysis suggests deregulation beta-catenin pathway contributes skin tumor phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.7466094803970774e-07)\n",
      "- Text: \"Partial loss presenilins causes seborrheic keratosis autoimmune disease mice . Presenilin ( PS1 ) ( PS2 ) centers gamma-secretase release Abeta APP @ DiseaseTgt $ ( @ DiseaseTgt $ ) . cleave signaling proteins like Notch downregulate beta-catenin modulate Wnt signaling . Inactivation PS1 PS1 PS2 causes prenatally lethal ' Notch phenotype , ' hampered investigation PS function adulthood seriously . thus turned towards PS1+/-PS2-/- mice carry severe reduction PS alleles compatible survival , analyze consequences impaired PS function especially adulthood . ' partial deficient ' mice , PS1 protein concentration considerably lowered , functionally reflected reduced gamma-secretase activity impaired beta-catenin downregulation . phenotype normal approximately 6 months , majority mice develop autoimmune disease characterized dermatitis , glomerulonephritis , keratitis vasculitis , seen human systemic lupus erythematosus . Besides B-cell dominated infiltrates , observe hypergammaglobulinemia immune complex deposits several tissues , high-titer nuclear autoantibodies increased @ GeneSrc $ + ratio . mice develop benign skin hyperplasia similar human seborrheic keratosis opposed malignant keratocarcinomata observed skin-specific PS1 ' full ' knockouts . partial reduction PS function PS1+/-PS2-/- mice causes novel phenotype adulthood unrelated developmental defects full knockouts . PS1+/-PS2+/- mice remain healthy , points towards sharply defined minimum PS function . Skin immune system appear especially sensitive targets impaired PS function may need careful monitoring gamma-secretase inhibitors envisaged treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0171786153360314)\n",
      "- Text: \"Long-term haematopoietic reconstitution Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - -p16Ink4a , p19Arf Trp53 ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype @ GeneSrc $ , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045806168844222)\n",
      "- Text: \"Subcellular localization APC protein : immunoelectron microscopic study association APC protein catenin . Mutations APC gene linked development sporadic @ DiseaseTgt $ well familial adenomatous polyposis . Recently , APC protein reported associated catenins , proteins bind cell adhesion molecule @ GeneSrc $ . present study , examined distribution localization APC protein alpha -catenin normal mouse intestine light immunoelectron microscopy using specific antibodies . APC protein found localized microvilli apical lateral cytoplasm epithelial cells , whereas alpha-catenin detected lateral cytoplasm . Double-labeling immunoelectron microscopy showed colocalization APC protein alpha-catenin lateral cytoplasm , especially along lateral plasma membrane , although certain portion APC protein region distributed independently alpha-catenin . results suggest portion APC protein localized lateral cytoplasm intestinal epithelial cells functions cooperation catenins , whereas APC protein microvilli apical cytoplasm functions independent catenins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.4969892105634413e-06)\n",
      "- Text: \"Cell-cycle-regulated activation Akt kinase phosphorylation carboxyl terminus . Akt , also known protein kinase B , plays key roles cell proliferation , survival metabolism . Akt hyperactivation contributes many pathophysiological conditions , including human @ DiseaseTgt $ , closely associated poor prognosis chemo- radiotherapeutic resistance . Phosphorylation Akt S473 ( ref . 5 ) T308 ( ref . 6 ) activates Akt . However , remains unclear whether mechanisms account full Akt activation , whether Akt hyperactivation linked misregulated cell cycle progression , another @ DiseaseTgt $ hallmark . report Akt activity fluctuates across cell cycle , mirroring cyclin expression . Mechanistically , phosphorylation S477 T479 Akt extreme carboxy terminus @ GeneSrc $ @ GeneSrc $ mTORC2 , distinct physiological conditions , promotes Akt activation facilitating , functionally compensating , S473 phosphorylation . Furthermore , deletion cyclin A2 allele mouse olfactory bulb leads reduced S477/T479 phosphorylation elevated cellular apoptosis . Notably , cyclin A2-deletion-induced cellular apoptosis mouse embryonic stem cells partly rescued S477D/T479E-Akt1 , supporting physiological role cyclin A2 governing Akt activation . Together , results study show Akt S477/T479 phosphorylation essential layer Akt activation mechanism regulate physiological functions , thereby providing new mechanistic link aberrant cell cycle progression Akt hyperactivation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001411584719001)\n",
      "- Text: \"Dietary salt promotes cognitive impairment tau phosphorylation . Dietary habits vascular risk factors promote @ DiseaseTgt $ cognitive impairment caused vascular factors1 - 3 . Furthermore , accumulation hyperphosphorylated tau , microtubule-associated protein hallmark @ DiseaseTgt $ , also linked vascular cognitive impairment5,6 . mice , salt-rich diet leads cognitive dysfunction associated nitric oxide deficit cerebral endothelial cells cerebral hypoperfusion7 . report dietary salt induces hyperphosphorylation tau followed cognitive dysfunction mice , effects prevented restoring endothelial nitric oxide production . nitric oxide deficiency reduces neuronal calpain nitrosylation results enzyme activation , , turn , leads tau phosphorylation activating @ GeneSrc $ . Salt-induced cognitive impairment observed tau-null mice mice treated anti-tau antibodies , despite persistent cerebral hypoperfusion neurovascular dysfunction . findings identify causal link dietary salt , endothelial dysfunction tau pathology , independent haemodynamic insufficiency . Avoidance excessive salt intake maintenance vascular health may help stave vascular neurodegenerative pathologies underlie dementia elderly .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.720237485355832e-07)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors alphaCaMKII . Furthermore , loss presenilins causes reduced expression CBP CREB/CBP target genes , c-fos BDNF . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels @ GeneSrc $ activator p25 hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.7032144137665e-07)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors alphaCaMKII . Furthermore , loss presenilins causes reduced expression CBP CREB/CBP target genes , c-fos BDNF . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels Cdk5 activator @ GeneSrc $ hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.5745544243813915e-05)\n",
      "- Text: \"p53 deletion impairs clearance chromosomal-instable stem cells aging telomere-dysfunctional mice . Telomere dysfunction limits proliferative capacity human cells induces organismal aging activation p53 p21 . Although deletion @ GeneSrc $ elongates lifespan telomere-dysfunctional mice , direct analysis p53 telomere-related aging hampered early @ DiseaseTgt $ formation p53 knockout mice . analyzed functional consequences conditional p53 deletion . Intestinal deletion p53 shortened lifespan telomere-dysfunctional mice without inducing @ DiseaseTgt $ formation . contrast @ GeneSrc $ deletion , deletion p53 impaired depletion chromosomal-instable intestinal stem cells aging telomere-dysfunctional mice . instable stem cells contributed epithelial regeneration leading accumulation chromosomal instability , increased apoptosis , altered epithelial cell differentiation premature intestinal failure . Together , results provide first experimental evidence organ system p53-dependent mechanisms prevent tissue destruction response telomere dysfunction depleting genetically instable stem cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9511583604258214)\n",
      "- Text: \"@ DiseaseTgt $ chemoprevention antioxidant tempol acts partially via p53 @ DiseaseTgt $ suppressor . previously demonstrated nitroxide antioxidant tempol ( 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl ) increased latency tumorigenesis doubled ( 100 % ) lifespan Atm-deficient mice , mouse model ataxia telangiectasia , displays accelerated oxidative damage stress . Tempol treatment @ DiseaseTgt $ p53-deficient mice resulted small significant ( 25 % ) increase lifespan prolonging latency tumorigenesis , demonstrating existing oxidative stress damage necessary chemopreventative effects tempol . However , relatively small effect latency p53-deficient mice finding tempol-mediated resistance oxidative insult p53-dependent suggested direct role p53 chemopreventative effects tempol . Surprisingly , tempol treatment specifically increased serine 18 phosphorylation p53 ( gamma-H2AX ) @ GeneSrc $ expression primary thymocytes vitro p53-dependent fashion . Inhibition phosphoinositide 3-kinase ( PI3 K ) family members suggested SMG-1 responsible tempol-mediated enhancement p53 serine 18 phosphorylation . data suggest chemopreventative effect tempol solely due reduction oxidative stress damage may also related redox-mediated signaling functions include p53 pathway activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001642299832504)\n",
      "- Text: \"C terminus p53 regulates gene expression multiple mechanisms target- tissue-specific manner vivo . p53 @ DiseaseTgt $ suppressor transcription factor mediates varied cellular responses . C terminus p53 subjected multiple diverse post-translational modifications . attractive hypothesis differing sets combinatorial modifications therein determine distinct cellular outcomes . address vivo , Trp53 ( DeltaCTD/DeltaCTD ) mouse generated endogenous p53 targeted replaced truncated mutant lacking C-terminal 24 amino acids . Trp53 ( DeltaCTD/DeltaCTD ) mice die within 2 wk post-partum hematopoietic failure impaired cerebellar development . Intriguingly , C terminus acts via three distinct mechanisms control p53-dependent gene expression depending tissue . First , bone marrow thymus , C terminus dampens p53 activity . Increased senescence Trp53 ( DeltaCTD/DeltaCTD ) bone marrow accompanied up-regulation @ GeneSrc $ ( @ GeneSrc $ ) . thymus , C-terminal domain negatively regulates p53-dependent gene expression inhibiting promoter occupancy . , hyperactive p53 ( DeltaCTD ) induces apoptosis via enhanced expression proapoptotic Bbc3 ( Puma ) Pmaip1 ( Noxa ) . liver , second mechanism prevails , since p53 ( DeltaCTD ) wild-type DNA binding impaired gene expression . Thus , C terminus p53 needed liver cells step subsequent DNA binding . Finally , spleen , C terminus controls p53 protein levels , overexpressed p53 ( DeltaCTD ) showing hyperactivity gene expression . Thus , C terminus p53 regulates gene expression via multiple mechanisms depending tissue target , leads specific phenotypic effects vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.865377258227455e-07)\n",
      "- Text: \"Linking p53 @ DiseaseTgt $ suppressor pathway somatic cell reprogramming . Reprogramming somatic cells induced pluripotent stem ( iPS ) cells accomplished expressing pluripotency factors oncogenes , low frequency tendency induce malignant transformation compromise clinical utility powerful approach . address issues investigating mechanisms limiting reprogramming efficiency somatic cells . show reprogramming factors activate p53 ( also known Trp53 mice , TP53 humans ) pathway . Reducing signalling p53 expressing mutated version one negative regulators , deleting knocking p53 target gene , @ GeneSrc $ ( also known @ GeneSrc $ ) , antagonizing reprogramming-induced apoptosis mouse fibroblasts increases reprogramming efficiency . Notably , decreasing p53 protein levels enabled fibroblasts give rise iPS cells capable generating germline-transmitting chimaeric mice using Oct4 ( also known Pou5f1 ) Sox2 . Furthermore , silencing p53 significantly increased reprogramming efficiency human somatic cells . results provide insights reprogramming mechanisms suggest new routes efficient reprogramming minimizing use oncogenes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.041130856887512e-05)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) @ GeneSrc $ ( encoded @ GeneSrc $ ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002291670797377)\n",
      "- Text: \"Atg7 modulates p53 activity regulate cell cycle survival metabolic stress . Withdrawal nutrients triggers exit cell division cycle , induction autophagy , eventually activation cell death pathways . relation , , among events well characterized . found starved mouse embryonic fibroblasts lacking essential autophagy gene product Atg7 failed undergo cell cycle arrest . Independent E1-like enzymatic activity , Atg7 could bind @ DiseaseTgt $ suppressor p53 regulate transcription gene encoding cell cycle inhibitor @ GeneSrc $ ) . prolonged metabolic stress , absence Atg7 resulted augmented DNA damage increased p53-dependent apoptosis . Inhibition DNA damage response deletion protein kinase Chk2 partially rescued postnatal lethality Atg7 ( -/- ) mice . Thus , nutrients limited , Atg7 regulates p53-dependent cell cycle cell death pathways .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7584255607944835)\n",
      "- Text: \"Long-term haematopoietic reconstitution @ GeneSrc $ multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - @ GeneSrc $ , @ GeneSrc $ Trp53 ( triple mutant mice ; @ GeneSrc $ @ GeneSrc $ alternative reading frames gene ( also called @ GeneSrc $ ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype c-kit+Sca-1+Flt3+CD150-CD48-Lin- , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate @ GeneSrc $ Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.002739339232476)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises @ GeneSrc $ genes encoding three potent @ DiseaseTgt $ suppressors , namely @ GeneSrc $ ) , p19 ( Arf ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather @ GeneSrc $ , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.384794768462364e-06)\n",
      "- Text: \"Delayed ageing damage protection Arf/p53 pathway . @ DiseaseTgt $ pathway formed alternative reading frame protein @ GeneSrc $ locus ( Arf ) p53 ( also called Trp53 ) plays central part detection elimination cellular damage , constitutes basis potent @ DiseaseTgt $ protection activity . Similar @ DiseaseTgt $ , ageing also results accumulation damage , therefore , reasoned Arf/p53 could anti-ageing activity alleviating load age-associated damage . show genetically manipulated mice increased , otherwise normally regulated , levels Arf p53 present strong @ DiseaseTgt $ resistance decreased levels ageing-associated damage . observations extend protective role Arf/p53 ageing , revealing previously unknown anti-ageing mechanism providing rationale co-evolution @ DiseaseTgt $ resistance longevity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.940444082625874)\n",
      "- Text: \"senescence program controlled p53 @ GeneSrc $ contributes outcome @ DiseaseTgt $ therapy . p53 @ GeneSrc $ mutations promote tumorigenesis drug resistance , part , disabling apoptosis . show primary murine lymphomas also respond chemotherapy engaging senescence program controlled p53 @ GeneSrc $ ) . Hence , @ DiseaseTgt $ p53 @ GeneSrc $ mutations-but lacking ARF alone-respond poorly cyclophosphamide therapy vivo . Moreover , @ DiseaseTgt $ harboring Bcl2-mediated apoptotic block undergo drug-induced cytostasis involving accumulation p53 , @ GeneSrc $ ) , senescence markers , typically acquire p53 @ GeneSrc $ mutations upon progression terminal stage . Finally , mice bearing @ DiseaseTgt $ capable drug-induced senescence much better prognosis following chemotherapy harboring @ DiseaseTgt $ senescence defects . Therefore , cellular senescence contributes treatment outcome vivo .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9948633759341476)\n",
      "- Text: \"inherent instability mutant p53 alleviated Mdm2 @ GeneSrc $ loss . p53 tumor suppressor often disrupted human @ DiseaseTgt $ acquisition missense mutations . generated mice missense mutation codon 172 mimics p53R175H hot spot mutation human @ DiseaseTgt $ . p53 homozygous mutant mice unstable mutant p53 normal cells stabilize mutant p53 @ DiseaseTgt $ . investigate significance data , examined regulation mutant p53 stability Mdm2 , E3 ubiquitin ligase targets p53 degradation , @ GeneSrc $ , member Rb tumor suppressor pathway . Mice lacking Mdm2 @ GeneSrc $ stabilized mutant p53 , revealed earlier age @ DiseaseTgt $ onset p53 mutant mice gain-of-function metastatic phenotype . Analysis @ DiseaseTgt $ p53 homozygous mutant mice stable p53 revealed defects Rb pathway . Additionally , ionizing radiation stabilizes wild-type mutant p53 . Thus , stabilization mutant p53 given prerequisite gain-of-function phenotype . Since mutant p53 stability mimics wild-type p53 , data indicate drugs aimed activating wild-type p53 also stabilize mutant p53 dire consequences .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.90927899777299)\n",
      "- Text: \"Inactivation Wip1 phosphatase inhibits mammary tumorigenesis p38 MAPK-mediated activation @ GeneSrc $ ) pathway . Modulation @ DiseaseTgt $ suppressor activities may provide new opportunities @ DiseaseTgt $ therapy . show disruption gene Ppm1d encoding Wip1 phosphatase activated p53 @ GeneSrc $ ( also called @ GeneSrc $ ( also called ARF ) pathways p38 MAPK signaling suppressed vitro transformation mouse embryo fibroblasts ( MEFs ) oncogenes . Disruption gene @ GeneSrc $ ( encoding @ GeneSrc $ p19 ) , Trp53 ( encoding p53 ) , reconstituted cell transformation Ppm1d-null MEFs . vivo , deletion Ppm1d mice bearing mouse mammary tumor virus ( MMTV ) promoter-driven oncogenes Erbb2 ( also called c-neu ) Hras1 impaired mammary carcinogenesis , whereas reduced expression @ GeneSrc $ p19 methylation-induced silencing inactivation p38 MAPK correlated @ DiseaseTgt $ appearance . conclude inactivation depletion Wip1 phosphatase resultant p38 MAPK activation suppresses @ DiseaseTgt $ appearance modulating @ GeneSrc $ @ DiseaseTgt $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2664471788321658)\n",
      "- Text: \"TEL-AML1 , expressed ( 12 ; 21 ) human acute lymphocytic leukemia , induces @ DiseaseTgt $ mice . TEL-AML1 expressed ( 12 ; 21 ) chromosomal translocation inB-precursor acute lymphocytic leukemia ( ) . Creation TEL-AML1fusion disrupts one copy TEL AML1 genes , loss TEL AML1 also associated cases @ DiseaseTgt $ without TEL-AML1 . determine whether TEL-AML1 contribute leukemogenesis , transduced marrow C57BL/6 mice retroviral vector expressing TEL-AML1 control vector . Transduced cells introduced irradiated syngeneic recipients . Two 9 TEL-AML1 mice developed ( one T-lineage one B-precursor ) , whereas 0 20 control mice developed leukemia . B-precursor retransplantable expressed TEL-AML1 . similarly transduced marrow C57BL/6 mice lacking overlapping @ GeneSrc $ ) genes transplanted cells wild-type recipients . control mice died , six eight TEL-AML1/p16p19 mice died leukemia . Overall , findings indicate TEL-AML1 contributes leukemogenesis may cooperate loss @ GeneSrc $ ) transform lymphoid progenitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.8135612623372165e-05)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises @ GeneSrc $ genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) @ GeneSrc $ ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.8574242797876124e-06)\n",
      "- Text: \"Inactivation Wip1 phosphatase inhibits mammary tumorigenesis p38 MAPK-mediated activation @ GeneSrc $ ) pathway . Modulation @ DiseaseTgt $ suppressor activities may provide new opportunities @ DiseaseTgt $ therapy . show disruption gene Ppm1d encoding Wip1 phosphatase activated p53 p16 ( also called @ GeneSrc $ ( also called ARF ) pathways p38 MAPK signaling suppressed vitro transformation mouse embryo fibroblasts ( MEFs ) oncogenes . Disruption gene Cdkn2a ( encoding p16 @ GeneSrc $ ) , Trp53 ( encoding p53 ) , reconstituted cell transformation Ppm1d-null MEFs . vivo , deletion Ppm1d mice bearing mouse mammary tumor virus ( MMTV ) promoter-driven oncogenes Erbb2 ( also called c-neu ) Hras1 impaired mammary carcinogenesis , whereas reduced expression p16 @ GeneSrc $ methylation-induced silencing inactivation p38 MAPK correlated @ DiseaseTgt $ appearance . conclude inactivation depletion Wip1 phosphatase resultant p38 MAPK activation suppresses @ DiseaseTgt $ appearance modulating Cdkn2a @ DiseaseTgt $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1082796758896779)\n",
      "- Text: \"TEL-AML1 , expressed ( 12 ; 21 ) human acute lymphocytic leukemia , induces @ DiseaseTgt $ mice . TEL-AML1 expressed ( 12 ; 21 ) chromosomal translocation inB-precursor acute lymphocytic leukemia ( ) . Creation TEL-AML1fusion disrupts one copy TEL AML1 genes , loss TEL AML1 also associated cases @ DiseaseTgt $ without TEL-AML1 . determine whether TEL-AML1 contribute leukemogenesis , transduced marrow C57BL/6 mice retroviral vector expressing TEL-AML1 control vector . Transduced cells introduced irradiated syngeneic recipients . Two 9 TEL-AML1 mice developed ( one T-lineage one B-precursor ) , whereas 0 20 control mice developed leukemia . B-precursor retransplantable expressed TEL-AML1 . similarly transduced marrow C57BL/6 mice lacking overlapping @ GeneSrc $ ) genes transplanted cells wild-type recipients . control mice died , six eight TEL-AML1/p16p19 mice died leukemia . Overall , findings indicate TEL-AML1 contributes leukemogenesis may cooperate loss p16 ( INK4a ) p14 ( ARF ) transform lymphoid progenitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.069223113767245e-06)\n",
      "- Text: \"Colonic polyposis caused mTOR-mediated chromosomal instability Apc+/Delta716 @ GeneSrc $ compound mutant mice . mammalian homeobox transcription factor CDX2 key roles intestinal development differentiation . Heterozygous @ GeneSrc $ mice develop one two benign hamartomas proximal colon , whereas heterozygous Apc ( Delta716 ) mice develop numerous adenomatous polyps , mostly small intestine . show colonic polyp number six times higher Apc+/Delta716 @ GeneSrc $ compound mutant mice . Levels APC @ GeneSrc $ significantly lower distal colon , caused high anaphase bridge index ( ABI ) associated higher frequency loss heterozygosity ( LOH ) Apc . cultured rat intestinal epithelial human @ DiseaseTgt $ cell lines , suppression CDX2 antisense RNA caused marked increases ABI chromosomal aberrations . mediated stimulation mTOR pathway , causing translational deregulation G1-S acceleration , associated low levels p27 activation cyclin E-Cdk2 . obtained similar results colonic mucosa Apc+/Delta716 ) @ GeneSrc $ compound mutant mice . Forced activation mTOR upstream regulator Akt also increased ABI @ DiseaseTgt $ cells . High ABI cell lines suppressed mTOR inhibitors LY294002 rapamycin . results suggest reduced expression @ GeneSrc $ important colon tumorigenesis mTOR-mediated chromosomal instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0211707632679115)\n",
      "- Text: \"rare truncating mutation @ GeneSrc $ ( G78Stop ) shows significant association @ DiseaseTgt $ large international sample . BACKGROUND : Alcohol dehydrogenases ( ADHs ) may involved pathogenesis neurodegenerative disorders multiple roles detoxification pathways retinoic acid synthesis . previous study , significant association ADH class IV allele @ DiseaseTgt $ ( @ DiseaseTgt $ ) found Swedish sample . PATIENTS : previously associated single-nucleotide polymorphism plus 12 polymorphisms ADH cluster human chromosome 4q23 screened association extension original sample included 123 Swedish @ DiseaseTgt $ patients 127 geographically matched control subjects . rare nonsense single-nucleotide polymorphism @ GeneSrc $ ( G78stop , rs283413 ) identified 3 patients controls . obtain sufficient power detect possible association rare variant disease , screened large international sample 1076 @ DiseaseTgt $ patients European ancestry 940 matched controls . RESULTS : previously identified association ADH class IV allele remained significant ( P < .02 ) extended Swedish study . Furthermore , international collaboration , G78stop mutation @ GeneSrc $ found 22 ( 2.0 % ) @ DiseaseTgt $ patients 6 controls ( 0.6 % ) . association statistically significant ( chi ( 2 ) ( 1 ) = 7.5 ; 2-sided P = .007 ; odds ratio , 3.25 [ 95 % confidence interval , 1.31 - 8.05 ] ) . addition , G78stop mutation identified 4 ( 10.0 % ) 40 Caucasian index cases @ DiseaseTgt $ mainly hereditary forms disorder . CONCLUSION : Findings presented herein provide evidence mutations genes encoding ADHs genetic risk factors @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.050737173934883)\n",
      "- Text: \"Dominant-negative mutations CEBPA , encoding CCAAT/enhancer binding protein-alpha ( C/EBPalpha ) , @ DiseaseTgt $ . transcription factor C/EBPalpha ( CCAAT/enhancer binding protein-alpha ; encoded gene CEBPA ) crucial differentiation granulocytes . Conditional expression C/EBPalpha triggers neutrophilic differentiation , mature granulocytes observed @ GeneSrc $ mice . identify heterozygous mutations CEBPA ten patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) . found five mutations amino terminus truncate full-length protein , affect 30-kD protein initiated downstream . mutant proteins block wild-type C/EBPalpha DNA binding transactivation granulocyte target genes dominant-negative manner , fails induce granulocytic differentiation . first report CEBPA mutations human neoplasia , mutations likely induce differentiation block found @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0244250129744314)\n",
      "- Text: \"AML1-ETO downregulates granulocytic differentiation factor C/EBPalpha ( 8 ; 21 ) myeloid leukemia . transcription factor CCAAT/enhancer binding protein alpha , C/EBPalpha , encoded CEBPA gene , crucial differentiation granulocytes . Conditional expression @ GeneSrc $ triggers neutrophilic differentiation , @ GeneSrc $ knockout mice exhibit early block maturation . Dominant-negative mutations CEBPA found patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) , @ DiseaseTgt $ ( 8 ; 21 ) translocation gives rise fusion gene RUNX1-CBF2T1 ( also known AML1-ETO ) encoding AML1-ETO fusion protein . RUNX1-CBF2T1 @ DiseaseTgt $ blasts eight-fold lower CEBPA RNA levels undetectable C/EBPalpha protein levels compared subgroups @ DiseaseTgt $ patients . Conditional expression RUNX1-CBF2T1 U937 cells downregulated CEBPA mRNA , protein DNA binding activity . AML1-ETO appears suppress C/EBPalpha expression indirectly inhibiting positive autoregulation CEBPA promoter . Conditional expression C/EBPalpha AML1-ETO-positive Kasumi-1 cells results neutrophilic differentiation . suggest restoring C/EBPalpha expression therapeutic implications RUNX1-CBF2T1-positive leukemias .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5)\n",
      "- Text: \"Chemoprevention @ DiseaseTgt $ targeting APC-deficient cells apoptosis . Cancer chemoprevention uses natural , synthetic , biological substances reverse , suppress , prevent either initial phase carcinogenesis progression neoplastic cells cancer . holds promise overcoming problems associated treatment late-stage cancers . However , broad application chemoprevention compromised present limited effectiveness potential toxicity . overcome challenges , developed new chemoprevention approach specifically targets premalignant tumour cells apoptosis . show deficiency adenomatous polyposis coli ( APC ) gene subsequent activation beta-catenin lead repression cellular caspase-8 inhibitor c-FLIP ( also known @ GeneSrc $ ) expression activation c-Myc , all-trans-retinyl acetate ( RAc ) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand ( TRAIL ) death receptors suppresses decoy receptors . Thus , combination TRAIL RAc induces apoptosis APC-deficient premalignant cells without affecting normal cells vitro . addition , show short-term non-continuous TRAIL RAc treatment induce apoptosis specifically intestinal polyps , strongly inhibit tumour growth , prolong survival multiple intestinal neoplasms C57BL/6J-Apc ( Min ) /J ( Apc ( Min ) ) mice . approach , demonstrate TRAIL RAc induce significant cell death human colon polyps , providing potentially selective approach @ DiseaseTgt $ chemoprevention targeting APC-deficient cells apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032290502077715)\n",
      "- Text: \"@ GeneSrc $ deficiency impairs microglial accumulation accelerates progression @ DiseaseTgt $ . Microglia principal immune cells brain . @ DiseaseTgt $ , brain mononuclear phagocytes recruited blood accumulate senile plaques . However , role microglia @ DiseaseTgt $ resolved . Microglia may neuroprotective phagocytosing amyloid-beta ( Abeta ) , activation secretion neurotoxins may also cause neurodegeneration . @ GeneSrc $ chemokine receptor expressed microglia , mediates accumulation mononuclear phagocytes sites inflammation . show @ GeneSrc $ deficiency accelerates early disease progression markedly impairs microglial accumulation transgenic mouse model @ DiseaseTgt $ ( Tg2576 ) . @ DiseaseTgt $ mice deficient @ GeneSrc $ accumulated Abeta earlier died prematurely , manner correlated @ GeneSrc $ gene dosage , indicating absence early microglial accumulation leads decreased Abeta clearance increased mortality . Thus , @ GeneSrc $ microglial accumulation plays protective role early stages @ DiseaseTgt $ promoting Abeta clearance .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4816983403338782)\n",
      "- Text: \"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression . Gain-of-function mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism LRRK2 action known . show LRRK2 interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila e2f1 dp messenger RNAs translationally repressed @ GeneSrc $ miR-184 * , respectively . Pathogenic LRRK2 antagonizes miRNAs , leading overproduction E2F1/DP , previously implicated cell cycle survival control shown critical LRRK2 pathogenesis . Genetic deletion @ GeneSrc $ , antagomir-mediated blockage @ GeneSrc $ miR-184 * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive @ GeneSrc $ toxic effects similar pathogenic LRRK2 . Conversely , increasing level @ GeneSrc $ miR-184 * attenuated pathogenic LRRK2 effects . LRRK2 associated Drosophila Argonaute-1 ( dAgo1 ) human Argonaute-2 ( hAgo2 ) RNA-induced silencing complex ( RISC ) . aged fly brain , dAgo1 protein level negatively regulated LRRK2 . , pathogenic LRRK2 promoted association phospho-4E-BP1 hAgo2 . results implicate deregulated synthesis E2F1/DP caused miRNA pathway impairment key event LRRK2 pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029734869900703)\n",
      "- Text: \"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression . Gain-of-function mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism LRRK2 action known . show LRRK2 interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila e2f1 dp messenger RNAs translationally repressed let-7 @ GeneSrc $ * , respectively . Pathogenic LRRK2 antagonizes miRNAs , leading overproduction E2F1/DP , previously implicated cell cycle survival control shown critical LRRK2 pathogenesis . Genetic deletion let-7 , antagomir-mediated blockage let-7 @ GeneSrc $ * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive let-7 toxic effects similar pathogenic LRRK2 . Conversely , increasing level let-7 @ GeneSrc $ * attenuated pathogenic LRRK2 effects . LRRK2 associated Drosophila Argonaute-1 ( dAgo1 ) human Argonaute-2 ( hAgo2 ) RNA-induced silencing complex ( RISC ) . aged fly brain , dAgo1 protein level negatively regulated LRRK2 . , pathogenic LRRK2 promoted association phospho-4E-BP1 hAgo2 . results implicate deregulated synthesis E2F1/DP caused miRNA pathway impairment key event LRRK2 pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001310631218575)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors alphaCaMKII . Furthermore , loss presenilins causes reduced expression CBP @ GeneSrc $ target genes , c-fos BDNF . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels Cdk5 activator p25 hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005049606094359)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors alphaCaMKII . Furthermore , loss presenilins causes reduced expression @ GeneSrc $ @ GeneSrc $ target genes , c-fos BDNF . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels Cdk5 activator p25 hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003301645271996)\n",
      "- Text: \"Antiamyloidogenic neuroprotective functions @ GeneSrc $ : implications @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) may result accumulation amyloid-beta ( Abeta ) peptides brain . cysteine protease @ GeneSrc $ ( @ GeneSrc $ ) associated amyloid plaques @ DiseaseTgt $ brains suspected increase Abeta production . , demonstrate @ GeneSrc $ actually reduces levels Abeta peptides , especially aggregation-prone species Abeta1 - 42 , proteolytic cleavage . Genetic inactivation @ GeneSrc $ mice neuronal expression familial @ DiseaseTgt $ human amyloid precursor protein ( hAPP ) increased relative abundance Abeta1 - 42 , worsening plaque deposition @ DiseaseTgt $ pathologies . Lentivirus-mediated expression @ GeneSrc $ aged hAPP mice reduced preexisting amyloid deposits , even thioflavin S-positive plaques . cell-free conditions , @ GeneSrc $ effectively cleaved Abeta1 - 42 , generating C-terminally truncated Abeta peptides less amyloidogenic . Thus , @ GeneSrc $ likely fulfills antiamyloidogenic neuroprotective functions . Insufficient @ GeneSrc $ activity might promote @ DiseaseTgt $ ; increasing @ GeneSrc $ activity could counteract neuropathology disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.26229617372659)\n",
      "- Text: \"PML/RARalpha FLT3-ITD induce APL-like disease mouse model . Acute promyelocytic leukemia ( APL ) cells invariably express aberrant fusion proteins involving retinoic acid receptor alpha ( RARalpha ) . common fusion partner promyelocytic leukemia protein ( PML ) , fused RARalpha balanced reciprocal chromosomal translocation , ( 15 ; 17 ) ( q22 : q11 ) . Expression PML/RARalpha @ GeneSrc $ promoter transgenic mice causes nonfatal myeloproliferative syndrome mice ; 15 % go develop APL long latent period , suggesting additional mutations required development APL . candidate target gene second mutation FLT3 , mutated approximately 40 % human APL cases . Activating mutations FLT3 , including internal tandem duplication ( ITD ) juxtamembrane domain , transform hematopoietic cell lines factor independent growth . FLT3-ITDs also induce myeloproliferative disease murine bone marrow transplant model , sufficient cause @ DiseaseTgt $ . , test hypothesis PML/RARalpha cooperate FLT3-ITD induce APL-like disease mouse . Retroviral transduction FLT3-ITD bone marrow cells obtained PML/RARalpha transgenic mice results short latency APL-like disease complete penetrance . disease resembles APL-like disease occurs long latency PML/RARalpha transgenics , suggesting activating mutations FLT3 functionally substitute additional mutations occur mouse APL progression . leukemia transplantable secondary recipients ATRA responsive . observations document cooperation PML/RARalpha FLT3-ITD development murine APL phenotype .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7365903683065128)\n",
      "- Text: \"Reduced beta-amyloid production increased inflammatory responses presenilin conditional knock-out mice . Mutations presenilins ( PS ) 1 2 major cause familial @ DiseaseTgt $ . Conditional double knock-out mice lacking presenilins postnatal forebrain ( PS cDKO mice ) exhibit memory synaptic plasticity impairments followed progressive neurodegeneration cerebral cortex . investigate molecular events may underlie observed phenotypes identify additional neuropathological markers PS cDKO brain . Enzyme-linked immunosorbent assay analysis showed reduced levels toxic beta-amyloid ( Abeta ) peptides cerebral cortex PS cDKO mice . Interestingly , reduction Abeta40 Abeta42 peptides similar PS1 conditional knock-out PS cDKO mice . examined gene expression profile oligonucleotide microarrays PS cDKO cerebral cortex found high number genes differentially expressed , notably group up-regulated inflammatory genes . Quantitative real-time reverse transcription PCR Western analyses confirmed elevated levels glial fibrillary acidic protein , complement component C1q , @ GeneSrc $ , up-regulation associated inflammatory responses various neurodegenerative processes . Immunohistochemical analysis revealed increase complement component C1q confined hippocampal formation , whereas glial fibrillary acidic protein @ GeneSrc $ up-regulated throughout entire neocortex hippocampus . addition , strong microglial activation occurs hippocampus deeper cortical layers PS cDKO mice . results indicate memory impairment neurodegeneration PS cDKO mice caused Abeta accumulation loss PS function leads differential up-regulation inflammatory markers cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.893433596462055e-05)\n",
      "- Text: \"Brain estrogen deficiency accelerates Abeta plaque formation @ DiseaseTgt $ animal model . Much evidence indicates women higher risk developing @ DiseaseTgt $ ( @ DiseaseTgt $ ) men . reason gender difference unclear . hypothesize estrogen deficiency brains women @ DiseaseTgt $ may key risk factor . rapidly acquired postmortem brains women @ DiseaseTgt $ , found greatly reduced estrogen levels compared age- gender-matched normal control subjects ; @ DiseaseTgt $ control subjects comparably low levels serum estrogen . examined onset severity @ DiseaseTgt $ pathology associated estrogen depletion using gene-based approach , crossing estrogen-synthesizing enzyme @ GeneSrc $ gene knockout mice APP23 transgenic mice , mouse model @ DiseaseTgt $ , produce estrogen-deficient APP23 mice . Compared APP23 transgenic control mice , estrogen-deficient APP23 mice exhibited greatly reduced brain estrogen early-onset increased beta amyloid peptide ( Abeta ) deposition . mice also exhibited increased Abeta production , microglia cultures prepared brains mice impaired Abeta clearance/degradation . contrast , ovariectomized APP23 mice exhibited plaque pathology similar observed APP23 transgenic control mice . results indicate estrogen depletion brain may significant risk factor developing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0120707622395113)\n",
      "- Text: \"Genetic alterations @ GeneSrc $ gene @ DiseaseTgt $ . @ GeneSrc $ zinc-finger tumor suppressor frequently mutated several human cancers broadly involved differentiation development , growth-related signal transduction , cell proliferation , apoptosis , angiogenesis . determine whether genetic alterations @ GeneSrc $ gene involved development and/or progression @ DiseaseTgt $ , screened set 80 sporadic @ DiseaseTgt $ mutations allele loss @ GeneSrc $ gene . Four missense mutations , S155R , P172 , S180L , R198 K , detected transactivation domain @ GeneSrc $ gene one biallelic mutations somatic mutation one allele loss remaining allele . cases mutation advanced @ DiseaseTgt $ lymph node metastasis . addition , 16 ( 43.2 % ) 37 informative cases showed allelic loss @ GeneSrc $ locus . Interestingly , allelic loss also frequent intestinal-type @ DiseaseTgt $ . Therefore , data suggest genetic alterations @ GeneSrc $ gene might play important role development progression sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7245074198065649)\n",
      "- Text: \"DDD mice , novel acute mouse model @ DiseaseTgt $ . describe development novel animal model acute severe dopamine ( DA ) deficiency using genetically altered mice lacking @ GeneSrc $ ( @ GeneSrc $ mice ) . absence @ GeneSrc $ recycling mechanism mice , striatal DA concentrations become entirely dependent de novo synthesis , acute pharmacologic inhibition tyrosine hydroxylase induces transient ( 16 hours ) elimination brain DA . Dopamine-deficient @ GeneSrc $ mice ( DDD mice ) demonstrate striking behavioral phenotype manifested severe akinesia , rigidity , tremor , ptosis . propose DDD mice represent novel acute model severe DA deficiency might used identify compounds potential therapeutic use treatment @ DiseaseTgt $ ( @ DiseaseTgt $ ) . model particularly promising tool evaluating efficacy compounds may induce movement independently DA . advantages limitations DDD mice comparison rodent @ DiseaseTgt $ models discussed .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0203065067308503)\n",
      "- Text: \"Acetylation-regulated interaction p53 SET reveals widespread regulatory mode . Although lysine acetylation recognized general protein modification histones non-histone proteins , mechanisms acetylation-mediated actions completely understood . Acetylation C-terminal domain ( CTD ) p53 ( also known TP53 ) early example non-histone protein acetylation precise role remains unclear . Lysine acetylation often creates binding sites bromodomain-containing ' reader ' proteins . use proteomic screen identify oncoprotein SET major cellular factor whose binding p53 dependent CTD acetylation status . SET profoundly inhibits p53 transcriptional activity unstressed cells , SET-mediated repression abolished stress-induced acetylation p53 CTD . Moreover , loss interaction SET activates p53 , resulting @ DiseaseTgt $ regression mouse xenograft models . Notably , acidic domain SET acts ' reader ' unacetylated CTD p53 mechanism acetylation-dependent regulation widespread nature . example , acetylation p53 also modulates interactions similar acidic domains found p53 regulators including VPRBP ( also known DCAF1 ) , @ GeneSrc $ PELP1 ( refs . 7 , 8 , 9 ) , computational analysis proteome identified numerous proteins potential serve acidic domain readers lysine-rich ligands . Unlike bromodomain readers , preferentially bind acetylated forms cognate ligands , acidic domain readers specifically recognize unacetylated forms ligands . Finally , acetylation-dependent regulation p53 validated vivo using knock-in mouse model expressing acetylation-mimicking form p53 . results reveal acidic-domain-containing factors act class acetylation-dependent regulators targeting p53 , potentially , proteins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.10504150790314e-05)\n",
      "- Text: \"@ GeneSrc $ constrains tumour progression via dependence receptor activity . role @ GeneSrc $ ( @ GeneSrc $ ) tumour suppressor matter debate past 15 years . @ GeneSrc $ gene expression lost markedly reduced majority advanced @ DiseaseTgt $ , functioning dependence receptor , @ GeneSrc $ shown induce apoptosis unless engaged ligand , netrin-1 ( ref . 2 ) . However , far animal model supported view @ GeneSrc $ loss-of-function causally implicated predisposing aggressive cancer development . investigate role @ GeneSrc $ apoptosis control tumour progression , created mouse model pro-apoptotic activity @ GeneSrc $ genetically silenced . Although loss @ GeneSrc $ apoptosis mouse model associated major disorganization intestines , leads spontaneous intestinal neoplasia relatively low frequency . Loss @ GeneSrc $ apoptosis also associated increase number aggressiveness intestinal tumours predisposing APC mutant context , resulting development highly invasive adenocarcinomas . results demonstrate @ GeneSrc $ functions tumour suppressor via ability trigger tumour cell apoptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4167369552962854)\n",
      "- Text: \"@ GeneSrc $ gene product induces apoptosis mechanism requiring receptor proteolysis . development colonic carcinoma associated mutation specific set genes . One , @ GeneSrc $ ( deleted @ DiseaseTgt $ ) , candidate tumour-suppressor gene , encodes receptor netrin-1 , molecule involved axon guidance . Loss @ GeneSrc $ expression tumours restricted colon carcinoma , , although increase frequency tumour formation @ GeneSrc $ hemizygous mice , reestablishment @ GeneSrc $ expression suppresses tumorigenicity . However , mechanism action @ GeneSrc $ unknown . show @ GeneSrc $ induces apoptosis absence ligand binding , blocks apoptosis engaged netrin-1 . Furthermore , @ GeneSrc $ caspase substrate , mutation site caspase-3 cleaves @ GeneSrc $ suppresses pro-apoptotic effect @ GeneSrc $ completely . results indicate @ GeneSrc $ may function tumour-suppressor protein inducing apoptosis settings ligand unavailable ( example , metastasis tumour growth beyond local blood supply ) functional caspase cascades mechanism requires cleavage @ GeneSrc $ Asp 1,290 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.758424775734905)\n",
      "- Text: \"Netrin-1 controls colorectal tumorigenesis regulating apoptosis . expression protein @ GeneSrc $ ( deleted @ DiseaseTgt $ ) lost markedly reduced numerous cancers majority @ DiseaseTgt $ due loss heterozygosity chromosome 18q , therefore proposed tumour suppressor . However , rarity mutations found @ GeneSrc $ , lack cancer predisposition @ GeneSrc $ mutant mice , presence tumour suppressor genes 18q raised doubts function @ GeneSrc $ tumour suppressor . Unlike classical tumour suppressors , @ GeneSrc $ shown induce apoptosis conditionally : functioning dependence receptor , @ GeneSrc $ induces apoptosis unless @ GeneSrc $ engaged ligand , netrin-1 ( ref . 3 ) . show inhibition cell death enforced expression netrin-1 mouse gastrointestinal tract leads spontaneous formation hyperplastic neoplastic lesions . Moreover , adenomatous polyposis coli mutant background associated adenoma formation , enforced expression netrin-1 engenders aggressive adenocarcinomatous malignancies . data demonstrate netrin-1 promote intestinal tumour development , probably regulating cell survival . Thus , netrin-1 receptor receptors function conditional tumour suppressors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8136956113435542)\n",
      "- Text: \"Deleted @ DiseaseTgt $ suppresses metastasis p53-deficient mammary tumours . Since discovery early 1990s @ GeneSrc $ ( @ GeneSrc $ ) gene , located chromosome 18q21 , proposed tumour suppressor gene loss implicated majority advanced @ DiseaseTgt $ . @ GeneSrc $ belongs family netrin 1 receptors , function dependence receptors control survival apoptosis depending ligand binding . However , role @ GeneSrc $ tumour suppressor remains controversial rarity @ GeneSrc $ mutations presence tumour suppressor genes chromosomal region . show mouse model mammary carcinoma based somatic inactivation p53 , additional loss @ GeneSrc $ promotes metastasis formation without affecting primary tumour phenotype . Furthermore , demonstrate cell cultures derived p53-deficient mouse mammary tumours @ GeneSrc $ expression controls netrin-1-dependent cell survival , providing mechanistic basis enhanced metastatic capacity tumour cells lacking @ GeneSrc $ . Consistent idea , vivo tumour-cell survival enhanced @ GeneSrc $ loss . Together , data support function @ GeneSrc $ context-dependent tumour suppressor limits survival disseminated tumour cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9772628449856904)\n",
      "- Text: \"Mice lacking presenilin genes exhibit early embryonic patterning defects . Genetic studies worms , flies , humans implicated presenilins regulation Notch signaling pathway pathogenesis @ DiseaseTgt $ . two highly homologous presenilin genes mammals , presenilin 1 ( PS1 ) presenilin 2 ( PS2 ) . mice , inactivation PS1 leads developmental defects culminate perinatal lethality . test possibility late lethality PS1-null mice reflects genetic redundancy presenilins , generated PS2-null mice gene targeting , subsequently , PS1/PS2 double-null mice . Mice homozygous targeted null mutation PS2 exhibit obvious defects ; however , loss PS2 PS1-null background leads embryonic lethality embryonic day 9.5 . Embryos lacking presenilins , surprisingly , carrying single copy PS2 PS1-null background , exhibit multiple early patterning defects , including lack somite segmentation , disorganization trunk ventral neural tube , midbrain mesenchyme cell loss , anterior neuropore closure delays , abnormal heart second branchial arch development . addition , @ GeneSrc $ ( @ GeneSrc $ ) Hes-5 , two genes lie downstream Notch pathway , misexpressed presenilin double-null embryos : Hes-5 expression undetectable mice , whereas @ GeneSrc $ expressed ectopically neural tube brain double-null embryos . conclude presenilins play widespread role embryogenesis , functional redundancy PS1 PS2 , vertebrate presenilins , like invertebrate homologs , essential Notch signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.385151162312261e-05)\n",
      "- Text: \"elaborate pathway required Ras-mediated epigenetic silencing . conversion normal cell @ DiseaseTgt $ cell occurs several steps typically involves activation oncogenes inactivation @ DiseaseTgt $ suppressor pro-apoptotic genes . many instances , inactivation genes critical @ DiseaseTgt $ development occurs epigenetic silencing , often involving hypermethylation CpG-rich promoter regions . remains determined whether silencing occurs random acquisition epigenetic marks confer selective growth advantage specific pathway initiated oncogene . perform genome-wide RNA interference ( RNAi ) screen K-ras-transformed NIH 3T3 cells identify 28 genes required Ras-mediated epigenetic silencing pro-apoptotic Fas gene . least nine RESEs ( Ras epigenetic silencing effectors ) , including DNA methyltransferase @ GeneSrc $ , directly associated specific regions Fas promoter K-ras-transformed NIH 3T3 cells untransformed NIH 3T3 cells . RNAi-mediated knockdown 28 RESEs results failure recruit @ GeneSrc $ Fas promoter , loss Fas promoter hypermethylation , derepression Fas expression . Analysis five epigenetically repressed genes indicates Ras directs silencing multiple unrelated genes largely common pathway . Last , show nine RESEs required anchorage-independent growth tumorigenicity K-ras-transformed NIH 3T3 cells ; nine genes previously implicated transformation Ras . results show Ras-mediated epigenetic silencing occurs specific , complex , pathway involving components required maintenance fully transformed phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002767819466792)\n",
      "- Text: \"Therapeutic targeting preleukemia cells mouse model NPM1 mutant @ DiseaseTgt $ . initiating mutations contribute cancer development sometimes present premalignant cells . Whether therapies targeting mutations eradicate premalignant cells unclear . @ DiseaseTgt $ ( @ DiseaseTgt $ ) attractive system investigating effect preventative treatment disease often preceded premalignant state ( clonal hematopoiesis myelodysplastic syndrome ) . @ GeneSrc $ mutant knock-in mice , model @ DiseaseTgt $ development , leukemia preceded period extended myeloid progenitor cell proliferation self-renewal . found self-renewal reversed oral administration small molecule ( VTP-50469 ) targets MLL1-Menin chromatin complex . preclinical results support hypothesis individuals high risk developing @ DiseaseTgt $ might benefit targeted epigenetic therapy preventative setting .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.644372860583733)\n",
      "- Text: \"R1441C mutation LRRK2 impairs dopaminergic neurotransmission mice . Dominantly inherited mutations leucine-rich repeat kinase 2 ( LRRK2 ) common genetic cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . importance R1441 residue pathogenesis highlighted identification three distinct missense mutations . investigate pathogenic mechanism underlying LRRK2 dysfunction , generated knockin ( KI ) mouse R1441C mutation expressed control endogenous regulatory elements . Homozygous R1441C KI mice appear grossly normal exhibit dopaminergic ( DA ) neurodegeneration alterations steady-state levels striatal dopamine 2 years age . However , KI mice show reductions amphetamine ( AMPH ) -induced locomotor activity stimulated catecholamine release cultured chromaffin cells . introduction R1441C mutation also impairs @ GeneSrc $ function , suggested decreased responses KI mice locomotor activity inhibitory effect @ GeneSrc $ agonist , quinpirole . Furthermore , firing nigral neurons R1441C KI mice show reduced sensitivity suppression induced quinpirole , dopamine , AMPH . Together , data suggest R1441C mutation LRRK2 impairs stimulated dopamine neurotransmission @ GeneSrc $ function , may represent pathogenic precursors preceding dopaminergic degeneration @ DiseaseTgt $ brains .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0082935959677286)\n",
      "- Text: \"Expression functional analysis Uch-L3 mouse development . Mice homozygous ( 1Acrg ) deletion @ GeneSrc $ locus arrest embryonic day 8.5 . determine molecular basis defect , initiated positional cloning ( 1Acrg ) minimal region . mouse Uch-L3 ( ubiquitin C-terminal hydrolase L3 ) gene mapped within ( 1Acrg ) minimal region . Uch-L3 transcripts present embryonic structures relevant ( 1Acrg ) phenotype , created targeted mutation Uch-L3 address role development possible contribution ( 1Acrg ) phenotype . Mice homozygous mutation Uch-L3 ( Delta3 - 7 ) viable , obvious developmental histological abnormalities . Although high levels Uch-L3 RNA detected testes thymus , Uch-L3 ( Delta3 - 7 ) homozygotes fertile , defect intrathymic T-cell differentiation detected . conclude @ DiseaseTgt $ phenotype either complex multigenic due loss another gene within region . propose Uch-L3 may functionally redundant homologue Uch-L1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.769618881665501e-06)\n",
      "- Text: \"Beta-catenin TCF mediate cell positioning intestinal epithelium controlling expression EphB/ephrinB . small intestine , progeny stem cells migrate precise patterns . Absorptive , enteroendocrine , goblet cells migrate toward villus Paneth cells occupy bottom crypts . show beta-catenin TCF inversely control expression EphB2/EphB3 receptors ligand @ GeneSrc $ @ DiseaseTgt $ along crypt-villus axis . Disruption EphB2 EphB3 genes reveals gene products restrict cell intermingling allocate cell populations within intestinal epithelium . EphB2/EphB3 null mice , proliferative differentiated populations intermingle . adult EphB3 ( -/- ) mice , Paneth cells follow downward migratory path , scatter along crypt villus . conclude intestinal epithelium beta-catenin TCF couple proliferation differentiation sorting cell populations EphB/ephrin-B system .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000640190360021)\n",
      "- Text: \"regulated interaction UIM protein Eps15 implicates parkin @ GeneSrc $ trafficking PI ( 3 ) K-Akt signalling . Mutations parkin gene responsible common familial form @ DiseaseTgt $ . parkin encodes E3 ubiquitin ligase , defects proteasome-mediated protein degradation believed central role pathogenesis @ DiseaseTgt $ . , report novel role parkin proteasome-independent ubiquitination pathway . identified regulated interaction parkin Eps15 , adaptor protein involved @ GeneSrc $ ( @ GeneSrc $ ) endocytosis trafficking . Treatment cells EGF stimulates parkin binding Eps15 @ GeneSrc $ promotes parkin-mediated ubiquitination Eps15 . Binding parkin ubiquitin-like ( Ubl ) domain Eps15 ubiquitin-interacting motifs ( UIMs ) required parkin-mediated Eps15 ubiquitination . Furthermore , @ GeneSrc $ endocytosis degradation accelerated parkin-deficient cells , @ GeneSrc $ signalling via phosphoinositide 3-kinase ( PI ( 3 ) K ) -Akt pathway reduced parkin knockout mouse brain . propose ubiquitinating Eps15 , parkin interferes ability Eps15 UIMs bind ubiquitinated @ GeneSrc $ , thereby delaying @ GeneSrc $ internalization degradation , promoting PI ( 3 ) K-Akt signalling . Considering role Akt neuronal survival , results broad new implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3369504033104536)\n",
      "- Text: \"Survival signalling Akt @ GeneSrc $ oncogenesis @ DiseaseTgt $ therapy . Evading apoptosis considered hallmark @ DiseaseTgt $ , mutations apoptotic regulators invariably accompany tumorigenesis . Many chemotherapeutic agents induce apoptosis , disruption apoptosis @ DiseaseTgt $ evolution promote drug resistance . example , Akt apoptotic regulator activated many @ DiseaseTgt $ may promote drug resistance vitro . Nevertheless , Akt disables apoptosis contribution clinical drug resistance unclear . Using murine lymphoma model , show Akt promotes tumorigenesis drug resistance disrupting apoptosis , disruption Akt signalling using mTOR inhibitor rapamycin reverses chemoresistance lymphomas expressing Akt , apoptotic defects . @ GeneSrc $ , translational regulator acts downstream Akt mTOR , recapitulates Akt 's action tumorigenesis drug resistance , unable confer sensitivity rapamycin chemotherapy . results establish Akt signalling mTOR @ GeneSrc $ important mechanism oncogenesis drug resistance vivo , reveal targeting apoptotic programmes restore drug sensitivity genotype-dependent manner .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0129180441298851)\n",
      "- Text: \"p53 regulation ammonia metabolism urea cycle controls polyamine biosynthesis . @ DiseaseTgt $ cells exhibit altered usually increased metabolic processes meet high biogenetic demands1,2 . conditions , ammonia concomitantly produced increased metabolic processing . However , unclear @ DiseaseTgt $ cells dispose excess ammonia outcomes might caused accumulation ammonia . report @ DiseaseTgt $ suppressor p53 , frequently mutated gene human @ DiseaseTgt $ , regulates ammonia metabolism repressing urea cycle . transcriptional downregulation @ GeneSrc $ , OTC ARG1 , p53 suppresses ureagenesis elimination ammonia vitro vivo , leading inhibition @ DiseaseTgt $ growth . Conversely , downregulation genes reciprocally activates p53 MDM2-mediated mechanism ( ) . Furthermore , accumulation ammonia causes significant decline mRNA translation polyamine biosynthetic rate-limiting enzyme ODC , thereby inhibiting biosynthesis polyamine cell proliferation . Together , findings link p53 ureagenesis ammonia metabolism , reveal role ammonia controlling polyamine biosynthesis cell proliferation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1537428935764051)\n",
      "- Text: \"Replication CLU , @ GeneSrc $ , PICALM associations @ DiseaseTgt $ . OBJECTIVE : test replication association variants CLU , @ GeneSrc $ , PICALM genes @ DiseaseTgt $ . DESIGN : Follow-up case-control association study . SETTING : Mayo Clinics Jacksonville , Florida , Rochester , Minnesota . PARTICIPANTS : Community-based patients European descent late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) controls without dementia seen Mayo clinics , autopsy-confirmed cases controls whose pathology evaluated Mayo Clinic Jacksonville . Additional samples obtained National Cell Repository @ DiseaseTgt $ ( NCRAD ) . total 1829 @ DiseaseTgt $ cases 2576 controls analyzed . INTERVENTIONS : significant single-nucleotide polymorphisms CLU ( rs11136000 ) , @ GeneSrc $ ( rs3818361 ) , PICALM ( rs3851179 ) tested allelic association @ DiseaseTgt $ . Main Outcome Measure Clinical pathology-confirmed diagnosis @ DiseaseTgt $ . RESULTS : Odds ratios CLU , @ GeneSrc $ , PICALM 0.82 , 1.15 , 0.80 , respectively , comparable direction magnitude originally reported . P values 8.6 x 10 ( -5 ) , .014 , 1.3 x 10 ( -5 ) , respectively ; remain significant even Bonferroni correction 3 single-nucleotide polymorphisms tested . CONCLUSION : results show near-perfect replication provide first additional evidence CLU , @ GeneSrc $ , PICALM associated risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.276211436686693)\n",
      "- Text: \"@ GeneSrc $ associated amyloid plaque burden age-related cognitive decline . OBJECTIVE : Recently , genome-wide association studies identified 3 new susceptibility loci @ DiseaseTgt $ ( @ DiseaseTgt $ ) , CLU , @ GeneSrc $ , PICALM . leveraged available neuropsychological autopsy data 2 cohort studies investigate whether loci associated cognitive decline @ DiseaseTgt $ neuropathology . METHODS : Religious Orders Study ( ROS ) Rush Memory Aging Project ( MAP ) longitudinal studies enroll nondemented subjects include annual clinical evaluations brain donation death . evaluated @ GeneSrc $ ( rs6656401 ) , CLU ( rs11136000 ) , PICALM ( rs7110631 ) 1,666 subjects . evaluated associations genotypes rate change cognitive function well @ DiseaseTgt $ pathology . Lastly , used pathway analysis determine whether relationships single nucleotide polymorphisms cognitive decline mediated @ DiseaseTgt $ pathology . RESULTS : Among study cohort , mean years follow-up 7.8 ROS 4.3 MAP . @ GeneSrc $ locus associated global cognitive decline ( p = 0.011 ) global @ DiseaseTgt $ pathology ( p = 0.025 ) . specifically , locus affects deposition neuritic amyloid plaque ( p = 0.009 ) . mediation analysis , controlling amyloid pathology strongly attenuated effect @ GeneSrc $ locus cognitive decline . INTERPRETATION : found common variation @ GeneSrc $ locus broad impact cognition effect largely mediated individual 's amyloid plaque burden . therefore highlight 1 functional consequence @ GeneSrc $ susceptibility allele generalize role locus cognitive aging general population .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0392472462763819)\n",
      "- Text: \"Meta-analysis confirms @ GeneSrc $ , CLU , PICALM @ DiseaseTgt $ risk loci reveals interactions APOE genotypes . OBJECTIVES : determine whether genotypes CLU , PICALM , @ GeneSrc $ confer risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) whether risk @ DiseaseTgt $ associated genes influenced apolipoprotein E ( APOE ) genotypes . DESIGN : Association study @ DiseaseTgt $ CLU , PICALM , @ GeneSrc $ , APOE genotypes . SETTING : Academic research institutions United States , Canada , Israel . PARTICIPANTS : Seven thousand seventy cases @ DiseaseTgt $ , 3055 autopsies , 8169 elderly cognitively normal controls , 1092 autopsies , 12 different studies , including white , African American , Israeli-Arab , Caribbean Hispanic individuals . RESULTS : Unadjusted , CLU ( odds ratio [ ] , 0.91 ; 95 % confidence interval [ CI ] , 0.85 - 0.96 single-nucleotide polymorphism [ SNP ] rs11136000 ) , @ GeneSrc $ ( , 1.14 ; 95 % CI , 1.07 - 1.22 ; SNP rs3818361 ) , PICALM ( , 0.89 ; 95 % CI , 0.84 - 0.94 , SNP rs3851179 ) associated @ DiseaseTgt $ white individuals . None significantly associated @ DiseaseTgt $ ethnic groups . APOE epsilon4 significantly associated @ DiseaseTgt $ ( ORs , 1.80 - 9.05 ) 1 small white cohort Arab cohort . Adjusting age , sex , presence least 1 APOE epsilon4 allele greatly reduced evidence association PICALM @ GeneSrc $ CLU . Models main SNP effect , presence absence APOE epsilon4 , interaction term showed significant interaction presence absence APOE epsilon4 PICALM . CONCLUSIONS : confirm completely independent data set @ GeneSrc $ , CLU , PICALM @ DiseaseTgt $ susceptibility loci European ancestry populations . Genotypes PICALM confer risk predominantly APOE epsilon4-positive subjects . Thus , APOE PICALM synergistically interact .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2004062747333614)\n",
      "- Text: \"Genome-wide association study identifies variants CLU @ GeneSrc $ associated @ DiseaseTgt $ . gene encoding apolipoprotein E ( APOE ) chromosome 19 confirmed susceptibility locus late-onset @ DiseaseTgt $ . identify risk loci , conducted large genome-wide association study 2,032 individuals France @ DiseaseTgt $ ( cases ) 5,328 controls . Markers outside APOE suggestive evidence association ( P < 10 ( -5 ) ) examined collections Belgium , Finland , Italy Spain totaling 3,978 @ DiseaseTgt $ cases 3,297 controls . Two loci gave replicated evidence association : one within CLU ( also called APOJ ) , encoding clusterin apolipoprotein J , chromosome 8 ( rs11136000 , = 0.86 , 95 % CI 0.81 - 0.90 , P = 7.5 x 10 ( -9 ) combined data ) within @ GeneSrc $ , encoding complement component ( 3b/4b ) receptor 1 , chromosome 1 ( rs6656401 , = 1.21 , 95 % CI 1.14 - 1.29 , P = 3.7 x 10 ( -9 ) combined data ) . Previous biological studies support roles CLU @ GeneSrc $ clearance beta amyloid ( Abeta ) peptide , principal constituent amyloid plaques , one major brain lesions individuals @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0034886440622106)\n",
      "- Text: \"Beta-catenin TCF mediate cell positioning intestinal epithelium controlling expression EphB/ephrinB . small intestine , progeny stem cells migrate precise patterns . Absorptive , enteroendocrine , goblet cells migrate toward villus Paneth cells occupy bottom crypts . show beta-catenin TCF inversely control expression @ GeneSrc $ receptors ligand ephrin-B1 @ DiseaseTgt $ along crypt-villus axis . Disruption @ GeneSrc $ EphB3 genes reveals gene products restrict cell intermingling allocate cell populations within intestinal epithelium . @ GeneSrc $ null mice , proliferative differentiated populations intermingle . adult EphB3 ( -/- ) mice , Paneth cells follow downward migratory path , scatter along crypt villus . conclude intestinal epithelium beta-catenin TCF couple proliferation differentiation sorting cell populations EphB/ephrin-B system .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.970894963345013e-05)\n",
      "- Text: \"Beta-catenin TCF mediate cell positioning intestinal epithelium controlling expression EphB/ephrinB . small intestine , progeny stem cells migrate precise patterns . Absorptive , enteroendocrine , goblet cells migrate toward villus Paneth cells occupy bottom crypts . show beta-catenin TCF inversely control expression @ GeneSrc $ receptors ligand ephrin-B1 @ DiseaseTgt $ along crypt-villus axis . Disruption EphB2 @ GeneSrc $ genes reveals gene products restrict cell intermingling allocate cell populations within intestinal epithelium . @ GeneSrc $ null mice , proliferative differentiated populations intermingle . adult @ GeneSrc $ ) mice , Paneth cells follow downward migratory path , scatter along crypt villus . conclude intestinal epithelium beta-catenin TCF couple proliferation differentiation sorting cell populations EphB/ephrin-B system .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.808585955184376e-05)\n",
      "- Text: \"CBP binding transcriptional repressor produced PS1/epsilon-cleavage N-cadherin inhibited PS1 @ DiseaseTgt $ mutations . Presenilin1 ( PS1 ) , protein implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , forms complexes N-cadherin , transmembrane protein important neuronal synaptic functions . , show PS1-dependent gamma-secretase protease activity promotes epsilon-like cleavage N-cadherin produce intracellular domain peptide , N-Cad/CTF2 . NMDA receptor agonists stimulate N-Cad/CTF2 production suggesting receptor regulates epsilon-cleavage N-cadherin . N-Cad/CTF2 binds transcription factor CBP promotes proteasomal degradation , inhibiting CRE-dependent transactivation . Thus , PS1-dependent epsilon-cleavage product N-Cad/CTF2 functions potent repressor @ GeneSrc $ transcription . Importantly , PS1 mutations associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) gamma-secretase dominant-negative mutation inhibit N-Cad/CTF2 production upregulate @ GeneSrc $ transcription indicating @ DiseaseTgt $ mutations cause gain transcriptional function inhibiting production transcriptional repressor N-Cad/CTF2 . data raise possibility @ DiseaseTgt $ mutation-induced transcriptional abnormalities maybe causally related dementia associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0102762678139048)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human colon cancers . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered colon cancers retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer @ DiseaseTgt $ . accumulation beta-catenin activates genes responsive transcription factors TCF/LEF family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets @ GeneSrc $ . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF colon-cancer cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0011472278270186)\n",
      "- Text: \"Molecular cloning human Nurr1 gene : characterization human gene cDNAs . Nurr1 member nuclear receptor superfamily transcription factors expressed predominantly central nervous system , including developing dopaminergic neurons . Recently , demonstrated Nurr1 critical midbrain dopaminergic cell differentiation . order investigate possible relation Nurr1 pathogenesis @ DiseaseTgt $ neuropsychiatric disorders , cloned characterized human Nurr1 gene . gene exists single copy human genome comprises eight exons spanning 8 kb . determined complete nucleotide sequence flanking regions gene . Potential regulatory regions included consensus binding sites NF-kappaB , @ GeneSrc $ , Sp1 . Isolation human Nurr1 cDNAs fetal brain suggested presence new splicing variant Nurr1 human brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human @ DiseaseTgt $ . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered @ DiseaseTgt $ retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer gastric hepatocellular carcinomas . accumulation beta-catenin activates genes responsive transcription factors TCF/LEF family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets @ GeneSrc $ . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF @ DiseaseTgt $ cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2181603873279424)\n",
      "- Text: \"regulated interaction UIM protein @ GeneSrc $ implicates parkin EGF receptor trafficking PI ( 3 ) K-Akt signalling . Mutations parkin gene responsible common familial form @ DiseaseTgt $ . parkin encodes E3 ubiquitin ligase , defects proteasome-mediated protein degradation believed central role pathogenesis @ DiseaseTgt $ . , report novel role parkin proteasome-independent ubiquitination pathway . identified regulated interaction parkin @ GeneSrc $ , adaptor protein involved epidermal growth factor ( EGF ) receptor ( EGFR ) endocytosis trafficking . Treatment cells EGF stimulates parkin binding @ GeneSrc $ EGFR promotes parkin-mediated ubiquitination @ GeneSrc $ . Binding parkin ubiquitin-like ( Ubl ) domain @ GeneSrc $ ubiquitin-interacting motifs ( UIMs ) required parkin-mediated @ GeneSrc $ ubiquitination . Furthermore , EGFR endocytosis degradation accelerated parkin-deficient cells , EGFR signalling via phosphoinositide 3-kinase ( PI ( 3 ) K ) -Akt pathway reduced parkin knockout mouse brain . propose ubiquitinating @ GeneSrc $ , parkin interferes ability @ GeneSrc $ UIMs bind ubiquitinated EGFR , thereby delaying EGFR internalization degradation , promoting PI ( 3 ) K-Akt signalling . Considering role Akt neuronal survival , results broad new implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0585964219196753)\n",
      "- Text: \"Reciprocal repression P53 TCTP . Screening genes reprogram @ DiseaseTgt $ cells @ DiseaseTgt $ reversion switch identified TCTP ( encoding translationally controlled tumor protein ) crucial regulator apoptosis . report negative feedback loop P53 TCTP . TCTP promotes P53 degradation competing NUMB binding P53-MDM2-containing complexes . TCTP inhibits MDM2 auto-ubiquitination promotes MDM2-mediated ubiquitination degradation P53 . Notably , Tctp haploinsufficient mice sensitized P53-dependent apoptosis . addition , P53 directly represses TCTP transcription . 508 breast cancers , high-TCTP status associates poorly differentiated , aggressive G3-grade @ DiseaseTgt $ , predicting poor prognosis ( P < 0.0005 ) . Tctp knockdown primary mammary tumor cells @ GeneSrc $ transgenic mice results increased P53 expression decreased number stem-like @ DiseaseTgt $ cells . pharmacological compounds sertraline thioridazine increase amount P53 neutralizing TCTP 's action MDM2-P53 axis . study links TCTP P53 previously unidentified regulatory circuitry may underlie relevance TCTP @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024456188269275)\n",
      "- Text: \"Inactivation Wip1 phosphatase inhibits mammary tumorigenesis p38 MAPK-mediated activation p16 ( Ink4a ) -p19 ( Arf ) pathway . Modulation @ DiseaseTgt $ suppressor activities may provide new opportunities @ DiseaseTgt $ therapy . show disruption gene Ppm1d encoding Wip1 phosphatase activated p53 p16 ( also called Ink4a ) -p19 ( also called ARF ) pathways p38 MAPK signaling suppressed vitro transformation mouse embryo fibroblasts ( MEFs ) oncogenes . Disruption gene Cdkn2a ( encoding p16 p19 ) , Trp53 ( encoding p53 ) , reconstituted cell transformation Ppm1d-null MEFs . vivo , deletion Ppm1d mice bearing mouse mammary tumor virus ( MMTV ) promoter-driven oncogenes @ GeneSrc $ ( also called @ GeneSrc $ ) Hras1 impaired mammary carcinogenesis , whereas reduced expression p16 p19 methylation-induced silencing inactivation p38 MAPK correlated @ DiseaseTgt $ appearance . conclude inactivation depletion Wip1 phosphatase resultant p38 MAPK activation suppresses @ DiseaseTgt $ appearance modulating Cdkn2a @ DiseaseTgt $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0119929913517839)\n",
      "- Text: \"@ GeneSrc $ binding transcriptional repressor produced PS1/epsilon-cleavage N-cadherin inhibited PS1 @ DiseaseTgt $ mutations . Presenilin1 ( PS1 ) , protein implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , forms complexes N-cadherin , transmembrane protein important neuronal synaptic functions . , show PS1-dependent gamma-secretase protease activity promotes epsilon-like cleavage N-cadherin produce intracellular domain peptide , N-Cad/CTF2 . NMDA receptor agonists stimulate N-Cad/CTF2 production suggesting receptor regulates epsilon-cleavage N-cadherin . N-Cad/CTF2 binds transcription factor @ GeneSrc $ promotes proteasomal degradation , inhibiting CRE-dependent transactivation . Thus , PS1-dependent epsilon-cleavage product N-Cad/CTF2 functions potent repressor @ GeneSrc $ transcription . Importantly , PS1 mutations associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) gamma-secretase dominant-negative mutation inhibit N-Cad/CTF2 production upregulate CREB-mediated transcription indicating @ DiseaseTgt $ mutations cause gain transcriptional function inhibiting production transcriptional repressor N-Cad/CTF2 . data raise possibility @ DiseaseTgt $ mutation-induced transcriptional abnormalities maybe causally related dementia associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0203369214658042)\n",
      "- Text: \"PML regulates p53 acetylation premature senescence induced oncogenic Ras . @ DiseaseTgt $ suppressor p53 induces cellular senescence response oncogenic signals . p53 activity modulated protein stability post-translational modification , including phosphorylation acetylation . mechanism p53 activation oncogenes remains largely unknown . report @ DiseaseTgt $ suppressor PML regulates p53 response oncogenic signals . found oncogenic Ras upregulates PML expression , overexpression PML induces senescence p53-dependent manner . p53 acetylated lysine 382 upon Ras expression , event essential biological function . Ras induces re-localization p53 CBP acetyltransferase within PML nuclear bodies induces formation trimeric @ GeneSrc $ complex . Lastly , Ras-induced p53 acetylation , @ GeneSrc $ complex stabilization senescence lost PML-/- fibroblasts . data establish link PML p53 indicate integrity PML bodies required p53 acetylation senescence upon oncogene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004334147713103)\n",
      "- Text: \"Activation @ GeneSrc $ increases estrogen receptor beta decreases apolipoprotein E expression hippocampus vitro vivo . Previous evidence indicates , carriers apolipoprotein E4 ( ApoE4 ) , estrogen therapy increased risk late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , whereas individuals carrying ApoE2/3 , estrogen therapy reduced risk @ DiseaseTgt $ [ Cauley JA , Zmuda JM , Yaffe K , Kuller LH , Ferrell , Wisniewski SR , Cummings SR ( 1999 ) J Bone Miner Res 14:1175 - 1181 ; Yaffe K , Haan , Byers , Tangen C , Kuller L ( 2000 ) Neurology 54:1949 - 1954 ] . Estrogen mechanisms action mediated two estrogen receptors ( ERs ) , @ GeneSrc $ ERbeta . study , determined relationship ER subtype estrogen regulation ApoE expression HT-22 cells ectopically transfected @ GeneSrc $ ERbeta , primary cultured rat hippocampal neurons vitro rat hippocampus vivo molecular biological pharmacological analyses . Results analyses demonstrated activation @ GeneSrc $ either 17beta-estradiol specific-agonist , propylpyrazole triol , up-regulated ApoE mRNA protein expression . contrast , ERbeta-selective agonist , diarylpropionitrile , down-regulated ApoE mRNA protein expression . results demonstrate , vitro vivo , ApoE expression differentially regulated depending activation ER subtypes . data suggest use ER-selective ligands could provide therapeutic benefit reduce risk @ DiseaseTgt $ increasing ApoE expression ApoE2/3 allele carriers decreasing ApoE expression ApoE4 allele carriers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1575656622968962)\n",
      "- Text: \"Modulation oestrogen receptor signalling association activated dioxin receptor . Environmental contaminants affect wide variety biological events many species . Dioxins typical environmental contaminants exert adverse oestrogen-related effects . Although anti-oestrogenic actions well described , dioxins also induce endometriosis oestrogen-dependent @ DiseaseTgt $ , implying possible oestrogenic effects . However , molecular mechanism underlying oestrogen-related actions dioxins remains largely unknown . heterodimer dioxin receptor ( AhR ) Arnt , basic helix-loop-helix/PAS-family transcription factors , mediates toxic effects dioxins . show agonist-activated AhR/Arnt heterodimer directly associates oestrogen receptors @ GeneSrc $ ER-beta . association results recruitment unliganded ER co-activator p300 oestrogen-responsive gene promoters , leading activation transcription oestrogenic effects . function liganded ER attenuated . Oestrogenic actions AhR agonists detected wild-type ovariectomized mouse uteri , absent AhR-/- @ GeneSrc $ ovariectomized mice . findings suggest novel mechanism ER-mediated oestrogen signalling modulated co-regulatory-like function activated AhR/Arnt , giving rise adverse oestrogen-related actions dioxin-type environmental contaminants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013423094131729)\n",
      "- Text: \"Activation estrogen receptor alpha increases @ GeneSrc $ decreases apolipoprotein E expression hippocampus vitro vivo . Previous evidence indicates , carriers apolipoprotein E4 ( ApoE4 ) , estrogen therapy increased risk late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , whereas individuals carrying ApoE2/3 , estrogen therapy reduced risk @ DiseaseTgt $ [ Cauley JA , Zmuda JM , Yaffe K , Kuller LH , Ferrell , Wisniewski SR , Cummings SR ( 1999 ) J Bone Miner Res 14:1175 - 1181 ; Yaffe K , Haan , Byers , Tangen C , Kuller L ( 2000 ) Neurology 54:1949 - 1954 ] . Estrogen mechanisms action mediated two estrogen receptors ( ERs ) , ERalpha @ GeneSrc $ . study , determined relationship ER subtype estrogen regulation ApoE expression HT-22 cells ectopically transfected ERalpha @ GeneSrc $ , primary cultured rat hippocampal neurons vitro rat hippocampus vivo molecular biological pharmacological analyses . Results analyses demonstrated activation ERalpha either 17beta-estradiol specific-agonist , propylpyrazole triol , up-regulated ApoE mRNA protein expression . contrast , @ GeneSrc $ agonist , diarylpropionitrile , down-regulated ApoE mRNA protein expression . results demonstrate , vitro vivo , ApoE expression differentially regulated depending activation ER subtypes . data suggest use ER-selective ligands could provide therapeutic benefit reduce risk @ DiseaseTgt $ increasing ApoE expression ApoE2/3 allele carriers decreasing ApoE expression ApoE4 allele carriers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0084744324387914)\n",
      "- Text: \"Modulation oestrogen receptor signalling association activated dioxin receptor . Environmental contaminants affect wide variety biological events many species . Dioxins typical environmental contaminants exert adverse oestrogen-related effects . Although anti-oestrogenic actions well described , dioxins also induce endometriosis oestrogen-dependent @ DiseaseTgt $ , implying possible oestrogenic effects . However , molecular mechanism underlying oestrogen-related actions dioxins remains largely unknown . heterodimer dioxin receptor ( AhR ) Arnt , basic helix-loop-helix/PAS-family transcription factors , mediates toxic effects dioxins . show agonist-activated AhR/Arnt heterodimer directly associates oestrogen receptors ER-alpha @ GeneSrc $ . association results recruitment unliganded ER co-activator p300 oestrogen-responsive gene promoters , leading activation transcription oestrogenic effects . function liganded ER attenuated . Oestrogenic actions AhR agonists detected wild-type ovariectomized mouse uteri , absent AhR-/- ER-alpha-/- ovariectomized mice . findings suggest novel mechanism ER-mediated oestrogen signalling modulated co-regulatory-like function activated AhR/Arnt , giving rise adverse oestrogen-related actions dioxin-type environmental contaminants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.066015771512546e-05)\n",
      "- Text: \"Fusion novel gene , BTL , @ GeneSrc $ @ DiseaseTgt $ ( 4 ; 12 ) ( q11-q12 ; p13 ) . @ GeneSrc $ gene ( also known @ GeneSrc $ ) main target chromosomal translocations affecting chromosome band 12p13 . rearrangements fuse @ GeneSrc $ wide variety partner genes myeloid lymphoid malignancies . report 4 new cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) immature myeloblasts ( French-American-British [ FAB ] -M0 ) ( 4 ; 12 ) ( q11-q12 ; p13 ) . cases , @ GeneSrc $ found recombined new gene , homologous mouse Brx gene . gene named BTL ( Brx-like Translocated Leukemia ) . Reverse transcriptase-polymerase chain reaction ( RT-PCR ) experiments indicate expression @ GeneSrc $ transcript , reciprocal @ GeneSrc $ transcript , common finding leukemias . contrast majority @ GeneSrc $ fusions , complete helix-loop-helix ( HLH ) ETS DNA binding domains @ GeneSrc $ present predicted @ GeneSrc $ fusion protein , chimeric gene transcribed BTL promoter .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9585886373157668)\n",
      "- Text: \"@ GeneSrc $ , expressed ( 12 ; 21 ) human acute lymphocytic leukemia , induces @ DiseaseTgt $ mice . TEL-AML1 expressed ( 12 ; 21 ) chromosomal translocation inB-precursor acute lymphocytic leukemia ( ) . Creation @ GeneSrc $ disrupts one copy TEL AML1 genes , loss @ GeneSrc $ AML1 also associated cases @ DiseaseTgt $ without TEL-AML1 . determine whether @ GeneSrc $ contribute leukemogenesis , transduced marrow C57BL/6 mice retroviral vector expressing @ GeneSrc $ control vector . Transduced cells introduced irradiated syngeneic recipients . Two 9 @ GeneSrc $ mice developed ( one T-lineage one B-precursor ) , whereas 0 20 control mice developed leukemia . B-precursor retransplantable expressed @ GeneSrc $ . similarly transduced marrow C57BL/6 mice lacking overlapping p16 ( INK4a ) p19 ( ARF ) genes transplanted cells wild-type recipients . control mice died , six eight @ GeneSrc $ mice died leukemia . Overall , findings indicate @ GeneSrc $ contributes leukemogenesis may cooperate loss p16 ( INK4a ) p14 ( ARF ) transform lymphoid progenitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0466368755374171)\n",
      "- Text: \"Accumulation parkin substrate , @ GeneSrc $ , plays key role dopaminergic neurodegeneration . study reports physical functional interplay @ GeneSrc $ ( @ GeneSrc $ ) , death-promoting protein , parkin , key susceptibility protein @ DiseaseTgt $ ( @ DiseaseTgt $ ) . found parkin acts E3 ubiquitin ligase ubiquitinate FAF1 vitro cellular level , identifying FAF1 direct substrate parkin . loss parkin function due @ DiseaseTgt $ mutations found disrupt ubiquitination degradation FAF1 , resulting elevated FAF1 expression SH-SY5Y cells . Moreover , FAF1-mediated cell death abolished wild-type parkin , @ DiseaseTgt $ parkin mutants , implying parkin antagonizes death potential FAF1 . led us investigate whether @ GeneSrc $ participates pathogenesis @ DiseaseTgt $ . address , used gene trap mutagenesis approach generate mutant mice diminished levels @ GeneSrc $ ( @ GeneSrc $ ) ) . Using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) -treated mouse model @ DiseaseTgt $ , found @ GeneSrc $ accumulated substantia nigra pars compacta ( SNc ) MPTP-treated @ DiseaseTgt $ mice , MPTP-induced dopaminergic cell loss SNc significantly attenuated @ GeneSrc $ ) mice versus @ GeneSrc $ ) mice . MPTP-induced reduction locomotor activity also lessened @ GeneSrc $ ) mice versus @ GeneSrc $ ) mice . Furthermore , found @ GeneSrc $ deficiency blocked @ DiseaseTgt $ biochemical events , including caspase activation , ROS generation , JNK activation cell death . Taken together , results suggest new role @ GeneSrc $ : positive modulator @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0333185144605329)\n",
      "- Text: \"Atomic view toxic amyloid small oligomer . Amyloid diseases , including @ DiseaseTgt $ , Parkinson 's , prion conditions , associated particular protein fibrillar form . amyloid fibrils long suspected disease agents , evidence suggests smaller , often transient polymorphic oligomers toxic entities . , identify segment amyloid-forming protein @ GeneSrc $ , forms oligomeric complex exhibiting properties amyloid oligomers : beta-sheet-rich structure , cytotoxicity , recognition oligomer-specific antibody . x-ray-derived atomic structure oligomer reveals cylindrical barrel , formed six antiparallel protein strands , term cylindrin . cylindrin structure compatible sequence segment beta-amyloid protein @ DiseaseTgt $ . Cylindrins offer models hitherto elusive structures amyloid oligomers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001052682087099)\n",
      "- Text: \"PIK3CA ( H1047R ) induces multipotency multi-lineage mammary tumours . adult mouse mammary epithelium contains self-sustained cell lineages form inner luminal outer basal cell layers , stem progenitor cells contributing proliferative regenerative potential . key issue breast cancer biology effect genomic lesions specific mammary cell lineages @ DiseaseTgt $ heterogeneity progression . impact transforming events fate conversion @ DiseaseTgt $ cells origin thus contribution @ DiseaseTgt $ heterogeneity remains largely elusive . Using situ genetic lineage tracing limiting dilution transplantation , unravelled potential PIK3CA ( H1047R ) , one frequent mutations occurring human breast cancer , induce multipotency tumorigenesis mammary gland . show expression PIK3CA ( H1047R ) lineage-committed basal @ GeneSrc $ luminal keratin-8-positive cells adult mouse mammary gland evokes cell dedifferentiation multipotent stem-like state , suggesting mechanism involved formation heterogeneous , multi-lineage mammary tumours . Moreover , show @ DiseaseTgt $ cell origin influences frequency malignant mammary tumours . results define key effect PIK3CA ( H1047R ) mammary cell fate pre-neoplastic mammary gland show cell origin PIK3CA ( H1047R ) @ DiseaseTgt $ dictates @ DiseaseTgt $ , thus revealing mechanism underlying @ DiseaseTgt $ heterogeneity aggressiveness .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3013279548864446)\n",
      "- Text: \"Regulation alpha-synuclein expression @ GeneSrc $ ( @ GeneSrc $ ) binding NACP-Rep1 polymorphic site upstream SNCA gene . Alleles NACP-Rep1 , polymorphic microsatellite repeat located approximately 10 kb upstream alpha -synuclein gene ( SNCA ) , associated , reports , differing risks sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . showed previously NACP-Rep1 acts negative modulator SNCA transcription , effect varied threefold among different NACP-Rep1 alleles . Given duplications triplications SNCA implicated familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) , even 1.5 - 2-fold increase alpha -synuclein expression may , many decades , contribute @ DiseaseTgt $ . Thus , association different NACP-Rep1 alleles @ DiseaseTgt $ may consequence polymorphic differences transcriptional regulation SNCA . aimed identify factor ( ) bind NACP-Rep1 potentially contribute SNCA transcriptional modulation , pulling proteins bind NACP-Rep1 identifying mass spectrometry . One proteins @ GeneSrc $ ( @ GeneSrc $ ) , DNA-binding protein transcriptional regulator . Electrophoresis mobility shift chromatin immunoprecipitation assays showed specific binding @ GeneSrc $ NACP-Rep1 . Inhibition @ GeneSrc $ 's catalytic domain increased endogenous SNCA mRNA levels cultured SH-SY5Y cells . Furthermore , @ GeneSrc $ binding NACP-Rep1 specifically reduced transcriptional activity SNCA promoter/enhancer luciferase reporter assays . down-regulation effect @ GeneSrc $ depended NACP-Rep1 present construct abrogated inhibiting @ GeneSrc $ 's catalytic activity 3-aminobenzamide . association different NACP-Rep1 alleles @ DiseaseTgt $ may mediated , part , effect @ GeneSrc $ , well factors , SNCA expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0699308564214982)\n",
      "- Text: \"Poly ( ADP-ribose ) drives pathologic alpha-synuclein neurodegeneration @ DiseaseTgt $ . pathologic accumulation aggregation alpha-synuclein ( alpha-syn ) underlies @ DiseaseTgt $ ( @ DiseaseTgt $ ) . molecular mechanisms pathologic alpha-syn causes neurodegeneration @ DiseaseTgt $ known . , found pathologic alpha-syn activates poly ( adenosine 5'-diphosphate-ribose ) ( PAR ) polymerase-1 ( @ GeneSrc $ ) , PAR generation accelerates formation pathologic alpha-syn , resulting cell death via parthanatos . PARP inhibitors genetic deletion @ GeneSrc $ prevented pathologic alpha-syn toxicity . feed-forward loop , PAR converted pathologic alpha-syn toxic strain . PAR levels increased cerebrospinal fluid brains patients @ DiseaseTgt $ , suggesting @ GeneSrc $ activation plays role @ DiseaseTgt $ pathogenesis . Thus , strategies aimed inhibiting @ GeneSrc $ activation could hold promise disease-modifying therapy prevent loss dopamine neurons @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.842111090414156)\n",
      "- Text: \"Wild-type PINK1 prevents basal induced neuronal apoptosis , protective effect abrogated @ DiseaseTgt $ mutations . Mutations PTEN-induced kinase 1 ( PINK1 ) gene recently implicated autosomal recessive early onset @ DiseaseTgt $ ( 1 , 2 ) . investigate role PINK1 neurodegeneration , designed human murine neuronal cell lines expressing either wild-type PINK1 PINK1 bearing mutation associated @ DiseaseTgt $ . show basal staurosporine-induced conditions , number terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling ( TUNEL ) -positive cells lower wild-type PINK1 expressing SH-SY5Y cells mock-transfected cells . phenotype due PINK1-mediated reduction cytochrome c release mitochondria , prevents subsequent caspase-3 activation . show overexpression wild-type PINK1 strongly reduced basal staurosporine-induced caspase 3 activity . Overexpression wild-type PINK1 also reduced levels cleaved caspase-9 , caspase-3 , caspase-7 , activated @ GeneSrc $ basal staurosporine-induced conditions . contrast , @ DiseaseTgt $ mutations kinase-inactive mutation PINK1 abrogated protective effect PINK1 . Together , results suggest PINK1 reduces basal neuronal pro-apoptotic activity protects neurons staurosporine-induced apoptosis . Loss protective function may therefore underlie degeneration nigral dopaminergic neurons patients PINK1 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1847632155582359)\n",
      "- Text: \"Long-term haematopoietic reconstitution Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - -p16Ink4a , p19Arf Trp53 ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype @ GeneSrc $ , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045806168844222)\n",
      "- Text: \"PML/RARalpha @ GeneSrc $ induce APL-like disease mouse model . Acute promyelocytic leukemia ( APL ) cells invariably express aberrant fusion proteins involving retinoic acid receptor alpha ( RARalpha ) . common fusion partner promyelocytic leukemia protein ( PML ) , fused RARalpha balanced reciprocal chromosomal translocation , ( 15 ; 17 ) ( q22 : q11 ) . Expression PML/RARalpha cathepsin G promoter transgenic mice causes nonfatal myeloproliferative syndrome mice ; 15 % go develop APL long latent period , suggesting additional mutations required development APL . candidate target gene second mutation FLT3 , mutated approximately 40 % human APL cases . Activating mutations @ GeneSrc $ , including internal tandem duplication ( ITD ) juxtamembrane domain , transform hematopoietic cell lines factor independent growth . @ GeneSrc $ also induce myeloproliferative disease murine bone marrow transplant model , sufficient cause @ DiseaseTgt $ . , test hypothesis PML/RARalpha cooperate @ GeneSrc $ induce APL-like disease mouse . Retroviral transduction @ GeneSrc $ bone marrow cells obtained PML/RARalpha transgenic mice results short latency APL-like disease complete penetrance . disease resembles APL-like disease occurs long latency PML/RARalpha transgenics , suggesting activating mutations @ GeneSrc $ functionally substitute additional mutations occur mouse APL progression . leukemia transplantable secondary recipients ATRA responsive . observations document cooperation PML/RARalpha @ GeneSrc $ development murine APL phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0505342948120684)\n",
      "- Text: \"Loss presenilin function causes impairments memory synaptic plasticity followed age-dependent neurodegeneration . Mutations presenilins major cause familial @ DiseaseTgt $ , pathogenic mechanism presenilin mutations cause memory loss neurodegeneration remains unclear . demonstrate conditional double knockout mice lacking presenilins postnatal forebrain exhibit impairments hippocampal memory synaptic plasticity . deficits associated specific reductions NMDA receptor-mediated responses synaptic levels NMDA receptors alphaCaMKII . Furthermore , loss presenilins causes reduced expression CBP CREB/CBP target genes , @ GeneSrc $ BDNF . increasing age , mutant mice develop striking neurodegeneration cerebral cortex worsening impairments memory synaptic function . Neurodegeneration accompanied increased levels Cdk5 activator p25 hyperphosphorylated tau . results define essential roles molecular targets presenilins synaptic plasticity , learning memory , neuronal survival adult cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.999763943981689e-05)\n",
      "- Text: \"LRP8 variant associated familial premature coronary artery disease @ DiseaseTgt $ . previous genomewide linkage scan 428 nuclear families ( GeneQuest ) identified significant genetic susceptibility locus premature @ DiseaseTgt $ ( MI ) chromosome 1p34 - 36 . analyzed candidate genes locus population-based association study involving probands premature coronary artery disease ( CAD ) and/or MI GeneQuest families ( 381 cases ) 560 controls without stenosis detectable coronary angiography . nonconservative substitution , R952Q , LRP8 significantly associated susceptibility premature CAD and/or MI use population-based family-based designs . Three additional white populations used follow-up replication studies : another independent cohort CAD- and/or MI-affected families ( GeneQuest II : 441 individuals 22 pedigrees ) , Italian cohort familial MI ( 248 cases ) 308 Italian controls , separate Cleveland GeneBank cohort sporadic MI ( 1,231 cases ) 560 controls . association significantly replicated two independent populations family history CAD and/or MI , GeneQuest II family-based replication cohort Italian cohort , population sporadic disease . R952Q variant LRP8 increased activation @ GeneSrc $ oxidized low-density lipoprotein . extensive study , involving multiple independent populations , provides first evidence genetic variants LRP8 may contribute development premature familial CAD MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001604936425887)\n",
      "- Text: \"Amplification PPM1D human @ DiseaseTgt $ abrogates p53 @ DiseaseTgt $ activity . Expression oncogenic Ras primary human cells activates p53 , thereby protecting cells transformation . show Ras-expressing IMR-90 cells , p53 phosphorylated Ser33 Ser46 @ GeneSrc $ ( @ GeneSrc $ ) . Activity p38 MAPK regulated p53-inducible phosphatase PPM1D , creating potential feedback loop . Expression oncogenic Ras suppresses PPM1D mRNA induction , leaving p53 phosphorylated Ser33 Ser46 active state . Retrovirus-mediated overexpression PPM1D reduced p53 phosphorylation sites , abrogated Ras-induced apoptosis partially rescued cells cell-cycle arrest . Inactivation p38 MAPK ( product @ GeneSrc $ ) vivo gene targeting PPM1D overexpression expedited @ DiseaseTgt $ formation injection mouse embryo fibroblasts ( MEFs ) expressing E1A+Ras nude mice . gene encoding PPM1D ( PPM1D , 17q22/q23 ) amplified human breast-tumor cell lines approximately 11 % primary breast tumors , harbor wildtype p53 . findings suggest inactivation p38 MAPK PPM1D overexpression resulting PPM1D amplification contributes development human @ DiseaseTgt $ suppressing p53 activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0295793411918713)\n",
      "- Text: \"FBXO11 promotes Neddylation p53 inhibits transcriptional activity . p53 @ DiseaseTgt $ suppressor regulated post-translational modification , including ubiquitination , phosphorylation acetylation . previously shown ubiquitin ligase Mdm2 also promotes conjugation Nedd8 , ubiquitin-like protein , p53 , inhibiting transcriptional activity . report identification FBXO11 , member F-box protein family component Skp1.Cullin1.F-box ( SCF ) complex , new p53-interacting protein . show FBXO11 promotes neddylation p53 vitro vivo . addition C-terminal lysine residues , FBXO11 also promote Nedd8 conjugation Lys-320 Lys-321 , neddylation p53 leads suppression p53 function . consistent recent studies showing lysine arginine mutation Lys-320 significantly enhances p53 function , although Lys-320 originally identified acetylation site involving PCAF-mediated activation p53 . study provides example F-box protein acting adaptor protein mediate neddylation @ GeneSrc $ substrate .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.35178784507181e-06)\n",
      "- Text: \"Presenilin couples paired phosphorylation beta-catenin independent axin : implications beta-catenin activation tumorigenesis . @ DiseaseTgt $ gene presenilin 1 ( PS1 ) required intramembrane proteolysis APP Notch . addition , recent observations strongly implicate PS1 negative regulator Wnt/beta-catenin signaling pathway , although mechanism underlying activity unknown . , show presenilin functions scaffold rapidly couples beta-catenin phosphorylation two sequential kinase activities independent Wnt-regulated @ GeneSrc $ complex . Thus , presenilin deficiency results increased beta-catenin stability vitro vivo disconnecting stepwise phosphorylation beta-catenin , presence absence Wnt stimulation . findings highlight aspect beta-catenin regulation outside canonical Wnt-regulated pathway function presenilin separate intramembrane proteolysis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.634554209240566e-05)\n",
      "- Text: \"@ GeneSrc $ ablation highlights critical role p53 invasiveness control . mature gut renews continuously rapidly throughout adult life , often damage-inflicting micro-environment . major driving force self-renewal intestinal epithelium Wnt-mediated signalling pathway , Wnt signalling frequently hyperactivated colorectal cancer . show casein kinase Ialpha ( @ GeneSrc $ ) , component beta-catenin-destruction complex , critical regulator Wnt signalling pathway . Inducing ablation Csnk1a1 ( gene encoding @ GeneSrc $ ) gut triggers massive Wnt activation , surprisingly without causing tumorigenesis . @ GeneSrc $ epithelium shows many features human colorectal tumours addition Wnt activation , particular induction DNA damage response cellular senescence , thought provide barrier malignant transformation . epithelial DNA damage response mice accompanied substantial activation p53 , suggesting p53 pathway may counteract pro-tumorigenic effects Wnt hyperactivation . Notably , transition benign adenomas invasive colorectal cancer humans typically linked p53 inactivation , underscoring importance p53 safeguard malignant progression ; however , mechanism p53-mediated @ DiseaseTgt $ suppression unknown . show maintenance intestinal homeostasis @ GeneSrc $ gut requires p53-mediated growth control , combined ablation @ GeneSrc $ either p53 target gene p21 ( also known Waf1 , Cip1 , Sdi1 Cdkn1a ) triggered high-grade dysplasia extensive proliferation . Unexpectedly , ablations also induced non-proliferating cells invade villous lamina propria rapidly , producing invasive @ DiseaseTgt $ throughout small bowel . Furthermore , p53-deficient gut , loss heterozygosity gene encoding @ GeneSrc $ caused highly invasive carcinoma , indicating @ GeneSrc $ functions @ DiseaseTgt $ suppressor p53 inactivated . identified set genes ( p53-suppressed invasiveness signature , PSIS ) activated loss p53 @ GeneSrc $ probably accounts brisk induction invasiveness . PSIS transcription tumour invasion suppressed p21 , independently cell cycle control . Restraining tissue invasion suppressing PSIS expression thus novel @ DiseaseTgt $ function wild-type p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7757598622054698)\n",
      "- Text: \"Treatment copper-zinc chelator markedly rapidly inhibits beta-amyloid accumulation @ DiseaseTgt $ transgenic mice . Inhibition neocortical beta-amyloid ( Abeta ) accumulation may essential effective therapeutic intervention @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Cu Zn enriched Abeta deposits @ DiseaseTgt $ , solubilized Cu/Zn-selective chelators vitro . report 49 % decrease brain Abeta deposition ( -375 microg/g wet weight , p = 0.0001 ) blinded study APP2576 transgenic mice treated orally 9 weeks clioquinol , antibiotic bioavailable Cu/Zn chelator . accompanied modest increase soluble Abeta ( 1.45 % total cerebral Abeta ) ; APP , synaptophysin , @ GeneSrc $ levels unaffected . General health body weight parameters significantly stable treated animals . results support targeting interactions Cu Zn Abeta novel therapy prevention treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004017607938757)\n",
      "- Text: \"Reduced beta-amyloid production increased inflammatory responses presenilin conditional knock-out mice . Mutations presenilins ( PS ) 1 2 major cause familial @ DiseaseTgt $ . Conditional double knock-out mice lacking presenilins postnatal forebrain ( PS cDKO mice ) exhibit memory synaptic plasticity impairments followed progressive neurodegeneration cerebral cortex . investigate molecular events may underlie observed phenotypes identify additional neuropathological markers PS cDKO brain . Enzyme-linked immunosorbent assay analysis showed reduced levels toxic beta-amyloid ( Abeta ) peptides cerebral cortex PS cDKO mice . Interestingly , reduction Abeta40 Abeta42 peptides similar PS1 conditional knock-out PS cDKO mice . examined gene expression profile oligonucleotide microarrays PS cDKO cerebral cortex found high number genes differentially expressed , notably group up-regulated inflammatory genes . Quantitative real-time reverse transcription PCR Western analyses confirmed elevated levels @ GeneSrc $ , complement component C1q , cathepsin , up-regulation associated inflammatory responses various neurodegenerative processes . Immunohistochemical analysis revealed increase complement component C1q confined hippocampal formation , whereas @ GeneSrc $ cathepsin up-regulated throughout entire neocortex hippocampus . addition , strong microglial activation occurs hippocampus deeper cortical layers PS cDKO mice . results indicate memory impairment neurodegeneration PS cDKO mice caused Abeta accumulation loss PS function leads differential up-regulation inflammatory markers cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012729352113651)\n",
      "- Text: \"Induction medulloblastomas p53-null mutant mice somatic inactivation Rb external granular layer cells cerebellum . Medulloblastomas among common @ DiseaseTgt $ childhood , associated substantial mortality morbidity . molecular pathogenesis well ontogeny @ DiseaseTgt $ still poorly understood . generated mouse model medulloblastoma Cre-LoxP-mediated inactivation Rb p53 @ DiseaseTgt $ suppressor genes cerebellar external granular layer ( EGL ) cells . @ GeneSrc $ recombination found astrocytes immature precursor cells EGL developing cerebellum . @ GeneSrc $ LoxP/LoxP ) mice developed highly aggressive embryonal tumors cerebellum typical features medulloblastoma . @ DiseaseTgt $ identified early 7 weeks age outer surface molecular layer , corresponding location EGL cells development . results demonstrate loss function RB essential medulloblastoma development mouse strongly support hypothesis medulloblastomas arise multipotent precursor cells located EGL .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0940156856439876)\n",
      "- Text: \"Association regulation casein kinase 2 activity adenomatous polyposis coli protein . Mutations adenomatous polyposis coli ( APC ) gene responsible familial adenomatous polyposis coli also sporadic @ DiseaseTgt $ development . using antibodies raised N-terminal region APC protein , detected variable masses endogenous APC proteins individual cell lines established human @ DiseaseTgt $ caused nonsense mutations gene . Phosphorylation immunoprecipitates full-length truncated APC observed vitro kinase reaction , indicating association APC protein kinase activity . kinase activity complexed APC sensitive heparin used GTP phosphoryl donor , suggesting involvement casein kinase 2 ( CK2 ) . @ GeneSrc $ beta-subunits found associate APC immunoprecipitates well pull-down assays , preferential interaction APC tetrameric CK2 holoenzyme . synchronized cell populations , association APC CK2 cell cycle dependent , highest association G ( 2 ) /M . Unexpectedly , APC immunoprecipitates containing full-length APC protein inhibited CK2 vitro , whereas immunoprecipitates truncated APC little effect . confirmed using recombinant APC , inhibitory region localized C terminus APC residues 2086 2394 . Overexpression fragment SW480 cells suppressed cell proliferation rates well tumorigenesis . results demonstrate previously uncharacterized functional interaction tumor suppressor protein APC CK2 suggest growth-inhibitory effects APC may regulated inhibition CK2 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008302646010077)\n",
      "- Text: \"Gene expression profiling isogenic cells different TP53 gene dosage reveals numerous genes affected TP53 dosage identifies @ GeneSrc $ direct target p53 . TP53 fully comply Knudson model [ Knudson , A. G. , Jr. ( 1971 ) Proc . Natl . Acad . Sci . USA 68 , 820 - 823 ] reduction constitutional expression p53 may sufficient @ DiseaseTgt $ predisposition . finding suggests gene-dosage effect p53 function . determine whether TP53 gene dosage affects transcriptional regulation target genes , performed oligonucleotide-array gene expression analysis using human cells wild-type p53 ( p53 + /+ ) , one ( p53 + /- ) , ( p53 -/- ) TP53 alleles disrupted homologous recombination . identified 35 genes whose expression significantly correlated dosage TP53 . genes involved variety cellular processes including signal transduction , cell adhesion , transcription regulation . Several involved neurogenesis neural crest migration , developmental processes p53 known play role . Motif search analysis revealed genes highly expressed p53 + /+ + /- cells , several contain putative p53 consensus binding site ( bs ) , suggesting could directly regulated p53 . Among genes , chose @ GeneSrc $ ( encodes @ GeneSrc $ ) study contains bona fide p53 bs first intron expression highly correlates TP53 dosage . using vitro vivo assays , showed @ GeneSrc $ directly transactivated p53 . conclusion , developed strategy demonstrate many genes affected TP53 gene dosage expression . report several candidate genes potential downstream targets p53 nonstressed cells . Among , @ GeneSrc $ validated directly transactivated p53 . method provides useful tool elucidate additional mechanisms p53 exerts functions .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0131248304217585)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near @ GeneSrc $ dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , MLXIPL , PCSK9 , GALNT2 GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 @ GeneSrc $ . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024771925687816)\n",
      "- Text: \"PIK3CA variants selectively initiate brain hyperactivity gliomagenesis . Glioblastoma universally lethal form brain cancer exhibits array pathophysiological phenotypes , many mediated interactions neuronal microenvironment1,2 . Recent studies shown increases neuronal activity important role proliferation progression glioblastoma3,4 . Whether reciprocal crosstalk glioblastoma neurons remains poorly defined , mechanisms underlie @ DiseaseTgt $ remodel neuronal milieu towards increased activity unknown . , using native mouse model glioblastoma , develop high-throughput vivo screening platform discover several driver variants PIK3CA . show @ DiseaseTgt $ driven variants divergent molecular properties manifest selective initiation brain hyperexcitability remodelling synaptic constituency . Furthermore , secreted members glypican ( GPC ) family selectively expressed @ DiseaseTgt $ , @ GeneSrc $ drives gliomagenesis hyperexcitability . Together , studies illustrate importance functionally interrogating diverse @ DiseaseTgt $ phenotypes driven individual , yet related , variants reveal glioblastoma alters neuronal microenvironment .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7079181176631283)\n",
      "- Text: \"GIGYF2 gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . @ GeneSrc $ GYF Protein 2 ( GIGYF2 ) initially identified interaction @ GeneSrc $ , adapter protein binds activated IGF-I insulin receptors . GIGYF2 gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( PARK11 locus ) , association GIGYF2 mutations @ DiseaseTgt $ described recent publications . study investigated consequences Gigyf2 gene disruption mice . Gigyf2 null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous Gigyf2 ( +/- ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , Gigyf2 ( +/- ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . alpha-synuclein positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts Gigyf2 null mice exhibit decreased IGF-I-stimulated IGF-I receptor tyrosine phosphorylation augmented ERK1/2 phosphorylation . data provide evidence important role GIGYF2 age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0848050923647636)\n",
      "- Text: \"Mutations cardiac transcription factor @ GeneSrc $ affect diverse cardiac developmental pathways . Heterozygous mutations @ GeneSrc $ , homeobox transcription factor , reported cause secundum atrial septal defects result atrioventricular ( AV ) conduction block postnatal life . characterize role @ GeneSrc $ cardiac morphogenesis , sought additional mutations groups probands cardiac anomalies first-degree AV block , idiopathic AV block , @ DiseaseTgt $ . identified 7 novel mutations sequence analysis @ GeneSrc $ region 26 individuals . Associated phenotypes included AV block , primary manifestation cardiac disease nearly quarter affected individuals , well atrial septal defect ventricular septal defect . Ventricular septal defect associated @ DiseaseTgt $ double-outlet right ventricle 3 individuals . Ebstein 's anomaly tricuspid valve abnormalities also present . Mutations human @ GeneSrc $ cause variety cardiac anomalies may account clinically significant portion @ DiseaseTgt $ idiopathic AV block . coinheritance @ GeneSrc $ mutations various congenital heart defects suggests transcription factor contributes diverse cardiac developmental pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1102959091265715)\n",
      "- Text: \"@ GeneSrc $ mutations patients @ DiseaseTgt $ . BACKGROUND : Recent reports implicated mutations transcription factor @ GeneSrc $ cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . estimate frequency @ GeneSrc $ mutations @ DiseaseTgt $ patients investigate genotype-phenotype correlation @ GeneSrc $ mutations , genotyped 114 @ DiseaseTgt $ patients . METHODS RESULTS : Patients recruited prospectively ( November 1992 June 1999 ) tested 22q11 deletion ; 22q11 deletion recognized chromosomal alteration excluded present study . Patients screened @ GeneSrc $ alterations conformation-sensitive gel electrophoresis sequencing fragments aberrant mobility . Four heterozygous mutations identified 6 unrelated patients cases @ DiseaseTgt $ , including 3 pulmonary atresia 5 right aortic arch ; none ECG evidence PR interval prolongation . Three 4 mutations ( Glu21Gln , Arg216Cys , Ala219Val ) altered highly conserved amino acids , 2 mapped conserved NK2 domain . fourth mutation ( Arg25Cys ) identified 3 unrelated probands present study previously reported . homeodomain mutations identified . CONCLUSIONS : @ GeneSrc $ mutations first gene defects identified @ DiseaseTgt $ patients . @ GeneSrc $ mutation present > /=4 % @ DiseaseTgt $ patients . Mutations identified present study mapped outside homeodomain , associated atrioventricular conduction disturbances , fully penetrant , contrast mutations previously reported impair homeodomain function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3041233975643008)\n",
      "- Text: \"New mutations ZFPM2/FOG2 gene @ DiseaseTgt $ double outlet right ventricle . Conotruncal defects ( CTDs ) represent 15 - 20 % congenital heart defects . Mutations number genes associated CTD humans animal models . investigated occurrence prevalence GATA4 , @ GeneSrc $ , ZFPM2/FOG2 , GDF1 , ISLET1 gene mutations large cohort individuals CTD , including @ DiseaseTgt $ without pulmonary atresia ( @ DiseaseTgt $ , 178 patients ) , double outlet right ventricle ( DORV , 13 patients ) , truncus arteriosus ( 11 patients ) . Denaturing high-performance liquid chromatography ( DHPLC ) analysis followed bidirectional sequencing disclosed putative pathogenic mutation GATA4 , ISLET1 , GDF1 genes . Two novel ( Ile227Val , Met544Ile ) one previously reported ( Glu30Gly ) possibly pathogenic missense variants identified ZFPM2/FOG2 gene 3 sporadic patients 202 ( 1.5 % ) CTD , including 1 178 ( 0.6 % ) @ DiseaseTgt $ 2 13 ( 15.4 % ) DORV . Mutation analysis also detected one known missense change ( Arg25Cys ) @ GeneSrc $ gene two ( 1.1 % ) sporadic patients @ DiseaseTgt $ . sequence alterations found absent 500 population-matched controls . conclusion , present results ( ) indicate confirm mutations GATA4 , GDF1 , ISLET1 genes major determinants pathogenesis @ DiseaseTgt $ , ( ii ) provide supportive evidence association ZFPM2/FOG2 gene @ DiseaseTgt $ , ( iii ) provide additional examples possible contribution Arg25Cys change @ GeneSrc $ small number @ DiseaseTgt $ cases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0783088613404342)\n",
      "- Text: \"@ GeneSrc $ mutations patients congenital heart disease . OBJECTIVES : purpose study estimate frequency @ GeneSrc $ mutations specific cardiovascular anomalies investigate genotype-phenotype correlations individuals @ GeneSrc $ mutations . BACKGROUND : Recent reports implicated mutations transcription factor @ GeneSrc $ cause various congenital heart defects ( CHD ) . METHODS : tested genomic deoxyribonucleic acid 608 prospectively recruited patients conotruncal anomalies ( n = 370 ) , left-sided lesions ( n = 160 ) , secundum atrial septal defect ( ASD ) ( n = 71 ) , Ebstein 's malformation ( n = 7 ) @ GeneSrc $ mutations . RESULTS : Twelve distinct mutations @ GeneSrc $ coding region identified 18 608 patients ( 3 % ) , including 9 201 ( 4 % ) @ DiseaseTgt $ , 3 71 ( 4 % ) secundum ASD , one truncus arteriosus , double-outlet right ventricle , L-transposition great arteries , interrupted aortic arch , hypoplastic left heart syndrome , aortic coarctation , patients D-transposition great arteries ( n = 86 ) valvar aortic stenosis ( n = 21 ) . Eleven mutations amino acid-altering missense nucleotide substitutions deletions , one predicted cause premature termination translation . None mutations homeodomain . Sixteen 18 individuals @ GeneSrc $ mutations study family history congenital cardiovascular anomalies , one first-degree atrioventricular ( AV ) block . CONCLUSIONS : @ GeneSrc $ mutations occur small percentage patients various CHD . mutations identified study missense , outside homeodomain , associated AV block . findings suggest @ GeneSrc $ mutations non-homeodomain regions may important development human structural cardiac defects .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017513453452441)\n",
      "- Text: \"Comprehensive genotype-phenotype analysis 230 patients @ DiseaseTgt $ . BACKGROUND : @ DiseaseTgt $ ( @ DiseaseTgt $ ) , frequent cyanotic congenital heart disease , associated wide range intra- extracardiac phenotypes . order get insight genotype-phenotype correlation , large cohort 230 unselected patients @ DiseaseTgt $ comprehensively investigated . METHODS RESULTS : 230 patients @ DiseaseTgt $ studied karyotyping , comprehensive 22q11.2 deletion testing sequencing TBX1 , @ GeneSrc $ JAG1 , well molecular karyotyping selected patients . Pathogenic genetic aberrations found 42 patients ( 18 % ) , 22q11.2 deletion common diagnosis ( 7.4 % ) , followed trisomy 21 ( 5.2 % ) chromosomal aberrations submicroscopic copy number changes ( 3 % ) . Mutations JAG1 detected three patients Alagille syndrome ( 1.3 % ) , @ GeneSrc $ mutations seen two patients non-syndromic @ DiseaseTgt $ ( 0.9 % ) . One patient showed recurrent polyalanine stretch elongation within TBX1 represents true mutation resulting loss transcriptional activity due cytoplasmatic protein aggregation . CONCLUSION : study shows 22q11.2 deletion represents common known cause @ DiseaseTgt $ , associated cardiac phenotype distinct obstruction proximal pulmonary artery , hypoplastic central pulmonary arteries subclavian artery anomalies . Atrioventricular septal defect associated @ DiseaseTgt $ suggestive trisomy 21 almost excludes 22q11.2 deletion . report patient recurrent polyalanine stretch elongation within TBX1 first time link TBX1 cytoplasmatic protein aggregation congenital heart defects .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3432980107758722)\n",
      "- Text: \"Mutational spectrum cardiac transcription factor gene @ GeneSrc $ ( @ GeneSrc $ ) associated congenital heart disease . Heterozygous mutations human transcription factor gene @ GeneSrc $ associated either isolated combined congenital heart disease ( CHD ) , primarily secundum atrial septal defect-II ( ASD-II ) , ventricular septal defect ( VSD ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Thus , @ GeneSrc $ important role different stages cardiac development . frequency @ GeneSrc $ mutations broader phenotypic spectrum CHD completely determined . , report identification two novel mutations @ GeneSrc $ gene screening 121 patients broad spectrum CHDs . However , mutations associated familial ASD-II , patients also showed atrioventricular ( AV ) block . found one missense mutation ( R190L ) two siblings ASD-II frame-shift mutation ( A255fsX38 ) C-terminus mother daughter . addition , single patient hypoplastic left heart syndrome ( HLHS ) reported sequence variant R25C . Importantly , sporadic cases CHD share phenotypic aspects @ GeneSrc $ mutation carriers negative genetic analysis . Thus , even important cardiac development , germline mutations @ GeneSrc $ rare patients sporadic CHD genetic and/or pathophysiologic heterogeneity likely sporadic forms CHD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0194799540031655)\n",
      "- Text: \"Mutations GATA4 @ GeneSrc $ genes Chinese pediatric patients non-familial congenital heart disease . number mutations GATA4 @ GeneSrc $ identified causative subset familial congenital heart defects ( CHDs ) small number sporadic CHDs . study , evaluated common GATA4 @ GeneSrc $ mutations 135 Chinese pediatric patients non-familial congenital heart defects . Two novel mutations coding region GATA4 identified , namely , 487C > ( Pro163Ser ) exon 1 child @ DiseaseTgt $ 1220C > ( Pro407Gln ) exon 6 pediatric patient outlet membranous ventricular septal defect . also found 848C > ( Pro283Gln ) exon 2 @ GeneSrc $ gene pediatric patient ventricular septal defect , patent ductus arteriosus aortic isthmus stenosis . None mutations detected healthy control subjects ( n = 114 ) . study suggests GATA4 @ GeneSrc $ missense mutations may associated congenital heart defects pediatric Chinese patients . clinical studies large samples warranted .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003964816854888)\n",
      "- Text: \"Destabilization @ GeneSrc $ mutations presenilin-1 potentiates neuronal apoptosis . Mutations presenilin-1 gene major cause familial early-onset @ DiseaseTgt $ . Presenilin-1 associate members catenin family signalling proteins , significance association unknown . show presenilin-1 forms complex @ GeneSrc $ vivo increases @ GeneSrc $ stability . Pathogenic mutations presenilin-1 gene reduce ability presenilin-1 stabilize beta-catenin , lead increased degradation beta-catenin brains transgenic mice . Moreover , @ GeneSrc $ levels markedly reduced brains @ DiseaseTgt $ patients presenilin-1 mutations . Loss @ GeneSrc $ signalling increases neuronal vulnerability apoptosis induced amyloid-beta protein . Thus , mutations presenilin-1 may increase neuronal apoptosis altering stability @ GeneSrc $ , predisposing individuals early-onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4590089579729401)\n",
      "- Text: \"Loss presenilin 1 associated enhanced beta-catenin signaling skin tumorigenesis . Presenilin 1 ( PS1 ) required proteolytic processing Notch beta-amyloid precursor protein ( APP ) , molecules play pivotal roles cell-fate determination development @ DiseaseTgt $ pathogenesis , respectively . addition , PS1 interacts @ GeneSrc $ promotes turnover independent mechanisms . Consistent activity , report PS1 important controlling epidermal cell proliferation vivo . PS1 knockout mice rescued neuronal expression human PS1 transgene develop spontaneous skin cancers . PS1-null keratinocytes exhibit higher cytosolic beta-catenin beta-catenin/lymphoid enhancer factor-1/T cell factor ( beta-catenin/LEF ) -mediated signaling . effect reversed reintroducing wild-type PS1 , PS1 mutant active Notch processing defective @ GeneSrc $ binding . Nuclear @ GeneSrc $ protein detected tumors . Elevated beta-catenin/LEF signaling correlated activation downstream target cyclin D1 accelerated entry G ( 1 ) phase cell cycle . report demonstrates function PS1 adult tissues , analysis suggests deregulation @ GeneSrc $ pathway contributes skin tumor phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005477515368539)\n",
      "- Text: \"Presenilin couples paired phosphorylation @ GeneSrc $ independent axin : implications @ GeneSrc $ activation tumorigenesis . @ DiseaseTgt $ gene presenilin 1 ( PS1 ) required intramembrane proteolysis APP Notch . addition , recent observations strongly implicate PS1 negative regulator @ GeneSrc $ signaling pathway , although mechanism underlying activity unknown . , show presenilin functions scaffold rapidly couples @ GeneSrc $ phosphorylation two sequential kinase activities independent Wnt-regulated Axin/CK1alpha complex . Thus , presenilin deficiency results increased @ GeneSrc $ stability vitro vivo disconnecting stepwise phosphorylation @ GeneSrc $ , presence absence Wnt stimulation . findings highlight aspect @ GeneSrc $ regulation outside canonical Wnt-regulated pathway function presenilin separate intramembrane proteolysis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.060099487652495)\n",
      "- Text: \"@ GeneSrc $ mutations @ DiseaseTgt $ correlate low rate loss heterozygosity . determine frequency Wnt/Wingless @ GeneSrc $ pathway alteration human @ DiseaseTgt $ , @ GeneSrc $ APC gene mutation screening performed series 119 tumors . activating @ GeneSrc $ mutation exon 3 found 18 % cases . Among tumors lacking @ GeneSrc $ mutation , APC mutation evidenced subset 30 cases tested . correlation @ GeneSrc $ mutation status chromosome segment deletions studied set 48 hyperploid tumors . Chromosome 1p , 4q 16p deletions significantly associated absence @ GeneSrc $ mutation ( P < 0.05 ) . Furthermore Fractional Allelic Loss significantly smaller @ GeneSrc $ mutated tumors non-mutated tumors ( 0.12 versus 022 ) . Taken together , results suggest , existence two carcinogenesis mechanisms . first mechanism implies @ GeneSrc $ activating mutation associated low rate loss heterozygosity . second mechanism , operating context chromosomal instability , would involve tumor suppressor genes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6732421096151064)\n",
      "- Text: \"@ GeneSrc $ regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human colon cancers . Loss functional APC protein results accumulation @ GeneSrc $ . Mutant forms @ GeneSrc $ discovered colon cancers retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer @ DiseaseTgt $ . accumulation @ GeneSrc $ activates genes responsive transcription factors TCF/LEF family , @ GeneSrc $ interacts . show @ GeneSrc $ activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant @ GeneSrc $ produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF colon-cancer cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels @ GeneSrc $ may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.085569961423424)\n",
      "- Text: \"AXIN1 mutations @ DiseaseTgt $ , growth suppression cancer cells virus-mediated transfer AXIN1 . Wnt signaling pathway essential development organogenesis . Wnt signaling stabilizes @ GeneSrc $ , accumulates cytoplasm , binds 1-cell factor ( TCF ; also known lymphocyte enhancer-binding factor , LEF ) upregulates downstream genes . Mutations @ GeneSrc $ ( encoding @ GeneSrc $ ) APC ( adenomatous polyposis coli ) reported human neoplasms including colon cancers @ DiseaseTgt $ ( @ DiseaseTgt $ ) . HCC5 tend show accumulation @ GeneSrc $ often mutations @ GeneSrc $ , looked mutations AXIN1 , encoding key factor Wnt signaling , 6 @ DiseaseTgt $ cell lines 100 primary HCC5 . Among 4 cell lines 87 HCC5 detect @ GeneSrc $ mutations , identified AXIN1 mutations 3 cell lines 6 mutations 5 primary @ DiseaseTgt $ . cell lines containing mutations either gene , observed increased DNA binding TCF associated @ GeneSrc $ nuclei . Adenovirus mediated gene transfer wild-type AXINI induced apoptosis hepatocellular colorectal cancer cells accumulated @ GeneSrc $ consequence either APC , @ GeneSrc $ AXIN1 mutation , suggesting axin may effective therapeutic molecule suppressing growth hepatocellular colorectal cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1342232756886919)\n",
      "- Text: \"CKIalpha ablation highlights critical role p53 invasiveness control . mature gut renews continuously rapidly throughout adult life , often damage-inflicting micro-environment . major driving force self-renewal intestinal epithelium Wnt-mediated signalling pathway , Wnt signalling frequently hyperactivated colorectal cancer . show casein kinase Ialpha ( CKIalpha ) , component @ GeneSrc $ complex , critical regulator Wnt signalling pathway . Inducing ablation Csnk1a1 ( gene encoding CKIalpha ) gut triggers massive Wnt activation , surprisingly without causing tumorigenesis . CKIalpha-deficient epithelium shows many features human colorectal tumours addition Wnt activation , particular induction DNA damage response cellular senescence , thought provide barrier malignant transformation . epithelial DNA damage response mice accompanied substantial activation p53 , suggesting p53 pathway may counteract pro-tumorigenic effects Wnt hyperactivation . Notably , transition benign adenomas invasive colorectal cancer humans typically linked p53 inactivation , underscoring importance p53 safeguard malignant progression ; however , mechanism p53-mediated @ DiseaseTgt $ suppression unknown . show maintenance intestinal homeostasis CKIalpha-deficient gut requires p53-mediated growth control , combined ablation Csnk1a1 either p53 target gene p21 ( also known Waf1 , Cip1 , Sdi1 Cdkn1a ) triggered high-grade dysplasia extensive proliferation . Unexpectedly , ablations also induced non-proliferating cells invade villous lamina propria rapidly , producing invasive @ DiseaseTgt $ throughout small bowel . Furthermore , p53-deficient gut , loss heterozygosity gene encoding CKIalpha caused highly invasive carcinoma , indicating CKIalpha functions @ DiseaseTgt $ suppressor p53 inactivated . identified set genes ( p53-suppressed invasiveness signature , PSIS ) activated loss p53 CKIalpha probably accounts brisk induction invasiveness . PSIS transcription tumour invasion suppressed p21 , independently cell cycle control . Restraining tissue invasion suppressing PSIS expression thus novel @ DiseaseTgt $ function wild-type p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1074623690200221)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway colorectal cancer well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) adenomatous polyposis coli ( APC ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies hMLH1 , hMSH2 , @ GeneSrc $ , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One @ DiseaseTgt $ ( 5 % ) found RER+ , @ DiseaseTgt $ stained positive hMLH1 hMSH2 . mutations detected MCR APC gene . @ GeneSrc $ showed increased nuclear expression loss membranous staining 10 @ DiseaseTgt $ ( 48 % ) . Absent decreased membrane expression E-cadherin found eight @ DiseaseTgt $ ( 38 % ) . Strong staining p53 found nucleus five @ DiseaseTgt $ ( 24 % ) . CONCLUSION : detect mutations MCR APC gene , suggests adenocarcinoma small intestine may follow different genetic pathway colorectal cancer . Abnormal expression E-cadherin @ GeneSrc $ common reflects early alternative APC pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0921316299652343)\n",
      "- Text: \"Mutational analysis @ GeneSrc $ gene Japanese @ DiseaseTgt $ : frequent mutations endometrioid carcinomas . investigate contribution @ GeneSrc $ gene development @ DiseaseTgt $ , mutational analysis exon 3 @ GeneSrc $ gene conducted . analyzed 61 @ DiseaseTgt $ , consisting 49 non-endometrioid-type 12 endometrioid-type tumors , genetic alteration @ GeneSrc $ gene . Five carcinomas showed @ GeneSrc $ mutations ( S37C , T41I , T41A ) , including 4 ( 33 % ) 12 endometrioid-type tumors 1 ( 14 % ) 7 mucinous-type tumors . mutations altered serine/threonine residues potential sites GSK3-beta phosphorylation . detected carcinomas interstitial deletion involving exon 3 @ GeneSrc $ . Furthermore , immunohistochemically studied 27 61 @ DiseaseTgt $ . nuclear cytoplasmic @ GeneSrc $ expressions demonstrated 4 27 @ DiseaseTgt $ tissue samples available examination . 4 cases exhibited mutations exon 3 @ GeneSrc $ , including mucinous carcinoma . results suggested @ GeneSrc $ gene mutation potential GSK3-beta phosphorylation sites results accumulation @ GeneSrc $ protein within cells translocation nuclei . Accumulated @ GeneSrc $ protein may involved development @ DiseaseTgt $ , @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0545854605779217)\n",
      "- Text: \"@ GeneSrc $ mutation expression analysis @ DiseaseTgt $ : exon 3 mutations nuclear translocation 16 % endometrioid tumours . molecular mechanisms involved generation epithelial ovarian cancers poorly understood , evidence suggests different histological subtypes may arise independent tumorigenic events . @ GeneSrc $ emerging important oncogene transformation number epithelial cancers , mutations reported small study @ DiseaseTgt $ . Mutations NH ( 2 ) -regulatory domain @ GeneSrc $ stabilise cytoplasmic levels protein , promotes up-regulation @ GeneSrc $ factor-lymphoid enhancer factor transcriptional complex . report @ GeneSrc $ ( @ GeneSrc $ ) exon 3 mutation analysis 149 epithelial ovarian carcinomas . revealed 10/63 ( 16 % ) @ DiseaseTgt $ activating mutations @ GeneSrc $ gene . mutations missense changes within GSK3beta consensus site , affecting serine residues codons 33 37 glycine codon 34 . Immuno-histochemical analysis identified cytoplasmic stabilisation nuclear translocation endometrioid tumours mutations . phenotypic change also identified 3 endometrioid tumours somatic mutations within exon 3 @ GeneSrc $ . Stabilisation free , monomeric pool @ GeneSrc $ probable resulting constitutive activation Tcf-associated transcriptional complex appears specific oncogenic event @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6686943173993459)\n",
      "- Text: \"Yeast artificial chromosome cloning @ GeneSrc $ locus human chromosome 3p21 - 22 . @ GeneSrc $ emerged important component adherens junctions epithelial cells . result studies interaction APC gene product , implicated development @ DiseaseTgt $ . alpha-Catenin , @ GeneSrc $ , E-cadherin APC appear mediate contact inhibition epithelia . part study organization @ GeneSrc $ gene , isolated yeast artificial chromosomes ( YACs ) characterize intron/exon structure . YAC fluorescence situ hybridization analysis polymerase chain reaction analysis somatic cell hybrid DNAs show @ GeneSrc $ maps 3p21 - 22 region , location tumour-suppressor genes deleted small-cell lung cancer ( SCLC ) disorders . @ GeneSrc $ YACs provide source microsatellite markers useful loss heterozygosity studies assess importance @ GeneSrc $ deletions SCLC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0083046142104538)\n",
      "- Text: \"common human skin tumour caused activating mutations @ GeneSrc $ . WNT signalling orchestrates number developmental programs . response stimulus , cytoplasmic @ GeneSrc $ ( encoded @ GeneSrc $ ) stabilized , enabling downstream transcriptional activation members LEF/TCF family . One target genes @ GeneSrc $ encodes c-MYC , explaining constitutive activation WNT pathway lead cancer , particularly colon . @ DiseaseTgt $ arise mutations gene encoding adenomatous polyposis coli ( APC ) , protein required ubiquitin-mediated degradation @ GeneSrc $ , small percentage colon cancers harbour @ GeneSrc $ mutations . Recently , discovered transgenic mice expressing activated beta-catenin predisposed developing skin tumours resembling pilomatricomas . Given skin adult mice also exhibits signs de novo hair-follicle morphogenesis , wondered whether human pilomatricomas might originate hair matrix cells whether might possess @ GeneSrc $ mutations . , explore cell origin aetiology common human skin tumour . found nuclear LEF-1 dividing tumour cells , providing biochemical evidence pilomatricomas derived hair matrix cells . least 75 % tumours possess mutations affecting amino-terminal segment , normally involved phosphorylation-dependent , ubiquitin-mediated degradation protein . percentage @ GeneSrc $ mutations greater human tumours examined thus far , directly implicates @ GeneSrc $ misregulation major cause hair matrix cell tumorigenesis humans .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9804332333585224)\n",
      "- Text: \"Targeted inactivation @ GeneSrc $ reveals unexpected effects @ GeneSrc $ mutation . Inactivating mutations adenomatous polyposis coli gene ( APC ) activating mutations @ GeneSrc $ gene ( @ GeneSrc $ ) initiate colorectal neoplasia . address biochemical physiologic effects mutant @ GeneSrc $ , disrupted either mutant wild-type @ GeneSrc $ allele human @ DiseaseTgt $ cell line . Cells wild-type @ GeneSrc $ decreased colony-forming ability plated low density , although growth similar parental cells passaged routine conditions . Immunohistochemistry cell-fractionation studies suggested mutant @ GeneSrc $ activity distinguished primarily cellular localization protein degradation . Surprisingly , found mutant @ GeneSrc $ bound less well E-cadherin wild-type @ GeneSrc $ , membranous localization wild-type mutant @ GeneSrc $ accordingly distinct . findings pose several challenges current models @ GeneSrc $ function .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9601687163948562)\n",
      "- Text: \"CDK8 @ DiseaseTgt $ oncogene regulates @ GeneSrc $ activity . Aberrant activation canonical @ GeneSrc $ pathway occurs almost @ DiseaseTgt $ contributes growth , invasion survival . Although dysregulated @ GeneSrc $ activity drives colon tumorigenesis , genetic perturbations required elaborate full malignant transformation . identify genes modulate @ GeneSrc $ activity essential @ DiseaseTgt $ cell proliferation , conducted two loss-of-function screens human @ DiseaseTgt $ cells compared genes identified screens analysis copy number alterations @ DiseaseTgt $ specimens . One genes , CDK8 , encodes member mediator complex , located 13q12.13 , region recurrent copy number gain substantial fraction @ DiseaseTgt $ . show suppression CDK8 expression inhibits proliferation @ DiseaseTgt $ cells characterized high levels CDK8 @ GeneSrc $ hyperactivity . CDK8 kinase activity necessary @ GeneSrc $ transformation expression several @ GeneSrc $ transcriptional targets . Together observations suggest therapeutic interventions targeting CDK8 may confer clinical benefit @ GeneSrc $ malignancies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1463555644884499)\n",
      "- Text: \"@ GeneSrc $ mutations cell lines established human @ DiseaseTgt $ . @ GeneSrc $ functions adhesion signaling molecule . Disruption functions mutations @ GeneSrc $ gene ( @ GeneSrc $ ) may important development @ DiseaseTgt $ . examined entire coding sequence @ GeneSrc $ reverse transcriptase-PCR ( RT-PCR ) direct sequencing 23 human @ DiseaseTgt $ cell lines 21 patients . two cell lines , apparent instability @ GeneSrc $ mRNA . Five different mutations ( 26 % ) found remaining 21cell lines ( 19 patients ) . three-base deletion ( codon 45 ) identified cell line HCT 116 , whereas cell lines SW 48 , HCA 46 , CACO 2 , Colo 201 contained single-base missense mutations ( codons 33 , 183 , 245 , 287 , respectively ) . 23 cell lines full-length @ GeneSrc $ protein detectable Western blotting coprecipitated E-cadherin . three cell lines @ GeneSrc $ mutations , complexes @ GeneSrc $ alpha-catenin APC detectable . SW48 HCA 46 , however , detect complexes @ GeneSrc $ protein alpha-catenin APC , respectively . results show selection @ GeneSrc $ mutations occurs 26 % @ DiseaseTgt $ cell lines derived . cases , mutation selection probably altered @ GeneSrc $ function , may significantly alter intracellular signaling intercellular adhesion may serve complement APC mutations early stages tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1459134379589233)\n",
      "- Text: \"Activation @ GeneSrc $ gene interstitial deletions involving exon 3 primary @ DiseaseTgt $ without adenomatous polyposis coli mutations . Among 222 primary @ DiseaseTgt $ examined , 58 showed detectable APC mutations protein truncation test . screened 58 tumors somatic mutations @ GeneSrc $ gene . Although amino acid substitutions serine threonine residues exon 3 reported , found mutations ; however , seven tumors , detected somatic interstitial deletions 234 - 760 bp , included part exon 3 . Short nucleotide sequences ends deletion either identical complementary , indicating repeated inversely repeated sequences involved somatic rearrangements . Reverse transcription-PCR experiments using RNAs isolated three seven tumors detected transcripts lacked exon 3 , addition normal transcript . one cases , confirmed accumulation aberrant @ GeneSrc $ protein cytoplasm nuclei cancer cells Western immunohistochemical analyses . result suggested , absence peptide encoded exon 3 , @ GeneSrc $ stabilized dominant oncogenic effect colorectal tumorigenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4682356586232731)\n",
      "- Text: \"Intestinal polyposis mice dominant stable mutation beta-catenin gene . Ectopic expression certain Wnt genes mouse mammary tissue tumorigenic , mutations stabilize @ GeneSrc $ found various human cancers including @ DiseaseTgt $ . determine role stabilized beta-catenin intestinal tumorigenesis mice , constructed embryonic stem ( ES ) cell-mediated homologous recombination , mutant beta-catenin allele whose exon 3 sandwiched loxP sequences . germline heterozygotes crossed mice expressing Cre recombinase intestines , serines threonine encoded exon 3 phosphorylated glycogen synthase kinase 3beta ( GSK3beta ) deleted offspring intestines , caused adenomatous intestinal polyps resembling Apc ( Delta716 ) knockout mice . nascent microadenomas also found colon . results present experimental genetic evidence activation Wnt signaling pathway cause intestinal colonic tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035838066900216)\n",
      "- Text: \"@ GeneSrc $ degradation mediated CID domain APC provides model selection APC mutations colorectal , desmoid duodenal tumours . Biallelic mutation ADENOMATOUS POLYPOSIS COLI ( APC ) gene hallmark @ DiseaseTgt $ colorectal , duodenal desmoid tumours develop familial adenomatous polyposis ( FAP ) patients . mutations affecting APC alleles interdependent , position first APC mutation determining second hit occur . results complex pattern mutation distribution APC sequence translates stabilization @ GeneSrc $ turn feeds affected cells permanent mitogenic signal . describe new APC domain , @ GeneSrc $ inhibitory domain ( CID ) APC located second third 20 amino acid repeats therefore present many truncated APC products found human tumours . truncated APC , CID absolutely necessary down-regulate transcriptional activity level @ GeneSrc $ , even axin/conductin binding site present . activity CID dramatically reduced several @ DiseaseTgt $ cell lines inhibited shorter truncated APC lacking CID . CID direct target selective pressure acting APC tumourigenesis . explains interdependence APC mutations , colorectal also duodenal desmoid tumours .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0344267948918587)\n",
      "- Text: \"Activation @ GeneSrc $ signaling @ DiseaseTgt $ mutations @ GeneSrc $ APC . Inactivation adenomatous polyposis coli ( APC ) tumor suppressor gene initiates colorectal neoplasia . One biochemical activities associated APC protein down-regulation transcriptional activation mediated @ GeneSrc $ cell transcription factor 4 ( Tcf-4 ) . protein products mutant APC genes present @ DiseaseTgt $ found defective activity . Furthermore , @ DiseaseTgt $ intact APC genes found contain activating mutations @ GeneSrc $ altered functionally significant phosphorylation sites . results indicate regulation @ GeneSrc $ critical APC 's tumor suppressive effect regulation circumvented mutations either APC @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8060569491504125)\n",
      "- Text: \"E2F1 represses @ GeneSrc $ transcription antagonized pRB CDK8 . E2F1 transcription factor promote proliferation apoptosis activated , key downstream target retinoblastoma tumour suppressor protein ( pRB ) . show E2F1 potent specific inhibitor @ GeneSrc $ factor ( TCF ) -dependent transcription , function contributes E2F1-induced apoptosis . E2F1 deregulation suppresses @ GeneSrc $ activity adenomatous polyposis coli ( APC ) /glycogen synthase kinase-3 ( GSK3 ) -independent manner , reducing expression key @ GeneSrc $ targets including c-MYC . interaction explains @ DiseaseTgt $ , depend @ GeneSrc $ transcription abnormal proliferation , keep RB1 intact . Remarkably , E2F1 activity also repressed cyclin-dependent kinase-8 ( CDK8 ) , colorectal oncoprotein . Elevated levels CDK8 protect @ GeneSrc $ transcription inhibition E2F1 . Thus , retaining RB1 amplifying CDK8 , @ DiseaseTgt $ cells select conditions collectively suppress E2F1 enhance activity @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.283216393163933)\n",
      "- Text: \"CRD-BP mediates stabilization betaTrCP1 c-myc mRNA response @ GeneSrc $ signalling . Although constitutive activation @ GeneSrc $ signalling implicated development human cancers , mechanisms @ GeneSrc $ pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show @ GeneSrc $ stabilizes mRNA encoding F-box protein betaTrCP1 , identify RNA-binding protein CRD-BP ( coding region determinant-binding protein ) previously unknown target @ GeneSrc $ transcription factor . CRD-BP binds coding region betaTrCP1 mRNA . Overexpression CRD-BP stabilizes betaTrCP1 mRNA elevates betaTrCP1 levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein ( SCF ) ( betaTrCP ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB @ GeneSrc $ . CRD-BP essential induction betaTrCP1 c-Myc @ GeneSrc $ signalling @ DiseaseTgt $ cells . High levels CRD-BP found primary human @ DiseaseTgt $ exhibiting active @ GeneSrc $ signalling implicates CRD-BP induction upregulation betaTrCP1 , activation dimeric transcription factor NF-kappaB suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.280934642461517)\n",
      "- Text: \"@ GeneSrc $ regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human @ DiseaseTgt $ . Loss functional APC protein results accumulation @ GeneSrc $ . Mutant forms @ GeneSrc $ discovered @ DiseaseTgt $ retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer gastric hepatocellular carcinomas . accumulation @ GeneSrc $ activates genes responsive transcription factors TCF/LEF family , @ GeneSrc $ interacts . show @ GeneSrc $ activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant @ GeneSrc $ produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF @ DiseaseTgt $ cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels @ GeneSrc $ may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2545926642464256)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway @ DiseaseTgt $ well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) adenomatous polyposis coli ( APC ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies hMLH1 , hMSH2 , @ GeneSrc $ , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One cancer ( 5 % ) found RER+ , tumours stained positive hMLH1 hMSH2 . mutations detected MCR APC gene . @ GeneSrc $ showed increased nuclear expression loss membranous staining 10 cancers ( 48 % ) . Absent decreased membrane expression E-cadherin found eight cancers ( 38 % ) . Strong staining p53 found nucleus five cancers ( 24 % ) . CONCLUSION : detect mutations MCR APC gene , suggests adenocarcinoma small intestine may follow different genetic pathway @ DiseaseTgt $ . Abnormal expression E-cadherin @ GeneSrc $ common reflects early alternative APC pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0049421424489474)\n",
      "- Text: \"@ GeneSrc $ complex imposes crypt progenitor phenotype @ DiseaseTgt $ cells . transactivation TCF target genes induced Wnt pathway mutations constitutes primary transforming event @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show disruption @ GeneSrc $ activity @ DiseaseTgt $ cells induces rapid G1 arrest blocks genetic program physiologically active proliferative compartment colon crypts . Coincidently , intestinal differentiation program induced . TCF-4 target gene c-MYC plays central role switch direct repression p21 ( CIP1/WAF1 ) promoter . Following disruption @ GeneSrc $ activity , decreased expression c-MYC releases p21 ( CIP1/WAF1 ) transcription , turn mediates G1 arrest differentiation . Thus , @ GeneSrc $ complex constitutes master switch controls proliferation versus differentiation healthy malignant intestinal epithelial cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8773452534223225)\n",
      "- Text: \"Topoisomerase-I- Alu-mediated genomic deletions APC gene familial adenomatous polyposis . Germline mutation adenomatous polyposis coli ( APC ) gene results familial adenomatous polyposis ( FAP ) , heritable form @ DiseaseTgt $ . previously reported two novel mutations delete exons 11 14 APC gene , respectively , cDNA level without splice junction defects genomic level . describe precise breakpoints two mutations possible mechanisms leading genomic rearrangement . first rearrangement likely topoisomerase-I-mediated non-homologous recombination resulting 2-kb deletion deletes exon 11 APC gene . 5 ' 3 ' breakpoints two topoisomerase recognition sites runs pyrimidines within 10-bp sequences vicinity . , 3 ' breakpoint adenine-thymidine-rich region . probably first report topoisomerase-I-mediated germline mutation tumor suppressor gene . second rearrangement likely Alu-Alu homologous recombination resulting 6-kb deletion encompassing exon 14 . Alu elements 5 ' 3 ' breakpoints include 26-bp core sequence thought stimulate recombination . rearrangements , partial sequences long interspersed nuclear element family vicinity breakpoints . serving markers regions DNA damage , precise role recombination events , , unclear . deletions result truncated APC proteins missing @ GeneSrc $ axin-binding domains , resulting severe polyposis cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.2937044869813273e-05)\n",
      "- Text: \"Adenomatous polyposis coli down-regulated ubiquitin-proteasome pathway process facilitated Axin . Adenomatous polyposis coli ( APC ) protein Axin form complex mediates down-regulation @ GeneSrc $ , key effector Wnt signaling . Truncation mutations APC responsible @ DiseaseTgt $ due failure down-regulation @ GeneSrc $ . regulation @ GeneSrc $ APC extensively studied , regulation APC received little attention . show level APC down-regulated ubiquitin-proteasome pathway Wnt signaling inhibits process . domain responsible down-regulation direct ubiquitination identified . also show unexpected role Axin facilitating ubiquitination-proteasome-mediated down-regulation APC oligomerization Axin . results suggest new mechanism regulation APC Axin Wnt signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0158034411925195)\n",
      "- Text: \"Dominant negative effect APC1309 mutation : possible explanation genotype-phenotype correlations familial adenomatous polyposis . Inactivation adenomatous polyposis coli ( APC ) gene product initiates colorectal tumorigenesis . Patients familial APC ( FAP ) carry germ-line mutations APC gene develop multiple colorectal adenomas subsequent carcinomas early life . severity disease correlates position inherited APC mutation ( genotype-phenotype correlation ) . Together fact germ-line sporadic APC mutations cluster central region APC gene , points dominant negative effect certain APC mutants . Loss APC function recently shown result enhanced @ GeneSrc $ transcription colon epithelial cells . , provide experimental evidence dominant negative effect APC gene products associated severe polyposis . Wild-type APC activity @ GeneSrc $ transcription strongly inhibited mutant APC truncated codon 1309 . contrast , mutant APC gene products associated attenuated polyposis ( codon 386 1465 ) interfered weakly wild-type APC activity . results suggest molecular explanation genotype-phenotype correlation FAP patients support idea @ DiseaseTgt $ growth might , part , driven selection mutation mutation cluster region .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.8416754287094784e-05)\n",
      "- Text: \"Identification c-MYC target APC pathway . adenomatous polyposis coli gene ( APC ) tumor suppressor gene inactivated @ DiseaseTgt $ . Mutations APC cause aberrant accumulation @ GeneSrc $ , binds cell factor-4 ( Tcf-4 ) , causing increased transcriptional activation unknown genes . , c-MYC oncogene identified target gene signaling pathway . Expression c-MYC shown repressed wild-type APC activated @ GeneSrc $ , effects mediated Tcf-4 binding sites c-MYC promoter . results provide molecular framework understanding previously enigmatic overexpression c-MYC @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000265300318605)\n",
      "- Text: \"role Adenomatous Polyposis Coli protein chromosome segregation . Mutations Adenomatous Polyposis Coli ( APC ) gene responsible @ DiseaseTgt $ also occur early stages sporadic @ DiseaseTgt $ . APC functions Wnt signalling pathway regulate degradation @ GeneSrc $ ( reviewed refs 1 - 3 ) . APC also binds stabilizes microtubules vivo vitro , localizes clusters ends microtubules near plasma membrane interphase cells , important regulator cytoskeletal function . show cells carrying truncated APC gene ( Min ) defective chromosome segregation . Moreover , mitosis , APC localizes ends microtubules embedded kinetochores forms complex checkpoint proteins Bub1 Bub3 . vitro , APC high-affinity substrate Bub kinases . data consistent role APC kinetochore-microtubule attachment suggest truncations APC eliminate microtubule binding may contribute chromosomal instability cancer cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6336112504391935)\n",
      "- Text: \"Binding APC human homolog Drosophila discs large tumor suppressor protein . adenomatous polyposis coli gene ( APC ) mutated familial adenomatous polyposis sporadic @ DiseaseTgt $ , product binds adherens junction protein @ GeneSrc $ . Overexpression APC blocks cell cycle progression . @ GeneSrc $ complex shown bind DLG , human homolog Drosophila discs large tumor suppressor protein . interaction required carboxyl-terminal region APC DLG homology repeat region DLG . APC colocalized DLG lateral cytoplasm rat colon epithelial cells synapse cultured hippocampal neurons . results suggest APC-DLG complex may participate regulation cell cycle progression neuronal function .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4044418570959746)\n",
      "- Text: \"Association APC gene product @ GeneSrc $ . Mutations human APC gene linked familial adenomatous polyposis progression sporadic @ DiseaseTgt $ . gain insight APC function , APC-associated proteins identified immunoprecipitation experiments . Antibodies APC precipitated 95-kilodalton protein purified identified sequencing @ GeneSrc $ , protein binds cell adhesion molecule E-cadherin . antibody specific @ GeneSrc $ also recognized 95-kilodalton protein immunoprecipitates . results suggest APC involved cell adhesion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0387417256638201)\n",
      "- Text: \"Binding GSK3beta @ GeneSrc $ complex regulation complex assembly . adenomatous polyposis coli gene ( APC ) mutated @ DiseaseTgt $ . APC protein binds cellular adhesion molecule @ GeneSrc $ , mammalian homolog @ GeneSrc $ , component WINGLESS signaling pathway Drosophila development . shown @ GeneSrc $ present excess , APC binds another component WINGLESS pathway , glycogen synthase kinase 3beta ( GSK3beta ) , mammalian homolog Drosophila ZESTE WHITE 3 . APC good substrate GSK3 beta vitro , phosphorylation sites mapped central region APC . Binding @ GeneSrc $ region dependent phosphorylation GSK3 beta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0155890253040703)\n",
      "- Text: \"Familial infiltrative fibromatosis ( desmoid tumours ) ( MIM135290 ) caused recurrent 3 ' APC gene mutation . Desmoid tumours generally rare occur 100 times frequently @ DiseaseTgt $ predisposition syndrome familial adenomatous polyposis ( MIM 175100 ) , represented 10 % patients . addition desmoid disease occurring familial adenomatous polyposis ( FAP ) exist familial infiltrative fibromatosis ( MIM 135290 ) kindreds evidence FAP . Previously described kindred familial infiltrative fibromatosis ( FIF ) desmoid tumours associated nonpolyposis colorectal cancer . FAP caused mutations APC gene various genotype-phenotype relationships defined including reports @ DiseaseTgt $ less severe mutations 5 ' codon 157 risk desmoid tumours high FAP patients APC gene mutations codons 1444 1598 . relatively little information phenotype APC gene mutations 3 ' codon 1598 ; however , one large family reported mutation codon 1987 presents highly variable phenotype includes desmoid disease . screened original FIF kindred three families similar phenotype mutations APC gene . 4 bp frameshift deletion codon 1962 identified original FIF kindred two apparently unrelated families . Haplotype analysis suggests common origin APC mutation three families . Affected individuals evidence congenital hypertrophy retinal pigment epithelium . @ DiseaseTgt $ variable , affected patients either none late onset polyps . findings demonstrate ( ) FAP FIF allelic , ( ii ) APC gene mutations truncate APC protein distal @ GeneSrc $ binding domain associated desmoid tumours , absent CHRPE variable attenuated polyposis expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005599186660333)\n",
      "- Text: \"APC mutations sporadic @ DiseaseTgt $ : mutational `` hotspot `` interdependence `` two hits `` . Although APC mutations occur high frequency @ DiseaseTgt $ , studies performed comprehensive analysis screening whole gene mutations assessing allelic loss . APC seems act tumor-suppressor gene `` nonclassical `` fashion : data familial adenomatous polyposis ( FAP ) show site germ-line mutation determines type `` second hit `` FAP tumors , simple protein inactivation selected weakly , . study , screened entire coding region APC mutations assessed allelic loss set 41 @ DiseaseTgt $ cell lines . 41 cancers , 32 ( 83 % ) showed evidence APC mutation and/or allelic loss . identified several APC mutations found `` hotspot `` somatic mutation sporadic @ DiseaseTgt $ codon 1,554 . results suggest APC mutations occur great majority @ DiseaseTgt $ , exceptions almost RER+ tumors , may substitute altered APC function mutations @ GeneSrc $ and/or loci . combined previously published data , results show interdependence `` two hits `` APC sporadic @ DiseaseTgt $ well FAP . APC mutations `` mutation cluster region , `` especially close codon 1,300 , associated allelic loss , whereas tumors mutations outside region tend harbor truncating mutations . causes phenomenon probably selection retained N-terminal lost C-terminal APC functions , effects @ GeneSrc $ levels , APC protein stability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0657946658483402)\n",
      "- Text: \"Association APC tumor suppressor protein catenins . Mutations APC appear initiate sporadic inherited forms human @ DiseaseTgt $ . Although mutations well characterized , little known function APC gene product . Two cellular proteins associate APC identified nucleotide sequence analysis peptide mapping E-cadherin-associated proteins alpha- @ GeneSrc $ . 27-residue fragment APC containing 15-amino acid repeat sufficient interaction catenins . results suggest important link tumor initiation cell adhesion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0128531478656817)\n",
      "- Text: \"Inactivation germline mutant APC alleles attenuated somatic mutations : molecular genetic mechanism attenuated familial adenomatous polyposis . Germline mutations adenomatous polyposis coli ( APC ) tumor-suppressor gene result familial adenomatous polyposis ( FAP ) . Patients FAP typically develop hundreds thousands @ DiseaseTgt $ early-onset @ DiseaseTgt $ . subset germline APC mutations results attenuated FAP ( AFAP ) phenotype , patients develop fewer tumors develop older age . Although genotype-phenotype correlation locations APC germline mutations development AFAP well documented , mechanism AFAP well defined . investigated mechanism AFAP patients carrying mutant APC allele ( APC ( AS9 ) ) mutation alternatively spliced region exon 9 . APC ( AS9 ) found down-regulate @ GeneSrc $ transcription , major tumor-suppressor function APC , wild-type APC . Mutation analysis showed APC ( AS9 ) wild-type APC alleles somatically mutated @ DiseaseTgt $ patients . Functional analysis showed 4666insA , common somatic mutation APC ( AS9 ) tumors , inactivate wild-type APC . results indicate carriers APC ( AS9 ) develop fewer @ DiseaseTgt $ typical patients FAP somatic inactivation APC alleles necessary colorectal tumorigenesis . However , patients develop @ DiseaseTgt $ frequently general population APC ( AS9 ) inactivated mutations inactivate wild-type APC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0015913522301262)\n",
      "- Text: \"Adenomatous polyposis coli ( APC ) differentially regulates @ GeneSrc $ phosphorylation ubiquitination @ DiseaseTgt $ cells . @ DiseaseTgt $ mutations adenomatous polyposis coli ( APC ) gene @ GeneSrc $ gene stabilize @ GeneSrc $ activate @ GeneSrc $ target genes , leading ultimately cancer . molecular mechanisms APC function @ GeneSrc $ degradation completely known . APC binds @ GeneSrc $ involved Axin complex , suggesting APC regulates @ GeneSrc $ phosphorylation . evidence also suggests APC regulates @ GeneSrc $ nuclear export . , examine effects APC mutations @ GeneSrc $ phosphorylation , ubiquitination , degradation @ DiseaseTgt $ cell lines SW480 , DLD-1 , HT29 , contains different APC truncation . Although current models suggest @ GeneSrc $ phosphorylation inhibited APC mutations , detected significant @ GeneSrc $ phosphorylation cells . However , @ GeneSrc $ ubiquitination degradation inhibited SW480 DLD-1 HT29 cells . ubiquitination ofbeta-catenin SW480 cells rescued exogenous expression APC . APC domains required @ GeneSrc $ ubiquitination analyzed . results suggest APC regulates @ GeneSrc $ phosphorylation ubiquitination distinct domains separate molecular mechanisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3583008149322707)\n",
      "- Text: \"Chemoprevention @ DiseaseTgt $ targeting APC-deficient cells apoptosis . Cancer chemoprevention uses natural , synthetic , biological substances reverse , suppress , prevent either initial phase carcinogenesis progression neoplastic cells cancer . holds promise overcoming problems associated treatment late-stage cancers . However , broad application chemoprevention compromised present limited effectiveness potential toxicity . overcome challenges , developed new chemoprevention approach specifically targets premalignant tumour cells apoptosis . show deficiency adenomatous polyposis coli ( APC ) gene subsequent activation @ GeneSrc $ lead repression cellular caspase-8 inhibitor c-FLIP ( also known CFLAR ) expression activation c-Myc , all-trans-retinyl acetate ( RAc ) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand ( TRAIL ) death receptors suppresses decoy receptors . Thus , combination TRAIL RAc induces apoptosis APC-deficient premalignant cells without affecting normal cells vitro . addition , show short-term non-continuous TRAIL RAc treatment induce apoptosis specifically intestinal polyps , strongly inhibit tumour growth , prolong survival multiple intestinal neoplasms C57BL/6J-Apc ( Min ) /J ( Apc ( Min ) ) mice . approach , demonstrate TRAIL RAc induce significant cell death human colon polyps , providing potentially selective approach @ DiseaseTgt $ chemoprevention targeting APC-deficient cells apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0131798213683532)\n",
      "- Text: \"Mutations AXIN2 cause @ DiseaseTgt $ defective mismatch repair activating @ GeneSrc $ signalling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.058234395700567)\n",
      "- Text: \"Genomic structure , chromosome mapping expression analysis human AXIN2 gene . Conductin Wnt signalling protein serves negative regulator @ GeneSrc $ stability . previously isolated human homolog ( AXIN2 ) murine conductin gene shown mutated @ DiseaseTgt $ ( @ DiseaseTgt $ ) defective mismatch repair ( MMR ) . report detailed genomic structure gene analysis cDNA genomic clones . gene spans > = 25 kb containing ten exons ranging 96 bp 904 bp . splice donor acceptor sites conform GT/AG rule . FISH ( Fluorescence situ Hybridization ) analysis localized gene human chromosome band 17q24 showed exists single copy human genome . Northern blot analysis different human organs demonstrated AXIN2 gene highly expressed human thymus , prostate , testis , small intestine ovarian tissues expressed lower level colon . data reported provides framework analysis important Wnt signalling protein vertebrate development tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1665626459196129)\n",
      "- Text: \"Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta @ DiseaseTgt $ pathology . abundance , resistance proteolysis , rapid aggregation neurotoxicity , N-terminally truncated , particular , pyroglutamate ( pE ) -modified Abeta peptides suggested important initiation pathological cascades resulting development @ DiseaseTgt $ . found N-terminal pE-formation catalyzed glutaminyl cyclase vivo . Glutaminyl cyclase expression upregulated cortices individuals @ DiseaseTgt $ correlated appearance pE-modified Abeta . Oral application glutaminyl cyclase inhibitor resulted reduced @ GeneSrc $ burden two different transgenic mouse models @ DiseaseTgt $ new Drosophila model . Treatment mice accompanied reductions Abeta ( x-40/42 ) , diminished plaque formation gliosis improved performance context memory spatial learning tests . observations consistent hypothesis @ GeneSrc $ acts seed Abeta aggregation self-aggregation co-aggregation Abeta ( 1 - 40/42 ) . Therefore , Abeta ( 3 ( pE ) -40/42 ) peptides seem represent Abeta forms exceptional potency disturbing neuronal function . reduction brain pE-Abeta inhibition glutaminyl cyclase offers new therapeutic option treatment @ DiseaseTgt $ provides implications amyloidoses , familial Danish dementia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0491217489497796)\n",
      "- Text: \"@ DiseaseTgt $ amyloid beta-clipping enzyme ( @ GeneSrc $ ) : identification , purification , characterization enzyme . @ DiseaseTgt $ ( @ DiseaseTgt $ ) frequent cause dementia , although genetic abnormality identified . Recent studies elucidated molecular defect @ DiseaseTgt $ , including abnormal deposition amyloid beta peptide ( beta/A4 ) senile plaques affected individuals . Normal brain contains enzyme , @ GeneSrc $ , cleaves inside beta/A4 portion precursor protein ( APP ) ; abnormal processing APP occurs @ DiseaseTgt $ brain . , evidence provided @ GeneSrc $ intracellular proteinase . prepared two synthetic substrates @ GeneSrc $ , contain cleavage point much sensitive substrates previously available identify @ GeneSrc $ . Using substrates , found intracellular proteinase @ GeneSrc $ activity . proteinase identified cathepsin B .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7266488980928484)\n",
      "- Text: \"Apolipoprotein E @ DiseaseTgt $ . Inheritance specific apolipoprotein E ( apoE ) alleles determines , large part , risk mean age onset late-onset @ DiseaseTgt $ . mechanism apoE isoforms differentially contribute disease expression , however , unknown . Isoform-specific differences identified binding apoE @ GeneSrc $ tau , forms paired helical filament neurofibrillary tangles , amyloid beta peptide , major component neuritic plaque . isoform-specific interactions apoE give rise testable hypotheses mechanism ( ) pathogenesis @ DiseaseTgt $ . unresolved issue increasing importance relationship structural pathological lesions cellular pathogenesis responsible clinical disease phenotype , progressive dementia . identification apoE cytoplasm human neurons characterization isoform-specific binding apoE microtubule-associated proteins tau MAP-2 present possibility apoE may affect microtubule function @ DiseaseTgt $ brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000132617073248)\n",
      "- Text: \"Interaction alpha-synuclein tau genotypes @ DiseaseTgt $ . determine whether @ GeneSrc $ tau ( MAPT ) alpha-synuclein ( SNCA ) genes interact confer @ DiseaseTgt $ ( @ DiseaseTgt $ ) susceptibility , conducted study 557 case-control pairs . increased risk @ DiseaseTgt $ persons either SNCA 261/261 MAPT H1/H1 genotypes compared persons neither ( odds ratio , 1.96 ; 95 % confidence interval , 1.34 - 2.86 ; p = 0.0003 ) . However , combined effect two genotypes either genotypes alone ( separate equal ) . findings consistent vitro experiments revealed tau-mediated fibrillization alpha-synuclein protein low concentrations ( dose threshold effect ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7083314085756316)\n",
      "- Text: \"Mice lacking presenilin genes exhibit early embryonic patterning defects . Genetic studies worms , flies , humans implicated presenilins regulation Notch signaling pathway pathogenesis @ DiseaseTgt $ . two highly homologous presenilin genes mammals , presenilin 1 ( PS1 ) presenilin 2 ( PS2 ) . mice , inactivation PS1 leads developmental defects culminate perinatal lethality . test possibility late lethality PS1-null mice reflects genetic redundancy presenilins , generated PS2-null mice gene targeting , subsequently , PS1/PS2 double-null mice . Mice homozygous targeted null mutation PS2 exhibit obvious defects ; however , loss PS2 PS1-null background leads embryonic lethality embryonic day 9.5 . Embryos lacking presenilins , surprisingly , carrying single copy PS2 PS1-null background , exhibit multiple early patterning defects , including lack somite segmentation , disorganization trunk ventral neural tube , midbrain mesenchyme cell loss , anterior neuropore closure delays , abnormal heart second branchial arch development . addition , Delta like-1 ( Dll1 ) @ GeneSrc $ , two genes lie downstream Notch pathway , misexpressed presenilin double-null embryos : @ GeneSrc $ expression undetectable mice , whereas Dll1 expressed ectopically neural tube brain double-null embryos . conclude presenilins play widespread role embryogenesis , functional redundancy PS1 PS2 , vertebrate presenilins , like invertebrate homologs , essential Notch signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.790811989447578e-06)\n",
      "- Text: \"@ DiseaseTgt $ chemoprevention antioxidant tempol acts partially via p53 @ DiseaseTgt $ suppressor . previously demonstrated nitroxide antioxidant tempol ( 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl ) increased latency tumorigenesis doubled ( 100 % ) lifespan Atm-deficient mice , mouse model ataxia telangiectasia , displays accelerated oxidative damage stress . Tempol treatment @ DiseaseTgt $ p53-deficient mice resulted small significant ( 25 % ) increase lifespan prolonging latency tumorigenesis , demonstrating existing oxidative stress damage necessary chemopreventative effects tempol . However , relatively small effect latency p53-deficient mice finding tempol-mediated resistance oxidative insult p53-dependent suggested direct role p53 chemopreventative effects tempol . Surprisingly , tempol treatment specifically increased serine 18 phosphorylation p53 ( @ GeneSrc $ ) p21 expression primary thymocytes vitro p53-dependent fashion . Inhibition phosphoinositide 3-kinase ( PI3 K ) family members suggested SMG-1 responsible tempol-mediated enhancement p53 serine 18 phosphorylation . data suggest chemopreventative effect tempol solely due reduction oxidative stress damage may also related redox-mediated signaling functions include p53 pathway activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0046346595961317)\n",
      "- Text: \"Organization human orphan nuclear receptor Nurr1 gene . Recent reports revealed Nurr1 ( also known NOT/TINUR/RNR-1/HZF-3 ) , member steroid/thyroid hormone nuclear receptor superfamily , predominantly expressed midbrain ; substantia nigra ( SN ) ventral tegmental area ( VTA ) . Nurr1 null mice born lethal , lacking midbrain dopamine ( DA ) neurons , suggesting Nurr1 essential development differentiation midbrain DA neurons . Human Nurr1 gene mapped chromosome 2q22 - 23 , reported associate weakly schizophrenia . cloned sequenced human Nurr1 gene , approximately 8.3 kb long , consisting eight exons seven introns . Comparisons human Nurr1 mouse Nurr1 , mouse @ GeneSrc $ human NOR-1 revealed genomic structures highly conserved . 5'-flanking region human Nurr1 included three transcriptional regulatory elements , cAMP-response element ( CRE ) , CArG-like element Sp-1 site , surrounded CpG island , showed strong homology mouse Nurr1 . performed primer extension analysis using mRNA HeLa S3 cells stimulated phorbol 12-myristate 13-acetate ( PMA ) , Ca2 + ionophore A23187 cycloheximide ( CHX ) order induce Nurr1 mRNA expression , determined one transcription initiation site within CRE . transient transfection assay indicates regulatory elements 5'-flanking region robust mitogen-induced expression human Nurr1 . analysis polymorphism human Nurr1 gene may reveal association diseases characterized changes DA system , @ DiseaseTgt $ schizophrenia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"@ GeneSrc $ regulator alpha-synuclein gene driving risk @ DiseaseTgt $ . Copy number mutations implicate excess production alpha-synuclein possibly causative factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Using unbiased screen targeting endogenous gene expression , discovered @ GeneSrc $ ( @ GeneSrc $ ) regulator alpha-synuclein gene ( SNCA ) . @ GeneSrc $ ligands modulate SNCA transcription histone 3 lysine 27 acetylation promoter enhancers . 11 years follow-up 4 million Norwegians , @ GeneSrc $ agonist salbutamol , brain-penetrant asthma medication , associated reduced risk developing @ DiseaseTgt $ ( rate ratio , 0.66 ; 95 % confidence interval , 0.58 0.76 ) . Conversely , @ GeneSrc $ antagonist correlated increased risk . @ GeneSrc $ activation protected model mice patient-derived cells . Thus , @ GeneSrc $ linked transcription alpha-synuclein risk @ DiseaseTgt $ ligand-specific fashion constitutes potential target therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.524133344834742)\n",
      "- Text: \"Postzygotic @ GeneSrc $ KRAS mutations cause nevus sebaceous Schimmelpenning syndrome . Nevus sebaceous common congenital cutaneous malformation . Affected individuals may develop benign malignant secondary @ DiseaseTgt $ nevi life . Schimmelpenning syndrome characterized association nevus sebaceous extracutaneous abnormalities . report 65 sebaceous nevi studied , 62 ( 95 % ) mutations @ GeneSrc $ gene 3 ( 5 % ) mutations KRAS gene . @ GeneSrc $ c.37G > C mutation , results p. Gly13Arg substitution , present 91 % lesions . Nonlesional tissues 18 individuals wild-type sequence , confirming genetic mosaicism . @ GeneSrc $ c.37G > C mutation also found 8 8 associated secondary @ DiseaseTgt $ . Mosaicism @ GeneSrc $ c.37G > C KRAS c.35G > mutations found two individuals Schimmelpenning syndrome . Functional analysis @ GeneSrc $ c.37G > C mutant cells showed constitutive activation MAPK PI3K-Akt signaling pathways . results indicate nevus sebaceous Schimmelpenning syndrome caused postzygotic @ GeneSrc $ KRAS mutations . mutations may predispose individuals development secondary @ DiseaseTgt $ nevus sebaceous .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6939534662922665)\n",
      "- Text: \"Kras regulatory elements exon 4A determine mutation specificity lung cancer . Kras frequently mutated ras family member lung carcinomas , whereas Hras mutations common @ DiseaseTgt $ stratified epithelia skin . Using @ GeneSrc $ knock-in mouse model , demonstrate specificity Kras mutations lung Hras mutations skin tumors determined local regulatory elements target ras genes . Although Kras 4A isoform dispensable mouse development , important isoform lung carcinogenesis vivo inhibitory effect wild-type ( WT ) Kras mutant allele . Kras 4A expression detected subpopulation normal lung epithelial cells , low levels lung tumors , suggesting may required @ DiseaseTgt $ progression . two Kras isoforms undergo different post-translational modifications ; therefore , findings implications design therapeutic strategies inhibiting oncogenic Kras activity human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0735714535503366)\n",
      "- Text: \"miR-380 - 5p represses p53 control cellular survival associated poor outcome MYCN-amplified neuroblastoma . Inactivation p53 @ DiseaseTgt $ suppressor pathway allows cell survival times stress occurs many human @ DiseaseTgt $ ; however , normal embryonic stem cells @ DiseaseTgt $ neuroblastoma maintain wild-type human TP53 mouse Trp53 ( referred collectively p53 herein ) . describe miRNA , miR-380 - 5p , represses p53 expression via conserved sequence p53 3 ' untranslated region ( UTR ) . miR-380 - 5p highly expressed mouse embryonic stem cells neuroblastomas , high expression correlates poor outcome neuroblastomas neuroblastoma derived v-myc myelocytomatosis viral-related oncogene ( MYCN ) amplification . miR-380 overexpression cooperates activated @ GeneSrc $ oncoprotein transform primary cells , block oncogene-induced senescence form @ DiseaseTgt $ mice . Conversely , inhibition endogenous miR-380 - 5p embryonic stem neuroblastoma cells results induction p53 , extensive apoptotic cell death . vivo delivery miR-380 - 5p antagonist decreases @ DiseaseTgt $ size orthotopic mouse model neuroblastoma . demonstrate new mechanism p53 regulation @ DiseaseTgt $ stem cells uncover potential therapeutic target neuroblastoma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0349223257303269)\n",
      "- Text: \"Inactivation Wip1 phosphatase inhibits mammary tumorigenesis p38 MAPK-mediated activation p16 ( Ink4a ) -p19 ( Arf ) pathway . Modulation @ DiseaseTgt $ suppressor activities may provide new opportunities @ DiseaseTgt $ therapy . show disruption gene Ppm1d encoding Wip1 phosphatase activated p53 p16 ( also called Ink4a ) -p19 ( also called ARF ) pathways p38 MAPK signaling suppressed vitro transformation mouse embryo fibroblasts ( MEFs ) oncogenes . Disruption gene Cdkn2a ( encoding p16 p19 ) , Trp53 ( encoding p53 ) , reconstituted cell transformation Ppm1d-null MEFs . vivo , deletion Ppm1d mice bearing mouse mammary tumor virus ( MMTV ) promoter-driven oncogenes Erbb2 ( also called c-neu ) @ GeneSrc $ impaired mammary carcinogenesis , whereas reduced expression p16 p19 methylation-induced silencing inactivation p38 MAPK correlated @ DiseaseTgt $ appearance . conclude inactivation depletion Wip1 phosphatase resultant p38 MAPK activation suppresses @ DiseaseTgt $ appearance modulating Cdkn2a @ DiseaseTgt $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0020492620376685)\n",
      "- Text: \"Different @ DiseaseTgt $ p53 mutants exhibit distinct biological activities . wild-type form , protein p53 interfere @ DiseaseTgt $ processes . @ DiseaseTgt $ cells often express mutant p53 . Full-length mutant forms p53 isolated far transformed mouse cells exhibit three common properties vitro : loss transformation-suppressing activity , gain pronounced transforming potential , ability bind heat shock protein cognate @ GeneSrc $ . @ DiseaseTgt $ mouse p53 variant described , whose site mutation corresponds hot spot p53 human @ DiseaseTgt $ . absolutely nonsuppressing , weakly transforming exhibits detectable @ GeneSrc $ binding . data suggest ability p53 mutant bind endogenous p53 sole determinant oncogenic potential . data also support existence gain-of-function p53 mutants .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9793349789552628)\n",
      "- Text: \"CHIP Hsp70 regulate tau ubiquitination , degradation aggregation . Molecular chaperones , ubiquitin ligases proteasome impairment implicated several neurodegenerative diseases , including @ DiseaseTgt $ , characterized accumulation abnormal protein aggregates ( e.g . tau alpha-synuclein respectively ) . report CHIP , ubiquitin ligase interacts directly Hsp70/90 , induces ubiquitination microtubule associated protein , tau . CHIP also increases tau aggregation . Consistent observation , diverse tau lesions human postmortem tissue found immunopositive CHIP . Conversely , induction Hsp70 treatment either geldanamycin @ GeneSrc $ leads decrease tau steady-state levels selective reduction detergent insoluble tau . Furthermore , 30-month-old mice overexpressing inducible Hsp70 show significant reduction tau levels . Together data demonstrate Hsp70/CHIP chaperone system plays important role regulation tau turnover selective elimination abnormal tau species . Hsp70/CHIP may therefore play important role pathogenesis tauopathies also represents potential therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.534205873267483e-07)\n",
      "- Text: \"CHIP @ GeneSrc $ regulate tau ubiquitination , degradation aggregation . Molecular chaperones , ubiquitin ligases proteasome impairment implicated several neurodegenerative diseases , including @ DiseaseTgt $ , characterized accumulation abnormal protein aggregates ( e.g . tau alpha-synuclein respectively ) . report CHIP , ubiquitin ligase interacts directly Hsp70/90 , induces ubiquitination microtubule associated protein , tau . CHIP also increases tau aggregation . Consistent observation , diverse tau lesions human postmortem tissue found immunopositive CHIP . Conversely , induction @ GeneSrc $ treatment either geldanamycin heat shock factor 1 leads decrease tau steady-state levels selective reduction detergent insoluble tau . Furthermore , 30-month-old mice overexpressing inducible @ GeneSrc $ show significant reduction tau levels . Together data demonstrate Hsp70/CHIP chaperone system plays important role regulation tau turnover selective elimination abnormal tau species . Hsp70/CHIP may therefore play important role pathogenesis tauopathies also represents potential therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006475885273558)\n",
      "- Text: \"Endoplasmic reticulum stress mitochondrial cell death pathways mediate A53 mutant alpha-synuclein-induced toxicity . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative movement disorder characterized selective loss dopaminergic neurons presence Lewy bodies . Alpha-synuclein major component Lewy bodies sporadic @ DiseaseTgt $ , mutations alpha-synuclein cause autosomal-dominant hereditary @ DiseaseTgt $ . , generated A53 mutant alpha-synuclein-inducible PC12 cell lines using Tet-off regulatory system . Inducing expression A53 alpha-synuclein differentiated PC12 cells decreased proteasome activity , increased intracellular ROS level caused approximately 40 % cell death , accompanied mitochondrial cytochrome C release elevation caspase-9 -3 activities . Cell death partially blocked cyclosporine [ inhibitor mitochondrial permeability transition ( MPT ) process ] , z-VAD ( pan-caspase inhibitor ) inhibitors caspase-9 -3 caspase-8 inhibitor . Furthermore , induction A53 alpha-synuclein increased endoplasmic reticulum ( ER ) stress elevated @ GeneSrc $ activity . RNA interference knock @ GeneSrc $ levels salubrinal ( ER stress inhibitor ) partially protected cell death reduced A53 toxicity treatment z-VAD . results indicate ER stress mitochondrial dysfunction contribute A53 alpha-synuclein-induced cell death . study sheds light pathogenesis alpha-synuclein cellular toxicity @ DiseaseTgt $ provides cell model screening @ DiseaseTgt $ therapeutic agents .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0123774810922487)\n",
      "- Text: \"Effect @ GeneSrc $ polymorphism efficacy donepezil patients @ DiseaseTgt $ . OBJECTIVE : evaluate influence single nucleotide polymorphism rs1080985 @ GeneSrc $ ( @ GeneSrc $ ) gene efficacy donepezil patients mild moderate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . METHODS : multicenter , prospective cohort study 127 white patients @ DiseaseTgt $ according National Institute Neurological Communicative Disorders @ DiseaseTgt $ Related Disorders Association Work Group criteria . Patients treated donepezil 5 - 10 mg/daily 6 months . Cognitive functional statuses evaluated baseline 6-month follow-up . Response therapy defined according National Institute Health Clinical Excellence criteria . Compliance drug-related adverse events also evaluated . analyses identifying @ GeneSrc $ APOE polymorphisms performed blinded fashion . RESULTS : 6-month follow-up , 69 115 patients ( 60 % ) responders 46 patients ( 40 % ) nonresponders donepezil treatment . significantly higher frequency patients G allele rs1080985 found nonresponders responders ( 58.7 % vs 34.8 % , p = 0.013 ) . Logistic regression analysis adjusted age , sex , Mini-Mental State Examination score baseline , APOE demonstrated patients G allele significantly higher risk poor response donepezil treatment ( odds ratio 3.431 , 95 % confidence interval 1.490 - 7.901 ) . CONCLUSIONS : single nucleotide polymorphism rs1080985 @ GeneSrc $ gene may influence clinical efficacy donepezil patients mild moderate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . analysis @ GeneSrc $ genotypes may useful identifying subgroups patients @ DiseaseTgt $ different clinical responses donepezil .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003854240924135)\n",
      "- Text: \"NUMB controls p53 @ DiseaseTgt $ suppressor activity . NUMB cell fate determinant , , asymmetrically partitioning mitosis , controls cell fate choices antagonising activity plasma membrane receptor NOTCH family . NUMB also endocytic protein , NOTCH-NUMB counteraction linked function . might , however , additional functions NUMB , witnessed proposed role @ DiseaseTgt $ suppressor breast cancer . describe previously unknown function human NUMB regulator @ DiseaseTgt $ protein p53 ( also known TP53 ) . NUMB enters tricomplex p53 @ GeneSrc $ HDM2 ( also known MDM2 ) , thereby preventing ubiquitination degradation p53 . results increased p53 protein levels activity , regulation p53-dependent phenotypes . breast cancers frequent loss NUMB expression . show , primary breast tumour cells , event causes decreased p53 levels increased chemoresistance . breast cancers , loss NUMB expression causes increased activity receptor NOTCH . Thus , @ DiseaseTgt $ , single event-loss NUMB expression-determines activation oncogene ( NOTCH ) attenuation p53 @ DiseaseTgt $ suppressor pathway . Biologically , results aggressive @ DiseaseTgt $ phenotype , witnessed findings NUMB-defective breast tumours display poor prognosis . results uncover previously unknown @ DiseaseTgt $ suppressor circuitry .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6696439615487713)\n",
      "- Text: \"Ubiquitination new form alpha-synuclein parkin human brain : implications @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative disorder characterized progressive accumulation selected neurons protein inclusions containing alpha-synuclein ubiquitin . Rare inherited forms @ DiseaseTgt $ caused autosomal dominant mutations alpha-synuclein autosomal recessive mutations parkin , @ GeneSrc $ . hypothesized two gene products interact functionally , namely , parkin ubiquitinates alpha-synuclein normally process altered @ DiseaseTgt $ . identified protein complex normal human brain includes parkin @ GeneSrc $ , UbcH7 associated E2 ubiquitin conjugating enzyme , new 22-kilodalton glycosylated form alpha-synuclein ( alphaSp22 ) substrate . contrast normal parkin , mutant parkin associated @ DiseaseTgt $ failed bind alphaSp22 . vitro ubiquitination assay , alphaSp22 modified normal mutant parkin polyubiquitinated , high molecular weight species . Accordingly , alphaSp22 accumulated non-ubiquitinated form parkin-deficient @ DiseaseTgt $ brains . conclude alphaSp22 substrate parkin 's ubiquitin ligase activity normal human brain loss parkin function causes pathological alphaSp22 accumulation . findings demonstrate critical biochemical reaction two @ DiseaseTgt $ gene products suggest reaction underlies accumulation ubiquitinated alpha-synuclein conventional @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6140781402980144)\n",
      "- Text: \"Structure Parkin in-between-ring domain provides insights E3-ligase dysfunction @ DiseaseTgt $ . Mutations Parkin one predominant hereditary factors found patients suffering autosomal recessive juvenile Parkinsonism . Parkin member @ GeneSrc $ family defined tripartite RING1-in-between-ring ( IBR ) -RING2 motif . Parkin , IBR domain shown augment binding E2 proteins UbcH7 UbcH8 , subsequent ubiquitination proteins synphilin-1 , Sept5 , SIM2 . facilitate understanding Parkin function , solution structure Parkin IBR domain solved using NMR spectroscopy . Folding IBR domain ( residues M327-S378 ) found zinc dependent , structure reveals domain forms unique pair scissor-like GAG knuckle-like zinc-binding sites , different zinc-binding motifs RING , LIM , PHD , B-box motifs . N terminus IBR domain , residues E307-E322 , unstructured . disease causing mutation T351P causes global unfolding , whereas mutation R334C causes structural rearrangement domain . contrast , protein containing mutation G328E appears properly folded . structure Parkin IBR domain , combination mutational data , allows model proposed IBR domain facilitates close arrangement adjacent RING1 RING2 domains facilitate protein interactions subsequent ubiquitination .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0849007964293215)\n",
      "- Text: \"Somatic mutations @ DiseaseTgt $ gene PARK2 glioblastoma human malignancies . Mutation gene PARK2 , encodes @ GeneSrc $ , common cause early-onset @ DiseaseTgt $ . search multisite tumor suppressors , identified PARK2 frequently targeted gene chromosome 6q25.2-q27 cancer . describe inactivating somatic mutations frequent intragenic deletions PARK2 human malignancies . PARK2 mutations cancer occur domains , sometimes residues , germline mutations causing familial @ DiseaseTgt $ . Cancer-specific mutations abrogate growth-suppressive effects PARK2 protein . PARK2 mutations cancer decrease PARK2 's E3 ligase activity , compromising ability ubiquitinate cyclin E resulting mitotic instability . data strongly point PARK2 tumor suppressor 6q25.2-q27 . Thus , PARK2 , gene causes neuronal dysfunction mutated germline , may instead contribute oncogenesis altered non-neuronal somatic cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9944907262228996)\n",
      "- Text: \"Nitrosative stress linked sporadic @ DiseaseTgt $ : S-nitrosylation parkin regulates @ GeneSrc $ activity . Many hereditary sporadic neurodegenerative disorders characterized accumulation aberrant proteins . sporadic @ DiseaseTgt $ , representing prevalent movement disorder , oxidative nitrosative stress believed contribute disease pathogenesis , exact molecular basis protein aggregation remains unclear . case autosomal recessive-juvenile Parkinsonism , mutation @ GeneSrc $ protein parkin linked death dopaminergic neurons . show vitro vivo nitrosative stress leads S-nitrosylation wild-type parkin , initially , dramatic increase followed decrease E3 ligase-ubiquitin-proteasome degradative pathway . initial increase parkin 's @ GeneSrc $ activity leads autoubiquitination parkin subsequent inhibition activity , would impair ubiquitination clearance parkin substrates . findings may thus provide molecular link free radical toxicity protein accumulation sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2349674174633035)\n",
      "- Text: \"BAG5 inhibits parkin enhances dopaminergic neuron degeneration . Loss-of-function mutations parkin gene , encodes @ GeneSrc $ , major cause early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Decreases parkin activity may also contribute neurodegeneration sporadic forms @ DiseaseTgt $ . , show bcl-2-associated athanogene 5 ( BAG5 ) , BAG family member , directly interacts parkin chaperone Hsp70 . Within complex , BAG5 inhibits parkin @ GeneSrc $ activity Hsp70-mediated refolding misfolded proteins . BAG5 enhances parkin sequestration within protein aggregates mitigates parkin-dependent preservation proteasome function . Finally , BAG5 enhances dopamine neuron death vivo model @ DiseaseTgt $ , whereas mutant inhibits BAG5 activity attenuates dopaminergic neurodegeneration . contrasts antideath functions ascribed BAG family members suggests potential role BAG5 promoting neurodegeneration sporadic @ DiseaseTgt $ functional interactions parkin Hsp70 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9729569711770278)\n",
      "- Text: \"Dopamine covalently modifies functionally inactivates parkin . Inherited mutations PARK2 , gene encoding parkin , cause selective degeneration catecholaminergic neurons substantia nigra locus coeruleus brainstem , resulting early-onset parkinsonism . role parkin common , sporadic forms @ DiseaseTgt $ remains unclear . report neurotransmitter dopamine covalently modifies parkin living dopaminergic cells , process increases parkin insolubility inactivates @ GeneSrc $ function . brains individuals sporadic @ DiseaseTgt $ , observed decreases parkin solubility consistent functional inactivation . Using new biochemical method , detected catechol-modified parkin substantia nigra regions normal human brain . findings show vulnerability parkin modification dopamine , principal transmitter lost @ DiseaseTgt $ , suggesting mechanism progressive loss parkin function dopaminergic neurons aging sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6380907225828105)\n",
      "- Text: \"Functional alteration PARL contributes mitochondrial dysregulation @ DiseaseTgt $ . Molecular genetics linked mitochondrial dysfunction pathogenesis @ DiseaseTgt $ discovery rare , inherited mutations gene products associate mitochondria . Mutations PTEN-induced kinase-1 ( PINK1 ) , encodes mitochondrial kinase , PARKIN , encoding @ GeneSrc $ , frequent causes recessive @ DiseaseTgt $ . Recent functional studies revealed PINK1 recruits PARKIN mitochondria initiate mitophagy , important autophagic quality control mechanism rids cell damaged mitochondria . PINK1 post-translationally processed cleaved form whose levels tightly regulated , although significance processing unknown . demonstrate mitochondrial protease presenilin-associated rhomboid-like ( PARL ) affect proteolytic processing PINK1 normal PINK1 localization stability requires PARL 's catalytic activity . PARL deficiency impairs PARKIN recruitment mitochondria , suggesting PINK1 's processing localization important determining interaction PARKIN . sequenced PARL gene @ DiseaseTgt $ patients discovered novel missense mutation functional domain PARL 's N-terminus . PARL mutant sufficient rescue PARKIN recruitment , suggesting impaired mitophagy may underlying mechanism disease pathogenesis patients PARL mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.231158225990144)\n",
      "- Text: \"Down-regulation parkin protein transient focal cerebral ischemia : link stroke degenerative disease ? Ubiquitylated protein aggregates characteristic features neurodegenerative disorders also found acute pathological states brain stroke . Many proteins connected neurodegenerative diseases play role ubiquitin-proteasomal pathway . Mutation one proteins , @ GeneSrc $ parkin , cause autosomal recessive juvenile @ DiseaseTgt $ . show transient focal cerebral ischemia 1-h duration induces marked depletion parkin protein levels , 60 % , 36 % , 33 % , 25 % controls 1 , 3 , 6 , 24 h reperfusion , ischemia cause lower protein levels E2 ubiquitin-conjugating enzymes Ubc6 , Ubc7 , Ubc9 . 3 h reperfusion , parkin protein levels already reduced < 40 % control , ATP levels almost completely recovered ischemia observe DNA fragmentation , suggesting parkin depletion preceded development neuronal cell death . Up-regulation expression parkin shown protect cells injury induced endoplasmic reticulum ( ER ) dysfunction , form cellular stress also triggered transient cerebral ischemia . However , contrast observations neuroblastoma cells , saw up-regulation parkin expression primary neuronal cell cultures induction ER dysfunction . data thus suggest ischemia-induced depletion parkin protein may contribute pathological process resulting cell injury increasing sensitivity neurons ER dysfunction aggregation ubiquitylated proteins reperfusion period .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.591620977481729e-06)\n",
      "- Text: \"S-nitrosylation parkin regulates ubiquitination compromises parkin 's protective function . Parkin @ GeneSrc $ involved ubiquitination proteins important survival dopamine neurons @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show parkin S-nitrosylated vitro , well vivo mouse model @ DiseaseTgt $ brains patients @ DiseaseTgt $ diffuse Lewy body disease . Moreover , S-nitrosylation inhibits parkin 's ubiquitin E3 ligase activity protective function . inhibition parkin 's ubiquitin E3 ligase activity S-nitrosylation could contribute degenerative process disorders impairing ubiquitination parkin substrates .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0034905262788423)\n",
      "- Text: \"Parkin ubiquitinates promotes degradation RanBP2 . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative disorder , involves deterioration dopaminergic neurons pars compacta substantia nigra . etiology @ DiseaseTgt $ still unknown , recent identification mutations familial cases @ DiseaseTgt $ advanced understanding molecular mechanisms neurological disease . Mutations parkin gene , encodes ubiquitin-protein ligase ( E3 ) , implicated autosomal recessive juvenile Parkinsonism , early onset common familial form @ DiseaseTgt $ . reported Parkin selectively binds RanBP2 , localized cytoplasmic filament nuclear pore complex belongs small ubiquitin-related modifier E3 ligase family . also demonstrated RanBP2 becomes target Parkin @ GeneSrc $ processed via Parkin-mediated ubiquitination subsequent proteasomal degradation . Furthermore , Parkin controls intracellular levels sumoylated HDAC4 , result ubiquitination degradation RanBP2 . findings suggested intracellular levels RanBP2 functional activity may modulated Parkin-mediated ubiquitination proteasomal pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0674458686604939)\n",
      "- Text: \"Parkin mediates proteasome-dependent protein degradation rupture outer mitochondrial membrane . Upon mitochondrial depolarization , Parkin , @ DiseaseTgt $ @ GeneSrc $ , translocates cytosol mitochondria promotes degradation mitophagy , selective type autophagy . , report addition mitophagy , Parkin mediates proteasome-dependent degradation outer membrane proteins Tom20 , Tom40 , Tom70 , Omp25 depolarized mitochondria . contrast , degradation inner membrane matrix proteins largely depends mitophagy . Furthermore , Parkin induces rupture outer membrane depolarized mitochondria , also depends proteasomal activity . Upon induction mitochondrial depolarization , proteasomes recruited mitochondria perinuclear region . Neither proteasome-dependent degradation outer membrane proteins outer membrane rupture required mitophagy . results suggest Parkin regulates degradation outer inner mitochondrial membrane proteins differently proteasome- mitophagy-dependent pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.197368461276139e-07)\n",
      "- Text: \"Aberrant folding pathogenic Parkin mutants : aggregation versus degradation . Loss-of-function mutations Parkin gene ( PARK2 ) responsible majority autosomal recessive Parkinson disease . growing body evidence indicates misfolding aggregation Parkin major mechanism Parkin inactivation , accounting loss-of-function phenotype various pathogenic Parkin mutants . Remarkably , wild-type Parkin also prone misfolding certain cellular conditions , suggesting general role Parkin pathogenesis @ DiseaseTgt $ . show misfolding Parkin lead two phenotypes : formation detergent-insoluble , aggregated Parkin , destabilization Parkin resulting accelerated proteasomal degradation . combining two pathogenic Parkin mutations , could demonstrate destabilization Parkin dominant formation detergent-insoluble Parkin aggregates . Furthermore , comparative analysis HHARI , @ GeneSrc $ RBR domain highly homologous Parkin , revealed folding Parkin specifically dependent integrity C-terminal domain , presence putative PDZ-binding motif extreme C terminus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.249680185029509e-07)\n",
      "- Text: \"FOG-2 , cofactor GATA transcription factors , essential heart morphogenesis development coronary vessels epicardium . disrupted FOG-2 gene mice define requirement vivo . FOG-2 ( -/- ) embryos die midgestation cardiac defect characterized thin ventricular myocardium , common atrioventricular canal , @ DiseaseTgt $ . Remarkably , coronary vasculature absent FOG-2 ( -/- ) hearts . Despite formation intact epicardial layer expression epicardium-specific genes , markers cardiac vessel development ( @ GeneSrc $ FLK-1 ) detected , indicative failure activate expression and/or initiate epithelial mesenchymal transformation epicardial cells . Transgenic reexpression FOG-2 cardiomyocytes rescues FOG-2 ( -/- ) vascular phenotype , demonstrating FOG-2 function myocardium required sufficient coronary vessel development . findings provide molecular inroad induction coronary vasculature myocardium developing heart .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002268046705934)\n",
      "- Text: \"@ GeneSrc $ regulates levels insulin , amyloid beta-protein , beta-amyloid precursor protein intracellular domain vivo . Two substrates @ GeneSrc $ ( @ GeneSrc $ ) , amyloid beta-protein ( Abeta ) insulin , critically important pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) type 2 diabetes mellitus ( DM2 ) , respectively . previously identified @ GeneSrc $ principal regulator Abeta levels neuronal microglial cells . small chromosomal region containing mutant IDE allele associated hyperinsulinemia glucose intolerance rat model DM2 . Human genetic studies implicated IDE region chromosome 10 @ DiseaseTgt $ DM2 . establish whether IDE hypofunction decreases Abeta insulin degradation vivo chronically increases levels , characterized mice homozygous deletions @ GeneSrc $ gene ( @ GeneSrc $ -- ) . IDE deficiency resulted > 50 % decrease Abeta degradation brain membrane fractions primary neuronal cultures similar deficit insulin degradation liver . @ GeneSrc $ -- mice showed increased cerebral accumulation endogenous Abeta , hallmark @ DiseaseTgt $ , hyperinsulinemia glucose intolerance , hallmarks DM2 . Moreover , mice elevated levels intracellular signaling domain beta-amyloid precursor protein , recently found degraded @ GeneSrc $ vitro . Together emerging genetic evidence , vivo findings suggest IDE hypofunction may underlie contribute forms @ DiseaseTgt $ DM2 provide mechanism recently recognized association among hyperinsulinemia , diabetes , @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6016654651249379)\n",
      "- Text: \"Enhanced proteolysis beta-amyloid APP transgenic mice prevents plaque formation , secondary pathology , premature death . Converging evidence suggests accumulation cerebral amyloid beta-protein ( Abeta ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) reflects imbalance production degradation self-aggregating peptide . Upregulation proteases degrade Abeta thus represents novel therapeutic approach lowering steady-state Abeta levels , consequences sustained upregulation vivo studied . show transgenic overexpression @ GeneSrc $ ( @ GeneSrc $ ) neprilysin ( NEP ) neurons significantly reduces brain Abeta levels , retards completely prevents amyloid plaque formation associated cytopathology , rescues premature lethality present amyloid precursor protein ( APP ) transgenic mice . findings demonstrate chronic upregulation Abeta-degrading proteases represents efficacious therapeutic approach combating @ DiseaseTgt $ pathology vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.116213200915924)\n",
      "- Text: \"Elevated amyloid beta protein ( Abeta42 ) late onset @ DiseaseTgt $ associated single nucleotide polymorphisms urokinase-type plasminogen activator gene . Plasma amyloid beta protein ( Abeta42 ) levels late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) linked region chromosome 10q . PLAU gene within region encodes urokinase-type plasminogen activator , converts plasminogen plasmin . Abeta aggregates induce PLAU expression thereby increasing plasmin , degrades aggregated non-aggregated forms Abeta . evaluated single nucleotide polymorphisms ( SNPs ) PLAU association Abeta42 @ DiseaseTgt $ . PLAU SNP compound genotypes composed haplotype pairs showed significant association @ DiseaseTgt $ three independent case-control series . PLAU SNP haplotypes associated significantly plasma Abeta42 10 extended @ DiseaseTgt $ families . One SNPs analyzed missense C/T polymorphism exon 6 PLAU ( PLAU_1=rs2227564 ) , causes proline leucine change ( P141L ) . analyzed PLAU_1 association @ DiseaseTgt $ six case-control series 24 extended @ DiseaseTgt $ families . CT TT PLAU_1 genotypes showed association ( P=0.05 ) overall estimated odds ratio 1.2 ( 1.0 - 1.5 ) . CT TT genotypes PLAU_1 also associated significant age-dependent elevation plasma Abeta42 24 extended @ DiseaseTgt $ families ( P=0.0006 ) . knockout mice lacking PLAU gene , plasma -- brain -- Abeta42 well Abeta40 significantly elevated , also age-dependent manner . PLAU_1 associations independent associations found among plasma Abeta42 , @ DiseaseTgt $ variants @ GeneSrc $ VR22 region . results provide strong evidence PLAU nearby gene involved development @ DiseaseTgt $ . PLAU_1 plausible pathogenic mutation could act increasing Abeta42 , additional biological experiments required show definitively .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.458850147474779e-05)\n",
      "- Text: \"PKCepsilon increases endothelin converting enzyme activity reduces amyloid plaque pathology transgenic mice . Deposition plaques containing amyloid beta ( Abeta ) peptides neuropathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate neuronal overexpression epsilon isozyme PKC decreases Abeta levels , plaque burden , plaque-associated neuritic dystrophy reactive astrocytosis transgenic mice expressing @ DiseaseTgt $ forms human amyloid precursor protein ( APP ) . Compared APP singly transgenic mice , APP/PKCepsilon doubly transgenic mice decreased Abeta levels showed evidence altered cleavage APP . Instead , PKCepsilon overexpression selectively increased activity endothelin-converting enzyme , degrades Abeta . activities Abeta-degrading enzymes , @ GeneSrc $ neprilysin , unchanged . results indicate increased neuronal PKCepsilon activity promote Abeta clearance reduce @ DiseaseTgt $ neuropathology increased endothelin-converting enzyme activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0647806649949679)\n",
      "- Text: \"27-Hydroxycholesterol links hypercholesterolemia breast cancer pathophysiology . Hypercholesterolemia risk factor estrogen receptor ( ER ) -positive breast cancers associated decreased response @ DiseaseTgt $ endocrine therapies . , show 27-hydroxycholesterol ( 27HC ) , primary metabolite cholesterol ER liver X receptor ( LXR ) ligand , increases ER-dependent growth LXR-dependent metastasis mouse models breast cancer . effects cholesterol @ DiseaseTgt $ pathology required conversion 27HC cytochrome P450 oxidase @ GeneSrc $ attenuated treatment @ GeneSrc $ inhibitors . human breast cancer specimens , @ GeneSrc $ expression levels correlated @ DiseaseTgt $ grade . high-grade @ DiseaseTgt $ , @ DiseaseTgt $ cells @ DiseaseTgt $ macrophages exhibited high expression levels enzyme . Thus , lowering circulating cholesterol levels interfering conversion 27HC may useful strategy prevent and/or treat breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0607463812483329)\n",
      "- Text: \"Critical role p110alpha phosphoinositide-3-OH kinase growth metabolic regulation . eight catalytic subunits mammalian phosphoinositide-3-OH kinase ( PI ( 3 ) K ) family form backbone evolutionarily conserved signalling pathway ; however , roles PI ( 3 ) K isoforms organismal physiology disease unknown . delineate role p110alpha , ubiquitously expressed PI ( 3 ) K involved tyrosine kinase Ras signalling , generated mice carrying knockin mutation ( D933A ) abrogates p110alpha kinase activity . Homozygosity kinase-dead p110alpha led embryonic lethality . Mice heterozygous mutation viable fertile , displayed severely blunted signalling via insulin-receptor substrate ( IRS ) proteins , key mediators insulin , @ GeneSrc $ leptin action . Defective responsiveness hormones led reduced somatic growth , hyperinsulinaemia , glucose intolerance , hyperphagia increased adiposity mice heterozygous D933A mutation . signalling function p110alpha derives highly selective recruitment activation IRS signalling complexes compared p110beta , broadly expressed PI ( 3 ) K isoform , contribute IRS-associated PI ( 3 ) K activity . p110alpha principal IRS-associated PI ( 3 ) K @ DiseaseTgt $ cell lines . findings demonstrate critical role p110alpha growth factor metabolic signalling also suggest explanation selective mutation overexpression p110alpha variety @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006218377220141)\n",
      "- Text: \"GIGYF2 gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . Grb10-Interacting GYF Protein 2 ( GIGYF2 ) initially identified interaction Grb10 , adapter protein binds activated @ GeneSrc $ insulin receptors . GIGYF2 gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( PARK11 locus ) , association GIGYF2 mutations @ DiseaseTgt $ described recent publications . study investigated consequences Gigyf2 gene disruption mice . Gigyf2 null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous Gigyf2 ( +/- ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , Gigyf2 ( +/- ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . alpha-synuclein positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts Gigyf2 null mice exhibit decreased @ GeneSrc $ IGF-I receptor tyrosine phosphorylation augmented ERK1/2 phosphorylation . data provide evidence important role GIGYF2 age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0091988948071661)\n",
      "- Text: \"GIGYF2 gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . Grb10-Interacting GYF Protein 2 ( GIGYF2 ) initially identified interaction Grb10 , adapter protein binds activated IGF-I insulin receptors . GIGYF2 gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( PARK11 locus ) , association GIGYF2 mutations @ DiseaseTgt $ described recent publications . study investigated consequences Gigyf2 gene disruption mice . Gigyf2 null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous Gigyf2 ( +/- ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , Gigyf2 ( +/- ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . alpha-synuclein positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts Gigyf2 null mice exhibit decreased IGF-I-stimulated @ GeneSrc $ tyrosine phosphorylation augmented ERK1/2 phosphorylation . data provide evidence important role GIGYF2 age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.014885069947341e-06)\n",
      "- Text: \"Hepatic @ GeneSrc $ prosurvival factor binds BAK , protects liver apoptosis , antagonizes proapoptotic actions p53 mitochondria . Liver generally refractory apoptosis induced p53 @ DiseaseTgt $ suppressor protein , molecular basis remains poorly understood . show p53 transcriptional activation leads enhanced expression hepatic @ GeneSrc $ ( @ GeneSrc $ ) . Exhibiting previously unanticipated role , portion intracellular @ GeneSrc $ protein localizes mitochondria binds proapoptotic protein BAK hinders BAK activation apoptosis induction . Interestingly , many cells tissues p53 also direct apoptotic function mitochondria includes BAK binding activation . @ GeneSrc $ complex BAK , formation proapoptotic p53/BAK complex apoptosis induction impaired , cultured cells liver . contrast , livers @ GeneSrc $ mice exhibit spontaneous apoptosis accompanied p53 mitochondrial accumulation evidence BAK oligomerization . data support importance BAK mediator p53 's mitochondrial function . results also identify @ GeneSrc $ negative regulator BAK-dependent pathway apoptosis , whose expression integrates transcriptional mitochondrial functions p53 @ DiseaseTgt $ suppressor protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.16570404854798)\n",
      "- Text: \"Large-scale meta-analysis genome-wide association data identifies six new risk loci @ DiseaseTgt $ . conducted meta-analysis @ DiseaseTgt $ genome-wide association studies using common set 7,893,274 variants across 13,708 cases 95,282 controls . Twenty-six loci identified genome-wide significant association ; 6 additional previously reported loci tested independent set 5,353 cases 5,551 controls . 32 tested SNPs , 24 replicated , including 6 newly identified loci . Conditional analyses within loci showed four loci , including GBA , @ GeneSrc $ , SNCA HLA region , contain secondary independent risk variant . total , identified replicated 28 independent risk variants @ DiseaseTgt $ across 24 loci . Although effect individual locus small , risk profile analysis showed substantial cumulative risk comparison highest lowest quintiles genetic risk ( odds ratio ( ) = 3.31 , 95 % confidence interval ( CI ) = 2.55 - 4.30 ; P = 2 x 10 ( -16 ) ) . also show six risk loci associated proximal gene expression DNA methylation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1672114291017722)\n",
      "- Text: \"Interaction DJ-1 @ GeneSrc $ inhibits apoptosis signal-regulating kinase 1 activity cell death . Investigations cellular molecular biology genes cause inherited forms @ DiseaseTgt $ , well downstream pathways trigger , shed considerable light understanding fundamental determinants life death dopaminergic neurons . Homozygous deletion missense mutation DJ-1 results autosomal recessively inherited @ DiseaseTgt $ , suggesting wild-type DJ-1 favorable role maintaining neurons . , show DJ-1 protects oxidative stress-induced cell death , relatively modest ability quench reactive oxygen species insufficient account robust cytoprotective effect . elucidate mechanism cell-preserving function , screened death protein @ GeneSrc $ DJ-1-interacting partner . demonstrate wild-type DJ-1 sequesters @ GeneSrc $ nucleus , prevents gaining access cytoplasm , binding activating effector kinase apoptosis signal-regulating kinase 1 , therefore , triggering ensuing death pathway . steps impaired disease-causing L166P mutant isoform DJ-1 . findings suggest regulated sequestration @ GeneSrc $ nucleus keeping apoptosis signal-regulating kinase 1 activation check critical mechanism DJ-1 exerts cytoprotective function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0337433723808667)\n",
      "- Text: \"Loss p53 triggers WNT-dependent systemic inflammation drive breast cancer metastasis . @ DiseaseTgt $ systemic inflammation strongly linked poor disease outcome patients cancer1,2 . human epithelial tumour types , high systemic neutrophil-to-lymphocyte ratios associated poor overall survival3 , experimental studies demonstrated causal relationship neutrophils metastasis4,5 . However , @ DiseaseTgt $ mechanisms dictate substantial heterogeneity systemic neutrophilic inflammation @ DiseaseTgt $ hosts largely unresolved . , using panel 16 distinct genetically engineered mouse models breast cancer , uncover role @ DiseaseTgt $ p53 key regulator pro-metastatic neutrophils . Mechanistically , loss p53 @ DiseaseTgt $ cells induced secretion WNT ligands stimulate @ DiseaseTgt $ macrophages produce @ GeneSrc $ , thus driving systemic inflammation . Pharmacological genetic blockade WNT secretion p53-null @ DiseaseTgt $ cells reverses macrophage production @ GeneSrc $ subsequent neutrophilic inflammation , resulting reduced metastasis formation . Collectively , demonstrate mechanistic link loss p53 @ DiseaseTgt $ cells , secretion WNT ligands systemic neutrophilia potentiates metastatic progression . insights illustrate importance genetic makeup breast tumours dictating pro-metastatic systemic inflammation , set stage personalized immune intervention strategies patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9605544757188562)\n",
      "- Text: \"Point mutations juxtamembrane domain FLT3 define new class activating mutations @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) , two clusters activating mutations known FMS-like tyrosine kinase-3 ( FLT3 ) gene : FLT3-internal tandem duplications ( FLT3-ITDs ) juxtamembrane ( JM ) domain 20 % 25 % patients , FLT3 point mutations tyrosine-kinase domain ( FLT3-TKD ) 7 % 10 % patients , respectively . , characterized new class activating point mutations ( PMs ) cluster 16-amino acid stretch juxtamembrane domain FLT3 ( FLT3-JM-PMs ) . Expression 4 FLT3-JM-PMs @ GeneSrc $ @ GeneSrc $ Ba/F3 cells led factor-independent growth , hyperresponsiveness FLT3 ligand , resistance apoptotic cell death . FLT3-JM-PM receptors autophosphorylated showed higher constitutive dimerization rate compared FLT3-wild-type ( WT ) receptor . molecular mechanism , could show activation STAT5 up-regulation Bcl-x ( L ) FLT3-JM-PMs . FLT3 inhibitor PKC412 abrogated factor-independent growth FLT3-JM-PM-expressing cells . Compared FLT3-ITD FLT3-TKD mutants , FLT3-JM-PMs showed weaker transforming potential related lower autophosphorylation receptor downstream target STAT5 . Mapping FLT3-JM-PMs crystal structure FLT3 showed mutations reduce stability autoinhibitory JM domain , provides structural basis transforming capacity new class gain-of-function mutations FLT3 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4672261554036945)\n",
      "- Text: \"Trp53 deficiency protects acute intestinal inflammation . p53 protein important @ DiseaseTgt $ suppressor activity also additional immunological functions , whose nature extent beginning recognized . article , show p53 novel inflammation-promoting action intestinal tract , loss p53 upstream activating kinase , ATM , protects acute intestinal inflammation murine models . Mechanistically , deficiency p53 leads increased survival epithelial cells lamina propria macrophages , higher @ GeneSrc $ expression owing enhanced glucose-dependent NF-kappaB activation , increased mucosal STAT3 activation . Blockade loss @ GeneSrc $ signaling reverses protective effects p53 deficiency . Conversely , @ GeneSrc $ treatment protects acute colitis manner dependent STAT3 signaling induction cytoprotective factors epithelial cells . Together , results indicate p53 promotes inflammation intestinal tract suppression epithelium-protective factors , thus significantly expanding spectrum physiological immunological p53 activities unrelated @ DiseaseTgt $ formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000662490374555)\n",
      "- Text: \"ACE I/D gene polymorphism : presence @ GeneSrc $ allele increases risk coronary artery disease younger individuals . BACKGROUND : Presence allele homozygosity deletion ( ) allele @ GeneSrc $ insertion/deletion ( I/D ) polymorphism discussed potent risk factor coronary artery disease ( CAD ) @ DiseaseTgt $ ( MI ) . METHODS RESULTS : 2267 male Caucasians relation ACE I/D gene polymorphism CAD MI investigated . association allele CAD detected younger subjects ( e.g . < 61.7 years , mean value ) , older patients ( e.g . > = 61.7 years ) . Additional exclusion individuals cardiovascular risk factors ( e.g . high BMI ) produced even stronger association allele CAD . contrast , relation polymorphism non-fatal MI observed older subjects ; additional limitation individuals without cardiovascular risk factors ( e.g . BMI and/or diabetes ) yielded enhancement association MI . younger subjects ( e.g . < 61.7 years ) gene polymorphism related non-fatal MI even exclusion additional risk factors . CONCLUSIONS : present large case-control study strengthens assumption association @ GeneSrc $ allele risk ischemic heart disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0014058974534186)\n",
      "- Text: \"Genetic susceptibility human familial essential hypertension region homology blood pressure linkage rat chromosome 10 . Hypertension significant risk factor @ DiseaseTgt $ stroke represents major public health burden high prevalence ( e.g . 15 - 20 % European American populations ) . Although blood pressure known strong genetic determination , genes responsible susceptibility essential hypertension mostly unknown . Loci involved blood pressure regulation found linkage experimental hereditary hypertensive rat strains , relationship human hypertension extensively investigated . One principal blood pressure loci mapped rat chromosome 10 undertaken investigation homologous region human chromosome 17 familial essential hypertension . Affected sib-pair analysis parametric analysis ascertainment correction gave significant evidence linkage ( P < 0.0001 analyses ) near two closely linked microsatellite markers , D17S183 D17S934 , reside 18 cM proximal @ GeneSrc $ locus homology region . results indicate chromosome 17q could contain susceptibility locus human hypertension show comparative mapping may useful approach identification loci humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003155767043106)\n",
      "- Text: \"Large-scale test hypothesised associations angiotensin-converting-enzyme insertion/deletion polymorphism @ DiseaseTgt $ 5000 cases 6000 controls . International Studies Infarct Survival ( ISIS ) Collaborators . BACKGROUND : original report possible association @ DiseaseTgt $ insertion/deletion ( I/D ) polymorphism gene @ GeneSrc $ ( @ GeneSrc $ ) indicated risk ratio @ DiseaseTgt $ DD genotype 1.34 ( 95 % CI 1.05 - 1.70 ) , association claimed particularly strong retrospectively defined low-risk subgroup ( 3.2 [ 95 % CI 1.7 - 5.9 ) . Subsequent investigations reached varying conclusions , small , much larger studies needed . METHODS : 4629 @ DiseaseTgt $ cases 5934 controls compared . Cases UK men aged 30 - 54 years women aged 30 - 64 years recruited presentation hospital confirmed @ DiseaseTgt $ . Controls aged 30 - 64 years history cardiovascular disease , siblings children @ DiseaseTgt $ survivors , spouses relatives . risk-ratio calculations allow relatedness controls . updated meta-analysis previous studies also conducted . FINDINGS : @ GeneSrc $ DD genotype found 1359 ( 29.4 % ) @ DiseaseTgt $ cases 1637 ( 27.6 % ) controls ( risk ratio 1.10 [ 95 % CI 1.00 - 1.21 ] ) . association @ DiseaseTgt $ DD genotype seem stronger subgroup defined low risk previously used criteria ( 234 [ 28 % ] 836 cases 911 [ 28 % ] 3253 controls : risk ratio 1.04 [ 95 % CI 0.87 - 1.24 ] ) , subgroup . @ GeneSrc $ I/D genotype predictive subsequent survival . INTERPRETATION : study involved many cases previously reported study question , confirm existence substantial association . updated meta-analysis results previously published studies , risk ratio @ DiseaseTgt $ DD genotype seems lie range 1.0 1.1 . Although increase risk 10 - 15 % ruled , substantially extreme risks . Moreover , especially strong associations subgroups previously selected emphasis . findings illustrate need studies candidate genes involve much larger populations customary , without undue emphasis retrospectively defined subgroups .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8051411881255451)\n",
      "- Text: \"cladistic model @ GeneSrc $ sequence variation implications @ DiseaseTgt $ , Alzheimer disease obesity . Sequence variation @ GeneSrc $ , encodes angiotensin converting enzyme , contributes large proportion variability plasma @ GeneSrc $ levels , extent impacts upon human disease unresolved . efforts associate @ GeneSrc $ heritable traits involved single Alu insertion/deletion polymorphism , despite probable existence functional sequence variants effects may consistently detectable solely typing Alu indel . , utilizing single nucleotide polymorphisms ( SNPs ) differentiate major @ GeneSrc $ clades European populations , demonstrate number significant phenotype associations across 4000 Swedish individuals . systematic analysis metabolic phenotypes , effects detected upon several traits , including fasting plasma glucose levels , insulin levels measures obesity ( P-values ranging 0.046 8.4 x 10 ( -6 ) ) . Extending cladistic models study @ DiseaseTgt $ Alzheimer disease , significant associations observed greater effect sizes typically obtained large-scale meta-analyses based Alu indel . Population frequencies @ GeneSrc $ genotypes also found change age , congruent previous data suggesting effects upon longevity . Clade models consistently outperformed based upon single markers , reinforcing importance taking consideration possible confounding effects allelic heterogeneity genomic region . Utilizing computational tools , potential functional variants highlighted may underlie phenotypic variability , discussed along broader implications results may studies attempting link variation @ GeneSrc $ human disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0568580281692252)\n",
      "- Text: \"@ DiseaseTgt $ . @ GeneSrc $ hearts .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.931337414631159e-05)\n",
      "- Text: \"Crystal structure human angiotensin-converting enzyme-lisinopril complex . Angiotensin-converting enzyme ( @ GeneSrc $ ) critical role cardiovascular function cleaving carboxy terminal His-Leu dipeptide angiotensin produce potent vasopressor octapeptide , angiotensin II . Inhibitors @ GeneSrc $ first line therapy hypertension , heart failure , @ DiseaseTgt $ diabetic nephropathy . Notably , inhibitors developed without knowledge structure human @ GeneSrc $ , instead designed basis assumed mechanistic homology carboxypeptidase . present X-ray structure human testicular @ GeneSrc $ complex one widely used inhibitors , lisinopril ( N2- [ ( ) -1-carboxy-3-phenylpropyl ] -L-lysyl-L-proline ; also known Prinivil Zestril ) , 2.0 resolution . Analysis three-dimensional structure @ GeneSrc $ shows bears little similarity carboxypeptidase , instead resembles neurolysin Pyrococcus furiosus carboxypeptidase -- zinc metallopeptidases detectable sequence similarity @ GeneSrc $ . structure provides opportunity design domain-selective ACE inhibitors may exhibit new pharmacological profiles .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0074856642805165)\n",
      "- Text: \"@ GeneSrc $ D/I polymorphism , migraine , cardiovascular disease women . BACKGROUND : Interrelationships among @ GeneSrc $ deletion/insertion ( D/I ) polymorphism ( rs1799752 ) , migraine , cardiovascular disease ( CVD ) biologically plausible remain controversial . METHODS : Association study among 25,000 white US women , participating Women 's Health Study , information @ GeneSrc $ D/I polymorphism . Migraine migraine aura status self-reported . Incident CVD events confirmed medical record review . used logistic regression investigate genotype-migraine association proportional hazards models evaluate interrelationship among genotype , migraine , incident CVD . RESULTS : baseline , 4,577 ( 18.3 % ) women reported history migraine ; 39.5 % 3,226 women active migraine indicated aura . 11.9 years follow-up , 625 CVD events occurred . find association @ GeneSrc $ D/I polymorphism migraine migraine aura status . lack association @ GeneSrc $ D/I polymorphism incident major CVD , ischemic stroke , @ DiseaseTgt $ . Migraine aura doubled risk CVD , carriers DD ( multivariable-adjusted relative risk [ RR ] = 2.10 ; 95 % CI = 1.22 - 3.59 ; p = 0.007 ) DI genotype ( multivariable-adjusted RR = 2.31 ; 95 % CI = 1.52 - 3.51 ; p < 0.0001 ) . risk significant among carriers II genotype , pattern observed @ DiseaseTgt $ ischemic stroke . CONCLUSIONS : Data large cohort women suggest association @ GeneSrc $ deletion/insertion ( D/I ) polymorphism migraine , migraine aura status , cardiovascular disease ( CVD ) . increased risk CVD among migraineurs aura apparent carriers DD/DI genotype . Due limited number outcome events , however , future studies warranted investigate association .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.542402384384699e-05)\n",
      "- Text: \"Allelotype adenoma differentiated @ DiseaseTgt $ . molecular mechanism gastric tumourigenesis yet clarified , although investigators postulated differentiated adenocarcinoma may arise pre-existing adenoma , similarly colorectal adenoma-carcinoma sequence . allelotype analysis performed identify chromosomal regions frequently deleted @ DiseaseTgt $ examine significance adenoma-carcinoma sequence gastric tumourigenesis . Forty-five @ DiseaseTgt $ , 20 adenomas , 25 differentiated adenocarcinomas examined loss heterozygosity ( LOH ) using 39 microsatellite markers covering non-acrocentric chromosome arm . Frequent LOH adenocarcinomas observed chromosomes 2q ( 33 per cent ) , 4p ( 33 per cent ) , 5q ( 50 per cent ) , 6p ( 33 per cent ) , 7q ( 43 per cent ) , 11q ( 36 per cent ) , 14q ( 38 per cent ) , 17p ( 45 per cent ) , 18q ( 36 per cent ) , 21q ( 40 per cent ) . contrast , incidence LOH adenomas exceed 10 per cent loci examined . addition p53 gene 17p @ GeneSrc $ gene 18q , known frequently deleted differentiated @ DiseaseTgt $ , unknown tumour suppressor genes above-mentioned chromosomes may also inactivated . observations suggest adenoma-carcinoma sequence major pathway gastric tumourigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1320864062679112)\n",
      "- Text: \"Identification chromosome 18q gene altered @ DiseaseTgt $ . Allelic deletions involving chromosome 18q occur 70 percent @ DiseaseTgt $ . deletions thought signal existence tumor suppressor gene affected region , candidate suppressor gene chromosomal arm identified . contiguous stretch DNA comprising 370 kilobase pairs ( kb ) cloned region chromosome 18q suspected reside near gene . Potential exons 370-kb region defined human-rodent sequence identities , expression potential exons assessed `` exon-connection `` strategy based polymerase chain reaction . Expressed exons used probes cDNA screening obtain clones encoded portion gene termed @ GeneSrc $ ; cDNA encoded least eight exons within 370-kb genomic region . predicted amino acid sequence cDNA specified protein sequence similarity neural cell adhesion molecules related cell surface glycoproteins . @ GeneSrc $ gene expressed normal tissues , including colonic mucosa , expression greatly reduced absent @ DiseaseTgt $ tested . Somatic mutations within @ GeneSrc $ gene observed @ DiseaseTgt $ included homozygous deletion 5 ' end gene , point mutation within one introns , ten examples DNA insertions within 0.17-kb fragment immediately downstream one exons . @ GeneSrc $ gene may play role pathogenesis human colorectal neoplasia , perhaps alteration normal cell-cell interactions controlling growth .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0187378673100801)\n",
      "- Text: \"@ GeneSrc $ gene : structural analysis mutations @ DiseaseTgt $ . @ GeneSrc $ candidate tumor-suppressor gene encoding protein sequence similarity cell adhesion molecules N-CAM . set overlapping YAC clones contains entire @ GeneSrc $ coding region isolated . Studies YAC contig showed @ GeneSrc $ gene spans approximately 1.4 Mb . elucidation exon-intron structure , lambda phage clones containing known coding sequences isolated genomic library . clones used demonstrate existence 29 @ GeneSrc $ exons , sequences exon-intron boundaries determined . Twenty-three polymorphic markers chromosome 18 studied panel primary @ DiseaseTgt $ lost , , chromosome 18 . tumors , region lost included @ GeneSrc $ . Finally , Southern blot PCR-based approaches used search subtle mutations several @ GeneSrc $ exons . One tumor point mutation exon 28 found , resulting proline histidine substitution . second tumor point mutation intron 13 also found . regional map genomic structure @ GeneSrc $ provide means extensively study @ GeneSrc $ gene alterations protein function normal neoplastic cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2909252404376785)\n",
      "- Text: \"deleted colon cancer ( @ GeneSrc $ ) gene consistently expressed @ DiseaseTgt $ metastases . @ GeneSrc $ ( @ GeneSrc $ ) gene originally identified candidate tumour suppressor gene colon carcinogenesis basis allelic losses chromosome 18q.21 70 % @ DiseaseTgt $ . Reverse transcriptase polymerase chain reaction ( RT-PCR ) @ GeneSrc $ mRNA suggests @ GeneSrc $ expression may also reduced @ DiseaseTgt $ . used monoclonal antibodies generated @ GeneSrc $ immunoglobulin-like domain investigate @ GeneSrc $ isoforms @ GeneSrc $ protein expression @ DiseaseTgt $ progression . Normal mucosa colonic tumour specimens representative range colonic tumour progression benign adenomatous polyps metastases compared Western blot analyses . show ( r ) 194 000 @ GeneSrc $ present normal colonic mucosa adenomatous polyps , also similarly expressed @ DiseaseTgt $ colonic metastases liver . presence @ GeneSrc $ protein consistent presence @ GeneSrc $ mRNA transcripts tissue specimens . Notably @ GeneSrc $ completely lost colonic tumour specimens examined , even progressed metastatic cancers . Quantitation @ GeneSrc $ protein expression tissue specimens densitometry demonstrated normal malignant specimens exhibit wide range @ GeneSrc $ protein levels significant correlation diminished @ GeneSrc $ protein expression @ DiseaseTgt $ progression . results demonstrate pattern expression @ GeneSrc $ gene product colonic tumour progression show absence @ GeneSrc $ expression associated colonic tumour progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6174625187931483)\n",
      "- Text: \"Function axonal chemoattractant modulated metalloprotease activity . axonal chemoattractant netrin-1 guides spinal commissural axons activating receptor @ GeneSrc $ ( Deleted @ DiseaseTgt $ ) . found chemical inhibitors metalloproteases potentiate netrin-mediated axon outgrowth vitro . also found @ GeneSrc $ substrate metalloprotease-dependent ectodomain shedding , inhibitors block proteolytic processing @ GeneSrc $ cause increase @ GeneSrc $ protein levels axons within spinal cord explants . Thus , potentiation netrin activity inhibitors may result stabilization @ GeneSrc $ axons , proteolytic activity may regulate axon migration controlling number functional extracellular axon guidance receptors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0112458112262899)\n",
      "- Text: \"Activation FAK Src receptor-proximal events required netrin signaling . axon guidance cue netrin importantly involved neuronal development . @ GeneSrc $ ( deleted @ DiseaseTgt $ ) functional receptor netrin mediates axon outgrowth steering response . show different regions intracellular domain @ GeneSrc $ directly interacted tyrosine kinases Src focal adhesion kinase ( FAK ) . Netrin activated FAK Src stimulated tyrosine phosphorylation @ GeneSrc $ . Inhibition Src family kinases reduced @ GeneSrc $ tyrosine phosphorylation blocked axon attraction outgrowth neurons response netrin . Mutation tyrosine phosphorylation residue @ GeneSrc $ abolished function mediating netrin-induced axon attraction . basis observations , suggest model @ GeneSrc $ functions kinase-coupled receptor , FAK Src act immediately downstream @ GeneSrc $ netrin signaling .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9821632962576112)\n",
      "- Text: \"@ GeneSrc $ protein prognosis @ DiseaseTgt $ . BACKGROUND : Allelic loss chromosome 18q predicts poor outcome patients @ DiseaseTgt $ . Although specific gene inactivated allelic loss elucidated , @ GeneSrc $ ( deleted @ DiseaseTgt $ ) gene candidate . investigated whether expression @ GeneSrc $ protein tumor cells prognostic marker @ DiseaseTgt $ . METHODS : expression @ GeneSrc $ evaluated immunohistochemically 132 paraffin-embedded samples patients curatively resected @ DiseaseTgt $ . Cox proportional-hazards model used adjust covariates including age , sex , tumor site , degree tumor differentiation , use adjuvant therapy . RESULTS : expression @ GeneSrc $ strong positive predictive factor survival stage II stage III colorectal carcinomas . patients stage II disease whose tumors expressed @ GeneSrc $ , five-year survival rate 94.3 percent , whereas patients @ GeneSrc $ tumors , survival rate 61.6 percent ( P < 0.001 ) . patients stage III disease , respective survival rates 59.3 percent 33.2 percent ( P=0.03 ) . CONCLUSIONS : @ GeneSrc $ prognostic marker patients @ DiseaseTgt $ . @ DiseaseTgt $ , absence @ GeneSrc $ identifies subgroup patients lesions behave like stage III cancers . findings may thus therapeutic implications group patients .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7624308889576045)\n",
      "- Text: \"Focal adhesion kinase netrin-1 signaling . Netrins family secreted molecules important axonal outgrowth guidance developing nervous system . However , signaling mechanisms lie immediately downstream netrin receptors remain poorly understood . report netrin receptor @ GeneSrc $ ( deleted @ DiseaseTgt $ ) interacts focal adhesion kinase ( FAK ) , kinase implicated regulating cell adhesion migration . FAK expressed developing brains localized @ GeneSrc $ cultured neurons . Netrin-1 induced FAK @ GeneSrc $ tyrosine phosphorylation . Disruption FAK signaling abolished netrin-1-induced neurite outgrowth attractive growth cone turning . Taken together , results indicate new signaling mechanism @ GeneSrc $ , FAK activated upon netrin-1 stimulation mediates netrin-1 function ; also identify critical role FAK axon navigation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0075122990624447)\n",
      "- Text: \"Mutations @ GeneSrc $ cause congenital mirror movements . Mirror movements involuntary contralateral movements mirror voluntary ones often associated defects midline crossing developing central nervous system . studied two large families , one French Canadian one Iranian , isolated congenital mirror movements inherited autosomal dominant trait . found affected individuals carried protein-truncating mutations @ GeneSrc $ ( deleted @ DiseaseTgt $ ) , gene chromosome 18q21.2 encodes receptor netrin-1 , diffusible protein helps guide axon growth across midline . Functional analysis mutant @ GeneSrc $ protein French Canadian family revealed defect netrin-1 binding . Thus , @ GeneSrc $ important role lateralization human nervous system .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8641557004295991)\n",
      "- Text: \"Evaluation candidate tumour suppressor genes chromosome 18 @ DiseaseTgt $ . Chromosome deletions common genetic events observed cancer . deletions generally thought reflect existence tumour suppressor gene within lost region . However , lost region precisely coincide hereditary cancer locus , identification putative tumour suppressor gene ( target deletion ) problematic . example , previous studies demonstrated chromosome 18q lost 60 % @ DiseaseTgt $ well cancers , lost region could precisely determined . present rigorous strategy mapping evaluating allelic deletions sporadic tumours , apply evaluation chromosome 18 @ DiseaseTgt $ . Using approach , define minimally lost region ( MLR ) chromosome 18q21 , contains least two candidate tumour suppressor genes , DPC4 @ GeneSrc $ . analysis suggested genetic heterogeneity , DPC4 deletion target third cases @ GeneSrc $ neighbouring gene target remaining tumours .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0095616464856243)\n",
      "- Text: \"Insertion/deletion ( I/D ) polymorphism locus @ GeneSrc $ @ DiseaseTgt $ . Male ( n = 185 ) female ( n = 49 ) survivors @ DiseaseTgt $ ( MI ) 56 61 years age , respectively , compared 366 controls respect distribution genotypes insertion/deletion ( ID ) polymorphism @ GeneSrc $ ( @ GeneSrc $ ) locus . frequency DD genotype ( homozygosity deletion allele ) significantly lower among male patients controls ( 22.7 % versus 34.9 % , p = 0.011 ) . `` low-risk `` group , defined less sex-specific , age-adjusted median values body mass index ( BMI ) apolipoprotein B ( apoB ) , respectively , absence treatment lipid-lowering drugs , prevalence DD genotype statistically different male patients controls . male `` high-risk `` group ( individuals defined `` low-risk `` subjects ) , prevalence DD genotype 20.9 % patients 38.3 % controls ( p = 0.002 ) . women , significant differences genotype frequencies patients controls found whole sample subgroup . results appear variance data reported recently Cambien et al . ( 1992 ) . difference may due chance , undetected selection biases , different gene-environment interactions Norway France Ireland , preferential loss DD individuals male `` high-risk `` group .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0526434021162407)\n",
      "- Text: \"@ GeneSrc $ gene deletion allele independently strongly associated coronary atherosclerosis @ DiseaseTgt $ . OBJECTIVE : investigate association three @ GeneSrc $ ( @ GeneSrc $ ) genotypes , DD , ID , II , occurrence absence coronary atherosclerosis @ DiseaseTgt $ hypertension . DESIGN : Cohort analysis study . SETTING : North-Italy reference centre . SUBJECTS : 388 white Italian patients ( 281 males ; mean age 60.7 ( SD 12.5 ) years ) proven coronary atherosclerosis ( n = 255 ) angiographically normal coronary arteries ( n = 133 ) . group 290 healthy blood donors tested allele frequency comparison . INTERVENTIONS : @ GeneSrc $ polymorphism analysed polymerase chain reaction DNA white blood cells . MAIN OUTCOME MEASURES : Coronary atherosclerosis , @ DiseaseTgt $ , hypertension . RESULTS : allele frequencies respectively 0.63 0.37 overall healthy blood donor group 0.66 0.34 overall study group . latter , univariate analysis showed ( 1 ) coronary atherosclerosis ( 255 patients ) associated deletion allele , odds ratio ( ) 5.78 DD/II , P < 0.001 , 2.39 ID/II , P = 0.006 ; ( 2 ) @ DiseaseTgt $ ( 154 patients ) associated DD genotype ( DD/II = 2.56 , P = 0.007 ) , ID genotype ( DD/II = 1.96 , P = 0.056 ) . Finally , hypertension proved unrelated @ GeneSrc $ genotype . distribution three genotypes known risk factors coronary artery disease similar . Logistic regression modelling , performed test association selected risk factors simultaneously coronary atherosclerosis @ DiseaseTgt $ , showed deletion allele ( whether DD ID ) strongest risk factor atherosclerosis , allele significantly associated risk infarction ( although lesser extent coronary atherosclerosis ) . CONCLUSION : @ GeneSrc $ deletion polymorphism strongly independently associated coronary atherosclerosis , lesser extent , @ DiseaseTgt $ . , results analogous already reported French white , Japanese , Welsh coronary patients .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8229815975586526)\n",
      "- Text: \"Deletion polymorphism gene @ GeneSrc $ potent risk factor @ DiseaseTgt $ . Factors involved pathogenesis atherosclerosis , thrombosis vasoconstriction contribute development coronary heart disease . study comparing patients @ DiseaseTgt $ controls , explored possible association coronary heart disease variation found gene encoding @ GeneSrc $ ( @ GeneSrc $ ) . polymorphism @ GeneSrc $ strongly associated level circulating enzyme . enzyme plays key role production angiotensin II catabolism bradykinin , two peptides involved modulation vascular tone proliferation smooth muscle cells . report DD genotype , associated higher levels circulating @ GeneSrc $ ID II genotypes , significantly frequent patients @ DiseaseTgt $ ( n = 610 ) controls ( n = 733 ) ( P = 0.007 ) , especially among subjects low body-mass index low plasma levels ApoB ( P < 0.0001 ) . @ GeneSrc $ polymorphism seems potent risk factor coronary heart disease subjects formerly considered low risk according common criteria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0902873585114982)\n",
      "- Text: \"Genetic predisposition diabetic nephropathy . Evidence role @ GeneSrc $ gene . search genetic determinants susceptibility diabetic nephropathy , examined association DNA sequence differences locus @ GeneSrc $ ( @ GeneSrc $ ) renal complications 151 insulin-dependent diabetes mellitus ( IDDM ) patients diabetes duration 16 - 21 years . nested case-control study included 77 normoalbuminuric control subjects ( albumin excretion rate < 30 micrograms/min ) 74 cases evidence nephropathy ranging microalbuminuria overt proteinuria . DNA patients genotyped @ GeneSrc $ locus three-allele restriction fragment-melting polymorphism ( RFMP ) ( Dde ) , described recently , two-allele insertion/deletion recognized Xba restriction fragment-length polymorphism , shown investigators associated serum levels @ GeneSrc $ risk @ DiseaseTgt $ . least common allele Dde RFMP significantly frequent among cases nephropathy among normoalbuminuric control subjects ( 12.8 vs. 4.5 % , P < 0.05 ) . deletion @ GeneSrc $ gene also frequent case control subjects ( 56.1 vs. 47.4 % ) , difference statistically significant ( P < 0.25 ) sample size . determine independence associations , two polymorphisms analyzed jointly identify Xba I/Dde haplotypes . might expected , carriers Xba I/Dde ' + = ' haplotype fourfold risk developing diabetic nephropathy ( odds ratio [ ] 4.0 , 95 % confidence interval [ CI ] 1.5 - 11.0 ) . However , explain excess Xba ' + ' allele among cases . ( ABSTRACT TRUNCATED 250 WORDS )\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.24225729974511e-05)\n",
      "- Text: \"Insertion/deletion ( I/D ) polymorphism locus @ GeneSrc $ parental history @ DiseaseTgt $ . One hundred eighty-one male 48 female @ DiseaseTgt $ ( MI ) survivors 172 male 194 female controls studied respect possible association premature parental MI ( age 61 years mothers and/or age 56 years fathers ) insertion/deletion ( I/D ) polymorphism gene encoding @ GeneSrc $ ( @ GeneSrc $ ) . total series , frequency premature parental MI 14 % DD ( homozygotes deletion ( ) allele ) genotypic group , 10.6 % ID ( heterozygotes ) genotypic group 6.1 % II ( homozygotes insertion ( ) allele ) genotypic group . males ( male MI survivors male controls combined ) , total series , significant excess DD individuals compared II individuals among parental history premature MI ( odds ratio 3.1 ( p = 0.03 ) 3.1 ( p = 0.009 ) , respectively ) . @ GeneSrc $ polymorphism may important genetic marker MI risk contribute clustering premature MI families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0258169749665497)\n",
      "- Text: \"Polymorphisms @ GeneSrc $ gene subjects die coronary heart disease . shown @ DiseaseTgt $ survivors likely carry insertion/deletion polymorphism ( I/D ) @ GeneSrc $ ( @ GeneSrc $ ) gene age-matched population controls . test whether association coronary risk under-estimated , frequency @ GeneSrc $ I/D studied 213 fatal cases definite possible @ DiseaseTgt $ came autopsy Belfast MONICA Project area . comparison controls population , autopsy cases increased frequency @ GeneSrc $ allele ( p < 0.02 ) . overall odds ratios 2.2 DD vs. II , 1.8 ID vs II ( test trend p = 0.01 ) . findings bear hypothesis @ GeneSrc $ I/D polymorphism risk factor fatal @ DiseaseTgt $ sudden cardiac death .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2670915311868462)\n",
      "- Text: \"Large-scale test hypothesised associations @ GeneSrc $ insertion/deletion polymorphism @ DiseaseTgt $ 5000 cases 6000 controls . International Studies Infarct Survival ( ISIS ) Collaborators . BACKGROUND : original report possible association @ DiseaseTgt $ insertion/deletion ( I/D ) polymorphism gene angiotensin-1-converting enzyme ( ACE ) indicated risk ratio @ DiseaseTgt $ DD genotype 1.34 ( 95 % CI 1.05 - 1.70 ) , association claimed particularly strong retrospectively defined low-risk subgroup ( 3.2 [ 95 % CI 1.7 - 5.9 ) . Subsequent investigations reached varying conclusions , small , much larger studies needed . METHODS : 4629 @ DiseaseTgt $ cases 5934 controls compared . Cases UK men aged 30 - 54 years women aged 30 - 64 years recruited presentation hospital confirmed @ DiseaseTgt $ . Controls aged 30 - 64 years history cardiovascular disease , siblings children @ DiseaseTgt $ survivors , spouses relatives . risk-ratio calculations allow relatedness controls . updated meta-analysis previous studies also conducted . FINDINGS : ACE DD genotype found 1359 ( 29.4 % ) @ DiseaseTgt $ cases 1637 ( 27.6 % ) controls ( risk ratio 1.10 [ 95 % CI 1.00 - 1.21 ] ) . association @ DiseaseTgt $ DD genotype seem stronger subgroup defined low risk previously used criteria ( 234 [ 28 % ] 836 cases 911 [ 28 % ] 3253 controls : risk ratio 1.04 [ 95 % CI 0.87 - 1.24 ] ) , subgroup . ACE I/D genotype predictive subsequent survival . INTERPRETATION : study involved many cases previously reported study question , confirm existence substantial association . updated meta-analysis results previously published studies , risk ratio @ DiseaseTgt $ DD genotype seems lie range 1.0 1.1 . Although increase risk 10 - 15 % ruled , substantially extreme risks . Moreover , especially strong associations subgroups previously selected emphasis . findings illustrate need studies candidate genes involve much larger populations customary , without undue emphasis retrospectively defined subgroups .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6206627425770713)\n",
      "- Text: \"cladistic model ACE sequence variation implications @ DiseaseTgt $ , Alzheimer disease obesity . Sequence variation ACE , encodes @ GeneSrc $ , contributes large proportion variability plasma ACE levels , extent impacts upon human disease unresolved . efforts associate ACE heritable traits involved single Alu insertion/deletion polymorphism , despite probable existence functional sequence variants effects may consistently detectable solely typing Alu indel . , utilizing single nucleotide polymorphisms ( SNPs ) differentiate major ACE clades European populations , demonstrate number significant phenotype associations across 4000 Swedish individuals . systematic analysis metabolic phenotypes , effects detected upon several traits , including fasting plasma glucose levels , insulin levels measures obesity ( P-values ranging 0.046 8.4 x 10 ( -6 ) ) . Extending cladistic models study @ DiseaseTgt $ Alzheimer disease , significant associations observed greater effect sizes typically obtained large-scale meta-analyses based Alu indel . Population frequencies ACE genotypes also found change age , congruent previous data suggesting effects upon longevity . Clade models consistently outperformed based upon single markers , reinforcing importance taking consideration possible confounding effects allelic heterogeneity genomic region . Utilizing computational tools , potential functional variants highlighted may underlie phenotypic variability , discussed along broader implications results may studies attempting link variation ACE human disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7271535565783352)\n",
      "- Text: \"prospective evaluation @ GeneSrc $ gene polymorphism risk ischemic heart disease . BACKGROUND : previous study , men history @ DiseaseTgt $ found increased prevalence homozygosity deletional allele ( ) @ GeneSrc $ ( @ GeneSrc $ ) gene . allele associated higher levels @ GeneSrc $ , may predispose person ischemic heart disease . investigated association @ GeneSrc $ genotype incidence @ DiseaseTgt $ , well manifestations ischemic heart disease , large , prospective cohort U.S. male physicians . METHODS : Physicians ' Health Study , ischemic heart disease defined angina , coronary revascularization , @ DiseaseTgt $ developed 1250 men 1992 . matched 2340 controls according age smoking history . Zygosity deletion-insertion ( D-I ) polymorphism @ GeneSrc $ gene determined assay based polymerase chain reaction . Data analyzed matched pairs unmatched samples , adjustment effects known suspected risk factors conditional nonconditional logistic regression , respectively . RESULTS : @ GeneSrc $ genotype associated occurrence either ischemic heart disease @ DiseaseTgt $ . adjusted relative risk associated allele 1.07 ( 95 percent confidence interval , 0.96 1.19 ; P = 0.24 ) ischemic heart disease 1.05 ( 95 percent confidence interval , 0.89 1.25 ; P = 0.56 ) @ DiseaseTgt $ , additive mode inheritance assumed . Additional analyses assuming dominant recessive effects allele also failed show association , examination low-risk subgroups . CONCLUSIONS : large , prospectively followed population U.S. male physicians , presence allele @ GeneSrc $ gene conferred appreciable increase risk ischemic heart disease @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0281142011112695)\n",
      "- Text: \"@ GeneSrc $ genetic risk factor coronary artery spasm . Implication pathogenesis @ DiseaseTgt $ . reported individuals allele insertion/deletion ( I/D ) polymorphism @ GeneSrc $ ( @ GeneSrc $ ) gene greater risk @ DiseaseTgt $ ( MI ) , especially among subjects normally considered low risk . However , little known mechanism @ GeneSrc $ polymorphism affects risk MI . Coronary artery spasm ( CAS ) considered one possible mechanism developing MI . therefore examined @ GeneSrc $ polymorphism relation CAS determine mechanism DD genotype influences MI . studied 150 angiographically assessed Japanese males , 60 yr old . CASs detected using intracoronary injection ergonovine maleate . Subjects divided three groups : CAS ( group 1 ) , without CAS , fixed organic stenosis ( group 2 ) ; without CAS organic stenosis ( group 3 ) . DD subjects significantly represented group 1 compared groups 2 ( P = 0.002 ) 3 ( P = 0.026 ) . results suggest DD genotype relates greater risk MI patients CAS .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.081907958290016)\n",
      "- Text: \"Crystal structure human @ GeneSrc $ complex . @ GeneSrc $ ( ACE ) critical role cardiovascular function cleaving carboxy terminal His-Leu dipeptide angiotensin produce potent vasopressor octapeptide , angiotensin II . Inhibitors ACE first line therapy hypertension , heart failure , @ DiseaseTgt $ diabetic nephropathy . Notably , inhibitors developed without knowledge structure human ACE , instead designed basis assumed mechanistic homology carboxypeptidase . present X-ray structure human testicular ACE complex one widely used inhibitors , lisinopril ( N2- [ ( ) -1-carboxy-3-phenylpropyl ] -L-lysyl-L-proline ; also known Prinivil Zestril ) , 2.0 resolution . Analysis three-dimensional structure ACE shows bears little similarity carboxypeptidase , instead resembles neurolysin Pyrococcus furiosus carboxypeptidase -- zinc metallopeptidases detectable sequence similarity ACE . structure provides opportunity design domain-selective ACE inhibitors may exhibit new pharmacological profiles .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001665448531031)\n",
      "- Text: \"Effect captopril mortality morbidity patients left ventricular dysfunction @ DiseaseTgt $ . Results survival ventricular enlargement trial . SAVE Investigators . BACKGROUND : Left ventricular dilatation dysfunction @ DiseaseTgt $ major predictors death . experimental clinical studies , longterm therapy @ GeneSrc $ inhibitor captopril attenuated ventricular dilatation remodeling . investigated whether captopril could reduce morbidity mortality patients left ventricular dysfunction @ DiseaseTgt $ . METHODS : Within 3 16 days @ DiseaseTgt $ , 2231 patients ejection fractions 40 percent less without overt heart failure symptoms myocardial ischemia randomly assigned receive doubleblind treatment either placebo ( 1116 patients ) captopril ( 1115 patients ) followed average 42 months . RESULTS : Mortality causes significantly reduced captopril group ( 228 deaths , 20 percent ) compared placebo group ( 275 deaths , 25 percent ) ; reduction risk 19 percent ( 95 percent confidence interval , 3 32 percent ; P = 0.019 ) . addition , incidence fatal nonfatal major cardiovascular events consistently reduced captopril group . reduction risk 21 percent ( 95 percent confidence interval , 5 35 percent ; P = 0.014 ) death cardiovascular causes , 37 percent ( 95 percent confidence interval , 20 50 percent ; P less 0.001 ) development severe heart failure , 22 percent ( 95 percent confidence interval , 4 37 percent ; P = 0.019 ) congestive heart failure requiring hospitalization , 25 percent ( 95 percent confidence interval , 5 40 percent ; P = 0.015 ) recurrent @ DiseaseTgt $ . CONCLUSIONS : patients asymptomatic left ventricular dysfunction @ DiseaseTgt $ , long-term administration captopril associated improvement survival reduced morbidity mortality due major cardiovascular events . benefits observed patients received thrombolytic therapy , aspirin , beta-blockers , well , suggesting treatment captopril leads additional improvement outcome among selected survivors @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0895286938180234)\n",
      "- Text: \"Insertion/deletion polymorphism @ GeneSrc $ gene strongly associated coronary heart disease non-insulin-dependent diabetes mellitus . Non-insulin-dependent diabetes mellitus ( NIDDM ) considered model premature atherosclerosis strong genetic component . investigated role @ GeneSrc $ ( @ GeneSrc $ ; EC 3.4.15.1 ) gene 316 unrelated NIDDM individuals , 132 @ DiseaseTgt $ significant coronary stenoses 184 history coronary heart disease ( CHD ) . deletion-polymorphism @ GeneSrc $ gene recently reported associated @ DiseaseTgt $ especially people classified low risk . report allele @ GeneSrc $ gene strong independent risk factor CHD NIDDM patients . allele associated early-onset CHD NIDDM , independently hypertension lipid values . progressively increasing relative risk individuals heterozygous homozygous allele observed ( odds ratios 1.41 2.35 , respectively ; P < 0.007 ) , suggesting codominant effect cardiovascular risk . percentage CHD attributable @ GeneSrc $ deletion allele 24 % NIDDM population . Identification NIDDM patients carrying putative CHD-susceptibility genotype would help early detection treatment CHD .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4752300187534432)\n",
      "- Text: \"@ GeneSrc $ gene polymorphism cardiovascular morbidity mortality : Rotterdam Study . BACKGROUND : Findings association insertion/deletion ( I/D ) polymorphism @ GeneSrc $ ( @ GeneSrc $ ) gene cardiovascular morbidity mortality inconsistent . Considering possible interaction polymorphism smoking , evaluated association ACE I/D polymorphism @ DiseaseTgt $ ( MI ) , mortality due coronary heart disease ( CHD ) , cardiovascular disease ( CVD ) . METHODS : study performed within Rotterdam Study , population based cohort study . ACE I/D polymorphism determined 6714 participants smoking status recorded baseline . Fatal non-fatal MIs mortality events regularly recorded . Cox proportional hazard analysis performed separately current smokers non-smokers . used age follow time , presenting age specific survivals . RESULTS : follow , 248 MIs 301 482 deaths , respectively , due CHD CVD occurred . significant differences genotypes regards MI incidence . Among smokers , increased risk CHD CVD mortality carriers DD genotype compared II genotype , diminished later ages ( p < 0.01 gene-age interaction ) . Subgroup analysis younger older group ( based median age 68.2 years ) showed significantly increased risk CVD mortality younger group ( hazard ratio = 5.19 ; 95 % confidence interval : 1.15 23.42 ) . CONCLUSIONS : study showed ACE I/D polymorphism strong risk factor MI interaction smoking might play role cardiovascular mortality especially younger ages .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1394944396585438)\n",
      "- Text: \"Deletion polymorphism @ GeneSrc $ gene associated increased plasma @ GeneSrc $ activity increased risk @ DiseaseTgt $ coronary artery disease . BACKGROUND : Previous research shown insertion/deletion ( I/D ) polymorphism @ GeneSrc $ ( @ GeneSrc $ ) gene major determinant plasma @ GeneSrc $ activity . suggested persons DD genotype ( express , average , highest levels circulating @ GeneSrc $ ) increased risk @ DiseaseTgt $ coronary artery disease , particularly otherwise low risk . Subsequent studies , however , confirmed ACE I/D gene polymorphism risk factor coronary artery disease @ DiseaseTgt $ . OBJECTIVE : investigate association I/D polymorphism @ GeneSrc $ gene risk coronary artery disease @ DiseaseTgt $ patients coronary artery disease status documented angiography . DESIGN : Cross-sectional study . SETTING : University medical center . PATIENTS : 209 male case-patients coronary artery disease 92 male controls without coronary artery disease , documented coronary angiography . MEASUREMENTS : Assessment cardiac risk profile questionnaire ; classification patients degree coronary artery stenosis ; levels lipoproteins , apolipoproteins , fibrinogen ; ACE I/D gene polymorphism assessed polymerase chain reaction amplification . RESULTS : Plasma @ GeneSrc $ activity significantly associated ACE I/D gene polymorphism . @ GeneSrc $ genotype associated presence coronary artery disease @ DiseaseTgt $ . recessive effect allele assumed ( DD compared DI II ) , relative risk 1.00 ( 95 % CI , 0.76 1.30 ) coronary artery disease 1.03 ( CI , 0.77 1.38 ) @ DiseaseTgt $ . Results analyses also negative dominant effect allele assumed low-risk subgroups examined . established risk factors age apolipoprotein B level emerged important risk predictors multivariate analyses , followed diastolic blood pressure fasting glucose levels . CONCLUSIONS : angiographically defined study sample , ACE I/D gene polymorphism associated increased risk coronary artery disease @ DiseaseTgt $ , despite effects plasma @ GeneSrc $ activity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.948756251019966)\n",
      "- Text: \"Functionally inactivating point mutation tumor-suppressor IRF-1 gene identified human @ DiseaseTgt $ . Loss heterozygosity ( LOH ) observed human tumors strongly suggests existence ( ) tumor-suppressor gene ( ) concerned locus . series studies revealed LOH long arm chromosome 5 ( 5q ) frequently occurs differentiated @ DiseaseTgt $ . Furthermore , shown interferon regulatory factor-1 ( IRF-1 ) locus chromosome 5q31.1 one common minimal regions LOH cancers . @ GeneSrc $ transcriptional activator shows tumor-suppressor activity mouse . present study , examined sequence IRF-1 gene 9 cases histologically differentiated @ DiseaseTgt $ , exhibited LOH IRF-1 locus . identified mis-sense mutation residual allele one case . mutated form IRF-1 showed markedly reduced transcriptional activity . addition , overexpression wild-type IRF-1 induced cell-cycle arrest , whereas activity attenuated mutant IRF-1 . results suggest loss functional IRF-1 critical development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0117158387143722)\n",
      "- Text: \"HIF-1 antagonizes p53-mediated apoptosis secreted neuronal tyrosinase . Hypoxia-inducible factor ( HIF ) transcription factor regulates fundamental cellular processes response changes oxygen concentration . HIFalpha protein levels increased solid @ DiseaseTgt $ correlate patient prognosis . link HIF apoptosis , major determinant @ DiseaseTgt $ progression treatment outcome , poorly understood . show Caenorhabditis elegans HIF-1 protects DNA-damage-induced germ cell apoptosis antagonizing function CEP-1 , homologue @ DiseaseTgt $ p53 . antiapoptotic property HIF-1 mediated means transcriptional upregulation tyrosinase family member TYR-2 ASJ sensory neurons . TYR-2 secreted ASJ sensory neurons antagonize CEP-1-dependent germline apoptosis . Knock TYR-2 homologue @ GeneSrc $ ( also called @ GeneSrc $ ) human melanoma cells similarly increases apoptosis , indicating evolutionarily conserved function . findings identify novel link hypoxia programmed cell death , provide paradigm HIF-1 dictating apoptotic cell fate distance .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0050859152367828)\n",
      "- Text: \"Complement microglia mediate early synapse loss @ DiseaseTgt $ mouse models . Synapse loss @ DiseaseTgt $ ( @ DiseaseTgt $ ) correlates cognitive decline . Involvement microglia complement @ DiseaseTgt $ attributed neuroinflammation , prominent late disease . show mouse models complement microglia mediate synaptic loss early @ DiseaseTgt $ . C1q , initiating protein classical complement cascade , increased associated synapses overt plaque deposition . Inhibition C1q , C3 , microglial complement receptor @ GeneSrc $ reduces number phagocytic microglia , well extent early synapse loss . C1q necessary toxic effects soluble beta-amyloid ( Abeta ) oligomers synapses hippocampal long-term potentiation . Finally , microglia adult brains engulf synaptic material @ GeneSrc $ process exposed soluble Abeta oligomers . Together , findings suggest complement-dependent pathway microglia prune excess synapses development inappropriately activated mediate synapse loss @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0335148025818356)\n",
      "- Text: \"FOG-2 , cofactor GATA transcription factors , essential heart morphogenesis development coronary vessels epicardium . disrupted FOG-2 gene mice define requirement vivo . FOG-2 ( -/- ) embryos die midgestation cardiac defect characterized thin ventricular myocardium , common atrioventricular canal , @ DiseaseTgt $ . Remarkably , coronary vasculature absent FOG-2 ( -/- ) hearts . Despite formation intact epicardial layer expression epicardium-specific genes , markers cardiac vessel development ( ICAM-2 @ GeneSrc $ ) detected , indicative failure activate expression and/or initiate epithelial mesenchymal transformation epicardial cells . Transgenic reexpression FOG-2 cardiomyocytes rescues FOG-2 ( -/- ) vascular phenotype , demonstrating FOG-2 function myocardium required sufficient coronary vessel development . findings provide molecular inroad induction coronary vasculature myocardium developing heart .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001091802847492)\n",
      "- Text: \"Modulation microRNA processing p53 . MicroRNAs ( miRNAs ) emerged key post-transcriptional regulators gene expression , involved diverse physiological pathological processes . Although miRNAs function @ DiseaseTgt $ suppressors oncogenes @ DiseaseTgt $ development , widespread downregulation miRNAs commonly observed human @ DiseaseTgt $ promotes cellular transformation tumorigenesis . indicates inherent significance small RNAs @ DiseaseTgt $ suppression . However , connection @ DiseaseTgt $ suppressor networks miRNA biogenesis machineries investigated depth . show central @ DiseaseTgt $ suppressor , p53 , enhances post-transcriptional maturation several miRNAs growth-suppressive function , including miR-16 - 1 , miR-143 miR-145 , response DNA damage . HCT116 cells human diploid fibroblasts , p53 interacts Drosha processing complex association DEAD-box RNA helicase @ GeneSrc $ ( also known @ GeneSrc $ ) facilitates processing primary miRNAs precursor miRNAs . also found transcriptionally inactive p53 mutants interfere functional assembly Drosha complex @ GeneSrc $ , leading attenuation miRNA processing activity . findings suggest transcription-independent modulation miRNA biogenesis intrinsically embedded @ DiseaseTgt $ suppressive program governed p53 . study reveals previously unrecognized function p53 miRNA processing , may underlie key aspects @ DiseaseTgt $ biology .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1652765897332958)\n",
      "- Text: \"Long-term haematopoietic reconstitution Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - -p16Ink4a , p19Arf Trp53 ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype @ GeneSrc $ , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045806168844222)\n",
      "- Text: \"Axonal transport amyloid precursor protein mediated direct binding kinesin light chain subunit kinesin-I . analyzed mechanism axonal transport amyloid precursor protein ( APP ) , plays major role development @ DiseaseTgt $ . Coimmunoprecipitation , sucrose gradient , direct vitro binding demonstrated APP forms complex microtubule motor , conventional kinesin ( kinesin-I ) , binding directly TPR domain kinesin light chain ( KLC ) subunit . estimated apparent Kd binding 15 - 20 nM , binding stoichiometry two APP per KLC . addition , association APP microtubules axonal transport APP greatly decreased gene-targeted mouse mutant neuronally enriched @ GeneSrc $ gene . propose one normal functions APP may membrane cargo receptor kinesin-I KLC important kinesin-I-driven transport APP axons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.027618839498925e-06)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , @ GeneSrc $ Sox2 remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.494305923819332e-06)\n",
      "- Text: \"Role @ GeneSrc $ Pten development mouse models endometriosis endometrioid ovarian cancer . Epithelial ovarian tumors present complex clinical , diagnostic therapeutic challenge difficulty early detection , lack known precursor lesions high mortality rates . Endometrioid ovarian carcinomas frequently associated endometriosis , mechanism association remains unknown . present first genetic models peritoneal endometriosis endometrioid ovarian adenocarcinoma mice , based activation oncogenic @ GeneSrc $ allele . addition , find expression oncogenic @ GeneSrc $ conditional Pten deletion within ovarian surface epithelium gives rise preneoplastic ovarian lesions endometrioid glandular morphology . Furthermore , combination two mutations ovary leads induction invasive widely metastatic endometrioid ovarian adenocarcinomas complete penetrance disease latency 7 weeks . ovarian cancer model described study recapitulates specific @ DiseaseTgt $ histomorphology metastatic potential human disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0043355199338573)\n",
      "- Text: \"elaborate pathway required Ras-mediated epigenetic silencing . conversion normal cell @ DiseaseTgt $ cell occurs several steps typically involves activation oncogenes inactivation @ DiseaseTgt $ suppressor pro-apoptotic genes . many instances , inactivation genes critical @ DiseaseTgt $ development occurs epigenetic silencing , often involving hypermethylation CpG-rich promoter regions . remains determined whether silencing occurs random acquisition epigenetic marks confer selective growth advantage specific pathway initiated oncogene . perform genome-wide RNA interference ( RNAi ) screen @ GeneSrc $ NIH 3T3 cells identify 28 genes required Ras-mediated epigenetic silencing pro-apoptotic Fas gene . least nine RESEs ( Ras epigenetic silencing effectors ) , including DNA methyltransferase DNMT1 , directly associated specific regions Fas promoter @ GeneSrc $ NIH 3T3 cells untransformed NIH 3T3 cells . RNAi-mediated knockdown 28 RESEs results failure recruit DNMT1 Fas promoter , loss Fas promoter hypermethylation , derepression Fas expression . Analysis five epigenetically repressed genes indicates Ras directs silencing multiple unrelated genes largely common pathway . Last , show nine RESEs required anchorage-independent growth tumorigenicity @ GeneSrc $ NIH 3T3 cells ; nine genes previously implicated transformation Ras . results show Ras-mediated epigenetic silencing occurs specific , complex , pathway involving components required maintenance fully transformed phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001163690109501)\n",
      "- Text: \"Analysis lung tumor initiation progression using conditional expression oncogenic @ GeneSrc $ . Adenocarcinoma lung common form lung cancer , cell origin stages progression @ DiseaseTgt $ type well understood . developed new model lung adenocarcinoma mice harboring conditionally activatable allele oncogenic @ GeneSrc $ . show use recombinant adenovirus expressing Cre recombinase ( AdenoCre ) induce @ GeneSrc $ G12D expression lungs mice allows control timing multiplicity @ DiseaseTgt $ initiation . ability synchronize @ DiseaseTgt $ initiation mice , able characterize stages @ DiseaseTgt $ progression . particular significance , system led identification new cell type contributing development pulmonary adenocarcinoma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2348825786986901)\n",
      "- Text: \"Differential effects oncogenic @ GeneSrc $ N-Ras proliferation , differentiation @ DiseaseTgt $ progression colon . @ GeneSrc $ commonly mutated colon cancers , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression @ GeneSrc $ ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation @ GeneSrc $ led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant @ GeneSrc $ Nras , suggest oncogenic phenotype mutant @ GeneSrc $ might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.060075706324566)\n",
      "- Text: \"Postzygotic HRAS @ GeneSrc $ mutations cause nevus sebaceous Schimmelpenning syndrome . Nevus sebaceous common congenital cutaneous malformation . Affected individuals may develop benign malignant secondary @ DiseaseTgt $ nevi life . Schimmelpenning syndrome characterized association nevus sebaceous extracutaneous abnormalities . report 65 sebaceous nevi studied , 62 ( 95 % ) mutations HRAS gene 3 ( 5 % ) mutations @ GeneSrc $ gene . HRAS c.37G > C mutation , results p. Gly13Arg substitution , present 91 % lesions . Nonlesional tissues 18 individuals wild-type sequence , confirming genetic mosaicism . HRAS c.37G > C mutation also found 8 8 associated secondary @ DiseaseTgt $ . Mosaicism HRAS c.37G > C @ GeneSrc $ c.35G > mutations found two individuals Schimmelpenning syndrome . Functional analysis HRAS c.37G > C mutant cells showed constitutive activation MAPK PI3K-Akt signaling pathways . results indicate nevus sebaceous Schimmelpenning syndrome caused postzygotic HRAS @ GeneSrc $ mutations . mutations may predispose individuals development secondary @ DiseaseTgt $ nevus sebaceous .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0190154252568781)\n",
      "- Text: \"Somatic activation @ GeneSrc $ oncogene causes early onset lung cancer mice . 30 % human @ DiseaseTgt $ carry ras gene mutations . three genes family ( composed K-ras , N-ras H-ras ) , K-ras frequently mutated member human @ DiseaseTgt $ , including adenocarcinomas pancreas ( approximately 70 - 90 % incidence ) , colon ( approximately 50 % ) lung ( approximately 25 - 50 % ) . construct mouse @ DiseaseTgt $ models involving @ GeneSrc $ , used new gene targeting procedure create mouse strains carrying oncogenic alleles @ GeneSrc $ activated spontaneous recombination event whole animal . show mice carrying mutations highly predisposed range @ DiseaseTgt $ types , predominantly early onset lung cancer . model characterized examining effects germline mutations @ DiseaseTgt $ suppressor gene p53 , known mutated along K-ras human @ DiseaseTgt $ . approach several advantages traditional transgenic strategies , including closely recapitulates spontaneous oncogene activation seen human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6471505553348571)\n",
      "- Text: \"Selective activation p53-mediated @ DiseaseTgt $ suppression high-grade @ DiseaseTgt $ . Non-small cell lung carcinoma ( NSCLC ) leading cause @ DiseaseTgt $ death worldwide , overall 5-year survival rate 10 - 15 % . Deregulation Ras pathway frequent hallmark NSCLC , often mutations directly activate @ GeneSrc $ . p53 also frequently inactivated NSCLC , oncogenic Ras potent trigger p53 ( ref . 3 ) , seems likely oncogenic Ras signalling major persistent role driving selection p53 . Hence , pharmacological restoration p53 appealing therapeutic strategy treating disease . model probable therapeutic impact p53 restoration spontaneously evolving mouse model NSCLC initiated sporadic oncogenic activation endogenous @ GeneSrc $ . Surprisingly , p53 restoration failed induce significant regression established @ DiseaseTgt $ , although result significant decrease relative proportion high-grade @ DiseaseTgt $ . due selective activation p53 aggressive @ DiseaseTgt $ cells within @ DiseaseTgt $ . selective activation p53 correlates marked upregulation Ras signal intensity induction oncogenic signalling sensor p19 ( ARF ) ( ) ( ref . 6 ) . data indicate p53-mediated @ DiseaseTgt $ suppression triggered oncogenic Ras signal flux exceeds critical threshold . Importantly , failure low-level oncogenic @ GeneSrc $ engage p53 reveals inherent limits capacity p53 restrain early @ DiseaseTgt $ evolution efficacy therapeutic p53 restoration eradicate @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3208309408469837)\n",
      "- Text: \"Mutant @ GeneSrc $ copy number defines metabolic reprogramming therapeutic susceptibilities . RAS/MAPK ( mitogen-activated protein kinase ) signalling pathway frequently deregulated non-small-cell lung cancer , often @ GeneSrc $ activating mutations . single endogenous mutant @ GeneSrc $ allele sufficient promote lung tumour formation mice malignant progression requires additional genetic alterations . recently showed advanced lung tumours @ GeneSrc $ mice frequently exhibit @ GeneSrc $ ) allelic enrichment ( @ GeneSrc $ ) > 1 ) ( ref . 7 ) , implying mutant @ GeneSrc $ copy gains positively selected progression . show , comprehensive analysis mutant @ GeneSrc $ homozygous heterozygous mouse embryonic fibroblasts lung cancer cells , genotypes phenotypically distinct . particular , @ GeneSrc $ ) cells exhibit glycolytic switch coupled increased channelling glucose-derived metabolites tricarboxylic acid cycle glutathione biosynthesis , resulting enhanced glutathione-mediated detoxification . metabolic rewiring recapitulated mutant @ GeneSrc $ homozygous non-small-cell lung cancer cells vivo , spontaneous advanced murine lung tumours ( display high frequency @ GeneSrc $ ) copy gain ) , corresponding early @ DiseaseTgt $ ( @ GeneSrc $ ) heterozygous ) . Finally , demonstrate mutant @ GeneSrc $ copy gain creates unique metabolic dependences exploited selectively target aggressive mutant @ GeneSrc $ @ DiseaseTgt $ . data demonstrate mutant @ GeneSrc $ lung tumours single disease rather heterogeneous group comprising two classes @ DiseaseTgt $ distinct metabolic profiles , prognosis therapeutic susceptibility , discriminated basis relative mutant allelic content . also provide first , knowledge , vivo evidence metabolic rewiring lung cancer malignant progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.921825987625025)\n",
      "- Text: \"Requirement NF-kappaB signalling mouse model lung adenocarcinoma . NF-kappaB transcription factors function crucial regulators inflammatory immune responses well cell survival . also implicated cellular transformation tumorigenesis . However , despite extensive biochemical characterization NF-kappaB signalling past twenty years , requirement NF-kappaB @ DiseaseTgt $ development vivo , particularly @ DiseaseTgt $ , completely understood . show NF-kappaB pathway required development @ DiseaseTgt $ mouse model lung adenocarcinoma . Concomitant loss p53 ( also known Trp53 ) expression oncogenic @ GeneSrc $ ) resulted NF-kappaB activation primary mouse embryonic fibroblasts . Conversely , lung tumour cell lines expressing @ GeneSrc $ ) lacking p53 , p53 restoration led NF-kappaB inhibition . Furthermore , inhibition NF-kappaB signalling induced apoptosis p53-null lung cancer cell lines . Inhibition pathway lung tumours vivo , time @ DiseaseTgt $ initiation @ DiseaseTgt $ progression , resulted significantly reduced @ DiseaseTgt $ development . Together , results indicate critical function NF-kappaB signalling lung tumour development , , requirement depends p53 status . findings also provide support development NF-kappaB inhibitory drugs targeted therapies treatment patients defined mutations Kras p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0135285750691367)\n",
      "- Text: \"Defining stem cell dynamics models intestinal @ DiseaseTgt $ initiation . @ DiseaseTgt $ disease cells accumulate genetic aberrations believed confer clonal advantage cells surrounding tissue . However , quantitative benefit frequently occurring mutations @ DiseaseTgt $ development remains unknown . quantified competitive advantage Apc loss , @ GeneSrc $ activation , P53 mutations mouse intestine . findings indicate fate conferred mutations deterministic , many mutated stem cells replaced wild-type stem cells biased , still stochastic events . Furthermore , P53 mutations display condition-dependent advantage , especially colitis-affected intestines , clones harboring mutations gene favored . work confirms previously theoretical notion tissue architecture intestine suppresses accumulation mutated lineages .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072127820366853)\n",
      "- Text: \"Wildtype @ GeneSrc $ inhibit lung carcinogenesis mice . Although ras genes long established proto-oncogenes , dominant role activated ras cell transformation questioned . Previous studies shown frequent loss wildtype Kras2 allele mouse human lung adenocarcinomas . address possible @ DiseaseTgt $ suppressor role wildtype @ GeneSrc $ lung tumorigenesis , carried lung tumor bioassay heterozygous @ GeneSrc $ mice . Mice heterozygous @ GeneSrc $ deficiency highly susceptible chemical induction lung tumors compared wildtype mice . Activating @ GeneSrc $ mutations detected chemically induced lung tumors obtained wildtype heterozygous @ GeneSrc $ mice . Furthermore , wildtype @ GeneSrc $ inhibited colony formation @ DiseaseTgt $ development transformed NIH/3T3 cells mouse lung tumor cell line containing activated @ GeneSrc $ allele . Allelic loss wildtype @ GeneSrc $ found 67 % 100 % chemically induced mouse lung adenocarcinomas harbor mutant @ GeneSrc $ allele . Finally , inverse correlation level wildtype @ GeneSrc $ expression extracellular signal-regulated kinase ( ERK ) activity observed cells . data strongly suggest wildtype @ GeneSrc $ @ DiseaseTgt $ suppressor activity frequently lost lung tumor progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5862469837246107)\n",
      "- Text: \"alpha-Ketoglutarate links p53 cell fate @ DiseaseTgt $ suppression . @ DiseaseTgt $ suppressor TP53 mutated majority human @ DiseaseTgt $ , 70 % pancreatic ductal adenocarcinoma ( PDAC ) 1,2 . Wild-type p53 accumulates response cellular stress , regulates gene expression alter cell fate prevent @ DiseaseTgt $ development2 . Wild-type p53 also known modulate cellular metabolic pathways3 , although p53-dependent metabolic alterations constrain @ DiseaseTgt $ progression remain poorly understood . find p53 remodels @ DiseaseTgt $ metabolism enforce changes chromatin gene expression favour premalignant cell fate . Restoring p53 function @ DiseaseTgt $ cells derived @ GeneSrc $ mouse models PDAC leads accumulation alpha-ketoglutarate ( alphaKG , also known 2-oxoglutarate ) , metabolite also serves obligate substrate subset chromatin-modifying enzymes . p53 induces transcriptional programs characteristic premalignant differentiation , effect partially recapitulated addition cell-permeable alphaKG . Increased levels alphaKG-dependent chromatin modification 5-hydroxymethylcytosine ( 5hmC ) accompany @ DiseaseTgt $ differentiation triggered p53 , whereas decreased 5hmC characterizes transition premalignant de-differentiated malignant lesions associated mutations Trp53 . Enforcing accumulation alphaKG p53-deficient PDAC cells inhibition oxoglutarate dehydrogenase-an enzyme tricarboxylic acid cycle-specifically results increased 5hmC , @ DiseaseTgt $ differentiation decreased @ DiseaseTgt $ fitness . Conversely , increasing intracellular levels succinate ( competitive inhibitor alphaKG-dependent dioxygenases ) blunts p53-driven @ DiseaseTgt $ suppression . data suggest alphaKG effector p53-mediated @ DiseaseTgt $ suppression , accumulation alphaKG p53-deficient @ DiseaseTgt $ drive @ DiseaseTgt $ differentiation antagonize malignant progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4257707225420251)\n",
      "- Text: \"p53 status determines role autophagy pancreatic tumour development . Macroautophagy ( hereafter referred autophagy ) process organelles termed autophagosomes deliver cytoplasmic constituents lysosomes degradation . Autophagy major role cellular homeostasis implicated various forms human disease . role autophagy @ DiseaseTgt $ seems complex , reports indicating pro-tumorigenic @ DiseaseTgt $ roles . show , humanized genetically-modified mouse model pancreatic ductal adenocarcinoma ( PDAC ) , autophagy 's role @ DiseaseTgt $ development intrinsically connected status @ DiseaseTgt $ suppressor p53 . Mice pancreases containing activated oncogenic allele @ GeneSrc $ ( also called @ GeneSrc $ common mutational event PDAC -- develop small number pre-cancerous lesions stochastically develop PDAC time . However , mice also lacking essential autophagy genes Atg5 Atg7 accumulate low-grade , pre-malignant pancreatic intraepithelial neoplasia lesions , progression high-grade pancreatic intraepithelial neoplasias PDAC blocked . marked contrast , mice containing oncogenic @ GeneSrc $ lacking p53 , loss autophagy longer blocks @ DiseaseTgt $ progression , actually accelerates @ DiseaseTgt $ onset , metabolic analysis revealing enhanced glucose uptake enrichment anabolic pathways , fuel @ DiseaseTgt $ growth . findings provide considerable insight role autophagy @ DiseaseTgt $ important implications autophagy inhibition @ DiseaseTgt $ therapy . regard , also show treatment mice autophagy inhibitor hydroxychloroquine , currently used several clinical trials , significantly accelerates @ DiseaseTgt $ formation mice containing oncogenic @ GeneSrc $ lacking p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9960808827969564)\n",
      "- Text: \"Differential effects oncogenic @ GeneSrc $ N-Ras proliferation , differentiation tumor progression colon . @ GeneSrc $ commonly mutated @ DiseaseTgt $ , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression @ GeneSrc $ ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation @ GeneSrc $ led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant @ GeneSrc $ Nras , suggest oncogenic phenotype mutant @ GeneSrc $ might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4333207383482407)\n",
      "- Text: \"PIK3CA ( H1047R ) induces multipotency multi-lineage mammary tumours . adult mouse mammary epithelium contains self-sustained cell lineages form inner luminal outer basal cell layers , stem progenitor cells contributing proliferative regenerative potential . key issue breast cancer biology effect genomic lesions specific mammary cell lineages @ DiseaseTgt $ heterogeneity progression . impact transforming events fate conversion @ DiseaseTgt $ cells origin thus contribution @ DiseaseTgt $ heterogeneity remains largely elusive . Using situ genetic lineage tracing limiting dilution transplantation , unravelled potential PIK3CA ( H1047R ) , one frequent mutations occurring human breast cancer , induce multipotency tumorigenesis mammary gland . show expression PIK3CA ( H1047R ) lineage-committed basal Lgr5-positive luminal @ GeneSrc $ cells adult mouse mammary gland evokes cell dedifferentiation multipotent stem-like state , suggesting mechanism involved formation heterogeneous , multi-lineage mammary tumours . Moreover , show @ DiseaseTgt $ cell origin influences frequency malignant mammary tumours . results define key effect PIK3CA ( H1047R ) mammary cell fate pre-neoplastic mammary gland show cell origin PIK3CA ( H1047R ) @ DiseaseTgt $ dictates @ DiseaseTgt $ , thus revealing mechanism underlying @ DiseaseTgt $ heterogeneity aggressiveness .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.095949285812558)\n",
      "- Text: \"Asef , link tumor suppressor APC G-protein signaling . adenomatous polyposis coli gene ( APC ) mutated familial adenomatous polyposis sporadic @ DiseaseTgt $ . APC gene product shown bind armadillo repeat domain Rac-specific guanine nucleotide exchange factor ( @ GeneSrc $ ) , termed Asef . Endogenous APC colocalized Asef mouse colon epithelial cells neuronal cells . Furthermore , APC enhanced @ GeneSrc $ activity Asef stimulated Asef-mediated cell flattening , membrane ruffling , lamellipodia formation MDCK cells . results suggest APC-Asef complex may regulate actin cytoskeletal network , cell morphology migration , neuronal function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0014726492944392)\n",
      "- Text: \"Critical role p110alpha phosphoinositide-3-OH kinase growth metabolic regulation . eight catalytic subunits mammalian phosphoinositide-3-OH kinase ( PI ( 3 ) K ) family form backbone evolutionarily conserved signalling pathway ; however , roles PI ( 3 ) K isoforms organismal physiology disease unknown . delineate role p110alpha , ubiquitously expressed PI ( 3 ) K involved tyrosine kinase Ras signalling , generated mice carrying knockin mutation ( D933A ) abrogates p110alpha kinase activity . Homozygosity kinase-dead p110alpha led embryonic lethality . Mice heterozygous mutation viable fertile , displayed severely blunted signalling via insulin-receptor substrate ( IRS ) proteins , key mediators insulin , insulin-like growth factor-1 @ GeneSrc $ action . Defective responsiveness hormones led reduced somatic growth , hyperinsulinaemia , glucose intolerance , hyperphagia increased adiposity mice heterozygous D933A mutation . signalling function p110alpha derives highly selective recruitment activation IRS signalling complexes compared p110beta , broadly expressed PI ( 3 ) K isoform , contribute IRS-associated PI ( 3 ) K activity . p110alpha principal IRS-associated PI ( 3 ) K @ DiseaseTgt $ cell lines . findings demonstrate critical role p110alpha growth factor metabolic signalling also suggest explanation selective mutation overexpression p110alpha variety @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0015690005055826)\n",
      "- Text: \"p53 regulates maternal reproduction @ GeneSrc $ . Extensive studies shown p53 important @ DiseaseTgt $ prevention . However , little known normal physiological function . show p53 important reproduction , gender-specific manner . Significant decreases embryonic implantation , pregnancy rate litter size observed matings p53-/- female mice p53-/- male mice . gene encoding @ GeneSrc $ ( @ GeneSrc $ ) , cytokine critical implantation , identified p53-regulated gene functions downstream mediator effect . p53 regulate basal inducible transcription @ GeneSrc $ . Loss p53 decreased level function @ GeneSrc $ uteri . Lower @ GeneSrc $ levels observed uteri p53-/- mice p53+/+ mice , particularly day 4 pregnancy , transiently induced high levels @ GeneSrc $ crucial embryonic implantation . observation probably accounts impaired implantation embryos p53-/- female mice . Administration @ GeneSrc $ pregnant p53-/- mice restored maternal reproduction improving implantation . results demonstrate function p53 maternal reproduction regulation @ GeneSrc $ . Evidence accumulating p53 may similar function humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010167884819688)\n",
      "- Text: \"Physiological pathological roles LRRK2 nuclear envelope integrity . Mutations LRRK2 cause @ DiseaseTgt $ , mechanisms involved LRRK2 toxicity @ DiseaseTgt $ yet fully understood . found LRRK2 translocates nucleus binding seven absentia homolog ( SIAH-1 ) , nucleus directly interacts @ GeneSrc $ , independent kinase activity . LRRK2 knockdown caused nuclear lamina abnormalities nuclear disruption . LRRK2 disease mutations mostly abolish interaction @ GeneSrc $ , similar LRRK2 knockdown , cause disorganization @ GeneSrc $ leakage nuclear proteins . Dopaminergic neurons LRRK2 G2019S transgenic LRRK2 -/- mice display decreased circularity nuclear lamina leakage nuclear protein 53BP1 cytosol . Dopaminergic nigral cortical neurons LRRK2 G2019S idiopathic @ DiseaseTgt $ patients exhibit abnormalities nuclear lamina . data indicate LRRK2 plays essential role maintaining nuclear envelope integrity . Disruption function disease mutations suggests novel phosphorylation-independent loss-of-function mechanism may synergize neurotoxic effects caused LRRK2 mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4765015640184052)\n",
      "- Text: \"Cooperative transcription activation Nurr1 Pitx3 induces embryonic stem cell maturation midbrain dopamine neuron phenotype . Midbrain dopamine ( DA ) neurons play central role regulation voluntary movement , degeneration associated @ DiseaseTgt $ . Cell replacement therapies , particular embryonic stem ( ES ) cell-derived DA neurons , offer potential therapeutic venue @ DiseaseTgt $ . sought identify genes potentiate maturation ES cell cultures midbrain DA neuron phenotype . number transcription factors implicated development midbrain DA neurons expression analyses loss-of-function knockout mouse studies , including Nurr1 , Pitx3 , @ GeneSrc $ , Engrailed-1 , Engrailed-2 . However , none factors appear sufficient alone induce mature midbrain DA neuron phenotype ES cell cultures vitro , suggesting complex regulatory network . show Nurr1 Pitx3 cooperatively promote terminal maturation midbrain DA neuron phenotype murine human ES cell cultures .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0035631584023476e-06)\n",
      "- Text: \"PINK1-phosphorylated @ GeneSrc $ Parkin receptor culling damaged mitochondria . Senescent damaged mitochondria undergo selective mitophagic elimination mechanisms requiring two @ DiseaseTgt $ factors , mitochondrial kinase PINK1 ( PTEN-induced putative kinase protein 1 ; PTEN phosphatase tensin homolog ) cytosolic ubiquitin ligase Parkin . nature PINK-Parkin interaction identity key factors directing Parkin damaged mitochondria unknown . show mitochondrial outer membrane guanosine triphosphatase @ GeneSrc $ mediates Parkin recruitment damaged mitochondria . Parkin bound @ GeneSrc $ PINK1-dependent manner ; PINK1 phosphorylated @ GeneSrc $ promoted Parkin-mediated ubiqitination . Ablation @ GeneSrc $ mouse cardiac myocytes prevented depolarization-induced translocation Parkin mitochondria suppressed mitophagy . Accumulation morphologically functionally abnormal mitochondria induced respiratory dysfunction @ GeneSrc $ mouse embryonic fibroblasts cardiomyocytes Parkin-deficient Drosophila heart tubes , causing dilated cardiomyopathy . Thus , @ GeneSrc $ functions mitochondrial receptor Parkin required quality control cardiac mitochondria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0601069718675032)\n",
      "- Text: \"C terminus p53 regulates gene expression multiple mechanisms target- tissue-specific manner vivo . p53 @ DiseaseTgt $ suppressor transcription factor mediates varied cellular responses . C terminus p53 subjected multiple diverse post-translational modifications . attractive hypothesis differing sets combinatorial modifications therein determine distinct cellular outcomes . address vivo , Trp53 ( DeltaCTD/DeltaCTD ) mouse generated endogenous p53 targeted replaced truncated mutant lacking C-terminal 24 amino acids . Trp53 ( DeltaCTD/DeltaCTD ) mice die within 2 wk post-partum hematopoietic failure impaired cerebellar development . Intriguingly , C terminus acts via three distinct mechanisms control p53-dependent gene expression depending tissue . First , bone marrow thymus , C terminus dampens p53 activity . Increased senescence Trp53 ( DeltaCTD/DeltaCTD ) bone marrow accompanied up-regulation Cdkn1 ( p21 ) . thymus , C-terminal domain negatively regulates p53-dependent gene expression inhibiting promoter occupancy . , hyperactive p53 ( DeltaCTD ) induces apoptosis via enhanced expression proapoptotic @ GeneSrc $ ( @ GeneSrc $ ) Pmaip1 ( Noxa ) . liver , second mechanism prevails , since p53 ( DeltaCTD ) wild-type DNA binding impaired gene expression . Thus , C terminus p53 needed liver cells step subsequent DNA binding . Finally , spleen , C terminus controls p53 protein levels , overexpressed p53 ( DeltaCTD ) showing hyperactivity gene expression . Thus , C terminus p53 regulates gene expression via multiple mechanisms depending tissue target , leads specific phenotypic effects vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.352217722987721e-06)\n",
      "- Text: \"deleterious mutation DNAJC6 encoding neuronal-specific clathrin-uncoating co-chaperone auxilin , associated juvenile parkinsonism . @ DiseaseTgt $ caused neuronal loss substantia nigra manifests abnormality movement , muscle tone , postural stability . Several genes implicated pathogenesis @ DiseaseTgt $ , underlying molecular basis still unknown ~70 % patients . Using homozygosity mapping whole exome sequencing identified deleterious mutation DNAJC6 two patients juvenile parkinsonism . mutation associated abnormal transcripts marked reduced DNAJC6 mRNA level . DNAJC6 encodes @ GeneSrc $ Auxilin , protein selectively expressed neurons confers specificity ATPase activity partner Hcs70 clathrin uncoating . Auxilin null mice previously shown abnormally increased retention assembled clathrin vesicles empty cages leads impaired synaptic vesicle recycling perturbed clathrin mediated endocytosis . Endocytosis function , studied transferring uptake , normal fibroblasts patients , likely presence another J-domain containing partner co-chaperones Hsc70-mediated uncoating activity non-neuronal cells . present report underscores importance endocytic/lysosomal pathway pathogenesis @ DiseaseTgt $ forms parkinsonism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1628633392755803)\n",
      "- Text: \"Intestinal tumorigenesis compound mutant mice @ GeneSrc $ ( @ GeneSrc $ ) Apc genes . @ GeneSrc $ ( @ GeneSrc $ ) gene plays key role TGFbeta signaling pathway . inactivated mouse homolog @ GeneSrc $ ( @ GeneSrc $ ) . homozygous mutants embryonic lethal , whereas heterozygotes showed abnormality . introduced @ GeneSrc $ mutation Apc ( delta716 ) knockout mice , model human familial adenomatous polyposis . Apc @ GeneSrc $ located chromosome 18 , constructed compound heterozygotes carrying mutations chromosome meiotic recombination . mice , intestinal polyps developed malignant tumors simple Apc ( delta716 ) heterozygotes , showing extensive stromal cell proliferation , submucosal invasion , cell type heterogeneity , vivo transplantability . results indicate mutations @ GeneSrc $ ( @ GeneSrc $ ) play significant role malignant progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0676139867708261)\n",
      "- Text: \"Direct generation functional dopaminergic neurons mouse human fibroblasts . Transplantation dopaminergic neurons potentially improve clinical outcome @ DiseaseTgt $ , neurological disorder resulting degeneration mesencephalic dopaminergic neurons . particular , transplantation embryonic-stem-cell-derived dopaminergic neurons shown efficient restoring motor symptoms conditions dopamine deficiency . However , use pluripotent-derived cells might lead development tumours properly controlled . identified minimal set three transcription factors -- @ GeneSrc $ ( also known @ GeneSrc $ ) , Nurr1 ( also known Nr4a2 ) Lmx1a -- able generate directly functional dopaminergic neurons mouse human fibroblasts without reverting progenitor cell stage . Induced dopaminergic ( iDA ) cells release dopamine show spontaneous electrical activity organized regular spikes consistent pacemaker activity featured brain dopaminergic neurons . three factors able elicit dopaminergic neuronal conversion prenatal adult fibroblasts healthy donors @ DiseaseTgt $ patients . Direct generation iDA cells somatic cells might significant implications understanding critical processes neuronal development , vitro disease modelling cell replacement therapies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.371694852090741e-05)\n",
      "- Text: \"Presenilin required proper morphology function neurons C. elegans . Mutations human presenilin genes cause frequent aggressive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show addition role cell fate decisions non-neuronal tissues , presenilin activity required terminally differentiated neurons vivo . Mutations Caenorhabditis elegans presenilin genes sel-12 @ GeneSrc $ result defect temperature memory animals . defect caused loss presenilin function two cholinergic interneurons display neurite morphology defects presenilin mutants . morphology function affected neurons sel-12 mutant animals restored expressing sel-12 cells . wild-type human presenilin PS1 , @ DiseaseTgt $ mutant PS1 A246E , also rescue morphological defects . lin-12 mutant animals display similar morphological functional defects presenilin mutants , suggest presenilins mediate activity postmitotic neurons facilitating Notch signalling . data indicate cell-autonomous evolutionarily conserved control neural morphology function presenilins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0588982079845786)\n",
      "- Text: \"Glia promote local synaptogenesis UNC-6 ( netrin ) signaling C. elegans . Neural circuits assembled coordinated innervation pre- postsynaptic partners . show connectivity two interneurons , AIY RIA , Caenorhabditis elegans orchestrated pair glial cells express UNC-6 ( netrin ) . postsynaptic neuron RIA , netrin receptor @ GeneSrc $ ( DCC , deleted @ DiseaseTgt $ ) plays conventional guidance role , directing outgrowth RIA process ventrally toward glia . presynaptic neuron AIY , @ GeneSrc $ ( DCC ) plays unexpected previously uncharacterized role : cell-autonomously promotes assembly presynaptic terminals immediate vicinity glial cell endfeet . results indicate netrin used guidance local synaptogenesis suggest glial cells function guideposts assembly neural circuits vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.884188753630957e-05)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation @ DiseaseTgt $ progression colon . Kras commonly mutated colon cancers , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation @ GeneSrc $ manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012351494620583)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation tumor progression colon . Kras commonly mutated @ DiseaseTgt $ , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation @ GeneSrc $ manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0194573139975719)\n",
      "- Text: \"Reciprocal repression P53 TCTP . Screening genes reprogram @ DiseaseTgt $ cells @ DiseaseTgt $ reversion switch identified TCTP ( encoding translationally controlled tumor protein ) crucial regulator apoptosis . report negative feedback loop P53 TCTP . TCTP promotes P53 degradation competing NUMB binding @ GeneSrc $ complexes . TCTP inhibits @ GeneSrc $ auto-ubiquitination promotes @ GeneSrc $ ubiquitination degradation P53 . Notably , Tctp haploinsufficient mice sensitized P53-dependent apoptosis . addition , P53 directly represses TCTP transcription . 508 breast cancers , high-TCTP status associates poorly differentiated , aggressive G3-grade @ DiseaseTgt $ , predicting poor prognosis ( P < 0.0005 ) . Tctp knockdown primary mammary tumor cells ErbB2 transgenic mice results increased P53 expression decreased number stem-like @ DiseaseTgt $ cells . pharmacological compounds sertraline thioridazine increase amount P53 neutralizing TCTP 's action @ GeneSrc $ axis . study links TCTP P53 previously unidentified regulatory circuitry may underlie relevance TCTP @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3496807374257829)\n",
      "- Text: \"transactivation-deficient mouse model provides insights Trp53 regulation function . gene Trp53 among frequently mutated studied genes human @ DiseaseTgt $ , mechanisms suppresses @ DiseaseTgt $ formation remain unclear . generated mice allele encoding changes Leu25 Trp26 , known essential transcriptional transactivation @ GeneSrc $ binding , enable analyses Trp53 structure function vivo . mutant Trp53 abundant , level affected DNA damage bound DNA constitutively ; however , showed defects cell-cycle regulation apoptosis . mutant Trp53-null mouse embryonic fibroblasts ( MEFs ) readily transformed oncogenes , corresponding mice prone @ DiseaseTgt $ . conclude determining pathway Trp53 @ DiseaseTgt $ function mice requires transactivation domain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2496921272246794)\n",
      "- Text: \"Ferroptosis p53-mediated activity @ DiseaseTgt $ suppression . Although p53-mediated cell-cycle arrest , senescence apoptosis serve critical barriers @ DiseaseTgt $ development , emerging evidence suggests metabolic activities p53 also important . show p53 inhibits cystine uptake sensitizes cells ferroptosis , non-apoptotic form cell death , repressing expression SLC7A11 , key component cystine/glutamate antiporter . Notably , p53 ( 3KR ) , acetylation-defective mutant fails induce cell-cycle arrest , senescence apoptosis , fully retains ability regulate SLC7A11 expression induce ferroptosis upon reactive oxygen species ( ROS ) -induced stress . Analysis mutant mice shows non-canonical p53 activities contribute embryonic development lethality associated loss @ GeneSrc $ . Moreover , SLC7A11 highly expressed human @ DiseaseTgt $ , overexpression inhibits ROS-induced ferroptosis abrogates p53 ( 3KR ) -mediated @ DiseaseTgt $ growth suppression xenograft models . findings uncover new mode @ DiseaseTgt $ suppression based p53 regulation cystine metabolism , ROS responses ferroptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0779384237397743)\n",
      "- Text: \"inherent instability mutant p53 alleviated @ GeneSrc $ p16INK4a loss . p53 tumor suppressor often disrupted human @ DiseaseTgt $ acquisition missense mutations . generated mice missense mutation codon 172 mimics p53R175H hot spot mutation human @ DiseaseTgt $ . p53 homozygous mutant mice unstable mutant p53 normal cells stabilize mutant p53 @ DiseaseTgt $ . investigate significance data , examined regulation mutant p53 stability @ GeneSrc $ , E3 ubiquitin ligase targets p53 degradation , p16INK4a , member Rb tumor suppressor pathway . Mice lacking @ GeneSrc $ p16INK4a stabilized mutant p53 , revealed earlier age @ DiseaseTgt $ onset p53 mutant mice gain-of-function metastatic phenotype . Analysis @ DiseaseTgt $ p53 homozygous mutant mice stable p53 revealed defects Rb pathway . Additionally , ionizing radiation stabilizes wild-type mutant p53 . Thus , stabilization mutant p53 given prerequisite gain-of-function phenotype . Since mutant p53 stability mimics wild-type p53 , data indicate drugs aimed activating wild-type p53 also stabilize mutant p53 dire consequences .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8986991909365293)\n",
      "- Text: \"UBE4B promotes Hdm2-mediated degradation @ DiseaseTgt $ suppressor p53 . TP53 gene ( encoding p53 @ DiseaseTgt $ suppressor ) rarely mutated , although frequently inactivated , medulloblastoma ependymoma . Recent work mouse models showed loss p53 accelerated development medulloblastoma . mechanism underlying p53 inactivation human brain tumors completely understood . show ubiquitination factor E4B ( UBE4B ) , E3 E4 ubiquitin ligase , physically interacts p53 Hdm2 ( also known @ GeneSrc $ mice ) . UBE4B promotes p53 polyubiquitination degradation inhibits p53-dependent transactivation apoptosis . Notably , silencing UBE4B expression impairs xenotransplanted @ DiseaseTgt $ growth p53-dependent manner overexpression UBE4B correlates decreased expression p53 @ DiseaseTgt $ . also show UBE4B overexpression often associated amplification gene human brain tumors . data indicate amplification overexpression UBE4B represent previously undescribed molecular mechanisms inactivation p53 brain tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1979135324496601)\n",
      "- Text: \"HIF-1 antagonizes p53-mediated apoptosis secreted neuronal tyrosinase . Hypoxia-inducible factor ( HIF ) transcription factor regulates fundamental cellular processes response changes oxygen concentration . HIFalpha protein levels increased solid @ DiseaseTgt $ correlate patient prognosis . link HIF apoptosis , major determinant @ DiseaseTgt $ progression treatment outcome , poorly understood . show Caenorhabditis elegans HIF-1 protects DNA-damage-induced germ cell apoptosis antagonizing function CEP-1 , homologue @ DiseaseTgt $ p53 . antiapoptotic property HIF-1 mediated means transcriptional upregulation tyrosinase family member TYR-2 ASJ sensory neurons . TYR-2 secreted ASJ sensory neurons antagonize @ GeneSrc $ germline apoptosis . Knock TYR-2 homologue TRP2 ( also called DCT ) human melanoma cells similarly increases apoptosis , indicating evolutionarily conserved function . findings identify novel link hypoxia programmed cell death , provide paradigm HIF-1 dictating apoptotic cell fate distance .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007964130995915)\n",
      "- Text: \"DJ-1 , cancer- @ DiseaseTgt $ protein , stabilizes antioxidant transcriptional master regulator Nrf2 . DJ-1/PARK7 , cancer- @ DiseaseTgt $ @ DiseaseTgt $ protein , protects cells toxic stresses . However , functional basis protection remained elusive . found loss DJ-1 leads deficits @ GeneSrc $ [ @ GeneSrc $ ] , detoxification enzyme . deficit attributed loss Nrf2 ( nuclear factor erythroid 2-related factor ) , master regulator antioxidant transcriptional responses . DJ-1 stabilizes Nrf2 preventing association inhibitor protein , Keap1 , Nrf2 's subsequent ubiquitination . Without intact DJ-1 , Nrf2 protein unstable , transcriptional responses thereby decreased basally induction . effect DJ-1 Nrf2 present transformed lines primary cells across human mouse species . DJ-1 's effect Nrf2 subsequent effects antioxidant responses may explain DJ-1 affects etiology cancer @ DiseaseTgt $ , seemingly disparate disorders . Furthermore , DJ-1/Nrf2 functional axis presents therapeutic target cancer treatment justifies DJ-1 tumor biomarker .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000227992484338)\n",
      "- Text: \"Therapeutic targeting preleukemia cells mouse model NPM1 mutant @ DiseaseTgt $ . initiating mutations contribute cancer development sometimes present premalignant cells . Whether therapies targeting mutations eradicate premalignant cells unclear . @ DiseaseTgt $ ( @ DiseaseTgt $ ) attractive system investigating effect preventative treatment disease often preceded premalignant state ( clonal hematopoiesis myelodysplastic syndrome ) . Npm1c/Dnmt3a mutant knock-in mice , model @ DiseaseTgt $ development , leukemia preceded period extended myeloid progenitor cell proliferation self-renewal . found self-renewal reversed oral administration small molecule ( VTP-50469 ) targets @ GeneSrc $ chromatin complex . preclinical results support hypothesis individuals high risk developing @ DiseaseTgt $ might benefit targeted epigenetic therapy preventative setting .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4638970666386762)\n",
      "- Text: \"Metabolic regulation brain Abeta @ GeneSrc $ . Amyloid beta peptide ( Abeta ) , pathogenic agent @ DiseaseTgt $ ( @ DiseaseTgt $ ) , physiological metabolite brain . examined role @ GeneSrc $ , candidate Abeta-degrading peptidase , metabolism using @ GeneSrc $ gene-disrupted mice . @ GeneSrc $ deficiency resulted defects degradation exogenously administered Abeta metabolic suppression endogenous Abeta levels gene dose-dependent manner . regional levels Abeta @ GeneSrc $ mouse brain distinct order hippocampus , cortex , thalamus/striatum , cerebellum , hippocampus highest level cerebellum lowest , correlating vulnerability Abeta deposition brains humans @ DiseaseTgt $ . observations suggest even partial down-regulation @ GeneSrc $ activity , could caused aging , contribute @ DiseaseTgt $ development promoting Abeta accumulation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0157264787996369)\n",
      "- Text: \"Enhanced proteolysis beta-amyloid APP transgenic mice prevents plaque formation , secondary pathology , premature death . Converging evidence suggests accumulation cerebral amyloid beta-protein ( Abeta ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) reflects imbalance production degradation self-aggregating peptide . Upregulation proteases degrade Abeta thus represents novel therapeutic approach lowering steady-state Abeta levels , consequences sustained upregulation vivo studied . show transgenic overexpression insulin-degrading enzyme ( IDE ) @ GeneSrc $ ( @ GeneSrc $ ) neurons significantly reduces brain Abeta levels , retards completely prevents amyloid plaque formation associated cytopathology , rescues premature lethality present amyloid precursor protein ( APP ) transgenic mice . findings demonstrate chronic upregulation Abeta-degrading proteases represents efficacious therapeutic approach combating @ DiseaseTgt $ pathology vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0468932001870485)\n",
      "- Text: \"Environmental enrichment reduces Abeta levels amyloid deposition transgenic mice . Cerebral deposition beta-amyloid ( Abeta ) peptides invariant pathological hallmark brains patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) transgenic mice coexpressing familial @ DiseaseTgt $ APP PS1 variants . report exposure transgenic mice `` enriched environment `` results pronounced reductions cerebral Abeta levels amyloid deposits , compared animals raised `` standard housing `` conditions . enzymatic activity Abeta-degrading endopeptidase , @ GeneSrc $ , elevated brains `` enriched `` mice inversely correlated amyloid burden . Moreover , DNA microarray analysis revealed selective upregulation levels transcripts encoded genes associated learning memory , vasculogenesis , neurogenesis , cell survival pathways , Abeta sequestration , prostaglandin synthesis . studies provide evidence environmental enrichment leads reductions steady-state levels cerebral Abeta peptides amyloid deposition selective upregulation levels specific transcripts brains transgenic mice .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6666027632233225)\n",
      "- Text: \"Presenilin-dependent transcriptional control Abeta-degrading enzyme @ GeneSrc $ intracellular domains betaAPP APLP . Amyloid beta-peptide ( Abeta ) , plays central role @ DiseaseTgt $ , generated presenilin-dependent gamma-secretase cleavage beta-amyloid precursor protein ( betaAPP ) . report presenilins ( PS1 PS2 ) also regulate Abeta degradation . Presenilin-deficient cells fail degrade Abeta drastic reductions transcription , expression , activity @ GeneSrc $ , key Abeta-degrading enzyme . @ GeneSrc $ activity expression also lowered gamma-secretase inhibitors PS1/PS2 deficiency mouse brain . @ GeneSrc $ activity restored transient expression PS1 PS2 expression amyloid intracellular domain ( AICD ) , cogenerated Abeta , gamma-secretase cleavage betaAPP . @ GeneSrc $ gene promoters transactivated AICDs APP-like proteins ( APP , APLP1 , APLP2 ) , Abeta gamma-secretase cleavage products Notch , N- E- cadherins . presenilin-dependent regulation @ GeneSrc $ , mediated AICDs , provides physiological means modulate Abeta levels varying levels gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016128131232671)\n",
      "- Text: \"PKCepsilon increases endothelin converting enzyme activity reduces amyloid plaque pathology transgenic mice . Deposition plaques containing amyloid beta ( Abeta ) peptides neuropathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate neuronal overexpression epsilon isozyme PKC decreases Abeta levels , plaque burden , plaque-associated neuritic dystrophy reactive astrocytosis transgenic mice expressing @ DiseaseTgt $ forms human amyloid precursor protein ( APP ) . Compared APP singly transgenic mice , APP/PKCepsilon doubly transgenic mice decreased Abeta levels showed evidence altered cleavage APP . Instead , PKCepsilon overexpression selectively increased activity endothelin-converting enzyme , degrades Abeta . activities Abeta-degrading enzymes , insulin degrading enzyme @ GeneSrc $ , unchanged . results indicate increased neuronal PKCepsilon activity promote Abeta clearance reduce @ DiseaseTgt $ neuropathology increased endothelin-converting enzyme activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2252984253697225)\n",
      "- Text: \"Genetic variability mitochondrial serine protease HTRA2 contributes risk @ DiseaseTgt $ . one genetic study , high temperature requirement A2 ( HTRA2 ) mitochondrial protein associated increased risk sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . One missense mutation , p. Gly399Ser , C-terminal PDZ domain ( initial letters postsynaptic density 95 , @ GeneSrc $ ; discs large ; zonula occludens-1 , ZO-1 proteins [ Kennedy , 1995 ] ) resulted defective protease activation , induced mitochondrial dysfunction overexpressed stably transfected cells . examined contribution genetic variability HTRA2 @ DiseaseTgt $ risk extended series 266 Belgian @ DiseaseTgt $ patients 273 control individuals . Mutation analysis identified novel p. Arg404Trp mutation within PDZ domain predicted freeze HTRA2 inactive form . Moreover , identified six patient-specific variants 5 ' 3 ' regulatory regions might affect HTRA2 expression supported data luciferase reporter gene analyses . study confirms role HTRA2 mitochondrial protein @ DiseaseTgt $ susceptibility mutations functional PDZ domain . addition , extends HTRA2 mutation spectrum functional variants possibly affecting transcriptional activity . latter underpins previously unrecognized role altered HTRA2 expression risk factor relevant @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0040580429556905)\n",
      "- Text: \"@ DiseaseTgt $ PS1 variant rescues developmental abnormalities PS1-deficient embryos . Mutations presenilin 1 ( PS1 ) cosegregate approximately 25 % early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . variety vitro vivo paradigms established one mechanism PS1 variants cause @ DiseaseTgt $ elevating production highly amyloidogenic Abeta1 - 42/43 peptides . PS1 homologous sel-12 , C. elegans protein facilitates signaling mediated @ GeneSrc $ family receptors . Wild-type human PS1 complements egg-laying defect C. elegans lacking sel-12 , @ DiseaseTgt $ PS1 variants exhibit reduced rescue activity . data suggested mutant PS1 may cause disease result reduction PS1 function . test function @ DiseaseTgt $ PS1 mammals , examined ability A246E PS1 variant complement embryonic lethality axial skeletal defects mice lacking PS1 . Finally , examine influence reduced PS1 levels Abeta production , quantified Abeta1 - 42/43 peptide levels PS1 heterozygous null mice ( PS1 [ +/- ] mice ) . report human wild-type A246E PS1 efficiently rescue phenotypes observed PS1 ( -/- ) embryos , findings consistent view @ DiseaseTgt $ PS1 mutants retain sufficient normal function mammalian embryonic development . Moreover , levels Abeta1 - 42/43 Abeta1 - 40 peptides PS1 ( +/- ) control mice indistinguishable . Collectively , data lead us conclude mutant PS1 causes @ DiseaseTgt $ loss normal PS1 function influencing amyloid precursor protein ( APP ) processing manner elevates Abeta1 - 42/43 production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.948250835476577)\n",
      "- Text: \"Neurogenic phenotypes altered Notch processing Drosophila Presenilin mutants . Presenilin proteins implicated developmental signalling cell-surface protein Notch pathogenesis @ DiseaseTgt $ . Loss presenilin function leads @ GeneSrc $ mutant phenotypes Caenorhabditis elegans reduced Notch1 expression mouse paraxial mesoderm . humans , presenilins associated @ DiseaseTgt $ stimulate overproduction neurotoxic 42-amino-acid beta-amyloid derivative ( Abeta42 ) amyloid-precursor protein APP . describe loss-of-function mutations Drosophila Presenilin gene cause lethal Notch-like phenotypes maternal neurogenic effects embryogenesis , loss lateral inhibition within proneural cell clusters , absence wing margin formation . show presenilin required normal proteolytic production carboxy-terminal Notch fragments needed receptor maturation signalling , genetically acts upstream membrane-bound form activated nuclear form Notch . findings provide evidence existence distinct processing sites modifications extracellular domain Notch . also link role presenilin Notch signalling effect amyloid production @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0222496044336933)\n",
      "- Text: \"Presenilin required proper morphology function neurons C. elegans . Mutations human presenilin genes cause frequent aggressive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show addition role cell fate decisions non-neuronal tissues , presenilin activity required terminally differentiated neurons vivo . Mutations Caenorhabditis elegans presenilin genes sel-12 hop-1 result defect temperature memory animals . defect caused loss presenilin function two cholinergic interneurons display neurite morphology defects presenilin mutants . morphology function affected neurons sel-12 mutant animals restored expressing sel-12 cells . wild-type human presenilin PS1 , @ DiseaseTgt $ mutant PS1 A246E , also rescue morphological defects . @ GeneSrc $ mutant animals display similar morphological functional defects presenilin mutants , suggest presenilins mediate activity postmitotic neurons facilitating Notch signalling . data indicate cell-autonomous evolutionarily conserved control neural morphology function presenilins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0496700399377421)\n",
      "- Text: \"HIF-1 antagonizes p53-mediated apoptosis secreted neuronal tyrosinase . Hypoxia-inducible factor ( HIF ) transcription factor regulates fundamental cellular processes response changes oxygen concentration . HIFalpha protein levels increased solid @ DiseaseTgt $ correlate patient prognosis . link HIF apoptosis , major determinant @ DiseaseTgt $ progression treatment outcome , poorly understood . show Caenorhabditis elegans HIF-1 protects DNA-damage-induced germ cell apoptosis antagonizing function CEP-1 , homologue @ DiseaseTgt $ p53 . antiapoptotic property HIF-1 mediated means transcriptional upregulation tyrosinase family member @ GeneSrc $ ASJ sensory neurons . @ GeneSrc $ secreted ASJ sensory neurons antagonize CEP-1-dependent germline apoptosis . Knock @ GeneSrc $ homologue TRP2 ( also called DCT ) human melanoma cells similarly increases apoptosis , indicating evolutionarily conserved function . findings identify novel link hypoxia programmed cell death , provide paradigm HIF-1 dictating apoptotic cell fate distance .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0204665168215071)\n",
      "- Text: \"Caenorhabditis elegans Parkin mutant altered solubility couples alpha-synuclein aggregation proteotoxic stress . Mutations human parkin gene encoding E3 ubiquitin ligase associated early-onset recessive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , molecular mechanisms mutations parkin gene cause @ DiseaseTgt $ still debate . , identified characterized Caenorhabditis elegans parkin homolog , @ GeneSrc $ . @ GeneSrc $ protein physically associates cooperates conserved degradation machinery mediate ubiquitin conjugation . Strikingly , contrast @ GeneSrc $ loss-of-function mutants , in-frame deletion variant altered solubility intracellular localization properties hypersensitive toward different proteotoxic stress conditions . endoplasmic reticulum-derived folding stress cytosolic stress conferred expression mutant human alpha-synuclein resulted severe developmental defects lethality @ GeneSrc $ ) mutant background . Furthermore , show corresponding truncated protein @ GeneSrc $ - 247 ) aggregates cell culture , still interacts ubiquitylation co-enzymes . Thus , might block cellular degradation/detoxification machinery therefore renders worms highly vulnerable protein folding stress . contrast complete gene knockouts RNAi models Parkin function , C. elegans model recapitulates Parkin insolubility aggregation similar several autosomal recessive juvenile parkinsonism ( AR-JP ) -linked Parkin mutations . suggest Parkin variants either confer neomorphic function partial loss-of-function may help elucidate biological function Parkin vivo pathogenic mechanisms resulting AR-JP . Due high-throughput capacity C. elegans , model particularly well suited identify genetic chemical modifiers toxicity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6473563217582711)\n",
      "- Text: \"Suppression intestinal polyps @ GeneSrc $ @ GeneSrc $ multiple intestinal neoplasia mice specific cyclooxygenase-2 inhibitor dual cyclooxygenase-1/2 inhibitor . Epidemiological studies suggest nonsteroidal anti-inflammatory agents decrease risk @ DiseaseTgt $ . believed mediated , least part , inhibition cyclooxygenase ( COX ) activity . two COX isoenzymes , namely constitutively expressed COX-1 inducible COX-2 . COX-2 overexpressed adenomas @ DiseaseTgt $ , COX-2-specific inhibitors shown inhibit intestinal polyps Apc ( Delta716 ) mice effectively dual COX-1/COX-2 inhibitors sulindac . Various Apc knockout mice , including multiple intestinal neoplasia ( Min ) mouse Apc ( Delta716 ) mouse , limited lack large numbers colonic adenomas aberrant crypt foci , putative precursors large-bowel polyps cancers . DNA mismatch-repair-deficient Min mouse model ( @ GeneSrc $ ) genetic features familial adenomatous polyposis hereditary nonpolyposis colorectal cancer , importantly , rapidly develops numerous small- large-bowel adenomas , well colonic aberrant crypt foci . purpose study determine effects COX inhibitors intestinal adenomas colonic aberrant crypt foci accelerated polyposis , mismatch-repair-deficient Min mouse model , addition standard Min mouse model . Weanling @ GeneSrc $ Min mice fed diets containing drug , sulindac , specific COX-2 inhibitor ( MF-tricyclic ) . @ GeneSrc $ Min mice sacrificed 4 weeks 5 months diet , respectively . @ GeneSrc $ mice treated MF-tricyclic significantly fewer small-bowel polyps ( mean + /- SD , 178 + /- 29 ) compared mice sulindac ( 278 + /- 80 ) , control diet ( 341 + /- 43 ; P < 0.001 ) . difference numbers large-bowel polyps aberrant crypt foci mice three groups . MF-tricyclic also effective reducing small- large-bowel polyps Min mice . Western analysis demonstrated COX-2 expression large- small-bowel polyps mice genotypes . study demonstrates specific COX-2 inhibitor effective preventing small-bowel polyps mismatch-repair-deficient Min mice small- large-bowel polyps standard Min mice . Therefore , specific COX-2 inhibitors may useful chemopreventive therapeutic agents humans risk colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007710257620679)\n",
      "- Text: \"deleterious mutation DNAJC6 encoding neuronal-specific clathrin-uncoating co-chaperone auxilin , associated juvenile parkinsonism . @ DiseaseTgt $ caused neuronal loss substantia nigra manifests abnormality movement , muscle tone , postural stability . Several genes implicated pathogenesis @ DiseaseTgt $ , underlying molecular basis still unknown ~70 % patients . Using homozygosity mapping whole exome sequencing identified deleterious mutation DNAJC6 two patients juvenile parkinsonism . mutation associated abnormal transcripts marked reduced DNAJC6 mRNA level . DNAJC6 encodes HSP40 Auxilin , protein selectively expressed neurons confers specificity @ GeneSrc $ activity partner Hcs70 clathrin uncoating . Auxilin null mice previously shown abnormally increased retention assembled clathrin vesicles empty cages leads impaired synaptic vesicle recycling perturbed clathrin mediated endocytosis . Endocytosis function , studied transferring uptake , normal fibroblasts patients , likely presence another J-domain containing partner co-chaperones Hsc70-mediated uncoating activity non-neuronal cells . present report underscores importance endocytic/lysosomal pathway pathogenesis @ DiseaseTgt $ forms parkinsonism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0177650746544471)\n",
      "- Text: \"@ GeneSrc $ amyloid-beta peptide neurotoxicity @ DiseaseTgt $ . Amyloid-beta peptide central pathology @ DiseaseTgt $ , neurotoxic -- directly inducing oxidant stress , indirectly activating microglia . specific cell-surface acceptor site could focus effects target cells postulated identified . present evidence ' receptor advanced glycation end products ' ( @ GeneSrc $ ) receptor , mediates effects peptide neurons microglia . Increased expressing @ GeneSrc $ @ DiseaseTgt $ brain indicates relevant pathogenesis neuronal dysfunction death .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1126407665002216)\n",
      "- Text: \"Suppression intestinal polyps Msh2-deficient non-Msh2-deficient multiple intestinal neoplasia mice specific cyclooxygenase-2 inhibitor dual cyclooxygenase-1/2 inhibitor . Epidemiological studies suggest nonsteroidal anti-inflammatory agents decrease risk @ DiseaseTgt $ . believed mediated , least part , inhibition cyclooxygenase ( COX ) activity . two COX isoenzymes , namely constitutively expressed @ GeneSrc $ inducible COX-2 . COX-2 overexpressed adenomas @ DiseaseTgt $ , COX-2-specific inhibitors shown inhibit intestinal polyps Apc ( Delta716 ) mice effectively dual @ GeneSrc $ inhibitors sulindac . Various Apc knockout mice , including multiple intestinal neoplasia ( Min ) mouse Apc ( Delta716 ) mouse , limited lack large numbers colonic adenomas aberrant crypt foci , putative precursors large-bowel polyps cancers . DNA mismatch-repair-deficient Min mouse model ( Apc+/-Msh2-/- ) genetic features familial adenomatous polyposis hereditary nonpolyposis colorectal cancer , importantly , rapidly develops numerous small- large-bowel adenomas , well colonic aberrant crypt foci . purpose study determine effects COX inhibitors intestinal adenomas colonic aberrant crypt foci accelerated polyposis , mismatch-repair-deficient Min mouse model , addition standard Min mouse model . Weanling Apc+/-Msh2-/- Min mice fed diets containing drug , sulindac , specific COX-2 inhibitor ( MF-tricyclic ) . Apc+/-Msh2-/- Min mice sacrificed 4 weeks 5 months diet , respectively . Apc+/-Msh2-/- mice treated MF-tricyclic significantly fewer small-bowel polyps ( mean + /- SD , 178 + /- 29 ) compared mice sulindac ( 278 + /- 80 ) , control diet ( 341 + /- 43 ; P < 0.001 ) . difference numbers large-bowel polyps aberrant crypt foci mice three groups . MF-tricyclic also effective reducing small- large-bowel polyps Min mice . Western analysis demonstrated COX-2 expression large- small-bowel polyps mice genotypes . study demonstrates specific COX-2 inhibitor effective preventing small-bowel polyps mismatch-repair-deficient Min mice small- large-bowel polyps standard Min mice . Therefore , specific COX-2 inhibitors may useful chemopreventive therapeutic agents humans risk colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0065715482086553)\n",
      "- Text: \"Suppression intestinal polyposis Apc delta716 knockout mice inhibition cyclooxygenase 2 ( COX-2 ) . Two cyclooxygenase isozymes catalyze conversion arachidonic acid prostaglandin H2 : constitutive @ GeneSrc $ inducible COX-2 . assess role COX-2 @ DiseaseTgt $ tumorigenisis , determined effects COX-2 gene ( Ptgs2 ) knockouts novel COX-2 inhibitor Apc delta716 knockout mice , model human familial adenomatous polyposis . Ptgs2 null mutation reduced number size intestinal polyps dramatically . Furthermore , treating Apc delta716 mice novel COX-2 inhibitor reduced polyp number significantly sulindac , inhibits isoenzymes . results provide direct genetic evidence COX-2 plays key role tumorigenesis indicate COX-2-selective inhibitors novel class therapeutic agents @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0171790453593405)\n",
      "- Text: \"Cyclooxygenase-2 overexpression tumor formation blocked sulindac murine model familial adenomatous polyposis . Inducible cyclooxygenase ( @ GeneSrc $ ) , also known prostaglandin H synthase 2 ( PGH-2 ) key enzyme formation prostaglandins thromboxanes . Cox-2 product immediate-early gene expressed response growth factors , tumor promoters , cytokines . Overexpression Cox-2 associated human @ DiseaseTgt $ suppression apoptosis cultured epithelia ] cells , activity reversed nonsteroidal anti-inflammatory drug , sulindac sulfide . address relationship @ GeneSrc $ , apoptosis , tumor development vivo , studied C57BL/6J-Min/+ ( Min ) mice , strain containing fully penetrant dominant mutation Apc gene , leading development gastrointestinal adenomas 110 days age . Min mice fed AIN-76A chow diet given sulindac ( 0.5 + /- 0.1 mg/day ) drinking water . Control Min mice homozygous C57BL/6J-+/+ normal littermates lacking Apc mutation ( + /+ ) fed AIN-76A diet given tap water drink . 110 days age , mice sacrificed , intestinal tracts examined . Control Min mice 11.9 + /- 7.8 tumors per mouse compared 0.1 + /- 0.1 tumors sulindac-treated Min mice . expected , + /+ littermates macroscopic tumors . Examination histologically normal-appearing small bowel Min animals revealed increased amounts @ GeneSrc $ prostaglandin E ( 2 ) compared + /+ littermates . Using two different situ techniques , terminal transferase-mediated dUTP nick end labeling direct immunoperoxidase method , Min animals also demonstrated 27 - 47 % decrease enterocyte apoptosis compared + /+ animals . Treatment sulindac inhibited tumor formation decreased small bowel @ GeneSrc $ prostaglandin E ( 2 ) baseline restored normal levels apoptosis . data suggest overexpression @ GeneSrc $ associated tumorigenesis gastrointestinal epithelium , inhibited sulindac administration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.814698083443124e-05)\n",
      "- Text: \"Suppression intestinal polyps Msh2-deficient non-Msh2-deficient multiple intestinal neoplasia mice specific cyclooxygenase-2 inhibitor dual cyclooxygenase-1/2 inhibitor . Epidemiological studies suggest nonsteroidal anti-inflammatory agents decrease risk @ DiseaseTgt $ . believed mediated , least part , inhibition cyclooxygenase ( COX ) activity . two COX isoenzymes , namely constitutively expressed COX-1 inducible @ GeneSrc $ . @ GeneSrc $ overexpressed adenomas @ DiseaseTgt $ , @ GeneSrc $ inhibitors shown inhibit intestinal polyps Apc ( Delta716 ) mice effectively dual @ GeneSrc $ inhibitors sulindac . Various Apc knockout mice , including multiple intestinal neoplasia ( Min ) mouse Apc ( Delta716 ) mouse , limited lack large numbers colonic adenomas aberrant crypt foci , putative precursors large-bowel polyps cancers . DNA mismatch-repair-deficient Min mouse model ( Apc+/-Msh2-/- ) genetic features familial adenomatous polyposis hereditary nonpolyposis colorectal cancer , importantly , rapidly develops numerous small- large-bowel adenomas , well colonic aberrant crypt foci . purpose study determine effects COX inhibitors intestinal adenomas colonic aberrant crypt foci accelerated polyposis , mismatch-repair-deficient Min mouse model , addition standard Min mouse model . Weanling Apc+/-Msh2-/- Min mice fed diets containing drug , sulindac , specific @ GeneSrc $ inhibitor ( MF-tricyclic ) . Apc+/-Msh2-/- Min mice sacrificed 4 weeks 5 months diet , respectively . Apc+/-Msh2-/- mice treated MF-tricyclic significantly fewer small-bowel polyps ( mean + /- SD , 178 + /- 29 ) compared mice sulindac ( 278 + /- 80 ) , control diet ( 341 + /- 43 ; P < 0.001 ) . difference numbers large-bowel polyps aberrant crypt foci mice three groups . MF-tricyclic also effective reducing small- large-bowel polyps Min mice . Western analysis demonstrated @ GeneSrc $ expression large- small-bowel polyps mice genotypes . study demonstrates specific @ GeneSrc $ inhibitor effective preventing small-bowel polyps mismatch-repair-deficient Min mice small- large-bowel polyps standard Min mice . Therefore , specific @ GeneSrc $ inhibitors may useful chemopreventive therapeutic agents humans risk colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0053079717279802)\n",
      "- Text: \"Neurodegeneration central nervous system apoE-deficient mice . Apolipoprotein E ( apoE ) involved development regeneration central nervous system ( CNS ) . ApoE may also necessary maintain integrity synapto-dendritic complexity . analyzed synaptic alterations CNS apoE-deficient ( knockout ) mice aging process . apoE-deficient homozygous mice , age-dependent 15 40 % loss synaptophysin-immunoreactive nerve terminals @ GeneSrc $ dendrites neocortex hippocampus , compared controls . Dendritic alterations observed early 4 months age . Ultrastructural analysis revealed extensive dendritic vacuolization disruption endomembrane system cytoskeleton apoE-deficient homozygous mice . immunocytochemical studies neuronal cytoskeleton showed apoE-deficient mice decrease immunoreactivity alpha beta tubulin ( kinesin ) cell bodies processes . results support contention apoE might play important role maintaining stability synapto-dendritic apparatus altered deficient functioning molecule could underlie synaptic cytoskeletal alterations @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"RAS regulated let-7 microRNA family . MicroRNAs ( miRNAs ) regulatory RNAs found multicellular eukaryotes , including humans , implicated @ DiseaseTgt $ . let-7 miRNA times seam cell terminal differentiation C. elegans . show let-7 family negatively regulates @ GeneSrc $ . Loss @ GeneSrc $ suppresses let-7 , @ GeneSrc $ 3'UTR contains multiple let-7 complementary sites ( LCSs ) , restricting reporter gene expression let-7-dependent manner . mir-84 , let-7 family member , largely absent vulval precursor cell P6.p time @ GeneSrc $ specifies 1 degrees vulval fate cell , mir-84 overexpression suppresses multivulva phenotype activating @ GeneSrc $ mutations . 3'UTRs human RAS genes contain multiple LCSs , allowing let-7 regulate RAS expression . let-7 expression lower lung tumors normal lung tissue , RAS protein significantly higher lung tumors , providing possible mechanism let-7 @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2003278215268743)\n",
      "- Text: \"epi-allelic series p53 hypomorphs created stable RNAi produces distinct @ DiseaseTgt $ phenotypes vivo . application RNA interference ( RNAi ) mammalian systems potential revolutionize genetics produce novel therapies . investigate whether RNAi applied well-characterized gene stably suppress gene expression hematopoietic stem cells produce detectable phenotypes mice . Deletion Trp53 @ DiseaseTgt $ suppressor gene greatly accelerates @ GeneSrc $ lymphomagenesis , resulting highly disseminated disease . determine whether RNAi suppression Trp53 could produce similar phenotype , introduced several Trp53 short hairpin RNAs ( shRNAs ) hematopoietic stem cells derived E ( mu ) -Myc transgenic mice , monitored @ DiseaseTgt $ onset overall pathology lethally irradiated recipients . Different Trp53 shRNAs produced distinct phenotypes vivo , ranging benign lymphoid hyperplasias highly disseminated lymphomas paralleled Trp53-/- lymphomagenesis E ( mu ) -Myc mouse . cases , severity type disease correlated extent specific shRNAs inhibited p53 activity . Therefore , RNAi stably suppress gene expression stem cells reconstituted organs derived cells . addition , intrinsic differences individual shRNA expression vectors targeting gene used create ' epi-allelic series ' dissecting gene function vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0050477807652038)\n",
      "- Text: \"Dissecting p53 @ DiseaseTgt $ suppressor functions vivo . Although p53 @ DiseaseTgt $ suppressor acts plethora processes influence cellular proliferation survival , remains unclear p53 functions essential @ DiseaseTgt $ suppression , consequence , selected @ DiseaseTgt $ development . Using mouse model harboring primary , genetically modified @ GeneSrc $ lymphomas , show disruption apoptosis downstream p53 Bcl2 dominant-negative caspase 9 confers-like p53 loss-a selective advantage , completely alleviates pressure inactivate p53 lymphomagenesis . Despite p53-null-like aggressive phenotype , apoptosis-defective lymphomas retain intact p53 genes display checkpoint defects gross aneuploidy characteristic p53 mutant @ DiseaseTgt $ . Therefore , apoptosis p53 function selected lymphoma development , whereas defective cell-cycle checkpoints aneuploidy mere byproducts p53 loss .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4103922001099349)\n",
      "- Text: \"p53 Pten control neural glioma stem/progenitor cell renewal differentiation . Glioblastoma ( GBM ) highly lethal brain tumour presenting one two subtypes distinct clinical histories molecular profiles . primary GBM subtype presents acutely high-grade disease typically harbours mutations EGFR , PTEN INK4A/ARF ( also known CDKN2A ) , secondary GBM subtype evolves slow progression low-grade disease classically possesses PDGF TP53 events . show concomitant central nervous system ( CNS ) -specific deletion p53 Pten mouse CNS generates penetrant acute-onset high-grade malignant glioma phenotype notable clinical , pathological molecular resemblance primary GBM humans . genetic observation prompted TP53 PTEN mutational analysis human primary GBM , demonstrating unexpectedly frequent inactivating mutations TP53 well expected PTEN mutations . Integrated transcriptomic profiling , silico promoter analysis functional studies murine neural stem cells ( NSCs ) established dual , singular , inactivation p53 Pten promotes undifferentiated state high renewal potential drives increased @ GeneSrc $ protein levels associated signature . Functional studies validated increased @ GeneSrc $ activity potent contributor impaired differentiation enhanced renewal NSCs doubly null p53 Pten ( p53 ( -/- ) Pten ( -/- ) ) well @ DiseaseTgt $ neurospheres ( TNSs ) derived model . @ GeneSrc $ also serves maintain robust tumorigenic potential p53 ( -/- ) Pten ( -/- ) TNSs . murine modelling studies , together confirmatory transcriptomic/promoter studies human primary GBM , validate pathogenetic role common @ DiseaseTgt $ suppressor mutation profile human primary GBM establish Myc important target cooperative actions p53 Pten regulation normal malignant stem/progenitor cell differentiation , self-renewal tumorigenic potential .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002881402819856)\n",
      "- Text: \"@ GeneSrc $ deletion rescues Apc deficiency small intestine . APC gene encodes adenomatous polyposis coli tumour suppressor protein , germline mutation characterizes familial adenomatous polyposis ( FAP ) , autosomal intestinal cancer syndrome . Inactivation APC also recognized key early event development @ DiseaseTgt $ , loss results constitutive activity beta-catenin-Tcf4 transcription complex . proto-oncogene c-MYC identified target Wnt pathway @ DiseaseTgt $ cells vitro , normal crypts vivo intestinal epithelial cells acutely transformed vivo deletion APC gene ; however , significance unclear . Therefore , elucidate role @ GeneSrc $ intestine Apc loss , simultaneously deleted Apc @ GeneSrc $ adult murine small intestine . show loss @ GeneSrc $ rescued phenotypes perturbed differentiation , migration , proliferation apoptosis , occur deletion Apc . Remarkably , rescue occurred presence high levels nuclear beta-catenin . Array analysis revealed @ GeneSrc $ required majority Wnt target gene activation following Apc loss . data establish @ GeneSrc $ critical mediator early stages neoplasia following Apc loss .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0098545941711453)\n",
      "- Text: \"Wild-type PINK1 prevents basal induced neuronal apoptosis , protective effect abrogated @ DiseaseTgt $ mutations . Mutations PTEN-induced kinase 1 ( PINK1 ) gene recently implicated autosomal recessive early onset @ DiseaseTgt $ ( 1 , 2 ) . investigate role PINK1 neurodegeneration , designed human murine neuronal cell lines expressing either wild-type PINK1 PINK1 bearing mutation associated @ DiseaseTgt $ . show basal staurosporine-induced conditions , number @ GeneSrc $ dUTP nick end labeling ( TUNEL ) -positive cells lower wild-type PINK1 expressing SH-SY5Y cells mock-transfected cells . phenotype due PINK1-mediated reduction cytochrome c release mitochondria , prevents subsequent caspase-3 activation . show overexpression wild-type PINK1 strongly reduced basal staurosporine-induced caspase 3 activity . Overexpression wild-type PINK1 also reduced levels cleaved caspase-9 , caspase-3 , caspase-7 , activated poly ( ADP-ribose ) polymerase basal staurosporine-induced conditions . contrast , @ DiseaseTgt $ mutations kinase-inactive mutation PINK1 abrogated protective effect PINK1 . Together , results suggest PINK1 reduces basal neuronal pro-apoptotic activity protects neurons staurosporine-induced apoptosis . Loss protective function may therefore underlie degeneration nigral dopaminergic neurons patients PINK1 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0341366179907856)\n",
      "- Text: \"Nf1 ; Trp53 mutant mice develop glioblastoma evidence strain-specific effects . Astrocytomas leading cause brain cancer humans . @ DiseaseTgt $ highly infiltrative , current treatments rely targeting @ DiseaseTgt $ mass often ineffective . mouse model astrocytoma would powerful tool dissecting @ DiseaseTgt $ progression testing therapeutics . Mouse models astrocytoma designed express oncogenic proteins astrocytes , limited success due low @ DiseaseTgt $ penetrance limited @ DiseaseTgt $ progression . present mouse model astrocytomas involving mutation two @ DiseaseTgt $ genes , @ GeneSrc $ Trp53 . Humans mutations NF1 develop neurofibromatosis type ( NF1 ) increased risk optic gliomas , astrocytomas glioblastomas . TP53 @ DiseaseTgt $ suppressor often mutated subset astrocytomas develop young age progress slowly glioblastoma ( termed secondary glioblastomas , contrast primary glioblastomas develop rapidly de novo ) . mouse model shows range astrocytoma stages , low-grade astrocytoma glioblastoma multiforme , may accurately model human secondary glioblastoma involving TP53 loss . first reported mouse model astrocytoma initiated loss @ DiseaseTgt $ suppressors , rather overexpression transgenic oncogenes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1362415026830141)\n",
      "- Text: \"Requirement @ GeneSrc $ signalling mouse model lung adenocarcinoma . @ GeneSrc $ transcription factors function crucial regulators inflammatory immune responses well cell survival . also implicated cellular transformation tumorigenesis . However , despite extensive biochemical characterization @ GeneSrc $ signalling past twenty years , requirement @ GeneSrc $ @ DiseaseTgt $ development vivo , particularly @ DiseaseTgt $ , completely understood . show @ GeneSrc $ pathway required development @ DiseaseTgt $ mouse model lung adenocarcinoma . Concomitant loss p53 ( also known Trp53 ) expression oncogenic Kras ( G12D ) resulted @ GeneSrc $ activation primary mouse embryonic fibroblasts . Conversely , lung tumour cell lines expressing Kras ( G12D ) lacking p53 , p53 restoration led @ GeneSrc $ inhibition . Furthermore , inhibition @ GeneSrc $ signalling induced apoptosis p53-null lung cancer cell lines . Inhibition pathway lung tumours vivo , time @ DiseaseTgt $ initiation @ DiseaseTgt $ progression , resulted significantly reduced @ DiseaseTgt $ development . Together , results indicate critical function @ GeneSrc $ signalling lung tumour development , , requirement depends p53 status . findings also provide support development NF-kappaB inhibitory drugs targeted therapies treatment patients defined mutations Kras p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.97287089111796)\n",
      "- Text: \"Trp53 deficiency protects acute intestinal inflammation . p53 protein important @ DiseaseTgt $ suppressor activity also additional immunological functions , whose nature extent beginning recognized . article , show p53 novel inflammation-promoting action intestinal tract , loss p53 upstream activating kinase , ATM , protects acute intestinal inflammation murine models . Mechanistically , deficiency p53 leads increased survival epithelial cells lamina propria macrophages , higher IL-6 expression owing enhanced glucose-dependent @ GeneSrc $ activation , increased mucosal STAT3 activation . Blockade loss IL-6 signaling reverses protective effects p53 deficiency . Conversely , IL-6 treatment protects acute colitis manner dependent STAT3 signaling induction cytoprotective factors epithelial cells . Together , results indicate p53 promotes inflammation intestinal tract suppression epithelium-protective factors , thus significantly expanding spectrum physiological immunological p53 activities unrelated @ DiseaseTgt $ formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.839405258354509e-05)\n",
      "- Text: \"@ GeneSrc $ antagonizes p53-mediated apoptosis secreted neuronal tyrosinase . Hypoxia-inducible factor ( HIF ) transcription factor regulates fundamental cellular processes response changes oxygen concentration . HIFalpha protein levels increased solid @ DiseaseTgt $ correlate patient prognosis . link HIF apoptosis , major determinant @ DiseaseTgt $ progression treatment outcome , poorly understood . show Caenorhabditis elegans @ GeneSrc $ protects DNA-damage-induced germ cell apoptosis antagonizing function CEP-1 , homologue @ DiseaseTgt $ p53 . antiapoptotic property @ GeneSrc $ mediated means transcriptional upregulation tyrosinase family member TYR-2 ASJ sensory neurons . TYR-2 secreted ASJ sensory neurons antagonize CEP-1-dependent germline apoptosis . Knock TYR-2 homologue TRP2 ( also called DCT ) human melanoma cells similarly increases apoptosis , indicating evolutionarily conserved function . findings identify novel link hypoxia programmed cell death , provide paradigm @ GeneSrc $ dictating apoptotic cell fate distance .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4085707182146034)\n",
      "- Text: \"@ DiseaseTgt $ PS1 variant rescues developmental abnormalities PS1-deficient embryos . Mutations presenilin 1 ( PS1 ) cosegregate approximately 25 % early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . variety vitro vivo paradigms established one mechanism PS1 variants cause @ DiseaseTgt $ elevating production highly amyloidogenic Abeta1 - 42/43 peptides . PS1 homologous @ GeneSrc $ , C. elegans protein facilitates signaling mediated Notch/lin-12 family receptors . Wild-type human PS1 complements egg-laying defect C. elegans lacking @ GeneSrc $ , @ DiseaseTgt $ PS1 variants exhibit reduced rescue activity . data suggested mutant PS1 may cause disease result reduction PS1 function . test function @ DiseaseTgt $ PS1 mammals , examined ability A246E PS1 variant complement embryonic lethality axial skeletal defects mice lacking PS1 . Finally , examine influence reduced PS1 levels Abeta production , quantified Abeta1 - 42/43 peptide levels PS1 heterozygous null mice ( PS1 [ +/- ] mice ) . report human wild-type A246E PS1 efficiently rescue phenotypes observed PS1 ( -/- ) embryos , findings consistent view @ DiseaseTgt $ PS1 mutants retain sufficient normal function mammalian embryonic development . Moreover , levels Abeta1 - 42/43 Abeta1 - 40 peptides PS1 ( +/- ) control mice indistinguishable . Collectively , data lead us conclude mutant PS1 causes @ DiseaseTgt $ loss normal PS1 function influencing amyloid precursor protein ( APP ) processing manner elevates Abeta1 - 42/43 production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.961460599433554)\n",
      "- Text: \"Presenilin required proper morphology function neurons C. elegans . Mutations human presenilin genes cause frequent aggressive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show addition role cell fate decisions non-neuronal tissues , presenilin activity required terminally differentiated neurons vivo . Mutations Caenorhabditis elegans presenilin genes @ GeneSrc $ hop-1 result defect temperature memory animals . defect caused loss presenilin function two cholinergic interneurons display neurite morphology defects presenilin mutants . morphology function affected neurons @ GeneSrc $ mutant animals restored expressing @ GeneSrc $ cells . wild-type human presenilin PS1 , @ DiseaseTgt $ mutant PS1 A246E , also rescue morphological defects . lin-12 mutant animals display similar morphological functional defects presenilin mutants , suggest presenilins mediate activity postmitotic neurons facilitating Notch signalling . data indicate cell-autonomous evolutionarily conserved control neural morphology function presenilins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2332359269445969)\n",
      "- Text: \"presenilin 1 C92S mutation increases abeta 42 production . Although wild-type human presenilin 1 ( PS1 ) rescues C. elegans egg-laying ( egl ) phenotype caused loss function mutation C. elegans presenilin homologue @ GeneSrc $ , @ DiseaseTgt $ @ DiseaseTgt $ PS1 mutants partially rescue phenotype . investigate effects loss function @ GeneSrc $ mutation Abeta production mammalian cells , analyzed Abeta production transfected H4 neuroglioma cells expressing PS1 homologue @ GeneSrc $ C60S mutant , PS1 C92S . analysis revealed PS1 C92S increased Abeta42 levels similar fashion pathogenic @ DiseaseTgt $ ( @ DiseaseTgt $ ) PS1 mutations . Significantly , PS1 C92S mutation recently identified pathogenic mutation Italian family @ DiseaseTgt $ . Thus , placing mutation results loss function C. elegans context whereby effect mammalian cells evaluated suggests @ DiseaseTgt $ PS1 mutants result increased Abeta42 production partial loss function mechanism .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9577846703109386)\n",
      "- Text: \"Glia promote local synaptogenesis @ GeneSrc $ ( netrin ) signaling C. elegans . Neural circuits assembled coordinated innervation pre- postsynaptic partners . show connectivity two interneurons , AIY RIA , Caenorhabditis elegans orchestrated pair glial cells express @ GeneSrc $ ( netrin ) . postsynaptic neuron RIA , netrin receptor UNC-40 ( DCC , deleted @ DiseaseTgt $ ) plays conventional guidance role , directing outgrowth RIA process ventrally toward glia . presynaptic neuron AIY , UNC-40 ( DCC ) plays unexpected previously uncharacterized role : cell-autonomously promotes assembly presynaptic terminals immediate vicinity glial cell endfeet . results indicate netrin used guidance local synaptogenesis suggest glial cells function guideposts assembly neural circuits vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.1499887254652206e-05)\n",
      "- Text: \"miR-380 - 5p represses p53 control cellular survival associated poor outcome @ GeneSrc $ neuroblastoma . Inactivation p53 @ DiseaseTgt $ suppressor pathway allows cell survival times stress occurs many human @ DiseaseTgt $ ; however , normal embryonic stem cells @ DiseaseTgt $ neuroblastoma maintain wild-type human TP53 mouse Trp53 ( referred collectively p53 herein ) . describe miRNA , miR-380 - 5p , represses p53 expression via conserved sequence p53 3 ' untranslated region ( UTR ) . miR-380 - 5p highly expressed mouse embryonic stem cells neuroblastomas , high expression correlates poor outcome neuroblastomas neuroblastoma derived v-myc myelocytomatosis viral-related oncogene ( @ GeneSrc $ ) amplification . miR-380 overexpression cooperates activated HRAS oncoprotein transform primary cells , block oncogene-induced senescence form @ DiseaseTgt $ mice . Conversely , inhibition endogenous miR-380 - 5p embryonic stem neuroblastoma cells results induction p53 , extensive apoptotic cell death . vivo delivery miR-380 - 5p antagonist decreases @ DiseaseTgt $ size orthotopic mouse model neuroblastoma . demonstrate new mechanism p53 regulation @ DiseaseTgt $ stem cells uncover potential therapeutic target neuroblastoma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0509560886086219)\n",
      "- Text: \"synthase 2 ( @ GeneSrc $ ) deletion promotes multiple pathologies mouse model @ DiseaseTgt $ . @ DiseaseTgt $ characterized two primary pathological features : amyloid plaques neurofibrillary tangles . interconnection amyloid tau aggregates intense interest , mouse models yet reveal direct interrelationship . show may key factor connects amyloid tau pathologies . Genetic removal synthase 2 mice expressing mutated amyloid precursor protein results pathological hyperphosphorylation mouse tau , redistribution somatodendritic compartment cortical hippocampal neurons , aggregate formation . Lack synthase 2 amyloid precursor protein Swedish mutant mouse increased insoluble beta-amyloid peptide levels , neuronal degeneration , caspase-3 activation , tau cleavage , suggesting acts junction point beta-amyloid peptides , caspase activation , tau aggregation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0209815322086916)\n",
      "- Text: \"Akt1 regulates pathological angiogenesis , vascular maturation permeability vivo . Akt kinases control essential cellular functions , including proliferation , apoptosis , metabolism transcription , proposed promising targets treatment angiogenesis-dependent pathologies , @ DiseaseTgt $ ischemic injury . precise roles neovascularization remain elusive . show Akt1 predominant isoform vascular cells describe unexpected consequences Akt1 knockout vascular integrity pathological angiogenesis . Angiogenic responses three distinct vivo models enhanced Akt1 ( -/- ) mice ; enhanced responses associated impairment blood vessel maturation increased vascular permeability . Although impaired vascular maturation Akt1 ( -/- ) mice may attributed reduced activation @ GeneSrc $ ( @ GeneSrc $ ) , major phenotypic changes vascular permeability angiogenesis linked reduced expression two endogenous vascular regulators , thrombospondins 1 ( TSP-1 ) 2 ( TSP-2 ) . Re-expression TSP-1 TSP-2 mice transplanted wild-type bone marrow corrected angiogenic abnormalities Akt1 ( -/- ) mice . findings establish crucial role Akt-thrombospondin axis angiogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0949029095959682e-05)\n",
      "- Text: \"Neurogenic phenotypes altered Notch processing Drosophila Presenilin mutants . Presenilin proteins implicated developmental signalling cell-surface protein Notch pathogenesis @ DiseaseTgt $ . Loss presenilin function leads Notch/lin-12-like mutant phenotypes Caenorhabditis elegans reduced @ GeneSrc $ expression mouse paraxial mesoderm . humans , presenilins associated @ DiseaseTgt $ stimulate overproduction neurotoxic 42-amino-acid beta-amyloid derivative ( Abeta42 ) amyloid-precursor protein APP . describe loss-of-function mutations Drosophila Presenilin gene cause lethal Notch-like phenotypes maternal neurogenic effects embryogenesis , loss lateral inhibition within proneural cell clusters , absence wing margin formation . show presenilin required normal proteolytic production carboxy-terminal Notch fragments needed receptor maturation signalling , genetically acts upstream membrane-bound form activated nuclear form Notch . findings provide evidence existence distinct processing sites modifications extracellular domain Notch . also link role presenilin Notch signalling effect amyloid production @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.012058981816844)\n",
      "- Text: \"Presenilin 2 deficiency causes mild pulmonary phenotype changes amyloid precursor protein processing enhances embryonic lethal phenotype presenilin 1 deficiency . Mutations homologous presenilin 1 ( PS1 ) presenilin 2 ( PS2 ) genes cause common aggressive form familial @ DiseaseTgt $ . Although PS1 function dysfunction extensively studied , little known function PS2 vivo . delineate relationships PS2 PS1 activities whether PS2 mutations involve gain loss function , generated PS2 homozygous deficient ( -/- ) PS1/PS2 double homozygous deficient mice . contrast PS1 ( -/- ) mice , PS2 ( -/- ) mice viable fertile develop mild pulmonary fibrosis hemorrhage age . Absence PS2 detectably alter processing amyloid precursor protein little effect physiologically important apoptotic processes , indicating @ DiseaseTgt $ mutations PS2 , PS1 , result gain function . Although PS1 ( +/- ) PS2 ( -/- ) mice survive relatively good health , complete deletion PS2 PS1 genes causes phenotype closely resembling full @ GeneSrc $ deficiency . results demonstrate vivo PS1 PS2 partially overlapping functions PS1 essential PS2 redundant normal Notch signaling mammalian embryological development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0632088835222575)\n",
      "- Text: \"Gleevec inhibits beta-amyloid production Notch cleavage . Amyloid-beta ( Abeta ) peptides , consisting mainly 40 42 aa ( Abeta40 Abeta42 , respectively ) , metabolites amyloid precursor protein believed major pathological determinants @ DiseaseTgt $ . proteolytic cleavages form Abeta N C termini catalyzed beta-secretase gamma-secretase , respectively . demonstrate gamma-secretase generation Abeta N2a cell-free system ATP dependent . addition , Abl kinase inhibitor imatinib mesylate ( Gleevec , STI571 ) , targets ATP-binding site Abl several tyrosine kinases , potently reduces Abeta production N2a cell-free system intact N2a cells . STI571 related compound , inhibitor 2 , also reduce Abeta production rat primary neuronal cultures vivo guinea pig brain . STI571 inhibit gamma-secretase-catalyzed S3 cleavage Notch-1 . Furthermore , production Abeta inhibition STI571 demonstrated occur similar extents Abl-/- WT mouse fibroblasts , indicating effect STI571 Abeta production involve Abl kinase . efficacy STI571 reducing Abeta without affecting @ GeneSrc $ cleavage may prove useful basis developing novel therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.628815778123162e-05)\n",
      "- Text: \"Therapeutic targeting preleukemia cells mouse model @ GeneSrc $ mutant @ DiseaseTgt $ . initiating mutations contribute cancer development sometimes present premalignant cells . Whether therapies targeting mutations eradicate premalignant cells unclear . @ DiseaseTgt $ ( @ DiseaseTgt $ ) attractive system investigating effect preventative treatment disease often preceded premalignant state ( clonal hematopoiesis myelodysplastic syndrome ) . Npm1c/Dnmt3a mutant knock-in mice , model @ DiseaseTgt $ development , leukemia preceded period extended myeloid progenitor cell proliferation self-renewal . found self-renewal reversed oral administration small molecule ( VTP-50469 ) targets MLL1-Menin chromatin complex . preclinical results support hypothesis individuals high risk developing @ DiseaseTgt $ might benefit targeted epigenetic therapy preventative setting .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6293245645610342)\n",
      "- Text: \"Differential effects oncogenic K-Ras @ GeneSrc $ proliferation , differentiation @ DiseaseTgt $ progression colon . Kras commonly mutated colon cancers , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . @ GeneSrc $ ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras @ GeneSrc $ , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0047793333587417)\n",
      "- Text: \"Differential effects oncogenic K-Ras @ GeneSrc $ proliferation , differentiation tumor progression colon . Kras commonly mutated @ DiseaseTgt $ , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . @ GeneSrc $ ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras @ GeneSrc $ , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0651535464747393)\n",
      "- Text: \"Comprehensive genotype-phenotype analysis 230 patients @ DiseaseTgt $ . BACKGROUND : @ DiseaseTgt $ ( @ DiseaseTgt $ ) , frequent cyanotic congenital heart disease , associated wide range intra- extracardiac phenotypes . order get insight genotype-phenotype correlation , large cohort 230 unselected patients @ DiseaseTgt $ comprehensively investigated . METHODS RESULTS : 230 patients @ DiseaseTgt $ studied karyotyping , comprehensive 22q11.2 deletion testing sequencing TBX1 , NKX2.5 @ GeneSrc $ , well molecular karyotyping selected patients . Pathogenic genetic aberrations found 42 patients ( 18 % ) , 22q11.2 deletion common diagnosis ( 7.4 % ) , followed trisomy 21 ( 5.2 % ) chromosomal aberrations submicroscopic copy number changes ( 3 % ) . Mutations @ GeneSrc $ detected three patients Alagille syndrome ( 1.3 % ) , NKX2.5 mutations seen two patients non-syndromic @ DiseaseTgt $ ( 0.9 % ) . One patient showed recurrent polyalanine stretch elongation within TBX1 represents true mutation resulting loss transcriptional activity due cytoplasmatic protein aggregation . CONCLUSION : study shows 22q11.2 deletion represents common known cause @ DiseaseTgt $ , associated cardiac phenotype distinct obstruction proximal pulmonary artery , hypoplastic central pulmonary arteries subclavian artery anomalies . Atrioventricular septal defect associated @ DiseaseTgt $ suggestive trisomy 21 almost excludes 22q11.2 deletion . report patient recurrent polyalanine stretch elongation within TBX1 first time link TBX1 cytoplasmatic protein aggregation congenital heart defects .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7937078766086311)\n",
      "- Text: \"@ GeneSrc $ ( @ GeneSrc $ ) mutations patients @ DiseaseTgt $ pulmonic stenosis . Mutations Notch pathway ligand @ GeneSrc $ ( @ GeneSrc $ ) cause Alagille syndrome ( AGS ) , well cardiac defects seemingly nonsyndromic individuals . estimate frequency @ GeneSrc $ mutations cases right-sided cardiac defects otherwise diagnosed AGS , screened 94 cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) 50 pulmonic stenosis/peripheral pulmonary stenosis ( PS/PPS ) pulmonary valve atresia intact ventricular septum ( PA ) mutations . Sequence changes identified three @ DiseaseTgt $ three PS/PPS/PA patients , present 100 controls . identified one frameshift two missense mutations @ DiseaseTgt $ cases , one frameshift two missense mutations cases PS/PPS/PA . four missense mutations assayed effect protein localization , posttranslational modification , ability activate Notch signaling . missense mutants displayed heterogeneous behavior assays , complete haploinsufficiency , suggesting additional modifiers leading organ specific features . identified functionally significant mutations 2 % ( 2/94 ) @ DiseaseTgt $ patients 4 % ( 2/50 ) PS/PPS/PA patients . Patients right-sided cardiac defects carefully screened features AGS family history cardiac defects might suggest presence @ GeneSrc $ mutation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.986124707806438)\n",
      "- Text: \"Familial Tetralogy Fallot caused mutation @ GeneSrc $ gene . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common form complex congenital heart disease , occurring approximately 1 3000 live births . Evaluation candidate loci large kindred segregating autosomal dominant @ DiseaseTgt $ reduced penetrance culminated identification missense mutation ( G274D ) @ GeneSrc $ , gene encoding @ GeneSrc $ , Notch ligand expressed developing right heart . Nine eleven mutation carriers manifested cardiac disease , including classic @ DiseaseTgt $ , ventricular septal defect aortic dextroposition isolated peripheral pulmonic stenosis ( PPS ) . forms @ DiseaseTgt $ represented , including variants pulmonic stenosis , pulmonic atresia absent pulmonary valve . individual within family met diagnostic criteria previously described clinical syndrome , including Alagille syndrome ( AGS ) , caused haploinsufficiency @ GeneSrc $ . mutation carriers characteristic variable facial features , including long , narrow upslanting palpebral fissures , prominent nasal bridge , square dental arch broad , prominent chin . appearance distinct unaffected family members typical AGS patients . glycine corresponding position 274 highly conserved epidermal growth factor-like domains @ GeneSrc $ proteins . substitution proteins associated mild atypical variants disease . data support either relative loss-of-function gain-of-function pathogenetic mechanism family suggest @ GeneSrc $ mutations may contribute significantly common variants right heart obstructive disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9510267264867508)\n",
      "- Text: \"@ GeneSrc $ mutations patients ascertained isolated congenital heart defects . Mutations @ GeneSrc $ cause Alagille syndrome ( AGS ) , pleiotropic disorder involvement liver , heart , skeleton , eyes , facial structures . Cardiac defects seen 95 % AGS patients . commonly right-sided defects ranging mild peripheral pulmonic stenosis severe forms @ DiseaseTgt $ . AGS demonstrates highly variable expressivity respect involved systems . leads us hypothesize defects @ GeneSrc $ found patients presumably isolated heart defects , @ DiseaseTgt $ pulmonic stenosis . Two patients heart defects type seen AGS relatives investigated alterations @ GeneSrc $ gene . @ GeneSrc $ screened combination cytogenetic molecular techniques . Patient 1 studied four-generation history pulmonic stenosis . Molecular analysis showed point mutation @ GeneSrc $ patient mother . Patient 2 investigated owing finding @ DiseaseTgt $ `` butterfly `` vertebra chest radiograph first noted age 5 years . found deletion chromosome region 20p12 encompassed entire @ GeneSrc $ gene . identification two patients suggests patients right-sided heart defects may subtle findings AGS @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3020430311693517)\n",
      "- Text: \"Familial deafness , congenital heart defects , posterior embryotoxon caused cysteine substitution first epidermal-growth-factor-like domain @ GeneSrc $ . present study , report kindred hearing loss , congenital heart defects , posterior embryotoxon , segregating autosomal dominant traits . Six seven available affected patients manifested mild-to-severe combined hearing loss , predominantly affecting middle frequencies . Two patients diagnosed vestibular pathology . patients congenital heart defects , including @ DiseaseTgt $ , ventricular septal defect , isolated peripheral pulmonic stenosis . individual family met diagnostic criteria previously described clinical syndrome . candidate-gene approach undertaken culminated identification novel @ GeneSrc $ ( @ GeneSrc $ ) missense mutation ( C234Y ) first cysteine first epidermal-growth-factor-like repeat domain protein . @ GeneSrc $ cell-surface ligand Notch signaling pathway . Mutations @ GeneSrc $ identified patients Alagille syndrome . findings revealed unique phenotype highly penetrant deafness , posterior embryotoxon , congenital heart defects variable expressivity large kindred , demonstrates mutation @ GeneSrc $ cause hearing loss .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012301911144174)\n",
      "- Text: \"Monozygotic twins severe form Alagille syndrome phenotypic discordance . Alagille syndrome autosomal dominant disorder affecting multiple organ systems , predominantly liver , heart , skeleton , eye , face , kidney . phenotype Alagille syndrome highly variable within families . report monozygotic twins Alagille syndrome concordant mutation @ GeneSrc $ discordant clinical phenotype . twins ' monozygosity confirmed molecular testing . de novo splice site mutation identified exon 6 ( 1329 + 2 -- > G ) children . twins display severe form Alagille syndrome ; however , one twin severe pulmonary atresia mild liver involvement , @ DiseaseTgt $ severe hepatic involvement , required liver transplantation . Potential mechanisms phenotypic variability among monozygotic twins discussed . first reported case discordance phenotype monozygotic twins Alagille syndrome . case implies genotypic variations alone explain clinical variability seen Alagille syndrome supports contributory role nongenetic factors phenotype determination .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.507776165583985e-05)\n",
      "- Text: \"Conditional @ GeneSrc $ mutation shows developing heart sensitive developing liver @ GeneSrc $ dosage . Mutations @ GeneSrc $ ( @ GeneSrc $ ) , ligand Notch signaling pathway , cause Alagille syndrome ( AGS ) . AGS autosomal dominant , multisystem disorder variable expressivity , characterized bile duct paucity resultant liver disease combination cardiac , ocular , skeletal , facial findings . @ GeneSrc $ mutations AGS include gene deletions protein truncating , splicing , missense mutations , suggesting haploinsufficiency mechanism disease causation . limited exceptions , genotype-phenotype correlation . studied @ GeneSrc $ missense mutation ( @ GeneSrc $ ) previously identified 13 individuals extended family cardiac defects type seen patients AGS ( e.g . , peripheral pulmonic stenosis @ DiseaseTgt $ ) absence liver dysfunction . data indicate mutation `` leaky . `` Two populations proteins produced allele . One population abnormally glycosylated retained intracellularly rather transported cell surface . second population normally glycosylated transported cell surface , able signal Notch receptor . @ GeneSrc $ protein temperature sensitive , abnormally glycosylated ( nonfunctional ) molecules produced higher temperatures . Carriers mutation therefore > 50 % < 100 % normal concentration @ GeneSrc $ molecules cell surface . cardiac-specific phenotype associated mutation suggests developing heart sensitive developing liver decreased dosage @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0383502810516912)\n",
      "- Text: \"DCC constrains tumour progression via dependence receptor activity . role deleted colorectal carcinoma ( DCC ) tumour suppressor matter debate past 15 years . DCC gene expression lost markedly reduced majority advanced @ DiseaseTgt $ , functioning dependence receptor , DCC shown induce apoptosis unless engaged ligand , @ GeneSrc $ ( ref . 2 ) . However , far animal model supported view DCC loss-of-function causally implicated predisposing aggressive cancer development . investigate role DCC-induced apoptosis control tumour progression , created mouse model pro-apoptotic activity DCC genetically silenced . Although loss DCC-induced apoptosis mouse model associated major disorganization intestines , leads spontaneous intestinal neoplasia relatively low frequency . Loss DCC-induced apoptosis also associated increase number aggressiveness intestinal tumours predisposing APC mutant context , resulting development highly invasive adenocarcinomas . results demonstrate DCC functions tumour suppressor via ability trigger tumour cell apoptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6615887478809545)\n",
      "- Text: \"DCC gene product induces apoptosis mechanism requiring receptor proteolysis . development colonic carcinoma associated mutation specific set genes . One , DCC ( deleted @ DiseaseTgt $ ) , candidate tumour-suppressor gene , encodes receptor @ GeneSrc $ , molecule involved axon guidance . Loss DCC expression tumours restricted colon carcinoma , , although increase frequency tumour formation DCC hemizygous mice , reestablishment DCC expression suppresses tumorigenicity . However , mechanism action DCC unknown . show DCC induces apoptosis absence ligand binding , blocks apoptosis engaged @ GeneSrc $ . Furthermore , DCC caspase substrate , mutation site caspase-3 cleaves DCC suppresses pro-apoptotic effect DCC completely . results indicate DCC may function tumour-suppressor protein inducing apoptosis settings ligand unavailable ( example , metastasis tumour growth beyond local blood supply ) functional caspase cascades mechanism requires cleavage DCC Asp 1,290 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1051007525163286)\n",
      "- Text: \"@ GeneSrc $ controls colorectal tumorigenesis regulating apoptosis . expression protein DCC ( deleted @ DiseaseTgt $ ) lost markedly reduced numerous cancers majority @ DiseaseTgt $ due loss heterozygosity chromosome 18q , therefore proposed tumour suppressor . However , rarity mutations found DCC , lack cancer predisposition DCC mutant mice , presence tumour suppressor genes 18q raised doubts function DCC tumour suppressor . Unlike classical tumour suppressors , DCC shown induce apoptosis conditionally : functioning dependence receptor , DCC induces apoptosis unless DCC engaged ligand , @ GeneSrc $ ( ref . 3 ) . show inhibition cell death enforced expression @ GeneSrc $ mouse gastrointestinal tract leads spontaneous formation hyperplastic neoplastic lesions . Moreover , adenomatous polyposis coli mutant background associated adenoma formation , enforced expression @ GeneSrc $ engenders aggressive adenocarcinomatous malignancies . data demonstrate @ GeneSrc $ promote intestinal tumour development , probably regulating cell survival . Thus , netrin-1 receptor receptors function conditional tumour suppressors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0771541031566526)\n",
      "- Text: \"Deleted @ DiseaseTgt $ suppresses metastasis p53-deficient mammary tumours . Since discovery early 1990s deleted colorectal cancer ( DCC ) gene , located chromosome 18q21 , proposed tumour suppressor gene loss implicated majority advanced @ DiseaseTgt $ . DCC belongs family netrin 1 receptors , function dependence receptors control survival apoptosis depending ligand binding . However , role DCC tumour suppressor remains controversial rarity DCC-specific mutations presence tumour suppressor genes chromosomal region . show mouse model mammary carcinoma based somatic inactivation p53 , additional loss DCC promotes metastasis formation without affecting primary tumour phenotype . Furthermore , demonstrate cell cultures derived p53-deficient mouse mammary tumours DCC expression controls @ GeneSrc $ cell survival , providing mechanistic basis enhanced metastatic capacity tumour cells lacking DCC . Consistent idea , vivo tumour-cell survival enhanced DCC loss . Together , data support function DCC context-dependent tumour suppressor limits survival disseminated tumour cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045352813203403)\n",
      "- Text: \"Reciprocal repression P53 TCTP . Screening genes reprogram @ DiseaseTgt $ cells @ DiseaseTgt $ reversion switch identified TCTP ( encoding translationally controlled tumor protein ) crucial regulator apoptosis . report negative feedback loop P53 TCTP . TCTP promotes P53 degradation competing @ GeneSrc $ binding P53-MDM2-containing complexes . TCTP inhibits MDM2 auto-ubiquitination promotes MDM2-mediated ubiquitination degradation P53 . Notably , Tctp haploinsufficient mice sensitized P53-dependent apoptosis . addition , P53 directly represses TCTP transcription . 508 breast cancers , high-TCTP status associates poorly differentiated , aggressive G3-grade @ DiseaseTgt $ , predicting poor prognosis ( P < 0.0005 ) . Tctp knockdown primary mammary tumor cells ErbB2 transgenic mice results increased P53 expression decreased number stem-like @ DiseaseTgt $ cells . pharmacological compounds sertraline thioridazine increase amount P53 neutralizing TCTP 's action MDM2-P53 axis . study links TCTP P53 previously unidentified regulatory circuitry may underlie relevance TCTP @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0127359791831237)\n",
      "- Text: \"Organization human orphan nuclear receptor Nurr1 gene . Recent reports revealed Nurr1 ( also known NOT/TINUR/RNR-1/HZF-3 ) , member steroid/thyroid hormone nuclear receptor superfamily , predominantly expressed midbrain ; substantia nigra ( SN ) ventral tegmental area ( VTA ) . @ GeneSrc $ null mice born lethal , lacking midbrain dopamine ( DA ) neurons , suggesting Nurr1 essential development differentiation midbrain DA neurons . Human Nurr1 gene mapped chromosome 2q22 - 23 , reported associate weakly schizophrenia . cloned sequenced human Nurr1 gene , approximately 8.3 kb long , consisting eight exons seven introns . Comparisons human Nurr1 mouse @ GeneSrc $ , mouse Nur77 human NOR-1 revealed genomic structures highly conserved . 5'-flanking region human Nurr1 included three transcriptional regulatory elements , cAMP-response element ( CRE ) , CArG-like element Sp-1 site , surrounded CpG island , showed strong homology mouse @ GeneSrc $ . performed primer extension analysis using mRNA HeLa S3 cells stimulated phorbol 12-myristate 13-acetate ( PMA ) , Ca2 + ionophore A23187 cycloheximide ( CHX ) order induce Nurr1 mRNA expression , determined one transcription initiation site within CRE . transient transfection assay indicates regulatory elements 5'-flanking region robust mitogen-induced expression human Nurr1 . analysis polymorphism human Nurr1 gene may reveal association diseases characterized changes DA system , @ DiseaseTgt $ schizophrenia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Dopamine neuron agenesis @ GeneSrc $ mice . Dopamine neurons substantia nigra ventral tegmental area regulate movement affective behavior degenerate @ DiseaseTgt $ . orphan nuclear receptor @ GeneSrc $ shown expressed developing dopamine neurons appearance known phenotypic markers cells . Mice lacking @ GeneSrc $ failed generate midbrain dopaminergic neurons , hypoactive , died soon birth . @ GeneSrc $ expression continued adulthood , brains heterozygous animals , otherwise apparently healthy , contained reduced dopamine levels . results suggest putative @ GeneSrc $ ligands may useful treatment @ DiseaseTgt $ disorders midbrain dopamine circuitry .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0042281633868311)\n",
      "- Text: \"@ GeneSrc $ repression mediates cardinal features @ DiseaseTgt $ alpha-synuclein transgenic mice . Duplication/triplication mutations SNCA locus , encoding alpha-synuclein ( ASYN ) , loss function mutations @ GeneSrc $ , nuclear receptor guiding midbrain dopaminergic neuron development , associated familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . age , expression levels two genes midbrain dopaminergic neurons follow opposite directions ASYN expression increases expression @ GeneSrc $ decreases . investigated effect ASYN @ GeneSrc $ age-related expression alterations pathogenesis @ DiseaseTgt $ coupling @ GeneSrc $ hemizygous ASYN ( ) ( heterozygote ) ASYN ( ) ( homozygote ) transgenic mice . @ GeneSrc $ ( 2-hit ) mice , contrary individual genetic traits , developed phenotypes consistent dopaminergic dysfunction . Aging ' 2-hit ' mice manifested kyphosis , severe rigid paralysis , L-DOPA responsive movement impairment cachexia died prematurely . Pathological abnormalities phenotypic mice included SN neuron degeneration , extensive neuroinflammation enhanced ASYN aggregation . Mice two wt @ GeneSrc $ alleles [ @ GeneSrc $ ] reduced ASYN load [ @ GeneSrc $ ] develop phenotype pathology . Critically , found aging ASYN ( ) , contrast ASYN ( ) , mice suppress @ GeneSrc $ levels brain region-specific manner , addition @ GeneSrc $ hemizygosity necessary instigate @ DiseaseTgt $ pathogenesis . experiments demonstrate ASYN-dependent @ DiseaseTgt $ pathophysiology mediated least part @ GeneSrc $ down-regulation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.813097615350867)\n",
      "- Text: \"Mutations @ GeneSrc $ associated familial @ DiseaseTgt $ . @ GeneSrc $ , encoding member nuclear receptor superfamily , essential differentiation nigral dopaminergic neurons . determine whether @ GeneSrc $ susceptibility gene @ DiseaseTgt $ , carried genetic analyses 201 individuals affected @ DiseaseTgt $ 221 age-matched unaffected controls . identified two mutations @ GeneSrc $ associated @ DiseaseTgt $ ( -291Tdel -245T -- > G ) , map first exon @ GeneSrc $ affect one allele 10 107 individuals familial @ DiseaseTgt $ individuals sporadic @ DiseaseTgt $ ( n = 94 ) unaffected controls ( n = 221 ) . age onset disease clinical features ten individuals different individuals typical @ DiseaseTgt $ . mutations resulted marked decrease @ GeneSrc $ mRNA levels transfected cell lines lymphocytes affected individuals . Additionally , mutations @ GeneSrc $ affect transcription gene encoding tyrosine hydroxylase . data suggest mutations @ GeneSrc $ cause dopaminergic dysfunction , associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6522978624138308)\n",
      "- Text: \"Cooperative transcription activation @ GeneSrc $ Pitx3 induces embryonic stem cell maturation midbrain dopamine neuron phenotype . Midbrain dopamine ( DA ) neurons play central role regulation voluntary movement , degeneration associated @ DiseaseTgt $ . Cell replacement therapies , particular embryonic stem ( ES ) cell-derived DA neurons , offer potential therapeutic venue @ DiseaseTgt $ . sought identify genes potentiate maturation ES cell cultures midbrain DA neuron phenotype . number transcription factors implicated development midbrain DA neurons expression analyses loss-of-function knockout mouse studies , including @ GeneSrc $ , Pitx3 , Lmx1b , Engrailed-1 , Engrailed-2 . However , none factors appear sufficient alone induce mature midbrain DA neuron phenotype ES cell cultures vitro , suggesting complex regulatory network . show @ GeneSrc $ Pitx3 cooperatively promote terminal maturation midbrain DA neuron phenotype murine human ES cell cultures .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002028916441518)\n",
      "- Text: \"Deletion polymorphism gene angiotensin-converting enzyme potent risk factor @ DiseaseTgt $ . Factors involved pathogenesis atherosclerosis , thrombosis vasoconstriction contribute development coronary heart disease . study comparing patients @ DiseaseTgt $ controls , explored possible association coronary heart disease variation found gene encoding angiotensin-converting enzyme ( ACE ) . polymorphism ACE/ID strongly associated level circulating enzyme . enzyme plays key role production @ GeneSrc $ catabolism bradykinin , two peptides involved modulation vascular tone proliferation smooth muscle cells . report DD genotype , associated higher levels circulating ACE ID II genotypes , significantly frequent patients @ DiseaseTgt $ ( n = 610 ) controls ( n = 733 ) ( P = 0.007 ) , especially among subjects low body-mass index low plasma levels ApoB ( P < 0.0001 ) . ACE/ID polymorphism seems potent risk factor coronary heart disease subjects formerly considered low risk according common criteria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039268893500478)\n",
      "- Text: \"Crystal structure human angiotensin-converting enzyme-lisinopril complex . Angiotensin-converting enzyme ( ACE ) critical role cardiovascular function cleaving carboxy terminal His-Leu dipeptide @ GeneSrc $ produce potent vasopressor octapeptide , @ GeneSrc $ . Inhibitors ACE first line therapy hypertension , heart failure , @ DiseaseTgt $ diabetic nephropathy . Notably , inhibitors developed without knowledge structure human ACE , instead designed basis assumed mechanistic homology carboxypeptidase . present X-ray structure human testicular ACE complex one widely used inhibitors , lisinopril ( N2- [ ( ) -1-carboxy-3-phenylpropyl ] -L-lysyl-L-proline ; also known Prinivil Zestril ) , 2.0 resolution . Analysis three-dimensional structure ACE shows bears little similarity carboxypeptidase , instead resembles neurolysin Pyrococcus furiosus carboxypeptidase -- zinc metallopeptidases detectable sequence similarity ACE . structure provides opportunity design domain-selective ACE inhibitors may exhibit new pharmacological profiles .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.358232495804026e-05)\n",
      "- Text: \"Divergently transcribed overlapping genes expressed liver kidney located 11p15.5 imprinted domain . Human chromosomal band 11p15.5 shown contain genes involved development several pediatric adult @ DiseaseTgt $ Beckwith-Wiedemann syndrome ( BWS ) . Overlapping P1 artificial chromosome clones region used templates genomic sequencing effort identify candidate genes disorders . PowerBLAST identified several matches expressed sequence tags ( ESTs ) fetal brain liver cDNA libraries . Northern blot analysis indicated two genes identified ESTs encode transcripts 1 - 1.5 kb predominant expression fetal adult liver kidney . RT-PCR RACE , full-length transcripts isolated two genes , largest open reading frames encoding putative proteins 253 424 amino acids . Database comparison predicted amino acid sequence larger transcript indicated homology integral membrane organic cation transporters ; hence , designate gene ORCTL2 ( organic cation transporter-like 2 ) . expressed sequence polymorphism provided evidence ORCTL2 gene exhibits `` leaky `` imprinting human fetal kidney human fetal liver . mouse orthologue ( @ GeneSrc $ ) identified , similar polymorphism used demonstrate maternal-specific expression gene fetal liver interspecific F1 mice . predicted protein smaller gene showed significant similarity database . Northern RACE analyses suggest gene may multiple transcription start sites . Determination genomic structure humans indicated 5'-end transcript overlaps divergent orientation first two exons ORCTL2 , suggesting possible role antisense regulation one gene . , therefore , provisionally name second transcript ORCTL2S ( ORCTL2-antisense ) . expression patterns genes imprinted expression ORCTL2 suggestive possible role development Wilms tumor ( WT ) hepatoblastoma . Although SSCP analysis 62 WT samples 10 BWS patients result identification mutations ORCTL2 ORCTL2S , important examine expression pattern @ DiseaseTgt $ BWS patients , since epigenetic alteration loci may play role etiology diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018355826008366)\n",
      "- Text: \"PAC1 phosphatase transcription target p53 signalling apoptosis growth suppression . p53 role many cellular processes transcriptional regulation target genes . @ GeneSrc $ ( phosphatase activated cells 1 ; also known @ GeneSrc $ , @ GeneSrc $ ) dual threonine/tyrosine phosphatase specifically dephosphorylates inactivates mitogen-activated protein ( MAP ) kinases . show apoptosis , p53 activates transcription @ GeneSrc $ binding palindromic site @ GeneSrc $ promoter . @ GeneSrc $ transcription induced response serum deprivation oxidative stress , results p53-dependent apoptosis , response gamma-irradiation , causes cell cycle arrest . Reduction @ GeneSrc $ transcription using small interfering RNA inhibits p53-mediated apoptosis , whereas overexpression @ GeneSrc $ increases susceptibility apoptosis suppresses @ DiseaseTgt $ formation . Moreover , activation p53 significantly inhibits MAP kinase activity . conclude , specific stress conditions , p53 regulates transcription @ GeneSrc $ new p53-binding site , @ GeneSrc $ necessary sufficient p53-mediated apoptosis . Identification palindromic motif p53-binding site may reveal novel mechanism whereby p53 regulates target genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2169480074255718)\n",
      "- Text: \"Mutations LRRK2 Roc-COR tandem domain link @ DiseaseTgt $ Wnt signalling pathways . Mutations PARK8 , encoding LRRK2 , common known cause @ DiseaseTgt $ . LRRK2 Roc-COR tandem domain exhibits GTPase activity controlling LRRK2 kinase activity via intramolecular process . report interaction LRRK2 dishevelled family phosphoproteins ( DVL1 - 3 ) , key regulators Wnt ( Wingless/Int ) signalling pathways important axon guidance , synapse formation neuronal maintenance . Interestingly , DVLs interact mediate activation small GTPases structural similarity LRRK2 Roc domain . LRRK2 Roc-COR domain @ GeneSrc $ DEP domain necessary sufficient @ GeneSrc $ interaction . Co-expression @ GeneSrc $ increased LRRK2 steady-state protein levels , effect dependent DEP domain . Strikingly , LRRK2-DVL1 - 3 interactions disrupted familial PARK8 mutation Y1699C , whereas pathogenic mutations residues R1441 R1728 strengthened @ GeneSrc $ interactions . Co-expression @ GeneSrc $ LRRK2 mammalian cells resulted redistribution LRRK2 typical cytoplasmic @ GeneSrc $ aggregates HEK293 SH-SY5Y cells co-localization neurites growth cones differentiated dopaminergic SH-SY5Y cells . first report modulation key LRRK2-accessory protein interaction PARK8 Roc-COR domain mutations segregating @ DiseaseTgt $ . Since @ GeneSrc $ DEP domain known involved regulation small GTPases , propose : ( ) DVLs may influence LRRK2 GTPase activity , ( ii ) Roc-COR domain mutations modulating LRRK2-DVL interactions indirectly influence kinase activity . findings also link LRRK2 Wnt signalling pathways , suggesting novel pathogenic mechanisms new targets genetic analysis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0627949749850354)\n",
      "- Text: \"Mutations LRRK2 Roc-COR tandem domain link @ DiseaseTgt $ Wnt signalling pathways . Mutations PARK8 , encoding LRRK2 , common known cause @ DiseaseTgt $ . LRRK2 Roc-COR tandem domain exhibits GTPase activity controlling LRRK2 kinase activity via intramolecular process . report interaction LRRK2 dishevelled family phosphoproteins ( @ GeneSrc $ ) , key regulators Wnt ( Wingless/Int ) signalling pathways important axon guidance , synapse formation neuronal maintenance . Interestingly , DVLs interact mediate activation small GTPases structural similarity LRRK2 Roc domain . LRRK2 Roc-COR domain DVL1 DEP domain necessary sufficient LRRK2-DVL1 interaction . Co-expression DVL1 increased LRRK2 steady-state protein levels , effect dependent DEP domain . Strikingly , @ GeneSrc $ interactions disrupted familial PARK8 mutation Y1699C , whereas pathogenic mutations residues R1441 R1728 strengthened LRRK2-DVL1 interactions . Co-expression DVL1 LRRK2 mammalian cells resulted redistribution LRRK2 typical cytoplasmic DVL1 aggregates HEK293 SH-SY5Y cells co-localization neurites growth cones differentiated dopaminergic SH-SY5Y cells . first report modulation key LRRK2-accessory protein interaction PARK8 Roc-COR domain mutations segregating @ DiseaseTgt $ . Since DVL1 DEP domain known involved regulation small GTPases , propose : ( ) DVLs may influence LRRK2 GTPase activity , ( ii ) Roc-COR domain mutations modulating LRRK2-DVL interactions indirectly influence kinase activity . findings also link LRRK2 Wnt signalling pathways , suggesting novel pathogenic mechanisms new targets genetic analysis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0015628659600679)\n",
      "- Text: \"@ GeneSrc $ represses beta-catenin transcription antagonized pRB CDK8 . @ GeneSrc $ transcription factor promote proliferation apoptosis activated , key downstream target retinoblastoma tumour suppressor protein ( pRB ) . show @ GeneSrc $ potent specific inhibitor beta-catenin/T-cell factor ( TCF ) -dependent transcription , function contributes @ GeneSrc $ apoptosis . @ GeneSrc $ deregulation suppresses beta-catenin activity adenomatous polyposis coli ( APC ) /glycogen synthase kinase-3 ( GSK3 ) -independent manner , reducing expression key beta-catenin targets including c-MYC . interaction explains @ DiseaseTgt $ , depend beta-catenin transcription abnormal proliferation , keep RB1 intact . Remarkably , @ GeneSrc $ activity also repressed cyclin-dependent kinase-8 ( CDK8 ) , colorectal oncoprotein . Elevated levels CDK8 protect beta-catenin/TCF-dependent transcription inhibition @ GeneSrc $ . Thus , retaining RB1 amplifying CDK8 , @ DiseaseTgt $ cells select conditions collectively suppress @ GeneSrc $ enhance activity beta-catenin .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3834065267134112)\n",
      "- Text: \"Critical role @ GeneSrc $ phosphoinositide-3-OH kinase growth metabolic regulation . eight catalytic subunits mammalian phosphoinositide-3-OH kinase ( PI ( 3 ) K ) family form backbone evolutionarily conserved signalling pathway ; however , roles PI ( 3 ) K isoforms organismal physiology disease unknown . delineate role @ GeneSrc $ , ubiquitously expressed PI ( 3 ) K involved tyrosine kinase Ras signalling , generated mice carrying knockin mutation ( D933A ) abrogates @ GeneSrc $ kinase activity . Homozygosity kinase-dead @ GeneSrc $ led embryonic lethality . Mice heterozygous mutation viable fertile , displayed severely blunted signalling via insulin-receptor substrate ( IRS ) proteins , key mediators insulin , insulin-like growth factor-1 leptin action . Defective responsiveness hormones led reduced somatic growth , hyperinsulinaemia , glucose intolerance , hyperphagia increased adiposity mice heterozygous D933A mutation . signalling function @ GeneSrc $ derives highly selective recruitment activation IRS signalling complexes compared p110beta , broadly expressed PI ( 3 ) K isoform , contribute IRS-associated PI ( 3 ) K activity . @ GeneSrc $ principal IRS-associated PI ( 3 ) K @ DiseaseTgt $ cell lines . findings demonstrate critical role @ GeneSrc $ growth factor metabolic signalling also suggest explanation selective mutation overexpression @ GeneSrc $ variety @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9522912713277304)\n",
      "- Text: \"Binding ras phosphoinositide 3-kinase @ GeneSrc $ required ras-driven tumorigenesis mice . Ras proteins signal direct interaction number effector enzymes , including type phosphoinositide ( PI ) 3-kinases . Although ability Ras control PI 3-kinase well established manipulated cell culture models , evidence role interaction endogenous Ras PI 3-kinase normal malignant cell growth vivo lacking . generate mice mutations Pi3kca gene encoding catalytic @ GeneSrc $ isoform block interaction Ras . Cells mice show proliferative defects selective disruption signaling growth factors PI 3-kinase . mice display defective development lymphatic vasculature , resulting perinatal appearance chylous ascites . importantly , highly resistant endogenous Ras oncogene-induced tumorigenesis . interaction Ras @ GeneSrc $ thus required vivo certain normal growth factor signaling Ras-driven @ DiseaseTgt $ formation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7851275061736368)\n",
      "- Text: \"PIK3CA ( H1047R ) induces multipotency multi-lineage mammary tumours . adult mouse mammary epithelium contains self-sustained cell lineages form inner luminal outer basal cell layers , stem progenitor cells contributing proliferative regenerative potential . key issue breast cancer biology effect genomic lesions specific mammary cell lineages @ DiseaseTgt $ heterogeneity progression . impact transforming events fate conversion @ DiseaseTgt $ cells origin thus contribution @ DiseaseTgt $ heterogeneity remains largely elusive . Using situ genetic lineage tracing limiting dilution transplantation , unravelled potential PIK3CA ( H1047R ) , one frequent mutations occurring human breast cancer , induce multipotency tumorigenesis mammary gland . show expression @ GeneSrc $ ) lineage-committed basal Lgr5-positive luminal keratin-8-positive cells adult mouse mammary gland evokes cell dedifferentiation multipotent stem-like state , suggesting mechanism involved formation heterogeneous , multi-lineage mammary tumours . Moreover , show @ DiseaseTgt $ cell origin influences frequency malignant mammary tumours . results define key effect PIK3CA ( H1047R ) mammary cell fate pre-neoplastic mammary gland show cell origin PIK3CA ( H1047R ) @ DiseaseTgt $ dictates @ DiseaseTgt $ , thus revealing mechanism underlying @ DiseaseTgt $ heterogeneity aggressiveness .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0956925798144393)\n",
      "- Text: \"Somatic @ GeneSrc $ Mutations Sporadic Cerebral Cavernous Malformations . BACKGROUND : Cerebral cavernous malformations ( CCMs ) common sporadic inherited vascular malformations central nervous system . Although familial CCMs linked loss-of-function mutations KRIT1 ( CCM1 ) , CCM2 , PDCD10 ( CCM3 ) , genetic cause sporadic CCMs , representing 80 % cases , remains incompletely understood . METHODS : developed two mouse models harboring mutations identified human meningiomas use prostaglandin D2 synthase ( PGDS ) promoter . performed targeted DNA sequencing surgically resected CCMs patients confirmed findings droplet digital polymerase-chain-reaction analysis . RESULTS : found mice expressing one two common genetic drivers meningioma - @ GeneSrc $ H1047R AKT1 E17 K - PGDS-positive cells , spectrum typical CCMs develops ( 22 % 11 % mice , respectively ) instead meningiomas , prompted us analyze tissue samples sporadic CCMs 88 patients . detected somatic activating PIK3CA AKT1 mutations 39 % 1 % , respectively , lesion tissue patients . 10 % lesions harbored mutations CCM genes . analyzed lesions induced activating mutations @ GeneSrc $ H1074R AKT1 E17 K mice identified PGDS-expressing pericyte probable cell origin . CONCLUSIONS : tissue samples sporadic CCMs , mutations PIK3CA represented greater extent mutations gene . contribution somatic mutations genes cause familial CCMs comparatively small . ( Funded Fondation ARC pour la Recherche contre le @ DiseaseTgt $ others . ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1393889277706895)\n",
      "- Text: \"Inhibition @ GeneSrc $ isoform PI 3-kinase stimulates nonfunctional @ DiseaseTgt $ angiogenesis . Understanding direct , @ DiseaseTgt $ cell-intrinsic effects PI 3-kinase ( PI3 K ) key focus research date . , report @ DiseaseTgt $ cell-extrinsic PI3 K activity , mediated @ GeneSrc $ isoform PI3 K , contributes unexpected way @ DiseaseTgt $ angiogenesis . syngeneic mouse models , inactivation stromal @ GeneSrc $ led increased vascular density , reduced vessel size , altered pericyte coverage . increased vascularity lacked functionality , correlating enhanced @ DiseaseTgt $ hypoxia necrosis , reduced @ DiseaseTgt $ growth . role @ GeneSrc $ @ DiseaseTgt $ angiogenesis multifactorial , includes regulation proliferation DLL4 expression endothelial cells . @ GeneSrc $ @ DiseaseTgt $ stroma thus regulator vessel formation , @ GeneSrc $ inactivation giving rise nonfunctional angiogenesis , stunt @ DiseaseTgt $ growth . type vascular aberration differs vascular endothelial growth factor-centered antiangiogenesis therapies , mainly lead vascular pruning . Inhibition @ GeneSrc $ may thus offer new antiangiogenic therapeutic opportunity @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9792512551413216)\n",
      "- Text: \"Reactivation multipotency oncogenic PIK3CA induces breast tumour heterogeneity . Breast cancer frequent @ DiseaseTgt $ women consists heterogeneous types @ DiseaseTgt $ classified different histological molecular subtypes . PIK3CA P53 ( also known TP53 ) two frequently mutated genes associated different types human breast cancers . cellular origin mechanisms leading PIK3CA-induced @ DiseaseTgt $ heterogeneity remain unknown . used genetic approach mice define cellular origin @ GeneSrc $ @ DiseaseTgt $ impact mutations gene @ DiseaseTgt $ heterogeneity . Surprisingly , oncogenic @ GeneSrc $ ) mutant expression physiological levels basal cells using keratin ( K ) 5-CreER ( T2 ) mice induced formation luminal oestrogen receptor ( ER ) -positive/progesterone receptor ( PR ) -positive @ DiseaseTgt $ , expression luminal cells using K8-CReER ( T2 ) mice gave rise luminal ER ( + ) PR ( + ) tumours basal-like ER ( - ) PR ( - @ DiseaseTgt $ . Concomitant deletion p53 expression @ GeneSrc $ ) accelerated @ DiseaseTgt $ development induced aggressive mammary tumours . Interestingly , expression @ GeneSrc $ ) unipotent basal cells gave rise luminal-like cells , expression unipotent luminal cells gave rise basal-like cells progressing invasive tumours . Transcriptional profiling cells underwent cell fate transition upon @ GeneSrc $ ) expression unipotent progenitors demonstrated profound oncogene-induced reprogramming newly formed cells identified gene signatures characteristic different cell fate switches occur upon @ GeneSrc $ ) expression basal luminal cells , correlated cell origin , @ DiseaseTgt $ type different clinical outcomes . Altogether study identifies cellular origin @ GeneSrc $ @ DiseaseTgt $ reveals oncogenic @ GeneSrc $ ) activates multipotent genetic program normally lineage-restricted populations early stage @ DiseaseTgt $ initiation , setting stage future intratumoural heterogeneity . results important implications understanding mechanisms controlling @ DiseaseTgt $ heterogeneity development new strategies block @ GeneSrc $ breast cancer initiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0477125264243487)\n",
      "- Text: \"@ GeneSrc $ variants selectively initiate brain hyperactivity gliomagenesis . Glioblastoma universally lethal form brain cancer exhibits array pathophysiological phenotypes , many mediated interactions neuronal microenvironment1,2 . Recent studies shown increases neuronal activity important role proliferation progression glioblastoma3,4 . Whether reciprocal crosstalk glioblastoma neurons remains poorly defined , mechanisms underlie @ DiseaseTgt $ remodel neuronal milieu towards increased activity unknown . , using native mouse model glioblastoma , develop high-throughput vivo screening platform discover several driver variants @ GeneSrc $ . show @ DiseaseTgt $ driven variants divergent molecular properties manifest selective initiation brain hyperexcitability remodelling synaptic constituency . Furthermore , secreted members glypican ( GPC ) family selectively expressed @ DiseaseTgt $ , GPC3 drives gliomagenesis hyperexcitability . Together , studies illustrate importance functionally interrogating diverse @ DiseaseTgt $ phenotypes driven individual , yet related , variants reveal glioblastoma alters neuronal microenvironment .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7996848699973156)\n",
      "- Text: \"Critical role p110alpha @ GeneSrc $ growth metabolic regulation . eight catalytic subunits mammalian phosphoinositide-3-OH kinase ( PI ( 3 ) K ) family form backbone evolutionarily conserved signalling pathway ; however , roles PI ( 3 ) K isoforms organismal physiology disease unknown . delineate role p110alpha , ubiquitously expressed PI ( 3 ) K involved tyrosine kinase Ras signalling , generated mice carrying knockin mutation ( D933A ) abrogates p110alpha kinase activity . Homozygosity kinase-dead p110alpha led embryonic lethality . Mice heterozygous mutation viable fertile , displayed severely blunted signalling via insulin-receptor substrate ( IRS ) proteins , key mediators insulin , insulin-like growth factor-1 leptin action . Defective responsiveness hormones led reduced somatic growth , hyperinsulinaemia , glucose intolerance , hyperphagia increased adiposity mice heterozygous D933A mutation . signalling function p110alpha derives highly selective recruitment activation IRS signalling complexes compared p110beta , broadly expressed PI ( 3 ) K isoform , contribute IRS-associated PI ( 3 ) K activity . p110alpha principal IRS-associated PI ( 3 ) K @ DiseaseTgt $ cell lines . findings demonstrate critical role p110alpha growth factor metabolic signalling also suggest explanation selective mutation overexpression p110alpha variety @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001791187064917)\n",
      "- Text: \"Inhibition p110alpha isoform @ GeneSrc $ stimulates nonfunctional @ DiseaseTgt $ angiogenesis . Understanding direct , @ DiseaseTgt $ cell-intrinsic effects @ GeneSrc $ ( PI3 K ) key focus research date . , report @ DiseaseTgt $ cell-extrinsic PI3 K activity , mediated p110alpha isoform PI3 K , contributes unexpected way @ DiseaseTgt $ angiogenesis . syngeneic mouse models , inactivation stromal p110alpha led increased vascular density , reduced vessel size , altered pericyte coverage . increased vascularity lacked functionality , correlating enhanced @ DiseaseTgt $ hypoxia necrosis , reduced @ DiseaseTgt $ growth . role p110alpha @ DiseaseTgt $ angiogenesis multifactorial , includes regulation proliferation DLL4 expression endothelial cells . p110alpha @ DiseaseTgt $ stroma thus regulator vessel formation , p110alpha inactivation giving rise nonfunctional angiogenesis , stunt @ DiseaseTgt $ growth . type vascular aberration differs vascular endothelial growth factor-centered antiangiogenesis therapies , mainly lead vascular pruning . Inhibition p110alpha may thus offer new antiangiogenic therapeutic opportunity @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9781975483867608)\n",
      "- Text: \"@ DiseaseTgt $ chemoprevention antioxidant tempol acts partially via p53 @ DiseaseTgt $ suppressor . previously demonstrated nitroxide antioxidant tempol ( 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl ) increased latency tumorigenesis doubled ( 100 % ) lifespan Atm-deficient mice , mouse model ataxia telangiectasia , displays accelerated oxidative damage stress . Tempol treatment @ DiseaseTgt $ p53-deficient mice resulted small significant ( 25 % ) increase lifespan prolonging latency tumorigenesis , demonstrating existing oxidative stress damage necessary chemopreventative effects tempol . However , relatively small effect latency p53-deficient mice finding tempol-mediated resistance oxidative insult p53-dependent suggested direct role p53 chemopreventative effects tempol . Surprisingly , tempol treatment specifically increased serine 18 phosphorylation p53 ( gamma-H2AX ) p21 expression primary thymocytes vitro p53-dependent fashion . Inhibition @ GeneSrc $ ( PI3 K ) family members suggested SMG-1 responsible tempol-mediated enhancement p53 serine 18 phosphorylation . data suggest chemopreventative effect tempol solely due reduction oxidative stress damage may also related redox-mediated signaling functions include p53 pathway activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1310074876543853)\n",
      "- Text: \"regulated interaction UIM protein Eps15 implicates parkin EGF receptor trafficking PI ( 3 ) K-Akt signalling . Mutations parkin gene responsible common familial form @ DiseaseTgt $ . parkin encodes E3 ubiquitin ligase , defects proteasome-mediated protein degradation believed central role pathogenesis @ DiseaseTgt $ . , report novel role parkin proteasome-independent ubiquitination pathway . identified regulated interaction parkin Eps15 , adaptor protein involved epidermal growth factor ( EGF ) receptor ( EGFR ) endocytosis trafficking . Treatment cells EGF stimulates parkin binding Eps15 EGFR promotes parkin-mediated ubiquitination Eps15 . Binding parkin ubiquitin-like ( Ubl ) domain Eps15 ubiquitin-interacting motifs ( UIMs ) required parkin-mediated Eps15 ubiquitination . Furthermore , EGFR endocytosis degradation accelerated parkin-deficient cells , EGFR signalling via @ GeneSrc $ ( PI ( 3 ) K ) -Akt pathway reduced parkin knockout mouse brain . propose ubiquitinating Eps15 , parkin interferes ability Eps15 UIMs bind ubiquitinated EGFR , thereby delaying EGFR internalization degradation , promoting PI ( 3 ) K-Akt signalling . Considering role Akt neuronal survival , results broad new implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018438657887326)\n",
      "- Text: \"Fyn kinase regulates misfolded alpha-synuclein uptake NLRP3 inflammasome activation microglia . Persistent microglia-mediated neuroinflammation major pathophysiological contributor progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) , cell-signaling mechanisms governing chronic neuroinflammation well understood . , show Fyn kinase , conjunction class B scavenger receptor CD36 , regulates microglial uptake aggregated human alpha-synuclein ( alphaSyn ) , major component @ DiseaseTgt $ . alphaSyn effectively mediate LPS-independent priming activation microglial NLRP3 inflammasome . Fyn kinase regulates processes ; mediates @ GeneSrc $ NF-kappaB-p65 nuclear translocation , leading inflammasome priming , facilitates alphaSyn import microglia , contributing generation mitochondrial reactive oxygen species consequently inflammasome activation . vivo experiments using A53 viral-alphaSyn overexpression mouse models well human @ DiseaseTgt $ neuropathological results confirm role Fyn NLRP3 inflammasome activation . Collectively , study identifies novel Fyn-mediated signaling mechanism amplifies neuroinflammation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0078121033005658)\n",
      "- Text: \"@ GeneSrc $ increases endothelin converting enzyme activity reduces amyloid plaque pathology transgenic mice . Deposition plaques containing amyloid beta ( Abeta ) peptides neuropathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate neuronal overexpression epsilon isozyme PKC decreases Abeta levels , plaque burden , plaque-associated neuritic dystrophy reactive astrocytosis transgenic mice expressing @ DiseaseTgt $ forms human amyloid precursor protein ( APP ) . Compared APP singly transgenic mice , @ GeneSrc $ doubly transgenic mice decreased Abeta levels showed evidence altered cleavage APP . Instead , @ GeneSrc $ overexpression selectively increased activity endothelin-converting enzyme , degrades Abeta . activities Abeta-degrading enzymes , insulin degrading enzyme neprilysin , unchanged . results indicate increased neuronal @ GeneSrc $ activity promote Abeta clearance reduce @ DiseaseTgt $ neuropathology increased endothelin-converting enzyme activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2158871126466894)\n",
      "- Text: \"Genetic identification @ GeneSrc $ , major modifier locus affecting Min-induced intestinal neoplasia mouse . Mutations human APC gene caused various familial @ DiseaseTgt $ . Multiple intestinal neoplasia ( Min ) mouse provides excellent model familial @ DiseaseTgt $ : carries mutant mouse Apc gene develops many intestinal adenomas . , analyze tumor phenotype dramatically modified genetic background . report genetic mapping locus strongly modifies tumor number Min/+ animals . gene , @ GeneSrc $ ( Modifier Min-1 ) , maps distal chromosome 4 controls 50 % genetic variation tumor number two intraspecific backcrosses . mapping supported LOD score exceeding 14 . Interestingly , @ GeneSrc $ lies region synteny conservation human chromosome 1p35 - 36 , region frequent somatic loss heterozygosity variety human tumors , including colon tumors . results provide evidence major modifier affecting expression inherited cancer syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0527916705251698)\n",
      "- Text: \"Elevated amyloid beta protein ( Abeta42 ) late onset @ DiseaseTgt $ associated single nucleotide polymorphisms @ GeneSrc $ gene . Plasma amyloid beta protein ( Abeta42 ) levels late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) linked region chromosome 10q . @ GeneSrc $ gene within region encodes @ GeneSrc $ , converts plasminogen plasmin . Abeta aggregates induce @ GeneSrc $ expression thereby increasing plasmin , degrades aggregated non-aggregated forms Abeta . evaluated single nucleotide polymorphisms ( SNPs ) @ GeneSrc $ association Abeta42 @ DiseaseTgt $ . @ GeneSrc $ SNP compound genotypes composed haplotype pairs showed significant association @ DiseaseTgt $ three independent case-control series . @ GeneSrc $ SNP haplotypes associated significantly plasma Abeta42 10 extended @ DiseaseTgt $ families . One SNPs analyzed missense C/T polymorphism exon 6 @ GeneSrc $ ( PLAU_1=rs2227564 ) , causes proline leucine change ( P141L ) . analyzed PLAU_1 association @ DiseaseTgt $ six case-control series 24 extended @ DiseaseTgt $ families . CT TT PLAU_1 genotypes showed association ( P=0.05 ) overall estimated odds ratio 1.2 ( 1.0 - 1.5 ) . CT TT genotypes PLAU_1 also associated significant age-dependent elevation plasma Abeta42 24 extended @ DiseaseTgt $ families ( P=0.0006 ) . knockout mice lacking @ GeneSrc $ gene , plasma -- brain -- Abeta42 well Abeta40 significantly elevated , also age-dependent manner . PLAU_1 associations independent associations found among plasma Abeta42 , @ DiseaseTgt $ variants IDE VR22 region . results provide strong evidence @ GeneSrc $ nearby gene involved development @ DiseaseTgt $ . PLAU_1 plausible pathogenic mutation could act increasing Abeta42 , additional biological experiments required show definitively .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3755490637810149)\n",
      "- Text: \"Elevated amyloid beta protein ( Abeta42 ) late onset @ DiseaseTgt $ associated single nucleotide polymorphisms urokinase-type plasminogen activator gene . Plasma amyloid beta protein ( Abeta42 ) levels late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) linked region chromosome 10q . PLAU gene within region encodes urokinase-type plasminogen activator , converts @ GeneSrc $ plasmin . Abeta aggregates induce PLAU expression thereby increasing plasmin , degrades aggregated non-aggregated forms Abeta . evaluated single nucleotide polymorphisms ( SNPs ) PLAU association Abeta42 @ DiseaseTgt $ . PLAU SNP compound genotypes composed haplotype pairs showed significant association @ DiseaseTgt $ three independent case-control series . PLAU SNP haplotypes associated significantly plasma Abeta42 10 extended @ DiseaseTgt $ families . One SNPs analyzed missense C/T polymorphism exon 6 PLAU ( PLAU_1=rs2227564 ) , causes proline leucine change ( P141L ) . analyzed PLAU_1 association @ DiseaseTgt $ six case-control series 24 extended @ DiseaseTgt $ families . CT TT PLAU_1 genotypes showed association ( P=0.05 ) overall estimated odds ratio 1.2 ( 1.0 - 1.5 ) . CT TT genotypes PLAU_1 also associated significant age-dependent elevation plasma Abeta42 24 extended @ DiseaseTgt $ families ( P=0.0006 ) . knockout mice lacking PLAU gene , plasma -- brain -- Abeta42 well Abeta40 significantly elevated , also age-dependent manner . PLAU_1 associations independent associations found among plasma Abeta42 , @ DiseaseTgt $ variants IDE VR22 region . results provide strong evidence PLAU nearby gene involved development @ DiseaseTgt $ . PLAU_1 plausible pathogenic mutation could act increasing Abeta42 , additional biological experiments required show definitively .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0067862053575235)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model @ GeneSrc $ loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show @ GeneSrc $ deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate @ GeneSrc $ specifically recruits Akt phosphatase PP2a well pAkt @ GeneSrc $ nuclear bodies . Notably , find @ GeneSrc $ cells impaired PP2a phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction @ GeneSrc $ dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor p27 ( kip1 ) . results demonstrate @ GeneSrc $ orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1419328757118617)\n",
      "- Text: \"PML/RARalpha FLT3-ITD induce APL-like disease mouse model . Acute promyelocytic leukemia ( APL ) cells invariably express aberrant fusion proteins involving retinoic acid receptor alpha ( RARalpha ) . common fusion partner @ GeneSrc $ ( @ GeneSrc $ ) , fused RARalpha balanced reciprocal chromosomal translocation , ( 15 ; 17 ) ( q22 : q11 ) . Expression PML/RARalpha cathepsin G promoter transgenic mice causes nonfatal myeloproliferative syndrome mice ; 15 % go develop APL long latent period , suggesting additional mutations required development APL . candidate target gene second mutation FLT3 , mutated approximately 40 % human APL cases . Activating mutations FLT3 , including internal tandem duplication ( ITD ) juxtamembrane domain , transform hematopoietic cell lines factor independent growth . FLT3-ITDs also induce myeloproliferative disease murine bone marrow transplant model , sufficient cause @ DiseaseTgt $ . , test hypothesis PML/RARalpha cooperate FLT3-ITD induce APL-like disease mouse . Retroviral transduction FLT3-ITD bone marrow cells obtained PML/RARalpha transgenic mice results short latency APL-like disease complete penetrance . disease resembles APL-like disease occurs long latency PML/RARalpha transgenics , suggesting activating mutations FLT3 functionally substitute additional mutations occur mouse APL progression . leukemia transplantable secondary recipients ATRA responsive . observations document cooperation PML/RARalpha FLT3-ITD development murine APL phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0090626188142309)\n",
      "- Text: \"@ GeneSrc $ FLT3-ITD induce APL-like disease mouse model . Acute promyelocytic leukemia ( APL ) cells invariably express aberrant fusion proteins involving retinoic acid receptor alpha ( RARalpha ) . common fusion partner promyelocytic leukemia protein ( PML ) , fused RARalpha balanced reciprocal chromosomal translocation , ( 15 ; 17 ) ( q22 : q11 ) . Expression @ GeneSrc $ cathepsin G promoter transgenic mice causes nonfatal myeloproliferative syndrome mice ; 15 % go develop APL long latent period , suggesting additional mutations required development APL . candidate target gene second mutation FLT3 , mutated approximately 40 % human APL cases . Activating mutations FLT3 , including internal tandem duplication ( ITD ) juxtamembrane domain , transform hematopoietic cell lines factor independent growth . FLT3-ITDs also induce myeloproliferative disease murine bone marrow transplant model , sufficient cause @ DiseaseTgt $ . , test hypothesis @ GeneSrc $ cooperate FLT3-ITD induce APL-like disease mouse . Retroviral transduction FLT3-ITD bone marrow cells obtained @ GeneSrc $ transgenic mice results short latency APL-like disease complete penetrance . disease resembles APL-like disease occurs long latency @ GeneSrc $ transgenics , suggesting activating mutations FLT3 functionally substitute additional mutations occur mouse APL progression . leukemia transplantable secondary recipients ATRA responsive . observations document cooperation @ GeneSrc $ FLT3-ITD development murine APL phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0373197962897057)\n",
      "- Text: \"MLH3 : DNA mismatch repair gene associated mammalian microsatellite instability . DNA mismatch repair important role maintaining genomic integrity association hereditary non-polyposis colon cancer ( HNPCC ) . identify new human mismatch repair proteins , probed nuclear extracts conserved carboxy-terminal MLH1 interaction domain . describe cloning complete genomic sequence MLH3 , encodes new DNA mismatch repair protein interacts MLH1 . MLH3 similar mismatch repair proteins yeast , plants , worms bacteria known mammalian protein , suggesting conserved sequence may confer unique functions mice humans . Cells culture stably expressing dominant-negative MLH3 protein exhibit microsatellite instability . Mlh3 highly expressed gastrointestinal epithelium physically maps mouse complex trait locus colon cancer susceptibility ( Ccs1 ) . Although unable identify mutation protein-coding region Mlh3 susceptible mouse strain , colon tumours congenic Ccs1 mice exhibit microsatellite instability . Functional redundancy among Mlh3 , Pms1 @ GeneSrc $ may explain neither Pms1 @ GeneSrc $ mutant mice develop @ DiseaseTgt $ , PMS1 @ GeneSrc $ mutations rarely found HNPCC families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.302147889407146e-05)\n",
      "- Text: \"@ GeneSrc $ , component presynaptic scaffold Lewy bodies , required suppression alpha-synuclein neurotoxicity . @ DiseaseTgt $ ( @ DiseaseTgt $ ) , alpha-synuclein aggregates called Lewy bodies often involve sequester @ GeneSrc $ ( @ GeneSrc $ ) , polymerizing scaffold protein . However , pathophysiological significance phenomenon unclear . , show physiological association @ GeneSrc $ alpha-synuclein , dopamine transporter , presynaptic proteins dopaminergic neurons ; mice lacking @ GeneSrc $ exhibit diminished dopaminergic neurotransmission due scarcity presynaptic proteins . data demonstrate important role septin scaffolds brain . transgenic mice express human alpha-synuclein ( A53 ) ( mutant protein responsible familial PD ) , loss @ GeneSrc $ significantly enhances neuropathology locomotor deterioration . @ DiseaseTgt $ model , insoluble deposits Ser129-phosphorylated alpha-synuclein ( A53 ) negatively correlated dosage @ GeneSrc $ . vitro , direct association @ GeneSrc $ protects alpha-synuclein self-aggregation Ser129 phosphorylation . Taken together , data show @ GeneSrc $ may involved @ DiseaseTgt $ dual susceptibility factor , insufficiency diminish dopaminergic neurotransmission enhance alpha-synuclein neurotoxicity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8131516223628433)\n",
      "- Text: \"Linking p53 @ DiseaseTgt $ suppressor pathway somatic cell reprogramming . Reprogramming somatic cells induced pluripotent stem ( iPS ) cells accomplished expressing pluripotency factors oncogenes , low frequency tendency induce malignant transformation compromise clinical utility powerful approach . address issues investigating mechanisms limiting reprogramming efficiency somatic cells . show reprogramming factors activate p53 ( also known Trp53 mice , TP53 humans ) pathway . Reducing signalling p53 expressing mutated version one negative regulators , deleting knocking p53 target gene , p21 ( also known Cdkn1a ) , antagonizing reprogramming-induced apoptosis mouse fibroblasts increases reprogramming efficiency . Notably , decreasing p53 protein levels enabled fibroblasts give rise iPS cells capable generating germline-transmitting chimaeric mice using @ GeneSrc $ ( also known @ GeneSrc $ ) Sox2 . Furthermore , silencing p53 significantly increased reprogramming efficiency human somatic cells . results provide insights reprogramming mechanisms suggest new routes efficient reprogramming minimizing use oncogenes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.214043428495856e-06)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors @ GeneSrc $ ( also known @ GeneSrc $ ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.4929631359217704e-05)\n",
      "- Text: \"survey @ GeneSrc $ sequence variation confirms association dementia . others conducted targeted genetic association analyses @ GeneSrc $ relation @ DiseaseTgt $ risk resultant mixture support refutation , previous studies based upon markers . , detailed survey genetic variation @ GeneSrc $ region performed total 1,567 Swedish dementia cases ( including 1,275 @ DiseaseTgt $ ) 2,203 controls , providing evidence association maximum significance marker rs2230805 ( odds ratio [ ] =1.39 ; 95 % confidence interval [ CI ] 1.23 - 1.57 , p=7.7x10 ( -8 ) ) . Haplotype-based tests confirmed association genomic region excluding rs2230805 , imputation reveal additional markers greater support . Significantly associating markers reside two distinct linkage disequilibrium blocks maxima near promoter terminal exon truncated @ GeneSrc $ splice form . putative risk allele rs2230805 also found associated reduced cerebrospinal fluid levels beta-amyloid . strongest evidence association obtained forms dementia considered together , effect sizes similar confirmed @ DiseaseTgt $ cases assessed . Results implicate @ GeneSrc $ dementia , reinforcing putative involvement lipid transport neurodegenerative disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0674476955326034)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association @ GeneSrc $ ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , MLXIPL , PCSK9 , GALNT2 GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0011251641520957)\n",
      "- Text: \"ApoE-directed therapeutics rapidly clear beta-amyloid reverse deficits @ DiseaseTgt $ mouse models . @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated impaired clearance beta-amyloid ( Abeta ) brain , process normally facilitated apolipoprotein E ( apoE ) . ApoE expression transcriptionally induced action nuclear receptors @ GeneSrc $ liver X receptors coordination retinoid X receptors ( RXRs ) . Oral administration RXR agonist bexarotene mouse model @ DiseaseTgt $ resulted enhanced clearance soluble Abeta within hours apoE-dependent manner . Abeta plaque area reduced 50 % within 72 hours . Furthermore , bexarotene stimulated rapid reversal cognitive , social , olfactory deficits improved neural circuit function . Thus , RXR activation stimulates physiological Abeta clearance mechanisms , resulting rapid reversal broad range Abeta-induced deficits .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016796266693516)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits Akt phosphatase @ GeneSrc $ well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired @ GeneSrc $ phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor p27 ( kip1 ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0626193736351801)\n",
      "- Text: \"Synphilin-1 attenuates neuronal degeneration A53 alpha-synuclein transgenic mouse model . Genetic alterations alpha-synuclein cause autosomal dominant familial Parkinsonism may contribute sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Synphilin-1 alpha-synuclein-interacting protein , implications @ DiseaseTgt $ pathogenesis related protein aggregation . Currently , vivo role synphilin-1 alpha-synuclein-linked pathogenesis fully understood . Using mouse @ GeneSrc $ promoter , generated synphilin-1 transgenic mice , display @ DiseaseTgt $ phenotypes . However , synphilin-1/A53 alpha-synuclein double-transgenic mice survived longer A53 alpha-synuclein single-transgenic mice . attenuated A53 alpha-synuclein-induced motor abnormalities decreased astroglial reaction neuronal degeneration brains double-transgenic mice . Overexpression synphilin-1 decreased caspase-3 activation , increased beclin-1 LC3 II expression promoted formation aggresome-like structures , suggesting synphilin-1 alters multiple cellular pathways protect neuronal degeneration . studies demonstrate synphilin-1 diminish severity alpha-synucleinopathy play neuroprotective role A53 alpha-synuclein toxicity vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0078974282174707)\n",
      "- Text: \"Candidate gene chromosome 1 familial @ DiseaseTgt $ locus . candidate gene chromosome 1 @ DiseaseTgt $ ( @ DiseaseTgt $ ) locus identified ( STM2 ) . predicted amino acid sequence STM2 homologous recently cloned chromosome 14 @ DiseaseTgt $ gene ( S182 ) . point mutation STM2 , resulting substitution isoleucine asparagine ( N141l ) , identified affected people Volga German @ DiseaseTgt $ kindreds . N141l mutation occurs amino acid residue conserved human S182 mouse @ GeneSrc $ homolog . presence missense mutations @ DiseaseTgt $ subjects two highly similar genes strongly supports hypothesis mutations pathogenic .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0151757730933093)\n",
      "- Text: \"Increased amyloid-beta42 ( 43 ) brains mice expressing mutant @ GeneSrc $ . Mutations genes encoding amyloid-beta precursor protein ( APP ) , @ GeneSrc $ ( @ GeneSrc $ ) presenilin 2 ( PS2 ) known cause early-onset , autosomal dominant @ DiseaseTgt $ . Studies plasma fibroblasts subjects mutations established alter amyloid beta-protein ( beta APP ) processing , normally leads secretion amyloid-beta protein ( relative molecular mass 4,000 ; ( r ) 4 K ; approximately 90 % beta1 - 40 , approximately 10 % beta1 - 42 ( 43 ) ) , extracellular concentration beta42 ( 43 ) increased . increase beta42 ( 43 ) believed critical change initiates @ DiseaseTgt $ pathogenesis beta42 ( 43 ) deposited early selectively senile plaques observed brains patients forms disease . establish presenilin mutations increase amount beta42 ( 43 ) brain test whether presenilin mutations act true ( gain function ) dominants , constructed mice expressing wild-type mutant presenilin genes . Analysis mice showed overexpression mutant , wild-type , @ GeneSrc $ selectively increases brain beta42 ( 43 ) . results indicate presenilin mutations probably cause @ DiseaseTgt $ gain deleterious function increases amount beta42 ( 43 ) brain .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8186869860625768)\n",
      "- Text: \"@ DiseaseTgt $ @ GeneSrc $ variants elevate Abeta1 - 42/1 - 40 ratio vitro vivo . Mutations @ GeneSrc $ ( @ GeneSrc $ ) presenilin 2 genes cosegregate majority early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . document Abeta1 - 42 ( 43 ) /Abeta1 - 40 ratio conditioned media independent N2a cell lines expressing three @ DiseaseTgt $ @ GeneSrc $ variants uniformly elevated relative cells expressing similar levels wild-type @ GeneSrc $ . Similarly , Abeta1 - 42 ( 43 ) /Abeta1 - 40 ratio elevated brains young transgenic animals coexpressing chimeric amyloid precursor protein ( APP ) @ DiseaseTgt $ PS1 variant compared brains transgenic mice expressing APP alone transgenic mice coexpressing wild-type human PS1 APP . studies provide compelling support view one mechanism mutant @ GeneSrc $ cause @ DiseaseTgt $ increasing extracellular concentration Abeta peptides terminating 42 ( 43 ) , species foster Abeta deposition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.988819962414476)\n",
      "- Text: \"Mutant presenilins @ DiseaseTgt $ increase production 42-residue amyloid beta-protein transfected cells transgenic mice . mechanism mutations presenilin ( PS ) genes cause aggressive form early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) unknown , fibroblasts mutation carriers secrete increased levels amyloidogenic beta 42 peptide , main component @ DiseaseTgt $ plaques . established transfected cell transgenic mouse models coexpress human PS amyloid beta-protein precursor ( APP ) genes analyzed quantitatively effects PS expression APP processing . models , expression wild-type PS genes alter APP levels , alpha- beta-secretase activity beta production . transfected cells , @ GeneSrc $ PS2 mutations caused highly significant increase beta 42 secretion mutant clones . Likewise , mutant wildtype @ GeneSrc $ transgenic mice showed significant overproduction beta 42 brain , effect detectable early 2 - 4 months age . Different PS mutations differential effects beta generation . extent beta 42 increase correlate presenilin expression levels . data demonstrate presenilin mutations cause dominant gain function may induce @ DiseaseTgt $ enhancing beta 42 production , thus promoting cerebral beta-amyloidosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.985686615086024)\n",
      "- Text: \"Skeletal CNS defects @ GeneSrc $ mice . @ GeneSrc $ ( @ GeneSrc $ ) major gene responsible early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . understand normal function @ GeneSrc $ , generated targeted null mutation murine homolog @ GeneSrc $ . report @ GeneSrc $ mice die shortly natural birth Caesarean section . skeleton homozygous mutants grossly deformed . Hemorrhages occur CNS @ GeneSrc $ null mutants varying location , severity , time onset . ventricular zone @ GeneSrc $ brains markedly thinner embryonic day 14.5 , indicating impairment neurogenesis . Bilateral cerebral cavitation caused massive neuronal loss specific subregions mutant brain prominent embryonic day 16.5 . results show @ GeneSrc $ required proper formation axial skeleton , normal neurogenesis , neuronal survival .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3920933023241646)\n",
      "- Text: \"Deficiency presenilin-1 inhibits normal cleavage amyloid precursor protein . Point mutations @ GeneSrc $ gene ( PS1 ) major cause @ DiseaseTgt $ . result selective increase production amyloidogenic peptide amyloid-beta ( 1 - 42 ) proteolytic processing amyloid precursor protein ( APP ) . investigate whether PS1 also involved normal APP processing neuronal cultures derived PS1-deficient mouse embryos . Cleavage alpha- beta-secretase extracellular domain APP affected absence PS1 , whereas cleavage gamma-secretase transmembrane domain APP prevented , causing carboxyl-terminal fragments APP accumulate fivefold drop production amyloid peptide . Pulse-chase experiments indicated PS1 deficiency specifically decreased turnover membrane-associated fragments APP . regulation cholesterol metabolism proteolysis membrane-bound transcription factor , PS1 appears facilitate proteolytic activity cleaves integral membrane domain APP . results indicate mutations PS1 manifest clinically cause gain function inhibition PS1 activity potential target anti-amyloidogenic therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.71496638748227)\n",
      "- Text: \"@ DiseaseTgt $ PS1 variant rescues developmental abnormalities PS1-deficient embryos . Mutations @ GeneSrc $ ( @ GeneSrc $ ) cosegregate approximately 25 % early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . variety vitro vivo paradigms established one mechanism PS1 variants cause @ DiseaseTgt $ elevating production highly amyloidogenic Abeta1 - 42/43 peptides . PS1 homologous sel-12 , C. elegans protein facilitates signaling mediated Notch/lin-12 family receptors . Wild-type human PS1 complements egg-laying defect C. elegans lacking sel-12 , @ DiseaseTgt $ PS1 variants exhibit reduced rescue activity . data suggested mutant PS1 may cause disease result reduction PS1 function . test function @ DiseaseTgt $ PS1 mammals , examined ability A246E PS1 variant complement embryonic lethality axial skeletal defects mice lacking @ GeneSrc $ . Finally , examine influence reduced @ GeneSrc $ levels Abeta production , quantified Abeta1 - 42/43 peptide levels @ GeneSrc $ heterozygous null mice ( @ GeneSrc $ ] mice ) . report human wild-type A246E PS1 efficiently rescue phenotypes observed PS1 ( -/- ) embryos , findings consistent view @ DiseaseTgt $ PS1 mutants retain sufficient normal function mammalian embryonic development . Moreover , levels Abeta1 - 42/43 Abeta1 - 40 peptides PS1 ( +/- ) control mice indistinguishable . Collectively , data lead us conclude mutant PS1 causes @ DiseaseTgt $ loss normal PS1 function influencing amyloid precursor protein ( APP ) processing manner elevates Abeta1 - 42/43 production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.951650595953934)\n",
      "- Text: \"Mutant human presenilin 1 protects presenilin 1 null mouse embryonic lethality elevates Abeta1 - 42/43 expression . Mutations presenilin 1 ( PS1 ) linked early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) shown foster production Abeta1 - 42/43 @ DiseaseTgt $ patients transgenic mice . @ GeneSrc $ null mice embryonic lethal exhibit axial skeleton malformation CNS defects . show transgenic mouse lines expressing either wild-type human PS1 protein human PS1 A246E @ DiseaseTgt $ mutation rescue PS1 knockout mouse embryonic lethality similar degrees , indicating mutation lead loss PS1 function development . Furthermore , 50 % reduction @ GeneSrc $ activity @ GeneSrc $ ) mice lead Abeta1 - 42/43 increase , whereas expression human mutant PS1 murine @ GeneSrc $ null background sufficient elevate Abeta1 - 42/43 , supporting gain-of-function activity result PS1 mutation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1299008754301021)\n",
      "- Text: \"Two transmembrane aspartates @ GeneSrc $ required presenilin endoproteolysis gamma-secretase activity . Accumulation amyloid-beta protein ( Abeta ) cerebral cortex early invariant event pathogenesis @ DiseaseTgt $ . final step generation Abeta beta-amyloid precursor protein apparently intramembranous proteolysis elusive gamma-secretase ( ) . common cause familial @ DiseaseTgt $ mutation genes encoding presenilins 1 2 , alters gamma-secretase activity increase production highly amyloidogenic Abeta42 isoform . Moreover , deletion @ GeneSrc $ mice greatly reduces gamma-secretase activity , indicating @ GeneSrc $ mediates proteolytic event . report mutation either two conserved transmembrane ( TM ) aspartate residues @ GeneSrc $ , Asp 257 ( TM6 ) Asp 385 ( TM7 ) , substantially reduces Abeta production increases amounts carboxy-terminal fragments beta-amyloid precursor protein substrates gamma-secretase . observed effects three different cell lines well cell-free microsomes . Either Asp -- > Ala mutations also prevented normal endoproteolysis @ GeneSrc $ TM6 -- > TM7 cytoplasmic loop . functional @ GeneSrc $ variant ( carrying deletion exon 9 ) associated familial @ DiseaseTgt $ require cleavage , Asp 385 -- > Ala mutation still inhibited gamma-secretase activity . results indicate two transmembrane aspartate residues critical @ GeneSrc $ endoproteolysis gamma-secretase activity , suggest @ GeneSrc $ either unique diaspartyl cofactor gamma-secretase gamma-secretase , autoactivated intramembranous aspartyl protease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4907541899844821)\n",
      "- Text: \"Presenilin 2 deficiency causes mild pulmonary phenotype changes amyloid precursor protein processing enhances embryonic lethal phenotype presenilin 1 deficiency . Mutations homologous @ GeneSrc $ ( @ GeneSrc $ ) presenilin 2 ( PS2 ) genes cause common aggressive form familial @ DiseaseTgt $ . Although @ GeneSrc $ function dysfunction extensively studied , little known function PS2 vivo . delineate relationships PS2 @ GeneSrc $ activities whether PS2 mutations involve gain loss function , generated PS2 homozygous deficient ( -/- ) @ GeneSrc $ double homozygous deficient mice . contrast @ GeneSrc $ ) mice , PS2 ( -/- ) mice viable fertile develop mild pulmonary fibrosis hemorrhage age . Absence PS2 detectably alter processing amyloid precursor protein little effect physiologically important apoptotic processes , indicating @ DiseaseTgt $ mutations PS2 , @ GeneSrc $ , result gain function . Although @ GeneSrc $ ) PS2 ( -/- ) mice survive relatively good health , complete deletion PS2 @ GeneSrc $ genes causes phenotype closely resembling full Notch-1 deficiency . results demonstrate vivo @ GeneSrc $ PS2 partially overlapping functions @ GeneSrc $ essential PS2 redundant normal Notch signaling mammalian embryological development .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9857182905768496)\n",
      "- Text: \"Mice lacking presenilin genes exhibit early embryonic patterning defects . Genetic studies worms , flies , humans implicated presenilins regulation Notch signaling pathway pathogenesis @ DiseaseTgt $ . two highly homologous presenilin genes mammals , @ GeneSrc $ ( @ GeneSrc $ ) presenilin 2 ( PS2 ) . mice , inactivation @ GeneSrc $ leads developmental defects culminate perinatal lethality . test possibility late lethality @ GeneSrc $ mice reflects genetic redundancy presenilins , generated PS2-null mice gene targeting , subsequently , @ GeneSrc $ double-null mice . Mice homozygous targeted null mutation PS2 exhibit obvious defects ; however , loss PS2 @ GeneSrc $ background leads embryonic lethality embryonic day 9.5 . Embryos lacking presenilins , surprisingly , carrying single copy PS2 @ GeneSrc $ background , exhibit multiple early patterning defects , including lack somite segmentation , disorganization trunk ventral neural tube , midbrain mesenchyme cell loss , anterior neuropore closure delays , abnormal heart second branchial arch development . addition , Delta like-1 ( Dll1 ) Hes-5 , two genes lie downstream Notch pathway , misexpressed presenilin double-null embryos : Hes-5 expression undetectable mice , whereas Dll1 expressed ectopically neural tube brain double-null embryos . conclude presenilins play widespread role embryogenesis , functional redundancy @ GeneSrc $ PS2 , vertebrate presenilins , like invertebrate homologs , essential Notch signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0878578606395673)\n",
      "- Text: \"Photoactivated gamma-secretase inhibitors directed active site covalently label presenilin 1 . Cleavage amyloid precursor protein ( APP ) beta- gamma-secretases generates amino carboxy termini , respectively , beta amyloidogenic peptides beta40 beta42 - -the major constituents amyloid plaques brain parenchyma @ DiseaseTgt $ patients . evidence polytopic membrane-spanning proteins , presenilin 1 2 ( PS1 PS2 ) , important determinants gamma-secretase activity : mutations PS1 PS2 associated early-onset familial @ DiseaseTgt $ increase production beta42 ( refs 4 - 6 ) , amyloidogenic peptide ; gamma-secretase activity reduced neuronal cultures derived @ GeneSrc $ mouse embryos ; directed mutagenesis two conserved aspartates transmembrane segments @ GeneSrc $ inactivates ability gamma-secretase catalyse processing APP within transmembrane domain . unknown , however , whether PS1 ( little homology known aspartyl protease ) transmembrane aspartyl protease gamma-secretase cofactor , helps colocalize gamma-secretase APP . report photoaffinity labelling PS1 ( PS2 ) potent gamma-secretase inhibitors designed function transition state analogue inhibitors directed active site aspartyl protease . observation indicates PS1 ( PS2 ) may contain active site gamma-secretase . Interestingly , intact , single-chain form wild-type PS1 labelled active-site-directed photoaffinity probe , suggesting intact wild-type PS1 may aspartyl protease zymogen .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.169997039374823)\n",
      "- Text: \"@ GeneSrc $ regulates neuronal threshold excitotoxicity physiologically pathologically . direct pathophysiological role @ DiseaseTgt $ @ DiseaseTgt $ @ GeneSrc $ ( @ GeneSrc $ ) mutations neuronal vulnerability remains controversial matter . evaluated relationship PS1 excitotoxicity four different experimental models neurotoxicity using primary neurons ( ) transgenic ( tg ) mice overexpressing human @ DiseaseTgt $ PS1 variant ( L286V mutation ) , ( ii ) tg mice overexpressing human wild-type ( wt ) PS1 , ( iii ) @ GeneSrc $ knockout mice , ( iv ) wt mice @ GeneSrc $ gene expression knocked antisense treatment . found primary neurons overexpressing mutated PS1 showed increased vulnerability excitotoxic hypoxic-hypoglycemic damage compared neurons obtained either mice overexpressing human wt PS1 wt mice . addition , reduced excitotoxic damage obtained neurons PS1 expression absent diminished . Data obtained vivo experimental models excitotoxicity partially supported vitro observations . Accelerated neuronal death demonstrated hippocampus mice overexpressing mutated @ GeneSrc $ peripheral administration kainic acid comparison wt animals . However , measurement infarct volume middle cerebral artery occlusion show significant difference two animal groups . results altogether suggest expression @ DiseaseTgt $ PS1 variants increases vulnerability neurons specific type damage excitotoxicity plays relevant role . addition , support view reduction endogenous @ GeneSrc $ expression results neuroprotection .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4340223310303553)\n",
      "- Text: \"Loss @ GeneSrc $ associated enhanced beta-catenin signaling skin tumorigenesis . @ GeneSrc $ ( PS1 ) required proteolytic processing Notch beta-amyloid precursor protein ( APP ) , molecules play pivotal roles cell-fate determination development @ DiseaseTgt $ pathogenesis , respectively . addition , PS1 interacts beta-catenin promotes turnover independent mechanisms . Consistent activity , report PS1 important controlling epidermal cell proliferation vivo . PS1 knockout mice rescued neuronal expression human PS1 transgene develop spontaneous skin cancers . PS1-null keratinocytes exhibit higher cytosolic beta-catenin beta-catenin/lymphoid enhancer factor-1/T cell factor ( beta-catenin/LEF ) -mediated signaling . effect reversed reintroducing wild-type PS1 , PS1 mutant active Notch processing defective beta-catenin binding . Nuclear beta-catenin protein detected tumors . Elevated beta-catenin/LEF signaling correlated activation downstream target cyclin D1 accelerated entry G ( 1 ) phase cell cycle . report demonstrates function PS1 adult tissues , analysis suggests deregulation beta-catenin pathway contributes skin tumor phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039596230616945)\n",
      "- Text: \"Accelerated plaque accumulation , associative learning deficits , up-regulation alpha 7 nicotinic receptor protein transgenic mice co-expressing mutant human presenilin 1 amyloid precursor proteins . @ DiseaseTgt $ mutations presenilin 1 2 amyloid precursor protein result elevated beta-amyloid , beta-amyloid accumulation , plaque formation brains affected individuals . crossing @ GeneSrc $ transgenic mice carrying A246E mutation plaque-producing amyloid precursor protein K670N/M671L transgenic mice ( Tg2576 ) , show co-expression mutant transgenes results acceleration amyloid accumulation associative learning deficits . 5 months age detectable plaque pathology , amyloid precursor protein transgenic animals impaired contextual fear learning following two pairings conditioned unconditioned stimuli appear normal following robust five-pairing training . 9 months age beta-amyloid deposition evident , mice impaired following two-pairing five-pairing protocols . Mice carrying transgenes impaired contextual fear conditioning either age . transgenic animal groups performed well controls cued fear conditioning , indicating contextual fear learning deficits hippocampus-specific . associative learning impairments coincident elevated alpha 7 nicotinic acetylcholine receptor protein dentate gyrus . findings provide two robust rapid assays beta-amyloid-associated effects performed young animals : impaired contextual fear learning up-regulation alpha 7 nicotinic receptors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0129829935152671)\n",
      "- Text: \"Presenilins required beta 42 production early secretory pathway . Presenilins 1 2 ( @ GeneSrc $ ) suggested gamma-secretases responsible proteolytic cleavage amyloid precursor protein ( APP ) form amyloid-beta ( beta ) , protein implicated development @ DiseaseTgt $ . examined whether presenilins required generation multiple beta species analyzing production several forms secreted intracellular beta mouse cells lacking @ GeneSrc $ , PS2 proteins . Although beta species abolished @ GeneSrc $ ) cells , production intracellular beta 42 generated endoplasmic reticulum/intermediate compartment unaffected absence proteins , either singly combination . results indicate production pool beta occurs independently @ GeneSrc $ , therefore , another gamma-secretase activity must responsible cleavage APP within early secretory compartments .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1324136270987146)\n",
      "- Text: \"Partial loss presenilins causes seborrheic keratosis autoimmune disease mice . Presenilin ( @ GeneSrc $ ) ( PS2 ) centers gamma-secretase release Abeta APP @ DiseaseTgt $ ( @ DiseaseTgt $ ) . cleave signaling proteins like Notch downregulate beta-catenin modulate Wnt signaling . Inactivation @ GeneSrc $ @ GeneSrc $ PS2 causes prenatally lethal ' Notch phenotype , ' hampered investigation PS function adulthood seriously . thus turned towards @ GeneSrc $ mice carry severe reduction PS alleles compatible survival , analyze consequences impaired PS function especially adulthood . ' partial deficient ' mice , @ GeneSrc $ protein concentration considerably lowered , functionally reflected reduced gamma-secretase activity impaired beta-catenin downregulation . phenotype normal approximately 6 months , majority mice develop autoimmune disease characterized dermatitis , glomerulonephritis , keratitis vasculitis , seen human systemic lupus erythematosus . Besides B-cell dominated infiltrates , observe hypergammaglobulinemia immune complex deposits several tissues , high-titer nuclear autoantibodies increased CD4+/CD8 + ratio . mice develop benign skin hyperplasia similar human seborrheic keratosis opposed malignant keratocarcinomata observed skin-specific @ GeneSrc $ ' full ' knockouts . partial reduction PS function @ GeneSrc $ mice causes novel phenotype adulthood unrelated developmental defects full knockouts . @ GeneSrc $ mice remain healthy , points towards sharply defined minimum PS function . Skin immune system appear especially sensitive targets impaired PS function may need careful monitoring gamma-secretase inhibitors envisaged treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8356123607982425)\n",
      "- Text: \"Reduced beta-amyloid production increased inflammatory responses presenilin conditional knock-out mice . Mutations presenilins ( PS ) 1 2 major cause familial @ DiseaseTgt $ . Conditional double knock-out mice lacking presenilins postnatal forebrain ( PS cDKO mice ) exhibit memory synaptic plasticity impairments followed progressive neurodegeneration cerebral cortex . investigate molecular events may underlie observed phenotypes identify additional neuropathological markers PS cDKO brain . Enzyme-linked immunosorbent assay analysis showed reduced levels toxic beta-amyloid ( Abeta ) peptides cerebral cortex PS cDKO mice . Interestingly , reduction Abeta40 Abeta42 peptides similar @ GeneSrc $ conditional knock-out PS cDKO mice . examined gene expression profile oligonucleotide microarrays PS cDKO cerebral cortex found high number genes differentially expressed , notably group up-regulated inflammatory genes . Quantitative real-time reverse transcription PCR Western analyses confirmed elevated levels glial fibrillary acidic protein , complement component C1q , cathepsin , up-regulation associated inflammatory responses various neurodegenerative processes . Immunohistochemical analysis revealed increase complement component C1q confined hippocampal formation , whereas glial fibrillary acidic protein cathepsin up-regulated throughout entire neocortex hippocampus . addition , strong microglial activation occurs hippocampus deeper cortical layers PS cDKO mice . results indicate memory impairment neurodegeneration PS cDKO mice caused Abeta accumulation loss PS function leads differential up-regulation inflammatory markers cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.1202852959167097e-05)\n",
      "- Text: \"Environmental enrichment reduces Abeta levels amyloid deposition transgenic mice . Cerebral deposition beta-amyloid ( Abeta ) peptides invariant pathological hallmark brains patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) transgenic mice coexpressing familial @ DiseaseTgt $ APP @ GeneSrc $ variants . report exposure transgenic mice `` enriched environment `` results pronounced reductions cerebral Abeta levels amyloid deposits , compared animals raised `` standard housing `` conditions . enzymatic activity Abeta-degrading endopeptidase , neprilysin , elevated brains `` enriched `` mice inversely correlated amyloid burden . Moreover , DNA microarray analysis revealed selective upregulation levels transcripts encoded genes associated learning memory , vasculogenesis , neurogenesis , cell survival pathways , Abeta sequestration , prostaglandin synthesis . studies provide evidence environmental enrichment leads reductions steady-state levels cerebral Abeta peptides amyloid deposition selective upregulation levels specific transcripts brains transgenic mice .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2860070649623796)\n",
      "- Text: \"Presenilin-dependent transcriptional control Abeta-degrading enzyme neprilysin intracellular domains betaAPP APLP . Amyloid beta-peptide ( Abeta ) , plays central role @ DiseaseTgt $ , generated presenilin-dependent gamma-secretase cleavage beta-amyloid precursor protein ( betaAPP ) . report presenilins ( @ GeneSrc $ PS2 ) also regulate Abeta degradation . Presenilin-deficient cells fail degrade Abeta drastic reductions transcription , expression , activity neprilysin , key Abeta-degrading enzyme . Neprilysin activity expression also lowered gamma-secretase inhibitors @ GeneSrc $ deficiency mouse brain . Neprilysin activity restored transient expression @ GeneSrc $ PS2 expression amyloid intracellular domain ( AICD ) , cogenerated Abeta , gamma-secretase cleavage betaAPP . Neprilysin gene promoters transactivated AICDs APP-like proteins ( APP , APLP1 , APLP2 ) , Abeta gamma-secretase cleavage products Notch , N- E- cadherins . presenilin-dependent regulation neprilysin , mediated AICDs , provides physiological means modulate Abeta levels varying levels gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004961620790156)\n",
      "- Text: \"Presenilins form ER Ca2 + leak channels , function disrupted familial @ DiseaseTgt $ mutations . @ DiseaseTgt $ ( @ DiseaseTgt $ ) progressive irreversible neurodegenerative disorder . Mutations presenilins 1 2 ( @ GeneSrc $ PS2 ) account approximately 40 % @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases . @ DiseaseTgt $ mutations genetic deletions presenilins associated calcium ( Ca ( 2 + ) ) signaling abnormalities . demonstrate wild-type presenilins , @ GeneSrc $ PS2-N141I @ DiseaseTgt $ mutants , form low-conductance divalent-cation-permeable ion channels planar lipid bilayers . experiments PS1/2 double knockout ( DKO ) mouse embryonic fibroblasts ( MEFs ) , find presenilins account approximately 80 % passive Ca ( 2 + ) leak endoplasmic reticulum . Deficient Ca ( 2 + ) signaling DKO MEFs rescued expression wild-type @ GeneSrc $ PS2 expression @ GeneSrc $ PS2-N141I mutants . ER Ca ( 2 + ) leak function presenilins independent gamma-secretase activity . data suggest Ca ( 2 + ) signaling function presenilins provide support `` Ca ( 2 + ) hypothesis @ DiseaseTgt $ . ``\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7628435620626374)\n",
      "- Text: \"Activation beta2-adrenergic receptor stimulates gamma-secretase activity accelerates amyloid plaque formation . Amyloid plaque hallmark primary cause @ DiseaseTgt $ . Mutations @ GeneSrc $ , gamma-secretase catalytic subunit , affect amyloid-beta ( Abeta ) production @ DiseaseTgt $ pathogenesis . However , largely unknown whether gamma-secretase activity amyloid plaque formation regulated environmental factors stress , mediated receptors including beta ( 2 ) -adrenergic receptor ( beta ( 2 ) -AR ) . report activation beta ( 2 ) -AR enhanced gamma-secretase activity thus Abeta production . enhancement involved association beta ( 2 ) -AR @ GeneSrc $ required agonist-induced endocytosis beta ( 2 ) -AR subsequent trafficking gamma-secretase late endosomes lysosomes , Abeta production elevated . Similar effects observed activation delta-opioid receptor . Furthermore , chronic treatment beta ( 2 ) -AR agonists increased cerebral amyloid plaques @ DiseaseTgt $ mouse model . Thus , beta ( 2 ) -AR activation stimulate gamma-secretase activity amyloid plaque formation , suggests abnormal activation beta ( 2 ) -AR might contribute Abeta accumulation @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0071091645173924)\n",
      "- Text: \"Two transmembrane aspartates presenilin-1 required presenilin endoproteolysis gamma-secretase activity . Accumulation amyloid-beta protein ( Abeta ) cerebral cortex early invariant event pathogenesis @ DiseaseTgt $ . final step generation Abeta beta-amyloid precursor protein apparently intramembranous proteolysis elusive gamma-secretase ( ) . common cause familial @ DiseaseTgt $ mutation genes encoding @ GeneSrc $ , alters gamma-secretase activity increase production highly amyloidogenic Abeta42 isoform . Moreover , deletion presenilin-1 mice greatly reduces gamma-secretase activity , indicating presenilin-1 mediates proteolytic event . report mutation either two conserved transmembrane ( TM ) aspartate residues presenilin-1 , Asp 257 ( TM6 ) Asp 385 ( TM7 ) , substantially reduces Abeta production increases amounts carboxy-terminal fragments beta-amyloid precursor protein substrates gamma-secretase . observed effects three different cell lines well cell-free microsomes . Either Asp -- > Ala mutations also prevented normal endoproteolysis presenilin-1 TM6 -- > TM7 cytoplasmic loop . functional presenilin-1 variant ( carrying deletion exon 9 ) associated familial @ DiseaseTgt $ require cleavage , Asp 385 -- > Ala mutation still inhibited gamma-secretase activity . results indicate two transmembrane aspartate residues critical presenilin-1 endoproteolysis gamma-secretase activity , suggest presenilin 1 either unique diaspartyl cofactor gamma-secretase gamma-secretase , autoactivated intramembranous aspartyl protease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0332223551086096)\n",
      "- Text: \"Presenilins required beta 42 production early secretory pathway . @ GeneSrc $ ( PS1/PS2 ) suggested gamma-secretases responsible proteolytic cleavage amyloid precursor protein ( APP ) form amyloid-beta ( beta ) , protein implicated development @ DiseaseTgt $ . examined whether presenilins required generation multiple beta species analyzing production several forms secreted intracellular beta mouse cells lacking PS1 , PS2 proteins . Although beta species abolished PS1/PS2 ( -/- ) cells , production intracellular beta 42 generated endoplasmic reticulum/intermediate compartment unaffected absence proteins , either singly combination . results indicate production pool beta occurs independently PS1/PS2 , therefore , another gamma-secretase activity must responsible cleavage APP within early secretory compartments .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0101366522935616)\n",
      "- Text: \"Reduced beta-amyloid production increased inflammatory responses presenilin conditional knock-out mice . Mutations @ GeneSrc $ major cause familial @ DiseaseTgt $ . Conditional double knock-out mice lacking presenilins postnatal forebrain ( PS cDKO mice ) exhibit memory synaptic plasticity impairments followed progressive neurodegeneration cerebral cortex . investigate molecular events may underlie observed phenotypes identify additional neuropathological markers PS cDKO brain . Enzyme-linked immunosorbent assay analysis showed reduced levels toxic beta-amyloid ( Abeta ) peptides cerebral cortex PS cDKO mice . Interestingly , reduction Abeta40 Abeta42 peptides similar PS1 conditional knock-out PS cDKO mice . examined gene expression profile oligonucleotide microarrays PS cDKO cerebral cortex found high number genes differentially expressed , notably group up-regulated inflammatory genes . Quantitative real-time reverse transcription PCR Western analyses confirmed elevated levels glial fibrillary acidic protein , complement component C1q , cathepsin , up-regulation associated inflammatory responses various neurodegenerative processes . Immunohistochemical analysis revealed increase complement component C1q confined hippocampal formation , whereas glial fibrillary acidic protein cathepsin up-regulated throughout entire neocortex hippocampus . addition , strong microglial activation occurs hippocampus deeper cortical layers PS cDKO mice . results indicate memory impairment neurodegeneration PS cDKO mice caused Abeta accumulation loss PS function leads differential up-regulation inflammatory markers cerebral cortex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0105363867274233)\n",
      "- Text: \"Presenilins form ER Ca2 + leak channels , function disrupted familial @ DiseaseTgt $ mutations . @ DiseaseTgt $ ( @ DiseaseTgt $ ) progressive irreversible neurodegenerative disorder . Mutations @ GeneSrc $ ( PS1 PS2 ) account approximately 40 % @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases . @ DiseaseTgt $ mutations genetic deletions presenilins associated calcium ( Ca ( 2 + ) ) signaling abnormalities . demonstrate wild-type presenilins , PS1-M146V PS2-N141I @ DiseaseTgt $ mutants , form low-conductance divalent-cation-permeable ion channels planar lipid bilayers . experiments @ GeneSrc $ double knockout ( DKO ) mouse embryonic fibroblasts ( MEFs ) , find presenilins account approximately 80 % passive Ca ( 2 + ) leak endoplasmic reticulum . Deficient Ca ( 2 + ) signaling DKO MEFs rescued expression wild-type PS1 PS2 expression PS1-M146V PS2-N141I mutants . ER Ca ( 2 + ) leak function presenilins independent gamma-secretase activity . data suggest Ca ( 2 + ) signaling function presenilins provide support `` Ca ( 2 + ) hypothesis @ DiseaseTgt $ . ``\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6463996074489349)\n",
      "- Text: \"Increased amyloid-beta42 ( 43 ) brains mice expressing mutant presenilin 1 . Mutations genes encoding amyloid-beta precursor protein ( APP ) , presenilin 1 ( PS1 ) @ GeneSrc $ ( @ GeneSrc $ ) known cause early-onset , autosomal dominant @ DiseaseTgt $ . Studies plasma fibroblasts subjects mutations established alter amyloid beta-protein ( beta APP ) processing , normally leads secretion amyloid-beta protein ( relative molecular mass 4,000 ; ( r ) 4 K ; approximately 90 % beta1 - 40 , approximately 10 % beta1 - 42 ( 43 ) ) , extracellular concentration beta42 ( 43 ) increased . increase beta42 ( 43 ) believed critical change initiates @ DiseaseTgt $ pathogenesis beta42 ( 43 ) deposited early selectively senile plaques observed brains patients forms disease . establish presenilin mutations increase amount beta42 ( 43 ) brain test whether presenilin mutations act true ( gain function ) dominants , constructed mice expressing wild-type mutant presenilin genes . Analysis mice showed overexpression mutant , wild-type , PS1 selectively increases brain beta42 ( 43 ) . results indicate presenilin mutations probably cause @ DiseaseTgt $ gain deleterious function increases amount beta42 ( 43 ) brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2113678539397695)\n",
      "- Text: \"@ DiseaseTgt $ presenilin 1 variants elevate Abeta1 - 42/1 - 40 ratio vitro vivo . Mutations presenilin 1 ( PS1 ) @ GeneSrc $ genes cosegregate majority early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigrees . document Abeta1 - 42 ( 43 ) /Abeta1 - 40 ratio conditioned media independent N2a cell lines expressing three @ DiseaseTgt $ PS1 variants uniformly elevated relative cells expressing similar levels wild-type PS1 . Similarly , Abeta1 - 42 ( 43 ) /Abeta1 - 40 ratio elevated brains young transgenic animals coexpressing chimeric amyloid precursor protein ( APP ) @ DiseaseTgt $ PS1 variant compared brains transgenic mice expressing APP alone transgenic mice coexpressing wild-type human PS1 APP . studies provide compelling support view one mechanism mutant PS1 cause @ DiseaseTgt $ increasing extracellular concentration Abeta peptides terminating 42 ( 43 ) , species foster Abeta deposition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9232309906414212)\n",
      "- Text: \"Mutant presenilins @ DiseaseTgt $ increase production 42-residue amyloid beta-protein transfected cells transgenic mice . mechanism mutations presenilin ( PS ) genes cause aggressive form early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) unknown , fibroblasts mutation carriers secrete increased levels amyloidogenic beta 42 peptide , main component @ DiseaseTgt $ plaques . established transfected cell transgenic mouse models coexpress human PS amyloid beta-protein precursor ( APP ) genes analyzed quantitatively effects PS expression APP processing . models , expression wild-type PS genes alter APP levels , alpha- beta-secretase activity beta production . transfected cells , PS1 @ GeneSrc $ mutations caused highly significant increase beta 42 secretion mutant clones . Likewise , mutant wildtype PS1 transgenic mice showed significant overproduction beta 42 brain , effect detectable early 2 - 4 months age . Different PS mutations differential effects beta generation . extent beta 42 increase correlate presenilin expression levels . data demonstrate presenilin mutations cause dominant gain function may induce @ DiseaseTgt $ enhancing beta 42 production , thus promoting cerebral beta-amyloidosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9496163622610962)\n",
      "- Text: \"Presenilin 2 deficiency causes mild pulmonary phenotype changes amyloid precursor protein processing enhances embryonic lethal phenotype presenilin 1 deficiency . Mutations homologous presenilin 1 ( PS1 ) @ GeneSrc $ ( @ GeneSrc $ ) genes cause common aggressive form familial @ DiseaseTgt $ . Although PS1 function dysfunction extensively studied , little known function @ GeneSrc $ vivo . delineate relationships @ GeneSrc $ PS1 activities whether @ GeneSrc $ mutations involve gain loss function , generated @ GeneSrc $ homozygous deficient ( -/- ) @ GeneSrc $ double homozygous deficient mice . contrast PS1 ( -/- ) mice , @ GeneSrc $ ) mice viable fertile develop mild pulmonary fibrosis hemorrhage age . Absence @ GeneSrc $ detectably alter processing amyloid precursor protein little effect physiologically important apoptotic processes , indicating @ DiseaseTgt $ mutations @ GeneSrc $ , PS1 , result gain function . Although PS1 ( +/- ) @ GeneSrc $ ( -/- ) mice survive relatively good health , complete deletion @ GeneSrc $ PS1 genes causes phenotype closely resembling full Notch-1 deficiency . results demonstrate vivo PS1 @ GeneSrc $ partially overlapping functions PS1 essential @ GeneSrc $ redundant normal Notch signaling mammalian embryological development .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9273556818564382)\n",
      "- Text: \"Mice lacking presenilin genes exhibit early embryonic patterning defects . Genetic studies worms , flies , humans implicated presenilins regulation Notch signaling pathway pathogenesis @ DiseaseTgt $ . two highly homologous presenilin genes mammals , presenilin 1 ( PS1 ) @ GeneSrc $ ( @ GeneSrc $ ) . mice , inactivation PS1 leads developmental defects culminate perinatal lethality . test possibility late lethality PS1-null mice reflects genetic redundancy presenilins , generated @ GeneSrc $ mice gene targeting , subsequently , @ GeneSrc $ double-null mice . Mice homozygous targeted null mutation @ GeneSrc $ exhibit obvious defects ; however , loss @ GeneSrc $ PS1-null background leads embryonic lethality embryonic day 9.5 . Embryos lacking presenilins , surprisingly , carrying single copy @ GeneSrc $ PS1-null background , exhibit multiple early patterning defects , including lack somite segmentation , disorganization trunk ventral neural tube , midbrain mesenchyme cell loss , anterior neuropore closure delays , abnormal heart second branchial arch development . addition , Delta like-1 ( Dll1 ) Hes-5 , two genes lie downstream Notch pathway , misexpressed presenilin double-null embryos : Hes-5 expression undetectable mice , whereas Dll1 expressed ectopically neural tube brain double-null embryos . conclude presenilins play widespread role embryogenesis , functional redundancy PS1 @ GeneSrc $ , vertebrate presenilins , like invertebrate homologs , essential Notch signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0064133113658877)\n",
      "- Text: \"Mutant @ GeneSrc $ transgenic mice . large increase levels Abeta 42 presumably associated low density membrane domain contains decreased levels glycerophospholipids sphingomyelin . N141I mutation @ GeneSrc $ tightly linked form autosomal dominant familial @ DiseaseTgt $ Volga German families . previously reported mouse brains harboring mutant @ GeneSrc $ contained increased levels amyloid beta protein ( Abeta ) 42 Tris-saline-soluble fraction ( Oyama , F. , Sawamura , N. , Kobayashi , K. , Morishima-Kawashima , M. , Kuramochi , T. , Ito , M. , Tomita , T. , Maruyama , K. , Saido , T. C. , Iwatsubo , T. , Capell , A. , Walter , J. , Grunberg , J. , Ueyama , Y. , Haass , C. Ihara , . ( 1998 ) J. Neurochem . 71 , 313 - 322 ) . , using new extraction protocol , quantitated Abeta40 Abeta42 levels Tris-saline-insoluble fraction . insoluble Abeta levels found higher soluble Abeta levels , insoluble Abeta42 levels markedly increased mutant @ GeneSrc $ transgenic mice . investigate origin insoluble Abeta42 , prepared detergent-insoluble , low density membrane fraction . fraction two independent lines mutant @ GeneSrc $ transgenic mice contained remarkably increased levels Abeta42 significantly low levels glycerophospholipids sphingomyelin . unexpected finding suggests large increase levels Abeta42 mutant @ GeneSrc $ mice presumably induced alterations lipid composition low density membrane domain brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.636148235132535e-05)\n",
      "- Text: \"Presenilins required beta 42 production early secretory pathway . Presenilins 1 2 ( @ GeneSrc $ ) suggested gamma-secretases responsible proteolytic cleavage amyloid precursor protein ( APP ) form amyloid-beta ( beta ) , protein implicated development @ DiseaseTgt $ . examined whether presenilins required generation multiple beta species analyzing production several forms secreted intracellular beta mouse cells lacking PS1 , @ GeneSrc $ proteins . Although beta species abolished @ GeneSrc $ ) cells , production intracellular beta 42 generated endoplasmic reticulum/intermediate compartment unaffected absence proteins , either singly combination . results indicate production pool beta occurs independently @ GeneSrc $ , therefore , another gamma-secretase activity must responsible cleavage APP within early secretory compartments .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0611961354015432)\n",
      "- Text: \"novel mutation PSEN2 gene ( T430 ) associated variable expression family early-onset @ DiseaseTgt $ . BACKGROUND : Autosomal dominant early-onset @ DiseaseTgt $ heterogeneous condition associated mutations 3 different genes : amyloid precursor protein ( APP ) , presenilin 1 ( PSEN1 ) , presenilin 2 ( PSEN2 ) genes . cases due mutations PSEN1 gene , whereas mutations APP PSEN2 genes rare . OBJECTIVE : describe novel mutation PSEN2 gene associated early-onset @ DiseaseTgt $ . PATIENTS METHODS : proband 49-year-old individual displayed progressive dementia beginning age 45 years . One parents one grandparents developed dementia ages 64 years 60 years , respectively , 1 sibling mild cognitive impairment . family members also Tourette syndrome . Mutation analysis APP , PSEN1 , PSEN2 , tau ( TAU ) genes performed . Apolipoprotein E ( APOE ) also genotyped . RESULTS : found missense mutation codon 430 PSEN2 gene predicts threonine-to-methionine substitution . mutation detected affected individuals 1 cognitively healthy sibling . mutation absent 260 control chromosomes . normal amino acid conserved human mouse PSEN1 mouse @ GeneSrc $ homologues . influence APOE genotype observed . CONCLUSIONS : found novel mutation PSEN2 gene family early-onset @ DiseaseTgt $ . variation age onset confirms PSEN2 mutations associated variable clinical expression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8452954389558721)\n",
      "- Text: \"Partial loss presenilins causes seborrheic keratosis autoimmune disease mice . Presenilin ( PS1 ) ( @ GeneSrc $ ) centers gamma-secretase release Abeta APP @ DiseaseTgt $ ( @ DiseaseTgt $ ) . cleave signaling proteins like Notch downregulate beta-catenin modulate Wnt signaling . Inactivation PS1 PS1 @ GeneSrc $ causes prenatally lethal ' Notch phenotype , ' hampered investigation PS function adulthood seriously . thus turned towards @ GeneSrc $ mice carry severe reduction PS alleles compatible survival , analyze consequences impaired PS function especially adulthood . ' partial deficient ' mice , PS1 protein concentration considerably lowered , functionally reflected reduced gamma-secretase activity impaired beta-catenin downregulation . phenotype normal approximately 6 months , majority mice develop autoimmune disease characterized dermatitis , glomerulonephritis , keratitis vasculitis , seen human systemic lupus erythematosus . Besides B-cell dominated infiltrates , observe hypergammaglobulinemia immune complex deposits several tissues , high-titer nuclear autoantibodies increased CD4+/CD8 + ratio . mice develop benign skin hyperplasia similar human seborrheic keratosis opposed malignant keratocarcinomata observed skin-specific PS1 ' full ' knockouts . partial reduction PS function @ GeneSrc $ mice causes novel phenotype adulthood unrelated developmental defects full knockouts . @ GeneSrc $ mice remain healthy , points towards sharply defined minimum PS function . Skin immune system appear especially sensitive targets impaired PS function may need careful monitoring gamma-secretase inhibitors envisaged treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0691263334268551)\n",
      "- Text: \"Presenilin-dependent transcriptional control Abeta-degrading enzyme neprilysin intracellular domains betaAPP APLP . Amyloid beta-peptide ( Abeta ) , plays central role @ DiseaseTgt $ , generated presenilin-dependent gamma-secretase cleavage beta-amyloid precursor protein ( betaAPP ) . report presenilins ( PS1 @ GeneSrc $ ) also regulate Abeta degradation . Presenilin-deficient cells fail degrade Abeta drastic reductions transcription , expression , activity neprilysin , key Abeta-degrading enzyme . Neprilysin activity expression also lowered gamma-secretase inhibitors @ GeneSrc $ deficiency mouse brain . Neprilysin activity restored transient expression PS1 @ GeneSrc $ expression amyloid intracellular domain ( AICD ) , cogenerated Abeta , gamma-secretase cleavage betaAPP . Neprilysin gene promoters transactivated AICDs APP-like proteins ( APP , APLP1 , APLP2 ) , Abeta gamma-secretase cleavage products Notch , N- E- cadherins . presenilin-dependent regulation neprilysin , mediated AICDs , provides physiological means modulate Abeta levels varying levels gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007593068190563)\n",
      "- Text: \"Presenilins form ER Ca2 + leak channels , function disrupted familial @ DiseaseTgt $ mutations . @ DiseaseTgt $ ( @ DiseaseTgt $ ) progressive irreversible neurodegenerative disorder . Mutations presenilins 1 2 ( PS1 @ GeneSrc $ ) account approximately 40 % @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases . @ DiseaseTgt $ mutations genetic deletions presenilins associated calcium ( Ca ( 2 + ) ) signaling abnormalities . demonstrate wild-type presenilins , PS1-M146V @ GeneSrc $ @ DiseaseTgt $ mutants , form low-conductance divalent-cation-permeable ion channels planar lipid bilayers . experiments PS1/2 double knockout ( DKO ) mouse embryonic fibroblasts ( MEFs ) , find presenilins account approximately 80 % passive Ca ( 2 + ) leak endoplasmic reticulum . Deficient Ca ( 2 + ) signaling DKO MEFs rescued expression wild-type PS1 @ GeneSrc $ expression PS1-M146V @ GeneSrc $ mutants . ER Ca ( 2 + ) leak function presenilins independent gamma-secretase activity . data suggest Ca ( 2 + ) signaling function presenilins provide support `` Ca ( 2 + ) hypothesis @ DiseaseTgt $ . ``\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7543713021964936)\n",
      "- Text: \"@ DiseaseTgt $ PI3 K activation resistant dietary restriction . Dietary restriction delays incidence decreases growth various types @ DiseaseTgt $ , mechanisms underlying sensitivity @ DiseaseTgt $ food restriction remain unknown . show certain human @ DiseaseTgt $ cell lines , grown @ DiseaseTgt $ xenografts mice , highly sensitive anti-growth effects dietary restriction , whereas others resistant . @ DiseaseTgt $ cells form dietary-restriction-resistant @ DiseaseTgt $ carry mutations cause constitutive activation phosphatidylinositol-3-kinase ( PI3 K ) pathway culture proliferate absence insulin insulin-like growth factor 1 . Substitution activated mutant allele PI3 K wild-type PI3 K otherwise isogenic @ DiseaseTgt $ cells , restoration PTEN expression PTEN-null @ DiseaseTgt $ cell line , sufficient convert dietary-restriction-resistant @ DiseaseTgt $ one dietary-restriction-sensitive . Dietary restriction affect @ GeneSrc $ mouse model prostate cancer , significantly decreases @ DiseaseTgt $ burden mouse model lung cancer lacking constitutive PI3 K signalling . Thus , PI3 K pathway important determinant sensitivity @ DiseaseTgt $ dietary restriction , activating mutations pathway may influence response @ DiseaseTgt $ dietary restriction-mimetic therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3225606759182279)\n",
      "- Text: \"Role K-ras @ GeneSrc $ development mouse models endometriosis endometrioid ovarian cancer . Epithelial ovarian tumors present complex clinical , diagnostic therapeutic challenge difficulty early detection , lack known precursor lesions high mortality rates . Endometrioid ovarian carcinomas frequently associated endometriosis , mechanism association remains unknown . present first genetic models peritoneal endometriosis endometrioid ovarian adenocarcinoma mice , based activation oncogenic K-ras allele . addition , find expression oncogenic K-ras conditional @ GeneSrc $ deletion within ovarian surface epithelium gives rise preneoplastic ovarian lesions endometrioid glandular morphology . Furthermore , combination two mutations ovary leads induction invasive widely metastatic endometrioid ovarian adenocarcinomas complete penetrance disease latency 7 weeks . ovarian cancer model described study recapitulates specific @ DiseaseTgt $ histomorphology metastatic potential human disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0094475731717645)\n",
      "- Text: \"deficiency Akt1 sufficient suppress @ DiseaseTgt $ development @ GeneSrc $ mice . @ DiseaseTgt $ suppressor PTEN frequently inactivated human @ DiseaseTgt $ . major downstream effector PTEN Akt , hyperactivated via PTEN inactivation . known , however , whether diminished Akt activity sufficient inhibit tumorigenesis initiated @ GeneSrc $ deficiency . showed deficiency Akt1 sufficient dramatically inhibit @ DiseaseTgt $ development @ GeneSrc $ mice . Akt1 deficiency profound effect endometrium prostate neoplasia , two types human @ DiseaseTgt $ , PTEN frequently mutated , also affected thyroid adrenal medulla tumors intestinal polyps . Even haplodeficiency Akt1 sufficient markedly attenuate development high-grade prostate intraepithelial neoplasia ( PIN ) endometrial carcinoma . results significant implications @ DiseaseTgt $ therapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5243582883733823)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear Akt function . proto-oncogene AKT ( also known PKB ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , AKT becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated AKT ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated AKT ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression @ GeneSrc $ mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits Akt phosphatase PP2a well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired PP2a phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor p27 ( kip1 ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance AKT compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.091379537651836)\n",
      "- Text: \"Crucial role p53-dependent cellular senescence suppression @ GeneSrc $ tumorigenesis . Cellular senescence theorized oppose neoplastic transformation triggered activation oncogenic pathways vitro , relevance senescence vivo established . PTEN p53 @ DiseaseTgt $ suppressors among commonly inactivated mutated genes human cancer including prostate cancer . Although functionally distinct , reciprocal cooperation proposed , PTEN thought regulate p53 stability , p53 enhance PTEN transcription . show conditional inactivation Trp53 mouse prostate fails produce @ DiseaseTgt $ phenotype , whereas complete @ GeneSrc $ inactivation prostate triggers non-lethal invasive prostate cancer long latency . Strikingly , combined inactivation @ GeneSrc $ Trp53 elicits invasive prostate cancer early 2 weeks puberty invariably lethal 7 months age . Importantly , acute @ GeneSrc $ inactivation induces growth arrest p53-dependent cellular senescence pathway vitro vivo , fully rescued combined loss Trp53 . Furthermore , detected evidence cellular senescence specimens early-stage human prostate cancer . results demonstrate relevance cellular senescence restricting tumorigenesis vivo support model cooperative @ DiseaseTgt $ suppression p53 essential failsafe protein @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8983972929663168)\n",
      "- Text: \"p53 @ GeneSrc $ control neural glioma stem/progenitor cell renewal differentiation . Glioblastoma ( GBM ) highly lethal brain tumour presenting one two subtypes distinct clinical histories molecular profiles . primary GBM subtype presents acutely high-grade disease typically harbours mutations EGFR , PTEN INK4A/ARF ( also known CDKN2A ) , secondary GBM subtype evolves slow progression low-grade disease classically possesses PDGF TP53 events . show concomitant central nervous system ( CNS ) -specific deletion p53 @ GeneSrc $ mouse CNS generates penetrant acute-onset high-grade malignant glioma phenotype notable clinical , pathological molecular resemblance primary GBM humans . genetic observation prompted TP53 PTEN mutational analysis human primary GBM , demonstrating unexpectedly frequent inactivating mutations TP53 well expected PTEN mutations . Integrated transcriptomic profiling , silico promoter analysis functional studies murine neural stem cells ( NSCs ) established dual , singular , inactivation p53 @ GeneSrc $ promotes undifferentiated state high renewal potential drives increased Myc protein levels associated signature . Functional studies validated increased Myc activity potent contributor impaired differentiation enhanced renewal NSCs doubly null p53 @ GeneSrc $ ( p53 ( -/- ) @ GeneSrc $ ) ) well @ DiseaseTgt $ neurospheres ( TNSs ) derived model . Myc also serves maintain robust tumorigenic potential p53 ( -/- ) @ GeneSrc $ ) TNSs . murine modelling studies , together confirmatory transcriptomic/promoter studies human primary GBM , validate pathogenetic role common @ DiseaseTgt $ suppressor mutation profile human primary GBM establish Myc important target cooperative actions p53 Pten regulation normal malignant stem/progenitor cell differentiation , self-renewal tumorigenic potential .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0528176408292117)\n",
      "- Text: \"PINK1-phosphorylated mitofusin 2 Parkin receptor culling damaged mitochondria . Senescent damaged mitochondria undergo selective mitophagic elimination mechanisms requiring two @ DiseaseTgt $ factors , mitochondrial kinase PINK1 ( PTEN-induced putative kinase protein 1 ; @ GeneSrc $ @ GeneSrc $ ) cytosolic ubiquitin ligase Parkin . nature PINK-Parkin interaction identity key factors directing Parkin damaged mitochondria unknown . show mitochondrial outer membrane guanosine triphosphatase mitofusin ( Mfn ) 2 mediates Parkin recruitment damaged mitochondria . Parkin bound Mfn2 PINK1-dependent manner ; PINK1 phosphorylated Mfn2 promoted Parkin-mediated ubiqitination . Ablation Mfn2 mouse cardiac myocytes prevented depolarization-induced translocation Parkin mitochondria suppressed mitophagy . Accumulation morphologically functionally abnormal mitochondria induced respiratory dysfunction Mfn2-deficient mouse embryonic fibroblasts cardiomyocytes Parkin-deficient Drosophila heart tubes , causing dilated cardiomyopathy . Thus , Mfn2 functions mitochondrial receptor Parkin required quality control cardiac mitochondria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.5343079797404528e-06)\n",
      "- Text: \"Lipocalin-type prostaglandin synthase/beta-trace major amyloid beta-chaperone human cerebrospinal fluid . conformational change amyloid beta ( Abeta ) peptide monomeric form aggregates crucial pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) . healthy brain , unidentified chaperones appear prevent aggregation Abeta . reported lipocalin-type prostaglandin synthase ( L-PGDS ) /beta-trace , abundant cerebrospinal fluid ( CSF ) protein produced brain , localized amyloid plaques @ DiseaseTgt $ patients @ DiseaseTgt $ Tg2576 mice . Surface plasmon resonance analysis revealed L-PGDS/beta-trace tightly bound Abeta monomers fibrils high affinity ( K ( ) = 18 - 50 nM ) @ GeneSrc $ recognized residues 25 - 28 Abeta , key region conformational change beta-sheet structure . results thioflavin fluorescence assay monitor Abeta aggregation disclosed @ GeneSrc $ inhibited spontaneous aggregation Abeta ( 1 - 40 ) Abeta ( 1 - 42 ) within physiological range ( 1 - 5 microM ) CSF . @ GeneSrc $ also prevented seed-dependent aggregation 50 microM Abeta K ( ) 0.75 microM . Moreover , inhibitory activity toward Abeta ( 1 - 40 ) aggregation human CSF decreased 60 % @ GeneSrc $ removed CSF immunoaffinity chromatography . deposition Abeta intraventricular infusion Abeta ( 1 - 42 ) 3.5-fold higher @ GeneSrc $ mice reduced 23 % @ GeneSrc $ mice compared wild-type levels . data indicate @ GeneSrc $ major endogenous Abeta-chaperone brain suggest disturbance function may involved onset progression @ DiseaseTgt $ . findings may provide diagnostic therapeutic approach @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0060655914695686)\n",
      "- Text: \"Somatic PIK3CA Mutations Sporadic Cerebral Cavernous Malformations . BACKGROUND : Cerebral cavernous malformations ( CCMs ) common sporadic inherited vascular malformations central nervous system . Although familial CCMs linked loss-of-function mutations KRIT1 ( CCM1 ) , CCM2 , PDCD10 ( CCM3 ) , genetic cause sporadic CCMs , representing 80 % cases , remains incompletely understood . METHODS : developed two mouse models harboring mutations identified human meningiomas use @ GeneSrc $ ( PGDS ) promoter . performed targeted DNA sequencing surgically resected CCMs patients confirmed findings droplet digital polymerase-chain-reaction analysis . RESULTS : found mice expressing one two common genetic drivers meningioma - Pik3ca H1047R AKT1 E17 K - @ GeneSrc $ cells , spectrum typical CCMs develops ( 22 % 11 % mice , respectively ) instead meningiomas , prompted us analyze tissue samples sporadic CCMs 88 patients . detected somatic activating PIK3CA AKT1 mutations 39 % 1 % , respectively , lesion tissue patients . 10 % lesions harbored mutations CCM genes . analyzed lesions induced activating mutations Pik3ca H1074R AKT1 E17 K mice identified @ GeneSrc $ pericyte probable cell origin . CONCLUSIONS : tissue samples sporadic CCMs , mutations PIK3CA represented greater extent mutations gene . contribution somatic mutations genes cause familial CCMs comparatively small . ( Funded Fondation ARC pour la Recherche contre le @ DiseaseTgt $ others . ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3884944578671026)\n",
      "- Text: \"Suppression intestinal polyps Msh2-deficient non-Msh2-deficient multiple intestinal neoplasia mice specific cyclooxygenase-2 inhibitor dual @ GeneSrc $ inhibitor . Epidemiological studies suggest nonsteroidal anti-inflammatory agents decrease risk @ DiseaseTgt $ . believed mediated , least part , inhibition cyclooxygenase ( COX ) activity . two COX isoenzymes , namely constitutively expressed COX-1 inducible COX-2 . COX-2 overexpressed adenomas @ DiseaseTgt $ , COX-2-specific inhibitors shown inhibit intestinal polyps Apc ( Delta716 ) mice effectively dual COX-1/COX-2 inhibitors sulindac . Various Apc knockout mice , including multiple intestinal neoplasia ( Min ) mouse Apc ( Delta716 ) mouse , limited lack large numbers colonic adenomas aberrant crypt foci , putative precursors large-bowel polyps cancers . DNA mismatch-repair-deficient Min mouse model ( Apc+/-Msh2-/- ) genetic features familial adenomatous polyposis hereditary nonpolyposis colorectal cancer , importantly , rapidly develops numerous small- large-bowel adenomas , well colonic aberrant crypt foci . purpose study determine effects COX inhibitors intestinal adenomas colonic aberrant crypt foci accelerated polyposis , mismatch-repair-deficient Min mouse model , addition standard Min mouse model . Weanling Apc+/-Msh2-/- Min mice fed diets containing drug , sulindac , specific COX-2 inhibitor ( MF-tricyclic ) . Apc+/-Msh2-/- Min mice sacrificed 4 weeks 5 months diet , respectively . Apc+/-Msh2-/- mice treated MF-tricyclic significantly fewer small-bowel polyps ( mean + /- SD , 178 + /- 29 ) compared mice sulindac ( 278 + /- 80 ) , control diet ( 341 + /- 43 ; P < 0.001 ) . difference numbers large-bowel polyps aberrant crypt foci mice three groups . MF-tricyclic also effective reducing small- large-bowel polyps Min mice . Western analysis demonstrated COX-2 expression large- small-bowel polyps mice genotypes . study demonstrates specific COX-2 inhibitor effective preventing small-bowel polyps mismatch-repair-deficient Min mice small- large-bowel polyps standard Min mice . Therefore , specific COX-2 inhibitors may useful chemopreventive therapeutic agents humans risk colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.6396370946420126e-05)\n",
      "- Text: \"@ GeneSrc $ overexpression tumor formation blocked sulindac murine model familial adenomatous polyposis . Inducible cyclooxygenase ( Cox-2 ) , also known prostaglandin H synthase 2 ( PGH-2 ) key enzyme formation prostaglandins thromboxanes . Cox-2 product immediate-early gene expressed response growth factors , tumor promoters , cytokines . Overexpression Cox-2 associated human @ DiseaseTgt $ suppression apoptosis cultured epithelia ] cells , activity reversed nonsteroidal anti-inflammatory drug , sulindac sulfide . address relationship Cox-2 , apoptosis , tumor development vivo , studied C57BL/6J-Min/+ ( Min ) mice , strain containing fully penetrant dominant mutation Apc gene , leading development gastrointestinal adenomas 110 days age . Min mice fed AIN-76A chow diet given sulindac ( 0.5 + /- 0.1 mg/day ) drinking water . Control Min mice homozygous C57BL/6J-+/+ normal littermates lacking Apc mutation ( + /+ ) fed AIN-76A diet given tap water drink . 110 days age , mice sacrificed , intestinal tracts examined . Control Min mice 11.9 + /- 7.8 tumors per mouse compared 0.1 + /- 0.1 tumors sulindac-treated Min mice . expected , + /+ littermates macroscopic tumors . Examination histologically normal-appearing small bowel Min animals revealed increased amounts Cox-2 prostaglandin E ( 2 ) compared + /+ littermates . Using two different situ techniques , terminal transferase-mediated dUTP nick end labeling direct immunoperoxidase method , Min animals also demonstrated 27 - 47 % decrease enterocyte apoptosis compared + /+ animals . Treatment sulindac inhibited tumor formation decreased small bowel Cox-2 prostaglandin E ( 2 ) baseline restored normal levels apoptosis . data suggest overexpression Cox-2 associated tumorigenesis gastrointestinal epithelium , inhibited sulindac administration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.473593984103272e-06)\n",
      "- Text: \"Suppression intestinal polyps Msh2-deficient non-Msh2-deficient multiple intestinal neoplasia mice specific @ GeneSrc $ inhibitor dual cyclooxygenase-1/2 inhibitor . Epidemiological studies suggest nonsteroidal anti-inflammatory agents decrease risk @ DiseaseTgt $ . believed mediated , least part , inhibition cyclooxygenase ( COX ) activity . two COX isoenzymes , namely constitutively expressed COX-1 inducible COX-2 . COX-2 overexpressed adenomas @ DiseaseTgt $ , COX-2-specific inhibitors shown inhibit intestinal polyps Apc ( Delta716 ) mice effectively dual COX-1/COX-2 inhibitors sulindac . Various Apc knockout mice , including multiple intestinal neoplasia ( Min ) mouse Apc ( Delta716 ) mouse , limited lack large numbers colonic adenomas aberrant crypt foci , putative precursors large-bowel polyps cancers . DNA mismatch-repair-deficient Min mouse model ( Apc+/-Msh2-/- ) genetic features familial adenomatous polyposis hereditary nonpolyposis colorectal cancer , importantly , rapidly develops numerous small- large-bowel adenomas , well colonic aberrant crypt foci . purpose study determine effects COX inhibitors intestinal adenomas colonic aberrant crypt foci accelerated polyposis , mismatch-repair-deficient Min mouse model , addition standard Min mouse model . Weanling Apc+/-Msh2-/- Min mice fed diets containing drug , sulindac , specific COX-2 inhibitor ( MF-tricyclic ) . Apc+/-Msh2-/- Min mice sacrificed 4 weeks 5 months diet , respectively . Apc+/-Msh2-/- mice treated MF-tricyclic significantly fewer small-bowel polyps ( mean + /- SD , 178 + /- 29 ) compared mice sulindac ( 278 + /- 80 ) , control diet ( 341 + /- 43 ; P < 0.001 ) . difference numbers large-bowel polyps aberrant crypt foci mice three groups . MF-tricyclic also effective reducing small- large-bowel polyps Min mice . Western analysis demonstrated COX-2 expression large- small-bowel polyps mice genotypes . study demonstrates specific COX-2 inhibitor effective preventing small-bowel polyps mismatch-repair-deficient Min mice small- large-bowel polyps standard Min mice . Therefore , specific COX-2 inhibitors may useful chemopreventive therapeutic agents humans risk colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000216610311514)\n",
      "- Text: \"Suppression intestinal polyposis Apc delta716 knockout mice inhibition @ GeneSrc $ ( @ GeneSrc $ ) . Two cyclooxygenase isozymes catalyze conversion arachidonic acid prostaglandin H2 : constitutive COX-1 inducible @ GeneSrc $ . assess role @ GeneSrc $ @ DiseaseTgt $ tumorigenisis , determined effects @ GeneSrc $ gene ( @ GeneSrc $ ) knockouts novel @ GeneSrc $ inhibitor Apc delta716 knockout mice , model human familial adenomatous polyposis . @ GeneSrc $ null mutation reduced number size intestinal polyps dramatically . Furthermore , treating Apc delta716 mice novel @ GeneSrc $ inhibitor reduced polyp number significantly sulindac , inhibits isoenzymes . results provide direct genetic evidence @ GeneSrc $ plays key role tumorigenesis indicate @ GeneSrc $ inhibitors novel class therapeutic agents @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0063253021036653)\n",
      "- Text: \"Unrepaired DNA breaks p53-deficient cells lead oncogenic gene amplification subsequent translocations . Amplification large genomic regions associated complex translocations ( complicons ) basis @ DiseaseTgt $ progression drug resistance . show pro-B lymphomas mice deficient p53 nonhomologous end-joining ( NHEJ ) contain complicons coamplify c-myc ( chromosome 15 ) IgH ( chromosome 12 ) sequences . carry translocated ( 12 ; 15 ) chromosome , coamplified sequences located within separate complicon often involves third chromosome . Complicon formation initiated recombination @ GeneSrc $ IgH locus double-strand breaks sequences downstream c-myc , generating dicentric ( 15 ; 12 ) chromosome amplification intermediate . recombination event employs microhomology-based end-joining repair pathway , opposed classic NHEJ homologous recombination . findings suggest general model oncogenic complicon formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.202440438585568e-06)\n",
      "- Text: \"PML/RARalpha FLT3-ITD induce APL-like disease mouse model . Acute promyelocytic leukemia ( APL ) cells invariably express aberrant fusion proteins involving @ GeneSrc $ ( @ GeneSrc $ ) . common fusion partner promyelocytic leukemia protein ( PML ) , fused @ GeneSrc $ balanced reciprocal chromosomal translocation , ( 15 ; 17 ) ( q22 : q11 ) . Expression PML/RARalpha cathepsin G promoter transgenic mice causes nonfatal myeloproliferative syndrome mice ; 15 % go develop APL long latent period , suggesting additional mutations required development APL . candidate target gene second mutation FLT3 , mutated approximately 40 % human APL cases . Activating mutations FLT3 , including internal tandem duplication ( ITD ) juxtamembrane domain , transform hematopoietic cell lines factor independent growth . FLT3-ITDs also induce myeloproliferative disease murine bone marrow transplant model , sufficient cause @ DiseaseTgt $ . , test hypothesis PML/RARalpha cooperate FLT3-ITD induce APL-like disease mouse . Retroviral transduction FLT3-ITD bone marrow cells obtained PML/RARalpha transgenic mice results short latency APL-like disease complete penetrance . disease resembles APL-like disease occurs long latency PML/RARalpha transgenics , suggesting activating mutations FLT3 functionally substitute additional mutations occur mouse APL progression . leukemia transplantable secondary recipients ATRA responsive . observations document cooperation PML/RARalpha FLT3-ITD development murine APL phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1267386957522658)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human @ DiseaseTgt $ . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable @ GeneSrc $ mTOR-independent cell proliferation associated AKT , ERK , GSK3beta phosphorylation . Paradoxically , GSK3beta inhibitors lithium chloride SB216763 selectively decreased proliferation human breast colorectal cancer cell lines oncogenic PIK3CA mutations led decrease GSK3beta target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 colon cancer cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest GSK3beta important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties @ DiseaseTgt $ harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0763129598901389)\n",
      "- Text: \"Mosaic overgrowth fibroadipose hyperplasia caused somatic activating mutations PIK3CA . phosphatidylinositol 3-kinase ( PI3K ) -AKT signaling pathway critical cellular growth metabolism . Correspondingly , loss function PTEN , negative regulator PI3 K , activating mutations AKT1 , AKT2 AKT3 found distinct disorders featuring overgrowth hypoglycemia . performed exome sequencing DNA unaffected affected cells individual unclassified syndrome congenital progressive segmental overgrowth fibrous adipose tissue bone identified @ DiseaseTgt $ mutation encoding p. His1047Leu PIK3CA , gene encodes p110alpha catalytic subunit PI3 K , affected cells . Sequencing PIK3CA ten additional individuals overlapping syndromes identified either p. His1047Leu alteration second @ DiseaseTgt $ alteration , p. His1047Arg , nine cases . Affected dermal fibroblasts showed enhanced basal @ GeneSrc $ @ GeneSrc $ phosphatidylinositol 3,4,5-trisphosphate ( PIP ( 3 ) ) generation concomitant activation downstream signaling relative unaffected counterparts . findings characterize distinct overgrowth syndrome , biochemically demonstrate activation PI3 K signaling thereby identify rational therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0030306070435391)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human cancers . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable @ GeneSrc $ mTOR-independent cell proliferation associated AKT , ERK , GSK3beta phosphorylation . Paradoxically , GSK3beta inhibitors lithium chloride SB216763 selectively decreased proliferation human breast @ DiseaseTgt $ cell lines oncogenic PIK3CA mutations led decrease GSK3beta target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 @ DiseaseTgt $ cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest GSK3beta important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties cancers harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003536704186125)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( @ GeneSrc $ , MLXIPL , PCSK9 , GALNT2 GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005989510785766)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human @ DiseaseTgt $ . profiled mutation status PIK3Ca gene National @ DiseaseTgt $ Institute ( NCI ) -60 panel human @ DiseaseTgt $ cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two ovarian cancer , one lung cancer . BRAF @ GeneSrc $ genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention @ DiseaseTgt $ harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012371517814618)\n",
      "- Text: \"molecular evolution acquired resistance targeted @ GeneSrc $ blockade colorectal cancers . Colorectal tumours wild type KRAS often sensitive @ GeneSrc $ blockade , almost always develop resistance within several months initiating therapy . mechanisms underlying acquired resistance @ GeneSrc $ antibodies largely unknown . situation marked contrast small-molecule targeted agents , inhibitors ABL , @ GeneSrc $ , BRAF MEK , mutations genes encoding protein targets render @ DiseaseTgt $ resistant effects drugs . simplest hypothesis account development resistance @ GeneSrc $ blockade rare cells KRAS mutations pre-exist low levels @ DiseaseTgt $ ostensibly wild-type KRAS genes . Although hypothesis would seem readily testable , evidence pre-clinical models support , data patients . test hypothesis , determined whether mutant KRAS DNA could detected circulation 28 patients receiving monotherapy panitumumab , therapeutic @ GeneSrc $ antibody . found 9 24 ( 38 % ) patients whose @ DiseaseTgt $ initially KRAS wild type developed detectable mutations KRAS sera , three developed multiple different KRAS mutations . appearance mutations consistent , generally occurring 5 6 months following treatment . Mathematical modelling indicated mutations present expanded subclones initiation panitumumab treatment . results suggest emergence KRAS mutations mediator acquired resistance @ GeneSrc $ blockade mutations detected non-invasive manner . explain @ DiseaseTgt $ develop resistance targeted therapies highly reproducible fashion .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.939470691198484)\n",
      "- Text: \"Restoration p53 function leads @ DiseaseTgt $ regression vivo . Tumorigenesis multi-step process requires activation oncogenes inactivation @ DiseaseTgt $ suppressor genes . Mouse models human @ DiseaseTgt $ recently demonstrated continuous expression dominantly acting oncogene ( example , Hras , Kras Myc ) often required @ DiseaseTgt $ maintenance ; phenotype referred oncogene addiction . concept received clinical validation development active anticancer drugs specifically inhibit function oncoproteins BCR-ABL , c-KIT @ GeneSrc $ . Identifying additional gene mutations required @ DiseaseTgt $ maintenance may therefore yield clinically useful targets new @ DiseaseTgt $ therapies . Although loss p53 function common feature human @ DiseaseTgt $ , known whether sustained inactivation @ DiseaseTgt $ suppressor pathways required @ DiseaseTgt $ maintenance . explore issue , developed Cre-loxP-based strategy temporally control @ DiseaseTgt $ suppressor gene expression vivo . show restoring endogenous p53 expression leads regression autochthonous lymphomas sarcomas mice without affecting normal tissues . mechanism responsible @ DiseaseTgt $ regression dependent @ DiseaseTgt $ type , main consequence p53 restoration apoptosis lymphomas suppression cell growth features cellular senescence sarcomas . results support efforts treat human @ DiseaseTgt $ way pharmacological reactivation p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9858185973323236)\n",
      "- Text: \"p53 Pten control neural glioma stem/progenitor cell renewal differentiation . Glioblastoma ( GBM ) highly lethal brain tumour presenting one two subtypes distinct clinical histories molecular profiles . primary GBM subtype presents acutely high-grade disease typically harbours mutations @ GeneSrc $ , PTEN INK4A/ARF ( also known CDKN2A ) , secondary GBM subtype evolves slow progression low-grade disease classically possesses PDGF TP53 events . show concomitant central nervous system ( CNS ) -specific deletion p53 Pten mouse CNS generates penetrant acute-onset high-grade malignant glioma phenotype notable clinical , pathological molecular resemblance primary GBM humans . genetic observation prompted TP53 PTEN mutational analysis human primary GBM , demonstrating unexpectedly frequent inactivating mutations TP53 well expected PTEN mutations . Integrated transcriptomic profiling , silico promoter analysis functional studies murine neural stem cells ( NSCs ) established dual , singular , inactivation p53 Pten promotes undifferentiated state high renewal potential drives increased Myc protein levels associated signature . Functional studies validated increased Myc activity potent contributor impaired differentiation enhanced renewal NSCs doubly null p53 Pten ( p53 ( -/- ) Pten ( -/- ) ) well @ DiseaseTgt $ neurospheres ( TNSs ) derived model . Myc also serves maintain robust tumorigenic potential p53 ( -/- ) Pten ( -/- ) TNSs . murine modelling studies , together confirmatory transcriptomic/promoter studies human primary GBM , validate pathogenetic role common @ DiseaseTgt $ suppressor mutation profile human primary GBM establish Myc important target cooperative actions p53 Pten regulation normal malignant stem/progenitor cell differentiation , self-renewal tumorigenic potential .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001019732345838)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two @ DiseaseTgt $ , one lung cancer . BRAF @ GeneSrc $ genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032160289141625)\n",
      "- Text: \"Localization novel v-erbB-related gene , c-erbB-2 , human chromosome 17 amplification @ DiseaseTgt $ cell line . c-erbB-2 gene v-erbB-related proto-oncogene distinct gene encoding @ GeneSrc $ . using two independent methods , hybridization sorted chromosomes metaphase spreads cloned c-erbB-2 DNA , mapped c-erbB-2 locus human chromosome 17 q21 , specific breakpoint observed translocation associated acute promyelocytic leukemia . Furthermore , observed amplification elevated expression c-erbB-2 gene MKN-7 @ DiseaseTgt $ cell line . data suggest possible involvement c-erbB-2 gene human cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007051238926897)\n",
      "- Text: \"Similarity protein encoded human c-erb-B-2 gene @ GeneSrc $ . novel v-erb-B-related gene , c-erb-B-2 , identified human genome , maps human chromosome 17 q21 ( ref . 40 ) , seems encode polypeptide kinase domain highly homologous , distinct , @ GeneSrc $ . c-erb-B-2 gene conserved vertebrates suggested neu gene , detected series rat neuro/glioblastomas , , fact , rat c-erb-B-2 gene . Amplification c-erb-B-2 gene salivary adenocarcinoma @ DiseaseTgt $ cell line MKN-7 suggests over-expression sometimes involved neoplastic process . determine nature c-erb-B-2 protein , molecularly cloned complementary DNA c-erb-B-2 messenger RNA prepared MKN-7 cells . sequence shows c-erb-B-2 gene encodes possible receptor protein allows analysis similarity protein @ GeneSrc $ neu product . consequence chromosomal aberration MKN-7 cells , 4.6-kilobase ( kb ) normal transcript truncated 2.3-kb transcript c-erb-B-2 synthesized elevated levels . latter transcript presumably encodes extracellular domain putative receptor .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0037842430253043)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two @ DiseaseTgt $ , two ovarian cancer , one lung cancer . BRAF @ GeneSrc $ genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.002312132822362)\n",
      "- Text: \"Unresponsiveness @ DiseaseTgt $ BRAF ( V600E ) inhibition feedback activation @ GeneSrc $ . Inhibition BRAF ( V600E ) oncoprotein small-molecule drug PLX4032 ( vemurafenib ) highly effective treatment melanoma . However , @ DiseaseTgt $ patients harbouring BRAF ( V600E ) oncogenic lesion poor prognosis show limited response drug . investigate cause limited therapeutic effect PLX4032 BRAF ( V600E ) mutant colon tumours , performed RNA-interference-based genetic screen human cells search kinases whose knockdown synergizes BRAF ( V600E ) inhibition . report blockade @ GeneSrc $ ( @ GeneSrc $ ) shows strong synergy BRAF ( V600E ) inhibition . find multiple BRAF ( V600E ) mutant @ DiseaseTgt $ inhibition @ GeneSrc $ antibody drug cetuximab small-molecule drugs gefitinib erlotinib strongly synergistic BRAF ( V600E ) inhibition , vitro vivo . Mechanistically , find BRAF ( V600E ) inhibition causes rapid feedback activation @ GeneSrc $ , supports continued proliferation presence BRAF ( V600E ) inhibition . Melanoma cells express low levels @ GeneSrc $ therefore subject feedback activation . Consistent , find ectopic expression @ GeneSrc $ melanoma cells sufficient cause resistance PLX4032 . data suggest BRAF ( V600E ) mutant @ DiseaseTgt $ ( approximately 8 - 10 % @ DiseaseTgt $ ) , currently targeted treatment options available , might benefit combination therapy consisting BRAF @ GeneSrc $ inhibitors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5970485764137508)\n",
      "- Text: \"Reversible adaptive resistance BRAF ( V600E ) inhibition melanoma . Treatment BRAF ( V600E ) mutant melanoma small molecule drugs target BRAF MEK kinases effective , resistance develops invariably . contrast , @ DiseaseTgt $ harbour BRAF ( V600E ) mutation intrinsically resistant BRAF inhibitors , due feedback activation @ GeneSrc $ ( @ GeneSrc $ ) . show 6 16 melanoma tumours analysed acquired @ GeneSrc $ expression development resistance BRAF MEK inhibitors . Using chromatin-regulator-focused short hairpin RNA ( shRNA ) library , find suppression sex determining region Y-box 10 ( SOX10 ) melanoma causes activation TGF-beta signalling , thus leading upregulation @ GeneSrc $ platelet-derived growth factor receptor-beta ( PDGFRB ) , confer resistance BRAF MEK inhibitors . Expression @ GeneSrc $ melanoma treatment TGF-beta results slow-growth phenotype cells displaying hallmarks oncogene-induced senescence . However , @ GeneSrc $ expression exposure TGF-beta becomes beneficial proliferation presence BRAF MEK inhibitors . heterogeneous population melanoma cells varying levels SOX10 suppression , cells low SOX10 consequently high @ GeneSrc $ expression rapidly enriched presence drug , reversed drug treatment discontinued . find evidence SOX10 loss and/or activation TGF-beta signalling 4 6 @ GeneSrc $ drug-resistant melanoma patient samples . findings provide rationale BRAF MEK inhibitor-resistant melanoma patients may regain sensitivity drugs ' drug holiday ' identify patients @ GeneSrc $ melanoma group may benefit re-treatment drug holiday .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5313430804717683)\n",
      "- Text: \"TOE1 interacts p53 modulate transactivation potential . TOE1 gene discovered target @ GeneSrc $ transcription factor participates cell growth regulation upregulation p21 cell cycle delay G2/M phase . report TOE1 able bind p53 @ DiseaseTgt $ suppressor protein , specifically interacting C terminal tetramerization domain p53 . characterized interaction determination binding kinetics using nanoporous optical interferometry demonstrated interaction capable enhancing transcriptional activity p53-dependent gene targets . results suggest mechanistic role TOE1 co-regulator p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0019969272035782)\n",
      "- Text: \"( 1 ; 12 ) ( q21 ; p13 ) translocation human @ DiseaseTgt $ results TEL-ARNT fusion . TEL/ETV6 gene located 12p13 encodes member ETS family transcription factors . Translocated ETS leukemia ( TEL ) frequently involved chromosomal translocations human malignancies , usually resulting expression fusion proteins amino-terminal part TEL either unrelated transcription factors protein tyrosine kinases . characterized ( 1 ; 12 ) ( q21 ; p13 ) translocation @ DiseaseTgt $ ( @ DiseaseTgt $ ) . protein level , untranslocated TEL copy , result ( 1 ; 12 ) translocation , fusion protein TEL essentially aryl hydrocarbon receptor nuclear translocator ( ARNT ) expressed . involvement ARNT human leukemogenesis previously described . ARNT protein belongs subfamily `` basic region helix-loop-helix `` ( bHLH ) protein shares additional region similarity called PAS ( Per , ARNT , SIM ) domain . ARNT central partner several heterodimeric transcription factors , including containing aryl hydrocarbon ( dioxin ) receptor ( @ GeneSrc $ ) hypoxia-inducible factor 1alpha ( HIF1alpha ) . results show TEL-ARNT fusion protein crucial product translocation suggest interference activity @ GeneSrc $ HIF1alpha contribute leukemogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0200601331264211)\n",
      "- Text: \"Induction medulloblastomas p53-null mutant mice somatic inactivation @ GeneSrc $ external granular layer cells cerebellum . Medulloblastomas among common @ DiseaseTgt $ childhood , associated substantial mortality morbidity . molecular pathogenesis well ontogeny @ DiseaseTgt $ still poorly understood . generated mouse model medulloblastoma Cre-LoxP-mediated inactivation @ GeneSrc $ p53 @ DiseaseTgt $ suppressor genes cerebellar external granular layer ( EGL ) cells . GFAP-Cre-mediated recombination found astrocytes immature precursor cells EGL developing cerebellum . @ GeneSrc $ LoxP/LoxP ) mice developed highly aggressive embryonal tumors cerebellum typical features medulloblastoma . @ DiseaseTgt $ identified early 7 weeks age outer surface molecular layer , corresponding location EGL cells development . results demonstrate loss function @ GeneSrc $ essential medulloblastoma development mouse strongly support hypothesis medulloblastomas arise multipotent precursor cells located EGL .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2768147530833773)\n",
      "- Text: \"crucial role adipose tissue p53 regulation insulin resistance . Various stimuli , telomere dysfunction oxidative stress , induce irreversible cell growth arrest , termed ' cellular senescence ' . response controlled @ DiseaseTgt $ suppressor proteins p53 @ GeneSrc $ . also evidence senescent cells promote changes related aging age-related diseases . show p53 expression adipose tissue crucially involved development insulin resistance , underlies age-related cardiovascular metabolic disorders . found excessive calorie intake led accumulation oxidative stress adipose tissue mice type 2 diabetes-like disease promoted senescence-like changes , increased activity senescence-associated beta-galactosidase , increased expression p53 increased production proinflammatory cytokines . Inhibition p53 activity adipose tissue markedly ameliorated senescence-like changes , decreased expression proinflammatory cytokines improved insulin resistance mice type 2 diabetes-like disease . Conversely , upregulation p53 adipose tissue caused inflammatory response led insulin resistance . Adipose tissue individuals diabetes also showed senescence-like features . results show previously unappreciated role adipose tissue p53 expression regulation insulin resistance suggest cellular aging signals adipose tissue could new target treatment diabetes ( pages 996 - 967 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1397746182395732)\n",
      "- Text: \"inherent instability mutant p53 alleviated Mdm2 p16INK4a loss . p53 tumor suppressor often disrupted human @ DiseaseTgt $ acquisition missense mutations . generated mice missense mutation codon 172 mimics p53R175H hot spot mutation human @ DiseaseTgt $ . p53 homozygous mutant mice unstable mutant p53 normal cells stabilize mutant p53 @ DiseaseTgt $ . investigate significance data , examined regulation mutant p53 stability Mdm2 , E3 ubiquitin ligase targets p53 degradation , p16INK4a , member @ GeneSrc $ tumor suppressor pathway . Mice lacking Mdm2 p16INK4a stabilized mutant p53 , revealed earlier age @ DiseaseTgt $ onset p53 mutant mice gain-of-function metastatic phenotype . Analysis @ DiseaseTgt $ p53 homozygous mutant mice stable p53 revealed defects @ GeneSrc $ pathway . Additionally , ionizing radiation stabilizes wild-type mutant p53 . Thus , stabilization mutant p53 given prerequisite gain-of-function phenotype . Since mutant p53 stability mimics wild-type p53 , data indicate drugs aimed activating wild-type p53 also stabilize mutant p53 dire consequences .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.986241439962587)\n",
      "- Text: \"Two transmembrane aspartates presenilin-1 required presenilin endoproteolysis gamma-secretase activity . Accumulation amyloid-beta protein ( Abeta ) cerebral cortex early invariant event pathogenesis @ DiseaseTgt $ . final step generation Abeta beta-amyloid precursor protein apparently intramembranous proteolysis elusive gamma-secretase ( ) . common cause familial @ DiseaseTgt $ mutation genes encoding presenilins 1 2 , alters gamma-secretase activity increase production highly amyloidogenic Abeta42 isoform . Moreover , deletion presenilin-1 mice greatly reduces gamma-secretase activity , indicating presenilin-1 mediates proteolytic event . report mutation either two conserved transmembrane ( TM ) aspartate residues presenilin-1 , Asp 257 ( TM6 ) Asp 385 ( TM7 ) , substantially reduces Abeta production increases amounts carboxy-terminal fragments beta-amyloid precursor protein substrates gamma-secretase . observed effects three different cell lines well cell-free microsomes . Either Asp -- > Ala mutations also prevented normal endoproteolysis presenilin-1 TM6 -- > TM7 cytoplasmic loop . functional presenilin-1 variant ( carrying deletion exon 9 ) associated familial @ DiseaseTgt $ require cleavage , Asp 385 -- > Ala mutation still inhibited gamma-secretase activity . results indicate two transmembrane aspartate residues critical presenilin-1 endoproteolysis gamma-secretase activity , suggest presenilin 1 either unique diaspartyl cofactor gamma-secretase gamma-secretase , autoactivated intramembranous @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0021414119387902)\n",
      "- Text: \"GSK-3alpha regulates production @ DiseaseTgt $ amyloid-beta peptides . @ DiseaseTgt $ associated increased production aggregation amyloid-beta ( Abeta ) peptides . Abeta peptides derived amyloid precursor protein ( APP ) sequential proteolysis , catalysed @ GeneSrc $ BACE , followed presenilin-dependent gamma-secretase cleavage . Presenilin interacts nicastrin , APH-1 PEN-2 ( ref . 6 ) , required gamma-secretase function . Presenilins also interact alpha-catenin , beta-catenin glycogen synthase kinase-3beta ( GSK-3beta ) , functional role proteins gamma-secretase activity established . show therapeutic concentrations lithium , GSK-3 inhibitor , block production Abeta peptides interfering APP cleavage gamma-secretase step , inhibit Notch processing . Importantly , lithium also blocks accumulation Abeta peptides brains mice overproduce APP . target lithium setting GSK-3alpha , required maximal processing APP . Since GSK-3 also phosphorylates tau protein , principal component neurofibrillary tangles , inhibition GSK-3alpha offers new approach reduce formation amyloid plaques neurofibrillary tangles , two pathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9343104024564952)\n",
      "- Text: \"eIF4F nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation RAS-RAF-MEK-ERK mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , PI ( 3 ) K-AKT-mTOR , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation eIF4F eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation eIF4F complex , comprising eIF4E cap-binding protein , eIF4 G scaffolding protein @ GeneSrc $ RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance eIF4F complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory eIF4E-binding protein 4EBP1 increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation eIF4 G . development situ method detect eIF4E-eIF4 G interactions shows eIF4F complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting eIF4F complex , either blocking eIF4E-eIF4 G interaction targeting @ GeneSrc $ , synergizes inhibiting BRAF ( V600 ) kill cancer cells . eIF4F appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) eIF4F may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001596079640785)\n",
      "- Text: \"Translation initiator EIF4G1 mutations familial @ DiseaseTgt $ . Genome-wide analysis multi-incident family autosomal-dominant parkinsonism implicated locus chromosomal region 3q26-q28 . Linkage disease segregation explained missense mutation c.3614G > ( p. Arg1205His ) eukaryotic translation initiation factor 4-gamma ( EIF4G1 ) . Subsequent sequence genotype analysis identified EIF4G1 c.1505C > ( p. Ala502Val ) , c.2056G > ( p. Gly686Cys ) , c.3490A > C ( p. Ser1164Arg ) , c.3589C > ( p. Arg1197Trp ) c.3614G > ( p. Arg1205His ) substitutions affected subjects familial parkinsonism idiopathic Lewy body disease control subjects . Despite different countries origin , persons EIF4G1 c.1505C > ( p. Ala502Val ) c.3614G > ( p. Arg1205His ) mutations appear share haplotypes consistent ancestral founders . eIF4G1 p. Ala502Val p. Arg1205His disrupt @ GeneSrc $ eIF3e binding , although wild-type protein , render mutant cells vulnerable reactive oxidative species . EIF4G1 mutations implicate mRNA translation initiation familial parkinsonism highlight convergent pathway monogenic , toxin perhaps virally-induced @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006140320373694)\n",
      "- Text: \"@ GeneSrc $ nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation RAS-RAF-MEK-ERK mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , PI ( 3 ) K-AKT-mTOR , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation @ GeneSrc $ eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation @ GeneSrc $ complex , comprising eIF4E cap-binding protein , eIF4 G scaffolding protein eIF4A RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance @ GeneSrc $ complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory @ GeneSrc $ protein 4EBP1 increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation eIF4 G . development situ method detect @ GeneSrc $ G interactions shows @ GeneSrc $ complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting @ GeneSrc $ complex , either blocking @ GeneSrc $ G interaction targeting eIF4A , synergizes inhibiting BRAF ( V600 ) kill cancer cells . @ GeneSrc $ appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) @ GeneSrc $ may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0523662457535189)\n",
      "- Text: \"TSC2 phosphorylated inhibited Akt suppresses mTOR signalling . Tuberous sclerosis ( TSC ) autosomal dominant disorder characterized formation hamartomas wide range human tissues . Mutation either TSC1 TSC2 @ DiseaseTgt $ suppressor gene responsible familial sporadic forms disease . TSC1 TSC2 proteins form physical functional complex vivo . , show TSC1-TSC2 inhibits p70 ribosomal protein S6 kinase 1 ( activator translation ) activates eukaryotic initiation factor 4E binding protein 1 ( @ GeneSrc $ , inhibitor translational initiation ) . functions TSC1-TSC2 mediated inhibition mammalian target rapamycin ( mTOR ) . Furthermore , TSC2 directly phosphorylated Akt , involved stimulating cell growth activated growth stimulating signals , insulin . TSC2 inactivated Akt-dependent phosphorylation , destabilizes TSC2 disrupts interaction TSC1 . data indicate molecular mechanism TSC2 insulin signalling , @ DiseaseTgt $ suppressor functions inhibition cell growth .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0033776270095144)\n",
      "- Text: \"eIF4F nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation RAS-RAF-MEK-ERK mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , PI ( 3 ) K-AKT-mTOR , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation eIF4F eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation eIF4F complex , comprising eIF4E cap-binding protein , eIF4 G scaffolding protein eIF4A RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance eIF4F complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory eIF4E-binding protein @ GeneSrc $ increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation eIF4 G . development situ method detect eIF4E-eIF4 G interactions shows eIF4F complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting eIF4F complex , either blocking eIF4E-eIF4 G interaction targeting eIF4A , synergizes inhibiting BRAF ( V600 ) kill cancer cells . eIF4F appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) eIF4F may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.2728869158021104e-07)\n",
      "- Text: \"Translation initiator @ GeneSrc $ mutations familial @ DiseaseTgt $ . Genome-wide analysis multi-incident family autosomal-dominant parkinsonism implicated locus chromosomal region 3q26-q28 . Linkage disease segregation explained missense mutation c.3614G > ( p. Arg1205His ) eukaryotic translation initiation factor 4-gamma ( @ GeneSrc $ ) . Subsequent sequence genotype analysis identified @ GeneSrc $ c.1505C > ( p. Ala502Val ) , c.2056G > ( p. Gly686Cys ) , c.3490A > C ( p. Ser1164Arg ) , c.3589C > ( p. Arg1197Trp ) c.3614G > ( p. Arg1205His ) substitutions affected subjects familial parkinsonism idiopathic Lewy body disease control subjects . Despite different countries origin , persons @ GeneSrc $ c.1505C > ( p. Ala502Val ) c.3614G > ( p. Arg1205His ) mutations appear share haplotypes consistent ancestral founders . @ GeneSrc $ p. Ala502Val p. Arg1205His disrupt eIF4E eIF3e binding , although wild-type protein , render mutant cells vulnerable reactive oxidative species . @ GeneSrc $ mutations implicate mRNA translation initiation familial parkinsonism highlight convergent pathway monogenic , toxin perhaps virally-induced @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.334103737105049)\n",
      "- Text: \"Whole exome sequencing rare variants @ GeneSrc $ VPS35 @ DiseaseTgt $ . OBJECTIVE : Recently , vacuolar protein sorting 35 ( VPS35 ) @ GeneSrc $ ( @ GeneSrc $ ) identified 2 causal @ DiseaseTgt $ ( @ DiseaseTgt $ ) genes . used whole exome sequencing rapid , parallel analysis variations 2 genes . METHODS : performed whole exome sequencing 213 patients @ DiseaseTgt $ 272 control individuals . rare variants ( RVs ) < 5 % frequency exome variant server database control data considered analysis . performed joint gene-based tests association using RVASSOC SKAT ( Sequence Kernel Association Test ) well single-variant test statistics . RESULTS : identified 3 novel VPS35 variations changed coded amino acid ( nonsynonymous ) 3 cases . Two variations multiplex families neither segregated @ DiseaseTgt $ . @ GeneSrc $ , identified 11 ( 9 nonsynonymous 2 small indels ) RVs including reported pathogenic mutation p. R1205H , segregated affected members large family , also 1 unaffected 86-year-old family member . Two additional RVs found isolated patients . Whereas initial association studies suggested association ( p = 0.04 ) RVs @ GeneSrc $ , subsequent testing second dataset driving variant ( p. F1461 ) suggested association RVs gene @ DiseaseTgt $ . CONCLUSIONS : confirm specific @ GeneSrc $ variation p. R1205H seems strong @ DiseaseTgt $ risk factor , nonpenetrant least one 86-year-old . select RVs genes could ruled causal . However , evidence overall contribution genetic variability VPS35 @ GeneSrc $ @ DiseaseTgt $ development dataset .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1294560491112282)\n",
      "- Text: \"@ GeneSrc $ neither strong common risk factor @ DiseaseTgt $ : evidence large European cohorts . BACKGROUND : Missense mutations @ GeneSrc $ ( @ GeneSrc $ ) gene previously implicated familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . large @ DiseaseTgt $ family autosomal-dominant segregation showed heterozygous missense mutation additional patients found unique sequence variants observed controls . Subsequent studies reported contradictory findings . METHODS : assessed relevance @ GeneSrc $ mutations European cohort 2146 @ DiseaseTgt $ patients . , 2051 sporadic @ DiseaseTgt $ patients screened reported p. Ala502Val p. Arg1205His mutations . addition , complete coding region @ GeneSrc $ directly sequenced 95 familial @ DiseaseTgt $ patients autosomal-dominant inheritance . Moreover , imputed p. Arg1205His substitution tested association @ DiseaseTgt $ Icelandic population ( 93 698 samples ) . RESULTS : observe presence p. Ala502Val substitution cohort ; however , p. Arg1205His mutation identified one sporadic @ DiseaseTgt $ patient . mutation also found 76 Icelandic subjects older 65 years using haplotype imputing . five subjects reported @ DiseaseTgt $ symptoms ( 1.3 , p=0.50 ) . Thus , causal , p. Arg1205His @ GeneSrc $ mutation low penetrance late onset manifestation . novel variant p. Arg566Cys found patient familial @ DiseaseTgt $ cosegregate @ DiseaseTgt $ three affected siblings . recently published @ GeneSrc $ mutations found cohort likely benign polymorphisms . CONCLUSIONS : largest genetic study @ GeneSrc $ mutations @ DiseaseTgt $ . data support @ GeneSrc $ gene high-risk @ DiseaseTgt $ locus , neither familial sporadic condition . Furthermore , p. Arg1205His mutation significantly associated increased risk @ DiseaseTgt $ Icelandic population . Therefore , caution exercised interpreting @ GeneSrc $ genotyping results isolated patients @ DiseaseTgt $ families . summary , diagnostic testing @ GeneSrc $ recommended clinical settings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.110075870980401)\n",
      "- Text: \"eIF4F nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation RAS-RAF-MEK-ERK mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , PI ( 3 ) K-AKT-mTOR , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation eIF4F eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation eIF4F complex , comprising eIF4E cap-binding protein , @ GeneSrc $ scaffolding protein eIF4A RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance eIF4F complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory eIF4E-binding protein 4EBP1 increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation @ GeneSrc $ development situ method detect @ GeneSrc $ interactions shows eIF4F complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting eIF4F complex , either blocking @ GeneSrc $ interaction targeting eIF4A , synergizes inhibiting BRAF ( V600 ) kill cancer cells . eIF4F appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) eIF4F may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.402639056271068e-05)\n",
      "- Text: \"Identification 46 novel SNPs 130-kb region containing myocardial infarction susceptibility gene chromosomal band 6p21 . identified total 187 single-nucleotide polymorphisms ( SNPs ) 11 gene loci 130-kb region chromosome 6p21 containing gene strongly associated @ DiseaseTgt $ ( MI ) . comparing data SNPs deposited dbSNP database National Center Biotechnology Information , 46 SNPs ( 24.6 % ) considered novel : four identified P5 - 1 locus , 14 MICB locus , nine BAT1 locus , one ATP6V1G2 locus , six NFKBIL1 locus , one LTA locus , one TNF locus , five LST1 locus , four LY117a locus , one @ GeneSrc $ locus . SNP map presented provide useful resource examining relationships genotypes susceptibility MI phenotype , also scanning complex diseases mapped local segment chromosome 6 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.1176862385829789e-07)\n",
      "- Text: \"@ GeneSrc $ complexes mediates endocytosis beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein . primary histopathological feature @ DiseaseTgt $ accumulation beta-amyloid ( beta ) brain afflicted individuals . However , beta produced continuously soluble protein healthy individuals detected serum CSF , suggesting existence cellular clearance mechanisms normally prevent accumulation aggregation . , demonstrate beta forms stable complexes activated @ GeneSrc $ ( @ GeneSrc $ ) , physiological ligand low-density lipoprotein receptor-related protein ( LRP ) abundantly expressed CNS . @ GeneSrc $ beta complexes immunoreactive anti-A beta @ GeneSrc $ IgG stable various pH conditions , sodium dodecyl sulfate , reducing agents , boiling . demonstrate @ GeneSrc $ beta complexes degraded glioblastoma cells fibroblasts via LRP , degradation partially inhibited receptor-associated protein ( RAP ) , antagonist ligand interactions LRP . contrast , degradation free 125I-A beta inhibited RAP thus must mediated via LRP-independent pathway . results suggest LRP function clearance receptor beta via physiological ligand .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0567639815272625)\n",
      "- Text: \"Modulation amyloid beta-protein clearance @ DiseaseTgt $ susceptibility LDL receptor-related protein pathway . Susceptibility @ DiseaseTgt $ ( @ DiseaseTgt $ ) governed multiple genetic factors . Remarkably , LDL receptor-related protein ( LRP ) ligands , apoE @ GeneSrc $ , genetically associated @ DiseaseTgt $ . study , provide evidence involvement LRP pathway amyloid deposition sequestration removal soluble amyloid beta-protein ( Abeta ) . demonstrate vitro LRP mediates clearance Abeta40 Abeta42 bona fide receptor-mediated uptake mechanism . vivo , reduced LRP expression associated LRP genotypes correlated enhanced soluble Abeta levels amyloid deposition . Although LRP proposed clearance pathway Abeta , work provides first vivo evidence LRP pathway may modulate Abeta deposition @ DiseaseTgt $ susceptibility regulating removal soluble Abeta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0821187680887371)\n",
      "- Text: \"Increased risk @ DiseaseTgt $ interaction MPO @ GeneSrc $ polymorphisms . BACKGROUND : genes encoding myeloperoxidase ( MPO ) @ GeneSrc $ ( @ GeneSrc $ ) involved molecular pathways leading beta-amyloid deposition . Two polymorphic sites genes ( MPO-G/A @ GeneSrc $ ) associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , conflicting findings reported populations different ethnic backgrounds . OBJECTIVES : study association MPO-G/A @ GeneSrc $ polymorphisms sporadic @ DiseaseTgt $ investigate interactions among MPO , @ GeneSrc $ , apolipoprotein E ( APOE ) gene polymorphisms determining risk development @ DiseaseTgt $ . DESIGN : Case-control study . SETTING : Referral center @ DiseaseTgt $ Calabria , southern Italy . PARTICIPANTS : One hundred forty-eight patients sporadic @ DiseaseTgt $ 158 healthy control subjects . RESULTS : MPO-G @ GeneSrc $ alleles found frequently cases controls , MPO-G/G @ GeneSrc $ genotypes . odds ratio ( ) MPO-G/G genotype 1.78 ( 95 % confidence interval [ CI ] , 1.13 - 2.80 ) ; @ GeneSrc $ genotype , 3.81 ( 95 % CI , 1.66 - 8.75 ) . presence MPO-G/G @ GeneSrc $ genotypes synergistically increased risk @ DiseaseTgt $ ( , 25.5 ; 95 % CI , 4.65 - 139.75 ) . Stratification cases sex , age onset @ DiseaseTgt $ , APOE-epsilon 4 status show significant differences distribution MPO @ GeneSrc $ polymorphisms . CONCLUSIONS : MPO @ GeneSrc $ polymorphisms associated sporadic @ DiseaseTgt $ southern Italy . Moreover , genomic interaction polymorphisms increases risk development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7691872419767319)\n",
      "- Text: \"4-bp deletion Birt-Hogg-Dube gene ( @ GeneSrc $ ) causes dominantly inherited spontaneous pneumothorax . Primary spontaneous pneumothorax ( PSP ) , condition air enters pleural space causes secondary lung collapse , mostly sporadic also occurs families . precise etiology PSP remains unknown , although associated emphysemalike changes ( bullae ) lungs almost patients . describe results genetic study large Finnish family dominantly inherited tendency PSP . genomewide scan suggested linkage chromosome 17p11 . Screening best candidate gene , @ GeneSrc $ , revealed 4-bp deletion first coding exon , causes frameshift predicts protein truncation 50 missense amino acids downstream . carriers deletion bullous lung lesions . Mutations @ GeneSrc $ also responsible Birt-Hogg-Dube ( BHD ) syndrome ( dominantly inherited disease characterized benign skin tumors , PSP , diverse types renal cancer ) , rarely , detected @ DiseaseTgt $ . Unlike @ GeneSrc $ mutations , exon 4 deletion seems associated bullous lung changes 100 % penetrance . results suggest changes @ GeneSrc $ may important role development PSP , importantly , emphysema , chronic pulmonary disease often leads formation bullous lesions lowered pulmonary function . Additionally , given strong association PSP BHD , connection conditions needs investigated , particularly patients familial PSP , may greater risk developing renal cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039215464564897)\n",
      "- Text: \"Investigation Birt-Hogg-Dube tumour suppressor gene ( @ GeneSrc $ ) @ DiseaseTgt $ . BACKGROUND Birt-Hogg-Dube ( BHD ) syndrome autosomal dominant multisystem disorder skin ( fibrofolliculomas trichodiscomas ) , lung ( cysts pneumothorax ) kidney ( renal cell carcinoma ) tumours . Although colorectal neoplasia reported initially part BHD phenotype , recent studies confirmed association . METHODS series clinical laboratory studies undertaken investigate possible relationships colorectal neoplasia BHD gene ( @ GeneSrc $ ) . studies investigated whether individuals @ DiseaseTgt $ unknown cause might unsuspected germline @ GeneSrc $ mutations , looked somatic @ GeneSrc $ C ( 8 ) tract mutations microsatellite unstable sporadic @ DiseaseTgt $ , assessed risk colorectal neoplasia possible genotype-phenotype correlations BHD patients . RESULTS Although found previously germline @ GeneSrc $ mutations detected approximately 5 % patients familial renal cell carcinoma , germline @ GeneSrc $ mutations detected 50 patients @ DiseaseTgt $ . Analysis genotype-phenotype correlations two recurrent @ GeneSrc $ mutations identified subset 51 families BHD demonstrated significantly higher risk colorectal neoplasia c.1285dupC mutation ( within exon 11 C ( 8 ) mononucleotide tract ) carriers c.610delGCinsTA mutation carriers ( chi ( 2 ) =5.78 , p=0.016 ) . Somatic frameshift mutations @ GeneSrc $ exon 11 C ( 8 ) mononucleotide tract detected 23 % sporadic @ DiseaseTgt $ microsatellite instability , suggesting @ GeneSrc $ inactivation might contribute @ DiseaseTgt $ . CONCLUSIONS findings suggest previously reported clinical heterogeneity colorectal neoplasia may reflect allelic heterogeneity risk colorectal neoplasia BHD syndrome requires investigation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9377537498422688)\n",
      "- Text: \"Cooperative transcription activation Nurr1 Pitx3 induces embryonic stem cell maturation midbrain dopamine neuron phenotype . Midbrain dopamine ( DA ) neurons play central role regulation voluntary movement , degeneration associated @ DiseaseTgt $ . Cell replacement therapies , particular embryonic stem ( ES ) cell-derived DA neurons , offer potential therapeutic venue @ DiseaseTgt $ . sought identify genes potentiate maturation ES cell cultures midbrain DA neuron phenotype . number transcription factors implicated development midbrain DA neurons expression analyses loss-of-function knockout mouse studies , including Nurr1 , Pitx3 , Lmx1b , Engrailed-1 , @ GeneSrc $ . However , none factors appear sufficient alone induce mature midbrain DA neuron phenotype ES cell cultures vitro , suggesting complex regulatory network . show Nurr1 Pitx3 cooperatively promote terminal maturation midbrain DA neuron phenotype murine human ES cell cultures .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.839910436663478e-06)\n",
      "- Text: \"TEL-AML1 , expressed ( 12 ; 21 ) human acute lymphocytic leukemia , induces @ DiseaseTgt $ mice . TEL-AML1 expressed ( 12 ; 21 ) chromosomal translocation inB-precursor acute lymphocytic leukemia ( ) . Creation TEL-AML1fusion disrupts one copy TEL AML1 genes , loss TEL AML1 also associated cases @ DiseaseTgt $ without TEL-AML1 . determine whether TEL-AML1 contribute leukemogenesis , transduced marrow C57BL/6 mice retroviral vector expressing TEL-AML1 control vector . Transduced cells introduced irradiated syngeneic recipients . Two 9 TEL-AML1 mice developed ( one T-lineage one B-precursor ) , whereas 0 20 control mice developed leukemia . B-precursor retransplantable expressed TEL-AML1 . similarly transduced marrow C57BL/6 mice lacking overlapping p16 ( INK4a ) p19 ( ARF ) genes transplanted cells wild-type recipients . control mice died , six eight TEL-AML1/p16p19 mice died leukemia . Overall , findings indicate TEL-AML1 contributes leukemogenesis may cooperate loss @ GeneSrc $ ) transform lymphoid progenitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.827120529509992e-05)\n",
      "- Text: \"Long-term haematopoietic reconstitution Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - -p16Ink4a , p19Arf Trp53 ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype @ GeneSrc $ , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045806168844222)\n",
      "- Text: \"Polyubiquitination p53 ubiquitin ligase activity @ GeneSrc $ . Rapid turnover @ DiseaseTgt $ suppressor protein p53 requires MDM2 ubiquitin ligase , interact @ GeneSrc $ protein transcriptional coactivator proteins . p53 stabilized binding @ GeneSrc $ oncoprotein E1A , suggesting @ GeneSrc $ regulates p53 degradation . Purified @ GeneSrc $ exhibited intrinsic ubiquitin ligase activity inhibited E1A . vitro , @ GeneSrc $ MDM2 catalyzed p53 polyubiquitination , whereas MDM2 catalyzed p53 monoubiquitination . E1A expression caused decrease polyubiquitinated monoubiquitinated p53 cells . Thus , generation polyubiquitinated forms p53 targeted proteasome degradation requires intrinsic ubiquitin ligase activities MDM2 @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5273104313448091)\n",
      "- Text: \"Mutations truncating @ GeneSrc $ acetylase human cancers . @ GeneSrc $ protein histone acetyltransferase regulates transcription via chromatin remodelling important processes cell proliferation differentiation . @ GeneSrc $ acetylation TP53 response DNA damage regulates DNA-binding transcription functions . role @ GeneSrc $ cancer implied fact targeted viral oncoproteins , fused MLL Leukaemia two missense sequence alterations @ GeneSrc $ identified epithelial malignancies . Nevertheless , direct demonstration role @ GeneSrc $ tumorigenesis inactivating mutations human cancers lacking . describe @ GeneSrc $ mutations , predict truncated protein , 6 ( 3 % ) 193 epithelial cancers analysed . six mutations , two primary tumours ( @ DiseaseTgt $ breast cancer ) four cancer cell lines ( @ DiseaseTgt $ , breast pancreatic ) . addition , identified somatic in-frame insertion primary breast cancer missense alterations primary @ DiseaseTgt $ two cell lines ( breast pancreatic ) . Inactivation second allele demonstrated five six cases truncating mutations two cases . data show @ GeneSrc $ mutated epithelial cancers provide first evidence behaves classical tumour-suppressor gene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.843141107634838)\n",
      "- Text: \"@ GeneSrc $ gene alterations @ DiseaseTgt $ . @ DiseaseTgt $ frequently loss heterozygosity chromosome 22q , suggesting inactivation tumor suppressor gene ( ) 22q participates tumor development . Neurofibromatosis 2 ( NF2 ) gene E1A binding protein @ GeneSrc $ gene , recently identified 22q , thought candidates tumor suppressor genes . study , mutation NF2 gene 59 @ DiseaseTgt $ , mutation @ GeneSrc $ gene 27 @ DiseaseTgt $ two gastric carcinomas , analysed using PCR-SSCP , RT-PCR-SSCP direct sequencing methods . Missense mutations @ GeneSrc $ gene detected @ DiseaseTgt $ , gastric carcinoma , though mutation NF2 gene detected . @ GeneSrc $ mutations somatic coupled deletion second allele gene , suggests inactivation @ GeneSrc $ gene , carcinomas . mutations located within Cys/His-rich regions , assumed play important roles function @ GeneSrc $ . first cases @ GeneSrc $ gene found altered alleles , suggesting inactivation @ GeneSrc $ gene may involved development carcinomas , gene may target loss 22q carcinomas digestive tract .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3389740877022728)\n",
      "- Text: \"del22q11.2 candidate gene Tbx1 controls regional outflow tract identity coronary artery patterning . TBX1 , encoding T-box containing transcription factor , major candidate gene del22q11.2 DiGeorge syndrome , characterized craniofacial cardiovascular defects including @ DiseaseTgt $ common arterial trunk . Mice lacking Tbx1 severe defects development pharyngeal derivatives including cardiac progenitor cells second heart field contribute arterial pole heart . outflow tract Tbx1 mutant embryos short narrow resulting common arterial trunk . show series genetic crosses using transgene markers second heart field derived myocardium coronary endothelial cells subdomain myocardium normally observed base pulmonary trunk reduced malpositioned Tbx1 mutant hearts . defect associated anomalous coronary artery patterning . right left coronary ostia form predominantly right/ventral sinus mutant hearts , proximal coronary arteries coursing across normally coronary free ventral region heart . identified @ GeneSrc $ Tbx1-dependent gene expressed subpulmonary myocardium . results implicate second heart field development coronary artery patterning provide new insights association conotruncal defects coronary artery anomalies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001573668114602)\n",
      "- Text: \"Common variants ABCA7 , MS4A6A/MS4A4E , @ GeneSrc $ , CD33 CD2AP associated @ DiseaseTgt $ . sought identify new susceptibility loci @ DiseaseTgt $ staged association study ( GERAD+ ) testing suggestive loci reported @ DiseaseTgt $ Genetic Consortium ( ADGC ) companion paper . undertook combined analysis four genome-wide association datasets ( stage 1 ) identified ten newly associated variants P < = 1 x 10 ( -5 ) . tested variants association independent sample ( stage 2 ) . Three SNPs two loci replicated showed evidence association sample ( stage 3 ) . Meta-analyses data provided compelling evidence ABCA7 ( rs3764650 , meta P = 4.5 x 10 ( -17 ) ; including ADGC data , meta P = 5.0 x 10 ( -21 ) ) MS4A gene cluster ( rs610932 , meta P = 1.8 x 10 ( -14 ) ; including ADGC data , meta P = 1.2 x 10 ( -16 ) ) new @ DiseaseTgt $ susceptibility loci . also found independent evidence association three loci reported ADGC , , combined , showed genome-wide significance : CD2AP ( GERAD+ , P = 8.0 x 10 ( -4 ) ; including ADGC data , meta P = 8.6 x 10 ( -9 ) ) , CD33 ( GERAD+ , P = 2.2 x 10 ( -4 ) ; including ADGC data , meta P = 1.6 x 10 ( -9 ) ) @ GeneSrc $ ( GERAD+ , P = 3.4 x 10 ( -4 ) ; including ADGC data , meta P = 6.0 x 10 ( -10 ) ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0094691880912002)\n",
      "- Text: \"new recurrent activating length mutation exon 20 FLT3 gene @ DiseaseTgt $ . Activating length mutations juxtamembrane ( JM ) domain FLT3 gene ( FLT3-LM ) mutations catalytic domain ( FLT3D835/836 ) receptor tyrosine kinase represent frequent genetic alterations @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , describe 6-bp insertion activation loop FLT3 codons 840 841 FLT3 ( FLT3 - 840GS ) 2 unrelated patients @ DiseaseTgt $ . Screening activating mutations FLT3 , KIT , NRAS showed genetic alterations patients carrying FLT3 - 840GS . functional analyses could show mutant hyperphosphorylated tyrosine confers interleukin 3-independent growth Ba/F3 cells , inhibited specific FLT3 @ GeneSrc $ ( @ GeneSrc $ ) inhibitor . results show first time addition known mutations JM catalytic domain , activating length mutations exist FLT3 gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1212426848496543)\n",
      "- Text: \"Tumours class 3 BRAF mutants sensitive inhibition activated RAS . Approximately 200 BRAF mutant alleles identified human tumours . Activating BRAF mutants cause feedback inhibition GTP-bound RAS , RAS-independent signal either active monomers ( class 1 ) constitutively active dimers ( class 2 ) . characterize third class BRAF mutants-those impaired kinase activity kinase-dead . mutants sensitive @ GeneSrc $ feedback activation signalling RAS-dependent . mutants bind tightly wild-type BRAF RAS-GTP , binding activation wild-type CRAF enhanced , leading increased @ GeneSrc $ signalling . model suggests dysregulation signalling mutants tumours requires coexistent mechanisms maintaining RAS activation despite @ GeneSrc $ feedback . Consistent hypothesis , melanomas class 3 BRAF mutations also harbour RAS mutations NF1 deletions . contrast , @ DiseaseTgt $ class 3 BRAF mutants , RAS typically activated receptor tyrosine kinase signalling . tumours sensitive inhibition RAS activation inhibitors receptor tyrosine kinases . thus defined three distinct functional classes BRAF mutants human tumours . mutants activate @ GeneSrc $ signalling different mechanisms dictate sensitivity therapeutic inhibitors pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0500409246182115)\n",
      "- Text: \"Oxidant stress evoked pacemaking dopaminergic neurons attenuated DJ-1 . @ DiseaseTgt $ pervasive , ageing-related neurodegenerative disease cardinal motor symptoms reflect loss small group neurons , dopaminergic neurons substantia nigra pars compacta ( SNc ) . Mitochondrial oxidant stress widely viewed responsible loss , particular neurons stressed mystery . show , using transgenic mice expressed redox-sensitive variant green fluorescent protein targeted mitochondrial matrix , engagement plasma membrane L-type calcium channels normal autonomous pacemaking created oxidant stress specific vulnerable SNc dopaminergic neurons . oxidant stress engaged defences induced transient , mild mitochondrial depolarization uncoupling . mild uncoupling affected deletion cyclophilin , component permeability transition pore , attenuated genipin purine nucleotides , antagonists cloned uncoupling proteins . Knocking DJ-1 ( also known PARK7 humans Park7 mice ) , gene associated early-onset form @ DiseaseTgt $ , downregulated expression two uncoupling proteins ( UCP4 ( SLC25A27 ) @ GeneSrc $ ( @ GeneSrc $ ) ) , compromised calcium-induced uncoupling increased oxidation matrix proteins specifically SNc dopaminergic neurons . drugs approved human use antagonize calcium entry L-type channels , results point novel neuroprotective strategy idiopathic familial forms @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1088754477517653)\n",
      "- Text: \"Resistance @ GeneSrc $ null mice @ DiseaseTgt $ neurotoxin MPTP . @ DiseaseTgt $ ( @ DiseaseTgt $ ) commonly sporadic illness , characterized degeneration substantia nigra dopamine ( DA ) neurons abnormal cytoplasmic aggregates @ GeneSrc $ . Rarely , @ DiseaseTgt $ may caused missense mutations @ GeneSrc $ . MPTP , neurotoxin inhibits mitochondrial complex , prototype environmental cause @ DiseaseTgt $ produces pattern DA neurodegeneration closely resembles neuropathology @ DiseaseTgt $ . show @ GeneSrc $ null mice display striking resistance MPTP-induced degeneration DA neurons DA release , resistance appears result inability toxin inhibit complex . Contrary predictions vitro data , resistance due abnormalities DA transporter , appears function normally @ GeneSrc $ null mice . results suggest genetic environmental factors increase susceptibility @ DiseaseTgt $ may interact common molecular pathway , represent first demonstration normal @ GeneSrc $ function may important DA neuron viability .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6401089984127956)\n",
      "- Text: \"Leucine-rich repeat kinase 2 regulates progression neuropathology induced @ DiseaseTgt $ mutant @ GeneSrc $ . Mutations @ GeneSrc $ Leucine-rich repeat kinase 2 ( LRRK2 ) linked autosomal dominant forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , little known potential pathophysiological interplay two @ DiseaseTgt $ genes . show transgenic mice although overexpression LRRK2 alone cause neurodegeneration , presence excess LRRK2 greatly accelerated progression neuropathological abnormalities developed @ DiseaseTgt $ A53 @ GeneSrc $ transgenic mice . Moreover , found LRRK2 promoted abnormal aggregation somatic accumulation @ GeneSrc $ A53 mice , likely resulted impairment microtubule dynamics , Golgi organization , ubiquitin-proteasome pathway . Conversely , genetic ablation LRRK2 preserved Golgi structure suppressed aggregation somatic accumulation @ GeneSrc $ , thereby delayed progression neuropathology A53 mice . findings demonstrate overexpression LRRK2 enhances @ GeneSrc $ cytotoxicity suggest inhibition LRRK2 expression potential therapeutic option ameliorating @ GeneSrc $ neurodegeneration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.165214704732504)\n",
      "- Text: \"Synphilin-1 attenuates neuronal degeneration A53 @ GeneSrc $ transgenic mouse model . Genetic alterations @ GeneSrc $ cause autosomal dominant familial Parkinsonism may contribute sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Synphilin-1 alpha-synuclein-interacting protein , implications @ DiseaseTgt $ pathogenesis related protein aggregation . Currently , vivo role synphilin-1 @ GeneSrc $ pathogenesis fully understood . Using mouse prion protein promoter , generated synphilin-1 transgenic mice , display @ DiseaseTgt $ phenotypes . However , synphilin-1/A53 @ GeneSrc $ double-transgenic mice survived longer A53 @ GeneSrc $ single-transgenic mice . attenuated A53 @ GeneSrc $ motor abnormalities decreased astroglial reaction neuronal degeneration brains double-transgenic mice . Overexpression synphilin-1 decreased caspase-3 activation , increased beclin-1 LC3 II expression promoted formation aggresome-like structures , suggesting synphilin-1 alters multiple cellular pathways protect neuronal degeneration . studies demonstrate synphilin-1 diminish severity alpha-synucleinopathy play neuroprotective role A53 alpha-synuclein toxicity vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0116966318149848)\n",
      "- Text: \"Extensive enteric nervous system abnormalities mice transgenic artificial chromosomes containing @ DiseaseTgt $ @ GeneSrc $ gene mutations precede central nervous system changes . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disease motor well non-motor signs gastrointestinal tract include dysphagia , gastroparesis , prolonged gastrointestinal transit time , constipation difficulty defecation . gastrointestinal dysfunction commonly precedes motor symptoms decades . @ DiseaseTgt $ sporadic unknown etiology , fraction familial . Among familial forms @ DiseaseTgt $ , small fraction caused missense ( A53 , A30P E46 K ) copy number mutations SNCA encodes alpha-synuclein , primary protein constituent Lewy bodies , pathognomonic protein aggregates found neurons @ DiseaseTgt $ . set develop transgenic mice expressing mutant @ GeneSrc $ ( either A53 A30P ) insertions entire human SNCA gene models familial disease . A53 A30P lines show robust abnormalities enteric nervous system ( ENS ) function synuclein-immunoreactive aggregates ENS ganglia 3 months age . A53 line also abnormal motor behavior neither demonstrates cardiac autonomic abnormalities , olfactory dysfunction , dopaminergic neurotransmitter deficits , Lewy body inclusions neurodegeneration . animals recapitulate early gastrointestinal abnormalities seen human @ DiseaseTgt $ . animals also serve vivo system investigate therapies reversing neurological dysfunction target @ GeneSrc $ toxicity earliest stages .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.952510896299844)\n",
      "- Text: \"Mice lacking @ GeneSrc $ display functional deficits nigrostriatal dopamine system . @ GeneSrc $ ( @ GeneSrc $ ) 14 kDa protein unknown function implicated pathophysiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , show @ GeneSrc $ mice viable fertile , exhibit intact brain architecture , possess normal complement dopaminergic cell bodies , fibers , synapses . Nigrostriatal terminals @ GeneSrc $ mice display standard pattern dopamine ( DA ) discharge reuptake response simple electrical stimulation . However , exhibit increased release paired stimuli mimicked elevated Ca2 + . Concurrent altered DA release , @ GeneSrc $ mice display reduction striatal DA attenuation DA-dependent locomotor response amphetamine . findings support hypothesis @ GeneSrc $ essential presynaptic , activity-dependent negative regulator DA neurotransmission .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0059462185880779)\n",
      "- Text: \"Fyn kinase regulates misfolded alpha-synuclein uptake NLRP3 inflammasome activation microglia . Persistent microglia-mediated neuroinflammation major pathophysiological contributor progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) , cell-signaling mechanisms governing chronic neuroinflammation well understood . , show Fyn kinase , conjunction class B scavenger receptor CD36 , regulates microglial uptake aggregated human alpha-synuclein ( alphaSyn ) , major component @ DiseaseTgt $ . alphaSyn effectively mediate LPS-independent priming activation microglial NLRP3 inflammasome . Fyn kinase regulates processes ; mediates PKCdelta-dependent NF-kappaB-p65 nuclear translocation , leading inflammasome priming , facilitates alphaSyn import microglia , contributing generation mitochondrial reactive oxygen species consequently inflammasome activation . vivo experiments using A53 @ GeneSrc $ overexpression mouse models well human @ DiseaseTgt $ neuropathological results confirm role Fyn NLRP3 inflammasome activation . Collectively , study identifies novel Fyn-mediated signaling mechanism amplifies neuroinflammation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.002458466819439)\n",
      "- Text: \"Nurr1 repression mediates cardinal features @ DiseaseTgt $ @ GeneSrc $ transgenic mice . Duplication/triplication mutations @ GeneSrc $ locus , encoding @ GeneSrc $ ( ASYN ) , loss function mutations Nurr1 , nuclear receptor guiding midbrain dopaminergic neuron development , associated familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . age , expression levels two genes midbrain dopaminergic neurons follow opposite directions ASYN expression increases expression Nurr1 decreases . investigated effect ASYN Nurr1 age-related expression alterations pathogenesis @ DiseaseTgt $ coupling Nurr1 hemizygous ASYN ( ) ( heterozygote ) ASYN ( ) ( homozygote ) transgenic mice . ASYN ( ) /Nurr1+/- ( 2-hit ) mice , contrary individual genetic traits , developed phenotypes consistent dopaminergic dysfunction . Aging ' 2-hit ' mice manifested kyphosis , severe rigid paralysis , L-DOPA responsive movement impairment cachexia died prematurely . Pathological abnormalities phenotypic mice included SN neuron degeneration , extensive neuroinflammation enhanced ASYN aggregation . Mice two wt Nurr1 alleles [ ASYN ( ) /Nurr1+/+ ] reduced ASYN load [ ASYN ( ) /Nurr1+/- ] develop phenotype pathology . Critically , found aging ASYN ( ) , contrast ASYN ( ) , mice suppress Nurr1-protein levels brain region-specific manner , addition Nurr1 hemizygosity necessary instigate @ DiseaseTgt $ pathogenesis . experiments demonstrate ASYN-dependent @ DiseaseTgt $ pathophysiology mediated least part Nurr1 down-regulation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6734334902671626)\n",
      "- Text: \"GIGYF2 gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . Grb10-Interacting GYF Protein 2 ( GIGYF2 ) initially identified interaction Grb10 , adapter protein binds activated IGF-I insulin receptors . GIGYF2 gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( PARK11 locus ) , association GIGYF2 mutations @ DiseaseTgt $ described recent publications . study investigated consequences Gigyf2 gene disruption mice . Gigyf2 null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous Gigyf2 ( +/- ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , Gigyf2 ( +/- ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . @ GeneSrc $ positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts Gigyf2 null mice exhibit decreased IGF-I-stimulated IGF-I receptor tyrosine phosphorylation augmented ERK1/2 phosphorylation . data provide evidence important role GIGYF2 age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.546506216093057e-05)\n",
      "- Text: \"Pathological @ GeneSrc $ transmission initiates Parkinson-like neurodegeneration nontransgenic mice . @ DiseaseTgt $ characterized abundant @ GeneSrc $ ( @ GeneSrc $ ) neuronal inclusions , known Lewy bodies Lewy neurites , massive loss midbrain dopamine neurons . However , cause-and-effect relationship Lewy inclusion formation neurodegeneration remains unclear . , found wild-type nontransgenic mice , single intrastriatal inoculation synthetic @ GeneSrc $ fibrils led cell-to-cell transmission pathologic @ GeneSrc $ @ DiseaseTgt $ anatomically interconnected regions . Lewy pathology accumulation resulted progressive loss dopamine neurons substantia nigra pars compacta , adjacent ventral tegmental area , accompanied reduced dopamine levels culminating motor deficits . recapitulation neurodegenerative cascade thus establishes mechanistic link transmission pathologic @ GeneSrc $ cardinal features @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1593580261716041)\n",
      "- Text: \"beta-amyloid peptides enhance @ GeneSrc $ accumulation neuronal deficits transgenic mouse model linking Alzheimer 's disease @ DiseaseTgt $ . Alzheimer 's disease @ DiseaseTgt $ associated cerebral accumulation beta-amyloid alpha-synuclein , respectively . patients clinical pathological features diseases , raising possibility overlapping pathogenetic pathways . generated transgenic ( tg ) mice neuronal expression human beta-amyloid peptides , @ GeneSrc $ , . functional morphological alterations doubly tg mice resembled Lewy-body variant Alzheimer 's disease . mice severe deficits learning memory , developed motor deficits @ GeneSrc $ singly tg mice , showed prominent age-dependent degeneration cholinergic neurons presynaptic terminals . also @ GeneSrc $ neuronal inclusions @ GeneSrc $ singly tg mice . Ultrastructurally , inclusions fibrillar doubly tg mice , whereas inclusions amorphous @ GeneSrc $ singly tg mice . beta-Amyloid peptides promoted aggregation @ GeneSrc $ cell-free system intraneuronal accumulation @ GeneSrc $ cell culture . beta-Amyloid peptides may contribute development Lewy-body diseases promoting aggregation @ GeneSrc $ exacerbating @ GeneSrc $ neuronal pathologies . Therefore , treatments block production accumulation beta-amyloid peptides could benefit broader spectrum disorders previously anticipated .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0169574389753604)\n",
      "- Text: \"Human mouse alpha-synuclein genes : comparative genomic sequence analysis identification novel gene regulatory element . human alpha-synuclein gene ( SNCA ) encodes presynaptic nerve terminal protein originally identified precursor non-beta-amyloid component Alzheimer 's disease plaques . recently , mutations SNCA identified cases familial @ DiseaseTgt $ , presenting numerous new areas investigation important disease . Molecular studies would benefit detailed information long-range sequence context @ GeneSrc $ . end , established complete genomic sequence chromosomal regions containing human mouse alpha-synuclein genes , objective using resulting sequence information identify conserved regions biological importance comparative sequence analysis . efforts yielded approximately 146 approximately 119 kb high-accuracy human mouse genomic sequence , respectively , revealing precise genetic architecture alpha-synuclein gene species . simple repeat element upstream @ GeneSrc $ identified shown necessary normal expression transient transfection assays using luciferase reporter construct . Together , studies provide valuable data facilitate detailed analysis medically important gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004864428988496)\n",
      "- Text: \"Expression @ GeneSrc $ , presynaptic protein implicated @ DiseaseTgt $ , erythropoietic lineage . present study investigated expression @ GeneSrc $ ( @ GeneSrc $ ) , presynaptic protein involved pathogenesis @ DiseaseTgt $ , erythroid cells . Using various immunological procedures , immunoreactivity @ GeneSrc $ unambiguously demonstrated erythroid lineage murine bone marrows peripheral erythrocytes . Expression @ GeneSrc $ mRNA also confirmed situ hybridization . Furthermore , flow cytometry analysis revealed approximately 80 % erythroid cells murine bone marrows expressed @ GeneSrc $ , 90 % peripheral erythrocytes expressed @ GeneSrc $ . Nonetheless , @ GeneSrc $ null mice exhibited apparently phenotypic changes erythroid cells case brains , suggesting might underlying redundant mechanisms . Together previous reports showing expression @ GeneSrc $ lymphocytes platelets , present finding supports contention @ GeneSrc $ might play important functions hematopoietic system .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4080701259733438)\n",
      "- Text: \"DJ-1 deficient mice demonstrate similar vulnerability pathogenic Ala53Thr human alpha-syn toxicity . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative movement disorder . pathological hallmark @ DiseaseTgt $ presence intraneuronal inclusions composed fibrillized alpha-synuclein ( alpha-syn ) affected brain regions . Mutations gene , PARK7 , encodes DJ-1 , cause autosomal recessive early-onset @ DiseaseTgt $ . Although DJ-1 shown involved diverse biological processes , several vitro studies suggest inhibit formation protect effects alpha-syn aggregation . previously established characterized transgenic mice expressing pathogenic Ala53Thr human alpha-syn ( M83 mice ) develop extensive @ GeneSrc $ pathologies neuroaxis resulting severe motor impairments eventual fatality . current study , crossbred M83 mice DJ-1 null background ( M83-DJnull mice ) efforts determine effects lack DJ-1 mice . Animals assessed compared survival rate , distribution @ GeneSrc $ inclusions , biochemical properties @ GeneSrc $ protein , demise function nigral dopaminergic neurons , extent gliosis neuroaxis . M83 M83-DJnull mice displayed similar onset disease pathological changes , none analyses assess changes pathogenesis revealed significant differences M83 M83-DJnull mice . findings suggest DJ-1 may function directly modulate @ GeneSrc $ DJ-1 appear play role protecting deleterious effects expressing pathogenic Ala53Thr alpha-syn vivo . possible @ GeneSrc $ DJ-1 mutations may lead @ DiseaseTgt $ via independent mechanisms .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0385565660375964)\n",
      "- Text: \"Human alpha-synuclein-harboring @ DiseaseTgt $ Ala-53 -- > Thr mutation causes neurodegenerative disease alpha-synuclein aggregation transgenic mice . Mutations alpha-synuclein ( alpha-Syn ) cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) small number pedigrees familial @ DiseaseTgt $ . Moreover , alpha-Syn accumulates major component Lewy bodies Lewy neurites , intraneuronal inclusions neuropathological hallmarks @ DiseaseTgt $ . better understand pathogenic relationship alterations biology alpha-Syn @ DiseaseTgt $ neurodegeneration , generated multiple lines transgenic mice expressing high levels either wild-type familial @ DiseaseTgt $ Ala-30 -- > Pro ( A30P ) Ala-53 -- > Thr ( A53 ) human alpha-Syns . mice expressing A53 human alpha-Syn , wild-type A30P variants , develop adult-onset neurodegenerative disease progressive motoric dysfunction leading death . Pathologically , affected mice exhibit neuronal abnormalities ( perikarya neurites ) including pathological accumulations @ GeneSrc $ ubiquitin . Consistent abnormal neuronal accumulation alpha-Syn , brain regions pathology exhibit increases detergent-insoluble @ GeneSrc $ alpha-Syn aggregates . results demonstrate A53 mutant alpha-Syn causes significantly greater vivo neurotoxicity compared alpha-Syn variants . , alpha-Syn-dependent neurodegeneration associated abnormal accumulation detergent-insoluble alpha-Syn .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2128367134926569)\n",
      "- Text: \"@ GeneSrc $ lowers p53-dependent apoptotic response neuronal cells . Abolishment 6-hydroxydopamine implication @ DiseaseTgt $ . examined influence @ GeneSrc $ responsiveness TSM1 neuronal cells apoptotic stimulus . show @ GeneSrc $ drastically lowers basal staurosporine-stimulated caspase 3 immunoreactivity activity . accompanied lower DNA fragmentation reduced number terminal deoxynucleotide transferase-mediated dUTP nick end labeling ( TUNEL ) -positive neurons . Interestingly , @ GeneSrc $ also diminishes p53 expression transcriptional activity . demonstrate antiapoptotic phenotype displayed @ GeneSrc $ fully reversed @ DiseaseTgt $ dopamine derivative 6-hydroxydopamine . Thus , 6-hydroxydopamine fully abolishes @ GeneSrc $ reduction caspase 3 activity reverses associated decrease p53 expression . 6-Hydroxydopamine triggers thioflavin T-positive deposits @ GeneSrc $ , mock-transfected TSM1 neurons , drastically increases @ GeneSrc $ immunoreactivity . Altogether , suggest @ GeneSrc $ lowers p53-dependent caspase 3 activation TSM1 response apoptotic stimuli propose natural toxin 6-hydroxydopamine abolishes antiapoptotic phenotype triggering @ GeneSrc $ aggregation , thereby likely contributing @ DiseaseTgt $ neuropathology .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1441193205733897)\n",
      "- Text: \"Synj1 haploinsufficiency causes dopamine neuron vulnerability @ GeneSrc $ accumulation mice . Synaptojanin1 ( synj1 ) phosphoinositide phosphatase dual SAC1 5'-phosphatase enzymatic activities regulating phospholipid signaling . brain-enriched isoform shown participate synaptic vesicle ( SV ) recycling . recently , recessive human mutations identified two phosphatase domains SYNJ1 , including R258Q , R459P R839C , linked rare forms early-onset Parkinsonism . demonstrate Synj1 heterozygous deletion ( Synj1+/- ) , associated impaired 5'-phosphatase activity , also leads @ DiseaseTgt $ @ DiseaseTgt $ pathologies mice . report male Synj1+/- mice display age-dependent motor function abnormalities well @ GeneSrc $ accumulation , impaired autophagy dopaminergic terminal degeneration . Synj1+/- mice contain elevated 5'-phosphatase substrate , PI ( 4,5 ) P2 , particularly midbrain neurons . Moreover , pharmacological elevation membrane PI ( 4,5 ) P2 cultured neurons impairs SV endocytosis , specifically midbrain neurons , exacerbates SV trafficking defects Synj1+/- midbrain neurons . demonstrate down-regulation SYNJ1 transcript subset sporadic @ DiseaseTgt $ brains , implicating potential role Synj1 deficiency decline dopaminergic function aging .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.270013990207956e-06)\n",
      "- Text: \"PIK3CA mutations associated gene signature low mTORC1 signaling better outcomes estrogen receptor-positive breast cancer . PIK3CA mutations reported present approximately 25 % breast cancer ( BC ) , particularly estrogen receptor-positive ( ER+ ) @ GeneSrc $ ( @ GeneSrc $ + ) subtypes , making one common genetic aberrations BC . experimental models , mutations shown activate AKT induce oncogenic transformation , hence lesions hypothesized render @ DiseaseTgt $ highly sensitive therapeutic PI3K/mTOR inhibition . analyzing gene expression protein data nearly 1,800 human BCs , report PIK3CA mutation-associated gene signature ( PIK3CA-GS ) derived exon 20 ( kinase domain ) mutations able predict PIK3CA mutation status two independent datasets , strongly suggesting characteristic set gene expression-induced changes . However , @ GeneSrc $ BC despite pathway activation , PIK3CA mutations associated phenotype relatively low mTORC1 signaling good prognosis tamoxifen monotherapy . relationship clinical outcome PIK3CA-GS also assessed . Although PIK3CA-GS associated prognosis ER- @ GeneSrc $ + BC , could identify better clinical outcomes @ GeneSrc $ disease . ER+ BC cell lines , PIK3CA mutations also associated sensitivity tamoxifen . findings could important implications treatment PIK3CA-mutant BCs development PI3K/mTOR inhibitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032500043097987)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human @ DiseaseTgt $ . profiled mutation status PIK3Ca gene National @ DiseaseTgt $ Institute ( NCI ) -60 panel human @ DiseaseTgt $ cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) @ GeneSrc $ PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention @ DiseaseTgt $ harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001554517620614)\n",
      "- Text: \"Steroid receptors prognostic factors primary breast cancer . review update published studies prognostic factors support following conclusions : number axillary lymph nodes involved @ DiseaseTgt $ remains important prognostic factor women primary breast cancer . stage disease , lack estrogen receptor ( ER ) seems important factor predicting earlier recurrence poorer survival . stage II breast cancer , progesterone receptor ( PgR ) content appears better ER content predicting disease-free overall survival . Measurement proliferative activity ( S-phase DNA ) thymidine labeling flow cytometry ( FCM ) aneuploidy FCM also provides prognostic information . Patients aneuploid tumors , high S-phase diploid @ DiseaseTgt $ , increased risk relapse . Amplification oncogenes , particularly @ GeneSrc $ , may provide additional prognostic information combination established prognostic factors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024682923137658)\n",
      "- Text: \"Regulation @ GeneSrc $ oestrogen receptor-PAX2 determines response tamoxifen . Crosstalk oestrogen receptor ( ER ) @ GeneSrc $ pathways long implicated breast cancer aetiology drug response , yet direct connection transcriptional level shown . show oestrogen-ER tamoxifen-ER complexes directly repress @ GeneSrc $ transcription means cis-regulatory element within @ GeneSrc $ gene human cell lines . implicate paired box 2 gene product ( PAX2 ) , previously unrecognized role , crucial mediator ER repression @ GeneSrc $ @ DiseaseTgt $ drug tamoxifen . show PAX2 ER co-activator AIB-1/SRC-3 compete binding regulation @ GeneSrc $ transcription , outcome determines tamoxifen response breast cancer cells . repression @ GeneSrc $ ER-PAX2 links two breast cancer subtypes suggests aggressive @ GeneSrc $ @ DiseaseTgt $ originate ER-positive @ DiseaseTgt $ circumventing repressive mechanism . data provide mechanistic insight molecular basis endocrine resistance breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0106527755383682)\n",
      "- Text: \"naturally occurring MTA1 variant sequesters oestrogen receptor-alpha cytoplasm . Oestrogen receptor ( ER ) good prognostic marker treatment breast cancers . Upregulation metastatic tumour antigen 1 ( MTA1 ) associated invasiveness metastatic potential several human @ DiseaseTgt $ acts co-repressor nuclear ER-alpha . identify naturally occurring short form MTA1 ( MTA1s ) contains previously unknown sequence 33 amino acids ER-binding motif , Leu-Arg-Ile-Leu-Leu ( LRILL ) . MTA1s localizes cytoplasm , sequesters ER cytoplasm , enhances non-genomic responses ER . Deleting LRILL motif MTA1s abolishes co-repressor function interaction ER , restores nuclear localization ER . Dysregulation human @ GeneSrc $ breast cancer cells enhances expression MTA1s cytoplasmic sequestration ER . Expression MTA1s breast cancer cells prevents ligand-induced nuclear translocation ER stimulates malignant phenotypes . MTA1s expression increased human breast tumours low nuclear ER . regulation cellular localization ER MTA1s represents mechanism redirecting nuclear receptor signalling nuclear exclusion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.644418619806736e-07)\n",
      "- Text: \"Classifying estrogen receptor status breast cancers expression profiles reveals poor prognosis subpopulation exhibiting high expression ERBB2 receptor . Recent work using expression profiling computationally predict estrogen receptor ( ER ) status breast tumors revealed certain @ DiseaseTgt $ characterized high prediction uncertainty ( ' low-confidence ' ) . analyzed ' low-confidence ' @ DiseaseTgt $ determined ' uncertain ' prediction status arises result widespread perturbations multiple genes whose expression important ER subtype discrimination . Patients ' low-confidence ' ER+ @ DiseaseTgt $ exhibited significantly worse overall survival ( P=0.03 ) shorter time distant metastasis ( P=0.004 ) compared ' high-confidence ' ER+ counterparts , indicating ' high- ' ' low-confidence ' binary distinction clinically meaningful . discovered elevated expression ERBB2 receptor significantly correlated breast tumor exhibiting ' low-confidence ' prediction , association subsequently validated across multiple independently derived breast cancer expression datasets employing variety different array technologies patient populations . Although @ GeneSrc $ signaling proposed inhibit transcriptional activity ER , large proportion perturbed genes ' @ GeneSrc $ + samples known estrogen responsive , recently described bioinformatic algorithm ( DEREF ) used demonstrate absence potential estrogen-response elements ( EREs ) promoters . propose significant portion @ GeneSrc $ 's effects ER+ breast tumors may involve ER-independent mechanisms gene activation , may contribute clinically aggressive behavior ' low-confidence ' breast tumor subtype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0044076678121629)\n",
      "- Text: \"PKB/Akt mediates cell-cycle progression phosphorylation p27 ( Kip1 ) threonine 157 modulation cellular localization . shown novel mechanism Akt-mediated regulation CDK inhibitor p27 ( kip1 ) . Blockade @ GeneSrc $ @ DiseaseTgt $ cells inhibits Akt kinase activity upregulates nuclear levels CDK inhibitor ( Kip1 ) . Recombinant Akt Akt precipitated @ DiseaseTgt $ cells phosphorylated wild-type p27 vitro . p27 contains Akt consensus RXRXXT ( 157 ) within nuclear localization motif . Active ( myristoylated ) Akt phosphorylated wild-type p27 vivo unable phosphorylate T157A-p27 mutant . Wild-type p27 localized cytosol nucleus , whereas T157A-p27 localized exclusively nucleus resistant nuclear exclusion Akt . T157A-p27 effective wild-type p27 inhibiting cyclin E/CDK2 activity cell proliferation ; effects rescued active Akt . Expression Ser ( 473 ) phospho Akt primary human breast cancers statistically correlated expression p27 @ DiseaseTgt $ cytosol . data indicate Akt may contribute @ DiseaseTgt $ proliferation phosphorylation cytosolic retention p27 , thus relieving CDK2 p27-induced inhibition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.012299694047561)\n",
      "- Text: \"Comprehensive genomic characterization defines human glioblastoma genes core pathways . Human @ DiseaseTgt $ cells typically harbour multiple chromosomal aberrations , nucleotide substitutions epigenetic modifications drive malignant transformation . @ DiseaseTgt $ Genome Atlas ( TCGA ) pilot project aims assess value large-scale multi-dimensional analysis molecular characteristics human @ DiseaseTgt $ provide data rapidly research community . report interim integrative analysis DNA copy number , gene expression DNA methylation aberrations 206 glioblastomas -- common type adult brain cancer -- nucleotide sequence aberrations 91 206 glioblastomas . analysis provides new insights roles @ GeneSrc $ , NF1 TP53 , uncovers frequent mutations phosphatidylinositol-3-OH kinase regulatory subunit gene PIK3R1 , provides network view pathways altered development glioblastoma . Furthermore , integration mutation , DNA methylation clinical treatment data reveals link MGMT promoter methylation hypermutator phenotype consequent mismatch repair deficiency treated glioblastomas , observation potential clinical implications . Together , findings establish feasibility power TCGA , demonstrating rapidly expand knowledge molecular basis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0485289590160244)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two @ DiseaseTgt $ , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) @ GeneSrc $ PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007742533217979)\n",
      "- Text: \"Localization novel v-erbB-related gene , @ GeneSrc $ , human chromosome 17 amplification @ DiseaseTgt $ cell line . @ GeneSrc $ gene v-erbB-related proto-oncogene distinct gene encoding epidermal growth factor receptor . using two independent methods , hybridization sorted chromosomes metaphase spreads cloned @ GeneSrc $ DNA , mapped @ GeneSrc $ locus human chromosome 17 q21 , specific breakpoint observed translocation associated acute promyelocytic leukemia . Furthermore , observed amplification elevated expression @ GeneSrc $ gene MKN-7 @ DiseaseTgt $ cell line . data suggest possible involvement @ GeneSrc $ gene human cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0202159743837783)\n",
      "- Text: \"Similarity protein encoded human @ GeneSrc $ gene epidermal growth factor receptor . novel v-erb-B-related gene , @ GeneSrc $ , identified human genome , maps human chromosome 17 q21 ( ref . 40 ) , seems encode polypeptide kinase domain highly homologous , distinct , epidermal growth factor ( EGF ) receptor . @ GeneSrc $ gene conserved vertebrates suggested @ GeneSrc $ gene , detected series rat neuro/glioblastomas , , fact , rat c-erb-B-2 gene . Amplification @ GeneSrc $ gene salivary adenocarcinoma @ DiseaseTgt $ cell line MKN-7 suggests over-expression sometimes involved neoplastic process . determine nature @ GeneSrc $ protein , molecularly cloned complementary DNA @ GeneSrc $ messenger RNA prepared MKN-7 cells . sequence shows @ GeneSrc $ gene encodes possible receptor protein allows analysis similarity protein EGF receptor @ GeneSrc $ product . consequence chromosomal aberration MKN-7 cells , 4.6-kilobase ( kb ) normal transcript truncated 2.3-kb transcript @ GeneSrc $ synthesized elevated levels . latter transcript presumably encodes extracellular domain putative receptor .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0150448419636269)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two @ DiseaseTgt $ , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) @ GeneSrc $ PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016905678965021)\n",
      "- Text: \"Identification novel family presenilin homologues . Presenilin 1 presenilin 2 polytopic membrane proteins , whose genes mutated individuals @ DiseaseTgt $ . Presenilins shown influence limited proteolysis amyloid beta protein precursor ( APP ) , Notch @ GeneSrc $ , proposed gamma-secretases perform terminal cleavage APP . model , two conserved apparently intramembranous aspartic acids participate catalysis . Highly sequence-similar presenilin homologues known plants , invertebrates vertebrates . work , used combination different sequence database search methods identify new family proteins homologous presenilins . Members family , term presenilin homologues ( PSH ) , significant sequence similarities presenilins also possess two conserved aspartic acid residues within adjacent predicted transmembrane segments . PSH family found throughout eukaryotes , fungi well plants animals , archaea . Five PSHs detectable human genome , three possess `` protease-associated `` domains consistent proposed protease function PSs . Based findings , propose PSs PSHs represent different sub-branches larger family polytopic membrane-associated aspartyl proteases .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5887547365936548)\n",
      "- Text: \"Linking p53 @ DiseaseTgt $ suppressor pathway somatic cell reprogramming . Reprogramming somatic cells induced pluripotent stem ( iPS ) cells accomplished expressing pluripotency factors oncogenes , low frequency tendency induce malignant transformation compromise clinical utility powerful approach . address issues investigating mechanisms limiting reprogramming efficiency somatic cells . show reprogramming factors activate p53 ( also known Trp53 mice , TP53 humans ) pathway . Reducing signalling p53 expressing mutated version one negative regulators , deleting knocking p53 target gene , p21 ( also known Cdkn1a ) , antagonizing reprogramming-induced apoptosis mouse fibroblasts increases reprogramming efficiency . Notably , decreasing p53 protein levels enabled fibroblasts give rise iPS cells capable generating germline-transmitting chimaeric mice using Oct4 ( also known Pou5f1 ) @ GeneSrc $ . Furthermore , silencing p53 significantly increased reprogramming efficiency human somatic cells . results provide insights reprogramming mechanisms suggest new routes efficient reprogramming minimizing use oncogenes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.2401531171272504e-06)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 @ GeneSrc $ remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation p53 ( encoded Trp53 ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.1091066817928888e-05)\n",
      "- Text: \"PIK3CA mutations associated gene signature low mTORC1 signaling better outcomes estrogen receptor-positive breast cancer . PIK3CA mutations reported present approximately 25 % breast cancer ( BC ) , particularly estrogen receptor-positive ( @ GeneSrc $ ) HER2-overexpressing ( HER2 + ) subtypes , making one common genetic aberrations BC . experimental models , mutations shown activate AKT induce oncogenic transformation , hence lesions hypothesized render @ DiseaseTgt $ highly sensitive therapeutic PI3K/mTOR inhibition . analyzing gene expression protein data nearly 1,800 human BCs , report PIK3CA mutation-associated gene signature ( PIK3CA-GS ) derived exon 20 ( kinase domain ) mutations able predict PIK3CA mutation status two independent datasets , strongly suggesting characteristic set gene expression-induced changes . However , @ GeneSrc $ BC despite pathway activation , PIK3CA mutations associated phenotype relatively low mTORC1 signaling good prognosis tamoxifen monotherapy . relationship clinical outcome PIK3CA-GS also assessed . Although PIK3CA-GS associated prognosis @ GeneSrc $ HER2 + BC , could identify better clinical outcomes @ GeneSrc $ disease . ER+ BC cell lines , PIK3CA mutations also associated sensitivity tamoxifen . findings could important implications treatment PIK3CA-mutant BCs development PI3K/mTOR inhibitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001433956802838)\n",
      "- Text: \"Methylation oestrogen receptor CpG island links ageing @ DiseaseTgt $ human colon . report CpG island methylation , epigenetic modification DNA known correlate closely silencing gene transcription , appears oestrogen receptor ( @ GeneSrc $ ) gene subpopulation cells increases direct function age human colonic mucosa . methylation change characterizes virtually cells 45 colorectal tumours examined , including earliest stages @ DiseaseTgt $ formation . @ GeneSrc $ gene expression diminished absent colorectal tumours , introduction exogenous @ GeneSrc $ gene cultured colon carcinoma cells resulted marked growth suppression . data suggest methylation associated inactivation @ GeneSrc $ gene ageing colorectal mucosa could one earliest events predispose sporadic colorectal tumorigenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8200317193466973)\n",
      "- Text: \"Regulation ERBB2 oestrogen receptor-PAX2 determines response tamoxifen . Crosstalk oestrogen receptor ( @ GeneSrc $ ) ERBB2/HER-2 pathways long implicated breast cancer aetiology drug response , yet direct connection transcriptional level shown . show @ GeneSrc $ @ GeneSrc $ complexes directly repress ERBB2 transcription means cis-regulatory element within ERBB2 gene human cell lines . implicate paired box 2 gene product ( PAX2 ) , previously unrecognized role , crucial mediator @ GeneSrc $ repression ERBB2 @ DiseaseTgt $ drug tamoxifen . show PAX2 @ GeneSrc $ co-activator AIB-1/SRC-3 compete binding regulation ERBB2 transcription , outcome determines tamoxifen response breast cancer cells . repression ERBB2 @ GeneSrc $ links two breast cancer subtypes suggests aggressive ERBB2-positive @ DiseaseTgt $ originate @ GeneSrc $ @ DiseaseTgt $ circumventing repressive mechanism . data provide mechanistic insight molecular basis endocrine resistance breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0871804604942134)\n",
      "- Text: \"naturally occurring MTA1 variant sequesters oestrogen receptor-alpha cytoplasm . Oestrogen receptor ( @ GeneSrc $ ) good prognostic marker treatment breast cancers . Upregulation metastatic tumour antigen 1 ( MTA1 ) associated invasiveness metastatic potential several human @ DiseaseTgt $ acts co-repressor nuclear ER-alpha . identify naturally occurring short form MTA1 ( MTA1s ) contains previously unknown sequence 33 amino acids @ GeneSrc $ motif , Leu-Arg-Ile-Leu-Leu ( LRILL ) . MTA1s localizes cytoplasm , sequesters @ GeneSrc $ cytoplasm , enhances non-genomic responses @ GeneSrc $ . Deleting LRILL motif MTA1s abolishes co-repressor function interaction @ GeneSrc $ , restores nuclear localization @ GeneSrc $ . Dysregulation human epidermal growth factor receptor-2 breast cancer cells enhances expression MTA1s cytoplasmic sequestration @ GeneSrc $ . Expression MTA1s breast cancer cells prevents ligand-induced nuclear translocation @ GeneSrc $ stimulates malignant phenotypes . MTA1s expression increased human breast tumours low nuclear @ GeneSrc $ . regulation cellular localization @ GeneSrc $ MTA1s represents mechanism redirecting nuclear receptor signalling nuclear exclusion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009059999057875)\n",
      "- Text: \"DHHC-7 -21 palmitoylacyltransferases sex steroid receptors . Classical estrogen , progesterone , androgen receptors ( ERs , PRs , ARs ) localize outside nucleus plasma membrane target cells . membrane , receptors signal activate kinase cascades essential modulation transcription nongenomic functions many target cells . @ GeneSrc $ , PR , AR trafficking membrane requires receptor palmitoylation palmitoylacyltransferase ( PAT ) protein ( ) . However , identity steroid receptor PAT ( ) unknown . identified DHHC-7 -21 proteins conserved PATs sex steroid receptors . DHHC-7 -21 knockdown studies , PATs required endogenous @ GeneSrc $ , PR , AR palmitoylation , membrane trafficking , rapid signal transduction @ DiseaseTgt $ cells . Thus DHHC-7 -21 proteins novel targets selectively inhibit membrane sex steroid receptor localization function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1476017815065134)\n",
      "- Text: \"Activating ESR1 mutations hormone-resistant metastatic breast cancer . Breast cancer prevalent @ DiseaseTgt $ women , two-thirds cases express estrogen receptor-alpha ( ER-alpha , encoded ESR1 ) . prospective clinical sequencing program advanced @ DiseaseTgt $ , enrolled 11 patients @ GeneSrc $ metastatic breast cancer . Whole-exome transcriptome analysis showed six cases harbored mutations ESR1 affecting ligand-binding domain ( LBD ) , treated anti-estrogens estrogen deprivation therapies . survey @ DiseaseTgt $ Genome Atlas ( TCGA ) identified four endometrial cancers similar mutations ESR1 . five new LBD-localized ESR1 mutations identified ( encoding p. Leu536Gln , p. Tyr537Ser , p. Tyr537Cys , p. Tyr537Asn p. Asp538Gly ) shown result constitutive activity continued responsiveness anti-estrogen therapies vitro . Taken together , studies suggest activating mutations ESR1 key mechanism acquired endocrine resistance breast cancer therapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0060779860291925)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription @ GeneSrc $ regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha hMSH2 interacted ligand-dependent manner , whereas ER beta hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 hMSH3/hMSH6 interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded ER alpha , ER beta . results suggest hMSH2 may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.4718719433776196e-05)\n",
      "- Text: \"Mutation PIK3CA gene anaplastic thyroid cancer . phosphatidylinositol 3'-kinase ( PI3 K ) pathway frequently activated thyroid carcinomas constitutive activation stimulatory molecules ( e.g . , Ras ) and/or loss expression and/or function inhibitory PTEN protein results @ GeneSrc $ activation . Recently , reported somatic mutations within PI3 K catalytic subunit , PIK3CA , common ( 25 - 40 % ) among colorectal , gastric , breast , ovarian cancers , high-grade brain tumors . Moreover , PIK3CA mutations tendency cluster within helical ( exon 9 ) kinase ( exon 20 ) domains . study , 13 thyroid cancer cell lines , 80 well-differentiated thyroid carcinomas follicular ( WDFC ) papillary ( WDPC ) type , 70 anaplastic thyroid carcinomas ( ATC ) investigated , PCR-direct sequencing , activating PIK3CA mutations exons 9 20 . Nonsynonymous somatic mutations found 16 ATC ( 23 % ) , two WDFC ( 8 % ) , one WDPC ( 2 % ) . 18 20 ATC cases showing coexisting differentiated @ DiseaseTgt $ , mutations , present , restricted ATC component located primarily within kinase domain . Three cell lines papillary follicular lineage ( K1 , K2 , K5 ) also found mutated . addition , activation @ GeneSrc $ observed ATC harboring PIK3CA mutations . findings indicate mutant PIK3CA likely function oncogene among ATC less frequently well-differentiated thyroid carcinomas . data also argue role PIK3CA targeting treatment ATC patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002155235629691)\n",
      "- Text: \"@ DiseaseTgt $ mutations PIK3CA oncogenic vivo . PIK3CA gene , coding catalytic subunit p110alpha class IA phosphatidylinositol 3-kinases ( PI3Ks ) , frequently mutated human @ DiseaseTgt $ . Mutated p110alpha proteins show gain enzymatic function vitro oncogenic cell culture . , show three prevalent mutants p110alpha , E542 K , E545 K , H1047R , oncogenic vivo . induce @ DiseaseTgt $ chorioallantoic membrane chicken embryo cause hemangiosarcomas animal . @ DiseaseTgt $ marked increased angiogenesis activation @ GeneSrc $ pathway . target rapamycin inhibitor RAD001 blocks @ DiseaseTgt $ growth induced H1047R p110alpha mutant . vivo oncogenicity PIK3CA mutants avian species strongly suggests critical role mutated proteins human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7421718429578906)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human @ DiseaseTgt $ . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable epidermal growth factor mTOR-independent cell proliferation associated @ GeneSrc $ , ERK , GSK3beta phosphorylation . Paradoxically , GSK3beta inhibitors lithium chloride SB216763 selectively decreased proliferation human breast colorectal cancer cell lines oncogenic PIK3CA mutations led decrease GSK3beta target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 colon cancer cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest GSK3beta important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties @ DiseaseTgt $ harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0080783606290838)\n",
      "- Text: \"PIK3CA oncogene cervical cancer . Amplification chromosome arm 3q consistent aberration cervical cancer , implicated progression dysplastic uterine cervical cells invasive cancer . present study employed ' positional candidate gene ' strategy determine contribution PIK3CA , located 3q26.3 , cervical tumorigenesis . PIK3CA known involved PI @ GeneSrc $ signaling pathway , plays important role regulating cell growth apoptosis . results comparative genomic hybridization show 3q26.3 amplification consistent chromosomal aberration primary tissues cervical carcinoma , positive correlation increased copy number PIK3CA ( detected competitive PCR ) 3q26.3 amplification found @ DiseaseTgt $ tissues cervical cancer cell lines . cervical cancer cell lines harboring amplified PIK3CA , expression gene product ( p110alpha ) PIK3CA increased , subsequently associated high kinase activity . addition , transformation phenotypes lines , including increased cell growth decreased apoptosis , found significantly affected treatment specific PI 3-kinase inhibitor , suggesting increased expression PIK3CA cervical cancer may result promoting cell proliferation reducing apoptosis . evidences support PIK3CA oncogene cervical cancer PIK3CA amplification may linked cervical tumorigenesis . Oncogene ( 2000 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.3166270211605984e-05)\n",
      "- Text: \"PIK3CA mutations associated gene signature low mTORC1 signaling better outcomes estrogen receptor-positive breast cancer . PIK3CA mutations reported present approximately 25 % breast cancer ( BC ) , particularly estrogen receptor-positive ( ER+ ) HER2-overexpressing ( HER2 + ) subtypes , making one common genetic aberrations BC . experimental models , mutations shown activate @ GeneSrc $ induce oncogenic transformation , hence lesions hypothesized render @ DiseaseTgt $ highly sensitive therapeutic PI3K/mTOR inhibition . analyzing gene expression protein data nearly 1,800 human BCs , report PIK3CA mutation-associated gene signature ( PIK3CA-GS ) derived exon 20 ( kinase domain ) mutations able predict PIK3CA mutation status two independent datasets , strongly suggesting characteristic set gene expression-induced changes . However , ER+/HER2- BC despite pathway activation , PIK3CA mutations associated phenotype relatively low mTORC1 signaling good prognosis tamoxifen monotherapy . relationship clinical outcome PIK3CA-GS also assessed . Although PIK3CA-GS associated prognosis ER- HER2 + BC , could identify better clinical outcomes ER+/HER2- disease . ER+ BC cell lines , PIK3CA mutations also associated sensitivity tamoxifen . findings could important implications treatment PIK3CA-mutant BCs development PI3K/mTOR inhibitors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.356917059922239)\n",
      "- Text: \"Mosaic overgrowth fibroadipose hyperplasia caused somatic activating mutations PIK3CA . phosphatidylinositol 3-kinase @ GeneSrc $ signaling pathway critical cellular growth metabolism . Correspondingly , loss function PTEN , negative regulator PI3 K , activating mutations @ GeneSrc $ , AKT2 AKT3 found distinct disorders featuring overgrowth hypoglycemia . performed exome sequencing DNA unaffected affected cells individual unclassified syndrome congenital progressive segmental overgrowth fibrous adipose tissue bone identified @ DiseaseTgt $ mutation encoding p. His1047Leu PIK3CA , gene encodes p110alpha catalytic subunit PI3 K , affected cells . Sequencing PIK3CA ten additional individuals overlapping syndromes identified either p. His1047Leu alteration second @ DiseaseTgt $ alteration , p. His1047Arg , nine cases . Affected dermal fibroblasts showed enhanced basal epidermal growth factor ( EGF ) -stimulated phosphatidylinositol 3,4,5-trisphosphate ( PIP ( 3 ) ) generation concomitant activation downstream signaling relative unaffected counterparts . findings characterize distinct overgrowth syndrome , biochemically demonstrate activation PI3 K signaling thereby identify rational therapeutic target .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7003078470241523)\n",
      "- Text: \"PIK3CA implicated oncogene ovarian cancer . Ovarian cancer leading cause death gynecological malignancy fourth leading cause @ DiseaseTgt $ death among American women , yet little known molecular aetiology . Studies using comparative genomic hybridization ( CGH ) revealed several regions recurrent , abnormal , DNA sequence copy number may encode genes involved genesis progression disease . One region 3q26 found increased copy number approximately 40 % ovarian others cancers contains PIK3CA , encodes p110alpha catalytic subunit phosphatidylinositol 3-kinase ( PI3-kinase ) . association PIK3CA copy number PI3-kinase activity makes PIK3CA candidate oncogene broad range @ DiseaseTgt $ functions associated PI3-kinase mediated signalling . include proliferation , glucose transport catabolism , cell adhesion , apoptosis , RAS signalling oncogenic transformation . addition , downstream effectors PI3-kinase , @ GeneSrc $ AKT2 , found amplified activated human @ DiseaseTgt $ , including ovarian cancer . show PIK3CA frequently increased copy number ovarian cancers , increased copy number associated increased PIK3CA transcription , p110alpha protein expression PI3-kinase activity treatment PI3-kinase inhibitor LY294002 decreases proliferation increases apoptosis . observations suggest PIK3CA oncogene important role ovarian cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0286546393931455)\n",
      "- Text: \"Germline PIK3CA @ GeneSrc $ mutations Cowden Cowden-like syndromes . Cowden syndrome ( CS ) difficult-to-recognize multiple hamartoma syndrome high risks breast , thyroid , cancers . Germline mutations PTEN 10q23 found cause 85 % CS accrued tertiary academic centers , prospective accrual community last 12 years revealed 25 % PTEN mutation frequency . PTEN phosphatase implicated heritable @ DiseaseTgt $ subsequently multiple @ DiseaseTgt $ developmental processes . PTEN antagonizes @ GeneSrc $ K signaling pathway roles cell cycle , migration , cell polarity , apoptosis . report 8 91 ( 8.8 % ) unrelated CS individuals without germline PTEN mutations carried 10 germline PIK3CA mutations ( 7 missense , 1 nonsense , 2 indels ) 2 ( 2.2 % ) @ GeneSrc $ mutations . mutations result significantly increased @ GeneSrc $ increased cellular PIP3 . observations suggest PIK3CA @ GeneSrc $ CS susceptibility genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0027043330045403)\n",
      "- Text: \"Somatic PIK3CA Mutations Sporadic Cerebral Cavernous Malformations . BACKGROUND : Cerebral cavernous malformations ( CCMs ) common sporadic inherited vascular malformations central nervous system . Although familial CCMs linked loss-of-function mutations KRIT1 ( CCM1 ) , CCM2 , PDCD10 ( CCM3 ) , genetic cause sporadic CCMs , representing 80 % cases , remains incompletely understood . METHODS : developed two mouse models harboring mutations identified human meningiomas use prostaglandin D2 synthase ( PGDS ) promoter . performed targeted DNA sequencing surgically resected CCMs patients confirmed findings droplet digital polymerase-chain-reaction analysis . RESULTS : found mice expressing one two common genetic drivers meningioma - Pik3ca H1047R AKT1 E17 K - PGDS-positive cells , spectrum typical CCMs develops ( 22 % 11 % mice , respectively ) instead meningiomas , prompted us analyze tissue samples sporadic CCMs 88 patients . detected somatic activating PIK3CA @ GeneSrc $ mutations 39 % 1 % , respectively , lesion tissue patients . 10 % lesions harbored mutations CCM genes . analyzed lesions induced activating mutations Pik3ca H1074R AKT1 E17 K mice identified PGDS-expressing pericyte probable cell origin . CONCLUSIONS : tissue samples sporadic CCMs , mutations PIK3CA represented greater extent mutations gene . contribution somatic mutations genes cause familial CCMs comparatively small . ( Funded Fondation ARC pour la Recherche contre le @ DiseaseTgt $ others . ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035861727437346)\n",
      "- Text: \"PTEN induces apoptosis cell cycle arrest @ GeneSrc $ -independent pathways . @ DiseaseTgt $ suppressor PTEN inhibits cell growth multiple mechanisms . previously demonstrated overexpression PTEN MCF-7 breast cancer cells causes G ( 1 ) arrest followed cell death , latter believed mediated phosphoinositol-3-kinase ( PI3 K ) @ GeneSrc $ pro-apoptotic pathways . present study , show culture presence low levels growth factors increased PTEN-mediated growth suppression enhancement PTEN-induced cell death . caspase 9-specific inhibitor , ZVAD , blocked PTEN-induced cell death without altering effect PTEN cell cycle distribution . Depending level expression , overexpression dominant-negative @ GeneSrc $ induces cell death less effect cell cycle induces similar decreased cell death without affecting cell cycle compared effects cell death cell cycle overexpressing PTEN . observations sum suggest , MCF-7 breast cancer cells , apoptotic cells induced overexpression PTEN derive G ( 1 ) -arrested cells . , effect PTEN cell death mediated @ GeneSrc $ pathway whereas PTEN-mediated cell cycle arrests @ GeneSrc $ -independent pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0598989456905212)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human @ DiseaseTgt $ . profiled mutation status PIK3Ca gene National @ DiseaseTgt $ Institute ( NCI ) -60 panel human @ DiseaseTgt $ cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen @ GeneSrc $ inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention @ DiseaseTgt $ harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001447735802668)\n",
      "- Text: \"Uncommon mutation , common amplifications , PIK3CA gene thyroid tumors . CONTEXT : many human @ DiseaseTgt $ , overactivation phosphotidylinositol 3-kinase @ GeneSrc $ signaling pathway occurs frequently thyroid cancer , mechanism completely clear . OBJECTIVE : activating mutations genomic amplification PIK3CA gene , encodes p110a catalytic subunit PI3 K , common many @ DiseaseTgt $ , sought investigate phenomenon thyroid tumors . DESIGN : search PIK3CA mutations , isolated genomic DNA primary thyroid tumors various types performed direct sequencing exons PIK3CA gene carry common mutations @ DiseaseTgt $ . used real-time quantitative PCR investigate genomic amplification PIK3CA gene . RESULTS : found PIK3CA gene mutations 37 benign thyroid adenomas , 52 papillary thyroid cancers , 25 follicular thyroid cancers , 13 anaplastic thyroid cancers , 13 medullary thyroid cancers , seven thyroid tumor cell lines . found C3075 single-nucleotide polymorphism exon 20 gene two cases . copy number 4 defined amplification , found PIK3CA gene amplification four 34 ( 12 % ) benign thyroid adenomas , three 59 ( 5 % ) papillary thyroid cancer , five 21 ( 24 % ) follicular thyroid cancer , none 14 ( 0 % ) medullary thyroid cancer , five seven ( 71 % ) thyroid tumor cell lines . PIK3CA gene amplification consequent @ GeneSrc $ activation confirmed fluorescence situ hybridization Western blotting studies using cell lines , respectively . CONCLUSION : data suggest mutation PIK3CA gene common , amplification relatively common may novel mechanism activating @ GeneSrc $ pathway thyroid tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022879901860974)\n",
      "- Text: \"Combined activation Ras Akt neural progenitors induces glioblastoma formation mice . Gliomas common primary malignant brain tumours classified four clinical grades , aggressive @ DiseaseTgt $ grade 4 astrocytomas ( also known glioblastoma multiforme ; GBM ) . Frequent genetic alterations GBMs ( refs 2 - 5 ) result stimulation common signal transduction pathways involving Ras , Akt proteins . known pathways , , sufficient induce GBM formation . transfer , tissue-specific manner , genes encoding activated forms Ras Akt astrocytes neural progenitors mice . found although neither activated Ras Akt alone sufficient induce GBM formation , combination activated Ras Akt induces high-grade gliomas histological features human GBMs . @ DiseaseTgt $ appear arise gene transfer neural progenitors , transfer differentiated astrocytes . Increased activity RAS found many human GBMs ( ref . 11 ) , show @ GeneSrc $ activity increased @ DiseaseTgt $ , implying combined activation two pathways accurately models biology disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.80551087360452)\n",
      "- Text: \"PTEN inversely correlated cell survival factor @ GeneSrc $ inactivated via multiple mechanismsin @ DiseaseTgt $ . PTEN novel @ DiseaseTgt $ suppressor gene encodes dual-specificity phosphatase homology adhesion molecules tensin auxillin . recently suggested PTEN dephosphorylates phosphatidylinositol 3,4,5-trisphosphate [ PtdIns ( 3 , 4,5 ) P3 ] , mediates growth factor-induced activation intracellular signalling , particular serine-threonine kinase @ GeneSrc $ , known cell survival-promoting factor . PTEN mapped 10q23.3 , region disrupted several human @ DiseaseTgt $ including @ DiseaseTgt $ . analysed PTEN series primary acute leukaemias non-Hodgkin 's lymphomas ( NHLs ) well cell lines . also examined whether correlation could found PTEN @ GeneSrc $ levels samples . show majority cell lines studied carries PTEN abnormalities . structural level , found mutations hemizygous deletions 40 % cell lines , smaller number primary @ DiseaseTgt $ , particular NHLs , carries PTEN mutations . Moreover , one-third cell lines low PTEN transcript levels , 60 % samples low absent PTEN protein , could attributed gene silencing hypermethylation . addition , found PTEN phosphorylated @ GeneSrc $ levels inversely correlated large majority examined samples . findings suggest PTEN plays role pathogenesis @ DiseaseTgt $ might inactivated wider range mechanisms initially considered . finding PTEN levels inversely correlate phosphorylated @ GeneSrc $ supports hypothesis PTEN regulates PtdIns ( 3,4,5 ) P3and suggests role PTEN apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0873821665574374)\n",
      "- Text: \"deficiency Akt1 sufficient suppress @ DiseaseTgt $ development Pten+/- mice . @ DiseaseTgt $ suppressor PTEN frequently inactivated human @ DiseaseTgt $ . major downstream effector PTEN @ GeneSrc $ , hyperactivated via PTEN inactivation . known , however , whether diminished Akt activity sufficient inhibit tumorigenesis initiated Pten deficiency . showed deficiency Akt1 sufficient dramatically inhibit @ DiseaseTgt $ development Pten+/- mice . Akt1 deficiency profound effect endometrium prostate neoplasia , two types human @ DiseaseTgt $ , PTEN frequently mutated , also affected thyroid adrenal medulla tumors intestinal polyps . Even haplodeficiency Akt1 sufficient markedly attenuate development high-grade prostate intraepithelial neoplasia ( PIN ) endometrial carcinoma . results significant implications @ DiseaseTgt $ therapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5721239149751699)\n",
      "- Text: \"transforming mutation pleckstrin homology domain @ GeneSrc $ @ DiseaseTgt $ . Although @ GeneSrc $ ( v-akt murine thymoma viral oncogene homologue 1 ) kinase central member possibly frequently activated proliferation survival pathway @ DiseaseTgt $ , mutation @ GeneSrc $ widely reported . report identification somatic mutation human breast , colorectal ovarian cancers results glutamic acid lysine substitution amino acid 17 ( E17 K ) lipid-binding pocket @ GeneSrc $ . Lys 17 alters electrostatic interactions pocket forms new hydrogen bonds phosphoinositide ligand . mutation activates @ GeneSrc $ means pathological localization plasma membrane , stimulates downstream signalling , transforms cells induces leukaemia mice . mechanism indicates direct role @ GeneSrc $ human @ DiseaseTgt $ , adds known genetic alterations promote oncogenesis phosphatidylinositol-3-OH @ GeneSrc $ pathway . Furthermore , E17 K substitution decreases sensitivity allosteric kinase inhibitor , mutation may important clinical utility @ GeneSrc $ drug development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0443603713670344)\n",
      "- Text: \"IkappaB kinase promotes tumorigenesis inhibition forkhead FOXO3a . Nuclear exclusion forkhead transcription factor FOXO3a protein kinase @ GeneSrc $ contributes cell survival . investigated pathological relationship @ GeneSrc $ ( @ GeneSrc $ ) FOXO3a primary @ DiseaseTgt $ . Surprisingly , FOXO3a found excluded nuclei @ DiseaseTgt $ lacking @ GeneSrc $ , suggesting @ GeneSrc $ mechanism regulating FOXO3a localization . provide evidence mechanism showing IkappaB kinase ( IKK ) physically interacts , phosphorylates , inhibits FOXO3a independent @ GeneSrc $ causes proteolysis FOXO3a via Ub-dependent proteasome pathway . Cytoplasmic FOXO3a correlates expression IKKbeta @ GeneSrc $ many @ DiseaseTgt $ associates poor survival breast cancer . , constitutive expression IKKbeta promotes cell proliferation tumorigenesis overridden FOXO3a . results suggest negative regulation FOXO factors IKK key mechanism promoting cell growth tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0303504437555664)\n",
      "- Text: \"pVHL suppresses kinase activity @ GeneSrc $ proline-hydroxylation-dependent manner . Activation serine-threonine kinase @ GeneSrc $ promotes survival proliferation various @ DiseaseTgt $ . Hypoxia promotes resistance @ DiseaseTgt $ cells specific therapies . therefore explored possible link hypoxia @ GeneSrc $ activity . found @ GeneSrc $ prolyl-hydroxylated oxygen-dependent hydroxylase EglN1 . von Hippel-Lindau protein ( pVHL ) bound directly hydroxylated @ GeneSrc $ inhibited @ GeneSrc $ activity . cells lacking oxygen functional pVHL , @ GeneSrc $ activated promote cell survival tumorigenesis . also identified @ DiseaseTgt $ @ GeneSrc $ mutations impair @ GeneSrc $ hydroxylation subsequent recognition pVHL , thus leading @ GeneSrc $ hyperactivation . results show microenvironmental changes , hypoxia , affect @ DiseaseTgt $ behaviors altering @ GeneSrc $ activation , critical role @ DiseaseTgt $ growth therapeutic resistance .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.904444830349927)\n",
      "- Text: \"TSC2 phosphorylated inhibited @ GeneSrc $ suppresses mTOR signalling . Tuberous sclerosis ( TSC ) autosomal dominant disorder characterized formation hamartomas wide range human tissues . Mutation either TSC1 TSC2 @ DiseaseTgt $ suppressor gene responsible familial sporadic forms disease . TSC1 TSC2 proteins form physical functional complex vivo . , show TSC1-TSC2 inhibits p70 ribosomal protein S6 kinase 1 ( activator translation ) activates eukaryotic initiation factor 4E binding protein 1 ( 4E-BP1 , inhibitor translational initiation ) . functions TSC1-TSC2 mediated inhibition mammalian target rapamycin ( mTOR ) . Furthermore , TSC2 directly phosphorylated @ GeneSrc $ , involved stimulating cell growth activated growth stimulating signals , insulin . TSC2 inactivated @ GeneSrc $ phosphorylation , destabilizes TSC2 disrupts interaction TSC1 . data indicate molecular mechanism TSC2 insulin signalling , @ DiseaseTgt $ suppressor functions inhibition cell growth .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0445212885876964)\n",
      "- Text: \"@ GeneSrc $ phosphorylates p27 , impairs nuclear import p27 opposes p27-mediated G1 arrest . Mechanisms linking mitogenic growth inhibitory cytokine signaling cell cycle fully elucidated either @ DiseaseTgt $ normal cells . show activation protein kinase B @ GeneSrc $ , contributes resistance antiproliferative signals breast cancer progression part impairing nuclear import action p27 . @ GeneSrc $ transfection caused cytoplasmic p27 accumulation resistance cytokine-mediated G1 arrest . nuclear localization signal p27 contains @ GeneSrc $ consensus site threonine 157 , p27 phosphorylation @ GeneSrc $ impaired nuclear import vitro . @ GeneSrc $ phosphorylated wild-type p27 p27T157A . cells transfected constitutively active @ GeneSrc $ ) ) , p27WT mislocalized cytoplasm , p27T157A nuclear . cells activated @ GeneSrc $ , p27WT failed cause G1 arrest , antiproliferative effect p27T157A impaired . Cytoplasmic p27 seen 41 % ( 52 128 ) primary human breast cancers conjunction @ GeneSrc $ activation correlated poor patient prognosis . Thus , show novel mechanism whereby @ GeneSrc $ impairs p27 function associated aggressive phenotype human breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2262753773121448)\n",
      "- Text: \"mosaic activating mutation @ GeneSrc $ associated Proteus syndrome . BACKGROUND : Proteus syndrome characterized overgrowth skin , connective tissue , brain , tissues . hypothesized syndrome caused somatic mosaicism mutation lethal nonmosaic state . METHODS : performed exome sequencing DNA biopsy samples obtained patients Proteus syndrome compared resultant DNA sequences unaffected tissues obtained patients . confirmed extended observed association , using custom restriction-enzyme assay analyze DNA 158 samples 29 patients Proteus syndrome . assayed activation @ GeneSrc $ protein affected tissues , using phosphorylation-specific antibodies Western blots . RESULTS : 29 patients Proteus syndrome , 26 somatic activating mutation ( c.49 G , p. Glu17Lys ) oncogene @ GeneSrc $ , encoding @ GeneSrc $ kinase , enzyme known mediate processes cell proliferation apoptosis . Tissues cell lines patients Proteus syndrome harbored admixtures mutant alleles ranged 1 % approximately 50 % . Mutant cell lines showed greater @ GeneSrc $ phosphorylation control cell lines . pair single-cell clones established starting culture differed respect mutation status different levels @ GeneSrc $ phosphorylation . CONCLUSIONS : Proteus syndrome caused somatic activating mutation @ GeneSrc $ , proving hypothesis somatic mosaicism implicating activation @ GeneSrc $ pathway characteristic clinical findings overgrowth @ DiseaseTgt $ susceptibility disorder . ( Funded Intramural Research Program National Human Genome Research Institute . ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.632034128601012)\n",
      "- Text: \"Cell-cycle-regulated activation Akt kinase phosphorylation carboxyl terminus . @ GeneSrc $ , also known protein kinase B , plays key roles cell proliferation , survival metabolism . @ GeneSrc $ hyperactivation contributes many pathophysiological conditions , including human @ DiseaseTgt $ , closely associated poor prognosis chemo- radiotherapeutic resistance . Phosphorylation @ GeneSrc $ S473 ( ref . 5 ) T308 ( ref . 6 ) activates @ GeneSrc $ . However , remains unclear whether mechanisms account full @ GeneSrc $ activation , whether @ GeneSrc $ hyperactivation linked misregulated cell cycle progression , another @ DiseaseTgt $ hallmark . report @ GeneSrc $ activity fluctuates across cell cycle , mirroring cyclin expression . Mechanistically , phosphorylation S477 T479 @ GeneSrc $ extreme carboxy terminus cyclin-dependent kinase 2 ( Cdk2 ) /cyclin mTORC2 , distinct physiological conditions , promotes @ GeneSrc $ activation facilitating , functionally compensating , S473 phosphorylation . Furthermore , deletion cyclin A2 allele mouse olfactory bulb leads reduced S477/T479 phosphorylation elevated cellular apoptosis . Notably , cyclin A2-deletion-induced cellular apoptosis mouse embryonic stem cells partly rescued S477D/T479E-Akt1 , supporting physiological role cyclin A2 governing Akt activation . Together , results study show @ GeneSrc $ S477/T479 phosphorylation essential layer @ GeneSrc $ activation mechanism regulate physiological functions , thereby providing new mechanistic link aberrant cell cycle progression @ GeneSrc $ hyperactivation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3157420606926945)\n",
      "- Text: \"Molecular cloning @ GeneSrc $ oncogene human homologues @ GeneSrc $ AKT2 : amplification @ GeneSrc $ primary human gastric adenocarcinoma . previous report described isolation directly transforming retrovirus , AKT8 , spontaneous thymoma AKR mouse . AKT8 provirus molecularly cloned transformed , nonproducer cell line . virus genome contains viral nonviral , cell-related sequences ; nonviral sequence designated v-akt , presumed viral oncogene AKT8 virus . gene lacks homology 16 oncogenes tested . cloned provirus undergone partial deletion , cell passage vitro , prevents direct demonstration transforming ability molecular clone . Two human homologues v-akt oncogene , @ GeneSrc $ AKT2 , cloned . survey 225 human @ DiseaseTgt $ changes involving @ GeneSrc $ led discovery 20-fold amplification gene one five gastric adenocarcinomas tested . results demonstrate AKT8 characteristic structure directly transforming retrovirus contains gene derived highly conserved cellular sequences may involved pathogenesis human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0326524516779774)\n",
      "- Text: \"@ GeneSrc $ mediates cell-cycle progression phosphorylation p27 ( Kip1 ) threonine 157 modulation cellular localization . shown novel mechanism @ GeneSrc $ regulation CDK inhibitor p27 ( kip1 ) . Blockade HER2/neu @ DiseaseTgt $ cells inhibits @ GeneSrc $ kinase activity upregulates nuclear levels CDK inhibitor ( Kip1 ) . Recombinant @ GeneSrc $ @ GeneSrc $ precipitated @ DiseaseTgt $ cells phosphorylated wild-type p27 vitro . p27 contains @ GeneSrc $ consensus RXRXXT ( 157 ) within nuclear localization motif . Active ( myristoylated ) @ GeneSrc $ phosphorylated wild-type p27 vivo unable phosphorylate T157A-p27 mutant . Wild-type p27 localized cytosol nucleus , whereas T157A-p27 localized exclusively nucleus resistant nuclear exclusion @ GeneSrc $ . T157A-p27 effective wild-type p27 inhibiting cyclin E/CDK2 activity cell proliferation ; effects rescued active @ GeneSrc $ . Expression Ser ( 473 ) phospho @ GeneSrc $ primary human breast cancers statistically correlated expression p27 @ DiseaseTgt $ cytosol . data indicate @ GeneSrc $ may contribute @ DiseaseTgt $ proliferation phosphorylation cytosolic retention p27 , thus relieving CDK2 p27-induced inhibition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9018030099899644)\n",
      "- Text: \"@ GeneSrc $ activation localisation correlate @ DiseaseTgt $ invasion oncogene expression thyroid cancer . INTRODUCTION : @ GeneSrc $ activation involved pathogenesis inherited thyroid cancer Cowden 's syndrome @ DiseaseTgt $ . cell culture , @ GeneSrc $ regulates thyroid cell growth survival ; recent data suggest @ GeneSrc $ also regulates cell motility non-thyroid cell lines . therefore sought evaluate role @ GeneSrc $ thyroid cancer progression . METHODS : evaluated 46 thyroid cancer , 20 thyroid follicular adenoma , adjacent normal tissues samples immunohistochemistry activated @ GeneSrc $ ( pAkt ) , Akt 1 , 2 , 3 , p27 expression . Immunoblots performed 14 samples . RESULTS : @ GeneSrc $ activation identified 10/10 @ DiseaseTgt $ , 26/26 papillary cancers , 2/10 follicular variant papillary cancers , 4/66 normal tissue samples 2/10 typical benign follicular adenomas . Immunoactive pAkt greatest regions capsular invasion ; localised nucleus @ DiseaseTgt $ cytoplasm papillary cancers , except invasive regions papillary cancers localised compartments . Immunoactive @ GeneSrc $ , Akt 2 Akt 3 , correlated pAkt localisation , nuclear pAkt associated cytoplasmic expression p27 . vitro studies using human thyroid cancer cells demonstrated nuclear translocation @ GeneSrc $ pAkt associated cytoplasmic p27 cell invasion migration . Cell migration localisation @ GeneSrc $ , pAkt , p27 inhibited PI3 kinase , MEK inhibition . DISCUSSION : data suggest important role nuclear activation @ GeneSrc $ thyroid cancer progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.101983470616362)\n",
      "- Text: \"Identification @ DiseaseTgt $ suppressor network opposing nuclear @ GeneSrc $ function . proto-oncogene @ GeneSrc $ ( also known @ GeneSrc $ ) activated many human @ DiseaseTgt $ , mostly owing loss PTEN @ DiseaseTgt $ suppressor . @ DiseaseTgt $ , @ GeneSrc $ becomes enriched cell membranes activated phosphorylation . Yet many targets inhibited phosphorylated @ GeneSrc $ ( example , FOXO transcription factors ) nuclear ; remained unclear relevant nuclear phosphorylated @ GeneSrc $ ( pAKT ) function tumorigenesis . show PMLtumour suppressor prevents @ DiseaseTgt $ inactivating pAKT inside nucleus . find mouse model Pml loss markedly accelerates @ DiseaseTgt $ onset , incidence progression Pten-heterozygous mutants , leads female sterility features recapitulate phenotype Foxo3a knockout mice . show Pml deficiency leads tumorigenesis prostate , tissue exquisitely sensitive pAkt levels , demonstrate Pml specifically recruits Akt phosphatase PP2a well pAkt Pml nuclear bodies . Notably , find Pml-null cells impaired PP2a phosphatase activity towards Akt , thus accumulate nuclear pAkt . consequence , progressive reduction Pml dose leads inactivation Foxo3a-mediated transcription proapoptotic Bim cell cycle inhibitor p27 ( kip1 ) . results demonstrate Pml orchestrates nuclear @ DiseaseTgt $ suppressor network inactivation nuclear pAkt , thus highlight importance @ GeneSrc $ compartmentalization human @ DiseaseTgt $ pathogenesis treatment .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9485193511832613)\n",
      "- Text: \"Cytoplasmic relocalization inhibition cyclin-dependent kinase inhibitor p27 ( Kip1 ) @ GeneSrc $ phosphorylation breast cancer . cyclin-dependent kinase inhibitor p27 ( kip1 ) putative @ DiseaseTgt $ suppressor human @ DiseaseTgt $ . mechanism underlying p27 ( kip1 ) deregulation human @ DiseaseTgt $ , however , poorly understood . demonstrate serine/threonine kinase @ GeneSrc $ regulates cell proliferation breast cancer cells preventing p27 ( kip1 ) -mediated growth arrest . Threonine 157 ( T157 ) , maps within nuclear localization signal p27 ( kip1 ) , predicted @ GeneSrc $ site . @ GeneSrc $ T157 phosphorylation causes retention p27 ( kip1 ) cytoplasm , precluding p27 ( kip1 ) -induced G1 arrest . Conversely , p27 ( kip1 ) -T157A mutant accumulates cell nuclei @ GeneSrc $ affect p27 ( kip1 ) -T157A-mediated cell cycle arrest . Lastly , T157-phosphorylated p27 ( kip1 ) accumulates cytoplasm primary human breast cancer cells coincident @ GeneSrc $ activation . Thus , cytoplasmic relocalization p27 ( kip1 ) , secondary @ GeneSrc $ phosphorylation , novel mechanism whereby growth inhibitory properties p27 ( kip1 ) functionally inactivated proliferation breast cancer cells sustained .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072201465152468)\n",
      "- Text: \"E3 ligase TRAF6 regulates @ GeneSrc $ ubiquitination activation . @ GeneSrc $ signaling plays central role many biological functions , cell proliferation apoptosis . @ GeneSrc $ ( also known protein kinase B ) resides primarily cytosol , known signaling molecules recruited plasma membrane subsequently activated growth factor stimuli . found protein kinase @ GeneSrc $ undergoes lysine-63 chain ubiquitination , important @ GeneSrc $ membrane localization phosphorylation . TRAF6 found direct E3 ligase @ GeneSrc $ essential @ GeneSrc $ ubiquitination , membrane recruitment , phosphorylation upon growth-factor stimulation . human @ DiseaseTgt $ @ GeneSrc $ mutant displayed increase @ GeneSrc $ ubiquitination , turn contributing enhancement @ GeneSrc $ membrane localization phosphorylation . Thus , @ GeneSrc $ ubiquitination important step oncogenic @ GeneSrc $ activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1925435713097157)\n",
      "- Text: \"@ GeneSrc $ regulation autophagy tumorigenesis Beclin 1 phosphorylation . Aberrant signaling class phosphatidylinositol 3-kinase @ GeneSrc $ axis frequent human @ DiseaseTgt $ . , show Beclin 1 , essential autophagy @ DiseaseTgt $ suppressor protein , target protein kinase @ GeneSrc $ . Expression Beclin 1 mutant resistant @ GeneSrc $ phosphorylation increased autophagy , reduced anchorage-independent growth , inhibited @ GeneSrc $ tumorigenesis . @ GeneSrc $ phosphorylation Beclin 1 enhanced interactions 14 - 3 - 3 vimentin intermediate filament proteins , vimentin depletion increased autophagy inhibited @ GeneSrc $ transformation . Thus , @ GeneSrc $ phosphorylation Beclin 1 functions autophagy inhibition , oncogenesis , formation autophagy-inhibitory Beclin 1/14 - 3 - 3/vimentin intermediate filament complex . findings broad implications understanding role @ GeneSrc $ signaling intermediate filament proteins autophagy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8546504049532163)\n",
      "- Text: \"gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 lipogenesis . @ DiseaseTgt $ cells increase lipogenesis proliferation activation sterol regulatory element-binding proteins ( SREBPs ) central role process . SREBPs inhibited complex composed INSIG proteins , SREBP cleavage-activating protein ( SCAP ) sterols endoplasmic reticulum . Regulation interaction INSIG proteins SCAP sterol levels critical dissociation SCAP-SREBP complex endoplasmic reticulum activation SREBPs1,2 . However , whether protein interaction regulated mechanism abundance sterol-and particular , whether oncogenic signalling role-is unclear . show activated @ GeneSrc $ human hepatocellular carcinoma ( HCC ) cells phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 ( PCK1 ) , rate-limiting enzyme gluconeogenesis , Ser90 . Phosphorylated PCK1 translocates endoplasmic reticulum , uses GTP phosphate donor phosphorylate INSIG1 Ser207 INSIG2 Ser151 . phosphorylation reduces binding sterols INSIG1 INSIG2 disrupts interaction INSIG proteins SCAP , leading translocation SCAP-SREBP complex Golgi apparatus , activation SREBP proteins ( SREBP1 SREBP2 ) transcription downstream lipogenesis-related genes , proliferation @ DiseaseTgt $ cells , tumorigenesis mice . addition , phosphorylation PCK1 Ser90 , INSIG1 Ser207 INSIG2 Ser151 positively correlated nuclear accumulation SREBP1 samples patients HCC , also associated poor HCC prognosis . findings highlight importance protein kinase activity PCK1 activation SREBPs , lipogenesis development HCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.8935913654259483e-07)\n",
      "- Text: \"PIK3CA implicated oncogene @ DiseaseTgt $ . @ DiseaseTgt $ leading cause death gynecological malignancy fourth leading cause cancer death among American women , yet little known molecular aetiology . Studies using comparative genomic hybridization ( CGH ) revealed several regions recurrent , abnormal , DNA sequence copy number may encode genes involved genesis progression disease . One region 3q26 found increased copy number approximately 40 % @ DiseaseTgt $ contains PIK3CA , encodes p110alpha catalytic subunit phosphatidylinositol 3-kinase ( PI3-kinase ) . association PIK3CA copy number PI3-kinase activity makes PIK3CA candidate oncogene broad range cancer-related functions associated PI3-kinase mediated signalling . include proliferation , glucose transport catabolism , cell adhesion , apoptosis , RAS signalling oncogenic transformation . addition , downstream effectors PI3-kinase , @ GeneSrc $ AKT2 , found amplified activated human tumours , including @ DiseaseTgt $ . show PIK3CA frequently increased copy number @ DiseaseTgt $ , increased copy number associated increased PIK3CA transcription , p110alpha protein expression PI3-kinase activity treatment PI3-kinase inhibitor LY294002 decreases proliferation increases apoptosis . observations suggest PIK3CA oncogene important role @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.186367588380095)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two @ DiseaseTgt $ , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen @ GeneSrc $ inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002601964410943)\n",
      "- Text: \"transforming mutation pleckstrin homology domain @ GeneSrc $ cancer . Although @ GeneSrc $ ( v-akt murine thymoma viral oncogene homologue 1 ) kinase central member possibly frequently activated proliferation survival pathway cancer , mutation @ GeneSrc $ widely reported . report identification somatic mutation human @ DiseaseTgt $ results glutamic acid lysine substitution amino acid 17 ( E17 K ) lipid-binding pocket @ GeneSrc $ . Lys 17 alters electrostatic interactions pocket forms new hydrogen bonds phosphoinositide ligand . mutation activates @ GeneSrc $ means pathological localization plasma membrane , stimulates downstream signalling , transforms cells induces leukaemia mice . mechanism indicates direct role @ GeneSrc $ human cancer , adds known genetic alterations promote oncogenesis phosphatidylinositol-3-OH @ GeneSrc $ pathway . Furthermore , E17 K substitution decreases sensitivity allosteric kinase inhibitor , mutation may important clinical utility @ GeneSrc $ drug development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0186463140274323)\n",
      "- Text: \"Increased @ GeneSrc $ Blood Cells LRRK2 G2019S Mutation Carriers . purpose study investigate whether differential phosphorylation states blood markers identify patients LRRK2 @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assessed phospho ( P ) -Ser-935-LRRK2 @ GeneSrc $ levels peripheral blood cells patients G2019S LRRK2-associated @ DiseaseTgt $ ( @ DiseaseTgt $ , n = 31 ) , G2019S LRRK2 non-manifesting carriers ( L2NMC , n = 26 ) , @ DiseaseTgt $ ( @ DiseaseTgt $ , n = 25 ) , controls ( n = 40 , total n = 122 ) . found differences P-Ser-935-LRRK2 groups detected specific increase @ GeneSrc $ levels G2019S carriers , either @ DiseaseTgt $ L2NMC , absent @ DiseaseTgt $ . Although insensitive LRRK2 inhibition , study identifies @ GeneSrc $ endogenous candidate biomarker peripheral inflammation G2019S carriers using accessible blood cells . ANN NEUROL 2022 ; 92:888 - 894 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0503422339901704)\n",
      "- Text: \"DJ-1 induces thioredoxin 1 expression Nrf2 pathway . DJ-1 , linked recessively inherited @ DiseaseTgt $ mutated , multi-functional protein anti-oxidant transcription regulatory activities . However , mechanism ( ) DJ-1 genes regulates provide neuroprotection fully understood . , show wild-type DJ-1 induces expression thioredoxin 1 ( Trx1 ) , protein disulfide oxidoreductase , whereas pathogenic mutant isoforms L166P M26I . Conversely , DJ-1 knockdown SH-SY5Y cells DJ-1 knockout mice result significant decrease Trx1 protein mRNA expression levels . importance Trx1 cytoprotective function DJ-1 confirmed using pharmacological inhibitor Trx reductase , 1-chloro-2,4-dinitrobenzene , Trx1 siRNA . approaches result partial loss DJ-1-mediated protection . Additionally , knockdown Trx1 significantly abrogates DJ-1-dependent , hydrogen peroxide-induced activation pro-survival factor @ GeneSrc $ . Promoter analysis human Trx1 gene identified antioxidant response element ( ) required DJ-1-dependent induction Trx1 expression . transcription factor Nuclear factor erythroid-2 related factor 2 ( Nrf2 ) , critical inducer ARE-mediated expression , regulated DJ-1 . Overexpression DJ-1 results increased Nrf2 protein levels , promotes translocation nucleus enhances recruitment onto site Trx1 promoter . , Nrf2 knockdown abolishes DJ-1-mediated Trx1 induction cytoprotection hydrogen peroxide , indicating critical role Nrf2 carrying protective functions DJ-1 oxidative stress . findings provide new mechanism support antioxidant function DJ-1 increasing Trx1 expression via Nrf2-mediated transcriptional induction .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.792232118508682e-05)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human cancers . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable epidermal growth factor mTOR-independent cell proliferation associated @ GeneSrc $ , ERK , GSK3beta phosphorylation . Paradoxically , GSK3beta inhibitors lithium chloride SB216763 selectively decreased proliferation human breast @ DiseaseTgt $ cell lines oncogenic PIK3CA mutations led decrease GSK3beta target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 @ DiseaseTgt $ cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest GSK3beta important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties cancers harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006783615998449)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two @ DiseaseTgt $ , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen @ GeneSrc $ inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001778920278515)\n",
      "- Text: \"eIF4F nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation RAS-RAF-MEK-ERK mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , @ GeneSrc $ , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation eIF4F eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation eIF4F complex , comprising eIF4E cap-binding protein , eIF4 G scaffolding protein eIF4A RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance eIF4F complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory eIF4E-binding protein 4EBP1 increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation eIF4 G . development situ method detect eIF4E-eIF4 G interactions shows eIF4F complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting eIF4F complex , either blocking eIF4E-eIF4 G interaction targeting eIF4A , synergizes inhibiting BRAF ( V600 ) kill cancer cells . eIF4F appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) eIF4F may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0336103922104912)\n",
      "- Text: \"Akt activation localisation correlate @ DiseaseTgt $ invasion oncogene expression thyroid cancer . INTRODUCTION : Akt activation involved pathogenesis inherited thyroid cancer Cowden 's syndrome @ DiseaseTgt $ . cell culture , Akt regulates thyroid cell growth survival ; recent data suggest Akt also regulates cell motility non-thyroid cell lines . therefore sought evaluate role Akt thyroid cancer progression . METHODS : evaluated 46 thyroid cancer , 20 thyroid follicular adenoma , adjacent normal tissues samples immunohistochemistry activated Akt ( pAkt ) , @ GeneSrc $ , p27 expression . Immunoblots performed 14 samples . RESULTS : Akt activation identified 10/10 @ DiseaseTgt $ , 26/26 papillary cancers , 2/10 follicular variant papillary cancers , 4/66 normal tissue samples 2/10 typical benign follicular adenomas . Immunoactive pAkt greatest regions capsular invasion ; localised nucleus @ DiseaseTgt $ cytoplasm papillary cancers , except invasive regions papillary cancers localised compartments . Immunoactive Akt 1 , Akt 2 Akt 3 , correlated pAkt localisation , nuclear pAkt associated cytoplasmic expression p27 . vitro studies using human thyroid cancer cells demonstrated nuclear translocation Akt 1 pAkt associated cytoplasmic p27 cell invasion migration . Cell migration localisation Akt 1 , pAkt , p27 inhibited PI3 kinase , MEK inhibition . DISCUSSION : data suggest important role nuclear activation Akt 1 thyroid cancer progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025709311073804)\n",
      "- Text: \"Mosaic overgrowth fibroadipose hyperplasia caused somatic activating mutations PIK3CA . phosphatidylinositol 3-kinase ( PI3K ) -AKT signaling pathway critical cellular growth metabolism . Correspondingly , loss function PTEN , negative regulator PI3 K , activating mutations AKT1 , @ GeneSrc $ AKT3 found distinct disorders featuring overgrowth hypoglycemia . performed exome sequencing DNA unaffected affected cells individual unclassified syndrome congenital progressive segmental overgrowth fibrous adipose tissue bone identified @ DiseaseTgt $ mutation encoding p. His1047Leu PIK3CA , gene encodes p110alpha catalytic subunit PI3 K , affected cells . Sequencing PIK3CA ten additional individuals overlapping syndromes identified either p. His1047Leu alteration second @ DiseaseTgt $ alteration , p. His1047Arg , nine cases . Affected dermal fibroblasts showed enhanced basal epidermal growth factor ( EGF ) -stimulated phosphatidylinositol 3,4,5-trisphosphate ( PIP ( 3 ) ) generation concomitant activation downstream signaling relative unaffected counterparts . findings characterize distinct overgrowth syndrome , biochemically demonstrate activation PI3 K signaling thereby identify rational therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2266736132954472)\n",
      "- Text: \"PIK3CA implicated oncogene ovarian cancer . Ovarian cancer leading cause death gynecological malignancy fourth leading cause @ DiseaseTgt $ death among American women , yet little known molecular aetiology . Studies using comparative genomic hybridization ( CGH ) revealed several regions recurrent , abnormal , DNA sequence copy number may encode genes involved genesis progression disease . One region 3q26 found increased copy number approximately 40 % ovarian others cancers contains PIK3CA , encodes p110alpha catalytic subunit phosphatidylinositol 3-kinase ( PI3-kinase ) . association PIK3CA copy number PI3-kinase activity makes PIK3CA candidate oncogene broad range @ DiseaseTgt $ functions associated PI3-kinase mediated signalling . include proliferation , glucose transport catabolism , cell adhesion , apoptosis , RAS signalling oncogenic transformation . addition , downstream effectors PI3-kinase , AKT1 @ GeneSrc $ , found amplified activated human @ DiseaseTgt $ , including ovarian cancer . show PIK3CA frequently increased copy number ovarian cancers , increased copy number associated increased PIK3CA transcription , p110alpha protein expression PI3-kinase activity treatment PI3-kinase inhibitor LY294002 decreases proliferation increases apoptosis . observations suggest PIK3CA oncogene important role ovarian cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0066120632320528)\n",
      "- Text: \"Molecular cloning akt oncogene human homologues AKT1 @ GeneSrc $ : amplification AKT1 primary human gastric adenocarcinoma . previous report described isolation directly transforming retrovirus , AKT8 , spontaneous thymoma AKR mouse . AKT8 provirus molecularly cloned transformed , nonproducer cell line . virus genome contains viral nonviral , cell-related sequences ; nonviral sequence designated v-akt , presumed viral oncogene AKT8 virus . gene lacks homology 16 oncogenes tested . cloned provirus undergone partial deletion , cell passage vitro , prevents direct demonstration transforming ability molecular clone . Two human homologues v-akt oncogene , AKT1 @ GeneSrc $ , cloned . survey 225 human @ DiseaseTgt $ changes involving AKT1 led discovery 20-fold amplification gene one five gastric adenocarcinomas tested . results demonstrate AKT8 characteristic structure directly transforming retrovirus contains gene derived highly conserved cellular sequences may involved pathogenesis human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010957682867997)\n",
      "- Text: \"Akt activation localisation correlate @ DiseaseTgt $ invasion oncogene expression thyroid cancer . INTRODUCTION : Akt activation involved pathogenesis inherited thyroid cancer Cowden 's syndrome @ DiseaseTgt $ . cell culture , Akt regulates thyroid cell growth survival ; recent data suggest Akt also regulates cell motility non-thyroid cell lines . therefore sought evaluate role Akt thyroid cancer progression . METHODS : evaluated 46 thyroid cancer , 20 thyroid follicular adenoma , adjacent normal tissues samples immunohistochemistry activated Akt ( pAkt ) , Akt 1 , 2 , 3 , p27 expression . Immunoblots performed 14 samples . RESULTS : Akt activation identified 10/10 @ DiseaseTgt $ , 26/26 papillary cancers , 2/10 follicular variant papillary cancers , 4/66 normal tissue samples 2/10 typical benign follicular adenomas . Immunoactive pAkt greatest regions capsular invasion ; localised nucleus @ DiseaseTgt $ cytoplasm papillary cancers , except invasive regions papillary cancers localised compartments . Immunoactive Akt 1 , @ GeneSrc $ Akt 3 , correlated pAkt localisation , nuclear pAkt associated cytoplasmic expression p27 . vitro studies using human thyroid cancer cells demonstrated nuclear translocation Akt 1 pAkt associated cytoplasmic p27 cell invasion migration . Cell migration localisation Akt 1 , pAkt , p27 inhibited PI3 kinase , MEK inhibition . DISCUSSION : data suggest important role nuclear activation Akt 1 thyroid cancer progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025064361150252)\n",
      "- Text: \"PIK3CA implicated oncogene @ DiseaseTgt $ . @ DiseaseTgt $ leading cause death gynecological malignancy fourth leading cause cancer death among American women , yet little known molecular aetiology . Studies using comparative genomic hybridization ( CGH ) revealed several regions recurrent , abnormal , DNA sequence copy number may encode genes involved genesis progression disease . One region 3q26 found increased copy number approximately 40 % @ DiseaseTgt $ contains PIK3CA , encodes p110alpha catalytic subunit phosphatidylinositol 3-kinase ( PI3-kinase ) . association PIK3CA copy number PI3-kinase activity makes PIK3CA candidate oncogene broad range cancer-related functions associated PI3-kinase mediated signalling . include proliferation , glucose transport catabolism , cell adhesion , apoptosis , RAS signalling oncogenic transformation . addition , downstream effectors PI3-kinase , AKT1 @ GeneSrc $ , found amplified activated human tumours , including @ DiseaseTgt $ . show PIK3CA frequently increased copy number @ DiseaseTgt $ , increased copy number associated increased PIK3CA transcription , p110alpha protein expression PI3-kinase activity treatment PI3-kinase inhibitor LY294002 decreases proliferation increases apoptosis . observations suggest PIK3CA oncogene important role @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1297668968864295)\n",
      "- Text: \"Disturbed activation endoplasmic reticulum stress transducers @ DiseaseTgt $ presenilin-1 mutations . Recent studies shown independently presenilin-1 ( PS1 ) null mutants @ DiseaseTgt $ @ DiseaseTgt $ mutants down-regulate signaling unfolded protein response ( UPR ) . However , difficult accept mutants possess effects UPR . Furthermore , contrary observations , neither loss PS1 PS2 function expression @ DiseaseTgt $ PS1 mutants reported discernable impact UPR . Therefore , re-examination detailed analyses needed clarify relationship PS1 function UPR signaling . , report PS1/PS2 null dominant negative PS1 mutants , mutated aspartate residue 257 385 , affect signaling UPR . contrast , @ DiseaseTgt $ PS1 mutants confirmed disturb UPR signaling inhibiting activation @ GeneSrc $ ATF6 , endoplasmic reticulum ( ER ) stress transducers UPR . Furthermore , PS1 mutants also disturbed activation PERK ( PKR-like ER kinase ) , plays crucial role inhibiting translation ER stress . Taken together , observations suggested PS1 mutations could affect signaling pathways controlled respective ER-stress transducers , possibly gain-of-function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0075077826103441)\n",
      "- Text: \"Trp53 deficiency protects acute intestinal inflammation . p53 protein important @ DiseaseTgt $ suppressor activity also additional immunological functions , whose nature extent beginning recognized . article , show p53 novel inflammation-promoting action intestinal tract , loss p53 upstream activating kinase , ATM , protects acute intestinal inflammation murine models . Mechanistically , deficiency p53 leads increased survival epithelial cells lamina propria macrophages , higher IL-6 expression owing enhanced glucose-dependent NF-kappaB activation , increased mucosal @ GeneSrc $ activation . Blockade loss IL-6 signaling reverses protective effects p53 deficiency . Conversely , IL-6 treatment protects acute colitis manner dependent @ GeneSrc $ signaling induction cytoprotective factors epithelial cells . Together , results indicate p53 promotes inflammation intestinal tract suppression epithelium-protective factors , thus significantly expanding spectrum physiological immunological p53 activities unrelated @ DiseaseTgt $ formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0053187868966475)\n",
      "- Text: \"Point mutations juxtamembrane domain FLT3 define new class activating mutations @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) , two clusters activating mutations known FMS-like tyrosine kinase-3 ( FLT3 ) gene : FLT3-internal tandem duplications ( FLT3-ITDs ) juxtamembrane ( JM ) domain 20 % 25 % patients , FLT3 point mutations tyrosine-kinase domain ( FLT3-TKD ) 7 % 10 % patients , respectively . , characterized new class activating point mutations ( PMs ) cluster 16-amino acid stretch juxtamembrane domain FLT3 ( FLT3-JM-PMs ) . Expression 4 FLT3-JM-PMs interleukin-3 ( IL-3 ) -dependent Ba/F3 cells led factor-independent growth , hyperresponsiveness FLT3 ligand , resistance apoptotic cell death . FLT3-JM-PM receptors autophosphorylated showed higher constitutive dimerization rate compared FLT3-wild-type ( WT ) receptor . molecular mechanism , could show activation @ GeneSrc $ up-regulation Bcl-x ( L ) FLT3-JM-PMs . FLT3 inhibitor PKC412 abrogated factor-independent growth FLT3-JM-PM-expressing cells . Compared FLT3-ITD FLT3-TKD mutants , FLT3-JM-PMs showed weaker transforming potential related lower autophosphorylation receptor downstream target STAT5 . Mapping FLT3-JM-PMs crystal structure FLT3 showed mutations reduce stability autoinhibitory JM domain , provides structural basis transforming capacity new class gain-of-function mutations FLT3 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7070137235623112)\n",
      "- Text: \"Microglia-derived @ GeneSrc $ specks cross-seed amyloid-beta @ DiseaseTgt $ . spreading pathology within brain areas hallmark neurodegenerative disorders . patients @ DiseaseTgt $ , deposition amyloid-beta accompanied activation innate immune system involves inflammasome-dependent formation ASC specks microglia . ASC specks released microglia bind rapidly amyloid-beta increase formation amyloid-beta oligomers aggregates , acting inflammation-driven cross-seed amyloid-beta pathology . show intrahippocampal injection @ GeneSrc $ specks resulted spreading amyloid-beta pathology transgenic double-mutant APPSwePSEN1dE9 mice . contrast , homogenates brains APPSwePSEN1dE9 mice failed induce seeding spreading amyloid-beta pathology @ GeneSrc $ APPSwePSEN1dE9 mice . Moreover , co-application @ GeneSrc $ antibody blocked increase amyloid-beta pathology APPSwePSEN1dE9 mice . findings support concept inflammasome activation connected seeding spreading amyloid-beta pathology patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0028770119480359)\n",
      "- Text: \"Neurodegeneration central nervous system apoE-deficient mice . Apolipoprotein E ( apoE ) involved development regeneration central nervous system ( CNS ) . ApoE may also necessary maintain integrity synapto-dendritic complexity . analyzed synaptic alterations CNS apoE-deficient ( knockout ) mice aging process . apoE-deficient homozygous mice , age-dependent 15 40 % loss @ GeneSrc $ nerve terminals microtubule-associated protein 2-immunoreactive dendrites neocortex hippocampus , compared controls . Dendritic alterations observed early 4 months age . Ultrastructural analysis revealed extensive dendritic vacuolization disruption endomembrane system cytoskeleton apoE-deficient homozygous mice . immunocytochemical studies neuronal cytoskeleton showed apoE-deficient mice decrease immunoreactivity alpha beta tubulin ( kinesin ) cell bodies processes . results support contention apoE might play important role maintaining stability synapto-dendritic apparatus altered deficient functioning molecule could underlie synaptic cytoskeletal alterations @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Treatment copper-zinc chelator markedly rapidly inhibits beta-amyloid accumulation @ DiseaseTgt $ transgenic mice . Inhibition neocortical beta-amyloid ( Abeta ) accumulation may essential effective therapeutic intervention @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Cu Zn enriched Abeta deposits @ DiseaseTgt $ , solubilized Cu/Zn-selective chelators vitro . report 49 % decrease brain Abeta deposition ( -375 microg/g wet weight , p = 0.0001 ) blinded study APP2576 transgenic mice treated orally 9 weeks clioquinol , antibiotic bioavailable Cu/Zn chelator . accompanied modest increase soluble Abeta ( 1.45 % total cerebral Abeta ) ; APP , @ GeneSrc $ , GFAP levels unaffected . General health body weight parameters significantly stable treated animals . results support targeting interactions Cu Zn Abeta novel therapy prevention treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013108554451045)\n",
      "- Text: \"MPO APOEepsilon4 polymorphisms interact increase risk @ DiseaseTgt $ Finnish males . BACKGROUND : Myeloperoxidase ( MPO ) present senile plaques surrounding reactive microglia , normal brain parenchyma . MPO plaques highest APOE epsilon4 carriers , suggesting functional interaction . MPO promoter polymorphism ( -463G/A ) linked increased MPO expression associated increased risk @ DiseaseTgt $ . METHODS : define possible interaction MPO APOE epsilon4 , examined 127 patients @ DiseaseTgt $ 174 controls genetically homogeneous Finnish population . RESULTS : significantly higher percentage male patients @ DiseaseTgt $ carried MPO APOE epsilon4 alleles relative men carrying neither allele ( p < 0.001 ; , 11.4 ; 95 % CI , 3.6 6.7 ) . Male APOE epsilon4 carriers lacking MPO allele 3.0 ( p = 0.01 ; 95 % CI , 1.3 6.9 ) , indicating MPO enhances @ DiseaseTgt $ risk 3.8-fold . Age onset lower men carrying MPO APOE epsilon4 alleles ( Kaplan-Meier survival analysis ; p = 0.01 ) . Also , MPO AA genotype associated selective mortality men , women . AA genotypes absent 159 male patients @ DiseaseTgt $ controls , representing expected 5 % 6 % women male controls younger age 20 . -463A creates @ GeneSrc $ binding site may contribute gender differences . CONCLUSIONS : MPO APOE epsilon4 alleles interact increase risk @ DiseaseTgt $ men women Finnish cohort .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004113908736696)\n",
      "- Text: \"Association @ GeneSrc $ gene variation cardiovascular disease . CONTEXT : Estrogen related hormone therapies activate estrogen receptors , turn regulate genes several cardiovascular disease ( CVD ) risk factors . Relatively little known , however , impact genetic variation @ GeneSrc $ ( @ GeneSrc $ ) CVD risk . OBJECTIVE : investigate whether @ GeneSrc $ c.454 - 397T > C polymorphism associated CVD risk . DESIGN , SETTING , PARTICIPANTS : Prospective study 1739 unrelated men women population-based offspring cohort Framingham Heart Study , followed 1971 1998 . MAIN OUTCOME MEASURES : Total atherosclerotic CVD events , defined recognized unrecognized @ DiseaseTgt $ ( MI ) , angina pectoris , coronary insufficiency , intermittent claudication , coronary heart disease death , atherothrombotic stroke ( n = 178 ) ; major atherosclerotic CVD , defined recognized @ DiseaseTgt $ , coronary insufficiency , coronary heart disease death , atherothrombotic stroke ( n = 83 ) ; recognized @ DiseaseTgt $ ( n = 59 ) . RESULTS : Twenty percent participants ( n = 352 ) homozygous @ GeneSrc $ c.454 - 397C allele . adjustment covariates ( age , sex , body mass index , hypertension , diabetes mellitus , total cholesterol , high-density lipoprotein cholesterol , cigarette smoking ) , CC genotype significantly associated major atherosclerotic CVD , odds ratio 2.0 ( 95 % confidence interval [ CI ] , 1.3 - 3.2 ; P = .004 ) compared individuals CT TT genotypes . Participants CC genotype 3.0-fold greater odds MI ( 95 % CI , 1.7 - 5.2 ; P < .001 ) compared CT TT genotype . results remained significant analyses restricted men ; women events study separately . CONCLUSIONS : Individuals common @ GeneSrc $ c.454 - 397CC genotype substantial increase risk MI . Whether @ GeneSrc $ c.454 - 397T > C causally related MI risk linkage disequilibrium 1 causal variants remains determined . findings support importance estrogen receptors CVD susceptibility , especially men . @ GeneSrc $ variation also potential explain recent conflicting data regarding effects hormone therapy CVD susceptibility women .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032690411815711)\n",
      "- Text: \"@ GeneSrc $ gene polymorphisms risk @ DiseaseTgt $ . CONTEXT : role estrogens ischemic heart disease ( IHD ) uncertain . Evidence suggests genetic variations @ GeneSrc $ ( @ GeneSrc $ ) gene may influence IHD risk , role common sequence variations @ GeneSrc $ gene unclear . OBJECTIVE : determine whether @ GeneSrc $ haplotype created c.454 - 397T > C ( PvuII ) c.454 - 351A > G ( XbaI ) polymorphisms associated @ DiseaseTgt $ ( MI ) IHD risk . DESIGN , SETTING , PARTICIPANTS : 2617 men 3791 postmenopausal women Rotterdam Study ( enrollment 1989 - 1993 follow-up January 2000 ) , population-based , prospective cohort study participants aged 55 years older , @ GeneSrc $ c.454 - 397T > C c.454 - 351A > G haplotypes determined . Detailed interviews physical examinations performed , blood samples obtained , cardiovascular risk factors assessed . MAIN OUTCOME MEASURE : primary outcome MI IHD defined MIs , revascularization procedures , IHD mortality . RESULTS : Approximately 29 % women 28.2 % men homozygous carriers @ GeneSrc $ haplotype 1 ( -397 -351 ) allele , 49 % women 50 % men heterozygous carriers , 22 % women 21.4 % men noncarriers . mean follow-up 7.0 years , 285 participants ( 115 women ; 170 men ) MI , 440 ( 168 women ; 272 men ) IHD event , 97 fatal . adjustment known cardiovascular risk factors , female heterozygous carriers haplotype 1 increased risk MI ( event rate , 2.8 % ; relative risk [ RR ] , 2.23 ; 95 % confidence interval [ CI ] , 1.13 - 4.43 ) compared noncarriers ( event rate , 1.3 % ) , whereas homozygous carriers increased risk ( event rate , 3.2 % ; RR , 2.48 ; 95 % CI , 1.22 - 5.03 ) . IHD events , observed similar association . women , effect haplotype 1 fatal IHD larger nonfatal IHD . men , @ GeneSrc $ haplotypes associated increased risk MI ( event rate , 5.7 % ; RR , 0.93 ; 95 % CI , 0.59 - 1.46 heterozygous carriers ; event rate , 5.1 % ; RR , 0.82 ; 95 % CI , 0.49 - 1.38 homozygous carriers ) compared noncarriers ( event rate , 5.8 % ) associated increased risk IHD . CONCLUSIONS : population-based , prospective cohort study , postmenopausal women carry @ GeneSrc $ haplotype 1 ( c.454 - 397 allele c.454 - 351 allele ) increased risk MI IHD , independent known cardiovascular risk factors . men , association observed .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0011246224139429)\n",
      "- Text: \"Tobacco smoking , @ GeneSrc $ gene variation small low density lipoprotein level . High levels small low density lipoprotein ( LDL ) particles major risk factor cardiovascular morbidity mortality . estrogens smoking , known anti-estrogenic effects , alter atherogenic lipid profile . tested role interaction smoking @ GeneSrc $ gene ( @ GeneSrc $ ) variation association plasma concentration atherogenic small LDL particles LDL particle size . studied 1727 unrelated subjects , 854 women 873 men , mean age 51 years ( SD 10 ) , population-based Framingham Heart Study . covariate adjustment , women smoked common @ GeneSrc $ c.454 - 397 TT genotype ( 30 % women , present chromosomes position 397 prior start exon 2 ) > 1.7-fold higher levels small LDL particles women alternative genotypes ( P-value smoking-genotype interaction 0.001 ) . Similar results obtained three @ GeneSrc $ variants including c.454 - 351A > G , linkage disequilibrium block . similar substantial gender-specific result also evident fifth variant , separate linkage disequilibrium block , exon 4 ( P = 0.003 ) . Women smoked specific , common @ GeneSrc $ genotypes substantially higher plasma concentration atherogenic small LDL particles . Significant results revealed dose-dependent effect smoking evident pre- postmenopausal women . reported association potential explain risks associated estrogen use certain women recent report association @ GeneSrc $ haplotype comprised c.454 - 397 c.454 - 351 alleles increased @ DiseaseTgt $ ischaemic heart disease , independent standard , established cardiovascular risk factors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001634643190686)\n",
      "- Text: \"@ GeneSrc $ polymorphisms risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0201589553999231)\n",
      "- Text: \"Mutation PIK3CA gene ovarian breast cancer . Phosphatidylinositol 3'-kinases lipid kinases important roles @ DiseaseTgt $ . Recently , high frequency somatic mutations PIK3CA reported among large series colorectal cancers . However , relevance PIK3CA mutation @ DiseaseTgt $ types remains unclear limited number @ DiseaseTgt $ investigated . screened total 284 primary human @ DiseaseTgt $ mutations coding exons PIK3CA using combination single stranded conformational polymorphism denaturing high-performance liquid chromatography analysis . Among 70 primary breast cancers , 40 % ( 28 70 ) harbored mutations PIK3CA , making common mutation described date @ DiseaseTgt $ type . Mutations associated histologic subtype , @ GeneSrc $ status , grade presence @ DiseaseTgt $ lymph nodes . Among primary epithelial ovarian cancers 11 167 ( 6.6 % ) contain somatic mutations , clear histologic subtype bias distribution . 2 88 ( 2.3 % ) serous carcinomas PIK3CA mutations compared 8 40 ( 20.0 % ) endometrioid clear cell cancers , highly significant ( P = 0.001 ) . contrast , PIK3CA gene amplification ( > 7-fold ) common among histologic subtypes ( 24.5 % ) inversely associated presence mutations . Overall , PIK3CA mutation gene amplification detected 30.5 % ovarian cancers 45 % endometrioid clear cell subtypes . study first direct evidence PIK3CA oncogene ovarian cancer greatly extends recent findings breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025852559683991)\n",
      "- Text: \"PIK3CA mutations associated gene signature low mTORC1 signaling better outcomes @ GeneSrc $ breast cancer . PIK3CA mutations reported present approximately 25 % breast cancer ( BC ) , particularly @ GeneSrc $ ( ER+ ) HER2-overexpressing ( HER2 + ) subtypes , making one common genetic aberrations BC . experimental models , mutations shown activate AKT induce oncogenic transformation , hence lesions hypothesized render @ DiseaseTgt $ highly sensitive therapeutic PI3K/mTOR inhibition . analyzing gene expression protein data nearly 1,800 human BCs , report PIK3CA mutation-associated gene signature ( PIK3CA-GS ) derived exon 20 ( kinase domain ) mutations able predict PIK3CA mutation status two independent datasets , strongly suggesting characteristic set gene expression-induced changes . However , ER+/HER2- BC despite pathway activation , PIK3CA mutations associated phenotype relatively low mTORC1 signaling good prognosis tamoxifen monotherapy . relationship clinical outcome PIK3CA-GS also assessed . Although PIK3CA-GS associated prognosis ER- HER2 + BC , could identify better clinical outcomes ER+/HER2- disease . ER+ BC cell lines , PIK3CA mutations also associated sensitivity tamoxifen . findings could important implications treatment PIK3CA-mutant BCs development PI3K/mTOR inhibitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039088937628873)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human @ DiseaseTgt $ . profiled mutation status PIK3Ca gene National @ DiseaseTgt $ Institute ( NCI ) -60 panel human @ DiseaseTgt $ cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels @ GeneSrc $ ( @ GeneSrc $ ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines @ GeneSrc $ inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention @ DiseaseTgt $ harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012023300728945)\n",
      "- Text: \"Screening ESR mutations breast ovarian cancer patients . present study , leukocyte DNA 143 patients familial clustering breast and/or ovarian cancer @ DiseaseTgt $ DNA 96 breast carcinomas screened base mutations @ GeneSrc $ gene ( ESR ) . Three patients family history @ DiseaseTgt $ carrying Gly160Cys germline substitution . alteration also detected eight ( four females four males ) 729 controls ( 366 female , 363 males ) , indicating substitution probably represents polymorphism . However , 229 female controls family history @ DiseaseTgt $ known , one two sister breast cancer carrying variant allele . Hence , possible clinical significance glycine cysteine completely ruled investigated . Somatic mutations detected @ DiseaseTgt $ studied , present data provide support somatic ESR base mutations important mechanism hormonal therapy resistance estrogen receptor-positive breast carcinomas .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4032905031352536)\n",
      "- Text: \"Coexpression alternatively spliced estrogen progesterone receptor transcripts human breast cancer . Primary transcripts human @ GeneSrc $ ( @ GeneSrc $ ) progesterone receptor ( PR ) subject number alternative splicing events resulting range variant messenger ribonucleic acid species receptor-positive tissues . Despite vitro demonstrations possible role variants hormonal sensitivity , clinical significance process uncertain . study coexpression variant @ GeneSrc $ PR transcripts documented RT-PCR Southern blot analysis series receptor-positive breast tumors . 35 @ GeneSrc $ @ DiseaseTgt $ , common profile variant @ GeneSrc $ transcripts present , @ DiseaseTgt $ containing delta2ER delta7ER , 94 % containing delta4ER , 83 % containing delta5ER . 25 cases , also PR positive , highly expressed PR variants , delta4PR , delta6PR , delta ( 4/2 ) PR , transcript 126-bp portion PR exon 4 deleted , detected 90 % cases . alternatively spliced @ GeneSrc $ variants expressed higher relative levels PR species , mean levels expression less 10 % wild-type PR . abundant species delta7ER , present levels ranging 29 - 83 % wild type . relationship level delta7ER individual @ DiseaseTgt $ pattern expression estrogen-responsive proteins PR pS2 . common profile alternatively spliced @ GeneSrc $ PR transcripts breast tumors means feature used discriminator hormone responsiveness clinical end points . , low level expression majority variant species calls question potential impacting significantly receptor function .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7540031015828089)\n",
      "- Text: \"Steroid receptors prognostic factors primary breast cancer . review update published studies prognostic factors support following conclusions : number axillary lymph nodes involved @ DiseaseTgt $ remains important prognostic factor women primary breast cancer . stage disease , lack @ GeneSrc $ ( @ GeneSrc $ ) seems important factor predicting earlier recurrence poorer survival . stage II breast cancer , progesterone receptor ( PgR ) content appears better @ GeneSrc $ content predicting disease-free overall survival . Measurement proliferative activity ( S-phase DNA ) thymidine labeling flow cytometry ( FCM ) aneuploidy FCM also provides prognostic information . Patients aneuploid tumors , high S-phase diploid @ DiseaseTgt $ , increased risk relapse . Amplification oncogenes , particularly HER-2/neu , may provide additional prognostic information combination established prognostic factors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4598029651738917)\n",
      "- Text: \"@ DiseaseTgt $ truncated @ GeneSrc $ splice variant enhances estrogen-stimulated gene expression . study examines cooperative effects human @ GeneSrc $ ( @ GeneSrc $ ) isoform estrogen ( E2 ) -mediated gene activation U2-OS osteosarcoma cells . Delta5ERalpha , alternatively spliced @ GeneSrc $ variant lacking exon 5 , coexpressed normal @ GeneSrc $ several E2-responsive neoplastic tissues . However , potential interactions delta5ERalpha normal @ GeneSrc $ functionally characterized . Delta5ERalpha encodes hormone-independent trans-activating function ( AF-1 ) , well constitutive receptor dimerization DNA-binding domains . generated alternate splice event omits exon 5 alters reading frame resulting mRNA . delta5ERalpha protein prematurely truncated lacks majority hormone-binding activating function-2 ( AF-2 ) domains . delta5ERalpha mammalian expression vector transfected alone human @ GeneSrc $ osteosarcoma U2-OS cells , effect either basal E2-mediated EREtk81Luc reporter transcriptional activity , transfected cells expressing control normal @ GeneSrc $ increased EREtk81 Luc activity 20-fold response 10 nM E2 . However , delta5ERalpha cotransfected normal @ GeneSrc $ , basal E2-stimulated EREtk81Luc reporter activation increased approximately 500 % levels observed cells transfected @ GeneSrc $ alone . Similar effects delta5ERalpha normal ERa coexpression observed using E2-responsive human C3 promoter/luciferase reporter construct . effects delta5ERalpha normal @ GeneSrc $ assessed U2-OS cells stably transfected normal @ GeneSrc $ . Transfection increasing amounts delta5ERalpha expression vector @ GeneSrc $ cells resulted potentiation E2-stimulated ERELuc activity synergistic , dose-dependent manner . Moreover , coexpression delta5ERalpha @ GeneSrc $ cells improved E2 sensitivity 100-fold cells expressing @ GeneSrc $ alone . Proliferation rates stable U2-OS cell lines expressing delta5ERalpha significantly increased ( P < 0.05 ) , cell doubling times reduced 35 h control parental U2-OS cells 28 h [ delta5ERalpha ] OS cells . However , growth rates affected either E2 tamoxifen treatment . Electromobility shift/supershift assays using nuclear extracts U2-OS cells stably transfected @ GeneSrc $ delta5ERalpha confirmed constitutive binding delta5ERalpha @ GeneSrc $ protein estrogen-response element ( ERE ) sequence independent E2 also showed increase @ GeneSrc $ complexes E2 treatment . data consistent interactive effects normal @ GeneSrc $ delta5ERalpha transcription classic ERE gene promoters . Delta5ERalpha appears therefore act dominant positive receptor increases basal E2-stimulated gene transactivation normal @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8324730701506915)\n",
      "- Text: \"@ GeneSrc $ mutations breast cancer . fairly well accepted presence @ GeneSrc $ ( @ GeneSrc $ ) identifies breast cancer patients lower risk relapse better overall survival [ Clark McGuire , 1988 ] , measurement @ GeneSrc $ become standard assay clinical management breast cancer . Receptor status also provides guideline @ DiseaseTgt $ may responsive hormonal intervention [ McGuire 1978 ; Osborne et al . , 1980 ; Rose et al . , 1985 ] . half @ GeneSrc $ patients respond various hormonal therapies available , initially respond , eventually develop hormonally unresponsive disease following period treatment even though @ GeneSrc $ often still present . Loss @ GeneSrc $ initially @ GeneSrc $ @ DiseaseTgt $ biopsied later date estimated 19 % [ Gross et al . , 1984 ] . Obviously simple measurement @ GeneSrc $ presence ligand-binding assays provide us adequate estimate functional state receptor . 1985 Sluyser Mester hypothesized loss hormone dependence certain breast tumors may due presence mutated truncated steroid receptors activate transcription even absence hormone [ Sluyser Mester , 1985 ] . Based recent identification several @ GeneSrc $ sequence variants human breast cancer cell lines @ DiseaseTgt $ specimens , would like propose identified mutations play role receptor dysfunction vivo , review @ GeneSrc $ mutations may prove important breast cancer progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0284097809019746)\n",
      "- Text: \"BRCA1 inhibition @ GeneSrc $ signaling transfected cells . Mutations breast cancer susceptibility gene BRCA1 confer increased risk breast , ovarian , prostatic cancers , clear mutations associated particular @ DiseaseTgt $ types . transient transfection assays , BRCA1 found inhibit signaling ligand-activated estrogen receptor ( @ GeneSrc $ ) estrogen-responsive enhancer element block transcriptional activation function AF-2 @ GeneSrc $ . results raise possibility wild-type BRCA1 suppresses estrogen-dependent transcriptional pathways related mammary epithelial cell proliferation loss ability contributes tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002908734139534)\n",
      "- Text: \"@ GeneSrc $ ( @ GeneSrc $ ) gene amplification frequent breast cancer . Using Affymetrix 10 K SNP array screen gene copy number changes breast cancer , detected single-gene amplification @ GeneSrc $ gene , encodes @ GeneSrc $ , 6q25 . subsequent tissue microarray analysis 2,000 clinical breast cancer samples showed @ GeneSrc $ amplification 20.6 % breast cancers . Ninety-nine percent @ DiseaseTgt $ @ GeneSrc $ amplification showed @ GeneSrc $ protein overexpression , compared 66.6 % @ DiseaseTgt $ without @ GeneSrc $ amplification ( P < 0.0001 ) . 175 women received adjuvant tamoxifen monotherapy , survival significantly longer women @ DiseaseTgt $ @ GeneSrc $ amplification women @ GeneSrc $ @ DiseaseTgt $ without @ GeneSrc $ amplification ( P = 0.023 ) . Notably , also found @ GeneSrc $ amplification benign precancerous breast diseases , suggesting @ GeneSrc $ amplification may common mechanism proliferative breast disease early genetic alteration large subset breast cancers .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8244170144620359)\n",
      "- Text: \"Cadmium mimics vivo effects estrogen uterus mammary gland . suggested environmental contaminants mimic effects estrogen contribute disruption reproductive systems animals wild , high incidence hormone-related @ DiseaseTgt $ diseases Western populations . Previous studies shown functionally , cadmium acts like steroidal estrogens breast cancer cells result ability form high-affinity complex hormone binding domain @ GeneSrc $ . results present study show cadmium also potent estrogen-like activity vivo . Exposure cadmium increased uterine wet weight , promoted growth development mammary glands induced hormone-regulated genes ovariectomized animals . uterus , increase wet weight accompanied proliferation endometrium induction progesterone receptor ( PgR ) complement component C3 . mammary gland , cadmium promoted increase formation side branches alveolar buds induction casein , whey acidic protein , PgR C3 . utero exposure metal also mimicked effects estrogens . Female offspring experienced earlier onset puberty increase epithelial area number terminal end buds mammary gland .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"naturally occurring MTA1 variant sequesters oestrogen receptor-alpha cytoplasm . Oestrogen receptor ( ER ) good prognostic marker treatment breast cancers . Upregulation metastatic tumour antigen 1 ( MTA1 ) associated invasiveness metastatic potential several human @ DiseaseTgt $ acts co-repressor nuclear @ GeneSrc $ . identify naturally occurring short form MTA1 ( MTA1s ) contains previously unknown sequence 33 amino acids ER-binding motif , Leu-Arg-Ile-Leu-Leu ( LRILL ) . MTA1s localizes cytoplasm , sequesters ER cytoplasm , enhances non-genomic responses ER . Deleting LRILL motif MTA1s abolishes co-repressor function interaction ER , restores nuclear localization ER . Dysregulation human epidermal growth factor receptor-2 breast cancer cells enhances expression MTA1s cytoplasmic sequestration ER . Expression MTA1s breast cancer cells prevents ligand-induced nuclear translocation ER stimulates malignant phenotypes . MTA1s expression increased human breast tumours low nuclear ER . regulation cellular localization ER MTA1s represents mechanism redirecting nuclear receptor signalling nuclear exclusion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.1005597646273148e-05)\n",
      "- Text: \"Classifying @ GeneSrc $ status breast cancers expression profiles reveals poor prognosis subpopulation exhibiting high expression ERBB2 receptor . Recent work using expression profiling computationally predict @ GeneSrc $ ( @ GeneSrc $ ) status breast tumors revealed certain @ DiseaseTgt $ characterized high prediction uncertainty ( ' low-confidence ' ) . analyzed ' low-confidence ' @ DiseaseTgt $ determined ' uncertain ' prediction status arises result widespread perturbations multiple genes whose expression important @ GeneSrc $ subtype discrimination . Patients ' low-confidence ' @ GeneSrc $ @ DiseaseTgt $ exhibited significantly worse overall survival ( P=0.03 ) shorter time distant metastasis ( P=0.004 ) compared ' high-confidence ' @ GeneSrc $ counterparts , indicating ' high- ' ' low-confidence ' binary distinction clinically meaningful . discovered elevated expression ERBB2 receptor significantly correlated breast tumor exhibiting ' low-confidence ' prediction , association subsequently validated across multiple independently derived breast cancer expression datasets employing variety different array technologies patient populations . Although ERBB2 signaling proposed inhibit transcriptional activity @ GeneSrc $ , large proportion perturbed genes ' low-confidence'/ERBB2 + samples known estrogen responsive , recently described bioinformatic algorithm ( DEREF ) used demonstrate absence potential estrogen-response elements ( EREs ) promoters . propose significant portion ERBB2 's effects @ GeneSrc $ breast tumors may involve @ GeneSrc $ mechanisms gene activation , may contribute clinically aggressive behavior ' low-confidence ' breast tumor subtype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.028026793360544)\n",
      "- Text: \"Novel mutations @ GeneSrc $ messenger RNA human breast cancers . One mechanism suggested play role progression human breast cancer hormone dependence independence expression altered expression mutant and/or variant forms @ GeneSrc $ ( @ GeneSrc $ ) . Two major types variant @ GeneSrc $ messenger ( ) RNA identified human breast biopsy samples far : truncated transcripts exon deleted transcripts . study provide data indicating existence novel type abnormal @ GeneSrc $ mRNA . transcripts identified larger wild-type @ GeneSrc $ mRNA RT-PCR products 9.4 % 212 human breast tumors analyzed . data suggest nucleotide insertions present @ GeneSrc $ mRNA breast tumors . Cloning sequencing larger RT-PCR products showed three different types : complete duplication exon 6 occurring 7.5 % @ DiseaseTgt $ ; complete duplication exons 3 4 occurring 1 @ DiseaseTgt $ ; 69 nucleotide insertion exons 5 6 occurring 3 @ DiseaseTgt $ . Open reading frame analysis suggested exon 6 duplicated transcripts encoded 51.4 kDa ER-like protein truncated exon 6 sequences ; exon 3 4 duplicated transcript encoded 83.3 kDa protein containing duplication @ GeneSrc $ amino acid residues encoded exons 3 4 ; 69 nucleotide insertion inframe , adding 23 novel amino acid residues residues 412 413 normal @ GeneSrc $ protein produce 68.8 kDa protein . unknown novel ER-like mRNAs stably translated vivo . resulting protein would structurally altered , however , possibly resulting altered function .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9128448728126288)\n",
      "- Text: \"27-Hydroxycholesterol links hypercholesterolemia breast cancer pathophysiology . Hypercholesterolemia risk factor @ GeneSrc $ ( ER ) -positive breast cancers associated decreased response @ DiseaseTgt $ endocrine therapies . , show 27-hydroxycholesterol ( 27HC ) , primary metabolite cholesterol ER liver X receptor ( LXR ) ligand , increases ER-dependent growth LXR-dependent metastasis mouse models breast cancer . effects cholesterol @ DiseaseTgt $ pathology required conversion 27HC cytochrome P450 oxidase CYP27A1 attenuated treatment CYP27A1 inhibitors . human breast cancer specimens , CYP27A1 expression levels correlated @ DiseaseTgt $ grade . high-grade @ DiseaseTgt $ , @ DiseaseTgt $ cells @ DiseaseTgt $ macrophages exhibited high expression levels enzyme . Thus , lowering circulating cholesterol levels interfering conversion 27HC may useful strategy prevent and/or treat breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0027281670298694)\n",
      "- Text: \"Truncated forms DNA-binding estrogen receptors human breast cancer . likelihood breast cancer respond antiestrogen therapy depends @ DiseaseTgt $ content immunoreactive ligand-binding @ GeneSrc $ ( @ GeneSrc $ ) . investigate failure many @ GeneSrc $ breast cancers respond antiestrogen therapy , examined gel-shift assay ability @ DiseaseTgt $ @ GeneSrc $ bind cognate estrogen response element ( ERE ) . Analysis 38 primary breast cancers showed @ DiseaseTgt $ containing abundant immunoreactive @ GeneSrc $ failed demonstrate DNA binding @ GeneSrc $ . many @ GeneSrc $ @ DiseaseTgt $ , fraction DNA binding @ GeneSrc $ low consisted primarily truncated receptor forms , Western analysis revealed 50 kD homodimers 67 - 50 kD @ GeneSrc $ heterodimers . use protease inhibitors @ DiseaseTgt $ extraction demonstration nuclear-localizing @ GeneSrc $ ERE-binding COUP ( chicken ovalbumin upstream promoter ) protein @ DiseaseTgt $ indicated truncated forms @ GeneSrc $ likely present vivo . presence intact DNA binding @ GeneSrc $ correlated higher @ DiseaseTgt $ content immunoreactive sex steroid receptors ( @ GeneSrc $ and/or PR ) , standard predictors @ DiseaseTgt $ responsiveness antiestrogen , suggesting loss truncation DNA binding @ GeneSrc $ may important prognostic parameter accounting forms clinical resistance antiestrogen therapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9301376772577918)\n",
      "- Text: \"Activating @ GeneSrc $ mutations hormone-resistant metastatic breast cancer . Breast cancer prevalent @ DiseaseTgt $ women , two-thirds cases express @ GeneSrc $ ( @ GeneSrc $ , encoded @ GeneSrc $ ) . prospective clinical sequencing program advanced @ DiseaseTgt $ , enrolled 11 patients ER-positive metastatic breast cancer . Whole-exome transcriptome analysis showed six cases harbored mutations @ GeneSrc $ affecting ligand-binding domain ( LBD ) , treated anti-estrogens estrogen deprivation therapies . survey @ DiseaseTgt $ Genome Atlas ( TCGA ) identified four endometrial cancers similar mutations @ GeneSrc $ . five new LBD-localized @ GeneSrc $ mutations identified ( encoding p. Leu536Gln , p. Tyr537Ser , p. Tyr537Cys , p. Tyr537Asn p. Asp538Gly ) shown result constitutive activity continued responsiveness anti-estrogen therapies vitro . Taken together , studies suggest activating mutations @ GeneSrc $ key mechanism acquired endocrine resistance breast cancer therapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9617986942644988)\n",
      "- Text: \"Selective expression estrogen receptor alpha beta isoforms human pituitary tumors . physiological effects estrogen pituitary , including cellular proliferation regulation hormone synthesis , mediated nuclear @ GeneSrc $ ( @ GeneSrc $ ) . @ GeneSrc $ acts dimer modulate gene transcription contains specific functional domains encoded different exons . Two separate , related , forms receptor ( @ GeneSrc $ ERbeta ) exist , distinct tissue cell patterns expression . Additional @ GeneSrc $ isoforms , generated alternative messenger ribonucleic acid ( mRNA ) exon splicing , defined several tissues postulated play role tumorigenesis modulating estrogen response . examined 71 human pituitary adenomas varying phenotypes 6 normal pituitary specimens @ GeneSrc $ mRNA forms RT-PCR hybridization blotting analysis . prolactinomas ( n = 14 ) contained @ GeneSrc $ , several contained ERbeta ( 5 14 ) mRNA . comparison , 6 @ DiseaseTgt $ expressed PRL GH expressed ERbeta ( 4 6 ) frequently @ GeneSrc $ ( 3 6 ) . ERbeta mRNA also found frequently null cell ( 8 24 @ GeneSrc $ 14 24 ERbeta ) gonadotrope ( 13 21 @ GeneSrc $ 18 21 ERbeta ) @ DiseaseTgt $ . Additionally , ERbeta found 4 6 @ DiseaseTgt $ contained GH , although @ GeneSrc $ observed @ DiseaseTgt $ type . Expression two @ GeneSrc $ forms within @ DiseaseTgt $ type overlapping , @ DiseaseTgt $ contained 1 isoform . Expression @ GeneSrc $ mRNA splice variants also varied cell type . normal pituitaries contained @ GeneSrc $ deletions exon 4 , 5 , 7 , whereas 2 6 samples contained exon 2 deletion variant . Although @ GeneSrc $ mRNA variants observed among various @ DiseaseTgt $ types , proportion specific splice variants expressed varied . example , @ GeneSrc $ prolactinomas expressed @ GeneSrc $ variants deletions exon 2 , 4 , 5 , whereas gonadotropin tumors preferentially expressed @ GeneSrc $ exon 7 deletion variant . novel ERbeta mRNA splice variant , missing exon 2 , observed majority ERbeta-positive @ DiseaseTgt $ . Immunoblotting analysis @ GeneSrc $ ERbeta proteins supported mRNA results . @ GeneSrc $ ERbeta different biological responses selective @ GeneSrc $ modulators , @ GeneSrc $ deletion variants biological effects distinct full-length @ GeneSrc $ , expression isoforms may influence biological properties @ DiseaseTgt $ affect ability respond estrogen antiestrogen therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9956086488588598)\n",
      "- Text: \"@ GeneSrc $ ligand-binding domain mutations hormone-resistant breast cancer . Seventy percent breast cancers express @ GeneSrc $ ( @ GeneSrc $ ) , sensitive @ GeneSrc $ inhibition . However , many @ DiseaseTgt $ unknown reasons become refractory inhibition estrogen action metastatic setting . conducted comprehensive genetic analysis two independent cohorts metastatic @ GeneSrc $ breast tumors identified mutations @ GeneSrc $ affecting ligand-binding domain ( LBD ) 14 80 cases . included highly recurrent mutations encoding p. Tyr537Ser , p. Tyr537Asn p. Asp538Gly alterations . Molecular dynamics simulations suggest structures Tyr537Ser Asp538Gly mutants involve hydrogen bonding mutant amino acids Asp351 , thus favoring agonist conformation receptor . Consistent model , mutant receptors drive @ GeneSrc $ transcription proliferation absence hormone reduce efficacy ER antagonists . data implicate LBD-mutant forms @ GeneSrc $ mediating clinical resistance hormonal therapy suggest potent ER antagonists may substantial therapeutic benefit .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1268838825435914)\n",
      "- Text: \"Possible linkage @ GeneSrc $ gene breast cancer family late-onset disease . @ GeneSrc $ locus candidate gene inherited susceptibility human breast cancer , particularly among families later onset , primarily @ GeneSrc $ @ DiseaseTgt $ . one extended family eight patients late-onset disease , one @ GeneSrc $ haplotype consistently coinherited breast cancer , yielding + 1.85 lod score linkage zero recombination . Simulation pedigree assuming independent inheritance breast cancer @ GeneSrc $ genotypes led lod score greater equal 1.85 2,000 replicates . suggest testing linkage gene breast cancer families late-onset disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3286887069414074)\n",
      "- Text: \"Identification novel @ GeneSrc $ fusion transcript expressed human @ DiseaseTgt $ cells . semi-nested reverse transcriptase-polymerase chain reaction ( RT-PCR ) applied evaluate presence @ GeneSrc $ ( @ GeneSrc $ ) human prostate cancer cells . Unexpectedly , novel fatty acid synthase @ GeneSrc $ fusion transcript identified , N-terminus FAS fused in-frame C-terminus @ GeneSrc $ . existence @ GeneSrc $ transcript confirmed RT-PCR analysis using various sets amplification primers different reverse-transcribed primers presence dimethyl sulfoxide eliminate secondary structure RNA . predicted @ GeneSrc $ protein would contain largely domain FAS entire ligand binding domain @ GeneSrc $ . @ GeneSrc $ expressed variety human @ DiseaseTgt $ cell lines including prostate , breast , cervical bladder cancer cell lines . data suggest presence @ GeneSrc $ may complicate FAS @ GeneSrc $ signalling pathway .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5726888458891689)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed @ GeneSrc $ hMSH2 interacted ligand-dependent manner , whereas ER beta hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 hMSH3/hMSH6 interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded @ GeneSrc $ , ER beta . results suggest hMSH2 may play important role putative coactivator @ GeneSrc $ dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0321119801076383)\n",
      "- Text: \"Mutation PIK3CA gene ovarian breast cancer . Phosphatidylinositol 3'-kinases lipid kinases important roles neoplasia . Recently , high frequency somatic mutations PIK3CA reported among large series colorectal cancers . However , relevance PIK3CA mutation cancer types remains unclear limited number tumors investigated . screened total 284 primary human tumors mutations coding exons PIK3CA using combination single stranded conformational polymorphism denaturing high-performance liquid chromatography analysis . Among 70 primary breast cancers , 40 % ( 28 70 ) harbored mutations PIK3CA , making common mutation described date cancer type . Mutations associated histologic subtype , @ GeneSrc $ status , grade presence tumor lymph nodes . Among primary epithelial ovarian cancers 11 167 ( 6.6 % ) contain somatic mutations , clear histologic subtype bias distribution . 2 88 ( 2.3 % ) serous carcinomas PIK3CA mutations compared 8 40 ( 20.0 % ) endometrioid clear cell cancers , highly significant ( P = 0.001 ) . contrast , PIK3CA gene amplification ( > 7-fold ) common among histologic subtypes ( 24.5 % ) inversely associated presence mutations . Overall , PIK3CA mutation gene amplification detected 30.5 % @ DiseaseTgt $ 45 % endometrioid clear cell subtypes . study first direct evidence PIK3CA oncogene @ DiseaseTgt $ greatly extends recent findings breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2028251224051202)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two @ DiseaseTgt $ , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels @ GeneSrc $ ( @ GeneSrc $ ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines @ GeneSrc $ inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000755098732895)\n",
      "- Text: \"Mutation PIK3CA gene ovarian breast cancer . Phosphatidylinositol 3'-kinases lipid kinases important roles neoplasia . Recently , high frequency somatic mutations PIK3CA reported among large series @ DiseaseTgt $ . However , relevance PIK3CA mutation cancer types remains unclear limited number tumors investigated . screened total 284 primary human tumors mutations coding exons PIK3CA using combination single stranded conformational polymorphism denaturing high-performance liquid chromatography analysis . Among 70 primary breast cancers , 40 % ( 28 70 ) harbored mutations PIK3CA , making common mutation described date cancer type . Mutations associated histologic subtype , @ GeneSrc $ status , grade presence tumor lymph nodes . Among primary epithelial ovarian cancers 11 167 ( 6.6 % ) contain somatic mutations , clear histologic subtype bias distribution . 2 88 ( 2.3 % ) serous carcinomas PIK3CA mutations compared 8 40 ( 20.0 % ) endometrioid clear cell cancers , highly significant ( P = 0.001 ) . contrast , PIK3CA gene amplification ( > 7-fold ) common among histologic subtypes ( 24.5 % ) inversely associated presence mutations . Overall , PIK3CA mutation gene amplification detected 30.5 % ovarian cancers 45 % endometrioid clear cell subtypes . study first direct evidence PIK3CA oncogene ovarian cancer greatly extends recent findings breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.68592853264732e-05)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two @ DiseaseTgt $ , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version KRAS gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels @ GeneSrc $ ( @ GeneSrc $ ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines @ GeneSrc $ inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013741255288223)\n",
      "- Text: \"Selective expression @ GeneSrc $ isoforms human pituitary tumors . physiological effects estrogen pituitary , including cellular proliferation regulation hormone synthesis , mediated nuclear estrogen receptor ( ER ) . ER acts dimer modulate gene transcription contains specific functional domains encoded different exons . Two separate , related , forms receptor ( ERalpha ERbeta ) exist , distinct tissue cell patterns expression . Additional ER isoforms , generated alternative messenger ribonucleic acid ( mRNA ) exon splicing , defined several tissues postulated play role tumorigenesis modulating estrogen response . examined 71 human pituitary adenomas varying phenotypes 6 normal pituitary specimens ER mRNA forms RT-PCR hybridization blotting analysis . prolactinomas ( n = 14 ) contained ERalpha , several contained ERbeta ( 5 14 ) mRNA . comparison , 6 @ DiseaseTgt $ expressed PRL GH expressed ERbeta ( 4 6 ) frequently ERalpha ( 3 6 ) . ERbeta mRNA also found frequently null cell ( 8 24 ERalpha 14 24 ERbeta ) gonadotrope ( 13 21 ERalpha 18 21 ERbeta ) @ DiseaseTgt $ . Additionally , ERbeta found 4 6 @ DiseaseTgt $ contained GH , although ERalpha observed @ DiseaseTgt $ type . Expression two ER forms within @ DiseaseTgt $ type overlapping , @ DiseaseTgt $ contained 1 isoform . Expression ERalpha mRNA splice variants also varied cell type . normal pituitaries contained ERalpha deletions exon 4 , 5 , 7 , whereas 2 6 samples contained exon 2 deletion variant . Although ERalpha mRNA variants observed among various @ DiseaseTgt $ types , proportion specific splice variants expressed varied . example , ER-positive prolactinomas expressed ERalpha variants deletions exon 2 , 4 , 5 , whereas gonadotropin tumors preferentially expressed ERalpha exon 7 deletion variant . novel ERbeta mRNA splice variant , missing exon 2 , observed majority ERbeta-positive @ DiseaseTgt $ . Immunoblotting analysis ERalpha ERbeta proteins supported mRNA results . ERalpha ERbeta different biological responses selective ER modulators , ER deletion variants biological effects distinct full-length ER , expression isoforms may influence biological properties @ DiseaseTgt $ affect ability respond estrogen antiestrogen therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.994847668212475)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction @ GeneSrc $ hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha hMSH2 interacted ligand-dependent manner , whereas ER beta hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 hMSH3/hMSH6 interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded ER alpha , ER beta . results suggest hMSH2 may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0564918078746151e-05)\n",
      "- Text: \"@ DiseaseTgt $ truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression . study examines cooperative effects human estrogen receptor-alpha ( ERalpha ) isoform estrogen ( E2 ) -mediated gene activation U2-OS osteosarcoma cells . Delta5ERalpha , alternatively spliced ERalpha variant lacking exon 5 , coexpressed normal ERalpha several E2-responsive neoplastic tissues . However , potential interactions delta5ERalpha normal ERalpha functionally characterized . Delta5ERalpha encodes hormone-independent trans-activating function ( AF-1 ) , well constitutive receptor dimerization DNA-binding domains . generated alternate splice event omits exon 5 alters reading frame resulting mRNA . delta5ERalpha protein prematurely truncated lacks majority hormone-binding activating function-2 ( AF-2 ) domains . delta5ERalpha mammalian expression vector transfected alone human @ GeneSrc $ osteosarcoma U2-OS cells , effect either basal E2-mediated EREtk81Luc reporter transcriptional activity , transfected cells expressing control normal ERalpha increased EREtk81 Luc activity 20-fold response 10 nM E2 . However , delta5ERalpha cotransfected normal ERalpha , basal E2-stimulated EREtk81Luc reporter activation increased approximately 500 % levels observed cells transfected ERalpha alone . Similar effects delta5ERalpha normal ERa coexpression observed using E2-responsive human C3 promoter/luciferase reporter construct . effects delta5ERalpha normal ERalpha assessed U2-OS cells stably transfected normal ERalpha . Transfection increasing amounts delta5ERalpha expression vector [ ERalpha+ ] OS cells resulted potentiation E2-stimulated ERELuc activity synergistic , dose-dependent manner . Moreover , coexpression delta5ERalpha [ ERalpha+ ] OS cells improved E2 sensitivity 100-fold cells expressing ERalpha alone . Proliferation rates stable U2-OS cell lines expressing delta5ERalpha significantly increased ( P < 0.05 ) , cell doubling times reduced 35 h control parental U2-OS cells 28 h [ delta5ERalpha ] OS cells . However , growth rates affected either E2 tamoxifen treatment . Electromobility shift/supershift assays using nuclear extracts U2-OS cells stably transfected ERalpha delta5ERalpha confirmed constitutive binding delta5ERalpha ERalpha protein estrogen-response element ( ERE ) sequence independent E2 also showed increase delta5ERalpha/ERalpha-ERE complexes E2 treatment . data consistent interactive effects normal ERalpha delta5ERalpha transcription classic ERE gene promoters . Delta5ERalpha appears therefore act dominant positive receptor increases basal E2-stimulated gene transactivation normal ERalpha .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.3856494878543835e-05)\n",
      "- Text: \"Selective expression estrogen receptor alpha beta isoforms human pituitary tumors . physiological effects estrogen pituitary , including cellular proliferation regulation hormone synthesis , mediated nuclear estrogen receptor ( ER ) . ER acts dimer modulate gene transcription contains specific functional domains encoded different exons . Two separate , related , forms receptor ( ERalpha @ GeneSrc $ ) exist , distinct tissue cell patterns expression . Additional ER isoforms , generated alternative messenger ribonucleic acid ( mRNA ) exon splicing , defined several tissues postulated play role tumorigenesis modulating estrogen response . examined 71 human pituitary adenomas varying phenotypes 6 normal pituitary specimens ER mRNA forms RT-PCR hybridization blotting analysis . prolactinomas ( n = 14 ) contained ERalpha , several contained @ GeneSrc $ ( 5 14 ) mRNA . comparison , 6 @ DiseaseTgt $ expressed PRL GH expressed @ GeneSrc $ ( 4 6 ) frequently ERalpha ( 3 6 ) . @ GeneSrc $ mRNA also found frequently null cell ( 8 24 ERalpha 14 24 @ GeneSrc $ ) gonadotrope ( 13 21 ERalpha 18 21 @ GeneSrc $ ) @ DiseaseTgt $ . Additionally , @ GeneSrc $ found 4 6 @ DiseaseTgt $ contained GH , although ERalpha observed @ DiseaseTgt $ type . Expression two ER forms within @ DiseaseTgt $ type overlapping , @ DiseaseTgt $ contained 1 isoform . Expression ERalpha mRNA splice variants also varied cell type . normal pituitaries contained ERalpha deletions exon 4 , 5 , 7 , whereas 2 6 samples contained exon 2 deletion variant . Although ERalpha mRNA variants observed among various @ DiseaseTgt $ types , proportion specific splice variants expressed varied . example , ER-positive prolactinomas expressed ERalpha variants deletions exon 2 , 4 , 5 , whereas gonadotropin tumors preferentially expressed ERalpha exon 7 deletion variant . novel @ GeneSrc $ mRNA splice variant , missing exon 2 , observed majority @ GeneSrc $ @ DiseaseTgt $ . Immunoblotting analysis ERalpha @ GeneSrc $ proteins supported mRNA results . ERalpha @ GeneSrc $ different biological responses selective ER modulators , ER deletion variants biological effects distinct full-length ER , expression isoforms may influence biological properties @ DiseaseTgt $ affect ability respond estrogen antiestrogen therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.995813751776528)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha hMSH2 interacted ligand-dependent manner , whereas @ GeneSrc $ hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 hMSH3/hMSH6 interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded ER alpha , @ GeneSrc $ . results suggest hMSH2 may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2337065288351038)\n",
      "- Text: \"Beta amyloid gene duplication @ DiseaseTgt $ karyotypically normal syndrome . recently cloned complementary DNA probe , lambda Am4 chromosome 21 gene encoding brain amyloid polypeptide ( beta amyloid protein ) @ DiseaseTgt $ , leukocyte DNA three patients sporadic @ DiseaseTgt $ two patients karyotypically normal syndrome found contain three copies gene . small region chromosome 21 containing @ GeneSrc $ gene duplicated patients @ DiseaseTgt $ , well karyotypically normal syndrome , duplication subsection critical segment chromosome 21 duplicated syndrome may genetic defect @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001015233744162)\n",
      "- Text: \"GATA transcription factors directly regulate @ DiseaseTgt $ gene alpha-synuclein . Increased alpha-synuclein gene ( SNCA ) dosage due locus multiplication causes autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Variation SNCA expression may critical common , genetically complex @ DiseaseTgt $ underlying regulatory mechanism unknown . show SNCA heme metabolism genes @ GeneSrc $ , FECH , BLVRB form block tightly correlated gene expression 113 samples human blood , SNCA naturally abounds ( validated P = 1.6 x 10 ( -11 ) , 1.8 x 10 ( -10 ) , 6.6 x 10 ( -5 ) ) . Genetic complementation analysis revealed four genes co-induced transcription factor GATA-1 . GATA-1 specifically occupies conserved region within SNCA intron-1 directly induces 6.9-fold increase alpha-synuclein . Endogenous GATA-2 highly expressed substantia nigra vulnerable @ DiseaseTgt $ , occupies intron-1 , modulates SNCA expression dopaminergic cells . critical link GATA factors SNCA may enable therapies designed lower alpha-synuclein production .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2738907786341953)\n",
      "- Text: \"Fetal origins @ GeneSrc $ fusion gene identical twins leukemia . @ GeneSrc $ @ GeneSrc $ ( CBFA2 ) gene fusion common reciprocal chromosomal rearrangement childhood cancer occurring approximately 25 % predominant subtype leukemia- common acute lymphoblastic leukemia . @ GeneSrc $ genomic sequence characterized pair monozygotic twins diagnosed ages 3 years , 6 months 4 years , 10 months common acute lymphoblastic leukemia . twin leukemic DNA shared unique ( clonotypic ) nonconstitutive @ GeneSrc $ fusion sequence . plausible explanation finding single cell origin @ DiseaseTgt $ fusion one fetus utero , probably leukemia-initiating mutation , followed intraplacental metastasis clonal progeny twin . Clonal identity supported finding leukemic cells two twins shared identical rearranged IGH allele . data implications etiology natural history childhood leukemia .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3656102319926061)\n",
      "- Text: \"TEL-AML1 , expressed ( 12 ; 21 ) human acute lymphocytic leukemia , induces @ DiseaseTgt $ mice . @ GeneSrc $ expressed ( 12 ; 21 ) chromosomal translocation inB-precursor acute lymphocytic leukemia ( ) . Creation TEL-AML1fusion disrupts one copy @ GeneSrc $ AML1 genes , loss TEL AML1 also associated cases @ DiseaseTgt $ without @ GeneSrc $ . determine whether TEL-AML1 contribute leukemogenesis , transduced marrow C57BL/6 mice retroviral vector expressing TEL-AML1 control vector . Transduced cells introduced irradiated syngeneic recipients . Two 9 TEL-AML1 mice developed ( one T-lineage one B-precursor ) , whereas 0 20 control mice developed leukemia . B-precursor retransplantable expressed TEL-AML1 . similarly transduced marrow C57BL/6 mice lacking overlapping p16 ( INK4a ) p19 ( ARF ) genes transplanted cells wild-type recipients . control mice died , six eight TEL-AML1/p16p19 mice died leukemia . Overall , findings indicate TEL-AML1 contributes leukemogenesis may cooperate loss p16 ( INK4a ) p14 ( ARF ) transform lymphoid progenitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0706426551937977)\n",
      "- Text: \"Somatic heterozygous mutations @ GeneSrc $ ( @ GeneSrc $ ) frequent absence @ GeneSrc $ protein @ DiseaseTgt $ . @ GeneSrc $ ( ets translocation variant gene 6 ) @ GeneSrc $ ( translocation ets leukemia ) , encoding transcriptional repressor , involved various translocations associated human malignancies . Strikingly , nonrearranged @ GeneSrc $ allele often deleted inactivated cells harboring translocations . Although @ GeneSrc $ translocations infrequent @ DiseaseTgt $ ( @ DiseaseTgt $ ) , mutations deregulated expression @ GeneSrc $ may contribute leukemogenesis . investigate involvement @ GeneSrc $ @ DiseaseTgt $ , analysed 300 newly diagnosed patients mutations coding region gene . Furthermore , studied protein expression 77 patients using two @ GeneSrc $ antibodies . Five somatic heterozygous mutations detected , affected either homodimerization- DNA-binding domain @ GeneSrc $ . proteins translated cDNAs mutants unable repress transcription showed dominant-negative effects . addition , demonstrate one-third @ DiseaseTgt $ patients deficient @ GeneSrc $ protein expression , related @ GeneSrc $ mRNA expression levels . conclusion , demonstrate @ GeneSrc $ abnormalities restricted translocations occur frequently @ DiseaseTgt $ previously thought . Additional comprehensive studies required define clinical consequence @ GeneSrc $ loss function @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8465950928710191)\n",
      "- Text: \"Fusion PDGF receptor beta novel ets-like gene , @ GeneSrc $ , chronic myelomonocytic leukemia ( 5 ; 12 ) chromosomal translocation . Chronic myelomonocytic leukemia ( CMML ) myelodysplastic syndrome characterized abnormal clonal myeloid proliferation progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) . CMML thus offers opportunity study early genetic events transition @ DiseaseTgt $ . recently recognized subgroup CMML ( 5 ; 12 ) ( q33 ; p13 ) balanced translocation . report consequence ( 5 ; 12 ) translocation expression fusion transcript tyrosine kinase domain platelet-derived growth factor receptor beta ( PDGFR beta ) chromosome 5 coupled novel ets-like gene , @ GeneSrc $ , chromosome 12 . @ GeneSrc $ beta fusion demonstrates oncogenic potential PDGFR beta may provide paradigm early events pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0042440225521114)\n",
      "- Text: \"( 1 ; 12 ) ( q21 ; p13 ) translocation human @ DiseaseTgt $ results @ GeneSrc $ fusion . @ GeneSrc $ gene located 12p13 encodes member ETS family transcription factors . @ GeneSrc $ ( @ GeneSrc $ ) frequently involved chromosomal translocations human malignancies , usually resulting expression fusion proteins amino-terminal part @ GeneSrc $ either unrelated transcription factors protein tyrosine kinases . characterized ( 1 ; 12 ) ( q21 ; p13 ) translocation @ DiseaseTgt $ ( @ DiseaseTgt $ ) . protein level , untranslocated @ GeneSrc $ copy , result ( 1 ; 12 ) translocation , fusion protein @ GeneSrc $ essentially aryl hydrocarbon receptor nuclear translocator ( ARNT ) expressed . involvement ARNT human leukemogenesis previously described . ARNT protein belongs subfamily `` basic region helix-loop-helix `` ( bHLH ) protein shares additional region similarity called PAS ( Per , ARNT , SIM ) domain . ARNT central partner several heterodimeric transcription factors , including containing aryl hydrocarbon ( dioxin ) receptor ( AhR ) hypoxia-inducible factor 1alpha ( HIF1alpha ) . results show @ GeneSrc $ fusion protein crucial product translocation suggest interference activity AhR HIF1alpha contribute leukemogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9119748119051992)\n",
      "- Text: \"novel cryptic translocation ( 12 ; 17 ) ( p13 ; p12-p13 ) secondary @ DiseaseTgt $ results fusion @ GeneSrc $ gene antisense strand PER1 gene . @ GeneSrc $ gene member ETS family transcription factors main target chromosomal rearrangements affecting chromosome band 12p13 . date , 15 fusion partners @ GeneSrc $ characterized molecular level . fusions encode chimeric proteins oncogenic properties . However , translocations produce functional fusion protein , may induce ectopic expression oncogenes located close breakpoint . herein report characterization cloning novel cryptic translocation , ( 12 ; 17 ) ( p13 ; p12-p13 ) , occurring patient @ DiseaseTgt $ evolving chronic myelomonocytic leukemia . Cytogenetic analysis suggested presence deletion short arm chromosome 12 , del ( 12 ) ( p13 ) , three five metaphase cells analyzed . However , fluorescence situ hybridization ( FISH ) @ GeneSrc $ cosmid clones 179A6 , 50F4 , 163E7 , 148B6 well probes hybridizing TP53 gene 17p13 subtelomeric region 17p revealed presence translocation 12p 17p . FISH , breakpoints could localized intron 1 @ GeneSrc $ centromeric TP53 . 3 ' rapid amplification cDNA ends-polymerase chain reaction ( 3 ' RACE-PCR ) , fusion transcript exon 1 @ GeneSrc $ antisense strand PER1 ( period homolog 1 , Drosophila ) , circadian clock gene , could identified . @ GeneSrc $ ( antisense PER1 strand ) fusion transcript produce fusion protein , fusion transcripts could detected . hypothesize absence fusion protein , inactivation PER1 deregulation gene neighborhood PER1 may contribute pathogenesis leukemias ( 12 ; 17 ) ( p13 ; p12-p13 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0136365139067767)\n",
      "- Text: \"Fusion @ GeneSrc $ novel ACS2 myelodysplastic syndrome @ DiseaseTgt $ ( 5 ; 12 ) ( q31 ; p13 ) . identified novel human long fatty acyl CoA synthetase 2 gene , ACS2 , new @ GeneSrc $ fusion partner gene recurrent ( 5 ; 12 ) ( q31 ; p13 ) translocation patient refractory anemia excess blasts ( RAEB ) basophilia , patient @ DiseaseTgt $ ( @ DiseaseTgt $ ) eosinophilia , patient acute eosinophilic leukemia ( AEL ) . ACS2 expressed brain bone marrow highly conserved man rats . resulting @ GeneSrc $ fusion transcripts showed out-frame fusion exon 1 @ GeneSrc $ exon 1 ACS2 AEL case , out-frame fusion exon 1 @ GeneSrc $ exon 11 ACS2 @ DiseaseTgt $ case , short in-frame fusion @ GeneSrc $ exon 1 3 ' untranslated region ACS2 RAEB case . Reciprocal @ GeneSrc $ transcripts identified two cases . Fluorescence situ hybridization ( FISH ) analysis @ GeneSrc $ cosmids 12p13 , BACs P1s 5q31 , demonstrated 5q31 breakpoints @ DiseaseTgt $ AEL cases involved 5 ' portion ACS2 gene , 5q31 , breakpoint RAEB case involved 3 ' portion ACS2 gene . None resulting chimeric transcripts except @ GeneSrc $ transcript RAEB case led fusion protein . Disruption second @ GeneSrc $ allele ( 12 ; 19 ) detected @ DiseaseTgt $ case FISH analysis . observations suggest disruption @ GeneSrc $ and/or ACS2 may lead pathogenesis hematologic malignancies ( 5 ; 12 ) ( q31 ; p13 ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9627324079978612)\n",
      "- Text: \"FLT3 mutations childhood acute lymphoblastic leukemia . Activating mutations FLT3 receptor tyrosine kinase common @ DiseaseTgt $ ( @ DiseaseTgt $ ) rare adult acute lymphoblastic leukemia ( ) . recently shown FLT3 highly expressed often mutated ALLs rearrangement mixed lineage leukemia ( MLL ) gene chromosome 11q23 . hyperdiploid samples also show high-level expression FLT3 , searched presence FLT3 mutations leukemic blasts 71 patients . data show approximately 25 % ( 6 25 ) hyperdiploid samples possess FLT3 mutations , whereas 1 29 @ GeneSrc $ samples harbored mutations ( P = .04 , Fisher exact test ) . Three mutations novel in-frame deletions within 7-amino acid region receptor juxtamembrane domain . Finally , 3 samples patients whose disease would relapse harbored FLT3 mutations . data suggest patients hyperdiploid relapsed might considered candidates therapy newly described small-molecule FLT3 inhibitors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3279851996702926)\n",
      "- Text: \"leukemic fusion gene @ GeneSrc $ suppresses CEBPA @ DiseaseTgt $ activation Calreticulin . leukemic fusion gene @ GeneSrc $ ( AME ) encodes chimeric transcription factor results ( 3,21 ) ( q26 ; q22 ) translocation seen patients @ DiseaseTgt $ , therapy-related myelodysplastic syndrome , chronic myeloid leukemia blast crisis . myeloid transcription factor CEBPA crucial normal granulopoiesis . , found conditional expression AME suppresses CEBPA protein 90.8 % DNA-binding activity 93.9 % . contrast , CEBPA mRNA levels remained unchanged . addition , detected differences CEBPA mRNA levels leukemic blasts patients carrying AME translocation ( n = 8 ) compared @ DiseaseTgt $ patients normal karyotype ( n = 9 ) . CEBPA protein binding activity , however , reduced significantly ( 100 % 92.1 % , respectively ) AME patient samples . Furthermore , observed calreticulin ( CRT ) , putative inhibitor CEBPA translation , strongly activated induction AME cell-line system ( 14.8-fold ) AME patient samples ( 12.2-fold ) . Moreover , inhibition CRT small interfering RNA powerfully restored CEBPA levels . results identify CEBPA key target leukemic fusion protein AME suggest modulation CEBPA CRT may represent mechanism involved differentiation block AME leukemias .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012291769321385)\n",
      "- Text: \"Genetic predisposition diabetic nephropathy . Evidence role angiotensin -- converting enzyme gene . search genetic determinants susceptibility diabetic nephropathy , examined association DNA sequence differences locus angiotensin I-converting enzyme ( ACE ) renal complications 151 insulin-dependent diabetes mellitus ( IDDM ) patients diabetes duration 16 - 21 years . nested case-control study included 77 normoalbuminuric control subjects ( @ GeneSrc $ excretion rate < 30 micrograms/min ) 74 cases evidence nephropathy ranging microalbuminuria overt proteinuria . DNA patients genotyped ACE locus three-allele restriction fragment-melting polymorphism ( RFMP ) ( Dde ) , described recently , two-allele insertion/deletion recognized Xba restriction fragment-length polymorphism , shown investigators associated serum levels ACE risk @ DiseaseTgt $ . least common allele Dde RFMP significantly frequent among cases nephropathy among normoalbuminuric control subjects ( 12.8 vs. 4.5 % , P < 0.05 ) . deletion ACE gene also frequent case control subjects ( 56.1 vs. 47.4 % ) , difference statistically significant ( P < 0.25 ) sample size . determine independence associations , two polymorphisms analyzed jointly identify Xba I/Dde haplotypes . might expected , carriers Xba I/Dde ' + = ' haplotype fourfold risk developing diabetic nephropathy ( odds ratio [ ] 4.0 , 95 % confidence interval [ CI ] 1.5 - 11.0 ) . However , explain excess Xba ' + ' allele among cases . ( ABSTRACT TRUNCATED 250 WORDS )\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.08906759420044e-06)\n",
      "- Text: \"del22q11.2 candidate gene @ GeneSrc $ controls regional outflow tract identity coronary artery patterning . @ GeneSrc $ , encoding T-box containing transcription factor , major candidate gene del22q11.2 DiGeorge syndrome , characterized craniofacial cardiovascular defects including @ DiseaseTgt $ common arterial trunk . Mice lacking @ GeneSrc $ severe defects development pharyngeal derivatives including cardiac progenitor cells second heart field contribute arterial pole heart . outflow tract @ GeneSrc $ mutant embryos short narrow resulting common arterial trunk . show series genetic crosses using transgene markers second heart field derived myocardium coronary endothelial cells subdomain myocardium normally observed base pulmonary trunk reduced malpositioned @ GeneSrc $ mutant hearts . defect associated anomalous coronary artery patterning . right left coronary ostia form predominantly right/ventral sinus mutant hearts , proximal coronary arteries coursing across normally coronary free ventral region heart . identified Semaphorin3c @ GeneSrc $ gene expressed subpulmonary myocardium . results implicate second heart field development coronary artery patterning provide new insights association conotruncal defects coronary artery anomalies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0710359296475355)\n",
      "- Text: \"Myeloid translocation gene family members associate T-cell factors ( TCFs ) influence TCF-dependent transcription . Canonical Wnt signaling mediated molecular `` switch `` regulates transcriptional properties T-cell factor ( TCF ) family DNA-binding proteins . Members myeloid translocation gene ( MTG ) family transcriptional corepressors frequently disrupted chromosomal translocations acute myeloid leukemia , whereas MTG16 may inactivated 40 % breast cancer MTG8 candidate cancer gene @ DiseaseTgt $ . Genetic studies imply corepressor family may function stem cells . Given mice lacking Myeloid Translocation Gene Related-1 ( Mtgr1 ) fail maintain secretory lineage small intestine , surveyed transcription factors might recruit Mtgr1 intestinal stem cells progenitor cells found MTG family members associate specifically @ GeneSrc $ . Coexpression beta-catenin disrupted association corepressors @ GeneSrc $ . Furthermore , expressed Xenopus embryos , MTG family members inhibited axis formation impaired ability beta-catenin XLef-1 induce axis duplication , indicating MTG family members act downstream beta-catenin . Moreover , found c-Myc , transcriptional target Wnt pathway , overexpressed small intestines mice lacking Mtgr1 , thus linking inactivation Mtgr1 activation potent oncogene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0396129751531795)\n",
      "- Text: \"Myc deletion rescues Apc deficiency small intestine . APC gene encodes adenomatous polyposis coli tumour suppressor protein , germline mutation characterizes familial adenomatous polyposis ( FAP ) , autosomal intestinal cancer syndrome . Inactivation APC also recognized key early event development @ DiseaseTgt $ , loss results constitutive activity @ GeneSrc $ transcription complex . proto-oncogene c-MYC identified target Wnt pathway @ DiseaseTgt $ cells vitro , normal crypts vivo intestinal epithelial cells acutely transformed vivo deletion APC gene ; however , significance unclear . Therefore , elucidate role Myc intestine Apc loss , simultaneously deleted Apc Myc adult murine small intestine . show loss Myc rescued phenotypes perturbed differentiation , migration , proliferation apoptosis , occur deletion Apc . Remarkably , rescue occurred presence high levels nuclear beta-catenin . Array analysis revealed Myc required majority Wnt target gene activation following Apc loss . data establish Myc critical mediator early stages neoplasia following Apc loss .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.007881112760491)\n",
      "- Text: \"Therapeutic targeting preleukemia cells mouse model NPM1 mutant @ DiseaseTgt $ . initiating mutations contribute cancer development sometimes present premalignant cells . Whether therapies targeting mutations eradicate premalignant cells unclear . @ DiseaseTgt $ ( @ DiseaseTgt $ ) attractive system investigating effect preventative treatment disease often preceded premalignant state ( clonal hematopoiesis myelodysplastic syndrome ) . Npm1c/Dnmt3a mutant knock-in mice , model @ DiseaseTgt $ development , leukemia preceded period extended myeloid progenitor cell proliferation self-renewal . found self-renewal reversed oral administration small molecule ( VTP-50469 ) targets @ GeneSrc $ chromatin complex . preclinical results support hypothesis individuals high risk developing @ DiseaseTgt $ might benefit targeted epigenetic therapy preventative setting .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4638970666386762)\n",
      "- Text: \"SRF @ GeneSrc $ regulate LRP-mediated amyloid-beta clearance brain vascular cells . Amyloid beta-peptide ( Abeta ) deposition cerebral vessels contributes cerebral amyloid angiopathy ( CAA ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , report @ DiseaseTgt $ patients two mouse models @ DiseaseTgt $ , overexpression serum response factor ( SRF ) @ GeneSrc $ ( @ GeneSrc $ ) cerebral vascular smooth muscle cells ( VSMCs ) generates Abeta non-clearing VSMC phenotype transactivation sterol regulatory element binding protein-2 , downregulates low density lipoprotein receptor-related protein-1 , key Abeta clearance receptor . Hypoxia stimulated SRF/MYOCD expression human cerebral VSMCs animal models @ DiseaseTgt $ . suggest SRF @ GeneSrc $ function transcriptional switch , controlling Abeta cerebrovascular clearance progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.03400268157682)\n",
      "- Text: \"Elevated amyloid beta protein ( Abeta42 ) late onset @ DiseaseTgt $ associated single nucleotide polymorphisms urokinase-type plasminogen activator gene . Plasma amyloid beta protein ( Abeta42 ) levels late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) linked region chromosome 10q . PLAU gene within region encodes urokinase-type plasminogen activator , converts plasminogen plasmin . Abeta aggregates induce PLAU expression thereby increasing plasmin , degrades aggregated non-aggregated forms Abeta . evaluated single nucleotide polymorphisms ( SNPs ) PLAU association Abeta42 @ DiseaseTgt $ . PLAU SNP compound genotypes composed haplotype pairs showed significant association @ DiseaseTgt $ three independent case-control series . PLAU SNP haplotypes associated significantly plasma Abeta42 10 extended @ DiseaseTgt $ families . One SNPs analyzed missense C/T polymorphism exon 6 PLAU ( PLAU_1=rs2227564 ) , causes proline leucine change ( P141L ) . analyzed PLAU_1 association @ DiseaseTgt $ six case-control series 24 extended @ DiseaseTgt $ families . CT TT PLAU_1 genotypes showed association ( P=0.05 ) overall estimated odds ratio 1.2 ( 1.0 - 1.5 ) . CT TT genotypes PLAU_1 also associated significant age-dependent elevation plasma Abeta42 24 extended @ DiseaseTgt $ families ( P=0.0006 ) . knockout mice lacking PLAU gene , plasma -- brain -- Abeta42 well Abeta40 significantly elevated , also age-dependent manner . PLAU_1 associations independent associations found among plasma Abeta42 , @ DiseaseTgt $ variants IDE @ GeneSrc $ region . results provide strong evidence PLAU nearby gene involved development @ DiseaseTgt $ . PLAU_1 plausible pathogenic mutation could act increasing Abeta42 , additional biological experiments required show definitively .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004722572453144)\n",
      "- Text: \"Evaluation molecular mechanisms involved gain function Li-Fraumeni TP53 mutation . TP53 @ DiseaseTgt $ suppressor gene frequent target genetic alterations human @ DiseaseTgt $ . TP53 gene alterations may result gain oncogenic functions neoangiogenesis resistance therapy . TP53 germ line mutation c.659A > C ( p. Y220S ) identified stored DNA related patients Li-Fraumeni syndrome ( LFS ) died developing clinically aggressive @ DiseaseTgt $ . patients treated protocols included doxorubicin hydrochloride ( DX ) pivotal drug . define vitro mutational phenotype germ line mutation , used murine fibroblasts explanted wild-type ( wt ) p53 knockout ( KO ) mice littermate . p53Y220S p53R175H fibroblasts , obtained p53KO fibroblasts transfected expression vectors encoding human Y220S R175H p53 mutants , respectively , exhibited resistance DX treatment . Moreover , p53Y220S fibroblasts exhibited angiogenetic properties , DX treatment , p53Y220S failed translocate nucleus showed increase cytosolic levels . DX treatment influence p53 distribution within nuclear cytosolic compartments p53R175H fibroblasts . @ GeneSrc $ ( @ GeneSrc $ ) , protein involved eliminating reactive oxygen species ( ROS ) , showed increased expression intensity p53Y220S fibroblasts DX treatment , observed two-dimensional electrophoresis analysis . Moreover , Thioredoxin ( Trx ) , protein cooperates @ GeneSrc $ , overexpressed p53Y220S mutants basal conditions . data suggest relationship presence p53Y220S mutation enhanced levels @ GeneSrc $ Trx mutant fibroblasts . Since one mechanisms DX antitumor effect ascribed production ROS , future studies evaluate involvement @ GeneSrc $ Trx chemoresistance p53Y220S fibroblasts DX .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0147408551397118)\n",
      "- Text: \"Mutant mice lacking p53 C-terminal domain model telomere syndromes . Mutations p53 , although frequent human @ DiseaseTgt $ , implicated telomere-related syndromes . , show homozygous mutant mice expressing p53Delta31 , p53 lacking C-terminal domain , exhibit increased p53 activity suffer aplastic anemia pulmonary fibrosis , hallmarks syndromes caused short telomeres . Indeed , p53Delta31/Delta31 mice short telomeres phenotypic traits associated telomere disease dyskeratosis congenita severe variant Hoyeraal-Hreidarsson syndrome . Heterozygous p53+/Delta31 mice mildly affected , decreased levels Mdm4 , negative regulator p53 , led dramatic aggravation symptoms . Importantly , several genes involved telomere metabolism downregulated p53Delta31/Delta31 cells , including Dyskerin , Rtel1 , Tinf2 , mutated dyskeratosis congenita , @ GeneSrc $ , implicated aplastic anemia . Together , data reveal truncating mutation activate p53 p53 plays major role regulation telomere metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.78425295901852e-07)\n",
      "- Text: \"MLH3 : DNA mismatch repair gene associated mammalian microsatellite instability . DNA mismatch repair important role maintaining genomic integrity association hereditary non-polyposis colon cancer ( HNPCC ) . identify new human mismatch repair proteins , probed nuclear extracts conserved carboxy-terminal MLH1 interaction domain . describe cloning complete genomic sequence MLH3 , encodes new DNA mismatch repair protein interacts MLH1 . MLH3 similar mismatch repair proteins yeast , plants , worms bacteria known mammalian protein , suggesting conserved sequence may confer unique functions mice humans . Cells culture stably expressing dominant-negative MLH3 protein exhibit microsatellite instability . @ GeneSrc $ highly expressed gastrointestinal epithelium physically maps mouse complex trait locus colon cancer susceptibility ( Ccs1 ) . Although unable identify mutation protein-coding region @ GeneSrc $ susceptible mouse strain , colon tumours congenic Ccs1 mice exhibit microsatellite instability . Functional redundancy among @ GeneSrc $ , Pms1 Pms2 may explain neither Pms1 Pms2 mutant mice develop @ DiseaseTgt $ , PMS1 PMS2 mutations rarely found HNPCC families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.765894405057036e-05)\n",
      "- Text: \"Amyloidogenic role cytokine @ GeneSrc $ transgenic mice @ DiseaseTgt $ . Deposition amyoid-beta peptide central nervous system hallmark @ DiseaseTgt $ possible cause neurodegeneration . factors initiate promote deposition amyloid-beta peptide known . transforming growth factor TGF-beta1 plays central role response brain injury , increased TGF-beta1 found central nervous system patients @ DiseaseTgt $ . report @ GeneSrc $ induces amyloid-beta deposition cerebral blood vessels meninges aged transgenic mice overexpressing cytokine astrocytes . Co-expression @ GeneSrc $ transgenic mice overexpressing amyloid-precursor protein , develop @ DiseaseTgt $ like pathology , accelerated deposition amyloid-beta peptide . @ GeneSrc $ messenger RNA present post-mortem brain tissue @ DiseaseTgt $ patients controls , levels correlating strongly amyloid-beta deposition damaged cerebral blood vessels patients cerebral amyloid angiopathy . results indicate overexpression @ GeneSrc $ may initiate promote amyloidogenesis @ DiseaseTgt $ experimental models may risk factor developing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.016793774735659)\n",
      "- Text: \"@ GeneSrc $ promotes microglial amyloid-beta clearance reduces plaque burden transgenic mice . Abnormal accumulation amyloid-beta peptide ( Abeta ) brain appears crucial pathogenesis forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , underlying mechanisms sporadic forms @ DiseaseTgt $ remain unknown . @ GeneSrc $ ( @ GeneSrc $ ) , key regulator brain 's responses injury inflammation , implicated Abeta deposition vivo . demonstrate modest increase astroglial @ GeneSrc $ production aged transgenic mice expressing human beta-amyloid precursor protein ( hAPP ) results three-fold reduction number parenchymal amyloid plaques , 50 % reduction overall Abeta load hippocampus neocortex , decrease number dystrophic neurites . mice expressing hAPP @ GeneSrc $ , Abeta accumulated substantially cerebral blood vessels , parenchymal plaques . human cases @ DiseaseTgt $ , Abeta immunoreactivity associated parenchymal plaques inversely correlated Abeta blood vessels cortical TGF-beta1 mRNA levels . reduction parenchymal plaques @ GeneSrc $ mice associated strong activation microglia increase inflammatory mediators . Recombinant @ GeneSrc $ stimulated Abeta clearance microglial cell cultures . results demonstrate @ GeneSrc $ important modifier amyloid deposition vivo indicate @ GeneSrc $ might promote microglial processes inhibit accumulation Abeta brain parenchyma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1080440940848505)\n",
      "- Text: \"Deficiency neuronal @ GeneSrc $ signaling promotes neurodegeneration @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized progressive neurodegeneration cerebral accumulation beta-amyloid peptide ( Abeta ) , unknown makes neurons susceptible degeneration . report TGF-beta type II receptor ( TbetaRII ) mainly expressed neurons , TbetaRII levels reduced human @ DiseaseTgt $ brain correlate pathological hallmarks disease . Reducing neuronal @ GeneSrc $ signaling mice resulted age-dependent neurodegeneration promoted Abeta accumulation dendritic loss mouse model @ DiseaseTgt $ . cultured cells , reduced @ GeneSrc $ signaling caused neuronal degeneration resulted increased levels secreted Abeta beta-secretase-cleaved soluble amyloid precursor protein . results show reduced neuronal @ GeneSrc $ signaling increases age-dependent neurodegeneration @ DiseaseTgt $ vivo . Increasing neuronal @ GeneSrc $ signaling may thus reduce neurodegeneration beneficial @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1406340362919362)\n",
      "- Text: \"Intestinal tumorigenesis compound mutant mice Dpc4 ( Smad4 ) Apc genes . DPC4 ( SMAD4 ) gene plays key role @ GeneSrc $ signaling pathway . inactivated mouse homolog Dpc4 ( Smad4 ) . homozygous mutants embryonic lethal , whereas heterozygotes showed abnormality . introduced Dpc4 mutation Apc ( delta716 ) knockout mice , model human familial adenomatous polyposis . Apc Dpc4 located chromosome 18 , constructed compound heterozygotes carrying mutations chromosome meiotic recombination . mice , intestinal polyps developed malignant tumors simple Apc ( delta716 ) heterozygotes , showing extensive stromal cell proliferation , submucosal invasion , cell type heterogeneity , vivo transplantability . results indicate mutations DPC4 ( SMAD4 ) play significant role malignant progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002566288013089)\n",
      "- Text: \"DDD mice , novel acute mouse model @ DiseaseTgt $ . describe development novel animal model acute severe dopamine ( DA ) deficiency using genetically altered mice lacking DA transporter ( DAT-KO mice ) . absence DAT-mediated recycling mechanism mice , striatal DA concentrations become entirely dependent de novo synthesis , acute pharmacologic inhibition @ GeneSrc $ induces transient ( 16 hours ) elimination brain DA . Dopamine-deficient DAT-KO mice ( DDD mice ) demonstrate striking behavioral phenotype manifested severe akinesia , rigidity , tremor , ptosis . propose DDD mice represent novel acute model severe DA deficiency might used identify compounds potential therapeutic use treatment @ DiseaseTgt $ ( @ DiseaseTgt $ ) . model particularly promising tool evaluating efficacy compounds may induce movement independently DA . advantages limitations DDD mice comparison rodent @ DiseaseTgt $ models discussed .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0046408568992626)\n",
      "- Text: \"Mutations NR4A2 associated familial @ DiseaseTgt $ . NR4A2 , encoding member nuclear receptor superfamily , essential differentiation nigral dopaminergic neurons . determine whether NR4A2 susceptibility gene @ DiseaseTgt $ , carried genetic analyses 201 individuals affected @ DiseaseTgt $ 221 age-matched unaffected controls . identified two mutations NR4A2 associated @ DiseaseTgt $ ( -291Tdel -245T -- > G ) , map first exon NR4A2 affect one allele 10 107 individuals familial @ DiseaseTgt $ individuals sporadic @ DiseaseTgt $ ( n = 94 ) unaffected controls ( n = 221 ) . age onset disease clinical features ten individuals different individuals typical @ DiseaseTgt $ . mutations resulted marked decrease NR4A2 mRNA levels transfected cell lines lymphocytes affected individuals . Additionally , mutations NR4A2 affect transcription gene encoding @ GeneSrc $ . data suggest mutations NR4A2 cause dopaminergic dysfunction , associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0154569710459637)\n",
      "- Text: \"@ GeneSrc $ phosphorylates p27 , impairs nuclear import p27 opposes p27-mediated G1 arrest . Mechanisms linking mitogenic growth inhibitory cytokine signaling cell cycle fully elucidated either @ DiseaseTgt $ normal cells . show activation @ GeneSrc $ @ GeneSrc $ , contributes resistance antiproliferative signals breast cancer progression part impairing nuclear import action p27 . Akt transfection caused cytoplasmic p27 accumulation resistance cytokine-mediated G1 arrest . nuclear localization signal p27 contains Akt consensus site threonine 157 , p27 phosphorylation Akt impaired nuclear import vitro . Akt phosphorylated wild-type p27 p27T157A . cells transfected constitutively active @ GeneSrc $ ) ) , p27WT mislocalized cytoplasm , p27T157A nuclear . cells activated Akt , p27WT failed cause G1 arrest , antiproliferative effect p27T157A impaired . Cytoplasmic p27 seen 41 % ( 52 128 ) primary human breast cancers conjunction Akt activation correlated poor patient prognosis . Thus , show novel mechanism whereby Akt impairs p27 function associated aggressive phenotype human breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0712280728420696)\n",
      "- Text: \"Cell-cycle-regulated activation Akt kinase phosphorylation carboxyl terminus . Akt , also known @ GeneSrc $ , plays key roles cell proliferation , survival metabolism . Akt hyperactivation contributes many pathophysiological conditions , including human @ DiseaseTgt $ , closely associated poor prognosis chemo- radiotherapeutic resistance . Phosphorylation Akt S473 ( ref . 5 ) T308 ( ref . 6 ) activates Akt . However , remains unclear whether mechanisms account full Akt activation , whether Akt hyperactivation linked misregulated cell cycle progression , another @ DiseaseTgt $ hallmark . report Akt activity fluctuates across cell cycle , mirroring cyclin expression . Mechanistically , phosphorylation S477 T479 Akt extreme carboxy terminus cyclin-dependent kinase 2 ( Cdk2 ) /cyclin mTORC2 , distinct physiological conditions , promotes Akt activation facilitating , functionally compensating , S473 phosphorylation . Furthermore , deletion cyclin A2 allele mouse olfactory bulb leads reduced S477/T479 phosphorylation elevated cellular apoptosis . Notably , cyclin A2-deletion-induced cellular apoptosis mouse embryonic stem cells partly rescued S477D/T479E-Akt1 , supporting physiological role cyclin A2 governing Akt activation . Together , results study show Akt S477/T479 phosphorylation essential layer Akt activation mechanism regulate physiological functions , thereby providing new mechanistic link aberrant cell cycle progression Akt hyperactivation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004297502844563)\n",
      "- Text: \"Phosphorylation regulation Akt/PKB rictor-mTOR complex . Deregulation @ GeneSrc $ ( @ GeneSrc $ ) implicated pathogenesis @ DiseaseTgt $ diabetes . @ GeneSrc $ activation requires phosphorylation Thr308 activation loop phosphoinositide-dependent kinase 1 ( PDK1 ) Ser473 within carboxyl-terminal hydrophobic motif unknown kinase . show Drosophila human cells target rapamycin ( TOR ) kinase associated protein rictor necessary Ser473 phosphorylation reduction rictor mammalian TOR ( mTOR ) expression inhibited @ GeneSrc $ effector . rictor-mTOR complex directly phosphorylated Akt/PKB Ser473 vitro facilitated Thr308 phosphorylation PDK1 . Rictor-mTOR may serve drug target @ DiseaseTgt $ lost expression PTEN , @ DiseaseTgt $ suppressor opposes Akt/PKB activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7951840300071013)\n",
      "- Text: \"E3 ligase TRAF6 regulates Akt ubiquitination activation . Akt signaling plays central role many biological functions , cell proliferation apoptosis . Akt ( also known @ GeneSrc $ ) resides primarily cytosol , known signaling molecules recruited plasma membrane subsequently activated growth factor stimuli . found protein kinase Akt undergoes lysine-63 chain ubiquitination , important Akt membrane localization phosphorylation . TRAF6 found direct E3 ligase Akt essential Akt ubiquitination , membrane recruitment , phosphorylation upon growth-factor stimulation . human @ DiseaseTgt $ Akt mutant displayed increase Akt ubiquitination , turn contributing enhancement Akt membrane localization phosphorylation . Thus , Akt ubiquitination important step oncogenic Akt activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.972168219677301e-05)\n",
      "- Text: \"Prevalence prognostic significance Flt3 internal tandem duplication pediatric @ DiseaseTgt $ . Flt3 gene encodes tyrosine kinase receptor regulates proliferation differentiation hematopoietic stem cells . internal tandem duplication Flt3 gene ( Flt3/ITD ) reported @ DiseaseTgt $ ( @ DiseaseTgt $ ) may associated poor prognosis . analyzed diagnostic bone marrow specimens 91 pediatric patients @ DiseaseTgt $ treated Children 's Cancer Group ( CCG ) -2891 presence Flt3/ITD correlated presence clinical outcome . Fifteen 91 samples ( 16.5 % ) positive Flt3/ITD . Flt3/ITD-positive patients median diagnostic white count 73 800 compared 28 400 Flt3/ITD-negative patients ( P = .05 ) . size duplication ranged 21 174 base pairs ( bp ) . Nucleotide sequencing abnormal polymerase chain reaction products demonstrated duplications involved exon 11 Flt3 gene also preserved reading frame . Lineage restriction analysis revealed Flt3/ITD present lymphocytes , suggesting lack stem cell involvement mutation . None Flt3/ITD-positive patients unfavorable cytogenetic markers , predominance particular @ GeneSrc $ class . remission induction rate 40 % Flt3/ITD-positive patients compared 74 % Flt3/ITD-negative ones ( P = .005 ) . Kaplan-Meier estimates event-free survival 8 years patients without Flt3/ITD 7 % 44 % , respectively ( P = .002 ) . Multivariate analysis demonstrated presence Flt3/ITD single significant , independent prognostic factor poor outcome ( P = .009 ) pediatric @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001267690454525)\n",
      "- Text: \"Mutations CEBPA @ DiseaseTgt $ @ GeneSrc $ types @ DiseaseTgt $ . CEBPA encodes transcription factor C/EBPalpha specifically up-regulated granulocytic differentiation . gene mutated approximately 20 % patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) FAB type M2 occurs absence ( 8 ; 21 ) . much way specific translocations associated particular @ DiseaseTgt $ @ GeneSrc $ type , identification non-random associations gene mutation karyotype @ GeneSrc $ type may helpful elucidating molecular basis certain forms leukemia . confirm initial findings , 99 patients @ DiseaseTgt $ M2 screened CEBPA mutations use PCR-single-strand conformational polymorphism sequencing approach . Nine CEBPA mutations identified eight patients . mutations clustered toward COOH terminal protein occurred exclusively intermediate cytogenetic risk group ( 8/64 , 12.5 % ) . Two patients biallelic mutation , one homozygous 1137Ins ( 57 bp ) another two CEBPA mutations , 1096Ins ( 27 bp ) 363Ins ( GGCC ) , observed . evidence deletion region six mutated samples analyzed fluorescence situ hybridization BAC clone spanning CEBPA locus . CEBPA mutation status demonstrated prognostic importance patient group , although may reflect selection size @ DiseaseTgt $ population studied . conclusion , mutation CEBPA recurrent finding @ DiseaseTgt $ appears specific intermediate cytogenetic risk group patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0452357855968449)\n",
      "- Text: \"Identification novel @ GeneSrc $ fusion transcript expressed human @ DiseaseTgt $ cells . semi-nested reverse transcriptase-polymerase chain reaction ( RT-PCR ) applied evaluate presence estrogen receptor-alpha ( ER-alpha ) human prostate cancer cells . Unexpectedly , novel @ GeneSrc $ @ GeneSrc $ fusion transcript identified , N-terminus @ GeneSrc $ fused in-frame C-terminus ER-alpha . existence @ GeneSrc $ transcript confirmed RT-PCR analysis using various sets amplification primers different reverse-transcribed primers presence dimethyl sulfoxide eliminate secondary structure RNA . predicted @ GeneSrc $ protein would contain largely domain @ GeneSrc $ entire ligand binding domain ER-alpha . @ GeneSrc $ expressed variety human @ DiseaseTgt $ cell lines including prostate , breast , cervical bladder cancer cell lines . data suggest presence @ GeneSrc $ may complicate @ GeneSrc $ ER-alpha signalling pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2979715451284465)\n",
      "- Text: \"Requirement NF-kappaB signalling mouse model lung adenocarcinoma . NF-kappaB transcription factors function crucial regulators inflammatory immune responses well cell survival . also implicated cellular transformation tumorigenesis . However , despite extensive biochemical characterization NF-kappaB signalling past twenty years , requirement NF-kappaB @ DiseaseTgt $ development vivo , particularly @ DiseaseTgt $ , completely understood . show NF-kappaB pathway required development @ DiseaseTgt $ mouse model lung adenocarcinoma . Concomitant loss @ GeneSrc $ ( also known @ GeneSrc $ ) expression oncogenic Kras ( G12D ) resulted NF-kappaB activation primary mouse embryonic fibroblasts . Conversely , lung tumour cell lines expressing Kras ( G12D ) lacking @ GeneSrc $ , @ GeneSrc $ restoration led NF-kappaB inhibition . Furthermore , inhibition NF-kappaB signalling induced apoptosis @ GeneSrc $ lung cancer cell lines . Inhibition pathway lung tumours vivo , time @ DiseaseTgt $ initiation @ DiseaseTgt $ progression , resulted significantly reduced @ DiseaseTgt $ development . Together , results indicate critical function NF-kappaB signalling lung tumour development , , requirement depends @ GeneSrc $ status . findings also provide support development NF-kappaB inhibitory drugs targeted therapies treatment patients defined mutations Kras @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9057252539545478)\n",
      "- Text: \"Long-term haematopoietic reconstitution @ GeneSrc $ multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - -p16Ink4a , p19Arf @ GeneSrc $ ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype c-kit+Sca-1+Flt3+CD150-CD48-Lin- , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf @ GeneSrc $ central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0535405250163905)\n",
      "- Text: \"Loss @ GeneSrc $ drives neuron reprogramming head neck cancer . solid @ DiseaseTgt $ microenvironment includes nerve fibres arise peripheral nervous system1,2 . Recent work indicates newly formed adrenergic nerve fibres promote @ DiseaseTgt $ growth , origin nerves mechanism inception unknown1,3 . , comparing transcriptomes @ DiseaseTgt $ trigeminal sensory neurons endogenous neurons mouse models oral cancer , identified adrenergic differentiation signature . show loss @ GeneSrc $ leads adrenergic transdifferentiation @ DiseaseTgt $ sensory nerves loss microRNA miR-34a . @ DiseaseTgt $ growth inhibited sensory denervation pharmacological blockade adrenergic receptors , chemical sympathectomy pre-existing adrenergic nerves . retrospective analysis samples oral cancer revealed @ GeneSrc $ status associated nerve density , turn associated poor clinical outcomes . crosstalk @ DiseaseTgt $ cells neurons represents mechanism @ DiseaseTgt $ neurons reprogrammed towards adrenergic phenotype stimulate @ DiseaseTgt $ progression , potential target anticancer therapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9212639179040286)\n",
      "- Text: \"Crucial role @ GeneSrc $ cellular senescence suppression Pten-deficient tumorigenesis . Cellular senescence theorized oppose neoplastic transformation triggered activation oncogenic pathways vitro , relevance senescence vivo established . PTEN p53 @ DiseaseTgt $ suppressors among commonly inactivated mutated genes human cancer including prostate cancer . Although functionally distinct , reciprocal cooperation proposed , PTEN thought regulate p53 stability , p53 enhance PTEN transcription . show conditional inactivation @ GeneSrc $ mouse prostate fails produce @ DiseaseTgt $ phenotype , whereas complete Pten inactivation prostate triggers non-lethal invasive prostate cancer long latency . Strikingly , combined inactivation Pten @ GeneSrc $ elicits invasive prostate cancer early 2 weeks puberty invariably lethal 7 months age . Importantly , acute Pten inactivation induces growth arrest p53-dependent cellular senescence pathway vitro vivo , fully rescued combined loss @ GeneSrc $ . Furthermore , detected evidence cellular senescence specimens early-stage human prostate cancer . results demonstrate relevance cellular senescence restricting tumorigenesis vivo support model cooperative @ DiseaseTgt $ suppression p53 essential failsafe protein Pten-deficient @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9770160816395952)\n",
      "- Text: \"Temporal dissection @ GeneSrc $ function vitro vivo . investigate functions @ GeneSrc $ @ DiseaseTgt $ suppressor , created new knock-in gene replacement mouse model endogenous @ GeneSrc $ gene substituted one encoding p53ER ( TAM ) , @ GeneSrc $ fusion protein whose function completely dependent ectopic provision 4-hydroxytamoxifen . show tissues vivo cells vitro derived mice rapidly toggled wild-type @ GeneSrc $ knockout states . Using rapid perturbation model , define kinetics , dependence , persistence reversibility @ GeneSrc $ responses DNA damage tissues vivo activation Ras oncoprotein stress vitro . first example knowledge new class genetic model allows specific , rapid reversible perturbation function single endogenous gene vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.079219749836934)\n",
      "- Text: \"C terminus @ GeneSrc $ regulates gene expression multiple mechanisms target- tissue-specific manner vivo . @ GeneSrc $ @ DiseaseTgt $ suppressor transcription factor mediates varied cellular responses . C terminus @ GeneSrc $ subjected multiple diverse post-translational modifications . attractive hypothesis differing sets combinatorial modifications therein determine distinct cellular outcomes . address vivo , @ GeneSrc $ ) mouse generated endogenous @ GeneSrc $ targeted replaced truncated mutant lacking C-terminal 24 amino acids . @ GeneSrc $ ) mice die within 2 wk post-partum hematopoietic failure impaired cerebellar development . Intriguingly , C terminus acts via three distinct mechanisms control @ GeneSrc $ gene expression depending tissue . First , bone marrow thymus , C terminus dampens @ GeneSrc $ activity . Increased senescence @ GeneSrc $ ) bone marrow accompanied up-regulation Cdkn1 ( p21 ) . thymus , C-terminal domain negatively regulates @ GeneSrc $ gene expression inhibiting promoter occupancy . , hyperactive @ GeneSrc $ ) induces apoptosis via enhanced expression proapoptotic Bbc3 ( Puma ) Pmaip1 ( Noxa ) . liver , second mechanism prevails , since @ GeneSrc $ ) wild-type DNA binding impaired gene expression . Thus , C terminus @ GeneSrc $ needed liver cells step subsequent DNA binding . Finally , spleen , C terminus controls @ GeneSrc $ protein levels , overexpressed @ GeneSrc $ ) showing hyperactivity gene expression . Thus , C terminus @ GeneSrc $ regulates gene expression via multiple mechanisms depending tissue target , leads specific phenotypic effects vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0088927809700536)\n",
      "- Text: \"epi-allelic series @ GeneSrc $ hypomorphs created stable RNAi produces distinct @ DiseaseTgt $ phenotypes vivo . application RNA interference ( RNAi ) mammalian systems potential revolutionize genetics produce novel therapies . investigate whether RNAi applied well-characterized gene stably suppress gene expression hematopoietic stem cells produce detectable phenotypes mice . Deletion @ GeneSrc $ @ DiseaseTgt $ suppressor gene greatly accelerates Myc-induced lymphomagenesis , resulting highly disseminated disease . determine whether RNAi suppression @ GeneSrc $ could produce similar phenotype , introduced several @ GeneSrc $ short hairpin RNAs ( shRNAs ) hematopoietic stem cells derived E ( mu ) -Myc transgenic mice , monitored @ DiseaseTgt $ onset overall pathology lethally irradiated recipients . Different @ GeneSrc $ shRNAs produced distinct phenotypes vivo , ranging benign lymphoid hyperplasias highly disseminated lymphomas paralleled @ GeneSrc $ lymphomagenesis E ( mu ) -Myc mouse . cases , severity type disease correlated extent specific shRNAs inhibited @ GeneSrc $ activity . Therefore , RNAi stably suppress gene expression stem cells reconstituted organs derived cells . addition , intrinsic differences individual shRNA expression vectors targeting gene used create ' epi-allelic series ' dissecting gene function vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2021413103181428)\n",
      "- Text: \"transactivation-deficient mouse model provides insights @ GeneSrc $ regulation function . gene Trp53 among frequently mutated studied genes human @ DiseaseTgt $ , mechanisms suppresses @ DiseaseTgt $ formation remain unclear . generated mice allele encoding changes Leu25 Trp26 , known essential transcriptional transactivation Mdm2 binding , enable analyses @ GeneSrc $ structure function vivo . mutant @ GeneSrc $ abundant , level affected DNA damage bound DNA constitutively ; however , showed defects cell-cycle regulation apoptosis . mutant @ GeneSrc $ mouse embryonic fibroblasts ( MEFs ) readily transformed oncogenes , corresponding mice prone @ DiseaseTgt $ . conclude determining pathway @ GeneSrc $ @ DiseaseTgt $ function mice requires transactivation domain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1022089529518891)\n",
      "- Text: \"Synergistic @ DiseaseTgt $ suppressor activity BRCA2 @ GeneSrc $ conditional mouse model breast cancer . Inheritance one defective BRCA2 allele predisposes humans breast cancer . establish mouse model BRCA2-associated breast cancer , generated mouse conditional mutants BRCA2 and/or @ GeneSrc $ inactivated various epithelial tissues , including mammary-gland epithelium . Although @ DiseaseTgt $ arose mice carrying conditional Brca2 alleles , mammary skin tumors developed frequently females carrying conditional Brca2 @ GeneSrc $ alleles . presence one wildtype Brca2 allele resulted markedly delayed @ DiseaseTgt $ formation ; loss wildtype Brca2 allele occurred subset @ DiseaseTgt $ . results show inactivation BRCA2 @ GeneSrc $ combine mediate mammary tumorigenesis , indicate disruption @ GeneSrc $ pathway pivotal BRCA2-associated breast cancer .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9783245779171442)\n",
      "- Text: \"Linking p53 @ DiseaseTgt $ suppressor pathway somatic cell reprogramming . Reprogramming somatic cells induced pluripotent stem ( iPS ) cells accomplished expressing pluripotency factors oncogenes , low frequency tendency induce malignant transformation compromise clinical utility powerful approach . address issues investigating mechanisms limiting reprogramming efficiency somatic cells . show reprogramming factors activate @ GeneSrc $ ( also known @ GeneSrc $ mice , TP53 humans ) pathway . Reducing signalling @ GeneSrc $ expressing mutated version one negative regulators , deleting knocking p53 target gene , p21 ( also known Cdkn1a ) , antagonizing reprogramming-induced apoptosis mouse fibroblasts increases reprogramming efficiency . Notably , decreasing @ GeneSrc $ protein levels enabled fibroblasts give rise iPS cells capable generating germline-transmitting chimaeric mice using Oct4 ( also known Pou5f1 ) Sox2 . Furthermore , silencing p53 significantly increased reprogramming efficiency human somatic cells . results provide insights reprogramming mechanisms suggest new routes efficient reprogramming minimizing use oncogenes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002797027383208)\n",
      "- Text: \"Ink4/Arf locus barrier iPS cell reprogramming . mechanisms involved reprogramming differentiated cells induced pluripotent stem ( iPS ) cells three transcription factors Oct4 ( also known Pou5f1 ) , Klf4 Sox2 remain poorly understood . Ink4/Arf locus comprises Cdkn2a-Cdkn2b genes encoding three potent @ DiseaseTgt $ suppressors , namely p16 ( Ink4a ) , p19 ( Arf ) p15 ( Ink4b ) , basally expressed differentiated cells upregulated aberrant mitogenic signals . show locus completely silenced iPS cells , well embryonic stem ( ES ) cells , acquiring epigenetic marks bivalent chromatin domain , retaining ability reactivated differentiation . Cell culture conditions reprogramming enhance expression Ink4/Arf locus , highlighting importance silencing locus allow proliferation reprogramming . Indeed , three factors together repress Ink4/Arf locus soon expression concomitant appearance first molecular markers ' stemness ' . downregulation also occurs cells carrying oncoprotein large-T , functionally inactivates pathways regulated Ink4/Arf locus , thus indicating silencing locus intrinsic reprogramming result selective process . Genetic inhibition Ink4/Arf locus profound positive effect efficiency iPS cell generation , increasing kinetics reprogramming number emerging iPS cell colonies . murine cells , Arf , rather Ink4a , main barrier reprogramming activation @ GeneSrc $ ( encoded @ GeneSrc $ ) p21 ( encoded Cdkn1a ) ; whereas , human fibroblasts , INK4a important ARF . Furthermore , organismal ageing upregulates Ink4/Arf locus , accordingly , reprogramming less efficient cells old organisms , defect rescued inhibiting locus short hairpin RNA . together , conclude silencing Ink4/Arf locus rate-limiting reprogramming , transient inhibition may significantly improve generation iPS cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0078855611417292)\n",
      "- Text: \"Delayed ageing damage protection @ GeneSrc $ pathway . @ DiseaseTgt $ pathway formed alternative reading frame protein Cdkn2a locus ( Arf ) @ GeneSrc $ ( also called @ GeneSrc $ ) plays central part detection elimination cellular damage , constitutes basis potent @ DiseaseTgt $ protection activity . Similar @ DiseaseTgt $ , ageing also results accumulation damage , therefore , reasoned @ GeneSrc $ could anti-ageing activity alleviating load age-associated damage . show genetically manipulated mice increased , otherwise normally regulated , levels Arf @ GeneSrc $ present strong @ DiseaseTgt $ resistance decreased levels ageing-associated damage . observations extend protective role @ GeneSrc $ ageing , revealing previously unknown anti-ageing mechanism providing rationale co-evolution @ DiseaseTgt $ resistance longevity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6447716270822693)\n",
      "- Text: \"alpha-Ketoglutarate links p53 cell fate @ DiseaseTgt $ suppression . @ DiseaseTgt $ suppressor TP53 mutated majority human @ DiseaseTgt $ , 70 % pancreatic ductal adenocarcinoma ( PDAC ) 1,2 . Wild-type p53 accumulates response cellular stress , regulates gene expression alter cell fate prevent @ DiseaseTgt $ development2 . Wild-type p53 also known modulate cellular metabolic pathways3 , although p53-dependent metabolic alterations constrain @ DiseaseTgt $ progression remain poorly understood . find p53 remodels @ DiseaseTgt $ metabolism enforce changes chromatin gene expression favour premalignant cell fate . Restoring @ GeneSrc $ function @ DiseaseTgt $ cells derived KRAS-mutant mouse models PDAC leads accumulation alpha-ketoglutarate ( alphaKG , also known 2-oxoglutarate ) , metabolite also serves obligate substrate subset chromatin-modifying enzymes . @ GeneSrc $ induces transcriptional programs characteristic premalignant differentiation , effect partially recapitulated addition cell-permeable alphaKG . Increased levels alphaKG-dependent chromatin modification 5-hydroxymethylcytosine ( 5hmC ) accompany @ DiseaseTgt $ differentiation triggered @ GeneSrc $ , whereas decreased 5hmC characterizes transition premalignant de-differentiated malignant lesions associated mutations @ GeneSrc $ . Enforcing accumulation alphaKG @ GeneSrc $ PDAC cells inhibition oxoglutarate dehydrogenase-an enzyme tricarboxylic acid cycle-specifically results increased 5hmC , @ DiseaseTgt $ differentiation decreased @ DiseaseTgt $ fitness . Conversely , increasing intracellular levels succinate ( competitive inhibitor alphaKG-dependent dioxygenases ) blunts @ GeneSrc $ @ DiseaseTgt $ suppression . data suggest alphaKG effector @ GeneSrc $ @ DiseaseTgt $ suppression , accumulation alphaKG @ GeneSrc $ @ DiseaseTgt $ drive @ DiseaseTgt $ differentiation antagonize malignant progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6275724565711298)\n",
      "- Text: \"Nf1 ; Trp53 mutant mice develop glioblastoma evidence strain-specific effects . Astrocytomas leading cause brain cancer humans . @ DiseaseTgt $ highly infiltrative , current treatments rely targeting @ DiseaseTgt $ mass often ineffective . mouse model astrocytoma would powerful tool dissecting @ DiseaseTgt $ progression testing therapeutics . Mouse models astrocytoma designed express oncogenic proteins astrocytes , limited success due low @ DiseaseTgt $ penetrance limited @ DiseaseTgt $ progression . present mouse model astrocytomas involving mutation two @ DiseaseTgt $ genes , Nf1 @ GeneSrc $ . Humans mutations NF1 develop neurofibromatosis type ( NF1 ) increased risk optic gliomas , astrocytomas glioblastomas . TP53 @ DiseaseTgt $ suppressor often mutated subset astrocytomas develop young age progress slowly glioblastoma ( termed secondary glioblastomas , contrast primary glioblastomas develop rapidly de novo ) . mouse model shows range astrocytoma stages , low-grade astrocytoma glioblastoma multiforme , may accurately model human secondary glioblastoma involving TP53 loss . first reported mouse model astrocytoma initiated loss @ DiseaseTgt $ suppressors , rather overexpression transgenic oncogenes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3849722403763875)\n",
      "- Text: \"antioxidant function @ GeneSrc $ @ DiseaseTgt $ suppressor . widely accepted @ GeneSrc $ @ DiseaseTgt $ suppressor restricts abnormal cells induction growth arrest triggering apoptosis . show , addition , @ GeneSrc $ protects genome oxidation reactive oxygen species ( ROS ) , major cause DNA damage genetic instability . absence severe stresses , relatively low levels @ GeneSrc $ sufficient upregulation several genes antioxidant products , associated decrease intracellular ROS . Downregulation @ GeneSrc $ results excessive oxidation DNA , increased mutation rate karyotype instability , prevented incubation antioxidant N-acetylcysteine ( NAC ) . Dietary supplementation NAC prevented frequent lymphomas characteristic @ GeneSrc $ mice , slowed growth lung cancer xenografts deficient @ GeneSrc $ . results provide new paradigm nonrestrictive @ DiseaseTgt $ suppressor function @ GeneSrc $ highlight potential importance antioxidants prophylaxis treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1940370040216857)\n",
      "- Text: \"@ GeneSrc $ deficiency protects acute intestinal inflammation . @ GeneSrc $ protein important @ DiseaseTgt $ suppressor activity also additional immunological functions , whose nature extent beginning recognized . article , show @ GeneSrc $ novel inflammation-promoting action intestinal tract , loss @ GeneSrc $ upstream activating kinase , ATM , protects acute intestinal inflammation murine models . Mechanistically , deficiency @ GeneSrc $ leads increased survival epithelial cells lamina propria macrophages , higher IL-6 expression owing enhanced glucose-dependent NF-kappaB activation , increased mucosal STAT3 activation . Blockade loss IL-6 signaling reverses protective effects @ GeneSrc $ deficiency . Conversely , IL-6 treatment protects acute colitis manner dependent STAT3 signaling induction cytoprotective factors epithelial cells . Together , results indicate @ GeneSrc $ promotes inflammation intestinal tract suppression epithelium-protective factors , thus significantly expanding spectrum physiological immunological @ GeneSrc $ activities unrelated @ DiseaseTgt $ formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2018404295225105)\n",
      "- Text: \"miR-380 - 5p represses p53 control cellular survival associated poor outcome MYCN-amplified neuroblastoma . Inactivation p53 @ DiseaseTgt $ suppressor pathway allows cell survival times stress occurs many human @ DiseaseTgt $ ; however , normal embryonic stem cells @ DiseaseTgt $ neuroblastoma maintain wild-type human TP53 mouse @ GeneSrc $ ( referred collectively @ GeneSrc $ herein ) . describe miRNA , miR-380 - 5p , represses p53 expression via conserved sequence p53 3 ' untranslated region ( UTR ) . miR-380 - 5p highly expressed mouse embryonic stem cells neuroblastomas , high expression correlates poor outcome neuroblastomas neuroblastoma derived v-myc myelocytomatosis viral-related oncogene ( MYCN ) amplification . miR-380 overexpression cooperates activated HRAS oncoprotein transform primary cells , block oncogene-induced senescence form @ DiseaseTgt $ mice . Conversely , inhibition endogenous miR-380 - 5p embryonic stem neuroblastoma cells results induction @ GeneSrc $ , extensive apoptotic cell death . vivo delivery miR-380 - 5p antagonist decreases @ DiseaseTgt $ size orthotopic mouse model neuroblastoma . demonstrate new mechanism p53 regulation @ DiseaseTgt $ stem cells uncover potential therapeutic target neuroblastoma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0887841168644643)\n",
      "- Text: \"Inappropriate p53 activation development induces features CHARGE syndrome . CHARGE syndrome multiple anomaly disorder patients present variety phenotypes , including ocular coloboma , heart defects , choanal atresia , retarded growth development , genitourinary hypoplasia ear abnormalities . Despite 70 - 90 % CHARGE syndrome cases resulting mutations gene CHD7 , encodes ATP-dependent chromatin remodeller , pathways underlying diverse phenotypes remain poorly understood . Surprisingly , studies knock-in mutant mouse strain expresses stabilized transcriptionally dead variant @ DiseaseTgt $ protein @ GeneSrc $ ( @ GeneSrc $ ) ) , along wild-type allele @ GeneSrc $ ( also known @ GeneSrc $ ) , revealed late-gestational embryonic lethality associated host phenotypes characteristic CHARGE syndrome , including coloboma , inner outer ear malformations , heart outflow tract defects craniofacial defects . found @ GeneSrc $ ) mutant protein stabilized hyperactivated wild-type @ GeneSrc $ , inappropriately induced target genes triggered cell-cycle arrest apoptosis development . Importantly , phenotypes observed wild-type p53 allele , p53 ( 25,26,53,54 ) ( /- ) embryos fully viable . Furthermore , found CHD7 bind p53 promoter , thereby negatively regulating p53 expression , CHD7 loss mouse neural crest cells samples patients CHARGE syndrome results @ GeneSrc $ activation . Strikingly , found @ GeneSrc $ heterozygosity partially rescued phenotypes Chd7-null mouse embryos , demonstrating @ GeneSrc $ contributes phenotypes result CHD7 loss . Thus , inappropriate p53 activation development promote CHARGE phenotypes , supporting idea p53 critical role developmental syndromes providing important insight mechanisms underlying CHARGE syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0714472623480121)\n",
      "- Text: \"Ultraviolet radiation accelerates BRAF-driven melanomagenesis targeting @ GeneSrc $ . Cutaneous melanoma epidemiologically linked ultraviolet radiation ( UVR ) , molecular mechanisms UVR drives melanomagenesis remain unclear . common somatic mutation melanoma V600E substitution BRAF , early event . investigate UVR accelerates oncogenic BRAF-driven melanomagenesis , used BRAF ( V600E ) mouse model . mice expressing BRAF ( V600E ) melanocytes , single dose UVR mimicked mild sunburn humans induced clonal expansion melanocytes , repeated doses UVR increased melanoma burden . show sunscreen ( UVA superior , UVB sun protection factor ( SPF ) 50 ) delayed onset UVR-driven melanoma , provided partial protection . UVR-exposed @ DiseaseTgt $ showed increased numbers single nucleotide variants observed mutations ( H39Y , S124F , R245C , R270C , C272 G ) @ GeneSrc $ @ DiseaseTgt $ suppressor approximately 40 % cases . TP53 accepted UVR target human non-melanoma skin cancer , thought major role melanoma . However , show , mice , mutant @ GeneSrc $ accelerated BRAF ( V600E ) -driven melanomagenesis , TP53 mutations linked evidence UVR-induced DNA damage human melanoma . Thus , provide mechanistic insight epidemiological data linking UVR acquired naevi humans . Furthermore , identify @ GeneSrc $ UVR-target gene cooperates BRAF ( V600E ) induce melanoma , providing molecular insight UVR accelerates melanomagenesis . study validates public health campaigns promote sunscreen protection individuals risk melanoma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0119787491488798)\n",
      "- Text: \"Acetylation-regulated interaction @ GeneSrc $ SET reveals widespread regulatory mode . Although lysine acetylation recognized general protein modification histones non-histone proteins , mechanisms acetylation-mediated actions completely understood . Acetylation C-terminal domain ( CTD ) @ GeneSrc $ ( also known @ GeneSrc $ ) early example non-histone protein acetylation precise role remains unclear . Lysine acetylation often creates binding sites bromodomain-containing ' reader ' proteins . use proteomic screen identify oncoprotein SET major cellular factor whose binding @ GeneSrc $ dependent CTD acetylation status . SET profoundly inhibits @ GeneSrc $ transcriptional activity unstressed cells , SET-mediated repression abolished stress-induced acetylation @ GeneSrc $ CTD . Moreover , loss interaction SET activates @ GeneSrc $ , resulting @ DiseaseTgt $ regression mouse xenograft models . Notably , acidic domain SET acts ' reader ' unacetylated CTD @ GeneSrc $ mechanism acetylation-dependent regulation widespread nature . example , acetylation @ GeneSrc $ also modulates interactions similar acidic domains found @ GeneSrc $ regulators including VPRBP ( also known DCAF1 ) , DAXX PELP1 ( refs . 7 , 8 , 9 ) , computational analysis proteome identified numerous proteins potential serve acidic domain readers lysine-rich ligands . Unlike bromodomain readers , preferentially bind acetylated forms cognate ligands , acidic domain readers specifically recognize unacetylated forms ligands . Finally , acetylation-dependent regulation @ GeneSrc $ validated vivo using knock-in mouse model expressing acetylation-mimicking form @ GeneSrc $ . results reveal acidic-domain-containing factors act class acetylation-dependent regulators targeting @ GeneSrc $ , potentially , proteins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0129571930525679)\n",
      "- Text: \"Inactivation Wip1 phosphatase inhibits mammary tumorigenesis p38 MAPK-mediated activation p16 ( Ink4a ) -p19 ( Arf ) pathway . Modulation @ DiseaseTgt $ suppressor activities may provide new opportunities @ DiseaseTgt $ therapy . show disruption gene Ppm1d encoding Wip1 phosphatase activated @ GeneSrc $ p16 ( also called Ink4a ) -p19 ( also called ARF ) pathways p38 MAPK signaling suppressed vitro transformation mouse embryo fibroblasts ( MEFs ) oncogenes . Disruption gene Cdkn2a ( encoding p16 p19 ) , @ GeneSrc $ ( encoding @ GeneSrc $ ) , reconstituted cell transformation Ppm1d-null MEFs . vivo , deletion Ppm1d mice bearing mouse mammary tumor virus ( MMTV ) promoter-driven oncogenes Erbb2 ( also called c-neu ) Hras1 impaired mammary carcinogenesis , whereas reduced expression p16 p19 methylation-induced silencing inactivation p38 MAPK correlated @ DiseaseTgt $ appearance . conclude inactivation depletion Wip1 phosphatase resultant p38 MAPK activation suppresses @ DiseaseTgt $ appearance modulating Cdkn2a @ DiseaseTgt $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0688756843428942)\n",
      "- Text: \"Functional inactivation structural mutation p53 causes @ DiseaseTgt $ . Structural mutations p53 gene seen virtually every form human cancer . determine whether mutations important initiating tumorigenesis , studying @ DiseaseTgt $ , cases associated chronic hepatitis B virus infections . Using transgenic mouse model expression single HBV gene product , HBx protein , induces progressive changes liver , show tumour development correlates precisely @ GeneSrc $ binding HBx cytoplasm complete blockage @ GeneSrc $ entry nucleus . Analysis tumour cell DNA shows evidence p53 mutation , except advanced tumours small proportion cells may acquired specific base substitutions . results suggest genetic changes p53 late events may contribute tumour progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4000986742514649)\n",
      "- Text: \"Senescence tumour clearance triggered @ GeneSrc $ restoration murine @ DiseaseTgt $ . Although cancer arises combination mutations oncogenes tumour suppressor genes , extent tumour suppressor gene loss required maintaining established tumours poorly understood . @ GeneSrc $ important tumour suppressor acts restrict proliferation response DNA damage deregulation mitogenic oncogenes , leading induction various cell cycle checkpoints , apoptosis cellular senescence . Consequently , @ GeneSrc $ mutations increase cell proliferation survival , settings promote genomic instability resistance certain chemotherapies . determine consequences reactivating @ GeneSrc $ pathway tumours , used RNA interference ( RNAi ) conditionally regulate endogenous @ GeneSrc $ expression mosaic mouse model @ DiseaseTgt $ . show even brief reactivation endogenous @ GeneSrc $ @ GeneSrc $ tumours produce complete tumour regressions . primary response @ GeneSrc $ apoptosis , instead involved induction cellular senescence program associated differentiation upregulation inflammatory cytokines . program , although producing cell cycle arrest vitro , also triggered innate immune response targeted tumour cells vivo , thereby contributing tumour clearance . study indicates @ GeneSrc $ loss required maintenance aggressive carcinomas , illustrates cellular senescence program act together innate immune system potently limit tumour growth .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.906278579968634)\n",
      "- Text: \"Reactivation multipotency oncogenic PIK3CA induces breast tumour heterogeneity . Breast cancer frequent @ DiseaseTgt $ women consists heterogeneous types @ DiseaseTgt $ classified different histological molecular subtypes . PIK3CA P53 ( also known TP53 ) two frequently mutated genes associated different types human breast cancers . cellular origin mechanisms leading PIK3CA-induced @ DiseaseTgt $ heterogeneity remain unknown . used genetic approach mice define cellular origin Pik3ca-derived @ DiseaseTgt $ impact mutations gene @ DiseaseTgt $ heterogeneity . Surprisingly , oncogenic Pik3ca ( H1047R ) mutant expression physiological levels basal cells using keratin ( K ) 5-CreER ( T2 ) mice induced formation luminal oestrogen receptor ( ER ) -positive/progesterone receptor ( PR ) -positive @ DiseaseTgt $ , expression luminal cells using K8-CReER ( T2 ) mice gave rise luminal ER ( + ) PR ( + ) tumours basal-like ER ( - ) PR ( - @ DiseaseTgt $ . Concomitant deletion @ GeneSrc $ expression Pik3ca ( H1047R ) accelerated @ DiseaseTgt $ development induced aggressive mammary tumours . Interestingly , expression Pik3ca ( H1047R ) unipotent basal cells gave rise luminal-like cells , expression unipotent luminal cells gave rise basal-like cells progressing invasive tumours . Transcriptional profiling cells underwent cell fate transition upon Pik3ca ( H1047R ) expression unipotent progenitors demonstrated profound oncogene-induced reprogramming newly formed cells identified gene signatures characteristic different cell fate switches occur upon Pik3ca ( H1047R ) expression basal luminal cells , correlated cell origin , @ DiseaseTgt $ type different clinical outcomes . Altogether study identifies cellular origin Pik3ca-induced @ DiseaseTgt $ reveals oncogenic Pik3ca ( H1047R ) activates multipotent genetic program normally lineage-restricted populations early stage @ DiseaseTgt $ initiation , setting stage future intratumoural heterogeneity . results important implications understanding mechanisms controlling @ DiseaseTgt $ heterogeneity development new strategies block PIK3CA breast cancer initiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0662701320090005)\n",
      "- Text: \"Selective activation @ GeneSrc $ @ DiseaseTgt $ suppression high-grade @ DiseaseTgt $ . Non-small cell lung carcinoma ( NSCLC ) leading cause @ DiseaseTgt $ death worldwide , overall 5-year survival rate 10 - 15 % . Deregulation Ras pathway frequent hallmark NSCLC , often mutations directly activate Kras . @ GeneSrc $ also frequently inactivated NSCLC , oncogenic Ras potent trigger @ GeneSrc $ ( ref . 3 ) , seems likely oncogenic Ras signalling major persistent role driving selection @ GeneSrc $ . Hence , pharmacological restoration @ GeneSrc $ appealing therapeutic strategy treating disease . model probable therapeutic impact @ GeneSrc $ restoration spontaneously evolving mouse model NSCLC initiated sporadic oncogenic activation endogenous Kras . Surprisingly , @ GeneSrc $ restoration failed induce significant regression established @ DiseaseTgt $ , although result significant decrease relative proportion high-grade @ DiseaseTgt $ . due selective activation @ GeneSrc $ aggressive @ DiseaseTgt $ cells within @ DiseaseTgt $ . selective activation @ GeneSrc $ correlates marked upregulation Ras signal intensity induction oncogenic signalling sensor p19 ( ARF ) ( ) ( ref . 6 ) . data indicate @ GeneSrc $ @ DiseaseTgt $ suppression triggered oncogenic Ras signal flux exceeds critical threshold . Importantly , failure low-level oncogenic Kras engage @ GeneSrc $ reveals inherent limits capacity @ GeneSrc $ restrain early @ DiseaseTgt $ evolution efficacy therapeutic @ GeneSrc $ restoration eradicate @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2809434665647876)\n",
      "- Text: \"Mutant Kras copy number defines metabolic reprogramming therapeutic susceptibilities . RAS/MAPK ( mitogen-activated protein kinase ) signalling pathway frequently deregulated non-small-cell lung cancer , often KRAS activating mutations . single endogenous mutant Kras allele sufficient promote lung tumour formation mice malignant progression requires additional genetic alterations . recently showed advanced lung tumours @ GeneSrc $ mice frequently exhibit Kras ( G12D ) allelic enrichment ( Kras ( G12D ) /Kras ( wild-type ) > 1 ) ( ref . 7 ) , implying mutant Kras copy gains positively selected progression . show , comprehensive analysis mutant Kras homozygous heterozygous mouse embryonic fibroblasts lung cancer cells , genotypes phenotypically distinct . particular , Kras ( G12D/G12D ) cells exhibit glycolytic switch coupled increased channelling glucose-derived metabolites tricarboxylic acid cycle glutathione biosynthesis , resulting enhanced glutathione-mediated detoxification . metabolic rewiring recapitulated mutant KRAS homozygous non-small-cell lung cancer cells vivo , spontaneous advanced murine lung tumours ( display high frequency Kras ( G12D ) copy gain ) , corresponding early @ DiseaseTgt $ ( Kras ( G12D ) heterozygous ) . Finally , demonstrate mutant Kras copy gain creates unique metabolic dependences exploited selectively target aggressive mutant Kras @ DiseaseTgt $ . data demonstrate mutant Kras lung tumours single disease rather heterogeneous group comprising two classes @ DiseaseTgt $ distinct metabolic profiles , prognosis therapeutic susceptibility , discriminated basis relative mutant allelic content . also provide first , knowledge , vivo evidence metabolic rewiring lung cancer malignant progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9832185960664522)\n",
      "- Text: \"Defining stem cell dynamics models intestinal @ DiseaseTgt $ initiation . @ DiseaseTgt $ disease cells accumulate genetic aberrations believed confer clonal advantage cells surrounding tissue . However , quantitative benefit frequently occurring mutations @ DiseaseTgt $ development remains unknown . quantified competitive advantage Apc loss , Kras activation , @ GeneSrc $ mutations mouse intestine . findings indicate fate conferred mutations deterministic , many mutated stem cells replaced wild-type stem cells biased , still stochastic events . Furthermore , @ GeneSrc $ mutations display condition-dependent advantage , especially colitis-affected intestines , clones harboring mutations gene favored . work confirms previously theoretical notion tissue architecture intestine suppresses accumulation mutated lineages .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0143311631384283)\n",
      "- Text: \"Specific P53 mutations associated de novo resistance doxorubicin breast cancer patients . mechanisms causing resistance chemotherapeutic drugs @ DiseaseTgt $ patients poorly understood . Recent evidence suggests different forms chemotherapy may exert cytotoxic effects inducing apoptosis . @ DiseaseTgt $ suppressor gene P53 pivotal role inducing apoptosis response cellular damage . vitro investigations shown intact p53 play critical role executing cell death response treatment cytotoxic drugs like 5-fluorouracil , etoposide doxorubicin . Recently , mutations @ GeneSrc $ gene found confer resistance anthracyclines mouse @ DiseaseTgt $ model , overexpression p53 protein ( , cases , due mutated gene ) found associated lack response cisplatin-based chemotherapy non-small cell lung cancer . Previous studies shown mutations P53 gene overexpression p53 protein predict poor prognosis , also beneficial effect adjuvant radiotherapy chemotherapy breast cancer . study present data linking specific mutations P53 gene primary resistance doxorubicin therapy early relapse breast cancer patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0652754951912639)\n",
      "- Text: \"Telomere dysfunction promotes non-reciprocal translocations @ DiseaseTgt $ mice . Aged humans sustain high rate @ DiseaseTgt $ carcinomas breast colon , whereas mice carrying common @ DiseaseTgt $ suppressor gene mutations typically develop soft tissue sarcomas lymphomas . Among many factors may contribute species variance differences telomere length regulation . Telomeres comprise nucleoprotein complexes cap ends eukaryotic chromosomes maintained reverse transcriptase , telomerase . human cells , insufficient levels telomerase lead telomere attrition cell division culture possibly ageing tumorigenesis vivo . contrast , critical reduction telomere length observed mouse owing promiscuous telomerase expression long telomeres . provide evidence telomere attrition ageing telomerase-deficient @ GeneSrc $ mutant mice promotes development @ DiseaseTgt $ process fusion-bridge breakage leads formation complex non-reciprocal translocations -- classical cytogenetic feature human @ DiseaseTgt $ . data suggest model telomere dysfunction brought continual epithelial renewal life generates massive ploidy changes associated development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.17446135111861)\n",
      "- Text: \"Reciprocal repression @ GeneSrc $ TCTP . Screening genes reprogram @ DiseaseTgt $ cells @ DiseaseTgt $ reversion switch identified TCTP ( encoding translationally controlled tumor protein ) crucial regulator apoptosis . report negative feedback loop @ GeneSrc $ TCTP . TCTP promotes @ GeneSrc $ degradation competing NUMB binding @ GeneSrc $ complexes . TCTP inhibits MDM2 auto-ubiquitination promotes MDM2-mediated ubiquitination degradation @ GeneSrc $ . Notably , Tctp haploinsufficient mice sensitized @ GeneSrc $ apoptosis . addition , @ GeneSrc $ directly represses TCTP transcription . 508 breast cancers , high-TCTP status associates poorly differentiated , aggressive G3-grade @ DiseaseTgt $ , predicting poor prognosis ( P < 0.0005 ) . Tctp knockdown primary mammary tumor cells ErbB2 transgenic mice results increased @ GeneSrc $ expression decreased number stem-like @ DiseaseTgt $ cells . pharmacological compounds sertraline thioridazine increase amount @ GeneSrc $ neutralizing TCTP 's action @ GeneSrc $ axis . study links TCTP @ GeneSrc $ previously unidentified regulatory circuitry may underlie relevance TCTP @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2123271742937379)\n",
      "- Text: \"Chromosome 17 deletions @ GeneSrc $ gene mutations colorectal carcinomas . Previous studies demonstrated allelic deletions short arm chromosome 17 occur 75 % colorectal carcinomas . Twenty chromosome 17p markers used localize common region deletion @ DiseaseTgt $ region contained within bands 17p12 17p13.3 . region contains gene transformation-associated protein @ GeneSrc $ . Southern Northern blot hybridization experiments provided evidence gross alterations @ GeneSrc $ gene surrounding sequences . rigorous test possibility @ GeneSrc $ target deletions , @ GeneSrc $ coding regions two @ DiseaseTgt $ analyzed ; two @ DiseaseTgt $ , like colorectal carcinomas , allelic deletions chromosome 17p expressed considerable amounts @ GeneSrc $ messenger RNA remaining allele . remaining @ GeneSrc $ allele mutated @ DiseaseTgt $ , alanine substituted valine codon 143 one @ DiseaseTgt $ histidine substituted arginine codon 175 second @ DiseaseTgt $ . mutations occurred highly conserved region @ GeneSrc $ gene previously found mutated murine @ GeneSrc $ oncogenes . data suggest @ GeneSrc $ gene mutations may involved @ DiseaseTgt $ , perhaps inactivation @ DiseaseTgt $ suppressor function wild-type @ GeneSrc $ gene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6472771492052803)\n",
      "- Text: \"@ GeneSrc $ deletion impairs clearance chromosomal-instable stem cells aging telomere-dysfunctional mice . Telomere dysfunction limits proliferative capacity human cells induces organismal aging activation p53 p21 . Although deletion p21 elongates lifespan telomere-dysfunctional mice , direct analysis @ GeneSrc $ telomere-related aging hampered early @ DiseaseTgt $ formation @ GeneSrc $ knockout mice . analyzed functional consequences conditional @ GeneSrc $ deletion . Intestinal deletion @ GeneSrc $ shortened lifespan telomere-dysfunctional mice without inducing @ DiseaseTgt $ formation . contrast p21 deletion , deletion @ GeneSrc $ impaired depletion chromosomal-instable intestinal stem cells aging telomere-dysfunctional mice . instable stem cells contributed epithelial regeneration leading accumulation chromosomal instability , increased apoptosis , altered epithelial cell differentiation premature intestinal failure . Together , results provide first experimental evidence organ system @ GeneSrc $ mechanisms prevent tissue destruction response telomere dysfunction depleting genetically instable stem cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9724606882641296)\n",
      "- Text: \"@ GeneSrc $ apoptosis absence transcriptional activation @ GeneSrc $ genes . @ DiseaseTgt $ suppressor @ GeneSrc $ required induce programmed cell death ( apoptosis ) DNA-damaging agents . @ GeneSrc $ transcriptional activator mediates gene induction DNA damage , proposed genetic switch activates apoptosis-mediator genes . evaluate role @ GeneSrc $ DNA-damage-induced apoptosis establishing derivatives GHFT1 cells , somatotropic progenitors immortalized expression SV40 T-antigen , express temperature-sensitive @ GeneSrc $ mutant . cells induction apoptosis DNA damage depends strictly @ GeneSrc $ function . shift permissive temperature triggers apoptosis following DNA damage , independent new RNA protein synthesis . extent apoptotic DNA cleavage directly proportional period @ GeneSrc $ functional . results support proposal @ GeneSrc $ activator apoptosis-mediator genes rather indicate @ GeneSrc $ either represses genes necessary cell survival component enzymatic machinery apoptotic cleavage repair DNA .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6906988020035404)\n",
      "- Text: \"Evaluation molecular mechanisms involved gain function Li-Fraumeni TP53 mutation . TP53 @ DiseaseTgt $ suppressor gene frequent target genetic alterations human @ DiseaseTgt $ . TP53 gene alterations may result gain oncogenic functions neoangiogenesis resistance therapy . TP53 germ line mutation c.659A > C ( p. Y220S ) identified stored DNA related patients Li-Fraumeni syndrome ( LFS ) died developing clinically aggressive @ DiseaseTgt $ . patients treated protocols included doxorubicin hydrochloride ( DX ) pivotal drug . define vitro mutational phenotype germ line mutation , used murine fibroblasts explanted wild-type ( wt ) @ GeneSrc $ knockout ( KO ) mice littermate . p53Y220S p53R175H fibroblasts , obtained p53KO fibroblasts transfected expression vectors encoding human Y220S R175H p53 mutants , respectively , exhibited resistance DX treatment . Moreover , p53Y220S fibroblasts exhibited angiogenetic properties , DX treatment , p53Y220S failed translocate nucleus showed increase cytosolic levels . DX treatment influence @ GeneSrc $ distribution within nuclear cytosolic compartments p53R175H fibroblasts . Peroxiredoxin II ( Prx II ) , protein involved eliminating reactive oxygen species ( ROS ) , showed increased expression intensity p53Y220S fibroblasts DX treatment , observed two-dimensional electrophoresis analysis . Moreover , Thioredoxin ( Trx ) , protein cooperates Prx II , overexpressed p53Y220S mutants basal conditions . data suggest relationship presence p53Y220S mutation enhanced levels Prx II Trx mutant fibroblasts . Since one mechanisms DX antitumor effect ascribed production ROS , future studies evaluate involvement PrxII Trx chemoresistance p53Y220S fibroblasts DX .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.6869494184222e-05)\n",
      "- Text: \"pathological response DNA damage contribute @ GeneSrc $ @ DiseaseTgt $ suppression . @ GeneSrc $ protein highly evolutionarily conserved role metazoans ' guardian genome ' , mediating cell-cycle arrest apoptosis response genotoxic injury . large , long-lived animals substantial somatic regenerative capacity , vertebrates , @ GeneSrc $ important @ DiseaseTgt $ suppressor -- attribute thought stem directly induction death arrest mutant cells damaged unstable genomes . Chemotherapy radiation exposure induce widespread @ GeneSrc $ DNA damage . triggers potentially lethal pathologies generally deemed unfortunate unavoidable consequence role @ GeneSrc $ @ DiseaseTgt $ suppression . show , using mouse model @ GeneSrc $ status reversibly switched vivo functional inactive states , @ GeneSrc $ pathological response whole-body irradiation , prototypical genotoxic carcinogen , irrelevant suppression radiation-induced lymphoma . contrast , delaying restoration @ GeneSrc $ function acute radiation response subsided abrogates radiation-induced pathology yet preserves much protection lymphoma . protection absolutely dependent p19 ( ARF ) -- @ DiseaseTgt $ suppressor induced DNA damage , oncogenic disruption cell cycle .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7234374089595271)\n",
      "- Text: \"Mice deficient @ GeneSrc $ developmentally normal susceptible spontaneous @ DiseaseTgt $ . Mutations p53 @ DiseaseTgt $ gene frequently observed genetic lesions human @ DiseaseTgt $ . investigate role p53 gene mammalian development tumorigenesis , null mutation introduced gene homologous recombination murine embryonic stem cells . Mice homozygous null allele appear normal prone spontaneous development variety @ DiseaseTgt $ 6 months age . observations indicate normal p53 gene dispensable embryonic development , absence predisposes animal neoplastic disease , oncogenic mutant form p53 obligatory genesis many types @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3135900826978343)\n",
      "- Text: \"Wild-type p53 activates transcription vitro . p53 protein important determinant human @ DiseaseTgt $ regulates growth cells culture . known sequence-specific DNA-binding protein powerful activation domain , established whether regulates transcription directly . show intact purified wild-type human murine @ GeneSrc $ proteins strongly activate transcription vitro . activation depends ability p53 bind template bearing p53-binding sequence . contrast , @ DiseaseTgt $ mutant p53 proteins activate transcription template , complexed wild-type p53 , mutants block transcriptional activation wild-type protein . Moreover , simian virus 40 large antigen inhibits wild-type p53 activating transcription . results support model p53 directly activates transcription activity inhibited mutant p53 SV40 large antigen interaction wild-type p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0038888017789233)\n",
      "- Text: \"@ DiseaseTgt $ chemoprevention antioxidant tempol acts partially via @ GeneSrc $ @ DiseaseTgt $ suppressor . previously demonstrated nitroxide antioxidant tempol ( 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl ) increased latency tumorigenesis doubled ( 100 % ) lifespan Atm-deficient mice , mouse model ataxia telangiectasia , displays accelerated oxidative damage stress . Tempol treatment @ DiseaseTgt $ @ GeneSrc $ mice resulted small significant ( 25 % ) increase lifespan prolonging latency tumorigenesis , demonstrating existing oxidative stress damage necessary chemopreventative effects tempol . However , relatively small effect latency @ GeneSrc $ mice finding tempol-mediated resistance oxidative insult @ GeneSrc $ suggested direct role @ GeneSrc $ chemopreventative effects tempol . Surprisingly , tempol treatment specifically increased serine 18 phosphorylation @ GeneSrc $ ( gamma-H2AX ) p21 expression primary thymocytes vitro @ GeneSrc $ fashion . Inhibition phosphoinositide 3-kinase ( PI3 K ) family members suggested SMG-1 responsible tempol-mediated enhancement @ GeneSrc $ serine 18 phosphorylation . data suggest chemopreventative effect tempol solely due reduction oxidative stress damage may also related redox-mediated signaling functions include @ GeneSrc $ pathway activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3812395696720714)\n",
      "- Text: \"Stage-specific sensitivity @ GeneSrc $ restoration lung cancer progression . Tumorigenesis multistep process results sequential accumulation mutations key oncogene @ DiseaseTgt $ suppressor pathways . Personalized @ DiseaseTgt $ therapy based targeting underlying genetic abnormalities presupposes sustained inactivation @ DiseaseTgt $ suppressors activation oncogenes essential advanced @ DiseaseTgt $ . Mutations p53 @ DiseaseTgt $ pathway common human @ DiseaseTgt $ significant efforts towards pharmaceutical reactivation defective p53 pathways underway . show restoration @ GeneSrc $ established murine lung tumours leads significant incomplete @ DiseaseTgt $ cell loss specifically malignant adenocarcinomas , adenomas . define amplification MAPK signalling critical determinant malignant progression also stimulator Arf @ DiseaseTgt $ expression . response @ GeneSrc $ restoration context critically dependent expression Arf . propose @ GeneSrc $ limits malignant progression suppressing acquisition alterations lead @ DiseaseTgt $ progression , also , context @ GeneSrc $ restoration , responds increased oncogenic signalling mediate @ DiseaseTgt $ regression . observations also underscore @ GeneSrc $ pathway engaged low levels oncogene activity sufficient early stages lung tumour development . data suggest restoration pathways important @ DiseaseTgt $ progression , opposed initiation , may lead incomplete @ DiseaseTgt $ regression due stage-heterogeneity @ DiseaseTgt $ cell populations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.923659074182)\n",
      "- Text: \"CKIalpha ablation highlights critical role p53 invasiveness control . mature gut renews continuously rapidly throughout adult life , often damage-inflicting micro-environment . major driving force self-renewal intestinal epithelium Wnt-mediated signalling pathway , Wnt signalling frequently hyperactivated colorectal cancer . show casein kinase Ialpha ( CKIalpha ) , component beta-catenin-destruction complex , critical regulator Wnt signalling pathway . Inducing ablation Csnk1a1 ( gene encoding CKIalpha ) gut triggers massive Wnt activation , surprisingly without causing tumorigenesis . CKIalpha-deficient epithelium shows many features human colorectal tumours addition Wnt activation , particular induction DNA damage response cellular senescence , thought provide barrier malignant transformation . epithelial DNA damage response mice accompanied substantial activation @ GeneSrc $ , suggesting @ GeneSrc $ pathway may counteract pro-tumorigenic effects Wnt hyperactivation . Notably , transition benign adenomas invasive colorectal cancer humans typically linked p53 inactivation , underscoring importance p53 safeguard malignant progression ; however , mechanism p53-mediated @ DiseaseTgt $ suppression unknown . show maintenance intestinal homeostasis CKIalpha-deficient gut requires p53-mediated growth control , combined ablation Csnk1a1 either p53 target gene p21 ( also known Waf1 , Cip1 , Sdi1 Cdkn1a ) triggered high-grade dysplasia extensive proliferation . Unexpectedly , ablations also induced non-proliferating cells invade villous lamina propria rapidly , producing invasive @ DiseaseTgt $ throughout small bowel . Furthermore , p53-deficient gut , loss heterozygosity gene encoding CKIalpha caused highly invasive carcinoma , indicating CKIalpha functions @ DiseaseTgt $ suppressor p53 inactivated . identified set genes ( p53-suppressed invasiveness signature , PSIS ) activated loss p53 CKIalpha probably accounts brisk induction invasiveness . PSIS transcription tumour invasion suppressed p21 , independently cell cycle control . Restraining tissue invasion suppressing PSIS expression thus novel @ DiseaseTgt $ function wild-type p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0335109135313047)\n",
      "- Text: \"Pharmacological rescue mutant @ GeneSrc $ conformation function . Compounds stabilize DNA binding domain @ GeneSrc $ active conformation identified . small synthetic molecules promoted stability wild-type @ GeneSrc $ also allowed mutant @ GeneSrc $ maintain active conformation . prototype compound caused accumulation conformationally active @ GeneSrc $ cells mutant @ GeneSrc $ , enabling activate transcription slow @ DiseaseTgt $ growth mice . work aimed improving potency , class compounds may developed anticancer drugs broad utility .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0241298514821704)\n",
      "- Text: \"Declining @ GeneSrc $ function aging process : possible mechanism increased @ DiseaseTgt $ incidence older populations . @ DiseaseTgt $ disease aging . accumulation mutations individual cells lifetime thought reason . work , explored additional hypothesis : could @ GeneSrc $ function decline age , would contribute enhanced mutation frequency tumorigenesis aging process ? efficiency @ GeneSrc $ response gamma-irradiation found decline significantly various tissues aging mice several inbred strains , including lower @ GeneSrc $ transcriptional activity @ GeneSrc $ apoptosis . decline resulted decreased stabilization @ GeneSrc $ protein stress . function Ataxia-telangiectasia mutated ( ATM ) kinase declined significantly age , may responsible decline @ GeneSrc $ response radiation . Declining @ GeneSrc $ responses stresses also observed cultured splenocytes aging mice . Interestingly , time onset decreased @ GeneSrc $ response correlated life span mice ; mice live longer delay onset decreased @ GeneSrc $ activity time . results suggest enhanced fixation mutations older individuals declining fidelity @ GeneSrc $ apoptosis senescence response stress , suggest plausible explanation correlation tumorigenesis aging process .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.329393976617869)\n",
      "- Text: \"Abnormal centrosome amplification absence @ GeneSrc $ . centrosome plays vital role mitotic fidelity , ensuring establishment bipolar spindles balanced chromosome segregation . Centrosome duplication occurs cell cycle therefore highly regulated . , shown mouse embryonic fibroblasts ( MEFs ) lacking @ GeneSrc $ @ DiseaseTgt $ suppressor protein , multiple copies functionally competent centrosomes generated single cell cycle . contrast , MEFs prepared normal mice mice deficient retinoblastoma tumor suppressor gene product display abnormalities . abnormally amplified centrosomes profoundly affect mitotic fidelity , resulting unequal segregation chromosomes . observations implicate @ GeneSrc $ regulation centrosome duplication suggest one possible mechanism loss @ GeneSrc $ may cause genetic instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0105711106801243)\n",
      "- Text: \"Interplay @ GeneSrc $ DNA-repair protein XRCC4 tumorigenesis , genomic stability development . XRCC4 non-homologous end-joining protein employed DNA double strand break repair V ( ) J recombination . mice , XRCC4-deficiency causes pleiotropic phenotype , includes embryonic lethality massive neuronal apoptosis . DNA damage repaired , activation cell cycle checkpoint protein @ GeneSrc $ lead apoptosis . show @ GeneSrc $ rescues several aspects XRCC4-deficient phenotype , including embryonic lethality , neuronal apoptosis , impaired cellular proliferation . However , significant rescue impaired V ( ) J recombination lymphocyte development . Although @ GeneSrc $ allowed postnatal survival XRCC4-deficient mice , routinely succumbed pro-B-cell lymphomas chromosomal translocations linking amplified c-myc oncogene IgH locus sequences . Moreover , even XRCC4-deficient embryonic fibroblasts exhibited marked genomic instability including chromosomal translocations . findings support crucial role non-homologous end-joining pathway caretaker mammalian genome , role required normal development suppression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.002306179153459)\n",
      "- Text: \"Super @ GeneSrc $ mice exhibit enhanced DNA damage response , @ DiseaseTgt $ resistant age normally . @ DiseaseTgt $ suppressor @ GeneSrc $ critical preventing @ DiseaseTgt $ due ability trigger proliferation arrest cell death upon occurrence variety stresses , notably , DNA damage oncogenic stress . , report generation characterization mice carrying supernumerary copies @ GeneSrc $ gene form large genomic transgenes . Prior , demonstrate @ GeneSrc $ transgenic allele ( @ GeneSrc $ ) , present @ GeneSrc $ genetic background , behaves functional replica endogenous gene . `` Super @ GeneSrc $ `` mice , carrying @ GeneSrc $ alleles addition two endogenous alleles , exhibit enhanced response DNA damage . Importantly , `` super @ GeneSrc $ `` mice significantly protected @ DiseaseTgt $ compared normal mice . Finally , contrast previously reported mice constitutively active @ GeneSrc $ , `` super @ GeneSrc $ `` mice show indication premature aging , probably reflecting fact @ GeneSrc $ normal regulatory control . Together , results prove @ DiseaseTgt $ resistance enhanced simple genetic modification absence undesirable effects .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9057029975640208)\n",
      "- Text: \"Cytokinesis failure generating tetraploids promotes tumorigenesis @ GeneSrc $ cells . long-standing hypothesis tumorigenesis cell division failure , generating genetically unstable tetraploid cells , facilitates development aneuploid malignancies . test idea transiently blocking cytokinesis @ GeneSrc $ ( @ GeneSrc $ ) mouse mammary epithelial cells ( MMECs ) , enabling isolation diploid tetraploid cultures . tetraploid cells increase frequency whole-chromosome mis-segregation chromosomal rearrangements . tetraploid cells transformed vitro exposure carcinogen . Furthermore , absence carcinogen , tetraploid cells gave rise @ DiseaseTgt $ mammary epithelial cancers transplanted subcutaneously nude mice . @ DiseaseTgt $ contained numerous non-reciprocal translocations 8 - 30-fold amplification chromosomal region containing cluster matrix metalloproteinase ( MMP ) genes . MMP overexpression linked mammary tumours humans animal models . Thus , tetraploidy enhances frequency chromosomal alterations promotes @ DiseaseTgt $ development @ GeneSrc $ MMECs .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9971370943867116)\n",
      "- Text: \"Different @ DiseaseTgt $ @ GeneSrc $ mutants exhibit distinct biological activities . wild-type form , protein @ GeneSrc $ interfere @ DiseaseTgt $ processes . @ DiseaseTgt $ cells often express mutant @ GeneSrc $ . Full-length mutant forms @ GeneSrc $ isolated far transformed mouse cells exhibit three common properties vitro : loss transformation-suppressing activity , gain pronounced transforming potential , ability bind heat shock protein cognate hsc70 . @ DiseaseTgt $ mouse @ GeneSrc $ variant described , whose site mutation corresponds hot spot p53 human @ DiseaseTgt $ . absolutely nonsuppressing , weakly transforming exhibits detectable hsc70 binding . data suggest ability @ GeneSrc $ mutant bind endogenous @ GeneSrc $ sole determinant oncogenic potential . data also support existence gain-of-function @ GeneSrc $ mutants .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9487435431330292)\n",
      "- Text: \"Molecular cloning vitro expression cDNA clone human cellular tumor antigen p53 . Three clones human @ DiseaseTgt $ antigen p53 isolated cDNA library prepared A431 cells . One clones , pR4 - 2 , contains entire coding region human p53 . clone directs synthesis polypeptide correct molecular weight immunological epitopes authentic p53 molecule vitro transcription-translation reaction . Although pR4 - 2 clone contains coding region p53 , full-length copy human p53 mRNA . Northern analysis showed p53 mRNA approximately 2,500 nucleotides long , whereas pR4 - 2 insert 1,760 base pairs length . Analysis DNA sequence clone suggests human p53 polypeptide 393 amino acids . compared predicted amino acid sequence pR4 - 2 clone similar clones mouse @ GeneSrc $ found long regions amino acid homology two molecules .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002819122737515)\n",
      "- Text: \"@ GeneSrc $ regulates maternal reproduction LIF . Extensive studies shown p53 important @ DiseaseTgt $ prevention . However , little known normal physiological function . show @ GeneSrc $ important reproduction , gender-specific manner . Significant decreases embryonic implantation , pregnancy rate litter size observed matings @ GeneSrc $ female mice @ GeneSrc $ male mice . gene encoding leukaemia inhibitory factor ( LIF ) , cytokine critical implantation , identified @ GeneSrc $ gene functions downstream mediator effect . @ GeneSrc $ regulate basal inducible transcription LIF . Loss @ GeneSrc $ decreased level function LIF uteri . Lower LIF levels observed uteri @ GeneSrc $ mice @ GeneSrc $ mice , particularly day 4 pregnancy , transiently induced high levels LIF crucial embryonic implantation . observation probably accounts impaired implantation embryos @ GeneSrc $ female mice . Administration LIF pregnant @ GeneSrc $ mice restored maternal reproduction improving implantation . results demonstrate function @ GeneSrc $ maternal reproduction regulation LIF . Evidence accumulating p53 may similar function humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.5862810249770605e-05)\n",
      "- Text: \"Ferroptosis p53-mediated activity @ DiseaseTgt $ suppression . Although p53-mediated cell-cycle arrest , senescence apoptosis serve critical barriers @ DiseaseTgt $ development , emerging evidence suggests metabolic activities p53 also important . show p53 inhibits cystine uptake sensitizes cells ferroptosis , non-apoptotic form cell death , repressing expression SLC7A11 , key component cystine/glutamate antiporter . Notably , p53 ( 3KR ) , acetylation-defective mutant fails induce cell-cycle arrest , senescence apoptosis , fully retains ability regulate SLC7A11 expression induce ferroptosis upon reactive oxygen species ( ROS ) -induced stress . Analysis mutant mice shows non-canonical @ GeneSrc $ activities contribute embryonic development lethality associated loss Mdm2 . Moreover , SLC7A11 highly expressed human @ DiseaseTgt $ , overexpression inhibits ROS-induced ferroptosis abrogates p53 ( 3KR ) -mediated @ DiseaseTgt $ growth suppression xenograft models . findings uncover new mode @ DiseaseTgt $ suppression based p53 regulation cystine metabolism , ROS responses ferroptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2607978991165965)\n",
      "- Text: \"@ GeneSrc $ mice extremely susceptible radiation-induced tumorigenesis . Mice constitutively lacking alleles @ GeneSrc $ @ DiseaseTgt $ suppressor gene spontaneously develop lymphomas sarcomas . report single dose 4 Gy radiation dramatically decreases latency @ DiseaseTgt $ development @ GeneSrc $ heterozygous mice . pattern genetic alterations remaining wild type allele @ DiseaseTgt $ differs substantially spontaneous @ DiseaseTgt $ similar mice indicating @ GeneSrc $ may target radiation-induced alterations . Lower dose irradiation ( 1 Gy ) preweanling @ GeneSrc $ null mice also significantly decreases @ DiseaseTgt $ latency , suggesting additional genetic targets involved radiation-induced @ DiseaseTgt $ . Thus @ GeneSrc $ mice provide sensitive model system studies consequences radiation exposure .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8593338364037393)\n",
      "- Text: \"High incidence lung , bone , lymphoid tumors transgenic mice overexpressing mutant alleles @ GeneSrc $ oncogene . investigated role @ GeneSrc $ gene oncogenesis vivo generating transgenic mice carrying murine @ GeneSrc $ genomic fragments isolated mouse Friend erythroleukemia cell line BALB/c mouse liver DNA . Elevated levels @ GeneSrc $ mRNA detected several tissues two transgenic lines tested . Increased levels @ GeneSrc $ protein also detected tissues analyzed Western blotting ( immunoblotting ) . transgenes encoded @ GeneSrc $ proteins antigenically distinct wild-type @ GeneSrc $ , possible demonstrate overexpression @ GeneSrc $ protein mostly , entirely , due expression transgenes . @ DiseaseTgt $ developed 20 % transgenic mice , high incidence lung adenocarcinomas , osteosarcomas , lymphomas . Tissues ovaries expressed transgene high levels higher risk malignant transformation tissues expressing @ GeneSrc $ protein much lower levels . long latent period low penetrance suggest overexpression @ GeneSrc $ alone sufficient induce @ DiseaseTgt $ additional events required . observations provide direct evidence mutant alleles @ GeneSrc $ oncogene oncogenic potential vivo different cell types show intrinsic differences susceptibility malignant transformation @ GeneSrc $ . Since recent data suggest @ GeneSrc $ may recessive oncogene , possible elevated @ DiseaseTgt $ incidence results functional inactivation endogenous @ GeneSrc $ overexpression mutant transgene . high incidence lung bone tumors suggests @ GeneSrc $ transgenic mice may provide useful model investigate molecular events underlie @ DiseaseTgt $ humans .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999873515028732)\n",
      "- Text: \"Gain function @ GeneSrc $ hot spot mutation mouse model Li-Fraumeni syndrome . Individuals Li-Fraumeni syndrome carry inherited mutations @ GeneSrc $ @ DiseaseTgt $ suppressor gene predisposed @ DiseaseTgt $ development . examine mechanistic nature @ GeneSrc $ missense mutations , generated mice harboring G-to-A substitution nucleotide 515 @ GeneSrc $ ( @ GeneSrc $ ) corresponding p53R175H hot spot mutation human @ DiseaseTgt $ . Although @ GeneSrc $ mice display similar @ DiseaseTgt $ spectrum survival curve @ GeneSrc $ mice , @ DiseaseTgt $ @ GeneSrc $ mice metastasized high frequency . Correspondingly , embryonic fibroblasts p53515A/515A mutant mice displayed enhanced cell proliferation , DNA synthesis , transformation potential . disruption p63 p73 @ GeneSrc $ cells increased transformation capacity reinitiated DNA synthesis levels observed p53515A/515A cells . Additionally , p63 p73 functionally inactivated p53515A cells . results provide vivo validation gain-of-function properties certain @ GeneSrc $ missense mutations suggest mechanistic basis phenotypes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7884803703111672)\n",
      "- Text: \"@ GeneSrc $ mutations increase resistance ionizing radiation . Mouse human @ DiseaseTgt $ diverse origin frequently somatically acquired mutations rearrangements @ GeneSrc $ gene , lost one copies gene . Although wild-type p53 protein believed function @ DiseaseTgt $ gene , yet unclear p53 mutations lead neoplastic development . Wild-type @ GeneSrc $ postulated play role DNA repair , suggesting expression mutant forms @ GeneSrc $ might alter cellular resistance DNA damage caused gamma radiation . Moreover , @ GeneSrc $ thought function cell cycle checkpoint irradiation , also suggesting mutant @ GeneSrc $ might change cellular proliferative response radiation . used transgenic mice expressing one two mutant alleles @ GeneSrc $ test prediction . results show expression mutant variants mouse @ GeneSrc $ gene significantly increases cellular resistance variety hematopoietic cell lineages gamma radiation . observations provide direct evidence @ GeneSrc $ mutations affect cellular response DNA damage , either increasing DNA repair processes , possibly , increasing cellular tolerance DNA damage . association @ GeneSrc $ mutations increased radioresistance suggests possible mechanisms alterations @ GeneSrc $ gene might lead oncogenic transformation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8177920653764795)\n",
      "- Text: \"Hepatic IGFBP1 prosurvival factor binds BAK , protects liver apoptosis , antagonizes proapoptotic actions @ GeneSrc $ mitochondria . Liver generally refractory apoptosis induced @ GeneSrc $ @ DiseaseTgt $ suppressor protein , molecular basis remains poorly understood . show @ GeneSrc $ transcriptional activation leads enhanced expression hepatic IGFBP1 ( insulin-like growth factor-binding protein-1 ) . Exhibiting previously unanticipated role , portion intracellular IGFBP1 protein localizes mitochondria binds proapoptotic protein BAK hinders BAK activation apoptosis induction . Interestingly , many cells tissues @ GeneSrc $ also direct apoptotic function mitochondria includes BAK binding activation . IGFBP1 complex BAK , formation proapoptotic @ GeneSrc $ complex apoptosis induction impaired , cultured cells liver . contrast , livers IGFBP1-deficient mice exhibit spontaneous apoptosis accompanied @ GeneSrc $ mitochondrial accumulation evidence BAK oligomerization . data support importance BAK mediator @ GeneSrc $ 's mitochondrial function . results also identify IGFBP1 negative regulator BAK-dependent pathway apoptosis , whose expression integrates transcriptional mitochondrial functions @ GeneSrc $ @ DiseaseTgt $ suppressor protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1351682045493236)\n",
      "- Text: \"Atg7 modulates @ GeneSrc $ activity regulate cell cycle survival metabolic stress . Withdrawal nutrients triggers exit cell division cycle , induction autophagy , eventually activation cell death pathways . relation , , among events well characterized . found starved mouse embryonic fibroblasts lacking essential autophagy gene product Atg7 failed undergo cell cycle arrest . Independent E1-like enzymatic activity , Atg7 could bind @ DiseaseTgt $ suppressor @ GeneSrc $ regulate transcription gene encoding cell cycle inhibitor p21 ( CDKN1A ) . prolonged metabolic stress , absence Atg7 resulted augmented DNA damage increased @ GeneSrc $ apoptosis . Inhibition DNA damage response deletion protein kinase Chk2 partially rescued postnatal lethality Atg7 ( -/- ) mice . Thus , nutrients limited , Atg7 regulates @ GeneSrc $ cell cycle cell death pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004268394084754)\n",
      "- Text: \"Meiotic recombination provokes functional activation p53 regulatory network . evolutionary appearance p53 protein probably preceded role @ DiseaseTgt $ suppression , suggesting may unappreciated functions protein . Using genetic reporters proxies follow vivo activation p53 network Drosophila , discovered process meiotic recombination instigates programmed activation p53 germ line . Specifically , double-stranded breaks DNA generated topoisomerase Spo11 provoked functional p53 activity , prolonged cells defective meiotic DNA repair . intrinsic stimulus p53 regulatory network highly conserved Spo11-dependent activation @ GeneSrc $ also occurs mice . findings establish physiological role p53 meiosis suggest @ DiseaseTgt $ functions may co-opted primordial activities linked recombination .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013308488448147)\n",
      "- Text: \"Induction medulloblastomas @ GeneSrc $ mutant mice somatic inactivation Rb external granular layer cells cerebellum . Medulloblastomas among common @ DiseaseTgt $ childhood , associated substantial mortality morbidity . molecular pathogenesis well ontogeny @ DiseaseTgt $ still poorly understood . generated mouse model medulloblastoma Cre-LoxP-mediated inactivation Rb @ GeneSrc $ @ DiseaseTgt $ suppressor genes cerebellar external granular layer ( EGL ) cells . GFAP-Cre-mediated recombination found astrocytes immature precursor cells EGL developing cerebellum . @ GeneSrc $ LoxP/LoxP ) mice developed highly aggressive embryonal tumors cerebellum typical features medulloblastoma . @ DiseaseTgt $ identified early 7 weeks age outer surface molecular layer , corresponding location EGL cells development . results demonstrate loss function RB essential medulloblastoma development mouse strongly support hypothesis medulloblastomas arise multipotent precursor cells located EGL .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2367755541149868)\n",
      "- Text: \"Synergistic response oncogenic mutations defines gene class critical @ DiseaseTgt $ phenotype . Understanding molecular underpinnings @ DiseaseTgt $ critical importance development targeted intervention strategies . Identification targets , however , notoriously difficult unpredictable . Malignant cell transformation requires cooperation oncogenic mutations cause substantial reorganization many cell features induce complex changes gene expression patterns . Genes critical multifaceted cellular phenotype therefore identified signalling pathway analysis ad hoc basis . observations cell transformation cooperating oncogenic lesions depends synergistic modulation downstream signalling circuitry suggest malignant transformation highly cooperative process , involving synergy multiple levels regulation , including gene expression . show large proportion genes controlled synergistically loss-of-function @ GeneSrc $ Ras activation critical malignant state murine human colon cells . Notably , 14 24 ' cooperation response genes ' found contribute @ DiseaseTgt $ gene perturbation experiments . contrast , 1 14 perturbations genes responding non-synergistic manner similar effect . Synergistic control gene expression oncogenic mutations thus emerges underlying key @ DiseaseTgt $ , provides attractive rationale identifying intervention targets gene networks downstream oncogenic gain- loss-of-function mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9840968754321)\n",
      "- Text: \"crucial role adipose tissue @ GeneSrc $ regulation insulin resistance . Various stimuli , telomere dysfunction oxidative stress , induce irreversible cell growth arrest , termed ' cellular senescence ' . response controlled @ DiseaseTgt $ suppressor proteins @ GeneSrc $ pRb . also evidence senescent cells promote changes related aging age-related diseases . show @ GeneSrc $ expression adipose tissue crucially involved development insulin resistance , underlies age-related cardiovascular metabolic disorders . found excessive calorie intake led accumulation oxidative stress adipose tissue mice type 2 diabetes-like disease promoted senescence-like changes , increased activity senescence-associated beta-galactosidase , increased expression @ GeneSrc $ increased production proinflammatory cytokines . Inhibition @ GeneSrc $ activity adipose tissue markedly ameliorated senescence-like changes , decreased expression proinflammatory cytokines improved insulin resistance mice type 2 diabetes-like disease . Conversely , upregulation @ GeneSrc $ adipose tissue caused inflammatory response led insulin resistance . Adipose tissue individuals diabetes also showed senescence-like features . results show previously unappreciated role adipose tissue @ GeneSrc $ expression regulation insulin resistance suggest cellular aging signals adipose tissue could new target treatment diabetes ( pages 996 - 967 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0874308932959844)\n",
      "- Text: \"Mutations p53 gene occur diverse human @ DiseaseTgt $ types . p53 gene constant source fascination since discovery nearly decade ago . Originally considered oncogene , several convergent lines research indicated wild-type gene product actually functions @ DiseaseTgt $ suppressor gene . example , expression @ DiseaseTgt $ phenotype inhibited , rather promoted , rat cells transfected murine wild-type @ GeneSrc $ gene together mutant p53 genes and/or oncogenes . Moreover , human @ DiseaseTgt $ , short arm chromosome 17 often deleted . colorectal cancers , smallest common region deletion centred 17p13.1 ; region harbours p53 gene , two @ DiseaseTgt $ examined detail , remaining ( non-deleted ) p53 alleles found contain mutations . result provocative allelic deletion coupled mutation remaining allele theoretical hallmark @ DiseaseTgt $ genes . present report , attempted determine generality observation ; , whether @ DiseaseTgt $ allelic deletions chromosome 17p contain mutant p53 genes allele retained . results suggest ( 1 ) @ DiseaseTgt $ allelic deletions contain p53 point mutations resulting amino-acid substitutions , ( 2 ) mutations confined @ DiseaseTgt $ allelic deletion , also occur least @ DiseaseTgt $ retained parental 17p alleles , ( 3 ) p53 gene mutations clustered four ' hot-spots ' exactly coincide four highly conserved regions gene . results suggest p53 mutations play role development many common human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8268828223941962)\n",
      "- Text: \"teratologic suppressor role @ GeneSrc $ benzo [ ] pyrene-treated transgenic @ GeneSrc $ mice . DNA damage may mediate birth defects caused many drugs environmental chemicals , therefore @ GeneSrc $ , @ DiseaseTgt $ suppressor gene facilitates DNA repair , may critically embryoprotective . studied effects environmental teratogen , benzo [ ] pyrene , pregnant heterozygous @ GeneSrc $ mice . mice exhibited 2- 4-fold higher embryotoxicity teratogenicity normal @ GeneSrc $ . Fetal resorptions reflecting utero death genotyped using polymerase chain reaction found increased 2.6-fold 3.6-fold respectively heterozygous homozygous @ GeneSrc $ embryos . results provide first direct evidence @ GeneSrc $ may important teratological suppressor gene protects embryo DNA-damaging chemicals developmental oxidative stress .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0039504547353437)\n",
      "- Text: \"Mutant @ GeneSrc $ gain function two mouse models Li-Fraumeni syndrome . p53 @ DiseaseTgt $ suppressor gene commonly altered human @ DiseaseTgt $ , predominantly missense mutations result accumulation mutant p53 protein . mutations may confer dominant-negative gain-of-function properties p53 . ascertain physiological effects p53 point mutation , structural mutant p53R172H contact mutant p53R270H ( codons 175 273 humans ) engineered endogenous @ GeneSrc $ locus mice . p53R270H/+ p53R172H/+ mice models Li-Fraumeni Syndrome ; developed allele-specific @ DiseaseTgt $ spectra distinct @ GeneSrc $ mice . addition , p53R270H/- p53R172H/- mice developed novel @ DiseaseTgt $ compared @ GeneSrc $ mice , including variety @ DiseaseTgt $ frequent @ DiseaseTgt $ . Dominant effects varied allele function observed primary cells derived p53R270H/+ p53R172H/+ mice . results demonstrate point mutant p53 alleles expressed physiological control enhanced oncogenic potential beyond simple loss p53 function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.10103484082011)\n",
      "- Text: \"Prevention Brca1-mediated mammary tumorigenesis mice progesterone antagonist . Women mutations breast cancer susceptibility gene BRCA1 predisposed breast ovarian cancers . BRCA1 protein suppresses @ DiseaseTgt $ development specifically ovarian hormone-sensitive tissues remains unclear . demonstrate mammary glands nulliparous @ GeneSrc $ mice accumulate lateral branches undergo extensive alveologenesis , phenotype occurs pregnancy wild-type mice . Progesterone receptors , estrogen receptors , overexpressed mutant mammary epithelial cells defect degradation proteasome pathway . Treatment @ GeneSrc $ mice progesterone antagonist mifepristone ( RU 486 ) prevented mammary tumorigenesis . findings reveal tissue-specific function BRCA1 protein raise possibility antiprogesterone treatment may useful breast cancer prevention individuals BRCA1 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.119118958022911e-07)\n",
      "- Text: \"Transcriptional activation miR-34a contributes p53-mediated apoptosis . p53 potent @ DiseaseTgt $ suppressor , whose biological effects largely due function transcriptional regulator . report , addition regulating expression hundreds protein-coding genes , p53 also modulates levels microRNAs ( miRNAs ) . Specifically , p53 induce expression microRNA-34a ( miR-34a ) cultured cells well irradiated mice , binding perfect @ GeneSrc $ binding site located within gene gives rise miR-34a . Processing primary transcript mature miR-34a involves excision 30 kb intron . Notably , inactivation miR-34a strongly attenuates p53-mediated apoptosis cells exposed genotoxic stress , whereas overexpression miR-34a mildly increases apoptosis . Hence , miR-34a direct proapoptotic transcriptional target p53 mediate p53 's biological effects . Perturbation miR-34a expression , occurs human @ DiseaseTgt $ , may thus contribute tumorigenesis attenuating p53-dependent apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001592288851626)\n",
      "- Text: \"subset @ GeneSrc $ embryos exhibit exencephaly . Defects neural tube formation among common malformations leading infant mortality . Although numerous genetic loci appear contribute defects observed humans animal model systems , genes involved characterized molecular level . Mice lacking @ GeneSrc $ @ DiseaseTgt $ suppressor gene predisposed @ DiseaseTgt $ , viability animals indicates @ GeneSrc $ function essential embryonic development . , demonstrate fraction @ GeneSrc $ embryos fact develop normally . animals display defects neural tube closure resulting overgrowth neural tissue region mid-brain , condition known exencephaly .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.45546225654524)\n",
      "- Text: \"@ GeneSrc $ status determines role autophagy pancreatic tumour development . Macroautophagy ( hereafter referred autophagy ) process organelles termed autophagosomes deliver cytoplasmic constituents lysosomes degradation . Autophagy major role cellular homeostasis implicated various forms human disease . role autophagy @ DiseaseTgt $ seems complex , reports indicating pro-tumorigenic @ DiseaseTgt $ roles . show , humanized genetically-modified mouse model pancreatic ductal adenocarcinoma ( PDAC ) , autophagy 's role @ DiseaseTgt $ development intrinsically connected status @ DiseaseTgt $ suppressor @ GeneSrc $ . Mice pancreases containing activated oncogenic allele Kras ( also called Ki-Ras ) -- common mutational event PDAC -- develop small number pre-cancerous lesions stochastically develop PDAC time . However , mice also lacking essential autophagy genes Atg5 Atg7 accumulate low-grade , pre-malignant pancreatic intraepithelial neoplasia lesions , progression high-grade pancreatic intraepithelial neoplasias PDAC blocked . marked contrast , mice containing oncogenic Kras lacking @ GeneSrc $ , loss autophagy longer blocks @ DiseaseTgt $ progression , actually accelerates @ DiseaseTgt $ onset , metabolic analysis revealing enhanced glucose uptake enrichment anabolic pathways , fuel @ DiseaseTgt $ growth . findings provide considerable insight role autophagy @ DiseaseTgt $ important implications autophagy inhibition @ DiseaseTgt $ therapy . regard , also show treatment mice autophagy inhibitor hydroxychloroquine , currently used several clinical trials , significantly accelerates @ DiseaseTgt $ formation mice containing oncogenic Kras lacking @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999974500521794)\n",
      "- Text: \"senescence program controlled @ GeneSrc $ p16INK4a contributes outcome @ DiseaseTgt $ therapy . @ GeneSrc $ INK4a/ARF mutations promote tumorigenesis drug resistance , part , disabling apoptosis . show primary murine lymphomas also respond chemotherapy engaging senescence program controlled @ GeneSrc $ p16 ( INK4a ) . Hence , @ DiseaseTgt $ @ GeneSrc $ INK4a/ARF mutations-but lacking ARF alone-respond poorly cyclophosphamide therapy vivo . Moreover , @ DiseaseTgt $ harboring Bcl2-mediated apoptotic block undergo drug-induced cytostasis involving accumulation @ GeneSrc $ , p16 ( INK4a ) , senescence markers , typically acquire @ GeneSrc $ INK4a mutations upon progression terminal stage . Finally , mice bearing @ DiseaseTgt $ capable drug-induced senescence much better prognosis following chemotherapy harboring @ DiseaseTgt $ senescence defects . Therefore , cellular senescence contributes treatment outcome vivo .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9911063947497424)\n",
      "- Text: \"Dissecting @ GeneSrc $ @ DiseaseTgt $ suppressor functions vivo . Although @ GeneSrc $ @ DiseaseTgt $ suppressor acts plethora processes influence cellular proliferation survival , remains unclear @ GeneSrc $ functions essential @ DiseaseTgt $ suppression , consequence , selected @ DiseaseTgt $ development . Using mouse model harboring primary , genetically modified myc-driven lymphomas , show disruption apoptosis downstream @ GeneSrc $ Bcl2 dominant-negative caspase 9 confers-like @ GeneSrc $ loss-a selective advantage , completely alleviates pressure inactivate @ GeneSrc $ lymphomagenesis . Despite @ GeneSrc $ aggressive phenotype , apoptosis-defective lymphomas retain intact @ GeneSrc $ genes display checkpoint defects gross aneuploidy characteristic @ GeneSrc $ mutant @ DiseaseTgt $ . Therefore , apoptosis @ GeneSrc $ function selected lymphoma development , whereas defective cell-cycle checkpoints aneuploidy mere byproducts @ GeneSrc $ loss .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.928909846511102)\n",
      "- Text: \"BID regulation p53 contributes chemosensitivity . role p53 protein ( encoded TP53 ) @ DiseaseTgt $ suppression relies partly ability p53 regulate transcription genes important cell-cycle arrest apoptosis . apoptotic pathway mediated p53 fully understood . show BID , member pro-apoptotic Bcl-2 family proteins , regulated p53 . BID mRNA increased @ GeneSrc $ manner vitro vivo , strong expression splenic red pulp colonic epithelium gamma-irradiated mice . human mouse BID genomic loci contain @ GeneSrc $ DNA response elements bind p53 mediate p53-dependent transactivation reporter gene . addition , BID-null mouse embryonic fibroblasts resistant wild-type fibroblasts DNA damaging agent adriamycin nucleotide analogue 5-fluorouracil , stabilize endogenous @ GeneSrc $ . results indicate BID p53-responsive ' chemosensitivity gene ' may enhance cell death response chemotherapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029927402957442)\n",
      "- Text: \"Mutant mice lacking @ GeneSrc $ C-terminal domain model telomere syndromes . Mutations p53 , although frequent human @ DiseaseTgt $ , implicated telomere-related syndromes . , show homozygous mutant mice expressing p53Delta31 , @ GeneSrc $ lacking C-terminal domain , exhibit increased @ GeneSrc $ activity suffer aplastic anemia pulmonary fibrosis , hallmarks syndromes caused short telomeres . Indeed , p53Delta31/Delta31 mice short telomeres phenotypic traits associated telomere disease dyskeratosis congenita severe variant Hoyeraal-Hreidarsson syndrome . Heterozygous @ GeneSrc $ mice mildly affected , decreased levels Mdm4 , negative regulator @ GeneSrc $ , led dramatic aggravation symptoms . Importantly , several genes involved telomere metabolism downregulated p53Delta31/Delta31 cells , including Dyskerin , Rtel1 , Tinf2 , mutated dyskeratosis congenita , Terf1 , implicated aplastic anemia . Together , data reveal truncating mutation activate @ GeneSrc $ @ GeneSrc $ plays major role regulation telomere metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.002336410910525)\n",
      "- Text: \"inherent instability mutant @ GeneSrc $ alleviated Mdm2 p16INK4a loss . p53 tumor suppressor often disrupted human @ DiseaseTgt $ acquisition missense mutations . generated mice missense mutation codon 172 mimics p53R175H hot spot mutation human @ DiseaseTgt $ . @ GeneSrc $ homozygous mutant mice unstable mutant @ GeneSrc $ normal cells stabilize mutant @ GeneSrc $ @ DiseaseTgt $ . investigate significance data , examined regulation mutant @ GeneSrc $ stability Mdm2 , E3 ubiquitin ligase targets @ GeneSrc $ degradation , p16INK4a , member Rb tumor suppressor pathway . Mice lacking Mdm2 p16INK4a stabilized mutant @ GeneSrc $ , revealed earlier age @ DiseaseTgt $ onset @ GeneSrc $ mutant mice gain-of-function metastatic phenotype . Analysis @ DiseaseTgt $ @ GeneSrc $ homozygous mutant mice stable @ GeneSrc $ revealed defects Rb pathway . Additionally , ionizing radiation stabilizes wild-type mutant @ GeneSrc $ . Thus , stabilization mutant @ GeneSrc $ given prerequisite gain-of-function phenotype . Since mutant @ GeneSrc $ stability mimics wild-type @ GeneSrc $ , data indicate drugs aimed activating wild-type @ GeneSrc $ also stabilize mutant @ GeneSrc $ dire consequences .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.989827648371174)\n",
      "- Text: \"Functional inactivation structural mutation p53 causes liver cancer . Structural mutations p53 gene seen virtually every form human @ DiseaseTgt $ . determine whether mutations important initiating tumorigenesis , studying hepatocellular carcinoma , cases associated chronic hepatitis B virus infections . Using transgenic mouse model expression single HBV gene product , HBx protein , induces progressive changes liver , show @ DiseaseTgt $ development correlates precisely @ GeneSrc $ binding HBx cytoplasm complete blockage @ GeneSrc $ entry nucleus . Analysis @ DiseaseTgt $ cell DNA shows evidence p53 mutation , except advanced @ DiseaseTgt $ small proportion cells may acquired specific base substitutions . results suggest genetic changes p53 late events may contribute @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9015848977704948)\n",
      "- Text: \"@ GeneSrc $ mutant mice display early ageing-associated phenotypes . @ GeneSrc $ @ DiseaseTgt $ suppressor activated numerous stressors induce apoptosis , cell cycle arrest , senescence . study biological effects altered @ GeneSrc $ function , generated mice deletion mutation first six exons @ GeneSrc $ gene express truncated RNA capable encoding carboxy-terminal @ GeneSrc $ fragment . mutation confers phenotypes consistent activated @ GeneSrc $ rather inactivated @ GeneSrc $ . Mutant ( @ GeneSrc $ ) mice exhibit enhanced resistance spontaneous @ DiseaseTgt $ compared wild-type ( @ GeneSrc $ ) littermates . @ GeneSrc $ mice age , display early onset phenotypes associated ageing . include reduced longevity , osteoporosis , generalized organ atrophy diminished stress tolerance . second line transgenic mice containing temperature-sensitive mutant allele @ GeneSrc $ also exhibits early ageing phenotypes . data suggest @ GeneSrc $ role regulating organismal ageing .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6338135917267828)\n",
      "- Text: \"Senescence @ DiseaseTgt $ clearance triggered @ GeneSrc $ restoration murine liver carcinomas . Although @ DiseaseTgt $ arises combination mutations oncogenes @ DiseaseTgt $ suppressor genes , extent @ DiseaseTgt $ suppressor gene loss required maintaining established @ DiseaseTgt $ poorly understood . @ GeneSrc $ important @ DiseaseTgt $ suppressor acts restrict proliferation response DNA damage deregulation mitogenic oncogenes , leading induction various cell cycle checkpoints , apoptosis cellular senescence . Consequently , @ GeneSrc $ mutations increase cell proliferation survival , settings promote genomic instability resistance certain chemotherapies . determine consequences reactivating @ GeneSrc $ pathway @ DiseaseTgt $ , used RNA interference ( RNAi ) conditionally regulate endogenous @ GeneSrc $ expression mosaic mouse model liver carcinoma . show even brief reactivation endogenous @ GeneSrc $ @ GeneSrc $ @ DiseaseTgt $ produce complete @ DiseaseTgt $ regressions . primary response @ GeneSrc $ apoptosis , instead involved induction cellular senescence program associated differentiation upregulation inflammatory cytokines . program , although producing cell cycle arrest vitro , also triggered innate immune response targeted @ DiseaseTgt $ cells vivo , thereby contributing @ DiseaseTgt $ clearance . study indicates @ GeneSrc $ loss required maintenance aggressive @ DiseaseTgt $ , illustrates cellular senescence program act together innate immune system potently limit @ DiseaseTgt $ growth .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7946908749874982)\n",
      "- Text: \"UBE4B promotes Hdm2-mediated degradation @ DiseaseTgt $ suppressor p53 . TP53 gene ( encoding p53 @ DiseaseTgt $ suppressor ) rarely mutated , although frequently inactivated , medulloblastoma ependymoma . Recent work mouse models showed loss @ GeneSrc $ accelerated development medulloblastoma . mechanism underlying p53 inactivation human brain tumors completely understood . show ubiquitination factor E4B ( UBE4B ) , E3 E4 ubiquitin ligase , physically interacts p53 Hdm2 ( also known Mdm2 mice ) . UBE4B promotes p53 polyubiquitination degradation inhibits p53-dependent transactivation apoptosis . Notably , silencing UBE4B expression impairs xenotransplanted @ DiseaseTgt $ growth p53-dependent manner overexpression UBE4B correlates decreased expression p53 @ DiseaseTgt $ . also show UBE4B overexpression often associated amplification gene human brain tumors . data indicate amplification overexpression UBE4B represent previously undescribed molecular mechanisms inactivation p53 brain tumors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8469345895806877)\n",
      "- Text: \"Loss @ GeneSrc $ triggers WNT-dependent systemic inflammation drive breast cancer metastasis . @ DiseaseTgt $ systemic inflammation strongly linked poor disease outcome patients cancer1,2 . human epithelial tumour types , high systemic neutrophil-to-lymphocyte ratios associated poor overall survival3 , experimental studies demonstrated causal relationship neutrophils metastasis4,5 . However , @ DiseaseTgt $ mechanisms dictate substantial heterogeneity systemic neutrophilic inflammation @ DiseaseTgt $ hosts largely unresolved . , using panel 16 distinct genetically engineered mouse models breast cancer , uncover role @ DiseaseTgt $ @ GeneSrc $ key regulator pro-metastatic neutrophils . Mechanistically , loss @ GeneSrc $ @ DiseaseTgt $ cells induced secretion WNT ligands stimulate @ DiseaseTgt $ macrophages produce IL-1beta , thus driving systemic inflammation . Pharmacological genetic blockade WNT secretion @ GeneSrc $ @ DiseaseTgt $ cells reverses macrophage production IL-1beta subsequent neutrophilic inflammation , resulting reduced metastasis formation . Collectively , demonstrate mechanistic link loss @ GeneSrc $ @ DiseaseTgt $ cells , secretion WNT ligands systemic neutrophilia potentiates metastatic progression . insights illustrate importance genetic makeup breast tumours dictating pro-metastatic systemic inflammation , set stage personalized immune intervention strategies patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8399393107978783)\n",
      "- Text: \"Sunburn @ GeneSrc $ onset skin cancer . Squamous cell carcinoma skin ( SCC ) progress stages : sun-damaged epidermis , individual disordered keratinocytes ; actinic keratosis ( AK ) , spontaneously regressing keratinized patches aberrant cell differentiation proliferation ; carcinoma situ ; SCC metastasis . understand sunlight acts carcinogen , determined stage sunlight mutates p53 @ DiseaseTgt $ gene identified function @ GeneSrc $ skin . p53 mutations induced ultraviolet radiation found > 90 % human SCCs present AKs . Inactivating @ GeneSrc $ mouse skin reduced appearance sunburn cells , apoptotic keratinocytes generated overexposure ultraviolet . Skin thus appears possess @ GeneSrc $ ' guardian-of-the-tissue ' response DNA damage aborts precancerous cells . response reduced single cell prior @ GeneSrc $ mutation , sunburn select clonal expansion p53-mutated cell AK . Sunlight act twice : @ DiseaseTgt $ initiator @ DiseaseTgt $ promoter .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0368538355711162)\n",
      "- Text: \"Unrepaired DNA breaks @ GeneSrc $ cells lead oncogenic gene amplification subsequent translocations . Amplification large genomic regions associated complex translocations ( complicons ) basis @ DiseaseTgt $ progression drug resistance . show pro-B lymphomas mice deficient @ GeneSrc $ nonhomologous end-joining ( NHEJ ) contain complicons coamplify c-myc ( chromosome 15 ) IgH ( chromosome 12 ) sequences . carry translocated ( 12 ; 15 ) chromosome , coamplified sequences located within separate complicon often involves third chromosome . Complicon formation initiated recombination RAG1/2-catalyzed IgH locus double-strand breaks sequences downstream c-myc , generating dicentric ( 15 ; 12 ) chromosome amplification intermediate . recombination event employs microhomology-based end-joining repair pathway , opposed classic NHEJ homologous recombination . findings suggest general model oncogenic complicon formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.167219224674603)\n",
      "- Text: \"@ GeneSrc $ Pten control neural glioma stem/progenitor cell renewal differentiation . Glioblastoma ( GBM ) highly lethal brain tumour presenting one two subtypes distinct clinical histories molecular profiles . primary GBM subtype presents acutely high-grade disease typically harbours mutations EGFR , PTEN INK4A/ARF ( also known CDKN2A ) , secondary GBM subtype evolves slow progression low-grade disease classically possesses PDGF TP53 events . show concomitant central nervous system ( CNS ) -specific deletion @ GeneSrc $ Pten mouse CNS generates penetrant acute-onset high-grade malignant glioma phenotype notable clinical , pathological molecular resemblance primary GBM humans . genetic observation prompted TP53 PTEN mutational analysis human primary GBM , demonstrating unexpectedly frequent inactivating mutations TP53 well expected PTEN mutations . Integrated transcriptomic profiling , silico promoter analysis functional studies murine neural stem cells ( NSCs ) established dual , singular , inactivation @ GeneSrc $ Pten promotes undifferentiated state high renewal potential drives increased Myc protein levels associated signature . Functional studies validated increased Myc activity potent contributor impaired differentiation enhanced renewal NSCs doubly null @ GeneSrc $ Pten ( @ GeneSrc $ ) Pten ( -/- ) ) well @ DiseaseTgt $ neurospheres ( TNSs ) derived model . Myc also serves maintain robust tumorigenic potential @ GeneSrc $ ) Pten ( -/- ) TNSs . murine modelling studies , together confirmatory transcriptomic/promoter studies human primary GBM , validate pathogenetic role common @ DiseaseTgt $ suppressor mutation profile human primary GBM establish Myc important target cooperative actions p53 Pten regulation normal malignant stem/progenitor cell differentiation , self-renewal tumorigenic potential .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0289362688783642)\n",
      "- Text: \"Transcriptional repression p53 parkin impairment mutations associated autosomal recessive @ DiseaseTgt $ . Mutations ubiquitin ligase parkin account autosomal recessive forms @ DiseaseTgt $ ( AR-JP ) . Several studies suggested parkin possesses DNA-binding transcriptional activity . report parkin p53 transcriptional repressor . First , parkin prevented 6-hydroxydopamine-induced caspase-3 activation p53-dependent manner . Concomitantly , parkin reduced p53 expression activity , effect abrogated familial parkin mutations known either abolish preserve ligase activity . ChIP experiments indicate overexpressed endogenous parkin interact physically p53 promoter pathogenic mutations abolish DNA binding promoter transactivation p53 . Parkin lowered @ GeneSrc $ mRNA levels repressed @ GeneSrc $ promoter transactivation Ring1 domain . Conversely , parkin depletion enhanced @ GeneSrc $ expression mRNA levels fibroblasts mouse brains , increased cellular p53 activity promoter transactivation cells . Finally , familial parkin missense deletion mutations enhanced p53 expression human brains affected AR-JP . study reveals ubiquitin ligase-independent function parkin control transcription functional link parkin p53 altered AR-JP mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4818105339793924)\n",
      "- Text: \"Alpha-synuclein lowers @ GeneSrc $ apoptotic response neuronal cells . Abolishment 6-hydroxydopamine implication @ DiseaseTgt $ . examined influence alpha-synuclein responsiveness TSM1 neuronal cells apoptotic stimulus . show alpha-synuclein drastically lowers basal staurosporine-stimulated caspase 3 immunoreactivity activity . accompanied lower DNA fragmentation reduced number terminal deoxynucleotide transferase-mediated dUTP nick end labeling ( TUNEL ) -positive neurons . Interestingly , alpha-synuclein also diminishes @ GeneSrc $ expression transcriptional activity . demonstrate antiapoptotic phenotype displayed alpha-synuclein fully reversed @ DiseaseTgt $ dopamine derivative 6-hydroxydopamine . Thus , 6-hydroxydopamine fully abolishes alpha-synuclein-mediated reduction caspase 3 activity reverses associated decrease @ GeneSrc $ expression . 6-Hydroxydopamine triggers thioflavin T-positive deposits alpha-synuclein , mock-transfected TSM1 neurons , drastically increases alpha-synuclein immunoreactivity . Altogether , suggest alpha-synuclein lowers @ GeneSrc $ caspase 3 activation TSM1 response apoptotic stimuli propose natural toxin 6-hydroxydopamine abolishes antiapoptotic phenotype triggering alpha-synuclein aggregation , thereby likely contributing @ DiseaseTgt $ neuropathology .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0513984048351732)\n",
      "- Text: \"Deleted @ DiseaseTgt $ suppresses metastasis @ GeneSrc $ mammary tumours . Since discovery early 1990s deleted colorectal cancer ( DCC ) gene , located chromosome 18q21 , proposed tumour suppressor gene loss implicated majority advanced @ DiseaseTgt $ . DCC belongs family netrin 1 receptors , function dependence receptors control survival apoptosis depending ligand binding . However , role DCC tumour suppressor remains controversial rarity DCC-specific mutations presence tumour suppressor genes chromosomal region . show mouse model mammary carcinoma based somatic inactivation @ GeneSrc $ , additional loss DCC promotes metastasis formation without affecting primary tumour phenotype . Furthermore , demonstrate cell cultures derived @ GeneSrc $ mouse mammary tumours DCC expression controls netrin-1-dependent cell survival , providing mechanistic basis enhanced metastatic capacity tumour cells lacking DCC . Consistent idea , vivo tumour-cell survival enhanced DCC loss . Together , data support function DCC context-dependent tumour suppressor limits survival disseminated tumour cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3289017953405522)\n",
      "- Text: \"Gain function p53 hot spot mutation mouse model Li-Fraumeni syndrome . Individuals Li-Fraumeni syndrome carry inherited mutations p53 @ DiseaseTgt $ suppressor gene predisposed @ DiseaseTgt $ development . examine mechanistic nature p53 missense mutations , generated mice harboring G-to-A substitution nucleotide 515 p53 ( p53+/515A ) corresponding p53R175H hot spot mutation human @ DiseaseTgt $ . Although p53+/515A mice display similar @ DiseaseTgt $ spectrum survival curve p53+/- mice , @ DiseaseTgt $ p53+/515A mice metastasized high frequency . Correspondingly , embryonic fibroblasts p53515A/515A mutant mice displayed enhanced cell proliferation , DNA synthesis , transformation potential . disruption @ GeneSrc $ p73 p53-/- cells increased transformation capacity reinitiated DNA synthesis levels observed p53515A/515A cells . Additionally , @ GeneSrc $ p73 functionally inactivated p53515A cells . results provide vivo validation gain-of-function properties certain p53 missense mutations suggest mechanistic basis phenotypes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4379040814587257)\n",
      "- Text: \"Gain function p53 hot spot mutation mouse model Li-Fraumeni syndrome . Individuals Li-Fraumeni syndrome carry inherited mutations p53 @ DiseaseTgt $ suppressor gene predisposed @ DiseaseTgt $ development . examine mechanistic nature p53 missense mutations , generated mice harboring G-to-A substitution nucleotide 515 p53 ( p53+/515A ) corresponding p53R175H hot spot mutation human @ DiseaseTgt $ . Although p53+/515A mice display similar @ DiseaseTgt $ spectrum survival curve p53+/- mice , @ DiseaseTgt $ p53+/515A mice metastasized high frequency . Correspondingly , embryonic fibroblasts p53515A/515A mutant mice displayed enhanced cell proliferation , DNA synthesis , transformation potential . disruption p63 @ GeneSrc $ p53-/- cells increased transformation capacity reinitiated DNA synthesis levels observed p53515A/515A cells . Additionally , p63 @ GeneSrc $ functionally inactivated p53515A cells . results provide vivo validation gain-of-function properties certain p53 missense mutations suggest mechanistic basis phenotypes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2680847597110313)\n",
      "- Text: \"Reciprocal repression P53 @ GeneSrc $ . Screening genes reprogram @ DiseaseTgt $ cells @ DiseaseTgt $ reversion switch identified @ GeneSrc $ ( encoding @ GeneSrc $ ) crucial regulator apoptosis . report negative feedback loop P53 @ GeneSrc $ . @ GeneSrc $ promotes P53 degradation competing NUMB binding P53-MDM2-containing complexes . @ GeneSrc $ inhibits MDM2 auto-ubiquitination promotes MDM2-mediated ubiquitination degradation P53 . Notably , @ GeneSrc $ haploinsufficient mice sensitized P53-dependent apoptosis . addition , P53 directly represses @ GeneSrc $ transcription . 508 breast cancers , @ GeneSrc $ status associates poorly differentiated , aggressive G3-grade @ DiseaseTgt $ , predicting poor prognosis ( P < 0.0005 ) . @ GeneSrc $ knockdown primary mammary tumor cells ErbB2 transgenic mice results increased P53 expression decreased number stem-like @ DiseaseTgt $ cells . pharmacological compounds sertraline thioridazine increase amount P53 neutralizing @ GeneSrc $ 's action MDM2-P53 axis . study links @ GeneSrc $ P53 previously unidentified regulatory circuitry may underlie relevance @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2649045617419895)\n",
      "- Text: \"Positional identification TNFSF4 , encoding @ GeneSrc $ , gene influences atherosclerosis susceptibility . @ GeneSrc $ quantitative trait locus mouse chromosome 1 renders C57BL/6 mice susceptible C3H/He mice resistant diet-induced atherosclerosis . quantitative trait locus region encompasses 11 known genes , including @ GeneSrc $ ( also called @ GeneSrc $ @ GeneSrc $ ) , encodes @ GeneSrc $ . report mice targeted mutations @ GeneSrc $ significantly ( P < or= 0.05 ) smaller atherosclerotic lesions control mice . addition , mice overexpressing @ GeneSrc $ significantly ( P < or= 0.05 ) larger atherosclerotic lesions control mice . two independent human populations , less common allele SNP rs3850641 TNFSF4 significantly frequent ( P < or= 0.05 ) individuals @ DiseaseTgt $ controls . therefore conclude @ GeneSrc $ underlies @ GeneSrc $ mice polymorphisms human homolog TNFSF4 increase risk @ DiseaseTgt $ humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0344516902782845)\n",
      "- Text: \"Evaluation molecular mechanisms involved gain function Li-Fraumeni TP53 mutation . TP53 @ DiseaseTgt $ suppressor gene frequent target genetic alterations human @ DiseaseTgt $ . TP53 gene alterations may result gain oncogenic functions neoangiogenesis resistance therapy . TP53 germ line mutation c.659A > C ( p. Y220S ) identified stored DNA related patients Li-Fraumeni syndrome ( LFS ) died developing clinically aggressive @ DiseaseTgt $ . patients treated protocols included doxorubicin hydrochloride ( DX ) pivotal drug . define vitro mutational phenotype germ line mutation , used murine fibroblasts explanted wild-type ( wt ) p53 knockout ( KO ) mice littermate . p53Y220S p53R175H fibroblasts , obtained p53KO fibroblasts transfected expression vectors encoding human Y220S R175H p53 mutants , respectively , exhibited resistance DX treatment . Moreover , p53Y220S fibroblasts exhibited angiogenetic properties , DX treatment , p53Y220S failed translocate nucleus showed increase cytosolic levels . DX treatment influence p53 distribution within nuclear cytosolic compartments p53R175H fibroblasts . Peroxiredoxin II ( Prx II ) , protein involved eliminating reactive oxygen species ( ROS ) , showed increased expression intensity p53Y220S fibroblasts DX treatment , observed two-dimensional electrophoresis analysis . Moreover , @ GeneSrc $ ( @ GeneSrc $ ) , protein cooperates Prx II , overexpressed p53Y220S mutants basal conditions . data suggest relationship presence p53Y220S mutation enhanced levels Prx II @ GeneSrc $ mutant fibroblasts . Since one mechanisms DX antitumor effect ascribed production ROS , future studies evaluate involvement PrxII @ GeneSrc $ chemoresistance p53Y220S fibroblasts DX .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018395736516738)\n",
      "- Text: \"Expression functional analysis Uch-L3 mouse development . Mice homozygous ( 1Acrg ) deletion Ednrb locus arrest embryonic day 8.5 . determine molecular basis defect , initiated positional cloning ( 1Acrg ) minimal region . mouse Uch-L3 ( ubiquitin C-terminal hydrolase L3 ) gene mapped within ( 1Acrg ) minimal region . Uch-L3 transcripts present embryonic structures relevant ( 1Acrg ) phenotype , created targeted mutation Uch-L3 address role development possible contribution ( 1Acrg ) phenotype . Mice homozygous mutation Uch-L3 ( Delta3 - 7 ) viable , obvious developmental histological abnormalities . Although high levels Uch-L3 RNA detected testes thymus , Uch-L3 ( Delta3 - 7 ) homozygotes fertile , defect intrathymic T-cell differentiation detected . conclude @ DiseaseTgt $ phenotype either complex multigenic due loss another gene within region . propose Uch-L3 may functionally redundant homologue @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005032531278145)\n",
      "- Text: \"S18Y polymorphic variant UCH-L1 confers antioxidant function neuronal cells . number studies associated S18Y polymorphic variant UCH-L1 protection sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . mechanism involved protective function unknown , generally assumed linked ubiquitin-proteasome system ( UPS ) . current study , investigated effects overexpression UCH-L1 variants , including S18Y , neuronal cells . find S18Y , WT , UCH-L1 confers specific antioxidant protective function expressed physiological levels human neuroblastoma cells primary cortical neurons . contrast , neither WT S18Y UCH-L1 appear directly impact proteasome , although lead stabilization free ubiquitin . Lack WT mouse @ GeneSrc $ neurons derived gad mice led decrease free ubiquitin , overall decrease UPS function enhanced sensitivity oxidative stress . conclude S18Y variant UCH-L1 confers novel antioxidant function present WT form function may underlie protective effects variant certain @ DiseaseTgt $ populations . results furthermore provide indirect evidence importance oxidative stress pathogenetic factor certain forms sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0047447187380668)\n",
      "- Text: \"27-Hydroxycholesterol links hypercholesterolemia breast cancer pathophysiology . Hypercholesterolemia risk factor estrogen receptor ( ER ) -positive breast cancers associated decreased response @ DiseaseTgt $ endocrine therapies . , show 27-hydroxycholesterol ( 27HC ) , primary metabolite cholesterol ER @ GeneSrc $ ( @ GeneSrc $ ) ligand , increases ER-dependent growth @ GeneSrc $ metastasis mouse models breast cancer . effects cholesterol @ DiseaseTgt $ pathology required conversion 27HC cytochrome P450 oxidase CYP27A1 attenuated treatment CYP27A1 inhibitors . human breast cancer specimens , CYP27A1 expression levels correlated @ DiseaseTgt $ grade . high-grade @ DiseaseTgt $ , @ DiseaseTgt $ cells @ DiseaseTgt $ macrophages exhibited high expression levels enzyme . Thus , lowering circulating cholesterol levels interfering conversion 27HC may useful strategy prevent and/or treat breast cancer .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6257470937425192)\n",
      "- Text: \"Functional aspects meningeal lymphatics ageing @ DiseaseTgt $ . Ageing major risk factor many neurological pathologies , mechanisms remain unclear . Unlike tissues , parenchyma central nervous system ( CNS ) lacks lymphatic vasculature waste products removed partly paravascular route . ( ) discovery characterization meningeal lymphatic vessels prompted assessment role waste clearance CNS . show meningeal lymphatic vessels drain macromolecules CNS ( cerebrospinal interstitial fluids ) cervical lymph nodes mice . Impairment meningeal lymphatic function slows paravascular influx macromolecules brain efflux macromolecules interstitial fluid , induces cognitive impairment mice . Treatment aged mice @ GeneSrc $ enhances meningeal lymphatic drainage macromolecules cerebrospinal fluid , improving brain perfusion learning memory performance . Disruption meningeal lymphatic vessels transgenic mouse models @ DiseaseTgt $ promotes amyloid-beta deposition meninges , resembles human meningeal pathology , aggravates parenchymal amyloid-beta accumulation . Meningeal lymphatic dysfunction may aggravating factor @ DiseaseTgt $ pathology age-associated cognitive decline . Thus , augmentation meningeal lymphatic function might promising therapeutic target preventing delaying age-associated neurological diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.032969833210364e-06)\n",
      "- Text: \"GATA transcription factors directly regulate @ DiseaseTgt $ gene alpha-synuclein . Increased alpha-synuclein gene ( SNCA ) dosage due locus multiplication causes autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Variation SNCA expression may critical common , genetically complex @ DiseaseTgt $ underlying regulatory mechanism unknown . show SNCA heme metabolism genes ALAS2 , @ GeneSrc $ , BLVRB form block tightly correlated gene expression 113 samples human blood , SNCA naturally abounds ( validated P = 1.6 x 10 ( -11 ) , 1.8 x 10 ( -10 ) , 6.6 x 10 ( -5 ) ) . Genetic complementation analysis revealed four genes co-induced transcription factor GATA-1 . GATA-1 specifically occupies conserved region within SNCA intron-1 directly induces 6.9-fold increase alpha-synuclein . Endogenous GATA-2 highly expressed substantia nigra vulnerable @ DiseaseTgt $ , occupies intron-1 , modulates SNCA expression dopaminergic cells . critical link GATA factors SNCA may enable therapies designed lower alpha-synuclein production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6609470433696147)\n",
      "- Text: \"polymorphism platelet glycoprotein receptor inherited risk factor coronary thrombosis . BACKGROUND : Platelet glycoprotein IIb/IIIa membrane receptor @ GeneSrc $ von Willebrand factor , important role platelet aggregation . known involved pathogenesis acute coronary syndromes . Previously , found high frequency particular polymorphism , PlA2 , gene encoding glycoprotein IIIa kindreds high prevalence premature @ DiseaseTgt $ . METHODS : investigate relation PlA2 polymorphism acute coronary syndromes , conducted case-control study 71 case patients @ DiseaseTgt $ unstable angina 68 inpatient controls without known heart disease . groups matched age , race , sex . used two methods determine PlA genotype : reverse dot blot hybridization allele-specific restriction digestion . RESULTS : prevalence PlA2 2.1 times higher among case patients among controls ( 39.4 percent vs. 19.1 percent , P=0.01 ) . subgroup patients whose disease began age 60 years , prevalence PlA2 50 percent , value 3.6 times among control subjects 60 years age ( 13.9 percent , P=0.002 ) . Among subjects PlA2 polymorphism , odds ratio coronary event 2.8 ( 95 percent confidence interval , 1.2 6.4 ) . patients less 60 years age onset disease , odds ratio 6.2 ( 95 percent confidence interval , 1.8 22.4 ) . CONCLUSIONS : observed strong association PlA2 polymorphism glycoprotein IIIa gene acute coronary thrombosis , association strongest patients coronary events age 60 years .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0135356448389953)\n",
      "- Text: \"Deletion polymorphism angiotensin I-converting enzyme gene associated increased plasma angiotensin-converting enzyme activity increased risk @ DiseaseTgt $ coronary artery disease . BACKGROUND : Previous research shown insertion/deletion ( I/D ) polymorphism angiotensin I-converting enzyme ( ACE ) gene major determinant plasma ACE activity . suggested persons DD genotype ( express , average , highest levels circulating ACE ) increased risk @ DiseaseTgt $ coronary artery disease , particularly otherwise low risk . Subsequent studies , however , confirmed ACE I/D gene polymorphism risk factor coronary artery disease @ DiseaseTgt $ . OBJECTIVE : investigate association I/D polymorphism ACE gene risk coronary artery disease @ DiseaseTgt $ patients coronary artery disease status documented angiography . DESIGN : Cross-sectional study . SETTING : University medical center . PATIENTS : 209 male case-patients coronary artery disease 92 male controls without coronary artery disease , documented coronary angiography . MEASUREMENTS : Assessment cardiac risk profile questionnaire ; classification patients degree coronary artery stenosis ; levels lipoproteins , apolipoproteins , @ GeneSrc $ ; ACE I/D gene polymorphism assessed polymerase chain reaction amplification . RESULTS : Plasma ACE activity significantly associated ACE I/D gene polymorphism . ACE genotype associated presence coronary artery disease @ DiseaseTgt $ . recessive effect allele assumed ( DD compared DI II ) , relative risk 1.00 ( 95 % CI , 0.76 1.30 ) coronary artery disease 1.03 ( CI , 0.77 1.38 ) @ DiseaseTgt $ . Results analyses also negative dominant effect allele assumed low-risk subgroups examined . established risk factors age apolipoprotein B level emerged important risk predictors multivariate analyses , followed diastolic blood pressure fasting glucose levels . CONCLUSIONS : angiographically defined study sample , ACE I/D gene polymorphism associated increased risk coronary artery disease @ DiseaseTgt $ , despite effects plasma ACE activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0960150099161197)\n",
      "- Text: \"Axis inhibition protein 2 ( AXIN2 ) polymorphisms tooth agenesis . Tooth agenesis common congenital disorder affects almost 20 % world 's population . number different genes shown associated cases tooth agenesis including AXIN2 , IRF6 , @ GeneSrc $ , MSX1 , PAX9 , TGFA . particular interest AXIN2 , linked two families segregating oligodontia @ DiseaseTgt $ . studied two collections families affected tooth agenesis tested association AXIN2 . Significant association tooth agenesis AXIN2 found ( p=0.02 ) cases least one missing incisor . work supports role AXIN2 human tooth agenesis first time suggests AXIN2 involved sporadic forms common incisor agenesis . Future studies identify specific tooth agenesis sub-phenotypes consequence AXIN2 genetic variations . sub-set cases could increased susceptibility @ DiseaseTgt $ types tumours knowledge would significant clinical implications .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0076891556729792)\n",
      "- Text: \"Oncogenic PIK3CA mutations occur epidermal nevi seborrheic keratoses characteristic mutation pattern . Activating mutations p110 alpha subunit PI3 K ( PIK3CA ) oncogene identified broad spectrum @ DiseaseTgt $ . However , role benign preneoplastic conditions unknown . Activating @ GeneSrc $ ( @ GeneSrc $ ) mutations common benign skin lesions , either embryonic mutations epidermal nevi ( EN ) somatic mutations seborrheic keratoses ( SK ) . @ GeneSrc $ mutations also common low-grade malignant bladder tumors , often occur association PIK3CA mutations . Therefore , examined exons 9 20 PIK3CA @ GeneSrc $ hotspot mutations EN ( n = 33 ) SK ( n = 62 ) , two proliferative skin lesions lacking malignant potential . Nine 33 ( 27 % ) EN harbored PIK3CA mutations ; cases showed E545 G substitution , uncommon @ DiseaseTgt $ . EN , R248C @ GeneSrc $ mutation identified . contrast , 10 62 ( 16 % ) SK revealed typical @ DiseaseTgt $ PIK3CA mutations E542 K , E545 K , H1047R . lesions displayed wide range @ GeneSrc $ mutations . Corresponding unaffected tissue available four EN two mutant SK : control samples displayed WT sequence , confirming somatic nature mutations found lesional tissue . Forty 95 ( 42 % ) lesions showed least one mutation either gene . PIK3CA @ GeneSrc $ mutations displayed independent distribution ; 5/95 lesions harbored mutations genes . findings suggest , addition role @ DiseaseTgt $ , oncogenic PIK3CA mutations contribute pathogenesis skin tumors lacking malignant potential . remarkable genotype-phenotype correlation observed study points distinct etiopathogenesis mutations keratinocytes occuring either fetal development adult life .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9627497013280356)\n",
      "- Text: \"Mosaicism oncogenic G12D KRAS mutation associated epidermal nevus , polycystic kidneys rhabdomyosarcoma . BACKGROUND : Epidermal nevus ( EN ) congenital disorder characterised hyperpigmented epidermal thickening following Blaschko 's line . due somatic mutations either @ GeneSrc $ PIK3CA half cases , remains unknown genetic origin half . EN also seen part complex developmental disorders association bladder carcinomas , also related @ GeneSrc $ PIK3CA mutations . Mosaic mutations genes occasionally found syndromic EN . CASE REPORT : co-occurrence EN , rhabdomyosarcoma , polycystic kidneys growth retardation infant described . RESULTS : oncogenic G12D KRAS mutation detected epidermal component EN rhabdomyosarcoma dermal component EN lesion unaffected tissues , including normal skin blood . CONCLUSION : report shows first time KRAS mutation epiderma causes EN . Observation G12D KRAS mutation two distinct regions body strongly suggests somatic mosaicism . Finally , report highlights potentially underestimated importance mosaic oncogene mutations childhood @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0669728238196566)\n",
      "- Text: \"Keratinocytic epidermal nevi associated mosaic RAS mutations . BACKGROUND : Activating RAS mutations germline cause rare developmental disorders Costello syndrome . Somatic RAS mutations found approximately 30 % human @ DiseaseTgt $ . Keratinocytic epidermal nevi ( KEN ) represent benign congenital skin lesions arranged along Blaschko 's lines . subgroup KEN caused hotspot oncogenic @ GeneSrc $ PIK3CA mutations mosaicism , majority lack mutations . METHODS : study screened 72 KEN activating mutations RAS genes oncogenes . RESULTS : Activating RAS mutations identified 28/72 ( 39 % ) KEN . HRAS commonly affected oncogene ( 86 % ) , HRAS p. G13R substitution representing new hotspot mutation . CONCLUSION : results indicate activating RAS somatic mutations leading mosaicism result benign KEN skin . Given prevalence KEN , mosaic HRAS mutations appear common patients germline ones . findings identify KEN mosaic RASopathy lend support notion genetic mosaicism important contributor disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003282014070262)\n",
      "- Text: \"Mutations fibroblast growth factor receptor 2 @ GeneSrc $ genes associated human gastric colorectal cancers . Autosomal dominant disorders skeletal cranial development linked fibroblast growth factor receptor ( FGFR ) 2 @ GeneSrc $ . report two identical mutations FGFR2 cause craniosynostosis syndromes , Crouzon , Apert , Pfeiffer @ DiseaseTgt $ . missense mutation ( Ser267Pro ) exon IIIa splice site mutation ( 940 - 2A -- > G ) exon IIIc detected @ DiseaseTgt $ patients . Interestingly , heterozygous somatic mutations identical germinal activating mutations FGFR2 reported previously craniosynostosis syndromes . addition , two novel mutations @ GeneSrc $ colorectal carcinomas identified . identified mutations occurred highly conserved sequences , FGFR family molecules , also throughout evolution clustered immunoglobulin-like loop-III domain , highlighting functional importance domain . results indicate FGFR2 @ GeneSrc $ , addition potential role skeletal dysplasias , play important role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0172452377428468)\n",
      "- Text: \"Mutations fibroblast growth factor receptor 2 @ GeneSrc $ genes associated human @ DiseaseTgt $ . Autosomal dominant disorders skeletal cranial development linked fibroblast growth factor receptor ( FGFR ) 2 @ GeneSrc $ . report two identical mutations FGFR2 cause craniosynostosis syndromes , Crouzon , Apert , Pfeiffer gastric carcinoma . missense mutation ( Ser267Pro ) exon IIIa splice site mutation ( 940 - 2A -- > G ) exon IIIc detected gastric cancer patients . Interestingly , heterozygous somatic mutations identical germinal activating mutations FGFR2 reported previously craniosynostosis syndromes . addition , two novel mutations @ GeneSrc $ @ DiseaseTgt $ identified . identified mutations occurred highly conserved sequences , FGFR family molecules , also throughout evolution clustered immunoglobulin-like loop-III domain , highlighting functional importance domain . results indicate FGFR2 @ GeneSrc $ , addition potential role skeletal dysplasias , play important role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0036861239040739)\n",
      "- Text: \"Mutations @ GeneSrc $ fibroblast growth factor receptor 3 genes associated human gastric colorectal cancers . Autosomal dominant disorders skeletal cranial development linked @ GeneSrc $ FGFR3 . report two identical mutations @ GeneSrc $ cause craniosynostosis syndromes , Crouzon , Apert , Pfeiffer @ DiseaseTgt $ . missense mutation ( Ser267Pro ) exon IIIa splice site mutation ( 940 - 2A -- > G ) exon IIIc detected @ DiseaseTgt $ patients . Interestingly , heterozygous somatic mutations identical germinal activating mutations @ GeneSrc $ reported previously craniosynostosis syndromes . addition , two novel mutations FGFR3 colorectal carcinomas identified . identified mutations occurred highly conserved sequences , FGFR family molecules , also throughout evolution clustered immunoglobulin-like loop-III domain , highlighting functional importance domain . results indicate @ GeneSrc $ FGFR3 , addition potential role skeletal dysplasias , play important role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3345191674870832)\n",
      "- Text: \"Assignment situ hybridization fibroblast growth factor receptor gene human chromosome band 10q26 . 2.3-kb cDNA probe human @ GeneSrc $ used determine chromosomal localization corresponding gene situ hybridization . results show gene , form amplified poorly differentiated @ DiseaseTgt $ , localized chromosome region 10q26 . two previously identified fibroblast growth factor receptor genes thus chromosome , related flg ( `` fms-like gene `` ) fibroblast growth factor receptor gene previously mapped human chromosome region 8p12 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072771739514246)\n",
      "- Text: \"Mutations @ GeneSrc $ fibroblast growth factor receptor 3 genes associated human @ DiseaseTgt $ . Autosomal dominant disorders skeletal cranial development linked @ GeneSrc $ FGFR3 . report two identical mutations @ GeneSrc $ cause craniosynostosis syndromes , Crouzon , Apert , Pfeiffer gastric carcinoma . missense mutation ( Ser267Pro ) exon IIIa splice site mutation ( 940 - 2A -- > G ) exon IIIc detected gastric cancer patients . Interestingly , heterozygous somatic mutations identical germinal activating mutations @ GeneSrc $ reported previously craniosynostosis syndromes . addition , two novel mutations FGFR3 @ DiseaseTgt $ identified . identified mutations occurred highly conserved sequences , FGFR family molecules , also throughout evolution clustered immunoglobulin-like loop-III domain , highlighting functional importance domain . results indicate @ GeneSrc $ FGFR3 , addition potential role skeletal dysplasias , play important role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0842417940977388)\n",
      "- Text: \"@ GeneSrc $ , link tumor suppressor APC G-protein signaling . adenomatous polyposis coli gene ( APC ) mutated familial adenomatous polyposis sporadic @ DiseaseTgt $ . APC gene product shown bind armadillo repeat domain Rac-specific guanine nucleotide exchange factor ( GEF ) , termed @ GeneSrc $ . Endogenous APC colocalized @ GeneSrc $ mouse colon epithelial cells neuronal cells . Furthermore , APC enhanced GEF activity @ GeneSrc $ stimulated @ GeneSrc $ cell flattening , membrane ruffling , lamellipodia formation MDCK cells . results suggest @ GeneSrc $ complex may regulate actin cytoskeletal network , cell morphology migration , neuronal function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0331338844330674)\n",
      "- Text: \"MLH3 : DNA mismatch repair gene associated mammalian microsatellite instability . DNA mismatch repair important role maintaining genomic integrity association hereditary non-polyposis colon cancer ( HNPCC ) . identify new human mismatch repair proteins , probed nuclear extracts conserved carboxy-terminal MLH1 interaction domain . describe cloning complete genomic sequence MLH3 , encodes new DNA mismatch repair protein interacts MLH1 . MLH3 similar mismatch repair proteins yeast , plants , worms bacteria known mammalian protein , suggesting conserved sequence may confer unique functions mice humans . Cells culture stably expressing dominant-negative MLH3 protein exhibit microsatellite instability . Mlh3 highly expressed gastrointestinal epithelium physically maps mouse complex trait locus colon cancer susceptibility ( Ccs1 ) . Although unable identify mutation protein-coding region Mlh3 susceptible mouse strain , colon tumours congenic Ccs1 mice exhibit microsatellite instability . Functional redundancy among Mlh3 , @ GeneSrc $ Pms2 may explain neither @ GeneSrc $ Pms2 mutant mice develop @ DiseaseTgt $ , @ GeneSrc $ PMS2 mutations rarely found HNPCC families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.983271417567613e-05)\n",
      "- Text: \"Parkin , gene implicated autosomal recessive juvenile parkinsonism , candidate tumor suppressor gene chromosome 6q25-q27 . effort identify tumor suppressor gene ( ) associated frequent loss heterozygosity observed chromosome 6q25-q27 , constructed contig derived sequences bacterial artificial chromosomeP1 bacteriophage artificial chromosome clones defined genetic interval D6S1581-D6S1579-D6S305-D6S1599-D6S1008 . Sequence analysis contig found contain eight known genes , including complete genomic structure Parkin gene . Loss heterozygosity ( LOH ) analysis 40 malignant @ DiseaseTgt $ identified common minimal region loss , including markers D6S305 ( 50 % ) D6S1599 ( 32 % ) . loci exhibited highest frequencies LOH study located within Parkin genomic structure . Whereas mutation analysis revealed missense substitutions , expression Parkin gene appeared down-regulated absent tumor biopsies tumor cell lines examined . addition , identification two truncating deletions 3 20 @ DiseaseTgt $ samples , well homozygous deletion exon 2 lung adenocarcinoma cell lines Calu-3 H-1573 , supports hypothesis hemizygous homozygous deletions responsible abnormal expression Parkin samples . data suggest LOH observed chromosome 6q25-q26 may contribute initiation andor progression cancer inactivating reducing expression Parkin gene . Parkin maps FRA6E , one active common fragile sites human genome , represents another example large tumor suppressor gene , like @ GeneSrc $ WWOX , located common fragile site .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0060113751169278)\n",
      "- Text: \"Alterations common fragile site gene Parkin @ DiseaseTgt $ . cloning characterization common fragile site ( CFS ) FRA6E ( 6q26 ) identified Parkin , gene involved pathogenesis many cases juvenile , early-onset , rarely , late-onset Parkinson 's disease , third large gene localized within large CFS . Initial analyses Parkin indicated addition playing role Parkinson 's disease , might also involved development and/or progression @ DiseaseTgt $ . analyses also indicated striking similarities among large CFS-locus genes : @ GeneSrc $ ( @ GeneSrc $ ; 3p14.2 ) , WW domain-containing oxidoreductase gene ( WWOX ; 16q23 ) , Parkin ( 6q26 ) . Analyses @ GeneSrc $ WWOX variety different cancer types identified presence alternative transcripts whole exon deletions . Interestingly , various whole exon duplications deletions identified Parkin juvenile early-onset Parkinson 's patients . Therefore , performed mutational/exon rearrangement analysis Parkin @ DiseaseTgt $ cell lines primary tumors . Four ( 66.7 % ) cell lines four ( 18.2 % ) primary tumors identified heterozygous duplication deletion Parkin exon . Additionally , three 23 ( 13.0 % ) nonovarian tumor-derived cell lines also identified duplication deletion one Parkin exons . Analysis Parkin protein expression antibodies revealed @ DiseaseTgt $ cell lines primary tumors diminished absent Parkin expression . functional analyses yet performed Parkin , data suggest like @ GeneSrc $ WWOX , Parkin may represent tumor suppressor gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0468099174807126)\n",
      "- Text: \"Alterations common fragile site gene Parkin ovarian cancers . cloning characterization common fragile site ( CFS ) FRA6E ( 6q26 ) identified Parkin , gene involved pathogenesis many cases juvenile , early-onset , rarely , late-onset @ DiseaseTgt $ , third large gene localized within large CFS . Initial analyses Parkin indicated addition playing role @ DiseaseTgt $ , might also involved development and/or progression ovarian cancer . analyses also indicated striking similarities among large CFS-locus genes : @ GeneSrc $ ( @ GeneSrc $ ; 3p14.2 ) , WW domain-containing oxidoreductase gene ( WWOX ; 16q23 ) , Parkin ( 6q26 ) . Analyses @ GeneSrc $ WWOX variety different cancer types identified presence alternative transcripts whole exon deletions . Interestingly , various whole exon duplications deletions identified Parkin juvenile early-onset @ DiseaseTgt $ patients . Therefore , performed mutational/exon rearrangement analysis Parkin ovarian cancer cell lines primary tumors . Four ( 66.7 % ) cell lines four ( 18.2 % ) primary tumors identified heterozygous duplication deletion Parkin exon . Additionally , three 23 ( 13.0 % ) nonovarian tumor-derived cell lines also identified duplication deletion one Parkin exons . Analysis Parkin protein expression antibodies revealed ovarian cancer cell lines primary tumors diminished absent Parkin expression . functional analyses yet performed Parkin , data suggest like @ GeneSrc $ WWOX , Parkin may represent tumor suppressor gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0799690261050458)\n",
      "- Text: \"@ GeneSrc $ gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . Grb10-Interacting GYF Protein 2 ( @ GeneSrc $ ) initially identified interaction Grb10 , adapter protein binds activated IGF-I insulin receptors . GIGYF2 gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( PARK11 locus ) , association GIGYF2 mutations @ DiseaseTgt $ described recent publications . study investigated consequences @ GeneSrc $ gene disruption mice . @ GeneSrc $ null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous @ GeneSrc $ ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , @ GeneSrc $ ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . alpha-synuclein positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts @ GeneSrc $ null mice exhibit decreased IGF-I-stimulated IGF-I receptor tyrosine phosphorylation augmented ERK1/2 phosphorylation . data provide evidence important role @ GeneSrc $ age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0556014311686387)\n",
      "- Text: \"@ DiseaseTgt $ presenilin 2 interacts @ GeneSrc $ , LIM-domain protein . Using yeast two-hybrid system , screened proteins interacting presenilin 2 ( PS2 ) cloned @ GeneSrc $ . @ GeneSrc $ LIM-only protein containing four LIM domains N-terminal half LIM domain . Previously @ GeneSrc $ cloned co-activator androgen receptor protein interacting DNA replication regulatory protein , hCDC47 . yeast two-hybrid assay showed @ GeneSrc $ interacted hydrophilic loop region ( amino acids 269 - 298 ) endoproteolytic N-terminal fragment PS2 , PS1 , although region 269 - 298 PS2 corresponding PS1 sequence differ three amino acids . point mutation within region , R275A , T280A , Q282A , R284A , N285A , P287 , I288L , F289A S296A , PS2 abolished binding . suggests @ GeneSrc $ recognizes PS2 structure specifically . vitro interaction confirmed affinity column assay physiological interactions endogenous PS2 @ GeneSrc $ co-immunoprecipitation human lung fibroblast MRC5 cells . Furthermore , PS2-overexpressing HEK293 cells , found increase amount @ GeneSrc $ membrane fraction increase amount @ GeneSrc $ co-immunoprecipitated PS2 . potential role @ GeneSrc $ cellular signaling suggests @ GeneSrc $ functions adaptor protein links PS2 intracellular signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000193639110052)\n",
      "- Text: \"Mutations ZFPM2/FOG2 gene sporadic cases @ DiseaseTgt $ . Two 47 patients sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) , common cyanotic conotruncal heart defect ( CTD ) , showed heterozygous missense mutations ZFPM2/FOG2 gene . Knockout mice carrying mutations @ GeneSrc $ gene similarly found exhibit @ DiseaseTgt $ . mutant ZFPM2/FOG2 proteins , E30 G ( c.88A > G ) S657 G ( c.1968A > G ) , retain ability bind partner protein GATA4 repress GATA4 mediated gene activation , S657 G , E30 G , mutation subtly impaired function . ZFPM2/FOG2 gene mutations may contribute sporadic cases @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4476341691346943)\n",
      "- Text: \"@ GeneSrc $ , cofactor GATA transcription factors , essential heart morphogenesis development coronary vessels epicardium . disrupted @ GeneSrc $ gene mice define requirement vivo . @ GeneSrc $ ) embryos die midgestation cardiac defect characterized thin ventricular myocardium , common atrioventricular canal , @ DiseaseTgt $ . Remarkably , coronary vasculature absent @ GeneSrc $ ) hearts . Despite formation intact epicardial layer expression epicardium-specific genes , markers cardiac vessel development ( ICAM-2 FLK-1 ) detected , indicative failure activate expression and/or initiate epithelial mesenchymal transformation epicardial cells . Transgenic reexpression @ GeneSrc $ cardiomyocytes rescues @ GeneSrc $ ) vascular phenotype , demonstrating @ GeneSrc $ function myocardium required sufficient coronary vessel development . findings provide molecular inroad induction coronary vasculature myocardium developing heart .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.009685703456071)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation @ DiseaseTgt $ progression colon . Kras commonly mutated colon cancers , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant K-Ras hypersensitive inhibition @ GeneSrc $ , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.404240361778816e-06)\n",
      "- Text: \"Distinct patterns KRAS mutations colorectal carcinomas according germline mismatch repair defects hMLH1 methylation status . sporadic colorectal tumours BRAFV600E associated microsatellite instability ( MSI-H ) inversely associated KRAS mutations . @ DiseaseTgt $ hereditary non-polyposis colorectal cancer ( HNPCC ) patients carrying germline mutations hMSH2 hMLH1 show BRAFV600E , however consistent data exist regarding KRAS mutation frequency spectrum HNPCC tumours . investigated KRAS 158 HNPCC tumours patients germline hMLH1 , hMSH2 hMSH6 mutations , 166 MSI-H 688 microsatellite stable ( MSS ) @ DiseaseTgt $ . @ DiseaseTgt $ characterized MSI 81 166 sporadic MSI-H colorectal cancer ( CRCs ) analysed hMLH1 promoter hypermethylation . KRAS mutations observed 40 % HNPCC tumours , mutation frequency varied upon mismatch repair gene affected : 48 % ( 29/61 ) hMSH2 , 32 % ( 29/91 ) hMLH1 83 % ( 5/6 ) hMSH6 ( P = 0.01 ) . KRAS mutation frequency different HNPCC , MSS MSI-H CRCs ( P = 0.002 ) , MSI-H hMLH1 hypermethylation ( P = 0.005 ) . Furthermore , HNPCC CRCs G13D mutations MSS ( P < 0.0001 ) , MSI-H ( P = 0.02 ) @ DiseaseTgt $ hMLH1 hypermethylation ( P = 0.03 ) . HNPCC colorectal sporadic MSI-H tumours without hMLH1 hypermethylation shared similar KRAS mutation frequency , particular G13D . conclusion , show depending genetic/epigenetic mechanism leading MSI-H , outcome terms oncogenic activation may different , reinforcing idea HNPCC , sporadic MSI-H ( depending hMLH1 status ) MSS CRCs , may target distinct kinases within @ GeneSrc $ pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001797258768341)\n",
      "- Text: \"Tumorigenesis : @ GeneSrc $ oncogenes mismatch-repair status . Genes @ GeneSrc $ family encode kinases regulated Ras mediate cellular responses growth signals . Activating mutations one @ GeneSrc $ gene , BRAF , found high proportion melanomas small fraction @ DiseaseTgt $ . show BRAF mutations colorectal cancers occur @ DiseaseTgt $ carry mutations RAS gene known KRAS , BRAF mutation linked proficiency @ DiseaseTgt $ repairing mismatched bases DNA . results provide genetic support idea mutations BRAF KRAS exert equivalent effects tumorigenesis , also emphasize role repair processes establishing mutation spectra underpin human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9729622034788028)\n",
      "- Text: \"Mutations BRAF RAS rare events germ cell tumours . BRAF gene , one human isoforms @ GeneSrc $ , activated oncogenic Ras , leading cooperative effects cells responding growth factor signals . Recently , somatic missense mutations BRAF gene detected variety human @ DiseaseTgt $ . studied male germ cell tumours ( GCT ) probable mutations BRAF Ras oncogene . Microsatellite instability ( MSI ) analysed using mono- di-nucleotide marker . Mutational analysis 62 GCT ( 30 seminomas 32 nonseminomas ) performed microdissection different @ DiseaseTgt $ components . expression Erk1/2 , important downstream point convergence @ GeneSrc $ pathway assessed immunohistochemically . Activating BRAF missense mutations identified 3 32 cases nonseminomas ( 9 % ) seminomas . mutations 1796T > mutations found within embryonic carcinoma component @ DiseaseTgt $ . Two 30 seminomas ( 7 % ) 3 32 nonseminomas ( 9 % ) exhibited KRAS gene mutations . MSI observed 4 62 @ DiseaseTgt $ ( 7 % ) [ 1 seminoma 3 nonseminomas ( embryonal carcinoma ) ] . microsatellite instable embryonal carcinomas mutated BRAF gene . 5 GCT RAS mutations intact BRAF gene . identified constitutively activated Erk almost @ DiseaseTgt $ tested . data indicate BRAF gene mutations rare event GCT independent KRAS mutations . embryonal carcinomas , BRAF mutations may linked proficiency @ DiseaseTgt $ repairing mismatched bases DNA . finding activated Erk suggests causative role MAPK activation GCT independent activating BRAF RAS mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9893038640962464)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation tumor progression colon . Kras commonly mutated @ DiseaseTgt $ , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant K-Ras hypersensitive inhibition @ GeneSrc $ , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001623778703955)\n",
      "- Text: \"eIF4F nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation @ GeneSrc $ mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , PI ( 3 ) K-AKT-mTOR , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation eIF4F eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation eIF4F complex , comprising eIF4E cap-binding protein , eIF4 G scaffolding protein eIF4A RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance eIF4F complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory eIF4E-binding protein 4EBP1 increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation eIF4 G . development situ method detect eIF4E-eIF4 G interactions shows eIF4F complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting eIF4F complex , either blocking eIF4E-eIF4 G interaction targeting eIF4A , synergizes inhibiting BRAF ( V600 ) kill cancer cells . eIF4F appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) eIF4F may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.007233667818215)\n",
      "- Text: \"BRAF screening low-cost effective strategy simplifying @ DiseaseTgt $ genetic testing . BACKGROUND : According international criteria @ DiseaseTgt $ ( @ DiseaseTgt $ ) diagnostics , cancer patients family history early onset @ DiseaseTgt $ showing high microsatellite instability ( MSI-H ) receive genetic counselling offered testing germline mutations DNA repair genes , mainly MLH1 MSH2 . Recently , oncogenic V600E hotspot mutation within BRAF , kinase encoding gene @ GeneSrc $ pathway , found associated sporadic MSI-H @ DiseaseTgt $ , association @ DiseaseTgt $ remains clarified . METHODS : BRAF-V600E mutations analysed automatic sequencing @ DiseaseTgt $ 206 sporadic cases MSI-H 111 @ DiseaseTgt $ cases known germline mutations MLH1 MSH2 . addition , 45 @ DiseaseTgt $ cases showing abnormal immunostaining MSH2 also analysed . RESULTS : BRAF-V600E hotspot mutation found 40 % ( 82/206 ) sporadic MSI-H tumours analysed none 111 tested @ DiseaseTgt $ 45 cases showing abnormal MSH2 immunostaining . CONCLUSIONS : Detection V600E mutation @ DiseaseTgt $ MSI-H tumour argues presence germline mutation either MLH1 MSH2 gene . Therefore , screening mismatch repair ( MMR ) genes avoided cases positive V600E significant evidence , fulfilment strict Amsterdam criteria , suggests MMR associated @ DiseaseTgt $ . context , mutation analysis BRAF hotspot reliable , fast , low cost strategy simplifies genetic testing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2485001532534367)\n",
      "- Text: \"Tumorigenesis : @ GeneSrc $ oncogenes mismatch-repair status . Genes @ GeneSrc $ family encode kinases regulated Ras mediate cellular responses growth signals . Activating mutations one @ GeneSrc $ gene , BRAF , found high proportion melanomas small fraction cancers . show BRAF mutations @ DiseaseTgt $ occur tumours carry mutations RAS gene known KRAS , BRAF mutation linked proficiency tumours repairing mismatched bases DNA . results provide genetic support idea mutations BRAF KRAS exert equivalent effects tumorigenesis , also emphasize role repair processes establishing mutation spectra underpin human cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2041950647983814)\n",
      "- Text: \"Identification novel homozygous mutation Arg459Pro SYNJ1 gene Indian family autosomal recessive juvenile Parkinsonism . BACKGROUND : novel homozygous missense mutation ( c.773 G > , p. Arg258Gln ) Synaptojanin 1 ( SYNJ1 , 21q22.2 ) recently reported two Italian one Iranian consanguineous families autosomal recessive juvenile Parkinsonism ( ARJP ) . Contribution synaptic gene related Parkinsonism phenotypes populations still remains unidentified . METHODS : ARJP family two affected siblings characterized frequent tremor bradykinesia rigidity recruited study . siblings showed intense dyskinesia dystonia administration Syndopa . family analyzed mutations exon dosage variations PARKIN , PINK1 DJ1 . , whole exome sequencing performed two affected one unaffected sibling family . RESULTS : identified novel homozygous mutation ( c.1376C > G , p. Arg459Pro ) SYNJ1 segregating family . p. Arg459Pro mutation observed 285 additional @ DiseaseTgt $ ( @ DiseaseTgt $ ) samples ( 32 familial , 81 early onset 172 late onset ) screened PCR-Sanger-sequencing . also absent dbSNP , 1000 Genomes , ExAC , NHLBI-ESP database > 250 ethnically matched exomes available laboratory . arginine residue highly conserved across species predicted damaging several silico tools . previous mutation p. Arg258Gln , p. Arg459Pro also present @ GeneSrc $ domain SYNJ1 wherein p. Arg258Gln mutation already described impair phosphatase activity . CONCLUSIONS : report another novel mutation SYNJ1 Indian consanguineous ARJP family . Finding additional mutation gene supports involvement SYNJ1 @ DiseaseTgt $ pathogenesis across different ethnicities .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0094481854439551)\n",
      "- Text: \"Disturbed activation endoplasmic reticulum stress transducers @ DiseaseTgt $ presenilin-1 mutations . Recent studies shown independently presenilin-1 ( PS1 ) null mutants @ DiseaseTgt $ @ DiseaseTgt $ mutants down-regulate signaling unfolded protein response ( UPR ) . However , difficult accept mutants possess effects UPR . Furthermore , contrary observations , neither loss PS1 PS2 function expression @ DiseaseTgt $ PS1 mutants reported discernable impact UPR . Therefore , re-examination detailed analyses needed clarify relationship PS1 function UPR signaling . , report PS1/PS2 null dominant negative PS1 mutants , mutated aspartate residue 257 385 , affect signaling UPR . contrast , @ DiseaseTgt $ PS1 mutants confirmed disturb UPR signaling inhibiting activation Ire1alpha @ GeneSrc $ , endoplasmic reticulum ( ER ) stress transducers UPR . Furthermore , PS1 mutants also disturbed activation PERK ( PKR-like ER kinase ) , plays crucial role inhibiting translation ER stress . Taken together , observations suggested PS1 mutations could affect signaling pathways controlled respective ER-stress transducers , possibly gain-of-function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0206284106198578)\n",
      "- Text: \"gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 lipogenesis . @ DiseaseTgt $ cells increase lipogenesis proliferation activation sterol regulatory element-binding proteins ( SREBPs ) central role process . SREBPs inhibited complex composed INSIG proteins , @ GeneSrc $ ( @ GeneSrc $ ) sterols endoplasmic reticulum . Regulation interaction INSIG proteins @ GeneSrc $ sterol levels critical dissociation @ GeneSrc $ complex endoplasmic reticulum activation SREBPs1,2 . However , whether protein interaction regulated mechanism abundance sterol-and particular , whether oncogenic signalling role-is unclear . show activated AKT human hepatocellular carcinoma ( HCC ) cells phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 ( PCK1 ) , rate-limiting enzyme gluconeogenesis , Ser90 . Phosphorylated PCK1 translocates endoplasmic reticulum , uses GTP phosphate donor phosphorylate INSIG1 Ser207 INSIG2 Ser151 . phosphorylation reduces binding sterols INSIG1 INSIG2 disrupts interaction INSIG proteins @ GeneSrc $ , leading translocation @ GeneSrc $ complex Golgi apparatus , activation SREBP proteins ( SREBP1 SREBP2 ) transcription downstream lipogenesis-related genes , proliferation @ DiseaseTgt $ cells , tumorigenesis mice . addition , phosphorylation PCK1 Ser90 , INSIG1 Ser207 INSIG2 Ser151 positively correlated nuclear accumulation SREBP1 samples patients HCC , also associated poor HCC prognosis . findings highlight importance protein kinase activity PCK1 activation SREBPs , lipogenesis development HCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.006913911215306)\n",
      "- Text: \"Exome sequencing identifies rare variants multiple genes atrioventricular septal defect . PURPOSE : genetic etiology atrioventricular septal defect ( AVSD ) unknown 40 % cases . Conventional sequencing arrays identified etiology minority nonsyndromic individuals AVSD . METHODS : Whole-exome sequencing performed 81 unrelated probands AVSD identify potentially causal variants comprehensive set 112 genes strong biological relevance AVSD . RESULTS : significant enrichment rare rare damaging variants identified gene set , compared controls ( odds ratio ( ) : 1.52 ; 95 % confidence interval ( CI ) : 1.35 - 1.71 ; P = 4.8 x 10 ( -11 ) ) . enrichment specific AVSD probands , compared cohort without AVSD @ DiseaseTgt $ ( : 2.25 ; 95 % CI : 1.84 - 2.76 ; P = 2.2 x 10 ( -16 ) ) . Six genes ( NIPBL , CHD7 , @ GeneSrc $ , BMPR1a , ZFPM2 , MDM4 ) enriched rare variants AVSD compared controls , including three syndrome-associated genes ( NIPBL , CHD7 , @ GeneSrc $ ) . findings confirmed replication cohort 81 AVSD probands . CONCLUSION : Mutations genes strong biological relevance AVSD , including syndrome-associated genes , contribute AVSD , even isolated heart disease . identification gene set associated AVSD facilitate targeted genetic screening cohort .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.0175314034706016e-06)\n",
      "- Text: \"p53 regulated lysine demethylase @ GeneSrc $ . p53 , @ DiseaseTgt $ suppressor transcriptional activator , regulated numerous post-translational modifications , including lysine methylation . Histone lysine methylation recently shown reversible ; however , known whether non-histone proteins substrates demethylation . show , human cells , histone lysine-specific demethylase @ GeneSrc $ ( refs 3 , 4 ) interacts p53 repress p53-mediated transcriptional activation inhibit role p53 promoting apoptosis . find , vitro , @ GeneSrc $ removes monomethylation ( K370me1 ) dimethylation ( K370me2 ) K370 , previously identified Smyd2-dependent monomethylation site . However , vivo , @ GeneSrc $ shows strong preference reverse K370me2 , performed distinct , unknown , methyltransferase . results indicate K370me2 different role regulating p53 K370me1 : K370me1 represses p53 function , whereas K370me2 promotes association coactivator 53BP1 ( p53-binding protein 1 ) tandem Tudor domains 53BP1 . , @ GeneSrc $ represses p53 function inhibition interaction p53 53BP1 . observations show p53 dynamically regulated lysine methylation demethylation methylation status single lysine residue confers distinct regulatory output . Lysine methylation therefore provides similar regulatory complexity non-histone proteins histones .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007359132355336)\n",
      "- Text: \"IkappaB kinase promotes tumorigenesis inhibition forkhead @ GeneSrc $ . Nuclear exclusion forkhead transcription factor @ GeneSrc $ protein kinase Akt contributes cell survival . investigated pathological relationship phosphoylated-Akt ( Akt-p ) @ GeneSrc $ primary @ DiseaseTgt $ . Surprisingly , @ GeneSrc $ found excluded nuclei @ DiseaseTgt $ lacking Akt-p , suggesting Akt-independent mechanism regulating @ GeneSrc $ localization . provide evidence mechanism showing IkappaB kinase ( IKK ) physically interacts , phosphorylates , inhibits @ GeneSrc $ independent Akt causes proteolysis @ GeneSrc $ via Ub-dependent proteasome pathway . Cytoplasmic @ GeneSrc $ correlates expression IKKbeta Akt-p many @ DiseaseTgt $ associates poor survival breast cancer . , constitutive expression IKKbeta promotes cell proliferation tumorigenesis overridden @ GeneSrc $ . results suggest negative regulation FOXO factors IKK key mechanism promoting cell growth tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0347369492121266)\n",
      "- Text: \"FOXO3a-dependent regulation Pink1 ( Park6 ) mediates survival signaling response cytokine deprivation . Loss-of-function mutations phosphatase/tensin homolog deleted chromosome 10 ( PTEN ) -induced putative kinase 1 ( Pink1 ) ( also known Park6 ) identified familial forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated compromised mitochondrial function . Emerging data suggest Pink1 essential pro-survival factor induced response oxidative stress . However , mechanisms regulating Pink1 expression stress conditions remain unknown . Forkhead box , subgroup ( FOXO ) transcription factors carry distinct biological functions response different extracellular signals . Notably , FOXO factors possess evolutionarily conserved roles protecting cells oxidative stress-induced death . report FOXO family member @ GeneSrc $ controls Pink1 transcription mouse human cells subjected growth factor deprivation regulation exerted evolutionarily conserved FOXO binding elements . Induction Pink1 @ GeneSrc $ crucial survival signals lymphocytes , depletion Pink1 sensitizes cells death induced deprivation essential growth factor . data reveal role FOXO factors protecting cells growth factor deprivation-triggered apoptosis underestimated FOXOs mediate protection transactivating anti-apoptotic effectors like Pink1 . Given essential role Pink1 combating cell death , findings may help dissect mechanisms FOXO proteins function anti-oxidative stress factors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.020096893561637)\n",
      "- Text: \"Assignment situ hybridization fibroblast growth factor receptor gene human chromosome band 10q26 . 2.3-kb cDNA probe human bek fibroblast growth factor receptor used determine chromosomal localization corresponding gene situ hybridization . results show gene , form amplified poorly differentiated @ DiseaseTgt $ , localized chromosome region 10q26 . two previously identified fibroblast growth factor receptor genes thus chromosome , related @ GeneSrc $ ( `` fms-like gene `` ) fibroblast growth factor receptor gene previously mapped human chromosome region 8p12 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8716706070631378)\n",
      "- Text: \"@ GeneSrc $ pathway microglia astrocytes protects dopaminergic neurons inflammation-induced death . Nurr1 , orphan nuclear receptor , plays essential role generation maintenance dopaminergic neurons brain . Rare mutations Nurr1 associated familial @ DiseaseTgt $ , underlying basis relationship established . , demonstrate Nurr1 unexpectedly functions inhibit expression pro-inflammatory neurotoxic mediators microglia astrocytes . Reduced Nurr1 expression results exaggerated inflammatory responses microglia amplified astrocytes , leading production factors cause death tyrosine hydroxylase-expressing neurons . Nurr1 exerts anti-inflammatory effects docking NF-kappaB-p65 target inflammatory gene promoters signal-dependent manner . Subsequently , Nurr1 recruits @ GeneSrc $ corepressor complex , resulting clearance NF-kappaB-p65 transcriptional repression . studies suggest Nurr1 protects loss dopaminergic neurons @ DiseaseTgt $ part limiting production neurotoxic mediators microglia astrocytes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0750080970856382)\n",
      "- Text: \"autosomal recessive juvenile Parkinson disease gene product , parkin , interacts ubiquitinates @ GeneSrc $ . Inactivating mutations gene encoding parkin responsible forms autosomal recessive juvenile Parkinson disease . Parkin ubiquitin ligase ubiquitinates misfolded proteins targeted proteasome-dependent protein degradation pathway . Using yeast two-hybrid system co-immunoprecipitation methods , identified @ GeneSrc $ protein interacts parkin . Parkin binds C2A C2B domains @ GeneSrc $ resulting polyubiquitination @ GeneSrc $ . Truncated missense mutated parkins reduce @ GeneSrc $ binding affinity ubiquitination . Parkin-mediated ubiquitination also enhances turnover @ GeneSrc $ . sporadic @ DiseaseTgt $ brain sections , @ GeneSrc $ found core Lewy bodies . Since @ GeneSrc $ member synaptotagmin family well characterized importance vesicle formation docking , interaction protein suggests role parkin regulation synaptic vesicle pool vesicle release . Loss parkin could thus affect multiple proteins controlling vesicle pools , docking release explain deficits dopaminergic function seen patients parkin mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0870606615528862)\n",
      "- Text: \"Cytoplasmic nucleophosmin @ DiseaseTgt $ normal karyotype . BACKGROUND : Nucleophosmin ( NPM ) , nucleocytoplasmic shuttling protein prominent nucleolar localization , regulates ARF-p53 tumor-suppressor pathway . Translocations involving NPM gene cause cytoplasmic dislocation NPM protein . METHODS : used immunohistochemical methods study subcellular localization NPM bone marrow-biopsy specimens 591 patients primary @ DiseaseTgt $ ( @ DiseaseTgt $ ) . correlated presence cytoplasmic NPM clinical biologic features disease . RESULTS : Cytoplasmic NPM detected 208 ( 35.2 percent ) 591 specimens patients primary @ DiseaseTgt $ 135 secondary @ DiseaseTgt $ specimens 980 hematopoietic extrahematopoietic neoplasms @ DiseaseTgt $ . associated wide spectrum morphologic subtypes disease , normal karyotype , responsiveness induction chemotherapy , recurrent genetic abnormalities . high frequency @ GeneSrc $ internal tandem duplications absence CD34 CD133 @ DiseaseTgt $ specimens normal karyotype cytoplasmic dislocation NPM , protein restricted nucleus . @ DiseaseTgt $ specimens cytoplasmic NPM carried mutations NPM gene predicted alter protein C-terminal ; mutant gene caused cytoplasmic localization NPM transfected cells . CONCLUSIONS : Cytoplasmic NPM characteristic feature large subgroup patients @ DiseaseTgt $ normal karyotype , NPM gene mutations , responsiveness induction chemotherapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1747363695898497)\n",
      "- Text: \"impact @ GeneSrc $ internal tandem duplication mutant level , number , size , interaction NPM1 mutations large cohort young adult patients @ DiseaseTgt $ . internal tandem duplication @ GeneSrc $ gene ( @ GeneSrc $ ) associated poor prognosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , impact mutant level , size , interaction nucleophosmin 1 ( NPM1 ) mutations remains controversial . evaluated characteristics large cohort young adult @ DiseaseTgt $ patients . highly significant trend worsening relapse risk ( RR ) overall survival ( OS ) increasing @ GeneSrc $ mutant level ( P < .001 ) , even low level mutant group ( 1 % -24 % total @ GeneSrc $ alleles ) , RR significantly worse @ GeneSrc $ wild-type ( WT ) group ( P < .001 ) . multivariate analysis , mutant level powerful prognostic factor RR . Mutant size number significant impact outcome . beneficial impact NPM1 mutation RR OS seen @ GeneSrc $ ) well @ GeneSrc $ patients ; markers highly significant independent predictors outcome ( P < .001 ) . Stratification using markers identified 3 prognostic groups : good ( @ GeneSrc $ ) ) , intermediate ( @ GeneSrc $ ) @ GeneSrc $ ) ) , poor ( @ GeneSrc $ ) ) . Patients high @ GeneSrc $ mutant level ( greater 50 % ) @ GeneSrc $ ) absence NPM1 mutation may good candidates experimental therapeutic approaches .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0112913252113191)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 @ GeneSrc $ mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . @ GeneSrc $ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent @ GeneSrc $ signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0264709480165054)\n",
      "- Text: \"@ GeneSrc $ mutations childhood acute lymphoblastic leukemia . Activating mutations @ GeneSrc $ receptor tyrosine kinase common @ DiseaseTgt $ ( @ DiseaseTgt $ ) rare adult acute lymphoblastic leukemia ( ) . recently shown @ GeneSrc $ highly expressed often mutated ALLs rearrangement mixed lineage leukemia ( MLL ) gene chromosome 11q23 . hyperdiploid samples also show high-level expression @ GeneSrc $ , searched presence @ GeneSrc $ mutations leukemic blasts 71 patients . data show approximately 25 % ( 6 25 ) hyperdiploid samples possess @ GeneSrc $ mutations , whereas 1 29 TEL/AML1-rearranged samples harbored mutations ( P = .04 , Fisher exact test ) . Three mutations novel in-frame deletions within 7-amino acid region receptor juxtamembrane domain . Finally , 3 samples patients whose disease would relapse harbored @ GeneSrc $ mutations . data suggest patients hyperdiploid relapsed might considered candidates therapy newly described small-molecule @ GeneSrc $ inhibitors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3174627816451524)\n",
      "- Text: \"Insertion @ GeneSrc $ internal tandem duplication tyrosine kinase domain-1 associated resistance chemotherapy inferior outcome . evaluate internal tandem duplication ( ITD ) insertion sites length well clinical impact younger adult patients @ GeneSrc $ @ DiseaseTgt $ ( @ DiseaseTgt $ ) , sequencing DNA-based amplification performed diagnostic samples 241 @ GeneSrc $ patients . patients treated 3 German-Austrian @ DiseaseTgt $ Study Group protocols . Thirty-four 241 patients 1 ITD , leading total 282 ITDs ; median ITD length 48 nucleotides ( range , 15 - 180 nucleotides ) . ITD integration sites categorized according functional regions FLT3 receptor : juxtamembrane domain ( JMD ) , n = 148 ; JMD hinge region , n = 48 ; beta1-sheet tyrosine kinase domain-1 ( TKD1 ) , n = 73 ; remaining TKD1 region , n = 13 . ITD length strongly correlated functional regions ( P < .001 ) . multivariable analyses , ITD integration site beta1-sheet identified unfavorable prognostic factor achievement complete remission ( odds ratio , 0.22 ; P = .01 ) , relapse-free survival ( hazard ratio , 1.86 ; P < .001 ) , overall survival ( hazard ratio , 1.59 ; P = .008 ) . ITD insertion site beta1-sheet appears important unfavorable prognostic factor young adult patients @ GeneSrc $ @ DiseaseTgt $ . clinical trials described herein registered follows : @ DiseaseTgt $ ( already published 2003 ) , @ DiseaseTgt $ HD98A ( NCT00146120 ; http : //www . ClinicalTrials.gov ) , AMLSG 07 - 04 ( NCT00151242 ; http : //www . ClinicalTrials.gov ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0049057280814743)\n",
      "- Text: \"Internal tandem duplication @ GeneSrc $ gene found @ DiseaseTgt $ . analyzed mRNA expression @ GeneSrc $ gene 30 patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) 50 acute lymphoblastic leukemia ( ) . Using reverse transcriptase-polymerase chain reaction ( RT-PCR ) , expression @ GeneSrc $ observed 61 patients ; 22 ( 73 % ) @ DiseaseTgt $ 39 ( 78 % ) . Among , five patients @ DiseaseTgt $ ( one M2 , two M4 , two M5 ) showed unexpected longer transcripts primer combination could amplify transmembrane ( TM ) domain juxtamembrane ( JM ) domain . patients expressed @ GeneSrc $ mRNA , extracellular domain @ GeneSrc $ gene also examined RT-PCR , length abnormality seen region . analyzed TM domain second tyrosine kinase domain genomic amplifications . five patients showed aberrant @ GeneSrc $ transcripts exhibited abnormal longer PCR products addition germline products region corresponding JM first TK ( TK1 ) domains . Sequence analyses abnormal RT-PCR products demonstrated partial sequences tandemly duplicated . altered transcripts in-frame , deduced protein products could expected . Sequence analyses genomic DNA revealed three five patients showed simple internal duplication within exon 11 ; one internal duplication ( 26 bp ) 4-bp insertion ; fifth patient , 136-bp sequence 3 ' part exon 11 intron 11 first 16-bp sequence exon 12 duplicated 1-bp insertion . order confirm tumor specificity alterations , DNA samples obtained complete remission also analyzed three patients harboring @ GeneSrc $ duplication , abnormal PCR product germline detected samples . results suggest internal tandem duplication JM/TK1 domains @ GeneSrc $ gene somatic change detected preferentially @ DiseaseTgt $ , possibly containing monocytic component .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0753865150814278)\n",
      "- Text: \"Prevalence prognostic significance @ GeneSrc $ internal tandem duplication pediatric @ DiseaseTgt $ . @ GeneSrc $ gene encodes tyrosine kinase receptor regulates proliferation differentiation hematopoietic stem cells . internal tandem duplication @ GeneSrc $ gene ( @ GeneSrc $ ) reported @ DiseaseTgt $ ( @ DiseaseTgt $ ) may associated poor prognosis . analyzed diagnostic bone marrow specimens 91 pediatric patients @ DiseaseTgt $ treated Children 's Cancer Group ( CCG ) -2891 presence @ GeneSrc $ correlated presence clinical outcome . Fifteen 91 samples ( 16.5 % ) positive @ GeneSrc $ . @ GeneSrc $ patients median diagnostic white count 73 800 compared 28 400 @ GeneSrc $ patients ( P = .05 ) . size duplication ranged 21 174 base pairs ( bp ) . Nucleotide sequencing abnormal polymerase chain reaction products demonstrated duplications involved exon 11 @ GeneSrc $ gene also preserved reading frame . Lineage restriction analysis revealed @ GeneSrc $ present lymphocytes , suggesting lack stem cell involvement mutation . None @ GeneSrc $ patients unfavorable cytogenetic markers , predominance particular FAB class . remission induction rate 40 % @ GeneSrc $ patients compared 74 % @ GeneSrc $ ones ( P = .005 ) . Kaplan-Meier estimates event-free survival 8 years patients without @ GeneSrc $ 7 % 44 % , respectively ( P = .002 ) . Multivariate analysis demonstrated presence @ GeneSrc $ single significant , independent prognostic factor poor outcome ( P = .009 ) pediatric @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1142037635501495)\n",
      "- Text: \"presence @ GeneSrc $ internal tandem duplication patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) adds important prognostic information cytogenetic risk group response first cycle chemotherapy : analysis 854 patients United Kingdom Medical Research Council @ DiseaseTgt $ 10 12 trials . @ DiseaseTgt $ ( @ DiseaseTgt $ ) , prognostic determinants required addition cytogenetics predict patients increased risk relapse . Recent studies indicated internal tandem duplication ( ITD ) @ GeneSrc $ gene may adversely affect clinical outcome . study evaluated impact @ GeneSrc $ mutation outcome 854 patients , mostly 60 years age younger , treated United Kingdom Medical Research Council ( MRC ) @ DiseaseTgt $ trials . @ GeneSrc $ mutation present 27 % patients associated leukocytosis high percentage bone marrow blast cells ( P < .001 ) . borderline association lower complete remission rate ( P = .05 ) higher induction death rate ( P = .04 ) , associated increased relapse risk ( RR ) , adverse disease-free survival ( DFS ) , event-free survival ( EFS ) , overall survival ( OS ) ( P < .001 ) . multivariate analysis , presence mutation significant prognostic factor predicting RR DFS ( P < .0001 ) still significant OS ( P = .009 ) EFS ( P = .002 ) . evidence relative effect @ GeneSrc $ differed cytogenetic risk groups . one mutation detected 23 % @ GeneSrc $ ) patients associated worse OS ( P = .04 ) EFS ( P = .07 ) . Biallelic disease partial/complete loss wild-type alleles present 10 % @ GeneSrc $ ) patients . suggestion made detection @ GeneSrc $ included routine test diagnosis evaluated therapeutic management .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0839855102114039)\n",
      "- Text: \"PML/RARalpha FLT3-ITD induce APL-like disease mouse model . Acute promyelocytic leukemia ( APL ) cells invariably express aberrant fusion proteins involving retinoic acid receptor alpha ( RARalpha ) . common fusion partner promyelocytic leukemia protein ( PML ) , fused RARalpha balanced reciprocal chromosomal translocation , ( 15 ; 17 ) ( q22 : q11 ) . Expression PML/RARalpha cathepsin G promoter transgenic mice causes nonfatal myeloproliferative syndrome mice ; 15 % go develop APL long latent period , suggesting additional mutations required development APL . candidate target gene second mutation @ GeneSrc $ , mutated approximately 40 % human APL cases . Activating mutations FLT3 , including internal tandem duplication ( ITD ) juxtamembrane domain , transform hematopoietic cell lines factor independent growth . FLT3-ITDs also induce myeloproliferative disease murine bone marrow transplant model , sufficient cause @ DiseaseTgt $ . , test hypothesis PML/RARalpha cooperate FLT3-ITD induce APL-like disease mouse . Retroviral transduction FLT3-ITD bone marrow cells obtained PML/RARalpha transgenic mice results short latency APL-like disease complete penetrance . disease resembles APL-like disease occurs long latency PML/RARalpha transgenics , suggesting activating mutations FLT3 functionally substitute additional mutations occur mouse APL progression . leukemia transplantable secondary recipients ATRA responsive . observations document cooperation PML/RARalpha FLT3-ITD development murine APL phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1897913432453837)\n",
      "- Text: \"Point mutations juxtamembrane domain @ GeneSrc $ define new class activating mutations @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) , two clusters activating mutations known @ GeneSrc $ ( @ GeneSrc $ ) gene : @ GeneSrc $ tandem duplications ( @ GeneSrc $ ) juxtamembrane ( JM ) domain 20 % 25 % patients , @ GeneSrc $ point mutations tyrosine-kinase domain ( @ GeneSrc $ ) 7 % 10 % patients , respectively . , characterized new class activating point mutations ( PMs ) cluster 16-amino acid stretch juxtamembrane domain @ GeneSrc $ ( @ GeneSrc $ ) . Expression 4 @ GeneSrc $ interleukin-3 ( IL-3 ) -dependent Ba/F3 cells led factor-independent growth , hyperresponsiveness @ GeneSrc $ ligand , resistance apoptotic cell death . @ GeneSrc $ receptors autophosphorylated showed higher constitutive dimerization rate compared @ GeneSrc $ ( WT ) receptor . molecular mechanism , could show activation STAT5 up-regulation Bcl-x ( L ) @ GeneSrc $ . @ GeneSrc $ inhibitor PKC412 abrogated factor-independent growth @ GeneSrc $ cells . Compared @ GeneSrc $ @ GeneSrc $ mutants , @ GeneSrc $ showed weaker transforming potential related lower autophosphorylation receptor downstream target STAT5 . Mapping @ GeneSrc $ crystal structure @ GeneSrc $ showed mutations reduce stability autoinhibitory JM domain , provides structural basis transforming capacity new class gain-of-function mutations @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5679409163201233)\n",
      "- Text: \"@ GeneSrc $ stop mutation increases @ GeneSrc $ ligand level risk autoimmune thyroid disease . Autoimmune thyroid disease common autoimmune disease highly heritable1 . , using genome-wide association study 30,234 cases 725,172 controls Iceland UK Biobank , find 99 sequence variants 93 loci , 84 variants previously unreported2 - 7 . low-frequency ( 1.36 % ) intronic variant @ GeneSrc $ ( rs76428106-C ) largest effect risk autoimmune thyroid disease ( odds ratio ( ) = 1.46 , P = 2.37 x 10 - 24 ) . rs76428106-C also associated systemic lupus erythematosus ( = 1.90 , P = 6.46 x 10 - 4 ) , rheumatoid factor and/or anti-CCP-positive rheumatoid arthritis ( = 1.41 , P = 4.31 x 10 - 4 ) coeliac disease ( = 1.62 , P = 1.20 x 10 - 4 ) . @ GeneSrc $ encodes @ GeneSrc $ , receptor regulates haematopoietic progenitor dendritic cells . RNA sequencing revealed rs76428106-C generates cryptic splice site , introduces stop codon 30 % transcripts predicted encode truncated protein , lacks tyrosine kinase domains . copy rs76428106-C doubles plasma levels FTL3 ligand . Activating somatic mutations @ GeneSrc $ associated @ DiseaseTgt $ poor prognosis rs76428106-C also predisposes individuals acute myeloid leukaemia ( = 1.90 , P = 5.40 x 10 - 3 ) . Thus , predicted loss-of-function germline mutation @ GeneSrc $ causes reduction full-length @ GeneSrc $ , compensatory increase levels ligand increased disease risk , similar gain-of-function mutation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1797157323018591)\n",
      "- Text: \"Activating mutation D835 within activation loop @ GeneSrc $ human hematologic malignancies . Mutations receptor tyrosine kinases implicated constitutive activation development human malignancy . internal tandem duplication ( ITD ) juxtamembrane ( JM ) domain-coding sequence @ GeneSrc $ gene ( @ GeneSrc $ ) found 20 % patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) strongly associated leukocytosis poor prognosis . hand , mutations c-KIT gene , found mast cell leukemia @ DiseaseTgt $ , clustered 2 distinct regions , JM domain D816 within activation loop . study designed analyze mutation D835 @ GeneSrc $ , corresponds D816 c-KIT , large series human hematologic malignancies . Several kinds missense mutations found 30 429 ( 7.0 % ) @ DiseaseTgt $ cases , 1 29 ( 3.4 % ) myelodysplastic syndrome ( MDS ) cases , 1 36 ( 2.8 % ) acute lymphocytic leukemia patients . D835Y mutation frequently found ( 22 32 D835 mutations ) , followed D835V ( 5 ) , D835H ( 1 ) , D835E ( 1 ) , D835N ( 1 ) mutations . note D835 mutations occurred independently @ GeneSrc $ . analysis 201 patients newly diagnosed @ DiseaseTgt $ ( excluding M3 ) revealed , contrast @ GeneSrc $ mutation ( n = 46 ) , D835 mutations ( n = 8 ) significantly related leukocytosis , tended worsen disease-free survival . D835-mutant @ GeneSrc $ constitutively tyrosine-phosphorylated transformed 32D cells , suggesting mutations constitutively active . results demonstrate @ GeneSrc $ gene target frequently mutated become constitutively active @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8258028811352933)\n",
      "- Text: \"new recurrent activating length mutation exon 20 @ GeneSrc $ gene @ DiseaseTgt $ . Activating length mutations juxtamembrane ( JM ) domain @ GeneSrc $ gene ( @ GeneSrc $ ) mutations catalytic domain ( FLT3D835/836 ) receptor tyrosine kinase represent frequent genetic alterations @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , describe 6-bp insertion activation loop @ GeneSrc $ codons 840 841 @ GeneSrc $ ( @ GeneSrc $ - 840GS ) 2 unrelated patients @ DiseaseTgt $ . Screening activating mutations @ GeneSrc $ , KIT , NRAS showed genetic alterations patients carrying @ GeneSrc $ - 840GS . functional analyses could show mutant hyperphosphorylated tyrosine confers interleukin 3-independent growth Ba/F3 cells , inhibited specific @ GeneSrc $ protein tyrosine kinase ( PTK ) inhibitor . results show first time addition known mutations JM catalytic domain , activating length mutations exist @ GeneSrc $ gene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3784827865691285)\n",
      "- Text: \"Arginine 595 duplicated patients @ DiseaseTgt $ carrying internal tandem duplications @ GeneSrc $ modulates transforming potential . @ GeneSrc $ tandem duplications ( @ GeneSrc $ ) comprise heterogeneous group mutations patients @ DiseaseTgt $ prognostically important . characterize mechanism transformation @ GeneSrc $ , sequenced juxtamembrane region ( JM ) @ GeneSrc $ 284 patients @ DiseaseTgt $ . length @ GeneSrc $ varied 2 42 amino acids ( AAs ) median 17 AAs . analysis duplicated AAs showed majority patients , duplications localize AAs 591 599 ( YVDFREYEY ) . Arginine 595 ( R595 ) within region duplicated 77 % patients . Single duplication R595 @ GeneSrc $ conferred factor-independent growth Ba/F3 cells activated STAT5 . Moreover , deletion substitution duplicated R595 2 @ GeneSrc $ constructs well deletion wild-type R595 @ GeneSrc $ substantially reduced transforming potential STAT5 activation , pointing critical role positive charge R595 stabilizing active confirmation @ GeneSrc $ . Deletion R595 @ GeneSrc $ nearly abrogated ligand-dependent activation @ GeneSrc $ . data provide important insights molecular mechanism transformation @ GeneSrc $ show duplication R595 important leukemic potential @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3364113249635181)\n",
      "- Text: \"Images clinical medicine . @ GeneSrc $ Mutation @ DiseaseTgt $ leukostasis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0241423079022432)\n",
      "- Text: \"Fusion TEL/ETV6 novel @ GeneSrc $ myelodysplastic syndrome @ DiseaseTgt $ ( 5 ; 12 ) ( q31 ; p13 ) . identified novel human @ GeneSrc $ gene , @ GeneSrc $ , new ETV6 fusion partner gene recurrent ( 5 ; 12 ) ( q31 ; p13 ) translocation patient refractory anemia excess blasts ( RAEB ) basophilia , patient @ DiseaseTgt $ ( @ DiseaseTgt $ ) eosinophilia , patient acute eosinophilic leukemia ( AEL ) . @ GeneSrc $ expressed brain bone marrow highly conserved man rats . resulting @ GeneSrc $ fusion transcripts showed out-frame fusion exon 1 ETV6 exon 1 @ GeneSrc $ AEL case , out-frame fusion exon 1 ETV6 exon 11 @ GeneSrc $ @ DiseaseTgt $ case , short in-frame fusion ETV6 exon 1 3 ' untranslated region @ GeneSrc $ RAEB case . Reciprocal @ GeneSrc $ transcripts identified two cases . Fluorescence situ hybridization ( FISH ) analysis ETV6 cosmids 12p13 , BACs P1s 5q31 , demonstrated 5q31 breakpoints @ DiseaseTgt $ AEL cases involved 5 ' portion @ GeneSrc $ gene , 5q31 , breakpoint RAEB case involved 3 ' portion @ GeneSrc $ gene . None resulting chimeric transcripts except @ GeneSrc $ transcript RAEB case led fusion protein . Disruption second ETV6 allele ( 12 ; 19 ) detected @ DiseaseTgt $ case FISH analysis . observations suggest disruption ETV6 and/or @ GeneSrc $ may lead pathogenesis hematologic malignancies ( 5 ; 12 ) ( q31 ; p13 ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8455759748728658)\n",
      "- Text: \"Autosomal dominant dopa-responsive parkinsonism multigenerational Swiss family . AIM : describe large family autosomal dominant parkinsonism . BACKGROUND : Seven genes directly implicated autosomally inherited parkinsonism . However , several multigenerational large families known identifiable mutation . MATERIAL METHODS : Family members evaluated clinically , history chart review . Genetic investigation included SCA2 , SCA3 , UCHL1 , SNCA , LRRK2 , PINK1 , PRKN , PGRN , @ GeneSrc $ premutation , MAPT . proband underwent brain fluorodopa PET ( FD-PET ) scan , one autopsy available . RESULTS : Eleven patients diagnosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , nine women . Mean age onset 52 tremor-predominant dopa-responsive parkinsonism . Disease progression slow severe motor fluctuations occurred . One patient required subthalamic nucleus deep-brain stimulation good motor outcome . One patient mental retardation , schizophrenia became demented , another patient demented . Three patients also two unaffected subjects mild learning difficulties . genetic tests yielded negative results . FD-PET showed marked asymmetric striatal tracer uptake deficiency , consistent @ DiseaseTgt $ . Pathological examination demonstrated Lewy bodies immunostaining negative alpha-synuclein . CONCLUSION : Apart younger age onset female predominance , phenotype indistinguishable @ DiseaseTgt $ , including FD-PET scan results . known genetic causes autosomal dominant @ DiseaseTgt $ excluded , family harbors novel genetic defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1490825151757459)\n",
      "- Text: \"@ DiseaseTgt $ chemoprevention antioxidant tempol acts partially via p53 @ DiseaseTgt $ suppressor . previously demonstrated nitroxide antioxidant tempol ( 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl ) increased latency tumorigenesis doubled ( 100 % ) lifespan Atm-deficient mice , mouse model ataxia telangiectasia , displays accelerated oxidative damage stress . Tempol treatment @ DiseaseTgt $ p53-deficient mice resulted small significant ( 25 % ) increase lifespan prolonging latency tumorigenesis , demonstrating existing oxidative stress damage necessary chemopreventative effects tempol . However , relatively small effect latency p53-deficient mice finding tempol-mediated resistance oxidative insult p53-dependent suggested direct role p53 chemopreventative effects tempol . Surprisingly , tempol treatment specifically increased serine 18 phosphorylation p53 ( gamma-H2AX ) p21 expression primary thymocytes vitro p53-dependent fashion . Inhibition phosphoinositide 3-kinase ( PI3 K ) family members suggested @ GeneSrc $ responsible tempol-mediated enhancement p53 serine 18 phosphorylation . data suggest chemopreventative effect tempol solely due reduction oxidative stress damage may also related redox-mediated signaling functions include p53 pathway activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0332914232961551)\n",
      "- Text: \"PEN-2 integral component gamma-secretase complex required coordinated expression presenilin @ GeneSrc $ . @ DiseaseTgt $ presenilin ( PS ) proteins apparently provide active site gamma-secretase , unusual intramembrane-cleaving aspartyl protease . PSs principally occur high molecular weight protein complexes contain @ GeneSrc $ ( @ GeneSrc $ ) additional far unidentified components . Recently , PEN-2 implicated gamma-secretase function . identify PEN-2 critical component PS1/gamma-secretase PS2/gamma-secretase complexes . Strikingly , absence PS1 PS1/PS2 , PEN-2 levels strongly reduced . Similarly , PEN-2 levels reduced upon RNA interference-mediated down-regulation @ GeneSrc $ . side , down-regulation PEN-2 RNA interference associated reduced PS levels , impaired @ GeneSrc $ maturation , deficient gamma-secretase complex formation . conclude PEN-2 integral gamma-secretase complex component gamma-secretase complex components expressed coordinated manner .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2012865036837769)\n",
      "- Text: \"Aph-1 , Pen-2 , @ GeneSrc $ Presenilin generate active gamma-Secretase complex . Gamma-Secretase cleaves Amyloid Precursor Protein ( APP ) transmembrane domain , releasing amyloid peptide Abeta . Abeta main constituent amyloid plaques brains patients suffering @ DiseaseTgt $ . Several type integral membrane proteins also cleaved protease . Recent work indicates gamma-Secretase multiprotein complex consisting Presenilin , @ GeneSrc $ , Aph-1 , Pen-2 four proteins necessary full proteolytic activity . Since several paralogs alternatively spliced variants least Presenilin Aph-1 identified well , anticipated gamma-Secretase homogeneous activity . Gamma-Secretase interesting complex drug target challenges classical thinking proteolytic processing intracellular signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0030551238793711)\n",
      "- Text: \"Presenilin-1 , @ GeneSrc $ , amyloid precursor protein , gamma-secretase activity co-localized lysosomal membrane . @ DiseaseTgt $ ( @ DiseaseTgt $ ) caused cerebral deposition beta-amyloid ( Abeta ) , 38 - 43-amino acid peptide derived proteolytic cleavage amyloid precursor protein ( APP ) . Initial studies indicated final cleavage APP gamma-secretase ( complex containing presenilin @ GeneSrc $ ) produce Abeta occurred endosomal/lysosomal system . However , studies showing predominant endoplasmic reticulum localization gamma-secretase proteins neutral pH optimum vitro gamma-secretase assays challenged conclusion . recently identified @ GeneSrc $ major lysosomal membrane protein . present work , use Western blotting immunogold electron microscopy demonstrate significant amounts mature @ GeneSrc $ , presenilin-1 , APP co-localized lysosomal associated membrane protein-1 ( cAMP-1 ) outer membranes lysosomes . Furthermore , demonstrate membranes contain acidic gamma-secretase activity , immunoprecipitable antibody @ GeneSrc $ . experiments establish APP , @ GeneSrc $ , presenilin-1 resident lysosomal membrane proteins indicate gamma-secretase lysosomal protease . data reassert importance lysosomal/endosomal system generation Abeta suggest role lysosomes pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2845399691260016)\n",
      "- Text: \"Negative control p53 @ GeneSrc $ promotes cell survival stress . NAD-dependent histone deacetylation Sir2 connects cellular metabolism gene silencing well aging yeast . , show mammalian @ GeneSrc $ physically interacts p53 attenuates p53-mediated functions . Nicotinamide ( Vitamin B3 ) inhibits NAD-dependent p53 deacetylation induced @ GeneSrc $ , also enhances p53 acetylation levels vivo . Furthermore , @ GeneSrc $ represses p53-dependent apoptosis response DNA damage oxidative stress , whereas expression @ GeneSrc $ point mutant increases sensitivity cells stress response . Thus , findings implicate p53 regulatory pathway mediated mammalian @ GeneSrc $ . results significant implications regarding important role @ GeneSrc $ modulating sensitivity cells p53-dependent apoptotic response possible effect @ DiseaseTgt $ therapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0126785471385868)\n",
      "- Text: \"New mutations @ GeneSrc $ gene @ DiseaseTgt $ double outlet right ventricle . Conotruncal defects ( CTDs ) represent 15 - 20 % congenital heart defects . Mutations number genes associated CTD humans animal models . investigated occurrence prevalence GATA4 , NKX2.5 , @ GeneSrc $ , GDF1 , ISLET1 gene mutations large cohort individuals CTD , including @ DiseaseTgt $ without pulmonary atresia ( @ DiseaseTgt $ , 178 patients ) , double outlet right ventricle ( DORV , 13 patients ) , truncus arteriosus ( 11 patients ) . Denaturing high-performance liquid chromatography ( DHPLC ) analysis followed bidirectional sequencing disclosed putative pathogenic mutation GATA4 , ISLET1 , GDF1 genes . Two novel ( Ile227Val , Met544Ile ) one previously reported ( Glu30Gly ) possibly pathogenic missense variants identified @ GeneSrc $ gene 3 sporadic patients 202 ( 1.5 % ) CTD , including 1 178 ( 0.6 % ) @ DiseaseTgt $ 2 13 ( 15.4 % ) DORV . Mutation analysis also detected one known missense change ( Arg25Cys ) NKX2.5 gene two ( 1.1 % ) sporadic patients @ DiseaseTgt $ . sequence alterations found absent 500 population-matched controls . conclusion , present results ( ) indicate confirm mutations GATA4 , GDF1 , ISLET1 genes major determinants pathogenesis @ DiseaseTgt $ , ( ii ) provide supportive evidence association @ GeneSrc $ gene @ DiseaseTgt $ , ( iii ) provide additional examples possible contribution Arg25Cys change NKX2.5 small number @ DiseaseTgt $ cases .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8051326311894614)\n",
      "- Text: \"Mutations @ GeneSrc $ gene sporadic cases @ DiseaseTgt $ . Two 47 patients sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) , common cyanotic conotruncal heart defect ( CTD ) , showed heterozygous missense mutations @ GeneSrc $ gene . Knockout mice carrying mutations @ GeneSrc $ gene similarly found exhibit @ DiseaseTgt $ . mutant @ GeneSrc $ proteins , E30 G ( c.88A > G ) S657 G ( c.1968A > G ) , retain ability bind partner protein GATA4 repress GATA4 mediated gene activation , S657 G , E30 G , mutation subtly impaired function . @ GeneSrc $ gene mutations may contribute sporadic cases @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9457612077294256)\n",
      "- Text: \"Exome sequencing identifies rare variants multiple genes atrioventricular septal defect . PURPOSE : genetic etiology atrioventricular septal defect ( AVSD ) unknown 40 % cases . Conventional sequencing arrays identified etiology minority nonsyndromic individuals AVSD . METHODS : Whole-exome sequencing performed 81 unrelated probands AVSD identify potentially causal variants comprehensive set 112 genes strong biological relevance AVSD . RESULTS : significant enrichment rare rare damaging variants identified gene set , compared controls ( odds ratio ( ) : 1.52 ; 95 % confidence interval ( CI ) : 1.35 - 1.71 ; P = 4.8 x 10 ( -11 ) ) . enrichment specific AVSD probands , compared cohort without AVSD @ DiseaseTgt $ ( : 2.25 ; 95 % CI : 1.84 - 2.76 ; P = 2.2 x 10 ( -16 ) ) . Six genes ( NIPBL , CHD7 , CEP152 , BMPR1a , @ GeneSrc $ , MDM4 ) enriched rare variants AVSD compared controls , including three syndrome-associated genes ( NIPBL , CHD7 , CEP152 ) . findings confirmed replication cohort 81 AVSD probands . CONCLUSION : Mutations genes strong biological relevance AVSD , including syndrome-associated genes , contribute AVSD , even isolated heart disease . identification gene set associated AVSD facilitate targeted genetic screening cohort .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.4530485692649426e-06)\n",
      "- Text: \"Novel @ GeneSrc $ variants patients double outlet right ventricle . Congenital heart defects ( CHDs ) occur 0.5 - 1 % newborns common birth defects . Double outlet right ventricle ( DORV ) accounts approximately 1 - 3 % CHDs . Similar @ DiseaseTgt $ ( @ DiseaseTgt $ ) , DORV subtype contruncal heart defects ( CTDs ) anatomically characterized malposition great arteries . described boy chromosomal translocation : 46 , XY ( 8 ; 18 ) ( q22 ; q21 ) may disrupts @ GeneSrc $ locus . coding sequences @ GeneSrc $ determined 38 patients sporadic DORV , 95 patients @ DiseaseTgt $ , 12 patients transposition great arteries . Five DNA sequence variants affecting variably conserved residues @ GeneSrc $ identified patients @ DiseaseTgt $ type ventricular septal defect type DORV . Three novel mutations ( p. V339I , p. K737E , p. A611 ) reported first time . two mutations ( p. M703L p. Q889E ) reported patients congenital diaphragmatic hernia patients CHD . finding suggests variants @ GeneSrc $ gene might common cause DORV .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1110909879395598)\n",
      "- Text: \"Ataxin-2 repeat-length variation neurodegeneration . Expanded glutamine repeats ataxin-2 ( ATXN2 ) protein cause spinocerebellar ataxia type 2 ( SCA2 ) , rare neurodegenerative disorder . recent studies suggested expanded ATXN2 repeats genetic risk factor amyotrophic lateral sclerosis ( ALS ) via RNA-dependent interaction @ GeneSrc $ . Given phenotypic diversity observed SCA2 patients , set determine polymorphic nature ATXN2 repeat length across spectrum neurodegenerative disorders . study , genotyped ATXN2 repeat 3919 neurodegenerative disease patients 4877 healthy controls performed logistic regression analysis determine association repeat length risk disease . confirmed presence significantly higher number expanded ATXN2 repeat carriers ALS patients compared healthy controls ( = 5.57 ; P= 0.001 ; repeat length > 30 units ) . Furthermore , observed significant association expanded ATXN2 repeats development progressive supranuclear palsy ( = 5.83 ; P= 0.004 ; repeat length > 30 units ) . Although expanded repeat carriers also identified frontotemporal lobar degeneration , @ DiseaseTgt $ patients , significantly frequent controls . note , study identified number healthy control individuals harbor expanded repeat alleles ( 31 - 33 units ) , suggests caution taken attributing specific disease phenotypes repeat lengths . conclusion , findings confirm role ATXN2 important risk factor ALS support hypothesis expanded ATXN2 repeats may predispose neurodegenerative diseases , including progressive supranuclear palsy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.393183880305047e-05)\n",
      "- Text: \"family Parkinsonism , essential tremor , restless legs syndrome , depression . BACKGROUND : Previous epidemiologic genetic studies suggested link @ DiseaseTgt $ ( @ DiseaseTgt $ ) , essential tremor ( ET ) , restless legs syndrome ( RLS ) . METHODS : describe clinical , PET , pathologic characteristics extensive kindred Arkansas hereditary PD , ET , RLS . pedigree contains 138 individuals . Sixty-five family members examined neurologically 3 times 2004 2010 . Clinical data collected medical records questionnaires . Genetic studies performed . Five family members underwent multitracer PET . Two individuals @ DiseaseTgt $ examined postmortem . RESULTS : Eleven family members @ DiseaseTgt $ generally mild slowly progressive symptoms . Age onset 39 74 years ( mean 59.1 , SD 13.4 ) . individuals treated l-dopa responded positively . Postural action tremor present 6 individuals @ DiseaseTgt $ , 19 additional family members . Fifteen persons reported symptoms RLS . PET showed reduced presynaptic dopamine function typical sporadic @ DiseaseTgt $ patient @ DiseaseTgt $ ET , persons ET RLS . inheritance pattern autosomal dominant @ DiseaseTgt $ RLS . known pathogenic mutation @ DiseaseTgt $ genes found . Fourteen family members @ DiseaseTgt $ , ET , RLS depression . Neuropathologic examination revealed pallidonigral pigment spheroid degeneration ubiquitin-positive axonal spheroids , @ GeneSrc $ pathology basal ganglia , hippocampus , brainstem , sparse Lewy bodies . CONCLUSION : Familial forms @ DiseaseTgt $ , ET , RLS , depression occur family . genetic cause remains elucidated .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0338100992656204)\n",
      "- Text: \"Interaction Ras ( V12 ) scribbled clones induces @ DiseaseTgt $ growth invasion . Human @ DiseaseTgt $ large degree cellular genetic heterogeneity . Complex cell interactions @ DiseaseTgt $ microenvironment thought important role tumorigenesis @ DiseaseTgt $ progression . Furthermore , cooperation oncogenic genetic lesions required @ DiseaseTgt $ development ; however , known cell interactions contribute oncogenic cooperation . genetic techniques available fruitfly Drosophila melanogaster allow analysis behaviour cells distinct mutations , making ideal model organism study cell interactions oncogenic cooperation . Drosophila eye-antennal discs , cooperation oncogenic protein Ras ( V12 ) ( ref . 5 ) loss-of-function mutations conserved @ DiseaseTgt $ suppressor scribbled ( scrib ) gives rise @ DiseaseTgt $ display many characteristics observed human @ DiseaseTgt $ . show clones cells bearing different mutations cooperate promote @ DiseaseTgt $ growth invasion Drosophila . found Ras ( V12 ) scrib ( - ) mutations also cause @ DiseaseTgt $ affect different adjacent epithelial cells . show interaction Ras ( V12 ) @ GeneSrc $ ) clones involves JNK signalling propagation JNK-induced upregulation JAK/STAT-activating cytokines , compensatory growth mechanism tissue homeostasis . development Ras ( V12 ) tumours also triggered tissue damage , stress condition activates JNK signalling . Given conservation pathways examined , similar cooperative mechanisms could role development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1847216462680815)\n",
      "- Text: \"Conservation synteny genome pufferfish ( Fugu rubripes ) region human chromosome 14 ( 14q24.3 ) associated @ DiseaseTgt $ ( AD3 locus ) genome pufferfish ( Fugu rubripes ) ( 400 Mb ) approximately 7.5 times smaller human genome , similar gene repertoire man . regions two genomes exhibited conservation gene order ( i.e . , syntenic ) , possible reduce dramatically effort required identification candidate genes human disease loci sequencing syntenic regions compact Fugu genome . demonstrated three genes ( dihydrolipoamide succinyltransferase , S31iii125 , S20i15 ) , linked @ GeneSrc $ @ DiseaseTgt $ focus ( AD3 ) human chromosome 14 , homologues Fugu genome adjacent Fugu @ GeneSrc $ . relative gene order @ GeneSrc $ , S31iii125 , S20i15 genomes , Fugu three genes lay within 12.4-kb region , compared > 600 kb human AD3 locus . results demonstrate conservation synteny genomes Fugu man highlight utility approach sequence-based identification genes human disease loci .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.281466357385863e-05)\n",
      "- Text: \"Common variants ABCA7 , MS4A6A/MS4A4E , EPHA1 , CD33 @ GeneSrc $ associated @ DiseaseTgt $ . sought identify new susceptibility loci @ DiseaseTgt $ staged association study ( GERAD+ ) testing suggestive loci reported @ DiseaseTgt $ Genetic Consortium ( ADGC ) companion paper . undertook combined analysis four genome-wide association datasets ( stage 1 ) identified ten newly associated variants P < = 1 x 10 ( -5 ) . tested variants association independent sample ( stage 2 ) . Three SNPs two loci replicated showed evidence association sample ( stage 3 ) . Meta-analyses data provided compelling evidence ABCA7 ( rs3764650 , meta P = 4.5 x 10 ( -17 ) ; including ADGC data , meta P = 5.0 x 10 ( -21 ) ) MS4A gene cluster ( rs610932 , meta P = 1.8 x 10 ( -14 ) ; including ADGC data , meta P = 1.2 x 10 ( -16 ) ) new @ DiseaseTgt $ susceptibility loci . also found independent evidence association three loci reported ADGC , , combined , showed genome-wide significance : @ GeneSrc $ ( GERAD+ , P = 8.0 x 10 ( -4 ) ; including ADGC data , meta P = 8.6 x 10 ( -9 ) ) , CD33 ( GERAD+ , P = 2.2 x 10 ( -4 ) ; including ADGC data , meta P = 1.6 x 10 ( -9 ) ) EPHA1 ( GERAD+ , P = 3.4 x 10 ( -4 ) ; including ADGC data , meta P = 6.0 x 10 ( -10 ) ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0121396486778319)\n",
      "- Text: \"Beta-secretase cleavage Alzheimer 's amyloid precursor protein transmembrane aspartic protease @ GeneSrc $ . Cerebral deposition amyloid beta peptide ( Abeta ) early critical feature @ DiseaseTgt $ . Abeta generation depends proteolytic cleavage amyloid precursor protein ( APP ) two unknown proteases : beta-secretase gamma-secretase . proteases prime therapeutic targets . transmembrane aspartic protease known characteristics beta-secretase cloned characterized . Overexpression protease , termed @ GeneSrc $ ( @ GeneSrc $ ) increased amount beta-secretase cleavage products , cleaved exactly known beta-secretase positions . Antisense inhibition endogenous @ GeneSrc $ messenger RNA decreased amount beta-secretase cleavage products , purified @ GeneSrc $ protein cleaved APP-derived substrates sequence specificity beta-secretase . Finally , expression pattern subcellular localization @ GeneSrc $ consistent expected beta-secretase . Future development @ GeneSrc $ inhibitors may prove beneficial treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1189814528964483)\n",
      "- Text: \"Membrane-anchored aspartyl protease @ DiseaseTgt $ beta-secretase activity . Mutations gene encoding amyloid protein precursor ( APP ) cause autosomal dominant @ DiseaseTgt $ . Cleavage APP unidentified proteases , referred beta- gamma-secretases , generates amyloid beta-peptide , main component amyloid plaques found @ DiseaseTgt $ patients . disease-causing mutations flank protease cleavage sites APP facilitate cleavage . identify new membrane-bound aspartyl protease ( @ GeneSrc $ ) beta-secretase activity . @ GeneSrc $ gene expressed widely brain tissues . Decreasing expression @ GeneSrc $ cells reduces amyloid beta-peptide production blocks accumulation carboxy-terminal APP fragment created beta-secretase cleavage . Solubilized @ GeneSrc $ protein cleaves synthetic APP peptide substrate beta-secretase site , rate cleavage increased tenfold mutation associated early-onset @ DiseaseTgt $ Sweden . Thus , @ GeneSrc $ new protein target drugs designed block production amyloid beta-peptide peptide consequent formation amyloid plaque @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2790927237180209)\n",
      "- Text: \"Mutant presenilins specifically elevate levels 42 residue beta-amyloid peptide vivo : evidence augmentation 42-specific gamma secretase . Amyloid precursor protein ( APP ) endoproteolytically processed @ GeneSrc $ gamma-secretase release amyloid peptides ( Abeta40 42 ) aggregate form senile plaques brains patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) . C-terminus Abeta40/42 generated gamma-secretase , whose activity dependent upon presenilin ( PS 1 2 ) . Missense mutations PS1 ( PS2 ) occur patients early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , previous studies transgenic mice cultured cell models demonstrated @ DiseaseTgt $ variants shift ratio Abeta40 : 42 favor Abeta42 . One hypothesis explain outcome mutant PS alters specificity gamma-secretase favor production Abeta42 expense Abeta40 . test hypothesis vivo , studied Abeta40 42 levels series transgenic mice co-express Swedish mutation APP ( APPswe ) two @ DiseaseTgt $ variants differentially accelerate amyloid pathology brain . demonstrate direct correlation concentration Abeta42 rate amyloid deposition . show shift Abeta42 : 40 ratios associated expression @ DiseaseTgt $ variants due specific elevation steady-state levels Abeta42 , maintaining constant level Abeta40 . data suggest PS1 variants simply alter preferred cleavage site gamma-secretase , rather complex effects regulation gamma-secretase access substrates .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8733442084728849)\n",
      "- Text: \"BACE1 deficiency rescues memory deficits cholinergic dysfunction mouse model @ DiseaseTgt $ . beta-site APP cleaving enzyme 1 ( BACE1 ) beta-secretase enzyme required generating pathogenic beta-amyloid ( Abeta ) peptides @ DiseaseTgt $ ( @ DiseaseTgt $ ) . BACE1 knockout mice lack Abeta phenotypically normal , suggesting therapeutic inhibition BACE1 may free mechanism-based side effects . However , direct evidence BACE1 inhibition would improve cognition lacking . show BACE1 null mice engineered overexpress human APP ( @ GeneSrc $ ) ) rescued Abeta-dependent hippocampal memory deficits . Moreover , impaired hippocampal cholinergic regulation neuronal excitability found Tg2576 @ DiseaseTgt $ model ameliorated BACE1 ( -/- ) .Tg2576 ( + ) bigenic mice . behavioral electrophysiological rescue deficits BACE1 ( -/- ) .Tg2576 ( + ) mice correlated dramatic reduction cerebral Abeta40 Abeta42 levels occurs amyloid deposition Tg2576 mice . gene-based approach demonstrates lower Abeta levels beneficial @ DiseaseTgt $ memory impairments , validating BACE1 therapeutic target @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0011589025009687)\n",
      "- Text: \"LRRK2 regulates autophagic activity localizes specific membrane microdomains novel human genomic reporter cellular model . Leucine rich repeat kinase 2 ( LRRK2 ) mutations common genetic cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) although LRRK2 function remains unclear . report new role LRRK2 regulating autophagy describe recruitment LRRK2 endosomal-autophagic pathway specific membrane subdomains . Using novel human genomic reporter cellular model , found LRRK2 locate membrane microdomains neck caveolae , microvilli/filopodia intraluminal vesicles multivesicular bodies ( MVBs ) . human brain cultured human cells LRRK2 present cytoplasmic puncta corresponding MVBs autophagic vacuoles ( AVs ) . Expression common R1441C mutation genomic DNA construct caused impaired autophagic balance evident accumulation MVBs large AVs containing incompletely degraded material increased levels @ GeneSrc $ . Furthermore , R1441C mutation induced formation skein-like abnormal MVBs . Conversely , LRRK2 siRNA knockdown increased autophagic activity prevented cell death caused inhibition autophagy starvation conditions . work necessitated developing new , efficient recombineering strategy , termed Sequential insertion Target ovErlapping Primers ( STEP ) seamlessly fuse green fluorescent protein-derivative YPet human LRRK2 protein LRRK2 genomic locus carried bacterial artificial chromosome . Taken together data demonstrate functional involvement LRRK2 endosomal-autophagic pathway recruitment specific membrane microdomains physiological human gene expression model suggesting novel function important @ DiseaseTgt $ protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0283773144771485)\n",
      "- Text: \"Ferroptosis p53-mediated activity @ DiseaseTgt $ suppression . Although p53-mediated cell-cycle arrest , senescence apoptosis serve critical barriers @ DiseaseTgt $ development , emerging evidence suggests metabolic activities p53 also important . show p53 inhibits cystine uptake sensitizes cells ferroptosis , non-apoptotic form cell death , repressing expression @ GeneSrc $ , key component cystine/glutamate antiporter . Notably , p53 ( 3KR ) , acetylation-defective mutant fails induce cell-cycle arrest , senescence apoptosis , fully retains ability regulate @ GeneSrc $ expression induce ferroptosis upon reactive oxygen species ( ROS ) -induced stress . Analysis mutant mice shows non-canonical p53 activities contribute embryonic development lethality associated loss Mdm2 . Moreover , @ GeneSrc $ highly expressed human @ DiseaseTgt $ , overexpression inhibits ROS-induced ferroptosis abrogates p53 ( 3KR ) -mediated @ DiseaseTgt $ growth suppression xenograft models . findings uncover new mode @ DiseaseTgt $ suppression based p53 regulation cystine metabolism , ROS responses ferroptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7427041143570694)\n",
      "- Text: \"@ GeneSrc $ knockout mice healthy despite lacking primary beta-secretase activity brain : implications @ DiseaseTgt $ therapeutics . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disorder characterized accumulation amyloid plaques neurofibrillary tangles brain . major components plaque , beta-amyloid peptides ( Abetas ) , produced amyloid precursor protein ( APP ) activity beta- gamma-secretases . beta-secretase activity cleaves APP define N-terminus Abeta1-x peptides , therefore , long- sought therapeutic target treatment @ DiseaseTgt $ . gene encoding beta-secretase beta-site APP cleaving enzyme ( @ GeneSrc $ ) identified recently . However , known whether @ GeneSrc $ primary beta-secretase mammalian brain whether inhibition beta-secretase might effects mammals would preclude utility therapeutic target . work described herein , generated two lines @ GeneSrc $ knockout mice characterized pathology , beta-secretase activity Abeta production . mice appeared develop normally showed consistent phenotypic differences wild-type littermates , including overall normal tissue morphology brain histochemistry , normal blood urine chemistries , normal blood-cell composition , overt behavioral neuromuscular effects . Brain primary cortical cultures @ GeneSrc $ knockout mice showed detectable beta-secretase activity , primary cortical cultures @ GeneSrc $ knockout mice produced much less Abeta APP . findings @ GeneSrc $ primary beta-secretase activity brain loss beta-secretase activity produces profound phenotypic defects concomitant reduction beta-amyloid peptide clearly indicate @ GeneSrc $ excellent therapeutic target treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3360414903684799)\n",
      "- Text: \"GSK-3alpha regulates production @ DiseaseTgt $ amyloid-beta peptides . @ DiseaseTgt $ associated increased production aggregation amyloid-beta ( Abeta ) peptides . Abeta peptides derived amyloid precursor protein ( APP ) sequential proteolysis , catalysed aspartyl protease @ GeneSrc $ , followed presenilin-dependent gamma-secretase cleavage . Presenilin interacts nicastrin , APH-1 PEN-2 ( ref . 6 ) , required gamma-secretase function . Presenilins also interact alpha-catenin , beta-catenin glycogen synthase kinase-3beta ( GSK-3beta ) , functional role proteins gamma-secretase activity established . show therapeutic concentrations lithium , GSK-3 inhibitor , block production Abeta peptides interfering APP cleavage gamma-secretase step , inhibit Notch processing . Importantly , lithium also blocks accumulation Abeta peptides brains mice overproduce APP . target lithium setting GSK-3alpha , required maximal processing APP . Since GSK-3 also phosphorylates tau protein , principal component neurofibrillary tangles , inhibition GSK-3alpha offers new approach reduce formation amyloid plaques neurofibrillary tangles , two pathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0791751239613193)\n",
      "- Text: \"@ GeneSrc $ deficiency rescues memory deficits cholinergic dysfunction mouse model @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) beta-secretase enzyme required generating pathogenic beta-amyloid ( Abeta ) peptides @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ knockout mice lack Abeta phenotypically normal , suggesting therapeutic inhibition @ GeneSrc $ may free mechanism-based side effects . However , direct evidence @ GeneSrc $ inhibition would improve cognition lacking . show @ GeneSrc $ null mice engineered overexpress human APP ( BACE1 ( -/- ) .Tg2576 ( + ) ) rescued Abeta-dependent hippocampal memory deficits . Moreover , impaired hippocampal cholinergic regulation neuronal excitability found Tg2576 @ DiseaseTgt $ model ameliorated @ GeneSrc $ ) bigenic mice . behavioral electrophysiological rescue deficits @ GeneSrc $ ) mice correlated dramatic reduction cerebral Abeta40 Abeta42 levels occurs amyloid deposition Tg2576 mice . gene-based approach demonstrates lower Abeta levels beneficial @ DiseaseTgt $ memory impairments , validating @ GeneSrc $ therapeutic target @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2018076225508921)\n",
      "- Text: \"prolyl isomerase @ GeneSrc $ regulates amyloid precursor protein processing amyloid-beta production . Neuropathological hallmarks @ DiseaseTgt $ neurofibrillary tangles composed tau neuritic plaques comprising amyloid-beta peptides ( Abeta ) derived amyloid precursor protein ( APP ) , exact relationship remains elusive . Phosphorylation tau APP certain serine threonine residues preceding proline affects tangle formation Abeta production vitro . Phosphorylated Ser/Thr-Pro motifs peptides exist cis trans conformations , conversion catalysed @ GeneSrc $ prolyl isomerase . @ GeneSrc $ proposed regulate protein function accelerating conformational changes , activity never visualized biological pathological significance @ GeneSrc $ substrate conformations unknown . Notably , @ GeneSrc $ downregulated and/or inhibited oxidation @ DiseaseTgt $ neurons , @ GeneSrc $ knockout causes tauopathy neurodegeneration , @ GeneSrc $ promoter polymorphisms appear associate reduced @ GeneSrc $ levels increased risk late-onset @ DiseaseTgt $ . However , role @ GeneSrc $ APP processing Abeta production unknown . show @ GeneSrc $ profound effects APP processing Abeta production . find @ GeneSrc $ binds phosphorylated Thr 668-Pro motif APP accelerates isomerization 1,000-fold , regulating APP intracellular domain two conformations , visualized NMR . Whereas @ GeneSrc $ overexpression reduces Abeta secretion cell cultures , knockout @ GeneSrc $ increases secretion . @ GeneSrc $ knockout alone combination overexpression mutant APP mice increases amyloidogenic APP processing selectively elevates insoluble Abeta42 ( major toxic species ) brains age-dependent manner , Abeta42 prominently localized multivesicular bodies neurons , shown @ DiseaseTgt $ plaque pathology . Thus , @ GeneSrc $ prolyl isomerization novel mechanism regulate APP processing Abeta production , deregulation may link tangle plaque pathologies . findings provide new insight pathogenesis treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3034932084893546)\n",
      "- Text: \"Parkin , gene implicated autosomal recessive juvenile parkinsonism , candidate tumor suppressor gene chromosome 6q25-q27 . effort identify tumor suppressor gene ( ) associated frequent loss heterozygosity observed chromosome 6q25-q27 , constructed contig derived sequences bacterial artificial chromosomeP1 bacteriophage artificial chromosome clones defined genetic interval D6S1581-D6S1579-D6S305-D6S1599-D6S1008 . Sequence analysis contig found contain eight known genes , including complete genomic structure Parkin gene . Loss heterozygosity ( LOH ) analysis 40 malignant @ DiseaseTgt $ identified common minimal region loss , including markers D6S305 ( 50 % ) D6S1599 ( 32 % ) . loci exhibited highest frequencies LOH study located within Parkin genomic structure . Whereas mutation analysis revealed missense substitutions , expression Parkin gene appeared down-regulated absent tumor biopsies tumor cell lines examined . addition , identification two truncating deletions 3 20 @ DiseaseTgt $ samples , well homozygous deletion exon 2 lung adenocarcinoma cell lines Calu-3 H-1573 , supports hypothesis hemizygous homozygous deletions responsible abnormal expression Parkin samples . data suggest LOH observed chromosome 6q25-q26 may contribute initiation andor progression cancer inactivating reducing expression Parkin gene . Parkin maps @ GeneSrc $ , one active common fragile sites human genome , represents another example large tumor suppressor gene , like FHIT WWOX , located common fragile site .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025217498071208)\n",
      "- Text: \"Colonic polyposis caused mTOR-mediated chromosomal instability Apc+/Delta716 Cdx2+/- compound mutant mice . mammalian homeobox transcription factor CDX2 key roles intestinal development differentiation . Heterozygous Cdx2 mice develop one two benign hamartomas proximal colon , whereas heterozygous Apc ( Delta716 ) mice develop numerous adenomatous polyps , mostly small intestine . show colonic polyp number six times higher Apc+/Delta716 Cdx2+/- compound mutant mice . Levels APC CDX2 significantly lower distal colon , caused high anaphase bridge index ( ABI ) associated higher frequency loss heterozygosity ( LOH ) Apc . cultured rat intestinal epithelial human @ DiseaseTgt $ cell lines , suppression CDX2 antisense RNA caused marked increases ABI chromosomal aberrations . mediated stimulation mTOR pathway , causing translational deregulation G1-S acceleration , associated low levels p27 activation cyclin E-Cdk2 . obtained similar results colonic mucosa Apc+/Delta716 ) Cdx2+/- compound mutant mice . Forced activation mTOR upstream regulator @ GeneSrc $ also increased ABI @ DiseaseTgt $ cells . High ABI cell lines suppressed mTOR inhibitors LY294002 rapamycin . results suggest reduced expression CDX2 important colon tumorigenesis mTOR-mediated chromosomal instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0203714298458224)\n",
      "- Text: \"Colonic polyposis caused mTOR-mediated chromosomal instability Apc+/Delta716 Cdx2+/- compound mutant mice . mammalian homeobox transcription factor CDX2 key roles intestinal development differentiation . Heterozygous Cdx2 mice develop one two benign hamartomas proximal colon , whereas heterozygous Apc ( Delta716 ) mice develop numerous adenomatous polyps , mostly small intestine . show colonic polyp number six times higher Apc+/Delta716 Cdx2+/- compound mutant mice . Levels @ GeneSrc $ CDX2 significantly lower distal colon , caused high anaphase bridge index ( ABI ) associated higher frequency loss heterozygosity ( LOH ) Apc . cultured rat intestinal epithelial human @ DiseaseTgt $ cell lines , suppression CDX2 antisense RNA caused marked increases ABI chromosomal aberrations . mediated stimulation mTOR pathway , causing translational deregulation G1-S acceleration , associated low levels p27 activation cyclin E-Cdk2 . obtained similar results colonic mucosa Apc+/Delta716 ) Cdx2+/- compound mutant mice . Forced activation mTOR upstream regulator Akt also increased ABI @ DiseaseTgt $ cells . High ABI cell lines suppressed mTOR inhibitors LY294002 rapamycin . results suggest reduced expression CDX2 important colon tumorigenesis mTOR-mediated chromosomal instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0147458637086475)\n",
      "- Text: \"target-selected @ GeneSrc $ rat kindred enhances modeling familial human @ DiseaseTgt $ . Progress toward understanding management human @ DiseaseTgt $ significantly advanced appropriate experimental platforms become available . investigated whether rat model carrying knockout allele gatekeeper gene @ GeneSrc $ ( @ GeneSrc $ ) recapitulates @ DiseaseTgt $ human closely existing murine models . established mutagen-induced nonsense allele rat @ GeneSrc $ gene inbred F344/NTac ( F344 ) genetic background . Carriers mutant allele develop multiple neoplasms distribution colon small intestine closely simulates found human familial adenomatous polyposis patients . distinguish phenotype predominantly small intestinal phenotype found Apc-mutant mouse strains , strain designated polyposis rat colon ( Pirc ) kindred . Pirc rat kindred provides several unique favorable features study @ DiseaseTgt $ . Tumor-bearing Pirc rats live least 17 months , carrying significant colonic tumor burden . tumors imaged micro computed tomography scanning classical endoscopy , enabling longitudinal studies tumor genotype phenotype function response chemopreventive therapeutic regimes . metacentric character rat karyotype , like human unlike acrocentric mouse , enabled us demonstrate loss wild-type @ GeneSrc $ allele tumors involve chromosome loss . believe Pirc rat kindred address many current gaps modeling human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0911449074225833)\n",
      "- Text: \"Neuroprotective effects @ GeneSrc $ rodent primate models @ DiseaseTgt $ . Profound neuronal dysfunction entorhinal cortex contributes early loss short-term memory @ DiseaseTgt $ . show broad neuroprotective effects entorhinal brain-derived neurotrophic factor ( BDNF ) administration several animal models @ DiseaseTgt $ , extension therapeutic benefits degenerating hippocampus . amyloid-transgenic mice , BDNF gene delivery , administered disease onset , reverses synapse loss , partially normalizes aberrant gene expression , improves cell signaling restores learning memory . outcomes occur independently effects amyloid plaque load . aged rats , @ GeneSrc $ infusion reverses cognitive decline , improves age-related perturbations gene expression restores cell signaling . adult rats primates , @ GeneSrc $ prevents lesion-induced death entorhinal cortical neurons . aged primates , @ GeneSrc $ reverses neuronal atrophy ameliorates age-related cognitive impairment . Collectively , findings indicate @ GeneSrc $ exerts substantial protective effects crucial neuronal circuitry involved @ DiseaseTgt $ , acting amyloid-independent mechanisms . @ GeneSrc $ therapeutic delivery merits exploration potential therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.004316882611623)\n",
      "- Text: \"Similarity protein encoded human c-erb-B-2 gene epidermal growth factor receptor . novel v-erb-B-related gene , c-erb-B-2 , identified human genome , maps human chromosome 17 q21 ( ref . 40 ) , seems encode polypeptide kinase domain highly homologous , distinct , epidermal growth factor ( EGF ) receptor . c-erb-B-2 gene conserved vertebrates suggested neu gene , detected series rat neuro/glioblastomas , , fact , rat @ GeneSrc $ gene . Amplification c-erb-B-2 gene salivary adenocarcinoma @ DiseaseTgt $ cell line MKN-7 suggests over-expression sometimes involved neoplastic process . determine nature c-erb-B-2 protein , molecularly cloned complementary DNA c-erb-B-2 messenger RNA prepared MKN-7 cells . sequence shows c-erb-B-2 gene encodes possible receptor protein allows analysis similarity protein EGF receptor neu product . consequence chromosomal aberration MKN-7 cells , 4.6-kilobase ( kb ) normal transcript truncated 2.3-kb transcript c-erb-B-2 synthesized elevated levels . latter transcript presumably encodes extracellular domain putative receptor .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.02642805449702e-05)\n",
      "- Text: \"Leucine-rich repeat kinase 2 deficiency protective rhabdomyolysis-induced kidney injury . Mutations leucine-rich repeat kinase 2 ( LRRK2 ) gene common known genetic cause @ DiseaseTgt $ , LRRK2 also linked Crohn 's Hansen 's disease . LRRK2 expressed many organs mammals particularly abundant kidney . find LRRK2 protein predominantly localized collecting duct cells rat kidney , much lower expression kidney cells . genetic knockout ( KO ) LRRK2 expression well-tolerated mice rats , unique age-dependent pathology develops kidney . cortex medulla LRRK2 KO rat kidneys become darkly pigmented early adulthood , yet aged animals display overt signs kidney failure . Accompanying dark pigment find substantial macrophage infiltration LRRK2 KO kidneys , suggesting presence chronic inflammation may predispose kidney disease . Unexpectedly , dark kidneys LRRK2 KO rats highly resistant rhabdomyolysis-induced acute kidney injury compared wild-type rats . Biochemical profiling LRRK2 KO kidneys using immunohistochemistry , proteomic lipidomic analyses show massive accumulation hemoglobin lipofuscin renal tubules account pigmentation . proximal tubules demonstrate corresponding up-regulation cytoprotective protein @ GeneSrc $ ( @ GeneSrc $ ) capable mitigating acute kidney injury . unusual kidney pathology LRRK2 KO rats highlights several novel physiological roles LRRK2 provides indirect evidence @ GeneSrc $ expression protective mechanism acute kidney injury LRRK2 deficiency .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001856572533381)\n",
      "- Text: \"Mutant mice lacking p53 C-terminal domain model telomere syndromes . Mutations p53 , although frequent human @ DiseaseTgt $ , implicated telomere-related syndromes . , show homozygous mutant mice expressing p53Delta31 , p53 lacking C-terminal domain , exhibit increased p53 activity suffer aplastic anemia pulmonary fibrosis , hallmarks syndromes caused short telomeres . Indeed , p53Delta31/Delta31 mice short telomeres phenotypic traits associated telomere disease dyskeratosis congenita severe variant Hoyeraal-Hreidarsson syndrome . Heterozygous p53+/Delta31 mice mildly affected , decreased levels Mdm4 , negative regulator p53 , led dramatic aggravation symptoms . Importantly , several genes involved telomere metabolism downregulated p53Delta31/Delta31 cells , including @ GeneSrc $ , Rtel1 , Tinf2 , mutated dyskeratosis congenita , Terf1 , implicated aplastic anemia . Together , data reveal truncating mutation activate p53 p53 plays major role regulation telomere metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Haplotypes gene expression implicate MAPT region @ DiseaseTgt $ : GenePD Study . BACKGROUND : Microtubule-associated protein tau ( MAPT ) associated several neurodegenerative disorders including forms parkinsonism @ DiseaseTgt $ ( @ DiseaseTgt $ ) . evaluated association MAPT region @ DiseaseTgt $ large cohort familial @ DiseaseTgt $ cases recruited GenePD Study . addition , postmortem brain samples patients @ DiseaseTgt $ neurologically normal controls used evaluate whether expression 3-repeat 4-repeat isoforms MAPT , neighboring genes @ GeneSrc $ ( @ GeneSrc $ ) KIAA1267 , altered @ DiseaseTgt $ cerebellum . METHODS : Twenty-one single-nucleotide polymorphisms ( SNPs ) region MAPT chromosome 17q21 genotyped GenePD Study . Single SNPs haplotypes , including H1 haplotype , evaluated association @ DiseaseTgt $ . Relative quantification gene expression performed using real-time RT-PCR . RESULTS : adjusting multiple comparisons , SNP rs1800547 significantly associated @ DiseaseTgt $ affection . H1 haplotype associated significantly increased risk @ DiseaseTgt $ , novel H1 subhaplotype identified predicted greater increased risk @ DiseaseTgt $ . expression 4-repeat MAPT , @ GeneSrc $ , KIAA1267 significantly increased @ DiseaseTgt $ brains relative controls . difference expression observed 3-repeat MAPT . CONCLUSIONS : study supports role MAPT pathogenesis familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Interestingly , results gene expression studies suggest genes vicinity MAPT , specifically @ GeneSrc $ KIAA1267 , may also role @ DiseaseTgt $ suggest complex effects genes region @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0774368709573446)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human @ DiseaseTgt $ . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable epidermal growth factor @ GeneSrc $ cell proliferation associated AKT , ERK , GSK3beta phosphorylation . Paradoxically , GSK3beta inhibitors lithium chloride SB216763 selectively decreased proliferation human breast colorectal cancer cell lines oncogenic PIK3CA mutations led decrease GSK3beta target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 colon cancer cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest GSK3beta important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties @ DiseaseTgt $ harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0030000603391647)\n",
      "- Text: \"PIK3CA mutations associated gene signature low mTORC1 signaling better outcomes estrogen receptor-positive breast cancer . PIK3CA mutations reported present approximately 25 % breast cancer ( BC ) , particularly estrogen receptor-positive ( ER+ ) HER2-overexpressing ( HER2 + ) subtypes , making one common genetic aberrations BC . experimental models , mutations shown activate AKT induce oncogenic transformation , hence lesions hypothesized render @ DiseaseTgt $ highly sensitive therapeutic @ GeneSrc $ inhibition . analyzing gene expression protein data nearly 1,800 human BCs , report PIK3CA mutation-associated gene signature ( PIK3CA-GS ) derived exon 20 ( kinase domain ) mutations able predict PIK3CA mutation status two independent datasets , strongly suggesting characteristic set gene expression-induced changes . However , ER+/HER2- BC despite pathway activation , PIK3CA mutations associated phenotype relatively low mTORC1 signaling good prognosis tamoxifen monotherapy . relationship clinical outcome PIK3CA-GS also assessed . Although PIK3CA-GS associated prognosis ER- HER2 + BC , could identify better clinical outcomes ER+/HER2- disease . ER+ BC cell lines , PIK3CA mutations also associated sensitivity tamoxifen . findings could important implications treatment PIK3CA-mutant BCs development @ GeneSrc $ inhibitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032830925461368)\n",
      "- Text: \"De novo somatic mutations components @ GeneSrc $ pathway cause hemimegalencephaly . De novo somatic mutations focal areas well documented diseases @ DiseaseTgt $ rarely reported malformation developing brain . Hemimegalencephaly ( HME ) characterized overgrowth either one two cerebral hemispheres . molecular etiology HME remains mystery . intractable epilepsy associated HME relieved surgical treatment hemispherectomy , allowing sampling diseased tissue . Exome sequencing mass spectrometry analysis paired brain-blood samples individuals HME ( n = 20 cases ) identified de novo somatic mutations 30 % affected individuals PIK3CA , AKT3 @ GeneSrc $ genes . recurrent PIK3CA c.1633G > mutation found four separate cases . Identified mutations present 8 - 40 % sequenced alleles various brain regions associated increased neuronal S6 protein phosphorylation brains affected individuals , indicating aberrant activation @ GeneSrc $ ( @ GeneSrc $ ) signaling . Thus HME probably genetically mosaic disease caused gain function phosphatidylinositol 3-kinase @ GeneSrc $ signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0109140250468326)\n",
      "- Text: \"TSC2 phosphorylated inhibited Akt suppresses @ GeneSrc $ signalling . Tuberous sclerosis ( TSC ) autosomal dominant disorder characterized formation hamartomas wide range human tissues . Mutation either TSC1 TSC2 @ DiseaseTgt $ suppressor gene responsible familial sporadic forms disease . TSC1 TSC2 proteins form physical functional complex vivo . , show TSC1-TSC2 inhibits p70 ribosomal protein S6 kinase 1 ( activator translation ) activates eukaryotic initiation factor 4E binding protein 1 ( 4E-BP1 , inhibitor translational initiation ) . functions TSC1-TSC2 mediated inhibition @ GeneSrc $ ( @ GeneSrc $ ) . Furthermore , TSC2 directly phosphorylated Akt , involved stimulating cell growth activated growth stimulating signals , insulin . TSC2 inactivated Akt-dependent phosphorylation , destabilizes TSC2 disrupts interaction TSC1 . data indicate molecular mechanism TSC2 insulin signalling , @ DiseaseTgt $ suppressor functions inhibition cell growth .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0308706688514676)\n",
      "- Text: \"Phosphorylation regulation Akt/PKB @ GeneSrc $ complex . Deregulation Akt/protein kinase B ( PKB ) implicated pathogenesis @ DiseaseTgt $ diabetes . Akt/PKB activation requires phosphorylation Thr308 activation loop phosphoinositide-dependent kinase 1 ( PDK1 ) Ser473 within carboxyl-terminal hydrophobic motif unknown kinase . show Drosophila human cells target rapamycin ( TOR ) kinase associated protein rictor necessary Ser473 phosphorylation reduction rictor mammalian TOR ( @ GeneSrc $ ) expression inhibited Akt/PKB effector . @ GeneSrc $ complex directly phosphorylated Akt/PKB Ser473 vitro facilitated Thr308 phosphorylation PDK1 . @ GeneSrc $ may serve drug target @ DiseaseTgt $ lost expression PTEN , @ DiseaseTgt $ suppressor opposes Akt/PKB activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0359343716568444)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human cancers . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable epidermal growth factor @ GeneSrc $ cell proliferation associated AKT , ERK , GSK3beta phosphorylation . Paradoxically , GSK3beta inhibitors lithium chloride SB216763 selectively decreased proliferation human breast @ DiseaseTgt $ cell lines oncogenic PIK3CA mutations led decrease GSK3beta target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 @ DiseaseTgt $ cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest GSK3beta important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties cancers harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008740405304693)\n",
      "- Text: \"eIF4F nexus resistance anti-BRAF anti-MEK cancer therapies . BRAF ( V600 ) -mutant tumours , mechanisms resistance drugs target BRAF and/or MEK kinases rely reactivation RAS-RAF-MEK-ERK mitogen-activated protein kinase ( MAPK ) signal transduction pathway , activation alternative , @ GeneSrc $ , pathway ( ERK independent ) modulation caspase-dependent apoptotic cascade . three pathways converge regulate formation eIF4F eukaryotic translation initiation complex , binds 7-methylguanylate cap ( ( 7 ) G ) 5 ' end messenger RNA , thereby modulating translation specific mRNAs . show persistent formation eIF4F complex , comprising eIF4E cap-binding protein , eIF4 G scaffolding protein eIF4A RNA helicase , associated resistance anti-BRAF , anti-MEK anti-BRAF plus anti-MEK drug combinations BRAF ( V600 ) -mutant melanoma , @ DiseaseTgt $ cell lines . Resistance treatment maintenance eIF4F complex formation associated one three mechanisms : reactivation MAPK signalling , persistent ERK-independent phosphorylation inhibitory eIF4E-binding protein 4EBP1 increased pro-apoptotic BCL-2-modifying factor ( BMF ) -dependent degradation eIF4 G . development situ method detect eIF4E-eIF4 G interactions shows eIF4F complex formation decreased tumours respond anti-BRAF therapy increased resistant metastases compared tumours treatment . Strikingly , inhibiting eIF4F complex , either blocking eIF4E-eIF4 G interaction targeting eIF4A , synergizes inhibiting BRAF ( V600 ) kill cancer cells . eIF4F appears indicator innate acquired resistance also promising therapeutic target . Combinations drugs targeting BRAF ( and/or MEK ) eIF4F may overcome resistance mechanisms arising BRAF ( V600 ) -mutant cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0336103922104912)\n",
      "- Text: \"molecular evolution acquired resistance targeted EGFR blockade colorectal cancers . Colorectal tumours wild type KRAS often sensitive EGFR blockade , almost always develop resistance within several months initiating therapy . mechanisms underlying acquired resistance anti-EGFR antibodies largely unknown . situation marked contrast small-molecule targeted agents , inhibitors @ GeneSrc $ , EGFR , BRAF MEK , mutations genes encoding protein targets render @ DiseaseTgt $ resistant effects drugs . simplest hypothesis account development resistance EGFR blockade rare cells KRAS mutations pre-exist low levels @ DiseaseTgt $ ostensibly wild-type KRAS genes . Although hypothesis would seem readily testable , evidence pre-clinical models support , data patients . test hypothesis , determined whether mutant KRAS DNA could detected circulation 28 patients receiving monotherapy panitumumab , therapeutic anti-EGFR antibody . found 9 24 ( 38 % ) patients whose @ DiseaseTgt $ initially KRAS wild type developed detectable mutations KRAS sera , three developed multiple different KRAS mutations . appearance mutations consistent , generally occurring 5 6 months following treatment . Mathematical modelling indicated mutations present expanded subclones initiation panitumumab treatment . results suggest emergence KRAS mutations mediator acquired resistance EGFR blockade mutations detected non-invasive manner . explain @ DiseaseTgt $ develop resistance targeted therapies highly reproducible fashion .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9347382658650784)\n",
      "- Text: \"Restoration p53 function leads @ DiseaseTgt $ regression vivo . Tumorigenesis multi-step process requires activation oncogenes inactivation @ DiseaseTgt $ suppressor genes . Mouse models human @ DiseaseTgt $ recently demonstrated continuous expression dominantly acting oncogene ( example , Hras , Kras Myc ) often required @ DiseaseTgt $ maintenance ; phenotype referred oncogene addiction . concept received clinical validation development active anticancer drugs specifically inhibit function oncoproteins @ GeneSrc $ , c-KIT EGFR . Identifying additional gene mutations required @ DiseaseTgt $ maintenance may therefore yield clinically useful targets new @ DiseaseTgt $ therapies . Although loss p53 function common feature human @ DiseaseTgt $ , known whether sustained inactivation @ DiseaseTgt $ suppressor pathways required @ DiseaseTgt $ maintenance . explore issue , developed Cre-loxP-based strategy temporally control @ DiseaseTgt $ suppressor gene expression vivo . show restoring endogenous p53 expression leads regression autochthonous lymphomas sarcomas mice without affecting normal tissues . mechanism responsible @ DiseaseTgt $ regression dependent @ DiseaseTgt $ type , main consequence p53 restoration apoptosis lymphomas suppression cell growth features cellular senescence sarcomas . results support efforts treat human @ DiseaseTgt $ way pharmacological reactivation p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9889596187720152)\n",
      "- Text: \"( 6 ; 9 ) chromosome translocation , associated specific subtype @ DiseaseTgt $ , leads aberrant transcription target gene 9q34 . specific ( 6 ; 9 ) ( p23 ; q34 ) chromosomal translocation associated defined subtype @ DiseaseTgt $ ( @ DiseaseTgt $ ) . 9q34 breakpoint located telomeric side @ GeneSrc $ gene . combination chromosome jumping , long-range mapping , chromosome walking , chromosome 9 breakpoints several @ DiseaseTgt $ patients localized within defined region 8 kilobases ( kb ) , 360 kb telomeric @ GeneSrc $ . Subsequent cDNA cloning revealed region represented intron middle gene , called Cain ( ) , encoding 7.5-kb transcript . Disruption gene translocation resulted expression new 5.5-kb mRNA 6p- chromosome . Isolation chromosome 6 sequences showed breakpoints 6p23 also clustered within limited stretch DNA . data strongly suggest direct involvement translocation leukemic process @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4033015900530502)\n",
      "- Text: \"role presenilin cofactors gamma-secretase complex . Mutations presenilin genes account majority cases familial form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Presenilin essential gamma-secretase activity , proteolytic activity involved intramembrane cleavage Notch beta-amyloid precursor protein ( betaAPP ) . Cleavage betaAPP @ DiseaseTgt $ mutant presenilin results overproduction highly amyloidogenic amyloid beta42 peptides . gamma-Secretase activity requires formation stable , high-molecular-mass protein complex , addition endoproteolysed fragmented form presenilin , contains essential cofactors including nicastrin , APH-1 ( refs 15 - 18 ) @ GeneSrc $ ( refs 16 , 19 ) . However , role protein complex formation generation enzymatic activity unclear . show Drosophila APH-1 ( Aph-1 ) increases stability Drosophila presenilin ( Psn ) holoprotein complex . Depletion @ GeneSrc $ RNA interference prevents endoproteolysis presenilin promotes stabilization holoprotein Drosophila mammalian cells , including primary neurons . Co-expression Drosophila @ GeneSrc $ Aph-1 nicastrin increases formation Psn fragments well gamma-secretase activity . Thus , APH-1 stabilizes presenilin holoprotein complex , whereas @ GeneSrc $ required endoproteolytic processing presenilin conferring gamma-secretase activity complex .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9236969600379424)\n",
      "- Text: \"reporter amyloid precursor protein gamma-secretase activity Drosophila . key event pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) deposition senile plaques consisting largely peptide known beta-amyloid ( Abeta ) derived amyloid precursor protein ( APP ) . proteolytic activity called gamma-secretase cleaves APP transmembrane domain required Abeta generation . Aberrant gamma-secretase cleavage APP underlies majority early onset , familial @ DiseaseTgt $ . gamma-Secretase resides large multi-protein complex , Presenilin , Nicastrin , APH-1 @ GeneSrc $ four essential components . Thus , identifying components pathways gamma-secretase activity regulated crucial understanding mechanisms underlying @ DiseaseTgt $ pathogenesis , may provide new diagnostic tools therapeutic targets . describe generation Drosophila act living reporters gamma-secretase activity fly eye . reporter flies size eye correlates level endogenous gamma-secretase activity , sensitive levels three genes required APP gamma-secretase activity , presenilin , nicastrin aph-1 . Thus , flies provide sensitized system identify components gamma-secretase complex regulators activity . used flies carry screen mutations suppress gamma-secretase activity identified small chromosomal region contains gene genes whose products may promote gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1269206758066801)\n",
      "- Text: \"Apolipoprotein ( apo ) E4 enhances amyloid beta peptide production cultured neuronal cells : apoE structure potential therapeutic target . Apolipoprotein ( apo ) E4 major risk factor @ DiseaseTgt $ , many studies suggested apoE isoform-specific effects deposition clearance amyloid beta ( Abeta ) peptides . examined effects apoE isoforms processing amyloid precursor protein ( APP ) Abeta production rat neuroblastoma B103 cells stably transfected human wild-type APP695 ( B103-APP ) . Lipid-poor apoE4 increased Abeta production B103-APP cells greater extent lipid-poor apoE3 ( 60 % vs. 30 % ) due pronounced stimulation APP recycling apoE4 apoE3 . difference Abeta production abolished preincubating cells receptor-associated protein ( 25 nM ) , blocks low-density lipoprotein receptor-related protein ( @ GeneSrc $ ) pathway , reducing @ GeneSrc $ expression small interference RNA . differences also attenuated replacing Arg-61 threonine apoE4 pretreating apoE4 small molecules , abolish apoE4 intramolecular domain interaction . Thus , apoE4 appears modulate APP processing Abeta production LRP pathway domain interaction . findings provide insights apoE4 associated increased risk @ DiseaseTgt $ may represent potential target drug development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.262571717014112e-05)\n",
      "- Text: \"mouse homolog human amyloid beta protein ( @ GeneSrc $ ) gene located distal end mouse chromosome 16 : extension homology human chromosome 21 mouse chromosome 16 . human amyloid beta protein major constituent brain amyloid plaques found @ DiseaseTgt $ . gene encodes protein located chromosome 21 , individuals syndrome ( trisomy 21 ) also exhibit early onset form @ DiseaseTgt $ . used cloned human amyloid beta protein gene panel somatic cell hybrids map location mouse homolog gene . report mouse gene located chromosome 16 within region 16C3 - -- -ter , common three genes map within syndrome region human chromosome 21 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1023854031863601)\n",
      "- Text: \"Fyn kinase regulates misfolded alpha-synuclein uptake NLRP3 inflammasome activation microglia . Persistent microglia-mediated neuroinflammation major pathophysiological contributor progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) , cell-signaling mechanisms governing chronic neuroinflammation well understood . , show Fyn kinase , conjunction class B scavenger receptor CD36 , regulates microglial uptake aggregated human alpha-synuclein ( alphaSyn ) , major component @ DiseaseTgt $ . alphaSyn effectively mediate LPS-independent priming activation microglial NLRP3 inflammasome . Fyn kinase regulates processes ; mediates PKCdelta-dependent NF-kappaB-p65 nuclear translocation , leading inflammasome priming , facilitates alphaSyn import microglia , contributing generation mitochondrial reactive oxygen species consequently inflammasome activation . vivo experiments using A53 viral-alphaSyn overexpression mouse models well human @ DiseaseTgt $ neuropathological results confirm role @ GeneSrc $ NLRP3 inflammasome activation . Collectively , study identifies novel @ GeneSrc $ signaling mechanism amplifies neuroinflammation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1331455064303445)\n",
      "- Text: \"Inducible expression mutant alpha-synuclein decreases proteasome activity increases sensitivity mitochondria-dependent apoptosis . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common progressive neurodegenerative disorder caused loss dopaminergic neurons substantia nigra . Although mutations alpha-synuclein identified autosomal dominant @ DiseaseTgt $ , mechanism dopaminergic neural cell death occurs remains unknown . Proteins encoded two genes mutations cause familial @ DiseaseTgt $ , parkin UCH-L1 , involved regulation ubiquitin-proteasome pathway , suggesting dysregulation ubiquitin-proteasome pathway involved mechanism mutations cause @ DiseaseTgt $ . established inducible PC12 cell lines wild-type mutant alpha-synuclein de-repressed removing doxycycline . Differentiated PC12 cell lines expressing mutant alpha-synuclein showed decreased activity proteasomes without direct toxicity . Cells expressing mutant alpha-synuclein showed increased sensitivity apoptotic cell death treated sub-toxic concentrations exogenous proteasome inhibitor . Apoptosis accompanied mitochondrial depolarization elevation @ GeneSrc $ , blocked cyclosporin . data suggest expression mutant alpha-synuclein results sensitivity impairment proteasome activity , leading mitochondrial abnormalities neuronal cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7310720552563339)\n",
      "- Text: \"Gleevec inhibits beta-amyloid production Notch cleavage . Amyloid-beta ( Abeta ) peptides , consisting mainly 40 42 aa ( Abeta40 Abeta42 , respectively ) , metabolites amyloid precursor protein believed major pathological determinants @ DiseaseTgt $ . proteolytic cleavages form Abeta N C termini catalyzed beta-secretase gamma-secretase , respectively . demonstrate gamma-secretase generation Abeta N2a cell-free system ATP dependent . addition , Abl kinase inhibitor imatinib mesylate ( Gleevec , STI571 ) , targets ATP-binding site Abl several tyrosine kinases , potently reduces Abeta production N2a cell-free system intact N2a cells . STI571 related compound , inhibitor 2 , also reduce Abeta production rat primary neuronal cultures vivo guinea pig brain . STI571 inhibit gamma-secretase-catalyzed S3 cleavage @ GeneSrc $ . Furthermore , production Abeta inhibition STI571 demonstrated occur similar extents Abl-/- WT mouse fibroblasts , indicating effect STI571 Abeta production involve Abl kinase . efficacy STI571 reducing Abeta without affecting Notch-1 cleavage may prove useful basis developing novel therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.797890736375783e-05)\n",
      "- Text: \"Specific inhibition CBP/beta-catenin interaction rescues defects neuronal differentiation caused presenilin-1 mutation . Wnt/beta-catenin signaling shown promote self-renewal variety tissue stem cells , including neuronal stem cells hematopoietic stem cells . However , activation Wnt/beta-catenin pathway promoted inhibition pathway prevented differentiation neuronal precursor cells . clear explanation differential effects Wnt/beta-catenin activation neuronal precursors available present . Presenilin-1 ( PS-1 ) polytopic protein comprised six eight transmembrane domains . PS-1 , part gamma-secretase complex , required intramembrane proteolysis amyloid precursor protein ( APP ) @ GeneSrc $ . Additionally , interactions beta-catenin , PS-1 associated modulation Wnt/beta-catenin signaling . @ DiseaseTgt $ PS-1 mutant , PS-1 ( L286V ) , causes dramatic increase cell factor ( TCF ) /beta-catenin transcription PC-12 cells , prevents normal nerve growth factor ( NGF ) -induced neuronal differentiation neurite outgrowth . Selective inhibition TCF/beta-catenin/cAMP-response element-binding protein ( CREB ) -binding protein ( CBP ) -mediated transcription , TCF/beta-catenin/p300 , recently described small molecule antagonist ICG-001 corrects defects neuronal differentiation , highlighting importance Wnt/beta-catenin signaling process . propose increased TCF/beta-catenin/CBP-mediated transcription , well failure switch TCF/beta-catenin/p300-mediated transcription , play important role decreasing neuronal differentiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0040131185765144)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , MLXIPL , @ GeneSrc $ , GALNT2 GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012659588948414)\n",
      "- Text: \"@ GeneSrc $ mutations cause autosomal recessive , early-onset parkinsonian-pyramidal syndrome . BACKGROUND : combination early-onset , progressive parkinsonism pyramidal tract signs known pallido-pyramidal parkinsonian-pyramidal syndrome since first description Davison 1954 . recently , locus mapped single family overlapping phenotype , @ GeneSrc $ gene mutation nominated likely disease cause . METHODS : performed clinical genetic studies two families early-onset , progressive parkinsonism pyramidal tract signs . RESULTS : @ GeneSrc $ homozygous truncating mutation ( Arg498Stop ) found Italian family , compound heterozygous mutations ( splice-site IVS7 + 1G/T mutation missense Thr22Met mutation ) present Dutch family . also found evidence expression novel normal splice-variants @ GeneSrc $ . phenotype associated @ GeneSrc $ mutations consisted early-onset , progressive parkinsonism pyramidal tract signs , thereby matching clinically pallido-pyramidal syndrome Davison . parkinsonism exhibits varying degrees levodopa responsiveness different patients . CONCLUSIONS : conclusively show recessive @ GeneSrc $ mutations cause progressive neurodegeneration extrapyramidal pyramidal system involvement , delineating novel genetically defined entity propose designate @ GeneSrc $ . Understanding @ GeneSrc $ mutations cause disease shed light molecular mechanisms neurodegeneration , potential implications also common forms parkinsonism , @ DiseaseTgt $ multiple system atrophy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0470936464422706)\n",
      "- Text: \"@ GeneSrc $ mutations promote protein aggregation mitochondria inhibit mitophagy . mutations @ GeneSrc $ ( @ GeneSrc $ ) gene ( T22 , R378 G R498X ) associated severe form autosomal recessive juvenile-onset Parkinson 's disease ( @ DiseaseTgt $ ) ( PARK 15 ) . demonstrated wild-type ( WT ) @ GeneSrc $ stress response protein play cytoprotective neurotoxic roles . WT @ GeneSrc $ protein vital cell mitophagy facilitate mitophagy protect cells , whereas mutant @ GeneSrc $ inhibits mitophagy . Upon stress , endogenous WT @ GeneSrc $ gets up-regulated , concentrates mitochondria forms @ GeneSrc $ aggregates mitochondria . However , @ GeneSrc $ mutations aggravate deleterious @ GeneSrc $ aggregation mitochondria . @ GeneSrc $ aggregation toxicity alleviated Proline , glutathione ( GSH ) coenzyme Q10 , whereas deleterious @ GeneSrc $ aggregation mitochondria aggravated prohibitin 1 ( PHB1 ) , mitochondrial protease inhibitor . overexpression WT @ GeneSrc $ could lead @ GeneSrc $ protein aggregation dopamine neuron degeneration transgenic Drosophila heads . elevated @ GeneSrc $ expression aggregation identified human fibroblast cells @ DiseaseTgt $ patients . @ GeneSrc $ also form aggregates brains @ DiseaseTgt $ Alzheimer 's disease . study provides novel pathophysiologic insights suggests @ GeneSrc $ may potential therapeutic target @ GeneSrc $ neuron degeneration @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9049998918753548)\n",
      "- Text: \"Large-scale meta-analysis genome-wide association data identifies six new risk loci @ DiseaseTgt $ . conducted meta-analysis @ DiseaseTgt $ genome-wide association studies using common set 7,893,274 variants across 13,708 cases 95,282 controls . Twenty-six loci identified genome-wide significant association ; 6 additional previously reported loci tested independent set 5,353 cases 5,551 controls . 32 tested SNPs , 24 replicated , including 6 newly identified loci . Conditional analyses within loci showed four loci , including GBA , @ GeneSrc $ , SNCA HLA region , contain secondary independent risk variant . total , identified replicated 28 independent risk variants @ DiseaseTgt $ across 24 loci . Although effect individual locus small , risk profile analysis showed substantial cumulative risk comparison highest lowest quintiles genetic risk ( odds ratio ( ) = 3.31 , 95 % confidence interval ( CI ) = 2.55 - 4.30 ; P = 2 x 10 ( -16 ) ) . also show six risk loci associated proximal gene expression DNA methylation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1672114291017722)\n",
      "- Text: \"Aberrant folding pathogenic Parkin mutants : aggregation versus degradation . Loss-of-function mutations Parkin gene ( PARK2 ) responsible majority autosomal recessive Parkinson disease . growing body evidence indicates misfolding aggregation Parkin major mechanism Parkin inactivation , accounting loss-of-function phenotype various pathogenic Parkin mutants . Remarkably , wild-type Parkin also prone misfolding certain cellular conditions , suggesting general role Parkin pathogenesis @ DiseaseTgt $ . show misfolding Parkin lead two phenotypes : formation detergent-insoluble , aggregated Parkin , destabilization Parkin resulting accelerated proteasomal degradation . combining two pathogenic Parkin mutations , could demonstrate destabilization Parkin dominant formation detergent-insoluble Parkin aggregates . Furthermore , comparative analysis @ GeneSrc $ , E3 ubiquitin ligase RBR domain highly homologous Parkin , revealed folding Parkin specifically dependent integrity C-terminal domain , presence putative PDZ-binding motif extreme C terminus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.2395776773012032e-05)\n",
      "- Text: \"Exome sequencing identifies rare variants multiple genes atrioventricular septal defect . PURPOSE : genetic etiology atrioventricular septal defect ( AVSD ) unknown 40 % cases . Conventional sequencing arrays identified etiology minority nonsyndromic individuals AVSD . METHODS : Whole-exome sequencing performed 81 unrelated probands AVSD identify potentially causal variants comprehensive set 112 genes strong biological relevance AVSD . RESULTS : significant enrichment rare rare damaging variants identified gene set , compared controls ( odds ratio ( ) : 1.52 ; 95 % confidence interval ( CI ) : 1.35 - 1.71 ; P = 4.8 x 10 ( -11 ) ) . enrichment specific AVSD probands , compared cohort without AVSD @ DiseaseTgt $ ( : 2.25 ; 95 % CI : 1.84 - 2.76 ; P = 2.2 x 10 ( -16 ) ) . Six genes ( @ GeneSrc $ , CHD7 , CEP152 , BMPR1a , ZFPM2 , MDM4 ) enriched rare variants AVSD compared controls , including three syndrome-associated genes ( @ GeneSrc $ , CHD7 , CEP152 ) . findings confirmed replication cohort 81 AVSD probands . CONCLUSION : Mutations genes strong biological relevance AVSD , including syndrome-associated genes , contribute AVSD , even isolated heart disease . identification gene set associated AVSD facilitate targeted genetic screening cohort .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.185443868685782e-06)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , MLXIPL , PCSK9 , @ GeneSrc $ GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002132128880097)\n",
      "- Text: \"Vitamin C selectively kills KRAS BRAF mutant colorectal cancer cells targeting @ GeneSrc $ . half human colorectal cancers ( CRCs ) carry either KRAS BRAF mutations often refractory approved targeted therapies . found cultured human CRC cells harboring KRAS BRAF mutations selectively killed exposed high levels vitamin C. effect due increased uptake oxidized form vitamin C , dehydroascorbate ( DHA ) , via GLUT1 glucose transporter . Increased DHA uptake causes oxidative stress intracellular DHA reduced vitamin C , depleting glutathione . Thus , reactive oxygen species accumulate inactivate @ GeneSrc $ ( @ GeneSrc $ ) . Inhibition @ GeneSrc $ highly glycolytic KRAS BRAF mutant cells leads energetic crisis cell death seen KRAS BRAF wild-type cells . High-dose vitamin C impairs @ DiseaseTgt $ growth Apc/Kras ( G12D ) mutant mice . results provide mechanistic rationale exploring therapeutic use vitamin C CRCs KRAS BRAF mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0573401675624735)\n",
      "- Text: \"Vitamin C selectively kills KRAS BRAF mutant @ DiseaseTgt $ cells targeting @ GeneSrc $ . half human @ DiseaseTgt $ ( @ DiseaseTgt $ ) carry either KRAS BRAF mutations often refractory approved targeted therapies . found cultured human @ DiseaseTgt $ cells harboring KRAS BRAF mutations selectively killed exposed high levels vitamin C. effect due increased uptake oxidized form vitamin C , dehydroascorbate ( DHA ) , via GLUT1 glucose transporter . Increased DHA uptake causes oxidative stress intracellular DHA reduced vitamin C , depleting glutathione . Thus , reactive oxygen species accumulate inactivate @ GeneSrc $ ( @ GeneSrc $ ) . Inhibition @ GeneSrc $ highly glycolytic KRAS BRAF mutant cells leads energetic crisis cell death seen KRAS BRAF wild-type cells . High-dose vitamin C impairs tumor growth Apc/Kras ( G12D ) mutant mice . results provide mechanistic rationale exploring therapeutic use vitamin C @ DiseaseTgt $ KRAS BRAF mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1912723426390901)\n",
      "- Text: \"APOE * 4-associated @ DiseaseTgt $ risk modified alpha 1-antichymotrypsin polymorphism . Genetic studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) , devastating neurodegenerative disorder , identified apolipoprotein E ( APOE ) gene strong susceptibility marker @ DiseaseTgt $ . E * 4 allele APOE major risk factor @ DiseaseTgt $ regardless age onset family history . However , observation APOE * 4 allele neither necessary sufficient expression @ DiseaseTgt $ emphasizes involvement environmental genetic elements , either conjunction APOE * 4 alone , increase individual 's risk developing @ DiseaseTgt $ . Among candidate genes may affect risk multifactorial disease gene coding alpha 1-antichymotrypsin ( ACT ) . Like APOE protein , ACT binds beta-amyloid peptide ( @ GeneSrc $ ) high affinity filamentous deposits found @ DiseaseTgt $ brain serves strong stimulatory factor polymerization @ GeneSrc $ amyloid filaments . @ DiseaseTgt $ brains , ACT expression enhanced , particularly areas develop amyloid plaques , suggesting ACT may play important role pathogenesis @ DiseaseTgt $ . show common polymorphism signal peptide ACT confers significant risk @ DiseaseTgt $ . Furthermore , APOE * 4 gene dosage effect associated @ DiseaseTgt $ risk significantly modified ACT polymorphism . also identified unique combination ACT/AA APOE 4/4 genotypes potential susceptibility marker @ DiseaseTgt $ , frequency 1/17 @ DiseaseTgt $ group compared 1/313 general population control . data show ACT behaves modifier gene alters @ DiseaseTgt $ risk conventionally associated APOE * 4 allele .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7211429377621841)\n",
      "- Text: \"Tumor suppressor candidate TSSC5 regulated UbcH6 novel ubiquitin ligase @ GeneSrc $ . region human chromosome 11p15.5 linked Beckwith-Wiedemann syndrome associated susceptibility Wilms ' tumor , rhabdomyosarcoma hepatoblastoma . TSSC5 ( @ DiseaseTgt $ subchromosomal transferable fragment cDNA ; also known ORCTL2/IMPT1/BWR1A/SLC22A1L ) located region . expression TSSC5 genes region regulated paternal imprinting . Mutations and/or reduced expression TSSC5 found certain @ DiseaseTgt $ . TSSC5 encodes efflux transporter-like protein 10 transmembrane domains , whose regulation may affect drug sensitivity , cellular metabolism growth . , present evidences indicating @ GeneSrc $ , novel conserved RING-finger protein PA ( protease-associated ) domain PEST sequence , ubiquitin ligase TSSC5 function concert ubiquitin-conjugating enzyme UbcH6 . polyubiquitin target site TSSC5 mapped region 6th hydrophilic loop . Ectopic expression @ GeneSrc $ HeLa cells caused accumulation cells G1 observed expression form @ GeneSrc $ residue within RING finger mutated inactivate ligase activity . @ GeneSrc $ may define novel ubiquitin-proteasome pathway targets TSSC5 mammalian cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0389134279779311)\n",
      "- Text: \"@ GeneSrc $ gene ( @ GeneSrc $ ) variants Asn56Ser Asn457Thr pathogenic @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) gene recently proposed responsible gene @ GeneSrc $ locus . Ten different putative pathogenic variants identified cohorts @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients Italy France . Among variants Asn56Ser Asn457Thr found repeatedly . present study screened 669 @ DiseaseTgt $ patients ( predominantly central European origin ) 1051 control individuals presence two variants . Asn56Ser found one patient positive family history disease one control individual . affected sister patient carry variant . Asn457Thr found one patient , exceptional Egyptian origin three control individuals . variant found 50 control individuals Egypt . conclude neither two variants plays major role pathogenesis @ DiseaseTgt $ study population .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9646500691834168)\n",
      "- Text: \"Variation @ GeneSrc $ associated @ DiseaseTgt $ . OBJECTIVE : recent study reported mutations gene chromosome 2q36 - 37 , @ GeneSrc $ , result @ DiseaseTgt $ ( @ DiseaseTgt $ ) . previously reported linkage chromosomal region sample multiplex @ DiseaseTgt $ families , strongest evidence linkage obtained using subset sample strongest family history disease meeting strictest diagnostic criteria . tested whether mutations @ GeneSrc $ may account previously observed linkage finding . METHODS : sequenced @ GeneSrc $ coding region 96 unrelated patients @ DiseaseTgt $ used original study contributed chromosome 2q36 - 37 linkage signal . Subsequently , genotyped entire sample 566 multiplex @ DiseaseTgt $ kindreds well 1,447 controls test whether variants @ GeneSrc $ causative increase susceptibility @ DiseaseTgt $ . RESULTS : detected three novel variants well one previously reported seven variants total five multiple @ DiseaseTgt $ families ; however , consistent evidence variants segregated @ DiseaseTgt $ families . also find significant increase risk @ DiseaseTgt $ among inheriting variants @ GeneSrc $ ( p = 0.28 ) . CONCLUSIONS : believe variation gene @ GeneSrc $ accounts previously reported linkage finding chromosome 2q36 - 37 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4909200459824069)\n",
      "- Text: \"Lack replication association @ GeneSrc $ variants @ DiseaseTgt $ . Mutations @ GeneSrc $ recently described causative @ DiseaseTgt $ Europeans . attempt replicate results independent populations , sequenced entire coding region @ GeneSrc $ large series Portuguese North American samples . report finding two previously published mutations neurologically normal Control individuals . suggests mutations @ GeneSrc $ strongly related development disease either populations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7899887605372641)\n",
      "- Text: \"GIGYF2 gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . Grb10-Interacting GYF Protein 2 ( GIGYF2 ) initially identified interaction Grb10 , adapter protein binds activated IGF-I insulin receptors . @ GeneSrc $ gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( @ GeneSrc $ locus ) , association @ GeneSrc $ mutations @ DiseaseTgt $ described recent publications . study investigated consequences Gigyf2 gene disruption mice . Gigyf2 null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous Gigyf2 ( +/- ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , Gigyf2 ( +/- ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . alpha-synuclein positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts Gigyf2 null mice exhibit decreased IGF-I-stimulated IGF-I receptor tyrosine phosphorylation augmented ERK1/2 phosphorylation . data provide evidence important role GIGYF2 age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0008165903183684)\n",
      "- Text: \"Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene @ GeneSrc $ locus familial @ DiseaseTgt $ . genetic basis association @ GeneSrc $ region chromosome 2 familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) unknown . study examined @ GeneSrc $ ( @ GeneSrc $ ) ( @ GeneSrc $ ) gene , contains @ GeneSrc $ microsatellite marker highest linkage score ( D2S206 , LOD 5.14 ) . 27 coding exons @ GeneSrc $ gene sequenced 123 Italian 126 French patients familial PD , plus 131 Italian 96 French controls . total seven different @ GeneSrc $ missense mutations resulting single amino acid substitutions present 12 unrelated @ DiseaseTgt $ index patients ( 4.8 % ) controls . Three amino acid insertions deletions found four index patients absent controls . Specific exon sequencing showed ten sequence changes absent 91 controls . four families amino acid substitutions least one @ DiseaseTgt $ case available , @ GeneSrc $ mutations ( Asn56Ser , Thr112Ala , Asp606Glu ) segregated @ DiseaseTgt $ . , however , two unaffected carriers one family , suggesting age-dependent incomplete penetrance . One index case ( @ DiseaseTgt $ onset age 33 ) inherited @ GeneSrc $ mutation ( Ile278Val ) affected father ( @ DiseaseTgt $ onset age 66 ) previously described @ DiseaseTgt $ mutation LRRK2 gene ( Ile1371Val ) affected mother ( @ DiseaseTgt $ onset age 61 ) . earlier onset severe clinical course index patient suggest additive effects @ GeneSrc $ LRRK2 mutations . data strongly support @ GeneSrc $ @ GeneSrc $ gene causal role familial PD .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.978705064870484)\n",
      "- Text: \"Non-synonymous @ GeneSrc $ variants @ DiseaseTgt $ two Asian populations . Mutations @ GeneSrc $ gene @ GeneSrc $ locus recently reported @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , pathogenicity mutations debated . conducted comprehensive genetic analysis entire @ GeneSrc $ gene cohort young onset familial @ DiseaseTgt $ patients , followed screening specific variants separate group @ DiseaseTgt $ healthy controls . total 850 study subjects [ 450 @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients 400 controls ] two Asian countries included . analysis revealed 17 variants distributed across entire @ GeneSrc $ gene . Ten novel variants eight non-synonymous ( heterozygous ) . eight , half novel polymorphic variants ( 0.2 - 2 % ) whereas four novel non-synonymous variants detected healthy controls . seven @ DiseaseTgt $ patients non-synonymous variants mean age age onset 55.3 50.9 years . typical features @ DiseaseTgt $ one positive family history . collective frequency non-synonymous variants higher @ DiseaseTgt $ compared controls ( 1.6 vs. 0 % , P = 0.016 , relative risk 1.9 , 95 % CI 1.2 , 1.9 ) . None previously reported pathogenic mutations Italian French patients present cohort . data suggest @ GeneSrc $ unlikely play major role Asian populations . Rare non-synonymous variants appeared enriched @ DiseaseTgt $ patients compared healthy controls . However , vivo functional studies segregation analysis large pedigrees needed determine single heterozygous variants represent rare mutations , risk alleles benign polymorphisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.962757564994346)\n",
      "- Text: \"GATA transcription factors directly regulate @ DiseaseTgt $ gene alpha-synuclein . Increased alpha-synuclein gene ( SNCA ) dosage due locus multiplication causes autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Variation SNCA expression may critical common , genetically complex @ DiseaseTgt $ underlying regulatory mechanism unknown . show SNCA heme metabolism genes ALAS2 , FECH , BLVRB form block tightly correlated gene expression 113 samples human blood , SNCA naturally abounds ( validated P = 1.6 x 10 ( -11 ) , 1.8 x 10 ( -10 ) , 6.6 x 10 ( -5 ) ) . Genetic complementation analysis revealed four genes co-induced transcription factor @ GeneSrc $ . @ GeneSrc $ specifically occupies conserved region within SNCA intron-1 directly induces 6.9-fold increase alpha-synuclein . Endogenous GATA-2 highly expressed substantia nigra vulnerable @ DiseaseTgt $ , occupies intron-1 , modulates SNCA expression dopaminergic cells . critical link GATA factors SNCA may enable therapies designed lower alpha-synuclein production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4751072643797093)\n",
      "- Text: \"Transcriptional regulation alpha-synuclein gene human brain tissue . transcriptional regulation gene encoding alpha-synuclein ( SNCA ) thought play critical role pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , common genetic variability gene associated elevated risk developing @ DiseaseTgt $ . However , relevant mechanisms still poorly understood . far , proteins identified transcription factors ( TFs ) SNCA cellular models . show two TFs bind DNA human brain tissue : zinc finger protein ZSCAN21 occupies region within SNCA intron 1 , described , @ GeneSrc $ occupies specific region within intron 2 , identified new binding site within complex structure 5'-promoter region SNCA . Electrophoretic mobility shift assays confirmed binding sites . Genetic investigations revealed polymorphisms mutations within sites . better understanding TF-DNA interactions within SNCA may allow develop novel therapies designed reduce alpha-synuclein levels .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1773659309161639)\n",
      "- Text: \"GATA transcription factors directly regulate @ DiseaseTgt $ gene alpha-synuclein . Increased alpha-synuclein gene ( SNCA ) dosage due locus multiplication causes autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Variation SNCA expression may critical common , genetically complex @ DiseaseTgt $ underlying regulatory mechanism unknown . show SNCA heme metabolism genes ALAS2 , FECH , BLVRB form block tightly correlated gene expression 113 samples human blood , SNCA naturally abounds ( validated P = 1.6 x 10 ( -11 ) , 1.8 x 10 ( -10 ) , 6.6 x 10 ( -5 ) ) . Genetic complementation analysis revealed four genes co-induced transcription factor GATA-1 . GATA-1 specifically occupies conserved region within SNCA intron-1 directly induces 6.9-fold increase alpha-synuclein . Endogenous @ GeneSrc $ highly expressed substantia nigra vulnerable @ DiseaseTgt $ , occupies intron-1 , modulates SNCA expression dopaminergic cells . critical link GATA factors SNCA may enable therapies designed lower alpha-synuclein production .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0742926711666131)\n",
      "- Text: \"New mutations ZFPM2/FOG2 gene @ DiseaseTgt $ double outlet right ventricle . Conotruncal defects ( CTDs ) represent 15 - 20 % congenital heart defects . Mutations number genes associated CTD humans animal models . investigated occurrence prevalence @ GeneSrc $ , NKX2.5 , ZFPM2/FOG2 , GDF1 , ISLET1 gene mutations large cohort individuals CTD , including @ DiseaseTgt $ without pulmonary atresia ( @ DiseaseTgt $ , 178 patients ) , double outlet right ventricle ( DORV , 13 patients ) , truncus arteriosus ( 11 patients ) . Denaturing high-performance liquid chromatography ( DHPLC ) analysis followed bidirectional sequencing disclosed putative pathogenic mutation @ GeneSrc $ , ISLET1 , GDF1 genes . Two novel ( Ile227Val , Met544Ile ) one previously reported ( Glu30Gly ) possibly pathogenic missense variants identified ZFPM2/FOG2 gene 3 sporadic patients 202 ( 1.5 % ) CTD , including 1 178 ( 0.6 % ) @ DiseaseTgt $ 2 13 ( 15.4 % ) DORV . Mutation analysis also detected one known missense change ( Arg25Cys ) NKX2.5 gene two ( 1.1 % ) sporadic patients @ DiseaseTgt $ . sequence alterations found absent 500 population-matched controls . conclusion , present results ( ) indicate confirm mutations @ GeneSrc $ , GDF1 , ISLET1 genes major determinants pathogenesis @ DiseaseTgt $ , ( ii ) provide supportive evidence association ZFPM2/FOG2 gene @ DiseaseTgt $ , ( iii ) provide additional examples possible contribution Arg25Cys change NKX2.5 small number @ DiseaseTgt $ cases .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6724755252871855)\n",
      "- Text: \"Mutations @ GeneSrc $ NKX2.5 genes Chinese pediatric patients non-familial congenital heart disease . number mutations @ GeneSrc $ NKX2.5 identified causative subset familial congenital heart defects ( CHDs ) small number sporadic CHDs . study , evaluated common @ GeneSrc $ NKX2.5 mutations 135 Chinese pediatric patients non-familial congenital heart defects . Two novel mutations coding region @ GeneSrc $ identified , namely , 487C > ( Pro163Ser ) exon 1 child @ DiseaseTgt $ 1220C > ( Pro407Gln ) exon 6 pediatric patient outlet membranous ventricular septal defect . also found 848C > ( Pro283Gln ) exon 2 NKX2.5 gene pediatric patient ventricular septal defect , patent ductus arteriosus aortic isthmus stenosis . None mutations detected healthy control subjects ( n = 114 ) . study suggests @ GeneSrc $ NKX2.5 missense mutations may associated congenital heart defects pediatric Chinese patients . clinical studies large samples warranted .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025229152211802)\n",
      "- Text: \"@ GeneSrc $ sequence variants patients congenital heart disease . BACKGROUND : Recent reports identified mutations transcription factor @ GeneSrc $ familial cases cardiac septal defects . prevalence @ GeneSrc $ mutations population patients septal defects unknown . Given patients septal conotruncal defect share common genetic basis , unclear whether patients additional types CHD might also @ GeneSrc $ mutations . AIMS : explore questions investigating large population 628 patients either septal conotruncal defects @ GeneSrc $ sequence variants . METHODS : @ GeneSrc $ coding region exon-intron boundaries investigated sequence variants using denaturing high-performance liquid chromatography conformation-sensitive gel electrophoresis . Samples showing peak band shifts reamplified genomic DNA sequenced . RESULTS : Four missense sequence variants ( Gly93Ala , Gln316Glu , Ala411Val , Asp425Asn ) identified five patients ( two atrial septal defect , two ventricular septal defect one @ DiseaseTgt $ ) , seen control population . four affected amino acid residues conserved across species , two sequence variants lead changes polarity . Ten synonymous sequence variants also identified 18 patients , seen control population . CONCLUSIONS : data suggest non-synonymous @ GeneSrc $ sequence variants found small percentage patients septal defects uncommonly found patients conotruncal defects .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1840716231009734)\n",
      "- Text: \"@ GeneSrc $ mutations 486 Chinese patients congenital heart disease . Recent studies reported germline mutations @ GeneSrc $ gene types congenital heart disease ( CHD ) . However , prevalence @ GeneSrc $ mutations CHD correlation @ GeneSrc $ genotype CHD phenotype extensively studied . screened germline mutations coding exons flanking intron sequences @ GeneSrc $ gene 486 CHD patients denaturing high-performance liquid chromatography ( DHPLC ) , confirmed mutations sequencing . Nine distinct mutations including one small deletion mutation ( 46delS ) , two small insertion mutations ( 118 - 119insA 125 - 126insAA ) , six non-synonymous mutations ( A6V , P163S , E359 K , P407Q , S429 A442V ) identified 12 486 patients ( nine ventricular septal defect , two @ DiseaseTgt $ , one endocardial cushion defect ) . , two patients carrying E359 K mutation two generations one family ventricular septal defect ( VSD ) . Interestingly , nucleotide insertion c.1146 + 25insA exon 6 detected five VSD patients , 486 normal healthy controls . findings useful understanding prevalence @ GeneSrc $ mutations correlation @ GeneSrc $ genotype CHD phenotype Chinese patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010638039972732)\n",
      "- Text: \"Mutations ZFPM2/FOG2 gene sporadic cases @ DiseaseTgt $ . Two 47 patients sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) , common cyanotic conotruncal heart defect ( CTD ) , showed heterozygous missense mutations ZFPM2/FOG2 gene . Knockout mice carrying mutations ZFPM2/FOG2 gene similarly found exhibit @ DiseaseTgt $ . mutant ZFPM2/FOG2 proteins , E30 G ( c.88A > G ) S657 G ( c.1968A > G ) , retain ability bind partner protein @ GeneSrc $ repress @ GeneSrc $ mediated gene activation , S657 G , E30 G , mutation subtly impaired function . ZFPM2/FOG2 gene mutations may contribute sporadic cases @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.094187364031331)\n",
      "- Text: \"novel GATA6 mutation patients @ DiseaseTgt $ atrial septal defect . GATA6 member GATA family transcription factors , expression functions overlap @ GeneSrc $ heart development . Mutations @ GeneSrc $ related human congenital heart diseases ( CHDs ) several studies , whereas mutations GATA6 recently reported patients persistent truncus arteriosus . Animal experiments revealed critical roles GATA6 development myocardium cardiac morphogenesis , thereby highlighting potential involvement GATA6 defects pathogenesis CHDs . , screened GATA6 270 individuals sporadic CHDs direct sequencing . identification mutation , luciferase reporter assay real-time quantitative polymerase chain reaction performed detect functional changes mutant transcription factor . heterozygous missense mutation ( Ser184Asn ) identified three patients , including one @ DiseaseTgt $ two atrial septal defects . mutation found 500 unrelated ethnically matched healthy subjects . Direct sequencing region parents three patients revealed mutation one parents patient , one parent carriers presented bicuspid aortic valve . Biological analysis revealed clearly decreased transcriptional activity GATA6 Ser184Asn vitro . data suggest GATA6 Ser184Asn novel mutation associated CHDs important role disease pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1355897061873524)\n",
      "- Text: \"Identification @ GeneSrc $ sequence variants patients congenital heart defects . Although etiology majority congenital heart disease ( CHD ) remains poorly understood , known genetic causes often result mutations cardiac developmental genes . @ GeneSrc $ encodes cardiac transcription factor , broadly expressed developing heart critical normal cardiac morphogenesis , making candidate gene congenital heart defects humans . objective study determine frequency @ GeneSrc $ sequence variants population individuals spectrum cardiac malformations . coding regions @ GeneSrc $ sequenced 310 individuals CHD . identified two novel sequence variations @ GeneSrc $ altered highly conserved amino acid residues ( A178V L198V ) found control population . variants identified two individuals ( one @ DiseaseTgt $ atrioventricular septal defect setting complex CHD ) . Biochemical studies demonstrate @ GeneSrc $ A178V mutant protein results increased transactivation ability compared wild-type @ GeneSrc $ . data suggest nonsynonymous @ GeneSrc $ sequence variants infrequently found individuals CHD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0829675841621677)\n",
      "- Text: \"novel @ GeneSrc $ mutation patients @ DiseaseTgt $ atrial septal defect . @ GeneSrc $ member GATA family transcription factors , expression functions overlap GATA4 heart development . Mutations GATA4 related human congenital heart diseases ( CHDs ) several studies , whereas mutations @ GeneSrc $ recently reported patients persistent truncus arteriosus . Animal experiments revealed critical roles @ GeneSrc $ development myocardium cardiac morphogenesis , thereby highlighting potential involvement @ GeneSrc $ defects pathogenesis CHDs . , screened @ GeneSrc $ 270 individuals sporadic CHDs direct sequencing . identification mutation , luciferase reporter assay real-time quantitative polymerase chain reaction performed detect functional changes mutant transcription factor . heterozygous missense mutation ( Ser184Asn ) identified three patients , including one @ DiseaseTgt $ two atrial septal defects . mutation found 500 unrelated ethnically matched healthy subjects . Direct sequencing region parents three patients revealed mutation one parents patient , one parent carriers presented bicuspid aortic valve . Biological analysis revealed clearly decreased transcriptional activity @ GeneSrc $ Ser184Asn vitro . data suggest @ GeneSrc $ Ser184Asn novel mutation associated CHDs important role disease pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9360810758452404)\n",
      "- Text: \"Whole exome sequencing identifies de novo mutations @ GeneSrc $ associated congenital diaphragmatic hernia . BACKGROUND : Congenital diaphragmatic hernia ( CDH ) common birth defect affecting 1 3000 births . characterised herniation abdominal viscera incompletely formed diaphragm . Although chromosomal anomalies mutations several genes implicated , cause patients unknown . METHODS : used whole exome sequencing two families CDH congenital heart disease , identified mutations @ GeneSrc $ . RESULTS : first family , identified de novo missense mutation ( c.1366C > , p. R456C ) sporadic CDH patient @ DiseaseTgt $ . second , nonsense mutation ( c.712G > , p. G238 * ) identified two siblings CDH large ventricular septal defect . G238 * mutation inherited mother , clinically affected congenital absence pericardium , patent ductus arteriosus intestinal malrotation . Deep sequencing blood saliva-derived DNA mother suggested somatic mosaicism explanation milder phenotype , approximately 15 % mutant alleles . determine frequency @ GeneSrc $ mutations CDH , sequenced gene 378 patients CDH . identified one additional de novo mutation ( c.1071delG , p. V358Cfs34 * ) . CONCLUSIONS : Mutations @ GeneSrc $ previously associated pancreatic agenesis congenital heart disease . conclude , addition heart pancreas , @ GeneSrc $ involved development two additional organs , diaphragm pericardium . addition , shown de novo mutations contribute development CDH , common birth defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0100960964403226)\n",
      "- Text: \"Genotype-phenotype correlations @ GeneSrc $ mutations @ DiseaseTgt $ risk onset . BACKGROUND : Mutations @ GeneSrc $ LRRK2 genes implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , particularly Ashkenazi Jews . METHODS : Israeli Ashkenazi cohort 420 patients @ DiseaseTgt $ , 333 elderly controls , 3,805 young controls screened eight @ GeneSrc $ mutations , associated mild ( N370S , R496H ) severe ( 84GG , IVS2 + 1 , V394L , D409H , L444P , RecTL ) Gaucher disease . Patients @ DiseaseTgt $ elderly controls also genotyped LRRK2 G2019S . RESULTS : @ GeneSrc $ carrier frequency 17.9 % patients @ DiseaseTgt $ compared 4.2 % elderly 6.35 % young controls . proportion severe mutation carriers among @ DiseaseTgt $ patient @ GeneSrc $ carriers 29 % compared 7 % among young controls . Severe mild @ GeneSrc $ mutations increased risk developing @ DiseaseTgt $ 13.6- 2.2-fold , affected average age @ DiseaseTgt $ onset ( AAO ) , 55.7 57.9 years , compared 60.7 years patients without known @ GeneSrc $ LRRK2 mutations . CONCLUSIONS : data demonstrate genotype-phenotype correlations different @ GeneSrc $ mutations @ DiseaseTgt $ ( @ DiseaseTgt $ ) risk AAO Ashkenazi Jews . Additionally , earlier AAO observed LRRK2 G2019S carrier @ DiseaseTgt $ patients . Finally , data demonstrate surprisingly high frequency , one third patient population , carried mutation @ GeneSrc $ LRRK2 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9261343500033392)\n",
      "- Text: \"@ GeneSrc $ gene mutations @ DiseaseTgt $ Norwegian population . association mutations @ GeneSrc $ ( @ GeneSrc $ ) gene @ DiseaseTgt $ ( @ DiseaseTgt $ ) recently reported Ashkenazi Jews . authors screened series 311 Norwegian patients @ DiseaseTgt $ 474 controls 2 common functional mutations @ GeneSrc $ protein , N370S L444P . Seven patients ( 2.3 % ) 8 controls ( 1.7 % ) carried mutant @ GeneSrc $ allele ( p = 0.58 ) . study indicate increased susceptibility @ DiseaseTgt $ @ GeneSrc $ mutations carriers Norway .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8813222875558747)\n",
      "- Text: \"Mutations @ GeneSrc $ gene @ DiseaseTgt $ : phenotype-genotype correlation . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene recently identified contributory @ DiseaseTgt $ ( @ DiseaseTgt $ ) Ashkenazi Jews . present study , clinical characteristics Ashkenazi patients @ DiseaseTgt $ @ GeneSrc $ mutations ( n = 40 ) compared Ashkenazi patients @ DiseaseTgt $ without known @ GeneSrc $ mutation ( n = 108 ) . overall clinical manifestations age disease onset differ patients @ GeneSrc $ mutations compared patients without mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9296689286592452)\n",
      "- Text: \"Large-scale meta-analysis genome-wide association data identifies six new risk loci @ DiseaseTgt $ . conducted meta-analysis @ DiseaseTgt $ genome-wide association studies using common set 7,893,274 variants across 13,708 cases 95,282 controls . Twenty-six loci identified genome-wide significant association ; 6 additional previously reported loci tested independent set 5,353 cases 5,551 controls . 32 tested SNPs , 24 replicated , including 6 newly identified loci . Conditional analyses within loci showed four loci , including @ GeneSrc $ , GAK-DGKQ , SNCA HLA region , contain secondary independent risk variant . total , identified replicated 28 independent risk variants @ DiseaseTgt $ across 24 loci . Although effect individual locus small , risk profile analysis showed substantial cumulative risk comparison highest lowest quintiles genetic risk ( odds ratio ( ) = 3.31 , 95 % confidence interval ( CI ) = 2.55 - 4.30 ; P = 2 x 10 ( -16 ) ) . also show six risk loci associated proximal gene expression DNA methylation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0178165660008445)\n",
      "- Text: \"@ GeneSrc $ gene mutations : risk factor Lewy body disorders . BACKGROUND : Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene reported modify risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) dementia Lewy bodies ( DLB ) . However , findings consistently replicated , studies substantial methodological shortcomings . OBJECTIVE : better assess role @ GeneSrc $ variants altering risk Lewy body disorders . DESIGN : Case-control study . SETTING : Four movement disorder clinics Seattle , Washington , area . PARTICIPANTS : Seven hundred twenty-one patients @ DiseaseTgt $ , 554 healthy control subjects , 57 patients DLB . MAIN OUTCOME MEASURES : Disease status presence absence 2 common @ GeneSrc $ mutations ( N370S L444P ) . RESULTS : observed significantly higher heterozygote frequency 2 mutations patients @ DiseaseTgt $ ( 2.9 % ; P < .001 ) DLB ( 3.5 % ; P = .045 ) compared control subjects ( 0.4 % ) . CONCLUSION : findings suggest @ GeneSrc $ mutations exert large effect susceptibility Lewy body disorders individual level associated modest ( approximately 3 % ) population-attributable risk individuals European ancestry .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.803450599500154)\n",
      "- Text: \"Mutations @ GeneSrc $ associated familial Parkinson disease susceptibility age onset . OBJECTIVE : characterize sequence variation within @ GeneSrc $ ( @ GeneSrc $ ) gene select subset sample patients familial Parkinson disease ( @ DiseaseTgt $ ) test full sample whether sequence variants increased risk @ DiseaseTgt $ associated earlier onset disease . METHODS : performed comprehensive study @ GeneSrc $ exons one patient @ DiseaseTgt $ 96 @ DiseaseTgt $ families , selected based family-specific lod scores @ GeneSrc $ locus . Identified @ GeneSrc $ variants subsequently screened 1325 @ DiseaseTgt $ cases 566 multiplex @ DiseaseTgt $ families 359 controls . RESULTS : Nine different @ GeneSrc $ variants , five previously reported , identified 21 96 @ DiseaseTgt $ cases sequenced . Screening variants full sample identified 161 variant carriers ( 12.2 % ) 99 different @ DiseaseTgt $ families . unbiased estimate frequency five previously reported @ GeneSrc $ variants familial @ DiseaseTgt $ sample 12.6 % control sample 5.3 % ( odds ratio 2.6 ; 95 % confidence interval 1.5 - 4.4 ) . Presence @ GeneSrc $ variant associated earlier age onset ( p = 0.0001 ) . average , patients carrying @ GeneSrc $ variant onset @ DiseaseTgt $ 6.04 years earlier without @ GeneSrc $ variant . CONCLUSIONS : study suggests @ GeneSrc $ susceptibility gene familial Parkinson disease ( @ DiseaseTgt $ ) patients @ GeneSrc $ variants earlier age onset patients @ DiseaseTgt $ without @ GeneSrc $ variants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2211106514746928)\n",
      "- Text: \"Interaction parkin mutant glucocerebrosidase variants : possible link @ DiseaseTgt $ Gaucher disease . Gaucher disease ( GD ) , sphingolipidosis characterized impaired activity lysosomal enzyme glucocerebrosidase ( GCase ) , results mutations GCase-encoding gene , @ GeneSrc $ . shown mutant GCase variants present variable degrees endoplasmic reticulum ( ER ) retention undergo ER-associated degradation ( ERAD ) proteasome . Furthermore , degree ERAD mutant GCase variants correlates one factors determine GD severity . association GD @ DiseaseTgt $ ( @ DiseaseTgt $ ) demonstrated concurrence @ DiseaseTgt $ GD patients identification GCase mutations probands sporadic @ DiseaseTgt $ . One genes involved @ DiseaseTgt $ PARK2 , encoding E3 ubiquitin ligase parkin . Parkin functions ERAD misfolded ER proteins , upregulated unfolded protein response . Loss parkin function leads accumulation substrates , deleterious dopaminergic neurons @ DiseaseTgt $ . , therefore , tested possibility association GD @ DiseaseTgt $ reflects fact parkin acts E3 ligase mutant GCase variants . results showed mutant GCase variants associate parkin . Normal parkin , RING finger mutants , affects stability mutant GCase variants . Parkin also promotes accumulation mutant GCase aggresome-like structures involved K48-mediated polyubiquitination GCase mutants , indicating function E3 ligase . suggest involvement parkin degradation mutant GCase explains concurrence GD @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0578565932324309)\n",
      "- Text: \"Wildtype Kras2 inhibit lung carcinogenesis mice . Although ras genes long established proto-oncogenes , dominant role activated ras cell transformation questioned . Previous studies shown frequent loss wildtype Kras2 allele mouse human lung adenocarcinomas . address possible @ DiseaseTgt $ suppressor role wildtype Kras2 lung tumorigenesis , carried lung tumor bioassay heterozygous Kras2-deficient mice . Mice heterozygous Kras2 deficiency highly susceptible chemical induction lung tumors compared wildtype mice . Activating Kras2 mutations detected chemically induced lung tumors obtained wildtype heterozygous Kras2-deficient mice . Furthermore , wildtype Kras2 inhibited colony formation @ DiseaseTgt $ development transformed NIH/3T3 cells mouse lung tumor cell line containing activated Kras2 allele . Allelic loss wildtype Kras2 found 67 % 100 % chemically induced mouse lung adenocarcinomas harbor mutant Kras2 allele . Finally , inverse correlation level wildtype Kras2 expression @ GeneSrc $ ( @ GeneSrc $ ) activity observed cells . data strongly suggest wildtype Kras2 @ DiseaseTgt $ suppressor activity frequently lost lung tumor progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1485922932027874)\n",
      "- Text: \"Inactivation Wip1 phosphatase inhibits mammary tumorigenesis @ GeneSrc $ activation p16 ( Ink4a ) -p19 ( Arf ) pathway . Modulation @ DiseaseTgt $ suppressor activities may provide new opportunities @ DiseaseTgt $ therapy . show disruption gene Ppm1d encoding Wip1 phosphatase activated p53 p16 ( also called Ink4a ) -p19 ( also called ARF ) pathways @ GeneSrc $ signaling suppressed vitro transformation mouse embryo fibroblasts ( MEFs ) oncogenes . Disruption gene Cdkn2a ( encoding p16 p19 ) , Trp53 ( encoding p53 ) , reconstituted cell transformation Ppm1d-null MEFs . vivo , deletion Ppm1d mice bearing mouse mammary tumor virus ( MMTV ) promoter-driven oncogenes Erbb2 ( also called c-neu ) Hras1 impaired mammary carcinogenesis , whereas reduced expression p16 p19 methylation-induced silencing inactivation @ GeneSrc $ correlated @ DiseaseTgt $ appearance . conclude inactivation depletion Wip1 phosphatase resultant @ GeneSrc $ activation suppresses @ DiseaseTgt $ appearance modulating Cdkn2a @ DiseaseTgt $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0485814312299131)\n",
      "- Text: \"GIGYF2 gene disruption mice results neurodegeneration altered insulin-like growth factor signaling . Grb10-Interacting GYF Protein 2 ( GIGYF2 ) initially identified interaction Grb10 , adapter protein binds activated IGF-I insulin receptors . GIGYF2 gene maps human chromosome 2q37 within region linked @ DiseaseTgt $ ( PARK11 locus ) , association GIGYF2 mutations @ DiseaseTgt $ described recent publications . study investigated consequences Gigyf2 gene disruption mice . Gigyf2 null mice undergo apparently normal embryonic development , fail feed die within first 2 post-natal days . Heterozygous Gigyf2 ( +/- ) mice survive adulthood evident metabolic growth defects . 12 - 15 months age , Gigyf2 ( +/- ) mice begin exhibit motor dysfunction manifested decreased balance time rotating horizontal rod . associated histopathological evidence neurodegeneration rare intracytoplasmic Lewy body-like inclusions spinal anterior horn motor neurons . alpha-synuclein positive neuritic plaques brainstem cerebellum , abnormalities substantia nigra . Primary cultured embryo fibroblasts Gigyf2 null mice exhibit decreased IGF-I-stimulated IGF-I receptor tyrosine phosphorylation augmented @ GeneSrc $ phosphorylation . data provide evidence important role GIGYF2 age-related neurodegeneration IGF pathway signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003753509764272)\n",
      "- Text: \"Accumulation parkin substrate , FAF1 , plays key role dopaminergic neurodegeneration . study reports physical functional interplay Fas-associated factor 1 ( FAF1 ) , death-promoting protein , parkin , key susceptibility protein @ DiseaseTgt $ ( @ DiseaseTgt $ ) . found parkin acts E3 ubiquitin ligase ubiquitinate FAF1 vitro cellular level , identifying FAF1 direct substrate parkin . loss parkin function due @ DiseaseTgt $ mutations found disrupt ubiquitination degradation FAF1 , resulting elevated FAF1 expression SH-SY5Y cells . Moreover , FAF1-mediated cell death abolished wild-type parkin , @ DiseaseTgt $ parkin mutants , implying parkin antagonizes death potential FAF1 . led us investigate whether FAF1 participates pathogenesis @ DiseaseTgt $ . address , used gene trap mutagenesis approach generate mutant mice diminished levels FAF1 ( Faf1 ( gt/gt ) ) . Using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) -treated mouse model @ DiseaseTgt $ , found FAF1 accumulated substantia nigra pars compacta ( SNc ) MPTP-treated @ DiseaseTgt $ mice , MPTP-induced dopaminergic cell loss SNc significantly attenuated Faf1 ( gt/gt ) mice versus Faf1 ( +/+ ) mice . MPTP-induced reduction locomotor activity also lessened Faf1 ( gt/gt ) mice versus Faf1 ( +/+ ) mice . Furthermore , found FAF1 deficiency blocked @ DiseaseTgt $ biochemical events , including caspase activation , ROS generation , @ GeneSrc $ activation cell death . Taken together , results suggest new role FAF1 : positive modulator @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0169429340740983)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , MLXIPL , PCSK9 , GALNT2 @ GeneSrc $ ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000135113618631)\n",
      "- Text: \"positive feedback loop p53 @ GeneSrc $ @ DiseaseTgt $ suppressors prevents tetraploidization . Damage mitotic spindle centrosome dysfunction lead @ DiseaseTgt $ . prevent , cells trigger succession checkpoint responses , initial mitotic delay followed slippage without cytokinesis , spawning tetraploid G1 cells undergo p53-dependent G1/S arrest . describe importance @ GeneSrc $ ( @ GeneSrc $ ) checkpoint response . @ GeneSrc $ binds Mdm2 , inhibits E3 ligase activity , activates p53 . Nocodazole , microtubule poison provokes centrosome/mitotic apparatus dysfunction , induces @ GeneSrc $ translocation centrosomes nucleus p53 accumulation . turn , p53 rapidly selectively up-regulates @ GeneSrc $ expression G2/M cells , thereby defining positive feedback loop . Abrogation @ GeneSrc $ promotes accumulation polyploid cells upon exposure nocodazole , prevented direct activation p53 . @ GeneSrc $ axis thus constitutes novel checkpoint pathway critical maintenance proper chromosome number .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4297198307879636)\n",
      "- Text: \"New mutations ZFPM2/FOG2 gene @ DiseaseTgt $ double outlet right ventricle . Conotruncal defects ( CTDs ) represent 15 - 20 % congenital heart defects . Mutations number genes associated CTD humans animal models . investigated occurrence prevalence GATA4 , NKX2.5 , ZFPM2/FOG2 , @ GeneSrc $ , ISLET1 gene mutations large cohort individuals CTD , including @ DiseaseTgt $ without pulmonary atresia ( @ DiseaseTgt $ , 178 patients ) , double outlet right ventricle ( DORV , 13 patients ) , truncus arteriosus ( 11 patients ) . Denaturing high-performance liquid chromatography ( DHPLC ) analysis followed bidirectional sequencing disclosed putative pathogenic mutation GATA4 , ISLET1 , @ GeneSrc $ genes . Two novel ( Ile227Val , Met544Ile ) one previously reported ( Glu30Gly ) possibly pathogenic missense variants identified ZFPM2/FOG2 gene 3 sporadic patients 202 ( 1.5 % ) CTD , including 1 178 ( 0.6 % ) @ DiseaseTgt $ 2 13 ( 15.4 % ) DORV . Mutation analysis also detected one known missense change ( Arg25Cys ) NKX2.5 gene two ( 1.1 % ) sporadic patients @ DiseaseTgt $ . sequence alterations found absent 500 population-matched controls . conclusion , present results ( ) indicate confirm mutations GATA4 , @ GeneSrc $ , ISLET1 genes major determinants pathogenesis @ DiseaseTgt $ , ( ii ) provide supportive evidence association ZFPM2/FOG2 gene @ DiseaseTgt $ , ( iii ) provide additional examples possible contribution Arg25Cys change NKX2.5 small number @ DiseaseTgt $ cases .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4094258368241686)\n",
      "- Text: \"RAS regulated @ GeneSrc $ microRNA family . MicroRNAs ( miRNAs ) regulatory RNAs found multicellular eukaryotes , including humans , implicated @ DiseaseTgt $ . @ GeneSrc $ miRNA times seam cell terminal differentiation C. elegans . show @ GeneSrc $ family negatively regulates let-60/RAS . Loss let-60/RAS suppresses @ GeneSrc $ , let-60/RAS 3'UTR contains multiple @ GeneSrc $ complementary sites ( LCSs ) , restricting reporter gene expression @ GeneSrc $ manner . mir-84 , @ GeneSrc $ family member , largely absent vulval precursor cell P6.p time let-60/RAS specifies 1 degrees vulval fate cell , mir-84 overexpression suppresses multivulva phenotype activating let-60/RAS mutations . 3'UTRs human RAS genes contain multiple LCSs , allowing @ GeneSrc $ regulate RAS expression . @ GeneSrc $ expression lower lung tumors normal lung tissue , RAS protein significantly higher lung tumors , providing possible mechanism @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1281589173966984)\n",
      "- Text: \"new splice variant @ GeneSrc $ , GFAP epsilon , interacts presenilin proteins . describe new human isoform , GFAP epsilon , intermediary filament protein @ GeneSrc $ ( @ GeneSrc $ ) . GFAP epsilon mRNA result alternative splicing new polyadenylation signal , thus GFAP epsilon new C-terminal protein sequence . provides GFAP epsilon capacity specific binding presenilin proteins yeast vitro . observations suggest direct link presenilins cytoskeleton GFAP epsilon incorporated . Mutations @ GeneSrc $ presenilins associated Alexander disease @ DiseaseTgt $ , respectively . Accordingly , GFAP epsilon taken consideration studying neurodegenerative diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0596128696815701)\n",
      "- Text: \"Mutant mice lacking p53 C-terminal domain model telomere syndromes . Mutations p53 , although frequent human @ DiseaseTgt $ , implicated telomere-related syndromes . , show homozygous mutant mice expressing p53Delta31 , p53 lacking C-terminal domain , exhibit increased p53 activity suffer aplastic anemia pulmonary fibrosis , hallmarks syndromes caused short telomeres . Indeed , p53Delta31/Delta31 mice short telomeres phenotypic traits associated telomere disease dyskeratosis congenita severe variant Hoyeraal-Hreidarsson syndrome . Heterozygous p53+/Delta31 mice mildly affected , decreased levels Mdm4 , negative regulator p53 , led dramatic aggravation symptoms . Importantly , several genes involved telomere metabolism downregulated p53Delta31/Delta31 cells , including Dyskerin , @ GeneSrc $ , Tinf2 , mutated dyskeratosis congenita , Terf1 , implicated aplastic anemia . Together , data reveal truncating mutation activate p53 p53 plays major role regulation telomere metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.91194255028748e-07)\n",
      "- Text: \"@ GeneSrc $ : DNA mismatch repair gene associated mammalian microsatellite instability . DNA mismatch repair important role maintaining genomic integrity association hereditary non-polyposis colon cancer ( HNPCC ) . identify new human mismatch repair proteins , probed nuclear extracts conserved carboxy-terminal MLH1 interaction domain . describe cloning complete genomic sequence @ GeneSrc $ , encodes new DNA mismatch repair protein interacts MLH1 . @ GeneSrc $ similar mismatch repair proteins yeast , plants , worms bacteria known mammalian protein , suggesting conserved sequence may confer unique functions mice humans . Cells culture stably expressing dominant-negative @ GeneSrc $ protein exhibit microsatellite instability . Mlh3 highly expressed gastrointestinal epithelium physically maps mouse complex trait locus colon cancer susceptibility ( Ccs1 ) . Although unable identify mutation protein-coding region Mlh3 susceptible mouse strain , colon tumours congenic Ccs1 mice exhibit microsatellite instability . Functional redundancy among Mlh3 , Pms1 Pms2 may explain neither Pms1 Pms2 mutant mice develop @ DiseaseTgt $ , PMS1 PMS2 mutations rarely found HNPCC families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.00173448067418)\n",
      "- Text: \"Germline somatic mutation analyses DNA mismatch repair gene @ GeneSrc $ : Evidence somatic mutation @ DiseaseTgt $ . DNA mismatch repair considerable scientific medical importance essential role maintaining genomic integrity , association hereditary non-polyposis colon cancer ( HNPCC ) . Germline mutations five mismatch repair genes ( MLH1 , MSH2 , PMS1 , PMS2 , MSH6 ) associated HNPCC susceptibility . laboratory recently identified @ GeneSrc $ , novel DNA mismatch repair gene . screened @ GeneSrc $ coding sequence 60 probands increased genetic risk factors @ DiseaseTgt $ susceptibility mutations candidate genes . definite @ GeneSrc $ germline mutations found . subsequently screened 36 colon tumors , discovered appreciable frequency somatic @ GeneSrc $ coding mutations MSI-H tumors ( 25 % ) . four six tumors , evidence biallelic inactivation noted . Furthermore , @ GeneSrc $ nonsense mutations identified two 12 microsatellite stable ( MSS ) tumors 14q24 loss heterozygosity . analyses exclude existence germline @ GeneSrc $ mutations patients increased genetic risk factors @ DiseaseTgt $ susceptibility , suggest mutations uncommon patient population . finding appreciable frequency somatic @ GeneSrc $ mutations consistent possible role gene progression @ DiseaseTgt $ tumorigenesis . Hum Mutat 17:389 - 396 , 2001 . Published 2001 Wiley-Liss , Inc .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5936051649217126)\n",
      "- Text: \"@ GeneSrc $ EXO1 alterations familial @ DiseaseTgt $ patients fulfilling Amsterdam criteria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0431068416075107)\n",
      "- Text: \"first functional study @ GeneSrc $ mutations found cancer patients . @ GeneSrc $ gene one five mismatch repair ( MMR ) genes associated hereditary nonpolyposis colorectal cancer ( HNPCC ) . Eighteen different inherited @ GeneSrc $ mutations reported pathogenic international mutation database . several cases , mutation found patient without family history suggestive inherited cancer susceptibility . cases , similar mutation also found sporadic patients and/or healthy controls . Four patients carried @ GeneSrc $ mutation together another inherited MMR gene variation . functional analyses performed assess pathogenicity 18 mutations . @ GeneSrc $ assumed less important MMR HNPCC susceptibility genes MSH2 , MSH6 , MLH1 , PMS2 , accordingly low-risk gene @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assess significance inherited sequence variations @ GeneSrc $ , functionally characterized seven missense mutations ( Q24E , R647C , S817 G , G933C , W1276R , A1394 , E1451 K ) scattered throughout @ GeneSrc $ polypeptide . mutations found @ DiseaseTgt $ endometrial cancer patients reported pathogenic . study showed seven mutated @ GeneSrc $ proteins , complex counterpart MLH1 ( MutLgamma ) , repaired mismatches wild type MutLgamma worse heterodimer MLH1 PMS2 ( MutLalpha ) . results confirm MutLgamma less efficient MMR complex MutLalpha show @ GeneSrc $ mutations alone interfere MMR . studies needed evaluate pathogenicity @ GeneSrc $ mutations compound MMR mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8670228126568669)\n",
      "- Text: \"Biochemical characterization @ GeneSrc $ missense mutations reveal apparent role @ GeneSrc $ Lynch syndrome . far 18 @ GeneSrc $ germline mutations/variants identified familial @ DiseaseTgt $ cases . Sixteen variants amino acid substitutions pathogenic nature still unclear . substitutions known unclassified variants UVs . clarify possible role eight @ GeneSrc $ UVs identified suspected Lynch syndrome patients , performed several biochemical tests . determined protein expression stability , protein localization interaction mutant @ GeneSrc $ proteins wildtype MLH1 . eight @ GeneSrc $ UVs gave protein expression levels comparable wildtype @ GeneSrc $ . Furthermore , UV-containing proteins , contrast previous studies , localized normally nucleus interacted normally wildtype MLH1 . different biochemical assays yielded evidence eight @ GeneSrc $ UVs tested cause @ DiseaseTgt $ , including Lynch syndrome .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3554327847777698)\n",
      "- Text: \"@ GeneSrc $ mutation endometrial cancer . @ GeneSrc $ recently described member DNA mismatch repair gene family . Based interaction MutL homologue MLH1 , postulated @ GeneSrc $ might play role tumorigenesis . Germ line somatic mutations @ GeneSrc $ identified small fraction @ DiseaseTgt $ , role @ GeneSrc $ @ DiseaseTgt $ tumorigenesis remains controversial . investigated @ GeneSrc $ 's role endometrial tumorigenesis analysis tumor germ line DNA 57 endometrial cancer patients increased risk inherited cancer susceptibility . Patients known MSH2 MSH6 mutations excluded well MLH1-methylated tumors . Sixteen different variants identified single-strand conformational variant analysis . 12 missense changes identified , three somatic mutations . One patient germ line missense variant loss heterozygosity ( LOH ) tumor specimen . evidence @ GeneSrc $ promoter methylation based combined bisulfite restriction analysis . identification inherited missense variants , somatic missense mutations ( present 3 57 tumors ) , LOH tumor patient germ line missense change suggest role @ GeneSrc $ endometrial tumorigenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6714855236227381)\n",
      "- Text: \"codon 47 polymorphism p53 functionally significant . addition common polymorphism codon 72 , p53 @ DiseaseTgt $ suppressor gene also contains rare single nucleotide polymorphism amino acid 47 . Wild type p53 encodes proline residue , < 5 % African Americans , amino acid serine . Notably , phosphorylation adjacent serine 46 proline-directed kinase p38 MAPK known greatly enhance ability p53 induce apoptosis . showed serine 47 polymorphic variant , replaces proline residue necessary recognition proline-directed kinases , markedly poorer substrate phosphorylation serine 46 p38 MAPK . Consistent finding , showed serine 47 variant 5-fold decreased ability induce apoptosis compared wild type p53 . Mechanistically , found variant decreased ability transactivate two p53 target genes , p53AIP1 @ GeneSrc $ , p53 response genes ; first time phosphorylation serine 46 implicated transactivation @ GeneSrc $ p53 . Down-regulation @ GeneSrc $ cells wild type p53 using short interfering RNAs reduced apoptosis cells level comparable cells containing serine 47 variant . combined data indicated , like codon 72 polymorphism , codon 47 polymorphism p53 functionally significant may play role @ DiseaseTgt $ risk , progression , efficacy therapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003889233397118)\n",
      "- Text: \"Myc suppression p21 ( Cip1 ) Cdk inhibitor influences outcome p53 response DNA damage . Activation @ DiseaseTgt $ suppressor p53 DNA damage induces either cell cycle arrest apoptotic cell death . cytostatic effect p53 mediated transcriptional activation cyclin-dependent kinase ( CDK ) inhibitor p21 ( Cip1 ) , whereas apoptotic effect mediated transcriptional activation mediators including @ GeneSrc $ PIG3 ( ref . 2 ) . determines choice cytostasis apoptosis clear . show transcription factor Myc principal determinant choice . Myc directly recruited p21 ( Cip1 ) promoter DNA-binding protein Miz-1 . interaction blocks p21 ( Cip1 ) induction p53 activators . result Myc switches , cytostatic apoptotic , p53-dependent response colon cancer cells DNA damage . Myc modify ability p53 bind p21 ( Cip1 ) @ GeneSrc $ promoters , selectively inhibits bound p53 activating p21 ( Cip1 ) transcription . inhibiting p21 ( Cip1 ) expression Myc favours initiation apoptosis , thereby influencing outcome p53 response favour cell death .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009191540583768)\n",
      "- Text: \"Acetylation p53 DNA-binding domain regulates apoptosis induction . ability p53 induce apoptosis plays important role @ DiseaseTgt $ suppression . , describe previously unknown posttranslational modification DNA-binding domain p53 . modification , acetylation lysine 120 ( K120 ) , occurs rapidly DNA damage catalyzed MYST family acetyltransferases hMOF TIP60 . Mutation K120 arginine , occurs human @ DiseaseTgt $ , debilitates K120 acetylation diminishes p53-mediated apoptosis without affecting cell-cycle arrest . K120R mutation selectively blocks transcription proapoptotic target genes BAX @ GeneSrc $ nonapoptotic targets p21 hMDM2 remain unaffected . Consistent , depletion hMOF and/or TIP60 inhibits ability p53 activate BAX @ GeneSrc $ transcription . Furthermore , acetyllysine 120 ( acetyl-K120 ) form p53 specifically accumulates proapoptotic target genes . data suggest K120 acetylation may help distinguish cell-cycle arrest apoptotic functions p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000162234658316)\n",
      "- Text: \"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression . Gain-of-function mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism LRRK2 action known . show LRRK2 interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila e2f1 dp messenger RNAs translationally repressed let-7 miR-184 * , respectively . Pathogenic LRRK2 antagonizes miRNAs , leading overproduction E2F1/DP , previously implicated cell cycle survival control shown critical LRRK2 pathogenesis . Genetic deletion let-7 , antagomir-mediated blockage let-7 miR-184 * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive let-7 toxic effects similar pathogenic LRRK2 . Conversely , increasing level let-7 miR-184 * attenuated pathogenic LRRK2 effects . LRRK2 associated Drosophila Argonaute-1 ( dAgo1 ) human @ GeneSrc $ ( @ GeneSrc $ ) RNA-induced silencing complex ( RISC ) . aged fly brain , dAgo1 protein level negatively regulated LRRK2 . , pathogenic LRRK2 promoted association phospho-4E-BP1 @ GeneSrc $ . results implicate deregulated synthesis E2F1/DP caused miRNA pathway impairment key event LRRK2 pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.030184487275603e-06)\n",
      "- Text: \"Long-term haematopoietic reconstitution Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors . Haematopoiesis maintained hierarchical system haematopoietic stem cells ( HSCs ) give rise multipotent progenitors , turn differentiate types mature blood cells . HSCs maintain lifetime organism ability self-renew . However , multipotent progenitors lack ability self-renew , therefore mitotic capacity expansion potential limited destined eventually stop proliferating finite number cell divisions . molecular mechanisms limit proliferation capacity multipotent progenitors mature progenitors fully understood . show bone marrow cells mice deficient three genes genetically downstream Bmi1 - -p16Ink4a , p19Arf Trp53 ( triple mutant mice ; p16Ink4a p19Arf alternative reading frames gene ( also called Cdkn2a ) encode different proteins ) -- approximately 10-fold increase cells able reconstitute blood long term . increase associated acquisition long-term reconstitution capacity cells phenotype @ GeneSrc $ , defines multipotent progenitors wild-type mice . pattern triple mutant multipotent progenitor response growth factors resembles wild-type multipotent progenitors wild-type HSCs . results demonstrate p16Ink4a/p19Arf Trp53 central role limiting expansion potential multipotent progenitors . pathways commonly repressed @ DiseaseTgt $ , suggesting mechanism early progenitor cells could gain ability self-renew become malignant oncogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045806168844222)\n",
      "- Text: \"Physiological pathological roles LRRK2 nuclear envelope integrity . Mutations LRRK2 cause @ DiseaseTgt $ , mechanisms involved LRRK2 toxicity @ DiseaseTgt $ yet fully understood . found LRRK2 translocates nucleus binding seven absentia homolog ( SIAH-1 ) , nucleus directly interacts lamin A/C , independent kinase activity . LRRK2 knockdown caused nuclear lamina abnormalities nuclear disruption . LRRK2 disease mutations mostly abolish interaction lamin A/C , similar LRRK2 knockdown , cause disorganization lamin A/C leakage nuclear proteins . Dopaminergic neurons LRRK2 G2019S transgenic LRRK2 -/- mice display decreased circularity nuclear lamina leakage nuclear protein @ GeneSrc $ cytosol . Dopaminergic nigral cortical neurons LRRK2 G2019S idiopathic @ DiseaseTgt $ patients exhibit abnormalities nuclear lamina . data indicate LRRK2 plays essential role maintaining nuclear envelope integrity . Disruption function disease mutations suggests novel phosphorylation-independent loss-of-function mechanism may synergize neurotoxic effects caused LRRK2 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002112107691081)\n",
      "- Text: \"Genomic organization human amyloid beta-protein precursor gene . Amyloid beta-protein ( BP ) deposited @ DiseaseTgt $ brains cleavage product larger precursor ( @ GeneSrc $ ) . @ GeneSrc $ gene encodes three types mRNA generated alternative splicing , two contain sequence encoding Kunitz-type serine-protease inhibitor ( serpin ) . investigate regulatory mechanisms @ GeneSrc $ synthesis gene level , isolated 36 genomic DNA clones covering exons human @ GeneSrc $ gene . gene consists 18 exons spans 170 kb . BP encoded 16th 17th exons serpin domain 7th exon . Sequence analysis showed 7th 8th introns lack typical branchpoint splicing . might relate alternative splicing . promoter @ GeneSrc $ gene characteristics housekeeping genes contains number possible methylation sites . methylation status promoter analyzed Southern blotting alteration observed among tissues control @ DiseaseTgt $ brains . also tested roles two possible activator protein-1-binding sites possible heat-shock element found within promoter . Northern blotting showed transcription @ GeneSrc $ gene apparently induced 12-O-tetradecanoylphorbol-13-acetate ( phorbol derivative ) HeLa cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0727366917381218)\n",
      "- Text: \"Polymorphism 5'-flanking region human glutamate-cysteine ligase modifier subunit gene associated @ DiseaseTgt $ . BACKGROUND : Human glutamate-cysteine @ GeneSrc $ ( @ GeneSrc $ ) rate-limiting enzyme synthesis glutathione plays crucial role antioxidant defense mechanisms mammalian cells , including vascular cells . Oxidants transcriptionally upregulate @ GeneSrc $ genes glutathione synthesis , providing protective mechanism oxidative stress-induced cellular dysfunction . study examined hypothesis variation @ GeneSrc $ genes may associated coronary artery disease oxidative stress plays pathogenetic role . METHODS RESULTS : searched common variants 5'-flanking region @ GeneSrc $ modifier subunit ( GCLM ) gene patients @ DiseaseTgt $ ( MI ) . found polymorphism ( -588C/T ) allele showed lower promoter activity ( 40 % 50 % C allele ) response oxidants luciferase reporter gene assay . Allele frequencies determined polymerase chain reaction-based analysis restriction fragment length polymorphism 429 patients MI 428 control subjects ( defined angiography ) Kumamoto Prefecture , Japan . frequency polymorphism significantly higher MI group control group ( CT TT genotypes : 31.5 % MI group versus 19.2 % control group ; P < 0.001 ) . multiple logistic regression analysis , polymorphism risk factor MI independent traditional coronary artery disease risk factors ( odds ratio , 1.98 ; 95 % confidence interval , 1.38 2.83 ; P < 0.001 ) . CONCLUSIONS : findings suggest -588 polymorphism GCLM gene may suppress GCLM gene induction response oxidants genetic risk factor MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2838928516295801)\n",
      "- Text: \"Polymorphism glutamate-cysteine ligase modifier subunit gene associated impairment nitric oxide-mediated coronary vasomotor function . BACKGROUND : minor -588 allele polymorphism -588C/T modifier subunit gene glutamate-cysteine ligase ( GCLM ) , rate-limiting enzyme glutathione ( GSH ) synthesis , associated lower plasma GSH levels risk factor @ DiseaseTgt $ . METHODS RESULTS : examined effects -588C/T polymorphism coronary arterial diameter blood flow responses intracoronary infusion acetylcholine 157 consecutive subjects normal coronary angiograms . multivariate linear regression analysis covariates including traditional risk factors , minor -588 allele independent association impaired dilation enhanced constriction epicardial coronary arteries response acetylcholine , independently associated blunted increase coronary flow response acetylcholine . subgroup 59 consecutive subjects , constrictor responses epicardial coronary diameter intracoronary infusion NG-monomethyl-l-arginine , reflecting presence coronary nitric oxide ( ) bioactivity , inverse independent association -588 allele multivariate analysis . CONCLUSIONS : -588 polymorphism GCLM gene causes decrease endothelial bioactivity , leading impairment endothelium-dependent vasomotor function large resistance coronary arteries . @ GeneSrc $ axis may play role defense system coronary artery disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.1908676661554924e-05)\n",
      "- Text: \"Association polymorphism glutamate-cysteine ligase catalytic subunit gene coronary vasomotor dysfunction @ DiseaseTgt $ . OBJECTIVES : purpose study test hypothesis polymorphisms promoter region glutamate-cysteine @ GeneSrc $ ( @ GeneSrc $ ) gene may associated coronary endothelial vasomotor dysfunction @ DiseaseTgt $ ( MI ) . BACKGROUND : Glutamate-cysteine ligase rate-limiting enzyme synthesis glutathione ( GSH ) plays crucial role intracellular antioxidant defense systems . Oxidants transcriptionally upregulate @ GeneSrc $ gene GSH synthesis , providing protective mechanism oxidant-induced endothelial dysfunction activation , plays pathogenetic role cardiovascular diseases . METHODS : association possible polymorphisms coronary arterial diameter responses acetylcholine determined 62 male subjects . frequency polymorphisms compared 255 male patients MI 179 male control subjects . RESULTS : found polymorphism ( -129C/T ) allele showed lower promoter activity ( 50 % 60 % activity C allele ) response H ( 2 ) ( 2 ) human endothelial cells . Endothelium-dependent dilation coronary arteries impaired subjects -129 allele ( n = 31 ) , compared age-matched subjects without -129 allele ( n = 31 ) . allele highly frequent patients MI compared control subjects , significant risk factor MI , independent traditional coronary risk factors ( odds ratio [ ] 1.81 , 95 % confidence interval [ CI ] 1.08 3.03 ; p = 0.03 ) . CONCLUSIONS : -129 polymorphism @ GeneSrc $ gene may suppress @ GeneSrc $ gene induction response oxidant , implicated coronary endothelial vasomotor dysfunction MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1819309517270268)\n",
      "- Text: \"Polymorphism 5'-flanking region human glutamate-cysteine @ GeneSrc $ gene associated @ DiseaseTgt $ . BACKGROUND : Human glutamate-cysteine ligase ( GCL ) rate-limiting enzyme synthesis glutathione plays crucial role antioxidant defense mechanisms mammalian cells , including vascular cells . Oxidants transcriptionally upregulate GCL genes glutathione synthesis , providing protective mechanism oxidative stress-induced cellular dysfunction . study examined hypothesis variation GCL genes may associated coronary artery disease oxidative stress plays pathogenetic role . METHODS RESULTS : searched common variants 5'-flanking region GCL modifier subunit ( GCLM ) gene patients @ DiseaseTgt $ ( MI ) . found polymorphism ( -588C/T ) allele showed lower promoter activity ( 40 % 50 % C allele ) response oxidants luciferase reporter gene assay . Allele frequencies determined polymerase chain reaction-based analysis restriction fragment length polymorphism 429 patients MI 428 control subjects ( defined angiography ) Kumamoto Prefecture , Japan . frequency polymorphism significantly higher MI group control group ( CT TT genotypes : 31.5 % MI group versus 19.2 % control group ; P < 0.001 ) . multiple logistic regression analysis , polymorphism risk factor MI independent traditional coronary artery disease risk factors ( odds ratio , 1.98 ; 95 % confidence interval , 1.38 2.83 ; P < 0.001 ) . CONCLUSIONS : findings suggest -588 polymorphism GCLM gene may suppress GCLM gene induction response oxidants genetic risk factor MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.6478742737606606e-05)\n",
      "- Text: \"Polymorphism glutamate-cysteine @ GeneSrc $ gene associated impairment nitric oxide-mediated coronary vasomotor function . BACKGROUND : minor -588 allele polymorphism -588C/T modifier subunit gene glutamate-cysteine ligase ( @ GeneSrc $ ) , rate-limiting enzyme glutathione ( GSH ) synthesis , associated lower plasma GSH levels risk factor @ DiseaseTgt $ . METHODS RESULTS : examined effects -588C/T polymorphism coronary arterial diameter blood flow responses intracoronary infusion acetylcholine 157 consecutive subjects normal coronary angiograms . multivariate linear regression analysis covariates including traditional risk factors , minor -588 allele independent association impaired dilation enhanced constriction epicardial coronary arteries response acetylcholine , independently associated blunted increase coronary flow response acetylcholine . subgroup 59 consecutive subjects , constrictor responses epicardial coronary diameter intracoronary infusion NG-monomethyl-l-arginine , reflecting presence coronary nitric oxide ( ) bioactivity , inverse independent association -588 allele multivariate analysis . CONCLUSIONS : -588 polymorphism @ GeneSrc $ gene causes decrease endothelial bioactivity , leading impairment endothelium-dependent vasomotor function large resistance coronary arteries . GCL-GSH-NO axis may play role defense system coronary artery disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001437200572534)\n",
      "- Text: \"Down-regulation parkin protein transient focal cerebral ischemia : link stroke degenerative disease ? Ubiquitylated protein aggregates characteristic features neurodegenerative disorders also found acute pathological states brain stroke . Many proteins connected neurodegenerative diseases play role ubiquitin-proteasomal pathway . Mutation one proteins , E3 ubiquitin ligase parkin , cause autosomal recessive juvenile @ DiseaseTgt $ . show transient focal cerebral ischemia 1-h duration induces marked depletion parkin protein levels , 60 % , 36 % , 33 % , 25 % controls 1 , 3 , 6 , 24 h reperfusion , ischemia cause lower protein levels @ GeneSrc $ Ubc6 , Ubc7 , Ubc9 . 3 h reperfusion , parkin protein levels already reduced < 40 % control , ATP levels almost completely recovered ischemia observe DNA fragmentation , suggesting parkin depletion preceded development neuronal cell death . Up-regulation expression parkin shown protect cells injury induced endoplasmic reticulum ( ER ) dysfunction , form cellular stress also triggered transient cerebral ischemia . However , contrast observations neuroblastoma cells , saw up-regulation parkin expression primary neuronal cell cultures induction ER dysfunction . data thus suggest ischemia-induced depletion parkin protein may contribute pathological process resulting cell injury increasing sensitivity neurons ER dysfunction aggregation ubiquitylated proteins reperfusion period .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.2430831011953374e-06)\n",
      "- Text: \"Brain cell type-specific enhancer-promoter interactome maps disease-risk association . Noncoding genetic variation major driver phenotypic diversity , functional interpretation challenging . better understand common genetic variation associated brain diseases , defined noncoding regulatory regions major cell types human brain . Whereas psychiatric disorders primarily associated variants transcriptional enhancers promoters neurons , sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) variants largely confined microglia enhancers . Interactome maps connecting disease-risk variants cell-type-specific enhancers promoters revealed extended microglia gene network @ DiseaseTgt $ . Deletion microglia-specific enhancer harboring @ DiseaseTgt $ variants ablated @ GeneSrc $ expression microglia , neurons astrocytes . findings revise expand list genes likely influenced noncoding variants @ DiseaseTgt $ suggest probable cell types function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2406849229364815)\n",
      "- Text: \"Loss function mutations gene encoding @ GeneSrc $ @ DiseaseTgt $ . Recently targeted disruption Omi/HtrA2 found cause neurodegeneration @ DiseaseTgt $ phenotype mice . Using candidate gene approach , performed mutation screening @ GeneSrc $ gene German @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients . four patients , identified novel heterozygous G399S mutation , absent healthy controls . Moreover , identified novel A141S polymorphism associated @ DiseaseTgt $ ( P < 0.05 ) . mutations resulted defective activation protease activity @ GeneSrc $ . Immunohistochemistry functional analysis stably transfected cells revealed S399 mutant @ GeneSrc $ lesser extent , risk allele A141S polymorphism induced mitochondrial dysfunction associated altered mitochondrial morphology . Cells overexpressing S399 mutant @ GeneSrc $ susceptible stress-induced cell death wild-type . basis functional genomics , results provide novel link mitochondrial dysfunction neurodegeneration @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5353284695671622)\n",
      "- Text: \"Sequencing analysis @ GeneSrc $ shows previously reported pathogenic mutations neurologically normal controls . novel heterozygous non-synonymous mutation novel polymorphism @ GeneSrc $ locus associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) German population . attempt replicate results independent population , analyzed entire coding region @ GeneSrc $ series 644 North American @ DiseaseTgt $ cases young- late-onset disease 828 North American neurologically normal controls . results show neither variants previously related @ DiseaseTgt $ associated @ DiseaseTgt $ cohort risk variants present neurologically normal controls .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6776848218166225)\n",
      "- Text: \"Novel variant Pro143Ala @ GeneSrc $ contributes @ DiseaseTgt $ inducing hyperphosphorylation @ GeneSrc $ protein mitochondria . Mutations gene encoding mitochondrial protein @ GeneSrc $ ( @ GeneSrc $ ) inconsistently associated risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assessed presence @ GeneSrc $ mutations among patients @ DiseaseTgt $ performed functional assay identified mutations variants . Among total 1,373 subjects , entire @ GeneSrc $ coding region sequenced 113 early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , 20 familial @ DiseaseTgt $ patients 150 control subjects . additional 390 sporadic late-onset @ DiseaseTgt $ patients 700 controls subsequently screened validate possible mutations found first set . identified two novel heterozygous variants , c.427C > G ( Pro143Ala ) c.906 + 3 G > , 2 ( 1.5 % ) @ DiseaseTgt $ patients . missense variant , Pro143Ala , also observed one late-onset @ DiseaseTgt $ patient absent total 850 control subjects ( relative risk 2.3 , 95 % CI 1.5 - 2.8 , P = 0.04 ) . Expressing Pro143Ala variant @ GeneSrc $ primary dopaminergic neurons causes neurite degeneration . Following exposure rotenone , ultra-structural mitochondrial abnormality , percentage mitochondrial dysfunction apoptosis cells carrying @ GeneSrc $ Pro143Ala variant significantly higher wild-type cells . Mechanistically , protein level phosphorylated @ GeneSrc $ increased cells carrying Pro143Ala variant , suggesting Pro143Ala variant promotes @ GeneSrc $ phosphorylation resultant mitochondrial dysfunction . results support biologically relevant role @ GeneSrc $ @ DiseaseTgt $ susceptibility Taiwanese . large-scale association studies warranted confirm role @ GeneSrc $ Pro143Ala variant risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2335399472011738)\n",
      "- Text: \"Genetic variability mitochondrial serine protease @ GeneSrc $ contributes risk @ DiseaseTgt $ . one genetic study , @ GeneSrc $ ( @ GeneSrc $ ) mitochondrial protein associated increased risk sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . One missense mutation , p. Gly399Ser , C-terminal PDZ domain ( initial letters postsynaptic density 95 , PSD-95 ; discs large ; zonula occludens-1 , ZO-1 proteins [ Kennedy , 1995 ] ) resulted defective protease activation , induced mitochondrial dysfunction overexpressed stably transfected cells . examined contribution genetic variability @ GeneSrc $ @ DiseaseTgt $ risk extended series 266 Belgian @ DiseaseTgt $ patients 273 control individuals . Mutation analysis identified novel p. Arg404Trp mutation within PDZ domain predicted freeze @ GeneSrc $ inactive form . Moreover , identified six patient-specific variants 5 ' 3 ' regulatory regions might affect @ GeneSrc $ expression supported data luciferase reporter gene analyses . study confirms role @ GeneSrc $ mitochondrial protein @ DiseaseTgt $ susceptibility mutations functional PDZ domain . addition , extends @ GeneSrc $ mutation spectrum functional variants possibly affecting transcriptional activity . latter underpins previously unrecognized role altered @ GeneSrc $ expression risk factor relevant @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2853935931247328)\n",
      "- Text: \"Drosophila @ GeneSrc $ binds damage response element reaper locus . @ DiseaseTgt $ suppressor gene p53 regulates multiple cellular responses DNA damage , transcriptional targets specify responses incompletely understood . describe Drosophila @ GeneSrc $ homolog demonstrate activate transcription promoter containing binding sites human p53 . Dominant-negative forms Drosophila @ GeneSrc $ inhibit transactivation cultured cells radiation-induced apoptosis developing tissues . cis-regulatory region proapoptotic gene reaper contains radiation-inducible enhancer includes consensus @ GeneSrc $ binding site . Drosophila @ GeneSrc $ activate transcription site yeast multimer site sufficient radiation induction vivo . results indicate reaper direct transcriptional target Drosophila @ GeneSrc $ following DNA damage .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0343390838947135)\n",
      "- Text: \"Meiotic recombination provokes functional activation @ GeneSrc $ regulatory network . evolutionary appearance @ GeneSrc $ protein probably preceded role @ DiseaseTgt $ suppression , suggesting may unappreciated functions protein . Using genetic reporters proxies follow vivo activation @ GeneSrc $ network Drosophila , discovered process meiotic recombination instigates programmed activation @ GeneSrc $ germ line . Specifically , double-stranded breaks DNA generated topoisomerase Spo11 provoked functional @ GeneSrc $ activity , prolonged cells defective meiotic DNA repair . intrinsic stimulus @ GeneSrc $ regulatory network highly conserved Spo11-dependent activation p53 also occurs mice . findings establish physiological role @ GeneSrc $ meiosis suggest @ DiseaseTgt $ functions may co-opted primordial activities linked recombination .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9486458692367672)\n",
      "- Text: \"Mutant mice lacking p53 C-terminal domain model telomere syndromes . Mutations p53 , although frequent human @ DiseaseTgt $ , implicated telomere-related syndromes . , show homozygous mutant mice expressing p53Delta31 , p53 lacking C-terminal domain , exhibit increased p53 activity suffer aplastic anemia pulmonary fibrosis , hallmarks syndromes caused short telomeres . Indeed , p53Delta31/Delta31 mice short telomeres phenotypic traits associated telomere disease dyskeratosis congenita severe variant Hoyeraal-Hreidarsson syndrome . Heterozygous p53+/Delta31 mice mildly affected , decreased levels Mdm4 , negative regulator p53 , led dramatic aggravation symptoms . Importantly , several genes involved telomere metabolism downregulated p53Delta31/Delta31 cells , including Dyskerin , Rtel1 , @ GeneSrc $ , mutated dyskeratosis congenita , Terf1 , implicated aplastic anemia . Together , data reveal truncating mutation activate p53 p53 plays major role regulation telomere metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.041895390054364e-07)\n",
      "- Text: \"High-content genome-wide RNAi screens identify regulators parkin upstream mitophagy . increasing body evidence points mitochondrial dysfunction contributor molecular pathogenesis neurodegenerative diseases @ DiseaseTgt $ . Recent studies @ DiseaseTgt $ associated genes PINK1 ( ref . 2 ) parkin ( PARK2 , ref . 3 ) indicate may act quality control pathway preventing accumulation dysfunctional mitochondria . elucidate regulators impact parkin translocation damaged mitochondria genome-wide small interfering RNA ( siRNA ) screens coupled high-content microscopy . Screening yielded gene candidates involved diverse cellular processes subsequently validated low-throughput assays . led characterization TOMM7 essential stabilizing PINK1 outer mitochondrial membrane following mitochondrial damage . also discovered HSPA1L ( HSP70 family member ) BAG4 mutually opposing roles regulation parkin translocation . screens revealed @ GeneSrc $ , found localize mitochondria , inhibits PINK1 accumulation mitochondrial insult , reducing parkin translocation . Overall , screens provide rich resource understand mitochondrial quality control .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0061024932041482)\n",
      "- Text: \"Haplotypes gene expression implicate MAPT region @ DiseaseTgt $ : GenePD Study . BACKGROUND : Microtubule-associated protein tau ( MAPT ) associated several neurodegenerative disorders including forms parkinsonism @ DiseaseTgt $ ( @ DiseaseTgt $ ) . evaluated association MAPT region @ DiseaseTgt $ large cohort familial @ DiseaseTgt $ cases recruited GenePD Study . addition , postmortem brain samples patients @ DiseaseTgt $ neurologically normal controls used evaluate whether expression 3-repeat 4-repeat isoforms MAPT , neighboring genes Saitohin ( STH ) @ GeneSrc $ , altered @ DiseaseTgt $ cerebellum . METHODS : Twenty-one single-nucleotide polymorphisms ( SNPs ) region MAPT chromosome 17q21 genotyped GenePD Study . Single SNPs haplotypes , including H1 haplotype , evaluated association @ DiseaseTgt $ . Relative quantification gene expression performed using real-time RT-PCR . RESULTS : adjusting multiple comparisons , SNP rs1800547 significantly associated @ DiseaseTgt $ affection . H1 haplotype associated significantly increased risk @ DiseaseTgt $ , novel H1 subhaplotype identified predicted greater increased risk @ DiseaseTgt $ . expression 4-repeat MAPT , STH , @ GeneSrc $ significantly increased @ DiseaseTgt $ brains relative controls . difference expression observed 3-repeat MAPT . CONCLUSIONS : study supports role MAPT pathogenesis familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Interestingly , results gene expression studies suggest genes vicinity MAPT , specifically STH @ GeneSrc $ , may also role @ DiseaseTgt $ suggest complex effects genes region @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0542592502112944)\n",
      "- Text: \"Neuronal @ GeneSrc $ mediates alpha-synuclein fibril uptake drives @ DiseaseTgt $ . Neuronal accumulation spread pathological alpha-synuclein ( alpha-syn ) fibrils key events @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathophysiology . However , neuronal mechanisms underlying uptake alpha-syn fibrils remain unclear . work , identified @ GeneSrc $ @ DiseaseTgt $ risk gene affects alpha-syn aggregation . Overexpressing @ GeneSrc $ promotes alpha-syn fibril endocytosis exacerbates spread neurotoxicity alpha-syn pathology . Neuronal-specific knockdown @ GeneSrc $ expression shows protective effects . Mechanistically , @ GeneSrc $ extracellular domain 1 interacts alpha-syn C terminus electrostatic forces , > 1000 times selective fibrils . Furthermore , identified bemcentinib effective blocker @ GeneSrc $ fibril interaction vitro binding assay , cellular models , mice . findings identified @ GeneSrc $ potential receptor neuronal uptake alpha-syn fibrils , thus , therapeutic target @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0066190043383532)\n",
      "- Text: \"novel transcript encoded within 10-kb first intron human p53 @ DiseaseTgt $ suppressor gene ( D17S2179E ) induced differentiation myeloid leukemia cells . Two promoters previously shown map 5'-end human p53 gene . p53p1 located upstream first exon responsible transcription major p53 mRNA species . p53p2 stronger promoter p53p1 located within 10 , 738-bp first intron , approximately 1000 bp downstream exon 1 . mRNA transcripts initiated p53p2 previously identified HL-60 cells primer extension analysis observed increase abundance differentiation HL-60 cells granulocytes . screening cDNA library probe derived sequences downstream p53p2 start site , cloned characterized cDNA represents mRNA appears initiated p53p2 promoter . designated gene encoding transcript Hp53int1 ( GDB designation D17S2179E ) . cDNA 1125 bp polyadenylated downstream consensus poly ( ) addition site . entire 1125 bp derived intron 1 p53 gene , introns removed . cDNA contains major open reading frame although reading frame + 1 contains relatively low abundance stop codons compared two reading frames could possibly encode protein 119 amino acids . Analysis + 1 reading frame shows region high homology portion DNA-binding domain NF-kappaB . results indicate novel polyadenylated transcript encoded first intron human p53 gene . Hp53int1 may pseudogene gene may encoded @ GeneSrc $ . Alternatively , transcript may function , since RNA transcripts gene present number human cells levels induced terminal differentiation myeloid leukemia cells HL-60 U937 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1012318144435419)\n",
      "- Text: \"Parkin facilitates elimination expanded polyglutamine proteins leads preservation proteasome function . Parkin , commonly mutated gene familial @ DiseaseTgt $ , encodes E3 ubiquitin ligase . number candidate substrates identified parkin ubiquitin ligase action including CDCrel-1 , o-glycosylated alpha-synuclein , @ GeneSrc $ , synphilin-1 . show parkin promotes ubiquitination degradation expanded polyglutamine protein . Overexpression parkin reduces aggregation cytotoxicity expanded polyglutamine ataxin-3 fragment . Using cellular proteasome indicator system based destabilized form green fluorescent protein , demonstrate parkin reduces proteasome impairment caspase-12 activation induced expanded polyglutamine protein . Parkin forms complex expanded polyglutamine protein , heat shock protein 70 ( Hsp70 ) proteasome , may important elimination expanded polyglutamine protein . Hsp70 enhances parkin binding ubiquitination expanded polyglutamine protein vitro suggesting Hsp70 may help recruit misfolded proteins substrates parkin E3 ubiquitin ligase activity . speculate parkin may function relieve endoplasmic reticulum stress preserving proteasome activity presence misfolded proteins . Loss parkin function resulting proteasomal impairment may contribute accumulation toxic aberrant proteins neurodegenerative diseases including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.2196027746414696e-05)\n",
      "- Text: \"CHIP associated Parkin , gene responsible familial @ DiseaseTgt $ , enhances ubiquitin ligase activity . Unfolded Pael receptor ( @ GeneSrc $ ) substrate E3 ubiquitin ligase Parkin . Accumulation @ GeneSrc $ endoplasmic reticulum ( ER ) dopaminergic neurons induces ER stress leading neurodegeneration . , show CHIP , Hsp70 , Parkin , @ GeneSrc $ formed complex vitro vivo . amount CHIP complex increased ER stress . CHIP promoted dissociation Hsp70 Parkin @ GeneSrc $ , thus facilitating Parkin-mediated @ GeneSrc $ ubiquitination . Moreover , CHIP enhanced Parkin-mediated vitro ubiquitination @ GeneSrc $ absence Hsp70 . Furthermore , CHIP enhanced ability Parkin inhibit cell death induced @ GeneSrc $ Taken together , results indicate CHIP mammalian E4-like molecule positively regulates Parkin E3 activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.090665325578584)\n",
      "- Text: \"H50Q mutation enhances alpha-synuclein aggregation , secretion , toxicity . last two decades , identification missense mutations alpha-synuclein ( alpha-Syn ) gene SNCA families inherited Parkinson disease ( @ DiseaseTgt $ ) reinforced central role alpha-Syn @ DiseaseTgt $ pathogenesis . Recently , new missense mutation ( H50Q ) alpha-Syn described patients familial form @ DiseaseTgt $ dementia . investigated effects novel mutation biophysical properties alpha-Syn consequences cellular function . found H50Q mutation affected neither structure free membrane-bound alpha-Syn monomer , interaction metals , capacity phosphorylated vitro . However , compared wild-type ( WT ) protein , H50Q mutation accelerated alpha-Syn fibrillization vitro . cell-based models , H50Q mutation affect alpha-Syn subcellular localization ability phosphorylated PLK2 @ GeneSrc $ . Interestingly , H50Q increased alpha-Syn secretion SHSY5Y cells culture medium induced mitochondrial fragmentation hippocampal neurons . Although transient overexpression WT H50Q induce toxicity , species induced significant cell death added culture medium hippocampal neurons . Strikingly , H50Q exhibited toxicity , suggesting H50Q-related enhancement alpha-Syn aggregation secretion may play role extracellular toxicity mutant . Together , results provide novel insight mechanism newly described @ DiseaseTgt $ mutation may contribute pathogenesis @ DiseaseTgt $ related disorders .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0075224342812709)\n",
      "- Text: \"Interaction @ GeneSrc $ scribbled clones induces @ DiseaseTgt $ growth invasion . Human @ DiseaseTgt $ large degree cellular genetic heterogeneity . Complex cell interactions @ DiseaseTgt $ microenvironment thought important role tumorigenesis @ DiseaseTgt $ progression . Furthermore , cooperation oncogenic genetic lesions required @ DiseaseTgt $ development ; however , known cell interactions contribute oncogenic cooperation . genetic techniques available fruitfly Drosophila melanogaster allow analysis behaviour cells distinct mutations , making ideal model organism study cell interactions oncogenic cooperation . Drosophila eye-antennal discs , cooperation oncogenic protein Ras ( V12 ) ( ref . 5 ) loss-of-function mutations conserved @ DiseaseTgt $ suppressor scribbled ( scrib ) gives rise @ DiseaseTgt $ display many characteristics observed human @ DiseaseTgt $ . show clones cells bearing different mutations cooperate promote @ DiseaseTgt $ growth invasion Drosophila . found @ GeneSrc $ scrib ( - ) mutations also cause @ DiseaseTgt $ affect different adjacent epithelial cells . show interaction @ GeneSrc $ scrib ( - ) clones involves JNK signalling propagation JNK-induced upregulation JAK/STAT-activating cytokines , compensatory growth mechanism tissue homeostasis . development Ras ( V12 ) tumours also triggered tissue damage , stress condition activates JNK signalling . Given conservation pathways examined , similar cooperative mechanisms could role development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8743221038353027)\n",
      "- Text: \"Autosomal dominant dopa-responsive parkinsonism multigenerational Swiss family . AIM : describe large family autosomal dominant parkinsonism . BACKGROUND : Seven genes directly implicated autosomally inherited parkinsonism . However , several multigenerational large families known identifiable mutation . MATERIAL METHODS : Family members evaluated clinically , history chart review . Genetic investigation included SCA2 , SCA3 , UCHL1 , SNCA , LRRK2 , PINK1 , PRKN , @ GeneSrc $ , FMR1 premutation , MAPT . proband underwent brain fluorodopa PET ( FD-PET ) scan , one autopsy available . RESULTS : Eleven patients diagnosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , nine women . Mean age onset 52 tremor-predominant dopa-responsive parkinsonism . Disease progression slow severe motor fluctuations occurred . One patient required subthalamic nucleus deep-brain stimulation good motor outcome . One patient mental retardation , schizophrenia became demented , another patient demented . Three patients also two unaffected subjects mild learning difficulties . genetic tests yielded negative results . FD-PET showed marked asymmetric striatal tracer uptake deficiency , consistent @ DiseaseTgt $ . Pathological examination demonstrated Lewy bodies immunostaining negative alpha-synuclein . CONCLUSION : Apart younger age onset female predominance , phenotype indistinguishable @ DiseaseTgt $ , including FD-PET scan results . known genetic causes autosomal dominant @ DiseaseTgt $ excluded , family harbors novel genetic defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0354347990697649)\n",
      "- Text: \"MLL CALM fused AF10 morphologically distinct subsets @ DiseaseTgt $ translocation ( 10 ; 11 ) : rearrangements associated poor prognosis . translocation ( 10 ; 11 ) ( p13 ; q14 ) observed acute lymphoblastic leukemia ( ) well @ DiseaseTgt $ ( @ DiseaseTgt $ ) . recent study showed MLL/AF10 fusion cases @ DiseaseTgt $ ( 10 ; 11 ) various breakpoints chromosome 11 ranging q13 q23 . recently cloned CALM ( Clathrin Assembly Lymphoid Myeloid leukemia gene ) , fusion partner AF10 11q14 monocytic cell line U937 . define role genes @ DiseaseTgt $ , 10 cases ( 9 @ DiseaseTgt $ 1 ) cytogenetically proven ( 10 ; 11 ) ( p12 - 14 ; q13 - 21 ) well-characterized morphology , immunophenotype , clinical course analyzed . Interphase fluorescence situ hybridization ( FISH ) performed 2 YACs flanking CALM region , YAC contig MLL region , YAC spanning AF10 breakpoint . Rearrangement least one genes detected cases balanced ( 10 ; 11 ) . 4 cases , including 3 @ DiseaseTgt $ immature morphology ( 1 @ DiseaseTgt $ 2 @ DiseaseTgt $ ) 1 , signals CALM YACS separated interphase cells , indicating translocation breakpoint within CALM region . MLL rearranged 3 @ DiseaseTgt $ myelomonocytic differentiation ( 2 @ DiseaseTgt $ 1 @ DiseaseTgt $ ) , including 1 secondary @ DiseaseTgt $ . 3 cases , characteristic immunophenotype identified ( CD4 + , @ GeneSrc $ , CD33 + , CD65s+ ) . AF-10 involved 5 6 evaluable cases , including 1 case without detectable CALM MLL rearrangement . 2 complex translocations , none three genes rearranged . cases remarkably poor prognosis , mean survival 9.6 + /- 6.6 months . 7 @ DiseaseTgt $ cases uniformly treated according AMLCG86/92 protocols , disease-free overall survival significantly worse overall study group ( P = .03 P = .01 , respectively ) . conclude ( 10 ; 11 ) ( p13 ; q14 ) indicates CALM MLL rearrangements morphologically distinct subsets @ DiseaseTgt $ may associated poor prognosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4263418234325936)\n",
      "- Text: \"Modulation microRNA processing p53 . MicroRNAs ( miRNAs ) emerged key post-transcriptional regulators gene expression , involved diverse physiological pathological processes . Although miRNAs function @ DiseaseTgt $ suppressors oncogenes @ DiseaseTgt $ development , widespread downregulation miRNAs commonly observed human @ DiseaseTgt $ promotes cellular transformation tumorigenesis . indicates inherent significance small RNAs @ DiseaseTgt $ suppression . However , connection @ DiseaseTgt $ suppressor networks miRNA biogenesis machineries investigated depth . show central @ DiseaseTgt $ suppressor , p53 , enhances post-transcriptional maturation several miRNAs growth-suppressive function , including miR-16 - 1 , miR-143 miR-145 , response DNA damage . HCT116 cells human diploid fibroblasts , p53 interacts @ GeneSrc $ processing complex association DEAD-box RNA helicase p68 ( also known DDX5 ) facilitates processing primary miRNAs precursor miRNAs . also found transcriptionally inactive p53 mutants interfere functional assembly @ GeneSrc $ complex p68 , leading attenuation miRNA processing activity . findings suggest transcription-independent modulation miRNA biogenesis intrinsically embedded @ DiseaseTgt $ suppressive program governed p53 . study reveals previously unrecognized function p53 miRNA processing , may underlie key aspects @ DiseaseTgt $ biology .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8973315781675468)\n",
      "- Text: \"Systematic RNA interference reveals oncogenic KRAS-driven @ DiseaseTgt $ require @ GeneSrc $ . proto-oncogene KRAS mutated wide array human @ DiseaseTgt $ , aggressive respond poorly standard therapies . Although identification specific oncogenes led development clinically effective , molecularly targeted therapies cases , KRAS remained refractory approach . complementary strategy targeting KRAS identify gene products , inhibited , result cell death presence oncogenic allele . used systematic RNA interference detect synthetic lethal partners oncogenic KRAS found non-canonical IkappaB kinase @ GeneSrc $ selectively essential cells contain mutant KRAS . Suppression @ GeneSrc $ induced apoptosis specifically human cancer cell lines depend oncogenic KRAS expression . cells , @ GeneSrc $ activated NF-kappaB anti-apoptotic signals involving c-Rel BCL-XL ( also known BCL2L1 ) essential survival , providing mechanistic insights synthetic lethal interaction . observations indicate @ GeneSrc $ NF-kappaB signalling essential KRAS mutant @ DiseaseTgt $ , establish general approach rational identification co-dependent pathways @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0613232174804263)\n",
      "- Text: \"situ hybridization analysis @ GeneSrc $ mRNA @ DiseaseTgt $ lesioned rat brain . @ GeneSrc $ ( @ GeneSrc $ ) gene mutations responsible majority early onset familial forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Neither @ GeneSrc $ 's anatomic distribution brain expression @ DiseaseTgt $ reported . Using situ hybridization rat forebrain , show @ GeneSrc $ mRNA expression primarily cortical hippocampal neurons , less expression subcortical structures , regional pattern similar APP695 . Excitotoxic lesions lead loss @ GeneSrc $ signal . neuronal pattern expression PS-1 mRNA also observed human hippocampal formation . @ DiseaseTgt $ control levels differ . @ GeneSrc $ expressed brain areas vulnerable @ DiseaseTgt $ changes areas spared @ DiseaseTgt $ ; however , @ GeneSrc $ expression sufficient mark vulnerable regions . Collectively , data suggest neuropathogenic process consequent @ GeneSrc $ mutations begins neuronal cell populations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0920081517483721)\n",
      "- Text: \"Specific inhibition CBP/beta-catenin interaction rescues defects neuronal differentiation caused @ GeneSrc $ mutation . Wnt/beta-catenin signaling shown promote self-renewal variety tissue stem cells , including neuronal stem cells hematopoietic stem cells . However , activation Wnt/beta-catenin pathway promoted inhibition pathway prevented differentiation neuronal precursor cells . clear explanation differential effects Wnt/beta-catenin activation neuronal precursors available present . @ GeneSrc $ ( @ GeneSrc $ ) polytopic protein comprised six eight transmembrane domains . @ GeneSrc $ , part gamma-secretase complex , required intramembrane proteolysis amyloid precursor protein ( APP ) Notch . Additionally , interactions beta-catenin , @ GeneSrc $ associated modulation Wnt/beta-catenin signaling . @ DiseaseTgt $ @ GeneSrc $ mutant , @ GeneSrc $ ) , causes dramatic increase cell factor ( TCF ) /beta-catenin transcription PC-12 cells , prevents normal nerve growth factor ( NGF ) -induced neuronal differentiation neurite outgrowth . Selective inhibition TCF/beta-catenin/cAMP-response element-binding protein ( CREB ) -binding protein ( CBP ) -mediated transcription , TCF/beta-catenin/p300 , recently described small molecule antagonist ICG-001 corrects defects neuronal differentiation , highlighting importance Wnt/beta-catenin signaling process . propose increased TCF/beta-catenin/CBP-mediated transcription , well failure switch TCF/beta-catenin/p300-mediated transcription , play important role decreasing neuronal differentiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003467035855377)\n",
      "- Text: \"Complex Effects ZSCAN21 Transcription Factor Transcriptional Regulation @ GeneSrc $ Primary Neuronal Cultures Vivo . @ GeneSrc $ , presynaptic neuronal protein encoded @ GeneSrc $ gene , strongly implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ DiseaseTgt $ pathogenesis linked increased @ GeneSrc $ levels ; however , transcriptional elements control @ GeneSrc $ expression still elusive . Previous experiments PC12 cells demonstrated transcription factor zinc finger SCAN domain containing 21 ( ZSCAN21 ) plays important regulatory role @ GeneSrc $ transcription . Currently , characterized role ZSCAN21 @ GeneSrc $ transcription primary neuronal cultures vivo found ZSCAN21 developmentally expressed neurons different rat brain regions . confirmed binding intron 1 region @ GeneSrc $ rat cortical cultures . Lentivirus-mediated silencing ZSCAN21 increased significantly @ GeneSrc $ promoter activity , mRNA , protein levels cultures . contrast , ZSCAN21 silencing reduced @ GeneSrc $ neurosphere cultures . Interestingly , ZSCAN21 overexpression cortical neurons led robust mRNA negligible protein expression , suggesting ZSCAN21 protein levels tightly regulated post-transcriptionally and/or post-translationally primary neurons . Efficient adeno-associated virus-mediated knockdown ZSCAN21 postnatal adult hippocampus , area linked non-motor @ DiseaseTgt $ symptoms , revealed significant alterations @ GeneSrc $ levels . Overall , study demonstrates ZSCAN21 involved transcriptional regulation @ GeneSrc $ primary neuronal cultures , direction effect variable , likely depending neuronal maturation . However , unaltered @ GeneSrc $ levels observed following ZSCAN21 down-regulation rat brain , possibly due compensatory mechanisms , imply ZSCAN21 master regulator @ GeneSrc $ vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0101441017771065)\n",
      "- Text: \"Inducible expression mutant @ GeneSrc $ decreases proteasome activity increases sensitivity mitochondria-dependent apoptosis . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common progressive neurodegenerative disorder caused loss dopaminergic neurons substantia nigra . Although mutations @ GeneSrc $ identified autosomal dominant @ DiseaseTgt $ , mechanism dopaminergic neural cell death occurs remains unknown . Proteins encoded two genes mutations cause familial @ DiseaseTgt $ , parkin UCH-L1 , involved regulation ubiquitin-proteasome pathway , suggesting dysregulation ubiquitin-proteasome pathway involved mechanism mutations cause @ DiseaseTgt $ . established inducible PC12 cell lines wild-type mutant @ GeneSrc $ de-repressed removing doxycycline . Differentiated PC12 cell lines expressing mutant @ GeneSrc $ showed decreased activity proteasomes without direct toxicity . Cells expressing mutant @ GeneSrc $ showed increased sensitivity apoptotic cell death treated sub-toxic concentrations exogenous proteasome inhibitor . Apoptosis accompanied mitochondrial depolarization elevation caspase-3 -9 , blocked cyclosporin . data suggest expression mutant @ GeneSrc $ results sensitivity impairment proteasome activity , leading mitochondrial abnormalities neuronal cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9711711377432636)\n",
      "- Text: \"Phosphorylation prompt , prevent , formation @ GeneSrc $ toxic species rat model @ DiseaseTgt $ . Phosphorylation involved numerous neurodegenerative diseases . particular , alpha-synuclein extensively phosphorylated aggregates patients suffering synucleinopathies . However , share modification events lead conversion alpha-synuclein aggregated toxic species needed clarified . rat model developed rAAV2/6-mediated expression @ GeneSrc $ demonstrates correlation neurodegeneration formation small filamentous @ GeneSrc $ aggregates . mutation preventing phosphorylation ( S129A ) significantly increases @ GeneSrc $ toxicity leads enhanced formation beta-sheet-rich , proteinase K-resistant aggregates , increased affinity intracellular membranes , disarrayed network neurofilaments enhanced @ GeneSrc $ nuclear localization . expression mutation mimicking phosphorylation ( S129D ) lead dopaminergic cell loss . Nevertheless , fewer larger aggregates formed , signals apoptosis also activated rats expressing phosphorylation-mimicking form @ GeneSrc $ . observations strongly suggest phosphorylation play active role accumulation cytotoxic pre-inclusion aggregates . Unexpectedly , study also demonstrates constitutive expression phosphorylation-mimicking forms @ GeneSrc $ protect neurodegeneration . role phosphorylation Serine 129 early phase @ DiseaseTgt $ examined , brings new perspective therapeutic approaches focusing modulation kinases/phosphatases activity control @ GeneSrc $ toxicity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0052063663539921)\n",
      "- Text: \"@ GeneSrc $ strains cause distinct synucleinopathies local systemic administration . Misfolded protein aggregates represent continuum overlapping features neurodegenerative diseases , differences protein components affected brain regions . molecular hallmark synucleinopathies @ DiseaseTgt $ , dementia Lewy bodies multiple system atrophy megadalton @ GeneSrc $ deposits suggestive one molecular event causing distinct disease phenotypes . Glial @ GeneSrc $ ( alpha-SYN ) filamentous deposits prominent multiple system atrophy neuronal alpha-SYN inclusions found @ DiseaseTgt $ dementia Lewy bodies . discovery alpha-SYN assemblies different structural characteristics ' strains ' led hypothesis strains could account different clinico-pathological traits within synucleinopathies . study show alpha-SYN strain conformation seeding propensity lead distinct histopathological behavioural phenotypes . assess properties structurally well-defined alpha-SYN assemblies ( oligomers , ribbons fibrils ) injection rat brain . prove alpha-SYN strains amplify vivo . Fibrils seem major toxic strain , resulting progressive motor impairment cell death , whereas ribbons cause distinct histopathological phenotype displaying @ DiseaseTgt $ multiple system atrophy traits . Additionally , show alpha-SYN assemblies cross blood-brain barrier distribute central nervous system intravenous injection . results demonstrate distinct alpha-SYN strains display differential seeding capacities , inducing strain-specific pathology neurotoxic phenotypes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9267941776249752)\n",
      "- Text: \"Endoplasmic reticulum stress mitochondrial cell death pathways mediate A53 mutant @ GeneSrc $ toxicity . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative movement disorder characterized selective loss dopaminergic neurons presence Lewy bodies . @ GeneSrc $ major component Lewy bodies sporadic @ DiseaseTgt $ , mutations @ GeneSrc $ cause autosomal-dominant hereditary @ DiseaseTgt $ . , generated A53 mutant @ GeneSrc $ PC12 cell lines using Tet-off regulatory system . Inducing expression A53 @ GeneSrc $ differentiated PC12 cells decreased proteasome activity , increased intracellular ROS level caused approximately 40 % cell death , accompanied mitochondrial cytochrome C release elevation caspase-9 -3 activities . Cell death partially blocked cyclosporine [ inhibitor mitochondrial permeability transition ( MPT ) process ] , z-VAD ( pan-caspase inhibitor ) inhibitors caspase-9 -3 caspase-8 inhibitor . Furthermore , induction A53 @ GeneSrc $ increased endoplasmic reticulum ( ER ) stress elevated caspase-12 activity . RNA interference knock caspase-12 levels salubrinal ( ER stress inhibitor ) partially protected cell death reduced A53 toxicity treatment z-VAD . results indicate ER stress mitochondrial dysfunction contribute A53 @ GeneSrc $ cell death . study sheds light pathogenesis @ GeneSrc $ cellular toxicity @ DiseaseTgt $ provides cell model screening @ DiseaseTgt $ therapeutic agents .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0173048655985812)\n",
      "- Text: \"Probing @ DiseaseTgt $ using induced pluripotent stem cells . understanding @ DiseaseTgt $ pathogenesis currently limited difficulties obtaining live neurons patients inability model sporadic form disease . may possible overcome challenges reprogramming primary cells patients induced pluripotent stem cells ( iPSCs ) . reprogrammed primary fibroblasts two patients familial @ DiseaseTgt $ , caused duplication amyloid-beta precursor protein gene ( APP ; termed APP ( Dp ) ) , two sporadic @ DiseaseTgt $ ( termed sAD1 , sAD2 ) two non-demented control individuals iPSC lines . Neurons differentiated cultures purified fluorescence-activated cell sorting characterized . Purified cultures contained 90 % neurons , clustered fetal brain messenger RNA samples microarray criteria , could form functional synaptic contacts . Virtually cells exhibited normal electrophysiological activity . Relative controls , iPSC-derived , purified neurons two APP ( Dp ) patients patient sAD2 exhibited significantly higher levels pathological markers amyloid-beta ( 1 - 40 ) , phospho-tau ( Thr 231 ) active @ GeneSrc $ ( aGSK-3beta ) . Neurons APP ( Dp ) sAD2 patients also accumulated large RAB5-positive early endosomes compared controls . Treatment purified neurons beta-secretase inhibitors , gamma-secretase inhibitors , caused significant reductions phospho-Tau ( Thr 231 ) aGSK-3beta levels . results suggest direct relationship APP proteolytic processing , amyloid-beta , @ GeneSrc $ activation tau phosphorylation human neurons . Additionally , observed neurons genome one sAD patient exhibited phenotypes seen familial @ DiseaseTgt $ samples . generally , demonstrate iPSC technology used observe phenotypes relevant @ DiseaseTgt $ , even though take decades overt disease manifest patients .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4363815305183355)\n",
      "- Text: \"Presenilin-1 mutation L271V results altered exon 8 splicing @ DiseaseTgt $ non-cored plaques neuritic dystrophy . mutation L271V exon 8 presenilin-1 ( PS-1 ) gene detected @ DiseaseTgt $ pedigree . Neuropathological examination affected individuals identified variant , large , non-cored plaques without neuritic dystrophy , reminiscent cotton wool plaques . Biochemical analysis L271V mutation showed increased secretion 42-amino acid amyloid-beta peptide , suggesting pathogenic mutation . Analysis PS-1 transcripts brains two mutation carriers revealed 17 - 50 % increase PS-1 transcripts deletion exon 8 ( PS-1deltaexon8 ) compared unrelated @ DiseaseTgt $ brains . Exon trapping analysis confirmed L271V mutation enhanced deletion exon 8 . Western blots brain lysates indicated PS-1deltaexon8 overexpressed affected individual . Biochemical analysis PS-1deltaexon8 COS BD8 cells indicate splice isoform intrinsically active interacts wild-type PS-1 generate amyloid-beta . Western blots cell lysates immunoprecipitated anti-Tau @ GeneSrc $ antibodies indicated PS-1deltaexon8 , unlike wild-type PS-1 , interact directly Tau @ GeneSrc $ , potential modifiers neuritic dystrophy . postulate variant plaques observed family due part effects PS-1deltaexon8 interaction PS-1 various protein complexes necessary neuritic plaque formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.617171493805359e-06)\n",
      "- Text: \"Abeta tau form soluble complexes may promote self aggregation insoluble forms observed @ DiseaseTgt $ . date , reasonable explanation plaques tangles simultaneously accumulate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate Western blotting ELISA stable complex form tau amyloid-beta protein ( Abeta ) . complex enhances tau phosphorylation @ GeneSrc $ , phosphorylation promotes dissociation complex . localized sites interaction using peptide membrane arrays . Abeta binds multiple tau peptides , especially exons 7 9 . binding sharply reduced abolished phosphorylation specific serine threonine residues . Conversely , tau binds multiple Abeta peptides mid C-terminal regions Abeta . binding also significantly decreased @ GeneSrc $ phosphorylation tau . used surface plasmon resonance determine binding affinity Abeta tau found low nanomolar range almost 1,000-fold higher tau . soluble extracts @ DiseaseTgt $ control brain tissue , detected Abeta bound tau ELISAs . also found double immunostaining @ DiseaseTgt $ brain tissue phosphorylated tau Abeta form separate insoluble complexes within neurons processes . hypothesize @ DiseaseTgt $ , initial step pathogenesis may intracellular binding soluble Abeta soluble nonphosphorylated tau , thus promoting tau phosphorylation Abeta nucleation . Blocking sites Abeta initially binds tau might arrest simultaneous formation plaques tangles @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0605948456991109)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human @ DiseaseTgt $ . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable epidermal growth factor mTOR-independent cell proliferation associated AKT , ERK , @ GeneSrc $ phosphorylation . Paradoxically , @ GeneSrc $ inhibitors lithium chloride SB216763 selectively decreased proliferation human breast colorectal cancer cell lines oncogenic PIK3CA mutations led decrease @ GeneSrc $ target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 colon cancer cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest @ GeneSrc $ important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties @ DiseaseTgt $ harbor mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2768358252724885)\n",
      "- Text: \"Mutational analysis beta-catenin gene Japanese @ DiseaseTgt $ : frequent mutations endometrioid carcinomas . investigate contribution beta-catenin gene development @ DiseaseTgt $ , mutational analysis exon 3 beta-catenin gene conducted . analyzed 61 @ DiseaseTgt $ , consisting 49 non-endometrioid-type 12 endometrioid-type tumors , genetic alteration beta-catenin gene . Five carcinomas showed beta-catenin mutations ( S37C , T41I , T41A ) , including 4 ( 33 % ) 12 endometrioid-type tumors 1 ( 14 % ) 7 mucinous-type tumors . mutations altered serine/threonine residues potential sites @ GeneSrc $ phosphorylation . detected carcinomas interstitial deletion involving exon 3 beta-catenin . Furthermore , immunohistochemically studied 27 61 @ DiseaseTgt $ . nuclear cytoplasmic beta-catenin expressions demonstrated 4 27 @ DiseaseTgt $ tissue samples available examination . 4 cases exhibited mutations exon 3 beta-catenin , including mucinous carcinoma . results suggested beta-catenin gene mutation potential @ GeneSrc $ phosphorylation sites results accumulation beta-catenin protein within cells translocation nuclei . Accumulated beta-catenin protein may involved development @ DiseaseTgt $ , @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001136637369183)\n",
      "- Text: \"beta-catenin mutation expression analysis @ DiseaseTgt $ : exon 3 mutations nuclear translocation 16 % endometrioid tumours . molecular mechanisms involved generation epithelial ovarian cancers poorly understood , evidence suggests different histological subtypes may arise independent tumorigenic events . beta-Catenin emerging important oncogene transformation number epithelial cancers , mutations reported small study @ DiseaseTgt $ . Mutations NH ( 2 ) -regulatory domain beta-catenin stabilise cytoplasmic levels protein , promotes up-regulation beta-catenin-T-cell factor-lymphoid enhancer factor transcriptional complex . report beta-catenin ( CTNNB1 ) exon 3 mutation analysis 149 epithelial ovarian carcinomas . revealed 10/63 ( 16 % ) @ DiseaseTgt $ activating mutations beta-catenin gene . mutations missense changes within @ GeneSrc $ consensus site , affecting serine residues codons 33 37 glycine codon 34 . Immuno-histochemical analysis identified cytoplasmic stabilisation nuclear translocation endometrioid tumours mutations . phenotypic change also identified 3 endometrioid tumours somatic mutations within exon 3 CTNNB1 . Stabilisation free , monomeric pool beta-catenin probable resulting constitutive activation Tcf-associated transcriptional complex appears specific oncogenic event @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0330227810659513)\n",
      "- Text: \"@ GeneSrc $ tau genes interact @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.709669342835689e-05)\n",
      "- Text: \"@ GeneSrc $ polymorphisms alter transcription splicing @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disorder characterized combination motor symptoms . identified two functional single nucleotide polymorphisms @ GeneSrc $ gene ( @ GeneSrc $ ) . promoter single nucleotide polymorphism ( rs334558 ) associated transcriptional strength vitro allele greater activity . intronic single nucleotide polymorphism ( rs6438552 ) regulates selection splice acceptor sites vitro . allele associated altered splicing lymphocytes increased levels @ GeneSrc $ transcripts lack exons 9 11 ( GSKDeltaexon9 + 11 ) . Increased levels GSKDeltaexon9 + 11 correlated enhanced phosphorylation substrate , Tau . comparison @ DiseaseTgt $ control brains , increased frequency allele ( rs6438552 ) corresponding increase GSKDeltaexon9 + 11 Tau phosphorylation @ DiseaseTgt $ brains . Conditional logistic regression indicated gene-gene interaction T/T genotype rs334558 H1/H1 haplotype microtubule-associated protein Tau ( MAPT ) gene ( p = 0.009 ) . association haplotype ( alleles @ GeneSrc $ polymorphisms ) disease risk stratification Tau haplotypes ( ( H1/H2+H2/H2 individuals : odds ratio , 1.64 ; p = 0.007 ; ( H1/H1 individuals : odds ratio , 0.68 ; p < 0.001 ) . results suggest @ GeneSrc $ polymorphisms alter transcription splicing interact Tau haplotypes modify disease risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2035957026948484)\n",
      "- Text: \"Tau alpha-synuclein susceptibility , dementia , @ DiseaseTgt $ . OBJECTIVE : @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative condition typically presents movement disorder known associated variable degrees cognitive impairment including dementia . investigated genetic basis susceptibility cognitive heterogeneity disease . METHODS : 659 @ DiseaseTgt $ patients , 109 followed 3.5 years diagnosis , 2,176 control subjects , studied candidate genes involved protein aggregation inclusion body formation , pathological hallmark parkinsonism : microtubule-associated protein tau ( MAPT ) , @ GeneSrc $ ( @ GeneSrc $ ) , alpha-synuclein ( SNCA ) . RESULTS : observed cognitive decline development @ DiseaseTgt $ strongly associated ( p = 10 ( -4 ) ) inversion polymorphism containing MAPT . also found novel synergistic interaction MAPT inversion polymorphism single nucleotide polymorphism rs356219 3 ' region SNCA . data , carrying risk genotype either loci marginally increases risk development @ DiseaseTgt $ , whereas carrying combination risk genotypes loci approximately doubles risk development disease ( p = 3 x 10 ( -6 ) ) . INTERPRETATION : data support hypothesis tau alpha-synuclein involved shared converging pathways pathogenesis @ DiseaseTgt $ , suggest tau inversion influences development cognitive impairment dementia patients idiopathic @ DiseaseTgt $ . findings potentially important implications understanding interface tau alpha-synuclein pathways neurodegenerative disorders unraveling biological basis cognitive impairment dementia @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1072202896695011)\n",
      "- Text: \"Knockin mutant PIK3CA activates multiple oncogenic pathways . phosphatidylinositol 3-kinase subunit PIK3CA frequently mutated human cancers . used gene targeting `` knock `` PIK3CA mutations human breast epithelial cells identify new therapeutic targets associated oncogenic PIK3CA . Mutant PIK3CA knockin cells capable epidermal growth factor mTOR-independent cell proliferation associated AKT , ERK , @ GeneSrc $ phosphorylation . Paradoxically , @ GeneSrc $ inhibitors lithium chloride SB216763 selectively decreased proliferation human breast @ DiseaseTgt $ cell lines oncogenic PIK3CA mutations led decrease @ GeneSrc $ target gene CYCLIN D1 . Oral treatment lithium preferentially inhibited growth nude mouse xenografts HCT-116 @ DiseaseTgt $ cells mutant PIK3CA compared isogenic HCT-116 knockout cells containing wild-type PIK3CA . findings suggest @ GeneSrc $ important effector mutant PIK3CA , lithium , FDA-approved therapy bipolar disorders , selective antineoplastic properties cancers harbor mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.371973034799566)\n",
      "- Text: \"Binding @ GeneSrc $ APC-beta-catenin complex regulation complex assembly . adenomatous polyposis coli gene ( APC ) mutated @ DiseaseTgt $ . APC protein binds cellular adhesion molecule beta-catenin , mammalian homolog ARMADILLO , component WINGLESS signaling pathway Drosophila development . shown beta-catenin present excess , APC binds another component WINGLESS pathway , @ GeneSrc $ ( @ GeneSrc $ ) , mammalian homolog Drosophila ZESTE WHITE 3 . APC good substrate @ GeneSrc $ vitro , phosphorylation sites mapped central region APC . Binding beta-catenin region dependent phosphorylation @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.023012883073914)\n",
      "- Text: \"Inducible expression mutant alpha-synuclein decreases proteasome activity increases sensitivity mitochondria-dependent apoptosis . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common progressive neurodegenerative disorder caused loss dopaminergic neurons substantia nigra . Although mutations alpha-synuclein identified autosomal dominant @ DiseaseTgt $ , mechanism dopaminergic neural cell death occurs remains unknown . Proteins encoded two genes mutations cause familial @ DiseaseTgt $ , parkin @ GeneSrc $ , involved regulation ubiquitin-proteasome pathway , suggesting dysregulation ubiquitin-proteasome pathway involved mechanism mutations cause @ DiseaseTgt $ . established inducible PC12 cell lines wild-type mutant alpha-synuclein de-repressed removing doxycycline . Differentiated PC12 cell lines expressing mutant alpha-synuclein showed decreased activity proteasomes without direct toxicity . Cells expressing mutant alpha-synuclein showed increased sensitivity apoptotic cell death treated sub-toxic concentrations exogenous proteasome inhibitor . Apoptosis accompanied mitochondrial depolarization elevation caspase-3 -9 , blocked cyclosporin . data suggest expression mutant alpha-synuclein results sensitivity impairment proteasome activity , leading mitochondrial abnormalities neuronal cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9224878509291824)\n",
      "- Text: \"Germline somatic mutation analyses DNA mismatch repair gene MLH3 : Evidence somatic mutation @ DiseaseTgt $ . DNA mismatch repair considerable scientific medical importance essential role maintaining genomic integrity , association hereditary non-polyposis colon cancer ( HNPCC ) . Germline mutations five mismatch repair genes ( MLH1 , MSH2 , PMS1 , PMS2 , @ GeneSrc $ ) associated HNPCC susceptibility . laboratory recently identified MLH3 , novel DNA mismatch repair gene . screened MLH3 coding sequence 60 probands increased genetic risk factors @ DiseaseTgt $ susceptibility mutations candidate genes . definite MLH3 germline mutations found . subsequently screened 36 colon tumors , discovered appreciable frequency somatic MLH3 coding mutations MSI-H tumors ( 25 % ) . four six tumors , evidence biallelic inactivation noted . Furthermore , MLH3 nonsense mutations identified two 12 microsatellite stable ( MSS ) tumors 14q24 loss heterozygosity . analyses exclude existence germline MLH3 mutations patients increased genetic risk factors @ DiseaseTgt $ susceptibility , suggest mutations uncommon patient population . finding appreciable frequency somatic MLH3 mutations consistent possible role gene progression @ DiseaseTgt $ tumorigenesis . Hum Mutat 17:389 - 396 , 2001 . Published 2001 Wiley-Liss , Inc .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3306299062730566)\n",
      "- Text: \"first functional study MLH3 mutations found cancer patients . MLH3 gene one five mismatch repair ( MMR ) genes associated hereditary nonpolyposis colorectal cancer ( HNPCC ) . Eighteen different inherited MLH3 mutations reported pathogenic international mutation database . several cases , mutation found patient without family history suggestive inherited cancer susceptibility . cases , similar mutation also found sporadic patients and/or healthy controls . Four patients carried MLH3 mutation together another inherited MMR gene variation . functional analyses performed assess pathogenicity 18 mutations . MLH3 assumed less important MMR HNPCC susceptibility genes MSH2 , @ GeneSrc $ , MLH1 , PMS2 , accordingly low-risk gene @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assess significance inherited sequence variations MLH3 , functionally characterized seven missense mutations ( Q24E , R647C , S817 G , G933C , W1276R , A1394 , E1451 K ) scattered throughout MLH3 polypeptide . mutations found @ DiseaseTgt $ endometrial cancer patients reported pathogenic . study showed seven mutated MLH3 proteins , complex counterpart MLH1 ( MutLgamma ) , repaired mismatches wild type MutLgamma worse heterodimer MLH1 PMS2 ( MutLalpha ) . results confirm MutLgamma less efficient MMR complex MutLalpha show MLH3 mutations alone interfere MMR . studies needed evaluate pathogenicity MLH3 mutations compound MMR mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3576317553838937)\n",
      "- Text: \"MLH3 mutation endometrial cancer . MLH3 recently described member DNA mismatch repair gene family . Based interaction MutL homologue MLH1 , postulated MLH3 might play role tumorigenesis . Germ line somatic mutations MLH3 identified small fraction @ DiseaseTgt $ , role MLH3 @ DiseaseTgt $ tumorigenesis remains controversial . investigated MLH3 's role endometrial tumorigenesis analysis tumor germ line DNA 57 endometrial cancer patients increased risk inherited cancer susceptibility . Patients known MSH2 @ GeneSrc $ mutations excluded well MLH1-methylated tumors . Sixteen different variants identified single-strand conformational variant analysis . 12 missense changes identified , three somatic mutations . One patient germ line missense variant loss heterozygosity ( LOH ) tumor specimen . evidence MLH3 promoter methylation based combined bisulfite restriction analysis . identification inherited missense variants , somatic missense mutations ( present 3 57 tumors ) , LOH tumor patient germ line missense change suggest role MLH3 endometrial tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0126123484469434)\n",
      "- Text: \"Vitamin K2 mitochondrial electron carrier rescues pink1 deficiency . Human @ GeneSrc $ localizes mitochondria converts vitamin K ( 1 ) vitamin K ( 2 ) . Vitamin K ( 2 ) best known cofactor blood coagulation , bacteria membrane-bound electron carrier . Whether vitamin K ( 2 ) exerts similar carrier function eukaryotic cells unknown . identified Drosophila @ GeneSrc $ modifier pink1 , gene mutated @ DiseaseTgt $ affects mitochondrial function . found vitamin K ( 2 ) necessary sufficient transfer electrons Drosophila mitochondria . Heix mutants showed severe mitochondrial defects rescued vitamin K ( 2 ) , , similar ubiquinone , vitamin K ( 2 ) transferred electrons Drosophila mitochondria , resulting efficient adenosine triphosphate ( ATP ) production . Thus , mitochondrial dysfunction rescued vitamin K ( 2 ) serves mitochondrial electron carrier , helping maintain normal ATP production .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.074013130869023)\n",
      "- Text: \"Localization LRRK2 membranous vesicular structures mammalian brain . OBJECTIVE : PARK8 gene responsible late-onset @ DiseaseTgt $ encodes large novel protein unknown biological function termed leucine-rich repeat kinase 2 ( LRRK2 ) . studies herein explore localization LRRK2 mammalian brain . METHODS : Polyclonal antibodies generated amino carboxy termini LRRK2 used examine biochemical , subcellular , immunohistochemical distribution LRRK2 . RESULTS : @ GeneSrc $ detected rat brain approximate 280kDa protein Western blot analysis . Subcellular fractionation demonstrates presence @ GeneSrc $ microsomal , synaptic vesicle-enriched synaptosomal cytosolic fractions rat brain , well mitochondrial outer membrane . Immunohistochemical analysis rat human brain tissue primary rat cortical neurons , @ GeneSrc $ antibodies , shows widespread neuronal-specific labeling localized exclusively punctate structures within perikarya , dendrites , axons . Confocal colocalization analysis primary cortical neurons shows partial yet significant overlap @ GeneSrc $ immunoreactivity markers specific mitochondria lysosomes . Furthermore , ultrastructural analysis rodent basal ganglia detects LRRK2 immunoreactivity associated membranous vesicular intracellular structures , including lysosomes , endosomes , transport vesicles , mitochondria . INTERPRETATION : association LRRK2 variety membrane vesicular structures , membrane-bound organelles , microtubules suggests affinity LRRK2 lipids lipid-associated proteins may suggest potential role biogenesis and/or regulation vesicular membranous intracellular structures within mammalian brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004251715047599)\n",
      "- Text: \"@ GeneSrc $ deficiency protective rhabdomyolysis-induced kidney injury . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene common known genetic cause @ DiseaseTgt $ , @ GeneSrc $ also linked Crohn 's Hansen 's disease . @ GeneSrc $ expressed many organs mammals particularly abundant kidney . find @ GeneSrc $ protein predominantly localized collecting duct cells rat kidney , much lower expression kidney cells . genetic knockout ( KO ) LRRK2 expression well-tolerated mice rats , unique age-dependent pathology develops kidney . cortex medulla @ GeneSrc $ KO rat kidneys become darkly pigmented early adulthood , yet aged animals display overt signs kidney failure . Accompanying dark pigment find substantial macrophage infiltration @ GeneSrc $ KO kidneys , suggesting presence chronic inflammation may predispose kidney disease . Unexpectedly , dark kidneys @ GeneSrc $ KO rats highly resistant rhabdomyolysis-induced acute kidney injury compared wild-type rats . Biochemical profiling @ GeneSrc $ KO kidneys using immunohistochemistry , proteomic lipidomic analyses show massive accumulation hemoglobin lipofuscin renal tubules account pigmentation . proximal tubules demonstrate corresponding up-regulation cytoprotective protein heme oxygenase-1 ( HO-1 ) capable mitigating acute kidney injury . unusual kidney pathology @ GeneSrc $ KO rats highlights several novel physiological roles @ GeneSrc $ provides indirect evidence HO-1 expression protective mechanism acute kidney injury LRRK2 deficiency .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0262236730418084)\n",
      "- Text: \"DNA damage response candidate @ DiseaseTgt $ barrier early human tumorigenesis . evolution @ DiseaseTgt $ , incipient @ DiseaseTgt $ experiences ' oncogenic stress ' , evokes counter-response eliminate hazardous cells . However , nature stress remains elusive , inducible @ DiseaseTgt $ barrier elicits growth arrest cell death . show clinical specimens different stages human tumours urinary bladder , breast , lung colon , early precursor lesions ( normal tissues ) commonly express markers activated DNA damage response . include phosphorylated kinases ATM Chk2 , phosphorylated histone @ GeneSrc $ p53 . Similar checkpoint responses induced cultured cells upon expression different oncogenes deregulate DNA replication . Together genetic analyses , including genome-wide assessment allelic imbalances , data indicate early tumorigenesis ( genomic instability malignant conversion ) , human cells activate ATR/ATM-regulated DNA damage response network delays prevents @ DiseaseTgt $ . Mutations compromising checkpoint , including defects ATM-Chk2-p53 pathway , might allow cell proliferation , survival , increased genomic instability @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1665953002196648)\n",
      "- Text: \"Activation DNA damage checkpoint genomic instability human precancerous lesions . DNA damage checkpoint genes , p53 , frequently mutated human @ DiseaseTgt $ , selective pressure inactivation remains elusive . analysed panel human lung hyperplasias , retained wild-type p53 genes signs gross chromosomal instability , found signs DNA damage response , including @ GeneSrc $ Chk2 phosphorylation , p53 accumulation , focal staining p53 binding protein 1 ( 53BP1 ) apoptosis . Progression @ DiseaseTgt $ associated p53 53BP1 inactivation decreased apoptosis . DNA damage response also observed dysplastic nevi human skin xenografts , hyperplasia induced overexpression growth factors . lung experimentally-induced skin hyperplasias showed allelic imbalance loci prone DNA double-strand break formation DNA replication compromised ( common fragile sites ) . propose , earliest stages , @ DiseaseTgt $ development associated DNA replication stress , leads DNA double-strand breaks , genomic instability selective pressure p53 mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5854674541680049)\n",
      "- Text: \"Complex Effects @ GeneSrc $ Transcription Factor Transcriptional Regulation alpha-Synuclein Primary Neuronal Cultures Vivo . alpha-Synuclein , presynaptic neuronal protein encoded SNCA gene , strongly implicated @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ DiseaseTgt $ pathogenesis linked increased SNCA levels ; however , transcriptional elements control SNCA expression still elusive . Previous experiments PC12 cells demonstrated transcription factor @ GeneSrc $ ( @ GeneSrc $ ) plays important regulatory role SNCA transcription . Currently , characterized role @ GeneSrc $ SNCA transcription primary neuronal cultures vivo found @ GeneSrc $ developmentally expressed neurons different rat brain regions . confirmed binding intron 1 region SNCA rat cortical cultures . Lentivirus-mediated silencing @ GeneSrc $ increased significantly SNCA promoter activity , mRNA , protein levels cultures . contrast , @ GeneSrc $ silencing reduced SNCA neurosphere cultures . Interestingly , @ GeneSrc $ overexpression cortical neurons led robust mRNA negligible protein expression , suggesting @ GeneSrc $ protein levels tightly regulated post-transcriptionally and/or post-translationally primary neurons . Efficient adeno-associated virus-mediated knockdown ZSCAN21 postnatal adult hippocampus , area linked non-motor @ DiseaseTgt $ symptoms , revealed significant alterations SNCA levels . Overall , study demonstrates @ GeneSrc $ involved transcriptional regulation SNCA primary neuronal cultures , direction effect variable , likely depending neuronal maturation . However , unaltered SNCA levels observed following @ GeneSrc $ down-regulation rat brain , possibly due compensatory mechanisms , imply @ GeneSrc $ master regulator SNCA vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.004468034813514)\n",
      "- Text: \"Presence potent transcription activating sequence p53 protein . p53 gene frequently mutated wide variety human @ DiseaseTgt $ . However , role wild-type p53 gene growth control known . Hybrid proteins contain DNA binding domain yeast GAL4 portions p53 used show p53 protein contains transcription-activating sequence functions yeast mammalian cells . NH2-terminal 73 residues p53 activated transcription mammalian cells efficiently herpes virus protein @ GeneSrc $ , contains one strongest known activation domains . Combined previous data showed p53 localized nucleus bind DNA , results support idea one function p53 activate transcription genes suppress cell proliferation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.5348292494800426e-06)\n",
      "- Text: \"MicroRNA-125b novel negative regulator @ GeneSrc $ . @ GeneSrc $ transcription factor key @ DiseaseTgt $ suppressor central regulator stress response . ensure robust precise response cellular signals , p53 gene expression must tightly regulated transcriptional post-translational levels . Computational predictions suggest several microRNAs involved post-transcriptional regulation @ GeneSrc $ . demonstrate miR-125b , brain-enriched microRNA , bona fide negative regulator @ GeneSrc $ zebrafish humans . miR-125b-mediated down-regulation p53 strictly dependent binding miR-125b microRNA response element 3 ' untranslated region p53 mRNA . Overexpression miR-125b represses endogenous level p53 protein suppresses apoptosis human neuroblastoma cells human lung fibroblast cells . contrast , knockdown miR-125b elevates level p53 protein induces apoptosis human lung fibroblasts zebrafish brain . phenotype rescued significantly either ablation endogenous @ GeneSrc $ function ectopic expression miR-125b zebrafish . Interestingly , miR-125b down-regulated zebrafish embryos treated gamma-irradiation camptothecin , corresponding rapid increase @ GeneSrc $ protein response DNA damage . Ectopic expression miR-125b suppresses increase @ GeneSrc $ stress-induced apoptosis . Together , study demonstrates miR-125b important negative regulator @ GeneSrc $ p53-induced apoptosis development stress response .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002418832435453)\n",
      "- Text: \"Deacetylation p53 modulates effect cell growth apoptosis . p53 @ DiseaseTgt $ transcriptional factor whose activity modulated protein stability post-translational modifications including acetylation . mechanism acetylated p53 maintained vivo remains unclear . show deacetylation p53 mediated @ GeneSrc $ @ GeneSrc $ complex . also purified p53 target protein deacetylase complexes ( designated PID ; identical metastasis-associated protein 2 ( MTA2 ) ) , identified component NuRD complex . PID specifically interacts p53 vitro vivo , expression reduces significantly steady-state levels acetylated p53 . PID expression strongly represses p53-dependent transcriptional activation , , notably , modulates p53-mediated cell growth arrest apoptosis . results show deacetylation functional interactions PID/MTA2-associated NuRD complex may represent important pathway regulate p53 function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.587660067069223e-06)\n",
      "- Text: \"Substitutions codon 22 @ DiseaseTgt $ induce diverse conformational changes apoptotic effects human cerebral endothelial cells . Cerebral amyloid angiopathy commonly associated normal aging @ DiseaseTgt $ also principal feature hereditary cerebral hemorrhage amyloidosis Dutch type , familial condition associated point mutation G C codon 693 amyloid beta ( Abeta ) precursor protein gene resulting Glu Gln substitution position 22 Abeta ( E22Q ) . patients carrying AbetaE22Q variant usually present lobar cerebral hemorrhages 50 years age . different mutation described several members three Italian kindred presented recurrent hemorrhagic strokes late life , 60 70 years age , also associated extensive cerebrovascular amyloid deposition found position 22 , time resulting Glu Lys substitution ( E22 K ) . compared secondary structure , aggregation , fibrillization properties two Abeta40 variants wild type peptide . Using flow cytometry analysis staining propidium iodide @ GeneSrc $ , also evaluated cytotoxic effects peptides human cerebral endothelial cells culture . conditions tested , E22Q peptide exhibited highest content beta-sheet conformation fastest aggregation/fibrillization properties . Dutch variant also induced apoptosis cerebral endothelial cells concentration 25 micrometer , whereas wild type Abeta E22 K mutant effect . data suggest different amino acids position 22 confer distinct structural properties peptides appear influence onset aggressiveness disease rather phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"@ GeneSrc $ RB cooperate induce gene repression cell-cycle arrest response p53 activation . human @ DiseaseTgt $ acquire mutations causing defects p53 signaling pathway . @ DiseaseTgt $ suppressor p53 becomes activated response genotoxic stress essential arresting cell cycle facilitate DNA repair initiate apoptosis . p53-induced cell cycle-arrest mediated expression CDK inhibitor p21WAF1/Cip1 , prevents phosphorylation inactivation pocket proteins RB , p130 , p107 . hypophosphorylated state , pocket proteins bind E2F factors forming RB-E2F @ GeneSrc $ transcriptional repressor complexes . , analyze influence RB @ GeneSrc $ p53-induced gene repression cell-cycle arrest . show abrogation @ GeneSrc $ function knockout @ GeneSrc $ component LIN37 results reduced repression cell-cycle genes . identify genes repressed @ GeneSrc $ pathway describe set genes downregulated p53 independent @ GeneSrc $ . strikingly , p53-dependent repression cell-cycle genes completely abrogated LIN37-/- ; RB-/- cells leading loss G1/S checkpoint . Taken together , show @ GeneSrc $ RB key factors p53 signaling pathway downregulate large number cell-cycle genes arrest cell cycle G1/S transition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7405144550921714)\n",
      "- Text: \"( 1 ; 12 ) ( q21 ; p13 ) translocation human @ DiseaseTgt $ results TEL-ARNT fusion . TEL/ETV6 gene located 12p13 encodes member ETS family transcription factors . Translocated ETS leukemia ( TEL ) frequently involved chromosomal translocations human malignancies , usually resulting expression fusion proteins amino-terminal part TEL either unrelated transcription factors protein tyrosine kinases . characterized ( 1 ; 12 ) ( q21 ; p13 ) translocation @ DiseaseTgt $ ( @ DiseaseTgt $ ) . protein level , untranslocated TEL copy , result ( 1 ; 12 ) translocation , fusion protein TEL essentially aryl hydrocarbon receptor nuclear translocator ( ARNT ) expressed . involvement ARNT human leukemogenesis previously described . ARNT protein belongs subfamily `` basic region helix-loop-helix `` ( bHLH ) protein shares additional region similarity called PAS ( Per , ARNT , SIM ) domain . ARNT central partner several heterodimeric transcription factors , including containing aryl hydrocarbon ( dioxin ) receptor ( AhR ) @ GeneSrc $ ( @ GeneSrc $ ) . results show TEL-ARNT fusion protein crucial product translocation suggest interference activity AhR @ GeneSrc $ contribute leukemogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.017370577802105)\n",
      "- Text: \"Familial Parkinson disease gene product , parkin , @ GeneSrc $ . Autosomal recessive juvenile parkinsonism ( AR-JP ) , one common familial forms @ DiseaseTgt $ , characterized selective dopaminergic neural cell death absence Lewy body , cytoplasmic inclusion body consisting aggregates abnormally accumulated proteins . previously cloned PARK2 , mutations cause AR-JP ( ref . 2 ) , function gene product , parkin , remains unknown . report parkin involved protein degradation @ GeneSrc $ collaborating ubiquitin-conjugating enzyme UbcH7 , mutant parkins AR-JP patients show loss @ GeneSrc $ activity . findings indicate accumulation proteins yet identified causes selective neural cell death without formation Lewy bodies . findings enhance exploration molecular mechanisms neurodegeneration @ DiseaseTgt $ well neurodegenerative diseases characterized involvement abnormal protein ubiquitination , including Alzheimer disease , tauopathies , CAG triplet repeat disorders amyotrophic lateral sclerosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0387136310173337)\n",
      "- Text: \"Ubiquitination alpha-synuclein Siah-1 promotes alpha-synuclein aggregation apoptotic cell death . Point mutations gene multiplication alpha-synuclein cause autosomal dominant familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Moreover , alpha-synuclein- ubiquitin-positive inclusion bodies pathological hallmarks @ DiseaseTgt $ several neurodegenerative diseases , dementia Lewy bodies multiple system atrophy . Despite presence ubiquitinated alpha-synuclein species Lewy bodies , regulation alpha-synuclein ubiquitination role Lewy body formation neurodegeneration remain poorly understood . , report alpha-synuclein interacts colocalizes mammalian seven absentia homologue-1 ( Siah-1 ) , RING-type E3 @ GeneSrc $ . Siah-1 binds brain-enriched E2 ubiquitin-conjugating enzyme UbcH8 facilitates mono- di-ubiquitination alpha-synuclein vivo . ubiquitination alpha-synuclein Siah-1 disrupted @ DiseaseTgt $ A30P mutation A53 mutation . find Siah-1-mediated ubiquitination target alpha-synuclein degradation proteasome , rather , promotes alpha-synuclein aggregation enhances alpha-synuclein toxicity . findings suggest Siah-1-mediated alpha-synuclein ubiquitination may play critical role Lewy body formation @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0180510854310438)\n",
      "- Text: \"Parkin functions E2-dependent ubiquitin- protein ligase promotes degradation synaptic vesicle-associated protein , CDCrel-1 . @ DiseaseTgt $ common neurodegenerative disorder familial-linked genes provided novel insights pathogenesis disorder . Mutations Parkin , ring-finger-containing protein unknown function , implicated pathogenesis autosomal recessive familial Parkinson 's disease . , show Parkin binds E2 ubiquitin-conjugating human enzyme 8 ( UbcH8 ) C-terminal ring-finger . Parkin @ GeneSrc $ activity presence UbcH8 . Parkin also ubiquitinates promotes degradation . also identify show synaptic vesicle-associated protein , CDCrel-1 , interacts Parkin ring-finger domains . Furthermore , Parkin ubiquitinates promotes degradation CDCrel-1 . Familial-linked mutations disrupt @ GeneSrc $ function Parkin impair Parkin CDCrel-1 degradation . results suggest Parkin functions E3 ubiquitin-protein ligase ring domains may control protein levels via ubiquitination . loss Parkin 's @ GeneSrc $ function familial-linked mutations suggests may cause familial autosomal recessive @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1936850582968479)\n",
      "- Text: \"Parkin ubiquitinates promotes degradation RanBP2 . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative disorder , involves deterioration dopaminergic neurons pars compacta substantia nigra . etiology @ DiseaseTgt $ still unknown , recent identification mutations familial cases @ DiseaseTgt $ advanced understanding molecular mechanisms neurological disease . Mutations parkin gene , encodes @ GeneSrc $ ( E3 ) , implicated autosomal recessive juvenile Parkinsonism , early onset common familial form @ DiseaseTgt $ . reported Parkin selectively binds RanBP2 , localized cytoplasmic filament nuclear pore complex belongs small ubiquitin-related modifier E3 ligase family . also demonstrated RanBP2 becomes target Parkin E3 ubiquitin-ligase processed via Parkin-mediated ubiquitination subsequent proteasomal degradation . Furthermore , Parkin controls intracellular levels sumoylated HDAC4 , result ubiquitination degradation RanBP2 . findings suggested intracellular levels RanBP2 functional activity may modulated Parkin-mediated ubiquitination proteasomal pathways .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9391237290318466)\n",
      "- Text: \"KRAS4A directly regulates @ GeneSrc $ . frequently mutated oncogene @ DiseaseTgt $ KRAS , uses alternative fourth exons generate two gene products ( KRAS4A KRAS4B ) differ C-terminal membrane-targeting region1 . oncogenic mutations occur exons 2 3 , two constitutively active KRAS proteins-each capable transforming cells-are encoded KRAS activated mutation2 . functional distinctions among splice variants far established . Oncogenic KRAS alters metabolism @ DiseaseTgt $ cells3 several ways , including increased glucose uptake glycolysis even presence abundant oxygen4 ( Warburg effect ) . Whereas metabolic effects oncogenic KRAS explained transcriptional upregulation glucose transporters glycolytic enzymes3 - 5 , known whether direct regulation metabolic enzymes . report direct , GTP-dependent interaction KRAS4A @ GeneSrc $ ( @ GeneSrc $ ) alters activity kinase , thereby establish @ GeneSrc $ effector KRAS4A . interaction unique KRAS4A palmitoylation-depalmitoylation cycle RAS isoform enables colocalization @ GeneSrc $ outer mitochondrial membrane . expression KRAS4A @ DiseaseTgt $ may drive unique metabolic vulnerabilities exploited therapeutically .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2639190169708639)\n",
      "- Text: \"reporter @ GeneSrc $ gamma-secretase activity Drosophila . key event pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) deposition senile plaques consisting largely peptide known beta-amyloid ( @ GeneSrc $ ) derived @ GeneSrc $ ( APP ) . proteolytic activity called gamma-secretase cleaves APP transmembrane domain required @ GeneSrc $ generation . Aberrant gamma-secretase cleavage APP underlies majority early onset , familial @ DiseaseTgt $ . gamma-Secretase resides large multi-protein complex , Presenilin , Nicastrin , APH-1 PEN-2 four essential components . Thus , identifying components pathways gamma-secretase activity regulated crucial understanding mechanisms underlying @ DiseaseTgt $ pathogenesis , may provide new diagnostic tools therapeutic targets . describe generation Drosophila act living reporters gamma-secretase activity fly eye . reporter flies size eye correlates level endogenous gamma-secretase activity , sensitive levels three genes required APP gamma-secretase activity , presenilin , nicastrin aph-1 . Thus , flies provide sensitized system identify components gamma-secretase complex regulators activity . used flies carry screen mutations suppress gamma-secretase activity identified small chromosomal region contains gene genes whose products may promote gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9420496497983885)\n",
      "- Text: \"Large-scale meta-analysis genome-wide association data identifies six new risk loci @ DiseaseTgt $ . conducted meta-analysis @ DiseaseTgt $ genome-wide association studies using common set 7,893,274 variants across 13,708 cases 95,282 controls . Twenty-six loci identified genome-wide significant association ; 6 additional previously reported loci tested independent set 5,353 cases 5,551 controls . 32 tested SNPs , 24 replicated , including 6 newly identified loci . Conditional analyses within loci showed four loci , including GBA , GAK-DGKQ , SNCA @ GeneSrc $ region , contain secondary independent risk variant . total , identified replicated 28 independent risk variants @ DiseaseTgt $ across 24 loci . Although effect individual locus small , risk profile analysis showed substantial cumulative risk comparison highest lowest quintiles genetic risk ( odds ratio ( ) = 3.31 , 95 % confidence interval ( CI ) = 2.55 - 4.30 ; P = 2 x 10 ( -16 ) ) . also show six risk loci associated proximal gene expression DNA methylation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0211968696221993)\n",
      "- Text: \"Participation presenilin 2 apoptosis : enhanced basal activity conferred @ DiseaseTgt $ mutation . Overexpression @ DiseaseTgt $ gene Presenilin 2 ( PS2 ) @ GeneSrc $ PC12 cells increased apoptosis induced trophic factor withdrawal beta-amyloid . Transfection antisense PS2 conferred protection apoptosis induced trophic withdrawal @ GeneSrc $ amyloid precursor protein-expressing PC12 cells . apoptotic cell death induced PS2 protein sensitive pertussis toxin , suggesting heterotrimeric GTP-binding proteins involved . PS2 mutation associated @ DiseaseTgt $ found generate molecule enhanced basal apoptotic activity . gain function might accelerate process neurodegeneration occurs @ DiseaseTgt $ , leading earlier age onset characteristic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.13172457249723)\n",
      "- Text: \"Specific inhibition CBP/beta-catenin interaction rescues defects neuronal differentiation caused presenilin-1 mutation . Wnt/beta-catenin signaling shown promote self-renewal variety tissue stem cells , including neuronal stem cells hematopoietic stem cells . However , activation Wnt/beta-catenin pathway promoted inhibition pathway prevented differentiation neuronal precursor cells . clear explanation differential effects Wnt/beta-catenin activation neuronal precursors available present . Presenilin-1 ( PS-1 ) polytopic protein comprised six eight transmembrane domains . PS-1 , part gamma-secretase complex , required intramembrane proteolysis amyloid precursor protein ( APP ) Notch . Additionally , interactions beta-catenin , PS-1 associated modulation Wnt/beta-catenin signaling . @ DiseaseTgt $ PS-1 mutant , PS-1 ( L286V ) , causes dramatic increase cell factor ( TCF ) /beta-catenin transcription PC-12 cells , prevents normal @ GeneSrc $ @ GeneSrc $ neuronal differentiation neurite outgrowth . Selective inhibition TCF/beta-catenin/cAMP-response element-binding protein ( CREB ) -binding protein ( CBP ) -mediated transcription , TCF/beta-catenin/p300 , recently described small molecule antagonist ICG-001 corrects defects neuronal differentiation , highlighting importance Wnt/beta-catenin signaling process . propose increased TCF/beta-catenin/CBP-mediated transcription , well failure switch TCF/beta-catenin/p300-mediated transcription , play important role decreasing neuronal differentiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.4412739328401603e-05)\n",
      "- Text: \"APC tumour suppressor nuclear export function . adenomatous polpyposis coli ( APC ) protein mutated @ DiseaseTgt $ . Nearly APC mutations truncations , many terminate mutation cluster region located halfway protein . cancer cells expressing mutant APC , @ GeneSrc $ stabilized translocates nucleus act transcriptional co-activator T-cell factor . normal development , APC also promotes destabilization @ GeneSrc $ Drosophila @ GeneSrc $ . binding Axin complex earmarks @ GeneSrc $ degradation proteasome pathway . APC regulatory role process , poorly understood . show APC contains highly conserved nuclear export signals 3 ' adjacent mutation cluster region enable exit nucleus . ability lost APC mutant cancer cells , provide evidence @ GeneSrc $ accumulates nucleus result . Thus , ability APC exit nucleus appears critical tumour suppressor function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0271029403252987)\n",
      "- Text: \"Dual positive negative regulation wingless signaling adenomatous polyposis coli . evolutionarily conserved Wnt/Wingless signal transduction pathway directs cell proliferation , cell fate , cell death development metazoans inappropriately activated several types cancer . majority @ DiseaseTgt $ contain truncating mutations adenomatous polyposis coli ( APC ) tumor suppressor , negative regulator Wnt/Wingless signaling . , demonstrate Drosophila Apc homologs also activating role physiological ectopic Wingless signaling . Apc amino terminus important activating function , whereas @ GeneSrc $ binding sites dispensable . Apc likely promotes Wingless transduction down-regulation Axin , negative regulator Wingless signaling . Given evolutionary conservation APC Wnt signal transduction , activating role may also present vertebrates relevance development cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2168918708566865)\n",
      "- Text: \"Binding GSK3beta APC-beta-catenin complex regulation complex assembly . adenomatous polyposis coli gene ( APC ) mutated @ DiseaseTgt $ . APC protein binds cellular adhesion molecule beta-catenin , mammalian homolog ARMADILLO , component WINGLESS signaling pathway Drosophila development . shown beta-catenin present excess , APC binds another component WINGLESS pathway , glycogen synthase kinase 3beta ( GSK3beta ) , mammalian homolog Drosophila @ GeneSrc $ WHITE 3 . APC good substrate GSK3 beta vitro , phosphorylation sites mapped central region APC . Binding beta-catenin region dependent phosphorylation GSK3 beta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005131094873273)\n",
      "- Text: \"Presenilin required activity nuclear access @ GeneSrc $ Drosophila . Presenilins membrane proteins multiple transmembrane domains thought contribute development @ DiseaseTgt $ affecting processing beta-amyloid precursor protein . Presenilins also facilitate activity transmembrane receptors @ GeneSrc $ family . ligand-induced processing , intracellular domain @ GeneSrc $ enter nucleus participate transcriptional control downstream target genes . show null mutations Drosophila Presenilin gene abolish @ GeneSrc $ signal transduction prevent intracellular domain entering nucleus . Furthermore , provide evidence presenilin required proteolytic release intracellular domain membrane following activation @ GeneSrc $ ligand .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2197185496548077)\n",
      "- Text: \"Neurogenic phenotypes altered @ GeneSrc $ processing Drosophila Presenilin mutants . Presenilin proteins implicated developmental signalling cell-surface protein @ GeneSrc $ pathogenesis @ DiseaseTgt $ . Loss presenilin function leads Notch/lin-12-like mutant phenotypes Caenorhabditis elegans reduced Notch1 expression mouse paraxial mesoderm . humans , presenilins associated @ DiseaseTgt $ stimulate overproduction neurotoxic 42-amino-acid beta-amyloid derivative ( Abeta42 ) amyloid-precursor protein APP . describe loss-of-function mutations Drosophila Presenilin gene cause lethal @ GeneSrc $ phenotypes maternal neurogenic effects embryogenesis , loss lateral inhibition within proneural cell clusters , absence wing margin formation . show presenilin required normal proteolytic production carboxy-terminal @ GeneSrc $ fragments needed receptor maturation signalling , genetically acts upstream membrane-bound form activated nuclear form @ GeneSrc $ . findings provide evidence existence distinct processing sites modifications extracellular domain @ GeneSrc $ . also link role presenilin @ GeneSrc $ signalling effect amyloid production @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3454608931202223)\n",
      "- Text: \"role presenilin cofactors gamma-secretase complex . Mutations presenilin genes account majority cases familial form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Presenilin essential gamma-secretase activity , proteolytic activity involved intramembrane cleavage @ GeneSrc $ beta-amyloid precursor protein ( betaAPP ) . Cleavage betaAPP @ DiseaseTgt $ mutant presenilin results overproduction highly amyloidogenic amyloid beta42 peptides . gamma-Secretase activity requires formation stable , high-molecular-mass protein complex , addition endoproteolysed fragmented form presenilin , contains essential cofactors including nicastrin , APH-1 ( refs 15 - 18 ) PEN-2 ( refs 16 , 19 ) . However , role protein complex formation generation enzymatic activity unclear . show Drosophila APH-1 ( Aph-1 ) increases stability Drosophila presenilin ( Psn ) holoprotein complex . Depletion PEN-2 RNA interference prevents endoproteolysis presenilin promotes stabilization holoprotein Drosophila mammalian cells , including primary neurons . Co-expression Drosophila Pen-2 Aph-1 nicastrin increases formation Psn fragments well gamma-secretase activity . Thus , APH-1 stabilizes presenilin holoprotein complex , whereas PEN-2 required endoproteolytic processing presenilin conferring gamma-secretase activity complex .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8119889139383552)\n",
      "- Text: \"Low cholesterol stimulates nonamyloidogenic pathway effect alpha -secretase ADAM 10 . Biochemical , epidemiological , genetic findings demonstrate link cholesterol levels , processing amyloid precursor protein ( APP ) , @ DiseaseTgt $ . present report , identify alpha-secretase ADAM 10 ( disintegrin metalloprotease ) major target cholesterol effects APP metabolism . Treatment various peripheral neural cell lines either cholesterol-extracting agent methyl-beta-cyclodextrin @ GeneSrc $ inhibitor lovastatin resulted drastic increase secreted alpha-secretase cleaved soluble APP . strong stimulatory effect range obtained phorbol esters increased cells overexpressing ADAM 10 . cells overexpressing APP , increase alpha-secretase activity resulted decreased secretion Abeta peptides . Several mechanisms elucidated basis enhanced alpha-secretase activity : increased membrane fluidity impaired internalization APP responsible effect observed methyl-beta-cyclodextrin ; treatment lovastatin resulted higher expression alpha-secretase ADAM 10 . results demonstrate cholesterol reduction promotes nonamyloidogenic alpha-secretase pathway formation neuroprotective alpha-secretase cleaved soluble APP several mechanisms suggest approaches prevention therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.258322091945848e-06)\n",
      "- Text: \"Regulation cholesterol sphingomyelin metabolism amyloid-beta presenilin . Amyloid beta peptide ( Abeta ) key role pathological process @ DiseaseTgt $ ( @ DiseaseTgt $ ) , physiological function Abeta amyloid precursor protein ( APP ) unknown . Recently , shown APP processing sensitive cholesterol lipids . @ GeneSrc $ ( @ GeneSrc $ ) sphingomyelinases ( SMases ) main enzymes regulate cholesterol biosynthesis sphingomyelin ( SM ) levels , respectively . show control cholesterol SM metabolism involves APP processing . Abeta42 directly activates neutral SMase downregulates SM levels , whereas Abeta40 reduces cholesterol de novo synthesis inhibition @ GeneSrc $ activity . process strictly depends gamma-secretase activity . line altered Abeta40/42 generation , pathological presenilin mutations result increased cholesterol decreased SM levels . results demonstrate biological function APP processing also functional basis link observed lipids @ DiseaseTgt $ ( @ DiseaseTgt $ ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2745738899560652)\n",
      "- Text: \"Vitamin K2 mitochondrial electron carrier rescues pink1 deficiency . Human UBIAD1 localizes mitochondria converts vitamin K ( 1 ) vitamin K ( 2 ) . Vitamin K ( 2 ) best known cofactor blood coagulation , bacteria membrane-bound electron carrier . Whether vitamin K ( 2 ) exerts similar carrier function eukaryotic cells unknown . identified Drosophila UBIAD1/Heix modifier @ GeneSrc $ , gene mutated @ DiseaseTgt $ affects mitochondrial function . found vitamin K ( 2 ) necessary sufficient transfer electrons Drosophila mitochondria . Heix mutants showed severe mitochondrial defects rescued vitamin K ( 2 ) , , similar ubiquinone , vitamin K ( 2 ) transferred electrons Drosophila mitochondria , resulting efficient adenosine triphosphate ( ATP ) production . Thus , mitochondrial dysfunction rescued vitamin K ( 2 ) serves mitochondrial electron carrier , helping maintain normal ATP production .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0630171830058512)\n",
      "- Text: \"Mitochondrial pathology muscle dopaminergic neuron degeneration caused inactivation Drosophila @ GeneSrc $ rescued Parkin . Mutations @ GeneSrc $ , gene encoding Ser/Thr kinase mitochondrial-targeting signal , associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , common movement disorder characterized selective loss dopaminergic neurons . mechanism loss @ GeneSrc $ leads neurodegeneration understood . show inhibition Drosophila @ GeneSrc $ ( @ GeneSrc $ ) function results energy depletion , shortened lifespan , degeneration select indirect flight muscles dopaminergic neurons . muscle pathology preceded mitochondrial enlargement disintegration . phenotypes could rescued wild type pathogenic C-terminal deleted form human Pink1 ( hPink1 ) . muscle dopaminergic phenotypes associated @ GeneSrc $ inactivation show similarity seen parkin mutant flies could suppressed overexpression Parkin DJ-1 . Consistent genetic rescue results , find , @ GeneSrc $ RNA interference ( RNAi ) animals , level Parkin protein significantly reduced . Together , results implicate @ GeneSrc $ Parkin common pathway regulates mitochondrial physiology cell survival Drosophila .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1964593801895609)\n",
      "- Text: \"Leucine-Rich Repeat Kinase 2 interacts Parkin , DJ-1 @ GeneSrc $ Drosophila melanogaster model @ DiseaseTgt $ . Mutations LRRK2 gene common genetic cause familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , physiological pathological functions unknown . Therefore , generated several independent Drosophila lines carrying WT mutant human LRRK2 ( mutations kinase , COR LRR domains , resp . ) . Ectopic expression WT mutant LRRK2 dopaminergic neurons caused significant loss accompanied complex age-dependent changes locomotor activity . Overall , ubiquitous expression LRRK2 increased lifespan fertility flies . However , flies sensitive rotenone . LRRK2 expression eye exacerbated retinal degeneration . Importantly , double transgenic flies , various indices eye dopaminergic survival modified complex fashion concomitant expression @ GeneSrc $ , DJ-1 Parkin . evidence suggests genetic interaction @ DiseaseTgt $ genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017767310630848)\n",
      "- Text: \"Mitochondrial dysfunction Drosophila @ GeneSrc $ mutants complemented parkin . Autosomal recessive juvenile parkinsonism ( AR-JP ) early-onset form @ DiseaseTgt $ characterized motor disturbances dopaminergic neurodegeneration . address underlying molecular pathogenesis , generated characterized loss-of-function mutants Drosophila @ GeneSrc $ ( @ GeneSrc $ ) , novel AR-JP-linked gene . , show @ GeneSrc $ mutants exhibit indirect flight muscle dopaminergic neuronal degeneration accompanied locomotive defects . Furthermore , transmission electron microscopy analysis rescue experiment Drosophila Bcl-2 demonstrated mitochondrial dysfunction accounts degenerative changes phenotypes @ GeneSrc $ mutants . Notably , also found @ GeneSrc $ mutants share marked phenotypic similarities parkin mutants . Transgenic expression Parkin markedly ameliorated @ GeneSrc $ loss-of-function phenotypes , vice versa , suggesting Parkin functions downstream @ GeneSrc $ . Taken together , genetic evidence clearly establishes Parkin @ GeneSrc $ act common pathway maintaining mitochondrial integrity function muscles dopaminergic neurons .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6451959347529418)\n",
      "- Text: \"Antioxidants protect @ GeneSrc $ dopaminergic neurons Drosophila . @ DiseaseTgt $ ( @ DiseaseTgt $ ) frequent neurodegenerative movement disorder . Mutations @ GeneSrc $ gene linked autosomal recessive early onset familial form @ DiseaseTgt $ . physiological function @ GeneSrc $ pathological abnormality @ DiseaseTgt $ @ GeneSrc $ mutants largely unknown . show inactivation Drosophila @ GeneSrc $ ( @ GeneSrc $ ) using RNAi results progressive loss dopaminergic neurons ommatidial degeneration compound eye , rescued expression human PINK1 ( hPINK1 ) . Expression human SOD1 suppresses neurodegeneration induced @ GeneSrc $ inactivation . Moreover , treatment @ GeneSrc $ RNAi flies antioxidants SOD vitamin E significantly inhibits ommatidial degeneration . Thus , @ GeneSrc $ plays essential role maintaining neuronal survival preventing neurons undergoing oxidative stress , thereby suggesting potential mechanism reduction @ GeneSrc $ function leads @ DiseaseTgt $ neurodegeneration .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9470378037125)\n",
      "- Text: \"Drosophila @ GeneSrc $ required mitochondrial function interacts genetically parkin . @ DiseaseTgt $ second common neurodegenerative disorder characterized degeneration dopaminergic neurons substantia nigra . Mitochondrial dysfunction implicated important trigger @ DiseaseTgt $ pathogenesis exposure environmental mitochondrial toxins leads @ DiseaseTgt $ pathology . Recently , multiple genes mediating familial forms @ DiseaseTgt $ identified , including @ GeneSrc $ ( @ GeneSrc $ ; PARK6 ) parkin ( PARK2 ) , also associated sporadic forms @ DiseaseTgt $ . PINK1 encodes putative serine/threonine kinase mitochondrial targeting sequence . far , vivo studies reported @ GeneSrc $ model system . show removal Drosophila @ GeneSrc $ homologue ( @ GeneSrc $ ; hereafter called @ GeneSrc $ ) function results male sterility , apoptotic muscle degeneration , defects mitochondrial morphology increased sensitivity multiple stresses including oxidative stress . @ GeneSrc $ localizes mitochondria , mitochondrial cristae fragmented @ GeneSrc $ mutants . Expression human PINK1 Drosophila testes restores male fertility normal mitochondrial morphology portion @ GeneSrc $ mutants , demonstrating functional conservation human Drosophila @ GeneSrc $ . Loss Drosophila parkin shows phenotypes similar loss @ GeneSrc $ function . Notably , overexpression parkin rescues male sterility mitochondrial morphology defects @ GeneSrc $ mutants , whereas double mutants removing @ GeneSrc $ parkin function show muscle phenotypes identical observed either mutant alone . observations suggest @ GeneSrc $ parkin function , least part , pathway , @ GeneSrc $ functioning upstream parkin . role @ GeneSrc $ pathway regulating mitochondrial function underscores importance mitochondrial dysfunction central mechanism @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8237653397006374)\n",
      "- Text: \"mitochondrial protein BNIP3L substrate PARK2 mediates mitophagy @ GeneSrc $ pathway . Mitochondrial dysfunction plays important roles @ DiseaseTgt $ ( @ DiseaseTgt $ ) degradation damaged mitochondria mitochondria quality control system important dopaminergic ( DA ) neuronal survival . BNIP3L/Nix mitochondrial outer membrane protein required selective clearance mitochondria . , found mitochondrial protein BNIP3L acts downstream @ GeneSrc $ pathway induce mitophagy . BNIP3L substrate PARK2 drive PARK2-mediated mitophagy . ubiquitination BNIP3L PARK2 recruits NBR1 mitochondria , thereby targeting mitochondria degradation . BNIP3L rescues mitochondrial defects @ GeneSrc $ mutant Drosophila park mutant Drosophila , indicating clearance mitochondria induced BNIP3L depends presence PARK2 . cells intoxicated mitochondrial complex inhibitors rotenone , 6-OHDA MPP ( + ) , disrupted mitochondria appropriately eliminated mitophagy due improper degradation BNIP3L . Thus , study demonstrates BNIP3L , substrate PARK2 , promotes mitophagy @ GeneSrc $ pathway associated @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0104407957950512)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human colon cancers . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered colon cancers retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer @ DiseaseTgt $ . accumulation beta-catenin activates genes responsive transcription factors @ GeneSrc $ family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus @ GeneSrc $ sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form @ GeneSrc $ colon-cancer cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative @ GeneSrc $ causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0143441583437935)\n",
      "- Text: \"AXIN1 mutations @ DiseaseTgt $ , growth suppression cancer cells virus-mediated transfer AXIN1 . Wnt signaling pathway essential development organogenesis . Wnt signaling stabilizes beta-catenin , accumulates cytoplasm , binds 1-cell factor ( @ GeneSrc $ ; also known lymphocyte enhancer-binding factor , LEF ) upregulates downstream genes . Mutations CTNNB1 ( encoding beta-catenin ) APC ( adenomatous polyposis coli ) reported human neoplasms including colon cancers @ DiseaseTgt $ ( @ DiseaseTgt $ ) . HCC5 tend show accumulation beta-catenin often mutations CTNNB1 , looked mutations AXIN1 , encoding key factor Wnt signaling , 6 @ DiseaseTgt $ cell lines 100 primary HCC5 . Among 4 cell lines 87 HCC5 detect CTNNB1 mutations , identified AXIN1 mutations 3 cell lines 6 mutations 5 primary @ DiseaseTgt $ . cell lines containing mutations either gene , observed increased DNA binding @ GeneSrc $ associated beta-catenin nuclei . Adenovirus mediated gene transfer wild-type AXINI induced apoptosis hepatocellular colorectal cancer cells accumulated beta-catenin consequence either APC , CTNNB1 AXIN1 mutation , suggesting axin may effective therapeutic molecule suppressing growth hepatocellular colorectal cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0536940103872739)\n",
      "- Text: \"common human skin tumour caused activating mutations beta-catenin . WNT signalling orchestrates number developmental programs . response stimulus , cytoplasmic beta-catenin ( encoded CTNNB1 ) stabilized , enabling downstream transcriptional activation members @ GeneSrc $ family . One target genes @ GeneSrc $ encodes c-MYC , explaining constitutive activation WNT pathway lead cancer , particularly colon . @ DiseaseTgt $ arise mutations gene encoding adenomatous polyposis coli ( APC ) , protein required ubiquitin-mediated degradation beta-catenin , small percentage colon cancers harbour beta-catenin-stabilizing mutations . Recently , discovered transgenic mice expressing activated beta-catenin predisposed developing skin tumours resembling pilomatricomas . Given skin adult mice also exhibits signs de novo hair-follicle morphogenesis , wondered whether human pilomatricomas might originate hair matrix cells whether might possess beta-catenin-stabilizing mutations . , explore cell origin aetiology common human skin tumour . found nuclear LEF-1 dividing tumour cells , providing biochemical evidence pilomatricomas derived hair matrix cells . least 75 % tumours possess mutations affecting amino-terminal segment , normally involved phosphorylation-dependent , ubiquitin-mediated degradation protein . percentage CTNNB1 mutations greater human tumours examined thus far , directly implicates beta-catenin/LEF misregulation major cause hair matrix cell tumorigenesis humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0853601841133593)\n",
      "- Text: \"Activation @ GeneSrc $ signaling @ DiseaseTgt $ mutations beta-catenin APC . Inactivation adenomatous polyposis coli ( APC ) tumor suppressor gene initiates colorectal neoplasia . One biochemical activities associated APC protein down-regulation transcriptional activation mediated beta-catenin cell transcription factor 4 ( Tcf-4 ) . protein products mutant APC genes present @ DiseaseTgt $ found defective activity . Furthermore , @ DiseaseTgt $ intact APC genes found contain activating mutations beta-catenin altered functionally significant phosphorylation sites . results indicate regulation beta-catenin critical APC 's tumor suppressive effect regulation circumvented mutations either APC beta-catenin .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6901908681803953)\n",
      "- Text: \"E2F1 represses beta-catenin transcription antagonized pRB CDK8 . E2F1 transcription factor promote proliferation apoptosis activated , key downstream target retinoblastoma tumour suppressor protein ( pRB ) . show E2F1 potent specific inhibitor beta-catenin/T-cell factor @ GeneSrc $ transcription , function contributes E2F1-induced apoptosis . E2F1 deregulation suppresses beta-catenin activity adenomatous polyposis coli ( APC ) /glycogen synthase kinase-3 ( GSK3 ) -independent manner , reducing expression key beta-catenin targets including c-MYC . interaction explains @ DiseaseTgt $ , depend beta-catenin transcription abnormal proliferation , keep RB1 intact . Remarkably , E2F1 activity also repressed cyclin-dependent kinase-8 ( CDK8 ) , colorectal oncoprotein . Elevated levels CDK8 protect @ GeneSrc $ transcription inhibition E2F1 . Thus , retaining RB1 amplifying CDK8 , @ DiseaseTgt $ cells select conditions collectively suppress E2F1 enhance activity beta-catenin .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0118545809603148)\n",
      "- Text: \"CRD-BP mediates stabilization betaTrCP1 c-myc mRNA response beta-catenin signalling . Although constitutive activation @ GeneSrc $ signalling implicated development human cancers , mechanisms @ GeneSrc $ pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show beta-catenin stabilizes mRNA encoding F-box protein betaTrCP1 , identify RNA-binding protein CRD-BP ( coding region determinant-binding protein ) previously unknown target beta-catenin/Tcf transcription factor . CRD-BP binds coding region betaTrCP1 mRNA . Overexpression CRD-BP stabilizes betaTrCP1 mRNA elevates betaTrCP1 levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein ( SCF ) ( betaTrCP ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB beta-catenin . CRD-BP essential induction betaTrCP1 c-Myc beta-catenin signalling @ DiseaseTgt $ cells . High levels CRD-BP found primary human @ DiseaseTgt $ exhibiting active @ GeneSrc $ signalling implicates CRD-BP induction upregulation betaTrCP1 , activation dimeric transcription factor NF-kappaB suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2428645628998591)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human @ DiseaseTgt $ . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered @ DiseaseTgt $ retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer gastric hepatocellular carcinomas . accumulation beta-catenin activates genes responsive transcription factors @ GeneSrc $ family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus @ GeneSrc $ sites necessary activation . oncoprotein p21ras activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form @ GeneSrc $ @ DiseaseTgt $ cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative @ GeneSrc $ causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7911492286526512)\n",
      "- Text: \"beta-catenin/TCF-4 complex imposes crypt progenitor phenotype @ DiseaseTgt $ cells . transactivation @ GeneSrc $ target genes induced Wnt pathway mutations constitutes primary transforming event @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show disruption beta-catenin/TCF-4 activity @ DiseaseTgt $ cells induces rapid G1 arrest blocks genetic program physiologically active proliferative compartment colon crypts . Coincidently , intestinal differentiation program induced . TCF-4 target gene c-MYC plays central role switch direct repression p21 ( CIP1/WAF1 ) promoter . Following disruption beta-catenin/TCF-4 activity , decreased expression c-MYC releases p21 ( CIP1/WAF1 ) transcription , turn mediates G1 arrest differentiation . Thus , beta-catenin/TCF-4 complex constitutes master switch controls proliferation versus differentiation healthy malignant intestinal epithelial cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7766880725767282)\n",
      "- Text: \"Dominant negative effect APC1309 mutation : possible explanation genotype-phenotype correlations familial adenomatous polyposis . Inactivation adenomatous polyposis coli ( APC ) gene product initiates colorectal tumorigenesis . Patients familial APC ( FAP ) carry germ-line mutations APC gene develop multiple colorectal adenomas subsequent carcinomas early life . severity disease correlates position inherited APC mutation ( genotype-phenotype correlation ) . Together fact germ-line sporadic APC mutations cluster central region APC gene , points dominant negative effect certain APC mutants . Loss APC function recently shown result enhanced @ GeneSrc $ transcription colon epithelial cells . , provide experimental evidence dominant negative effect APC gene products associated severe polyposis . Wild-type APC activity @ GeneSrc $ transcription strongly inhibited mutant APC truncated codon 1309 . contrast , mutant APC gene products associated attenuated polyposis ( codon 386 1465 ) interfered weakly wild-type APC activity . results suggest molecular explanation genotype-phenotype correlation FAP patients support idea @ DiseaseTgt $ growth might , part , driven selection mutation mutation cluster region .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.8416754287094784e-05)\n",
      "- Text: \"Mutations AXIN2 cause @ DiseaseTgt $ defective mismatch repair activating @ GeneSrc $ signalling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.058234395700567)\n",
      "- Text: \"Compromised @ GeneSrc $ function limit p53 expression human breast tumours . Expression p53 gene protects cells malignant transformation . Whereas control p53 degradation subject intense scrutiny , little known factors regulate p53 synthesis . show p53 messenger RNA levels low large proportion breast tumours . Seeking potential regulators p53 transcription , found consensus HOX binding sites p53 promoterS . Transient transfection @ GeneSrc $ activated p53 promoter . Expression @ GeneSrc $ @ DiseaseTgt $ cells expressing wild-type p53 , isogenic variants lacking p53 gene , led apoptotic cell death . Moreover , breast cancer cell lines patient @ DiseaseTgt $ display coordinate loss p53 @ GeneSrc $ mRNA protein expression . @ GeneSrc $ promoter region methylated 16 20 p53-negative breast tumour specimens . conclude loss expression p53 human breast cancer may primarily due lack expression @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7042995048190704)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets @ GeneSrc $ MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0084047728372629)\n",
      "- Text: \"Inappropriate p53 activation development induces features CHARGE syndrome . CHARGE syndrome multiple anomaly disorder patients present variety phenotypes , including ocular coloboma , heart defects , choanal atresia , retarded growth development , genitourinary hypoplasia ear abnormalities . Despite 70 - 90 % CHARGE syndrome cases resulting mutations gene CHD7 , encodes ATP-dependent chromatin remodeller , pathways underlying diverse phenotypes remain poorly understood . Surprisingly , studies knock-in mutant mouse strain expresses stabilized transcriptionally dead variant @ DiseaseTgt $ protein p53 ( p53 ( 25,26,53,54 ) ) , along wild-type allele p53 ( also known Trp53 ) , revealed late-gestational embryonic lethality associated host phenotypes characteristic CHARGE syndrome , including coloboma , inner outer ear malformations , heart outflow tract defects craniofacial defects . found p53 ( 25,26,53,54 ) mutant protein stabilized hyperactivated wild-type p53 , inappropriately induced target genes triggered cell-cycle arrest apoptosis development . Importantly , phenotypes observed wild-type p53 allele , p53 ( 25,26,53,54 ) ( /- ) embryos fully viable . Furthermore , found CHD7 bind p53 promoter , thereby negatively regulating p53 expression , @ GeneSrc $ loss mouse neural crest cells samples patients CHARGE syndrome results p53 activation . Strikingly , found p53 heterozygosity partially rescued phenotypes @ GeneSrc $ mouse embryos , demonstrating p53 contributes phenotypes result @ GeneSrc $ loss . Thus , inappropriate p53 activation development promote CHARGE phenotypes , supporting idea p53 critical role developmental syndromes providing important insight mechanisms underlying CHARGE syndrome .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9457344794983524)\n",
      "- Text: \"Acetylation-regulated interaction p53 SET reveals widespread regulatory mode . Although lysine acetylation recognized general protein modification histones non-histone proteins , mechanisms acetylation-mediated actions completely understood . Acetylation C-terminal domain ( CTD ) p53 ( also known TP53 ) early example non-histone protein acetylation precise role remains unclear . Lysine acetylation often creates binding sites bromodomain-containing ' reader ' proteins . use proteomic screen identify oncoprotein SET major cellular factor whose binding p53 dependent CTD acetylation status . SET profoundly inhibits p53 transcriptional activity unstressed cells , SET-mediated repression abolished stress-induced acetylation p53 CTD . Moreover , loss interaction SET activates p53 , resulting @ DiseaseTgt $ regression mouse xenograft models . Notably , acidic domain SET acts ' reader ' unacetylated CTD p53 mechanism acetylation-dependent regulation widespread nature . example , acetylation p53 also modulates interactions similar acidic domains found p53 regulators including @ GeneSrc $ ( also known DCAF1 ) , DAXX PELP1 ( refs . 7 , 8 , 9 ) , computational analysis proteome identified numerous proteins potential serve acidic domain readers lysine-rich ligands . Unlike bromodomain readers , preferentially bind acetylated forms cognate ligands , acidic domain readers specifically recognize unacetylated forms ligands . Finally , acetylation-dependent regulation p53 validated vivo using knock-in mouse model expressing acetylation-mimicking form p53 . results reveal acidic-domain-containing factors act class acetylation-dependent regulators targeting p53 , potentially , proteins .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.053746445326028e-06)\n",
      "- Text: \"transcriptionally [ correction transcriptively ] active complex APP @ GeneSrc $ histone acetyltransferase Tip60 . Amyloid-beta precursor protein ( APP ) , widely expressed cell-surface protein , cleaved transmembrane region gamma-secretase . gamma-Cleavage APP produces extracellular amyloid beta-peptide @ DiseaseTgt $ releases intracellular tail fragment unknown physiological function . demonstrate cytoplasmic tail APP forms multimeric complex nuclear adaptor protein @ GeneSrc $ histone acetyltransferase Tip60 . complex potently stimulates transcription via heterologous Gal4- LexA-DNA binding domains , suggesting release cytoplasmic tail APP gamma-cleavage may function gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.257006649371059e-07)\n",
      "- Text: \"phosphorylated , carboxy-terminal fragment beta-amyloid precursor protein localizes splicing factor compartment . Beta-amyloid precursor protein ( APP ) implicated pathobiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) . gain insight function , investigated proteolytic processing post-translational modification APP relation intracellular traffic localization . proteolytic processing generates amyloid beta-peptide ( Abeta ) also releases cytoplasm carboxy-terminal fragment APP , Cgamma . Using catecholaminergic cell line , CAD , antibody form APP phosphorylated Thr668 ( pAPP ; numbering APP695 ) , show phosphorylated , carboxy-terminal fragment APP , probably Cgamma , present nucleus , localizes subnuclear particles . labeling anti-pAPP antibody co-localizes proteins define splicing factor compartment ( SFC ) [ e.g . small nuclear ribonucleoprotein ( snRNP ) , U2B , serine/arginine-rich ( SR ) proteins ] , excluded coiled bodies gems . distribution pAPP epitopes found CAD cells independent state differentiation , well primary cortical neurons , epithelial cells fibroblasts . show exogenously expressed Cgamma becomes phosphorylated , distributes throughout cell . fraction Cgamma translocated nucleus , co-localizes endogenous pAPP epitopes . Finally , show APP binding , scaffolding protein , @ GeneSrc $ co-localizes pAPP epitopes expressed Cgamma intranuclear speckles . results suggest phosphorylated Cgamma accumulates SFC . Thus , APP may play role pre-mRNA splicing , @ GeneSrc $ APP phosphorylation may regulate function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0054080807794876)\n",
      "- Text: \"Beta-catenin mutations @ DiseaseTgt $ correlate low rate loss heterozygosity . determine frequency Wnt/Wingless beta catenin pathway alteration human @ DiseaseTgt $ , beta catenin @ GeneSrc $ gene mutation screening performed series 119 tumors . activating beta catenin mutation exon 3 found 18 % cases . Among tumors lacking beta catenin mutation , @ GeneSrc $ mutation evidenced subset 30 cases tested . correlation beta catenin mutation status chromosome segment deletions studied set 48 hyperploid tumors . Chromosome 1p , 4q 16p deletions significantly associated absence beta catenin mutation ( P < 0.05 ) . Furthermore Fractional Allelic Loss significantly smaller beta catenin mutated tumors non-mutated tumors ( 0.12 versus 022 ) . Taken together , results suggest , existence two carcinogenesis mechanisms . first mechanism implies beta catenin activating mutation associated low rate loss heterozygosity . second mechanism , operating context chromosomal instability , would involve tumor suppressor genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0919151144286648)\n",
      "- Text: \"AXIN1 mutations @ DiseaseTgt $ , growth suppression cancer cells virus-mediated transfer AXIN1 . Wnt signaling pathway essential development organogenesis . Wnt signaling stabilizes beta-catenin , accumulates cytoplasm , binds 1-cell factor ( TCF ; also known lymphocyte enhancer-binding factor , LEF ) upregulates downstream genes . Mutations CTNNB1 ( encoding beta-catenin ) @ GeneSrc $ ( @ GeneSrc $ ) reported human neoplasms including colon cancers @ DiseaseTgt $ ( @ DiseaseTgt $ ) . HCC5 tend show accumulation beta-catenin often mutations CTNNB1 , looked mutations AXIN1 , encoding key factor Wnt signaling , 6 @ DiseaseTgt $ cell lines 100 primary HCC5 . Among 4 cell lines 87 HCC5 detect CTNNB1 mutations , identified AXIN1 mutations 3 cell lines 6 mutations 5 primary @ DiseaseTgt $ . cell lines containing mutations either gene , observed increased DNA binding TCF associated beta-catenin nuclei . Adenovirus mediated gene transfer wild-type AXINI induced apoptosis hepatocellular colorectal cancer cells accumulated beta-catenin consequence either @ GeneSrc $ , CTNNB1 AXIN1 mutation , suggesting axin may effective therapeutic molecule suppressing growth hepatocellular colorectal cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.021429991354657)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation @ DiseaseTgt $ progression colon . Kras commonly mutated colon cancers , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context @ GeneSrc $ colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.523444479857327e-06)\n",
      "- Text: \"Vitamin C selectively kills KRAS BRAF mutant colorectal cancer cells targeting GAPDH . half human colorectal cancers ( CRCs ) carry either KRAS BRAF mutations often refractory approved targeted therapies . found cultured human CRC cells harboring KRAS BRAF mutations selectively killed exposed high levels vitamin C. effect due increased uptake oxidized form vitamin C , dehydroascorbate ( DHA ) , via GLUT1 glucose transporter . Increased DHA uptake causes oxidative stress intracellular DHA reduced vitamin C , depleting glutathione . Thus , reactive oxygen species accumulate inactivate glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) . Inhibition GAPDH highly glycolytic KRAS BRAF mutant cells leads energetic crisis cell death seen KRAS BRAF wild-type cells . High-dose vitamin C impairs @ DiseaseTgt $ growth @ GeneSrc $ ) mutant mice . results provide mechanistic rationale exploring therapeutic use vitamin C CRCs KRAS BRAF mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001095047605057)\n",
      "- Text: \"novel case germline p53 gene mutation concurrent multiple primary colon tumours . search causative genes patients concurrent multiple primary colon tumours , found novel case germline mutation p53 gene , GCC ( Ala ) GTC ( Val ) codon 189 . six primary colon tumours patient , one large advanced @ DiseaseTgt $ exhibited somatic p53 mutation somatic @ GeneSrc $ mutation , addition germline p53 mutation . Two early @ DiseaseTgt $ three adenomas somatic @ GeneSrc $ mutations somatic p53 mutation loss p53 allele . K-ras-2 mutations detected advanced @ DiseaseTgt $ early @ DiseaseTgt $ . present results suggest patient certain type germline p53 mutation predisposed concurrent multiple colon tumours . also suggested patient , somatic @ GeneSrc $ mutation involved @ DiseaseTgt $ formation additional somatic p53 mutation contributes @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9715377994169764)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway colorectal cancer well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) @ GeneSrc $ ( @ GeneSrc $ ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies hMLH1 , hMSH2 , beta-catenin , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One @ DiseaseTgt $ ( 5 % ) found RER+ , @ DiseaseTgt $ stained positive hMLH1 hMSH2 . mutations detected MCR @ GeneSrc $ gene . beta-Catenin showed increased nuclear expression loss membranous staining 10 @ DiseaseTgt $ ( 48 % ) . Absent decreased membrane expression E-cadherin found eight @ DiseaseTgt $ ( 38 % ) . Strong staining p53 found nucleus five @ DiseaseTgt $ ( 24 % ) . CONCLUSION : detect mutations MCR @ GeneSrc $ gene , suggests adenocarcinoma small intestine may follow different genetic pathway colorectal cancer . Abnormal expression E-cadherin beta-catenin common reflects early alternative @ GeneSrc $ pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7957872315461901)\n",
      "- Text: \"GAPPS - Gastric Adenocarcinoma Proximal Polyposis Stomach Syndrome 8 Families Tested Masaryk Memorial Cancer Institute - Prevention Prophylactic Gastrectomies . Gastric adenocarcinoma proximal polyposis stomach ( GAPPS ) rare variant familial adenomatous polyposis . autosomal-dominant cancer-predisposition syndrome massive polyposis stomach significant risk @ DiseaseTgt $ . Li et al . , 2016 , described point mutations Ying Yang 1 binding site APC gene 1B promoter associated GAPPS syndrome . first GAPPS syndrome Czech family described 2016 . Masaryk Memorial Cancer Institute , GAPPS syndrome diagnosed eight families using Sanger sequencing . families , one mutation promoter 1B @ GeneSrc $ gene NM_001127511 : c.-191T > C detected . mutation found patient multiple colon polyposis without detected classic mutation @ GeneSrc $ gene . total , 24 carriers mutation promoter 1B @ GeneSrc $ gene detected . 24 carriers , 20 massive gastric polyposis 100 fundic glandular polyps diagnosed age 22 65 , 5 already died @ DiseaseTgt $ ( ages 29 , 40 , 59 , 60 64 , respectively ) another woman treated age 29 . Two female carriers yet polyposis stomach ages 31 65 , respectively ; one female carrier incipient polyposis age 58 . male carrier clinical symptoms , gastroscopy indicated age . Prophylactic total gastrectomy D2 lymphadenectomy already performed 6 times Masaryk Memorial Cancer Institute , 5 cases without adenocarcinoma ages 27 , 34 , 44 , 51 66 , respectively ; one female carrier @ DiseaseTgt $ detected histology specimen . Two prophylactic gastrectomies D1 lymphadenectomy performed University Hospital Brno ages 42 50 , respectively . Czech Republic point mutation c.-191T > C ( rs879253783 ) 1B promoter @ GeneSrc $ gene frequent cause gastric polyposis high risk @ DiseaseTgt $ , even young age . Positively tested individuals recommended high-risk oncology clinic . necessary part discussion patient information preventive gastrectomy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0335874014703032)\n",
      "- Text: \"Two Asian families @ DiseaseTgt $ proximal polyposis stomach successfully treated via laparoscopic total gastrectomy . Family 1 : 39-year-old woman sister admitted hospital fundic gland polyps ( FGPs ) . mother died @ DiseaseTgt $ FGPs . performed repeated biopsies close intervals , suspecting @ DiseaseTgt $ proximal polyposis stomach ( GAPPS ) . 1-year follow-up , sisters diagnosed @ DiseaseTgt $ FGP . performed laparoscopic total gastrectomies D1+lymph node dissection . Promoter 1B ( exon 1B ) @ GeneSrc $ gene ( chr5 : 112,043,224 > C ) contained point mutation . sisters subsequently diagnosed GAPPS per mutational analysis . Family 2 ( unrelated Family 1 ) : a-24-year-old woman referred epigastralgia . EGD revealed FGPs localized proximal stomach . Pathological biopsy results showed severe dysplasia adenocarcinoma situ . father simultaneously diagnosed FGPs GC localized proximal stomach . performed laparoscopic total gastrectomies D1+lymph node dissection . gene mutation family 1 . , report two Asian families GAPPS successfully treated via laparoscopic total gastrectomy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3302937334592845)\n",
      "- Text: \"Point Mutations Exon 1B @ GeneSrc $ Reveal Gastric Adenocarcinoma Proximal Polyposis Stomach Familial Adenomatous Polyposis Variant . Gastric adenocarcinoma proximal polyposis stomach ( GAPPS ) autosomal-dominant cancer-predisposition syndrome significant risk @ DiseaseTgt $ . mapped gene 5q22 found loss wild-type allele 5q fundic gland polyps affected individuals . Whole-exome -genome sequencing failed find causal mutations , Sanger sequencing , identified point mutations APC promoter 1B co-segregated disease six families . mutations reduced binding YY1 transcription factor impaired activity APC promoter 1B luciferase assays . Analysis blood saliva carriers showed allelic imbalance @ GeneSrc $ , suggesting mutations lead decreased allele-specific expression vivo . Similar mutations APC promoter 1B occur rare families familial adenomatous polyposis ( FAP ) . Promoter 1A methylated GAPPS sporadic FGPs normal stomach , suggests 1B transcripts important 1A gastric mucosa . might explain known GAPPS-affected families carry promoter 1B point mutations rare FAP-affected families carry similar mutations , colonic cells usually protected expression 1A isoform . Gastric polyposis cancer previously described FAP-affected individuals large deletions around promoter 1B . finding GAPPS caused point mutations promoter suggests families mutations affecting promoter 1B risk @ DiseaseTgt $ , regardless whether colorectal polyps present .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0061733284195079)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation tumor progression colon . Kras commonly mutated @ DiseaseTgt $ , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context @ GeneSrc $ colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003106345896947)\n",
      "- Text: \"Yeast artificial chromosome cloning beta-catenin locus human chromosome 3p21 - 22 . beta-Catenin emerged important component adherens junctions epithelial cells . result studies interaction @ GeneSrc $ gene product , implicated development @ DiseaseTgt $ . alpha-Catenin , beta-catenin , E-cadherin @ GeneSrc $ appear mediate contact inhibition epithelia . part study organization beta-catenin gene , isolated yeast artificial chromosomes ( YACs ) characterize intron/exon structure . YAC fluorescence situ hybridization analysis polymerase chain reaction analysis somatic cell hybrid DNAs show beta-catenin maps 3p21 - 22 region , location tumour-suppressor genes deleted small-cell lung cancer ( SCLC ) disorders . beta-Catenin YACs provide source microsatellite markers useful loss heterozygosity studies assess importance beta-catenin deletions SCLC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004167994229623)\n",
      "- Text: \"Targeted inactivation CTNNB1 reveals unexpected effects beta-catenin mutation . Inactivating mutations @ GeneSrc $ gene ( APC ) activating mutations beta-catenin gene ( CTNNB1 ) initiate colorectal neoplasia . address biochemical physiologic effects mutant beta-catenin , disrupted either mutant wild-type CTNNB1 allele human @ DiseaseTgt $ cell line . Cells wild-type beta-catenin decreased colony-forming ability plated low density , although growth similar parental cells passaged routine conditions . Immunohistochemistry cell-fractionation studies suggested mutant beta-catenin activity distinguished primarily cellular localization protein degradation . Surprisingly , found mutant beta-catenin bound less well E-cadherin wild-type beta-catenin , membranous localization wild-type mutant beta-catenin accordingly distinct . findings pose several challenges current models APC/beta-catenin function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0034310376791924)\n",
      "- Text: \"Beta-catenin mutations cell lines established human @ DiseaseTgt $ . beta-catenin functions adhesion signaling molecule . Disruption functions mutations beta-catenin gene ( CTNNB1 ) may important development @ DiseaseTgt $ . examined entire coding sequence beta-catenin reverse transcriptase-PCR ( RT-PCR ) direct sequencing 23 human @ DiseaseTgt $ cell lines 21 patients . two cell lines , apparent instability beta-catenin mRNA . Five different mutations ( 26 % ) found remaining 21cell lines ( 19 patients ) . three-base deletion ( codon 45 ) identified cell line HCT 116 , whereas cell lines SW 48 , HCA 46 , CACO 2 , Colo 201 contained single-base missense mutations ( codons 33 , 183 , 245 , 287 , respectively ) . 23 cell lines full-length beta-catenin protein detectable Western blotting coprecipitated E-cadherin . three cell lines CTNNB1 mutations , complexes beta-catenin alpha-catenin @ GeneSrc $ detectable . SW48 HCA 46 , however , detect complexes beta-catenin protein alpha-catenin @ GeneSrc $ , respectively . results show selection CTNNB1 mutations occurs 26 % @ DiseaseTgt $ cell lines derived . cases , mutation selection probably altered beta-catenin function , may significantly alter intracellular signaling intercellular adhesion may serve complement @ GeneSrc $ mutations early stages tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001688925668049)\n",
      "- Text: \"Beta-catenin degradation mediated CID domain @ GeneSrc $ provides model selection @ GeneSrc $ mutations colorectal , desmoid duodenal tumours . Biallelic mutation @ GeneSrc $ ( @ GeneSrc $ ) gene hallmark @ DiseaseTgt $ colorectal , duodenal desmoid tumours develop familial adenomatous polyposis ( FAP ) patients . mutations affecting @ GeneSrc $ alleles interdependent , position first @ GeneSrc $ mutation determining second hit occur . results complex pattern mutation distribution @ GeneSrc $ sequence translates stabilization beta-catenin turn feeds affected cells permanent mitogenic signal . describe new @ GeneSrc $ domain , beta-catenin inhibitory domain ( CID ) @ GeneSrc $ located second third 20 amino acid repeats therefore present many truncated @ GeneSrc $ products found human tumours . truncated @ GeneSrc $ , CID absolutely necessary down-regulate transcriptional activity level beta-catenin , even axin/conductin binding site present . activity CID dramatically reduced several @ DiseaseTgt $ cell lines inhibited shorter truncated @ GeneSrc $ lacking CID . CID direct target selective pressure acting @ GeneSrc $ tumourigenesis . explains interdependence @ GeneSrc $ mutations , colorectal also duodenal desmoid tumours .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3922638592087715)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway @ DiseaseTgt $ well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) @ GeneSrc $ ( @ GeneSrc $ ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies hMLH1 , hMSH2 , beta-catenin , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One cancer ( 5 % ) found RER+ , tumours stained positive hMLH1 hMSH2 . mutations detected MCR @ GeneSrc $ gene . beta-Catenin showed increased nuclear expression loss membranous staining 10 cancers ( 48 % ) . Absent decreased membrane expression E-cadherin found eight cancers ( 38 % ) . Strong staining p53 found nucleus five cancers ( 24 % ) . CONCLUSION : detect mutations MCR @ GeneSrc $ gene , suggests adenocarcinoma small intestine may follow different genetic pathway @ DiseaseTgt $ . Abnormal expression E-cadherin beta-catenin common reflects early alternative @ GeneSrc $ pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.074110521551046)\n",
      "- Text: \"@ GeneSrc $ gene : database germline somatic mutations human tumors cell lines . database described 700 mutations human @ GeneSrc $ gene tumors ( @ DiseaseTgt $ predominantly ) compiled literature . includes molecular informations mutations also clinical data patients . software designed order analyse informations database .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0709453179069091)\n",
      "- Text: \"Variable phenotype familial adenomatous polyposis pedigrees 3 ' mutation @ GeneSrc $ gene . BACKGROUND : Germline mutation @ GeneSrc $ ( @ GeneSrc $ ) gene chromosome 5 causes familial adenomatous polyposis . `` Attenuated `` phenotype reported mutation 5 ' end gene ( 5 ' codon 158 ) , genotype-phenotype relations 3 ' end ( 3 ' codon 1596 ) described fully . AIMS : describe compare colorectal extracolonic phenotypes case series families mutation 3 ' end @ GeneSrc $ gene . METHODS : Thirty one risk affected members four families mutation @ GeneSrc $ gene located codon 1979 2644 evaluated . RESULTS : Variable intrapedigree colorectal phenotype observed : members older age oligopolyposis ( fewer one hundred colorectal adenomas ) whereas members classic polyposis young age . @ DiseaseTgt $ diagnosed older mean age ( 50 ( 7 ) years ) four families classic FAP pedigrees ( 39 ( 14 ) years ) . Extracolonic lesions characteristic FAP occurred 3 ' @ GeneSrc $ mutations , variability intrapedigree interpedigree extracolonic phenotype dissociation severity extracolonic manifestations number colorectal polyps noted . CONCLUSIONS : Families 3 ' mutations @ GeneSrc $ gene exhibit variable intrapedigree phenotype similar heterogeneity noted families proximal 5 ' mutations . Genotyping FAP oligopolyposis pedigrees guide appropriate surveillance upper lower gastrointestinal tract affected members .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0086231802355121)\n",
      "- Text: \"@ GeneSrc $ mutation phenotypic spectrum Singapore familial adenomatous polyposis patients . Familial adenomatous polyposis ( FAP ) familial form @ DiseaseTgt $ caused mutation @ GeneSrc $ ( @ GeneSrc $ ) gene . Although @ GeneSrc $ gene extensively studied Caucasian population , previously described Chinese population . present study , investigated @ GeneSrc $ mutation phenotypic spectrum Singapore FAP families predominantly Chinese . protein truncation test ( PTT ) used screen entire @ GeneSrc $ gene germline mutations 28 unrelated families . Fifteen different mutations identified 22 families . Eight mutations 1 - 11 basepair deletions insertions ; three involved deletions whole exons four nonsense mutations . Nine mutations , including two complex rearrangements , novel . Eight families including three de novo cases ( AAAGA ) deletion codon 1309 , indicating like Western families , codon 1309 also mutation ' hot spot ' Singapore FAP families . contrast , find mutation codon 1061 , second hot spot Western population . Congenital hypertrophy retinal pigment epithelium ( CHRPE ) consistently associated prescribed domain ( codons 463 1387 ) phenotype intra-family variation . CHRPE , differences type frequency extracolonic manifestations within FAP families suggest influence modifying genes environmental factors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4042025544804856)\n",
      "- Text: \"Molecular analysis @ GeneSrc $ mutations familial adenomatous polyposis @ DiseaseTgt $ . Mutations @ GeneSrc $ gene give rise familial adenomatous polyposis ( FAP ) also occur many , perhaps , sporadic @ DiseaseTgt $ . screening single-strand conformation polymorphism analysis identified several mutations small region @ GeneSrc $ gene FAP sporadic cancers . mutations either point mutations small deletions insertions causing frameshifts , generated stop codons . One 5 base-pair deletion found sporadic colon tumour , @ DiseaseTgt $ cell line derived sporadic colon tumour , four unrelated FAP patients . mutation produces distinctive heteroduplex bands , detected simple non-radioactive assay . findings suggest highly localised short sequences , essentially runs code adenine thymine , may account 20 % observed @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6855025362231775)\n",
      "- Text: \"Topoisomerase-I- Alu-mediated genomic deletions @ GeneSrc $ gene familial adenomatous polyposis . Germline mutation @ GeneSrc $ ( @ GeneSrc $ ) gene results familial adenomatous polyposis ( FAP ) , heritable form @ DiseaseTgt $ . previously reported two novel mutations delete exons 11 14 @ GeneSrc $ gene , respectively , cDNA level without splice junction defects genomic level . describe precise breakpoints two mutations possible mechanisms leading genomic rearrangement . first rearrangement likely topoisomerase-I-mediated non-homologous recombination resulting 2-kb deletion deletes exon 11 @ GeneSrc $ gene . 5 ' 3 ' breakpoints two topoisomerase recognition sites runs pyrimidines within 10-bp sequences vicinity . , 3 ' breakpoint adenine-thymidine-rich region . probably first report topoisomerase-I-mediated germline mutation tumor suppressor gene . second rearrangement likely Alu-Alu homologous recombination resulting 6-kb deletion encompassing exon 14 . Alu elements 5 ' 3 ' breakpoints include 26-bp core sequence thought stimulate recombination . rearrangements , partial sequences long interspersed nuclear element family vicinity breakpoints . serving markers regions DNA damage , precise role recombination events , , unclear . deletions result truncated @ GeneSrc $ proteins missing beta-catenin- axin-binding domains , resulting severe polyposis cancer .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8660624037448535)\n",
      "- Text: \"@ GeneSrc $ down-regulated ubiquitin-proteasome pathway process facilitated Axin . @ GeneSrc $ ( @ GeneSrc $ ) protein Axin form complex mediates down-regulation beta-catenin , key effector Wnt signaling . Truncation mutations @ GeneSrc $ responsible @ DiseaseTgt $ due failure down-regulation beta-catenin . regulation beta-catenin @ GeneSrc $ extensively studied , regulation @ GeneSrc $ received little attention . show level @ GeneSrc $ down-regulated ubiquitin-proteasome pathway Wnt signaling inhibits process . domain responsible down-regulation direct ubiquitination identified . also show unexpected role Axin facilitating ubiquitination-proteasome-mediated down-regulation @ GeneSrc $ oligomerization Axin . results suggest new mechanism regulation @ GeneSrc $ Axin Wnt signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1217695009296708)\n",
      "- Text: \"Genetic identification Mom-1 , major modifier locus affecting Min-induced intestinal neoplasia mouse . Mutations human @ GeneSrc $ gene caused various familial @ DiseaseTgt $ . Multiple intestinal neoplasia ( Min ) mouse provides excellent model familial @ DiseaseTgt $ : carries mutant mouse Apc gene develops many intestinal adenomas . , analyze tumor phenotype dramatically modified genetic background . report genetic mapping locus strongly modifies tumor number Min/+ animals . gene , Mom-1 ( Modifier Min-1 ) , maps distal chromosome 4 controls 50 % genetic variation tumor number two intraspecific backcrosses . mapping supported LOD score exceeding 14 . Interestingly , Mom-1 lies region synteny conservation human chromosome 1p35 - 36 , region frequent somatic loss heterozygosity variety human tumors , including colon tumors . results provide evidence major modifier affecting expression inherited cancer syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.003894488619324)\n",
      "- Text: \"Dominant negative effect APC1309 mutation : possible explanation genotype-phenotype correlations familial adenomatous polyposis . Inactivation @ GeneSrc $ ( @ GeneSrc $ ) gene product initiates colorectal tumorigenesis . Patients familial APC ( FAP ) carry germ-line mutations @ GeneSrc $ gene develop multiple colorectal adenomas subsequent carcinomas early life . severity disease correlates position inherited @ GeneSrc $ mutation ( genotype-phenotype correlation ) . Together fact germ-line sporadic @ GeneSrc $ mutations cluster central region @ GeneSrc $ gene , points dominant negative effect certain @ GeneSrc $ mutants . Loss @ GeneSrc $ function recently shown result enhanced beta-catenin-/Tcf-mediated transcription colon epithelial cells . , provide experimental evidence dominant negative effect @ GeneSrc $ gene products associated severe polyposis . Wild-type @ GeneSrc $ activity beta-catenin-/Tcf-mediated transcription strongly inhibited mutant @ GeneSrc $ truncated codon 1309 . contrast , mutant @ GeneSrc $ gene products associated attenuated polyposis ( codon 386 1465 ) interfered weakly wild-type @ GeneSrc $ activity . results suggest molecular explanation genotype-phenotype correlation FAP patients support idea @ DiseaseTgt $ growth might , part , driven selection mutation mutation cluster region .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3896234465450999)\n",
      "- Text: \"ABC @ GeneSrc $ . Familial adenomatous polyposis ( FAP ) autosomal dominant inherited disease characterized presence adenomatous polyps colon rectum , inevitable development @ DiseaseTgt $ left untreated . FAP caused germline mutations @ GeneSrc $ ( @ GeneSrc $ ) gene . Somatic mutations @ GeneSrc $ gene early event colorectal tumorigenesis , detected majority @ DiseaseTgt $ . @ GeneSrc $ gene encodes large protein multiple cellular functions interactions , including roles signal transduction wnt-signalling pathway , mediation intercellular adhesion , stabilization cytoskeleton possibly regulation cell cycle apoptosis . fact @ GeneSrc $ integral part many different pathways makes ideal target mutation carcinogenesis . review deals understanding date mutations @ GeneSrc $ gene translate changes protein level , turn contribute role @ GeneSrc $ tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2444202796975516)\n",
      "- Text: \"targeted chain-termination mutation mouse Apc gene results multiple intestinal tumors . Germ-line mutations human @ GeneSrc $ ( @ GeneSrc $ ) gene result familial adenomatous polyposis , autosomal dominant disorder characterized early onset multiple adenomatous polyps large bowel high likelihood developing @ DiseaseTgt $ . understand role @ GeneSrc $ intestinal tumor formation , introduced chain-termination mutation 15th exon mouse Apc gene employed modify endogenous gene homologous recombination embryonic stem cells . Mice heterozygous Apc gene modification progressively develop intestinal tumors manner similar observed patients familial adenomatous polyposis mice carry mutation called multiple intestinal neoplasia ( Min ) . results indicate Apc gene modification critical event initiation intestinal tumor formation results autosomal dominant predisposition toward development spontaneous colonic intestinal tumors mice .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0273986687679201)\n",
      "- Text: \"@ GeneSrc $ variants I1307 K E1317Q associated @ DiseaseTgt $ , always family history . Classical familial adenomatous polyposis ( FAP ) high-penetrance autosomal dominant disease predisposes hundreds thousands colorectal adenomas carcinoma results truncating mutations @ GeneSrc $ gene . variant FAP attenuated adenomatous polyposis coli , results germ-line mutations 5 ' 3 ' regions @ GeneSrc $ gene . Attenuated adenomatous polyposis coli patients `` multiple `` colorectal adenomas ( typically fewer 100 ) without florid phenotype classical FAP . Another group patients multiple adenomas mutations @ GeneSrc $ gene , phenotype probably results variation locus , loci , elsewhere genome . Recently , however , missense variant @ GeneSrc $ ( I1307 K ) described confers increased risk @ DiseaseTgt $ , including multiple adenomas , Ashkenazim . studied set 164 patients multiple colorectal adenomas and/or carcinoma analyzed codons 1263 - 1377 ( exon 15 G ) @ GeneSrc $ gene germ-line variants . Three patients I1307 K allele detected , Ashkenazi descent . Four patients germ-line E1317Q missense variant @ GeneSrc $ present controls ; one individuals unusually large number metaplastic polyps colorectum . increasing evidence exist germ-line variants @ GeneSrc $ gene predispose development multiple colorectal adenomas carcinoma , without florid phenotype classical FAP , possibly importance @ DiseaseTgt $ risk general population .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1162655646457923)\n",
      "- Text: \"Yeast artificial chromosomes molecular analysis familial polyposis APC gene region . Two yeast artificial chromosomes ( YACs ) spanning total distance 1.1 megabase pairs DNA around MCC ( mutated @ DiseaseTgt $ ) @ GeneSrc $ ( adenomatous polyposis coli ) genes 5q21 isolated characterized . Starting MCC gene , strategy undertaken identify constitutional submicroscopic deletions familial adenomatous polyposis patients might considerably narrow position @ GeneSrc $ gene . end , YACs identified MCC gene screened across chromosome 5-specific cosmid library provide source DNA probes genomic scanning . cosmids isolated experiments used screen panel somatic cell hybrids containing chromosome 5 segregated patients suspected carry putative interstitial deletions . screening approach led confirmation small heterozygous deletion polyposis patient overlaps one two isolated YACs . YAC shown contain entire @ GeneSrc $ gene , addition significant portion DNA flanking 5 ' end gene , therefore prove valuable resource functional studies transfer @ DiseaseTgt $ cell lines .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1790543052741135)\n",
      "- Text: \"molecular basis Turcot 's syndrome . BACKGROUND : Turcot 's syndrome characterized clinically concurrence primary brain tumor multiple colorectal adenomas . attempted define syndrome molecular level . METHODS : Fourteen families Turcot 's syndrome identified two registries family originally described Turcot colleagues studied . Germ-line mutations @ GeneSrc $ ( @ GeneSrc $ ) gene characteristic familial adenomatous polyposis evaluated , well DNA replication errors germline mutations nucleotide mismatch-repair genes characteristic hereditary nonpolyposis colorectal cancer . addition , formal risk analysis brain tumors familial adenomatous polyposis performed registry data base . RESULTS : Genetic abnormalities identified 13 14 registry families . Germ-line @ GeneSrc $ mutations detected 10 . predominant brain tumor 10 families medulloblastoma ( 11 14 patients , 79 percent ) , relative risk cerebellar medulloblastoma patients familial adenomatous polyposis 92 times general population ( 95 percent confidence interval , 29 269 ; P < 0.001 ) . contrast , type brain tumor four families glioblastoma multiforme . glioblastomas @ DiseaseTgt $ three families original family studied Turcot replication errors characteristic hereditary nonpolyposis colorectal cancer . addition , germ-line mutations mismatch-repair genes hMLH1 hPMS2 found two families . CONCLUSIONS : association brain tumors multiple colorectal adenomas result two distinct types germ-line defects : mutation @ GeneSrc $ gene mutation mismatch-repair gene . Molecular diagnosis may contribute appropriate care affected patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2425045302065588)\n",
      "- Text: \"Somatic instability @ GeneSrc $ I1307 K allele colorectal neoplasia . @ GeneSrc $ ( @ GeneSrc $ ) gene proposed function gatekeeper colorectal neoplasia . germ-line variant gene , @ GeneSrc $ I1307 K allele , present approximately 6 % Ashkenazi Jewish population . assess role tumorigenesis variant ( ) 8 tract produced allele , undertook somatic mutation analysis region surrounding codon 1307 @ DiseaseTgt $ @ GeneSrc $ I1307 K carriers . Somatic mutations involving variant ( ) 8 tract identified 53 127 ( 42 % ) tumors @ GeneSrc $ I1307 K carriers compared 5 127 ( 4 % ) mutations involving wild-type allele tumors ( P < 0.0001 ) . Loss heterozygosity wild-type allele significantly common tumors @ GeneSrc $ I1307 K allele mutations ( 25 41 , 61 % ) compared @ GeneSrc $ I1307 K carrier tumors without mutation variant ( ) 8 tract ( 12 53 , 23 % ; P < 0.0005 ) . somatic biallelic @ GeneSrc $ inactivation confirms biological importance I1307 K germ-line variant . vast majority @ GeneSrc $ I1307 K somatic mutations consisted single adenine insertion ( insA ) involving variant ( ) 8 tract . insA mutation mutually exclusive presence microsatellite instability 0 49 tumors insA displaying BAT-26 instability compared 9 78 tumors without insA ( P=0.01 ) . findings support model somatic instability ( ) 8 tract produced @ GeneSrc $ I1307 K allele leads increased @ GeneSrc $ gene inactivation directly accounts 42 % @ DiseaseTgt $ occurring @ GeneSrc $ I1307 K carriers .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8904276167880304)\n",
      "- Text: \"Inherited colorectal polyposis cancer risk @ GeneSrc $ I1307 K polymorphism . Germ-line somatic truncating mutations @ GeneSrc $ gene thought initiate @ DiseaseTgt $ formation familial adenomatous polyposis syndrome sporadic colorectal carcinogenesis , respectively . Recently , isoleucine -- > lysine polymorphism codon 1307 ( I1307 K ) @ GeneSrc $ gene identified 6 % -7 % Ashkenazi Jewish population . assess risk common @ GeneSrc $ allelic variant colorectal carcinogenesis , analyzed large cohort unselected Ashkenazi Jewish subjects adenomatous polyps and.or @ DiseaseTgt $ , @ GeneSrc $ I1307 K polymorphism . @ GeneSrc $ I1307 K allele identified 48 ( 10.1 % ) 476 patients . Compared frequency two separate population control groups , @ GeneSrc $ I1307 K allele associated estimated relative risk 1.5 - 1.7 colorectal neoplasia ( P=.01 ) . Furthermore , compared noncarriers , @ GeneSrc $ I1307 K carriers increased numbers adenomas @ DiseaseTgt $ per patient ( P=.03 ) , well younger age diagnosis . conclude @ GeneSrc $ I1307 K variant leads increased adenoma formation directly contributes 3 % -4 % Ashkenazi Jewish @ DiseaseTgt $ . estimated relative risk carriers may justify specific clinical screening 360,000 Americans expected harbor allele , genetic testing setting long-term-outcome studies may impact significantly @ DiseaseTgt $ prevention population .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.647466513086023)\n",
      "- Text: \"Multiple forms @ GeneSrc $ gene transcripts tissue-specific expression . detected multiple forms RNA transcript @ GeneSrc $ , gene responsible familial adenomatous polyposis ( FAP ) . Transcriptional initiation occurs three sites two distinct non-translating exons 5 ' end gene . least five different forms 5 ' non-coding sequences , generated alternative splicing , exist . splicing mechanism seems regulated tissue-specific fashion , one type transcript contained additional exon , transcribed specifically brain . Analyses mRNAs two @ DiseaseTgt $ cell lines reverse-transcriptase polymerase chain reaction ( RT-PCR ) revealed one another transcriptional forms absent cell lines . observation suggested presence mutations control region first exon @ GeneSrc $ , mutation ( ) could affected splicing efficiency transcriptional initiation gene tumors . Furthermore , found alternative splicing involving 19 kDa protein signal recognition particle ( SRP19 ) gene , known occur exon 14 @ GeneSrc $ , also controlled tissue-specific manner , one type transcript lacked organs .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0629348718398331)\n",
      "- Text: \"Identification c-MYC target @ GeneSrc $ pathway . @ GeneSrc $ ( @ GeneSrc $ ) tumor suppressor gene inactivated @ DiseaseTgt $ . Mutations @ GeneSrc $ cause aberrant accumulation beta-catenin , binds cell factor-4 ( Tcf-4 ) , causing increased transcriptional activation unknown genes . , c-MYC oncogene identified target gene signaling pathway . Expression c-MYC shown repressed wild-type @ GeneSrc $ activated beta-catenin , effects mediated Tcf-4 binding sites c-MYC promoter . results provide molecular framework understanding previously enigmatic overexpression c-MYC @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0044935425599758)\n",
      "- Text: \"Association regulation casein kinase 2 activity @ GeneSrc $ . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene responsible familial adenomatous polyposis coli also sporadic @ DiseaseTgt $ development . using antibodies raised N-terminal region @ GeneSrc $ protein , detected variable masses endogenous @ GeneSrc $ proteins individual cell lines established human @ DiseaseTgt $ caused nonsense mutations gene . Phosphorylation immunoprecipitates full-length truncated @ GeneSrc $ observed vitro kinase reaction , indicating association @ GeneSrc $ protein kinase activity . kinase activity complexed @ GeneSrc $ sensitive heparin used GTP phosphoryl donor , suggesting involvement casein kinase 2 ( CK2 ) . CK2alpha- beta-subunits found associate @ GeneSrc $ immunoprecipitates well pull-down assays , preferential interaction @ GeneSrc $ tetrameric CK2 holoenzyme . synchronized cell populations , association @ GeneSrc $ CK2 cell cycle dependent , highest association G ( 2 ) /M . Unexpectedly , @ GeneSrc $ immunoprecipitates containing full-length @ GeneSrc $ protein inhibited CK2 vitro , whereas immunoprecipitates truncated @ GeneSrc $ little effect . confirmed using recombinant @ GeneSrc $ , inhibitory region localized C terminus @ GeneSrc $ residues 2086 2394 . Overexpression fragment SW480 cells suppressed cell proliferation rates well tumorigenesis . results demonstrate previously uncharacterized functional interaction tumor suppressor protein @ GeneSrc $ CK2 suggest growth-inhibitory effects @ GeneSrc $ may regulated inhibition CK2 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8812781364639886)\n",
      "- Text: \"Identification FAP locus genes chromosome 5q21 . Recent studies suggest one genes chromosome 5q21 important development @ DiseaseTgt $ , particularly associated familial adenomatous polyposis ( FAP ) . facilitate identification genes locus , portion region tightly linked FAP cloned . Six contiguous stretches sequence ( contigs ) containing approximately 5.5 Mb DNA isolated . Subclones contigs used identify position six genes , expressed normal colonic mucosa . Two genes ( @ GeneSrc $ MCC ) likely contribute colorectal tumorigenesis . MCC gene previously identified virtue mutation human @ DiseaseTgt $ . @ GeneSrc $ gene identified contig initiated MCC gene found encode unusually large protein . two closely spaced genes encode proteins predicted contain coiled-coil regions . genes also expressed wide variety tissues . studies MCC @ GeneSrc $ potential interaction prove useful understanding colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029894328925976)\n",
      "- Text: \"role @ GeneSrc $ chromosome segregation . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene responsible @ DiseaseTgt $ also occur early stages sporadic @ DiseaseTgt $ . @ GeneSrc $ functions Wnt signalling pathway regulate degradation beta-catenin ( reviewed refs 1 - 3 ) . @ GeneSrc $ also binds stabilizes microtubules vivo vitro , localizes clusters ends microtubules near plasma membrane interphase cells , important regulator cytoskeletal function . show cells carrying truncated @ GeneSrc $ gene ( Min ) defective chromosome segregation . Moreover , mitosis , @ GeneSrc $ localizes ends microtubules embedded kinetochores forms complex checkpoint proteins Bub1 Bub3 . vitro , @ GeneSrc $ high-affinity substrate Bub kinases . data consistent role @ GeneSrc $ kinetochore-microtubule attachment suggest truncations @ GeneSrc $ eliminate microtubule binding may contribute chromosomal instability cancer cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9554275440905028)\n",
      "- Text: \"Mapping multiple intestinal neoplasia ( Min ) proximal chromosome 18 mouse . Min ( multiple intestinal neoplasia ) mutation mouse mapped analyzing inheritance restriction fragment length polymorphisms simple sequence length polymorphisms progeny two intraspecific crosses segregating Min mutation . Min , mutant allele Apc , mouse homolog human @ GeneSrc $ ( @ GeneSrc $ ) gene , maps proximal chromosome 18 . synteny Apc Mcc , mouse homolog human MCC ( mutated @ DiseaseTgt $ ) gene , conserved mouse human , although gene order Apc Mcc interval different @ GeneSrc $ MCC interval .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2195004603706304)\n",
      "- Text: \"@ DiseaseTgt $ Ashkenazim due hypermutable tract @ GeneSrc $ . Approximately 130,000 cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) diagnosed United States year , 15 % hereditary component . Two well-defined syndromes , familial adenomatous polyposis ( FAP ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) , account 5 % total new cases @ DiseaseTgt $ . Truncating @ GeneSrc $ mutations responsible FAP , defective mismatch repair genes cause @ DiseaseTgt $ . However , genes responsible familial cases unknown . report mutation ( @ GeneSrc $ nucleotide 3920 ) found 6 % Ashkenazi Jews 28 % Ashkenazim family history @ DiseaseTgt $ . Rather altering function encoded protein , mutation creates small hypermutable region gene , indirectly causing cancer predisposition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5303682351071345)\n",
      "- Text: \"type somatic mutation @ GeneSrc $ familial adenomatous polyposis determined site germline mutation : new facet Knudson 's ' two-hit ' hypothesis . @ GeneSrc $ often cited prime example tumor suppressor gene . Truncating germline somatic mutations ( , infrequently , allelic loss ) occur tumors FAP ( familial adenomatous polyposis ) . @ DiseaseTgt $ also two @ GeneSrc $ mutations . Clues attenuated polyposis , missense germline variants mild disease somatic mutation cluster region ( codons 1,250 - 1,450 ) indicate , however , @ GeneSrc $ mutations might result simple loss protein function . found FAP patients germline @ GeneSrc $ mutations within small region ( codons 1,194 - 1,392 ) mainly show allelic loss colorectal adenomas , contrast FAP patients , whose ' second hits ' tend occur truncating mutations mutation cluster region . results indicate different @ GeneSrc $ mutations provide cells different selective advantages , mutations close codon 1,300 providing greatest advantage . Allelic loss selected strongly cells one mutation near codon 1,300 . different germline-somatic @ GeneSrc $ mutation association exists FAP desmoids . @ GeneSrc $ , therefore , classical tumor suppressor . findings also indicate new mechanism disease severity : broader spectrum mutations selected tumors , somatic mutation rate effectively higher tumors grow .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3619450917987196)\n",
      "- Text: \"Binding APC human homolog Drosophila discs large tumor suppressor protein . @ GeneSrc $ gene ( APC ) mutated familial adenomatous polyposis sporadic @ DiseaseTgt $ , product binds adherens junction protein beta-catenin . Overexpression APC blocks cell cycle progression . APC-beta-catenin complex shown bind DLG , human homolog Drosophila discs large tumor suppressor protein . interaction required carboxyl-terminal region APC DLG homology repeat region DLG . APC colocalized DLG lateral cytoplasm rat colon epithelial cells synapse cultured hippocampal neurons . results suggest APC-DLG complex may participate regulation cell cycle progression neuronal function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0030430149139868)\n",
      "- Text: \"Somatic mutations @ GeneSrc $ gene @ DiseaseTgt $ : mutation cluster region @ GeneSrc $ gene . examined somatic mutations @ GeneSrc $ ( @ GeneSrc $ ) gene 63 @ DiseaseTgt $ ( 16 adenomas 47 carcinomas ) developed familial adenomatous polyposis ( FAP ) non-FAP patients . addition loss heterozygosity ( LOH ) @ GeneSrc $ locus 30 tumors , 43 somatic mutations detected . Twenty-one point mutations ; 16 nonsense two missense mutations , three occurred introns splicing site . Twenty-two tumors frameshift mutations due deletion insertion ; nineteen deletions one 31 bp three 1-bp insertion . One tumor 1-bp deletion intron near splicing site . Hence , 41 ( 95 % ) 43 mutations resulted truncation @ GeneSrc $ protein . 60 % somatic mutations @ GeneSrc $ gene clustered within small region exon 15 , designated MCR ( mutation cluster region ) , accounted less 10 % coding region . Combining data results LOH , 80 % tumors ( 14 adenomas 39 carcinomas ) least one mutation @ GeneSrc $ gene , 60 % ( 9 adenomas 23 carcinomas ) two mutations . results strongly suggest somatic mutations @ GeneSrc $ gene associated development great majority @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0445568028502264)\n",
      "- Text: \"Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene . Several investigators reported germline mutations @ GeneSrc $ gene patients familial adenomatous polyposis ( FAP ) well somatic mutations tumors developed digestive organs ( stomach , pancreas , colon , rectum ) . results provide evidence inactivation @ GeneSrc $ gene plays significant role FAP sporadic tumors tissues . @ GeneSrc $ mutations led interesting observations . First , great majority mutations found date would result truncation @ GeneSrc $ product . Second , almost mutations occurred within first half coding sequence , somatic mutations @ DiseaseTgt $ clustered particular region called MCR ( mutation cluster region ) . Third , identified point mutations @ GeneSrc $ gene transitions cytosine nucleotides . Fourth , location germ-line mutations tends correlate number colorectal polyps FAP patients . Furthermore , inactivation alleles @ GeneSrc $ gene seems required early event develop adenomas carcinomas colon rectum well stomach .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3430857559365375)\n",
      "- Text: \"Mutations chromosome 5q21 genes FAP @ DiseaseTgt $ patients . Previous studies suggested one genes chromosome 5q21 responsible inheritance familial adenomatous polyposis ( FAP ) Gardner 's syndrome ( GS ) , contribute tumor development patients noninherited forms @ DiseaseTgt $ . Two genes 5q21 tightly linked FAP ( MCC @ GeneSrc $ ) found somatically altered tumors sporadic @ DiseaseTgt $ patients . One genes ( @ GeneSrc $ ) also found altered point mutation germ line FAP GS patients . data suggest one gene chromosome 5q21 may contribute colorectal neoplasia , mutations @ GeneSrc $ gene cause FAP GS . identification genes aid understanding pathogenesis colorectal neoplasia diagnosis counseling patients inherited predispositions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.107507793942549)\n",
      "- Text: \"Restriction ocular fundus lesions specific subgroup @ GeneSrc $ mutations adenomatous polyposis coli patients . humans , alteration tumor suppressor gene , @ GeneSrc $ , causes adenomatous polyposis coli , condition causing predisposition @ DiseaseTgt $ . syndrome inconsistently associates characteristic patches congenital hypertrophy retinal pigment epithelium ( CHRPE ) . Ocular examination revealed patients expressing CHRPE tend cluster within specific families . exact @ GeneSrc $ mutation identified 42 unrelated patients . cases mutations predicted lead synthesis truncated protein . extent CHRPE found dependent position mutation along coding sequence . CHRPE lesions almost always absent mutation occurs exon 9 , systematically present occurs exon . Thus , range phenotypic expression observed among affected patients may result part different allelic manifestations @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8502263075628238)\n",
      "- Text: \"Somatic mutations @ GeneSrc $ gene sporadic hepatoblastomas . Hepatoblastoma rare hepatic malignancy occurs children average age 2 3 years known one extracolonic manifestations familial adenomatous polyposis . single hepatoblastoma germ-line mutation @ GeneSrc $ ( @ GeneSrc $ ) gene reported thus far . elucidate possible roles @ GeneSrc $ gene alterations sporadic hepatoblastomas , examined loss heterozygosity ( LOH ) @ GeneSrc $ MCC loci performed sequencing analysis part @ GeneSrc $ gene , including mutation cluster region , 13 hepatoblastomas non-familial adenomatous polyposis patients . LOH @ GeneSrc $ and/or MCC loci observed four seven ( 57 % ) informative cases . 13 cases , somatic mutations detected 8 ( 61.5 % ) , 9 ( 69 % ) cases showing genetic alterations @ GeneSrc $ gene LOH somatic mutations . Two cases demonstrated double mutations . Furthermore , nature somatic mutations observed present study unusual 9 10 mutations missense , 1 case featuring frame-shift mutation due insertion . Previous reports described almost ( > 90 % ) mutations @ GeneSrc $ gene @ DiseaseTgt $ result truncated @ GeneSrc $ protein due either frame-shift nonsense mutations . findings suggest mutation @ GeneSrc $ gene may play important role genesis sporadic hepatoblastomas , mechanisms @ GeneSrc $ gene alteration may different reported previously @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2387937881541176)\n",
      "- Text: \"Nuclear cytoplasmic localizations @ GeneSrc $ . Mutation @ GeneSrc $ ( @ GeneSrc $ ) gene early step initiation @ DiseaseTgt $ . distribution pattern protein within cell provide important clues function , used combination immunofluorescence microscopy biochemical fractionation determine location @ GeneSrc $ protein epithelial cells . Immunofluorescence microscopy placed full-length @ GeneSrc $ protein nucleus cytoplasm . nuclear @ GeneSrc $ protein concentrated discrete subnuclear regions , including nucleoli , whereas cytoplasmic @ GeneSrc $ protein concentrated leading edge migrating cells . Colocalization @ GeneSrc $ protein rRNA confirmed nucleolar localization . immunocytochemical findings supported cell fractionation , demonstrated full-length @ GeneSrc $ protein located membrane/cytoskeletal nuclear fractions .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7336766117342459)\n",
      "- Text: \"Genetic anthropology @ DiseaseTgt $ allele @ GeneSrc $ I1307 K : evidence genetic drift within Ashkenazim . @ GeneSrc $ ( @ GeneSrc $ ) I1307 K allele found 6 % Ashkenazi Jewish population 1 % -2 % Sephardi Jews ; confers relative risk 1.5 - 2.0 @ DiseaseTgt $ ( @ DiseaseTgt $ ) carriers . Within Ashkenazim , existence numerous high-prevalence mutations , including I1307 K , sparked controversy whether genetic drift selection underlying cause . present population-based case-control study @ DiseaseTgt $ Israel , tested whether selection operated I1307 K . also estimated age I1307 K allele , understand origin context Jewish diasporas subsequent founder events . genotyped 83 matched pairs , one members pair carried I1307 K , three microsatellites two SNPs . Haplotypes statistically constructed using PHASE software . Single-marker age estimates I1307 K calculated using approach described Risch et al . common progenitor haplotype spanned across @ GeneSrc $ I1307 K centromeric marker D5S135 telomeric marker D5S346 observed individuals Ashkenazi , Sephardi , Arab descent . ancestor modern I1307 K alleles existed 87.9 - 118 generations ago ( approximately 2,200 - 2,950 years ago ) . age estimate indicates I1307 K existed time beginning Jewish diaspora , explaining presence non-Ashkenazi populations . data indicate selection operated I1307 K ( D5S346 , P=.114 ; D5S135 , P=.373 ) , providing compelling evidence high frequency disease-susceptibility alleles Ashkenazim due genetic drift , selection . research underscores importance migratory patterns ancestral populations ethnic geographic distribution @ GeneSrc $ I1307 K .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0911358160138887)\n",
      "- Text: \"@ GeneSrc $ mutations occur early colorectal tumorigenesis . Human tumorigenesis associated accumulation mutations oncogenes tumour suppressor genes . common adult cancer mutations critical early stages tumorigenic process defined . attempted determine mutations @ GeneSrc $ gene play role human @ DiseaseTgt $ , evolve small benign tumours ( adenomas ) larger malignant tumours ( carcinomas ) course several decades . report sequence analysis 41 @ DiseaseTgt $ revealed majority @ DiseaseTgt $ ( 60 % ) adenomas ( 63 % ) contained mutated @ GeneSrc $ gene . Furthermore , @ GeneSrc $ gene met two criteria importance tumour initiation . First , mutations gene found earliest tumours could analysed , including adenomas small 0.5 cm diameter . Second , frequency mutations remained constant tumours progressed benign malignant stages . data provide strong evidence mutations @ GeneSrc $ gene play major role early development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.986164667656923)\n",
      "- Text: \"Missense mutations disease genes : Bayesian approach evaluate causality . problem interpreting missense mutations disease-causing genes increasingly important one . point mutations result alteration single amino acid protein product , often unclear whether change alone sufficient cause disease . propose Bayesian approach utilizes genetic information affected relatives families ascertained known missense-mutation carriers . method useful evaluating known disease genes common disease phenotypes , breast cancer @ DiseaseTgt $ . posterior probability missense mutation disease causing conditioned relationship relatives proband , population frequency mutation , phenocopy rate disease . approach demonstrated two cancer data sets : BRCA1 R841W @ GeneSrc $ I1307 K . examples , method helps establish mutations likely disease causing , Bayes factors favor causality 5.09 66.97 , respectively , posterior probabilities .836 .985 . also develop simple approximation rare alleles consider case unknown penetrance allele frequency .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0148536673560909)\n",
      "- Text: \"I1307 K polymorphism @ GeneSrc $ gene @ DiseaseTgt $ . BACKGROUND & AIMS : @ DiseaseTgt $ one frequent cancers humans . Recently , germline missense mutation , I1307 K , identified @ GeneSrc $ ( @ GeneSrc $ ) gene suggested increase cancer predisposition Ashkenazi Jews . However , second study indicated I1307 K mutation contribute greatly risk @ DiseaseTgt $ Ashkenazi breast-ovarian cancer families , role mismatch repair deficiency suggested . study investigated frequency I1307 K mutation several non-Ashkenazi Jewish populations . also compared distribution frequency @ GeneSrc $ mutations colon tumors positive negative I1307 K mutation . Finally , association presence mutations I1307 K region mismatch repair deficiency studied . METHODS : tested I1307 K 345 patients Ashkenazi Jews using heteroduplex screen . also performed extensive mutational analysis region @ GeneSrc $ gene DNA extracted 240 Italian , Finnish , Hawaiian-Japanese colon tumors determined replication error status . RESULTS : I1307 K mutation found among 345 non-Ashkenazis . Somatic mutations occurred lower frequency randomly distributed I1307 K allele present . common characteristic somatic mutation occurring around codon 1307 I1307K-positive patients occur tumors negative I1307 K mutation . association mutations region around @ GeneSrc $ codon 1307 mismatch repair deficiency found . CONCLUSIONS : findings support hypothesis I1307 K mutation unique Ashkenazi Jews , contributes tumor predisposition @ DiseaseTgt $ , unrelated mismatch repair deficiency .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5715671672927716)\n",
      "- Text: \"Association @ GeneSrc $ gene product beta-catenin . Mutations human @ GeneSrc $ gene linked familial adenomatous polyposis progression sporadic @ DiseaseTgt $ . gain insight @ GeneSrc $ function , @ GeneSrc $ proteins identified immunoprecipitation experiments . Antibodies @ GeneSrc $ precipitated 95-kilodalton protein purified identified sequencing beta-catenin , protein binds cell adhesion molecule E-cadherin . antibody specific beta-catenin also recognized 95-kilodalton protein immunoprecipitates . results suggest @ GeneSrc $ involved cell adhesion .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0779095769782696)\n",
      "- Text: \"Binding GSK3beta APC-beta-catenin complex regulation complex assembly . @ GeneSrc $ gene ( APC ) mutated @ DiseaseTgt $ . APC protein binds cellular adhesion molecule beta-catenin , mammalian homolog ARMADILLO , component WINGLESS signaling pathway Drosophila development . shown beta-catenin present excess , APC binds another component WINGLESS pathway , glycogen synthase kinase 3beta ( GSK3beta ) , mammalian homolog Drosophila ZESTE WHITE 3 . APC good substrate GSK3 beta vitro , phosphorylation sites mapped central region APC . Binding beta-catenin region dependent phosphorylation GSK3 beta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0020898769074983)\n",
      "- Text: \"Familial infiltrative fibromatosis ( desmoid tumours ) ( MIM135290 ) caused recurrent 3 ' @ GeneSrc $ gene mutation . Desmoid tumours generally rare occur 100 times frequently @ DiseaseTgt $ predisposition syndrome familial adenomatous polyposis ( MIM 175100 ) , represented 10 % patients . addition desmoid disease occurring familial adenomatous polyposis ( FAP ) exist familial infiltrative fibromatosis ( MIM 135290 ) kindreds evidence FAP . Previously described kindred familial infiltrative fibromatosis ( FIF ) desmoid tumours associated nonpolyposis colorectal cancer . FAP caused mutations @ GeneSrc $ gene various genotype-phenotype relationships defined including reports @ DiseaseTgt $ less severe mutations 5 ' codon 157 risk desmoid tumours high FAP patients @ GeneSrc $ gene mutations codons 1444 1598 . relatively little information phenotype @ GeneSrc $ gene mutations 3 ' codon 1598 ; however , one large family reported mutation codon 1987 presents highly variable phenotype includes desmoid disease . screened original FIF kindred three families similar phenotype mutations @ GeneSrc $ gene . 4 bp frameshift deletion codon 1962 identified original FIF kindred two apparently unrelated families . Haplotype analysis suggests common origin @ GeneSrc $ mutation three families . Affected individuals evidence congenital hypertrophy retinal pigment epithelium . @ DiseaseTgt $ variable , affected patients either none late onset polyps . findings demonstrate ( ) FAP FIF allelic , ( ii ) @ GeneSrc $ gene mutations truncate @ GeneSrc $ protein distal beta-catenin binding domain associated desmoid tumours , absent CHRPE variable attenuated polyposis expression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6104583926501536)\n",
      "- Text: \"Prevalence I1307 K @ GeneSrc $ gene variant Israeli Jews differing ethnic origin risk @ DiseaseTgt $ . BACKGROUND & AIMS : Israeli Jews European birth , i.e . , Ashkenazim , highest @ DiseaseTgt $ incidence Israeli ethnic group . I1307 K @ GeneSrc $ gene variant found 6.1 % American Jews , 28 % familial @ DiseaseTgt $ cases , non-Jews . assessed I1307 K prevalence Israeli Jews differing ethnic origin risk @ DiseaseTgt $ . METHODS : DNA samples 500 unrelated Jews European non-European origin , without personal and/or family history neoplasia , examined I1307 K variant allele-specific oligonucleotide ( ASO ) method . RESULTS : persons average risk @ DiseaseTgt $ , I1307 K found 5.0 % 120 European 1.6 % 188 non-European Jews ( P = 0.08 ) . occurred 15.4 % 52 Ashkenazi Israelis familial cancer ( P = 0.02 ) detected 51 non-European Jews increased cancer risk . Colorectal neoplasia occurred personally families 13 20 Ashkenazi I1307 K carriers , 8 also personal family history noncolonic neoplasia . CONCLUSIONS : I1307 K @ GeneSrc $ variant may represent susceptibility gene @ DiseaseTgt $ Ashkenazi Jews , partially explains higher incidence @ DiseaseTgt $ European Israelis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0247927553956736)\n",
      "- Text: \"Notable intrafamilial phenotypic variability kindred familial adenomatous polyposis @ GeneSrc $ mutation exon 9 . BACKGROUND : phenotypic spectrum familial adenomatous polyposis ( FAP ) varies classic appearance hundreds adenomatous colonic polyps young adult early onset @ DiseaseTgt $ , occurrence sparse adenomas older adult , `` attenuated `` FAP , due mutations 5 ' 3 ' ends @ GeneSrc $ gene . AIMS : investigate marked intrafamilial phenotypic variation occurring family @ GeneSrc $ gene mutation exon 9 . PATIENTS : extended kindred 22 people 16 colorectal neoplasia and/or @ GeneSrc $ mutation carriers . RESULTS : Phenotypic manifestation varied classic FAP complete lack clinical endoscopic , bioptic disease five people three different generations . occurred four two generations , spite confirmed 11 bp insertion causing frame shift stop codon ( 363 ) exon 9 @ GeneSrc $ gene . CONCLUSIONS : present , assumed family alternative splicing @ GeneSrc $ gene , and/or unidentified modifying genetic factors . family illustrates importance genetic testing evaluating carrier status clinical examination . clinical observation also high- lights dilemma recognising possible contribution low penetrance germline @ GeneSrc $ mutations considered `` sporadic `` colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0117694080419455)\n",
      "- Text: \"@ GeneSrc $ mutations sporadic @ DiseaseTgt $ : mutational `` hotspot `` interdependence `` two hits `` . Although @ GeneSrc $ mutations occur high frequency @ DiseaseTgt $ , studies performed comprehensive analysis screening whole gene mutations assessing allelic loss . @ GeneSrc $ seems act tumor-suppressor gene `` nonclassical `` fashion : data familial adenomatous polyposis ( FAP ) show site germ-line mutation determines type `` second hit `` FAP tumors , simple protein inactivation selected weakly , . study , screened entire coding region @ GeneSrc $ mutations assessed allelic loss set 41 @ DiseaseTgt $ cell lines . 41 cancers , 32 ( 83 % ) showed evidence @ GeneSrc $ mutation and/or allelic loss . identified several @ GeneSrc $ mutations found `` hotspot `` somatic mutation sporadic @ DiseaseTgt $ codon 1,554 . results suggest @ GeneSrc $ mutations occur great majority @ DiseaseTgt $ , exceptions almost RER+ tumors , may substitute altered @ GeneSrc $ function mutations beta-catenin and/or loci . combined previously published data , results show interdependence `` two hits `` @ GeneSrc $ sporadic @ DiseaseTgt $ well FAP . @ GeneSrc $ mutations `` mutation cluster region , `` especially close codon 1,300 , associated allelic loss , whereas tumors mutations outside region tend harbor truncating mutations . causes phenomenon probably selection retained N-terminal lost C-terminal @ GeneSrc $ functions , effects beta-catenin levels , @ GeneSrc $ protein stability .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7318818162344489)\n",
      "- Text: \"Clinical screening implications I1307 K @ GeneSrc $ gene variant Israeli Ashkenazi Jews familial colorectal neoplasia . Evidence founder effect . BACKGROUND : authors previously found I1307 K @ GeneSrc $ ( @ GeneSrc $ ) gene variant 5 % Ashkenazi control participants , 15.4 % familial colorectal neoplasia , also 1.6 % non-Ashkenazi control participants . study , evaluated use screening program familial colorectal neoplasia examined founder effect . METHODS : Consecutive Ashkenazim personal and/or family history colorectal neoplasia DNA test . Markers flanking @ GeneSrc $ gene examined Ashkenazi non-Ashkenazi I1307 K carriers noncarriers . RESULTS : Among 718 persons , I1307 K occurred 6.2 % Ashkenazi participants , 1.5 % non-Ashkenazi control participants ( P = 0.02 ) , 10.7 % Ashkenazim familial neoplasia ( relative risk , 1.73 [ significant compared controls ] ; 95 % confidence interval , 0.7 - 3.2 ) . Colorectal neoplasia detected carriers younger age ( P < 0.05 ) without excess risk multiple colorectal neoplasia noncolorectal neoplasia . I1307 K attributable risk colorectal neoplasia 0.5 - 0.6 % . Compared noncarriers , Ashkenazi non-Ashkenazi I1307 K carriers similar flanking polymorphic alleles ( P < 0.01 ) . CONCLUSIONS : I1307 K low-penetrance genetic variant indicates 1.7 relative risk neoplasia carriers familial carcinoma , clinically equivalent obtaining family history sporadic colorectal neoplasia promoting early screening . I1307 K founder genetic variant Jews different ethnic origin , mainly Ashkenazim , explains partially higher incidence @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013901354818152)\n",
      "- Text: \"@ GeneSrc $ gene product normal tumor cells . @ GeneSrc $ gene found mutated development sporadic @ DiseaseTgt $ well germ line familial adenomatous polyposis patients . facilitate characterization normal mutant @ GeneSrc $ protein , series monoclonal polyclonal antibodies specific @ GeneSrc $ protein produced . lymphoblastoid cell lines derived seven familial adenomatous polyposis patients known mutations analyzed Western blot , approximately 300-kDa protein corresponding predicted size full-length @ GeneSrc $ detected 7 cell lines . addition , truncated @ GeneSrc $ proteins corresponding product known mutated alleles could detected 4 7 lines . Similar analysis 23 colon carcinoma 9 adenoma cell lines revealed truncated proteins 24 ( 75 % ) cell lines . Moreover , 26 ( 81 % ) colon tumor lines totally devoid normal , full-length protein . contrast , Western blot analysis 40 cell lines derived sporadic tumors organs detected full-length @ GeneSrc $ . Immunohistochemical analysis @ GeneSrc $ normal colonic mucosa revealed cytoplasmic staining intense staining basolateral margins epithelial cell . staining markedly increased upper portions crypts , suggesting increased level expression maturation . studies provide initial clues function cytoplasmic protein @ GeneSrc $ demonstrate feasibility identifying @ GeneSrc $ mutations direct analysis @ GeneSrc $ protein .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7030669597330453)\n",
      "- Text: \"Genotype-phenotype correlations attenuated adenomatous polyposis coli . Germ-line mutations tumor suppressor @ GeneSrc $ implicated attenuated adenomatous polyposis coli ( AAPC ) , variant familial adenomatous polyposis ( FAP ) . AAPC recognized occurrence < 100 colonic adenomas later onset @ DiseaseTgt $ ( age > 40 years ) . aim study assess genotype-phenotype correlations AAPC families . protein-truncation test ( PTT ) assay , entire coding region @ GeneSrc $ gene screened affected individuals 11 AAPC kindreds , phenotypic differences examined . Five novel germ-line @ GeneSrc $ mutations identified seven kindreds . Mutations located three different regions @ GeneSrc $ gene : ( 1 ) 5 ' end spanning exons 4 5 , ( 2 ) within exon 9 , ( 3 ) 3 ' distal end gene . Variability number colorectal adenomas apparent individuals mutations region 1 , upper-gastrointestinal manifestations severe . individuals mutations either region 2 region 3 , average number adenomas tended lower individuals mutations region 1 , although age diagnosis similar . AAPC kindreds , predominance right-sided colorectal adenomas rectal polyp sparing observed . desmoid tumors found kindreds . data suggest , AAPC families , location @ GeneSrc $ mutation may partially predict specific phenotypic expression . help design tailored clinical-management protocols subset FAP patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1666163225849462)\n",
      "- Text: \"identical 5 ' splice-site acceptor mutation five attenuated APC families Newfoundland demonstrates founder effect . Inherited mutations @ GeneSrc $ gene predispose carriers multiple adenomatous polyps colon rectum @ DiseaseTgt $ . Mutations located extreme 5 ' end @ GeneSrc $ gene , however , associated less severe disease known attenuated adenomatous polyposis coli ( AAPC ) . Many individuals AAPC develop relatively colorectal polyps still high risk @ DiseaseTgt $ . report identification 5 ' @ GeneSrc $ germline mutation five separately ascertained AAPC families Newfoundland , Canada . disease-causing mutation single basepair change ( G ) splice-acceptor region @ GeneSrc $ intron 3 creates mutant RNA without exon 4 @ GeneSrc $ . observation @ GeneSrc $ mutation five families geographic area demonstrates founder effect . Furthermore , identification germline mutation strengthens correlation 5 ' location @ GeneSrc $ disease-causing mutation attenuated polyposis phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0021000436978121)\n",
      "- Text: \"Carrier rate @ GeneSrc $ I1307 K increased inflammatory bowel disease patients Ashkenazi Jewish origin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) occurs increased incidence individuals chronic inflammatory bowel disease ( IBD ) colon . Recent data suggest family history @ DiseaseTgt $ independent risk factor @ DiseaseTgt $ IBD , observation implies genetic factors relevant development @ DiseaseTgt $ context . Among genetic defects associated @ DiseaseTgt $ , @ GeneSrc $ I1307 K mutation detected nearly exclusively individuals Ashkenazi Jewish ( AJ ) origin , occurring 6 % -7 % AJ general population 10 % -28 % AJ either personal family history @ DiseaseTgt $ adenomatous polyps . findings , together increased incidence IBD AJ , prompted current analysis contribution @ GeneSrc $ I1307 K variant @ DiseaseTgt $ AJ IBD patients . @ GeneSrc $ I1307 K carrier frequencies determined 306 AJ individuals affected IBD 308 unaffected relatives ascertained family collection obtained identification IBD susceptibility genes . Prevalence I1307 K variant significantly different among individuals IBD , Crohn 's disease , ulcerative colitis , unaffected relatives ( 6.9 % , 7.6 % , 4.7 % , 6.2 % , respectively ) , mutation detected one five IBD-affected individuals diagnosis @ DiseaseTgt $ . results reveal IBD patients AJ origin carry @ GeneSrc $ I1307 K variant rate individuals within general AJ population . Lack increased @ GeneSrc $ I1307 K carrier rate suggests mutation account increased @ DiseaseTgt $ susceptibility associated IBD .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4611431800757372)\n",
      "- Text: \"Whole-gene @ GeneSrc $ deletions cause classical familial adenomatous polyposis , attenuated polyposis `` multiple `` colorectal adenomas . Familial adenomatous polyposis ( FAP ) dominantly inherited @ DiseaseTgt $ predisposition results germ-line mutations @ GeneSrc $ gene ( chromosome 5q21 ) . FAP shows substantial phenotypic variability : classical polyposis patients develop 100 colorectal adenomas , whereas attenuated polyposis ( AAPC ) fewer 100 adenomas . group individuals , so-called `` multiple `` adenoma patients , phenotype like AAPC , 3 - 99 polyps throughout colorectum , mostly demonstrable germ-line @ GeneSrc $ mutation . Routine mutation detection techniques fail detect pathogenic @ GeneSrc $ germ-line mutation approximately 30 % patients classical polyposis 90 % AAPC/multiple adenomas . developed real-time quantitative multiplex PCR assay detect @ GeneSrc $ exon 14 deletions . technique applied set 60 classical polyposis 143 AAPC/multiple adenoma patients apparent @ GeneSrc $ germ-line mutation , deletions found exclusively individuals classical polyposis ( 7 60 , 12 % ) . Fine-mapping region suggested majority ( 6 7 ) deletions encompassed entire @ GeneSrc $ locus , confirming haploinsufficiency result classical polyposis phenotype . Screening germ-line deletions @ GeneSrc $ mutation-negative individuals classical polyposis seems warranted .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3828227425040924)\n",
      "- Text: \"Association APC tumor suppressor protein catenins . Mutations @ GeneSrc $ appear initiate sporadic inherited forms human @ DiseaseTgt $ . Although mutations well characterized , little known function @ GeneSrc $ gene product . Two cellular proteins associate @ GeneSrc $ identified nucleotide sequence analysis peptide mapping E-cadherin-associated proteins alpha- beta-catenin . 27-residue fragment @ GeneSrc $ containing 15-amino acid repeat sufficient interaction catenins . results suggest important link tumor initiation cell adhesion .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9505852030184918)\n",
      "- Text: \"Different familial adenomatous polyposis phenotypes resulting deletions entire @ GeneSrc $ exon 15 . Germline mutations @ GeneSrc $ ( @ GeneSrc $ ) gene cause familial adenomatous polyposis ( FAP ) , autosomal , dominantly inherited disease predisposes patients @ DiseaseTgt $ . @ GeneSrc $ gene composed 15 coding exons encodes open reading frame 8.5 kb . 3 ' 6.5 kb APCopen reading frame encoded single exon , exon 15 . identified @ GeneSrc $ mutations 5 ' half @ GeneSrc $ open reading frame nucleotide substitutions small deletions insertions result truncation @ GeneSrc $ protein . well-characterized gross alterations @ GeneSrc $ reported . Patients FAP typically develop hundreds thousands @ DiseaseTgt $ beginning adolescence . subgroup patients FAP develop fewer tumors older age called attenuated FAP ( AFAP ) . Accumulating evidence indicates patients carrying germline @ GeneSrc $ mutations first four coding exons , alternatively spliced region exon 9 , 3 ' half coding region usually develop AFAP . characterized two germline @ GeneSrc $ alterations deleted entire @ GeneSrc $ exon 15 result 56-kb 73-kb deletions @ GeneSrc $ locus . surprising finding one proband typical FAP phenotype , whereas phenotype consistent AFAP .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9169169215442498)\n",
      "- Text: \"Genotype-phenotype correlation position constitutional @ GeneSrc $ gene mutation CHRPE expression familial adenomatous polyposis . Mutations @ GeneSrc $ ( @ GeneSrc $ ) gene responsible disease familial adenomatous polyposis ( FAP ) , dominantly inherited predisposition @ DiseaseTgt $ . common extra-colonic manifestation congenital hypertrophy retinal pigment epithelium ( CHRPE ) , expressed 90 % FAP kindreds . Chain-terminating @ GeneSrc $ mutations characterised 26 unrelated FAP patients . Results show CHRPE expression determined length truncated protein product . CHRPE therefore first extracolonic manifestation FAP shown control @ GeneSrc $ mutation site facilitate detection constitutional @ GeneSrc $ mutations FAP kindreds .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0682519315580236)\n",
      "- Text: \"Germline mutations 3 ' part @ GeneSrc $ exon 15 result truncated proteins associated attenuated adenomatous polyposis coli . Familial adenomatous polyposis ( FAP ) inherited predisposition @ DiseaseTgt $ characterized development numerous adenomatous polyps predominantly colorectal region . Germline mutations @ GeneSrc $ ( @ GeneSrc $ ) gene responsible cases FAP . Mutations 5 ' end @ GeneSrc $ known associated relatively mild form disease , called attenuated adenomatous polyposis coli ( AAPC ) . identified frameshift mutation 3 ' part exon 15 , resulting stop codon 1862 , large Dutch kindred AAPC . Western blot analysis lymphoblastoid cell lines derived affected family members kindred , well previously reported Swiss family carrying frameshift mutation codon 1987 displaying similar attenuated phenotype , showed wild-type @ GeneSrc $ protein . study indicates chain-terminating mutations located 3 ' part @ GeneSrc $ result detectable truncated polypeptides hypothesize likely basis observed AAPC phenotype .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6589740550563123)\n",
      "- Text: \"Molecular analysis @ GeneSrc $ gene 105 Dutch kindreds familial adenomatous polyposis : 67 germline mutations identified DGGE , PTT , southern analysis . Germline mutations @ GeneSrc $ ( @ GeneSrc $ ) gene responsible familial adenomatous polyposis ( FAP ) , autosomal dominant predisposition @ DiseaseTgt $ . screened entire coding region @ GeneSrc $ gene mutations unselected series 105 Dutch FAP kindreds . analysis exons 1 - 14 , employed GC-clamped denaturing gradient gel electrophoresis ( DGGE ) , large exon 15 examined using protein truncation test . Using approach , identified 65 pathogenic mutations 105 apparently unrelated FAP families . mutations predominantly either frameshifts ( 39/65 ) single base substitutions ( 18/65 ) , resulting premature stop codons . Mutations would predict abnormal RNA splicing identified seven cases . one families , nonconservative amino acid change found segregate disease . spite large number @ GeneSrc $ mutations reported date , identified 27 novel germline mutations patients , reiterates great heterogeneity mutation spectrum FAP . addition point mutations identified patients , structural rearrangements @ GeneSrc $ found two pedigrees , Southern blot analysis . present study indicates combined use DGGE , protein truncation test , Southern blot analysis offers efficient strategy presymptomatic diagnosis FAP direct mutation detection . found combined use currently available molecular approaches still fails identify underlying genetic defect significant subset FAP families . possible causes limitation discussed .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2165973333019859)\n",
      "- Text: \"Evidence novel exon coding region @ GeneSrc $ ( @ GeneSrc $ ) gene . Germline mutations tumor suppressor gene @ GeneSrc $ cause familial adenomatous polyposis . Somatic @ GeneSrc $ alterations involved several sporadic neoplasms , including @ DiseaseTgt $ . @ GeneSrc $ mRNA encoded 15 exons . Additional transcripts reported , due alternative splicing coding well noncoding regions . Two mRNA isoforms occur due deletion exon 7 partial deletion exon 9 . identified novel exon , flanked @ GeneSrc $ exons 10 11 , expressed alternatively transcribed product gene . , shown novel exon consists heptad repeat motif conserved across species .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0388398173172293)\n",
      "- Text: \"Human @ GeneSrc $ gene expression rodent colonic epithelium vivo using liposomal gene delivery . Mutations loss APC tumor-suppressor gene important development @ DiseaseTgt $ , little known function gene normal tissue . study role @ GeneSrc $ genes colonocytes vivo , system developed whereby transient expression genes established normal rodent colonic epithelium , using liposomal gene delivery rectal catheter infusion . Expression beta-galactosidase reporter gene human @ GeneSrc $ gene constitutive promoter demonstrated . high efficiency transfection maintained , close 100 % epithelial cells expressing introduced gene . Expression transient persist beyond 4 days , consistent normal turnover time gut epithelium , maintained repeated treatments . Human @ GeneSrc $ expressed three weeks conditions approximately one-tenth level endogenous @ GeneSrc $ gene , toxicity observed beyond attributed repeated rectal enemas . results reveal vivo expression exogenous gene feasible using liposomal delivery system suggest method study physiologic role @ GeneSrc $ genes interrelated process colonic epithelial proliferation differentiation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004300039938131)\n",
      "- Text: \"APCI1307 K allele cancer risk community-based study Ashkenazi Jews . Mutations @ GeneSrc $ classically associated familial adenomatous polyposis ( FAP ) , highly penetrant autosomal dominant disorder characterized multiple intestinal polyps , without surgical intervention , development @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ tumour-suppressor gene , somatic loss occurs tumours . germline T-to-A transversion responsible @ GeneSrc $ I1307 K allele converts wild-type sequence homopolymer tract ( A8 ) genetically unstable prone somatic mutation . I1307 K allele found 6.1 % unselected Ashkenazi Jews higher proportions Ashkenazim family personal histories @ DiseaseTgt $ ( ref . 2 ) . evaluate role I1307 K cancer , genotyped 5,081 Ashkenazi volunteers community survey . Risk developing colorectal , breast cancers compared genotyped I1307 K carriers non-carriers first-degree relatives .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0140677431585054)\n",
      "- Text: \"I1307 K @ GeneSrc $ hMLH1 mutations non-Jewish family @ DiseaseTgt $ . describe French Canadian @ DiseaseTgt $ ( @ DiseaseTgt $ ) kindred carries novel truncating mutation hMLH1 . Interestingly , I1307 K @ GeneSrc $ polymorphism , associated increased risk @ DiseaseTgt $ , also present family . I1307 K polymorphism previously identified individuals self-reported Ashkenazi Jewish origins . addition , family , appears relationship I1307 K polymorphism presence absence cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0353281147056145)\n",
      "- Text: \"@ GeneSrc $ ( @ GeneSrc $ ) differentially regulates beta-catenin phosphorylation ubiquitination @ DiseaseTgt $ cells . @ DiseaseTgt $ mutations @ GeneSrc $ ( @ GeneSrc $ ) gene beta-catenin gene stabilize beta-catenin activate beta-catenin target genes , leading ultimately cancer . molecular mechanisms @ GeneSrc $ function beta-catenin degradation completely known . @ GeneSrc $ binds beta-catenin involved Axin complex , suggesting @ GeneSrc $ regulates beta-catenin phosphorylation . evidence also suggests @ GeneSrc $ regulates beta-catenin nuclear export . , examine effects @ GeneSrc $ mutations beta-catenin phosphorylation , ubiquitination , degradation @ DiseaseTgt $ cell lines SW480 , DLD-1 , HT29 , contains different @ GeneSrc $ truncation . Although current models suggest beta-catenin phosphorylation inhibited @ GeneSrc $ mutations , detected significant beta-catenin phosphorylation cells . However , beta-catenin ubiquitination degradation inhibited SW480 DLD-1 HT29 cells . ubiquitination ofbeta-catenin SW480 cells rescued exogenous expression @ GeneSrc $ . @ GeneSrc $ domains required beta-catenin ubiquitination analyzed . results suggest @ GeneSrc $ regulates beta-catenin phosphorylation ubiquitination distinct domains separate molecular mechanisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.469555942259128)\n",
      "- Text: \"Chemoprevention @ DiseaseTgt $ targeting @ GeneSrc $ cells apoptosis . Cancer chemoprevention uses natural , synthetic , biological substances reverse , suppress , prevent either initial phase carcinogenesis progression neoplastic cells cancer . holds promise overcoming problems associated treatment late-stage cancers . However , broad application chemoprevention compromised present limited effectiveness potential toxicity . overcome challenges , developed new chemoprevention approach specifically targets premalignant tumour cells apoptosis . show deficiency @ GeneSrc $ ( @ GeneSrc $ ) gene subsequent activation beta-catenin lead repression cellular caspase-8 inhibitor c-FLIP ( also known CFLAR ) expression activation c-Myc , all-trans-retinyl acetate ( RAc ) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand ( TRAIL ) death receptors suppresses decoy receptors . Thus , combination TRAIL RAc induces apoptosis @ GeneSrc $ premalignant cells without affecting normal cells vitro . addition , show short-term non-continuous TRAIL RAc treatment induce apoptosis specifically intestinal polyps , strongly inhibit tumour growth , prolong survival multiple intestinal neoplasms C57BL/6J-Apc ( Min ) /J ( Apc ( Min ) ) mice . approach , demonstrate TRAIL RAc induce significant cell death human colon polyps , providing potentially selective approach @ DiseaseTgt $ chemoprevention targeting @ GeneSrc $ cells apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0904387912458896)\n",
      "- Text: \"Vitamin C selectively kills KRAS BRAF mutant @ DiseaseTgt $ cells targeting GAPDH . half human @ DiseaseTgt $ ( @ DiseaseTgt $ ) carry either KRAS BRAF mutations often refractory approved targeted therapies . found cultured human @ DiseaseTgt $ cells harboring KRAS BRAF mutations selectively killed exposed high levels vitamin C. effect due increased uptake oxidized form vitamin C , dehydroascorbate ( DHA ) , via GLUT1 glucose transporter . Increased DHA uptake causes oxidative stress intracellular DHA reduced vitamin C , depleting glutathione . Thus , reactive oxygen species accumulate inactivate glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) . Inhibition GAPDH highly glycolytic KRAS BRAF mutant cells leads energetic crisis cell death seen KRAS BRAF wild-type cells . High-dose vitamin C impairs tumor growth @ GeneSrc $ ) mutant mice . results provide mechanistic rationale exploring therapeutic use vitamin C @ DiseaseTgt $ KRAS BRAF mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0362066396642289)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human colon cancers . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered colon cancers retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer @ DiseaseTgt $ . accumulation beta-catenin activates genes responsive transcription factors TCF/LEF family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein @ GeneSrc $ activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF colon-cancer cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.663281593275015e-05)\n",
      "- Text: \"Germline mutations @ GeneSrc $ proto-oncogene cause Costello syndrome . Costello syndrome multiple congenital anomaly mental retardation syndrome characterized coarse face , loose skin , cardiomyopathy predisposition @ DiseaseTgt $ . identified four heterozygous de novo mutations @ GeneSrc $ 12 13 affected individuals , previously reported somatic oncogenic mutations various @ DiseaseTgt $ . observations suggest germline mutations @ GeneSrc $ perturb human development increase susceptibility @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1409684254394176)\n",
      "- Text: \"evidence genetic heterogeneity Costello syndrome : involvement KRAS gene . Costello syndrome autosomal dominant disorder comprising growth deficiency , mental retardation , curly hair , coarse facial features , nasal papillomata , low-set ears large lobes , cardiac anomalies , redundant skin palms soles prominent creases , dark skin , propensity certain solid @ DiseaseTgt $ . @ GeneSrc $ mutations implicated approximately 85 % affected cases . clinical overlap among Costello , Noonan , cardiofaciocutaneous syndromes better understood given common molecular background , syndromes constitute class disorders caused deregulated RAS-MAPK signaling . report novel KRAS gene mutation patient presenting clinical features typical Costello syndrome additional findings seen Noonan syndrome . description emphasizes subset patients Costello syndrome could harbor mutations genes involved RAS-MAPK signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1120856740667396)\n",
      "- Text: \"Keratinocytic epidermal nevi associated mosaic RAS mutations . BACKGROUND : Activating RAS mutations germline cause rare developmental disorders Costello syndrome . Somatic RAS mutations found approximately 30 % human @ DiseaseTgt $ . Keratinocytic epidermal nevi ( KEN ) represent benign congenital skin lesions arranged along Blaschko 's lines . subgroup KEN caused hotspot oncogenic FGFR3 PIK3CA mutations mosaicism , majority lack mutations . METHODS : study screened 72 KEN activating mutations RAS genes oncogenes . RESULTS : Activating RAS mutations identified 28/72 ( 39 % ) KEN . @ GeneSrc $ commonly affected oncogene ( 86 % ) , @ GeneSrc $ p. G13R substitution representing new hotspot mutation . CONCLUSION : results indicate activating RAS somatic mutations leading mosaicism result benign KEN skin . Given prevalence KEN , mosaic @ GeneSrc $ mutations appear common patients germline ones . findings identify KEN mosaic RASopathy lend support notion genetic mosaicism important contributor disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0088130334005029)\n",
      "- Text: \"Somatic activation K-ras oncogene causes early onset lung cancer mice . 30 % human @ DiseaseTgt $ carry ras gene mutations . three genes family ( composed K-ras , N-ras @ GeneSrc $ ) , K-ras frequently mutated member human @ DiseaseTgt $ , including adenocarcinomas pancreas ( approximately 70 - 90 % incidence ) , colon ( approximately 50 % ) lung ( approximately 25 - 50 % ) . construct mouse @ DiseaseTgt $ models involving K-ras , used new gene targeting procedure create mouse strains carrying oncogenic alleles K-ras activated spontaneous recombination event whole animal . show mice carrying mutations highly predisposed range @ DiseaseTgt $ types , predominantly early onset lung cancer . model characterized examining effects germline mutations @ DiseaseTgt $ suppressor gene p53 , known mutated along K-ras human @ DiseaseTgt $ . approach several advantages traditional transgenic strategies , including closely recapitulates spontaneous oncogene activation seen human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8729005191050224)\n",
      "- Text: \"Mutational activation K-ras oncogene . possible pathogenetic factor adenocarcinoma lung . define role cellular oncogenes human @ DiseaseTgt $ , studied prevalence mutational activation ras oncogenes untreated non-small-cell lung cancer . Genomic DNA extracted 39 @ DiseaseTgt $ specimens obtained thoracotomy examined activating point mutations codons 12 , 13 , 61 @ GeneSrc $ , K-ras , N-ras genes . novel , highly sensitive assay based oligonucleotide hybridization following vitro amplification step employed . K-ras gene found activated point mutations codon 12 5 10 adenocarcinomas . Two @ DiseaseTgt $ less 2 cm size metastasized . ras gene mutations observed 15 squamous-cell carcinomas , 10 large-cell carcinomas , 1 carcinoid , 2 metastatic adenocarcinomas primary @ DiseaseTgt $ outside lung , 1 small-cell carcinoma . approximately 20-fold amplification unmutated K-ras gene observed @ DiseaseTgt $ proved solitary lung metastasis rectal carcinoma . conclude mutational K-ras activation may important early event pathogenesis adenocarcinoma lung amplification ras genes mutational activation @ GeneSrc $ N-ras play major part non-small-cell lung cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1730658463338635)\n",
      "- Text: \"KRAS codon 12 mutations occur frequently pancreatic adenocarcinomas . DNAs human pancreatic adenocarcinomas analyzed presence mutations codons 12 , 13 61 NRAS , KRAS @ GeneSrc $ gene . Formalin-fixed paraffin-embedded tissue used directly vitro amplification reaction expand relevant RAS sequences . mutations detected selective hybridization using mutation-specific synthetic oligonucleotides . 28 30 patients found mutation codon 12 KRAS gene . result confirms findings Almoguera et al . [ Cell 53 ( 1988 ) 549 - 554 ] KRAS mutations occur frequently adenocarcinomas exocrine pancreas . mutations predominantly G-T transversions , contrast KRAS mutations colon tumors mainly G-A transitions . Furthermore , portion @ DiseaseTgt $ mutation appears homozygous .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1319789468906395)\n",
      "- Text: \"Specific pattern RAS oncogene mutations follicular thyroid tumors . prevalence @ GeneSrc $ , K-RAS , N-RAS gene mutations thyroid tumors according @ DiseaseTgt $ histology controversial . Differences methodology histological classifications may explain discrepant results . address issue , first performed pooled analysis 269 mutations garnered 39 previous studies . Mutations proved significantly less frequent detected direct sequencing without ( 12.3 % vs. 17 % ) . rate mutation involving N-RAS exon 1 ( N1 ) K-RAS exon 2 ( K2 ) less 1 % . Mutations codon 61 N-RAS ( N2 ) significantly frequent @ DiseaseTgt $ ( 19 % ) papillary cancers ( 5 % ) significantly frequent malignant ( 25 % ) @ DiseaseTgt $ ( 14 % ) @ DiseaseTgt $ . @ GeneSrc $ mutations codons 12/13 ( H1 ) found 2 - 3 % types @ DiseaseTgt $ , @ GeneSrc $ mutations codon 61 ( H2 ) observed 1.4 % @ DiseaseTgt $ , almost malignant . K-RAS mutations exon 1 found often papillary follicular cancers ( 2.7 % vs. 1.6 % ) sometimes correlated special epidemiological circumstances . second part study involved analysis 80 @ DiseaseTgt $ patients living Marseille ( France ) Kiev ( Ukraine ) . used direct sequencing PCR amplification exons 1 2 three RAS genes . Common atypical adenomas separated using strict cytological criteria . Mutations H1-RAS found 12.5 % common adenomas one follicular carcinoma ( 2.9 % ) . Mutations N2-RAS occurred 23.3 % 17.6 % atypical adenomas follicular carcinomas , respectively . results confirm predominance N2-RAS mutations thyroid follicular tumors correlation @ DiseaseTgt $ . support implication N2-RAS mutations malignant progression thyroid follicular tumors assumption atypical adenomas precursors follicular carcinomas .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4367000858327007)\n",
      "- Text: \"Kras regulatory elements exon 4A determine mutation specificity lung cancer . Kras frequently mutated ras family member lung carcinomas , whereas @ GeneSrc $ mutations common @ DiseaseTgt $ stratified epithelia skin . Using Hras knock-in mouse model , demonstrate specificity Kras mutations lung @ GeneSrc $ mutations skin tumors determined local regulatory elements target ras genes . Although Kras 4A isoform dispensable mouse development , important isoform lung carcinogenesis vivo inhibitory effect wild-type ( WT ) Kras mutant allele . Kras 4A expression detected subpopulation normal lung epithelial cells , low levels lung tumors , suggesting may required @ DiseaseTgt $ progression . two Kras isoforms undergo different post-translational modifications ; therefore , findings implications design therapeutic strategies inhibiting oncogenic Kras activity human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2039573827084245)\n",
      "- Text: \"Restoration p53 function leads @ DiseaseTgt $ regression vivo . Tumorigenesis multi-step process requires activation oncogenes inactivation @ DiseaseTgt $ suppressor genes . Mouse models human @ DiseaseTgt $ recently demonstrated continuous expression dominantly acting oncogene ( example , @ GeneSrc $ , Kras Myc ) often required @ DiseaseTgt $ maintenance ; phenotype referred oncogene addiction . concept received clinical validation development active anticancer drugs specifically inhibit function oncoproteins BCR-ABL , c-KIT EGFR . Identifying additional gene mutations required @ DiseaseTgt $ maintenance may therefore yield clinically useful targets new @ DiseaseTgt $ therapies . Although loss p53 function common feature human @ DiseaseTgt $ , known whether sustained inactivation @ DiseaseTgt $ suppressor pathways required @ DiseaseTgt $ maintenance . explore issue , developed Cre-loxP-based strategy temporally control @ DiseaseTgt $ suppressor gene expression vivo . show restoring endogenous p53 expression leads regression autochthonous lymphomas sarcomas mice without affecting normal tissues . mechanism responsible @ DiseaseTgt $ regression dependent @ DiseaseTgt $ type , main consequence p53 restoration apoptosis lymphomas suppression cell growth features cellular senescence sarcomas . results support efforts treat human @ DiseaseTgt $ way pharmacological reactivation p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9879684070793244)\n",
      "- Text: \"Beta-catenin regulates expression cyclin D1 colon carcinoma cells . Mutations adenomatous polyposis coli ( APC ) tumour-suppressor gene occur human @ DiseaseTgt $ . Loss functional APC protein results accumulation beta-catenin . Mutant forms beta-catenin discovered @ DiseaseTgt $ retain wild-type APC genes , also melanomas , medulloblastomas , prostate cancer gastric hepatocellular carcinomas . accumulation beta-catenin activates genes responsive transcription factors TCF/LEF family , beta-catenin interacts . show beta-catenin activates transcription cyclin D1 promoter , sequences within promoter related consensus TCF/LEF-binding sites necessary activation . oncoprotein @ GeneSrc $ activates transcription cyclin D1 gene , sites within promoter bind transcriptional regulators Ets CREB . Cells expressing mutant beta-catenin produce high levels cyclin D1 messenger RNA protein constitutively . Furthermore , expression dominant-negative form TCF @ DiseaseTgt $ cells strongly inhibits expression cyclin D1 without affecting expression cyclin D2 , cyclin E , cyclin-dependent kinases 2 , 4 6 . dominant-negative TCF causes cells arrest G1 phase cell cycle ; phenotype rescued expression cyclin D1 cytomegalovirus promoter . Abnormal levels beta-catenin may therefore contribute neoplastic transformation causing accumulation cyclin D1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0208644492583358)\n",
      "- Text: \"RAB32 Ser71Arg autosomal dominant @ DiseaseTgt $ : linkage , association , functional analyses . BACKGROUND : @ DiseaseTgt $ progressive neurodegenerative disorder multifactorial causes , among genetic risk factors play part . @ GeneSrc $ GTPases regulators substrates LRRK2 , variants LRRK2 gene important risk factors @ DiseaseTgt $ . aimed explore genetic variability @ GeneSrc $ GTPases within cases familial @ DiseaseTgt $ . METHODS : whole-exome sequencing probands families Canada Tunisia @ DiseaseTgt $ without genetic cause , recruited Centre Applied Neurogenetics ( Vancouver , BC , Canada ) , international consortium includes people @ DiseaseTgt $ 36 sites 24 countries . 61 @ GeneSrc $ GTPases genetically screened , candidate variants genotyped relatives probands assess disease segregation linkage analysis . Genotyping also done assess variant frequencies individuals @ DiseaseTgt $ controls , matched age sex , also Centre Applied Neurogenetics unrelated probands . participants aged 18 years older . sequencing genotyping findings validated case-control association analyses using bioinformatic data obtained publicly available clinicogenomic databases ( AMP-PD , GP2 , 100 000 Genomes Project ) private German clinical diagnostic database ( University Tubingen ) . Clinical pathological findings summarised haplotypes determined . In-vitro studies done investigate protein interactions enzyme activities . FINDINGS : June 1 , 2010 , May 31 , 2017 , 130 probands Canada Tunisia ( 47 [ 36 % ] female 83 [ 64 % ] male ; mean age 72 7 years [ SD 11 7 ; range 38 - 96 ] ; 109 White European ancestry , 18 north African , two east Asian , one Hispanic ] underwent whole-exome sequencing . 15 variants @ GeneSrc $ GTPase genes identified , RAB32 variant c.213C > G ( Ser71Arg ) cosegregated autosomal dominant @ DiseaseTgt $ three families ( nine affected individuals ; non-parametric linkage Z score=1 95 ; p=0 03 ) . 2604 unrelated individuals @ DiseaseTgt $ 344 matched controls additionally genotyped , five people originating five countries ( Canada , Italy , Poland , Turkey , Tunisia ) identified RAB32 variant . database searches , 6043 individuals @ DiseaseTgt $ 62 549 controls included , another eight individuals identified RAB32 variant four countries ( Canada , Germany , UK , USA ) . Overall , association RAB32 c.213C > G ( Ser71Arg ) @ DiseaseTgt $ significant ( odds ratio [ ] 13 17 , 95 % CI 2 15 - 87 23 ; p=0 0055 ; I2=99 96 % ) . people variant , @ DiseaseTgt $ presented age 54 6 years ( SD 12 75 , range 31 - 81 , n=16 ) , two-thirds family history parkinsonism . RAB32 Ser71Arg heterozygotes shared common haplotype , although penetrance incomplete . Findings one individual autopsy showed sparse neurofibrillary tangle pathology midbrain thalamus , without Lewy body pathology . functional studies , RAB32 Arg71 activated LRRK2 kinase level greater RAB32 Ser71 . INTERPRETATION : RAB32 Ser71Arg novel genetic risk factor @ DiseaseTgt $ , reduced penetrance . variant found individuals @ DiseaseTgt $ multiple ethnic groups , haplotype . In-vitro assays show RAB32 Arg71 activates LRRK2 kinase , indicates genetically distinct causes familial parkinsonism share mechanism . discovery RAB32 Ser71Arg also suggests several genetically inherited causes @ DiseaseTgt $ originated control intracellular immunity . shared aetiology considered future translational research , global epidemiology RAB32 Ser71Arg needs assessed inform genetic counselling . FUNDING : National Institutes Health , Canada Excellence Research Chairs program , Aligning Science Across @ DiseaseTgt $ , Michael J Fox Foundation @ DiseaseTgt $ Research , UK Medical Research Council .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4167080403460884)\n",
      "- Text: \"Promoter mutations increase amyloid precursor-protein expression associated @ DiseaseTgt $ . Genetic variations promoter sequences alter gene expression play prominent role increasing susceptibility complex diseases . Also , expression levels APP essentially regulated core promoter 5 ' upstream regulatory region correlate amyloid beta levels @ DiseaseTgt $ ( @ DiseaseTgt $ ) brains . , systematically sequenced proximal promoter ( -766/+204 ) two functional distal regions ( -2634/-2159 -2096/-1563 ) APP two independent @ DiseaseTgt $ series onset ages < = 70 years ( Belgian sample , n=180 ; Dutch sample , n=111 ) identified eight novel sequence variants . Three mutations ( -118C -- > , -369C -- > G , -534G -- > ) identified patients @ DiseaseTgt $ showed , vitro , nearly twofold neuron-specific increase APP transcriptional activity , similar expected triplication APP syndrome . mutations either abolished ( AP-2 @ GeneSrc $ ) created ( Oct1 ) transcription-factor binding sites involved development differentiation neuronal systems . Also , two clustered 200-bp region ( -540/-340 ) APP promoter showed highest degree species conservation . present study provides evidence APP-promoter mutations significantly increase APP expression levels associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072809451175816)\n",
      "- Text: \"Modulation oestrogen receptor signalling association activated dioxin receptor . Environmental contaminants affect wide variety biological events many species . Dioxins typical environmental contaminants exert adverse oestrogen-related effects . Although anti-oestrogenic actions well described , dioxins also induce endometriosis oestrogen-dependent @ DiseaseTgt $ , implying possible oestrogenic effects . However , molecular mechanism underlying oestrogen-related actions dioxins remains largely unknown . heterodimer dioxin receptor ( AhR ) Arnt , basic helix-loop-helix/PAS-family transcription factors , mediates toxic effects dioxins . show agonist-activated AhR/Arnt heterodimer directly associates oestrogen receptors ER-alpha ER-beta . association results recruitment unliganded ER co-activator @ GeneSrc $ oestrogen-responsive gene promoters , leading activation transcription oestrogenic effects . function liganded ER attenuated . Oestrogenic actions AhR agonists detected wild-type ovariectomized mouse uteri , absent AhR-/- ER-alpha-/- ovariectomized mice . findings suggest novel mechanism ER-mediated oestrogen signalling modulated co-regulatory-like function activated AhR/Arnt , giving rise adverse oestrogen-related actions dioxin-type environmental contaminants .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.650707464039268e-06)\n",
      "- Text: \"Phosphorylation regulation Akt/PKB @ GeneSrc $ complex . Deregulation Akt/protein kinase B ( PKB ) implicated pathogenesis @ DiseaseTgt $ diabetes . Akt/PKB activation requires phosphorylation Thr308 activation loop phosphoinositide-dependent kinase 1 ( PDK1 ) Ser473 within carboxyl-terminal hydrophobic motif unknown kinase . show Drosophila human cells target rapamycin ( TOR ) kinase associated protein @ GeneSrc $ necessary Ser473 phosphorylation reduction @ GeneSrc $ mammalian TOR ( mTOR ) expression inhibited Akt/PKB effector . @ GeneSrc $ complex directly phosphorylated Akt/PKB Ser473 vitro facilitated Thr308 phosphorylation PDK1 . @ GeneSrc $ may serve drug target @ DiseaseTgt $ lost expression PTEN , @ DiseaseTgt $ suppressor opposes Akt/PKB activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.111216336765453)\n",
      "- Text: \"High-content genome-wide RNAi screens identify regulators parkin upstream mitophagy . increasing body evidence points mitochondrial dysfunction contributor molecular pathogenesis neurodegenerative diseases @ DiseaseTgt $ . Recent studies @ DiseaseTgt $ associated genes PINK1 ( ref . 2 ) parkin ( PARK2 , ref . 3 ) indicate may act quality control pathway preventing accumulation dysfunctional mitochondria . elucidate regulators impact parkin translocation damaged mitochondria genome-wide small interfering RNA ( siRNA ) screens coupled high-content microscopy . Screening yielded gene candidates involved diverse cellular processes subsequently validated low-throughput assays . led characterization TOMM7 essential stabilizing PINK1 outer mitochondrial membrane following mitochondrial damage . also discovered @ GeneSrc $ ( HSP70 family member ) BAG4 mutually opposing roles regulation parkin translocation . screens revealed SIAH3 , found localize mitochondria , inhibits PINK1 accumulation mitochondrial insult , reducing parkin translocation . Overall , screens provide rich resource understand mitochondrial quality control .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0027504495187578)\n",
      "- Text: \"Association DJ-1 parkin mediated pathogenic DJ-1 mutations oxidative stress . identification rare monogenic forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) provided tremendous insight molecular pathogenesis disorder . Heritable mutations alpha-synuclein , parkin , DJ-1 PINK1 cause familial forms @ DiseaseTgt $ . common sporadic form @ DiseaseTgt $ , oxidative stress derangements mitochondrial complex-I function considered play prominent role disease pathogenesis . However , relationship DJ-1 @ DiseaseTgt $ genes oxidative stress explored . , show pathogenic mutant forms DJ-1 specifically differentially associate parkin , E3 ubiquitin ligase . Chemical cross-linking shows pathogenic DJ-1 mutants exhibit impairments homo-dimer formation , suggesting parkin may bind monomeric DJ-1 . Parkin fails specifically ubiquitinate enhance degradation L166P M26I mutant DJ-1 , instead promotes stability cultured cells . interaction parkin L166P DJ-1 may involve larger protein complex contains CHIP @ GeneSrc $ , perhaps accounting lack parkin-mediated ubiquitination . Oxidative stress also promotes interaction DJ-1 parkin , result ubiquitination degradation DJ-1 . Parkin-mediated alterations DJ-1 protein stability may pathogenically relevant DJ-1 levels dramatically increased detergent-insoluble fraction sporadic @ DiseaseTgt $ brains , reduced insoluble fraction parkin-linked autosomal recessive juvenile-onset @ DiseaseTgt $ brains . data potentially link DJ-1 parkin common molecular pathway multiple levels may important implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.683400261072177)\n",
      "- Text: \"Parkin facilitates elimination expanded polyglutamine proteins leads preservation proteasome function . Parkin , commonly mutated gene familial @ DiseaseTgt $ , encodes E3 ubiquitin ligase . number candidate substrates identified parkin ubiquitin ligase action including CDCrel-1 , o-glycosylated alpha-synuclein , Pael-R , synphilin-1 . show parkin promotes ubiquitination degradation expanded polyglutamine protein . Overexpression parkin reduces aggregation cytotoxicity expanded polyglutamine ataxin-3 fragment . Using cellular proteasome indicator system based destabilized form green fluorescent protein , demonstrate parkin reduces proteasome impairment caspase-12 activation induced expanded polyglutamine protein . Parkin forms complex expanded polyglutamine protein , @ GeneSrc $ ( @ GeneSrc $ ) proteasome , may important elimination expanded polyglutamine protein . @ GeneSrc $ enhances parkin binding ubiquitination expanded polyglutamine protein vitro suggesting @ GeneSrc $ may help recruit misfolded proteins substrates parkin E3 ubiquitin ligase activity . speculate parkin may function relieve endoplasmic reticulum stress preserving proteasome activity presence misfolded proteins . Loss parkin function resulting proteasomal impairment may contribute accumulation toxic aberrant proteins neurodegenerative diseases including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022428033311779)\n",
      "- Text: \"CHIP associated Parkin , gene responsible familial @ DiseaseTgt $ , enhances ubiquitin ligase activity . Unfolded Pael receptor ( Pael-R ) substrate E3 ubiquitin ligase Parkin . Accumulation Pael-R endoplasmic reticulum ( ER ) dopaminergic neurons induces ER stress leading neurodegeneration . , show CHIP , @ GeneSrc $ , Parkin , Pael-R formed complex vitro vivo . amount CHIP complex increased ER stress . CHIP promoted dissociation @ GeneSrc $ Parkin Pael-R , thus facilitating Parkin-mediated Pael-R ubiquitination . Moreover , CHIP enhanced Parkin-mediated vitro ubiquitination Pael-R absence @ GeneSrc $ . Furthermore , CHIP enhanced ability Parkin inhibit cell death induced Pael-R. Taken together , results indicate CHIP mammalian E4-like molecule positively regulates Parkin E3 activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1955064424252278)\n",
      "- Text: \"BAG5 inhibits parkin enhances dopaminergic neuron degeneration . Loss-of-function mutations parkin gene , encodes E3 ubiquitin ligase , major cause early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Decreases parkin activity may also contribute neurodegeneration sporadic forms @ DiseaseTgt $ . , show bcl-2-associated athanogene 5 ( BAG5 ) , BAG family member , directly interacts parkin chaperone @ GeneSrc $ . Within complex , BAG5 inhibits parkin E3 ubiquitin ligase activity @ GeneSrc $ refolding misfolded proteins . BAG5 enhances parkin sequestration within protein aggregates mitigates parkin-dependent preservation proteasome function . Finally , BAG5 enhances dopamine neuron death vivo model @ DiseaseTgt $ , whereas mutant inhibits BAG5 activity attenuates dopaminergic neurodegeneration . contrasts antideath functions ascribed BAG family members suggests potential role BAG5 promoting neurodegeneration sporadic @ DiseaseTgt $ functional interactions parkin @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2358893658007673)\n",
      "- Text: \"CHIP Hsp70 regulate tau ubiquitination , degradation aggregation . Molecular chaperones , ubiquitin ligases proteasome impairment implicated several neurodegenerative diseases , including @ DiseaseTgt $ , characterized accumulation abnormal protein aggregates ( e.g . tau alpha-synuclein respectively ) . report CHIP , ubiquitin ligase interacts directly Hsp70/90 , induces ubiquitination microtubule associated protein , tau . CHIP also increases tau aggregation . Consistent observation , diverse tau lesions human postmortem tissue found immunopositive CHIP . Conversely , induction Hsp70 treatment either geldanamycin heat shock factor 1 leads decrease tau steady-state levels selective reduction detergent insoluble tau . Furthermore , 30-month-old mice overexpressing inducible Hsp70 show significant reduction tau levels . Together data demonstrate @ GeneSrc $ chaperone system plays important role regulation tau turnover selective elimination abnormal tau species . @ GeneSrc $ may therefore play important role pathogenesis tauopathies also represents potential therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001257960200834)\n",
      "- Text: \"High-content genome-wide RNAi screens identify regulators parkin upstream mitophagy . increasing body evidence points mitochondrial dysfunction contributor molecular pathogenesis neurodegenerative diseases @ DiseaseTgt $ . Recent studies @ DiseaseTgt $ associated genes PINK1 ( ref . 2 ) parkin ( PARK2 , ref . 3 ) indicate may act quality control pathway preventing accumulation dysfunctional mitochondria . elucidate regulators impact parkin translocation damaged mitochondria genome-wide small interfering RNA ( siRNA ) screens coupled high-content microscopy . Screening yielded gene candidates involved diverse cellular processes subsequently validated low-throughput assays . led characterization TOMM7 essential stabilizing PINK1 outer mitochondrial membrane following mitochondrial damage . also discovered HSPA1L ( @ GeneSrc $ family member ) BAG4 mutually opposing roles regulation parkin translocation . screens revealed SIAH3 , found localize mitochondria , inhibits PINK1 accumulation mitochondrial insult , reducing parkin translocation . Overall , screens provide rich resource understand mitochondrial quality control .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004991236859083)\n",
      "- Text: \"CHIP Hsp70 regulate tau ubiquitination , degradation aggregation . Molecular chaperones , ubiquitin ligases proteasome impairment implicated several neurodegenerative diseases , including @ DiseaseTgt $ , characterized accumulation abnormal protein aggregates ( e.g . tau alpha-synuclein respectively ) . report CHIP , ubiquitin ligase interacts directly @ GeneSrc $ , induces ubiquitination microtubule associated protein , tau . CHIP also increases tau aggregation . Consistent observation , diverse tau lesions human postmortem tissue found immunopositive CHIP . Conversely , induction Hsp70 treatment either geldanamycin heat shock factor 1 leads decrease tau steady-state levels selective reduction detergent insoluble tau . Furthermore , 30-month-old mice overexpressing inducible Hsp70 show significant reduction tau levels . Together data demonstrate Hsp70/CHIP chaperone system plays important role regulation tau turnover selective elimination abnormal tau species . Hsp70/CHIP may therefore play important role pathogenesis tauopathies also represents potential therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004859407083702)\n",
      "- Text: \"Aberrant interaction @ DiseaseTgt $ mutant UCH-L1 lysosomal receptor chaperone-mediated autophagy . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative movement disorder . increase amount alpha-synuclein protein could constitute cause @ DiseaseTgt $ . Alpha-synuclein degraded least partly chaperone-mediated autophagy ( CMA ) . I93 mutation ubiquitin C-terminal hydrolase L1 ( UCH-L1 ) associated familial @ DiseaseTgt $ . However , relationship alpha-synuclein UCH-L1 pathogenesis @ DiseaseTgt $ remained largely unclear . study , found UCH-L1 physically interacts LAMP-2A , lysosomal receptor CMA , @ GeneSrc $ Hsp90 , function components CMA pathway . interactions abnormally enhanced I93 mutation independent monoubiquitin binding UCH-L1 . cell-free system , UCH-L1 directly interacted cytosolic region LAMP-2A . Expression I93 UCH-L1 cells induced CMA inhibition-associated increase amount alpha-synuclein . findings may provide novel insights molecular links alpha-synuclein UCH-L1 suggest aberrant interaction mutant UCH-L1 CMA machinery , least partly , underlies pathogenesis @ DiseaseTgt $ associated I93 UCH-L1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0291389798470539)\n",
      "- Text: \"Regulation alpha-synuclein chaperones mammalian cells . Neurodegeneration patients @ DiseaseTgt $ correlated occurrence Lewy bodies-intracellular inclusions contain aggregates intrinsically disordered protein alpha-synuclein1 . aggregation propensity alpha-synuclein cells modulated specific factors include post-translational modifications2,3 , Abelson-kinase-mediated phosphorylation4,5 interactions intracellular machineries molecular chaperones , although underlying mechanisms unclear6 - 8 . systematically characterize interaction molecular chaperones alpha-synuclein vitro well cells atomic level . find six highly divergent molecular chaperones commonly recognize canonical motif alpha-synuclein , consisting N terminus segment around Tyr39 , hinder aggregation alpha-synuclein . NMR experiments9 cells show transient interaction pattern preserved inside living mammalian cells . Specific inhibition interactions alpha-synuclein chaperone @ GeneSrc $ members HSP90 family , including HSP90beta , results transient membrane binding triggers remarkable re-localization alpha-synuclein mitochondria concomitant formation aggregates . Phosphorylation alpha-synuclein Tyr39 directly impairs interaction alpha-synuclein chaperones , thus providing functional explanation role Abelson kinase @ DiseaseTgt $ . results establish master regulatory mechanism alpha-synuclein function aggregation mammalian cells , extending functional repertoire molecular chaperones highlighting new perspectives therapeutic interventions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.899942311702815e-05)\n",
      "- Text: \"deleterious mutation DNAJC6 encoding neuronal-specific clathrin-uncoating co-chaperone auxilin , associated juvenile parkinsonism . @ DiseaseTgt $ caused neuronal loss substantia nigra manifests abnormality movement , muscle tone , postural stability . Several genes implicated pathogenesis @ DiseaseTgt $ , underlying molecular basis still unknown ~70 % patients . Using homozygosity mapping whole exome sequencing identified deleterious mutation DNAJC6 two patients juvenile parkinsonism . mutation associated abnormal transcripts marked reduced DNAJC6 mRNA level . DNAJC6 encodes HSP40 Auxilin , protein selectively expressed neurons confers specificity ATPase activity partner Hcs70 clathrin uncoating . Auxilin null mice previously shown abnormally increased retention assembled clathrin vesicles empty cages leads impaired synaptic vesicle recycling perturbed clathrin mediated endocytosis . Endocytosis function , studied transferring uptake , normal fibroblasts patients , likely presence another J-domain containing partner co-chaperones @ GeneSrc $ uncoating activity non-neuronal cells . present report underscores importance endocytic/lysosomal pathway pathogenesis @ DiseaseTgt $ forms parkinsonism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0350900888479912)\n",
      "- Text: \"Aberrant interaction @ DiseaseTgt $ mutant UCH-L1 lysosomal receptor chaperone-mediated autophagy . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative movement disorder . increase amount alpha-synuclein protein could constitute cause @ DiseaseTgt $ . Alpha-synuclein degraded least partly chaperone-mediated autophagy ( CMA ) . I93 mutation ubiquitin C-terminal hydrolase L1 ( UCH-L1 ) associated familial @ DiseaseTgt $ . However , relationship alpha-synuclein UCH-L1 pathogenesis @ DiseaseTgt $ remained largely unclear . study , found UCH-L1 physically interacts LAMP-2A , lysosomal receptor CMA , Hsc70 @ GeneSrc $ , function components CMA pathway . interactions abnormally enhanced I93 mutation independent monoubiquitin binding UCH-L1 . cell-free system , UCH-L1 directly interacted cytosolic region LAMP-2A . Expression I93 UCH-L1 cells induced CMA inhibition-associated increase amount alpha-synuclein . findings may provide novel insights molecular links alpha-synuclein UCH-L1 suggest aberrant interaction mutant UCH-L1 CMA machinery , least partly , underlies pathogenesis @ DiseaseTgt $ associated I93 UCH-L1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0150958450880858)\n",
      "- Text: \"Regulation alpha-synuclein chaperones mammalian cells . Neurodegeneration patients @ DiseaseTgt $ correlated occurrence Lewy bodies-intracellular inclusions contain aggregates intrinsically disordered protein alpha-synuclein1 . aggregation propensity alpha-synuclein cells modulated specific factors include post-translational modifications2,3 , Abelson-kinase-mediated phosphorylation4,5 interactions intracellular machineries molecular chaperones , although underlying mechanisms unclear6 - 8 . systematically characterize interaction molecular chaperones alpha-synuclein vitro well cells atomic level . find six highly divergent molecular chaperones commonly recognize canonical motif alpha-synuclein , consisting N terminus segment around Tyr39 , hinder aggregation alpha-synuclein . NMR experiments9 cells show transient interaction pattern preserved inside living mammalian cells . Specific inhibition interactions alpha-synuclein chaperone HSC70 members @ GeneSrc $ family , including HSP90beta , results transient membrane binding triggers remarkable re-localization alpha-synuclein mitochondria concomitant formation aggregates . Phosphorylation alpha-synuclein Tyr39 directly impairs interaction alpha-synuclein chaperones , thus providing functional explanation role Abelson kinase @ DiseaseTgt $ . results establish master regulatory mechanism alpha-synuclein function aggregation mammalian cells , extending functional repertoire molecular chaperones highlighting new perspectives therapeutic interventions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002214054439576)\n",
      "- Text: \"Pink1 Parkinson mutations , @ GeneSrc $ chaperones Parkin influence maturation subcellular distribution Pink1 . Mutations ubiquitously expressed gene PTEN-induced kinase 1 ( Pink1 ) cause autosomal recessive @ DiseaseTgt $ . Pink1 encodes putative serine/threonine kinase N-terminal mitochondrial targeting sequence . mechanism leads selective degeneration dopaminergic neurons via Pink1 mutations unknown . full-length pre-protein ( 66 kDa ) N-terminally truncated mature form ( 55 kDa ) described human brain . , report endogenous 66 kDa 55 kDa Pink1 forms cultured cells exclusive mitochondria also occur cytosolic microsome-rich fractions . Pink1 66 kDa predominant isoform cultured cells . Using unbiased analyses immunoisolated Pink1 complexes mass spectrometry , co-immunoprecipitation @ GeneSrc $ inhibitor studies , identify Pink1 novel @ GeneSrc $ client kinase . chaperone system influences subcellular distribution 66/55 kDa protein ratio Pink1 . @ DiseaseTgt $ Pink1 mutations decrease whereas Parkin expression increases Pink1 66/55 kDa protein ratio , biochemically linking Pink1 Parkin highlighting potential relevance ratio @ DiseaseTgt $ pathogenesis . Finally , document influence Parkin Pink1 subcellular distribution , providing evidence common pathogenic pathway recessive @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5154963966182068)\n",
      "- Text: \"Regulation alpha-synuclein chaperones mammalian cells . Neurodegeneration patients @ DiseaseTgt $ correlated occurrence Lewy bodies-intracellular inclusions contain aggregates intrinsically disordered protein alpha-synuclein1 . aggregation propensity alpha-synuclein cells modulated specific factors include post-translational modifications2,3 , Abelson-kinase-mediated phosphorylation4,5 interactions intracellular machineries molecular chaperones , although underlying mechanisms unclear6 - 8 . systematically characterize interaction molecular chaperones alpha-synuclein vitro well cells atomic level . find six highly divergent molecular chaperones commonly recognize canonical motif alpha-synuclein , consisting N terminus segment around Tyr39 , hinder aggregation alpha-synuclein . NMR experiments9 cells show transient interaction pattern preserved inside living mammalian cells . Specific inhibition interactions alpha-synuclein chaperone HSC70 members HSP90 family , including @ GeneSrc $ , results transient membrane binding triggers remarkable re-localization alpha-synuclein mitochondria concomitant formation aggregates . Phosphorylation alpha-synuclein Tyr39 directly impairs interaction alpha-synuclein chaperones , thus providing functional explanation role Abelson kinase @ DiseaseTgt $ . results establish master regulatory mechanism alpha-synuclein function aggregation mammalian cells , extending functional repertoire molecular chaperones highlighting new perspectives therapeutic interventions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002905768408317)\n",
      "- Text: \"Mutational analysis DJ-1 Drosophila implicates functional inactivation oxidative damage aging . Inherited mutations PARK7 , gene encoding DJ-1 , associated loss protein function early-onset parkinsonism . Like human DJ-1 ( @ GeneSrc $ ) , Drosophila DJ-1b protects oxidative insult modified oxidation . demonstrate @ GeneSrc $ rescues flies mutant DJ-1b , conserved cysteine residue fly protein ( C104 , analogous C106 @ GeneSrc $ ) critical biological antioxidant function vivo . Targeted mutagenesis suggests modification DJ-1b residue inactivates protective activity protein oxidative stress . studies show DJ-1 modification increases dramatically age flies , mice , humans , aged flies showing strikingly increased susceptibility oxidative stress markedly enhanced DJ-1b modification upon oxidative challenge . Overoxidation DJ-1 age exposure oxidative toxins may lead inactivation DJ-1 function , suggesting role susceptibility sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022339058699042)\n",
      "- Text: \"role presenilin cofactors gamma-secretase complex . Mutations presenilin genes account majority cases familial form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Presenilin essential gamma-secretase activity , proteolytic activity involved intramembrane cleavage Notch beta-amyloid precursor protein ( betaAPP ) . Cleavage betaAPP @ DiseaseTgt $ mutant presenilin results overproduction highly amyloidogenic amyloid beta42 peptides . gamma-Secretase activity requires formation stable , high-molecular-mass protein complex , addition endoproteolysed fragmented form presenilin , contains essential cofactors including nicastrin , @ GeneSrc $ ( refs 15 - 18 ) PEN-2 ( refs 16 , 19 ) . However , role protein complex formation generation enzymatic activity unclear . show Drosophila @ GeneSrc $ ( @ GeneSrc $ ) increases stability Drosophila presenilin ( Psn ) holoprotein complex . Depletion PEN-2 RNA interference prevents endoproteolysis presenilin promotes stabilization holoprotein Drosophila mammalian cells , including primary neurons . Co-expression Drosophila Pen-2 @ GeneSrc $ nicastrin increases formation Psn fragments well gamma-secretase activity . Thus , @ GeneSrc $ stabilizes presenilin holoprotein complex , whereas PEN-2 required endoproteolytic processing presenilin conferring gamma-secretase activity complex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1278731424340548)\n",
      "- Text: \"reporter amyloid precursor protein gamma-secretase activity Drosophila . key event pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) deposition senile plaques consisting largely peptide known beta-amyloid ( Abeta ) derived amyloid precursor protein ( APP ) . proteolytic activity called gamma-secretase cleaves APP transmembrane domain required Abeta generation . Aberrant gamma-secretase cleavage APP underlies majority early onset , familial @ DiseaseTgt $ . gamma-Secretase resides large multi-protein complex , Presenilin , Nicastrin , @ GeneSrc $ PEN-2 four essential components . Thus , identifying components pathways gamma-secretase activity regulated crucial understanding mechanisms underlying @ DiseaseTgt $ pathogenesis , may provide new diagnostic tools therapeutic targets . describe generation Drosophila act living reporters gamma-secretase activity fly eye . reporter flies size eye correlates level endogenous gamma-secretase activity , sensitive levels three genes required APP gamma-secretase activity , presenilin , nicastrin @ GeneSrc $ . Thus , flies provide sensitized system identify components gamma-secretase complex regulators activity . used flies carry screen mutations suppress gamma-secretase activity identified small chromosomal region contains gene genes whose products may promote gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.090838783184678)\n",
      "- Text: \"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression . Gain-of-function mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism LRRK2 action known . show LRRK2 interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila e2f1 dp messenger RNAs translationally repressed let-7 miR-184 * , respectively . Pathogenic LRRK2 antagonizes miRNAs , leading overproduction E2F1/DP , previously implicated cell cycle survival control shown critical LRRK2 pathogenesis . Genetic deletion let-7 , antagomir-mediated blockage let-7 miR-184 * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive let-7 toxic effects similar pathogenic LRRK2 . Conversely , increasing level let-7 miR-184 * attenuated pathogenic LRRK2 effects . LRRK2 associated Drosophila Argonaute-1 ( dAgo1 ) human Argonaute-2 ( hAgo2 ) RNA-induced silencing complex ( RISC ) . aged fly brain , dAgo1 protein level negatively regulated LRRK2 . , pathogenic LRRK2 promoted association @ GeneSrc $ hAgo2 . results implicate deregulated synthesis E2F1/DP caused miRNA pathway impairment key event LRRK2 pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Insertion/deletion ( I/D ) polymorphism locus angiotensin I-converting enzyme @ DiseaseTgt $ . Male ( n = 185 ) female ( n = 49 ) survivors @ DiseaseTgt $ ( MI ) 56 61 years age , respectively , compared 366 controls respect distribution genotypes insertion/deletion ( ID ) polymorphism angiotensin I-converting enzyme ( ACE ) locus . frequency DD genotype ( homozygosity deletion allele ) significantly lower among male patients controls ( 22.7 % versus 34.9 % , p = 0.011 ) . `` low-risk `` group , defined less sex-specific , age-adjusted median values body mass index ( BMI ) @ GeneSrc $ ( @ GeneSrc $ ) , respectively , absence treatment lipid-lowering drugs , prevalence DD genotype statistically different male patients controls . male `` high-risk `` group ( individuals defined `` low-risk `` subjects ) , prevalence DD genotype 20.9 % patients 38.3 % controls ( p = 0.002 ) . women , significant differences genotype frequencies patients controls found whole sample subgroup . results appear variance data reported recently Cambien et al . ( 1992 ) . difference may due chance , undetected selection biases , different gene-environment interactions Norway France Ireland , preferential loss DD individuals male `` high-risk `` group .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0022878328697445)\n",
      "- Text: \"Deletion polymorphism gene angiotensin-converting enzyme potent risk factor @ DiseaseTgt $ . Factors involved pathogenesis atherosclerosis , thrombosis vasoconstriction contribute development coronary heart disease . study comparing patients @ DiseaseTgt $ controls , explored possible association coronary heart disease variation found gene encoding angiotensin-converting enzyme ( ACE ) . polymorphism ACE/ID strongly associated level circulating enzyme . enzyme plays key role production angiotensin II catabolism bradykinin , two peptides involved modulation vascular tone proliferation smooth muscle cells . report DD genotype , associated higher levels circulating ACE ID II genotypes , significantly frequent patients @ DiseaseTgt $ ( n = 610 ) controls ( n = 733 ) ( P = 0.007 ) , especially among subjects low body-mass index low plasma levels @ GeneSrc $ ( P < 0.0001 ) . ACE/ID polymorphism seems potent risk factor coronary heart disease subjects formerly considered low risk according common criteria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032592603917684)\n",
      "- Text: \"Deletion polymorphism angiotensin I-converting enzyme gene associated increased plasma angiotensin-converting enzyme activity increased risk @ DiseaseTgt $ coronary artery disease . BACKGROUND : Previous research shown insertion/deletion ( I/D ) polymorphism angiotensin I-converting enzyme ( ACE ) gene major determinant plasma ACE activity . suggested persons DD genotype ( express , average , highest levels circulating ACE ) increased risk @ DiseaseTgt $ coronary artery disease , particularly otherwise low risk . Subsequent studies , however , confirmed ACE I/D gene polymorphism risk factor coronary artery disease @ DiseaseTgt $ . OBJECTIVE : investigate association I/D polymorphism ACE gene risk coronary artery disease @ DiseaseTgt $ patients coronary artery disease status documented angiography . DESIGN : Cross-sectional study . SETTING : University medical center . PATIENTS : 209 male case-patients coronary artery disease 92 male controls without coronary artery disease , documented coronary angiography . MEASUREMENTS : Assessment cardiac risk profile questionnaire ; classification patients degree coronary artery stenosis ; levels lipoproteins , apolipoproteins , fibrinogen ; ACE I/D gene polymorphism assessed polymerase chain reaction amplification . RESULTS : Plasma ACE activity significantly associated ACE I/D gene polymorphism . ACE genotype associated presence coronary artery disease @ DiseaseTgt $ . recessive effect allele assumed ( DD compared DI II ) , relative risk 1.00 ( 95 % CI , 0.76 1.30 ) coronary artery disease 1.03 ( CI , 0.77 1.38 ) @ DiseaseTgt $ . Results analyses also negative dominant effect allele assumed low-risk subgroups examined . established risk factors age @ GeneSrc $ level emerged important risk predictors multivariate analyses , followed diastolic blood pressure fasting glucose levels . CONCLUSIONS : angiographically defined study sample , ACE I/D gene polymorphism associated increased risk coronary artery disease @ DiseaseTgt $ , despite effects plasma ACE activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0057586143563956)\n",
      "- Text: \"High prevalence pathogenic mutations patients early-onset dementia detected sequence analyses four different genes . Clinical differential diagnosis early-onset dementia ( EOD ) includes @ DiseaseTgt $ ( @ DiseaseTgt $ ) hereditary prion disease . disease entities , postmortem brain histopathological examination essential unambiguous diagnosis . Mutations genes encoding presenilins ( @ GeneSrc $ PS2 ) amyloid precursor protein ( APP ) associated @ DiseaseTgt $ , whereas mutations prion protein ( PrP ) gene associated prion disease . investigate proportion EOD attributable known genes , prospectively ( i.e . , antemortem ) screened four genes mutations sequencing genomic PCR products patients EOD age 60 years . Family history dementia positive ( PFH ) 16 patients , negative ( NFH ) 17 patients , unknown ( UFH ) 3 patients . 12 patients , found five novel mutations ( @ GeneSrc $ , F105L ; PS2 , T122P M239I ; PrP , Q160X T188 K ) five previously reported mutations ( APP , three patients likely unrelated , V717I ; @ GeneSrc $ , A79V M139V ; PrP , P102L T183A ) considered disease causing . 12 patients , 9 PFH . indicates detection rate 56 % ( 9/16 ) patients PFH . found two mutations ( APP V717I ) two three UFH patients , one mutation ( PrP T188 K ) 1 17 patients NFH . conclude lack specific antemortem diagnostic markers @ DiseaseTgt $ hereditary prion disease , four genes included molecular diagnostic program patients EOD PFH .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035141812676615)\n",
      "- Text: \"High prevalence pathogenic mutations patients early-onset dementia detected sequence analyses four different genes . Clinical differential diagnosis early-onset dementia ( EOD ) includes @ DiseaseTgt $ ( @ DiseaseTgt $ ) hereditary prion disease . disease entities , postmortem brain histopathological examination essential unambiguous diagnosis . Mutations genes encoding presenilins ( PS1 @ GeneSrc $ ) amyloid precursor protein ( APP ) associated @ DiseaseTgt $ , whereas mutations prion protein ( PrP ) gene associated prion disease . investigate proportion EOD attributable known genes , prospectively ( i.e . , antemortem ) screened four genes mutations sequencing genomic PCR products patients EOD age 60 years . Family history dementia positive ( PFH ) 16 patients , negative ( NFH ) 17 patients , unknown ( UFH ) 3 patients . 12 patients , found five novel mutations ( PS1 , F105L ; @ GeneSrc $ , T122P M239I ; PrP , Q160X T188 K ) five previously reported mutations ( APP , three patients likely unrelated , V717I ; PS1 , A79V M139V ; PrP , P102L T183A ) considered disease causing . 12 patients , 9 PFH . indicates detection rate 56 % ( 9/16 ) patients PFH . found two mutations ( APP V717I ) two three UFH patients , one mutation ( PrP T188 K ) 1 17 patients NFH . conclude lack specific antemortem diagnostic markers @ DiseaseTgt $ hereditary prion disease , four genes included molecular diagnostic program patients EOD PFH .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0014514259047909)\n",
      "- Text: \"Coexpression alternatively spliced estrogen progesterone receptor transcripts human breast cancer . Primary transcripts human estrogen receptor ( ER ) progesterone receptor ( PR ) subject number alternative splicing events resulting range variant messenger ribonucleic acid species receptor-positive tissues . Despite vitro demonstrations possible role variants hormonal sensitivity , clinical significance process uncertain . study coexpression variant ER PR transcripts documented RT-PCR Southern blot analysis series receptor-positive breast tumors . 35 ER-positive @ DiseaseTgt $ , common profile variant ER transcripts present , @ DiseaseTgt $ containing delta2ER delta7ER , 94 % containing delta4ER , 83 % containing delta5ER . 25 cases , also PR positive , highly expressed PR variants , delta4PR , delta6PR , delta ( 4/2 ) PR , transcript 126-bp portion PR exon 4 deleted , detected 90 % cases . alternatively spliced ER variants expressed higher relative levels PR species , mean levels expression less 10 % wild-type PR . abundant species delta7ER , present levels ranging 29 - 83 % wild type . relationship level delta7ER individual @ DiseaseTgt $ pattern expression estrogen-responsive proteins PR @ GeneSrc $ . common profile alternatively spliced ER PR transcripts breast tumors means feature used discriminator hormone responsiveness clinical end points . , low level expression majority variant species calls question potential impacting significantly receptor function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1275430554412672)\n",
      "- Text: \"Naturally secreted oligomers amyloid beta protein potently inhibit hippocampal long-term potentiation vivo . Although extensive data support central pathogenic role amyloid beta protein ( Abeta ) @ DiseaseTgt $ , amyloid hypothesis remains controversial , part specific neurotoxic species Abeta nature effects synaptic function defined vivo . report natural oligomers human Abeta formed soon generation peptide within specific intracellular vesicles subsequently secreted cell . Cerebral microinjection cell medium containing oligomers abundant Abeta monomers amyloid fibrils markedly inhibited hippocampal long-term potentiation ( LTP ) rats vivo . Immunodepletion medium Abeta species completely abrogated effect . Pretreatment medium @ GeneSrc $ , degrades Abeta monomers oligomers , prevent inhibition LTP . Therefore , Abeta oligomers , absence monomers amyloid fibrils , disrupted synaptic plasticity vivo concentrations found human brain cerebrospinal fluid . Finally , treatment cells gamma-secretase inhibitors prevented oligomer formation doses allowed appreciable monomer production , medium longer disrupted LTP , indicating synaptotoxic Abeta oligomers targeted therapeutically .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.524805360980819e-05)\n",
      "- Text: \"Insulin-degrading enzyme regulates levels insulin , amyloid beta-protein , beta-amyloid precursor protein intracellular domain vivo . Two substrates insulin-degrading enzyme ( IDE ) , amyloid beta-protein ( Abeta ) insulin , critically important pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) type 2 diabetes mellitus ( DM2 ) , respectively . previously identified IDE principal regulator Abeta levels neuronal microglial cells . small chromosomal region containing mutant @ GeneSrc $ allele associated hyperinsulinemia glucose intolerance rat model DM2 . Human genetic studies implicated @ GeneSrc $ region chromosome 10 @ DiseaseTgt $ DM2 . establish whether IDE hypofunction decreases Abeta insulin degradation vivo chronically increases levels , characterized mice homozygous deletions IDE gene ( IDE -- ) . IDE deficiency resulted > 50 % decrease Abeta degradation brain membrane fractions primary neuronal cultures similar deficit insulin degradation liver . IDE -- mice showed increased cerebral accumulation endogenous Abeta , hallmark @ DiseaseTgt $ , hyperinsulinemia glucose intolerance , hallmarks DM2 . Moreover , mice elevated levels intracellular signaling domain beta-amyloid precursor protein , recently found degraded IDE vitro . Together emerging genetic evidence , vivo findings suggest IDE hypofunction may underlie contribute forms @ DiseaseTgt $ DM2 provide mechanism recently recognized association among hyperinsulinemia , diabetes , @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0245633807031347)\n",
      "- Text: \"Integration @ GeneSrc $ signalling p53 responses @ DiseaseTgt $ suppression antiviral defence . Swift elimination undesirable cells important feature @ DiseaseTgt $ suppression immunity . @ DiseaseTgt $ suppressor p53 interferon-alpha -beta ( IFN-alpha/beta ) essential induction apoptosis @ DiseaseTgt $ cells antiviral immune responses , respectively , little known interrelationship . show transcription p53 gene induced IFN-alpha/beta , accompanied increase p53 protein level . IFN-alpha/beta signalling activate p53 ; rather , contributes boosting p53 responses stress signals . show examples p53 gene induction IFN-alpha/beta contributes @ DiseaseTgt $ suppression . Furthermore , show p53 activated virally infected cells evoke apoptotic response p53 critical antiviral defence host . study reveals hitherto unrecognized link p53 IFN-alpha/beta @ DiseaseTgt $ suppression antiviral immunity , may therapeutic implications .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4448103138852294)\n",
      "- Text: \"Integration interferon-alpha/beta signalling p53 responses @ DiseaseTgt $ suppression antiviral defence . Swift elimination undesirable cells important feature @ DiseaseTgt $ suppression immunity . @ DiseaseTgt $ suppressor p53 interferon-alpha -beta ( @ GeneSrc $ ) essential induction apoptosis @ DiseaseTgt $ cells antiviral immune responses , respectively , little known interrelationship . show transcription p53 gene induced @ GeneSrc $ , accompanied increase p53 protein level . @ GeneSrc $ signalling activate p53 ; rather , contributes boosting p53 responses stress signals . show examples p53 gene induction @ GeneSrc $ contributes @ DiseaseTgt $ suppression . Furthermore , show p53 activated virally infected cells evoke apoptotic response p53 critical antiviral defence host . study reveals hitherto unrecognized link p53 @ GeneSrc $ @ DiseaseTgt $ suppression antiviral immunity , may therapeutic implications .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.750760932936905)\n",
      "- Text: \"Integration interferon-alpha/beta signalling p53 responses @ DiseaseTgt $ suppression antiviral defence . Swift elimination undesirable cells important feature @ DiseaseTgt $ suppression immunity . @ DiseaseTgt $ suppressor p53 @ GeneSrc $ ( IFN-alpha/beta ) essential induction apoptosis @ DiseaseTgt $ cells antiviral immune responses , respectively , little known interrelationship . show transcription p53 gene induced IFN-alpha/beta , accompanied increase p53 protein level . IFN-alpha/beta signalling activate p53 ; rather , contributes boosting p53 responses stress signals . show examples p53 gene induction IFN-alpha/beta contributes @ DiseaseTgt $ suppression . Furthermore , show p53 activated virally infected cells evoke apoptotic response p53 critical antiviral defence host . study reveals hitherto unrecognized link p53 IFN-alpha/beta @ DiseaseTgt $ suppression antiviral immunity , may therapeutic implications .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6963104595680817)\n",
      "- Text: \"Parkin PINK1 mitigate STING-induced inflammation . Although serum patients @ DiseaseTgt $ contains elevated levels numerous pro-inflammatory cytokines including IL-6 , TNF , IL-1beta , @ GeneSrc $ , whether inflammation contributes consequence neuronal loss remains unknown1 . Mutations parkin , E3 ubiquitin ligase , PINK1 , ubiquitin kinase , cause early onset Parkinson 's disease2,3 . PINK1 parkin function within biochemical pathway remove damaged mitochondria cells culture animal models via mitophagy , selective form autophagy4 . vivo role mitophagy , however , unclear , partly mice lack either PINK1 parkin substantial @ DiseaseTgt $ phenotypes5 - 7 . Mitochondrial stress lead release damage-associated molecular patterns ( DAMPs ) activate innate immunity8 - 12 , suggesting mitophagy may mitigate inflammation . report strong inflammatory phenotype Prkn-/- Pink1-/- mice following exhaustive exercise Prkn-/- ; mutator mice , accumulate mutations mitochondrial DNA ( mtDNA ) 13,14 . Inflammation resulting either exhaustive exercise mtDNA mutation completely rescued concurrent loss STING , central regulator type interferon response cytosolic DNA15,16 . loss dopaminergic neurons substantia nigra pars compacta motor defect observed aged Prkn-/- ; mutator mice also rescued loss STING , suggesting inflammation facilitates phenotype . Humans mono- biallelic PRKN mutations also display elevated cytokines . results support role PINK1- parkin-mediated mitophagy restraining innate immunity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0679337825109375)\n",
      "- Text: \"@ DiseaseTgt $ PI3 K activation resistant dietary restriction . Dietary restriction delays incidence decreases growth various types @ DiseaseTgt $ , mechanisms underlying sensitivity @ DiseaseTgt $ food restriction remain unknown . show certain human @ DiseaseTgt $ cell lines , grown @ DiseaseTgt $ xenografts mice , highly sensitive anti-growth effects dietary restriction , whereas others resistant . @ DiseaseTgt $ cells form dietary-restriction-resistant @ DiseaseTgt $ carry mutations cause constitutive activation phosphatidylinositol-3-kinase ( PI3 K ) pathway culture proliferate absence insulin @ GeneSrc $ . Substitution activated mutant allele PI3 K wild-type PI3 K otherwise isogenic @ DiseaseTgt $ cells , restoration PTEN expression PTEN-null @ DiseaseTgt $ cell line , sufficient convert dietary-restriction-resistant @ DiseaseTgt $ one dietary-restriction-sensitive . Dietary restriction affect PTEN-null mouse model prostate cancer , significantly decreases @ DiseaseTgt $ burden mouse model lung cancer lacking constitutive PI3 K signalling . Thus , PI3 K pathway important determinant sensitivity @ DiseaseTgt $ dietary restriction , activating mutations pathway may influence response @ DiseaseTgt $ dietary restriction-mimetic therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7864607240177343)\n",
      "- Text: \"Association study GAB2 gene risk developing @ DiseaseTgt $ . first genome-wide association @ DiseaseTgt $ ( @ DiseaseTgt $ ) suggested GAB2 gene rs2373115 polymorphism may strong risk factor @ GeneSrc $ varepsilon4-carriers . failed detect association rs2373115 risk developing @ DiseaseTgt $ three populations ( totalling 1406 controls 1749 @ DiseaseTgt $ cases ) whatever @ GeneSrc $ status , even observed slight tendency increase GG genotype ( ( GG versus GT+TT ) =1.3 , 95 % CI 1.0 - 1.6 , p=0.09 ) G allele frequency ( OR=1.3 , 95 % CI 1.0 - 1.6 , p=0.05 ) varepsilon4-carriers . addition , rs2373115 modulate extent tau phosphorylation brain 89 @ DiseaseTgt $ cases . GAB2 gene best minor genetic determinant @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002611903441447)\n",
      "- Text: \"Implication sex SORL1 variants italian patients @ DiseaseTgt $ . OBJECTIVE : investigate association genetic variants sortilin-related receptor ( SORL1 ) , proposed important genetic contributor late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . DESIGN : analyzed 13 SORL1 single-nucleotide polymorphisms ( SNPs ) relative haplotypes case-control association study . PARTICIPANTS : sample included 708 Italian subjects : 251 unrelated , sporadic patients @ DiseaseTgt $ , 99 sporadic patients early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , 358 healthy controls . MAIN OUTCOME MEASURES : analyzed 13 SNPs SORL1 gene studied previous reports using case-control methods included sex , @ GeneSrc $ ( @ GeneSrc $ ) genotype , age @ DiseaseTgt $ onset covariates . RESULTS : SNPs 4 ( rs661057 ) , 7 ( rs12364988 ) , 10 ( rs641120 ) significantly associated @ DiseaseTgt $ compared controls . found association 3 variants sex , suggesting SORL1 may possibly affect @ DiseaseTgt $ female-specific mechanism . interest , association SNPs @ DiseaseTgt $ confined @ GeneSrc $ epsilon4 noncarriers . Several haplotypic associations 5 ' end SORL1 found , including previously associated CGC haplotype SNPs 8 10 . CONCLUSIONS : results confirm association SORL1 @ DiseaseTgt $ show possible effect female sex , suggesting gene may promising susceptibility factor @ DiseaseTgt $ . studies detect pathogenic variants elucidate effect SORL1 development @ DiseaseTgt $ necessary .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2811574867149415)\n",
      "- Text: \"Comment `` ApoE-directed therapeutics rapidly clear beta-amyloid reverse deficits @ DiseaseTgt $ mouse models `` . Cramer et al . ( Reports , 23 March 2012 , p. 1503 ; published online 9 February 2012 ) demonstrated mouse model @ DiseaseTgt $ ( @ DiseaseTgt $ ) treatment APP/PS1DeltaE9 mice bexarotene decreased Abeta pathology ameliorated memory deficits . confirm reversal memory deficits APP/PS1DeltaE9 mice expressing human @ GeneSrc $ @ GeneSrc $ levels nontransgenic controls significant decrease interstitial fluid Abeta , effects amyloid deposition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018797904450362)\n",
      "- Text: \"Genome-wide association study identifies variants CLU PICALM associated @ DiseaseTgt $ . undertook two-stage genome-wide association study ( GWAS ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) involving 16,000 individuals , powerful @ DiseaseTgt $ GWAS date . stage 1 ( 3,941 cases 7,848 controls ) , replicated established association @ GeneSrc $ ( @ GeneSrc $ ) locus ( significant SNP , rs2075650 , P = 1.8 x 10 ( -157 ) ) observed genome-wide significant association SNPs two loci previously associated disease : CLU ( also known APOJ ) gene ( rs11136000 , P = 1.4 x 10 ( -9 ) ) 5 ' PICALM gene ( rs3851179 , P = 1.9 x 10 ( -8 ) ) . associations replicated stage 2 ( 2,023 cases 2,340 controls ) , producing compelling evidence association @ DiseaseTgt $ combined dataset ( rs11136000 , P = 8.5 x 10 ( -10 ) , odds ratio = 0.86 ; rs3851179 , P = 1.3 x 10 ( -9 ) , odds ratio = 0.86 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0028759709413144)\n",
      "- Text: \"Meta-analysis confirms CR1 , CLU , PICALM @ DiseaseTgt $ risk loci reveals interactions @ GeneSrc $ genotypes . OBJECTIVES : determine whether genotypes CLU , PICALM , CR1 confer risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) whether risk @ DiseaseTgt $ associated genes influenced @ GeneSrc $ ( @ GeneSrc $ ) genotypes . DESIGN : Association study @ DiseaseTgt $ CLU , PICALM , CR1 , @ GeneSrc $ genotypes . SETTING : Academic research institutions United States , Canada , Israel . PARTICIPANTS : Seven thousand seventy cases @ DiseaseTgt $ , 3055 autopsies , 8169 elderly cognitively normal controls , 1092 autopsies , 12 different studies , including white , African American , Israeli-Arab , Caribbean Hispanic individuals . RESULTS : Unadjusted , CLU ( odds ratio [ ] , 0.91 ; 95 % confidence interval [ CI ] , 0.85 - 0.96 single-nucleotide polymorphism [ SNP ] rs11136000 ) , CR1 ( , 1.14 ; 95 % CI , 1.07 - 1.22 ; SNP rs3818361 ) , PICALM ( , 0.89 ; 95 % CI , 0.84 - 0.94 , SNP rs3851179 ) associated @ DiseaseTgt $ white individuals . None significantly associated @ DiseaseTgt $ ethnic groups . APOE epsilon4 significantly associated @ DiseaseTgt $ ( ORs , 1.80 - 9.05 ) 1 small white cohort Arab cohort . Adjusting age , sex , presence least 1 APOE epsilon4 allele greatly reduced evidence association PICALM CR1 CLU . Models main SNP effect , presence absence APOE epsilon4 , interaction term showed significant interaction presence absence APOE epsilon4 PICALM . CONCLUSIONS : confirm completely independent data set CR1 , CLU , PICALM @ DiseaseTgt $ susceptibility loci European ancestry populations . Genotypes PICALM confer risk predominantly APOE epsilon4-positive subjects . Thus , @ GeneSrc $ PICALM synergistically interact .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1416091926991552)\n",
      "- Text: \"Genome-wide association study identifies variants CLU CR1 associated @ DiseaseTgt $ . gene encoding @ GeneSrc $ ( @ GeneSrc $ ) chromosome 19 confirmed susceptibility locus late-onset @ DiseaseTgt $ . identify risk loci , conducted large genome-wide association study 2,032 individuals France @ DiseaseTgt $ ( cases ) 5,328 controls . Markers outside @ GeneSrc $ suggestive evidence association ( P < 10 ( -5 ) ) examined collections Belgium , Finland , Italy Spain totaling 3,978 @ DiseaseTgt $ cases 3,297 controls . Two loci gave replicated evidence association : one within CLU ( also called APOJ ) , encoding clusterin apolipoprotein J , chromosome 8 ( rs11136000 , = 0.86 , 95 % CI 0.81 - 0.90 , P = 7.5 x 10 ( -9 ) combined data ) within CR1 , encoding complement component ( 3b/4b ) receptor 1 , chromosome 1 ( rs6656401 , = 1.21 , 95 % CI 1.14 - 1.29 , P = 3.7 x 10 ( -9 ) combined data ) . Previous biological studies support roles CLU CR1 clearance beta amyloid ( Abeta ) peptide , principal constituent amyloid plaques , one major brain lesions individuals @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.040935115640865)\n",
      "- Text: \"Meta-analysis 74,046 individuals identifies 11 new susceptibility loci @ DiseaseTgt $ . Eleven susceptibility loci late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) identified previous studies ; however , large portion genetic risk disease remains unexplained . conducted large , two-stage meta-analysis genome-wide association studies ( GWAS ) individuals European ancestry . stage 1 , used genotyped imputed data ( 7,055,881 SNPs ) perform meta-analysis 4 previously published GWAS data sets consisting 17,008 @ DiseaseTgt $ cases 37,154 controls . stage 2 , 11,632 SNPs genotyped tested association independent set 8,572 @ DiseaseTgt $ cases 11,312 controls . addition @ GeneSrc $ locus ( encoding @ GeneSrc $ ) , 19 loci reached genome-wide significance ( P < 5 x 10 ( -8 ) ) combined stage 1 stage 2 analysis , 11 newly associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0854075532110474)\n",
      "- Text: \"Effect CYP2D6 polymorphism efficacy donepezil patients @ DiseaseTgt $ . OBJECTIVE : evaluate influence single nucleotide polymorphism rs1080985 cytochrome P450 2D6 ( CYP2D6 ) gene efficacy donepezil patients mild moderate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . METHODS : multicenter , prospective cohort study 127 white patients @ DiseaseTgt $ according National Institute Neurological Communicative Disorders @ DiseaseTgt $ Related Disorders Association Work Group criteria . Patients treated donepezil 5 - 10 mg/daily 6 months . Cognitive functional statuses evaluated baseline 6-month follow-up . Response therapy defined according National Institute Health Clinical Excellence criteria . Compliance drug-related adverse events also evaluated . analyses identifying CYP2D6 @ GeneSrc $ polymorphisms performed blinded fashion . RESULTS : 6-month follow-up , 69 115 patients ( 60 % ) responders 46 patients ( 40 % ) nonresponders donepezil treatment . significantly higher frequency patients G allele rs1080985 found nonresponders responders ( 58.7 % vs 34.8 % , p = 0.013 ) . Logistic regression analysis adjusted age , sex , Mini-Mental State Examination score baseline , @ GeneSrc $ demonstrated patients G allele significantly higher risk poor response donepezil treatment ( odds ratio 3.431 , 95 % confidence interval 1.490 - 7.901 ) . CONCLUSIONS : single nucleotide polymorphism rs1080985 CYP2D6 gene may influence clinical efficacy donepezil patients mild moderate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . analysis CYP2D6 genotypes may useful identifying subgroups patients @ DiseaseTgt $ different clinical responses donepezil .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.663375874764124e-05)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated @ GeneSrc $ ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , MLXIPL , PCSK9 , GALNT2 GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0119420453544772)\n",
      "- Text: \"phase 2 multiple ascending dose trial bapineuzumab mild moderate @ DiseaseTgt $ . BACKGROUND : Bapineuzumab , humanized anti-amyloid-beta ( Abeta ) monoclonal antibody potential treatment @ DiseaseTgt $ ( @ DiseaseTgt $ ) , evaluated multiple ascending dose , safety , efficacy study mild moderate @ DiseaseTgt $ . METHODS : study enrolled 234 patients , randomly assigned IV bapineuzumab placebo 4 dose cohorts ( 0.15 , 0.5 , 1.0 , 2.0 mg/kg ) . Patients received 6 infusions , 13 weeks apart , final assessments week 78 . prespecified primary efficacy analysis modified intent-to-treat population assumed linear decline compared treatment differences within dose cohorts @ DiseaseTgt $ Assessment Scale-Cognitive Disability Assessment Dementia . Exploratory analyses combined dose cohorts assume specific pattern decline . RESULTS : significant differences found primary efficacy analysis . Exploratory analyses showed potential treatment differences ( p < 0.05 , unadjusted multiple comparisons ) cognitive functional endpoints study `` completers `` @ GeneSrc $ epsilon4 noncarriers . Reversible vasogenic edema , detected brain MRI 12/124 ( 9.7 % ) bapineuzumab-treated patients , frequent higher dose groups @ GeneSrc $ epsilon4 carriers . Six vasogenic edema patients asymptomatic ; 6 experienced transient symptoms . CONCLUSIONS : Primary efficacy outcomes phase 2 trial significant . Potential treatment differences exploratory analyses support investigation bapineuzumab phase 3 special attention @ GeneSrc $ epsilon4 carrier status . CLASSIFICATION EVIDENCE : Due varying doses lack statistical precision , Class II ascending dose trial provides insufficient evidence support refute benefit bapineuzumab .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0014545517267244)\n",
      "- Text: \"@ GeneSrc $ allele risk factor familial sporadic presenile @ DiseaseTgt $ homozygote heterozygote carriers . apoliprotein E ( @ GeneSrc $ epsilon 4 allele well established risk factor familial sporadic senile @ DiseaseTgt $ ( @ DiseaseTgt $ ) , role development rarer presenile early onset type controversial . Early studies showed association ; later ones found enrichment epsilon 4 allele familial sporadic types . ApoE genotyped series Scottish people ( n = 85 ) early onset @ DiseaseTgt $ . find highly significant enrichment homozygote heterozygote ApoE epsilon 4 allele carriers familial sporadic early onset @ DiseaseTgt $ pattern closely resembling late onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6806822792876249)\n",
      "- Text: \"Evidence @ GeneSrc $ locus influences rate disease progression late onset familial @ DiseaseTgt $ causative . association observed several independent data sets late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) @ GeneSrc $ locus chromosome 19 . examined genotype family history positive ( FHP ) family history negative ( FHN ) cases find distortion @ GeneSrc $ allele frequencies accord previous studies . However , examined allele distribution at-risk siblings FHP group found excess epsilon 4 allele also differs significantly historic controls affected siblings . age distribution affected unaffected siblings similar , suggesting allelic frequency distortion unaffected siblings due mean age onset . Lod score linkage analysis , age dependent onset non-stringent specification genetic parameters , suggest linkage @ GeneSrc $ locus . Furthermore , analysis variance age disease free survival suggested @ GeneSrc $ genotype contributes small fraction total variance indicating @ GeneSrc $ locus poor predictor disease free survival age within late onset families . One explanation age dependent association reported groups , results , @ GeneSrc $ locus enhances rate progression disease process otherwise predisposed individuals variation locus able cause disease . suggest hypothesis compatible current literature regarding @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2579579299737801)\n",
      "- Text: \"Allele epsilon 4 @ GeneSrc $ shows dose effect age onset Pick disease . Pick disease rare progressive dementing illness characterized severe atrophy frontal temporal lobes . Clinically , Pick disease may difficult distinguish @ DiseaseTgt $ ( @ DiseaseTgt $ ) . fact Pick disease often familial , evidence suggesting epsilon 4 allele @ GeneSrc $ ( @ GeneSrc $ ) risk factor @ DiseaseTgt $ possibly dementias , prompted us study @ GeneSrc $ isoforms Pick disease . @ GeneSrc $ genotypes evaluated autopsy series 21 @ DiseaseTgt $ 12 Pick cases compared published data large group adults participating Framingham Study . distributions @ GeneSrc $ genotypes @ DiseaseTgt $ Pick patients controls significantly different one another . frequency epsilon 4 50.0 , 20.0 , 13.6 % respective groups . Linear regression analysis showed number epsilon 4 alleles inversely related age onset Pick disease ( P < 0.03 ) accounted 40 % variation age onset . results suggest epsilon 4 may susceptibility factor dementia specifically @ DiseaseTgt $ . Experiments using monoclonal antibody @ GeneSrc $ suggest neurons Pick bodies immunoreactive @ GeneSrc $ dose effect epsilon 4 allele age onset dementias @ DiseaseTgt $ association @ GeneSrc $ immunoreactivity neurons Pick bodies support broader role @ GeneSrc $ pathogenesis neuronal degeneration interactions neuronal cytoskeleton .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3212188558984105)\n",
      "- Text: \"@ GeneSrc $ animal models CNS injury @ DiseaseTgt $ . Recent evidence indicates @ GeneSrc $ ( @ GeneSrc $ ) plays central role hippocampal response injury . co-ordinated expression @ GeneSrc $ receptor , @ GeneSrc $ [ low density lipoprotein ( LDL ) ] receptor , appears regulate transport cholesterol phospholipids early intermediate phases reinnervation process . dendritic remodeling synaptogenesis , neurons progressively repress synthesis cholesterol favor cholesterol internalization @ GeneSrc $ receptor pathway . discovery epsilon 4 allele strongly linked sporadic familial late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) raises possibility dysfunction lipid-transport system associated compensatory sprouting synaptic remodeling could central @ DiseaseTgt $ process . role @ GeneSrc $ CNS particularly important relation function cholinergic system , relies certain extent integrity phospholipid homeostasis neurons . Recent evidence suggests epsilon 4 allele direct impact cholinergic function @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0051685758859505)\n",
      "- Text: \"LDL receptor-related protein , multifunctional ApoE receptor , binds secreted beta-amyloid precursor protein mediates degradation . secreted form beta-amyloid precursor protein ( APP ) containing Kunitz proteinase inhibitor ( KPI ) domain , also called protease nexin II , internalized degraded cells . show low density lipoprotein ( LDL ) receptor-related protein ( LRP ) responsible endocytosis secreted APP . APPs770 degradation inhibited LRP antagonist called receptor-associated protein ( RAP ) LRP antibodies greatly diminished fibroblasts genetically deficient LRP . APPs695 , lacks KPI domain , poor LRP ligand . Since LRP also binds @ GeneSrc $ @ GeneSrc $ lipoproteins inheritance epsilon 4 allele @ GeneSrc $ gene risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , data link single metabolic pathway two molecules strongly implicated pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001635208900032)\n",
      "- Text: \"@ GeneSrc $ genotypes age onset early-onset familial @ DiseaseTgt $ . effect @ GeneSrc $ allele age onset analyzed two groups families early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , ( 1 ) Volga German ( VG ) kindreds , @ DiseaseTgt $ caused unknown locus ( 2 ) early-onset non-VG families showing evidence linkage chromosome 14 . epsilon 4 allele detectable effect age onset either group . finding suggests forms early-onset familial @ DiseaseTgt $ modifiable APOE status , @ DiseaseTgt $ caused APOE-independent pathways .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4677733297491143)\n",
      "- Text: \"@ GeneSrc $ allele associated deposition amyloid beta-protein following head injury . Deposition amyloid beta-protein ( beta ) brain plays key role pathogenesis @ DiseaseTgt $ . @ GeneSrc $ allele ( apo E-epsilon 4 ) strong risk factor @ DiseaseTgt $ , vitro evidence @ GeneSrc $ directly involved beta deposition . Head injury epidemiological risk factor @ DiseaseTgt $ deposition beta occurs approximately one-third individuals dying severe head injury . report frequency apo E-epsilon 4 individuals beta deposition following head injury ( 0.52 ) higher studies @ DiseaseTgt $ , head-injured individuals without beta deposition apo E-epsilon 4 frequency ( 0.16 ) similar controls without @ DiseaseTgt $ ( P < 0.00001 ) . finding provides evidence linking apo E-epsilon 4 beta deposition vivo suggests known environmental genetic risk factors @ DiseaseTgt $ may act additively . addition finding indicates genetic susceptibility effects head injury .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0810407439817937)\n",
      "- Text: \"case-control study @ GeneSrc $ genotypes @ DiseaseTgt $ associated 's syndrome . Dutch Study Group 's Syndrome Ageing . prevalence clinical signs neuropathological findings @ DiseaseTgt $ ( @ DiseaseTgt $ ) high 's syndrome ( DS ) . general population , @ GeneSrc $ isoform important risk @ DiseaseTgt $ . studied allelic frequencies ApoE 26 DS cases fulfilling clinical diagnostic criteria @ DiseaseTgt $ 26 DS controls matched age , sex , premorbid level mental retardation . meta-analysis data available literature used comparison allele frequencies @ DiseaseTgt $ control populations . ApoE type 2 , 3 , 4 allele frequencies significantly different @ DiseaseTgt $ cases DS controls . ApoE epsilon 4 frequency DS cases @ DiseaseTgt $ ( 0.14 ; CI , 0.06 - 0.26 ) significantly lower @ DiseaseTgt $ population studied far within range nondemented controls general population . findings suggest ApoE epsilon 4 significantly affect pathogenesis @ DiseaseTgt $ DS patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2038689738428111)\n",
      "- Text: \"@ GeneSrc $ cerebral hemorrhage associated amyloid angiopathy . Cerebral amyloid angiopathy ( CAA ) characterized cerebrovascular deposition amyloid beta-peptide , leading intracerebral hemorrhage severe cases . rare familial cases , identified risks CAA advancing age accompanying @ DiseaseTgt $ . tested whether @ GeneSrc $ ( apoE epsilon 4 ) allele associated CAA hemorrhage whether association independent @ DiseaseTgt $ . apoE epsilon 4 genotype determined without knowledge pathology 93 postmortem cases systematically graded severity CAA 15 patients CAA-associated intracerebral hemorrhage . found significant independent effect @ GeneSrc $ genotype cohorts . Among postmortem cases , presence apoE epsilon 4 increased odds ratio moderate severe CAA 2.9-fold , relative cases without epsilon 4 ; two copies epsilon 4 increased odds ratio 13.1-fold . cohort CAA-associated cerebral hemorrhages , apoE epsilon 4 allele frequency 0.40 , significantly greater control frequency 0.14 . increase CAA remained even controlling presence @ DiseaseTgt $ , suggesting apoE epsilon 4 risk factor CAA CAA-related hemorrhage , independent association @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0689995116851938)\n",
      "- Text: \"@ GeneSrc $ allele associated earlier age onset amyotrophic lateral sclerosis . @ GeneSrc $ allele 4 ( apo E epsilon 4 ) known genetic disequilibrium @ DiseaseTgt $ associated earlier age onset dementia . Whether apo E epsilon 4 specific risk factor @ DiseaseTgt $ general susceptibility factor shifts age onset neurodegenerative diseases earlier ages unknown . test possibilities , determined @ GeneSrc $ genotypes subjects familial sporadic amyotrophic lateral sclerosis ( ALS ) . @ GeneSrc $ allele frequencies @ GeneSrc $ gene ALS subjects ( n = 170 , epsilon 2 = 0.071 , epsilon 3 = 0.771 , epsilon 4 = 0.159 ) found comparable allele frequencies general population . Furthermore , significant association observed age onset duration ALS inheritance apoE epsilon 4 : subjects least one copy epsilon 4 ( sporadic ALS : n = 15 , onset 57.7 + /- 13.9 years ; familial ALS : n = 23 , onset 53.6 + /- 9.5 years , duration [ n = 14 ] 2.6 + /- 1.6 years ) comparable ages onset durations subjects without epsilon 4 ( sporadic ALS : n = 28 , onset 53.1 + /- 17.0 years ; familial ALS : n = 56 , onset 50.8 + /- 12.1 years , duration [ n = 30 ] 1.9 + /- 0.8 years ) . lack association apoE epsilon 4 age onset duration ALS suggests apoE epsilon 4 global effect pathogenesis neurodegenerative diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009398130277043)\n",
      "- Text: \"Lack association @ GeneSrc $ @ DiseaseTgt $ elderly Nigerians . part community-based study @ DiseaseTgt $ ( @ DiseaseTgt $ ) Nigerian population aged 65 years , determined @ GeneSrc $ ( @ GeneSrc $ ) genotypes 56 subjects ( 39 controls 17 subjects dementia , including 12 @ DiseaseTgt $ ) . epsilon 4 allele @ GeneSrc $ associated @ DiseaseTgt $ dementia community-based sample . epsilon 4 allele frequency 17.6 % demented patients 16.7 % @ DiseaseTgt $ patients compared 20.5 % control subjects . findings marked contrast strong association epsilon 4 allele @ DiseaseTgt $ previously reported study African Americans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0037027420981169)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ risk modified alpha 1-antichymotrypsin polymorphism . Genetic studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) , devastating neurodegenerative disorder , identified @ GeneSrc $ ( @ GeneSrc $ ) gene strong susceptibility marker @ DiseaseTgt $ . E * 4 allele @ GeneSrc $ major risk factor @ DiseaseTgt $ regardless age onset family history . However , observation @ GeneSrc $ allele neither necessary sufficient expression @ DiseaseTgt $ emphasizes involvement environmental genetic elements , either conjunction @ GeneSrc $ alone , increase individual 's risk developing @ DiseaseTgt $ . Among candidate genes may affect risk multifactorial disease gene coding alpha 1-antichymotrypsin ( ACT ) . Like @ GeneSrc $ protein , ACT binds beta-amyloid peptide ( beta P ) high affinity filamentous deposits found @ DiseaseTgt $ brain serves strong stimulatory factor polymerization beta P amyloid filaments . @ DiseaseTgt $ brains , ACT expression enhanced , particularly areas develop amyloid plaques , suggesting ACT may play important role pathogenesis @ DiseaseTgt $ . show common polymorphism signal peptide ACT confers significant risk @ DiseaseTgt $ . Furthermore , @ GeneSrc $ gene dosage effect associated @ DiseaseTgt $ risk significantly modified ACT polymorphism . also identified unique combination ACT/AA @ GeneSrc $ 4/4 genotypes potential susceptibility marker @ DiseaseTgt $ , frequency 1/17 @ DiseaseTgt $ group compared 1/313 general population control . data show ACT behaves modifier gene alters @ DiseaseTgt $ risk conventionally associated @ GeneSrc $ allele .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9002653583652097)\n",
      "- Text: \"@ GeneSrc $ allele frequency increased progressive supranuclear palsy . examined @ GeneSrc $ ( @ GeneSrc $ ) immunoreactivity allele frequency 12 autopsied cases progressive supranuclear palsy ( PSP ) , neurodegenerative disease characterized diffuse neurofibrillary tangle ( NFT ) formation without beta-amyloid deposits . spite @ GeneSrc $ immunoreactivity associated NFTs , PSP @ GeneSrc $ allele frequency comparable age-matched normal controls . suggests @ DiseaseTgt $ increased frequency ApoE epsilon 4 influence neurofibrillary degeneration , probably linked beta-amyloid deposition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0150926100781849)\n",
      "- Text: \"Cerebrospinal fluid @ GeneSrc $ reduced @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) implicated pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ synthesized within brain suggested involved re-utilization membrane lipids neuronal repair remyelination injury . Spherical @ GeneSrc $ lipoprotein particles found cerebrospinal fluid ( CSF ) . study pathogenetic role @ GeneSrc $ degenerative brain disorders , analysed @ GeneSrc $ CSF . significant ( p < 0.001 ) reduction CSF @ GeneSrc $ ( 1.5 + /- 1.2 ng ml-1 ) found @ DiseaseTgt $ compared controls ( 5.0 + /- 2.7 ng ml-1 ) . less pronounced reduction also found frontal lobe dementia ( 3.1 + /- 1.5 ng ml-1 ; p < 0.05 ) . findings support hypothesis @ GeneSrc $ involved pathogenesis degenerative brain disorders @ DiseaseTgt $ . increased reutilization @ GeneSrc $ complexes brain , part generalized repair process , may explain low CSF @ GeneSrc $ @ DiseaseTgt $ . Alternatively , reduction CSF @ GeneSrc $ may caused absorption @ GeneSrc $ senile plaques neurofibrillary tangles .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.189313239044788)\n",
      "- Text: \"Apolipoprotein E epsilon 2 allele promotes longevity protects patients 's syndrome dementia . Although individuals 's syndrome nearly always develop clinical pathological features @ DiseaseTgt $ , clearly become demented despite living sixth seventh decades . Genetic variation @ GeneSrc $ locus recently shown important determinant @ DiseaseTgt $ , epsilon 4 allele shown associated disease , least cases , epsilon 2 allele negatively associated disease . show , series clinically assessed individuals 's syndrome , epsilon 2 allele @ GeneSrc $ associated longevity absence clinical evidence dementia . data show clinical phenotype 's syndrome modulated genes chromosomes chromosome 21 . importance observation pathogenesis @ DiseaseTgt $ , 's syndrome general , discussed .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0074528260009003)\n",
      "- Text: \"Quantitative analysis senile plaques @ DiseaseTgt $ : observation log-normal size distribution molecular epidemiology differences associated @ GeneSrc $ genotype trisomy 21 ( syndrome ) . discovery epsilon 4 allele @ GeneSrc $ ( @ GeneSrc $ ) gene putative risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) general population highlighted role genetic influences extremely common disabling illness . long recognized another genetic abnormality , trisomy 21 ( syndrome ) , associated early severe development AD neuropathological lesions . remains challenge , however , understand facts relate pathological changes brains @ DiseaseTgt $ patients . used computerized image analysis examine size distribution one characteristic neuropathological lesions @ DiseaseTgt $ , deposits beta peptide senile plaques ( SPs ) . Surprisingly , find log-normal distribution fits SP size distribution quite well , motivating porous model SP morphogenesis . analyzed SP size distribution curves genotypically defined subgroups @ DiseaseTgt $ patients . data demonstrate apoE epsilon @ DiseaseTgt $ trisomy @ DiseaseTgt $ lead increased amyloid deposition , apparently different mechanisms . size distribution curve shifted toward larger plaques trisomy @ DiseaseTgt $ , probably reflecting increased beta production . apoE epsilon @ DiseaseTgt $ , size distribution unchanged number SP increased compared @ GeneSrc $ epsilon 3 , suggesting increased probability SP initiation . results demonstrate subgroups @ DiseaseTgt $ patients defined basis molecular characteristics quantitatively different neuropathological phenotypes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7788283219444653)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ . Inheritance specific @ GeneSrc $ ( @ GeneSrc $ ) alleles determines , large part , risk mean age onset late-onset @ DiseaseTgt $ . mechanism @ GeneSrc $ isoforms differentially contribute disease expression , however , unknown . Isoform-specific differences identified binding @ GeneSrc $ microtubule-associated protein tau , forms paired helical filament neurofibrillary tangles , amyloid beta peptide , major component neuritic plaque . isoform-specific interactions @ GeneSrc $ give rise testable hypotheses mechanism ( ) pathogenesis @ DiseaseTgt $ . unresolved issue increasing importance relationship structural pathological lesions cellular pathogenesis responsible clinical disease phenotype , progressive dementia . identification @ GeneSrc $ cytoplasm human neurons characterization isoform-specific binding @ GeneSrc $ microtubule-associated proteins tau MAP-2 present possibility @ GeneSrc $ may affect microtubule function @ DiseaseTgt $ brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0030327827693211)\n",
      "- Text: \"@ GeneSrc $ genotype Lewy body disease . determine whether @ GeneSrc $ ( @ GeneSrc $ ) genotype affects neuropathology Lewy body disease ( LBD ) , examined 18 cases LBD concurrent @ DiseaseTgt $ CERAD criteria . obtained @ GeneSrc $ genotypes , determined diffuse beta-amyloid plaque ( beta P ) Lewy body densities multiple brain regions , graded intensity CA2 - 3 ubiquitin-positive neurites , vacuolar change , nigral pathology , amyloid angiopathy , subpial amyloid deposition . @ GeneSrc $ allele frequencies follows : epsilon 2 , 0.14 + /- 0.07 ; epsilon 3 , 0.64 + /- 0.08 ; epsilon 4 , 0.22 + /- 0.03 . mean beta P density lower APOE epsilon 3/3 cases ( 14.5 beta Ps per mm2 ) groups @ GeneSrc $ epsilon 2 ( 67.0 ) APOE epsilon 4 ( 46.6 ) alleles . difference due largely difference beta P density @ GeneSrc $ epsilon 2 group APOE epsilon 3/3 group ( F = 5.525 , p < 0.02 ) . CA2 - 3 neuritic degeneration greater APOE epsilon 4 allele APOE epsilon 3/3 genotype ( grade = 1.9 + /- 1.3 versus 0.938 + /- 0.9 ; Kruskal-Wallis test statistic = 6.962 , p < 0.05 ) . data consistent hypothesis @ GeneSrc $ genotype may affect neuropathology LBD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003350085994002)\n",
      "- Text: \"@ GeneSrc $ allele frequencies @ DiseaseTgt $ , Lewy body dementia , @ DiseaseTgt $ cerebrovascular disease vascular dementia . Apolipoprotein ( @ GeneSrc $ ) genotyped using fluorescent PCR-RFLP assay 187 patients probable possible clinical diagnosis sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) 166 autopsied patients dementia ( 21 presenile @ DiseaseTgt $ , 70 senile @ DiseaseTgt $ , 18 Lewy body dementia ( LBD ) , 38 @ DiseaseTgt $ ( @ DiseaseTgt $ ) , 19 vascular dementia ) . relative epsilon 4 allele frequency 0.472 LBD , 0.513 @ DiseaseTgt $ , 0.405 presenile @ DiseaseTgt $ , 0.364 senile @ DiseaseTgt $ , 0.079 vascular dementia . relative epsilon 2 allele frequency 0.211 vascular dementia , 0.083 LBD , 0.047 presenile @ DiseaseTgt $ , 0.100 senile @ DiseaseTgt $ 0.039 @ DiseaseTgt $ CVD . infer @ GeneSrc $ major risk factor structural phenotypes dementia involving @ DiseaseTgt $ , alone conjunction another pathology . addition , epsilon 2 allele likely represent risk factor vascular morbidity , relative epsilon 2 allele frequency 0.211 patients vascular dementia compared 0.144 elderly controls .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2321201286842764)\n",
      "- Text: \"Protective effect apolipoprotein E type 2 allele late onset @ DiseaseTgt $ . Gene dosage @ GeneSrc $ allele major risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) late onset ( age 60 ) . studied large series 115 @ DiseaseTgt $ case subjects 243 controls well 150 affected 197 unaffected members 66 @ DiseaseTgt $ families . data demonstrate protective effect epsilon 2 allele , addition dose effect epsilon 4 allele sporadic @ DiseaseTgt $ . Although substantial proportion ( 65 % ) @ DiseaseTgt $ attributable presence epsilon 4 alleles , risk @ DiseaseTgt $ lowest subjects epsilon 2/epsilon 3 genotype , additional 23 % @ DiseaseTgt $ attributable absence epsilon 2 allele . opposite actions epsilon 2 epsilon 4 alleles support direct involvement APOE pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0599281452966279)\n",
      "- Text: \"Dose-dependent association @ GeneSrc $ allele epsilon 4 late-onset , sporadic @ DiseaseTgt $ . examined @ GeneSrc $ ( @ GeneSrc $ ) genotypes 47 patients late-onset sporadic @ DiseaseTgt $ ( mean age onset + /- standard deviation , 72.2 + /- 6.4 years ) , 8 late-onset familial @ DiseaseTgt $ ( 75.5 + /- 5.1 years ) , 18 early-onset sporadic @ DiseaseTgt $ ( 52.8 + /- 4.7 years ) , 10 early-onset familial @ DiseaseTgt $ ( 52.0 + /- 6.8 years ) Japan compared genotypes control subjects . late-onset sporadic @ DiseaseTgt $ , apo E-epsilon 4 frequency increased significantly ( epsilon 4 frequency : 0.34 vs 0.095 controls , p < 0.0001 ) , odds ratio , represents strength association @ DiseaseTgt $ apo E-epsilon 4 , markedly increased increasing dose apo E-epsilon 4 gene ( 3 [ 95 % confidence interval , 2 - 6 ] one dose ; 43 [ 95 % confidence interval , 12 - 154 ] two doses ) . study also suggested apo E-epsilon 4 associated late-onset ( epsilon 4 : 0.31 ) early-onset familial @ DiseaseTgt $ ( epsilon 4 : 0.35 ) . contrast , found association apo E-epsilon 4 early-onset sporadic @ DiseaseTgt $ ( epsilon 4 : 0.08 ) . results indicate risk developing late-onset sporadic @ DiseaseTgt $ markedly dependent dose apo E-epsilon 4 , apo E-epsilon 4 appear major risk factor early-onset sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0231105517973341)\n",
      "- Text: \"@ GeneSrc $ allele doses late-onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1337426455560756)\n",
      "- Text: \"@ GeneSrc $ polymorphism Japanese patients @ DiseaseTgt $ vascular dementia . @ GeneSrc $ ( @ GeneSrc $ ) plays key part lipid metabolism liver , CNS . clarify association @ GeneSrc $ polymorphism @ DiseaseTgt $ vascular dementia Japan , 13 patients early onset ( age > = 65 ) sporadic @ DiseaseTgt $ , 40 patients late onset ( age < = 65 ) sporadic @ DiseaseTgt $ , 19 patients vascular dementia , 49 non-demented control subjects analysed . results showed significantly increased frequency epsilon 4 allele patients late onset sporadic @ DiseaseTgt $ ( 0.25 ) , patients early onset sporadic @ DiseaseTgt $ ( 0.04 ) patients vascular dementia ( 0.13 ) compared controls ( 0.09 ) . raised frequency epsilon 4 allele patients late onset sporadic @ DiseaseTgt $ lower magnitude United States Canadian studies . may part due lower epsilon 4 frequency normal Japanese population reflect lower morbidity @ DiseaseTgt $ Japan .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.860598762811347)\n",
      "- Text: \"Predictive value @ GeneSrc $ genotyping @ DiseaseTgt $ : results autopsy series analysis several combined studies . Apoliprotein E ( @ GeneSrc $ ) associated Alzheimer 's neurofibrillary tangles beta-amyloid protein senile plaques . Recent studies shown increased frequency epsilon 4 allele @ GeneSrc $ gene familial sporadic cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) . present case control study , determined @ GeneSrc $ genotype allele-specific extension 113 postmortem cases sporadic @ DiseaseTgt $ 77 control brains shown free @ DiseaseTgt $ neuropathological features calculated frequency various allelic forms @ GeneSrc $ ( epsilon 2 , epsilon 3 , epsilon 4 ) . odds ratio associating epsilon 4 @ DiseaseTgt $ 15.5 ( 95 % confidence interval [ CI ] 6.2 - 38.5 ) , population attributable risk 0.53 . also combined results study several others calculate parameters larger population ( 570 controls 961 @ DiseaseTgt $ subjects ) ; odds ratio larger group 6.2 ( 95 % CI 4.9 - 7.8 ) population attributable risk 0.57 . results substantiate strengthen association epsilon 4 allele @ GeneSrc $ gene @ DiseaseTgt $ . also used results investigate usefulness determination epsilon 4 carrier status diagnosis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3157464122481225)\n",
      "- Text: \"apolipoprotein epsilon 4 allele Parkinson 's disease without dementia . epsilon 4 isoform @ GeneSrc $ ( @ GeneSrc $ ) may confer genetic susceptibility familial sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . dementia @ DiseaseTgt $ Parkinson 's disease ( PD ) share many biologic clinical features , determined @ GeneSrc $ genotypes 79 patients PD , 22 demented , 44 age-matched healthy elderly controls community . hypothesized dementia similar @ DiseaseTgt $ , would higher allele frequency apolipoprotein epsilon 4 ( Apo epsilon 4 ) demented PD patients compared nondemented PD patients controls . epsilon 4 allele frequency PD without dementia 0.132 , PD dementia , 0.068 , controls , 0.102 . association Apo epsilon 4 dementia PD patients . conclude biologic basis dementia PD may differ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0333666113109535)\n",
      "- Text: \"@ GeneSrc $ associates beta amyloid peptide @ DiseaseTgt $ form novel monofibrils . Isoform @ GeneSrc $ associates efficiently @ GeneSrc $ . Late-onset sporadic @ DiseaseTgt $ associated apolipoprotein E ( apoE ) type 4 allele expressing protein isoform @ GeneSrc $ . @ GeneSrc $ binds avidly beta amyloid ( beta ) peptide , major component senile plaque @ DiseaseTgt $ , isoform-specific manner . @ GeneSrc $ isoform binds beta peptide rapidly @ GeneSrc $ . observed soluble SDS-stable complexes @ GeneSrc $ @ GeneSrc $ , formed coincubation beta peptide , precipitated several days incubation 37 degrees C @ GeneSrc $ complexes precipitating rapidly @ GeneSrc $ complexes . beta ( 1 - 28 ) beta ( 1 - 40 ) peptides incubated presence absence @ GeneSrc $ , @ GeneSrc $ , bovine serum albumin 4 37 degrees C ( pH 7.3 ) . Negative stain electron microscopy revealed beta peptide alone self-assembled twisted ribbons containing two three strands occasionally multistranded sheets . @ GeneSrc $ coincubates yielded monofibrils 7 nm diameter . ApoE4/A beta coincubates yielded denser matrix monofibrils apoE3/A beta coincubates . Unlike purely monofibrillar apoE4/A beta coincubates , apoE3/A beta coincubates also contained double- triple-stranded structures . apoE isoforms shown immunogold labeling uniformly distributed along beta peptide monofibrils . Monofibrils appeared earlier apoE4/A beta apoE3/A beta time-course experiments . Thus @ GeneSrc $ @ GeneSrc $ interact beta amyloid peptide form novel monofibrillar structures , @ GeneSrc $ avidly , finding consistent biochemical genetic association @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4324734268102752)\n",
      "- Text: \"@ GeneSrc $ allele frequency vascular dementia @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0028360061412459)\n",
      "- Text: \"Association @ GeneSrc $ allele epsilon 4 late-onset familial sporadic @ DiseaseTgt $ . @ GeneSrc $ , type epsilon 4 allele ( APOE epsilon 4 ) , associated late-onset familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . high avidity specific binding amyloid beta-peptide protein @ GeneSrc $ test hypothesis late-onset familial @ DiseaseTgt $ may represent clustering sporadic @ DiseaseTgt $ families large enough studied , extended analyses @ GeneSrc $ alleles several series sporadic @ DiseaseTgt $ patients . APOE epsilon 4 significantly associated series probable sporadic @ DiseaseTgt $ patients ( 0.36 + /- 0.042 , @ DiseaseTgt $ , versus 0.16 + /- 0.027 , controls [ allele frequency estimate + /- standard error ] , p = 0.00031 ) . Spouse controls differ CEPH grandparent controls Centre d'Etude du Polymorphisme Humain ( CEPH ) literature controls . large combined series autopsy-documented sporadic @ DiseaseTgt $ patients also demonstrated highly significant association APOE epsilon 4 allele ( 0.40 + /- 0.026 , p < = 0.00001 ) . data support involvement ApoE epsilon 4 pathogenesis late-onset @ DiseaseTgt $ . @ GeneSrc $ isoforms may play important role metabolism beta-peptide , APOE epsilon 4 may operate susceptibility gene ( risk factor ) clinical expression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.122260259651891)\n",
      "- Text: \"Binding human @ GeneSrc $ synthetic amyloid beta peptide : isoform-specific effects implications late-onset @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) , plasma apolipoprotein plays central role lipoprotein metabolism , localized senile plaques , congophilic angiopathy , neurofibrillary tangles @ DiseaseTgt $ . Late-onset @ DiseaseTgt $ patients increased frequency one three common @ GeneSrc $ alleles , epsilon 4 , suggesting @ GeneSrc $ associated increased susceptibility disease . follow suggestion , compared binding synthetic amyloid beta ( beta/A4 ) peptide purified @ GeneSrc $ @ GeneSrc $ , common isoform . isoforms bound synthetic beta/A4 peptide , primary constituent plaque angiopathy , forming complex resisted dissociation boiling SDS . Oxygen-mediated complex formation implicated binding increased oxygenated buffer , reduced nitrogen-purged buffer , prevented reduction dithiothreitol 2-mercaptoethanol . Binding beta/A4 peptide saturable 10 ( -4 ) peptide required residues 12 - 28 . Examination @ GeneSrc $ fragments revealed residues 244 - 272 critical complex formation . oxidized @ GeneSrc $ @ GeneSrc $ bound beta/A4 peptide ; however , binding @ GeneSrc $ observed minutes , whereas binding @ GeneSrc $ required hours . addition , @ GeneSrc $ bind beta/A4 peptide pH < 6.6 , whereas @ GeneSrc $ bound beta/A4 peptide pH 7.6 4.6 . Together results indicate differences two isoforms complexing beta/A4 peptide . Binding beta/A4 peptide oxidized @ GeneSrc $ may determine sequestration targeting either @ GeneSrc $ beta/A4 peptide , isoform-specific differences @ GeneSrc $ binding oxidation may involved pathogenesis intra- extracellular lesions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9611544655690448)\n",
      "- Text: \"@ GeneSrc $ : high-avidity binding beta-amyloid increased frequency type 4 allele late-onset @ DiseaseTgt $ . @ GeneSrc $ immunochemically localized senile plaques , vascular amyloid , neurofibrillary tangles @ DiseaseTgt $ . vitro , @ GeneSrc $ cerebrospinal fluid binds synthetic beta A4 peptide ( primary constituent senile plaque ) high avidity . Amino acids 12 - 28 beta A4 peptide required . gene @ GeneSrc $ located chromosome 19q13.2 , within region previously associated linkage late-onset @ DiseaseTgt $ . Analysis @ GeneSrc $ alleles @ DiseaseTgt $ controls demonstrated highly significant association apolipoprotein E type 4 allele ( APOE-epsilon 4 ) late-onset @ DiseaseTgt $ . allele frequency APOE-epsilon 4 30 random affected patients , different @ DiseaseTgt $ family , 0.50 + /- 0.06 ; allele frequency APOE-epsilon 4 91 age-matched unrelated controls 0.16 + /- 0.03 ( Z = 2.44 , P = 0.014 ) . functional role apolipoprotein E-E4 isoform pathogenesis late-onset @ DiseaseTgt $ suggested .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1049076553509541)\n",
      "- Text: \"@ GeneSrc $ inclusion body myositis . genetic predisposition inclusion body myositis ( IBM ) probably multifactorial . deposition beta-amyloid protein characteristic histological feature IBM @ DiseaseTgt $ ( @ DiseaseTgt $ ) . epsilon 4 allele @ GeneSrc $ ( @ GeneSrc $ ) strongly associated familial late-onset @ DiseaseTgt $ . therefore compared @ GeneSrc $ allele frequencies group 14 patients IBM group patients inflammatory muscle diseases general population . frequency epsilon 4 allele IBM increased ( 0.29 ) compared patients inflammatory muscle diseases ( 0.15 ) general population ( 0.13 ) ( p < 0.05 ) . data suggest @ GeneSrc $ genotype may one factors involved determining predisposition development IBM .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0102727192729886)\n",
      "- Text: \"@ GeneSrc $ association dementia population-based study : Framingham study . Apolipoprotein E type 4 allele ( apoE epsilon4 ) associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) late-onset familial form sporadic cases , age-associated risk randomly sampled elderly population established . examined association apoE epsilon4 @ DiseaseTgt $ dementias ( mainly multi-infarct dementia following stroke ) 1,030 persons aged 71 100 years population-based Framingham Study cohort . Kaplan-Meier survival analysis revealed 55 % apoE epsilon4/epsilon4 homozygotes developed @ DiseaseTgt $ age 80 , whereas 27 % @ GeneSrc $ epsilon3/epsilon4 heterozygotes developed @ DiseaseTgt $ age 85 , 9 % without 4 allele developed @ DiseaseTgt $ age 85 years . comparison persons without 4 allele , risk ration @ DiseaseTgt $ 3.7 ( 95 % CI = 1.9 7.5 ) @ GeneSrc $ epsilon3/epsilon4 heterozygotes 30.1 ( 95 % CI = 10.7 84.4 ) apoE epsilon4 homozygotes . @ GeneSrc $ epsilon2 ( 2/2 , 2/3 , 2/4 genotypes ) associated absence @ DiseaseTgt $ . One-half ( n=21 ) 43 @ DiseaseTgt $ patients either homozygous heterozygous apoE epsilon4 . found evidence association apoE epsilon4 dementia , primarily multi-infarct dementia stroke . risk ratio 2.3 ( 95 % CI = 0.9 6.1 ) @ DiseaseTgt $ among persons @ GeneSrc $ epsilon3/epsilon4 . Although apoE epsilon4 allele potent risk factor @ DiseaseTgt $ may associated forms dementia , apoE epsilon4 carriers develop dementia , one-half @ DiseaseTgt $ apoE epsilon4 associated . low positive predictive value marker ( 0.10 ) suggest use @ GeneSrc $ genotyping screening test @ DiseaseTgt $ supported .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4279203585314655)\n",
      "- Text: \"@ GeneSrc $ allele predictor cholinergic deficits treatment outcome @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) critical modulation cholesterol phospholipid transport cells different types . Human @ GeneSrc $ polymorphic protein three common alleles , APO epsilon 2 , APO epsilon 3 , APO epsilon 4 . @ GeneSrc $ associated sporadic late-onset familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Gene dose shown effect risk developing @ DiseaseTgt $ , age onset , accumulation senile plaques brain , reduction choline acetyltransferase ( ChAT ) activity hippocampus @ DiseaseTgt $ subjects . characterize possible impact @ GeneSrc $ allele cholinergic markers @ DiseaseTgt $ , examined effect @ GeneSrc $ allele copy number pre- postsynaptic markers cholinergic activity . @ GeneSrc $ allele copy number showed inverse relationship residual brain ChAT activity nicotinic receptor binding sites hippocampal formation temporal cortex @ DiseaseTgt $ subjects . @ DiseaseTgt $ cases lacking @ GeneSrc $ allele showed ChAT activities close within age-matched normal control values . effect @ GeneSrc $ allele cholinomimetic drug responsiveness assessed next group ( n = 40 ) @ DiseaseTgt $ patients completed double-blind , 30-week clinical trial cholinesterase inhibitor tacrine . Results showed > 80 % @ GeneSrc $ @ DiseaseTgt $ patients showed marked improvement 30 weeks measured @ DiseaseTgt $ assessment scale ( ADAS ) , whereas 60 % @ GeneSrc $ carriers ADAS scores worse compared baseline . results strongly support concept @ GeneSrc $ plays crucial role cholinergic dysfunction associated @ DiseaseTgt $ may prognostic indicator poor response therapy acetylcholinesterase inhibitors @ DiseaseTgt $ patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2904382502504139)\n",
      "- Text: \"High @ GeneSrc $ allele frequency age-related memory decline . Many studies demonstrated strong association presence one two epsilon 4 alleles @ DiseaseTgt $ ( @ DiseaseTgt $ ) , although data available @ GeneSrc $ ( @ GeneSrc $ ) epsilon 4 frequencies preclinical stages @ DiseaseTgt $ . Thus , view determining whether @ GeneSrc $ genotyping could useful early detection @ DiseaseTgt $ , determined @ GeneSrc $ allele frequencies patients memory complaints without dementia ( age-related memory decline , ARMD ) . found APOE epsilon 4 allele frequency 0.315 ARMD group , similar 0.293 @ DiseaseTgt $ group , contrast 0.057 control group . Significant differences ( t=-2.91 , df=25 , p=0.008 ) found @ DiseaseTgt $ Assessment Scale ( ADAS ) total scores ARMD patients least one epsilon 4 allele ( mean=24.2 ) compared ARMD patients without epsilon 4 allele ( mean=14.7 ) . results suggest patients memory complaints , high ADAS score , presence one two @ GeneSrc $ alleles could high risk developing @ DiseaseTgt $ . Thus , propose genotyping conjunction ADAS scale may prove useful diagnostic markers @ DiseaseTgt $ presymptomatic stages .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.485539888022455)\n",
      "- Text: \"Relative risk @ DiseaseTgt $ age-at-onset distributions , based @ GeneSrc $ genotypes among elderly African Americans , Caucasians , Hispanics New York City . @ GeneSrc $ ( APOE-epsilon 4 ) consistently associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) may responsible earlier age onset . previously reported diminished association APOE-epsilon 4 @ DiseaseTgt $ African Americans . Using new method , allows inclusion censored information , compared relative risks @ GeneSrc $ genotypes expanded collection cases controls three ethnic groups New York community . relative risk @ DiseaseTgt $ associated APOE-epsilon 4 homozygosity increased ethnic groups ( African American relative risk [ RR ] =3.0 ; 95 % confidence interval [ CI ] =1.5 - 5.9 ; Caucasian RR=7.3 , 95 % CI=2.5 - 21.6 ; Hispanic RR=2.5 , 95 % CI=1.1 - 5.7 ) , compared @ GeneSrc $ 3/epsilon 3 genotypes . risk also increased APOE-epsilon 4 heterozygous Caucasians ( RR=2.9 , 95 % CI=1.7 - 5.1 ) Hispanics ( RR=1.6 , 95 % CI=1.1 - 2.3 ) , African Americans ( RR=0.6 , 95 % Ci=0.4 - 0.9 ) . age distribution proportion Caucasians Hispanics without @ DiseaseTgt $ consistently lower APOE-epsilon 4 homozygous APOE-epsilon 4 heterozygous individuals @ GeneSrc $ genotypes . African Americans relationship observed APOE-epsilon 4 homozygotes . results confirm @ GeneSrc $ genotypes influence RR @ DiseaseTgt $ Caucasians Hispanics . Differences risk among APOE-epsilon 4 heterozygote African Americans suggest genetic environmental factors may modify effect APOE-epsilon 4 populations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2182522837849766)\n",
      "- Text: \"Gender difference @ GeneSrc $ risk familial @ DiseaseTgt $ : possible clue higher incidence @ DiseaseTgt $ women . Late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated @ GeneSrc $ allele . late-onset familial @ DiseaseTgt $ , women significantly higher risk developing disease men . aim study determine whether gender difference familial @ DiseaseTgt $ function @ GeneSrc $ genotype . studied 58 late-onset familial @ DiseaseTgt $ kindreds . Kaplan-Meier survival analysis used assess genotype-specific distributions age onset . Odds ratios estimated logistic regression adjustment age conditional logistic regression stratification families . methods detected significant gender difference epsilon4 heterozygous genotype . women , epsilon4 heterozygotes higher risk without epsilon4 ; significant difference epsilon4 heterozygotes epsilon4 homozygotes . men , epsilon4 heterozygotes lower risk epsilon4 homozygotes ; significant difference epsilon4 heterozygotes without epsilon4 . direct comparison epsilon4 heterozygous men women revealed significant twofold increased risk women . confirmed results 15 autopsy-confirmed @ DiseaseTgt $ kindreds National Cell Repository Indiana University @ DiseaseTgt $ Center . observations consistent increased incidence familial @ DiseaseTgt $ women may critical clue role gender pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0041253358624974)\n",
      "- Text: \"@ GeneSrc $ allele Parkinson 's disease @ DiseaseTgt $ . association @ GeneSrc $ ) epsilon 4 allele Parkinson 's disease ( PD ) coexistent dementia remained controversial . determined ApoE allele frequencies 35 subjects neuropathologically confirmed Lewy body Parkinsonism without concomitant @ DiseaseTgt $ , 27 patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) , 54 controls without neurodegenerative disease . hypothesized @ DiseaseTgt $ PD evolve pathomechanism `` pure @ DiseaseTgt $ , `` ApoE epsilon 4 allele frequency PD @ DiseaseTgt $ ( @ DiseaseTgt $ ) pure @ DiseaseTgt $ similar . frequency ApoE epsilon 4 allele differed significantly @ DiseaseTgt $ ( 13.3 % ) @ DiseaseTgt $ cases ( 35.2 % ) , @ DiseaseTgt $ PD without @ DiseaseTgt $ pathology ( 12.5 % ) controls ( 11.1 % ) . conclude ApoE epsilon 4 allele function risk factor influences development @ DiseaseTgt $ PD . data suggest Parkinson 's disease @ DiseaseTgt $ @ DiseaseTgt $ coexistent Parkinsonian features represent two distinct entities clinicopathological molecular genetic levels .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5984364259578703)\n",
      "- Text: \"@ GeneSrc $ allele associated increased neuritic plaques cerebral amyloid angiopathy @ DiseaseTgt $ Lewy body variant . OBJECTIVE : determine relationship @ GeneSrc $ ( @ GeneSrc $ ) genotype neuropathologic lesions @ DiseaseTgt $ ( @ DiseaseTgt $ ) Lewy body variant ( LBV ) . DESIGN : Retrospective genetic-neuropathologic study @ DiseaseTgt $ LBV cases . main neuropathologic outcome measures modeled function @ GeneSrc $ genotype , neuropathologic diagnosis , gender . Age death duration symptom effects controlled ANCOVA . PATIENTS : One hundred twenty-seven cases neuropathologically diagnosed @ DiseaseTgt $ ( n = 84 ) LBV ( n = 43 ) . MAIN OUTCOME MEASURES : Quantitative scores neuritic plaques ( NPs ) , neurofibrillary tangles ( NFTs ) , cerebral amyloid angiopathy ( CAA ) severity , CAA prevalence averaged across four brain regions : midfrontal , inferior parietal , superior temporal , hippocampal . RESULTS : @ GeneSrc $ epsilon 4 allele associated increased NPs within @ DiseaseTgt $ LBV . epsilon 4 allele associated increased frequency CAA @ DiseaseTgt $ LBV groups combined groups combined LBV alone . CAA severity NETs increased epsilon 4/4 homozygous case @ DiseaseTgt $ LBV combined , significant effects within @ DiseaseTgt $ LBV alone . CONCLUSIONS : @ GeneSrc $ epsilon 4 allele strongly associated increased NPs , neocortical NFTs , @ DiseaseTgt $ LBV .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2076195925015899)\n",
      "- Text: \"@ GeneSrc $ allele , cognitive decline , deterioration everyday performance @ DiseaseTgt $ . Many studies demonstrated association @ GeneSrc $ epsilon 4 allele @ DiseaseTgt $ ( @ DiseaseTgt $ ) . present study concerned relationship apoE epsilon 4 allele progression symptoms @ DiseaseTgt $ . determined rates cognitive decline deterioration everyday performance prospectively 3 years 64 patients clinically diagnosed @ DiseaseTgt $ using Cambridge Cognitive Examination ( CAMCOG ) , Mini-Mental State Examination ( MMSE ) , Dementia Scale ( DS ) included Cambridge Mental Disorders Elderly Examination ( CAMDEX ) . Carriers noncarriers epsilon 4 allele significantly differ cognitive functioning everyday performance baseline measurements . time elapsed since estimated onset symptoms also different two groups . suggested clinical progression @ DiseaseTgt $ associated epsilon 4 status patients entered study . prospective observation , rate cognitive decline assessed CAMCOG MMSE rate deterioration everyday performance rated DS also different carriers noncarriers epsilon 4 allele . conclude clinical course @ DiseaseTgt $ independent apoE epsilon 4 allele .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032199448558712)\n",
      "- Text: \"@ GeneSrc $ genotype influence rates cognitive decline @ DiseaseTgt $ . BACKGROUND : Inheritance apolipoprotein E ( apoE ) epsilon 4 allele risk factor developing @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated lower age dementia onset . purpose study determine whether apoE genotypes differentially influence course cognitive decline @ DiseaseTgt $ . METHODS : administered nine cognitive tests assessed explicit memory , attention , language , visuospatial function , frontal-lobe function , logical reasoning abilities 66 probable @ DiseaseTgt $ patients every 6 24 months span 5.5 years . identified apoE genotype PCR-based method ; 16 patients epsilon 3/3 , 34 epsilon 3/4 , 16 epsilon 4/4 . Using regression statistical methods , computed change performance test patient time . analyzed mean change test patients grouped according apoE genotype . RESULTS : @ DiseaseTgt $ patients group , performance cognitive tests declined significantly time , rate decline vary significantly across apoE genotypes cognitive test . Specifically , rate cognitive decline faster patients epsilon 4 allele epsilon 3/3 . CONCLUSIONS : results indicate mechanism placing individuals epsilon 4 allele risk developing @ DiseaseTgt $ influence rate cognitive decline . observations imply influence apoE epsilon 4 either precedes occurs early point @ DiseaseTgt $ process .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029223733344537)\n",
      "- Text: \"@ GeneSrc $ epsilon 4 allele cognitive decline patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001094872362168)\n",
      "- Text: \"Apolipoprotein E type epsilon 4 allele frequency increased patients schizophrenia . Apolipoprotein E type epsilon 4 alleles increased @ DiseaseTgt $ ( @ DiseaseTgt $ ) cortical Lewy body dementia , epsilon 2 allele associated protective factor development dementia @ DiseaseTgt $ . determined @ GeneSrc $ genotype schizophrenic patients coming autopsy ( age range 19 - 95 years ) . allele frequencies group : epsilon 2 , 6.0 % ; epsilon 3 , 67.9 % ; epsilon 4 , 26.2 % . Three patients ( 14 % ) homozygous epsilon 4 allele . Thus , schizophrenia associated increased epsilon 4 allele frequency , compared controls ( P = 0.01 ) , indistinguishable found either @ DiseaseTgt $ Lewy body dementia . increased epsilon 4 allele frequency associated increased age schizophrenia patient , indicating due co-existence @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0572189507186209)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ : genotype-specific risks age sex . distribution @ GeneSrc $ ( @ GeneSrc $ ) genotypes function age sex examined French population 417 @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients 1,030 control subjects . compared @ GeneSrc $ epsilon3 allele , increased risk associated @ GeneSrc $ epsilon4 allele ( odds ratio [ ] [ epsilon4 ] = 2.7 95 % confidence interval [ CI ] = 2.0 - 3.6 ; P < .001 ) protective effect @ GeneSrc $ epsilon2 allele ( [ epsilon2 ] = 0.5 95 % CI = 0.3 - 0.98 ; P = .012 ) retrieved . effect epsilon4 allele dosage susceptibility confirmed ( [ epsilon4/epsilon4 ] vs. epsilon3/epsilon3 genotype = 11.2 [ 95 % CI = 4.0 - 31.6 ] ; [ epsilon3/epsilon4 ] vs. epsilon3/epsilon3 genotype = 2.2 [ 95 % CI = 1.5 - 3.5 ] ) . frequency epsilon4 allele lower male cases female cases , , since similar difference found controls , lead difference sex . ORs epsilon4 allele versus epsilon3 allele , ( epsilon4 ) , equal age classes : ( epsilon4 ) extreme groups onset < 60 years > 79 years significantly lower age groups 60 - 79 years . epsilon3/epsilon4 individuals , sex-specific lifetime risk estimates age 85 years ( i.e . , sex-specific penetrances age 85 years ) 0.14 ( 95 % CI 0.04 - 0.30 ) men 0.17 ( 95 % CI 0.09 - 0.28 ) women .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0567990729678578)\n",
      "- Text: \"prospective study cognitive health elderly ( Oregon Brain Aging Study ) : effects family history @ GeneSrc $ genotype . oldest old fastest-growing segment population highest prevalence dementia . Little known genetics cognitive health old . aim study determine whether genetic risk factors @ DiseaseTgt $ @ DiseaseTgt $ , @ GeneSrc $ ( @ GeneSrc $ ) epsilon4 allele family history dementia-continue important factors cognitive health old . Case-control studies suggest effect genetic factors diminishes age > 75 years . present prospective study provided evidence contrary . studied 114 Caucasian subjects physically healthy cognitively intact age 75 years followed , average 4 years , neurological , psychometric , neuroimaging examinations . Excellent health entry protect cognitive decline . Incidence cognitive decline rose sharply age . epsilon4 family history dementia ( independent epsilon4 ) associated earlier age onset dementia . Subjects epsilon4 family history dementia ninefold-higher age-specific risk dementia neither epsilon4 family history dementia . observations suggest rate cognitive decline increases age @ GeneSrc $ familial/genetic factors influence onset age throughout life .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0044487827116937)\n",
      "- Text: \"High frequency apolipoprotein E epsilon 2 allele hemorrhage due cerebral amyloid angiopathy . somewhat conflicting published data @ GeneSrc $ ( @ GeneSrc $ ) genotype hemorrhage due cerebral amyloid angiopathy ( CAA ) , unclear whether @ GeneSrc $ genotype influences risk CAA-related hemorrhage independently association concomitant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . determined @ GeneSrc $ genotypes 36 patients presenting cerebral hemorrhage associated histologically confirmed CAA . frequency apoE epsilon 2 0.25 frequency apoE epsilon 4 0.18 . Patients CAA-related hemorrhage concomitant @ DiseaseTgt $ pathology ( CERAD criteria , n = 17 ) high apoE epsilon 4 frequency , close @ DiseaseTgt $ cases without hemorrhage . Patients CAA-related hemorrhage occurred absence significant @ DiseaseTgt $ pathology ( n = 13 ) apoE epsilon 4 frequency somewhat lower @ DiseaseTgt $ controls without hemorrhage . However , CAA-related hemorrhage , apoE epsilon 2 frequency high regardless whether significant @ DiseaseTgt $ pathology present . conclude whereas possession apoE epsilon 2 may risk factor cerebral hemorrhage due CAA , apoE epsilon 4 risk factor concomitant @ DiseaseTgt $ independent risk factor CAA-related hemorrhage .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0585223679012705)\n",
      "- Text: \"role presenilin 1 genetics @ DiseaseTgt $ . Approximately 75 % @ DiseaseTgt $ patients onset disease age 60 years , 60 % @ DiseaseTgt $ patients family history disease . cases EOAD clearly inherited autosomal-dominant manner . beta APP gene chromosome 21 , PS-1 gene chromosome 14 , PS-2 gene chromosome 1 characterized genes mutations lead familial EOAD . LOAD , work @ GeneSrc $ indicates epsilon 4 allele risk factor developing @ DiseaseTgt $ . However , 35 - 50 % @ DiseaseTgt $ patients epsilon 4 allele . loci contributing LOAD remain mapped characterized . complex disorders , additional loci may involve genetic interactions known @ DiseaseTgt $ loci . Identification susceptibility loci @ DiseaseTgt $ major goal resolving pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6659935772193049)\n",
      "- Text: \"@ GeneSrc $ genotype risk factor nonpresenilin early-onset @ DiseaseTgt $ families . @ GeneSrc $ ( @ GeneSrc $ ) genotype significant risk factor modulator age onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . analyzed effect @ GeneSrc $ genotype two distinct early-onset @ DiseaseTgt $ groups : families mutation presenilin-1 gene ( PS-1 ) chromosome 14 , families without mutation detectable PS-1 , presenilin-2 ( PS-2 ) , amyloid precursor protein ( APP ) gene ( non-PS early-onset @ DiseaseTgt $ ) . @ GeneSrc $ genotype clearly shown modulate age onset families mutation PS-1 gene families lesion detectable either presenilin APP gene . effects double dose @ GeneSrc $ age onset assessed PS-1 AD families due lack affected @ GeneSrc $ homozygotes sample set ; insufficiency need assessed studies . association @ GeneSrc $ allele @ DiseaseTgt $ PS-1 families . Non-PS early-onset @ DiseaseTgt $ families shown significantly higher frequency @ GeneSrc $ compared controls PS-1 AD group . observations important suggest 1 ) genetic environmental factors modify @ DiseaseTgt $ phenotype PS-1 non-PS early-onset families ; 2 ) @ GeneSrc $ allele significant risk factor etiology non-PS early-onset @ DiseaseTgt $ useful adjunct diagnosis unaffected family members .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.452315560003748)\n",
      "- Text: \"@ GeneSrc $ genotype predicts -- whether -- one predisposed develop @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2253793209540339)\n",
      "- Text: \"Age onset Huntington disease : sex specific influence @ GeneSrc $ genotype normal CAG repeat length . Age onset ( AO ) Huntington disease ( HD ) known correlated length expanded CAG repeat HD gene . @ GeneSrc $ ( @ GeneSrc $ ) genotype , turn , known influence AO @ DiseaseTgt $ , rendering @ GeneSrc $ gene likely candidate affect AO neurological diseases . therefore determined @ GeneSrc $ genotype normal CAG repeat length HD gene 138 HD patients previously analysed respect CAG repeat length . Genotyping @ GeneSrc $ performed blind clinical information . addition highlighting effect normal repeat length upon AO maternally inherited HD male patients , show @ GeneSrc $ epsilon2epsilon3 genotype associated significantly earlier AO males females . sex difference AO apparent @ GeneSrc $ genotypes . findings suggest subtle differences course neurodegeneration HD may allow interacting genes exert gender specific effects upon AO .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0278878481240162)\n",
      "- Text: \"Expression human @ GeneSrc $ reduces amyloid-beta deposition mouse model @ DiseaseTgt $ . epsilon4 allele @ GeneSrc $ ( @ GeneSrc $ ) associated increased risk developing @ DiseaseTgt $ ( @ DiseaseTgt $ ) . may due interactions @ GeneSrc $ amyloid-beta protein ( Abeta ) . assess effects human @ GeneSrc $ isoforms Abeta deposition vivo , bred @ GeneSrc $ @ GeneSrc $ hemizygous ( + /- ) transgenic mice expressing @ GeneSrc $ astrocytes mice homozygous ( + /+ ) mutant amyloid precursor protein ( APPV717F ) transgene develop age-dependent @ DiseaseTgt $ . mice mouse @ GeneSrc $ null ( -/- ) background . nine months age , APPV717F+/- , @ GeneSrc $ mice developed Abeta deposition , , reported previously , quantity Abeta deposits significantly less seen APPV717F+/- mice expressing mouse apo E. contrast effects mouse @ GeneSrc $ , similar levels human @ GeneSrc $ @ GeneSrc $ markedly suppressed early Abeta deposition nine months age APPV717F+/- transgenic mice , even compared mice lacking apo E. findings suggest human @ GeneSrc $ isoforms decrease Abeta aggregation increase Abeta clearance relative environment mouse @ GeneSrc $ @ GeneSrc $ present . results may important implications understanding mechanisms underlying link @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0049302197196472)\n",
      "- Text: \"Association @ DiseaseTgt $ NOS3 gene . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common form neurodegenerative disorder later life . Genetic studies demonstrated @ GeneSrc $ ( @ GeneSrc $ ) gene important susceptibility locus ; however , environmental genetic factors operating alone combination @ GeneSrc $ must also involved . Among candidate genes may contribute residual risk endothelial nitric oxide synthase ( NOS3 ) gene . release vascular endothelium accounts large part endothelium-derived relaxing factor bioactivity . Abnormalities cerebral small vessels occur early @ DiseaseTgt $ , demonstrated recently beta-amyloid interacts endothelial cells blood vessels produce excess superoxide radicals . genotyped 122 cases early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) 317 cases late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) well 392 controls common structural polymorphism Glu/Asp codon 298 NOS3 gene . find highly significant enrichment Glu/Glu homozygotes @ DiseaseTgt $ compared controls . effect appears independent @ GeneSrc $ status . NOS3 may new genetic risk factor @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9925521396508054)\n",
      "- Text: \"Independent association @ GeneSrc $ gene promoter polymorphism increased risk myocardial infarction decreased @ GeneSrc $ plasma concentrations-the ECTIM study . @ GeneSrc $ ( @ GeneSrc $ ) major protein lipid metabolism existing three common isoforms : @ GeneSrc $ . varepsilon4 allele @ GeneSrc $ gene ( @ GeneSrc $ ) coding @ GeneSrc $ isoform associated increased risk myocardial infarction ( MI ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Recently , several polymorphisms @ GeneSrc $ regulatory region reported . associated @ DiseaseTgt $ modified @ GeneSrc $ allelic mRNA expression @ DiseaseTgt $ brains . , investigated whether three promoter polymorphisms ( -491AT , -427CT -219GT ) also modify cardiovascular risk . hypothesis tested large multicentre case-control study MI , ECTIM Study , 567 cases 678 controls . Among three @ GeneSrc $ promoter polymorphisms tested , the-219 allele associated significantly increased risk MI ( = 1.29 , 95 % CI : 1.09 - 1.52 , P < 0.003 ) effect shown independent presence mutations , including @ GeneSrc $ epsilon2/epsilon3/epsilon4 polymorphism . Moreover , the-219 allele greatly decreased @ GeneSrc $ plasma concentrations dose-dependent manner ( P < 0.008 ) . data indicate the-219GT polymorphism @ GeneSrc $ regulatory region emerges new genetic susceptibility risk factor MI constitutes another common risk factor neurodegenerative cardiovascular diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1316594659965662)\n",
      "- Text: \"Apolipoprotein E isoform-dependent amyloid deposition neuritic degeneration mouse model @ DiseaseTgt $ . Apolipoprotein E ( @ GeneSrc $ ) alleles determine age-adjusted relative risk ( epsilon4 > epsilon3 ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ may affect @ DiseaseTgt $ pathogenesis promoting deposition amyloid-beta ( Abeta ) peptide conversion fibrillar form . determine effect @ GeneSrc $ Abeta deposition @ DiseaseTgt $ pathology , compared APP ( V717F ) transgenic ( TG ) mice expressing mouse , human , @ GeneSrc $ ( @ GeneSrc $ ) ) . severe , plaque-associated neuritic dystrophy developed APP ( V717F ) TG mice expressing mouse human @ GeneSrc $ Though significant levels Abeta deposition also occurred APP ( V717F ) TG , @ GeneSrc $ ) mice , neuritic degeneration virtually absent . Expression apoE3 apoE4 APP ( V717F ) TG , @ GeneSrc $ ) mice resulted fibrillar Abeta deposits neuritic plaques 15 months age substantially ( > 10-fold ) fibrillar deposits observed apoE4-expressing APP ( V717F ) TG mice . data demonstrate critical isoform-specific role @ GeneSrc $ neuritic plaque formation , pathological hallmark @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0400610419016615)\n",
      "- Text: \"@ GeneSrc $ ( @ GeneSrc $ ) allele distribution world . @ GeneSrc $ ' thrifty ' allele ? @ GeneSrc $ ( @ GeneSrc $ = gene , @ GeneSrc $ = protein ) plays central role plasma lipoprotein metabolism lipid transport within tissues . @ GeneSrc $ shows genetic polymorphism determined three common alleles , @ GeneSrc $ , @ GeneSrc $ , @ GeneSrc $ product three alleles differs several functional properties . @ GeneSrc $ involved development certain pathological conditions . particular , @ GeneSrc $ allele risk factor susceptibility coronary artery disease ( CAD ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . present study analyzed @ GeneSrc $ allele distribution world . @ GeneSrc $ frequent human groups , especially populations long-established agricultural economy like Mediterranean basin ( 0.849 - 0.898 ) . frequency @ GeneSrc $ , ancestral allele , remains higher populations like Pygmies ( 0.407 ) Khoi San ( 0.370 ) , aborigines Malaysia ( 0.240 ) Australia ( 0.260 ) , Papuans ( 0.368 ) , Native Americans ( 0.280 ) , Lapps ( 0.310 ) economy foraging still exists , food supply ( recent past ) scarce sporadically available . @ GeneSrc $ frequency fluctuates apparent trend ( 0.145 - 0.02 ) absent Native Americans . suggest @ GeneSrc $ , based functional properties distribution among human populations , could identified ' thrifty ' allele . exposure @ GeneSrc $ contemporary environmental conditions ( Western diet , longer lifespans ) could rendered susceptibility allele CAD @ DiseaseTgt $ . absence association @ GeneSrc $ CAD @ DiseaseTgt $ Sub-Saharan Africans , presence African Americans , seems confirm hypothesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.039499733141542)\n",
      "- Text: \"@ GeneSrc $ variation sequence haplotype level : implications origin maintenance major human polymorphism . Three common protein isoforms @ GeneSrc $ ( @ GeneSrc $ ) , encoded epsilon2 , epsilon3 , epsilon4 alleles @ GeneSrc $ gene , differ association cardiovascular @ DiseaseTgt $ risk . gain better understanding genetic variation underlying important polymorphism , identified sequence haplotype variation 5.5 kb genomic DNA encompassing whole @ GeneSrc $ locus adjoining flanking regions 96 individuals four populations : blacks Jackson , MS ( n=48 chromosomes ) , Mayans Campeche , Mexico ( n=48 ) , Finns North Karelia , Finland ( n=48 ) , non-Hispanic whites Rochester , MN ( n=48 ) . region sequenced , 23 sites varied ( 21 single nucleotide polymorphisms , SNPs , 1 diallelic indel , 1 multiallelic indel ) . 22 diallelic sites defined 31 distinct haplotypes sample . estimate nucleotide diversity ( site-specific heterozygosity ) locus 0.0005+/-0.0003 . Sequence analysis chimpanzee @ GeneSrc $ gene showed closely related human epsilon4-type haplotypes , differing human consensus sequence 67 synonymous ( 54 substitutions 13 indels ) 9 nonsynonymous fixed positions . evolutionary history allelic divergence within humans inferred pattern haplotype relationships . analysis suggests haplotypes defining epsilon3 epsilon2 alleles derived ancestral epsilon4s epsilon3 group haplotypes increased frequency , relative epsilon4s , past 200,000 years . Substantial heterogeneity exists within three classes sequence haplotypes , important interpopulation differences sequence variation underlying protein isoforms may relevant interpreting conflicting reports phenotypic associations variation common protein isoforms .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0556541772745039)\n",
      "- Text: \"Modulation amyloid beta-protein clearance @ DiseaseTgt $ susceptibility LDL receptor-related protein pathway . Susceptibility @ DiseaseTgt $ ( @ DiseaseTgt $ ) governed multiple genetic factors . Remarkably , LDL receptor-related protein ( LRP ) ligands , @ GeneSrc $ alpha2 , genetically associated @ DiseaseTgt $ . study , provide evidence involvement LRP pathway amyloid deposition sequestration removal soluble amyloid beta-protein ( Abeta ) . demonstrate vitro LRP mediates clearance Abeta40 Abeta42 bona fide receptor-mediated uptake mechanism . vivo , reduced LRP expression associated LRP genotypes correlated enhanced soluble Abeta levels amyloid deposition . Although LRP proposed clearance pathway Abeta , work provides first vivo evidence LRP pathway may modulate Abeta deposition @ DiseaseTgt $ susceptibility regulating removal soluble Abeta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0609864834835576)\n",
      "- Text: \"MPO APOEepsilon4 polymorphisms interact increase risk @ DiseaseTgt $ Finnish males . BACKGROUND : Myeloperoxidase ( MPO ) present senile plaques surrounding reactive microglia , normal brain parenchyma . MPO plaques highest @ GeneSrc $ epsilon4 carriers , suggesting functional interaction . MPO promoter polymorphism ( -463G/A ) linked increased MPO expression associated increased risk @ DiseaseTgt $ . METHODS : define possible interaction MPO @ GeneSrc $ epsilon4 , examined 127 patients @ DiseaseTgt $ 174 controls genetically homogeneous Finnish population . RESULTS : significantly higher percentage male patients @ DiseaseTgt $ carried MPO @ GeneSrc $ epsilon4 alleles relative men carrying neither allele ( p < 0.001 ; , 11.4 ; 95 % CI , 3.6 6.7 ) . Male @ GeneSrc $ epsilon4 carriers lacking MPO allele 3.0 ( p = 0.01 ; 95 % CI , 1.3 6.9 ) , indicating MPO enhances @ DiseaseTgt $ risk 3.8-fold . Age onset lower men carrying MPO @ GeneSrc $ epsilon4 alleles ( Kaplan-Meier survival analysis ; p = 0.01 ) . Also , MPO AA genotype associated selective mortality men , women . AA genotypes absent 159 male patients @ DiseaseTgt $ controls , representing expected 5 % 6 % women male controls younger age 20 . -463A creates estrogen receptor binding site may contribute gender differences . CONCLUSIONS : MPO @ GeneSrc $ epsilon4 alleles interact increase risk @ DiseaseTgt $ men women Finnish cohort .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2443405403418517)\n",
      "- Text: \"Effect @ GeneSrc $ genotype promoter polymorphism risk @ DiseaseTgt $ . OBJECTIVE : verify association @ GeneSrc $ gene promoter polymorphisms development @ DiseaseTgt $ determine whether effect promoter polymorphisms @ DiseaseTgt $ independent @ GeneSrc $ epsilon4 allele . BACKGROUND : Three polymorphisms @ GeneSrc $ promoter shown modify @ GeneSrc $ expression vitro . Several studies suggested polymorphisms may also modulate risk @ DiseaseTgt $ , either independently modifying effect @ GeneSrc $ coding polymorphism . METHODS : authors analyzed allele genotype distributions @ GeneSrc $ three known @ GeneSrc $ promoter polymorphisms ( -491 A/T , -427 T/C , -219 G/T ) study group consisting 237 subjects @ DiseaseTgt $ 274 age-matched controls . used log-linear logistic regression analyses test possible interactions @ GeneSrc $ genotype promoter polymorphisms risk @ DiseaseTgt $ . CONCLUSION : strong association @ GeneSrc $ epsilon 4 allele @ DiseaseTgt $ detected regardless promoter polymorphism status . addition , -491 AA genotype appears independent genetic risk factor @ DiseaseTgt $ . -427 T/C polymorphism -219 T/G polymorphism directly associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1953668446475747)\n",
      "- Text: \"@ GeneSrc $ genotype predicts @ DiseaseTgt $ dementia ischemic cerebrovascular disease . BACKGROUND : @ GeneSrc $ polymorphism important modulator plasma lipoproteins risk factor @ DiseaseTgt $ . hypothesis @ GeneSrc $ genotype , effect lipoproteins , common risk factor ischemic cerebrovascular disease ( ICVD ) , @ DiseaseTgt $ , dementia ( OD ) tested . METHODS : authors genotyped 9241 individuals general population , 452 patients ICVD > = 50 % stenosis carotid arteries , 75 patients ICVD age 50 years . Among individuals general population , 211 ICVD , 26 @ DiseaseTgt $ , 28 OD . RESULTS : @ GeneSrc $ polymorphism associated ICVD three patient groups . contrast , epsilon43 epsilon44 genotypes associated 3- 10-fold risks @ DiseaseTgt $ ( 95 % CI = 1.4 8.0 2.5 41.0 ) , epsilon43 genotype also associated 2.5-fold risk OD ( 95 % CI = 1.1 5.5 ) . increases risk abolished adjustment lipids lipoproteins . fraction @ DiseaseTgt $ could attributed epsilon43 epsilon44 genotypes 37 20 % general population , whereas fraction OD could attributed epsilon43 genotype 26 % . CONCLUSION : @ GeneSrc $ polymorphism risk factor @ DiseaseTgt $ OD independent lipid lipoprotein levels affect risk ICVD .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3138302443361029)\n",
      "- Text: \"@ GeneSrc $ stimulates sulfation glycosaminoglycans neural cells . @ GeneSrc $ externally added neuroblastoma cells culture stimulates [ 35S ] sulfate incorporation cell extracellular matrix glycosaminoglycans ( sGAG ) . stimulation mainly observed @ GeneSrc $ compared @ GeneSrc $ . increase sulfation due increased synthesis corresponding increase [ 3H ] glucosamine incorporation . Since presence @ GeneSrc $ risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) presence sGAG could facilitate assembly main components , beta-amyloid tau proteins , aberrant structures found @ DiseaseTgt $ , present study indicates possible relation factors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0153945923330785)\n",
      "- Text: \"Increased CSF cortisol @ DiseaseTgt $ function @ GeneSrc $ genotype . BACKGROUND : Increased hypothalamic-pituitary-adrenal ( HPA ) axis activity manifested elevated cortisol levels observed @ DiseaseTgt $ may contribute @ DiseaseTgt $ lowering threshold neuronal degeneration . Presence @ GeneSrc $ allele increases risk @ DiseaseTgt $ . Increased cortisol concentrations @ GeneSrc $ mice suggest @ GeneSrc $ genotype may influence cortisol concentrations @ DiseaseTgt $ . METHODS : authors measured cortisol levels CSF determined @ GeneSrc $ genotypes 64 subjects @ DiseaseTgt $ 34 nondemented older control subjects . RESULTS : CSF cortisol significantly higher @ DiseaseTgt $ control subjects . CSF cortisol concentrations differed respect @ GeneSrc $ genotype subjects @ DiseaseTgt $ ( epsilon4/epsilon4 > epsilon3/4epsilon > epsilon3/epsilon3 ) normal older control subjects ( epsilon3/epsilon4 > epsilon3/epsilon3 > epsilon2/epsilon3 ) . Comparison CSF cortisol concentrations within epsilon3/epsilon4 epsilon3/epsilon3 genotypes revealed differences @ DiseaseTgt $ control subject groups . CONCLUSIONS : Higher CSF cortisol concentrations associated increased frequency @ GeneSrc $ allele decreased frequency @ GeneSrc $ allele @ DiseaseTgt $ subjects relative control subjects . effect @ GeneSrc $ genotype HPA axis activity may related increased risk @ DiseaseTgt $ persons carrying @ GeneSrc $ allele decreased risk @ DiseaseTgt $ persons carrying @ GeneSrc $ allele .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0519942535350338)\n",
      "- Text: \"Local cellular sources @ GeneSrc $ human retina retinal pigmented epithelium : implications process drusen formation . PURPOSE : inheritance specific @ GeneSrc $ allelles linked atherosclerosis , @ DiseaseTgt $ , , recently , incidence age-related macular degeneration . @ GeneSrc $ common component extracellular plaques deposits characteristic disorders , including drusen , hallmark age-related macular degeneration . Accordingly , assessed potential biosynthetic contribution local ocular cell types @ GeneSrc $ found drusen . METHODS : measured @ GeneSrc $ mRNA levels human donor tissues using quantitative assay @ GeneSrc $ transcription , localized @ GeneSrc $ protein specific cell types compartments neural retina , retinal pigmented epithelium , choroid using laser scanning confocal immunofluorescence microscopy . RESULTS : @ GeneSrc $ immunoreactivity associated photoreceptor outer segments , retinal ganglion cell layer , retinal pigmented epithelium basal cytoplasm basal lamina , collagenous layers Bruch membrane . @ GeneSrc $ appears ubiquitous component drusen , irrespective clinical phenotype . also accumulates cytoplasm subpopulation retinal pigmented epithelial cells , many overlie flank drusen . Mean levels @ GeneSrc $ mRNA adult human retina 45 % 150 % levels measured liver adult brain , two abundant biosynthetic sources @ GeneSrc $ @ GeneSrc $ mRNA levels highest inner retina , lowest outer retina photoreceptors predominate . Significant levels @ GeneSrc $ mRNA also present retinal pigmented epithelium/choroid complex cultured human retinal pigmented epithelial cells . CONCLUSIONS : @ GeneSrc $ protein strategically located anatomic locus drusen situated , retinal pigmented epithelium likely local biosynthetic source @ GeneSrc $ location . Age-related alteration lipoprotein biosynthesis and/or processing level retinal pigmented epithelium and/or Bruch membrane may significant contributing factor drusen formation age-related macular degeneration pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8786014907602654)\n",
      "- Text: \"Association @ GeneSrc $ sleep-disordered breathing adults . CONTEXT : @ GeneSrc $ epsilon4 ) well-known risk factor @ DiseaseTgt $ cardiovascular disease . Sleep-disordered breathing occurs @ DiseaseTgt $ patients increases risks cardiovascular disease . Complex interactions among sleep , brain pathology , cardiovascular disease may occur ApoE epsilon4 carriers . OBJECTIVE : study whether genetic variation level @ GeneSrc $ associated sleep-disordered breathing sleep abnormalities general population . DESIGN , SETTING , PARTICIPANTS : Ongoing longitudinal cohort study sleep disorders US university beginning 1989 , providing population-based probability sample 791 middle-aged adults ( mean [ SD ] age , 49 [ 8 ] years ; range , 32 - 68 years ) . MAIN OUTCOME MEASURE : Nocturnal polysomnography evaluate apnea-hypopnea index . RESULTS : probability moderate-to-severe sleep-disordered breathing ( apnea-hypopnea index > /=15 % ) significantly higher participants epsilon4 , independent age , sex , body mass index , ethnicity ( 12.0 % vs 7.0 % ; P = .003 ) . Mean ( SEM ) apnea-hypopnea index also significantly higher participants ApoE epsilon4 ( 6.5 [ 0.6 ] vs 4.8 [ 0.3 ] ; P = .01 ) . effects increased number ApoE epsilon4 alleles carried . CONCLUSIONS : significant portion sleep-disordered breathing associated ApoE epsilon4 general population .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Gender age modify association @ GeneSrc $ @ DiseaseTgt $ neuropathology . OBJECTIVE : assess impact @ GeneSrc $ ( @ GeneSrc $ ) polymorphism @ DiseaseTgt $ neurofibrillary tangle ( NFT ) formation senile plaques ( SP ) . METHODS : sample 729 routine autopsy brains ( 359 men , 370 women ; age range , 60 99 years ) investigated . brains classified neuropathologically according procedure permitting differentiation six NFT stages three SP stages . @ GeneSrc $ genotyping performed cases . RESULTS : epsilon4 allele @ GeneSrc $ associated SP ( p < 0.0001 ) also NFT formation ( p < 0.0001 ) . effect epsilon4 allele NFT formation noted ages > = 80 years ( p < 0.0001 ) ages 60 79 years ( p = 0.12 ) . association epsilon4 allele SP women found ages 60 79 years ( p < 0.0001 ) > = 80 years age ( p = 0.063 ) . comparison , men showed association age categories ( p = 0.001 p = 0.001 ) . CONCLUSION : results confirm association epsilon4 allele types @ DiseaseTgt $ show association differentially modified age gender .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0078812228160243)\n",
      "- Text: \"D10S1423 identifies susceptibility locus @ DiseaseTgt $ prospective , longitudinal , double-blind study asymptomatic individuals . Typical , later-onset forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) appear influenced multiple susceptibility loci , combinations contribute development disorder . previously reported results systematic survey human genome identification highly informative DNA polymorphisms ( SSTRPs ) target new @ DiseaseTgt $ risk genes . addition @ GeneSrc $ locus , survey detected five new candidate susceptibility loci @ DiseaseTgt $ , including D10S1423 . association D10S1423 234-bp allele @ DiseaseTgt $ reported three independent samples @ DiseaseTgt $ cases controls ( Boston , Pittsburgh , Bonn ) . Data case-control studies suggest strong synergistic interaction D10S1423 234-bp APOE E4 risk alleles ( 234-bp carrier : = 2.5 , 95 % CI = 1.4 - -4.5 ; E4 carrier : = 8.3 , 95 % CI = 4.3 - -15.8 ; alleles : = 23.1 , 95 % CI = 5.3 - -99.5 ) . report describes prospective , longitudinal , double-blind assessment age-specific risk @ DiseaseTgt $ encountered 325 asymptomatic first-degree relatives @ DiseaseTgt $ probands carried D10S1423 234-bp allele , APOE E4 allele , , 11.5 years systematic follow-up . total 18 incident cases @ DiseaseTgt $ detected first 3379 subject-years longitudinal study . effects carrying either D10S1423 234-bp APOE E4 alleles age-specific risk developing @ DiseaseTgt $ determined using Kaplan-Meier survival analysis . age-specific risk developing @ DiseaseTgt $ greatest individuals carried alleles ( Mantel -- Cox statistic = 20.12 , df = 3 , P = 0.0002 ; Breslow statistic = 13.36 , df = 3 , P = 0.004 ) . Cox proportional hazards models developed estimate risk ratios genotype , controlling potential effects age recruitment , sex , years education . resulting best fitting model , individuals carried risk alleles exhibited risk ratio differed significantly 1 ( risk ratio = 16.2 , P = 0.008 , 95 % CI = 2.1 - -128.3 ) . controlling genotypes , female gender also significantly associated increased risk developing @ DiseaseTgt $ ( risk ratio = 5.1 , P = 0.02 , 95 % CI = 1.2 - -21.1 ) . Neither age recruitment years education made significant contributions model .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1090178792902705)\n",
      "- Text: \"@ GeneSrc $ fragments present @ DiseaseTgt $ brains induce neurofibrillary tangle-like intracellular inclusions neurons . Human @ GeneSrc $ , major risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , occurs amyloid plaques neurofibrillary tangles ( NFTs ) @ DiseaseTgt $ brains ; however , role pathogenesis lesions unclear . demonstrate carboxyl-terminal-truncated forms @ GeneSrc $ , occur @ DiseaseTgt $ brains cultured neurons , induce intracellular NFT-like inclusions neurons . cytosolic inclusions composed phosphorylated tau , phosphorylated neurofilaments high molecular weight , truncated @ GeneSrc $ Truncated @ GeneSrc $ , especially @ GeneSrc $ 272 - -299 ) , induced inclusions 75 % transfected neuronal cells , transfected nonneuronal cells . @ GeneSrc $ susceptible truncation @ GeneSrc $ resulted much greater intracellular inclusion formation . results suggest @ GeneSrc $ preferentially undergoes intracellular processing , creating bioactive fragment interacts cytoskeletal components induces NFT-like inclusions containing phosphorylated tau phosphorylated neurofilaments high molecular weight neurons .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4619762819681335)\n",
      "- Text: \"Increased CSF cortisol @ DiseaseTgt $ function @ GeneSrc $ genotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1944985359021974)\n",
      "- Text: \"@ GeneSrc $ age onset @ DiseaseTgt $ African American patients . authors examined whether @ GeneSrc $ allele associated earlier age onset @ DiseaseTgt $ 71 African American patients probable @ DiseaseTgt $ . authors found linear dose effect copy epsilon4 allele associated 3.6-year earlier onset @ DiseaseTgt $ , indicating dose-dependent relationship @ GeneSrc $ age onset @ DiseaseTgt $ African Americans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0804950813234331)\n",
      "- Text: \"Age onset Parkinson disease @ GeneSrc $ genotypes . Several lines evidence suggest variable age onset Parkinson disease ( PD ) likely influenced genes . @ GeneSrc $ ( @ GeneSrc $ ) gene associated onset @ DiseaseTgt $ , possibly neurodegenerative disorders . @ GeneSrc $ investigated relation onset PD , results inconsistent . aim present study determine @ GeneSrc $ genotypes associated onset age PD , using patient population large enough assure sufficient power . studied 521 unrelated Caucasian patients idiopathic PD movement disorder clinics Oregon Washington . Genotyping statistical analyses carried using standard methods . Age onset PD significantly earlier patients varepsilon3varepsilon4/varepsilon4varepsilon4 genotype patients varepsilon3varepsilon3 genotype ( 56.1 + /- 10.9 vs. 59.6 + /- 11.0 , P = 0.003 ) . significantly earlier onset PD influenced possible effects recruitment site , family history gender . effect varepsilon2varepsilon3 genotype onset PD differed two recruitment sites . trend earlier onset PD varepsilon2varepsilon3 patients varepsilon3varepsilon3 patients Oregon sample . conclusion , @ GeneSrc $ associated age onset PD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0813353496138101)\n",
      "- Text: \"Accelerated hippocampal atrophy @ DiseaseTgt $ @ GeneSrc $ allele . Although @ GeneSrc $ established risk factor @ DiseaseTgt $ , effect rate progression @ DiseaseTgt $ remains unknown . purpose longitudinal study elucidate whether rate hippocampal atrophy function @ GeneSrc $ genotypes severity disease . Fifty-five patients probable @ DiseaseTgt $ subjects . annual rate hippocampal atrophy determined using magnetic resonance imaging repeated 1-year interval . two-way analysis variance , effect @ GeneSrc $ allele hippocampal atrophy significant , neither effect severity interaction term significant . analysis one-way analysis variance , mean annual rate hippocampal atrophy significantly different groups patients ( 9.76 + /- 4.27 % ) without @ GeneSrc $ allele ( 6.99 + /- 4.24 % ) . @ GeneSrc $ dose significantly correlated rate hippocampal atrophy ( rs = 0.277 , Spearman rank correlation coefficient ) , suggesting gene dose effect . involvement @ GeneSrc $ allele progression hippocampal atrophy implications therapeutic approaches @ DiseaseTgt $ taken consideration longitudinal studies including clinical drug trials .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0027192897732578)\n",
      "- Text: \"@ GeneSrc $ genotype survival men women @ DiseaseTgt $ . BACKGROUND : epsilon 4 allele @ GeneSrc $ gene ( @ GeneSrc $ ) frequent patients @ DiseaseTgt $ general population , studies inconclusive whether affects rate progression survival . survival @ DiseaseTgt $ generally longer women men , authors investigated whether @ GeneSrc $ affects 10-year survival equally men women . METHODS : @ GeneSrc $ testing performed 125 patients probable @ DiseaseTgt $ enrolled Johns Hopkins @ DiseaseTgt $ Research Center November 1984 March 1987 . 39 men 86 women followed 6-month intervals censoring ( death withdrawal study ) March 1997 . Patients dichotomized without least one epsilon 4 allele . sex , Cox proportional hazards regression , allowing delayed entry covarying age onset , used examine effect epsilon 4 survival . RESULTS : patients died study period autopsy ( n = 92 ) found definite @ DiseaseTgt $ . Average survival disease onset differ sex ( 12.1 years men ; 12.3 years women ) . neither sex differences found epsilon 4-positive epsilon 4-negative subgroups education , duration @ DiseaseTgt $ entry , severity dementia . However , sexes epsilon 4-positive subgroup approximately 3 years older onset @ DiseaseTgt $ entry study epsilon 4-negative subgroup . Adjusting age onset , presence epsilon 4 allele significantly increased relative risk death men ( RR = 2.69 ; 95 % CI = 1.23 5.87 ) . CONCLUSIONS : sample mostly white , well-educated research participants @ DiseaseTgt $ , @ GeneSrc $ epsilon 4 allele associated shorter survival men women .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017906687189545)\n",
      "- Text: \"Association @ GeneSrc $ genotype psychopathologic symptoms @ DiseaseTgt $ . BACKGROUND : Psychiatric symptoms occur frequently course @ DiseaseTgt $ , frequent contributor institutionalization , predict cognitive decline death , often require treatment psychotropic medications . Previous studies investigating association @ GeneSrc $ genotype psychiatric symptomatology @ DiseaseTgt $ reported contradictory results . OBJECTIVE : determine whether @ GeneSrc $ genotype predicts incident psychiatric symptomatology patients @ DiseaseTgt $ . METHODS : Eighty-seven patients @ DiseaseTgt $ early stages psychiatric history followed semiannually 9.3 years ( mean 5.5 years ) development delusions , illusions , hallucinations , behavioral symptoms , depression . Cox proportional hazards models used examine relative risk incident psychiatric symptomatology ( outcome ) relation @ GeneSrc $ genotype ( predictor ) . RESULTS : presence one epsilon4 allele carried 2.5-fold risk , whereas presence two epsilon4 alleles carried 5.6-fold risk development delusions . associations remained significant even age , ethnicity , sex , education , duration disease , cognitive functional performance controlled . presence two epsilon4 alleles associated reduced risk developing hallucinations adjusted analysis . significant associations detected @ GeneSrc $ genotype incidence illusions , behavioral symptoms , depression . CONCLUSION : presence one epsilon4 alleles significant predictor incidence delusions course @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.003877368419191)\n",
      "- Text: \"@ GeneSrc $ single-nucleotide polymorphisms affect phenotype primary open-angle glaucoma demonstrate interaction myocilin gene . Primary open-angle glaucoma ( POAG ) optic neuropathy high worldwide prevalence shows strong evidence complex inheritance . myocilin ( MYOC ) gene one thus far shown mutations patients POAG . @ GeneSrc $ ( @ GeneSrc $ ) plays essential role lipid metabolism , @ GeneSrc $ gene involved neuronal degeneration occurs @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , report two @ GeneSrc $ single-nucleotide polymorphisms ( SNPs ) previously associated @ DiseaseTgt $ also modify POAG phenotype . @ GeneSrc $ G ) associated increased optic nerve damage , reflected increased cup : disk ratio visual field alteration . addition , @ GeneSrc $ ) , interacting highly significant level SNP MYOC promoter , MYOC ( -1000 G ) , associated increased intraocular pressure ( IOP ) limited effectiveness IOP-lowering treatments patients POAG . Together , findings establish @ GeneSrc $ potent modifier POAG , could explain linkage chromosome 19q previously observed use genome scan condition increased frequency glaucoma patients @ DiseaseTgt $ . findings also shed new light potential mechanisms optic nerve damage IOP regulation POAG .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0111210426084589)\n",
      "- Text: \"Contribution @ GeneSrc $ promoter polymorphisms @ DiseaseTgt $ risk . OBJECTIVE : determine whether effects @ GeneSrc $ promoter polymorphisms @ DiseaseTgt $ independent @ GeneSrc $ allele . BACKGROUND : Recently , -491 -- > -219 G -- > polymorphisms located @ GeneSrc $ promoter suggested risk factors @ DiseaseTgt $ . However , effects polymorphisms always reproduced case-control studies , possibly strong linkage disequilibrium existing locus characteristics populations studied . METHODS : Data collection performed six independent samples ( 1,732 patients @ DiseaseTgt $ 1,926 control subjects ) genotyped @ GeneSrc $ exon 4 two @ GeneSrc $ promoter polymorphisms . risks associated @ GeneSrc $ polymorphisms developing @ DiseaseTgt $ estimated using logistic regression procedures calculation odds ratios 95 % CI adjusted age , sex , collection center . Independence @ GeneSrc $ promoter polymorphisms tested stratification @ GeneSrc $ tertile design used age stratification . RESULTS : independence -491 AA genotype observed whole sample whereas independence -219 TT genotype observed oldest population . CONCLUSION : -491 -219 @ GeneSrc $ promoter polymorphisms incur risk @ DiseaseTgt $ addition risk associated @ GeneSrc $ allele , age accentuating effect -219 TT genotype . polymorphisms appear influence @ GeneSrc $ levels , results suggest @ GeneSrc $ expression important determinant @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.455558956982668)\n",
      "- Text: \"@ GeneSrc $ allele decline different cognitive systems 6-year period . CONTEXT : Impairment episodic memory early defining feature @ DiseaseTgt $ ( @ DiseaseTgt $ ) . apolipoprotein E ( APOE ) epsilon 4 allele known influence risk @ DiseaseTgt $ difficult establish whether affects episodic memory differently cognitive functions . OBJECTIVE : examine association epsilon 4 decline different cognitive systems . DESIGN : Longitudinal cohort study . SETTING : 40 groups Catholic clergy across United States . PARTICIPANTS : Older Catholic clergy members without clinical evidence dementia baseline underwent annual clinical evaluations 6 years . 624 persons eligible follow-up , 611 ( 98 % ) participated , 161 ( 26 % ) least 1 epsilon 4 allele . completed average 5.5 evaluations ( range , 2 - 7 ) . MAIN OUTCOME MEASURES : Incident @ DiseaseTgt $ annual rates change episodic memory , semantic memory , working memory , perceptual speed , visuospatial ability . RESULTS : presence epsilon 4 associated risk developing @ DiseaseTgt $ follow-up ( relative risk , 1.92 ; 95 % confidence interval , 1.27 - 2.89 ) . series random effects models , epsilon 4 associated impaired baseline function episodic memory visuospatial ability rapid decline domains . effect epsilon 4 annual decline episodic memory ( > 3-fold increase ) significantly stronger effect decline cognitive systems ( P < .01 ) , baseline , effect episodic memory marginally stronger effect cognitive domains ( P = .06 ) . CONCLUSION : results suggest APOE epsilon 4 allele influences risk @ DiseaseTgt $ relatively selective effect episodic memory .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025552020341834)\n",
      "- Text: \"Cognitive change @ GeneSrc $ epsilon 4 allele . marked variation whether people retain sufficient cognitive function maintain quality life independence old age , even among without dementia , would valuable identify determinants normal age-related cognitive change . retested non-demented 80-year-olds participants Scottish Mental Survey 1932 , find variation non-pathological cognitive change age 11 80 related @ GeneSrc $ ( @ GeneSrc $ ) genotype . effect @ GeneSrc $ epsilon 4 allele normal cognitive ageing may mediated mechanism least partly independent predisposing effect towards @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024948293247981)\n",
      "- Text: \"@ GeneSrc $ epsilon4 allele , @ DiseaseTgt $ pathology , clinical expression @ DiseaseTgt $ . OBJECTIVE : test hypothesis @ GeneSrc $ epsilon4 allele associated clinical manifestations @ DiseaseTgt $ association pathologic hallmarks disease . METHODS : Participants older Catholic nuns , priests , brothers agreed annual neurologic neuropsychological evaluation @ DiseaseTgt $ common neurologic conditions brain autopsy time death . 77 persons without dementia 51 probable @ DiseaseTgt $ ; 38 participants one epsilon4 alleles . RESULTS : logistic regression analyses , controlling age , sex , education , epsilon4 allele strongly associated likelihood clinical @ DiseaseTgt $ ( odds = 3.46 , 95 % CI = 1.44 8.33 ) . However , controlling effect @ DiseaseTgt $ pathology , association epsilon allele clinical @ DiseaseTgt $ reduced > 50 % longer significant ( odds = 1.58 , 95 % CI = 0.56 4.43 ) . Similarly , linear regression analyses , controlling age , sex , education , epsilon4 allele strongly associated level cognitive function proximate death ( regression coefficient = -0.477 , p = 0.005 ) . However , controlling effect @ DiseaseTgt $ pathology , association epsilon4 allele level cognition reduced > 80 % longer significant ( regression coefficient = -0.093 ) . Similar results found analyses using separate measures neuritic plaques , diffuse plaques , neurofibrillary tangles , analyses five different cognitive systems ( episodic memory , semantic memory , working memory , perceptual speed , visuospatial ability ) . CONCLUSIONS : @ GeneSrc $ epsilon4 allele appears associated clinical manifestations @ DiseaseTgt $ association pathologic hallmarks @ DiseaseTgt $ rather another mechanism .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7437374692037211)\n",
      "- Text: \"Apolipoprotein Eepsilon4 modifies @ DiseaseTgt $ onset E280A PS1 kindred . previously identified large kindred Colombia @ DiseaseTgt $ ( @ DiseaseTgt $ ) caused E280A presenilin 1 ( PS1 ) mutation . objective study examine whether environmental genetic factors responsible variation phenotypic expression E280A PS1 mutation . genotyped coding promoter polymorphisms @ GeneSrc $ gene carriers E280A PS1 mutation . Kaplan-Meier product-limit Cox proportional hazard models used statistical analyses . DNA available 114 carriers E280A PS1 mutation , including 52 subjects @ DiseaseTgt $ . @ GeneSrc $ epsilon 4 allele carriers likely develop @ DiseaseTgt $ earlier age subjects without epsilon 4 allele ( hazard ratio , 2.07 ; 95 % confidence interval , 1.07 - 3.99 ; p = 0.030 ) . Subjects low education likely develop @ DiseaseTgt $ later higher education ( hazard ratio , 0.476 ; 95 % confidence interval , 0.26 - 0.87 ) . Low educational level associated rural residence ( p < 0.001 ) . Promoter @ GeneSrc $ variants influence either onset duration disease . study first knowledge demonstrate genetic environmental factors influence age onset kindred familial @ DiseaseTgt $ mutation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9187703872830546)\n",
      "- Text: \"Association late-onset @ DiseaseTgt $ genotype PLAU , gene encoding urokinase-type plasminogen activator chromosome 10q22.2 . Urokinase-type plasminogen activator ( uPA ) converts plasminogen plasmin . Plasmin involved processing amyloid precursor protein degrades secreted aggregated amyloid-beta , hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . PLAU , gene encoding uPA , maps chromosome 10q22.2 two regions showing linkage late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . genotyped frequent C/T single nucleotide polymorphism codon 141 PLAU ( P141L ) 347 patients @ DiseaseTgt $ 291 control subjects . @ DiseaseTgt $ associated homozygous C/C PLAU genotype whole sample ( chi2=15.7 , P=0.00039 , df 2 ) , well sub-samples stratified gender @ GeneSrc $ epsilon4 carrier status ( chi2 > = 6.84 , P < = 0.033 , df 2 ) . Odds ratio @ DiseaseTgt $ due homozygosity C/C 1.89 ( 95 % confidence interval 1.37 - 2.61 ) . PLAU promising new candidate gene @ DiseaseTgt $ , allele C ( P141 ) recessive risk allele allele ( L141 ) conferring protection .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2441420116235536)\n",
      "- Text: \"novel mutation PSEN2 gene ( T430 ) associated variable expression family early-onset @ DiseaseTgt $ . BACKGROUND : Autosomal dominant early-onset @ DiseaseTgt $ heterogeneous condition associated mutations 3 different genes : amyloid precursor protein ( APP ) , presenilin 1 ( PSEN1 ) , presenilin 2 ( PSEN2 ) genes . cases due mutations PSEN1 gene , whereas mutations APP PSEN2 genes rare . OBJECTIVE : describe novel mutation PSEN2 gene associated early-onset @ DiseaseTgt $ . PATIENTS METHODS : proband 49-year-old individual displayed progressive dementia beginning age 45 years . One parents one grandparents developed dementia ages 64 years 60 years , respectively , 1 sibling mild cognitive impairment . family members also Tourette syndrome . Mutation analysis APP , PSEN1 , PSEN2 , tau ( TAU ) genes performed . @ GeneSrc $ ( @ GeneSrc $ ) also genotyped . RESULTS : found missense mutation codon 430 PSEN2 gene predicts threonine-to-methionine substitution . mutation detected affected individuals 1 cognitively healthy sibling . mutation absent 260 control chromosomes . normal amino acid conserved human mouse PSEN1 mouse PSEN2 homologues . influence @ GeneSrc $ genotype observed . CONCLUSIONS : found novel mutation PSEN2 gene family early-onset @ DiseaseTgt $ . variation age onset confirms PSEN2 mutations associated variable clinical expression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9901556732819922)\n",
      "- Text: \"Combined effects @ GeneSrc $ genotype , blood pressure , antihypertensive drug use incident @ DiseaseTgt $ . OBJECTIVE : study hypotheses @ GeneSrc $ allele may interact blood pressure affect @ DiseaseTgt $ ( @ DiseaseTgt $ ) occurrence antihypertensive therapy could modify effect . METHODS : dementia-free cohort 966 community-dwelling persons aged 75 years older Stockholm , Sweden followed detect patients @ DiseaseTgt $ using Diagnostic Statistical Manual Mental Disorders , Revised Third Edition ( DSM-III-R ) diagnostic criteria . Data analyzed using Cox proportional hazards models adjustment several potential confounders . RESULTS : 6-year follow-up period , @ DiseaseTgt $ diagnosed 204 persons . @ GeneSrc $ allele , high systolic pressure ( > = 140 mm Hg ) , low diastolic pressure ( < 70 mm Hg ) associated increased risk @ DiseaseTgt $ . @ GeneSrc $ allele combined low diastolic pressure greatly increased risk @ DiseaseTgt $ independent antihypertensive drug use . Antihypertensive therapy significantly reduced risk @ DiseaseTgt $ regardless @ GeneSrc $ status counteracted combined risk effect epsilon4 allele high systolic pressure disease . CONCLUSIONS : Elderly people genetic susceptibility @ DiseaseTgt $ may experience increased disease risk either high systolic pressure low diastolic pressure . Antihypertensive therapy decreases risk @ DiseaseTgt $ exerted @ GeneSrc $ allele .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.009912892210119)\n",
      "- Text: \"Association @ GeneSrc $ alleles calcific valvular heart disease . BACKGROUND : Studies @ GeneSrc $ ( @ GeneSrc $ ) alleles reported increased risk coronary heart disease patients @ GeneSrc $ allele . Given risk factor histological similarities coronary calcific valvular heart disease ( aortic stenosis [ ] mitral annular calcification [ MAC ] ) , postulated @ GeneSrc $ alleles might associated development valvular lesions . METHODS RESULTS : evaluated association @ GeneSrc $ alleles calcific valvular lesions 802 patients undergoing transthoracic echocardiography using logistic regression analyses . difference noted genotype distribution ( P=0.59 ) prevalence @ GeneSrc $ without MAC ( 30 % versus 27 % , respectively ; P=0.57 ) . Compared patients without , genotype distribution patients differed significantly ( P=0.03 ) , increasing prevalences @ GeneSrc $ 4 allele ( 27 % without versus 40 % ; P=0.01 ) . multivariate analyses adjusting age , gender , low-density lipoprotein cholesterol levels , coronary artery disease , increasing age @ GeneSrc $ allele significant independent predictors ( odds ratio , 1.94 ; 95 % confidence interval , 1.01 3.71 ; P=0.046 ) , whereas @ GeneSrc $ allele predictive MAC . CONCLUSIONS : findings support extension importance @ GeneSrc $ allele beyond atherosclerosis @ DiseaseTgt $ calcific .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0091947198970014)\n",
      "- Text: \"Increased risk @ DiseaseTgt $ interaction MPO A2 polymorphisms . BACKGROUND : genes encoding myeloperoxidase ( MPO ) alpha ( 2 ) -macroglobulin ( A2 ) involved molecular pathways leading beta-amyloid deposition . Two polymorphic sites genes ( MPO-G/A A2M-Ile/Val ) associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , conflicting findings reported populations different ethnic backgrounds . OBJECTIVES : study association MPO-G/A A2M-Ile/Val polymorphisms sporadic @ DiseaseTgt $ investigate interactions among MPO , A2 , @ GeneSrc $ ( @ GeneSrc $ ) gene polymorphisms determining risk development @ DiseaseTgt $ . DESIGN : Case-control study . SETTING : Referral center @ DiseaseTgt $ Calabria , southern Italy . PARTICIPANTS : One hundred forty-eight patients sporadic @ DiseaseTgt $ 158 healthy control subjects . RESULTS : MPO-G A2M-Val alleles found frequently cases controls , MPO-G/G A2M-Val/Val genotypes . odds ratio ( ) MPO-G/G genotype 1.78 ( 95 % confidence interval [ CI ] , 1.13 - 2.80 ) ; A2M-Val/Val genotype , 3.81 ( 95 % CI , 1.66 - 8.75 ) . presence MPO-G/G A2M-Val/Val genotypes synergistically increased risk @ DiseaseTgt $ ( , 25.5 ; 95 % CI , 4.65 - 139.75 ) . Stratification cases sex , age onset @ DiseaseTgt $ , @ GeneSrc $ 4 status show significant differences distribution MPO A2 polymorphisms . CONCLUSIONS : MPO A2 polymorphisms associated sporadic @ DiseaseTgt $ southern Italy . Moreover , genomic interaction polymorphisms increases risk development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4330956318330273)\n",
      "- Text: \"Impact @ GeneSrc $ genotype neuropathologic neurochemical markers @ DiseaseTgt $ . BACKGROUND : @ GeneSrc $ epsilon4 allele emerged major genetic factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , presence associated increase beta-amyloid senile plaques ( SPs ) neuritic plaques ( NPs ) . Whether affects neurofibrillary tangle ( NFT ) accumulation cholinergic losses @ DiseaseTgt $ remains controversial . contrast , epsilon2 allele reported decrease risk @ DiseaseTgt $ . However , effect neuropathologic neurochemical markers disease unclear . OBJECTIVE : investigate relationship @ GeneSrc $ genotype pathologic severity cholinergic dysfunction @ DiseaseTgt $ . METHODS : autopsy series 296 patients @ DiseaseTgt $ , @ GeneSrc $ genotype determined blood postmortem brain tissue . NPs NFTs counted midfrontal ( MF ) , inferior parietal ( IP ) , superior temporal ( ST ) cortices hippocampus . Choline acetyltransferase ( ChAT ) activity assessed MF , IP , ST cortices . RESULTS : Compared patients epsilon4 alleles , epsilon4 carriers ( patients either one two epsilon4 alleles ) differ significantly regard pathologic neurochemical measures , except increased ST NPs . However , cases stratified three groups according number epsilon4 alleles , patients two epsilon4 alleles significantly NPs NFTs neocortical regions either one epsilon4 alleles . association epsilon4/4 genotype neocortical pathologic severity remained significant even adjusting age onset age death . contrast , significant group differences regard neocortical ChAT activity . pathologic neurochemical measures compared patients epsilon2 allele without , strong relationship emerged epsilon2 allele decreased NPs neocortical regions . CONCLUSIONS : epsilon4 allele predict cholinergic decline @ DiseaseTgt $ . Although presence single epsilon4 allele appears effect , presence two epsilon4 alleles important determinant NP NFT accumulation . putative protective role epsilon2 allele @ DiseaseTgt $ may mediated reduced plaque burden .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0245489004231224)\n",
      "- Text: \"Longitudinal changes cognition behavior asymptomatic carriers @ GeneSrc $ e4 allele . OBJECTIVE : determine whether memory loss detectable symptomatic presentation mild cognitive impairment ( MCI ) greater genetic risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) based upon presence absence e4 allele @ GeneSrc $ . METHODS : Participants age 50 years older responded newspaper advertisements . total 212 cognitively normal individuals known @ GeneSrc $ genotype initially enrolled match paradigm included e4 homozygotes , e3/4 heterozygotes , e4 noncarriers 1:1:2 ratio ( 53 sets ) . original 212 individually matched participants , 180 completed least two epochs testing including 45 @ GeneSrc $ e4/4 homozygotes , 42 @ GeneSrc $ e3/4 heterozygotes , 93 @ GeneSrc $ e4 noncarriers , mean age 60 ( + /-6.2 ) years . , four developed MCI @ DiseaseTgt $ follow-up period excluded analysis . Longitudinal neuropsychological study included two verbal ( Auditory Verbal Learning Test [ AVLT ] , Selective Reminding Test [ SRT ] ) two visual ( Complex Figure Test [ CFT ] , Visual Retention Test ) memory tests . RESULTS : Multiple measures verbal memory tests showed poorer performance mean interval 33 months e4 carriers noncarriers : AVLT total learning , long term delayed recall ; SRT free cued recall . Among age 50 59 years , AVLT long term delayed recall , SRT free cued recall , CFT recall declined @ GeneSrc $ e4 carriers . differences found domains language , spatial skills , executive function . CONCLUSIONS : Memory declined @ GeneSrc $ e4 carriers symptomatic presentation MCI cohort whose mean age 60 years median period 33 months . decline began prior age 60 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0032137169794267)\n",
      "- Text: \"@ GeneSrc $ controls risk age onset Parkinson disease . BACKGROUND : Similarities @ DiseaseTgt $ ( @ DiseaseTgt $ ) Parkinson disease ( PD ) suggest possible role @ GeneSrc $ ( @ GeneSrc $ ) PD . previous studies seeking establish link used case-control datasets results inconsistent . OBJECTIVE : investigate @ GeneSrc $ 's role PD using family-based association analyses . METHODS : @ GeneSrc $ functional polymorphisms genotyped 658 PD affected families , including 282 multiplex 376 singleton families . pedigree disequilibrium test ( PDT ) genotype-PDT used test risk effect @ GeneSrc $ . Monks-Kaplan test used evaluate effect @ GeneSrc $ age onset PD . RESULTS : @ GeneSrc $ significantly associated risk developing PD . Stratified analysis revealed @ GeneSrc $ strongly associated families positive PD family history ( global p = 0.003 ) . Like @ DiseaseTgt $ , @ GeneSrc $ allele increases disease risk @ GeneSrc $ allele decreases risk . detected positive association @ GeneSrc $ ( p = 0.019 ) negative association @ GeneSrc $ ( p = 0.015 ) age onset PD . CONCLUSIONS : @ GeneSrc $ allele increases risk decreases age onset PD , association may dependent upon cognitive impairment .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1362486691763285)\n",
      "- Text: \"@ GeneSrc $ epsilon4 allele associated reduced cerebrospinal fluid levels Abeta42 . epsilon4 allele @ GeneSrc $ risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) . analysis large cohort @ DiseaseTgt $ patients ( n = 563 ) control subjects ( n = 118 ) , shown epsilon4 allele strongly associated reduced CSF levels beta-amyloid ( 1 - 42 ) ( Abeta42 ) @ DiseaseTgt $ ( p < 10 ( -9 ) ) control ( p = 0.0012 ) populations . associations @ GeneSrc $ variants indexes @ DiseaseTgt $ severity observed , effect may reflect fundamental involvement @ GeneSrc $ Abeta metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1042893958783814)\n",
      "- Text: \"@ GeneSrc $ allele associated higher prevalence sporadic Parkinson disease . BACKGROUND : link @ GeneSrc $ -epsilon4 allele @ DiseaseTgt $ ( @ DiseaseTgt $ ) led studies investigating role @ GeneSrc $ polymorphisms Parkinson disease ( PD ) . authors hypothesized association PD @ GeneSrc $ alleles genotypes would small detected precisely estimated individual case-controlled study . METHOD : hypothesis tested systematic review meta-analysis results case-control studies provided clear clinical pathologic criteria PD reported @ GeneSrc $ genotype frequencies . Published reports obtained MEDLINE , Biosis Previews , ISI Web Science searches , supplemented citation analysis retrieved articles . authors estimated compared prevalence odds ratios ( ) PD relation allele genotype . RESULTS : Twenty-two eligible studies identified . evidence heterogeneity ( p > 0.4 ) publication bias ( p > 0.2 ) allele genotype . estimated summary one copies @ GeneSrc $ allele 1.20 @ GeneSrc $ ( 95 % CI , 1.02 1.42 ) , 0.83 @ GeneSrc $ ( 95 % CI , 0.63 1.09 ) , 0.99 @ GeneSrc $ ( 95 % CI , 0.87 1.14 ) . CONCLUSIONS : Unlike @ DiseaseTgt $ , @ GeneSrc $ allele increases prevalence @ GeneSrc $ allele protective , authors ' analysis shows @ GeneSrc $ allele , @ GeneSrc $ allele , positively associated sporadic Parkinson disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0068994405231316)\n",
      "- Text: \"Allelic expression @ GeneSrc $ human brain : effects epsilon status promoter haplotypes . epsilon4 haplotype @ GeneSrc $ undisputed genetic risk factor late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . proposed least two polymorphisms promoter @ GeneSrc $ gene ( -219G > -491A > ) might also contribute disease susceptibility , modulate impact structural changes @ GeneSrc $ protein , altering expression . order assess extent cis-acting influences @ GeneSrc $ expression human brain , highly quantitative measures allele discrimination applied cortical RNA individuals heterozygous epsilon alleles . small , significant , increase expression epsilon4 allele observed relative epsilon3 epsilon2 alleles ( P < 0.0001 ) . Similar differences observed brain tissue confirmed @ DiseaseTgt $ subjects , cortical regions BA10 ( frontopolar ) BA20 ( inferior temporal ) . Stratification epsilon4/epsilon3 allelic expression ratios according heterozygosity -219G > promoter polymorphism revealed significantly lower relative expression haplotypes containing -219 allele ( P=0.02 ) . data indicate , human brain , cis-acting variance @ GeneSrc $ expression accounted epsilon4 haplotype , additional , small , cis-acting influences associated promoter genotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.003782761819834)\n",
      "- Text: \"Impact @ GeneSrc $ mild cognitive impairment . OBJECTIVE : authors aimed use baseline data ongoing large , prospective study subjects mild cognitive impairment ( MCI ) investigate impact @ GeneSrc $ genotype symptom profile condition . METHODS : Cognitive assessments included @ DiseaseTgt $ Assessment Scale cognitive subscale ( ADAS-cog ) , Mini-Mental State Examination ( MMSE ) , cognitive battery assessment memory , attention , executive function . Behavioral assessments included Neuropsychiatric Inventory Beck Depression Inventory . Activities daily living assessed @ DiseaseTgt $ Cooperative Study Activities Daily Living ( ADCS-ADL ) scale . Hippocampal volumes measured MRI . RESULTS : total 494 1,018 study subjects provided @ GeneSrc $ data . Approximately 40 % subjects @ GeneSrc $ epsilon4 carriers . @ GeneSrc $ epsilon4 carriers lower MMSE ( p = 0.01 ) higher ADAS-cog ( p < 0.0001 ) scores noncarriers , indicating worse cognitive impairment . @ GeneSrc $ epsilon4 carriers also greater deficits New York University delayed paragraph recall Buschke free cued selective reminding tests , ADCS-ADL scale ( p < 0.001 ) . also smaller hippocampal volumes ( p = 0.002 ) . Behavioral scores similar across subgroups . CONCLUSION : MCI subjects carrying @ GeneSrc $ epsilon4 allele showed distinct cognitive imaging profiles , appeared resemble early @ DiseaseTgt $ patients . @ GeneSrc $ epsilon4 genotype associated greater impairments memory functional activities well hippocampal atrophy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003984779738363)\n",
      "- Text: \"@ GeneSrc $ genotype , family history dementia , @ DiseaseTgt $ risk : 6-year follow-up study . BACKGROUND : family aggregation @ GeneSrc $ epsilon4 allele well-known risk factors dementia , relation two factors remains unclear . OBJECTIVE : explore whether risk dementia @ DiseaseTgt $ ( @ DiseaseTgt $ ) due positive family history explained @ GeneSrc $ genotypes . DESIGN : Community-based cohort study . SETTING : Kungsholmen district Stockholm , Sweden . PARTICIPANTS : total 907 nondemented people 75 years older , followed 6 years detect incident dementia @ DiseaseTgt $ cases according diagnostic criteria Diagnostic Statistical Manual Mental Disorders , Revised Third Edition . MAIN OUTCOME MEASURES : Risk dementia @ DiseaseTgt $ Cox proportional hazards models controlling several potential confounders . RESULTS : Subjects least 2 siblings dementia increased risk @ DiseaseTgt $ . Individuals @ GeneSrc $ epsilon4 allele least 2 affected first-degree relatives higher risk dementia @ DiseaseTgt $ compared without 2 factors . Similar results obtained history dementia separately parents siblings . Among epsilon4 allele carriers , subjects 2 first-degree demented relatives increased risk dementia @ DiseaseTgt $ , whereas increased risk detected among non-epsilon4 carriers . CONCLUSIONS : Family history dementia associated increased risk dementia @ DiseaseTgt $ old population , among @ GeneSrc $ epsilon4 carriers . suggests existence genetic environmental risk factors may active presence @ GeneSrc $ epsilon4 allele .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0449868141478056)\n",
      "- Text: \"Gene delivery human @ GeneSrc $ alters brain Abeta burden mouse model @ DiseaseTgt $ . Apolipoprotein E ( @ GeneSrc $ ) alleles important genetic risk factors @ DiseaseTgt $ ( @ DiseaseTgt $ ) , epsilon4 allele increasing epsilon2 allele decreasing risk developing @ DiseaseTgt $ . @ GeneSrc $ shown influence brain amyloid-beta peptide ( Abeta ) amyloid burden , humans transgenic mice . show direct intracerebral administration lentiviral vectors expressing three common human @ GeneSrc $ isoforms differentially alters hippocampal Abeta amyloid burden PDAPP mouse model @ DiseaseTgt $ . Expression apoE4 absence mouse @ GeneSrc $ increases hippocampal Abeta ( 1 - 42 ) levels amyloid burden . contrast , expression @ GeneSrc $ , even presence mouse @ GeneSrc $ , markedly reduces hippocampal Abeta burden . data demonstrate rapid @ GeneSrc $ isoform-dependent effects brain Abeta burden mouse model @ DiseaseTgt $ . Gene delivery @ GeneSrc $ may prevent reduce brain Abeta burden subsequent development neuritic plaques .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.010864576280648)\n",
      "- Text: \"Genetic association @ GeneSrc $ allele Lewy bodies @ DiseaseTgt $ . OBJECTIVE : explore association @ GeneSrc $ pathologically confirmed cases Lewy body ( LB ) variant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . METHODS : use alpha-synuclein ( ) immunohistochemistry , LBs detected 74 131 ( 56.5 % ) @ DiseaseTgt $ + LB cases ; remaining 57 cases ( 43.5 % ) LBs . RESULTS : differences gender age Caucasian subjects @ DiseaseTgt $ + LB @ DiseaseTgt $ alone control subjects . @ GeneSrc $ allele frequency highest @ DiseaseTgt $ + LB group ( 47.3 % ; 95 % CI = 37.8 57.0 % ) , intermediate @ DiseaseTgt $ group ( 35.1 % ; 95 % CI = 25.3 46.3 % ) , lowest control group ( 14.2 % ; 95 % CI = 10.5 18.9 % ) . use logistic regression analysis , odds @ DiseaseTgt $ + LB vs @ DiseaseTgt $ alone 2.1-fold ( 95 % CI = 1.0 4.5 , p = 0.055 ) greater persons @ GeneSrc $ allele without @ GeneSrc $ allele . CONCLUSION : @ GeneSrc $ allele associated presence concomitant Lewy bodies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0177337153808783)\n",
      "- Text: \"@ GeneSrc $ genotype , cholesterol level , lipid-lowering treatment , dementia : Three-City Study . OBJECTIVE : examine association plasma cholesterol levels , lipid-lowering agent ( LLA ) intake , @ GeneSrc $ genotype dementia prevalence . METHODS : Three-City Study population-based cohort 9,294 subjects selected electoral rolls three French cities ( Bordeaux , Dijon , Montpellier ) . Baseline examination included extensive assessment exposure vascular risk factors ( including cholesterol levels LLA use [ statin fibrate ] ) clinical diagnosis dementia . RESULTS : Two percent participants demented baseline . Overall 32.4 % participants hyperlipidemia , 15.6 % prescribed statins 13.7 % fibrates . adjusting age , gender , education level , study center , odds ratio ( ) dementia observed lower among LLA users ( = 0.61 , 95 % CI = 0.41 0.91 ) compared subjects taking LLAs . differential effect statin fibrate users . odds dementia increased subjects hyperlipidemia ( = 1.43 , 95 % CI = 1.03 1.99 ) . adjustment potential confounders modify associations . addition , association LLA intake dementia modified @ GeneSrc $ genotype , whereas hyperlipidemia significantly associated increased dementia prevalence non-epsilon4 carriers @ DiseaseTgt $ cases . Finally , participants taking LLAs , odds dementia decreased normal lipid levels . CONCLUSIONS : observational study provides evidence lipid-lowering agents associated decreased risk dementia , whereas hyperlipidemia associated increased odds @ DiseaseTgt $ dementia . effects appear independent major potential confounders .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.661494547492693e-05)\n",
      "- Text: \"Predictive utility @ GeneSrc $ genotype @ DiseaseTgt $ outpatients mild cognitive impairment . BACKGROUND : cognitively impaired patients without dementia , utility @ GeneSrc $ ( @ GeneSrc $ ) genotyping unclear . OBJECTIVE : evaluate predictive utility @ GeneSrc $ epsilon4 genotype conversion probable @ DiseaseTgt $ ( @ DiseaseTgt $ ) . DESIGN : Naturalistic , longitudinal study . SETTING : Memory disorders outpatient clinic . PATIENTS : total 136 patients memory complaints determined mild cognitive impairment evaluated every 6 months . Fifty-seven age- sex-matched healthy controls evaluated annually . MAIN OUTCOME MEASURES : Primary outcome measures included conversion @ DiseaseTgt $ . Secondary outcome measures included change time Mini-Mental State Examination ( MMSE ) score Selective Reminding Test ( SRT ) delayed recall score . RESULTS : @ GeneSrc $ epsilon4 allele present 25 % patients 21 % healthy controls . mean + /- SD follow-up 35.2 + /- 24.3 months , 35 136 patients converted @ DiseaseTgt $ . @ GeneSrc $ epsilon4 carrier status differ converters ( 31 % ) nonconverters @ DiseaseTgt $ ( 23 % , P = .3 ) affect time trend MMSE SRT scores entire sample . Four 5 @ GeneSrc $ epsilon4 homozygotes converted @ DiseaseTgt $ compared 7 29 heterozygotes ( P = .02 ) . Cox proportional hazards model stratified age quartiles , controlling sex , education , MMSE score , SRT delayed recall score , @ GeneSrc $ epsilon4 increased risk @ DiseaseTgt $ patients 70 85 years old ( n = 57 ; risk ratio , 2.77 ; 95 % confidence interval , 1.1 - 7.3 ; P = .03 ) patients 55 69 years old ( n = 79 ; P = .7 ) . CONCLUSIONS : @ GeneSrc $ epsilon4 carrier status associated conversion @ DiseaseTgt $ older outpatients controlling known demographic clinical risk factors , @ GeneSrc $ epsilon4 homozygosity associated increased risk conversion @ DiseaseTgt $ . However , @ GeneSrc $ epsilon4 carrier status predict cognitive decline conversion @ DiseaseTgt $ , indicating @ GeneSrc $ genotyping patients mild cognitive impairment may limited clinical applicability prediction outcome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0613320509670475)\n",
      "- Text: \"Apolipoprotein E allele-dependent pathogenesis : model age-related retinal degeneration . Age-related macular degeneration ( AMD ) late-onset , multifactorial , neurodegenerative disease retina leading cause irreversible vision loss elderly Western world . describe murine model combines three known AMD risk factors : advanced age , high fat cholesterol-rich ( HF-C ) diet , @ GeneSrc $ ( @ GeneSrc $ ) genotype . Eyes aged , targeted replacement mice expressing human @ GeneSrc $ , @ GeneSrc $ , @ GeneSrc $ maintained HF-C diet show @ GeneSrc $ isoform-dependent pathologies differential severity . @ GeneSrc $ mice severely affected . develop constellation changes mimic pathology associated human AMD . alterations include diffuse sub-retinal pigment epithelial deposits , drusenoid deposits , thickened Bruch 's membrane , atrophy , hypopigmentation , hyperpigmentation retinal pigment epithelium . extreme cases , @ GeneSrc $ mice also develop marked choroidal neovascularization , hallmark exudative AMD . Neither age HF-C diet alone sufficient elicit changes . document choroidal neovascularization AMD-like ocular pathologies animal model exploits known AMD risk factors . model additionally attractive complicated invasive experimental intervention . findings model implicate human @ GeneSrc $ E4 allele susceptibility gene AMD support hypothesis common pathogenic mechanisms may underlie AMD @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.340822499656815e-05)\n",
      "- Text: \"Sense antisense transcripts apolipoprotein E gene normal ApoE knockout mice , expression spinal cord injury corresponding human transcripts . @ GeneSrc $ ( @ GeneSrc $ ) gene linked maladies hypercholesterolemia , CNS injury disease . study , present evidence , addition known transcript ( ApoE S1 ) translates @ GeneSrc $ , three additional transcripts mice . Two transcripts , @ GeneSrc $ S2 @ GeneSrc $ S3 , predicted transmembrane proteins , transcribed sense strand . @ GeneSrc $ AS1 transcribed antisense strand complementary exon 4 ApoE S1 . open reading frame @ GeneSrc $ AS1 conserved human mouse . antisense transcript falls within region human epsilon 4 allele linked familial onset form @ DiseaseTgt $ . also demonstrate expression @ GeneSrc $ S3 @ GeneSrc $ AS1 @ GeneSrc $ knockout mice , ApoE S1 @ GeneSrc $ S2 get transcribed . previously identified ApoE S1 upregulated mice spinal cord injury . study , show spinal cord-injured C57BL/6 mice , ApoE S1 ApoE S3 transcripts 10-fold upregulated antisense @ GeneSrc $ AS1 100-fold upregulated compared normal levels . data suggest alternate transcripts involved molecular pathogenesis CNS disease perhaps @ GeneSrc $ expression general , show @ GeneSrc $ S2 AS1 also transcribed human .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0112031595891781)\n",
      "- Text: \"Neuropsychological function nondemented carriers presenilin-1 mutations . BACKGROUND : Prospective case-control studies demonstrated memory loss executive dysfunction occur early @ DiseaseTgt $ ( @ DiseaseTgt $ ) . OBJECTIVE : investigate observations study persons risk autosomal dominant forms @ DiseaseTgt $ . METHODS : Neuropsychological genetic tests performed 51 nondemented at-risk members 10 Mexican families two distinct presenilin-1 ( PS1 ) mutations . Test scores compared PS1 mutation carriers ( MCs ; n = 30 ) noncarriers ( NCs ; n = 21 ) analyses variance , co-varying family specific mutation . Regression analyses performed , taking account age relative median age dementia diagnosis family ( adjusted age ) , gender , Beck Depression Inventory ( BDI ) scores , education , number @ GeneSrc $ epsilon4 alleles . Subjects divided age tertiles scores compared within groups . Composite scores Verbal Memory , Executive Function/Working Memory , Language , Visuospatial Function created , scores compared MCs NCs . RESULTS : MCs performed worse NCs Mini-Mental State Examination , Trails Making Tests B , Delayed Recall 10-Word List , Wechsler Adult Intelligence Scale WAIS Block Design . multiple linear regression analyses , BDI score , gender , number @ GeneSrc $ epsilon4 alleles consistently affect test scores . differences seen MCs NCs due differences oldest tertile . MCs lower Visuospatial Executive Function/Working Memory Verbal Memory Language composite scores . CONCLUSIONS : study consistent findings sporadic @ DiseaseTgt $ early problems memory , visuospatial function , particularly executive function PS1 mutation carriers . Depression , gender , presence @ GeneSrc $ epsilon4 allele demonstrate large influences neuropsychological performance .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0105724824985325)\n",
      "- Text: \"@ GeneSrc $ epsilon4 associated @ DiseaseTgt $ elderly Nigerians . Since 1992 , research teams Indiana University University Ibadan collecting comparing data two diverse , elderly populations identify risk factors dementia @ DiseaseTgt $ . @ GeneSrc $ ( @ GeneSrc $ ) genotyped 2,245 Nigerian samples . , 830 diagnosis : 459 normal , 140 dementia including 123 diagnosed @ DiseaseTgt $ . contrast populations , @ GeneSrc $ epsilon4 allele significantly associated @ DiseaseTgt $ dementia . lack association Yoruba might reflect genetic variation , environmental factors , well genetic/environmental interactions .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0054692442059618)\n",
      "- Text: \"Towards compendia negative genetic association studies : example @ DiseaseTgt $ . genetic sequence variants contribute variability complex human traits small effects readily detectable population samples typically used genetic association studies . potentially valuable tool gene discovery process meta-analysis accumulated published data , order valid require sample studies representative true genetic effect thus hypothetically include positive abundance negative reports . survey literature association studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) January 2004-April 2005 , identified 138 studies , 86 reported positive findings @ GeneSrc $ ( @ GeneSrc $ ) , strongly indicative publication bias . report analysis 62 genetic markers , tested association @ DiseaseTgt $ risk well possible effects upon quantitative indices @ DiseaseTgt $ severity ( mini-mental state examination scores , age-at-onset , cerebrospinal fluid ( CSF ) beta-amyloid ( Abeta ) CSF tau proteins ) . Within set , modest signals present , exception @ GeneSrc $ easily lost corrections multiple hypotheses applied . isolation , results thus broadly negative . Genes studied encompass novel candidates well several recently claimed associated @ DiseaseTgt $ ( e.g . urokinase plasminogen activator ( PLAU ) acetyl-coenzyme acetyltransferase 1 ( ACAT1 ) ) . reporting data hope encourage publication gene compendia guide studies aid future meta-analyses aimed resolving involvement genes complex human traits .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999988202933578)\n",
      "- Text: \"@ GeneSrc $ enhances amyloid beta peptide production cultured neuronal cells : @ GeneSrc $ structure potential therapeutic target . @ GeneSrc $ major risk factor @ DiseaseTgt $ , many studies suggested @ GeneSrc $ isoform-specific effects deposition clearance amyloid beta ( Abeta ) peptides . examined effects @ GeneSrc $ isoforms processing amyloid precursor protein ( APP ) Abeta production rat neuroblastoma B103 cells stably transfected human wild-type APP695 ( B103-APP ) . Lipid-poor @ GeneSrc $ increased Abeta production B103-APP cells greater extent lipid-poor @ GeneSrc $ ( 60 % vs. 30 % ) due pronounced stimulation APP recycling @ GeneSrc $ @ GeneSrc $ . difference Abeta production abolished preincubating cells receptor-associated protein ( 25 nM ) , blocks low-density lipoprotein receptor-related protein ( LRP ) pathway , reducing LRP expression small interference RNA . differences also attenuated replacing Arg-61 threonine @ GeneSrc $ pretreating @ GeneSrc $ small molecules , abolish @ GeneSrc $ intramolecular domain interaction . Thus , @ GeneSrc $ appears modulate APP processing Abeta production LRP pathway domain interaction . findings provide insights @ GeneSrc $ associated increased risk @ DiseaseTgt $ may represent potential target drug development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0044247389889243)\n",
      "- Text: \"@ GeneSrc $ alpha brain rhythms mild cognitive impairment : multicentric electroencephalogram study . OBJECTIVE : Relationships @ GeneSrc $ epsilon4 allele electroencephalographic ( EEG ) rhythmicity demonstrated @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients preclinical stage prodromic , namely , mild cognitive impairment ( MCI ) . present multicentric EEG study tested hypothesis presence epsilon4 affects sources resting EEG rhythms MCI @ DiseaseTgt $ subjects . METHODS : enrolled 89 MCI subjects ( 34.8 % epsilon4 ) 103 @ DiseaseTgt $ patients ( 50.4 % epsilon4 ) . Resting eyes-closed EEG data recorded subjects . EEG rhythms interest delta ( 2 - 4 Hz ) , theta ( 4 - 8 Hz ) , alpha 1 ( 8 - 10.5 Hz ) , alpha 2 ( 10.5 - 13Hz ) , beta 1 ( 13 - 20 Hz ) , beta 2 ( 20 - 30 Hz ) . EEG cortical sources estimated low-resolution brain electromagnetic tomography . RESULTS : Results showed amplitude alpha 1 2 sources occipital , temporal , limbic areas lower subjects carrying epsilon4 allele carrying epsilon4 allele ( p < 0.01 ) . true MCI @ DiseaseTgt $ . first time knowledge , relationship shown @ GeneSrc $ genotype global neurophysiological phenotype ( ie , cortical alpha rhythmicity ) preclinical @ DiseaseTgt $ condition , MCI , addition clinically manifest @ DiseaseTgt $ . INTERPRETATION : demonstration motivates future genotype-EEG phenotype studies early prediction @ DiseaseTgt $ conversion individual MCI subjects .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002645402995795)\n",
      "- Text: \"Founder effect Ala431Glu mutation presenilin 1 gene causing early-onset @ DiseaseTgt $ Mexican families . etiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) complex . date , molecular genetic studies several families affected @ DiseaseTgt $ identified three genes associated highly penetrant early-onset @ DiseaseTgt $ : Presenilin 1 ( PSEN1 ) , Presenilin 2 ( PSEN2 ) beta-amyloid precursor protein ( APP ) ; one gene ( @ GeneSrc $ ) associated late-onset @ DiseaseTgt $ . Molecular analysis PSEN1 gene performed direct sequencing genomic DNA . possible founder effect investigated analyzing two highly polymorphic microsatellite markers flanking PSEN1 gene . Twelve unrelated Mexican families early-onset @ DiseaseTgt $ analyzed . Ala431Glu mutation exon 12 PSEN1 found nine ( 75 % ) families , segregated showing autosomal dominant inheritance . families bearing mutation State Jalisco ( located Western Mexico ) , founder effect hypothesized . Microsatellite haplotype analysis suggested common ancestor nine kindreds . conclusion , Ala431Glu mutation prevalent cause early-onset familial @ DiseaseTgt $ families State Jalisco , Mexico . Genetic evidence supports founder mutation descending single common ancestor . findings important implications prompt diagnosis genetic counseling Mexican patients familial @ DiseaseTgt $ Jalisco .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5187054275821014)\n",
      "- Text: \"Age @ GeneSrc $ allele effects cerebrospinal fluid beta-amyloid 42 adults normal cognition . BACKGROUND : Decreased cerebrospinal fluid ( CSF ) beta-amyloid 42 ( beta 42 ) concentration , beta 40 concentration , biomarker @ DiseaseTgt $ . beta 42 concentration decrease CSF likely reflects precipitation beta 42 amyloid plaques brain parenchyma . pathogenic plaque deposition begins years clinical expression dementia @ DiseaseTgt $ . Normal aging presence @ GeneSrc $ ( @ GeneSrc $ ) allele important known risk factors @ DiseaseTgt $ . OBJECTIVE : estimate interactive effects normal aging presence @ GeneSrc $ allele CSF beta 42 concentration adults normal cognition across life span . DESIGN : CSF collected morning overnight fast using Sprotte 24-g atraumatic spinal needles . CSF beta 42 beta 40 concentrations measured 10th milliliter CSF collected sandwich enzyme-linked immunosorbent assay . @ GeneSrc $ genotype determined restriction digest method . Subjects One hundred eighty-four community volunteers normal cognition aged 21 88 years . RESULTS : CSF beta 42 , beta 40 , concentration decreased significantly age . sharp decrease CSF beta 42 concentration beginning sixth decade subjects @ GeneSrc $ allele . age-associated decrease CSF beta 42 concentration significantly substantially greater subjects @ GeneSrc $ allele compared without @ GeneSrc $ allele . CONCLUSION : CSF beta 42 findings consistent acceleration @ GeneSrc $ allele pathogenic beta 42 brain deposition starting later middle age persons normal cognition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0115770128308472)\n",
      "- Text: \"effect @ GeneSrc $ genotype clinical phenotype @ DiseaseTgt $ . authors classified 100 patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) presenting memory nonmemory phenotype . @ GeneSrc $ genotype determined . association @ GeneSrc $ clinical phenotype ( odds ratio = 3.0 ; 95 % CI : 1.2 7.8 ) , suggesting two subtypes @ DiseaseTgt $ identified . typical amnestic phenotype seems promoted @ GeneSrc $ allele , whereas atypical nonmemory phenotype occurs absence @ GeneSrc $ allele .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7027518683057745)\n",
      "- Text: \"effect @ GeneSrc $ genotype clinical phenotype @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0940343555502381)\n",
      "- Text: \"@ GeneSrc $ polymorphisms patients primary open-angle glaucoma . PURPOSE : investigate @ GeneSrc $ ( @ GeneSrc $ ) polymorphisms , known influence risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) , patients primary open-angle glaucoma ( POAG ) . DESIGN : Retrospective case-control association study . METHODS : Patients POAG ( n = 242 ) controls ( n = 187 ) analyzed @ GeneSrc $ epsilon 2/epsilon 3/epsilon 4 polymorphisms using minisequencing technique . RESULTS : @ DiseaseTgt $ @ GeneSrc $ epsilon 4 allele similar frequencies POAG group control group . difference cases controls regard @ GeneSrc $ genotypes . CONCLUSIONS : common pathogenic mechanism exists two age-related neurodegenerative diseases , POAG @ DiseaseTgt $ , involve @ GeneSrc $ polymorphisms .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1942578539401498)\n",
      "- Text: \"Association extended tau haplotype frontotemporal dementia . BACKGROUND : Recent studies shown association extended tau haplotype ( H1 ) covers entire human tau gene progressive supranuclear palsy , inconsistently , neurodegenerative disorders , corticobasal degeneration , @ DiseaseTgt $ , Alzheimer disease , frontotemporal dementia ( FTD ) . addition , disease-causing mutations tau gene chromosome 17 detected families autosomal dominant FTD parkinsonism . FTD , pathological accumulation microtubule-associated protein tau suggests tau gene may genetic risk factor disorder . OBJECTIVE : confirm refute association H1 haplotype H1H1 genotype tau gene FTD . DESIGN : Case-control study . SETTING : Neurology departments 12 French university hospitals . PARTICIPANTS : One hundred unrelated patients FTD 79 controls . METHODS : Tau genotype ( contiguous polymorphisms exons 1 , 7 , 13 intron 9 used reconstruct extended haplotypes H1 H2 ) . Clinical examination , psychometric testing , laboratory tests , computed tomography magnetic resonance imaging , single-photon emission computed tomography , electroencephalography patients FTD . RESULTS : H1H1 genotype significantly overrepresented patients FTD compared controls ( 62 % vs 46 % ; P=.01 , 1-sided ; odds ratio adjusted age sex , 1.95 ) . stratification according @ GeneSrc $ ( @ GeneSrc $ ) genotype , found significant interaction @ GeneSrc $ tau genotypes ( P=.03 ) . CONCLUSIONS : study largest series patients FTD confirms primary role tau FTD establishes H1 haplotype tau gene E2 allele @ GeneSrc $ interact unknown mechanism increases risk FTD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0011972304190074)\n",
      "- Text: \"LRRK2 gene @ DiseaseTgt $ : mutation analysis case control association study . BACKGROUND : addition four well-confirmed genes linked early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( SNCA , PARKIN , DJ-1 , PINK1 ) , mutations leucine-rich repeat kinase 2 gene ( LRRK2 ) recently identified families autosomal dominant late-onset @ DiseaseTgt $ . OBJECTIVE : perform mutation analysis LRRK2 probands families showing dominant inheritance @ DiseaseTgt $ conduct case control association study test hypothesis common coding variations might associated increased susceptibility @ DiseaseTgt $ . METHODS : 51 LRRK2 coding exons sequenced 23 probands mutation frequencies evaluated 180 neurologically normal control subjects . association study authors genotyped four coding LRRK2 polymorphisms 250 normal control subjects 121 patients @ DiseaseTgt $ ( predominantly white patients Canadian origin ) , 84 % age onset 50 years 42 % positive family history . RESULTS : authors identified three probands heterozygous LRRK2 mutations : two known G2019S substitution one proband novel I1371V substitution . Mutation analysis large family demonstrated complete segregation G2019S @ DiseaseTgt $ . However , association @ DiseaseTgt $ four polymorphisms allelic genotypic levels ( p > 0.17 ) . Furthermore , authors detect modifying effect genotype @ GeneSrc $ genotypes upon age onset @ DiseaseTgt $ group ( p > 0.20 ) . CONCLUSIONS : results support prior suggestion LRRK2 mutations cause @ DiseaseTgt $ . disease families reported presents phenotype indistinguishable typical @ DiseaseTgt $ . three families demonstrate variable age onset explained @ GeneSrc $ genotypes . common coding variations LRRK2 gene neither constitute strong @ DiseaseTgt $ risk factors modify age onset ; however , possibility modest risk effect remains assessed large datasets .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7983686748201179)\n",
      "- Text: \"M6P/IGF2R gene mutated human @ DiseaseTgt $ loss heterozygosity . mannose 6-phosphate/insulin-like growth factor-II receptor ( M6P/IGF2R ) functions intracellular trafficking lysosomal enzymes , activation potent growth inhibitor , transforming growth factor beta 2 , degradation @ GeneSrc $ ( ref . 1 ) , mitogen often overproduced tumours . recently shown 70 % human hepatocellular tumours loss heterozygosity ( LOH ) M6P/IGF2R locus maps chromosome 6q26-q27 ( ref . 8 ) . Using coarse screen , identified point mutations remaining allele 25 % human @ DiseaseTgt $ ( @ DiseaseTgt $ ) LOH . mutations give rise truncated receptor protein significant amino acid substitutions , provide evidence M6P/IGF2R gene functions tumour suppressor human liver carcinogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4167022274950084)\n",
      "- Text: \"@ GeneSrc $ gene mutated human @ DiseaseTgt $ loss heterozygosity . mannose @ GeneSrc $ ( @ GeneSrc $ ) functions intracellular trafficking lysosomal enzymes , activation potent growth inhibitor , transforming growth factor beta 2 , degradation IGF2 ( ref . 1 ) , mitogen often overproduced tumours . recently shown 70 % human hepatocellular tumours loss heterozygosity ( LOH ) @ GeneSrc $ locus maps chromosome 6q26-q27 ( ref . 8 ) . Using coarse screen , identified point mutations remaining allele 25 % human @ DiseaseTgt $ ( @ DiseaseTgt $ ) LOH . mutations give rise truncated receptor protein significant amino acid substitutions , provide evidence @ GeneSrc $ gene functions tumour suppressor human liver carcinogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8878379088535564)\n",
      "- Text: \"Frequent loss heterozygosity 6q mannose @ GeneSrc $ locus human hepatocellular tumors . mannose @ GeneSrc $ ( @ GeneSrc $ ) required activation transforming growth factor beta , previously found expression significantly reduced rat human @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Therefore , postulated loss @ GeneSrc $ gene may mechanistically involved liver carcinogenesis . Using polymerase chain reaction , utilized two polymorphisms 3 ' untranslated region @ GeneSrc $ gene screen non-cirrhotic , hepatitis virus negative patients hepatocellular tumors LOH . Twenty-two 36 ( 61 % ) patients informative ( heterozygous ) , 14/22 ( 64 % ) liver tumors LOH ; 11/16 ( 69 % ) carcinomas , 1/3 ( 33 % ) fibrolamellar tumors 2/3 ( 67 % ) adenomas . first report LOH @ GeneSrc $ locus human hepatocellular tumors , presence LOH adenomas suggests allelic loss may early event etiology @ DiseaseTgt $ . results support hypothesis @ GeneSrc $ gene may function tumor suppressor gene liver .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1048698466308209)\n",
      "- Text: \"Apolipoprotein E associates beta amyloid peptide @ DiseaseTgt $ form novel monofibrils . Isoform apoE4 associates efficiently apoE3 . Late-onset sporadic @ DiseaseTgt $ associated apolipoprotein E ( apoE ) type 4 allele expressing protein isoform apoE4 . Apolipoprotein E binds avidly beta amyloid ( beta ) peptide , major component senile plaque @ DiseaseTgt $ , isoform-specific manner . apoE4 isoform binds beta peptide rapidly apoE3 . observed soluble SDS-stable complexes apoE3 apoE4 , formed coincubation beta peptide , precipitated several days incubation 37 degrees C apoE4 complexes precipitating rapidly apoE3 complexes . beta ( 1 - 28 ) beta ( 1 - 40 ) peptides incubated presence absence apoE3 , apoE4 , bovine serum albumin 4 37 degrees C ( pH 7.3 ) . Negative stain electron microscopy revealed beta peptide alone self-assembled twisted ribbons containing two three strands occasionally multistranded sheets . apoE/A beta coincubates yielded monofibrils 7 nm diameter . @ GeneSrc $ coincubates yielded denser matrix monofibrils apoE3/A beta coincubates . Unlike purely monofibrillar @ GeneSrc $ coincubates , apoE3/A beta coincubates also contained double- triple-stranded structures . apoE isoforms shown immunogold labeling uniformly distributed along beta peptide monofibrils . Monofibrils appeared earlier @ GeneSrc $ apoE3/A beta time-course experiments . Thus apoE3 apoE4 interact beta amyloid peptide form novel monofibrillar structures , apoE4 avidly , finding consistent biochemical genetic association apoE4 @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0543649371952534)\n",
      "- Text: \"Fetal origins TEL-AML1 fusion gene identical twins leukemia . TEL ( ETV6 ) -AML1 ( CBFA2 ) gene fusion common reciprocal chromosomal rearrangement childhood cancer occurring approximately 25 % predominant subtype leukemia- common acute lymphoblastic leukemia . TEL-AML1 genomic sequence characterized pair monozygotic twins diagnosed ages 3 years , 6 months 4 years , 10 months common acute lymphoblastic leukemia . twin leukemic DNA shared unique ( clonotypic ) nonconstitutive TEL-AML1 fusion sequence . plausible explanation finding single cell origin @ DiseaseTgt $ fusion one fetus utero , probably leukemia-initiating mutation , followed intraplacental metastasis clonal progeny twin . Clonal identity supported finding leukemic cells two twins shared identical rearranged @ GeneSrc $ allele . data implications etiology natural history childhood leukemia .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3746384362399954)\n",
      "- Text: \"Vitamin K2 mitochondrial electron carrier rescues pink1 deficiency . Human UBIAD1 localizes mitochondria converts vitamin K ( 1 ) vitamin K ( 2 ) . Vitamin K ( 2 ) best known cofactor blood coagulation , bacteria membrane-bound electron carrier . Whether vitamin K ( 2 ) exerts similar carrier function eukaryotic cells unknown . identified Drosophila @ GeneSrc $ modifier pink1 , gene mutated @ DiseaseTgt $ affects mitochondrial function . found vitamin K ( 2 ) necessary sufficient transfer electrons Drosophila mitochondria . @ GeneSrc $ mutants showed severe mitochondrial defects rescued vitamin K ( 2 ) , , similar ubiquinone , vitamin K ( 2 ) transferred electrons Drosophila mitochondria , resulting efficient adenosine triphosphate ( ATP ) production . Thus , mitochondrial dysfunction rescued vitamin K ( 2 ) serves mitochondrial electron carrier , helping maintain normal ATP production .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7282232620346863)\n",
      "- Text: \"SRF myocardin regulate LRP-mediated @ GeneSrc $ clearance brain vascular cells . Amyloid beta-peptide ( @ GeneSrc $ ) deposition cerebral vessels contributes cerebral amyloid angiopathy ( CAA ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , report @ DiseaseTgt $ patients two mouse models @ DiseaseTgt $ , overexpression serum response factor ( SRF ) myocardin ( MYOCD ) cerebral vascular smooth muscle cells ( VSMCs ) generates @ GeneSrc $ non-clearing VSMC phenotype transactivation sterol regulatory element binding protein-2 , downregulates low density lipoprotein receptor-related protein-1 , key @ GeneSrc $ clearance receptor . Hypoxia stimulated SRF/MYOCD expression human cerebral VSMCs animal models @ DiseaseTgt $ . suggest SRF MYOCD function transcriptional switch , controlling @ GeneSrc $ cerebrovascular clearance progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0015376607684039)\n",
      "- Text: \"Functional aspects meningeal lymphatics ageing @ DiseaseTgt $ . Ageing major risk factor many neurological pathologies , mechanisms remain unclear . Unlike tissues , parenchyma central nervous system ( CNS ) lacks lymphatic vasculature waste products removed partly paravascular route . ( ) discovery characterization meningeal lymphatic vessels prompted assessment role waste clearance CNS . show meningeal lymphatic vessels drain macromolecules CNS ( cerebrospinal interstitial fluids ) cervical lymph nodes mice . Impairment meningeal lymphatic function slows paravascular influx macromolecules brain efflux macromolecules interstitial fluid , induces cognitive impairment mice . Treatment aged mice vascular endothelial growth factor C enhances meningeal lymphatic drainage macromolecules cerebrospinal fluid , improving brain perfusion learning memory performance . Disruption meningeal lymphatic vessels transgenic mouse models @ DiseaseTgt $ promotes @ GeneSrc $ deposition meninges , resembles human meningeal pathology , aggravates parenchymal @ GeneSrc $ accumulation . Meningeal lymphatic dysfunction may aggravating factor @ DiseaseTgt $ pathology age-associated cognitive decline . Thus , augmentation meningeal lymphatic function might promising therapeutic target preventing delaying age-associated neurological diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.007768501088058)\n",
      "- Text: \"recessive mutation APP gene dominant-negative effect amyloidogenesis . @ GeneSrc $ ( APP ) mutations cause familial @ DiseaseTgt $ nearly complete penetrance . found APP mutation [ alanine-673 - - > valine-673 ( A673V ) ] causes disease homozygous state , whereas heterozygous carriers unaffected , consistent recessive Mendelian trait inheritance . A673V mutation affected APP processing , resulting enhanced beta-amyloid ( @ GeneSrc $ ) production formation amyloid fibrils vitro . Co-incubation mutated wild-type peptides conferred instability @ GeneSrc $ aggregates inhibited amyloidogenesis neurotoxicity . highly amyloidogenic effect A673V mutation homozygous state anti-amyloidogenic effect heterozygous state account autosomal recessive pattern inheritance implications genetic screening potential treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2798246123135033)\n",
      "- Text: \"Probing @ DiseaseTgt $ using induced pluripotent stem cells . understanding @ DiseaseTgt $ pathogenesis currently limited difficulties obtaining live neurons patients inability model sporadic form disease . may possible overcome challenges reprogramming primary cells patients induced pluripotent stem cells ( iPSCs ) . reprogrammed primary fibroblasts two patients familial @ DiseaseTgt $ , caused duplication amyloid-beta precursor protein gene ( APP ; termed APP ( Dp ) ) , two sporadic @ DiseaseTgt $ ( termed sAD1 , sAD2 ) two non-demented control individuals iPSC lines . Neurons differentiated cultures purified fluorescence-activated cell sorting characterized . Purified cultures contained 90 % neurons , clustered fetal brain messenger RNA samples microarray criteria , could form functional synaptic contacts . Virtually cells exhibited normal electrophysiological activity . Relative controls , iPSC-derived , purified neurons two APP ( Dp ) patients patient sAD2 exhibited significantly higher levels pathological markers amyloid-beta ( 1 - 40 ) , phospho-tau ( Thr 231 ) active glycogen synthase kinase-3beta ( aGSK-3beta ) . Neurons APP ( Dp ) sAD2 patients also accumulated large RAB5-positive early endosomes compared controls . Treatment purified neurons beta-secretase inhibitors , gamma-secretase inhibitors , caused significant reductions phospho-Tau ( Thr 231 ) aGSK-3beta levels . results suggest direct relationship APP proteolytic processing , @ GeneSrc $ , GSK-3beta activation tau phosphorylation human neurons . Additionally , observed neurons genome one sAD patient exhibited phenotypes seen familial @ DiseaseTgt $ samples . generally , demonstrate iPSC technology used observe phenotypes relevant @ DiseaseTgt $ , even though take decades overt disease manifest patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1647823774294087)\n",
      "- Text: \"mutation APP protects @ DiseaseTgt $ age-related cognitive decline . prevalence dementia Western world people age 60 estimated greater 5 % , two-thirds due @ DiseaseTgt $ . age-specific prevalence @ DiseaseTgt $ nearly doubles every 5 years age 65 , leading prevalence greater 25 % age 90 ( ref . 3 ) . , search low-frequency variants @ GeneSrc $ ( APP ) gene significant effect risk @ DiseaseTgt $ , studied coding variants APP set whole-genome sequence data 1,795 Icelanders . found coding mutation ( A673 ) APP gene protects @ DiseaseTgt $ cognitive decline elderly without @ DiseaseTgt $ . substitution adjacent aspartyl protease beta-site APP , results approximately 40 % reduction formation amyloidogenic peptides vitro . strong protective effect A673 substitution @ DiseaseTgt $ provides proof principle hypothesis reducing beta-cleavage APP may protect disease . Furthermore , A673 allele also protects cognitive decline elderly without @ DiseaseTgt $ , two may mediated similar mechanisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3319004253046516)\n",
      "- Text: \"NLRP3 inflammasome activation drives tau pathology . @ DiseaseTgt $ characterized accumulation @ GeneSrc $ plaques , aggregation hyperphosphorylated tau neurofibrillary tangles neuroinflammation , together resulting neurodegeneration cognitive decline1 . NLRP3 inflammasome assembles inside microglia activation , leading increased cleavage activity caspase-1 downstream interleukin-1beta release2 . Although NLRP3 inflammasome shown essential development progression @ GeneSrc $ pathology mice3 , precise effect tau pathology remains unknown . show loss NLRP3 inflammasome function reduced tau hyperphosphorylation aggregation regulating tau kinases phosphatases . Tau activated NLRP3 inflammasome intracerebral injection fibrillar @ GeneSrc $ brain homogenates induced tau pathology NLRP3-dependent manner . data identify important role microglia NLRP3 inflammasome activation pathogenesis tauopathies support amyloid-cascade hypothesis @ DiseaseTgt $ , demonstrating neurofibrillary tangles develop downstream @ GeneSrc $ microglial activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3155172543462224)\n",
      "- Text: \"Genome-wide association study identifies variants CLU CR1 associated @ DiseaseTgt $ . gene encoding apolipoprotein E ( APOE ) chromosome 19 confirmed susceptibility locus late-onset @ DiseaseTgt $ . identify risk loci , conducted large genome-wide association study 2,032 individuals France @ DiseaseTgt $ ( cases ) 5,328 controls . Markers outside APOE suggestive evidence association ( P < 10 ( -5 ) ) examined collections Belgium , Finland , Italy Spain totaling 3,978 @ DiseaseTgt $ cases 3,297 controls . Two loci gave replicated evidence association : one within CLU ( also called APOJ ) , encoding clusterin apolipoprotein J , chromosome 8 ( rs11136000 , = 0.86 , 95 % CI 0.81 - 0.90 , P = 7.5 x 10 ( -9 ) combined data ) within CR1 , encoding complement component ( 3b/4b ) receptor 1 , chromosome 1 ( rs6656401 , = 1.21 , 95 % CI 1.14 - 1.29 , P = 3.7 x 10 ( -9 ) combined data ) . Previous biological studies support roles CLU CR1 clearance beta amyloid ( @ GeneSrc $ ) peptide , principal constituent amyloid plaques , one major brain lesions individuals @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001707741311576)\n",
      "- Text: \"Decreased clearance CNS beta-amyloid @ DiseaseTgt $ . @ DiseaseTgt $ hypothesized caused imbalance beta-amyloid ( @ GeneSrc $ ) production clearance leads @ GeneSrc $ accumulation central nervous system ( CNS ) . @ GeneSrc $ production clearance key targets development disease-modifying therapeutic agents @ DiseaseTgt $ . However , direct evidence altered @ GeneSrc $ production clearance @ DiseaseTgt $ . using metabolic labeling , measured @ GeneSrc $ Abeta40 production clearance rates CNS participants @ DiseaseTgt $ cognitively normal controls . Clearance rates @ GeneSrc $ Abeta40 impaired @ DiseaseTgt $ compared controls . average , differences Abeta40 @ GeneSrc $ production rates . Thus , common late-onset form @ DiseaseTgt $ characterized overall impairment @ GeneSrc $ clearance .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3230792039691629)\n",
      "- Text: \"Prion-like behaviour tau-dependent cytotoxicity pyroglutamylated amyloid-beta . Extracellular plaques @ GeneSrc $ intraneuronal neurofibrillary tangles made tau histopathological signatures @ DiseaseTgt $ . Plaques comprise @ GeneSrc $ fibrils assemble monomeric oligomeric intermediates , prognostic indicators @ DiseaseTgt $ . Despite importance plaques @ DiseaseTgt $ , oligomers considered principal toxic forms @ GeneSrc $ . Interestingly , many adverse responses @ GeneSrc $ , cytotoxicity , microtubule loss , impaired memory learning , neuritic degeneration , greatly amplified tau expression . Amino-terminally truncated , pyroglutamylated ( pE ) forms @ GeneSrc $ strongly associated @ DiseaseTgt $ , toxic @ GeneSrc $ , residues 1 - 42 ( Abeta ( 1 - 42 ) ) Abeta ( 1 - 40 ) , proposed initiators @ DiseaseTgt $ pathogenesis . report mechanism pE-Abeta may trigger @ DiseaseTgt $ . Abeta ( 3 ( pE ) -42 ) co-oligomerizes excess Abeta ( 1 - 42 ) form metastable low-n oligomers ( LNOs ) structurally distinct far cytotoxic cultured neurons comparable LNOs made Abeta ( 1 - 42 ) alone . Tau required cytotoxicity , LNOs comprising 5 % Abeta ( 3 ( pE ) -42 ) plus 95 % Abeta ( 1 - 42 ) ( 5 % pE-Abeta ) seed new cytotoxic LNOs multiple serial dilutions Abeta ( 1 - 42 ) monomers absence additional Abeta ( 3 ( pE ) -42 ) . LNOs isolated human @ DiseaseTgt $ brain contained Abeta ( 3 ( pE ) -42 ) , enhanced Abeta ( 3 ( pE ) -42 ) formation mice triggered neuron loss gliosis 3 months , tau-null background . conclude Abeta ( 3 ( pE ) -42 ) confers tau-dependent neuronal death causes template-induced misfolding Abeta ( 1 - 42 ) structurally distinct LNOs propagate prion-like mechanism . results raise possibility Abeta ( 3 ( pE ) -42 ) acts similarly primary step @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9916409484934604)\n",
      "- Text: \"PGC-1alpha expression decreases @ DiseaseTgt $ brain function dementia . OBJECTIVES : explore mechanisms altered peroxisome proliferator-activated receptor gamma coactivator 1alpha ( PGC-1alpha ) expression may influence @ DiseaseTgt $ ( @ DiseaseTgt $ ) amyloid neuropathology test hypothesis promotion PGC-1alpha expression neurons might developed novel therapeutic strategy @ DiseaseTgt $ . DESIGN : Case-control . Patients Human postmortem brain ( hippocampal formation ) samples @ DiseaseTgt $ cases age-matched @ DiseaseTgt $ cases . RESULTS : Using genome-wide complementary DNA microarray analysis , found PGC-1alpha messenger RNA expression significantly decreased function progression clinical dementia @ DiseaseTgt $ brain . Following confirmatory real-time polymerase chain reaction assay , continued explore role PGC-1alpha clinical dementia found PGC-1alpha protein content negatively associated @ DiseaseTgt $ neuritic plaque pathology beta-amyloid @ GeneSrc $ ) contents . Moreover , found predicted elevation amyloidogenic Abeta ( 1 - 42 ) Abeta ( 1 - 40 ) peptide accumulation embryonic cortico-hippocampal neurons derived Tg2576 @ DiseaseTgt $ mice hyperglycemic conditions ( glucose level , 182 - 273 mg/dL ) coincided dose-dependent attenuation PGC-1alpha expression . importantly , found reconstitution exogenous PGC-1alpha expression Tg2576 neurons attenuated hyperglycemic-mediated beta-amyloidogenesis mechanisms involving promotion `` nonamyloidogenic `` alpha-secretase processing @ GeneSrc $ attenuation forkheadlike transcription factor 1 ( FoxO3a ) expression . CONCLUSION : Therapeutic preservation neuronal PGC-1alpha expression promotes nonamyloidogenic processing @ GeneSrc $ precluding generation amyloidogenic @ GeneSrc $ peptides .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0055935296330055)\n",
      "- Text: \"Structural variation @ GeneSrc $ fibrils @ DiseaseTgt $ clinical subtypes . Aggregation @ GeneSrc $ peptides fibrils self-assembled states central pathogenesis @ DiseaseTgt $ . Fibrils formed vitro 40- 42-residue @ GeneSrc $ peptides ( Abeta40 @ GeneSrc $ ) polymorphic , variations molecular structure depend fibril growth conditions . Recent experiments suggest variations @ GeneSrc $ fibril structure vivo may correlate variations @ DiseaseTgt $ phenotype , analogy distinct prion strains associated different clinical pathological phenotypes . investigate correlations structural variation @ DiseaseTgt $ phenotype using solid-state nuclear magnetic resonance ( ssNMR ) measurements Abeta40 @ GeneSrc $ fibrils prepared seeded growth extracts @ DiseaseTgt $ brain cortex . compared two atypical @ DiseaseTgt $ clinical subtypes-the rapidly progressive form ( @ DiseaseTgt $ ) posterior cortical atrophy variant @ DiseaseTgt $ typical prolonged-duration form ( @ DiseaseTgt $ ) . basis ssNMR data 37 cortical tissue samples 18 individuals , find single Abeta40 fibril structure abundant samples patients @ DiseaseTgt $ @ DiseaseTgt $ , whereas Abeta40 fibrils @ DiseaseTgt $ samples exhibit significantly greater proportion additional structures . Data @ GeneSrc $ fibrils indicate structural heterogeneity samples patient categories , least two prevalent structures . results demonstrate existence specific predominant Abeta40 fibril structure @ DiseaseTgt $ @ DiseaseTgt $ , suggest @ DiseaseTgt $ may relate additional fibril structures indicate qualitative difference Abeta40 @ GeneSrc $ aggregates brain tissue patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4294483246952581)\n",
      "- Text: \"phase 2 multiple ascending dose trial bapineuzumab mild moderate @ DiseaseTgt $ . BACKGROUND : Bapineuzumab , humanized @ GeneSrc $ ( @ GeneSrc $ ) monoclonal antibody potential treatment @ DiseaseTgt $ ( @ DiseaseTgt $ ) , evaluated multiple ascending dose , safety , efficacy study mild moderate @ DiseaseTgt $ . METHODS : study enrolled 234 patients , randomly assigned IV bapineuzumab placebo 4 dose cohorts ( 0.15 , 0.5 , 1.0 , 2.0 mg/kg ) . Patients received 6 infusions , 13 weeks apart , final assessments week 78 . prespecified primary efficacy analysis modified intent-to-treat population assumed linear decline compared treatment differences within dose cohorts @ DiseaseTgt $ Assessment Scale-Cognitive Disability Assessment Dementia . Exploratory analyses combined dose cohorts assume specific pattern decline . RESULTS : significant differences found primary efficacy analysis . Exploratory analyses showed potential treatment differences ( p < 0.05 , unadjusted multiple comparisons ) cognitive functional endpoints study `` completers `` APOE epsilon4 noncarriers . Reversible vasogenic edema , detected brain MRI 12/124 ( 9.7 % ) bapineuzumab-treated patients , frequent higher dose groups APOE epsilon4 carriers . Six vasogenic edema patients asymptomatic ; 6 experienced transient symptoms . CONCLUSIONS : Primary efficacy outcomes phase 2 trial significant . Potential treatment differences exploratory analyses support investigation bapineuzumab phase 3 special attention APOE epsilon4 carrier status . CLASSIFICATION EVIDENCE : Due varying doses lack statistical precision , Class II ascending dose trial provides insufficient evidence support refute benefit bapineuzumab .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0928274435761017)\n",
      "- Text: \"Visinin-like protein-1 : diagnostic prognostic biomarker @ DiseaseTgt $ . OBJECTIVE : growing need identify cerebrospinal fluid ( CSF ) markers detect @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathology cognitively normal individuals population disease-modifying therapies may greatest chance success . @ DiseaseTgt $ pathology estimated begin ~10 - 15 years prior onset cognitive decline , substantial neuronal loss present time earliest signs cognitive impairment appear . Visinin-like protein-1 ( VILIP-1 ) demonstrated potential utility marker neuronal injury . investigate CSF VILIP-1 VILIP-1/amyloid-beta42 ( @ GeneSrc $ ) ratio diagnostic prognostic markers early @ DiseaseTgt $ . METHODS : assessed CSF levels VILIP-1 , tau , phosphorylated-tau181 ( p-tau181 ) , @ GeneSrc $ cognitively normal controls ( CNC ) ( n = 211 ) , individuals early symptomatic @ DiseaseTgt $ ( n = 98 ) , individuals dementias ( n = 19 ) . Structural magnetic resonance imaging ( n = 192 ) amyloid imaging Pittsburgh Compound-B ( n = 156 ) obtained subsets cohort . Among CNC cohort , 164 individuals follow-up annual cognitive assessments 2 - 3 years . RESULTS : CSF VILIP-1 levels differentiated individuals @ DiseaseTgt $ CNC individuals dementias . CSF VILIP-1 levels correlated CSF tau , p-tau181 , brain volumes @ DiseaseTgt $ . VILIP-1 @ GeneSrc $ predicted future cognitive impairment CNC follow-up period . Importantly , CSF @ GeneSrc $ predicted future cognitive impairment least well @ GeneSrc $ @ GeneSrc $ . INTERPRETATION : findings suggest CSF VILIP-1 @ GeneSrc $ offer diagnostic utility early @ DiseaseTgt $ , predict future cognitive impairment cognitively normal individuals similarly tau @ GeneSrc $ , respectively .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3078917237319883)\n",
      "- Text: \"Functional links Abeta toxicity , endocytic trafficking , @ DiseaseTgt $ risk factors yeast . @ GeneSrc $ ( @ GeneSrc $ ) important contributor @ DiseaseTgt $ ( @ DiseaseTgt $ ) . modeled Abeta toxicity yeast directing peptide secretory pathway . genome-wide screen toxicity modifiers identified yeast homolog phosphatidylinositol binding clathrin assembly protein ( PICALM ) endocytic factors connected @ DiseaseTgt $ whose relationship @ GeneSrc $ previously unknown . factors identified yeast modified Abeta toxicity glutamatergic neurons Caenorhabditis elegans primary rat cortical neurons . yeast , @ GeneSrc $ impaired endocytic trafficking plasma membrane receptor , ameliorated endocytic pathway factors identified yeast screen . Thus , links @ GeneSrc $ , endocytosis , human @ DiseaseTgt $ risk factors ascertained yeast model system .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1584971345736424)\n",
      "- Text: \"Microglia-derived ASC specks cross-seed @ GeneSrc $ @ DiseaseTgt $ . spreading pathology within brain areas hallmark neurodegenerative disorders . patients @ DiseaseTgt $ , deposition @ GeneSrc $ accompanied activation innate immune system involves inflammasome-dependent formation ASC specks microglia . ASC specks released microglia bind rapidly @ GeneSrc $ increase formation @ GeneSrc $ oligomers aggregates , acting inflammation-driven cross-seed @ GeneSrc $ pathology . show intrahippocampal injection ASC specks resulted spreading @ GeneSrc $ pathology transgenic double-mutant APPSwePSEN1dE9 mice . contrast , homogenates brains APPSwePSEN1dE9 mice failed induce seeding spreading @ GeneSrc $ pathology ASC-deficient APPSwePSEN1dE9 mice . Moreover , co-application anti-ASC antibody blocked increase @ GeneSrc $ pathology APPSwePSEN1dE9 mice . findings support concept inflammasome activation connected seeding spreading @ GeneSrc $ pathology patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0128440392699051)\n",
      "- Text: \"pathogenic mutation probable @ DiseaseTgt $ APP gene N-terminus beta-amyloid . Mutations codon 717 exon 17 @ GeneSrc $ ( APP ) gene previously shown segregate early onset @ DiseaseTgt $ families . identified double mutation codons 670 671 ( APP 770 transcript ) exon 16 co-segregates disease two large ( probably related ) early-onset @ DiseaseTgt $ families Sweden . Two base pair transversions ( G , C ) normal sequence predict Lys Asn Met Leu amino acid substitutions codons 670 671 APP transcript . mutation occurs amino terminal beta-amyloid may pathogenic occurs close endosomal/lysosomal cleavage site molecule . Thus , pathogenic mutations APP frame beta-amyloid sequence .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1904580756545729)\n",
      "- Text: \"@ DiseaseTgt $ cerebral haemorrhage linked mutation codon 692 @ GeneSrc $ gene . Several families early-onset form familial @ DiseaseTgt $ found harbour mutations specific codon ( 717 ) gene @ GeneSrc $ ( APP ) chromosome 21 . report , novel base mutation exon APP gene co-segregates one family @ DiseaseTgt $ cerebral haemorrhage due cerebral amyloid angiopathy . mutation results substitution alanine glycine codon 692 . results suggest clinically distinct entities , @ DiseaseTgt $ cerebral amyloid angiopathy , caused mutation APP gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1791075643611061)\n",
      "- Text: \"Mutation codon 713 @ GeneSrc $ gene presenting schizophrenia . Following reports mutations codon 717 exon 17 @ GeneSrc $ ( APP ) gene early-onset familial @ DiseaseTgt $ , screened exon 17 new mutations presenile dementia . majority 105 patients screened definite probable @ DiseaseTgt $ , also included atypical cases chronic schizophrenics . identified single abnormal case -- chronic schizophrenic cognitive defects . Sequencing revealed C nucleotide substitution produces alanine valine change codon 713 . unable detect mutation remaining members original cohort 100 chronic schizophrenics 100 non-demented controls . Nonetheless , position mutation critical portion APP gene suggests may well prove pathogenic .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3979962738143023)\n",
      "- Text: \"Linkage mutational analysis @ DiseaseTgt $ kindreds APP gene region . large number @ DiseaseTgt $ ( @ DiseaseTgt $ ) kindreds examined determine whether mutations @ GeneSrc $ ( APP ) gene could responsible disease . Previous studies identified three mutations APP codon 717 pathogenic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Samples affected subjects examined mutations exons 16 17 APP gene . combination direct sequencing single-strand conformational polymorphism analysis used . Sporadic @ DiseaseTgt $ normal controls also examined methods . Five sequence variants identified . One variant APP codon 693 resulted Glu -- > Gly change . codon hereditary cerebral hemorrhage amyloidosis-Dutch type Glu -- > Gln mutation . Another single-base change APP codon 708 alter amino acid encoded site . Two point mutations 6-bp deletion identified intronic sequences surrounding exon 17 . None variants could unambiguously determined responsible @ DiseaseTgt $ . larger families also analyzed testing linkage @ DiseaseTgt $ highly polymorphic short tandem repeat marker ( D21S210 ) tightly linked APP . Highly negative LOD scores obtained family groups tested , linkage formally excluded beyond theta = .10 Volga German kindreds , theta = .20 early-onset non-Volga Germans , theta = .10 late-onset families . LOD scores linkage @ DiseaseTgt $ markers centromeric APP ( D21S1/S11 , D21S13 , D21S215 ) also negative three family groups . studies show APP mutations account @ DiseaseTgt $ small fraction @ DiseaseTgt $ kindreds .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.95060844115776)\n",
      "- Text: \"Mutation @ GeneSrc $ @ DiseaseTgt $ increases beta-protein production . Progressive cerebral deposition 39 - 43-amino-acid amyloid beta-protein ( @ GeneSrc $ ) invariant feature @ DiseaseTgt $ precedes symptoms dementia years decades . specific molecular defects cause @ DiseaseTgt $ identified far missense mutations gene encoding @ GeneSrc $ ( beta-APP ) certain families autosomal dominant form disease ( @ DiseaseTgt $ , @ DiseaseTgt $ ) . mutations located within immediately flanking @ GeneSrc $ region beta-APP , mechanism cause pathological phenotype early accelerated @ GeneSrc $ deposition unknown . report cultured cells express @ GeneSrc $ complementary DNA bearing double mutation ( Lys Asn residue 595 plus Met Leu position 596 ) found Swedish @ DiseaseTgt $ family produce approximately 6 - 8-fold @ GeneSrc $ cells expressing normal beta-APP . Met 596 Leu mutation principally responsible increase . data establish direct link @ DiseaseTgt $ genotype clinicopathological phenotype . , confirm relevance continuous @ GeneSrc $ production cultured cells elucidating fundamental mechanism @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8973148446926298)\n",
      "- Text: \"Molecular prospective phenotypic characterization pedigree @ DiseaseTgt $ missense mutation codon 717 @ GeneSrc $ gene . present prospective clinical neuropathologic details pedigree segregating @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated mutation ( G -- -- substitution ) nucleotide 2149 exon 17 @ GeneSrc $ ( APP ) gene . mutation , predicted cause missense substitution isoleucine valine codon 717 APP , cosegregated perfectly @ DiseaseTgt $ trait ( lod score = 3.49 theta = 0.00 ) . earliest clinical manifestations disease relate deficits memory function , cognitive processing speed , attention complex cognitive sets . changes occurred absence changes nonmemory language visuospatial functions . neuropathologic features @ DiseaseTgt $ associated APP717 mutation family include severe neuronal loss , abundant neurofibrillary tangles , amyloid plaques , amyloid angiopathy . results provide independent confirmation mutations APP gene linked @ DiseaseTgt $ trait families .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8604321350383537)\n",
      "- Text: \"Segregation missense mutation @ GeneSrc $ gene @ DiseaseTgt $ . locus segregating @ DiseaseTgt $ ( @ DiseaseTgt $ ) mapped chromosome 21 , close @ GeneSrc $ ( APP ) gene . Recombinants APP gene @ DiseaseTgt $ locus reported seemed exclude site mutation causing @ DiseaseTgt $ . recent genetic analysis large number @ DiseaseTgt $ families demonstrated disease heterogeneous . Families late-onset @ DiseaseTgt $ show linkage chromosome 21 markers . families early-onset @ DiseaseTgt $ show linkage chromosome 21 markers , . led suggestion non-allelic genetic heterogeneity even within early onset @ DiseaseTgt $ . avoid problems heterogeneity poses genetic analysis , examined cosegregation @ DiseaseTgt $ markers along long arm chromosome 21 single family @ DiseaseTgt $ confirmed autopsy . demonstrate kindred , shows linkage chromosome 21 markers , point mutation APP gene . mutation causes amino-acid substitution ( Val -- -- Ile ) close carboxy terminus @ GeneSrc $ . Screening cases @ DiseaseTgt $ revealed second unrelated family variant occurs . suggests cases @ DiseaseTgt $ could caused mutations APP gene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5344131519392699)\n",
      "- Text: \"APP717 , APP693 , PRIP gene mutations rare @ DiseaseTgt $ . @ GeneSrc $ ( APP ) gene codes precursor beta-protein found amyloid deposits @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Recently Goate et al . identified codon 717 gene missense mutation segregates @ DiseaseTgt $ @ DiseaseTgt $ ( @ DiseaseTgt $ ) kindred . mutation also found affected subjects second @ DiseaseTgt $ family @ DiseaseTgt $ families normal controls . following work undertaken determine frequency codon 717 mutation @ DiseaseTgt $ nonfamilial @ DiseaseTgt $ cases normal controls . tested 76 @ DiseaseTgt $ families , 127 `` sporadic `` @ DiseaseTgt $ subjects , 16 syndrome cases , 256 normal controls mutation , none positive . also tested APP codon 693 mutation associated hereditary cerebral hemorrhage amyloidosis-Dutch type , PRIP gene missense mutations codons 102 , 117 , 200 , PRIP insertion mutations associated Creutzfeld-Jakob disease Gerstmann-Straussler Scheinker syndrome . examples mutations found population . Thus APP PRIP mutations rare @ DiseaseTgt $ nonfamilial @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9894934820777164)\n",
      "- Text: \"Increased gene expression @ DiseaseTgt $ @ GeneSrc $ senescent cultured fibroblasts . pathological hallmark @ DiseaseTgt $ accumulation neurofibrillary tangles neuritic plaques brains patients . Plaque cores contain 4- 5-kDa amyloid beta-protein fragment also found cerebral blood vessels affected individuals . Since amyloid deposition brain increases age even normal people , sought establish whether disease state bears direct relationship normal aging processes . model biological aging , process cellular senescence vitro used . mRNA levels @ GeneSrc $ associated @ DiseaseTgt $ compared human fibroblasts culture early passage fibroblasts grown senescence 52 population doublings . dramatic increase mRNA observed senescent IMR-90 fibroblasts compared early-passage cells . Hybridization mRNA senescent early proliferating fibroblasts oligonucleotide probes specific three alternatively spliced transcripts gene gave similar results , indicating increase senescence three forms . similar , though modest , increase message levels also observed early-passage fibroblasts made quiescent serum deprivation ; repletion serum , however , expression returned previous low levels . ELISAs performed cell extracts senescent , early proliferating , quiescent fibroblasts , quiescent fibroblasts repleted serum 48 hr , using polyclonal antibodies synthetic peptide beta-amyloid precursor . results confirmed differences mRNA expression partially reflected protein level . Regulated expression @ GeneSrc $ may important determinant growth metabolic responses serum growth factors physiological well pathological conditions .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.008772261132486)\n",
      "- Text: \"717Val -- -- Ile substitution @ GeneSrc $ associated @ DiseaseTgt $ regardless ethnic groups . @ DiseaseTgt $ ( @ DiseaseTgt $ ) devastating neurological disorder leading cause dementia among aged individuals . human amyloid beta protein , cleavage product @ GeneSrc $ ( APP ) , major component amyloid deposited brain patients @ DiseaseTgt $ . using PCR direct sequencing exon 17 ( encoding part beta protein ) APP gene , found Japanese @ DiseaseTgt $ patient harbours C substitution , responsible valine isoleucine change position 717 , heterogeneously . mutation exactly found Caucasian @ DiseaseTgt $ family Goate et al . ( 1 ) . Furthermore , mutation shown co-segregate @ DiseaseTgt $ family . results suggest Val -- -- Ile change APP causes @ DiseaseTgt $ , regardless ethnic background .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2087446626986761)\n",
      "- Text: \"mutation @ GeneSrc $ associated hereditary @ DiseaseTgt $ . @ DiseaseTgt $ form localized amyloidosis characterized cerebral cortical amyloid plaques , neurofibrillary tangles , amyloid deposits within walls leptomeningeal vessels . Although cases @ DiseaseTgt $ sporadic , kindreds autosomal-dominant inheritance syndrome suggest single mutation may important pathogenesis . Direct sequencing DNA family autopsy-proven @ DiseaseTgt $ revealed single amino acid substitution ( Phe Val ) transmembrane domain @ GeneSrc $ . mutation correlates presence @ DiseaseTgt $ patients study , may inherited factor causing amyloid fibril formation dementia .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7601749844526245)\n",
      "- Text: \"Early-onset @ DiseaseTgt $ caused mutations codon 717 @ GeneSrc $ gene . mutation codon 717 @ GeneSrc $ gene found cosegregate familial @ DiseaseTgt $ single family . mutation reported five approximately 100 families multiply affected @ DiseaseTgt $ . identified another family , F19 , detected linkage @ GeneSrc $ gene @ DiseaseTgt $ . Direct sequencing exon 17 affected individuals family revealed base change producing Val -- -- Gly substitution , also codon 717 . occurrence second allelic variant codon 717 linked @ DiseaseTgt $ phenotype supports hypothesis pathogenic mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2130925428319391)\n",
      "- Text: \"Cleavage amyloid beta peptide constitutive processing precursor . amyloid beta peptide ( beta P ) small fragment much larger , broadly distributed @ GeneSrc $ ( APP ) . Abundant beta P deposition brains patients @ DiseaseTgt $ suggests altered APP processing may represent key pathogenic event . Direct protein structural analyses showed constitutive processing human embryonic kidney 293 cells cleaves APP interior beta P , thus preventing beta P deposition . deficiency processing event may ultimately prove etiological event @ DiseaseTgt $ gives rise senile plaque formation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5078825438923562)\n",
      "- Text: \"@ GeneSrc $ , potent antichymotrypsin , shows identity amyloid beta-protein precursor . @ GeneSrc $ ( @ GeneSrc $ ) protease inhibitor forms SDS-resistant inhibitory complexes epidermal growth factor ( EGF ) -binding protein , gamma-subunit nerve growth factor , trypsin . properties @ GeneSrc $ indicate role regulation certain proteases extracellular environment . describe amino-acid sequence @ GeneSrc $ identity deduced sequence amyloid beta-protein precursor ( APP ) . Amyloid beta-protein present neuritic plaques cerebrovascular deposits individuals @ DiseaseTgt $ 's syndrome . monoclonal antibody @ GeneSrc $ ( designated mAbP2 - 1 ) recognized @ GeneSrc $ immunoblots serum-free culture medium human glioblastoma cells neuroblastoma cells , well homogenates normal @ DiseaseTgt $ brains . addition , mAbP2 - 1 stained neuritic plaques @ DiseaseTgt $ brain . @ GeneSrc $ potent inhibitor chymotrypsin inhibition constant Ki 6 x 10 ( -10 ) M. Together , data demonstrate @ GeneSrc $ APP probably protein . regulation extracellular proteolysis @ GeneSrc $ deposition least parts molecule senile plaques consistent previous reports implicate altered proteolysis pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7490760819861891)\n",
      "- Text: \"Protease inhibitor domain encoded @ GeneSrc $ mRNA associated @ DiseaseTgt $ . Amyloid B-protein/amyloid A4 peptide present neuritic plaques , neurofibrillary tangles cerebrovascular deposits patients @ DiseaseTgt $ 's syndrome ( trisomy 21 ) may involved pathogenesis @ DiseaseTgt $ . Recent molecular genetic studies indicated amyloid protein encoded part larger protein gene human chromosome 21 ( refs 6 - 9 ) . @ GeneSrc $ ( APP ) gene expressed brain several peripheral tissues , specific biochemical events leading deposition amyloid known . screened complementary DNA libraries constructed peripheral tissues determine whether messenger RNA encoding APP tissues identical expressed brain , identify second APP mRNA encodes additional internal domain sequence characteristic Kunitz-type serine protease inhibitor . alternative APP mRNA present brain peripheral tissues normal individuals @ DiseaseTgt $ , pattern expression differs previously reported APP mRNA .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8491136526574561)\n",
      "- Text: \"Gene dosage @ GeneSrc $ @ DiseaseTgt $ . progressive deposition human brain amyloid filaments composed @ GeneSrc $ protein principal feature @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Densitometric analysis Southern blots probed complementary DNA amyloid protein carried determine relative dosage gene genomic DNA 14 patients @ DiseaseTgt $ , 12 aged normal subjects , 10 patients trisomy 21 ( syndrome ) . Whereas patients last group showed expected 1.5-fold increase dosage gene , none patients @ DiseaseTgt $ gene dosage higher normal controls . results support hypothesis genetic defect @ DiseaseTgt $ involves duplication segment chromosome 21 containing amyloid gene . Alternative mechanisms brain-specific increase amyloid protein deposition @ DiseaseTgt $ considered .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7222121817318788)\n",
      "- Text: \"beta-Amyloid gene present three copies autopsy-validated @ DiseaseTgt $ . Recently , suggested @ DiseaseTgt $ associated duplication @ GeneSrc $ gene localized chromosome 21q21 . study , cloned DNA probe ( B2.3 ) , complementary sequence coding @ GeneSrc $ , DNA polymorphisms adjacent sequence used determine number copies beta-amyloid gene DNA isolated human blood brain . Individuals trisomy 21 ( syndrome ) heterozygous polymorphisms showed gene-dosage effect , one allele exhibiting twice autoradiographic intensity . Heterozygous individuals @ DiseaseTgt $ controls showed equal intensities two allelic bands , suggesting two copies beta-amyloid gene individuals . individuals @ DiseaseTgt $ controls homozygous polymorphisms , number copies beta-amyloid gene determined comparing autoradiographic intensity beta-amyloid alleles DNA fragments detected reference probe . difference detected two groups .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6649683446869751)\n",
      "- Text: \"Swedish mutation causes early-onset @ DiseaseTgt $ beta-secretase cleavage within secretory pathway . Several missense mutations causing early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) described gene coding @ GeneSrc $ ( beta APP ) . double mutation found Swedish family located amyloid beta-peptide ( @ GeneSrc $ ) region beta APP results increased production secretion @ GeneSrc $ . show increased production @ GeneSrc $ results cellular mechanism , differs substantially responsible production @ GeneSrc $ wild-type beta APP . latter case , @ GeneSrc $ generation requires reinternalization recycling beta APP . case Swedish mutation N-terminal beta-secretase cleavage @ GeneSrc $ occurs Golgi-derived vesicles , likely within secretory vesicles . Therefore , cleavage occurs compartment alpha-secretase cleavage , normally prevents @ GeneSrc $ production , explaining increased @ GeneSrc $ generation competition alpha- beta-secretase .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999886025984196)\n",
      "- Text: \"LDL receptor-related protein , multifunctional ApoE receptor , binds secreted @ GeneSrc $ mediates degradation . secreted form @ GeneSrc $ ( APP ) containing Kunitz proteinase inhibitor ( KPI ) domain , also called @ GeneSrc $ , internalized degraded cells . show low density lipoprotein ( LDL ) receptor-related protein ( LRP ) responsible endocytosis secreted APP . APPs770 degradation inhibited LRP antagonist called receptor-associated protein ( RAP ) LRP antibodies greatly diminished fibroblasts genetically deficient LRP . APPs695 , lacks KPI domain , poor LRP ligand . Since LRP also binds apolipoprotein E ( apoE ) -enriched lipoproteins inheritance epsilon 4 allele apoE gene risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , data link single metabolic pathway two molecules strongly implicated pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.083910061611572)\n",
      "- Text: \"Apolipoprotein E epsilon 4 allele associated deposition amyloid beta-protein following head injury . Deposition amyloid beta-protein ( @ GeneSrc $ ) brain plays key role pathogenesis @ DiseaseTgt $ . Apolipoprotein E epsilon 4 allele ( apo E-epsilon 4 ) strong risk factor @ DiseaseTgt $ , vitro evidence apo E directly involved @ GeneSrc $ deposition . Head injury epidemiological risk factor @ DiseaseTgt $ deposition @ GeneSrc $ occurs approximately one-third individuals dying severe head injury . report frequency apo E-epsilon 4 individuals @ GeneSrc $ deposition following head injury ( 0.52 ) higher studies @ DiseaseTgt $ , head-injured individuals without @ GeneSrc $ deposition apo E-epsilon 4 frequency ( 0.16 ) similar controls without @ DiseaseTgt $ ( P < 0.00001 ) . finding provides evidence linking apo E-epsilon 4 @ GeneSrc $ deposition vivo suggests known environmental genetic risk factors @ DiseaseTgt $ may act additively . addition finding indicates genetic susceptibility effects head injury .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2280969107581608)\n",
      "- Text: \"APOE * 4-associated @ DiseaseTgt $ risk modified alpha 1-antichymotrypsin polymorphism . Genetic studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) , devastating neurodegenerative disorder , identified apolipoprotein E ( APOE ) gene strong susceptibility marker @ DiseaseTgt $ . E * 4 allele APOE major risk factor @ DiseaseTgt $ regardless age onset family history . However , observation APOE * 4 allele neither necessary sufficient expression @ DiseaseTgt $ emphasizes involvement environmental genetic elements , either conjunction APOE * 4 alone , increase individual 's risk developing @ DiseaseTgt $ . Among candidate genes may affect risk multifactorial disease gene coding alpha 1-antichymotrypsin ( ACT ) . Like APOE protein , ACT binds @ GeneSrc $ ( beta P ) high affinity filamentous deposits found @ DiseaseTgt $ brain serves strong stimulatory factor polymerization beta P amyloid filaments . @ DiseaseTgt $ brains , ACT expression enhanced , particularly areas develop amyloid plaques , suggesting ACT may play important role pathogenesis @ DiseaseTgt $ . show common polymorphism signal peptide ACT confers significant risk @ DiseaseTgt $ . Furthermore , APOE * 4 gene dosage effect associated @ DiseaseTgt $ risk significantly modified ACT polymorphism . also identified unique combination ACT/AA APOE 4/4 genotypes potential susceptibility marker @ DiseaseTgt $ , frequency 1/17 @ DiseaseTgt $ group compared 1/313 general population control . data show ACT behaves modifier gene alters @ DiseaseTgt $ risk conventionally associated APOE * 4 allele .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5871635200291342)\n",
      "- Text: \"RFLP analysis APP 717 mutations associated @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) shown associated three distinct point mutations within codon @ GeneSrc $ ( APP ) gene . mutation identified Indiana kindred G -- > transversion first position codon amino acid 717 , resulting substitution phenylalanine valine APP protein . Screening persons risk APP Phe-717 mutation using variation polymerase chain reaction identified nine positives among 34 tested . addition , DNA 145 @ DiseaseTgt $ subjects tested three known APP 717 mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4155636346126888)\n",
      "- Text: \"Quantitative analysis senile plaques @ DiseaseTgt $ : observation log-normal size distribution molecular epidemiology differences associated apolipoprotein E genotype trisomy 21 ( syndrome ) . discovery epsilon 4 allele apolipoprotein E ( apoE ) gene putative risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) general population highlighted role genetic influences extremely common disabling illness . long recognized another genetic abnormality , trisomy 21 ( syndrome ) , associated early severe development AD neuropathological lesions . remains challenge , however , understand facts relate pathological changes brains @ DiseaseTgt $ patients . used computerized image analysis examine size distribution one characteristic neuropathological lesions @ DiseaseTgt $ , deposits beta peptide senile plaques ( SPs ) . Surprisingly , find log-normal distribution fits SP size distribution quite well , motivating porous model SP morphogenesis . analyzed SP size distribution curves genotypically defined subgroups @ DiseaseTgt $ patients . data demonstrate apoE epsilon @ DiseaseTgt $ trisomy @ DiseaseTgt $ lead increased amyloid deposition , apparently different mechanisms . size distribution curve shifted toward larger plaques trisomy @ DiseaseTgt $ , probably reflecting increased @ GeneSrc $ production . apoE epsilon @ DiseaseTgt $ , size distribution unchanged number SP increased compared apoE epsilon 3 , suggesting increased probability SP initiation . results demonstrate subgroups @ DiseaseTgt $ patients defined basis molecular characteristics quantitatively different neuropathological phenotypes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9372782738966384)\n",
      "- Text: \"Alzheimer-type neuropathology transgenic mice overexpressing V717F beta-amyloid precursor protein . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common cause progressive intellectual failure aged humans . @ DiseaseTgt $ brains contain numerous amyloid plaques surrounded dystrophic neurites , show profound synaptic loss , neurofibrillary tangle formation gliosis . amyloid plaques composed amyloid beta-peptide ( @ GeneSrc $ ) , 40 - 42-amino-acid fragment @ GeneSrc $ ( APP ) . primary pathogenic role @ GeneSrc $ suggested missense mutations APP tightly linked autosomal dominant forms @ DiseaseTgt $ . major obstacle elucidating treating @ DiseaseTgt $ lack animal model . Animals transgenic APP previously failed show extensive @ DiseaseTgt $ neuropathology , report production transgenic mice express high levels human mutant APP ( valine residue 717 substituted phenylalanine ) progressively develop many pathological hallmarks @ DiseaseTgt $ , including numerous extracellular thioflavin S-positive beta deposits , neuritic plaques , synaptic loss , astrocytosis microgliosis . mice support primary role APP/A beta genesis @ DiseaseTgt $ could provide preclinical model testing therapeutic drugs .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999986337852932)\n",
      "- Text: \"Excessive production amyloid beta-protein peripheral cells symptomatic presymptomatic patients carrying Swedish @ DiseaseTgt $ mutation . 39- 43-amino acid amyloid beta-protein ( @ GeneSrc $ ) , progressively deposited cerebral plaques blood vessels @ DiseaseTgt $ ( @ DiseaseTgt $ ) , secreted cultured human cells normal metabolism . studies cell lines transfected @ GeneSrc $ ( beta APP ) cDNAs , beta APP mutation K670N/M671L found Swedish @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigree previously shown cause marked augmentation @ GeneSrc $ secretion . , conducted blinded analyses beta APP metabolism primary skin fibroblasts affected members Swedish @ DiseaseTgt $ pedigree unaffected siblings spouses . fibroblasts continuously secrete homogenous population @ GeneSrc $ molecules starting Asp-1 ( D672 beta APP ) . found consistent significant approximately 3-fold elevation @ GeneSrc $ release biopsied skin fibroblasts bearing @ DiseaseTgt $ mutation . significant alterations metabolic derivatives beta APP detected . elevated @ GeneSrc $ levels found cells patients clinical @ DiseaseTgt $ presymptomatic subjects . Thus , @ GeneSrc $ overproduction @ DiseaseTgt $ pedigree secondary event consistent causal role development disease . Increased @ GeneSrc $ secretion begin many years prior onset symptoms , even peripheral tissues , indicating require preexisting neural abnormalities .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9920719586221256)\n",
      "- Text: \"Altered cleavage secretion recombinant beta-APP bearing Swedish @ DiseaseTgt $ mutation . Mutations within @ GeneSrc $ gene cosegregate early-onset form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . known mutations result disease ; however , one early-onset @ DiseaseTgt $ mutation Swedish kindred increases potentially amyloidogenic fragments beta-protein production cells expressing mutant beta-APP . Using novel recombinant reporter system found qualitative change secreted product , cleavage within beta-protein sequence cleavage near N-terminal region beta-protein , even though total amount secreted mutant product similar wild-type . results suggest increased formation potentially amyloidogenic fragments cells expressing Swedish @ DiseaseTgt $ occurs enzymatic cleavage secretory pathway . Alterations secretory process may predispose individual @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999950113030672)\n",
      "- Text: \"Apolipoprotein E associates @ GeneSrc $ @ DiseaseTgt $ form novel monofibrils . Isoform apoE4 associates efficiently apoE3 . Late-onset sporadic @ DiseaseTgt $ associated apolipoprotein E ( apoE ) type 4 allele expressing protein isoform apoE4 . Apolipoprotein E binds avidly beta amyloid ( beta ) peptide , major component senile plaque @ DiseaseTgt $ , isoform-specific manner . apoE4 isoform binds beta peptide rapidly apoE3 . observed soluble SDS-stable complexes apoE3 apoE4 , formed coincubation beta peptide , precipitated several days incubation 37 degrees C apoE4 complexes precipitating rapidly apoE3 complexes . beta ( 1 - 28 ) beta ( 1 - 40 ) peptides incubated presence absence apoE3 , apoE4 , bovine serum albumin 4 37 degrees C ( pH 7.3 ) . Negative stain electron microscopy revealed beta peptide alone self-assembled twisted ribbons containing two three strands occasionally multistranded sheets . apoE/A beta coincubates yielded monofibrils 7 nm diameter . ApoE4/A beta coincubates yielded denser matrix monofibrils apoE3/A beta coincubates . Unlike purely monofibrillar apoE4/A beta coincubates , apoE3/A beta coincubates also contained double- triple-stranded structures . apoE isoforms shown immunogold labeling uniformly distributed along beta peptide monofibrils . Monofibrils appeared earlier apoE4/A beta apoE3/A beta time-course experiments . Thus apoE3 apoE4 interact @ GeneSrc $ form novel monofibrillar structures , apoE4 avidly , finding consistent biochemical genetic association apoE4 @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002199721719887)\n",
      "- Text: \"Novel @ GeneSrc $ gene mutation ( codon 665Asp ) patient late-onset @ DiseaseTgt $ . Amyloid plaques @ DiseaseTgt $ contain beta-amyloid , encoded portions exons 16 17 @ GeneSrc $ . specific association rare @ GeneSrc $ mutations kindreds early-onset @ DiseaseTgt $ suggests specific abnormalities @ GeneSrc $ may contribute pathogenesis @ DiseaseTgt $ . , evidence suggesting @ GeneSrc $ mutations could involved late-onset sporadic @ DiseaseTgt $ . used reverse transcription-polymerase chain reaction , denaturing gradient gel electrophoresis , direct DNA sequencing analyze @ GeneSrc $ exons 16 17 postmortem cerebellar samples patients histologically confirmed @ DiseaseTgt $ control subjects . found novel point mutation , substitution cytosine guanine , nucleotide 2119 ( @ GeneSrc $ 770 messenger RNA transcript ) patient late-onset @ DiseaseTgt $ . substitution deletes BglII site substitutes aspartate glutamine codon 665 . Denaturing gradient gel electrophoresis analysis showed mutation absent 40 control subjects 127 dementia patients . Whether mutation rare normal variant contributes development @ DiseaseTgt $ known . BglII restriction fragment length polymorphism enables investigators determine frequency polymorphism normal subjects @ DiseaseTgt $ patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2695403374806097)\n",
      "- Text: \"increased percentage long amyloid beta protein secreted familial amyloid beta protein precursor ( beta APP717 ) mutants . Normal processing amyloid beta protein precursor ( beta APP ) results secretion soluble 4-kilodalton protein essentially identical amyloid beta protein ( @ GeneSrc $ ) forms insoluble fibrillar deposits @ DiseaseTgt $ . Human neuroblastoma ( M17 ) cells transfected constructs expressing wild-type beta APP beta APP717 mutants linked familial @ DiseaseTgt $ compared ( ) isolation metabolically labeled 4-kilodalton @ GeneSrc $ conditioned medium , digestion cyanogen bromide , analysis carboxyl-terminal peptides released , ( ii ) analysis @ GeneSrc $ conditioned medium sandwich enzyme-linked immunosorbent assays discriminate beta 1 - 40 longer beta 1 - 42 . methods demonstrated 4-kilodalton @ GeneSrc $ released wild-type beta APP primarily exclusively beta 1 - 40 . beta APP717 mutations , located three residues carboxyl @ GeneSrc $ 43 , consistently caused 1.5- 1.9-fold increase percentage longer @ GeneSrc $ generated . Long beta ( example , beta 1 - 42 ) forms insoluble amyloid fibrils rapidly beta 1 - 40 . Thus , beta APP717 mutants may cause @ DiseaseTgt $ secrete increased amounts long beta , thereby fostering amyloid deposition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2628894875997044)\n",
      "- Text: \"Binding human apolipoprotein E synthetic amyloid beta peptide : isoform-specific effects implications late-onset @ DiseaseTgt $ . Apolipoprotein E ( apoE ) , plasma apolipoprotein plays central role lipoprotein metabolism , localized senile plaques , congophilic angiopathy , neurofibrillary tangles @ DiseaseTgt $ . Late-onset @ DiseaseTgt $ patients increased frequency one three common apoE alleles , epsilon 4 , suggesting apoE4 associated increased susceptibility disease . follow suggestion , compared binding synthetic @ GeneSrc $ purified apoE4 apoE3 , common isoform . isoforms bound synthetic beta/A4 peptide , primary constituent plaque angiopathy , forming complex resisted dissociation boiling SDS . Oxygen-mediated complex formation implicated binding increased oxygenated buffer , reduced nitrogen-purged buffer , prevented reduction dithiothreitol 2-mercaptoethanol . Binding beta/A4 peptide saturable 10 ( -4 ) peptide required residues 12 - 28 . Examination apoE fragments revealed residues 244 - 272 critical complex formation . oxidized apoE4 apoE3 bound beta/A4 peptide ; however , binding apoE4 observed minutes , whereas binding apoE3 required hours . addition , apoE4 bind beta/A4 peptide pH < 6.6 , whereas apoE3 bound beta/A4 peptide pH 7.6 4.6 . Together results indicate differences two isoforms complexing beta/A4 peptide . Binding beta/A4 peptide oxidized apoE may determine sequestration targeting either apoE beta/A4 peptide , isoform-specific differences apoE binding oxidation may involved pathogenesis intra- extracellular lesions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0117528909743007)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ reduction copper ( II ) copper ( ) transition metal ion copper ( II ) critical role chronic neurologic diseases . @ GeneSrc $ ( APP ) @ DiseaseTgt $ synthetic peptide representing copper-binding site reduced bound copper ( II ) copper ( ) . copper ion-mediated redox reaction led disulfide bond formation APP , indicated free sulfhydryl groups APP involved . Neither superoxide hydrogen peroxide effect kinetics copper ( II ) reduction . reduction copper ( II ) copper ( ) APP involves electron-transfer reaction could enhance production hydroxyl radicals , could attack nearby sites . Thus , copper-mediated toxicity may contribute neurodegeneration @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0146900843795123)\n",
      "- Text: \"G protein-mediated neuronal DNA fragmentation induced familial @ DiseaseTgt $ mutants APP . Missense mutations 695-amino acid form @ GeneSrc $ ( APP695 ) cosegregate disease phenotype families dominantly inherited @ DiseaseTgt $ . mutations convert valine position 642 isoleucine , phenylalanine , glycine . Expression mutant proteins , normal APP695 , shown induce nucleosomal DNA fragmentation neuronal cells . Induction DNA fragmentation required cytoplasmic domain mutants appeared mediated heterotrimeric guanosine triphosphate-binding proteins ( G proteins ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2314880626073343)\n",
      "- Text: \"Secreted amyloid beta-protein similar senile plaques @ DiseaseTgt $ increased vivo presenilin 1 2 APP mutations linked @ DiseaseTgt $ . determine whether presenilin 1 ( PS1 ) , presenilin 2 ( PS2 ) amyloid beta-protein precursor ( APP ) mutations linked @ DiseaseTgt $ ( @ DiseaseTgt $ ) increase extracellular concentration amyloid beta-protein ( @ GeneSrc $ ) ending beta 42 ( 43 ) vivo , performed blinded comparison plasma @ GeneSrc $ levels carriers mutations controls . beta 1 - 42 ( 43 ) elevated plasma subjects @ DiseaseTgt $ PS1 ( P < 0.0001 ) , PS2N1411 ( P = 0.009 ) , APPK670N , M671L ( P < 0.0001 ) , APPV7171 ( one subject ) mutations . @ GeneSrc $ ending beta 42 ( 43 ) also significantly elevated fibroblast media subjects PS1 ( P < 0.0001 ) PS2 ( P = 0.03 ) mutations . findings indicate @ DiseaseTgt $ mutations may cause Alzhelmer 's disease increasing extracellular concentration beta 42 ( 43 ) , thereby fostering cerebral deposition highly amyloidogenic peptide .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8503602959050702)\n",
      "- Text: \"Correlative memory deficits , Abeta elevation , amyloid plaques transgenic mice . Transgenic mice overexpressing 695-amino acid isoform human @ DiseaseTgt $ beta-amyloid ( @ GeneSrc $ ) precursor protein containing Lys670 -- > Asn , Met671 -- > Leu mutation normal learning memory spatial reference alternation tasks 3 months age showed impairment 9 10 months age . fivefold increase Abeta ( 1 - 40 ) 14-fold increase Abeta ( 1 - 42/43 ) accompanied appearance behavioral deficits . Numerous Abeta plaques stained Congo red dye present cortical limbic structures mice elevated amounts Abeta . correlative appearance behavioral , biochemical , pathological abnormalities reminiscent @ DiseaseTgt $ transgenic mice suggests new opportunities exploring pathophysiology neurobiology disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0782777761738346)\n",
      "- Text: \"E280A presenilin 1 @ DiseaseTgt $ mutation produces increased @ GeneSrc $ deposition severe cerebellar pathology . Missense mutations presenilin 1 ( PS1 ) gene cause common form dominant early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated increased levels amyloid beta-peptides ( beta ) ending residue 42 ( @ GeneSrc $ ) plasma skin fibroblast media gene carriers . @ GeneSrc $ aggregates readily appears provide nidus subsequent aggregation beta 40 ( ref . 4 ) , resulting formation innumerable neuritic plaques . obtain vivo information PS1 mutations cause @ DiseaseTgt $ pathology early ages , characterized neuropathological phenotype four @ DiseaseTgt $ patients large Colombian kindred bearing codon 280 Glu Ala substitution ( Glu280Ala ) PS1 mutation . Using antibodies specific alternative carboxy-termini beta , detected massive deposition @ GeneSrc $ , earliest predominant form plaque beta occur @ DiseaseTgt $ ( ref . 6 - 8 ) , many brain regions . Computer-assisted quantification revealed significant increase @ GeneSrc $ , beta 40 , burden brains 4 @ DiseaseTgt $ patients compared 12 sporadic @ DiseaseTgt $ patients . Severe cerebellar pathology included numerous @ GeneSrc $ plaques , many bearing dystrophic neurites reactive glia . results brain tissue consistent recent biochemical evidence increased @ GeneSrc $ levels @ DiseaseTgt $ patients strongly suggest mutant PS1 proteins alter proteolytic processing @ GeneSrc $ C-terminus beta favor deposition @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5912409025175215)\n",
      "- Text: \"@ DiseaseTgt $ mutations Val717 @ GeneSrc $ specific increased secretion beta 42 ( 43 ) . pedigrees @ DiseaseTgt $ ( @ DiseaseTgt $ ) , three mutations @ GeneSrc $ ( APP ) found Val717 residue ( Ile , Phe , Cly ) mutations increase secretion beta 42 ( 43 ) . study specificity effects mutations APP processing , transiently expressed APP genes mutations Val717 Lys , Ser , Glu , Cys COS cells . three familial @ DiseaseTgt $ mutations increased levels ratios beta 42 ( 43 ) , whereas secretion beta 40 decreased . mutations irrelevant @ DiseaseTgt $ except Val717 Lys little effect ratio beta 42 ( 43 ) . Substitution Lys decreased secretion beta 42 ( 43 ) ; substitution Glu Gly decreased amount intracellular C-terminal fragment produced alpha-secretase , whereas increased mutations Phe , Cys , Lys . However , levels secretion soluble APP constant , substitution Glu reduced . results suggest specific role Val717 residue APP processing , especially , gamma-cleavage .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7832193943292542)\n",
      "- Text: \"presenilin 2 mutation ( N141I ) linked @ DiseaseTgt $ ( Volga German families ) increases secretion amyloid beta protein ending 42nd ( 43rd ) residue . gain insights significance presenilins ( PS ) pathogenetic mechanisms early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , expressed cDNAs wild-type PS2 PS2 Volga German ( N141I ) mutation cultured cells examined metabolism transfected proteins effect C-terminal properties secreted amyloid beta protein ( @ GeneSrc $ ) . PS2 identified 50- 55-kDa protein , cleaved produce N-terminal fragments 35 - 40 kDa C-terminal fragments 19 - 23 kDa . Volga German ( N141I ) mutation cause significant change metabolism PS2 . COS-1 cells doubly transfected cDNAs N141I mutant PS2 human @ GeneSrc $ ( betaAPP ) C-terminal fragment thereof , well mouse Neuro2a neuroblastoma cells stably transfected N141I mutant PS2 alone , secreted 1.5- 10-fold @ GeneSrc $ ending residues 42 ( 43 ) [ beta42 ( 43 ) ] compared expressing wild-type PS2 . results strongly suggest PS2 mutation ( N141I ) linked @ DiseaseTgt $ alters metabolism @ GeneSrc $ foster production form @ GeneSrc $ readily deposits amyloid plaques . Thus , mutant PS2 may lead @ DiseaseTgt $ altering metabolism @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8509676980893282)\n",
      "- Text: \"Intracellular secreted Alzheimer beta-amyloid species generated distinct mechanisms cultured hippocampal neurons . Cerebral plaques containing beta-amyloid ( beta A4 ) represent invariant pathological feature @ DiseaseTgt $ ( @ DiseaseTgt $ ) . beta A4 proteolytically generated parent molecule , @ GeneSrc $ ( APP ) . non-neuronal cells beta A4 shown secreted via pH-sensitive endocytosis-dependent pathway , process , occurring brain , considered play important role @ DiseaseTgt $ . neurons mechanisms beta A4 production known . analyzed mechanisms expressing human APP mutant versions hippocampal neurons using Semliki forest virus system . show cells initially generate two pools beta A4 , extracellular intracellular , extracellular pool produced via pH-sensitive endocytosis-dependent pathway . Thus , hippocampal neurons able utilize alternate pathway produce intracellular beta A4 . also show common feature two types APP mutations ( `` Swedish `` `` London `` ) implicated early-onset @ DiseaseTgt $ increased production C-terminally elongated beta A4 ( beta 42 ) , intra- extracellularly . Since neurons cells produce substantial levels intracellular beta A4 also main victims @ DiseaseTgt $ , findings may provide important link beta A4 neurodegeneration .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8020176183414465)\n",
      "- Text: \"new pathogenic mutation APP gene ( I716V ) increases relative proportion @ GeneSrc $ 42 ( 43 ) . report novel mutation @ GeneSrc $ gene ( APP I716V ) probably leads familial early onset @ DiseaseTgt $ onset age mid 50s . Cells transfected cDNAs bearing mutation produce beta 1 - 42 ( 43 ) transfected wild-type APP effect additive previously reported APP V717I mutation thus providing novel approach increasing beta 1 - 42 ( 43 ) model systems .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.458578810563023)\n",
      "- Text: \"Amyloidogenic role cytokine TGF-beta1 transgenic mice @ DiseaseTgt $ . Deposition amyoid-beta peptide central nervous system hallmark @ DiseaseTgt $ possible cause neurodegeneration . factors initiate promote deposition amyloid-beta peptide known . transforming growth factor TGF-beta1 plays central role response brain injury , increased TGF-beta1 found central nervous system patients @ DiseaseTgt $ . report TGF-beta1 induces @ GeneSrc $ deposition cerebral blood vessels meninges aged transgenic mice overexpressing cytokine astrocytes . Co-expression TGF-beta1 transgenic mice overexpressing amyloid-precursor protein , develop @ DiseaseTgt $ like pathology , accelerated deposition amyloid-beta peptide . TGF-beta1 messenger RNA present post-mortem brain tissue @ DiseaseTgt $ patients controls , levels correlating strongly @ GeneSrc $ deposition damaged cerebral blood vessels patients cerebral amyloid angiopathy . results indicate overexpression TGF-beta1 may initiate promote amyloidogenesis @ DiseaseTgt $ experimental models may risk factor developing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0135797539719009)\n",
      "- Text: \"Alpha2-macroglobulin complexes mediates endocytosis @ GeneSrc $ via cell surface low-density lipoprotein receptor-related protein . primary histopathological feature @ DiseaseTgt $ accumulation beta-amyloid ( @ GeneSrc $ ) brain afflicted individuals . However , @ GeneSrc $ produced continuously soluble protein healthy individuals detected serum CSF , suggesting existence cellular clearance mechanisms normally prevent accumulation aggregation . , demonstrate @ GeneSrc $ forms stable complexes activated alpha2-macroglobulin ( alpha2 * ) , physiological ligand low-density lipoprotein receptor-related protein ( LRP ) abundantly expressed CNS . alpha2M * /125I-A beta complexes immunoreactive @ GeneSrc $ anti-alpha2 IgG stable various pH conditions , sodium dodecyl sulfate , reducing agents , boiling . demonstrate alpha2M * /125I-A beta complexes degraded glioblastoma cells fibroblasts via LRP , degradation partially inhibited receptor-associated protein ( RAP ) , antagonist ligand interactions LRP . contrast , degradation free 125I-A beta inhibited RAP thus must mediated via LRP-independent pathway . results suggest LRP function clearance receptor @ GeneSrc $ via physiological ligand .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0595512834885978)\n",
      "- Text: \"Estimation genetic contribution presenilin-1 -2 mutations population-based study presenile @ DiseaseTgt $ . Two closely related genes , presenilins ( PS ) , located chromosomes 14q24.3 1q42.1 , identified autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) onset age 65 years ( presenile @ DiseaseTgt $ ) . performed systematic mutation analysis coding 5'-non-coding exons PS -1 PS -2 population-based epidemiological series 101 unrelated familial sporadic presenile @ DiseaseTgt $ cases . familial cases included 10 patients autosomal dominant @ DiseaseTgt $ families sampled linkage analysis studies . patients mutations @ GeneSrc $ gene ( APP ) previously excluded . Four different PS -1 missense mutations identified six familial cases , two autosomal dominant cases . Three mutations resulted onset ages 55 years , one segregating autosomal dominant family mean onset age 64 years ( range 50 - 78 years ) . One PS -2 mutation identified sporadic case onset age 62 years . mutation data provided estimates PS -1 PS -2 mutation frequencies presenile @ DiseaseTgt $ 6 1 % respectively . family history accounted mutation frequencies PS -1 9 % familial cases 18 % autosomal dominant cases . , polymorphisms detected promoter 5'-non-coding region PS -1 intronic exonic sequences PS -2 useful genetic association studies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9958164324381656)\n",
      "- Text: \"Frameshift mutants @ GeneSrc $ ubiquitin-B @ DiseaseTgt $ patients . cerebral cortex @ DiseaseTgt $ syndrome patients characterized presence protein deposits neurofibrillary tangles , neuritic plaques , neuropil threads . structures shown contain forms @ GeneSrc $ ubiquitin-B aberrant ( + 1 proteins ) carboxyl terminus . + 1 proteins found young control patients , whereas presence ubiquitin-B+1 elderly control patients may indicate early stages neurodegeneration . two species + 1 proteins displayed cellular colocalization , suggesting common origin , operating transcriptional level posttranscriptional editing RNA . type transcript mutation likely important factor widely occurring nonfamilial early- late-onset forms @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5)\n",
      "- Text: \"ApoE genotype risk factor nonpresenilin early-onset @ DiseaseTgt $ families . apolipoprotein E ( ApoE ) genotype significant risk factor modulator age onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . analyzed effect ApoE genotype two distinct early-onset @ DiseaseTgt $ groups : families mutation presenilin-1 gene ( PS-1 ) chromosome 14 , families without mutation detectable PS-1 , presenilin-2 ( PS-2 ) , @ GeneSrc $ ( APP ) gene ( non-PS early-onset @ DiseaseTgt $ ) . ApoE genotype clearly shown modulate age onset families mutation PS-1 gene families lesion detectable either presenilin APP gene . effects double dose ApoE4 age onset assessed PS-1 AD families due lack affected ApoE4 homozygotes sample set ; insufficiency need assessed studies . association ApoE4 allele @ DiseaseTgt $ PS-1 families . Non-PS early-onset @ DiseaseTgt $ families shown significantly higher frequency ApoE4 compared controls PS-1 AD group . observations important suggest 1 ) genetic environmental factors modify @ DiseaseTgt $ phenotype PS-1 non-PS early-onset families ; 2 ) ApoE4 allele significant risk factor etiology non-PS early-onset @ DiseaseTgt $ useful adjunct diagnosis unaffected family members .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.637595617311248)\n",
      "- Text: \"Estrogen reduces neuronal generation Alzheimer beta-amyloid peptides . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized accumulation cerebral plaques composed 40- 42-amino acid beta-amyloid ( @ GeneSrc $ ) peptides , autosomal dominant forms @ DiseaseTgt $ appear cause disease promoting brain @ GeneSrc $ accumulation . Recent studies indicate postmenopausal estrogen replacement therapy may prevent delay onset @ DiseaseTgt $ . present evidence physiological levels 17beta-estradiol reduce generation @ GeneSrc $ neuroblastoma cells primary cultures rat , mouse human embryonic cerebrocortical neurons . results suggest mechanism estrogen replacement therapy delay prevent @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5621469119016156)\n",
      "- Text: \"variant @ DiseaseTgt $ spastic paraparesis unusual plaques due deletion exon 9 presenilin 1 . describe novel variant @ DiseaseTgt $ ( @ DiseaseTgt $ ) Finnish pedigree 17 affected individuals sexes three generations . disease characterized progressive dementia , cases , preceded spastic paraparesis . Neuropathological investigations revealed numerous , distinct , large , round eosinophilic plaques well neurofibrillary tangles amyloid angiopathy throughout cerebral cortex . predominant plaques resembled cotton wool balls immunoreactive @ GeneSrc $ lacked congophilic dense core marked plaque-related neuritic pathology . Molecular genetic analysis revealed disease caused deletion exon 9 ( delta9 ) presenilin 1 ( PS1 ) gene mRNA : unlike previous examples delta9 variant , deletion caused splice acceptor site mutation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4302058328224662)\n",
      "- Text: \"Cholesterol depletion inhibits generation beta-amyloid hippocampal neurons . @ GeneSrc $ ( APP ) plays crucial role pathogenesis @ DiseaseTgt $ . intracellular transport APP undergoes series proteolytic cleavages lead release either amyloidogenic fragment called beta-amyloid ( @ GeneSrc $ ) nonamyloidogenic secreted form consisting ectodomain APP ( APPsec ) . @ GeneSrc $ accumulates brain lesions thought cause disease . reducing cellular cholesterol level living hippocampal neurons 70 % lovastatin methyl-beta-cyclodextrin , show formation @ GeneSrc $ completely inhibited generation APPsec unperturbed . inhibition @ GeneSrc $ formation accompanied increased solubility detergent Triton X-100 fully reversible readdition cholesterol previously depleted cells . results show cholesterol required @ GeneSrc $ formation occur imply link cholesterol , @ GeneSrc $ , @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9230778469399068)\n",
      "- Text: \"@ DiseaseTgt $ characterized amyloid angiopathy large amyloid core type senile plaques APP 692Ala -- > Gly mutation . Mutations codons 717 670/671 @ GeneSrc $ ( APP ) rare genetic causes familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . mutation codon 693 APP also described genetic defect hereditary cerebral hemorrhage amyloidosis Dutch type ( HCHWA-D ) . reported APP692Ala -- > Gly ( Flemish ) mutation cause intracerebral hemorrhage presenile dementia diagnosed probable @ DiseaseTgt $ Dutch family . describe post-mortem examination two demented patients APP692 mutation . neuropathological findings support diagnosis @ DiseaseTgt $ . Leptomeningial parenchymal vessels showed extensive deposition Abeta amyloid protein . Numerous senile plaques consisted large @ GeneSrc $ amyloid cores , often measuring 30 microm diameter surrounded fine meshwork dystrophic neurites . addition , large number paired helical filaments pyramidal neurons dystrophic neurites . findings show APP692 mutation leads morphological abnormalities similar @ DiseaseTgt $ , morphology senile plaques clearly distinct described sporadic chromosome 14-linked @ DiseaseTgt $ patients , patients APP717 mutations causing familial , presenile @ DiseaseTgt $ patients APP693 mutation causing HCHWA-D .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1814725895496175)\n",
      "- Text: \"Flemish Dutch mutations @ GeneSrc $ different effects @ GeneSrc $ secretion . Mutations @ GeneSrc $ ( APP ) gene cosegregate autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Brain pathology @ DiseaseTgt $ characterized amyloid deposition senile plaques neurofibrillary tangles . Amyloid deposits @ DiseaseTgt $ brains consist @ GeneSrc $ ( @ GeneSrc $ , 4-kDa proteolytic product APP . contrast , two mutations APP , Flemish APP692 Dutch APP693 mutations , associated autosomal dominant cerebral hemorrhages due congophilic amyloid angiopathy ( CAA ) presence absence @ DiseaseTgt $ pathology , respectively . mutations located within @ GeneSrc $ near constitutive cleavage site . common effect @ DiseaseTgt $ mutations elevate @ GeneSrc $ extracellular concentrations , much known effect APP692 APP693 . provide evidence APP692 APP693 different effect @ GeneSrc $ secretion determined cDNA transfection experiments . APP692 upregulates beta 40 @ GeneSrc $ secretion , APP693 . data corroborate previous findings increased @ GeneSrc $ secretion particularly @ GeneSrc $ , specific @ DiseaseTgt $ pathology .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5113233705488258)\n",
      "- Text: \"Expression human apolipoprotein E reduces amyloid-beta deposition mouse model @ DiseaseTgt $ . epsilon4 allele apolipoprotein E ( apo E ) associated increased risk developing @ DiseaseTgt $ ( @ DiseaseTgt $ ) . may due interactions apo E amyloid-beta protein ( Abeta ) . assess effects human apo E isoforms Abeta deposition vivo , bred apo E3 apo E4 hemizygous ( + /- ) transgenic mice expressing apo E astrocytes mice homozygous ( + /+ ) mutant amyloid precursor protein ( APPV717F ) transgene develop age-dependent @ DiseaseTgt $ . mice mouse apo E null ( -/- ) background . nine months age , APPV717F+/- , apo E-/- mice developed Abeta deposition , , reported previously , quantity Abeta deposits significantly less seen APPV717F+/- mice expressing mouse apo E. contrast effects mouse apo E , similar levels human apo E3 apo E4 markedly suppressed early Abeta deposition nine months age APPV717F+/- transgenic mice , even compared mice lacking apo E. findings suggest human apo E isoforms decrease Abeta aggregation increase @ GeneSrc $ clearance relative environment mouse apo E apo E present . results may important implications understanding mechanisms underlying link apo E @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.0331097505678658e-06)\n",
      "- Text: \"Unusual phenotypic alteration @ GeneSrc $ ( betaAPP ) maturation new Val-715 -- > Met betaAPP-770 mutation responsible probable early-onset @ DiseaseTgt $ . identified novel @ GeneSrc $ ( betaAPP ) mutation ( V715M-betaAPP770 ) cosegregates early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) pedigree . Unlike @ DiseaseTgt $ betaAPP mutations reported date , overexpression V715M-betaAPP human HEK293 cells murine neurons reduces total @ GeneSrc $ production increases recovery physiologically secreted product , APPalpha . V715M-betaAPP significantly reduces Abeta40 secretion without affecting @ GeneSrc $ production HEK293 cells . However , marked increase N-terminally truncated @ GeneSrc $ ending position 42 ( x-42Abeta ) observed , whereas counterpart x-40Abeta affected . results suggest , cases , @ DiseaseTgt $ may associated reduction overall production @ GeneSrc $ may caused increased production truncated forms @ GeneSrc $ ending 42 position .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9972033957255516)\n",
      "- Text: \"presenilin-1-dependent gamma-secretase-like protease mediates release Notch intracellular domain . Signalling receptor protein Notch , involved crucial cell-fate decisions development , requires ligand-induced cleavage Notch . cleavage occurs within predicted transmembrane domain , releasing Notch intracellular domain ( NICD ) , reminiscent gamma-secretase-mediated cleavage @ GeneSrc $ ( APP ) , critical event pathogenesis @ DiseaseTgt $ . deficiency presenilin-1 ( PS1 ) inhibits processing APP gamma-secretase mammalian cells , genetic interactions Notch PS1 homologues Caenorhabditis elegans indicate presenilins may modulate Notch signalling pathway . report , mammalian cells , PS1 deficiency also reduces proteolytic release NICD truncated Notch construct , thus identifying specific biochemical step Notch signalling pathway affected PS1 . Moreover , several gamma-secretase inhibitors block step Notch processing , indicating related protease activities responsible cleavage within predicted transmembrane domains Notch APP . Thus targeting gamma-secretase treatment @ DiseaseTgt $ may risk toxicity caused reduced Notch signalling .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5653291613621336)\n",
      "- Text: \"Neurogenic phenotypes altered Notch processing Drosophila Presenilin mutants . Presenilin proteins implicated developmental signalling cell-surface protein Notch pathogenesis @ DiseaseTgt $ . Loss presenilin function leads Notch/lin-12-like mutant phenotypes Caenorhabditis elegans reduced Notch1 expression mouse paraxial mesoderm . humans , presenilins associated @ DiseaseTgt $ stimulate overproduction neurotoxic 42-amino-acid beta-amyloid derivative ( @ GeneSrc $ ) @ GeneSrc $ APP . describe loss-of-function mutations Drosophila Presenilin gene cause lethal Notch-like phenotypes maternal neurogenic effects embryogenesis , loss lateral inhibition within proneural cell clusters , absence wing margin formation . show presenilin required normal proteolytic production carboxy-terminal Notch fragments needed receptor maturation signalling , genetically acts upstream membrane-bound form activated nuclear form Notch . findings provide evidence existence distinct processing sites modifications extracellular domain Notch . also link role presenilin Notch signalling effect amyloid production @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0296841146749878)\n",
      "- Text: \"Involvement caspases proteolytic cleavage @ DiseaseTgt $ amyloidogenic beta peptide formation . @ GeneSrc $ ( APP ) directly efficiently cleaved caspases apoptosis , resulting elevated @ GeneSrc $ ( @ GeneSrc $ ) peptide formation . predominant site caspase-mediated proteolysis within cytoplasmic tail APP , cleavage site occurs hippocampal neurons vivo following acute excitotoxic ischemic brain injury . Caspase-3 predominant caspase involved APP cleavage , consistent marked elevation dying neurons @ DiseaseTgt $ brains colocalization APP cleavage product @ GeneSrc $ senile plaques . Caspases thus appear play dual role proteolytic processing APP resulting propensity beta peptide formation , well ultimate apoptotic death neurons @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7831065036251214)\n",
      "- Text: \"Aberrant splicing presenilin-1 intron 4 mutation causes presenile @ DiseaseTgt $ increased @ GeneSrc $ secretion . previously described splice donor site mutation intron 4 presenilin-1 ( PSEN1 ) two patients autopsy-confirmed early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . provide evidence intron 4 mutation present four additional unrelated early-onset @ DiseaseTgt $ cases , mutation segregates autosomal dominant manner cases one common ancestor . demonstrate intron 4 mutation produces three different transcripts , two deletion transcripts ( Delta4 Delta4cryptic ) one insertion transcript ( insTAC ) , aberrant splicing . deletion transcripts result formation C-truncated ( approximately 7 kDa ) PSEN1 proteins insertion transcript produces full-length PSEN1 one extra amino acid ( Thr ) inserted codons 113 114 ( PSEN1 T113 - 114ins ) . truncated proteins detectable vivo brain homogenates lymphoblast lysates mutation carriers . vitro HEK-293 cells overexpressing Delta4 , Delta4cryptic insTACPSEN1 cDNAs showed increased @ GeneSrc $ secretion ( approximately 3.4 times ) insertion cDNA construct . Increased @ GeneSrc $ production also observed brain homogenates . data indicate case intron 4 mutation , @ DiseaseTgt $ pathophysiology results presence PSEN1 T113 - 114ins protein comparable cases carrying dominant PSEN1 missense mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1535457456741558)\n",
      "- Text: \"Immunization amyloid-beta attenuates @ DiseaseTgt $ pathology PDAPP mouse . Amyloid-beta peptide ( Abeta ) seems central role neuropathology @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Familial forms disease linked mutations @ GeneSrc $ ( APP ) presenilin genes . Disease-linked mutations genes result increased production 42-amino-acid form peptide ( @ GeneSrc $ ) , predominant form found amyloid plaques @ DiseaseTgt $ . PDAPP transgenic mouse , overexpresses mutant human APP ( amino acid position 717 phenylalanine instead normal valine ) , progressively develops many neuropathological hallmarks @ DiseaseTgt $ age- brain-region-dependent manner . present study , transgenic animals immunized @ GeneSrc $ , either onset @ DiseaseTgt $ neuropathologies ( 6 weeks age ) older age ( 11 months ) , amyloid-beta deposition several subsequent neuropathological changes well established . report immunization young animals essentially prevented development beta-amyloid-plaque formation , neuritic dystrophy astrogliosis . Treatment older animals also markedly reduced extent progression @ DiseaseTgt $ neuropathologies . results raise possibility immunization amyloid-beta may effective preventing treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9097225476868996)\n",
      "- Text: \"Early-onset autosomal dominant @ DiseaseTgt $ : prevalence , genetic heterogeneity , mutation spectrum . determine prevalence early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) autosomal dominant forms @ DiseaseTgt $ ( ADEOAD ) , performed population-based study city Rouen ( 426,710 residents ) . @ DiseaseTgt $ defined onset disease age < 61 years , ADEOAD defined occurrence least three @ DiseaseTgt $ cases three generations . Using stringent criteria , calculated @ DiseaseTgt $ ADEOAD prevalences per 100,000 persons risk 41.2 5.3 , respectively . performed mutational analysis genes @ GeneSrc $ ( APP ) , presenilin 1 ( PSEN1 ) , presenilin 2 ( PSEN2 ) 34 families ADEOAD ascertained France . 19 ( 56 % ) families , identified 16 distinct PSEN1 missense mutations , including 4 ( Thr147Ile , Trp165Cys , Leu173Trp , Ser390Ile ) reported elsewhere . APP mutations , including novel mutation located codon 715 , identified 5 ( 15 % ) families . 10 remaining ADEOAD families 9 additional autosomal dominant @ DiseaseTgt $ families fulfill strict criteria ADEOAD , PSEN1 , PSEN2 , APP mutation identified . results show ( 1 ) PSEN1 APP mutations account 71 % ADEOAD families ( 2 ) nonpenetrance age < 61 years probably infrequent PSEN1 APP mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9961940405979072)\n",
      "- Text: \"Beta-secretase cleavage Alzheimer 's amyloid precursor protein transmembrane aspartic protease BACE . Cerebral deposition amyloid beta peptide ( @ GeneSrc $ ) early critical feature @ DiseaseTgt $ . @ GeneSrc $ generation depends proteolytic cleavage @ GeneSrc $ ( APP ) two unknown proteases : beta-secretase gamma-secretase . proteases prime therapeutic targets . transmembrane aspartic protease known characteristics beta-secretase cloned characterized . Overexpression protease , termed BACE ( beta-site APP-cleaving enzyme ) increased amount beta-secretase cleavage products , cleaved exactly known beta-secretase positions . Antisense inhibition endogenous BACE messenger RNA decreased amount beta-secretase cleavage products , purified BACE protein cleaved APP-derived substrates sequence specificity beta-secretase . Finally , expression pattern subcellular localization BACE consistent expected beta-secretase . Future development BACE inhibitors may prove beneficial treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1990521426548253)\n",
      "- Text: \"Membrane-anchored aspartyl protease @ DiseaseTgt $ beta-secretase activity . Mutations gene encoding @ GeneSrc $ ( APP ) cause autosomal dominant @ DiseaseTgt $ . Cleavage APP unidentified proteases , referred beta- gamma-secretases , generates amyloid beta-peptide , main component amyloid plaques found @ DiseaseTgt $ patients . disease-causing mutations flank protease cleavage sites APP facilitate cleavage . identify new membrane-bound aspartyl protease ( Asp2 ) beta-secretase activity . Asp2 gene expressed widely brain tissues . Decreasing expression Asp2 cells reduces amyloid beta-peptide production blocks accumulation carboxy-terminal APP fragment created beta-secretase cleavage . Solubilized Asp2 protein cleaves synthetic APP peptide substrate beta-secretase site , rate cleavage increased tenfold mutation associated early-onset @ DiseaseTgt $ Sweden . Thus , Asp2 new protein target drugs designed block production amyloid beta-peptide peptide consequent formation amyloid plaque @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3896709632375469)\n",
      "- Text: \"Apolipoprotein E essential amyloid deposition APP ( V717F ) transgenic mouse model @ DiseaseTgt $ . quantified amount amyloid beta-peptide ( Abeta ) immunoreactivity well amyloid deposits large cohort transgenic mice overexpressing V717F human @ GeneSrc $ ( APP ( V717F+/- ) TG mice ) , one , two mouse apolipoprotein E ( Apoe ) alleles various ages . Remarkably , amyloid deposits found brain region APP ( V717F+/- ) Apoe ( -/- ) TG mice old 22 mo age , whereas age-matched APP ( V717F + /- ) Apoe ( +/- ) Apoe ( +/+ ) TG mice display abundant amyloid deposition . amount Abeta immunoreactivity hippocampus also markedly reduced Apoe gene dose-dependent manner ( Apoe ( +/+ ) > Apoe ( +/- ) > > Apoe ( -/- ) ) , Abeta immunoreactivity detected cerebral cortex APP ( V717F+/- ) Apoe ( -/- ) TG mice time points examined . absence apolipoprotein E protein ( apoE ) dramatically reduced amount Abeta ( 1 - 40 ) Abeta ( 1 - 42 ) immunoreactive deposits well resulting astrogliosis microgliosis normally observed APP ( V717F ) TG mice . ApoE immunoreactivity detected subset Abeta immunoreactive deposits virtually thioflavine-S-fluorescent amyloid deposits . absence apoE alters neither transcription translation APP ( V717F ) transgene processing Abeta peptide ( ) , postulate apoE promotes deposition fibrillization Abeta , ultimately affecting clearance protease-resistant Abeta/apoE aggregates . ApoE appears play essential role amyloid deposition brain , one neuropathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002925417734328)\n",
      "- Text: \"High prevalence pathogenic mutations patients early-onset dementia detected sequence analyses four different genes . Clinical differential diagnosis early-onset dementia ( EOD ) includes @ DiseaseTgt $ ( @ DiseaseTgt $ ) hereditary prion disease . disease entities , postmortem brain histopathological examination essential unambiguous diagnosis . Mutations genes encoding presenilins ( PS1 PS2 ) @ GeneSrc $ ( APP ) associated @ DiseaseTgt $ , whereas mutations prion protein ( PrP ) gene associated prion disease . investigate proportion EOD attributable known genes , prospectively ( i.e . , antemortem ) screened four genes mutations sequencing genomic PCR products patients EOD age 60 years . Family history dementia positive ( PFH ) 16 patients , negative ( NFH ) 17 patients , unknown ( UFH ) 3 patients . 12 patients , found five novel mutations ( PS1 , F105L ; PS2 , T122P M239I ; PrP , Q160X T188 K ) five previously reported mutations ( APP , three patients likely unrelated , V717I ; PS1 , A79V M139V ; PrP , P102L T183A ) considered disease causing . 12 patients , 9 PFH . indicates detection rate 56 % ( 9/16 ) patients PFH . found two mutations ( APP V717I ) two three UFH patients , one mutation ( PrP T188 K ) 1 17 patients NFH . conclude lack specific antemortem diagnostic markers @ DiseaseTgt $ hereditary prion disease , four genes included molecular diagnostic program patients EOD PFH .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0511900796260494)\n",
      "- Text: \"Levels alpha- beta-secretase cleaved @ GeneSrc $ cerebrospinal fluid @ DiseaseTgt $ patients . Alternative cleavage @ GeneSrc $ ( APP ) results generation secretion soluble APP ( sAPP ) beta-amyloid ( @ GeneSrc $ ) . @ GeneSrc $ main component amyloid depositions brains @ DiseaseTgt $ ( @ DiseaseTgt $ ) patients . Using Western blotting , compared levels alpha-secretase cleaved sAPP , beta-secretase cleaved sAPP total sAPP , cerebrospinal fluid ( CSF ) 13 sporadic @ DiseaseTgt $ patients 13 healthy controls . findings show significant amounts beta-secretase cleaved sAPP CSF . statistically significant difference levels beta-secretase cleaved sAPP @ DiseaseTgt $ patients controls . levels alpha-secretase cleaved sAPP total sAPP , however , found significantly lower @ DiseaseTgt $ patients controls .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9030422957368196)\n",
      "- Text: \"Variant @ DiseaseTgt $ spastic paraparesis : clinical characterization . OBJECTIVE : present clinical , neuroimaging , electrophysiologic characteristics variant @ DiseaseTgt $ phenotype . BACKGROUND : authors identified large Finnish kindred @ DiseaseTgt $ spastic paraparesis due deletion exon 9 presenilin 1 . Neuropathologic analysis showed unusual cortical `` cotton wool `` plaques , immunoreactive @ GeneSrc $ lacking congophilic cores . PATIENTS METHODS : Twenty-two affected individuals ( 16 men 6 women ) identified four successive generations . surviving five patients examined subjected molecular genetic analysis . addition , neurologic records nine deceased patients evaluated . Electrophysiologic investigations available eight cases . CT MRI head performed 11 patients PET performed three patients . RESULT : mean age onset ( + /-SD ) 50.9 + /- 5.2 years ( range 40 61 years ) . Memory impairment present patients . Memory impairment appeared simultaneously preceded walking difficulty due spasticity lower extremities ( 10/14 ) . Impaired fine coordination hands ( 9/14 ) dysarthria ( 6/14 ) patients suggested cerebellar involvement . EEG showed intermittent generalized delta-theta activity . Head MRI showed temporal hippocampal atrophy ; PET showed bilateral temporo-parietal hypometabolism . CONCLUSION : Spastic paraparesis brisk stretch reflexes lower extremities clumsiness hands combined dementia suggests variant @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045447362096195)\n",
      "- Text: \"@ GeneSrc $ interacts @ GeneSrc $ : potential toxic mechanism @ DiseaseTgt $ . Amyloid beta protein ( @ GeneSrc $ ) deposition brain hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . fibrillar form @ GeneSrc $ neurotoxic , although mechanism toxicity unknown . showed conversion @ GeneSrc $ fibrillar form markedly increased binding specific neuronal membrane proteins , including @ GeneSrc $ ( APP ) . Nanomolar concentrations fibrillar @ GeneSrc $ bound cell-surface holo-APP cortical neurons . Reduced vulnerability cultured APP-null neurons @ GeneSrc $ neurotoxicity suggested @ GeneSrc $ neurotoxicity involves APP . Thus @ GeneSrc $ toxicity may mediated interaction fibrillar @ GeneSrc $ neuronal membrane proteins , notably APP . @ GeneSrc $ interaction reminiscent pathogenic mechanism prions may thus contribute neuronal degeneration @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3645171629843199)\n",
      "- Text: \"Substitutions codon 22 @ DiseaseTgt $ induce diverse conformational changes apoptotic effects human cerebral endothelial cells . Cerebral amyloid angiopathy commonly associated normal aging @ DiseaseTgt $ also principal feature hereditary cerebral hemorrhage amyloidosis Dutch type , familial condition associated point mutation G C codon 693 @ GeneSrc $ @ GeneSrc $ precursor protein gene resulting Glu Gln substitution position 22 Abeta ( E22Q ) . patients carrying AbetaE22Q variant usually present lobar cerebral hemorrhages 50 years age . different mutation described several members three Italian kindred presented recurrent hemorrhagic strokes late life , 60 70 years age , also associated extensive cerebrovascular amyloid deposition found position 22 , time resulting Glu Lys substitution ( E22 K ) . compared secondary structure , aggregation , fibrillization properties two Abeta40 variants wild type peptide . Using flow cytometry analysis staining propidium iodide annexin V , also evaluated cytotoxic effects peptides human cerebral endothelial cells culture . conditions tested , E22Q peptide exhibited highest content beta-sheet conformation fastest aggregation/fibrillization properties . Dutch variant also induced apoptosis cerebral endothelial cells concentration 25 micrometer , whereas wild type Abeta E22 K mutant effect . data suggest different amino acids position 22 confer distinct structural properties peptides appear influence onset aggressiveness disease rather phenotype .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005886880261783)\n",
      "- Text: \"Photoactivated gamma-secretase inhibitors directed active site covalently label presenilin 1 . Cleavage @ GeneSrc $ ( APP ) beta- gamma-secretases generates amino carboxy termini , respectively , @ GeneSrc $ amyloidogenic peptides beta40 @ GeneSrc $ - -the major constituents amyloid plaques brain parenchyma @ DiseaseTgt $ patients . evidence polytopic membrane-spanning proteins , presenilin 1 2 ( PS1 PS2 ) , important determinants gamma-secretase activity : mutations PS1 PS2 associated early-onset familial @ DiseaseTgt $ increase production @ GeneSrc $ ( refs 4 - 6 ) , amyloidogenic peptide ; gamma-secretase activity reduced neuronal cultures derived PS1-deficient mouse embryos ; directed mutagenesis two conserved aspartates transmembrane segments PS1 inactivates ability gamma-secretase catalyse processing APP within transmembrane domain . unknown , however , whether PS1 ( little homology known aspartyl protease ) transmembrane aspartyl protease gamma-secretase cofactor , helps colocalize gamma-secretase APP . report photoaffinity labelling PS1 ( PS2 ) potent gamma-secretase inhibitors designed function transition state analogue inhibitors directed active site aspartyl protease . observation indicates PS1 ( PS2 ) may contain active site gamma-secretase . Interestingly , intact , single-chain form wild-type PS1 labelled active-site-directed photoaffinity probe , suggesting intact wild-type PS1 may aspartyl protease zymogen .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.172006928426005)\n",
      "- Text: \"Early-onset @ DiseaseTgt $ caused new mutation ( V717L ) @ GeneSrc $ gene . CONTEXT : @ DiseaseTgt $ common form dementia . Mutations genes @ GeneSrc $ ( APP ) , presenilin 1 ( PS1 ) presenilin 2 ( PS2 ) found early-onset familial forms @ DiseaseTgt $ OBJECTIVE : determine cause dementia family early-onset illness . DESIGN , SETTING , PARTICIPANTS : family history dementia referred Indiana @ DiseaseTgt $ Center , Indianapolis . research study done university university hospital . proband 4 siblings took part study . proband , still alive , showed symptoms @ DiseaseTgt $ 38 years age . Genomic DNA obtained blood samples 5 family members . APPandPS1genes proband screened mutations amplification followed direct sequencing . RESULTS : Sequence exon 17 APPgene revealed single nucleotide ( guanine cytosine ) substitution 1 allele , resulting amino acid change codon 717 ( valine leucine ) . proband 's siblings tested mutation direct sequencing . Two 4 found mutation ; one recently clinically diagnosed age 36 years . CONCLUSIONS : novel mutation APPgene ( V717L ) found family history dementia , beginning mid late 30s . age onset family earlier families @ DiseaseTgt $ also APPmutations . Arch Neurol . 2000 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.693783209028569)\n",
      "- Text: \"presenilin 1 C92S mutation increases @ GeneSrc $ production . Although wild-type human presenilin 1 ( PS1 ) rescues C. elegans egg-laying ( egl ) phenotype caused loss function mutation C. elegans presenilin homologue sel12 , @ DiseaseTgt $ @ DiseaseTgt $ PS1 mutants partially rescue phenotype . investigate effects loss function sel12 mutation @ GeneSrc $ production mammalian cells , analyzed @ GeneSrc $ production transfected H4 neuroglioma cells expressing PS1 homologue sel12 C60S mutant , PS1 C92S . analysis revealed PS1 C92S increased @ GeneSrc $ levels similar fashion pathogenic @ DiseaseTgt $ ( @ DiseaseTgt $ ) PS1 mutations . Significantly , PS1 C92S mutation recently identified pathogenic mutation Italian family @ DiseaseTgt $ . Thus , placing mutation results loss function C. elegans context whereby effect mammalian cells evaluated suggests @ DiseaseTgt $ PS1 mutants result increased @ GeneSrc $ production partial loss function mechanism .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5998623735220155)\n",
      "- Text: \"Nonfibrillar diffuse amyloid deposition due gamma ( 42 ) -secretase site mutation points essential role N-truncated @ GeneSrc $ @ DiseaseTgt $ . Amyloidogenic processing @ GeneSrc $ ( APP ) deposition brain 42 amino acid long amyloid beta-peptide ( @ GeneSrc $ ) considered central @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathology . However , generally believed nonfibrillar pre-amyloid @ GeneSrc $ deposits mature presence beta ( 40 ) fibrillar amyloid plaques cause neurodegeneration . , describe aggressive form @ DiseaseTgt $ caused novel missense mutation APP ( T714I ) directly involving gamma-secretase cleavages APP . mutation drastic effect @ GeneSrc $ beta ( 40 ) ratio vitro approximately 11-fold , simultaneously increasing @ GeneSrc $ decreasing beta ( 40 ) secretion , measured matrix-assisted laser disorption ionization time-of-flight mass spectrometry . coincided brain deposition abundant predominant nonfibrillar pre-amyloid plaques composed primarily N-truncated @ GeneSrc $ complete absence beta ( 40 ) . data indicate N-truncated @ GeneSrc $ diffuse nonfibrillar plaques essential undermined role @ DiseaseTgt $ pathology . Importantly , inhibiting secretion full-length @ GeneSrc $ therapeutic targeting APP processing result secretion equally toxic N-truncated @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9712164356061322)\n",
      "- Text: \"Modulation amyloid beta-protein clearance @ DiseaseTgt $ susceptibility LDL receptor-related protein pathway . Susceptibility @ DiseaseTgt $ ( @ DiseaseTgt $ ) governed multiple genetic factors . Remarkably , LDL receptor-related protein ( LRP ) ligands , apoE alpha2 , genetically associated @ DiseaseTgt $ . study , provide evidence involvement LRP pathway amyloid deposition sequestration removal soluble amyloid beta-protein ( @ GeneSrc $ ) . demonstrate vitro LRP mediates clearance Abeta40 @ GeneSrc $ bona fide receptor-mediated uptake mechanism . vivo , reduced LRP expression associated LRP genotypes correlated enhanced soluble @ GeneSrc $ levels amyloid deposition . Although LRP proposed clearance pathway @ GeneSrc $ , work provides first vivo evidence LRP pathway may modulate @ GeneSrc $ deposition @ DiseaseTgt $ susceptibility regulating removal soluble @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0105469604284713)\n",
      "- Text: \"Variable phenotype @ DiseaseTgt $ spastic paraparesis . variant form @ DiseaseTgt $ ( @ DiseaseTgt $ ) , spastic paraparesis ( SP ) precedes dementia , characterised large , noncored , weakly neuritic @ GeneSrc $ plaques resembling cotton wool balls caused genomic deletion presenilin 1 exon 9 . pedigree 5.9 kb exon 9 deletion shows phenotypic spectrum including subjects typical @ DiseaseTgt $ SP numerous cotton wool plaques . SP subjects , dementia onset delayed modified . phenotypic variation suggests modifying factors associated exon 9 deletions .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0119225973254697)\n",
      "- Text: \"Low cholesterol stimulates nonamyloidogenic pathway effect alpha -secretase ADAM 10 . Biochemical , epidemiological , genetic findings demonstrate link cholesterol levels , processing @ GeneSrc $ ( APP ) , @ DiseaseTgt $ . present report , identify alpha-secretase ADAM 10 ( disintegrin metalloprotease ) major target cholesterol effects APP metabolism . Treatment various peripheral neural cell lines either cholesterol-extracting agent methyl-beta-cyclodextrin hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin resulted drastic increase secreted alpha-secretase cleaved soluble APP . strong stimulatory effect range obtained phorbol esters increased cells overexpressing ADAM 10 . cells overexpressing APP , increase alpha-secretase activity resulted decreased secretion @ GeneSrc $ peptides . Several mechanisms elucidated basis enhanced alpha-secretase activity : increased membrane fluidity impaired internalization APP responsible effect observed methyl-beta-cyclodextrin ; treatment lovastatin resulted higher expression alpha-secretase ADAM 10 . results demonstrate cholesterol reduction promotes nonamyloidogenic alpha-secretase pathway formation neuroprotective alpha-secretase cleaved soluble APP several mechanisms suggest approaches prevention therapy @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001500776671641)\n",
      "- Text: \"vitro studies amyloid beta-protein fibril assembly toxicity provide clues aetiology Flemish variant ( Ala692 - - > Gly ) @ DiseaseTgt $ . Flemish kindred , Ala ( 692 ) -- > Gly amino acid substitution amyloid beta-protein precursor ( AbetaPP ) causes form early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) displays prominent amyloid angiopathy unusually large senile plaque cores . mechanistic basis Flemish form @ DiseaseTgt $ unknown . Previous vitro studies amyloid beta-protein ( @ GeneSrc $ ) production HEK-293 cells transfected cDNA encoding Flemish AbetaPP shown full-length [ Abeta ( 1 - 40 ) ] truncated [ @ GeneSrc $ Abeta ( 11 - 40 ) ] forms @ GeneSrc $ produced . effort determine peptides might contribute pathogenesis Flemish disease , comparative biophysical neurotoxicity studies performed wild-type Flemish Abeta ( 1 - 40 ) , @ GeneSrc $ Abeta ( 11 - 40 ) . results revealed Flemish amino acid substitution increased solubility form peptide , decreased rate formation thioflavin-T-positive assemblies , increased SDS-stability peptide oligomers . Although kinetics peptide assembly altered Ala ( 21 ) -- > Gly substitution , three Flemish variants formed fibrils , wild-type peptides . Importantly , toxicity studies using cultured primary rat cortical cells showed Flemish assemblies potent neurotoxin wild-type assemblies . results consistent pathogenetic process conformational changes @ GeneSrc $ induced Ala ( 21 ) -- > Gly substitution would facilitate peptide adherence vascular endothelium , creating nidi amyloid growth . Increased peptide solubility assembly stability would favour formation larger deposits inhibit elimination . addition , increased concentrations neurotoxic assemblies would accelerate neuronal injury death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9826482903363778)\n",
      "- Text: \"TGF-beta1 promotes microglial amyloid-beta clearance reduces plaque burden transgenic mice . Abnormal accumulation amyloid-beta peptide ( @ GeneSrc $ ) brain appears crucial pathogenesis forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , underlying mechanisms sporadic forms @ DiseaseTgt $ remain unknown . Transforming growth factor beta1 ( TGF-beta1 ) , key regulator brain 's responses injury inflammation , implicated Abeta deposition vivo . demonstrate modest increase astroglial TGF-beta1 production aged transgenic mice expressing human @ GeneSrc $ ( hAPP ) results three-fold reduction number parenchymal amyloid plaques , 50 % reduction overall @ GeneSrc $ load hippocampus neocortex , decrease number dystrophic neurites . mice expressing hAPP TGF-beta1 , Abeta accumulated substantially cerebral blood vessels , parenchymal plaques . human cases @ DiseaseTgt $ , @ GeneSrc $ immunoreactivity associated parenchymal plaques inversely correlated @ GeneSrc $ blood vessels cortical TGF-beta1 mRNA levels . reduction parenchymal plaques hAPP/TGF-beta1 mice associated strong activation microglia increase inflammatory mediators . Recombinant TGF-beta1 stimulated Abeta clearance microglial cell cultures . results demonstrate TGF-beta1 important modifier amyloid deposition vivo indicate TGF-beta1 might promote microglial processes inhibit accumulation @ GeneSrc $ brain parenchyma .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0087107289647515)\n",
      "- Text: \"Metabolic regulation brain Abeta neprilysin . Amyloid beta peptide ( Abeta ) , pathogenic agent @ DiseaseTgt $ ( @ DiseaseTgt $ ) , physiological metabolite brain . examined role neprilysin , candidate Abeta-degrading peptidase , metabolism using neprilysin gene-disrupted mice . Neprilysin deficiency resulted defects degradation exogenously administered Abeta metabolic suppression endogenous Abeta levels gene dose-dependent manner . regional levels Abeta neprilysin-deficient mouse brain distinct order hippocampus , cortex , thalamus/striatum , cerebellum , hippocampus highest level cerebellum lowest , correlating vulnerability @ GeneSrc $ deposition brains humans @ DiseaseTgt $ . observations suggest even partial down-regulation neprilysin activity , could caused aging , contribute @ DiseaseTgt $ development promoting Abeta accumulation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004285672339027)\n",
      "- Text: \"-48 C/T polymorphism presenilin 1 promoter associated increased risk developing @ DiseaseTgt $ increased @ GeneSrc $ load brain . Mutations presenilin 1 gene ( PS1 ) account majority early onset , familial , autosomal dominant forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , whereas role late onset forms @ DiseaseTgt $ remains unclear . -48 C/T polymorphism PS1 promoter associated increased genetic risk early onset complex @ DiseaseTgt $ moreover shown influence expression PS1 gene . raises possibility previous conflicting findings association studies homozygosity PS1 intron 8 polymorphism might result linkage disequilibrium -48 CC genotype . provide evidence increased risk @ DiseaseTgt $ associated homozygosity -48 CC genotype ( odds ratio=1.6 ) . also report phenotypic correlation Abeta ( 40 ) , Abeta ( 42 ( 43 ) ) , total @ GeneSrc $ load @ DiseaseTgt $ brains . -48 CC genotype associated 47 % greater total @ GeneSrc $ load ( p < 0.003 ) compared CT + TT genotype bearers . results suggest -48 C/T polymorphism PS1 promoter may increase risk @ DiseaseTgt $ , perhaps altering PS1 gene expression thereby influencing @ GeneSrc $ load .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024644742968867)\n",
      "- Text: \"Novel @ GeneSrc $ mutation Iowa family dementia severe cerebral amyloid angiopathy . Several mutations @ GeneSrc $ ( APP ) gene found associate pathologic deposition @ GeneSrc $ ( @ GeneSrc $ ) neuritic plaques walls cerebral vessels . report mutation novel site APP three-generation Iowa family autosomal dominant dementia beginning sixth seventh decade life . proband affected brother progressive aphasic dementia , leukoencephalopathy , occipital calcifications . Neuropathological examination proband revealed severe cerebral amyloid angiopathy , widespread neurofibrillary tangles , unusually extensive distribution Abeta40 plaques . affected brothers shared missense mutation APP , resulting substitution asparagine aspartic acid position 694 . site corresponds residue 23 @ GeneSrc $ , thus differing @ DiseaseTgt $ mutations , occur outside @ GeneSrc $ sequence . Restriction enzyme analysis DNA 94 unrelated patients sporadic cerebral amyloid angiopathy-related hemorrhage found instances mutation . results suggest novel site within @ GeneSrc $ may promote deposition toxicity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2467117563473979)\n",
      "- Text: \"transcriptionally [ correction transcriptively ] active complex APP Fe65 histone acetyltransferase Tip60 . @ GeneSrc $ ( APP ) , widely expressed cell-surface protein , cleaved transmembrane region gamma-secretase . gamma-Cleavage APP produces extracellular amyloid beta-peptide @ DiseaseTgt $ releases intracellular tail fragment unknown physiological function . demonstrate cytoplasmic tail APP forms multimeric complex nuclear adaptor protein Fe65 histone acetyltransferase Tip60 . complex potently stimulates transcription via heterologous Gal4- LexA-DNA binding domains , suggesting release cytoplasmic tail APP gamma-cleavage may function gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.014751557901144e-05)\n",
      "- Text: \"Pathogenic APP mutations near gamma-secretase cleavage site differentially affect @ GeneSrc $ secretion APP C-terminal fragment stability . Release @ GeneSrc $ ( @ GeneSrc $ ) @ GeneSrc $ ( APP ) requires cleavages beta- gamma-secretases plays crucial role @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathogenesis . Missense mutations APP gene causing familial @ DiseaseTgt $ clustered around beta- , alpha- particular gamma-secretase cleavage sites . systematically compare primary neurons effect APP processing series clinical APP mutations ( two characterized ) located close proximity gamma-secretase cleavage site . confirm extend previous observations showing mutations ( T714I , V715 , V715A , I716V , V717I V717L ) affect gamma-secretase cleavage causing increased relative ratio @ GeneSrc $ Abeta40 . Taking advantage extended series APP mutations able demonstrate inverse correlation ratios age onset disease different families . addition , subset mutations caused accumulation APP C-terminal fragments indicating mutations also influence stability APP C-terminal fragments . However , unlikely fragments contribute significantly disease process .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9911650891580094)\n",
      "- Text: \"' Arctic ' APP mutation ( E693 G ) causes @ DiseaseTgt $ enhanced @ GeneSrc $ protofibril formation . Several pathogenic @ DiseaseTgt $ ( @ DiseaseTgt $ ) mutations described , cause increased amyloid beta-protein ( @ GeneSrc $ ) levels . present studies pathogenic @ GeneSrc $ ( APP ) mutation , located within @ GeneSrc $ sequence codon 693 ( E693 G ) , causes @ DiseaseTgt $ Swedish family . Carriers ' Arctic ' mutation showed decreased @ GeneSrc $ Abeta40 levels plasma . Additionally , low levels @ GeneSrc $ detected conditioned media cells transfected APPE693 G . Fibrillization studies demonstrated difference fibrillization rate , @ GeneSrc $ Arctic mutation formed protofibrils much higher rate larger quantities wild-type ( wt ) @ GeneSrc $ . finding increased protofibril formation decreased @ GeneSrc $ plasma levels Arctic @ DiseaseTgt $ may reflect alternative pathogenic mechanism @ DiseaseTgt $ involving rapid @ GeneSrc $ protofibril formation leading accelerated buildup insoluble @ GeneSrc $ intra- and/or extracellularly .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8472443422049903)\n",
      "- Text: \"Acyl-coenzyme : cholesterol acyltransferase modulates generation amyloid beta-peptide . pathogenic event common forms @ DiseaseTgt $ abnormal accumulation amyloid beta-peptide ( @ GeneSrc $ ) . provide strong evidence intracellular cholesterol compartmentation modulates generation @ GeneSrc $ . Using genetic , biochemical metabolic approaches , found cholesteryl-ester levels directly correlated @ GeneSrc $ production . Acyl-coenzyme : cholesterol acyltransferase ( ACAT ) , enzyme catalyses formation cholesteryl esters , modulates generation @ GeneSrc $ tight control equilibrium free cholesterol cholesteryl esters . also show pharmacological inhibitors ACAT , developed treatment atherosclerosis , potent modulators @ GeneSrc $ generation , indicating potential use treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2080658234421781)\n",
      "- Text: \"founder mutation presenilin 1 causing early-onset @ DiseaseTgt $ unrelated Caribbean Hispanic families . CONTEXT : Genetic determinants @ DiseaseTgt $ ( @ DiseaseTgt $ ) comprehensively examined Caribbean Hispanics , population United States frequency @ DiseaseTgt $ higher compared non-Hispanic whites . OBJECTIVE : identify variant alleles genes related familial early-onset @ DiseaseTgt $ among Caribbean Hispanics . DESIGN SETTING : Family-based case series conducted 1998 - 2001 @ DiseaseTgt $ research center New York , NY , clinics Dominican Republic . PATIENTS : Among 206 Caribbean Hispanic families 2 living members @ DiseaseTgt $ identified , 19 ( 9.2 % ) least 1 individual onset @ DiseaseTgt $ age 55 years . MAIN OUTCOME MEASURE : entire coding region presenilin 1 gene exons 16 17 @ GeneSrc $ gene sequenced probands 19 families living relatives . RESULTS : G-to-C nucleotide change resulting glycine-alanine amino acid substitution codon 206 ( Gly206Ala ) exon 7 presenilin 1 observed 23 individuals 8 ( 42 % ) 19 families . Caribbean Hispanic individual Gly206Ala mutation early-onset familial disease also found sequencing corresponding genes 319 unrelated individuals New York City . Gly206Ala mutation found public genetic databases reported 5 individuals 4 Hispanic families @ DiseaseTgt $ referred genetic testing . None members families related one another , yet carriers Gly206Ala mutation tested shared variant allele 2 nearby microsatellite polymorphisms , indicating common ancestor . mutations found @ GeneSrc $ gene . CONCLUSIONS : Gly206Ala mutation found 8 19 unrelated Caribbean Hispanic families early-onset familial @ DiseaseTgt $ . genetic change may prevalent cause early-onset familial @ DiseaseTgt $ Caribbean Hispanic population .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0637250447767354)\n",
      "- Text: \"Kinesin-mediated axonal transport membrane compartment containing beta-secretase presenilin-1 requires APP . Proteolytic processing @ GeneSrc $ ( APP ) generates amyloid-beta peptide implicated pathogenesis @ DiseaseTgt $ . However , normal function APP , whether function related proteolytic processing APP , processing takes place neurons vivo remain unknown . previously shown axonal transport APP neurons mediated direct binding APP kinesin light chain subunit kinesin-I , microtubule motor protein . identify axonal membrane compartment contains APP , beta-secretase presenilin-1 . fast anterograde axonal transport compartment mediated APP kinesin-I . Proteolytic processing APP occur compartment vitro vivo axons . proteolysis generates @ GeneSrc $ carboxy-terminal fragment APP , liberates kinesin-I membrane . results suggest APP functions kinesin-I membrane receptor , mediating axonal transport beta-secretase presenilin-1 , processing APP @ GeneSrc $ secretases occur axonal membrane compartment transported kinesin-I .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.284731373061762)\n",
      "- Text: \"Estrogen lowers @ DiseaseTgt $ beta-amyloid generation stimulating trans-Golgi network vesicle biogenesis . Estrogen reduces risk @ DiseaseTgt $ post-menopausal women , beta-amyloid ( @ GeneSrc $ ) burden animal models @ DiseaseTgt $ , secretion @ GeneSrc $ neuronal cultures . biological basis effects remains unknown . , utilizing cell-free systems derived neuroblastoma cells primary neurons , demonstrate 17beta-estradiol ( 17beta-E2 ) stimulates formation vesicles containing @ GeneSrc $ ( betaAPP ) trans-Golgi network ( TGN ) . Accelerated betaAPP trafficking precludes maximal @ GeneSrc $ generation within TGN . 17beta-E2 appears modulate TGN phospholipid levels , particularly phosphatidylinositol , recruit soluble trafficking factors , Rab11 , TGN . Together , results suggest estrogen may exert @ GeneSrc $ effects regulating betaAPP trafficking within late secretory pathway . results suggest novel mechanism 17beta-E2 may act estrogen-responsive tissues illustrate altering kinetics transport protein influence metabolic fate .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0144049717488067)\n",
      "- Text: \"Brain plasma amyloid-beta efflux : measure brain amyloid burden mouse model @ DiseaseTgt $ . deposition amyloid-beta ( Abeta ) peptides amyloid plaques precedes cognitive dysfunction @ DiseaseTgt $ ( @ DiseaseTgt $ ) years . Biomarkers indicative brain amyloid burden could useful identifying individuals high risk developing @ DiseaseTgt $ . @ DiseaseTgt $ humans , baseline plasma @ GeneSrc $ levels transgenic mouse model @ DiseaseTgt $ correlate brain amyloid burden . However , peripheral administration monoclonal antibody @ GeneSrc $ ( m266 ) , observed rapid increase plasma Abeta magnitude increase highly correlated amyloid burden hippocampus cortex . method may useful quantifying brain amyloid burden patients risk diagnosed @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.520135673398862e-05)\n",
      "- Text: \"Naturally secreted oligomers amyloid beta protein potently inhibit hippocampal long-term potentiation vivo . Although extensive data support central pathogenic role amyloid beta protein ( @ GeneSrc $ ) @ DiseaseTgt $ , amyloid hypothesis remains controversial , part specific neurotoxic species @ GeneSrc $ nature effects synaptic function defined vivo . report natural oligomers human @ GeneSrc $ formed soon generation peptide within specific intracellular vesicles subsequently secreted cell . Cerebral microinjection cell medium containing oligomers abundant @ GeneSrc $ monomers amyloid fibrils markedly inhibited hippocampal long-term potentiation ( LTP ) rats vivo . Immunodepletion medium @ GeneSrc $ species completely abrogated effect . Pretreatment medium insulin-degrading enzyme , degrades @ GeneSrc $ monomers oligomers , prevent inhibition LTP . Therefore , @ GeneSrc $ oligomers , absence monomers amyloid fibrils , disrupted synaptic plasticity vivo concentrations found human brain cerebrospinal fluid . Finally , treatment cells gamma-secretase inhibitors prevented oligomer formation doses allowed appreciable monomer production , medium longer disrupted LTP , indicating synaptotoxic @ GeneSrc $ oligomers targeted therapeutically .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1587177999014732)\n",
      "- Text: \"Inclusion body myositis-like phenotype induced transgenic overexpression beta APP skeletal muscle . Inclusion body myositis ( IBM ) , common age-related muscle disease elderly population , incurable disorder leading severe disability . Sporadic IBM unknown etiology , although affected muscle fibers characterized many pathobiochemical alterations traditionally associated neurodegenerative brain disorders @ DiseaseTgt $ . Accumulation @ GeneSrc $ peptide , derived proteolysis larger @ GeneSrc $ ( betaAPP ) , seems early pathological event @ DiseaseTgt $ also IBM , latter , predominantly occurs intracellularly within affected myofibers . elucidate possible role betaAPP mismetabolism pathogenesis IBM , transgenic mice derived selectively targeted betaAPP overexpression skeletal muscle using muscle creatine kinase promoter . report older ( > 10 months ) transgenic mice exhibit intracellular immunoreactivity betaAPP proteolytic derivatives skeletal muscle . transgenic model , selective overexpression betaAPP leads development subset histopathological clinical features characteristic IBM , including centric nuclei , inflammation , deficiencies motor performance . results consistent pathogenic role betaAPP mismetabolism human IBM .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025041195003177)\n",
      "- Text: \"Presenilin-1 mutations leucine 166 equally affect generation Notch APP intracellular domains independent effect @ GeneSrc $ production . @ DiseaseTgt $ @ DiseaseTgt $ presenilin ( PS ) proteins required gamma-secretase cleavages @ GeneSrc $ site 3 ( S3 ) protease cleavage Notch . intramembrane cleavages release amyloid-beta peptide ( @ GeneSrc $ ) , including pathogenic 42-aa variant ( @ GeneSrc $ ) , well @ GeneSrc $ Notch intracellular domains ( AICD , NICD ) . Whereas @ GeneSrc $ generated endoproteolysis middle transmembrane domain , AICD NICD generated cleavages analogous positions close cytoplasmic border transmembrane domain . Numerous mutations causing @ DiseaseTgt $ ( @ DiseaseTgt $ ) cause increased production @ GeneSrc $ found PS1 gene . investigated previously uncharacterized , aggressive @ DiseaseTgt $ mutation L166P causes onset @ DiseaseTgt $ adolescence . Strikingly , PS1 L166P mutation induces exceptionally high increase @ GeneSrc $ production also impairs NICD production Notch signaling , well AICD generation . Thus , @ DiseaseTgt $ PS mutants affect generation NICD , also AICD . Moreover , analysis artificial L166 mutants revealed gamma-secretase cleavage position 40/42 S3-like gamma-secretase cleavage position 49 @ GeneSrc $ domain differentially affected PS1 L166 mutants . Finally , show PS1 L166 mutants affect generation NICD AICD similar manner , supporting concept S3 protease S3-like gamma-secretase cleavages mediated identical proteolytic activities .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9892173267155774)\n",
      "- Text: \"@ GeneSrc $ immunotherapy @ DiseaseTgt $ : end beginning .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004866476431106)\n",
      "- Text: \"Presenilin-1 mutation L271V results altered exon 8 splicing @ DiseaseTgt $ non-cored plaques neuritic dystrophy . mutation L271V exon 8 presenilin-1 ( PS-1 ) gene detected @ DiseaseTgt $ pedigree . Neuropathological examination affected individuals identified variant , large , non-cored plaques without neuritic dystrophy , reminiscent cotton wool plaques . Biochemical analysis L271V mutation showed increased secretion 42-amino acid amyloid-beta peptide , suggesting pathogenic mutation . Analysis PS-1 transcripts brains two mutation carriers revealed 17 - 50 % increase PS-1 transcripts deletion exon 8 ( PS-1deltaexon8 ) compared unrelated @ DiseaseTgt $ brains . Exon trapping analysis confirmed L271V mutation enhanced deletion exon 8 . Western blots brain lysates indicated PS-1deltaexon8 overexpressed affected individual . Biochemical analysis PS-1deltaexon8 COS BD8 cells indicate splice isoform intrinsically active interacts wild-type PS-1 generate @ GeneSrc $ . Western blots cell lysates immunoprecipitated anti-Tau anti-GSK-3beta antibodies indicated PS-1deltaexon8 , unlike wild-type PS-1 , interact directly Tau GSK-3beta , potential modifiers neuritic dystrophy . postulate variant plaques observed family due part effects PS-1deltaexon8 interaction PS-1 various protein complexes necessary neuritic plaque formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.9713450224861378e-06)\n",
      "- Text: \"Putative function ADAM9 , ADAM10 , ADAM17 APP alpha-secretase . putative alpha-secretase cleaves @ GeneSrc $ ( APP ) @ DiseaseTgt $ middle amyloid beta peptide ( @ GeneSrc $ ) domain . generally thought alpha-secretase pathway mitigates @ GeneSrc $ formation normal brain . Several studies suggested ADAM9 , ADAM10 , ADAM17 candidate alpha-secretases belonging ADAM ( disintegrin metalloprotease ) family , membrane-anchored cell surface proteins . comparative study ADAM9 , ADAM10 , ADAM17 , examined physiological role ADAMs expressing ADAMs COS-7 cells , `` constitutive `` `` regulated `` alpha-secretase activities ADAMs determined . tried suppress expression ADAMs human glioblastoma A172 cells , contain large amounts endogenous alpha-secretase , lipofection double-stranded RNA ( dsRNA ) encoding ADAMs . results indicate ADAM9 , ADAM10 , ADAM17 catalyze alpha-secretory cleavage therefore act alpha-secretases A172 cells . first report suggest endogenous alpha-secretase composed several ADAM enzymes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1031607222257601)\n",
      "- Text: \"role presenilin cofactors gamma-secretase complex . Mutations presenilin genes account majority cases familial form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Presenilin essential gamma-secretase activity , proteolytic activity involved intramembrane cleavage Notch @ GeneSrc $ ( betaAPP ) . Cleavage betaAPP @ DiseaseTgt $ mutant presenilin results overproduction highly amyloidogenic amyloid beta42 peptides . gamma-Secretase activity requires formation stable , high-molecular-mass protein complex , addition endoproteolysed fragmented form presenilin , contains essential cofactors including nicastrin , APH-1 ( refs 15 - 18 ) PEN-2 ( refs 16 , 19 ) . However , role protein complex formation generation enzymatic activity unclear . show Drosophila APH-1 ( Aph-1 ) increases stability Drosophila presenilin ( Psn ) holoprotein complex . Depletion PEN-2 RNA interference prevents endoproteolysis presenilin promotes stabilization holoprotein Drosophila mammalian cells , including primary neurons . Co-expression Drosophila Pen-2 Aph-1 nicastrin increases formation Psn fragments well gamma-secretase activity . Thus , APH-1 stabilizes presenilin holoprotein complex , whereas PEN-2 required endoproteolytic processing presenilin conferring gamma-secretase activity complex .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7612302546777237)\n",
      "- Text: \"@ DiseaseTgt $ C allele promoter polymorphism -22C > causes critical neuron-specific decrease presenilin 1 expression . , amongst others , shown CC homozygosity -22C > promoter polymorphism presenilin 1 ( PSEN1 ) associated increased risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Also , studies @ DiseaseTgt $ brains suggested CC homozygosity increased risk @ DiseaseTgt $ increasing @ GeneSrc $ load . characterized PSEN1 promoter deletion mapping , analysed effect -22C -22 alleles transcriptional activity PSEN1 transient transfection system . showed neuron-specific 2-fold decrease promoter activity -22C risk allele , homozygous individuals would lead critical decrease PSEN1 expression . deletion mapping suggested 13 bp region ( -33/-20 ) spanning -22C > polymorphism harbours binding site negative regulatory factor . factor higher affinity -22C risk allele strongly dependent downstream sequences cell-type-specific expression differences . Together , studies provide evidence increased risk @ DiseaseTgt $ associated PSEN1 may result genetic variations regulatory region , leading altered expression levels PSEN1 neurons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1253528873567928)\n",
      "- Text: \"APP processing synaptic function . large body evidence implicated @ GeneSrc $ peptides derivatives @ GeneSrc $ ( APP ) central pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , functional relationship APP proteolytic derivatives neuronal electrophysiology known . , show neuronal activity modulates formation secretion @ GeneSrc $ peptides hippocampal slice neurons overexpress APP . turn , @ GeneSrc $ selectively depresses excitatory synaptic transmission onto neurons overexpress APP , well nearby neurons . depression depends NMDA-R activity reversed blockade neuronal activity . Synaptic depression excessive @ GeneSrc $ could contribute cognitive decline early @ DiseaseTgt $ . addition , propose activity-dependent modulation endogenous @ GeneSrc $ production may normally participate negative feedback could keep neuronal hyperactivity check . Disruption feedback system could contribute disease progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0600547064378064)\n",
      "- Text: \"Aph-1 , Pen-2 , Nicastrin Presenilin generate active gamma-Secretase complex . Gamma-Secretase cleaves @ GeneSrc $ ( APP ) transmembrane domain , releasing amyloid peptide @ GeneSrc $ . @ GeneSrc $ main constituent amyloid plaques brains patients suffering @ DiseaseTgt $ . Several type integral membrane proteins also cleaved protease . Recent work indicates gamma-Secretase multiprotein complex consisting Presenilin , Nicastrin , Aph-1 , Pen-2 four proteins necessary full proteolytic activity . Since several paralogs alternatively spliced variants least Presenilin Aph-1 identified well , anticipated gamma-Secretase homogeneous activity . Gamma-Secretase interesting complex drug target challenges classical thinking proteolytic processing intracellular signaling .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8678817808209751)\n",
      "- Text: \"Common structure soluble amyloid oligomers implies common mechanism pathogenesis . Soluble oligomers common amyloids may represent primary toxic species amyloids , like @ GeneSrc $ peptide @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show soluble oligomers tested display common conformation-dependent structure unique soluble oligomers regardless sequence . vitro toxicity soluble oligomers inhibited oligomer-specific antibody . Soluble oligomers unique distribution human @ DiseaseTgt $ brain distinct fibrillar amyloid . results indicate different types soluble amyloid oligomers common structure suggest share common mechanism toxicity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1921073365618338)\n",
      "- Text: \"Presenilin-1 , nicastrin , @ GeneSrc $ , gamma-secretase activity co-localized lysosomal membrane . @ DiseaseTgt $ ( @ DiseaseTgt $ ) caused cerebral deposition beta-amyloid ( @ GeneSrc $ ) , 38 - 43-amino acid peptide derived proteolytic cleavage @ GeneSrc $ ( APP ) . Initial studies indicated final cleavage APP gamma-secretase ( complex containing presenilin nicastrin ) produce @ GeneSrc $ occurred endosomal/lysosomal system . However , studies showing predominant endoplasmic reticulum localization gamma-secretase proteins neutral pH optimum vitro gamma-secretase assays challenged conclusion . recently identified nicastrin major lysosomal membrane protein . present work , use Western blotting immunogold electron microscopy demonstrate significant amounts mature nicastrin , presenilin-1 , APP co-localized lysosomal associated membrane protein-1 ( cAMP-1 ) outer membranes lysosomes . Furthermore , demonstrate membranes contain acidic gamma-secretase activity , immunoprecipitable antibody nicastrin . experiments establish APP , nicastrin , presenilin-1 resident lysosomal membrane proteins indicate gamma-secretase lysosomal protease . data reassert importance lysosomal/endosomal system generation @ GeneSrc $ suggest role lysosomes pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6885115235503141)\n",
      "- Text: \"Presenilin 1 mutation african american family presenting atypical @ DiseaseTgt $ . BACKGROUND : @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized memory visuospatial deficits relative sparing personality . Mutations 3 genes ( presenilin 1 2 @ GeneSrc $ ) associated presenile @ DiseaseTgt $ . Presenilin 1 gene mutations described African Americans . METHODS : studied African American family autosomal dominant rapidly progressive dementia psychosis occurring early fifth decade life . performed neurologic evaluations , psychometrics , neuroimaging . sequenced @ GeneSrc $ gene , presenilin 1 2 , tau affected unaffected family members . One patient underwent brain biopsy subsequent autopsy . RESULTS : Personality change , auditory visual hallucinations , delusions , memory impairment , word-finding difficulties , subsequent rigidity , dystonia , myoclonus , mutism developed 2 brothers . Neuropsychometric testing one consistent frontotemporal dementia atypical @ DiseaseTgt $ . Neuroimaging studies showed diffuse cortical involvement . clinical diagnosis @ DiseaseTgt $ made . However , results temporal lobe biopsy one revealed amyloid neuritic plaques , autopsy results confirmed diagnosis @ DiseaseTgt $ . Gene sequencing revealed presenilin 1 point mutation ( M139V ) cosegregating disease . tau polymorphism exon 7 ( A178 ) found affected brother unaffected relatives . CONCLUSIONS : report first documented presenilin mutation African American patients presenting early personality change , psychosis , memory loss preserved praxis . M139V mutation present differently kindreds , features suggestive frontal lobe syndrome . M139V mutation lead atypical @ DiseaseTgt $ , genetic background may role determining phenotype genetically defined @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9541829928272216)\n",
      "- Text: \"Association late-onset @ DiseaseTgt $ genotype PLAU , gene encoding urokinase-type plasminogen activator chromosome 10q22.2 . Urokinase-type plasminogen activator ( uPA ) converts plasminogen plasmin . Plasmin involved processing @ GeneSrc $ degrades secreted aggregated @ GeneSrc $ , hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . PLAU , gene encoding uPA , maps chromosome 10q22.2 two regions showing linkage late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . genotyped frequent C/T single nucleotide polymorphism codon 141 PLAU ( P141L ) 347 patients @ DiseaseTgt $ 291 control subjects . @ DiseaseTgt $ associated homozygous C/C PLAU genotype whole sample ( chi2=15.7 , P=0.00039 , df 2 ) , well sub-samples stratified gender APOE epsilon4 carrier status ( chi2 > = 6.84 , P < = 0.033 , df 2 ) . Odds ratio @ DiseaseTgt $ due homozygosity C/C 1.89 ( 95 % confidence interval 1.37 - 2.61 ) . PLAU promising new candidate gene @ DiseaseTgt $ , allele C ( P141 ) recessive risk allele allele ( L141 ) conferring protection .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.955412127241912)\n",
      "- Text: \"Frameshifted @ GeneSrc $ ( APP+1 ) secretory protein , level APP+1 cerebrospinal fluid linked @ DiseaseTgt $ pathology . Molecular misreading @ GeneSrc $ ( APP ) gene generates mRNA dinucleotide deletions GAGAG motifs . resulting truncated partly frameshifted APP protein ( APP+1 ) accumulates dystrophic neurites neurofibrillary tangles cortex hippocampus @ DiseaseTgt $ patients . contrast , show neuronal cells transfected APP+1 proficiently secreted APP+1 . various secretory APP isoforms present cerebrospinal fluid ( CSF ) , study aimed determine whether APP+1 also secretory protein detected CSF . Post-mortem CSF obtained autopsy 50 non-demented controls 122 @ DiseaseTgt $ patients ; subjects staged neuropathology ( Braak score ) . Unexpectedly , found APP+1 level CSF non-demented controls much higher ( 1.75 ng/ml ) CSF @ DiseaseTgt $ patients ( 0.51 ng/ml ) ( p < 0.001 ) , level APP+1 CSF inversely correlated severity neuropathology . Moreover earliest neuropathological changes already reflected significant decrease APP+1 level CSF . data show APP+1 normally secreted neurons , preventing intra-neuronal accumulation APP+1 brains non-demented controls without neurofibrillary pathology .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2452300651966832)\n",
      "- Text: \"novel mutation PSEN2 gene ( T430 ) associated variable expression family early-onset @ DiseaseTgt $ . BACKGROUND : Autosomal dominant early-onset @ DiseaseTgt $ heterogeneous condition associated mutations 3 different genes : @ GeneSrc $ ( APP ) , presenilin 1 ( PSEN1 ) , presenilin 2 ( PSEN2 ) genes . cases due mutations PSEN1 gene , whereas mutations APP PSEN2 genes rare . OBJECTIVE : describe novel mutation PSEN2 gene associated early-onset @ DiseaseTgt $ . PATIENTS METHODS : proband 49-year-old individual displayed progressive dementia beginning age 45 years . One parents one grandparents developed dementia ages 64 years 60 years , respectively , 1 sibling mild cognitive impairment . family members also Tourette syndrome . Mutation analysis APP , PSEN1 , PSEN2 , tau ( TAU ) genes performed . Apolipoprotein E ( APOE ) also genotyped . RESULTS : found missense mutation codon 430 PSEN2 gene predicts threonine-to-methionine substitution . mutation detected affected individuals 1 cognitively healthy sibling . mutation absent 260 control chromosomes . normal amino acid conserved human mouse PSEN1 mouse PSEN2 homologues . influence APOE genotype observed . CONCLUSIONS : found novel mutation PSEN2 gene family early-onset @ DiseaseTgt $ . variation age onset confirms PSEN2 mutations associated variable clinical expression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9967409541964484)\n",
      "- Text: \"PS1 @ DiseaseTgt $ family spastic paraplegia : search gene modifier . PS1 mutations associated classic @ DiseaseTgt $ ( @ DiseaseTgt $ ) ; however , families develop @ DiseaseTgt $ spastic paraplegia ( SP ) brain pathology characterized @ GeneSrc $ cotton wool plaques . authors report variant @ DiseaseTgt $ family E280Q PS1 mutation . fact PS1 mutation found patients either variant classic @ DiseaseTgt $ argues favor presence genetic modifier . authors excluded modifier effect originates coding sequence variations three SP genes second mutation @ DiseaseTgt $ genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024300360709824)\n",
      "- Text: \"Identification new presenilin gene mutations early-onset @ DiseaseTgt $ . BACKGROUND : Mutations presenilin 1 ( PS1 ) presenilin 2 ( PS2 ) genes , rarely @ GeneSrc $ ( betaAPP ) , underlie pathogenesis cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) . OBJECTIVE : screen entire coding region PS1 PS2 genes exons 16 17 betaAPP find pathogenetic mutations @ DiseaseTgt $ . Patients Patients @ DiseaseTgt $ consecutively enrolled among outpatients neurology departments Universities Florence Parma Santa Maria Nuova Hospital Reggio Emilia , Italy . DESIGN METHODS : Polymerase chain reaction-single-strand conformation polymorphism DNA se-quencing used investigate affected members families @ DiseaseTgt $ . RESULTS : identified family carrying novel Ser130Leu mutation PS2 gene . Moreover , found 2 novel PS1 mutations : Cys92Ser exon 4 2 unrelated families Leu174Met exon 6 PS1 gene . also found fourth Italian family betaAPP Val717Ile mutation . CONCLUSIONS : One novel PS2 mutation associated highly penetrant variable age onset ( 35 - 85 years ) 2 novel PS1 missense mutations associated early-onset @ DiseaseTgt $ age 49 54 years identified Italian families . Screening new mutations presenilin betaAPP genes beneficial characterizing gene function @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8034571621865367)\n",
      "- Text: \"Mutant presenilins specifically elevate levels 42 residue @ GeneSrc $ vivo : evidence augmentation 42-specific gamma secretase . @ GeneSrc $ ( APP ) endoproteolytically processed BACE1 gamma-secretase release amyloid peptides ( Abeta40 42 ) aggregate form senile plaques brains patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) . C-terminus @ GeneSrc $ generated gamma-secretase , whose activity dependent upon presenilin ( PS 1 2 ) . Missense mutations PS1 ( PS2 ) occur patients early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , previous studies transgenic mice cultured cell models demonstrated @ DiseaseTgt $ variants shift ratio Abeta40 : 42 favor @ GeneSrc $ . One hypothesis explain outcome mutant PS alters specificity gamma-secretase favor production @ GeneSrc $ expense Abeta40 . test hypothesis vivo , studied Abeta40 42 levels series transgenic mice co-express Swedish mutation APP ( APPswe ) two @ DiseaseTgt $ variants differentially accelerate amyloid pathology brain . demonstrate direct correlation concentration @ GeneSrc $ rate amyloid deposition . show shift @ GeneSrc $ : 40 ratios associated expression @ DiseaseTgt $ variants due specific elevation steady-state levels @ GeneSrc $ , maintaining constant level Abeta40 . data suggest PS1 variants simply alter preferred cleavage site gamma-secretase , rather complex effects regulation gamma-secretase access substrates .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9411751143664104)\n",
      "- Text: \"phosphorylated , carboxy-terminal fragment @ GeneSrc $ localizes splicing factor compartment . @ GeneSrc $ ( APP ) implicated pathobiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) . gain insight function , investigated proteolytic processing post-translational modification APP relation intracellular traffic localization . proteolytic processing generates amyloid beta-peptide ( @ GeneSrc $ ) also releases cytoplasm carboxy-terminal fragment APP , Cgamma . Using catecholaminergic cell line , CAD , antibody form APP phosphorylated Thr668 ( pAPP ; numbering APP695 ) , show phosphorylated , carboxy-terminal fragment APP , probably Cgamma , present nucleus , localizes subnuclear particles . labeling anti-pAPP antibody co-localizes proteins define splicing factor compartment ( SFC ) [ e.g . small nuclear ribonucleoprotein ( snRNP ) , U2B , serine/arginine-rich ( SR ) proteins ] , excluded coiled bodies gems . distribution pAPP epitopes found CAD cells independent state differentiation , well primary cortical neurons , epithelial cells fibroblasts . show exogenously expressed Cgamma becomes phosphorylated , distributes throughout cell . fraction Cgamma translocated nucleus , co-localizes endogenous pAPP epitopes . Finally , show APP binding , scaffolding protein , Fe65 co-localizes pAPP epitopes expressed Cgamma intranuclear speckles . results suggest phosphorylated Cgamma accumulates SFC . Thus , APP may play role pre-mRNA splicing , Fe65 APP phosphorylation may regulate function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1097370559139523)\n",
      "- Text: \"Dissecting pathological effects human Abeta40 @ GeneSrc $ Drosophila : potential model @ DiseaseTgt $ . Accumulation @ GeneSrc $ ( @ GeneSrc $ ) peptides brain suggested primary event sequential progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , use Drosophila examine whether expression either human Abeta40 @ GeneSrc $ peptide Drosophila brain induce pathological phenotypes resembling @ DiseaseTgt $ . expression @ GeneSrc $ led formation diffused amyloid deposits , age-dependent learning defects , extensive neurodegeneration . contrast , expression Abeta40 caused age-dependent learning defects lead formation amyloid deposits neurodegeneration . results strongly suggest accumulation @ GeneSrc $ brain sufficient cause behavioral deficits neurodegeneration . Moreover , Drosophila may serve model facilitating understanding molecular mechanisms underlying @ GeneSrc $ toxicity discovery novel therapeutic targets @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0059189912837741)\n",
      "- Text: \"Presenilin 1 stabilizes C-terminal fragment @ GeneSrc $ independently gamma-secretase activity . cleavage transmembrane @ GeneSrc $ ( APP ) beta-secretase leaves C-terminal fragment APP , C99 , anchored plasma membrane . C99 subsequently processed gamma-secretase , unusual aspartyl protease activity largely dependent presenilin ( PS ) , generating amyloid beta-peptide ( @ GeneSrc $ ) accumulates brain patients @ DiseaseTgt $ . suggested PS proteins catalytic core proteolytic activity , number proteins mandatory gamma-secretase cleavage also discovered . exact role PS gamma-secretase activity remains matter debate , cells devoid PS still produce forms @ GeneSrc $ . , used insect cells expressing C99 demonstrate expression presenilin 1 ( PS1 ) , binds C99 , increases production @ GeneSrc $ cells also increases intracellular levels C99 extent . Using pulse-chase experiments , established results increased half-life C99 cells expressing PS1 . Chinese hamster ovary cells producing C99 full-length human APP , similar results observed . Finally , show functional inhibitor gamma-secretase alter ability PS1 increase intracellular levels C99 . finding suggests binding PS1 C99 necessarily lead immediate cleavage gamma-secretase , could spatio-temporally regulated induced event , provides biochemical evidence existence substrate-docking site PS1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2036296778313655)\n",
      "- Text: \"Somatic germline mosaicism sporadic early-onset @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) commonest neurodegenerative disease worldwide . Rare familial cases may caused mutations one three @ GeneSrc $ , presenilin-1 presenilin-2 ; however , molecular basis > 99 % @ DiseaseTgt $ cases unknown . Somatic mutation considered mechanism may account proportion sporadic cases @ DiseaseTgt $ , date evidence . report sporadic early-onset patient @ DiseaseTgt $ , show individual somatic mosaic mutation presenilin-1 gene , suggesting novel molecular mechanism @ DiseaseTgt $ . Quantification mosaicism demonstrated degree mosaicism 8 % peripheral lymphocytes 14 % cerebral cortex index patient ; clear gene dosage effect age presentation clinical phenotypic presentation demonstrated . finding important implications aetiology sporadic @ DiseaseTgt $ , apparently sporadic neurodegenerative diseases Parkinson 's disease , motor neuron disease Creutzfeldt-Jakob disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.936049984075854)\n",
      "- Text: \"APOE epsilon4 allele associated reduced cerebrospinal fluid levels @ GeneSrc $ . epsilon4 allele APOE risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) . analysis large cohort @ DiseaseTgt $ patients ( n = 563 ) control subjects ( n = 118 ) , shown epsilon4 allele strongly associated reduced CSF levels beta-amyloid ( 1 - 42 ) ( @ GeneSrc $ ) @ DiseaseTgt $ ( p < 10 ( -9 ) ) control ( p = 0.0012 ) populations . associations APOE variants indexes @ DiseaseTgt $ severity observed , effect may reflect fundamental involvement ApoE @ GeneSrc $ metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0354099510270915)\n",
      "- Text: \"Identification loci determining susceptibility lethal effects @ GeneSrc $ transgene overexpression . Phenotypes produced expression human @ GeneSrc $ ( APP ) transgenes vary depending genetic background mouse . FVB/N mice overexpressing human APP695 develop central nervous system disorder die prematurely , precluding development @ GeneSrc $ peptide amyloid plaques . 129S6 mice resistant lethal effects APP overexpression , allowing sufficient levels Abeta expression development amyloid plaques age-dependent memory deficits . identify genes determine susceptibility resistance APP analyzed crosses involving FVB/NCr 129S6.Tg2576 mice overexpress ' Swedish ' mutant ( K670N , M671L ) APP695 . APP transgene-positive FVB129S6F1 ( F1 ) mice resistant lethal effects APP overexpression , FVBxF1 backcross F2 intercross offspring produced . Analysis age death quantitative trait revealed significant linkage loci proximal chromosome 14 chromosome 9 ; 129S6 alleles protect lethal effects APP . Within chromosome 14 interval segments homologous regions human chromosome 10 linked late onset @ DiseaseTgt $ levels @ GeneSrc $ peptide plasma . However , analysis plasma @ GeneSrc $ peptide concentrations 6 weeks backcross offspring produced significant linkage . Similarly , elevation human @ GeneSrc $ peptide concentrations expression mutant presenilin transgenes increase proportion mice dying prematurely , suggesting early death reflects effects APP fragments @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0448345485892196)\n",
      "- Text: \"ACAT inhibitor CP-113,818 markedly reduces amyloid pathology mouse model @ DiseaseTgt $ . Amyloid beta-peptide ( Abeta ) accumulation specific brain regions pathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . previously reported well-characterized acyl-coenzyme : cholesterol acyltransferase ( ACAT ) inhibitor , CP-113,818 , inhibits Abeta production cell-based experiments . , assessed efficacy CP-113,818 reducing @ DiseaseTgt $ pathology brains transgenic mice expressing human APP ( 751 ) containing London ( V717I ) Swedish ( K670M/N671L ) mutations . Two months treatment CP-113,818 reduced accumulation amyloid plaques 88 % -99 % membrane/insoluble Abeta levels 83 % -96 % , also decreasing brain cholesteryl-esters 86 % . Additionally , soluble @ GeneSrc $ reduced 34 % brain homogenates . Spatial learning slightly improved correlated decreased @ GeneSrc $ levels . nontransgenic littermates , CP-113,818 also reduced ectodomain shedding endogenous APP brain . results suggest ACAT inhibition may effective prevention treatment @ DiseaseTgt $ inhibiting generation Abeta peptide .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001031096489936)\n",
      "- Text: \"Aggressive amyloidosis mice expressing human amyloid peptides Arctic mutation . Arctic mutation within @ GeneSrc $ ( @ GeneSrc $ ) peptide causes @ DiseaseTgt $ . vitro , Arctic-mutant @ GeneSrc $ forms ( proto ) fibrils effectively wild-type @ GeneSrc $ . generated transgenic mouse lines expressing Arctic-mutant human amyloid precursor proteins ( hAPP ) . Amyloid plaques formed faster extensive Arctic mice hAPP mice expressing wild-type @ GeneSrc $ , even though Arctic mice lower Abeta ( 1 - 42/1 - 40 ) ratios . Thus , Arctic mutation highly amyloidogenic vivo .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3045673304348469)\n",
      "- Text: \"novel presenilin-1 mutation ( Leu85Pro ) early-onset @ DiseaseTgt $ spastic paraparesis . BACKGROUND : Early-onset @ DiseaseTgt $ caused mutations @ GeneSrc $ ( APP ) , presenilin-1 ( PSEN1 ) , presenilin-2 ( PSEN2 ) genes . Phenotypic diversity reported associated various mutations PSEN1 . Various mutations PSEN1 reported cases early-onset @ DiseaseTgt $ spastic paraparesis . OBJECTIVE : describe novel mutation PSEN1 gene associated early-onset @ DiseaseTgt $ spastic paraparesis . PATIENT METHODS : patient 27-year-old man developed early-onset dementia spastic paraparesis . examined sequences PSEN1 , PSEN2 , APP genes patient family . detect possible mutation effect production amyloid-beta peptide ( @ GeneSrc $ ) , transfected HEK293 cells examined @ GeneSrc $ Abeta40 production . RESULTS : found novel mutation ( Leu85Pro ) PSEN1 . mutation influenced production @ GeneSrc $ , resulting 2-fold elevation @ GeneSrc $ production @ GeneSrc $ ratio . CONCLUSION : knowledge , first report early-onset @ DiseaseTgt $ spastic paraparesis visual variant form disease , associated visuospatial cognitive disorder . Leu85Pro mutation PSEN1 pathogenic .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9557224519949816)\n",
      "- Text: \"Self-propagating , molecular-level polymorphism @ DiseaseTgt $ beta-amyloid fibrils . Amyloid fibrils commonly exhibit multiple distinct morphologies electron microscope atomic force microscope images , often within single image field . using electron microscopy solid-state nuclear magnetic resonance measurements fibrils formed 40-residue @ GeneSrc $ @ DiseaseTgt $ ( Abeta ( 1 - 40 ) ) , show different fibril morphologies different underlying molecular structures , predominant structure controlled subtle variations fibril growth conditions , morphology molecular structure self-propagating fibrils grow preformed seeds . Different Abeta ( 1 - 40 ) fibril morphologies also significantly different toxicities neuronal cell cultures . results implications mechanism amyloid formation , phenomenon strains prion diseases , role amyloid fibrils amyloid diseases , development amyloid-based nano-materials .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0344700655440063)\n",
      "- Text: \"Gene delivery human apolipoprotein E alters brain Abeta burden mouse model @ DiseaseTgt $ . Apolipoprotein E ( apoE ) alleles important genetic risk factors @ DiseaseTgt $ ( @ DiseaseTgt $ ) , epsilon4 allele increasing epsilon2 allele decreasing risk developing @ DiseaseTgt $ . ApoE shown influence brain amyloid-beta peptide ( @ GeneSrc $ ) amyloid burden , humans transgenic mice . show direct intracerebral administration lentiviral vectors expressing three common human apoE isoforms differentially alters hippocampal Abeta amyloid burden PDAPP mouse model @ DiseaseTgt $ . Expression apoE4 absence mouse apoE increases hippocampal Abeta ( 1 - 42 ) levels amyloid burden . contrast , expression apoE2 , even presence mouse apoE , markedly reduces hippocampal Abeta burden . data demonstrate rapid apoE isoform-dependent effects brain Abeta burden mouse model @ DiseaseTgt $ . Gene delivery apoE2 may prevent reduce brain Abeta burden subsequent development neuritic plaques .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002251445712445)\n",
      "- Text: \"Environmental enrichment reduces Abeta levels amyloid deposition transgenic mice . Cerebral deposition beta-amyloid ( @ GeneSrc $ ) peptides invariant pathological hallmark brains patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) transgenic mice coexpressing familial @ DiseaseTgt $ APP PS1 variants . report exposure transgenic mice `` enriched environment `` results pronounced reductions cerebral Abeta levels amyloid deposits , compared animals raised `` standard housing `` conditions . enzymatic activity Abeta-degrading endopeptidase , neprilysin , elevated brains `` enriched `` mice inversely correlated amyloid burden . Moreover , DNA microarray analysis revealed selective upregulation levels transcripts encoded genes associated learning memory , vasculogenesis , neurogenesis , cell survival pathways , Abeta sequestration , prostaglandin synthesis . studies provide evidence environmental enrichment leads reductions steady-state levels cerebral Abeta peptides amyloid deposition selective upregulation levels specific transcripts brains transgenic mice .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5167334314239443)\n",
      "- Text: \"Somatostatin regulates brain amyloid beta peptide @ GeneSrc $ modulation proteolytic degradation . Expression somatostatin brain declines aging various mammals including apes humans . prominent decrease neuropeptide also represents pathological characteristic @ DiseaseTgt $ . Using vitro vivo paradigms , show somatostatin regulates metabolism amyloid beta peptide ( @ GeneSrc $ ) , primary pathogenic agent @ DiseaseTgt $ , brain modulating proteolytic degradation catalyzed neprilysin . Among various effector candidates , somatostatin upregulated neprilysin activity primary cortical neurons . genetic deficiency somatostatin altered hippocampal neprilysin activity localization , increased quantity hydrophobic 42-mer form @ GeneSrc $ , @ GeneSrc $ , manner similar presenilin gene mutations cause @ DiseaseTgt $ . results indicate aging-induced downregulation somatostatin expression may trigger @ GeneSrc $ accumulation leading late-onset sporadic @ DiseaseTgt $ , suggest somatostatin receptors may pharmacological-target candidates prevention treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0264390503686936)\n",
      "- Text: \"Molecular diagnosis autosomal dominant early onset @ DiseaseTgt $ : update . BACKGROUND : Autosomal dominant early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) genetically heterogeneous . Mutations @ GeneSrc $ ( APP ) , presenilin 1 ( PSEN1 ) , presenilin 2 ( PSEN2 ) genes identified . OBJECTIVE : clarify respective contribution genes @ DiseaseTgt $ . METHODS : 31 novel families investigated . ascertained using stringent criteria ( occurrence probable definite cases @ DiseaseTgt $ onset 60 years age three generations ) . cases fulfilled NINCDS-ADRDA criteria probable definite @ DiseaseTgt $ . entire coding regions PSEN1 PSEN2 genes exons 16 17 APP gene sequenced genomic DNA RESULTS : PSEN1 mutations , including eight previously unreported mutations , detected 24 31 families , APP mutations found five families . sample , mean ages disease onset PSEN1 APP mutation carriers 41.7 51.2 years , respectively . CONCLUSIONS : Combining data previously published data , yielding 65 @ DiseaseTgt $ families , 66 % cases attributable PSEN1 mutations 16 % APP mutations , 18 % remained unexplained .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9932069432936984)\n",
      "- Text: \"@ DiseaseTgt $ : decreases CSF @ GeneSrc $ levels precede cognitive decline . CSF amyloid beta-peptide 42 ( @ GeneSrc $ ) levels presymptomatic subjects pathogenic mutations PS1 gene significantly lower age-matched control group . Consequently , subjects , window opportunity estimated least 4 12 years evaluate ability putative prophylactic therapy decrease , arrest , reverse abnormalities @ GeneSrc $ metabolism many years clinical symptoms @ DiseaseTgt $ otherwise likely occur .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1693754215936108)\n",
      "- Text: \"novel @ GeneSrc $ mutation exclusively associated cerebral amyloid angiopathy . Mutations @ GeneSrc $ cause deposition @ GeneSrc $ amyloid fibrils brain parenchyma cerebral vessels , resulting @ DiseaseTgt $ ( @ DiseaseTgt $ ) and/or cerebral amyloid angiopathy ( CAA ) . report novel mutation ( L705V ) within @ GeneSrc $ sequence @ GeneSrc $ family autosomal dominant , recurrent intracerebral hemorrhages . Pathological examination disclosed severe CAA , without parenchymal amyloid plaques neurofibrillary tangles . variant highlights vascular tropism mutated @ GeneSrc $ , resulting CAA instead pathological hallmarks @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.405417388174776)\n",
      "- Text: \"Regulation cholesterol sphingomyelin metabolism @ GeneSrc $ presenilin . Amyloid beta peptide ( @ GeneSrc $ ) key role pathological process @ DiseaseTgt $ ( @ DiseaseTgt $ ) , physiological function @ GeneSrc $ @ GeneSrc $ ( APP ) unknown . Recently , shown APP processing sensitive cholesterol lipids . Hydroxymethylglutaryl-CoA reductase ( HMGR ) sphingomyelinases ( SMases ) main enzymes regulate cholesterol biosynthesis sphingomyelin ( SM ) levels , respectively . show control cholesterol SM metabolism involves APP processing . @ GeneSrc $ directly activates neutral SMase downregulates SM levels , whereas Abeta40 reduces cholesterol de novo synthesis inhibition HMGR activity . process strictly depends gamma-secretase activity . line altered @ GeneSrc $ generation , pathological presenilin mutations result increased cholesterol decreased SM levels . results demonstrate biological function APP processing also functional basis link observed lipids @ DiseaseTgt $ ( @ DiseaseTgt $ ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1270953734176655)\n",
      "- Text: \"Towards compendia negative genetic association studies : example @ DiseaseTgt $ . genetic sequence variants contribute variability complex human traits small effects readily detectable population samples typically used genetic association studies . potentially valuable tool gene discovery process meta-analysis accumulated published data , order valid require sample studies representative true genetic effect thus hypothetically include positive abundance negative reports . survey literature association studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) January 2004-April 2005 , identified 138 studies , 86 reported positive findings apolipoprotein E ( APOE ) , strongly indicative publication bias . report analysis 62 genetic markers , tested association @ DiseaseTgt $ risk well possible effects upon quantitative indices @ DiseaseTgt $ severity ( mini-mental state examination scores , age-at-onset , cerebrospinal fluid ( CSF ) beta-amyloid ( @ GeneSrc $ ) CSF tau proteins ) . Within set , modest signals present , exception APOE easily lost corrections multiple hypotheses applied . isolation , results thus broadly negative . Genes studied encompass novel candidates well several recently claimed associated @ DiseaseTgt $ ( e.g . urokinase plasminogen activator ( PLAU ) acetyl-coenzyme acetyltransferase 1 ( ACAT1 ) ) . reporting data hope encourage publication gene compendia guide studies aid future meta-analyses aimed resolving involvement genes complex human traits .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9287542784292008)\n",
      "- Text: \"Apolipoprotein ( apo ) E4 enhances amyloid beta peptide production cultured neuronal cells : apoE structure potential therapeutic target . Apolipoprotein ( apo ) E4 major risk factor @ DiseaseTgt $ , many studies suggested apoE isoform-specific effects deposition clearance @ GeneSrc $ ( @ GeneSrc $ ) peptides . examined effects apoE isoforms processing @ GeneSrc $ ( APP ) Abeta production rat neuroblastoma B103 cells stably transfected human wild-type APP695 ( B103-APP ) . Lipid-poor apoE4 increased Abeta production B103-APP cells greater extent lipid-poor apoE3 ( 60 % vs. 30 % ) due pronounced stimulation APP recycling apoE4 apoE3 . difference Abeta production abolished preincubating cells receptor-associated protein ( 25 nM ) , blocks low-density lipoprotein receptor-related protein ( LRP ) pathway , reducing LRP expression small interference RNA . differences also attenuated replacing Arg-61 threonine apoE4 pretreating apoE4 small molecules , abolish apoE4 intramolecular domain interaction . Thus , apoE4 appears modulate APP processing @ GeneSrc $ production LRP pathway domain interaction . findings provide insights apoE4 associated increased risk @ DiseaseTgt $ may represent potential target drug development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072574761841895)\n",
      "- Text: \"@ GeneSrc $ tau form soluble complexes may promote self aggregation insoluble forms observed @ DiseaseTgt $ . date , reasonable explanation plaques tangles simultaneously accumulate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate Western blotting ELISA stable complex form tau amyloid-beta protein ( @ GeneSrc $ ) . complex enhances tau phosphorylation GSK3beta , phosphorylation promotes dissociation complex . localized sites interaction using peptide membrane arrays . @ GeneSrc $ binds multiple tau peptides , especially exons 7 9 . binding sharply reduced abolished phosphorylation specific serine threonine residues . Conversely , tau binds multiple @ GeneSrc $ peptides mid C-terminal regions @ GeneSrc $ . binding also significantly decreased GSK3beta phosphorylation tau . used surface plasmon resonance determine binding affinity @ GeneSrc $ tau found low nanomolar range almost 1,000-fold higher tau . soluble extracts @ DiseaseTgt $ control brain tissue , detected @ GeneSrc $ bound tau ELISAs . also found double immunostaining @ DiseaseTgt $ brain tissue phosphorylated tau @ GeneSrc $ form separate insoluble complexes within neurons processes . hypothesize @ DiseaseTgt $ , initial step pathogenesis may intracellular binding soluble @ GeneSrc $ soluble nonphosphorylated tau , thus promoting tau phosphorylation @ GeneSrc $ nucleation . Blocking sites @ GeneSrc $ initially binds tau might arrest simultaneous formation plaques tangles @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0101829163922202)\n",
      "- Text: \"Phospholipase D1 corrects impaired betaAPP trafficking neurite outgrowth @ DiseaseTgt $ presenilin-1 mutant neurons . Presenilins ( PS1/PS2 ) regulate proteolysis @ GeneSrc $ ( betaAPP ) affect intracellular trafficking . , demonstrate PS1-interacting protein , phospholipase D1 ( PLD1 ) , affects intracellular trafficking betaAPP . Overexpression PLD1 PS1wt cells promotes generation betaAPP-containing vesicles trans-Golgi network . Conversely , inhibition PLD1 activity 1-butanol decreases betaAPP trafficking wt PS1-deficient cells . subcellular localization PLD1 altered , PLD enzymatic activity reduced cells expressing @ DiseaseTgt $ ( @ DiseaseTgt $ ) PS1 mutations compared PS1wt cells . Overexpression wt , catalytically inactive , PLD1 increases budding betaAPP-containing vesicles trans-Golgi network @ DiseaseTgt $ mutant cells . Surface delivery betaAPP also increased PLD1 cells . impaired neurite outgrowth capacity @ DiseaseTgt $ mutant neurons corrected introducing PLD1 cells . results indicate PLD1 may represent therapeutic target rescuing compromised neuronal function @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1413810862508203)\n",
      "- Text: \"specific amyloid-beta protein assembly brain impairs memory . Memory function often declines age , believed deteriorate initially changes synaptic function rather loss neurons . individuals go develop @ DiseaseTgt $ neurodegeneration . use Tg2576 mice , express human @ GeneSrc $ ( APP ) variant linked @ DiseaseTgt $ , investigate cause memory decline absence neurodegeneration amyloid-beta protein amyloidosis . Young Tg2576 mice ( < 6 months old ) normal memory lack neuropathology , middle-aged mice ( 6 - 14 months old ) develop memory deficits without neuronal loss , old mice ( > 14 months old ) form abundant neuritic plaques containing @ GeneSrc $ ( refs 3 - 6 ) . found memory deficits middle-aged Tg2576 mice caused extracellular accumulation 56-kDa soluble @ GeneSrc $ assembly , term Abeta * 56 ( Abeta star 56 ) . Abeta * 56 purified brains impaired Tg2576 mice disrupts memory administered young rats . propose Abeta * 56 impairs memory independently plaques neuronal loss , may contribute cognitive deficits associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0785074542210355)\n",
      "- Text: \"Founder effect Ala431Glu mutation presenilin 1 gene causing early-onset @ DiseaseTgt $ Mexican families . etiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) complex . date , molecular genetic studies several families affected @ DiseaseTgt $ identified three genes associated highly penetrant early-onset @ DiseaseTgt $ : Presenilin 1 ( PSEN1 ) , Presenilin 2 ( PSEN2 ) @ GeneSrc $ ( APP ) ; one gene ( apolipoprotein E ) associated late-onset @ DiseaseTgt $ . Molecular analysis PSEN1 gene performed direct sequencing genomic DNA . possible founder effect investigated analyzing two highly polymorphic microsatellite markers flanking PSEN1 gene . Twelve unrelated Mexican families early-onset @ DiseaseTgt $ analyzed . Ala431Glu mutation exon 12 PSEN1 found nine ( 75 % ) families , segregated showing autosomal dominant inheritance . families bearing mutation State Jalisco ( located Western Mexico ) , founder effect hypothesized . Microsatellite haplotype analysis suggested common ancestor nine kindreds . conclusion , Ala431Glu mutation prevalent cause early-onset familial @ DiseaseTgt $ families State Jalisco , Mexico . Genetic evidence supports founder mutation descending single common ancestor . findings important implications prompt diagnosis genetic counseling Mexican patients familial @ DiseaseTgt $ Jalisco .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4477587104026362)\n",
      "- Text: \"Reversal @ DiseaseTgt $ pathology behavior human APP transgenic mice mutation Asp664 . deficits characteristic @ DiseaseTgt $ ( @ DiseaseTgt $ ) believed result , least part , neurotoxic effects beta-amyloid peptides , set 39 - 43 amino acid fragments derived proteolytically @ GeneSrc $ ( APP ) . APP also cleaved intracytoplasmically Asp-664 generate second cytotoxic peptide , APP-C31 , whether C-terminal processing APP plays role pathogenesis @ DiseaseTgt $ unknown . Therefore , compared elements @ DiseaseTgt $ phenotype transgenic mice modeling @ DiseaseTgt $ vs. without functional Asp-664 caspase cleavage site . Surprisingly , whereas beta-amyloid production plaque formation unaltered , synaptic loss , astrogliosis , dentate gyral atrophy , increased neuronal precursor proliferation , behavioral abnormalities completely prevented mutation Asp-664 . results suggest Asp-664 plays critical role generation @ DiseaseTgt $ pathophysiological behavioral changes human APP transgenic mice , possibly cleavage site via protein-protein interactions .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9938266100357191)\n",
      "- Text: \"Promoter mutations increase @ GeneSrc $ expression associated @ DiseaseTgt $ . Genetic variations promoter sequences alter gene expression play prominent role increasing susceptibility complex diseases . Also , expression levels APP essentially regulated core promoter 5 ' upstream regulatory region correlate @ GeneSrc $ levels @ DiseaseTgt $ ( @ DiseaseTgt $ ) brains . , systematically sequenced proximal promoter ( -766/+204 ) two functional distal regions ( -2634/-2159 -2096/-1563 ) APP two independent @ DiseaseTgt $ series onset ages < = 70 years ( Belgian sample , n=180 ; Dutch sample , n=111 ) identified eight novel sequence variants . Three mutations ( -118C -- > , -369C -- > G , -534G -- > ) identified patients @ DiseaseTgt $ showed , vitro , nearly twofold neuron-specific increase APP transcriptional activity , similar expected triplication APP syndrome . mutations either abolished ( AP-2 HES-1 ) created ( Oct1 ) transcription-factor binding sites involved development differentiation neuronal systems . Also , two clustered 200-bp region ( -540/-340 ) APP promoter showed highest degree species conservation . present study provides evidence APP-promoter mutations significantly increase APP expression levels associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0056856481542164)\n",
      "- Text: \"PKCepsilon increases endothelin converting enzyme activity reduces amyloid plaque pathology transgenic mice . Deposition plaques containing amyloid beta ( Abeta ) peptides neuropathological hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate neuronal overexpression epsilon isozyme PKC decreases Abeta levels , plaque burden , plaque-associated neuritic dystrophy reactive astrocytosis transgenic mice expressing @ DiseaseTgt $ forms human @ GeneSrc $ ( APP ) . Compared APP singly transgenic mice , APP/PKCepsilon doubly transgenic mice decreased Abeta levels showed evidence altered cleavage APP . Instead , PKCepsilon overexpression selectively increased activity endothelin-converting enzyme , degrades Abeta . activities Abeta-degrading enzymes , insulin degrading enzyme neprilysin , unchanged . results indicate increased neuronal PKCepsilon activity promote Abeta clearance reduce @ DiseaseTgt $ neuropathology increased endothelin-converting enzyme activity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6753817024124981)\n",
      "- Text: \"Mean age-of-onset @ DiseaseTgt $ caused presenilin mutations correlates increased @ GeneSrc $ decreased Abeta40 . varied ways mutations presenilins ( PSEN1 PSEN2 ) affect @ GeneSrc $ ( APP ) processing causing early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) complex yet properly understood . Nonetheless , one useful diagnostic marker increased ratio @ GeneSrc $ Ab40 ( @ GeneSrc $ ) patients ' brain biological fluids well transgenic mice cells . studied Ab APP processing set nine clinical PSEN mutations novel highly reproducible enzyme-linked immunosorbent assay ( ELISA ) -based vitro method also sought correlation brain Ab analyzed image densitometry mass spectrometry . mutations significantly increased @ GeneSrc $ vitro significantly decreasing Ab40 accumulation APP C-terminal fragments , sign decreased PSEN activity . significant increase absolute levels @ GeneSrc $ observed half mutations tested . also showed age-of-onset PSEN1-linked @ DiseaseTgt $ correlated inversely @ GeneSrc $ ( r = -0.89 ; P = 0.001 ) absolute levels @ GeneSrc $ ( r = -0.83 ; P = 0.006 ) , directly Ab40 levels ( r = 0.69 ; P = 0.035 ) . changes also partly correlated brain @ GeneSrc $ Ab40 levels . Together , data suggested Ab40 might protective perhaps sequestering toxic @ GeneSrc $ facilitating clearance . Also , vitro method describe valid tool assaying pathogenic potential clinical PSEN mutations molecular diagnostic setting .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9999977033317708)\n",
      "- Text: \"Age apolipoprotein E * 4 allele effects cerebrospinal fluid beta-amyloid 42 adults normal cognition . BACKGROUND : Decreased cerebrospinal fluid ( CSF ) beta-amyloid 42 ( @ GeneSrc $ ) concentration , beta 40 concentration , biomarker @ DiseaseTgt $ . @ GeneSrc $ concentration decrease CSF likely reflects precipitation @ GeneSrc $ amyloid plaques brain parenchyma . pathogenic plaque deposition begins years clinical expression dementia @ DiseaseTgt $ . Normal aging presence apolipoprotein E ( APOE * 4 ) allele important known risk factors @ DiseaseTgt $ . OBJECTIVE : estimate interactive effects normal aging presence APOE * 4 allele CSF @ GeneSrc $ concentration adults normal cognition across life span . DESIGN : CSF collected morning overnight fast using Sprotte 24-g atraumatic spinal needles . CSF @ GeneSrc $ beta 40 concentrations measured 10th milliliter CSF collected sandwich enzyme-linked immunosorbent assay . APOE genotype determined restriction digest method . Subjects One hundred eighty-four community volunteers normal cognition aged 21 88 years . RESULTS : CSF @ GeneSrc $ , beta 40 , concentration decreased significantly age . sharp decrease CSF @ GeneSrc $ concentration beginning sixth decade subjects APOE * 4 allele . age-associated decrease CSF @ GeneSrc $ concentration significantly substantially greater subjects APOE * 4 allele compared without APOE * 4 allele . CONCLUSION : CSF @ GeneSrc $ findings consistent acceleration APOE * 4 allele pathogenic @ GeneSrc $ brain deposition starting later middle age persons normal cognition .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0050901977981268)\n",
      "- Text: \"Antiamyloidogenic neuroprotective functions cathepsin B : implications @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) may result accumulation amyloid-beta ( Abeta ) peptides brain . cysteine protease cathepsin B ( CatB ) associated amyloid plaques @ DiseaseTgt $ brains suspected increase Abeta production . , demonstrate CatB actually reduces levels Abeta peptides , especially aggregation-prone species Abeta1 - 42 , proteolytic cleavage . Genetic inactivation CatB mice neuronal expression familial @ DiseaseTgt $ human @ GeneSrc $ ( hAPP ) increased relative abundance Abeta1 - 42 , worsening plaque deposition @ DiseaseTgt $ pathologies . Lentivirus-mediated expression CatB aged hAPP mice reduced preexisting amyloid deposits , even thioflavin S-positive plaques . cell-free conditions , CatB effectively cleaved Abeta1 - 42 , generating C-terminally truncated Abeta peptides less amyloidogenic . Thus , CatB likely fulfills antiamyloidogenic neuroprotective functions . Insufficient CatB activity might promote @ DiseaseTgt $ ; increasing CatB activity could counteract neuropathology disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2131910734276959)\n",
      "- Text: \"Exogenous induction cerebral beta-amyloidogenesis governed agent host . Protein aggregation established pathogenic mechanism @ DiseaseTgt $ , little known initiation process vivo . Intracerebral injection dilute , @ GeneSrc $ @ GeneSrc $ brain extracts humans @ DiseaseTgt $ beta-amyloid precursor protein ( APP ) transgenic mice induced cerebral beta-amyloidosis associated pathology APP transgenic mice time- concentration-dependent manner . seeding activity brain extracts reduced abolished @ GeneSrc $ immunodepletion , protein denaturation , Abeta immunization host . phenotype exogenously induced amyloidosis depended host source agent , suggesting existence polymorphic Abeta strains varying biological activities reminiscent prion strains .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0066637287833157)\n",
      "- Text: \"Deficiency neuronal TGF-beta signaling promotes neurodegeneration @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized progressive neurodegeneration cerebral accumulation @ GeneSrc $ ( @ GeneSrc $ ) , unknown makes neurons susceptible degeneration . report TGF-beta type II receptor ( TbetaRII ) mainly expressed neurons , TbetaRII levels reduced human @ DiseaseTgt $ brain correlate pathological hallmarks disease . Reducing neuronal TGF-beta signaling mice resulted age-dependent neurodegeneration promoted Abeta accumulation dendritic loss mouse model @ DiseaseTgt $ . cultured cells , reduced TGF-beta signaling caused neuronal degeneration resulted increased levels secreted Abeta beta-secretase-cleaved soluble amyloid precursor protein . results show reduced neuronal TGF-beta signaling increases age-dependent neurodegeneration @ DiseaseTgt $ vivo . Increasing neuronal TGF-beta signaling may thus reduce neurodegeneration beneficial @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5)\n",
      "- Text: \"Presenilin mutations linked @ DiseaseTgt $ cause imbalance phosphatidylinositol 4,5-bisphosphate metabolism . Phosphatidylinositol 4,5-bisphosphate ( PIP2 ) important cellular effector whose functions include regulation ion channels membrane trafficking . Aberrant PIP2 metabolism also implicated variety human disease states , e.g . , cancer diabetes . report @ DiseaseTgt $ @ DiseaseTgt $ presenilin mutations cause imbalance PIP2 metabolism . find transient receptor potential melastatin 7 ( TRPM7 ) -associated Mg2 + -inhibited cation ( MIC ) channel underlies ion channel dysfunction presenilin @ DiseaseTgt $ mutant cells , observed channel deficits restored addition PIP2 , known regulator MIC/TRPM7 channel . Lipid analyses show PIP2 turnover selectively affected @ DiseaseTgt $ mutant presenilin cells . also find modulation cellular PIP2 closely correlates 42-residue amyloid beta-peptide ( @ GeneSrc $ ) levels . data suggest PIP2 imbalance may contribute @ DiseaseTgt $ pathogenesis affecting multiple cellular pathways , generation toxic @ GeneSrc $ well activity MIC/TRPM7 channel , linked neurodegenerative conditions . Thus , study suggests brain-specific modulation PIP2 may offer therapeutic approach @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.049310263330493)\n",
      "- Text: \"Extreme cerebrospinal fluid @ GeneSrc $ levels identify family late-onset @ DiseaseTgt $ presenilin 1 mutation . OBJECTIVE : Aggregation deposition @ GeneSrc $ ( @ GeneSrc $ ) brain thought central pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Recent studies suggest cerebrospinal fluid ( CSF ) @ GeneSrc $ levels strongly correlated @ DiseaseTgt $ status progression , may meaningful endophenotype @ DiseaseTgt $ . Mutations presenilin 1 ( PSEN1 ) known cause @ DiseaseTgt $ change @ GeneSrc $ levels . study , investigated DNA sequence variation presenilin ( PSEN1 ) gene using CSF @ GeneSrc $ levels endophenotype @ DiseaseTgt $ . METHODS : sequenced exons flanking intronic regions PSEN1 clinically characterized research subjects extreme values CSF @ GeneSrc $ levels . RESULTS : novel approach led directly identification disease-causing mutation family late-onset @ DiseaseTgt $ . INTERPRETATION : finding suggests CSF @ GeneSrc $ may useful endophenotype genetic studies @ DiseaseTgt $ . results also suggest PSEN1 mutations cause @ DiseaseTgt $ large range age onset , spanning early- late-onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9160618255544538)\n",
      "- Text: \"Lipocalin-type prostaglandin synthase/beta-trace major @ GeneSrc $ human cerebrospinal fluid . conformational change @ GeneSrc $ ( @ GeneSrc $ ) peptide monomeric form aggregates crucial pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) . healthy brain , unidentified chaperones appear prevent aggregation @ GeneSrc $ . reported lipocalin-type prostaglandin synthase ( L-PGDS ) /beta-trace , abundant cerebrospinal fluid ( CSF ) protein produced brain , localized amyloid plaques @ DiseaseTgt $ patients @ DiseaseTgt $ Tg2576 mice . Surface plasmon resonance analysis revealed L-PGDS/beta-trace tightly bound @ GeneSrc $ monomers fibrils high affinity ( K ( ) = 18 - 50 nM ) L-PGDS/beta-trace recognized residues 25 - 28 @ GeneSrc $ , key region conformational change beta-sheet structure . results thioflavin fluorescence assay monitor @ GeneSrc $ aggregation disclosed L-PGDS/beta-trace inhibited spontaneous aggregation Abeta ( 1 - 40 ) Abeta ( 1 - 42 ) within physiological range ( 1 - 5 microM ) CSF . L-PGDS/beta-trace also prevented seed-dependent aggregation 50 microM @ GeneSrc $ K ( ) 0.75 microM . Moreover , inhibitory activity toward Abeta ( 1 - 40 ) aggregation human CSF decreased 60 % L-PGDS/beta-trace removed CSF immunoaffinity chromatography . deposition @ GeneSrc $ intraventricular infusion Abeta ( 1 - 42 ) 3.5-fold higher L-PGDS-deficient mice reduced 23 % L-PGDS-overexpressing mice compared wild-type levels . data indicate L-PGDS/beta-trace major endogenous @ GeneSrc $ brain suggest disturbance function may involved onset progression @ DiseaseTgt $ . findings may provide diagnostic therapeutic approach @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0686818513040744)\n",
      "- Text: \"Association presenilin 1 S170F mutation novel @ DiseaseTgt $ molecular phenotype . OBJECTIVE : report ataxic variant @ DiseaseTgt $ expressing novel molecular phenotype . DESIGN : Description novel phenotype associated presenilin 1 mutation . SETTING : subject outpatient diagnosed local referral center . PATIENT : 28-year-old man presented psychiatric symptoms cerebellar signs , followed cognitive dysfunction . Severe beta-amyloid ( @ GeneSrc $ ) deposition accompanied neurofibrillary tangles cell loss cerebral cortex Purkinje cell dendrite loss cerebellum . presenilin 1 gene ( PSEN1 ) S170F mutation detected . MAIN OUTCOME MEASURES : analyzed processing @ GeneSrc $ precursor protein vitro well @ GeneSrc $ species brain tissue . RESULTS : PSEN1 S170F mutation induced 3-fold increase secreted @ GeneSrc $ Abeta ( 40 ) species 60 % increase secreted @ GeneSrc $ precursor protein transfected cells . Soluble insoluble fractions isolated brain tissue showed prevalence N-terminally truncated @ GeneSrc $ species ending residues 40 42 . CONCLUSION : findings define new @ DiseaseTgt $ molecular phenotype support concept phenotypic variability associated PSEN1 mutations may dictated @ GeneSrc $ aggregates ' composition .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.392575694802122)\n",
      "- Text: \"Parkin promotes intracellular Abeta1 - 42 clearance . Alzheimer 's disease @ DiseaseTgt $ common neurodegenerative diseases may share underlying mechanisms pathogenesis . Abeta ( 1 - 42 ) fragments found intracellularly , extracellularly amyloid plaques , Alzheimer 's disease dementia Lewy Bodies . Parkin E3-ubiquitin ligase involved proteasomal degradation intracellular proteins . Mutations parkin , result loss parkin function , lead early onset Parkinsonism . tested whether ubiquitin ligase activity parkin could lead reduction intracellular human Abeta ( 1 - 42 ) . Lentiviral constructs encoding either human parkin human Abeta ( 1 - 42 ) used infect M17 neuroblastoma cells . Parkin expression resulted reduction intracellular human Abeta ( 1 - 42 ) levels protected toxicity M17 cells . Co-injection lentiviral constructs control rat primary motor cortex demonstrated parkin co-expression reduced human Abeta ( 1 - 42 ) levels Abeta ( 1 - 42 ) -induced neuronal degeneration vivo . Parkin increased proteasomal activity , proteasomal inhibition blocked effects parkin reducing Abeta ( 1 - 42 ) levels . Incubation Abeta ( 1 - 42 ) cell lysates ubiquitin , presence parkin , demonstrated generation @ GeneSrc $ complexes . data indicate parkin promotes ubiquitination proteasomal degradation intracellular Abeta ( 1 - 42 ) demonstrate protective effect neurodegenerative diseases @ GeneSrc $ deposits .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Structural disorder monomeric alpha-synuclein persists mammalian cells . Intracellular aggregation human amyloid protein alpha-synuclein causally linked @ DiseaseTgt $ . isolated protein intrinsically disordered , native structure mammalian cells known . use nuclear magnetic resonance ( NMR ) electron paramagnetic resonance ( EPR ) spectroscopy derive atomic-resolution insights structure dynamics alpha-synuclein different mammalian cell types . show disordered nature monomeric alpha-synuclein stably preserved non-neuronal neuronal cells . physiological cell conditions , alpha-synuclein amino-terminally acetylated adopts conformations compact buffer , residues aggregation-prone @ GeneSrc $ component ( NAC ) region shielded exposure cytoplasm , presumably counteracts spontaneous aggregation . results establish different types crowded intracellular environments inherently promote alpha-synuclein oligomerization , generally , intrinsic structural disorder sustainable mammalian cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.951192977344532e-06)\n",
      "- Text: \"alpha-Synuclein aggregates interfere Parkin solubility distribution : role pathogenesis @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) belongs heterogeneous group neurodegenerative disorders movement alterations , cognitive impairment , alpha-synuclein accumulation cortical subcortical regions . Jointly , disorders denominated Lewy body disease . Mutations parkin gene common cause familial parkinsonism , growing number studies shown stress factors associated sporadic @ DiseaseTgt $ promote parkin accumulation insoluble fraction . alpha-Synuclein parkin accumulation mutations genes associated familial @ DiseaseTgt $ . investigate whether alpha-synuclein accumulation might involved pathogenesis disorders interfering parkin solubility , synuclein-transfected neuronal cells transduced lentiviral vectors expressing parkin . Challenging neurons proteasome inhibitors @ GeneSrc $ resulted accumulation insoluble parkin , lesser extent , alpha-tubulin . Similarly neurons brains patients Lewy body disease , co-transduced cells alpha-synuclein parkin colocalized co-immunoprecipitated . effects resulted decreased parkin alpha-tubulin ubiquitination , accumulation insoluble parkin , cytoskeletal alterations reduced neurite outgrowth . Taken together , accumulation alpha-synuclein might contribute pathogenesis @ DiseaseTgt $ Lewy body diseases promoting alterations parkin tubulin solubility , turn might compromise neural function damaging neuronal cytoskeleton . studies provide new perspective potential nature pathogenic alpha-synuclein parkin interactions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5972171634015894)\n",
      "- Text: \"Interfering apoptosis : Ca ( 2+ ) -binding protein ALG-2 @ DiseaseTgt $ gene ALG-3 . Two apoptosis-linked genes , named ALG-2 ALG-3 , identified means functional selection strategy . ALG-2 codes Ca ( 2+ ) -binding protein required cell receptor- , @ GeneSrc $ , glucocorticoid-induced cell death . ALG-3 , partial complementary DNA homologous familial @ DiseaseTgt $ gene STM2 , rescues cell hybridoma cell receptor- @ GeneSrc $ apoptosis . findings suggest ALG-2 may mediate Ca ( 2+ ) -regulated signals along death pathway cell death may play role @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0303458674011488)\n",
      "- Text: \"IkappaB kinase promotes tumorigenesis inhibition forkhead FOXO3a . Nuclear exclusion forkhead transcription factor FOXO3a protein kinase Akt contributes cell survival . investigated pathological relationship phosphoylated-Akt ( Akt-p ) FOXO3a primary @ DiseaseTgt $ . Surprisingly , FOXO3a found excluded nuclei @ DiseaseTgt $ lacking Akt-p , suggesting Akt-independent mechanism regulating FOXO3a localization . provide evidence mechanism showing IkappaB kinase ( IKK ) physically interacts , phosphorylates , inhibits FOXO3a independent Akt causes proteolysis FOXO3a via Ub-dependent proteasome pathway . Cytoplasmic FOXO3a correlates expression @ GeneSrc $ Akt-p many @ DiseaseTgt $ associates poor survival breast cancer . , constitutive expression @ GeneSrc $ promotes cell proliferation tumorigenesis overridden FOXO3a . results suggest negative regulation FOXO factors IKK key mechanism promoting cell growth tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003486308619366)\n",
      "- Text: \"NLRP3 inflammasome activation drives tau pathology . @ DiseaseTgt $ characterized accumulation amyloid-beta plaques , aggregation hyperphosphorylated tau neurofibrillary tangles neuroinflammation , together resulting neurodegeneration cognitive decline1 . NLRP3 inflammasome assembles inside microglia activation , leading increased cleavage activity caspase-1 downstream @ GeneSrc $ release2 . Although NLRP3 inflammasome shown essential development progression amyloid-beta pathology mice3 , precise effect tau pathology remains unknown . show loss NLRP3 inflammasome function reduced tau hyperphosphorylation aggregation regulating tau kinases phosphatases . Tau activated NLRP3 inflammasome intracerebral injection fibrillar amyloid-beta-containing brain homogenates induced tau pathology NLRP3-dependent manner . data identify important role microglia NLRP3 inflammasome activation pathogenesis tauopathies support amyloid-cascade hypothesis @ DiseaseTgt $ , demonstrating neurofibrillary tangles develop downstream amyloid-beta-induced microglial activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0028953880517323)\n",
      "- Text: \"Parkin PINK1 mitigate STING-induced inflammation . Although serum patients @ DiseaseTgt $ contains elevated levels numerous pro-inflammatory cytokines including IL-6 , TNF , @ GeneSrc $ , IFNgamma , whether inflammation contributes consequence neuronal loss remains unknown1 . Mutations parkin , E3 ubiquitin ligase , PINK1 , ubiquitin kinase , cause early onset Parkinson 's disease2,3 . PINK1 parkin function within biochemical pathway remove damaged mitochondria cells culture animal models via mitophagy , selective form autophagy4 . vivo role mitophagy , however , unclear , partly mice lack either PINK1 parkin substantial @ DiseaseTgt $ phenotypes5 - 7 . Mitochondrial stress lead release damage-associated molecular patterns ( DAMPs ) activate innate immunity8 - 12 , suggesting mitophagy may mitigate inflammation . report strong inflammatory phenotype Prkn-/- Pink1-/- mice following exhaustive exercise Prkn-/- ; mutator mice , accumulate mutations mitochondrial DNA ( mtDNA ) 13,14 . Inflammation resulting either exhaustive exercise mtDNA mutation completely rescued concurrent loss STING , central regulator type interferon response cytosolic DNA15,16 . loss dopaminergic neurons substantia nigra pars compacta motor defect observed aged Prkn-/- ; mutator mice also rescued loss STING , suggesting inflammation facilitates phenotype . Humans mono- biallelic PRKN mutations also display elevated cytokines . results support role PINK1- parkin-mediated mitophagy restraining innate immunity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0140458611742262)\n",
      "- Text: \"new recurrent activating length mutation exon 20 FLT3 gene @ DiseaseTgt $ . Activating length mutations juxtamembrane ( JM ) domain FLT3 gene ( FLT3-LM ) mutations catalytic domain ( FLT3D835/836 ) receptor tyrosine kinase represent frequent genetic alterations @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , describe 6-bp insertion activation loop FLT3 codons 840 841 FLT3 ( FLT3 - 840GS ) 2 unrelated patients @ DiseaseTgt $ . Screening activating mutations FLT3 , KIT , NRAS showed genetic alterations patients carrying FLT3 - 840GS . functional analyses could show mutant hyperphosphorylated tyrosine confers @ GeneSrc $ growth Ba/F3 cells , inhibited specific FLT3 protein tyrosine kinase ( PTK ) inhibitor . results show first time addition known mutations JM catalytic domain , activating length mutations exist FLT3 gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0065696616038843)\n",
      "- Text: \"Parkin PINK1 mitigate STING-induced inflammation . Although serum patients @ DiseaseTgt $ contains elevated levels numerous pro-inflammatory cytokines including @ GeneSrc $ , TNF , IL-1beta , IFNgamma , whether inflammation contributes consequence neuronal loss remains unknown1 . Mutations parkin , E3 ubiquitin ligase , PINK1 , ubiquitin kinase , cause early onset Parkinson 's disease2,3 . PINK1 parkin function within biochemical pathway remove damaged mitochondria cells culture animal models via mitophagy , selective form autophagy4 . vivo role mitophagy , however , unclear , partly mice lack either PINK1 parkin substantial @ DiseaseTgt $ phenotypes5 - 7 . Mitochondrial stress lead release damage-associated molecular patterns ( DAMPs ) activate innate immunity8 - 12 , suggesting mitophagy may mitigate inflammation . report strong inflammatory phenotype Prkn-/- Pink1-/- mice following exhaustive exercise Prkn-/- ; mutator mice , accumulate mutations mitochondrial DNA ( mtDNA ) 13,14 . Inflammation resulting either exhaustive exercise mtDNA mutation completely rescued concurrent loss STING , central regulator type interferon response cytosolic DNA15,16 . loss dopaminergic neurons substantia nigra pars compacta motor defect observed aged Prkn-/- ; mutator mice also rescued loss STING , suggesting inflammation facilitates phenotype . Humans mono- biallelic PRKN mutations also display elevated cytokines . results support role PINK1- parkin-mediated mitophagy restraining innate immunity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0118657712445356)\n",
      "- Text: \"Dual positive negative regulation wingless signaling adenomatous polyposis coli . evolutionarily conserved @ GeneSrc $ signal transduction pathway directs cell proliferation , cell fate , cell death development metazoans inappropriately activated several types cancer . majority @ DiseaseTgt $ contain truncating mutations adenomatous polyposis coli ( APC ) tumor suppressor , negative regulator @ GeneSrc $ signaling . , demonstrate Drosophila Apc homologs also activating role physiological ectopic Wingless signaling . Apc amino terminus important activating function , whereas beta-catenin binding sites dispensable . Apc likely promotes Wingless transduction down-regulation Axin , negative regulator Wingless signaling . Given evolutionary conservation APC @ GeneSrc $ signal transduction , activating role may also present vertebrates relevance development cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0019395991124828)\n",
      "- Text: \"@ GeneSrc $ ( INHA ) gene locus changes paediatric @ DiseaseTgt $ TP53 R337H mutation heterozygote carriers . R337H TP53 mutation low-penetrance molecular defect predisposes @ DiseaseTgt $ ( @ DiseaseTgt $ ) formation Brazilian possibly populations . Additional genetic defects may responsible variable expression ACTs cases . @ GeneSrc $ gene ( INHA ) 2q33-qter implicated mouse adrenocortical tumourigenesis . studied 46 pediatric patients ACTs Brazil INHA genetic alterations ; 39 patients heterozygous carriers R337H TP53 mutation . first mapped INHA gene radiation hybrid analysis determined 10 linked microsatellite markers area flanked D2S1371 D2S206 2q33-qter . markers used loss heterozygozity ( LOH ) studies nine paired germline @ DiseaseTgt $ DNA samples . Mapping placed INHA gene close proximity D2S2848 ( SHGC11864 ) log odds ( LOD ) score 5.84 . LOH least one marker region identified 8/9 @ DiseaseTgt $ ( 89 % ) . Six patients heterozygous three INHA mutations : one exon 1 , 127C > G , two exon 2 , 3998G > 4088G > , leading amino acid substitutions ( P43A , G227R , A257 , respectively ) . A257 located conserved INHA region , highly homologous transforming growth factor-beta ; G227R A257 change polarity , , addition , G227R changes pH . conclude sequence alterations detected 2q allelic changes suggest INHA may one contributing factors needed @ DiseaseTgt $ formation pediatric patient carriers R337H TP53 mutation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4918798301259149)\n",
      "- Text: \"Colonic polyposis caused mTOR-mediated chromosomal instability Apc+/Delta716 Cdx2+/- compound mutant mice . mammalian homeobox transcription factor CDX2 key roles intestinal development differentiation . Heterozygous Cdx2 mice develop one two benign hamartomas proximal colon , whereas heterozygous Apc ( Delta716 ) mice develop numerous adenomatous polyps , mostly small intestine . show colonic polyp number six times higher Apc+/Delta716 Cdx2+/- compound mutant mice . Levels APC CDX2 significantly lower distal colon , caused high anaphase bridge index ( ABI ) associated higher frequency loss heterozygosity ( LOH ) Apc . cultured rat intestinal epithelial human @ DiseaseTgt $ cell lines , suppression CDX2 antisense RNA caused marked increases ABI chromosomal aberrations . mediated stimulation mTOR pathway , causing translational deregulation G1-S acceleration , associated low levels p27 activation cyclin @ GeneSrc $ . obtained similar results colonic mucosa Apc+/Delta716 ) Cdx2+/- compound mutant mice . Forced activation mTOR upstream regulator Akt also increased ABI @ DiseaseTgt $ cells . High ABI cell lines suppressed mTOR inhibitors LY294002 rapamycin . results suggest reduced expression CDX2 important colon tumorigenesis mTOR-mediated chromosomal instability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0045939842295369)\n",
      "- Text: \"cladistic model ACE sequence variation implications @ DiseaseTgt $ , Alzheimer disease obesity . Sequence variation ACE , encodes angiotensin converting enzyme , contributes large proportion variability plasma ACE levels , extent impacts upon human disease unresolved . efforts associate ACE heritable traits involved single Alu insertion/deletion polymorphism , despite probable existence functional sequence variants effects may consistently detectable solely typing Alu indel . , utilizing single nucleotide polymorphisms ( SNPs ) differentiate major ACE clades European populations , demonstrate number significant phenotype associations across 4000 Swedish individuals . systematic analysis metabolic phenotypes , effects detected upon several traits , including fasting plasma glucose levels , @ GeneSrc $ levels measures obesity ( P-values ranging 0.046 8.4 x 10 ( -6 ) ) . Extending cladistic models study @ DiseaseTgt $ Alzheimer disease , significant associations observed greater effect sizes typically obtained large-scale meta-analyses based Alu indel . Population frequencies ACE genotypes also found change age , congruent previous data suggesting effects upon longevity . Clade models consistently outperformed based upon single markers , reinforcing importance taking consideration possible confounding effects allelic heterogeneity genomic region . Utilizing computational tools , potential functional variants highlighted may underlie phenotypic variability , discussed along broader implications results may studies attempting link variation ACE human disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.899491519971631e-05)\n",
      "- Text: \"@ DiseaseTgt $ PI3 K activation resistant dietary restriction . Dietary restriction delays incidence decreases growth various types @ DiseaseTgt $ , mechanisms underlying sensitivity @ DiseaseTgt $ food restriction remain unknown . show certain human @ DiseaseTgt $ cell lines , grown @ DiseaseTgt $ xenografts mice , highly sensitive anti-growth effects dietary restriction , whereas others resistant . @ DiseaseTgt $ cells form dietary-restriction-resistant @ DiseaseTgt $ carry mutations cause constitutive activation phosphatidylinositol-3-kinase ( PI3 K ) pathway culture proliferate absence @ GeneSrc $ insulin-like growth factor 1 . Substitution activated mutant allele PI3 K wild-type PI3 K otherwise isogenic @ DiseaseTgt $ cells , restoration PTEN expression PTEN-null @ DiseaseTgt $ cell line , sufficient convert dietary-restriction-resistant @ DiseaseTgt $ one dietary-restriction-sensitive . Dietary restriction affect PTEN-null mouse model prostate cancer , significantly decreases @ DiseaseTgt $ burden mouse model lung cancer lacking constitutive PI3 K signalling . Thus , PI3 K pathway important determinant sensitivity @ DiseaseTgt $ dietary restriction , activating mutations pathway may influence response @ DiseaseTgt $ dietary restriction-mimetic therapies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9074561480470384)\n",
      "- Text: \"TSC2 phosphorylated inhibited Akt suppresses mTOR signalling . Tuberous sclerosis ( TSC ) autosomal dominant disorder characterized formation hamartomas wide range human tissues . Mutation either TSC1 TSC2 @ DiseaseTgt $ suppressor gene responsible familial sporadic forms disease . TSC1 TSC2 proteins form physical functional complex vivo . , show TSC1-TSC2 inhibits p70 ribosomal protein S6 kinase 1 ( activator translation ) activates eukaryotic initiation factor 4E binding protein 1 ( 4E-BP1 , inhibitor translational initiation ) . functions TSC1-TSC2 mediated inhibition mammalian target rapamycin ( mTOR ) . Furthermore , TSC2 directly phosphorylated Akt , involved stimulating cell growth activated growth stimulating signals , @ GeneSrc $ . TSC2 inactivated Akt-dependent phosphorylation , destabilizes TSC2 disrupts interaction TSC1 . data indicate molecular mechanism TSC2 @ GeneSrc $ signalling , @ DiseaseTgt $ suppressor functions inhibition cell growth .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000520471457465)\n",
      "- Text: \"gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 lipogenesis . @ DiseaseTgt $ cells increase lipogenesis proliferation activation sterol regulatory element-binding proteins ( SREBPs ) central role process . SREBPs inhibited complex composed INSIG proteins , SREBP cleavage-activating protein ( SCAP ) sterols endoplasmic reticulum . Regulation interaction INSIG proteins SCAP sterol levels critical dissociation SCAP-SREBP complex endoplasmic reticulum activation SREBPs1,2 . However , whether protein interaction regulated mechanism abundance sterol-and particular , whether oncogenic signalling role-is unclear . show activated AKT human hepatocellular carcinoma ( HCC ) cells phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 ( PCK1 ) , rate-limiting enzyme gluconeogenesis , Ser90 . Phosphorylated PCK1 translocates endoplasmic reticulum , uses GTP phosphate donor phosphorylate @ GeneSrc $ Ser207 INSIG2 Ser151 . phosphorylation reduces binding sterols @ GeneSrc $ INSIG2 disrupts interaction INSIG proteins SCAP , leading translocation SCAP-SREBP complex Golgi apparatus , activation SREBP proteins ( SREBP1 SREBP2 ) transcription downstream lipogenesis-related genes , proliferation @ DiseaseTgt $ cells , tumorigenesis mice . addition , phosphorylation PCK1 Ser90 , @ GeneSrc $ Ser207 INSIG2 Ser151 positively correlated nuclear accumulation SREBP1 samples patients HCC , also associated poor HCC prognosis . findings highlight importance protein kinase activity PCK1 activation SREBPs , lipogenesis development HCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000277409756675)\n",
      "- Text: \"gluconeogenic enzyme PCK1 phosphorylates @ GeneSrc $ lipogenesis . @ DiseaseTgt $ cells increase lipogenesis proliferation activation sterol regulatory element-binding proteins ( SREBPs ) central role process . SREBPs inhibited complex composed INSIG proteins , SREBP cleavage-activating protein ( SCAP ) sterols endoplasmic reticulum . Regulation interaction INSIG proteins SCAP sterol levels critical dissociation SCAP-SREBP complex endoplasmic reticulum activation SREBPs1,2 . However , whether protein interaction regulated mechanism abundance sterol-and particular , whether oncogenic signalling role-is unclear . show activated AKT human hepatocellular carcinoma ( HCC ) cells phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 ( PCK1 ) , rate-limiting enzyme gluconeogenesis , Ser90 . Phosphorylated PCK1 translocates endoplasmic reticulum , uses GTP phosphate donor phosphorylate INSIG1 Ser207 INSIG2 Ser151 . phosphorylation reduces binding sterols INSIG1 INSIG2 disrupts interaction INSIG proteins SCAP , leading translocation SCAP-SREBP complex Golgi apparatus , activation SREBP proteins ( SREBP1 SREBP2 ) transcription downstream lipogenesis-related genes , proliferation @ DiseaseTgt $ cells , tumorigenesis mice . addition , phosphorylation PCK1 Ser90 , INSIG1 Ser207 INSIG2 Ser151 positively correlated nuclear accumulation SREBP1 samples patients HCC , also associated poor HCC prognosis . findings highlight importance protein kinase activity PCK1 activation SREBPs , lipogenesis development HCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.004182989276704e-05)\n",
      "- Text: \"Translation initiator EIF4G1 mutations familial @ DiseaseTgt $ . Genome-wide analysis multi-incident family autosomal-dominant parkinsonism implicated locus chromosomal region 3q26-q28 . Linkage disease segregation explained missense mutation c.3614G > ( p. Arg1205His ) eukaryotic translation initiation factor 4-gamma ( EIF4G1 ) . Subsequent sequence genotype analysis identified EIF4G1 c.1505C > ( p. Ala502Val ) , c.2056G > ( p. Gly686Cys ) , c.3490A > C ( p. Ser1164Arg ) , c.3589C > ( p. Arg1197Trp ) c.3614G > ( p. Arg1205His ) substitutions affected subjects familial parkinsonism idiopathic Lewy body disease control subjects . Despite different countries origin , persons EIF4G1 c.1505C > ( p. Ala502Val ) c.3614G > ( p. Arg1205His ) mutations appear share haplotypes consistent ancestral founders . eIF4G1 p. Ala502Val p. Arg1205His disrupt eIF4E @ GeneSrc $ binding , although wild-type protein , render mutant cells vulnerable reactive oxidative species . EIF4G1 mutations implicate mRNA translation initiation familial parkinsonism highlight convergent pathway monogenic , toxin perhaps virally-induced @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.944708762771011e-05)\n",
      "- Text: \"@ GeneSrc $ PDEdelta sustains spatial organization signalling Ras family proteins . identify role @ GeneSrc $ ( @ GeneSrc $ ) PDEdelta modulating signalling Ras family G proteins sustaining dynamic distribution cellular membranes . show GDI-like pocket PDEdelta binds solubilizes farnesylated Ras proteins , thereby enhancing diffusion cytoplasm . mechanism allows effective trapping depalmitoylated Ras proteins Golgi polycationic Ras proteins plasma membrane counter entropic tendency distribute proteins intracellular membranes . Thus , PDEdelta activity augments K/Hras signalling enriching Ras plasma membrane ; conversely , PDEdelta down-modulation randomizes Ras distributions membranes cell suppresses regulated signalling wild-type Ras also constitutive oncogenic Ras signalling @ DiseaseTgt $ cells . findings link activity PDEdelta determining Ras protein topography Ras-dependent signalling .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6946423409756481)\n",
      "- Text: \"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression . Gain-of-function mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism LRRK2 action known . show LRRK2 interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila e2f1 dp messenger RNAs translationally repressed let-7 miR-184 * , respectively . Pathogenic LRRK2 antagonizes miRNAs , leading overproduction E2F1/DP , previously implicated cell cycle survival control shown critical LRRK2 pathogenesis . Genetic deletion let-7 , antagomir-mediated blockage let-7 miR-184 * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive let-7 toxic effects similar pathogenic LRRK2 . Conversely , increasing level let-7 miR-184 * attenuated pathogenic LRRK2 effects . LRRK2 associated Drosophila @ GeneSrc $ ( @ GeneSrc $ ) human Argonaute-2 ( hAgo2 ) RNA-induced silencing complex ( RISC ) . aged fly brain , @ GeneSrc $ protein level negatively regulated LRRK2 . , pathogenic LRRK2 promoted association phospho-4E-BP1 hAgo2 . results implicate deregulated synthesis E2F1/DP caused miRNA pathway impairment key event LRRK2 pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.89353003879956e-05)\n",
      "- Text: \"Functionally inactivating point mutation tumor-suppressor @ GeneSrc $ gene identified human @ DiseaseTgt $ . Loss heterozygosity ( LOH ) observed human tumors strongly suggests existence ( ) tumor-suppressor gene ( ) concerned locus . series studies revealed LOH long arm chromosome 5 ( 5q ) frequently occurs differentiated @ DiseaseTgt $ . Furthermore , shown @ GeneSrc $ ( @ GeneSrc $ ) locus chromosome 5q31.1 one common minimal regions LOH cancers . IRF-1 transcriptional activator shows tumor-suppressor activity mouse . present study , examined sequence @ GeneSrc $ gene 9 cases histologically differentiated @ DiseaseTgt $ , exhibited LOH @ GeneSrc $ locus . identified mis-sense mutation residual allele one case . mutated form @ GeneSrc $ showed markedly reduced transcriptional activity . addition , overexpression wild-type @ GeneSrc $ induced cell-cycle arrest , whereas activity attenuated mutant @ GeneSrc $ . results suggest loss functional @ GeneSrc $ critical development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4468718874852951)\n",
      "- Text: \"Axis inhibition protein 2 ( AXIN2 ) polymorphisms tooth agenesis . Tooth agenesis common congenital disorder affects almost 20 % world 's population . number different genes shown associated cases tooth agenesis including AXIN2 , @ GeneSrc $ , FGFR1 , MSX1 , PAX9 , TGFA . particular interest AXIN2 , linked two families segregating oligodontia @ DiseaseTgt $ . studied two collections families affected tooth agenesis tested association AXIN2 . Significant association tooth agenesis AXIN2 found ( p=0.02 ) cases least one missing incisor . work supports role AXIN2 human tooth agenesis first time suggests AXIN2 involved sporadic forms common incisor agenesis . Future studies identify specific tooth agenesis sub-phenotypes consequence AXIN2 genetic variations . sub-set cases could increased susceptibility @ DiseaseTgt $ types tumours knowledge would significant clinical implications .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0191701149915012)\n",
      "- Text: \"@ DiseaseTgt $ presenilin 2 interacts DRAL , LIM-domain protein . Using yeast two-hybrid system , screened proteins interacting presenilin 2 ( PS2 ) cloned DRAL . DRAL LIM-only protein containing four LIM domains N-terminal half LIM domain . Previously DRAL cloned co-activator @ GeneSrc $ protein interacting DNA replication regulatory protein , hCDC47 . yeast two-hybrid assay showed DRAL interacted hydrophilic loop region ( amino acids 269 - 298 ) endoproteolytic N-terminal fragment PS2 , PS1 , although region 269 - 298 PS2 corresponding PS1 sequence differ three amino acids . point mutation within region , R275A , T280A , Q282A , R284A , N285A , P287 , I288L , F289A S296A , PS2 abolished binding . suggests DRAL recognizes PS2 structure specifically . vitro interaction confirmed affinity column assay physiological interactions endogenous PS2 DRAL co-immunoprecipitation human lung fibroblast MRC5 cells . Furthermore , PS2-overexpressing HEK293 cells , found increase amount DRAL membrane fraction increase amount DRAL co-immunoprecipitated PS2 . potential role DRAL cellular signaling suggests DRAL functions adaptor protein links PS2 intracellular signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0060482118938494)\n",
      "- Text: \"New mutations ZFPM2/FOG2 gene @ DiseaseTgt $ double outlet right ventricle . Conotruncal defects ( CTDs ) represent 15 - 20 % congenital heart defects . Mutations number genes associated CTD humans animal models . investigated occurrence prevalence GATA4 , NKX2.5 , ZFPM2/FOG2 , GDF1 , @ GeneSrc $ gene mutations large cohort individuals CTD , including @ DiseaseTgt $ without pulmonary atresia ( @ DiseaseTgt $ , 178 patients ) , double outlet right ventricle ( DORV , 13 patients ) , truncus arteriosus ( 11 patients ) . Denaturing high-performance liquid chromatography ( DHPLC ) analysis followed bidirectional sequencing disclosed putative pathogenic mutation GATA4 , @ GeneSrc $ , GDF1 genes . Two novel ( Ile227Val , Met544Ile ) one previously reported ( Glu30Gly ) possibly pathogenic missense variants identified ZFPM2/FOG2 gene 3 sporadic patients 202 ( 1.5 % ) CTD , including 1 178 ( 0.6 % ) @ DiseaseTgt $ 2 13 ( 15.4 % ) DORV . Mutation analysis also detected one known missense change ( Arg25Cys ) NKX2.5 gene two ( 1.1 % ) sporadic patients @ DiseaseTgt $ . sequence alterations found absent 500 population-matched controls . conclusion , present results ( ) indicate confirm mutations GATA4 , GDF1 , @ GeneSrc $ genes major determinants pathogenesis @ DiseaseTgt $ , ( ii ) provide supportive evidence association ZFPM2/FOG2 gene @ DiseaseTgt $ , ( iii ) provide additional examples possible contribution Arg25Cys change NKX2.5 small number @ DiseaseTgt $ cases .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6437057812178797)\n",
      "- Text: \"Notch ligands , Delta1 @ GeneSrc $ , substrates presenilin-dependent `` gamma-secretase `` cleavage . evolutionary conserved Notch signaling pathway involved cell fate specification mediated molecular interactions Notch receptors Notch ligands , Delta , Serrate , Jagged . report , demonstrate like Notch , Delta1 @ GeneSrc $ subject presenilin ( PS ) -dependent , intramembranous `` gamma-secretase `` processing , resulting production soluble intracellular derivatives . Moreover , paralleling observation expression familial @ DiseaseTgt $ mutant PS1 compromises production Notch S3/NICD , show PS-dependent production Delta1 cytoplasmic derivatives also reduced cells expressing mutant PS1 . studies led us conclude similar molecular apparatus responsible intramembranous processing Notch 's ligands . assess potential role cytoplasmic derivative nuclear transcriptional events , expressed Delta1-Gal4VP16 chimera demonstrated marked transcriptional stimulation luciferase-based reporter . findings offer proposal Delta1 @ GeneSrc $ play dual roles activators Notch receptor signaling receptors mediate nuclear signaling events via gamma-secretase-generated cytoplasmic domains .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.269005949271983)\n",
      "- Text: \"Modulation @ GeneSrc $ p53 ovarian cancer cells . constitutive activation @ GeneSrc $ ( @ GeneSrc $ ) mutation p53 @ DiseaseTgt $ suppressor detected human @ DiseaseTgt $ . examined potential regulation @ GeneSrc $ phosphorylation wild-type ( wt ) p53 human ovarian cancer cell lines , Caov-3 MDAH2774 , harbor mutant form p53 @ DiseaseTgt $ suppressor gene high levels phosphorylated @ GeneSrc $ . wt p53 gene re-introduced cells using adenovirus vector . addition wt p53 , mutant p53 22/23 , mutant p53 - 175 , NCV ( negative control virus ) introduced cells control groups . Expression wt p53 , p53 - 175 mutant , diminished @ GeneSrc $ tyrosine phosphorylation MDAH2774 Caov-3 cell lines . Expression wt p53 p53 22/23 mutant cause reduction phosphorylation unrelated protein kinases , ERK1 ERK2 ( ERK1/2 ) . inhibition @ GeneSrc $ tyrosine phosphorylation reversed tyrosine phosphatase inhibitor , sodium orthovanadate . Protein tyrosine phosphatase 1-B levels increased introduction wt p53 may involved dephosphorylation @ GeneSrc $ . findings present possible p53-dependent cellular process modulating @ GeneSrc $ tyrosine phosphorylation ovarian cancer cell lines .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0945848970703317)\n",
      "- Text: \"JAK2 V617F mutation de novo @ DiseaseTgt $ . missense somatic mutation @ GeneSrc $ gene ( JAK2 V617F ) recently reported chronic myeloproliferative disorders , including polycythemia vera , essential thrombocythemia myelofibrosis myeloid metaplasia , strongly suggesting role pathogenesis myeloid disorders . activation @ GeneSrc $ signaling occurred malignancies well , analysed 558 tissues common human cancers , including colon , breast lung carcinomas , 143 @ DiseaseTgt $ polymerase chain reaction -- single strand conformation polymorphism analysis . found three @ GeneSrc $ mutations 113 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( 2.7 % ) , none cancers . mutations consisted two V617F mutations one K607N mutation . None @ DiseaseTgt $ patients JAK2 V617F mutation history previous hematologic disorders . first report @ GeneSrc $ gene mutation @ DiseaseTgt $ , data indicated @ GeneSrc $ gene mutation may contribute development chronic myeloid disorders , also @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7614942809471166)\n",
      "- Text: \"Genomic organization human amyloid beta-protein precursor gene . Amyloid beta-protein ( BP ) deposited @ DiseaseTgt $ brains cleavage product larger precursor ( BPP ) . BPP gene encodes three types mRNA generated alternative splicing , two contain sequence encoding Kunitz-type serine-protease inhibitor ( serpin ) . investigate regulatory mechanisms BPP synthesis gene level , isolated 36 genomic DNA clones covering exons human BPP gene . gene consists 18 exons spans 170 kb . BP encoded 16th 17th exons serpin domain 7th exon . Sequence analysis showed 7th 8th introns lack typical branchpoint splicing . might relate alternative splicing . promoter BPP gene characteristics housekeeping genes contains number possible methylation sites . methylation status promoter analyzed Southern blotting alteration observed among tissues control @ DiseaseTgt $ brains . also tested roles two possible @ GeneSrc $ sites possible heat-shock element found within promoter . Northern blotting showed transcription BPP gene apparently induced 12-O-tetradecanoylphorbol-13-acetate ( phorbol derivative ) HeLa cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.91204183171384e-06)\n",
      "- Text: \"Transcriptional map 170-kb region chromosome 11p15.5 : identification mutational analysis BWR1A gene reveals presence mutations @ DiseaseTgt $ samples . Chromosome region 11p15.5 harbors unidentified genes involved @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome . genetic analysis 170-kb region 11p15.5 loci D11S601 D11S679 resulted identification six transcriptional units . Three genes , hNAP2 , CDKN1C , @ GeneSrc $ , well characterized , whereas three genes novel . three additional genes designated BWR1A , BWR1B , BWR1C . Full-length cDNAs three genes cloned nucleotide sequences determined . work progress , BWR1C cDNA described IPL [ Qian , N. , Franck , D. , O'Keefe , D. , Dao , D. , Zhao , L. , Yuan , L. , Wang , Q. , Keating , M. , Walsh , C. & Tycko , B . ( 1997 ) Hum . Mol . Genet . 6 , 2021 - 2029 ] . cloning mapping genes together fine mapping three known genes indicates transcriptional map region likely complete . region frequently altered @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome , carried mutational analysis @ DiseaseTgt $ cell lines Beckwith-Wiedemann syndrome samples resulted identification genetic alterations BWR1A gene : insertion introduced stop codon breast cancer cell line BT549 point mutation rhabdomyosarcoma cell line TE125-T . results indicate BWR1A may play role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.502512570416246e-05)\n",
      "- Text: \"Towards compendia negative genetic association studies : example @ DiseaseTgt $ . genetic sequence variants contribute variability complex human traits small effects readily detectable population samples typically used genetic association studies . potentially valuable tool gene discovery process meta-analysis accumulated published data , order valid require sample studies representative true genetic effect thus hypothetically include positive abundance negative reports . survey literature association studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) January 2004-April 2005 , identified 138 studies , 86 reported positive findings apolipoprotein E ( APOE ) , strongly indicative publication bias . report analysis 62 genetic markers , tested association @ DiseaseTgt $ risk well possible effects upon quantitative indices @ DiseaseTgt $ severity ( mini-mental state examination scores , age-at-onset , cerebrospinal fluid ( CSF ) beta-amyloid ( Abeta ) CSF tau proteins ) . Within set , modest signals present , exception APOE easily lost corrections multiple hypotheses applied . isolation , results thus broadly negative . Genes studied encompass novel candidates well several recently claimed associated @ DiseaseTgt $ ( e.g . urokinase plasminogen activator ( PLAU ) @ GeneSrc $ ( @ GeneSrc $ ) ) . reporting data hope encourage publication gene compendia guide studies aid future meta-analyses aimed resolving involvement genes complex human traits .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.96001817472372)\n",
      "- Text: \"Phosphorylation regulation Akt/PKB rictor-mTOR complex . Deregulation Akt/protein kinase B ( PKB ) implicated pathogenesis @ DiseaseTgt $ diabetes . Akt/PKB activation requires phosphorylation Thr308 activation loop phosphoinositide-dependent kinase 1 ( PDK1 ) Ser473 within carboxyl-terminal hydrophobic motif unknown kinase . show Drosophila human cells target rapamycin ( TOR ) kinase associated protein rictor necessary Ser473 phosphorylation reduction rictor mammalian TOR ( mTOR ) expression inhibited Akt/PKB effector . rictor-mTOR complex directly phosphorylated Akt/PKB Ser473 vitro facilitated Thr308 phosphorylation @ GeneSrc $ . Rictor-mTOR may serve drug target @ DiseaseTgt $ lost expression PTEN , @ DiseaseTgt $ suppressor opposes Akt/PKB activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004018753415932)\n",
      "- Text: \"Restoration p53 function leads @ DiseaseTgt $ regression vivo . Tumorigenesis multi-step process requires activation oncogenes inactivation @ DiseaseTgt $ suppressor genes . Mouse models human @ DiseaseTgt $ recently demonstrated continuous expression dominantly acting oncogene ( example , Hras , Kras Myc ) often required @ DiseaseTgt $ maintenance ; phenotype referred oncogene addiction . concept received clinical validation development active anticancer drugs specifically inhibit function oncoproteins BCR-ABL , @ GeneSrc $ EGFR . Identifying additional gene mutations required @ DiseaseTgt $ maintenance may therefore yield clinically useful targets new @ DiseaseTgt $ therapies . Although loss p53 function common feature human @ DiseaseTgt $ , known whether sustained inactivation @ DiseaseTgt $ suppressor pathways required @ DiseaseTgt $ maintenance . explore issue , developed Cre-loxP-based strategy temporally control @ DiseaseTgt $ suppressor gene expression vivo . show restoring endogenous p53 expression leads regression autochthonous lymphomas sarcomas mice without affecting normal tissues . mechanism responsible @ DiseaseTgt $ regression dependent @ DiseaseTgt $ type , main consequence p53 restoration apoptosis lymphomas suppression cell growth features cellular senescence sarcomas . results support efforts treat human @ DiseaseTgt $ way pharmacological reactivation p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9865512990402768)\n",
      "- Text: \"Activating mutation D835 within activation loop FLT3 human hematologic malignancies . Mutations receptor tyrosine kinases implicated constitutive activation development human malignancy . internal tandem duplication ( ITD ) juxtamembrane ( JM ) domain-coding sequence FLT3 gene ( FLT3/ITD ) found 20 % patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) strongly associated leukocytosis poor prognosis . hand , mutations @ GeneSrc $ gene , found mast cell leukemia @ DiseaseTgt $ , clustered 2 distinct regions , JM domain D816 within activation loop . study designed analyze mutation D835 FLT3 , corresponds D816 @ GeneSrc $ , large series human hematologic malignancies . Several kinds missense mutations found 30 429 ( 7.0 % ) @ DiseaseTgt $ cases , 1 29 ( 3.4 % ) myelodysplastic syndrome ( MDS ) cases , 1 36 ( 2.8 % ) acute lymphocytic leukemia patients . D835Y mutation frequently found ( 22 32 D835 mutations ) , followed D835V ( 5 ) , D835H ( 1 ) , D835E ( 1 ) , D835N ( 1 ) mutations . note D835 mutations occurred independently FLT3/ITD . analysis 201 patients newly diagnosed @ DiseaseTgt $ ( excluding M3 ) revealed , contrast FLT3/ITD mutation ( n = 46 ) , D835 mutations ( n = 8 ) significantly related leukocytosis , tended worsen disease-free survival . D835-mutant FLT3 constitutively tyrosine-phosphorylated transformed 32D cells , suggesting mutations constitutively active . results demonstrate FLT3 gene target frequently mutated become constitutively active @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4177965123621081)\n",
      "- Text: \"new recurrent activating length mutation exon 20 FLT3 gene @ DiseaseTgt $ . Activating length mutations juxtamembrane ( JM ) domain FLT3 gene ( FLT3-LM ) mutations catalytic domain ( FLT3D835/836 ) receptor tyrosine kinase represent frequent genetic alterations @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , describe 6-bp insertion activation loop FLT3 codons 840 841 FLT3 ( FLT3 - 840GS ) 2 unrelated patients @ DiseaseTgt $ . Screening activating mutations FLT3 , @ GeneSrc $ , NRAS showed genetic alterations patients carrying FLT3 - 840GS . functional analyses could show mutant hyperphosphorylated tyrosine confers interleukin 3-independent growth Ba/F3 cells , inhibited specific FLT3 protein tyrosine kinase ( PTK ) inhibitor . results show first time addition known mutations JM catalytic domain , activating length mutations exist FLT3 gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0166714308994528)\n",
      "- Text: \"Deletion polymorphism gene angiotensin-converting enzyme potent risk factor @ DiseaseTgt $ . Factors involved pathogenesis atherosclerosis , thrombosis vasoconstriction contribute development coronary heart disease . study comparing patients @ DiseaseTgt $ controls , explored possible association coronary heart disease variation found gene encoding angiotensin-converting enzyme ( ACE ) . polymorphism ACE/ID strongly associated level circulating enzyme . enzyme plays key role production angiotensin II catabolism @ GeneSrc $ , two peptides involved modulation vascular tone proliferation smooth muscle cells . report DD genotype , associated higher levels circulating ACE ID II genotypes , significantly frequent patients @ DiseaseTgt $ ( n = 610 ) controls ( n = 733 ) ( P = 0.007 ) , especially among subjects low body-mass index low plasma levels ApoB ( P < 0.0001 ) . ACE/ID polymorphism seems potent risk factor coronary heart disease subjects formerly considered low risk according common criteria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0090365141396593)\n",
      "- Text: \"p53 regulation ammonia metabolism urea cycle controls polyamine biosynthesis . @ DiseaseTgt $ cells exhibit altered usually increased metabolic processes meet high biogenetic demands1,2 . conditions , ammonia concomitantly produced increased metabolic processing . However , unclear @ DiseaseTgt $ cells dispose excess ammonia outcomes might caused accumulation ammonia . report @ DiseaseTgt $ suppressor p53 , frequently mutated gene human @ DiseaseTgt $ , regulates ammonia metabolism repressing urea cycle . transcriptional downregulation CPS1 , OTC @ GeneSrc $ , p53 suppresses ureagenesis elimination ammonia vitro vivo , leading inhibition @ DiseaseTgt $ growth . Conversely , downregulation genes reciprocally activates p53 MDM2-mediated mechanism ( ) . Furthermore , accumulation ammonia causes significant decline mRNA translation polyamine biosynthetic rate-limiting enzyme ODC , thereby inhibiting biosynthesis polyamine cell proliferation . Together , findings link p53 ureagenesis ammonia metabolism , reveal role ammonia controlling polyamine biosynthesis cell proliferation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0429813110601265)\n",
      "- Text: \"Regional chromosomal localization N-ras , K-ras-1 , K-ras-2 myb oncogenes human cells . identification transforming genes human @ DiseaseTgt $ cells made possible DNA mediated gene transfer techniques . date , possible show transforming genes activated cellular analogues ras oncogene family . better understand relationship oncogenes human genes , determined chromosomal localization analyzing human rodent somatic cell hybrids molecularly cloned human proto-oncogene probes . possible assign N-ras chromosome 1 regionally localize @ GeneSrc $ c-K-ras-2 human chromosomes 6pter-q13 12q , respectively . results along previous studies demonstrate highly dispersed nature ras genes human genome . Previous reports indicated c-myb gene also resides chromosome 6 . possible sublocalize c-myb long arm chromosome 6 ( q15-q21 ) . non-random aberrations chromosomes 1 , 6 12 occur certain human @ DiseaseTgt $ suggest possible etiologic involvement ras and/or myb oncogenes @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5672806184752233)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human @ DiseaseTgt $ . profiled mutation status PIK3Ca gene National @ DiseaseTgt $ Institute ( NCI ) -60 panel human @ DiseaseTgt $ cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version @ GeneSrc $ gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention @ DiseaseTgt $ harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009306541858772)\n",
      "- Text: \"human carcinomas exocrine pancreas contain mutant @ GeneSrc $ genes . Using vitro gene amplification polymerase chain reaction ( PCR ) mutation detection RNAase mismatch cleavage method , examined @ GeneSrc $ genes human pancreatic carcinomas . used frozen @ DiseaseTgt $ specimens single 5 micron sections formalin-fixed , paraffin-embedded @ DiseaseTgt $ tissue surgically removed obtained autopsy . Twenty-one 22 carcinomas exocrine pancreas contained @ GeneSrc $ genes mutations codon 12 . seven cases tested , mutation present primary @ DiseaseTgt $ corresponding metastases . mutations detected normal tissue @ DiseaseTgt $ patients five gall bladder carcinomas . conclude results @ GeneSrc $ somatic mutational activation critical event oncogenesis , , human cancers exocrine pancreas .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9426664954390044)\n",
      "- Text: \"Cigarette smoking strongly associated mutation @ GeneSrc $ gene patients primary adenocarcinoma lung . BACKGROUND : majority lung carcinoma cases occur current former smokers . @ GeneSrc $ gene mutations common lung adenocarcinoma associated cigarette smoking , asbestos exposure , female gender . METHODS : current study , authors examined contribution cigarette smoking @ GeneSrc $ gene mutations patients primary lung adenocarcinoma . Smoking histories obtained 106 prospectively enrolled patients primary adenocarcinoma lung . RESULTS : @ GeneSrc $ mutations detected primary @ DiseaseTgt $ using allele-specific ligation assay . Ninety-two 106 patients ( 87 % ) lung adenocarcinoma smokers . Nonsmokers @ DiseaseTgt $ likely women ( 11 14 ; 79 % ) , whereas majority smokers ( 57 % ) men . @ GeneSrc $ mutations detected 40 106 @ DiseaseTgt $ ( 38 % ) significantly common smokers compared nonsmokers ( 43 % vs. 0 % ; P = 0.001 ) . CONCLUSIONS : results current study confirm extend previous observations smokers adenocarcinoma lung likely @ GeneSrc $ mutant @ DiseaseTgt $ compared nonsmokers . strong link cigarette smoking @ GeneSrc $ mutations adenocarcinoma lung supports role specific tobacco carcinogens etiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0837076261689477)\n",
      "- Text: \"@ GeneSrc $ directly regulates hexokinase 1 . frequently mutated oncogene @ DiseaseTgt $ @ GeneSrc $ , uses alternative fourth exons generate two gene products ( @ GeneSrc $ @ GeneSrc $ ) differ C-terminal membrane-targeting region1 . oncogenic mutations occur exons 2 3 , two constitutively active @ GeneSrc $ proteins-each capable transforming cells-are encoded @ GeneSrc $ activated mutation2 . functional distinctions among splice variants far established . Oncogenic @ GeneSrc $ alters metabolism @ DiseaseTgt $ cells3 several ways , including increased glucose uptake glycolysis even presence abundant oxygen4 ( Warburg effect ) . Whereas metabolic effects oncogenic @ GeneSrc $ explained transcriptional upregulation glucose transporters glycolytic enzymes3 - 5 , known whether direct regulation metabolic enzymes . report direct , GTP-dependent interaction @ GeneSrc $ hexokinase 1 ( HK1 ) alters activity kinase , thereby establish HK1 effector @ GeneSrc $ interaction unique @ GeneSrc $ palmitoylation-depalmitoylation cycle RAS isoform enables colocalization HK1 outer mitochondrial membrane . expression @ GeneSrc $ @ DiseaseTgt $ may drive unique metabolic vulnerabilities exploited therapeutically .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9466169223400204)\n",
      "- Text: \"Biochemical characterization novel @ GeneSrc $ insertion mutation human leukemia . novel alteration exon 1 @ GeneSrc $ detected single strand conformational polymorphism analysis DNA amplified bone marrow 4-year-old child myeloid leukemia . Sequencing mutant allele revealed insertion three nucleotides codons 10 11 resulting in-frame insertion glycine . Expression mutant protein NIH 3T3 cells caused cellular transformation , expression COS cells activated Ras-mitogen-activated protein kinase signaling pathway . Surprisingly , Ras . GTP levels measured COS cells established novel mutant accumulates 90 % GTP state , considerably higher residue 12 mutant . Biochemical analysis confirmed higher Ras . GTP levels correspond dramatic decrease intrinsic GTP hydrolysis well resistance GTPase-activating proteins . mutation first dominant Ras mutation found human @ DiseaseTgt $ involve residues 12 , 13 , 61 , biochemical properties help elucidate mechanism oncogenic activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0011961369215366)\n",
      "- Text: \"@ GeneSrc $ mutations patients early colorectal cancers . BACKGROUND : Published data contradictory importance @ GeneSrc $ mutations advanced @ DiseaseTgt $ available early @ DiseaseTgt $ . AIMS : establish whether specific @ GeneSrc $ mutations prognostic markers early stage colorectal adenocarcinoma . METHODS : presence @ GeneSrc $ exon 1 mutations correlated @ DiseaseTgt $ recurrence two groups patients : group 1 consecutive series patients resected colorectal adenocarcinoma low risk recurrence ; group 2 patients referred chemotherapy relapse previously resected early stage @ DiseaseTgt $ . @ GeneSrc $ mutations detected direct sequencing whole tissue samples patients , leading edge centre @ DiseaseTgt $ also microdissected individually sequenced . RESULTS : Mutations present 26 ( 26.5 % ) 98 patients group 1 ; 14 patients developed recurrence , four ( 28.5 % ) @ GeneSrc $ mutation . Seventy nine patients developed @ DiseaseTgt $ recurrence , 22 ( 28 % ) mutation ( p = 0.84 ) . @ GeneSrc $ mutations present five 14 patients group 2 . Microdissection increase number mutations detected . CONCLUSIONS : Individual @ GeneSrc $ genotypes distributed homogeneously throughout early stage colorectal adenocarcinomas , detection mutation apparent prognostic value .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1752720124966481)\n",
      "- Text: \"PKC regulates farnesyl-electrostatic switch @ GeneSrc $ promotes association Bcl-XL mitochondria induces apoptosis . @ GeneSrc $ associates plasma membrane ( PM ) farnesylation functions conjunction adjacent polybasic sequence . show phosphorylation protein kinase C ( PKC ) S181 within polybasic region promotes rapid dissociation @ GeneSrc $ PM association intracellular membranes , including outer membrane mitochondria @ GeneSrc $ interacts Bcl-XL . PKC agonists promote apoptosis cells transformed oncogenic @ GeneSrc $ S181-dependent manner . @ GeneSrc $ phosphomimetic residue position 181 induces apoptosis via pathway requires Bcl-XL . PKC agonist bryostatin-1 inhibited growth vitro vivo cells transformed oncogenic @ GeneSrc $ S181-dependent fashion . data demonstrate location function @ GeneSrc $ regulated directly PKC suggest approach therapy @ GeneSrc $ @ DiseaseTgt $ agents stimulate phosphorylation S181 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4054237031859478)\n",
      "- Text: \"evidence genetic heterogeneity Costello syndrome : involvement @ GeneSrc $ gene . Costello syndrome autosomal dominant disorder comprising growth deficiency , mental retardation , curly hair , coarse facial features , nasal papillomata , low-set ears large lobes , cardiac anomalies , redundant skin palms soles prominent creases , dark skin , propensity certain solid @ DiseaseTgt $ . HRAS mutations implicated approximately 85 % affected cases . clinical overlap among Costello , Noonan , cardiofaciocutaneous syndromes better understood given common molecular background , syndromes constitute class disorders caused deregulated RAS-MAPK signaling . report novel @ GeneSrc $ gene mutation patient presenting clinical features typical Costello syndrome additional findings seen Noonan syndrome . description emphasizes subset patients Costello syndrome could harbor mutations genes involved RAS-MAPK signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0016938460880278)\n",
      "- Text: \"Systematic RNA interference reveals oncogenic @ GeneSrc $ @ DiseaseTgt $ require TBK1 . proto-oncogene @ GeneSrc $ mutated wide array human @ DiseaseTgt $ , aggressive respond poorly standard therapies . Although identification specific oncogenes led development clinically effective , molecularly targeted therapies cases , @ GeneSrc $ remained refractory approach . complementary strategy targeting @ GeneSrc $ identify gene products , inhibited , result cell death presence oncogenic allele . used systematic RNA interference detect synthetic lethal partners oncogenic @ GeneSrc $ found non-canonical IkappaB kinase TBK1 selectively essential cells contain mutant @ GeneSrc $ . Suppression TBK1 induced apoptosis specifically human cancer cell lines depend oncogenic @ GeneSrc $ expression . cells , TBK1 activated NF-kappaB anti-apoptotic signals involving c-Rel BCL-XL ( also known BCL2L1 ) essential survival , providing mechanistic insights synthetic lethal interaction . observations indicate TBK1 NF-kappaB signalling essential @ GeneSrc $ mutant @ DiseaseTgt $ , establish general approach rational identification co-dependent pathways @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5071154130283182)\n",
      "- Text: \"Mutations @ GeneSrc $ oncogene progressive stages human colon carcinoma . series colon carcinomas , adenomas , adjacent tissues analyzed ploidy alterations mutations @ GeneSrc $ . increase sensitivity identifying mutations , used histological enrichment , cell sorting , DNA amplification polymerase-catalyzed chain reaction followed direct DNA sequence analysis . 40 @ DiseaseTgt $ analyzed , 27 contained aneuploid cells 26 contained mutations first position codon 12 @ GeneSrc $ . 12 adenomas studied , 4 contained aneuploid cells 9 contained mutation codon 12 . adenomas carcinomas , mutations identified diploid aneuploid cells . cases , regions histologically benign mucosa adjacent @ DiseaseTgt $ contained mutations . combined results suggest mutations @ GeneSrc $ occur early development human colon carcinoma , change ploidy , mutations exist diploid cells aneuploid subpopulation arises . Furthermore , mutations may exist histologically normal mucosa regions adjacent @ DiseaseTgt $ , suggesting field genetically abnormal mucosa may surround @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7821647078650837)\n",
      "- Text: \"Mosaicism oncogenic G12D @ GeneSrc $ mutation associated epidermal nevus , polycystic kidneys rhabdomyosarcoma . BACKGROUND : Epidermal nevus ( EN ) congenital disorder characterised hyperpigmented epidermal thickening following Blaschko 's line . due somatic mutations either FGFR3 PIK3CA half cases , remains unknown genetic origin half . EN also seen part complex developmental disorders association bladder carcinomas , also related FGFR3 PIK3CA mutations . Mosaic mutations genes occasionally found syndromic EN . CASE REPORT : co-occurrence EN , rhabdomyosarcoma , polycystic kidneys growth retardation infant described . RESULTS : oncogenic G12D @ GeneSrc $ mutation detected epidermal component EN rhabdomyosarcoma dermal component EN lesion unaffected tissues , including normal skin blood . CONCLUSION : report shows first time @ GeneSrc $ mutation epiderma causes EN . Observation G12D @ GeneSrc $ mutation two distinct regions body strongly suggests somatic mosaicism . Finally , report highlights potentially underestimated importance mosaic oncogene mutations childhood @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0030691445888213)\n",
      "- Text: \"Diverging gain-of-function mechanisms two novel @ GeneSrc $ mutations associated Noonan cardio-facio-cutaneous syndromes . Activating somatic germline mutations closely related RAS genes ( H , K , N ) found various types @ DiseaseTgt $ patients developmental disorders , respectively . involvement RAS signalling pathways developmental disorders recently emerged one important drivers RAS research . present study , investigated biochemical cell biological properties two novel missense @ GeneSrc $ mutations ( Y71H K147E ) . mutations affect residues highly conserved within RAS family . @ GeneSrc $ ) showed clear differences @ GeneSrc $ ) , except increased binding affinity major effector , RAF1 kinase . Consistent finding , even though detected similar levels active @ GeneSrc $ ) compared wild-type protein , observed increased activation MEK1/2 , irrespective stimulation conditions . contrast , @ GeneSrc $ ) exhibited tremendous increase nucleotide dissociation generating self-activating RAS protein act independently upstream signals . consequence , levels active @ GeneSrc $ ) strongly increased regardless serum stimulation similar oncogenic @ GeneSrc $ ) . spite , @ GeneSrc $ ) downstream signalling reach level triggered oncogenic @ GeneSrc $ ) , especially @ GeneSrc $ ) downregulated RASGAP moreover exhibited 2-fold lower affinity RAF kinase . , findings clearly emphasize individual RAS mutations , despite associated comparable phenotypes developmental disorders patients , cause remarkably diverse biochemical effects common outcome , namely rather moderate gain-of-function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001857088769799)\n",
      "- Text: \"clinical @ GeneSrc $ ) inhibitor AMG 510 drives @ DiseaseTgt $ immunity . @ GeneSrc $ frequently mutated oncogene @ DiseaseTgt $ encodes key signalling protein tumours1,2 . @ GeneSrc $ ) mutant cysteine residue exploited design covalent inhibitors promising preclinical activity3 - 5 . optimized series inhibitors , using novel binding interactions markedly enhance potency selectivity . efforts led discovery AMG 510 , , knowledge , first @ GeneSrc $ ) inhibitor clinical development . preclinical analyses , treatment AMG 510 led regression KRASG12C @ DiseaseTgt $ improved @ DiseaseTgt $ efficacy chemotherapy targeted agents . immune-competent mice , treatment AMG 510 resulted pro-inflammatory @ DiseaseTgt $ microenvironment produced durable cures alone well combination immune-checkpoint inhibitors . Cured mice rejected growth isogenic KRASG12D @ DiseaseTgt $ , suggests adaptive immunity shared antigens . Furthermore , clinical trials , AMG 510 demonstrated @ DiseaseTgt $ activity first dosing cohorts represents potentially transformative therapy patients effective treatments lacking .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7398668923443881)\n",
      "- Text: \"Detection rare point mutation @ GeneSrc $ human bladder cancer xenograft polymerase chain reaction direct sequencing . paper represents first report codon 59 mutation @ GeneSrc $ spontaneous human transitional cell carcinoma bladder . Point mutations potential activate ras genes occur critical coding regions . include sequences codons 12 , 13 , 59 , 61 63 . Mutations codons 12 , 13 61 reported wide variety human @ DiseaseTgt $ , including transitional cell carcinoma bladder . However mutations codon 59 reported retroviral @ GeneSrc $ result vitro mutagenesis experiments . used polymerase chain reaction direct sequencing detect mutations @ GeneSrc $ , allele-specific restriction analysis detect mutations N-ras xenografts continuous cell lines established bladder cancer biopsies ten different patients well direct biopsy specimens five human bladder tumours . studies @ GeneSrc $ , 139 bp fragment spanned critical codons 12 13 128 bp fragment spanned sequences codon 59 , 61 63 enzymatically amplified sequenced . N-ras mutations detected . heterozygous mutation @ GeneSrc $ codon 59 GCA -- -- G/ACA detected one line . mutation expressed appears stable detected several xenograft passages present paraffin-embedded tissue primary @ DiseaseTgt $ patient . biological significance mutation bladder cancer currently study .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013998188223903)\n",
      "- Text: \"molecular evolution acquired resistance targeted EGFR blockade colorectal cancers . Colorectal tumours wild type @ GeneSrc $ often sensitive EGFR blockade , almost always develop resistance within several months initiating therapy . mechanisms underlying acquired resistance anti-EGFR antibodies largely unknown . situation marked contrast small-molecule targeted agents , inhibitors ABL , EGFR , BRAF MEK , mutations genes encoding protein targets render @ DiseaseTgt $ resistant effects drugs . simplest hypothesis account development resistance EGFR blockade rare cells @ GeneSrc $ mutations pre-exist low levels @ DiseaseTgt $ ostensibly wild-type @ GeneSrc $ genes . Although hypothesis would seem readily testable , evidence pre-clinical models support , data patients . test hypothesis , determined whether mutant @ GeneSrc $ DNA could detected circulation 28 patients receiving monotherapy panitumumab , therapeutic anti-EGFR antibody . found 9 24 ( 38 % ) patients whose @ DiseaseTgt $ initially @ GeneSrc $ wild type developed detectable mutations @ GeneSrc $ sera , three developed multiple different @ GeneSrc $ mutations . appearance mutations consistent , generally occurring 5 6 months following treatment . Mathematical modelling indicated mutations present expanded subclones initiation panitumumab treatment . results suggest emergence @ GeneSrc $ mutations mediator acquired resistance EGFR blockade mutations detected non-invasive manner . explain @ DiseaseTgt $ develop resistance targeted therapies highly reproducible fashion .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9768399757035352)\n",
      "- Text: \"@ GeneSrc $ oncogene activation adenocarcinoma human pancreas . study 82 @ DiseaseTgt $ using combination mutant-enriched polymerase chain reaction analysis allele-specific oligonucleotide hybridization . examined 82 surgically resected biopsied , formalin-fixed , paraffin-embedded primary adenocarcinomas pancreas presence activating point mutations codon 12 @ GeneSrc $ oncogene . Mutations detected using primer-mediated , mutant-enriched , polymerase chain reaction-restriction fragment length polymorphism analysis characterized allele-specific oligonucleotide hybridization . combination mutant-enriched polymerase chain reaction-restriction fragment length polymorphism analysis allele-specific oligonucleotide hybridization results rapid sensitive characterization mutations codon 12 @ GeneSrc $ . Sixty-eight ( 83 % ) 82 @ DiseaseTgt $ examined harbored point mutation . 68 mutations , 33 ( 49 % ) guanine adenine transitions , 27 ( 39 % ) guanine thymine transversions , eight ( 12 % ) guanine cytosine transversions . Mutations found carcinomas head ( 61 75 , 81 % ) well carcinomas body tail ( seven seven , 100 % ) pancreas . overall prevalence @ GeneSrc $ point mutations adenocarcinomas pancreas obtained patients smoked cigarettes point lives ( 88 % ; 86 % current smokers 89 % ex-smokers ) greater seen pancreatic adenocarcinomas patients never smoked cigarettes ( 68 % , P = 0.046 ) . presence @ GeneSrc $ point mutations correlate @ DiseaseTgt $ ploidy , @ DiseaseTgt $ proliferating index , patient survival . results demonstrate primer-mediated , mutant-enriched polymerase chain reaction-restriction fragment length polymorphism analysis combined allele-specific oligonucleotide hybridization used detect characterize mutations codon 12 @ GeneSrc $ oncogene formalin-fixed , paraffin-embedded tissues , results confirm activating point mutations codon 12 @ GeneSrc $ oncogene occur frequently adenocarcinomas pancreas .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0277256790934469)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation @ DiseaseTgt $ progression colon . Kras commonly mutated colon cancers , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant @ GeneSrc $ hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.877440962470228e-06)\n",
      "- Text: \"Somatic activation K-ras oncogene causes early onset lung cancer mice . 30 % human @ DiseaseTgt $ carry ras gene mutations . three genes family ( composed @ GeneSrc $ , N-ras H-ras ) , @ GeneSrc $ frequently mutated member human @ DiseaseTgt $ , including adenocarcinomas pancreas ( approximately 70 - 90 % incidence ) , colon ( approximately 50 % ) lung ( approximately 25 - 50 % ) . construct mouse @ DiseaseTgt $ models involving K-ras , used new gene targeting procedure create mouse strains carrying oncogenic alleles K-ras activated spontaneous recombination event whole animal . show mice carrying mutations highly predisposed range @ DiseaseTgt $ types , predominantly early onset lung cancer . model characterized examining effects germline mutations @ DiseaseTgt $ suppressor gene p53 , known mutated along @ GeneSrc $ human @ DiseaseTgt $ . approach several advantages traditional transgenic strategies , including closely recapitulates spontaneous oncogene activation seen human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.508253976547367)\n",
      "- Text: \"Mutational analysis BRAF @ GeneSrc $ gastric cancers : absence BRAF mutations gastric cancers . Recently , BRAF mutations found variety human @ DiseaseTgt $ . Interestingly , common BRAF mutation ( V599E ) identified @ DiseaseTgt $ @ GeneSrc $ mutations . Whereas majority human @ DiseaseTgt $ types screened BRAF mutations , detailed studies gastric cancers investigated . Thus , decided investigate incidence BRAF mutations gastric cancers , relationship BRAF @ GeneSrc $ mutations @ DiseaseTgt $ . Three non-pathogenic BRAF polymorphisms seven @ GeneSrc $ missense mutations found 66 gastric cancers 16 gastric cancer cell lines . Although 9 % gastric cancer panels @ GeneSrc $ mutations , incidence BRAF mutations high . Thus , BRAF mutations , present variety human @ DiseaseTgt $ , seem involved gastric cancer development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1838749307240136)\n",
      "- Text: \"Mutations Kirsten-ras proto-oncogene human preleukaemia . myelodysplastic syndrome ( MDS ) preleukaemia haematological disorder characterized low blood counts , bone marrow cells abnormal appearance progression acute leukaemia many 30 % patients . distinctive preleukaemic leukaemic phases disease make attractive model neoplastic progression human @ DiseaseTgt $ . reasoned , dominantly transforming genes ( mutant alleles ras proto-oncogenes ) found frequently acute leukaemia , search genetic lesions clinical course patients MDS might give us insight function oncogenes leukaemogenesis . report bone marrow cells two four patients preleukaemia , one patient progressed acute leukaemia MDS , contained transforming allele @ GeneSrc $ proto-oncogene . one preleukaemic patient , novel mutation codon 13 ras gene detected bone marrow cells harvested 1.5 years acute leukaemia developed . findings provide evidence ras mutations may involved early stages human leukaemia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.2285092685398336e-05)\n",
      "- Text: \"Characterization human colon/lung carcinoma oncogene . DNA sequences capable inducing oncogenic transformation NIH3T3 mouse cells found number human @ DiseaseTgt $ cell lines . DNAs cell lines applied monolayer cultures mouse fibroblasts , foci transformed cells observed 2 - 3 weeks later . DNA cells primary foci used turn induce foci second cycle gene transfer . human DNA sequences responsible transformation called oncogenes , best characterized closely related Harvey murine sarcoma virus oncogene . present characterization oncogene found originally present DNA SW480 colon carcinoma cell line . indicate structural outlines demonstrate , extension reported results , presence activated form genome several types human @ DiseaseTgt $ cell lines well biopsy tissue adenocarcinoma large bowel . identify @ DiseaseTgt $ oncogene @ GeneSrc $ , one two known members Kirsten ras family human proto-oncogenes , extending series recent reports demonstrated homologies human oncogenes Harvey Kirsten murine sarcoma viruses . @ GeneSrc $ oncogene several @ DiseaseTgt $ cell lines shown amplified .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0420841071039974)\n",
      "- Text: \"Regional chromosomal localization N-ras , @ GeneSrc $ , @ GeneSrc $ myb oncogenes human cells . identification transforming genes human @ DiseaseTgt $ cells made possible DNA mediated gene transfer techniques . date , possible show transforming genes activated cellular analogues ras oncogene family . better understand relationship oncogenes human genes , determined chromosomal localization analyzing human rodent somatic cell hybrids molecularly cloned human proto-oncogene probes . possible assign N-ras chromosome 1 regionally localize c-K-ras-1 c-K-ras-2 human chromosomes 6pter-q13 12q , respectively . results along previous studies demonstrate highly dispersed nature ras genes human genome . Previous reports indicated c-myb gene also resides chromosome 6 . possible sublocalize c-myb long arm chromosome 6 ( q15-q21 ) . non-random aberrations chromosomes 1 , 6 12 occur certain human @ DiseaseTgt $ suggest possible etiologic involvement ras and/or myb oncogenes @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6797455295542388)\n",
      "- Text: \"Clinicopathologic significance @ GeneSrc $ gene codon 12 point mutation stomach cancer . analysis 140 cases . BACKGROUND : frequency clinicopathologic significance @ GeneSrc $ gene point mutation stomach cancer remain defined . METHODS : authors investigated frequency @ GeneSrc $ codon 12 point mutations stomach cancer using sensitive polymerase chain reaction ( PCR ) -based method 140 samples correlated findings various clinicopathologic characteristics patients . RESULTS : overall frequency @ GeneSrc $ codon 12 point mutations stomach cancer 7.9 % ( 11/140 ) . DNA sequencing nine cases @ GeneSrc $ codon 12 point mutations identified seven cases single-base substitution GGT AGT ( glycine serine ) two single-base substitution GGT AGT ( aspartic acid ) . @ DiseaseTgt $ located upper third stomach significantly higher frequency @ GeneSrc $ codon 12 mutations ( 3/8 , 37.5 % ) compared @ DiseaseTgt $ located middle ( 4/29 , 13.8 % ) lower ( 3/99 , 3.0 % ) thirds stomach ( P = 0.001 ) . significant difference observed frequency @ GeneSrc $ codon 12 mutations terms various clinicopathologic characteristics including @ DiseaseTgt $ DNA ploidy S-phase fraction . median follow-up 26 months , disease free overall survival significantly different patients stomach cancer without @ GeneSrc $ codon 12 mutation . Among eight patients stomach cancer located upper part stomach , none three patients @ GeneSrc $ gene-mutated @ DiseaseTgt $ died versus four five @ DiseaseTgt $ without @ GeneSrc $ gene mutations ( P = 0.064 ) . CONCLUSIONS : @ GeneSrc $ codon 12 point mutations uncommon stomach cancer ( 7.9 % ) . significant correlation @ GeneSrc $ mutations vertical @ DiseaseTgt $ location stomach , suggesting different mechanisms may play role pathogenesis stomach cancer according location @ DiseaseTgt $ stomach .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9085263849164804)\n",
      "- Text: \"Common occurrence multiple @ GeneSrc $ mutations pancreatic cancers associated precursor lesions @ DiseaseTgt $ . Recent studies small series pancreatic cancer ( PC ) foci pancreatic intraepithelial neoplasia ( PanIN ) , putative precursor lesion , shown multiple @ GeneSrc $ mutations may coexist neoplastic pancreas . see whether @ GeneSrc $ polyclonality common specific feature pancreatic carcinogenesis , investigated unselected series @ DiseaseTgt $ ( 41 pancreatic , 13 biliary two ampullary adenocarcinomas ) . hemi-nested polymerase chain reaction ( PCR ) , mutations identified single strand conformation polymorphism ( SSCP ) confirmed allele-specific PCR sequencing . @ GeneSrc $ codon 12 mutated 34 ( 83 % ) pancreatic cancers 11 ( 85 % ) @ DiseaseTgt $ . Multiple distinct @ GeneSrc $ mutations found 16 PC ( 39 % cases , 47 % mutated @ GeneSrc $ ) eight @ DiseaseTgt $ ( 62 72 % , respectively ) . PC , multiple @ GeneSrc $ mutations frequent ( P < 0.001 ) @ DiseaseTgt $ ( nine 12 , 75 % ) without detectable PanIN ( seven 29 , 24 % ) . Individual precursor lesions neoplastic pancreas found harbor distinct mutations . Results show multiple @ GeneSrc $ mutations frequent PC associated PanIN @ DiseaseTgt $ , indicate clonally distinct precursor lesions PC might variably contribute @ DiseaseTgt $ development .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6816842577938792)\n",
      "- Text: \"Requirement NF-kappaB signalling mouse model lung adenocarcinoma . NF-kappaB transcription factors function crucial regulators inflammatory immune responses well cell survival . also implicated cellular transformation tumorigenesis . However , despite extensive biochemical characterization NF-kappaB signalling past twenty years , requirement NF-kappaB @ DiseaseTgt $ development vivo , particularly @ DiseaseTgt $ , completely understood . show NF-kappaB pathway required development @ DiseaseTgt $ mouse model lung adenocarcinoma . Concomitant loss p53 ( also known Trp53 ) expression oncogenic Kras ( G12D ) resulted NF-kappaB activation primary mouse embryonic fibroblasts . Conversely , lung tumour cell lines expressing Kras ( G12D ) lacking p53 , p53 restoration led NF-kappaB inhibition . Furthermore , inhibition NF-kappaB signalling induced apoptosis p53-null lung cancer cell lines . Inhibition pathway lung tumours vivo , time @ DiseaseTgt $ initiation @ DiseaseTgt $ progression , resulted significantly reduced @ DiseaseTgt $ development . Together , results indicate critical function NF-kappaB signalling lung tumour development , , requirement depends p53 status . findings also provide support development NF-kappaB inhibitory drugs targeted therapies treatment patients defined mutations @ GeneSrc $ p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0221849468512972)\n",
      "- Text: \"Isolation transforming sequences two human lung carcinomas : structural functional analysis activated @ GeneSrc $ oncogenes . Human lung tumors PR310 PR371 maintained nude mice contain activated @ GeneSrc $ oncogenes detectable ability DNAs induce morphological transformation NIH 3T3 mouse fibroblasts . Using phage libraries constructed DNA NIH 3T3 mouse fibroblast transformants , isolated human sequences span greater 40 kilobase pairs @ GeneSrc $ oncogene . Based conservation human sequences mouse fibroblast transformants , conclude transforming ability oncogene activated @ DiseaseTgt $ resides within 43- 46-kilobase-pair DNA region . clear differences observed structures PR310 PR371 cloned oncogene sequences . Nucleotide sequence analysis concert DNA transfection experiments suggests PR371 oncogene activated single base change first exon , results substitution cysteine glycine position 12 predicted amino acid sequence . genetic alteration responsible transforming activity PR310 oncogene , however , reside first exon . results indicate activation @ GeneSrc $ oncogene human lung cancer occur different mutational events .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3640322934934624)\n",
      "- Text: \"Detection point mutations Kirsten-ras oncogene provides evidence multicentricity pancreatic carcinoma . reported multicentricity pancreatic carcinomas extending beyond pancreatic duct occur 15 % 40 % patients . difficult confirm , however , currently available histologic techniques . Mutations @ GeneSrc $ oncogene , detected frequently pancreatic carcinomas using polymerase chain reaction ( PCR ) , may serve potential clonal marker @ DiseaseTgt $ cells . Fifty-three patients histopathologic diagnosis pancreatic carcinoma selected determination certain @ GeneSrc $ mutations PCR . authors identified mutations @ GeneSrc $ codon 12 46 53 @ DiseaseTgt $ . Two 46 @ DiseaseTgt $ two different mutations aspartic acid ( GAT ) valine ( GTT ) @ GeneSrc $ codon 12 . Another isolate additional mutation @ GeneSrc $ codon 13 . detection different mutations @ DiseaseTgt $ suggests may multicentricity pancreatic carcinomas frequency may low 6 % @ DiseaseTgt $ . results imply total pancreatectomy eliminating @ DiseaseTgt $ recurrence due multicentricity may warranted .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3723784439297367)\n",
      "- Text: \"High frequency @ GeneSrc $ mutations human colorectal hyperplastic polyps . BACKGROUND : Hyperplastic polyps common benign colorectal polyps , thought little association @ DiseaseTgt $ colorectum . However , several reports suggest hyperplastic polyps may develop colorectal neoplasms . AIM : clarify genetic alterations colorectal hyperplastic polyps . METHODS : Twenty eight colorectal polyps serrated components resected patients endoscopically . @ GeneSrc $ gene mutations codons 12 13 analysed PCR-RFLP . Intranuclear p53 protein immunostained avidin-biotin complex method . RESULTS : mutation @ GeneSrc $ gene detected nine ( 47 % ) 19 hyperplastic polyps , five ( 56 % ) nine adenomas . p53 protein nuclear accumulation detected immunohistochemically two ( 22 % ) nine adenomas , hyperplastic polyps . CONCLUSION : hyperplastic polyps may true neoplastic lesions , could precursors @ DiseaseTgt $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004076546790791)\n",
      "- Text: \"Distinct patterns @ GeneSrc $ mutations colorectal carcinomas according germline mismatch repair defects hMLH1 methylation status . sporadic colorectal tumours BRAFV600E associated microsatellite instability ( MSI-H ) inversely associated @ GeneSrc $ mutations . @ DiseaseTgt $ hereditary non-polyposis colorectal cancer ( HNPCC ) patients carrying germline mutations hMSH2 hMLH1 show BRAFV600E , however consistent data exist regarding @ GeneSrc $ mutation frequency spectrum HNPCC tumours . investigated @ GeneSrc $ 158 HNPCC tumours patients germline hMLH1 , hMSH2 hMSH6 mutations , 166 MSI-H 688 microsatellite stable ( MSS ) @ DiseaseTgt $ . @ DiseaseTgt $ characterized MSI 81 166 sporadic MSI-H colorectal cancer ( CRCs ) analysed hMLH1 promoter hypermethylation . @ GeneSrc $ mutations observed 40 % HNPCC tumours , mutation frequency varied upon mismatch repair gene affected : 48 % ( 29/61 ) hMSH2 , 32 % ( 29/91 ) hMLH1 83 % ( 5/6 ) hMSH6 ( P = 0.01 ) . @ GeneSrc $ mutation frequency different HNPCC , MSS MSI-H CRCs ( P = 0.002 ) , MSI-H hMLH1 hypermethylation ( P = 0.005 ) . Furthermore , HNPCC CRCs G13D mutations MSS ( P < 0.0001 ) , MSI-H ( P = 0.02 ) @ DiseaseTgt $ hMLH1 hypermethylation ( P = 0.03 ) . HNPCC colorectal sporadic MSI-H tumours without hMLH1 hypermethylation shared similar @ GeneSrc $ mutation frequency , particular G13D . conclusion , show depending genetic/epigenetic mechanism leading MSI-H , outcome terms oncogenic activation may different , reinforcing idea HNPCC , sporadic MSI-H ( depending hMLH1 status ) MSS CRCs , may target distinct kinases within RAS/RAF/MAPK pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2398609317195019)\n",
      "- Text: \"Somatic @ GeneSrc $ mutations associated human nonmalignant syndrome autoimmunity abnormal leukocyte homeostasis . Somatic gain-of-function mutations members RAS subfamily small guanosine triphosphatases found > 30 % human @ DiseaseTgt $ . recently described syndrome chronic nonmalignant lymphadenopathy , splenomegaly , autoimmunity associated mutation NRAS affecting hematopoietic cells , initially classified disease variant autoimmune lymphoproliferative syndrome . , demonstrate somatic mutations related @ GeneSrc $ gene also associated nonmalignant syndrome autoimmunity breakdown leukocyte homeostasis . activating @ GeneSrc $ mutation impaired cytokine withdrawal-induced T-cell apoptosis suppression proapoptotic protein BCL-2 interacting mediator cell death facilitated proliferation p27 ( kip1 ) down-regulation . defects could corrected vitro mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 phosphatidyl inositol-3 kinase inhibition . suggest use term RAS-associated autoimmune leukoproliferative disease differentiate disorder autoimmune lymphoproliferative syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1800495227643646)\n",
      "- Text: \"Somatic Activating @ GeneSrc $ Mutations Arteriovenous Malformations Brain . BACKGROUND : Sporadic arteriovenous malformations brain , morphologically abnormal connections arteries veins brain vasculature , leading cause hemorrhagic stroke young adults children . genetic cause rare focal disorder unknown . METHODS : analyzed tissue blood samples patients arteriovenous malformations brain detect somatic mutations . performed exome DNA sequencing tissue samples arteriovenous malformations brain 26 patients main study group paired blood samples 17 patients . confirm findings , performed droplet digital polymerase-chain-reaction ( PCR ) analysis tissue samples 39 patients main study group ( 21 matching blood samples ) 33 patients independent validation group . interrogated downstream signaling pathways , changes gene expression , cellular phenotype induced activating @ GeneSrc $ mutations , discovered tissue samples . RESULTS : detected somatic activating @ GeneSrc $ mutations tissue samples 45 72 patients none 21 paired blood samples . endothelial cell-enriched cultures derived arteriovenous malformations brain , detected @ GeneSrc $ mutations observed expression mutant @ GeneSrc $ ( KRASG12V ) endothelial cells vitro induced increased ERK ( extracellular signal-regulated kinase ) activity , increased expression genes related angiogenesis Notch signaling , enhanced migratory behavior . processes reversed inhibition MAPK ( mitogen-activated protein kinase ) -ERK signaling . CONCLUSIONS : identified activating @ GeneSrc $ mutations majority tissue samples arteriovenous malformations brain analyzed . propose malformations develop result @ GeneSrc $ activation MAPK-ERK signaling pathway brain endothelial cells . ( Funded Swiss @ DiseaseTgt $ League others . ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2305210978890295)\n",
      "- Text: \"Mutational activation @ GeneSrc $ oncogene . possible pathogenetic factor adenocarcinoma lung . define role cellular oncogenes human @ DiseaseTgt $ , studied prevalence mutational activation ras oncogenes untreated non-small-cell lung cancer . Genomic DNA extracted 39 @ DiseaseTgt $ specimens obtained thoracotomy examined activating point mutations codons 12 , 13 , 61 H-ras , @ GeneSrc $ , N-ras genes . novel , highly sensitive assay based oligonucleotide hybridization following vitro amplification step employed . @ GeneSrc $ gene found activated point mutations codon 12 5 10 adenocarcinomas . Two @ DiseaseTgt $ less 2 cm size metastasized . ras gene mutations observed 15 squamous-cell carcinomas , 10 large-cell carcinomas , 1 carcinoid , 2 metastatic adenocarcinomas primary @ DiseaseTgt $ outside lung , 1 small-cell carcinoma . approximately 20-fold amplification unmutated @ GeneSrc $ gene observed @ DiseaseTgt $ proved solitary lung metastasis rectal carcinoma . conclude mutational @ GeneSrc $ activation may important early event pathogenesis adenocarcinoma lung amplification ras genes mutational activation H-ras N-ras play major part non-small-cell lung cancer .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4198996593857745)\n",
      "- Text: \"Chromosomal localization three human ras genes situ molecular hybridization . Three human ras family protooncogenes , c-Ki-ras-1 , @ GeneSrc $ , N-ras , mapped chromosome bands 6p11 - 12 , 12p11.1 - 12.1 , 1p11 - 13 , respectively situ molecular hybridization . Certain human @ DiseaseTgt $ display consistent specific alterations involving chromosomes 1 , 6 , 12 . precise chromosomal localization ras genes permit evaluation possible effect chromosome changes structure activities ras protooncogenes human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0074975451014177)\n",
      "- Text: \"Serum concentrations organochlorine compounds @ GeneSrc $ mutations exocrine pancreatic cancer . PANKRAS II Study Group . BACKGROUND : Organochlorine compounds 1,1,1-trichloro-2,2-bis ( p-chlorophenyl ) -ethane ( p , p'-DDT ) , 1,1-dichloro-2,2-bis ( p-chlorophenyl ) ethylene ( p , p'-DDE ) , polychlorinated biphenyls ( PCBs ) carcinogenic animals possibly also human beings . Occupational exposure DDT may increase risk pancreas cancer . high frequency @ GeneSrc $ mutations pancreatic cancer remains unexplained . analysed relation serum concentrations selected organochlorine compounds mutations codon 12 @ GeneSrc $ gene patients exocrine pancreatic cancer . METHODS : Cases prospectively identified five hospitals . Mutations @ GeneSrc $ analysed PCR artificial restriction fragment length polymorphism . Cases pancreatic cancer wild-type @ GeneSrc $ ( n=17 ) frequency matched age sex cases pancreatic cancer @ GeneSrc $ mutation ( n=34 , case-case study ) . 51 cases compared 26 hospital controls ( case-control comparison ) . Serum organochlorine concentrations measured high-resolution gas chromatography electron-capture detection negative ion chemical ionisation mass spectrometry . FINDINGS : Serum concentrations p , p'-DDT significantly higher pancreatic cancer cases @ GeneSrc $ mutation cases without mutation ( odds ratio upper tertile 8.7 [ 95 % CI 1.6 - 48.5 ] , p trend=0.005 ) . p , p'-DDE corresponding figures 5.3 ( 1.1 - 25.2 , p trend=0.031 ) . estimates held adjusting total lipids , covariates , total PCBs . specific association observed glycine valine substitution codon 12 p , p'-DDT p , p'-DDE concentrations ( odds ratio 15.9 , p=0.044 odds ratio 24.1 , p=0.028 ; respectively ) . similar pattern shown major di-ortho-chlorinated PCBs ( congeners 138 , 153 , 180 ) , even adjustment p , p'-DDE , without specific association spectrum . Concentrations p , p'-DDT p , p'-DDE similar among wild-type cases controls , significantly higher @ GeneSrc $ mutated cases controls ( p < 0.01 ) . INTERPRETATION : Organochlorine compounds p , p'-DDT , p , p'-DDE , PCBs could play part pathogenesis exocrine pancreatic cancer modulation @ GeneSrc $ activation . results require replication , suggest new roles organochlorines development several @ DiseaseTgt $ human beings .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9531262359799132)\n",
      "- Text: \"new verdict old convict . Certain human @ DiseaseTgt $ carcinogen-induced rodent @ DiseaseTgt $ commonly contain @ GeneSrc $ mutations . activated form ras always described dominant oncogene . new study indicates wildtype @ GeneSrc $ properties @ DiseaseTgt $ suppressor gene may capacity reduce transforming potential oncogenically activated ras .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0160581292929375)\n",
      "- Text: \"Tumorigenesis : RAF/RAS oncogenes mismatch-repair status . Genes RAF family encode kinases regulated Ras mediate cellular responses growth signals . Activating mutations one RAF gene , BRAF , found high proportion melanomas small fraction @ DiseaseTgt $ . show BRAF mutations colorectal cancers occur @ DiseaseTgt $ carry mutations RAS gene known @ GeneSrc $ , BRAF mutation linked proficiency @ DiseaseTgt $ repairing mismatched bases DNA . results provide genetic support idea mutations BRAF @ GeneSrc $ exert equivalent effects tumorigenesis , also emphasize role repair processes establishing mutation spectra underpin human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9739648212473416)\n",
      "- Text: \"coding-independent function gene pseudogene mRNAs regulates @ DiseaseTgt $ biology . canonical role messenger RNA ( mRNA ) deliver protein-coding information sites protein synthesis . However , given microRNAs bind RNAs , hypothesized RNAs could possess regulatory role relies ability compete microRNA binding , independently protein-coding function . model protein-coding-independent role RNAs , describe functional relationship mRNAs produced PTEN @ DiseaseTgt $ suppressor gene pseudogene PTENP1 critical consequences interaction . find PTENP1 biologically active regulate cellular levels PTEN exert growth-suppressive role . also show PTENP1 locus selectively lost human @ DiseaseTgt $ . extended analysis @ DiseaseTgt $ genes possess pseudogenes , oncogenic @ GeneSrc $ . also demonstrate transcripts protein-coding genes PTEN biologically active . findings attribute novel biological role expressed pseudogenes , regulate coding gene expression , reveal non-coding function mRNAs .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0485866210975186)\n",
      "- Text: \"Oculoectodermal syndrome mosaic RASopathy associated @ GeneSrc $ alterations . Oculoectodermal syndrome ( OES ) rare disease characterized combination congenital scalp lesions ocular dermoids , additional manifestations including non-ossifying fibromas giant cell granulomas jaw occurring first decade life . identify genetic etiology OES , conducted whole-genome sequencing several tissues affected individual . Comparison DNA non-ossifying fibroma blood-derived DNA allowed identification somatic missense alteration @ GeneSrc $ @ GeneSrc $ > , resulting p. Gly13Asp . alteration also observed patient 's affected tissues including skin muscle . Targeted sequencing second , unrelated OES patient identified @ GeneSrc $ > C , p. Leu19Phe alteration . Allelic frequencies fell 40 % tissues examined patients , suggesting OES mosaic RAS-related disorder , RASopathy . characteristic findings OES , including scalp lesions , ocular dermoids , @ DiseaseTgt $ , found mosaic germline RASopathies . discovery also broadens understanding spectrum phenotypes resulting @ GeneSrc $ alterations . Future research disease progression regard @ DiseaseTgt $ risk investigation RAS-targeted therapies OES warranted . @ GeneSrc $ sequencing clinically available may also improve OES diagnostic criteria .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2156090544316921)\n",
      "- Text: \"Identification ras oncogene mutations stool patients curable colorectal tumors . Colorectal ( CR ) tumors usually curable detected metastasis . genetic alterations associated development @ DiseaseTgt $ , mutant genes may found stool individuals CR neoplasms . stools nine patients whose @ DiseaseTgt $ contained mutations @ GeneSrc $ analyzed . eight nine cases , ras mutations detectable DNA purified stool . patients included benign @ DiseaseTgt $ proximal distal colonic epithelium . Thus , colorectal tumors detected noninvasive method based molecular pathogenesis disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9731276826947348)\n",
      "- Text: \"@ GeneSrc $ codon 12 mutations occur frequently pancreatic adenocarcinomas . DNAs human pancreatic adenocarcinomas analyzed presence mutations codons 12 , 13 61 NRAS , @ GeneSrc $ HRAS gene . Formalin-fixed paraffin-embedded tissue used directly vitro amplification reaction expand relevant RAS sequences . mutations detected selective hybridization using mutation-specific synthetic oligonucleotides . 28 30 patients found mutation codon 12 @ GeneSrc $ gene . result confirms findings Almoguera et al . [ Cell 53 ( 1988 ) 549 - 554 ] @ GeneSrc $ mutations occur frequently adenocarcinomas exocrine pancreas . mutations predominantly G-T transversions , contrast @ GeneSrc $ mutations colon tumors mainly G-A transitions . Furthermore , portion @ DiseaseTgt $ mutation appears homozygous .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6677621388089875)\n",
      "- Text: \"Malignant activation @ GeneSrc $ oncogene lung carcinoma normal tissue patient . single genetic alteration , guanine-to-cytosine transversion , responsible acquisition malignant properties @ GeneSrc $ genes two human @ DiseaseTgt $ cell lines established carcinomas bladder ( A1698 ) lung ( A2182 ) . consequence , arginine instead normal glycine incorporated @ GeneSrc $ p21 proteins amino acid position 12 . mutation creates restriction enzyme polymorphism used screen human cells transforming @ GeneSrc $ genes . approach used identify mutational event responsible malignant activation @ GeneSrc $ oncogene squamous cell lung carcinoma 66-year-old man ; point mutation present either normal bronchial parenchymal tissue blood lymphocytes . Hence , malignant activation ras oncogene appears specifically associated development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0058421397416976)\n",
      "- Text: \"Mutations BRAF RAS rare events germ cell tumours . BRAF gene , one human isoforms RAF , activated oncogenic Ras , leading cooperative effects cells responding growth factor signals . Recently , somatic missense mutations BRAF gene detected variety human @ DiseaseTgt $ . studied male germ cell tumours ( GCT ) probable mutations BRAF Ras oncogene . Microsatellite instability ( MSI ) analysed using mono- di-nucleotide marker . Mutational analysis 62 GCT ( 30 seminomas 32 nonseminomas ) performed microdissection different @ DiseaseTgt $ components . expression Erk1/2 , important downstream point convergence Ras-RAF-MEK-Erk pathway assessed immunohistochemically . Activating BRAF missense mutations identified 3 32 cases nonseminomas ( 9 % ) seminomas . mutations 1796T > mutations found within embryonic carcinoma component @ DiseaseTgt $ . Two 30 seminomas ( 7 % ) 3 32 nonseminomas ( 9 % ) exhibited @ GeneSrc $ gene mutations . MSI observed 4 62 @ DiseaseTgt $ ( 7 % ) [ 1 seminoma 3 nonseminomas ( embryonal carcinoma ) ] . microsatellite instable embryonal carcinomas mutated BRAF gene . 5 GCT RAS mutations intact BRAF gene . identified constitutively activated Erk almost @ DiseaseTgt $ tested . data indicate BRAF gene mutations rare event GCT independent @ GeneSrc $ mutations . embryonal carcinomas , BRAF mutations may linked proficiency @ DiseaseTgt $ repairing mismatched bases DNA . finding activated Erk suggests causative role MAPK activation GCT independent activating BRAF RAS mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2443771002975132)\n",
      "- Text: \"@ GeneSrc $ mutations human @ DiseaseTgt $ occur preferentially codon 12 . study carried determine frequency distribution mutations @ GeneSrc $ gene human @ DiseaseTgt $ tissue . study done total 51 lung , colon breast carcinoma tumors using panel oligonucleotides coding wild type possible mutations codons 12 61 @ GeneSrc $ gene . Four 16 colon carcinomas , two 27 lung carcinomas one eight breast carcinomas found contain mutations codon 12 . mutations found position 61 . six possible amino acid replacements codon 12 , one represented seven mutations identified .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0434746195483328)\n",
      "- Text: \"Specific pattern RAS oncogene mutations follicular thyroid tumors . prevalence H-RAS , @ GeneSrc $ , N-RAS gene mutations thyroid tumors according @ DiseaseTgt $ histology controversial . Differences methodology histological classifications may explain discrepant results . address issue , first performed pooled analysis 269 mutations garnered 39 previous studies . Mutations proved significantly less frequent detected direct sequencing without ( 12.3 % vs. 17 % ) . rate mutation involving N-RAS exon 1 ( N1 ) @ GeneSrc $ exon 2 ( K2 ) less 1 % . Mutations codon 61 N-RAS ( N2 ) significantly frequent @ DiseaseTgt $ ( 19 % ) papillary cancers ( 5 % ) significantly frequent malignant ( 25 % ) @ DiseaseTgt $ ( 14 % ) @ DiseaseTgt $ . H-RAS mutations codons 12/13 ( H1 ) found 2 - 3 % types @ DiseaseTgt $ , H-RAS mutations codon 61 ( H2 ) observed 1.4 % @ DiseaseTgt $ , almost malignant . @ GeneSrc $ mutations exon 1 found often papillary follicular cancers ( 2.7 % vs. 1.6 % ) sometimes correlated special epidemiological circumstances . second part study involved analysis 80 @ DiseaseTgt $ patients living Marseille ( France ) Kiev ( Ukraine ) . used direct sequencing PCR amplification exons 1 2 three RAS genes . Common atypical adenomas separated using strict cytological criteria . Mutations H1-RAS found 12.5 % common adenomas one follicular carcinoma ( 2.9 % ) . Mutations N2-RAS occurred 23.3 % 17.6 % atypical adenomas follicular carcinomas , respectively . results confirm predominance N2-RAS mutations thyroid follicular tumors correlation @ DiseaseTgt $ . support implication N2-RAS mutations malignant progression thyroid follicular tumors assumption atypical adenomas precursors follicular carcinomas .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6252491315726907)\n",
      "- Text: \"@ GeneSrc $ regulatory elements exon 4A determine mutation specificity lung cancer . @ GeneSrc $ frequently mutated ras family member lung carcinomas , whereas Hras mutations common @ DiseaseTgt $ stratified epithelia skin . Using Hras knock-in mouse model , demonstrate specificity @ GeneSrc $ mutations lung Hras mutations skin tumors determined local regulatory elements target ras genes . Although @ GeneSrc $ isoform dispensable mouse development , important isoform lung carcinogenesis vivo inhibitory effect wild-type ( WT ) @ GeneSrc $ mutant allele . @ GeneSrc $ expression detected subpopulation normal lung epithelial cells , low levels lung tumors , suggesting may required @ DiseaseTgt $ progression . two @ GeneSrc $ isoforms undergo different post-translational modifications ; therefore , findings implications design therapeutic strategies inhibiting oncogenic @ GeneSrc $ activity human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1578819413078064)\n",
      "- Text: \"@ GeneSrc $ splice variant widely expressed @ DiseaseTgt $ uses hybrid membrane-targeting motif . two products @ GeneSrc $ locus , @ GeneSrc $ @ GeneSrc $ , encoded alternative fourth exons therefore , possess distinct membrane-targeting sequences . common activating mutations occur exons 1 2 therefore , render splice variants oncogenic . @ GeneSrc $ understudied , considered minor splice variant . priming splice junction , developed quantitative RT-PCR assay @ GeneSrc $ @ GeneSrc $ message capable measuring absolute amounts two transcripts . found @ GeneSrc $ widely expressed 30 30 human @ DiseaseTgt $ cell lines amounts equal @ GeneSrc $ 17 human colorectal tumors . Using splice variant-specific antibodies , detected @ GeneSrc $ protein several @ DiseaseTgt $ cell lines level equal greater @ GeneSrc $ addition CAAX motif , C terminus @ GeneSrc $ contains site palmitoylation well bipartite polybasic region . Although required maximal efficiency , could independently deliver @ GeneSrc $ plasma membrane . Thus , among four Ras proteins , @ GeneSrc $ unique possessing dual membrane-targeting motif . also found , unlike @ GeneSrc $ , @ GeneSrc $ bind cytosolic chaperone delta-subunit cGMP phosphodiesterase type 6 ( PDE6delta ) . conclude efforts develop @ GeneSrc $ drugs interfere membrane trafficking take account distinct modes targeting two @ GeneSrc $ splice variants .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5660805260970105)\n",
      "- Text: \"Syndecan 1 critical mediator macropinocytosis pancreatic cancer . Pancreatic ductal adenocarcinoma ( PDAC ) remains recalcitrant forms @ DiseaseTgt $ treatment carries five-year survival rate 8 % 1 . Inhibition oncogenic @ GeneSrc $ ( hereafter @ GeneSrc $ * ) , earliest lesion disease development present 90 % PDACs , signalling surrogates yielded encouraging preclinical results experimental agents2 - 4 . However , @ GeneSrc $ disease recurrence following genetic extinction @ GeneSrc $ * mouse models anticipates need co-extinction strategies5,6 . Multiple oncogenic processes initiated cell surface , @ GeneSrc $ * physically functionally interacts direct signalling essential malignant transformation @ DiseaseTgt $ maintenance . Insights complexity functional cell-surface-protein repertoire ( surfaceome ) technologically limited recently and-in case PDAC-the genetic control function composition PDAC surfaceome context @ GeneSrc $ * signalling remains largely unknown . develop unbiased , functional target-discovery platform query @ GeneSrc $ changes PDAC surfaceome , reveals syndecan 1 ( SDC1 , also known CD138 ) protein upregulated cell surface @ GeneSrc $ Localization SDC1 cell surface-where regulates macropinocytosis , essential metabolic pathway fuels PDAC cell growth-is essential disease maintenance progression . Thus , study forges mechanistic link @ GeneSrc $ * signalling targetable molecule driving nutrient salvage pathways PDAC validates oncogene-driven surfaceome annotation strategy identify @ DiseaseTgt $ vulnerabilities .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.242401787538723)\n",
      "- Text: \"Wildtype Kras2 inhibit lung carcinogenesis mice . Although ras genes long established proto-oncogenes , dominant role activated ras cell transformation questioned . Previous studies shown frequent loss wildtype @ GeneSrc $ allele mouse human lung adenocarcinomas . address possible @ DiseaseTgt $ suppressor role wildtype Kras2 lung tumorigenesis , carried lung tumor bioassay heterozygous Kras2-deficient mice . Mice heterozygous Kras2 deficiency highly susceptible chemical induction lung tumors compared wildtype mice . Activating Kras2 mutations detected chemically induced lung tumors obtained wildtype heterozygous Kras2-deficient mice . Furthermore , wildtype Kras2 inhibited colony formation @ DiseaseTgt $ development transformed NIH/3T3 cells mouse lung tumor cell line containing activated Kras2 allele . Allelic loss wildtype Kras2 found 67 % 100 % chemically induced mouse lung adenocarcinomas harbor mutant Kras2 allele . Finally , inverse correlation level wildtype Kras2 expression extracellular signal-regulated kinase ( ERK ) activity observed cells . data strongly suggest wildtype Kras2 @ DiseaseTgt $ suppressor activity frequently lost lung tumor progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9812461476715132)\n",
      "- Text: \"Glucose deprivation contributes development @ GeneSrc $ pathway mutations @ DiseaseTgt $ cells . @ DiseaseTgt $ progression driven genetic mutations , little known environmental conditions select mutations . Studying transcriptomes paired colorectal cancer cell lines differed mutational status @ GeneSrc $ BRAF genes , found GLUT1 , encoding glucose transporter-1 , one three genes consistently up-regulated cells @ GeneSrc $ BRAF mutations . mutant cells exhibited enhanced glucose uptake glycolysis survived low-glucose conditions , phenotypes required GLUT1 expression . contrast , cells wild-type @ GeneSrc $ alleles subjected low-glucose environment , cells survived . surviving cells expressed high levels GLUT1 , 4 % survivors acquired @ GeneSrc $ mutations present parents . glycolysis inhibitor 3-bromopyruvate preferentially suppressed growth cells @ GeneSrc $ BRAF mutations . Together , data suggest glucose deprivation drive acquisition @ GeneSrc $ pathway mutations human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6493590859728584)\n",
      "- Text: \"Vitamin C selectively kills @ GeneSrc $ BRAF mutant colorectal cancer cells targeting GAPDH . half human colorectal cancers ( CRCs ) carry either @ GeneSrc $ BRAF mutations often refractory approved targeted therapies . found cultured human CRC cells harboring @ GeneSrc $ BRAF mutations selectively killed exposed high levels vitamin C. effect due increased uptake oxidized form vitamin C , dehydroascorbate ( DHA ) , via GLUT1 glucose transporter . Increased DHA uptake causes oxidative stress intracellular DHA reduced vitamin C , depleting glutathione . Thus , reactive oxygen species accumulate inactivate glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) . Inhibition GAPDH highly glycolytic @ GeneSrc $ BRAF mutant cells leads energetic crisis cell death seen @ GeneSrc $ BRAF wild-type cells . High-dose vitamin C impairs @ DiseaseTgt $ growth @ GeneSrc $ ) mutant mice . results provide mechanistic rationale exploring therapeutic use vitamin C CRCs @ GeneSrc $ BRAF mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009736664501749)\n",
      "- Text: \"Mutations @ GeneSrc $ , p53 APC genes adenocarcinomas human small intestine . contrast origins colorectal carcinomas , mechanisms carcinogenesis small intestine remain unclear . therefore analyzed mutational status @ GeneSrc $ , p53 , adenomatous polyposis coli ( APC ) genes primary carcinomas small intestine compared mutation patterns established colorectal cancers . DNA extracted 15 formalin-fixed , paraffin-embedded lesions . Codons 12 , 13 61 @ GeneSrc $ gene , exons 5 - 8 p53 gene , codons 1268 - 1569 , contain mutation cluster region ( MCR ) APC gene , amplified means PCR , subcloned sequenced . Mutations @ GeneSrc $ p53 genes observed 8 ( 53.3 % ) 4 lesions ( 26.7 % ) , respectively . mutational frequency @ GeneSrc $ gene present series small intestinal carcinomas similar , p53 gene slightly lower reported frequencies colorectal carcinomas . one case showed mutation APC gene , involving insertional mutation adenine codons 1554 - 1556 formation stop codon immediately downstream . Since occurrence APC mutation considered early event colorectal carcinogenesis , findings indicating extremely low frequency changes around MCR suggest carcinomas small intestine arise via genetic pathway distinct involved development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010938724214825)\n",
      "- Text: \"novel case germline p53 gene mutation concurrent multiple primary colon tumours . search causative genes patients concurrent multiple primary colon tumours , found novel case germline mutation p53 gene , GCC ( Ala ) GTC ( Val ) codon 189 . six primary colon tumours patient , one large advanced @ DiseaseTgt $ exhibited somatic p53 mutation somatic APC mutation , addition germline p53 mutation . Two early @ DiseaseTgt $ three adenomas somatic APC mutations somatic p53 mutation loss p53 allele . @ GeneSrc $ mutations detected advanced @ DiseaseTgt $ early @ DiseaseTgt $ . present results suggest patient certain type germline p53 mutation predisposed concurrent multiple colon tumours . also suggested patient , somatic APC mutation involved @ DiseaseTgt $ formation additional somatic p53 mutation contributes @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9230001069232564)\n",
      "- Text: \"DEC1 , basic helix-loop-helix transcription factor novel target gene p53 family , mediates p53-dependent premature senescence . Cellular senescence plays important role @ DiseaseTgt $ suppression . p53 tumor suppressor reported crucial cellular senescence . However , underlying mechanism poorly understood . regard , cDNA microarray assay performed identify p53 targets involved senescence . Among many candidates DEC1 , basic helix-loop-helix transcription factor recently shown up-regulated @ GeneSrc $ premature senescence . However , clear whether DEC1 capable inducing senescence . , found DEC1 novel target gene p53 family mediates p53-dependent premature senescence . Specifically , showed DEC1 induced p53 family DNA damage p53-dependent manner . also found p53 family proteins bind , activate , promoter DEC1 gene . addition , showed overexpression DEC1 induces G ( 1 ) arrest promotes senescence . Moreover , found targeting endogenous DEC1 attenuates p53-mediated premature senescence response DNA damage . Furthermore , overexpression DEC1 induces cellular senescence p53-knockdown cells , albeit lesser extent . Finally , showed DEC1-induced senescence p21-independent . Taken together , data provided strong evidence DEC1 one effectors downstream p53 promote premature senescence .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.662619454296736e-05)\n",
      "- Text: \"Restoration p53 function leads @ DiseaseTgt $ regression vivo . Tumorigenesis multi-step process requires activation oncogenes inactivation @ DiseaseTgt $ suppressor genes . Mouse models human @ DiseaseTgt $ recently demonstrated continuous expression dominantly acting oncogene ( example , Hras , @ GeneSrc $ Myc ) often required @ DiseaseTgt $ maintenance ; phenotype referred oncogene addiction . concept received clinical validation development active anticancer drugs specifically inhibit function oncoproteins BCR-ABL , c-KIT EGFR . Identifying additional gene mutations required @ DiseaseTgt $ maintenance may therefore yield clinically useful targets new @ DiseaseTgt $ therapies . Although loss p53 function common feature human @ DiseaseTgt $ , known whether sustained inactivation @ DiseaseTgt $ suppressor pathways required @ DiseaseTgt $ maintenance . explore issue , developed Cre-loxP-based strategy temporally control @ DiseaseTgt $ suppressor gene expression vivo . show restoring endogenous p53 expression leads regression autochthonous lymphomas sarcomas mice without affecting normal tissues . mechanism responsible @ DiseaseTgt $ regression dependent @ DiseaseTgt $ type , main consequence p53 restoration apoptosis lymphomas suppression cell growth features cellular senescence sarcomas . results support efforts treat human @ DiseaseTgt $ way pharmacological reactivation p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9866700945539616)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two colon cancer , two @ DiseaseTgt $ , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version @ GeneSrc $ gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0063134950028272)\n",
      "- Text: \"Clinicopathologic significance @ GeneSrc $ gene codon 12 point mutation @ DiseaseTgt $ . analysis 140 cases . BACKGROUND : frequency clinicopathologic significance @ GeneSrc $ gene point mutation @ DiseaseTgt $ remain defined . METHODS : authors investigated frequency @ GeneSrc $ codon 12 point mutations @ DiseaseTgt $ using sensitive polymerase chain reaction ( PCR ) -based method 140 samples correlated findings various clinicopathologic characteristics patients . RESULTS : overall frequency @ GeneSrc $ codon 12 point mutations @ DiseaseTgt $ 7.9 % ( 11/140 ) . DNA sequencing nine cases @ GeneSrc $ codon 12 point mutations identified seven cases single-base substitution GGT AGT ( glycine serine ) two single-base substitution GGT AGT ( aspartic acid ) . Tumors located upper third stomach significantly higher frequency @ GeneSrc $ codon 12 mutations ( 3/8 , 37.5 % ) compared tumors located middle ( 4/29 , 13.8 % ) lower ( 3/99 , 3.0 % ) thirds stomach ( P = 0.001 ) . significant difference observed frequency @ GeneSrc $ codon 12 mutations terms various clinicopathologic characteristics including tumor DNA ploidy S-phase fraction . median follow-up 26 months , disease free overall survival significantly different patients @ DiseaseTgt $ without @ GeneSrc $ codon 12 mutation . Among eight patients @ DiseaseTgt $ located upper part stomach , none three patients @ GeneSrc $ gene-mutated tumors died versus four five tumors without @ GeneSrc $ gene mutations ( P = 0.064 ) . CONCLUSIONS : @ GeneSrc $ codon 12 point mutations uncommon @ DiseaseTgt $ ( 7.9 % ) . significant correlation @ GeneSrc $ mutations vertical tumor location stomach , suggesting different mechanisms may play role pathogenesis @ DiseaseTgt $ according location tumors stomach .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9612896842403218)\n",
      "- Text: \"Mutational analysis BRAF @ GeneSrc $ @ DiseaseTgt $ : absence BRAF mutations @ DiseaseTgt $ . Recently , BRAF mutations found variety human cancers . Interestingly , common BRAF mutation ( V599E ) identified tumors @ GeneSrc $ mutations . Whereas majority human cancer types screened BRAF mutations , detailed studies @ DiseaseTgt $ investigated . Thus , decided investigate incidence BRAF mutations @ DiseaseTgt $ , relationship BRAF @ GeneSrc $ mutations cancers . Three non-pathogenic BRAF polymorphisms seven @ GeneSrc $ missense mutations found 66 @ DiseaseTgt $ 16 @ DiseaseTgt $ cell lines . Although 9 % @ DiseaseTgt $ panels @ GeneSrc $ mutations , incidence BRAF mutations high . Thus , BRAF mutations , present variety human cancers , seem involved @ DiseaseTgt $ development .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3312660487188994)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation tumor progression colon . Kras commonly mutated @ DiseaseTgt $ , mutations Nras rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant @ GeneSrc $ hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010837329876893)\n",
      "- Text: \"Correlation PIK3Ca mutations gene expression drug sensitivity NCI-60 cell lines . gene encodes alpha-isoform phosphatidylinositol 3-kinase ( PIK3Ca ) frequently mutated human cancers . profiled mutation status PIK3Ca gene National Cancer Institute ( NCI ) -60 panel human cancer cell lines maintained Developmental Therapeutics Program NCI . Mutation hotspots gene PCR amplified sequenced , trace data analyzed software designed detect mutations . Seven cell lines tested PIK3Ca mutations : two lines derived breast cancer , two @ DiseaseTgt $ , two ovarian cancer , one lung cancer . BRAF EGFR genes normal PIK3Ca mutant lines . Two cell lines mutant PIK3Ca also mutant version @ GeneSrc $ gene . mutation status correlated array-based gene expression publicly available NCI-60 cell lines . found increased expression levels estrogen receptor ( ER ) ERBB2 PIK3Ca mutant lines . PIK3Ca mutation status also correlated compound screening data cell lines . PIK3Ca-mutant cell lines relatively sensitive PIK3Ca-normal cell lines ER inhibitor tamoxifen AKT inhibitor triciribine , among compounds . results provide insights role mutant PIK3Ca oncogenic signaling allow preliminary identification novel targets therapeutic intervention cancers harboring PIK3Ca mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072279647185322)\n",
      "- Text: \"Mutations APC , @ GeneSrc $ , p53 - -alternative genetic pathways @ DiseaseTgt $ . @ DiseaseTgt $ one significant causes cancer death . genetic model @ DiseaseTgt $ proposed sequential accumulation mutations specific genes , including adenomatous polyposis coli ( APC ) , @ GeneSrc $ ( @ GeneSrc $ ) , p53 , drives transition healthy colonic epithelia increasingly dysplastic adenoma @ DiseaseTgt $ . characterized tumor mutation spectra large cohort @ DiseaseTgt $ patients . marked contrast predictions sequential model mutation accumulation , 6.6 % tumors found contain mutations APC , @ GeneSrc $ , p53 , 38.7 % tumors containing mutations one genes . common combination mutations p53 APC ( 27.1 % ) , whereas mutations p53 @ GeneSrc $ extremely rare . Statistical analysis ( two-sided Fisher 's exact test ) confirmed mutations @ GeneSrc $ p53 co-occurred less frequently expected chance ( P < 0.01 , Fisher 's exact test ) . finding suggests mutations lie alternate pathways @ DiseaseTgt $ development . heterogeneous pattern tumor mutations patient cohort suggests multiple alternative genetic pathways @ DiseaseTgt $ exist widely accepted genetic model cancer development representative majority @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0850777063892372)\n",
      "- Text: \"BRAF mutations @ DiseaseTgt $ suggest two entities microsatellite-unstable tumors . BACKGROUND : Alterations BRAF implicated carcinogenesis @ DiseaseTgt $ microsatellite instability ( MSI ) . alterations attributed defective DNA mismatch repair , underlies MSI . objective study clarify role BRAF @ DiseaseTgt $ MSI . METHODS : sequencing BRAF @ GeneSrc $ 82 @ DiseaseTgt $ samples without MSI , mismatch repair protein expression analyzed immunohistochemistry , promoter methylation hMLH1 analyzed methylation-specific polymerase chain reaction . Results correlated germline status hMLH1 hMSH2 clinical characteristics . RESULTS : BRAF mutated often tumors MSI tumors without MSI ( 27 % vs. 5 % ; P = 0.016 ) . prevalent BRAF alteration , V599E , occurred tumors MSI . BRAF V599E associated frequent hMLH1 promoter methylation ( P = 0.07 ) loss hMLH1 ( P = 0.02 ) . median age patients BRAF V599E older compared median age patients without mutation ( P = 0.001 ; 78 vs. 49 yrs ) . BRAF alterations occurred patients germline mutations mismatch repair genes . Five novel BRAF mutations identified . CONCLUSIONS : Although BRAF V599E common @ DiseaseTgt $ MSI , consequence deficient mismatch repair . current data showed instead BRAF V599E mutation associated subgroup @ DiseaseTgt $ MSI obtained older patients without hereditary nonpolyposis colorectal carcinoma showed epigenetic silencing hMLH1 . results indicated tumors MSI caused epigenetic MLH1 silencing distinct mutational background tumors genetic loss mismatch repair , suggesting two genetically distinct entities microsatellite-instable tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1008227911271029)\n",
      "- Text: \"Tumorigenesis : RAF/RAS oncogenes mismatch-repair status . Genes RAF family encode kinases regulated Ras mediate cellular responses growth signals . Activating mutations one RAF gene , BRAF , found high proportion melanomas small fraction cancers . show BRAF mutations @ DiseaseTgt $ occur tumours carry mutations RAS gene known @ GeneSrc $ , BRAF mutation linked proficiency tumours repairing mismatched bases DNA . results provide genetic support idea mutations BRAF @ GeneSrc $ exert equivalent effects tumorigenesis , also emphasize role repair processes establishing mutation spectra underpin human cancer .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7624294791834282)\n",
      "- Text: \"Vitamin C selectively kills @ GeneSrc $ BRAF mutant @ DiseaseTgt $ cells targeting GAPDH . half human @ DiseaseTgt $ ( @ DiseaseTgt $ ) carry either @ GeneSrc $ BRAF mutations often refractory approved targeted therapies . found cultured human @ DiseaseTgt $ cells harboring @ GeneSrc $ BRAF mutations selectively killed exposed high levels vitamin C. effect due increased uptake oxidized form vitamin C , dehydroascorbate ( DHA ) , via GLUT1 glucose transporter . Increased DHA uptake causes oxidative stress intracellular DHA reduced vitamin C , depleting glutathione . Thus , reactive oxygen species accumulate inactivate glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) . Inhibition GAPDH highly glycolytic @ GeneSrc $ BRAF mutant cells leads energetic crisis cell death seen @ GeneSrc $ BRAF wild-type cells . High-dose vitamin C impairs tumor growth @ GeneSrc $ ) mutant mice . results provide mechanistic rationale exploring therapeutic use vitamin C @ DiseaseTgt $ @ GeneSrc $ BRAF mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0912834726218942)\n",
      "- Text: \"Modulation p53 function @ GeneSrc $ methylation lysine 382 . Reversible covalent methylation lysine residues histone proteins constitutes principal molecular mechanism links chromatin states diverse biological outcomes . Recently , lysine methylation observed nonhistone proteins , suggesting broad cellular roles enzymes generating removing methyl moieties . report lysine methyltransferase enzyme @ GeneSrc $ regulates @ DiseaseTgt $ suppressor protein p53 . find @ GeneSrc $ specifically monomethylates p53 lysine 382 ( p53K382me1 ) . methylation event robustly suppresses p53-mediated transcription activation highly responsive target genes little influence weak targets . , depletion @ GeneSrc $ augments proapoptotic checkpoint activation functions p53 , accordingly , @ GeneSrc $ expression downregulated upon DNA damage . Together , study identifies @ GeneSrc $ p53-modifying enzyme , identifies p53K382me1 regulatory posttranslational modification p53 , begins dissect methylation may contribute dynamic posttranslational code modulates distinct p53 functions .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0084796881059139)\n",
      "- Text: \"Glutathione s-transferase omega 1 activity sufficient suppress neurodegeneration Drosophila model @ DiseaseTgt $ . loss-of-function mutation gene parkin causes common neurodegenerative disease may caused mitochondrial dysfunction . Glutathione S-transferase Omega ( GSTO ) involved cell defense mechanisms , little known role GSTO progression @ DiseaseTgt $ . , report restoration Drosophila GSTO1 ( @ GeneSrc $ ) , down-regulated parkin mutants , alleviates parkin pathogenic phenotypes loss @ GeneSrc $ function enhances parkin mutant phenotypes . identified ATP synthase beta subunit novel vivo target @ GeneSrc $ . found glutathionylation ATP synthase beta subunit rescued @ GeneSrc $ expression @ GeneSrc $ partially restores activity assembly mitochondrial F ( 1 ) F ( 0 ) -ATP synthase parkin mutants . results suggest novel mechanism protective role @ GeneSrc $ parkin mutants , regulation ATP synthase activity , provide insight potential therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0148507690573702)\n",
      "- Text: \"Glutathione s-transferase omega 1 activity sufficient suppress neurodegeneration Drosophila model @ DiseaseTgt $ . loss-of-function mutation gene parkin causes common neurodegenerative disease may caused mitochondrial dysfunction . Glutathione S-transferase Omega ( GSTO ) involved cell defense mechanisms , little known role GSTO progression @ DiseaseTgt $ . , report restoration Drosophila @ GeneSrc $ ( DmGSTO1 ) , down-regulated parkin mutants , alleviates parkin pathogenic phenotypes loss DmGSTO1 function enhances parkin mutant phenotypes . identified ATP synthase beta subunit novel vivo target DmGSTO1 . found glutathionylation ATP synthase beta subunit rescued DmGSTO1 expression DmGSTO1 partially restores activity assembly mitochondrial F ( 1 ) F ( 0 ) -ATP synthase parkin mutants . results suggest novel mechanism protective role DmGSTO1 parkin mutants , regulation ATP synthase activity , provide insight potential therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001517571853985)\n",
      "- Text: \"Pathological alpha-synuclein transmission initiated binding lymphocyte-activation gene 3 . Emerging evidence indicates pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) may due cell-to-cell transmission misfolded preformed fibrils ( PFF ) alpha-synuclein ( alpha-syn ) . mechanism alpha-syn PFF spreads neuron neuron known . , show @ GeneSrc $ ( @ GeneSrc $ ) binds alpha-syn PFF high affinity ( dissociation constant = 77 nanomolar ) , whereas alpha-syn monomer exhibited minimal binding . alpha-Syn-biotin PFF binding @ GeneSrc $ initiated alpha-syn PFF endocytosis , transmission , toxicity . Lack @ GeneSrc $ substantially delayed alpha-syn PFF-induced loss dopamine neurons , well biochemical behavioral deficits vivo . identification @ GeneSrc $ receptor binds alpha-syn PFF provides target developing therapeutics designed slow progression @ DiseaseTgt $ related alpha-synucleinopathies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0497557416382295)\n",
      "- Text: \"Homozygous @ GeneSrc $ Missense Variant ( p. Arg122Gln ) Individual Intellectual Disability , Generalized Epilepsy , Juvenile Parkinsonism . Biallelic variants @ GeneSrc $ associated autosomal recessive intellectual disability , spasticity , juvenile parkinsonism , reported cases . , present clinical genetic findings female Austrian origin exhibiting infantile neurodevelopmental abnormalities , intellectual disability , childhood-onset @ DiseaseTgt $ , consistent established phenotypic spectrum . Notably , developed genetic generalized epilepsy age 4 , persisting adulthood . Using diagnostic exome sequencing , identified homozygous missense variant ( c.365 G > , p. ( Arg122Gln ) ) @ GeneSrc $ ( NM_001013663 ) . summary , findings support existing link biallelic @ GeneSrc $ variants parkinsonism neurodevelopmental abnormalities also suggest potential extension phenotypic spectrum include generalized epilepsy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0129606696742647)\n",
      "- Text: \"Glutathione s-transferase omega 1 activity sufficient suppress neurodegeneration Drosophila model @ DiseaseTgt $ . loss-of-function mutation gene parkin causes common neurodegenerative disease may caused mitochondrial dysfunction . Glutathione S-transferase Omega ( GSTO ) involved cell defense mechanisms , little known role GSTO progression @ DiseaseTgt $ . , report restoration Drosophila GSTO1 ( DmGSTO1 ) , down-regulated parkin mutants , alleviates parkin pathogenic phenotypes loss DmGSTO1 function enhances parkin mutant phenotypes . identified @ GeneSrc $ subunit novel vivo target DmGSTO1 . found glutathionylation @ GeneSrc $ subunit rescued DmGSTO1 expression DmGSTO1 partially restores activity assembly mitochondrial F ( 1 ) F ( 0 ) -ATP synthase parkin mutants . results suggest novel mechanism protective role DmGSTO1 parkin mutants , regulation ATP synthase activity , provide insight potential therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0034024851445251)\n",
      "- Text: \"Presenilin-1 , nicastrin , amyloid precursor protein , gamma-secretase activity co-localized lysosomal membrane . @ DiseaseTgt $ ( @ DiseaseTgt $ ) caused cerebral deposition beta-amyloid ( Abeta ) , 38 - 43-amino acid peptide derived proteolytic cleavage amyloid precursor protein ( APP ) . Initial studies indicated final cleavage APP gamma-secretase ( complex containing presenilin nicastrin ) produce Abeta occurred endosomal/lysosomal system . However , studies showing predominant endoplasmic reticulum localization gamma-secretase proteins neutral pH optimum vitro gamma-secretase assays challenged conclusion . recently identified nicastrin major lysosomal membrane protein . present work , use Western blotting immunogold electron microscopy demonstrate significant amounts mature nicastrin , presenilin-1 , APP co-localized @ GeneSrc $ ( cAMP-1 ) outer membranes lysosomes . Furthermore , demonstrate membranes contain acidic gamma-secretase activity , immunoprecipitable antibody nicastrin . experiments establish APP , nicastrin , presenilin-1 resident lysosomal membrane proteins indicate gamma-secretase lysosomal protease . data reassert importance lysosomal/endosomal system generation Abeta suggest role lysosomes pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1339882033340327)\n",
      "- Text: \"Antioxidants protect PINK1-dependent dopaminergic neurons Drosophila . @ DiseaseTgt $ ( @ DiseaseTgt $ ) frequent neurodegenerative movement disorder . Mutations PINK1 gene linked autosomal recessive early onset familial form @ DiseaseTgt $ . physiological function PINK1 pathological abnormality @ DiseaseTgt $ PINK1 mutants largely unknown . show inactivation Drosophila PINK1 ( dPINK1 ) using RNAi results progressive loss dopaminergic neurons ommatidial degeneration compound eye , rescued expression human PINK1 ( hPINK1 ) . Expression human SOD1 suppresses neurodegeneration induced dPINK1 inactivation . Moreover , treatment dPINK1 RNAi flies antioxidants @ GeneSrc $ vitamin E significantly inhibits ommatidial degeneration . Thus , dPINK1 plays essential role maintaining neuronal survival preventing neurons undergoing oxidative stress , thereby suggesting potential mechanism reduction PINK1 function leads @ DiseaseTgt $ neurodegeneration .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4885295957124179)\n",
      "- Text: \"Apolipoprotein E animal models CNS injury @ DiseaseTgt $ . Recent evidence indicates apolipoprotein E ( ApoE ) plays central role hippocampal response injury . co-ordinated expression ApoE receptor , ApoE/ApoB [ low density lipoprotein ( LDL ) ] receptor , appears regulate transport cholesterol phospholipids early intermediate phases reinnervation process . dendritic remodeling synaptogenesis , neurons progressively repress synthesis cholesterol favor cholesterol internalization @ GeneSrc $ pathway . discovery epsilon 4 allele strongly linked sporadic familial late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) raises possibility dysfunction lipid-transport system associated compensatory sprouting synaptic remodeling could central @ DiseaseTgt $ process . role ApoE CNS particularly important relation function cholinergic system , relies certain extent integrity phospholipid homeostasis neurons . Recent evidence suggests epsilon 4 allele direct impact cholinergic function @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0034130551809091)\n",
      "- Text: \"Array-based multiplex analysis candidate genes reveals two independent additive genetic risk factors @ DiseaseTgt $ Finnish population . analysed common variants eight genes implicated previously risk factors coronary heart disease @ DiseaseTgt $ ( MI ) cross-sectional study patients history MI carefully matched controls Finnish population . common @ GeneSrc $ mutations Finland also included analysis . Multiplex genotyping target genes performed using specific efficient array-based minisequencing system . 4 G allele plasminogen activator inhibitor gene ( P < 0.05 ) PlA2 allele glycoprotein IIIa gene ( P < 0.01 ) associated increased risk MI study population . analysed combined effect risk alleles found concurrent carrier status two genetic variants conferred high risk development MI sample ( = 4.5 , P = 0.001 ) , particularly prominent male subjects ( = 6.4 , P = 0.0005 ) . study demonstrates application new powerful tool genome analysis yield information inherited determinants susceptibility MI . observation two separate genes contributing additive risk developing MI exemplifies advantages multiplex analysis genetic variation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0618387093210608)\n",
      "- Text: \"5-Methylcytosine endogenous mutagen human @ GeneSrc $ p53 genes . Direct genomic sequencing revealed cytosine residues known undergone germ-line mutation @ GeneSrc $ gene somatic mutations p53 @ DiseaseTgt $ suppressor gene methylated normal human tissues analyzed . Thus , mutations scored transitions 5-methylcytosine thymine rather cytosine thymine . Methylated cytosines occur exclusively CpG dinucleotides , , although markedly underrepresented human DNA , sites 30 percent known disease-related point mutations . Thus , 5-methylcytosine functions endogenous mutagen carcinogen humans , methylation seems increase potential mutation cytosine residues least factor 10 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2184735786682372)\n",
      "- Text: \"Functional variation @ GeneSrc $ confers risk @ DiseaseTgt $ regulates lymphotoxin-alpha secretion vitro . @ DiseaseTgt $ ( MI ) become one leading causes death world . pathogenesis includes chronic formation plaque inside vessel wall coronary artery acute rupture artery , implicating number inflammation-mediating molecules , cytokine lymphotoxin-alpha ( LTA ) . Functional variations LTA associated susceptibility MI . show LTA protein binds @ GeneSrc $ , member galactose-binding lectin family . case-control association study Japanese population showed single nucleotide polymorphism @ GeneSrc $ encoding @ GeneSrc $ significantly associated susceptibility MI . genetic substitution affects transcriptional level @ GeneSrc $ vitro , potentially leading altered secretion LTA , would affect degree inflammation ; however , relevance populations remains clarified . Smooth muscle cells macrophages human atherosclerotic lesions expressed @ GeneSrc $ LTA . findings thus suggest link LTA cascade pathogenesis MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0348482588848477)\n",
      "- Text: \"transcriptionally [ correction transcriptively ] active complex APP Fe65 histone acetyltransferase Tip60 . Amyloid-beta precursor protein ( APP ) , widely expressed cell-surface protein , cleaved transmembrane region gamma-secretase . gamma-Cleavage APP produces extracellular amyloid beta-peptide @ DiseaseTgt $ releases intracellular tail fragment unknown physiological function . demonstrate cytoplasmic tail APP forms multimeric complex nuclear adaptor protein Fe65 histone acetyltransferase Tip60 . complex potently stimulates transcription via heterologous @ GeneSrc $ LexA-DNA binding domains , suggesting release cytoplasmic tail APP gamma-cleavage may function gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.8761710858601045e-07)\n",
      "- Text: \"p53 : transdominant regulator transcription whose function ablated mutations occurring human @ DiseaseTgt $ . @ GeneSrc $ fusion constructs demonstrate wild type p53 potent transactivator human lung cancer cells transactivation domain p53 residing amino acids 1 - 42 . Strikingly , variety lung cancer derived p53 mutations occurring outside domain disrupt activity . Temperature sensitive conformational shifts p53 mutant proteins wild type form exist , temperature downshift , several mutants become transcriptionally active . Wild type p53 protein known form oligomers mutant p53 cotransfection wild type mutant genes shows p53 acts transdominant manner independent DNA binding specificity . Transcription either increased decreased depending whether wild type less abundant mutant form . Finally , lung cancers differ ability support transactivation related functions , providing evidence abnormalities p53 system human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0036939957720005)\n",
      "- Text: \"Myeloid translocation gene family members associate T-cell factors ( TCFs ) influence TCF-dependent transcription . Canonical Wnt signaling mediated molecular `` switch `` regulates transcriptional properties T-cell factor ( TCF ) family DNA-binding proteins . Members myeloid translocation gene ( MTG ) family transcriptional corepressors frequently disrupted chromosomal translocations acute myeloid leukemia , whereas MTG16 may inactivated 40 % breast cancer MTG8 candidate cancer gene @ DiseaseTgt $ . Genetic studies imply corepressor family may function stem cells . Given mice lacking Myeloid Translocation Gene Related-1 ( Mtgr1 ) fail maintain secretory lineage small intestine , surveyed transcription factors might recruit Mtgr1 intestinal stem cells progenitor cells found MTG family members associate specifically TCF4 . Coexpression beta-catenin disrupted association corepressors TCF4 . Furthermore , expressed Xenopus embryos , MTG family members inhibited axis formation impaired ability @ GeneSrc $ XLef-1 induce axis duplication , indicating MTG family members act downstream beta-catenin . Moreover , found c-Myc , transcriptional target Wnt pathway , overexpressed small intestines mice lacking Mtgr1 , thus linking inactivation Mtgr1 activation potent oncogene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.0888555249190096e-05)\n",
      "- Text: \"Activation FoxO LRRK2 induces expression proapoptotic proteins alters survival postmitotic dopaminergic neuron Drosophila . Missense mutations leucine-rich repeat kinase 2 ( LRRK2 ) /Dardarin gene , product encodes kinase multiple domains , known cause autosomal dominant late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . current study , report gene product LRRK2 directly phosphorylates forkhead box transcription factor FoxO1 enhances transcriptional activity . pathway found conserved Drosophila , Drosophila LRRK2 homolog ( dLRRK ) enhanced neuronal toxicity FoxO . Importantly , FoxO mutants resistant LRRK2/dLRRK-induced phosphorylation suppressed neurotoxicity . Moreover , determined FoxO targets @ GeneSrc $ bim Drosophila human , respectively , responsible LRRK2/dLRRK-mediated cell death . data suggest cell death molecules regulated FoxO key factors neurodegeneration LRRK2-linked @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004803545610857)\n",
      "- Text: \"Drosophila p53 binds damage response element @ GeneSrc $ locus . @ DiseaseTgt $ suppressor gene p53 regulates multiple cellular responses DNA damage , transcriptional targets specify responses incompletely understood . describe Drosophila p53 homolog demonstrate activate transcription promoter containing binding sites human p53 . Dominant-negative forms Drosophila p53 inhibit transactivation cultured cells radiation-induced apoptosis developing tissues . cis-regulatory region proapoptotic gene @ GeneSrc $ contains radiation-inducible enhancer includes consensus p53 binding site . Drosophila p53 activate transcription site yeast multimer site sufficient radiation induction vivo . results indicate @ GeneSrc $ direct transcriptional target Drosophila p53 following DNA damage .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0051486664143651)\n",
      "- Text: \"Direct generation functional dopaminergic neurons mouse human fibroblasts . Transplantation dopaminergic neurons potentially improve clinical outcome @ DiseaseTgt $ , neurological disorder resulting degeneration mesencephalic dopaminergic neurons . particular , transplantation embryonic-stem-cell-derived dopaminergic neurons shown efficient restoring motor symptoms conditions dopamine deficiency . However , use pluripotent-derived cells might lead development tumours properly controlled . identified minimal set three transcription factors -- Mash1 ( also known Ascl1 ) , Nurr1 ( also known Nr4a2 ) @ GeneSrc $ -- able generate directly functional dopaminergic neurons mouse human fibroblasts without reverting progenitor cell stage . Induced dopaminergic ( iDA ) cells release dopamine show spontaneous electrical activity organized regular spikes consistent pacemaker activity featured brain dopaminergic neurons . three factors able elicit dopaminergic neuronal conversion prenatal adult fibroblasts healthy donors @ DiseaseTgt $ patients . Direct generation iDA cells somatic cells might significant implications understanding critical processes neuronal development , vitro disease modelling cell replacement therapies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.671434529978304e-06)\n",
      "- Text: \"Akt regulates growth directly phosphorylating @ GeneSrc $ . direct mechanism serine/threonine kinase Akt ( also known protein kinase B ( PKB ) ) regulates cell growth unknown . , report Drosophila melanogaster Akt/PKB stimulates growth phosphorylating @ GeneSrc $ ( @ GeneSrc $ ) @ DiseaseTgt $ suppressor inhibiting formation @ GeneSrc $ complex . show Akt/PKB directly phosphorylates Drosophila @ GeneSrc $ vitro conserved residues , Ser 924 Thr 1518 . Mutation sites renders @ GeneSrc $ insensitive Akt/PKB signalling , increasing stability @ GeneSrc $ complex within cell . Stimulating Akt/PKB signalling vivo markedly increases cell growth/size , disrupts @ GeneSrc $ complex disturbs distinct subcellular localization Tsc1 @ GeneSrc $ . Furthermore , Akt/PKB growth signals blocked expression @ GeneSrc $ mutant lacking Akt phosphorylation sites . Thus , @ GeneSrc $ seems critical target Akt mediating growth signals insulin signalling pathway .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6057959219980339)\n",
      "- Text: \"@ GeneSrc $ required activity nuclear access Notch Drosophila . Presenilins membrane proteins multiple transmembrane domains thought contribute development @ DiseaseTgt $ affecting processing beta-amyloid precursor protein . Presenilins also facilitate activity transmembrane receptors LIN-12/Notch family . ligand-induced processing , intracellular domain LIN-12/Notch enter nucleus participate transcriptional control downstream target genes . show null mutations Drosophila @ GeneSrc $ gene abolish Notch signal transduction prevent intracellular domain entering nucleus . Furthermore , provide evidence @ GeneSrc $ required proteolytic release intracellular domain membrane following activation Notch ligand .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0426578350234257)\n",
      "- Text: \"Neurogenic phenotypes altered Notch processing Drosophila @ GeneSrc $ mutants . @ GeneSrc $ proteins implicated developmental signalling cell-surface protein Notch pathogenesis @ DiseaseTgt $ . Loss @ GeneSrc $ function leads Notch/lin-12-like mutant phenotypes Caenorhabditis elegans reduced Notch1 expression mouse paraxial mesoderm . humans , presenilins associated @ DiseaseTgt $ stimulate overproduction neurotoxic 42-amino-acid beta-amyloid derivative ( Abeta42 ) amyloid-precursor protein APP . describe loss-of-function mutations Drosophila @ GeneSrc $ gene cause lethal Notch-like phenotypes maternal neurogenic effects embryogenesis , loss lateral inhibition within proneural cell clusters , absence wing margin formation . show @ GeneSrc $ required normal proteolytic production carboxy-terminal Notch fragments needed receptor maturation signalling , genetically acts upstream membrane-bound form activated nuclear form Notch . findings provide evidence existence distinct processing sites modifications extracellular domain Notch . also link role @ GeneSrc $ Notch signalling effect amyloid production @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0646770197395194)\n",
      "- Text: \"role @ GeneSrc $ cofactors gamma-secretase complex . Mutations @ GeneSrc $ genes account majority cases familial form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ essential gamma-secretase activity , proteolytic activity involved intramembrane cleavage Notch beta-amyloid precursor protein ( betaAPP ) . Cleavage betaAPP @ DiseaseTgt $ mutant @ GeneSrc $ results overproduction highly amyloidogenic amyloid beta42 peptides . gamma-Secretase activity requires formation stable , high-molecular-mass protein complex , addition endoproteolysed fragmented form @ GeneSrc $ , contains essential cofactors including nicastrin , APH-1 ( refs 15 - 18 ) PEN-2 ( refs 16 , 19 ) . However , role protein complex formation generation enzymatic activity unclear . show Drosophila APH-1 ( Aph-1 ) increases stability Drosophila @ GeneSrc $ ( @ GeneSrc $ ) holoprotein complex . Depletion PEN-2 RNA interference prevents endoproteolysis @ GeneSrc $ promotes stabilization holoprotein Drosophila mammalian cells , including primary neurons . Co-expression Drosophila Pen-2 Aph-1 nicastrin increases formation @ GeneSrc $ fragments well gamma-secretase activity . Thus , APH-1 stabilizes @ GeneSrc $ holoprotein complex , whereas PEN-2 required endoproteolytic processing @ GeneSrc $ conferring gamma-secretase activity complex .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9927033133850552)\n",
      "- Text: \"reporter amyloid precursor protein gamma-secretase activity Drosophila . key event pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) deposition senile plaques consisting largely peptide known beta-amyloid ( Abeta ) derived amyloid precursor protein ( APP ) . proteolytic activity called gamma-secretase cleaves APP transmembrane domain required Abeta generation . Aberrant gamma-secretase cleavage APP underlies majority early onset , familial @ DiseaseTgt $ . gamma-Secretase resides large multi-protein complex , @ GeneSrc $ , Nicastrin , APH-1 PEN-2 four essential components . Thus , identifying components pathways gamma-secretase activity regulated crucial understanding mechanisms underlying @ DiseaseTgt $ pathogenesis , may provide new diagnostic tools therapeutic targets . describe generation Drosophila act living reporters gamma-secretase activity fly eye . reporter flies size eye correlates level endogenous gamma-secretase activity , sensitive levels three genes required APP gamma-secretase activity , @ GeneSrc $ , nicastrin aph-1 . Thus , flies provide sensitized system identify components gamma-secretase complex regulators activity . used flies carry screen mutations suppress gamma-secretase activity identified small chromosomal region contains gene genes whose products may promote gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1435646590963783)\n",
      "- Text: \"SRF myocardin regulate @ GeneSrc $ amyloid-beta clearance brain vascular cells . Amyloid beta-peptide ( Abeta ) deposition cerebral vessels contributes cerebral amyloid angiopathy ( CAA ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , report @ DiseaseTgt $ patients two mouse models @ DiseaseTgt $ , overexpression serum response factor ( SRF ) myocardin ( MYOCD ) cerebral vascular smooth muscle cells ( VSMCs ) generates Abeta non-clearing VSMC phenotype transactivation sterol regulatory element binding protein-2 , downregulates @ GeneSrc $ , key Abeta clearance receptor . Hypoxia stimulated SRF/MYOCD expression human cerebral VSMCs animal models @ DiseaseTgt $ . suggest SRF MYOCD function transcriptional switch , controlling Abeta cerebrovascular clearance progression @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0134797669337401)\n",
      "- Text: \"LDL receptor-related protein , multifunctional ApoE receptor , binds secreted beta-amyloid precursor protein mediates degradation . secreted form beta-amyloid precursor protein ( APP ) containing Kunitz proteinase inhibitor ( KPI ) domain , also called protease nexin II , internalized degraded cells . show low density lipoprotein ( LDL ) receptor-related protein ( @ GeneSrc $ ) responsible endocytosis secreted APP . APPs770 degradation inhibited @ GeneSrc $ antagonist called receptor-associated protein ( RAP ) @ GeneSrc $ antibodies greatly diminished fibroblasts genetically deficient @ GeneSrc $ . APPs695 , lacks KPI domain , poor @ GeneSrc $ ligand . Since @ GeneSrc $ also binds apolipoprotein E ( apoE ) -enriched lipoproteins inheritance epsilon 4 allele apoE gene risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , data link single metabolic pathway two molecules strongly implicated pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8254088508673765)\n",
      "- Text: \"Alpha2-macroglobulin complexes mediates endocytosis beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein . primary histopathological feature @ DiseaseTgt $ accumulation beta-amyloid ( beta ) brain afflicted individuals . However , beta produced continuously soluble protein healthy individuals detected serum CSF , suggesting existence cellular clearance mechanisms normally prevent accumulation aggregation . , demonstrate beta forms stable complexes activated alpha2-macroglobulin ( alpha2 * ) , physiological ligand low-density lipoprotein receptor-related protein ( @ GeneSrc $ ) abundantly expressed CNS . alpha2M * /125I-A beta complexes immunoreactive anti-A beta anti-alpha2 IgG stable various pH conditions , sodium dodecyl sulfate , reducing agents , boiling . demonstrate alpha2M * /125I-A beta complexes degraded glioblastoma cells fibroblasts via @ GeneSrc $ , degradation partially inhibited receptor-associated protein ( RAP ) , antagonist ligand interactions @ GeneSrc $ . contrast , degradation free 125I-A beta inhibited RAP thus must mediated via @ GeneSrc $ pathway . results suggest @ GeneSrc $ function clearance receptor beta via physiological ligand .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.019488162968545)\n",
      "- Text: \"Modulation amyloid beta-protein clearance @ DiseaseTgt $ susceptibility @ GeneSrc $ pathway . Susceptibility @ DiseaseTgt $ ( @ DiseaseTgt $ ) governed multiple genetic factors . Remarkably , @ GeneSrc $ ( @ GeneSrc $ ) ligands , apoE alpha2 , genetically associated @ DiseaseTgt $ . study , provide evidence involvement @ GeneSrc $ pathway amyloid deposition sequestration removal soluble amyloid beta-protein ( Abeta ) . demonstrate vitro @ GeneSrc $ mediates clearance Abeta40 Abeta42 bona fide receptor-mediated uptake mechanism . vivo , reduced @ GeneSrc $ expression associated @ GeneSrc $ genotypes correlated enhanced soluble Abeta levels amyloid deposition . Although @ GeneSrc $ proposed clearance pathway Abeta , work provides first vivo evidence @ GeneSrc $ pathway may modulate Abeta deposition @ DiseaseTgt $ susceptibility regulating removal soluble Abeta .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2262968682984313)\n",
      "- Text: \"Apolipoprotein ( apo ) E4 enhances amyloid beta peptide production cultured neuronal cells : apoE structure potential therapeutic target . Apolipoprotein ( apo ) E4 major risk factor @ DiseaseTgt $ , many studies suggested apoE isoform-specific effects deposition clearance amyloid beta ( Abeta ) peptides . examined effects apoE isoforms processing amyloid precursor protein ( APP ) Abeta production rat neuroblastoma B103 cells stably transfected human wild-type APP695 ( B103-APP ) . Lipid-poor apoE4 increased Abeta production B103-APP cells greater extent lipid-poor apoE3 ( 60 % vs. 30 % ) due pronounced stimulation APP recycling apoE4 apoE3 . difference Abeta production abolished preincubating cells receptor-associated protein ( 25 nM ) , blocks low-density lipoprotein receptor-related protein ( LRP ) pathway , reducing LRP expression small interference RNA . differences also attenuated replacing Arg-61 threonine apoE4 pretreating apoE4 small molecules , abolish apoE4 intramolecular domain interaction . Thus , apoE4 appears modulate APP processing Abeta production @ GeneSrc $ pathway domain interaction . findings provide insights apoE4 associated increased risk @ DiseaseTgt $ may represent potential target drug development .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 8.74641804138761e-06)\n",
      "- Text: \"LDL receptor-related protein , multifunctional ApoE receptor , binds secreted beta-amyloid precursor protein mediates degradation . secreted form beta-amyloid precursor protein ( APP ) containing Kunitz proteinase inhibitor ( KPI ) domain , also called protease nexin II , internalized degraded cells . show low density lipoprotein ( LDL ) receptor-related protein ( LRP ) responsible endocytosis secreted APP . APPs770 degradation inhibited LRP antagonist called @ GeneSrc $ ( @ GeneSrc $ ) LRP antibodies greatly diminished fibroblasts genetically deficient LRP . APPs695 , lacks KPI domain , poor LRP ligand . Since LRP also binds apolipoprotein E ( apoE ) -enriched lipoproteins inheritance epsilon 4 allele apoE gene risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , data link single metabolic pathway two molecules strongly implicated pathophysiology @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0113745700383328)\n",
      "- Text: \"Alpha2-macroglobulin complexes mediates endocytosis beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein . primary histopathological feature @ DiseaseTgt $ accumulation beta-amyloid ( beta ) brain afflicted individuals . However , beta produced continuously soluble protein healthy individuals detected serum CSF , suggesting existence cellular clearance mechanisms normally prevent accumulation aggregation . , demonstrate beta forms stable complexes activated alpha2-macroglobulin ( alpha2 * ) , physiological ligand low-density lipoprotein receptor-related protein ( LRP ) abundantly expressed CNS . alpha2M * /125I-A beta complexes immunoreactive anti-A beta anti-alpha2 IgG stable various pH conditions , sodium dodecyl sulfate , reducing agents , boiling . demonstrate alpha2M * /125I-A beta complexes degraded glioblastoma cells fibroblasts via LRP , degradation partially inhibited @ GeneSrc $ ( @ GeneSrc $ ) , antagonist ligand interactions LRP . contrast , degradation free 125I-A beta inhibited @ GeneSrc $ thus must mediated via LRP-independent pathway . results suggest LRP function clearance receptor beta via physiological ligand .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.060560049319109)\n",
      "- Text: \"Analysis p53 transactivation high-affinity binding sites . Alterations elimination p53 protein frequently occurring human carcinogenesis . Overexpression wild-type p53 profound growth-inhibitory effect many cell lines , including strong apparently non-sequence specific repression number promoters . Consistent hypothesis acts transcriptional regulator , wild-type p53 protein binds DNA activates transcription several promoters . studied DNA binding transactivation ( TA ) properties human wild-type mutant p53 proteins representing four major mutational hotspots . DNA-gel retardation used detect specific p53-DNA complexes nuclear extracts , radiolabelled oligonucleotides representing high affinity p53-binding sites ( HBS ) probe . p53-specific complexes identified competition unlabelled ' self ' oligos double band-shifts presence anti-p53 antibodies . show transactivation p53 , TK promoter-driven CAT reporter gene placed 3 ' p53-binding site . CAT activity assayed co-transfection reporters either wild-type ( WT ) mutant p53 expression constructs human cells express p53 ( SKOV3 ) . found wild-type p53 strong transactivating effect reporter . mutants , exception His273 , inactive TA-assay . p53 target several oncogenes found DNA @ DiseaseTgt $ viruses . examined effect either SV40 T-ag 55 kDa EIB protein Ad5 DNA binding transactivation p53 transformed COS-1 293 cell lines , respectively . COS-1 extracts produced strong p53-dependent band-shift HBS oligos , doubleshifted anti-p53 @ GeneSrc $ antibodies , indicating @ GeneSrc $ part complex . COS-1 cells high level WT p53-dependent expression transfected CAT reporter , indicating presence transactivation-competent p53 , acting HBS element . human Ad-transformed 293 cells , endogenous p53 also transactivation competent capable DNA binding . summary , found efficient transactivation HBS motif WT His273-p53 . Studies COS-1 293 cells suggest proportion p53 transformed cells display wild-type DNA binding TA properties expression transcriptionally inactive mutant p53 proteins cells interfere WT-dependent transactivation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.4474256533281485e-06)\n",
      "- Text: \"Identification 46 novel SNPs 130-kb region containing myocardial infarction susceptibility gene chromosomal band 6p21 . identified total 187 single-nucleotide polymorphisms ( SNPs ) 11 gene loci 130-kb region chromosome 6p21 containing gene strongly associated @ DiseaseTgt $ ( MI ) . comparing data SNPs deposited dbSNP database National Center Biotechnology Information , 46 SNPs ( 24.6 % ) considered novel : four identified P5 - 1 locus , 14 MICB locus , nine BAT1 locus , one ATP6V1G2 locus , six NFKBIL1 locus , one @ GeneSrc $ locus , one TNF locus , five LST1 locus , four LY117a locus , one AIF-1 locus . SNP map presented provide useful resource examining relationships genotypes susceptibility MI phenotype , also scanning complex diseases mapped local segment chromosome 6 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.7800358436074089e-07)\n",
      "- Text: \"Allele-specific repression @ GeneSrc $ activated B cell factor-1 . Genetic variation human @ GeneSrc $ locus , encoding @ GeneSrc $ , associated susceptibility @ DiseaseTgt $ , asthma diseases . detailed haplotypic analysis locus , identified single-nucleotide polymorphism ( SNP ) @ GeneSrc $ main predictor @ GeneSrc $ protein production human B cells . found activated B-cell factor-1 ( ABF-1 ) binds site vitro suppresses reporter gene expression , presence @ GeneSrc $ allele . Using haplotype-specific chromatin immunoprecipitation , confirmed ABF-1 preferentially recruited low-producer allele vivo . findings provide molecular model @ GeneSrc $ expression may genetically regulated allele-specific recruitment transcriptional repressor ABF-1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0064772825335141)\n",
      "- Text: \"Functional SNPs @ GeneSrc $ gene associated susceptibility @ DiseaseTgt $ . means large-scale , case-control association study using 92,788 gene-based single-nucleotide polymorphism ( SNP ) markers , identified candidate locus chromosome 6p21 associated susceptibility @ DiseaseTgt $ . Subsequent linkage-disequilibrium ( LD ) mapping analyses haplotype structure showed significant associations @ DiseaseTgt $ single 50 kb halpotype comprised five SNPs @ GeneSrc $ ( encoding @ GeneSrc $ ) , NFKBIL1 ( encoding nuclear factor kappa light polypeptide gene enhancer B cells , inhibitor-like 1 ) BAT1 ( encoding HLA-B associated transcript 1 ) . Homozygosity respect two SNPs @ GeneSrc $ significantly associated increased risk @ DiseaseTgt $ ( odds ratio = 1.78 , chi ( 2 ) = 21.6 , P = 0.00000033 ; 1,133 affected individuals versus 1,006 controls ) . vitro functional analyses indicated one SNP coding region @ GeneSrc $ , changed amino-acid residue threonine asparagine ( Thr26Asn ) , effected twofold increase induction several cell-adhesion molecules , including VCAM1 , vascular smooth-muscle cells human coronary artery . Moreover , SNP , intron 1 @ GeneSrc $ , enhanced transcriptional level @ GeneSrc $ . results indicate variants @ GeneSrc $ risk factors myocardial infraction implicate @ GeneSrc $ pathogenesis disorder .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0409976546417157)\n",
      "- Text: \"Functional variation LGALS2 confers risk @ DiseaseTgt $ regulates @ GeneSrc $ secretion vitro . @ DiseaseTgt $ ( MI ) become one leading causes death world . pathogenesis includes chronic formation plaque inside vessel wall coronary artery acute rupture artery , implicating number inflammation-mediating molecules , cytokine @ GeneSrc $ ( @ GeneSrc $ ) . Functional variations @ GeneSrc $ associated susceptibility MI . show @ GeneSrc $ protein binds galectin-2 , member galactose-binding lectin family . case-control association study Japanese population showed single nucleotide polymorphism LGALS2 encoding galectin-2 significantly associated susceptibility MI . genetic substitution affects transcriptional level galectin-2 vitro , potentially leading altered secretion @ GeneSrc $ , would affect degree inflammation ; however , relevance populations remains clarified . Smooth muscle cells macrophages human atherosclerotic lesions expressed galectin-2 @ GeneSrc $ . findings thus suggest link @ GeneSrc $ cascade pathogenesis MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.060913472595056)\n",
      "- Text: \"( 1 ; 12 ) ( q21 ; p13 ) translocation human @ DiseaseTgt $ results @ GeneSrc $ fusion . TEL/ETV6 gene located 12p13 encodes member ETS family transcription factors . Translocated ETS leukemia ( TEL ) frequently involved chromosomal translocations human malignancies , usually resulting expression fusion proteins amino-terminal part TEL either unrelated transcription factors protein tyrosine kinases . characterized ( 1 ; 12 ) ( q21 ; p13 ) translocation @ DiseaseTgt $ ( @ DiseaseTgt $ ) . protein level , untranslocated TEL copy , result ( 1 ; 12 ) translocation , fusion protein TEL essentially @ GeneSrc $ ( @ GeneSrc $ ) expressed . involvement @ GeneSrc $ human leukemogenesis previously described . @ GeneSrc $ protein belongs subfamily `` basic region helix-loop-helix `` ( bHLH ) protein shares additional region similarity called PAS ( Per , @ GeneSrc $ , SIM ) domain . @ GeneSrc $ central partner several heterodimeric transcription factors , including containing aryl hydrocarbon ( dioxin ) receptor ( AhR ) hypoxia-inducible factor 1alpha ( HIF1alpha ) . results show @ GeneSrc $ fusion protein crucial product translocation suggest interference activity AhR HIF1alpha contribute leukemogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5357181419654136)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation @ GeneSrc $ , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0013007909914327)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , @ GeneSrc $ , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018555057560108)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 @ GeneSrc $ predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.001639957158616)\n",
      "- Text: \"Modulation microRNA processing p53 . MicroRNAs ( miRNAs ) emerged key post-transcriptional regulators gene expression , involved diverse physiological pathological processes . Although miRNAs function @ DiseaseTgt $ suppressors oncogenes @ DiseaseTgt $ development , widespread downregulation miRNAs commonly observed human @ DiseaseTgt $ promotes cellular transformation tumorigenesis . indicates inherent significance small RNAs @ DiseaseTgt $ suppression . However , connection @ DiseaseTgt $ suppressor networks miRNA biogenesis machineries investigated depth . show central @ DiseaseTgt $ suppressor , p53 , enhances post-transcriptional maturation several miRNAs growth-suppressive function , including miR-16 - 1 , @ GeneSrc $ miR-145 , response DNA damage . HCT116 cells human diploid fibroblasts , p53 interacts Drosha processing complex association DEAD-box RNA helicase p68 ( also known DDX5 ) facilitates processing primary miRNAs precursor miRNAs . also found transcriptionally inactive p53 mutants interfere functional assembly Drosha complex p68 , leading attenuation miRNA processing activity . findings suggest transcription-independent modulation miRNA biogenesis intrinsically embedded @ DiseaseTgt $ suppressive program governed p53 . study reveals previously unrecognized function p53 miRNA processing , may underlie key aspects @ DiseaseTgt $ biology .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6136658245943262)\n",
      "- Text: \"Modulation microRNA processing p53 . MicroRNAs ( miRNAs ) emerged key post-transcriptional regulators gene expression , involved diverse physiological pathological processes . Although miRNAs function @ DiseaseTgt $ suppressors oncogenes @ DiseaseTgt $ development , widespread downregulation miRNAs commonly observed human @ DiseaseTgt $ promotes cellular transformation tumorigenesis . indicates inherent significance small RNAs @ DiseaseTgt $ suppression . However , connection @ DiseaseTgt $ suppressor networks miRNA biogenesis machineries investigated depth . show central @ DiseaseTgt $ suppressor , p53 , enhances post-transcriptional maturation several miRNAs growth-suppressive function , including miR-16 - 1 , miR-143 @ GeneSrc $ , response DNA damage . HCT116 cells human diploid fibroblasts , p53 interacts Drosha processing complex association DEAD-box RNA helicase p68 ( also known DDX5 ) facilitates processing primary miRNAs precursor miRNAs . also found transcriptionally inactive p53 mutants interfere functional assembly Drosha complex p68 , leading attenuation miRNA processing activity . findings suggest transcription-independent modulation miRNA biogenesis intrinsically embedded @ DiseaseTgt $ suppressive program governed p53 . study reveals previously unrecognized function p53 miRNA processing , may underlie key aspects @ DiseaseTgt $ biology .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5992677210752722)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation @ GeneSrc $ . experiments demonstrated up-regulation @ GeneSrc $ independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found @ GeneSrc $ strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.024564617270276)\n",
      "- Text: \"Modulation microRNA processing p53 . MicroRNAs ( miRNAs ) emerged key post-transcriptional regulators gene expression , involved diverse physiological pathological processes . Although miRNAs function @ DiseaseTgt $ suppressors oncogenes @ DiseaseTgt $ development , widespread downregulation miRNAs commonly observed human @ DiseaseTgt $ promotes cellular transformation tumorigenesis . indicates inherent significance small RNAs @ DiseaseTgt $ suppression . However , connection @ DiseaseTgt $ suppressor networks miRNA biogenesis machineries investigated depth . show central @ DiseaseTgt $ suppressor , p53 , enhances post-transcriptional maturation several miRNAs growth-suppressive function , including @ GeneSrc $ , miR-143 miR-145 , response DNA damage . HCT116 cells human diploid fibroblasts , p53 interacts Drosha processing complex association DEAD-box RNA helicase p68 ( also known DDX5 ) facilitates processing primary miRNAs precursor miRNAs . also found transcriptionally inactive p53 mutants interfere functional assembly Drosha complex p68 , leading attenuation miRNA processing activity . findings suggest transcription-independent modulation miRNA biogenesis intrinsically embedded @ DiseaseTgt $ suppressive program governed p53 . study reveals previously unrecognized function p53 miRNA processing , may underlie key aspects @ DiseaseTgt $ biology .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5914992699598945)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including @ GeneSrc $ miR-128a predicted target several HOX genes . Indeed , confirmed @ GeneSrc $ targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0037760708442884)\n",
      "- Text: \"Transactivation @ GeneSrc $ p53 broadly influences gene expression promotes apoptosis . p53 tumor suppressor protein critical regulator cellular response @ DiseaseTgt $ insults genotoxic stress . report , demonstrate microRNAs ( miRNAs ) important components p53 transcriptional network . Global miRNA expression analyses identified cohort miRNAs exhibit p53-dependent upregulation following DNA damage . One miRNA , @ GeneSrc $ , commonly deleted human @ DiseaseTgt $ , shown , frequently absent pancreatic cancer cells . Characterization @ GeneSrc $ primary transcript promoter demonstrates miRNA directly transactivated p53 . Expression @ GeneSrc $ causes dramatic reprogramming gene expression promotes apoptosis . Much like known set p53-regulated genes , @ GeneSrc $ genes highly enriched regulate cell-cycle progression , apoptosis , DNA repair , angiogenesis . Therefore , likely important function @ GeneSrc $ modulation fine-tuning gene expression program initiated p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0392965457080507)\n",
      "- Text: \"microRNA component p53 @ DiseaseTgt $ suppressor network . global decrease microRNA ( miRNA ) levels often observed human @ DiseaseTgt $ , indicating small RNAs may intrinsic function @ DiseaseTgt $ suppression . identify miRNA components @ DiseaseTgt $ suppressor pathways , compared miRNA expression profiles wild-type p53-deficient cells . describe family miRNAs , miR-34a-c , whose expression reflected p53 status . Genes encoding miRNAs @ GeneSrc $ family direct transcriptional targets p53 , whose induction DNA damage oncogenic stress depends p53 vitro vivo . Ectopic expression @ GeneSrc $ induces cell cycle arrest primary @ DiseaseTgt $ cell lines , consistent observed ability @ GeneSrc $ downregulate programme genes promoting cell cycle progression . p53 network suppresses @ DiseaseTgt $ formation coordinated activation multiple transcriptional targets , @ GeneSrc $ may act concert effectors inhibit inappropriate cell proliferation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9890389528888524)\n",
      "- Text: \"Transcriptional activation @ GeneSrc $ contributes p53-mediated apoptosis . p53 potent @ DiseaseTgt $ suppressor , whose biological effects largely due function transcriptional regulator . report , addition regulating expression hundreds protein-coding genes , p53 also modulates levels microRNAs ( miRNAs ) . Specifically , p53 induce expression microRNA-34a ( miR-34a ) cultured cells well irradiated mice , binding perfect p53 binding site located within gene gives rise miR-34a . Processing primary transcript mature @ GeneSrc $ involves excision 30 kb intron . Notably , inactivation @ GeneSrc $ strongly attenuates p53-mediated apoptosis cells exposed genotoxic stress , whereas overexpression @ GeneSrc $ mildly increases apoptosis . Hence , miR-34a direct proapoptotic transcriptional target p53 mediate p53 's biological effects . Perturbation @ GeneSrc $ expression , occurs human @ DiseaseTgt $ , may thus contribute tumorigenesis attenuating p53-dependent apoptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5721116126636274)\n",
      "- Text: \"Evaluation candidate tumour suppressor genes chromosome 18 @ DiseaseTgt $ . Chromosome deletions common genetic events observed cancer . deletions generally thought reflect existence tumour suppressor gene within lost region . However , lost region precisely coincide hereditary cancer locus , identification putative tumour suppressor gene ( target deletion ) problematic . example , previous studies demonstrated chromosome 18q lost 60 % @ DiseaseTgt $ well cancers , lost region could precisely determined . present rigorous strategy mapping evaluating allelic deletions sporadic tumours , apply evaluation chromosome 18 @ DiseaseTgt $ . Using approach , define minimally lost region ( MLR ) chromosome 18q21 , contains least two candidate tumour suppressor genes , @ GeneSrc $ DCC . analysis suggested genetic heterogeneity , @ GeneSrc $ deletion target third cases DCC neighbouring gene target remaining tumours .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1220860439145716)\n",
      "- Text: \"PINK1 loss-of-function mutations affect mitochondrial complex activity via NdufA10 ubiquinone uncoupling . resting conditions , Pink1 knockout cells cells derived patients PINK1 mutations display loss mitochondrial complex reductive activity , causing decrease mitochondrial membrane potential . Analyzing phosphoproteome complex liver brain Pink1 ( -/- ) mice , found specific loss phosphorylation serine-250 complex subunit NdufA10 . Phosphorylation serine-250 needed ubiquinone reduction complex I. Phosphomimetic NdufA10 reversed Pink1 deficits mouse knockout cells rescued mitochondrial depolarization synaptic transmission defects @ GeneSrc $ mutant Drosophila . Complex deficits adenosine triphosphate synthesis also rescued cells derived PINK1 patients . Thus , evolutionary conserved pathway may contribute pathogenic cascade eventually leads @ DiseaseTgt $ patients PINK1 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0044602651104574)\n",
      "- Text: \"Interaction Ras ( V12 ) scribbled clones induces @ DiseaseTgt $ growth invasion . Human @ DiseaseTgt $ large degree cellular genetic heterogeneity . Complex cell interactions @ DiseaseTgt $ microenvironment thought important role tumorigenesis @ DiseaseTgt $ progression . Furthermore , cooperation oncogenic genetic lesions required @ DiseaseTgt $ development ; however , known cell interactions contribute oncogenic cooperation . genetic techniques available fruitfly Drosophila melanogaster allow analysis behaviour cells distinct mutations , making ideal model organism study cell interactions oncogenic cooperation . Drosophila eye-antennal discs , cooperation oncogenic protein @ GeneSrc $ ( ref . 5 ) loss-of-function mutations conserved @ DiseaseTgt $ suppressor scribbled ( scrib ) gives rise @ DiseaseTgt $ display many characteristics observed human @ DiseaseTgt $ . show clones cells bearing different mutations cooperate promote @ DiseaseTgt $ growth invasion Drosophila . found Ras ( V12 ) scrib ( - ) mutations also cause @ DiseaseTgt $ affect different adjacent epithelial cells . show interaction Ras ( V12 ) scrib ( - ) clones involves JNK signalling propagation JNK-induced upregulation JAK/STAT-activating cytokines , compensatory growth mechanism tissue homeostasis . development Ras ( V12 ) tumours also triggered tissue damage , stress condition activates JNK signalling . Given conservation pathways examined , similar cooperative mechanisms could role development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4709411789352707)\n",
      "- Text: \"Microglia-derived ASC specks cross-seed amyloid-beta @ DiseaseTgt $ . spreading pathology within brain areas hallmark neurodegenerative disorders . patients @ DiseaseTgt $ , deposition amyloid-beta accompanied activation innate immune system involves inflammasome-dependent formation @ GeneSrc $ specks microglia . @ GeneSrc $ specks released microglia bind rapidly amyloid-beta increase formation amyloid-beta oligomers aggregates , acting inflammation-driven cross-seed amyloid-beta pathology . show intrahippocampal injection ASC specks resulted spreading amyloid-beta pathology transgenic double-mutant APPSwePSEN1dE9 mice . contrast , homogenates brains APPSwePSEN1dE9 mice failed induce seeding spreading amyloid-beta pathology ASC-deficient APPSwePSEN1dE9 mice . Moreover , co-application anti-ASC antibody blocked increase amyloid-beta pathology APPSwePSEN1dE9 mice . findings support concept inflammasome activation connected seeding spreading amyloid-beta pathology patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0249931183463756)\n",
      "- Text: \"Apolipoprotein E @ DiseaseTgt $ . Inheritance specific apolipoprotein E ( apoE ) alleles determines , large part , risk mean age onset late-onset @ DiseaseTgt $ . mechanism apoE isoforms differentially contribute disease expression , however , unknown . Isoform-specific differences identified binding apoE microtubule-associated protein tau , forms paired helical filament neurofibrillary tangles , amyloid beta peptide , major component neuritic plaque . isoform-specific interactions apoE give rise testable hypotheses mechanism ( ) pathogenesis @ DiseaseTgt $ . unresolved issue increasing importance relationship structural pathological lesions cellular pathogenesis responsible clinical disease phenotype , progressive dementia . identification apoE cytoplasm human neurons characterization isoform-specific binding apoE microtubule-associated proteins tau @ GeneSrc $ present possibility apoE may affect microtubule function @ DiseaseTgt $ brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.591833820883098e-05)\n",
      "- Text: \"Association study GAB2 gene risk developing @ DiseaseTgt $ . first genome-wide association @ DiseaseTgt $ ( @ DiseaseTgt $ ) suggested GAB2 gene rs2373115 polymorphism may strong risk factor APOE varepsilon4-carriers . failed detect association rs2373115 risk developing @ DiseaseTgt $ three populations ( totalling 1406 controls 1749 @ DiseaseTgt $ cases ) whatever APOE status , even observed slight tendency increase GG genotype ( ( GG versus GT+TT ) =1.3 , 95 % CI 1.0 - 1.6 , p=0.09 ) G allele frequency ( OR=1.3 , 95 % CI 1.0 - 1.6 , p=0.05 ) varepsilon4-carriers . addition , rs2373115 modulate extent @ GeneSrc $ phosphorylation brain 89 @ DiseaseTgt $ cases . GAB2 gene best minor genetic determinant @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.573256464380736e-05)\n",
      "- Text: \"Probing @ DiseaseTgt $ using induced pluripotent stem cells . understanding @ DiseaseTgt $ pathogenesis currently limited difficulties obtaining live neurons patients inability model sporadic form disease . may possible overcome challenges reprogramming primary cells patients induced pluripotent stem cells ( iPSCs ) . reprogrammed primary fibroblasts two patients familial @ DiseaseTgt $ , caused duplication amyloid-beta precursor protein gene ( APP ; termed APP ( Dp ) ) , two sporadic @ DiseaseTgt $ ( termed sAD1 , sAD2 ) two non-demented control individuals iPSC lines . Neurons differentiated cultures purified fluorescence-activated cell sorting characterized . Purified cultures contained 90 % neurons , clustered fetal brain messenger RNA samples microarray criteria , could form functional synaptic contacts . Virtually cells exhibited normal electrophysiological activity . Relative controls , iPSC-derived , purified neurons two APP ( Dp ) patients patient sAD2 exhibited significantly higher levels pathological markers amyloid-beta ( 1 - 40 ) , phospho-tau ( Thr 231 ) active glycogen synthase kinase-3beta ( aGSK-3beta ) . Neurons APP ( Dp ) sAD2 patients also accumulated large RAB5-positive early endosomes compared controls . Treatment purified neurons beta-secretase inhibitors , gamma-secretase inhibitors , caused significant reductions phospho-Tau ( Thr 231 ) aGSK-3beta levels . results suggest direct relationship APP proteolytic processing , amyloid-beta , GSK-3beta activation @ GeneSrc $ phosphorylation human neurons . Additionally , observed neurons genome one sAD patient exhibited phenotypes seen familial @ DiseaseTgt $ samples . generally , demonstrate iPSC technology used observe phenotypes relevant @ DiseaseTgt $ , even though take decades overt disease manifest patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0728450738829561)\n",
      "- Text: \"NLRP3 inflammasome activation drives @ GeneSrc $ pathology . @ DiseaseTgt $ characterized accumulation amyloid-beta plaques , aggregation hyperphosphorylated @ GeneSrc $ neurofibrillary tangles neuroinflammation , together resulting neurodegeneration cognitive decline1 . NLRP3 inflammasome assembles inside microglia activation , leading increased cleavage activity caspase-1 downstream interleukin-1beta release2 . Although NLRP3 inflammasome shown essential development progression amyloid-beta pathology mice3 , precise effect @ GeneSrc $ pathology remains unknown . show loss NLRP3 inflammasome function reduced tau hyperphosphorylation aggregation regulating tau kinases phosphatases . @ GeneSrc $ activated NLRP3 inflammasome intracerebral injection fibrillar amyloid-beta-containing brain homogenates induced @ GeneSrc $ pathology NLRP3-dependent manner . data identify important role microglia NLRP3 inflammasome activation pathogenesis tauopathies support amyloid-cascade hypothesis @ DiseaseTgt $ , demonstrating neurofibrillary tangles develop downstream amyloid-beta-induced microglial activation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2914546732339058)\n",
      "- Text: \"Prion-like behaviour @ GeneSrc $ cytotoxicity pyroglutamylated amyloid-beta . Extracellular plaques amyloid-beta intraneuronal neurofibrillary tangles made @ GeneSrc $ histopathological signatures @ DiseaseTgt $ . Plaques comprise amyloid-beta fibrils assemble monomeric oligomeric intermediates , prognostic indicators @ DiseaseTgt $ . Despite importance plaques @ DiseaseTgt $ , oligomers considered principal toxic forms amyloid-beta . Interestingly , many adverse responses amyloid-beta , cytotoxicity , microtubule loss , impaired memory learning , neuritic degeneration , greatly amplified @ GeneSrc $ expression . Amino-terminally truncated , pyroglutamylated ( pE ) forms amyloid-beta strongly associated @ DiseaseTgt $ , toxic amyloid-beta , residues 1 - 42 ( Abeta ( 1 - 42 ) ) Abeta ( 1 - 40 ) , proposed initiators @ DiseaseTgt $ pathogenesis . report mechanism pE-Abeta may trigger @ DiseaseTgt $ . Abeta ( 3 ( pE ) -42 ) co-oligomerizes excess Abeta ( 1 - 42 ) form metastable low-n oligomers ( LNOs ) structurally distinct far cytotoxic cultured neurons comparable LNOs made Abeta ( 1 - 42 ) alone . @ GeneSrc $ required cytotoxicity , LNOs comprising 5 % Abeta ( 3 ( pE ) -42 ) plus 95 % Abeta ( 1 - 42 ) ( 5 % pE-Abeta ) seed new cytotoxic LNOs multiple serial dilutions Abeta ( 1 - 42 ) monomers absence additional Abeta ( 3 ( pE ) -42 ) . LNOs isolated human @ DiseaseTgt $ brain contained Abeta ( 3 ( pE ) -42 ) , enhanced Abeta ( 3 ( pE ) -42 ) formation mice triggered neuron loss gliosis 3 months , @ GeneSrc $ background . conclude Abeta ( 3 ( pE ) -42 ) confers @ GeneSrc $ neuronal death causes template-induced misfolding Abeta ( 1 - 42 ) structurally distinct LNOs propagate prion-like mechanism . results raise possibility Abeta ( 3 ( pE ) -42 ) acts similarly primary step @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2188654540484269)\n",
      "- Text: \"Visinin-like protein-1 : diagnostic prognostic biomarker @ DiseaseTgt $ . OBJECTIVE : growing need identify cerebrospinal fluid ( CSF ) markers detect @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathology cognitively normal individuals population disease-modifying therapies may greatest chance success . @ DiseaseTgt $ pathology estimated begin ~10 - 15 years prior onset cognitive decline , substantial neuronal loss present time earliest signs cognitive impairment appear . Visinin-like protein-1 ( VILIP-1 ) demonstrated potential utility marker neuronal injury . investigate CSF VILIP-1 VILIP-1/amyloid-beta42 ( Abeta42 ) ratio diagnostic prognostic markers early @ DiseaseTgt $ . METHODS : assessed CSF levels VILIP-1 , @ GeneSrc $ , phosphorylated-tau181 ( p-tau181 ) , Abeta42 cognitively normal controls ( CNC ) ( n = 211 ) , individuals early symptomatic @ DiseaseTgt $ ( n = 98 ) , individuals dementias ( n = 19 ) . Structural magnetic resonance imaging ( n = 192 ) amyloid imaging Pittsburgh Compound-B ( n = 156 ) obtained subsets cohort . Among CNC cohort , 164 individuals follow-up annual cognitive assessments 2 - 3 years . RESULTS : CSF VILIP-1 levels differentiated individuals @ DiseaseTgt $ CNC individuals dementias . CSF VILIP-1 levels correlated CSF @ GeneSrc $ , p-tau181 , brain volumes @ DiseaseTgt $ . VILIP-1 VILIP-1/Abeta42 predicted future cognitive impairment CNC follow-up period . Importantly , CSF VILIP-1/Abeta42 predicted future cognitive impairment least well @ GeneSrc $ p-tau181/Abeta42 . INTERPRETATION : findings suggest CSF VILIP-1 VILIP-1/Abeta42 offer diagnostic utility early @ DiseaseTgt $ , predict future cognitive impairment cognitively normal individuals similarly @ GeneSrc $ @ GeneSrc $ , respectively .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0717095359265396)\n",
      "- Text: \"Apolipoprotein E @ DiseaseTgt $ . Inheritance specific apolipoprotein E ( apoE ) alleles determines , large part , risk mean age onset late-onset @ DiseaseTgt $ . mechanism apoE isoforms differentially contribute disease expression , however , unknown . Isoform-specific differences identified binding apoE microtubule-associated protein @ GeneSrc $ , forms paired helical filament neurofibrillary tangles , amyloid beta peptide , major component neuritic plaque . isoform-specific interactions apoE give rise testable hypotheses mechanism ( ) pathogenesis @ DiseaseTgt $ . unresolved issue increasing importance relationship structural pathological lesions cellular pathogenesis responsible clinical disease phenotype , progressive dementia . identification apoE cytoplasm human neurons characterization isoform-specific binding apoE microtubule-associated proteins @ GeneSrc $ MAP-2 present possibility apoE may affect microtubule function @ DiseaseTgt $ brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009001306502205)\n",
      "- Text: \"Apolipoprotein E4 stimulates sulfation glycosaminoglycans neural cells . Apolipoprotein E externally added neuroblastoma cells culture stimulates [ 35S ] sulfate incorporation cell extracellular matrix glycosaminoglycans ( sGAG ) . stimulation mainly observed ApoE4 compared ApoE3 . increase sulfation due increased synthesis corresponding increase [ 3H ] glucosamine incorporation . Since presence ApoE risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) presence sGAG could facilitate assembly main components , beta-amyloid @ GeneSrc $ proteins , aberrant structures found @ DiseaseTgt $ , present study indicates possible relation factors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0594667046342943)\n",
      "- Text: \"Apolipoprotein E fragments present @ DiseaseTgt $ brains induce neurofibrillary tangle-like intracellular inclusions neurons . Human apolipoprotein ( apo ) E4 , major risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) , occurs amyloid plaques neurofibrillary tangles ( NFTs ) @ DiseaseTgt $ brains ; however , role pathogenesis lesions unclear . demonstrate carboxyl-terminal-truncated forms apoE , occur @ DiseaseTgt $ brains cultured neurons , induce intracellular NFT-like inclusions neurons . cytosolic inclusions composed phosphorylated @ GeneSrc $ , phosphorylated neurofilaments high molecular weight , truncated apoE . Truncated apoE4 , especially apoE4 ( Delta 272 - -299 ) , induced inclusions 75 % transfected neuronal cells , transfected nonneuronal cells . ApoE4 susceptible truncation apoE3 resulted much greater intracellular inclusion formation . results suggest apoE4 preferentially undergoes intracellular processing , creating bioactive fragment interacts cytoskeletal components induces NFT-like inclusions containing phosphorylated @ GeneSrc $ phosphorylated neurofilaments high molecular weight neurons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0083844779394102)\n",
      "- Text: \"Presenilin-1 mutation L271V results altered exon 8 splicing @ DiseaseTgt $ non-cored plaques neuritic dystrophy . mutation L271V exon 8 presenilin-1 ( PS-1 ) gene detected @ DiseaseTgt $ pedigree . Neuropathological examination affected individuals identified variant , large , non-cored plaques without neuritic dystrophy , reminiscent cotton wool plaques . Biochemical analysis L271V mutation showed increased secretion 42-amino acid amyloid-beta peptide , suggesting pathogenic mutation . Analysis PS-1 transcripts brains two mutation carriers revealed 17 - 50 % increase PS-1 transcripts deletion exon 8 ( PS-1deltaexon8 ) compared unrelated @ DiseaseTgt $ brains . Exon trapping analysis confirmed L271V mutation enhanced deletion exon 8 . Western blots brain lysates indicated PS-1deltaexon8 overexpressed affected individual . Biochemical analysis PS-1deltaexon8 COS BD8 cells indicate splice isoform intrinsically active interacts wild-type PS-1 generate amyloid-beta . Western blots cell lysates immunoprecipitated @ GeneSrc $ anti-GSK-3beta antibodies indicated PS-1deltaexon8 , unlike wild-type PS-1 , interact directly @ GeneSrc $ GSK-3beta , potential modifiers neuritic dystrophy . postulate variant plaques observed family due part effects PS-1deltaexon8 interaction PS-1 various protein complexes necessary neuritic plaque formation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001525126529216)\n",
      "- Text: \"Presenilin 1 mutation african american family presenting atypical @ DiseaseTgt $ . BACKGROUND : @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized memory visuospatial deficits relative sparing personality . Mutations 3 genes ( presenilin 1 2 amyloid precursor protein ) associated presenile @ DiseaseTgt $ . Presenilin 1 gene mutations described African Americans . METHODS : studied African American family autosomal dominant rapidly progressive dementia psychosis occurring early fifth decade life . performed neurologic evaluations , psychometrics , neuroimaging . sequenced amyloid precursor protein gene , presenilin 1 2 , @ GeneSrc $ affected unaffected family members . One patient underwent brain biopsy subsequent autopsy . RESULTS : Personality change , auditory visual hallucinations , delusions , memory impairment , word-finding difficulties , subsequent rigidity , dystonia , myoclonus , mutism developed 2 brothers . Neuropsychometric testing one consistent frontotemporal dementia atypical @ DiseaseTgt $ . Neuroimaging studies showed diffuse cortical involvement . clinical diagnosis @ DiseaseTgt $ made . However , results temporal lobe biopsy one revealed amyloid neuritic plaques , autopsy results confirmed diagnosis @ DiseaseTgt $ . Gene sequencing revealed presenilin 1 point mutation ( M139V ) cosegregating disease . @ GeneSrc $ polymorphism exon 7 ( A178 ) found affected brother unaffected relatives . CONCLUSIONS : report first documented presenilin mutation African American patients presenting early personality change , psychosis , memory loss preserved praxis . M139V mutation present differently kindreds , features suggestive frontal lobe syndrome . M139V mutation lead atypical @ DiseaseTgt $ , genetic background may role determining phenotype genetically defined @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8076335561137689)\n",
      "- Text: \"novel mutation PSEN2 gene ( T430 ) associated variable expression family early-onset @ DiseaseTgt $ . BACKGROUND : Autosomal dominant early-onset @ DiseaseTgt $ heterogeneous condition associated mutations 3 different genes : amyloid precursor protein ( APP ) , presenilin 1 ( PSEN1 ) , presenilin 2 ( PSEN2 ) genes . cases due mutations PSEN1 gene , whereas mutations APP PSEN2 genes rare . OBJECTIVE : describe novel mutation PSEN2 gene associated early-onset @ DiseaseTgt $ . PATIENTS METHODS : proband 49-year-old individual displayed progressive dementia beginning age 45 years . One parents one grandparents developed dementia ages 64 years 60 years , respectively , 1 sibling mild cognitive impairment . family members also Tourette syndrome . Mutation analysis APP , PSEN1 , PSEN2 , @ GeneSrc $ ( @ GeneSrc $ ) genes performed . Apolipoprotein E ( APOE ) also genotyped . RESULTS : found missense mutation codon 430 PSEN2 gene predicts threonine-to-methionine substitution . mutation detected affected individuals 1 cognitively healthy sibling . mutation absent 260 control chromosomes . normal amino acid conserved human mouse PSEN1 mouse PSEN2 homologues . influence APOE genotype observed . CONCLUSIONS : found novel mutation PSEN2 gene family early-onset @ DiseaseTgt $ . variation age onset confirms PSEN2 mutations associated variable clinical expression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9923741177125238)\n",
      "- Text: \"Pick bodies family presenilin-1 @ DiseaseTgt $ . Presenilin-1 ( PS-1 ) mutations cause Pick 's disease without evidence @ DiseaseTgt $ ( @ DiseaseTgt $ ) . describe family PS-1 M146L mutation Pick bodies @ DiseaseTgt $ . Sarkosyl-insoluble hyperphosphorylated @ GeneSrc $ showed three bands consistent @ DiseaseTgt $ , although dephosphorylation showed primarily three-repeat isoforms . M146L mutant PS-1 may predispose Pick 's disease @ DiseaseTgt $ affecting multiple intracellular pathways involving @ GeneSrc $ phosphorylation amyloid metabolism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0063493863886187)\n",
      "- Text: \"Towards compendia negative genetic association studies : example @ DiseaseTgt $ . genetic sequence variants contribute variability complex human traits small effects readily detectable population samples typically used genetic association studies . potentially valuable tool gene discovery process meta-analysis accumulated published data , order valid require sample studies representative true genetic effect thus hypothetically include positive abundance negative reports . survey literature association studies @ DiseaseTgt $ ( @ DiseaseTgt $ ) January 2004-April 2005 , identified 138 studies , 86 reported positive findings apolipoprotein E ( APOE ) , strongly indicative publication bias . report analysis 62 genetic markers , tested association @ DiseaseTgt $ risk well possible effects upon quantitative indices @ DiseaseTgt $ severity ( mini-mental state examination scores , age-at-onset , cerebrospinal fluid ( CSF ) beta-amyloid ( Abeta ) CSF @ GeneSrc $ proteins ) . Within set , modest signals present , exception APOE easily lost corrections multiple hypotheses applied . isolation , results thus broadly negative . Genes studied encompass novel candidates well several recently claimed associated @ DiseaseTgt $ ( e.g . urokinase plasminogen activator ( PLAU ) acetyl-coenzyme acetyltransferase 1 ( ACAT1 ) ) . reporting data hope encourage publication gene compendia guide studies aid future meta-analyses aimed resolving involvement genes complex human traits .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.978166076085723)\n",
      "- Text: \"Frameshift proteins autosomal dominant forms @ DiseaseTgt $ tauopathies . Frameshift ( + 1 ) proteins APP ( +1 ) UBB ( +1 ) accumulate sporadic cases @ DiseaseTgt $ ( @ DiseaseTgt $ ) older subjects syndrome ( DS ) . investigated whether proteins also accumulate early stage neuropathogenesis young DS individuals without neuropathology early-onset familial forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , well tauopathies , Pick disease ( PiD ) progressive supranuclear palsy ( PSP ) . APP ( +1 ) present many neurons beaded neurites young cases DS , suggests axonally transported . older DS patients ( > 37 years ) , mixed pattern APP ( +1 ) immunoreactivity observed healthy looking neurons neurites , dystrophic neurites , association neuritic plaques , well neurofibrillary tangles . UBB ( +1 ) immunoreactivity exclusively present @ DiseaseTgt $ type neuropathology . similar pattern APP ( +1 ) UBB ( +1 ) immunoreactivity also observed @ DiseaseTgt $ much less explicit nondemented controls age 51 years . Furthermore , observed accumulation + 1 proteins types tauopathies , PiD , frontotemporal dementia , PSP argyrophylic grain disease . data suggest accumulation + 1 proteins contributes early stages dementia plays pathogenic role number diseases involve accumulation @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7407926096673633)\n",
      "- Text: \"Abeta @ GeneSrc $ form soluble complexes may promote self aggregation insoluble forms observed @ DiseaseTgt $ . date , reasonable explanation plaques tangles simultaneously accumulate @ DiseaseTgt $ ( @ DiseaseTgt $ ) . demonstrate Western blotting ELISA stable complex form @ GeneSrc $ amyloid-beta protein ( Abeta ) . complex enhances @ GeneSrc $ phosphorylation GSK3beta , phosphorylation promotes dissociation complex . localized sites interaction using peptide membrane arrays . Abeta binds multiple @ GeneSrc $ peptides , especially exons 7 9 . binding sharply reduced abolished phosphorylation specific serine threonine residues . Conversely , @ GeneSrc $ binds multiple Abeta peptides mid C-terminal regions Abeta . binding also significantly decreased GSK3beta phosphorylation @ GeneSrc $ . used surface plasmon resonance determine binding affinity Abeta @ GeneSrc $ found low nanomolar range almost 1,000-fold higher @ GeneSrc $ . soluble extracts @ DiseaseTgt $ control brain tissue , detected Abeta bound @ GeneSrc $ ELISAs . also found double immunostaining @ DiseaseTgt $ brain tissue phosphorylated @ GeneSrc $ Abeta form separate insoluble complexes within neurons processes . hypothesize @ DiseaseTgt $ , initial step pathogenesis may intracellular binding soluble Abeta soluble nonphosphorylated @ GeneSrc $ , thus promoting @ GeneSrc $ phosphorylation Abeta nucleation . Blocking sites Abeta initially binds @ GeneSrc $ might arrest simultaneous formation plaques tangles @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6368383501768139)\n",
      "- Text: \"@ GeneSrc $ haplotypes regulate transcription associated @ DiseaseTgt $ . primary haplotype ( H1 ) @ GeneSrc $ ( @ GeneSrc $ ) gene associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , mechanism disease susceptibility remains unknown . examined promoter region @ GeneSrc $ identified single nucleotide polymorphisms insertions 1 11 nucleotides . polymorphisms corresponded previously characterized haplotypes , H1 H2 , well novel variant H1 haplotype , H1 ' . observed studies , demonstrated significant association H1/H1 promoter genotype @ DiseaseTgt $ cohort 206 idiopathic late-onset cases . contrast panel 13 early-onset @ DiseaseTgt $ patients , detect mutations @ GeneSrc $ . examining single nucleotide polymorphisms adjacent genes , showed linkage disequilibrium extend beyond @ GeneSrc $ haplotype neighboring genes . define mechanism disease susceptibility , examined transcriptional activity promoter haplotypes using luciferase reporter assay . demonstrated two human cell lines , SK-N-MC 293 , H1 haplotype efficient driving gene expression H2 haplotype . data suggest increase expression @ GeneSrc $ gene susceptibility factor idiopathic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3182371921125619)\n",
      "- Text: \"Progressive supranuclear palsy @ DiseaseTgt $ family new mutation @ GeneSrc $ gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010312389417497)\n",
      "- Text: \"Genome-wide association study identifies common variants four loci genetic risk factors @ DiseaseTgt $ . identify susceptibility variants @ DiseaseTgt $ ( @ DiseaseTgt $ ) , performed genome-wide association study ( GWAS ) two replication studies total 2,011 cases 18,381 controls Japan . identified new susceptibility locus 1q32 ( P = 1.52 x 10 ( -12 ) ) designated PARK16 , also identified BST1 4p15 second new risk locus ( P = 3.94 x 10 ( -9 ) ) . also detected strong associations SNCA 4q22 ( P = 7.35 x 10 ( -17 ) ) LRRK2 12q12 ( P = 2.72 x 10 ( -8 ) ) , implicated autosomal dominant forms parkinsonism . comparing results GWAS performed individuals European ancestry , identified PARK16 , SNCA LRRK2 shared risk loci @ DiseaseTgt $ BST1 @ GeneSrc $ loci showing population differences . results identify two new @ DiseaseTgt $ susceptibility loci , show involvement autosomal dominant parkinsonism loci typical @ DiseaseTgt $ suggest population differences contribute genetic heterogeneity @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0072827509516734)\n",
      "- Text: \"Linkage disequilibrium fine mapping haplotype association analysis @ GeneSrc $ gene progressive supranuclear palsy corticobasal degeneration . BACKGROUND : haplotype H1 @ GeneSrc $ gene , @ GeneSrc $ , highly associated progressive supranuclear palsy ( PSP ) corticobasal degeneration ( CBD ) . OBJECTIVE : investigate pathogenic basis association . METHODS : Detailed linkage disequilibrium common haplotype structure @ GeneSrc $ examined 27 CEPH trios using validated HapMap genotype data 24 single nucleotide polymorphisms ( SNPs ) spanning @ GeneSrc $ . RESULTS : Multiple variants H1 haplotype resolved , reflecting far greater diversity @ GeneSrc $ explained H1 H2 clades alone . Based , six haplotype tagging SNPs ( htSNPs ) capture 95 % common haplotype diversity used genotype well characterised PSP CBD case-control cohorts . addition strong association PSP CBD individual SNPs , two common haplotypes derived htSNPs identified highly associated PSP : sole H2 derived haplotype underrepresented one common H1 derived haplotypes highly associated , similar trend observed CBD . powerful highly significant associations PSP CBD haplotypes formed three H1 specific SNPs . made possible define candidate region least approximately 56 kb , spanning sequences upstream @ GeneSrc $ exon 1 intron 9 . H1 haplotype background , could harbour pathogenic variants . CONCLUSIONS : findings support pathological evidence underlying variations @ GeneSrc $ could contribute disease pathogenesis subtle effects gene expression and/or splicing . also form basis investigation possible genetic role @ GeneSrc $ @ DiseaseTgt $ tauopathies , including Alzheimer 's disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029394386200649)\n",
      "- Text: \"Familial atypical progressive supranuclear palsy associated homozigosity delN296 mutation @ GeneSrc $ gene . Heterozygous missense splice-site mutations @ GeneSrc $ gene previously identified familial frontotemporal dementia autosomal dominant inheritance . report Spanish kindred two brothers born third-degree consanguineous marriage affected atypical progressive supranuclear palsy . homozygous deletion codon 296 ( delN296 ) identified one affected siblings . Among heterozygous carriers , two members probable @ DiseaseTgt $ identified , none heterozygotes developed atypical parkinsonism . delN296 mutation lies sequence corresponding second tubulin-binding repeat @ GeneSrc $ protein affects one asparagine residue absolutely conserved species . finding indicates homozygous mutations @ GeneSrc $ gene may also cause hereditary tauopathies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006747572238942)\n",
      "- Text: \"Glycogen synthase kinase-3 beta @ GeneSrc $ genes interact @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0633039868345347)\n",
      "- Text: \"GSK3B polymorphisms alter transcription splicing @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disorder characterized combination motor symptoms . identified two functional single nucleotide polymorphisms glycogen synthase kinase-3beta gene ( GSK3B ) . promoter single nucleotide polymorphism ( rs334558 ) associated transcriptional strength vitro allele greater activity . intronic single nucleotide polymorphism ( rs6438552 ) regulates selection splice acceptor sites vitro . allele associated altered splicing lymphocytes increased levels GSK3B transcripts lack exons 9 11 ( GSKDeltaexon9 + 11 ) . Increased levels GSKDeltaexon9 + 11 correlated enhanced phosphorylation substrate , @ GeneSrc $ . comparison @ DiseaseTgt $ control brains , increased frequency allele ( rs6438552 ) corresponding increase GSKDeltaexon9 + 11 @ GeneSrc $ phosphorylation @ DiseaseTgt $ brains . Conditional logistic regression indicated gene-gene interaction T/T genotype rs334558 H1/H1 haplotype @ GeneSrc $ ( @ GeneSrc $ ) gene ( p = 0.009 ) . association haplotype ( alleles GSK3B polymorphisms ) disease risk stratification @ GeneSrc $ haplotypes ( ( H1/H2+H2/H2 individuals : odds ratio , 1.64 ; p = 0.007 ; ( H1/H1 individuals : odds ratio , 0.68 ; p < 0.001 ) . results suggest GSK3B polymorphisms alter transcription splicing interact @ GeneSrc $ haplotypes modify disease risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0237193117720637)\n",
      "- Text: \"Association single-nucleotide polymorphisms @ GeneSrc $ gene late-onset @ DiseaseTgt $ . CONTEXT : human @ GeneSrc $ gene , promotes assembly neuronal microtubules , associated several rare neurologic diseases clinically include @ DiseaseTgt $ . recently observed linkage @ DiseaseTgt $ ( @ DiseaseTgt $ ) region chromosome 17q21 contains @ GeneSrc $ gene . factors make @ GeneSrc $ good candidate investigation susceptibility gene idiopathic @ DiseaseTgt $ , common form disease . OBJECTIVE : investigate whether @ GeneSrc $ gene involved idiopathic @ DiseaseTgt $ . DESIGN , SETTING , PARTICIPANTS : Among sample 1056 individuals 235 families selected 13 clinical centers United States Australia family ascertainment core center , tested 5 single-nucleotide polymorphisms ( SNPs ) within @ GeneSrc $ gene association @ DiseaseTgt $ , using family-based tests association . affected ( n = 426 ) unaffected ( n = 579 ) family members included ; 51 individuals unclear @ DiseaseTgt $ status . Analyses conducted test individual SNPs SNP haplotypes within @ GeneSrc $ gene . MAIN OUTCOME MEASURE : Family-based tests association , calculated using asymptotic distributions . RESULTS : Analysis association SNPs @ DiseaseTgt $ yielded significant evidence association 3 5 SNPs tested : SNP 3 , P = .03 ; SNP 9i , P = .04 ; SNP 11 , P = .04 . 2 SNPs show evidence significant association ( SNP 9ii , P = .11 , SNP 9iii , P = .87 ) . Strong evidence association found haplotype analysis , positive association one haplotype ( P = .009 ) negative association another haplotype ( P = .007 ) . Substantial linkage disequilibrium ( P < .001 ) detected 4 5 SNPs ( SNPs 3 , 9i , 9ii , 11 ) . CONCLUSIONS : integrated approach genetic linkage positional association analyses implicates @ GeneSrc $ susceptibility gene idiopathic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.89945224035239)\n",
      "- Text: \"Association analysis @ GeneSrc $ H1 haplotype subhaplotypes @ DiseaseTgt $ . OBJECTIVE : inversion polymorphism approximately 900 kb chromosome 17q21 , includes @ GeneSrc $ ( @ GeneSrc $ ) gene defines two haplotype clades , H1 H2 . Several small case-control studies observed marginally significant excess H1/H1 diplotype among patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) , one reported refining association region spanning exons 1 4 @ GeneSrc $ . sought replicate findings . METHODS : genotyped 1,762 @ DiseaseTgt $ patients 2,010 control subjects single nucleotide polymorphism ( SNP ) differentiates H1 H2 clades . also analyzed four SNPs define subhaplotypes within H1 previously reported associate @ DiseaseTgt $ neurodegenerative disorders . RESULTS : adjusting age , sex , site , observed robust association H1/H1 diplotype @ DiseaseTgt $ risk ( odds ratio H1/H1 vs H1/H2 H2/H2 , 1.46 ; 95 % confidence interval , 1.25 - 1.69 ; p = 8 x 10 ( -7 ) ) . effect evident familial sporadic subgroups , men women , early- late-onset disease . Within H1/H1 individuals , significant difference cases control subjects overall frequency distribution H1 subhaplotypes . INTERPRETATION : data provide strong evidence H1 clade , contains @ GeneSrc $ several genes , risk factor @ DiseaseTgt $ . However , attributing finding variants within specific region @ GeneSrc $ premature . Thorough fine-mapping H1 clade large numbers individuals needed identify underlying functional variant ( ) alter susceptibility @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7108359496840435)\n",
      "- Text: \"familial Parkinsonism gene LRRK2 regulates neurite process morphology . Mutations LRRK2 underlie autosomal-dominant , inherited form @ DiseaseTgt $ ( @ DiseaseTgt $ ) mimics clinical features common `` sporadic `` form @ DiseaseTgt $ . LRRK2 protein includes putative GTPase , protein kinase , WD40 repeat , leucine-rich repeat ( LRR ) domains unknown function . show @ DiseaseTgt $ LRRK2 mutations display disinhibited kinase activity induce progressive reduction neurite length branching primary neuronal cultures intact rodent CNS . contrast , LRRK2 deficiency leads increased neurite length branching . Neurons express @ DiseaseTgt $ LRRK2 mutations additionally harbor prominent @ GeneSrc $ inclusions lysosomal characteristics ultimately undergo apoptosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9945410185443452)\n",
      "- Text: \"Autosomal dominant dopa-responsive parkinsonism multigenerational Swiss family . AIM : describe large family autosomal dominant parkinsonism . BACKGROUND : Seven genes directly implicated autosomally inherited parkinsonism . However , several multigenerational large families known identifiable mutation . MATERIAL METHODS : Family members evaluated clinically , history chart review . Genetic investigation included SCA2 , SCA3 , UCHL1 , SNCA , LRRK2 , PINK1 , PRKN , PGRN , FMR1 premutation , @ GeneSrc $ . proband underwent brain fluorodopa PET ( FD-PET ) scan , one autopsy available . RESULTS : Eleven patients diagnosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , nine women . Mean age onset 52 tremor-predominant dopa-responsive parkinsonism . Disease progression slow severe motor fluctuations occurred . One patient required subthalamic nucleus deep-brain stimulation good motor outcome . One patient mental retardation , schizophrenia became demented , another patient demented . Three patients also two unaffected subjects mild learning difficulties . genetic tests yielded negative results . FD-PET showed marked asymmetric striatal tracer uptake deficiency , consistent @ DiseaseTgt $ . Pathological examination demonstrated Lewy bodies immunostaining negative alpha-synuclein . CONCLUSION : Apart younger age onset female predominance , phenotype indistinguishable @ DiseaseTgt $ , including FD-PET scan results . known genetic causes autosomal dominant @ DiseaseTgt $ excluded , family harbors novel genetic defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.150757143231127)\n",
      "- Text: \"Dementia risk @ DiseaseTgt $ : disentangling role @ GeneSrc $ haplotypes . BACKGROUND : Dementia @ DiseaseTgt $ ( @ DiseaseTgt $ ) causes nursing home placement , caregiver distress , higher health care burden , increased mortality . OBJECTIVE : determine whether @ GeneSrc $ ( @ GeneSrc $ ) H1 haplotype @ GeneSrc $ subhaplotypes play role risk @ DiseaseTgt $ Parkinson disease-dementia ( PDD ) complex . DESIGN : Case-control genetic analysis . SETTING : Movement Disorders Memory Units , Hospital de Sant Pau , Barcelona , Spain . PARTICIPANTS : Two hundred two patients @ DiseaseTgt $ ( 48 developed dementia > 2 years disease onset ) , 41 patients Lewy body dementia ( LBD , pathologically confirmed 17 ) , 164 patients Alzheimer disease ( AD ) , 374 controls . METHODS : @ GeneSrc $ haplotype determined testing 238-base pair deletion exons 9 10 , characteristic H2 haplotype . Haploview used visualize linkage disequilibrium relationships genetic variants ( 5 single-nucleotide polymorphisms del-In9 variant ) within surrounding @ GeneSrc $ region . RESULTS : H1 haplotype significantly overrepresented @ DiseaseTgt $ patients compared controls ( P=.001 ) . Stratifying @ DiseaseTgt $ sample presence dementia revealed stronger association PDD patients ( sex- age-adjusted odds ratio , 3.73 ; P=.002 ) @ DiseaseTgt $ patients without dementia ( sex- age-adjusted odds ratio , 1.89 ; P=.04 ) . Examination specific subhaplotypes showed rare version H1 haplotype ( named H1p ) overrepresented PDD patients compared controls ( 2.3 % vs 0.1 % ; P=.003 ) . positive signals @ GeneSrc $ variants H1 subhaplotypes found AD LBD . CONCLUSIONS : data confirm MAPT H1 associated @ DiseaseTgt $ strong influence risk dementia @ DiseaseTgt $ patients . results also suggest none @ GeneSrc $ subhaplotypes play significant role neurodegenerative diseases , LBD AD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1295252998858943)\n",
      "- Text: \"Independent joint effects @ GeneSrc $ SNCA genes @ DiseaseTgt $ . OBJECTIVE : studied independent joint effects genes encoding alpha-synuclein ( SNCA ) @ GeneSrc $ ( @ GeneSrc $ ) @ DiseaseTgt $ ( @ DiseaseTgt $ ) part large meta-analysis individual data case-control studies participating Genetic Epidemiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) consortium . METHODS : Participants Caucasian ancestry genotyped total 4 SNCA ( rs2583988 , rs181489 , rs356219 , rs11931074 ) 2 @ GeneSrc $ ( rs1052553 , rs242557 ) single nucleotide polymorphism ( SNPs ) . Individual joint effects SNCA @ GeneSrc $ SNPs investigated using fixed- random-effects logistic regression models . Interactions studied multiplicative additive scale , using case-control case-only approach . RESULTS : Fifteen @ DiseaseTgt $ sites contributed total 5,302 cases 4,161 controls . 4 SNCA SNPs @ GeneSrc $ H1-haplotype-defining SNP ( rs1052553 ) displayed highly significant marginal association @ DiseaseTgt $ significance level adjusted multiple comparisons . SNCA , strongest associations observed SNPs located 3 ' end gene . evidence statistical interaction 4 SNCA SNPs rs1052553 rs242557 , neither multiplicative additive scale . INTERPRETATION : study confirms association @ DiseaseTgt $ SNCA SNPs H1 @ GeneSrc $ haplotype . shows , based variety approaches , joint action variants 2 loci consistent independent effects genes without additional interacting effects .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3986677345751694)\n",
      "- Text: \"Interaction alpha-synuclein @ GeneSrc $ genotypes @ DiseaseTgt $ . determine whether microtubule-associated protein @ GeneSrc $ ( @ GeneSrc $ ) alpha-synuclein ( SNCA ) genes interact confer @ DiseaseTgt $ ( @ DiseaseTgt $ ) susceptibility , conducted study 557 case-control pairs . increased risk @ DiseaseTgt $ persons either SNCA 261/261 @ GeneSrc $ H1/H1 genotypes compared persons neither ( odds ratio , 1.96 ; 95 % confidence interval , 1.34 - 2.86 ; p = 0.0003 ) . However , combined effect two genotypes either genotypes alone ( separate equal ) . findings consistent vitro experiments revealed @ GeneSrc $ fibrillization alpha-synuclein protein low concentrations ( dose threshold effect ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.649365037303053)\n",
      "- Text: \"@ GeneSrc $ alpha-synuclein susceptibility , dementia , @ DiseaseTgt $ . OBJECTIVE : @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative condition typically presents movement disorder known associated variable degrees cognitive impairment including dementia . investigated genetic basis susceptibility cognitive heterogeneity disease . METHODS : 659 @ DiseaseTgt $ patients , 109 followed 3.5 years diagnosis , 2,176 control subjects , studied candidate genes involved protein aggregation inclusion body formation , pathological hallmark parkinsonism : @ GeneSrc $ ( @ GeneSrc $ ) , glycogen synthase kinase-3beta ( GSK3B ) , alpha-synuclein ( SNCA ) . RESULTS : observed cognitive decline development @ DiseaseTgt $ strongly associated ( p = 10 ( -4 ) ) inversion polymorphism containing @ GeneSrc $ . also found novel synergistic interaction @ GeneSrc $ inversion polymorphism single nucleotide polymorphism rs356219 3 ' region SNCA . data , carrying risk genotype either loci marginally increases risk development @ DiseaseTgt $ , whereas carrying combination risk genotypes loci approximately doubles risk development disease ( p = 3 x 10 ( -6 ) ) . INTERPRETATION : data support hypothesis @ GeneSrc $ alpha-synuclein involved shared converging pathways pathogenesis @ DiseaseTgt $ , suggest @ GeneSrc $ inversion influences development cognitive impairment dementia patients idiopathic @ DiseaseTgt $ . findings potentially important implications understanding interface @ GeneSrc $ alpha-synuclein pathways neurodegenerative disorders unraveling biological basis cognitive impairment dementia @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1925066812272921)\n",
      "- Text: \"Association extended @ GeneSrc $ haplotype frontotemporal dementia . BACKGROUND : Recent studies shown association extended @ GeneSrc $ haplotype ( H1 ) covers entire human @ GeneSrc $ gene progressive supranuclear palsy , inconsistently , neurodegenerative disorders , corticobasal degeneration , @ DiseaseTgt $ , Alzheimer disease , frontotemporal dementia ( FTD ) . addition , disease-causing mutations @ GeneSrc $ gene chromosome 17 detected families autosomal dominant FTD parkinsonism . FTD , pathological accumulation microtubule-associated protein @ GeneSrc $ suggests @ GeneSrc $ gene may genetic risk factor disorder . OBJECTIVE : confirm refute association H1 haplotype H1H1 genotype @ GeneSrc $ gene FTD . DESIGN : Case-control study . SETTING : Neurology departments 12 French university hospitals . PARTICIPANTS : One hundred unrelated patients FTD 79 controls . METHODS : @ GeneSrc $ genotype ( contiguous polymorphisms exons 1 , 7 , 13 intron 9 used reconstruct extended haplotypes H1 H2 ) . Clinical examination , psychometric testing , laboratory tests , computed tomography magnetic resonance imaging , single-photon emission computed tomography , electroencephalography patients FTD . RESULTS : H1H1 genotype significantly overrepresented patients FTD compared controls ( 62 % vs 46 % ; P=.01 , 1-sided ; odds ratio adjusted age sex , 1.95 ) . stratification according apolipoprotein E ( APOE ) genotype , found significant interaction APOE @ GeneSrc $ genotypes ( P=.03 ) . CONCLUSIONS : study largest series patients FTD confirms primary role @ GeneSrc $ FTD establishes H1 haplotype @ GeneSrc $ gene E2 allele APOE interact unknown mechanism increases risk FTD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005908609027995)\n",
      "- Text: \"Leucine-rich repeat kinase 2 ( LRRK2 ) interacts parkin , mutant LRRK2 induces neuronal degeneration . @ DiseaseTgt $ ( @ DiseaseTgt $ ) disorder movement , cognition , emotion , characterized pathologically neuronal degeneration Lewy bodies , cytoplasmic inclusion bodies containing deposits aggregated proteins . @ DiseaseTgt $ cases appear sporadic , genetic forms disease , caused mutations alpha-synuclein , parkin , genes , helped elucidate pathogenesis . Mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause autosomal-dominant Parkinsonism clinical features @ DiseaseTgt $ pleomorphic pathology including deposits aggregated protein . study expression interactions LRRK2 , synthesized cDNAs generated expression constructs coding human WT mutant LRRK2 proteins . Expression full-length LRRK2 cells culture suggests protein predominately cytoplasmic , endogenous protein subcellular fractionation . Using coimmunoprecipitation , find LRRK2 , expressed cells culture , interacts parkin alpha-synuclein , DJ-1 , @ GeneSrc $ . small proportion cells overexpressing LRRK2 contain protein aggregates , proportion greatly increased coexpression parkin . addition , parkin increases ubiquitination aggregated protein . Also , mutant LRRK2 causes neuronal degeneration SH-SY5Y cells primary neurons . cell model may useful studies @ DiseaseTgt $ cellular pathogenesis therapeutics . findings suggest gain-of-function mechanism pathogenesis LRRK2-linked @ DiseaseTgt $ suggest LRRK2 may involved pathogenic pathway @ DiseaseTgt $ proteins parkin , may help illuminate familial sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0239231248232002)\n",
      "- Text: \"CHIP Hsp70 regulate @ GeneSrc $ ubiquitination , degradation aggregation . Molecular chaperones , ubiquitin ligases proteasome impairment implicated several neurodegenerative diseases , including @ DiseaseTgt $ , characterized accumulation abnormal protein aggregates ( e.g . @ GeneSrc $ alpha-synuclein respectively ) . report CHIP , ubiquitin ligase interacts directly Hsp70/90 , induces ubiquitination microtubule associated protein , @ GeneSrc $ . CHIP also increases @ GeneSrc $ aggregation . Consistent observation , diverse @ GeneSrc $ lesions human postmortem tissue found immunopositive CHIP . Conversely , induction Hsp70 treatment either geldanamycin heat shock factor 1 leads decrease @ GeneSrc $ steady-state levels selective reduction detergent insoluble @ GeneSrc $ . Furthermore , 30-month-old mice overexpressing inducible Hsp70 show significant reduction @ GeneSrc $ levels . Together data demonstrate Hsp70/CHIP chaperone system plays important role regulation @ GeneSrc $ turnover selective elimination abnormal @ GeneSrc $ species . Hsp70/CHIP may therefore play important role pathogenesis tauopathies also represents potential therapeutic target .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0093575290357256)\n",
      "- Text: \"Linkage disequilibrium association MAPT H1 @ DiseaseTgt $ . MAPT H1 haplotype associated four-repeat ( 4R ) tauopathies , including progressive supranuclear palsy , corticobasal degeneration , argyrophilic grain disease . controversial haplotype associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Using H1-specific single-nucleotide polymorphisms , demonstrate MAPT H1 misnomer consists family recombining H1 alleles . Population genetics , linkage disequilibrium , association analyses shown specific MAPT H1 subhaplotypes preferentially associated @ DiseaseTgt $ . Using sliding scale MAPT H1-specific haplotypes -- age/sex-matched @ DiseaseTgt $ cases controls central Norway -- refined disease association within approximately 90-kb interval 5 ' end @ GeneSrc $ locus .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0208510040999517)\n",
      "- Text: \"Haplotypes gene expression implicate @ GeneSrc $ region @ DiseaseTgt $ : GenePD Study . BACKGROUND : @ GeneSrc $ ( @ GeneSrc $ ) associated several neurodegenerative disorders including forms parkinsonism @ DiseaseTgt $ ( @ DiseaseTgt $ ) . evaluated association @ GeneSrc $ region @ DiseaseTgt $ large cohort familial @ DiseaseTgt $ cases recruited GenePD Study . addition , postmortem brain samples patients @ DiseaseTgt $ neurologically normal controls used evaluate whether expression 3-repeat 4-repeat isoforms @ GeneSrc $ , neighboring genes Saitohin ( STH ) KIAA1267 , altered @ DiseaseTgt $ cerebellum . METHODS : Twenty-one single-nucleotide polymorphisms ( SNPs ) region @ GeneSrc $ chromosome 17q21 genotyped GenePD Study . Single SNPs haplotypes , including H1 haplotype , evaluated association @ DiseaseTgt $ . Relative quantification gene expression performed using real-time RT-PCR . RESULTS : adjusting multiple comparisons , SNP rs1800547 significantly associated @ DiseaseTgt $ affection . H1 haplotype associated significantly increased risk @ DiseaseTgt $ , novel H1 subhaplotype identified predicted greater increased risk @ DiseaseTgt $ . expression 4-repeat @ GeneSrc $ , STH , KIAA1267 significantly increased @ DiseaseTgt $ brains relative controls . difference expression observed 3-repeat @ GeneSrc $ . CONCLUSIONS : study supports role @ GeneSrc $ pathogenesis familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Interestingly , results gene expression studies suggest genes vicinity @ GeneSrc $ , specifically STH KIAA1267 , may also role @ DiseaseTgt $ suggest complex effects genes region @ DiseaseTgt $ risk .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0789792359848316)\n",
      "- Text: \"@ GeneSrc $ gene delN296 mutation , @ DiseaseTgt $ , atypical supranuclear palsy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004395294316361)\n",
      "- Text: \"RING finger 1 mutations Parkin produce altered localization protein . Parkin gene ( PRKN ) encodes E3 protein-ubiquitin ligase loss function associated autosomal-recessive juvenile ( < 20 years ) early-onset Parkinsonism ( < 45 years ) . Although detailed pathological reports scarce , brains patients homozygous exonic deletions demonstrate neuronal loss substantia nigra , albeit without Lewy body pathology characteristic @ DiseaseTgt $ . However , rare descriptions florid pathology , including Lewy bodies @ GeneSrc $ positive astrocytes individuals compound heterozygous mutations . present study examined whether PRKN point mutations , leading amino acid substitutions , may alter cellular distribution protein produced . Wild-type Parkin homogeneously distributed throughout cytoplasm small amount protein nucleus transfection human embryonic kidney cells . Mutant isoforms A82E , G328E C431F amino acid substitutions also normally distributed . However , two mutant isoforms , R256C R275W , within RING finger 1 Parkin protein ( 238 - 293 amino acids ) , produced unusual distribution protein , large cytoplasmic nuclear inclusions . replicated observation primary cultured neurons demonstrate , accumulation/co-localization cytoskeletal protein vimentin , inclusion bodies aggresomes , cellular response misfolded protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Genome-wide association study reveals genetic risk underlying @ DiseaseTgt $ . performed genome-wide association study ( GWAS ) 1,713 individuals European ancestry @ DiseaseTgt $ ( @ DiseaseTgt $ ) 3,978 controls . replication 3,361 cases 4,573 controls , observed two strong association signals , one gene encoding alpha-synuclein ( SNCA ; rs2736990 , = 1.23 , P = 2.24 x 10 ( -16 ) ) another @ GeneSrc $ locus ( rs393152 , = 0.77 , P = 1.95 x 10 ( -16 ) ) . exchanged data colleagues performing GWAS Japanese @ DiseaseTgt $ cases . Association @ DiseaseTgt $ SNCA replicated Japanese GWAS , confirming major risk locus across populations . replicated effect new locus detected Japanese cohort ( PARK16 , rs823128 , = 0.66 , P = 7.29 x 10 ( -8 ) ) provide supporting evidence common variation around LRRK2 modulates risk @ DiseaseTgt $ ( rs1491923 , = 1.14 , P = 1.55 x 10 ( -5 ) ) . data demonstrate unequivocal role common genetic variants etiology typical @ DiseaseTgt $ suggest population-specific genetic heterogeneity disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0224575256601898)\n",
      "- Text: \"Yeast artificial chromosomes molecular analysis familial polyposis APC gene region . Two yeast artificial chromosomes ( YACs ) spanning total distance 1.1 megabase pairs DNA around @ GeneSrc $ ( mutated @ DiseaseTgt $ ) APC ( adenomatous polyposis coli ) genes 5q21 isolated characterized . Starting @ GeneSrc $ gene , strategy undertaken identify constitutional submicroscopic deletions familial adenomatous polyposis patients might considerably narrow position APC gene . end , YACs identified @ GeneSrc $ gene screened across chromosome 5-specific cosmid library provide source DNA probes genomic scanning . cosmids isolated experiments used screen panel somatic cell hybrids containing chromosome 5 segregated patients suspected carry putative interstitial deletions . screening approach led confirmation small heterozygous deletion polyposis patient overlaps one two isolated YACs . YAC shown contain entire APC gene , addition significant portion DNA flanking 5 ' end gene , therefore prove valuable resource functional studies transfer @ DiseaseTgt $ cell lines .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0846156726053379)\n",
      "- Text: \"Identification FAP locus genes chromosome 5q21 . Recent studies suggest one genes chromosome 5q21 important development @ DiseaseTgt $ , particularly associated familial adenomatous polyposis ( FAP ) . facilitate identification genes locus , portion region tightly linked FAP cloned . Six contiguous stretches sequence ( contigs ) containing approximately 5.5 Mb DNA isolated . Subclones contigs used identify position six genes , expressed normal colonic mucosa . Two genes ( APC @ GeneSrc $ ) likely contribute colorectal tumorigenesis . @ GeneSrc $ gene previously identified virtue mutation human @ DiseaseTgt $ . APC gene identified contig initiated @ GeneSrc $ gene found encode unusually large protein . two closely spaced genes encode proteins predicted contain coiled-coil regions . genes also expressed wide variety tissues . studies @ GeneSrc $ APC potential interaction prove useful understanding colorectal neoplasia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0195838429454803)\n",
      "- Text: \"Mapping multiple intestinal neoplasia ( Min ) proximal chromosome 18 mouse . Min ( multiple intestinal neoplasia ) mutation mouse mapped analyzing inheritance restriction fragment length polymorphisms simple sequence length polymorphisms progeny two intraspecific crosses segregating Min mutation . Min , mutant allele Apc , mouse homolog human APC ( adenomatous polyposis coli ) gene , maps proximal chromosome 18 . synteny Apc @ GeneSrc $ , mouse homolog human @ GeneSrc $ ( mutated @ DiseaseTgt $ ) gene , conserved mouse human , although gene order Apc @ GeneSrc $ interval different APC @ GeneSrc $ interval .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1813494573755892)\n",
      "- Text: \"Mutations chromosome 5q21 genes FAP @ DiseaseTgt $ patients . Previous studies suggested one genes chromosome 5q21 responsible inheritance familial adenomatous polyposis ( FAP ) Gardner 's syndrome ( GS ) , contribute tumor development patients noninherited forms @ DiseaseTgt $ . Two genes 5q21 tightly linked FAP ( @ GeneSrc $ APC ) found somatically altered tumors sporadic @ DiseaseTgt $ patients . One genes ( APC ) also found altered point mutation germ line FAP GS patients . data suggest one gene chromosome 5q21 may contribute colorectal neoplasia , mutations APC gene cause FAP GS . identification genes aid understanding pathogenesis colorectal neoplasia diagnosis counseling patients inherited predispositions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1026359205332918)\n",
      "- Text: \"Somatic mutations APC gene sporadic hepatoblastomas . Hepatoblastoma rare hepatic malignancy occurs children average age 2 3 years known one extracolonic manifestations familial adenomatous polyposis . single hepatoblastoma germ-line mutation adenomatous polyposis coli ( APC ) gene reported thus far . elucidate possible roles APC gene alterations sporadic hepatoblastomas , examined loss heterozygosity ( LOH ) APC @ GeneSrc $ loci performed sequencing analysis part APC gene , including mutation cluster region , 13 hepatoblastomas non-familial adenomatous polyposis patients . LOH APC and/or @ GeneSrc $ loci observed four seven ( 57 % ) informative cases . 13 cases , somatic mutations detected 8 ( 61.5 % ) , 9 ( 69 % ) cases showing genetic alterations APC gene LOH somatic mutations . Two cases demonstrated double mutations . Furthermore , nature somatic mutations observed present study unusual 9 10 mutations missense , 1 case featuring frame-shift mutation due insertion . Previous reports described almost ( > 90 % ) mutations APC gene @ DiseaseTgt $ result truncated APC protein due either frame-shift nonsense mutations . findings suggest mutation APC gene may play important role genesis sporadic hepatoblastomas , mechanisms APC gene alteration may different reported previously @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.121081225091474e-05)\n",
      "- Text: \"Identification gene located chromosome 5q21 mutated @ DiseaseTgt $ . Recent studies suggested existence tumor suppressor gene located chromosome region 5q21 . DNA probes region used study panel @ DiseaseTgt $ . One probes , cosmid 5.71 , detected somatically rearranged restriction fragment DNA single tumor . analysis 5.71 cosmid revealed two regions highly conserved rodent DNA . sequences used identify gene , @ GeneSrc $ ( mutated @ DiseaseTgt $ ) , encodes 829-amino acid protein short region similarity G protein-coupled m3 muscarinic acetylcholine receptor . rearrangement tumor disrupted coding region @ GeneSrc $ gene . Moreover , two @ DiseaseTgt $ found somatically acquired point mutations @ GeneSrc $ resulted amino acid substitutions . @ GeneSrc $ thus candidate putative @ DiseaseTgt $ suppressor gene located 5q21 . studies required determine whether gene mutated sporadic tumors germ line patients inherited predisposition colonic tumorigenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9599685185002502)\n",
      "- Text: \"Mitochondrial p53 activates Bak causes disruption @ GeneSrc $ complex . @ DiseaseTgt $ suppressor activity p53 protein explained ability induce apoptosis response variety cellular stresses . Thus , understanding mechanism p53 functions execution cell death pathways considerable importance @ DiseaseTgt $ biology . Recent studies indicated p53 direct signalling role mitochondria induction apoptosis , although mechanisms involved completely understood . show , cell stress , p53 interacts pro-apoptotic mitochondrial membrane protein Bak . Interaction p53 Bak causes oligomerization Bak release cytochrome c mitochondria . Notably , show formation p53-Bak complex coincides loss interaction Bak anti-apoptotic Bcl2-family member @ GeneSrc $ . results consistent model p53 @ GeneSrc $ opposing effects mitochondrial apoptosis interacting , modulating activity , death effector Bak .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0125144398744121)\n",
      "- Text: \"Activation @ GeneSrc $ LRRK2 induces expression proapoptotic proteins alters survival postmitotic dopaminergic neuron Drosophila . Missense mutations leucine-rich repeat kinase 2 ( LRRK2 ) /Dardarin gene , product encodes kinase multiple domains , known cause autosomal dominant late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . current study , report gene product LRRK2 directly phosphorylates @ GeneSrc $ transcription factor @ GeneSrc $ enhances transcriptional activity . pathway found conserved Drosophila , Drosophila LRRK2 homolog ( dLRRK ) enhanced neuronal toxicity @ GeneSrc $ Importantly , @ GeneSrc $ mutants resistant LRRK2/dLRRK-induced phosphorylation suppressed neurotoxicity . Moreover , determined @ GeneSrc $ targets hid bim Drosophila human , respectively , responsible LRRK2/dLRRK-mediated cell death . data suggest cell death molecules regulated @ GeneSrc $ key factors neurodegeneration LRRK2-linked @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5247778796888997)\n",
      "- Text: \"FBXO11 promotes Neddylation p53 inhibits transcriptional activity . p53 @ DiseaseTgt $ suppressor regulated post-translational modification , including ubiquitination , phosphorylation acetylation . previously shown ubiquitin ligase @ GeneSrc $ also promotes conjugation Nedd8 , ubiquitin-like protein , p53 , inhibiting transcriptional activity . report identification FBXO11 , member F-box protein family component Skp1.Cullin1.F-box ( SCF ) complex , new p53-interacting protein . show FBXO11 promotes neddylation p53 vitro vivo . addition C-terminal lysine residues , FBXO11 also promote Nedd8 conjugation Lys-320 Lys-321 , neddylation p53 leads suppression p53 function . consistent recent studies showing lysine arginine mutation Lys-320 significantly enhances p53 function , although Lys-320 originally identified acetylation site involving PCAF-mediated activation p53 . study provides example F-box protein acting adaptor protein mediate neddylation non-cullin substrate .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025102650588545)\n",
      "- Text: \"positive feedback loop p53 Lats2 @ DiseaseTgt $ suppressors prevents tetraploidization . Damage mitotic spindle centrosome dysfunction lead @ DiseaseTgt $ . prevent , cells trigger succession checkpoint responses , initial mitotic delay followed slippage without cytokinesis , spawning tetraploid G1 cells undergo p53-dependent G1/S arrest . describe importance Lats2 ( Large Tumor Suppressor 2 ) checkpoint response . Lats2 binds @ GeneSrc $ , inhibits E3 ligase activity , activates p53 . Nocodazole , microtubule poison provokes centrosome/mitotic apparatus dysfunction , induces Lats2 translocation centrosomes nucleus p53 accumulation . turn , p53 rapidly selectively up-regulates Lats2 expression G2/M cells , thereby defining positive feedback loop . Abrogation Lats2 promotes accumulation polyploid cells upon exposure nocodazole , prevented direct activation p53 . @ GeneSrc $ axis thus constitutes novel checkpoint pathway critical maintenance proper chromosome number .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.010935475130102)\n",
      "- Text: \"Methylation profile TP53 regulatory pathway mtDNA alterations breast cancer patients lacking TP53 mutations . present study investigated promoter hypermethylation TP53 regulatory pathways providing potential link epigenetic changes mitochondrial DNA ( mtDNA ) alterations breast cancer patients lacking TP53 mutation . possibility using @ DiseaseTgt $ alterations serum samples blood-based test also explored . Triple-matched samples ( cancerous tissues , matched adjacent normal tissues serum samples ) breast cancer patients screened TP53 mutations , promoter methylation profile P14 ( ARF ) , @ GeneSrc $ , TP53 PTEN genes analyzed well mtDNA alterations , including D-loop mutations mtDNA content . studied cohort , mutation found TP53 ( DNA-binding domain ) . Comparison P14 ( ARF ) PTEN methylation patterns showed significant hypermethylation levels @ DiseaseTgt $ tissues ( P < 0.05 < 0.01 , respectively ) whereas TP53 @ DiseaseTgt $ suppressor gene hypermethylated ( P < 0.511 ) . proportion PTEN methylation significantly higher serum normal tissues significant correlation @ DiseaseTgt $ tissues ( P < 0.05 ) . mtDNA analysis revealed 36.36 % somatic 90.91 % germline mutations D-loop region also significant mtDNA depletion @ DiseaseTgt $ tissues ( P < 0.01 ) . addition , mtDNA content matched serum significantly lower normal tissues ( P < 0.05 ) . data provide insight management therapeutic approach based reversal epigenetic silencing crucial genes involved regulatory pathways @ DiseaseTgt $ suppressor TP53 . Additionally , release significant aberrant methylated PTEN matched serum samples might represent promising biomarker breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0289602031837055)\n",
      "- Text: \"Altered expression Rb p53 uveal melanomas following plaque radiotherapy . PURPOSE : examine expression proteins Rb p53 @ DiseaseTgt $ suppressor pathways uveal melanomas following plaque radiotherapy . METHODS : Immunohistochemistry cell culture studies . Immunohistochemistry Rb , p16 , cyclin D1 , p53 , @ GeneSrc $ , Bcl-2 performed twelve eyes containing posterior uveal melanomas enucleated following plaque radiotherapy . Cell culture studies performed three cases . RESULTS : irradiated eyes enucleated radiation complications ( five cases ) , local @ DiseaseTgt $ recurrence ( three cases ) , reasons ( four cases ) . histopathologic examination , cases showed evidence @ DiseaseTgt $ cell loss . However , residual @ DiseaseTgt $ cells present cases , including clinically regressed . Residual cells three clinically regressed cases cultured demonstrated minimal cell division , marked cell death , extensive chromosomal damage . Strong p53 staining observed six cases ( 50 % ) significantly associated recent radiotherapy ( P = .04 ) . Abnormal cytoplasmic staining Rb observed four cases ( 33 % ) . CONCLUSIONS : Plaque radiotherapy uveal melanomas induces DNA damage , inhibits cell division , promotes cell death . changes may due , least part , induction p53 , activates genes involved cell cycle arrest apoptosis . Plaque radiotherapy also cause alterations expression Rb , significance finding require study .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0239494074266659)\n",
      "- Text: \"Impact @ GeneSrc $ SNP309 p53 Arg72Pro polymorphism age @ DiseaseTgt $ onset Li-Fraumeni syndrome . Li-Fraumeni syndrome , resulting p53 ( TP53 ) germline mutations , represents one devastating genetic predispositions @ DiseaseTgt $ . Recently , @ GeneSrc $ SNP309 ( -- > G variation ) shown associated accelerated @ DiseaseTgt $ formation p53 mutation carriers . impact common p53 codon 72 polymorphism @ DiseaseTgt $ risk remains controversial . therefore investigated effect two polymorphisms 61 French carriers p53 germline mutation . mean age @ DiseaseTgt $ onset MDMD2 SNP309 G allele carriers ( 19.6 years ) significantly different observed patients homozygous allele ( 29.9 years , p < 0.05 ) . p53 codon 72 polymorphism , mean age @ DiseaseTgt $ onset Arg allele carriers ( 21.8 years ) also different Pro/Pro patients ( 34.4 years , p < 0.05 ) . observed cumulative effect polymorphisms mean ages @ DiseaseTgt $ onset carriers @ GeneSrc $ G p53Arg alleles ( 16.9 years ) @ GeneSrc $ p53Pro/Pro genotypes ( 43 years ) clearly different ( p < 0.02 ) . Therefore , results confirm impact @ GeneSrc $ SNP309 G allele age @ DiseaseTgt $ onset germline p53 mutation carriers , suggest effect may amplified p53 72Arg allele . Polymorphisms affecting p53 degradation therefore represent one rare examples modifier genetic factors identified date mendelian predispositions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.996833025339527)\n",
      "- Text: \"Pleckstrin homology domain-containing protein PHLDB3 supports @ DiseaseTgt $ growth via negative feedback loop involving p53 . @ DiseaseTgt $ suppressor p53 transactivates expression target genes exert functions . , identify pleckstrin homology domain-containing protein ( PHLDB3 ) -encoding gene p53 target . PHLDB3 overexpression increases proliferation restrains apoptosis wild-type p53-harboring @ DiseaseTgt $ cells reducing p53 protein levels . PHLDB3 binds @ GeneSrc $ ( @ GeneSrc $ ) facilitates @ GeneSrc $ ubiquitination degradation p53 . Knockdown PHLDB3 efficiently inhibits growth mouse xenograft @ DiseaseTgt $ derived human colon cancer HCT116 cells contain wild type p53 compared p53-deficient HCT116 cells , also sensitizes @ DiseaseTgt $ cells doxorubicin 5-Fluorouracil . Analysis @ DiseaseTgt $ genomic databases reveals PHLDB3 amplified and/or highly expressed numerous human @ DiseaseTgt $ . Altogether , results demonstrate PHLDB3 promotes @ DiseaseTgt $ growth inactivating p53 negative feedback fashion suggest PHLDB3 potential therapeutic target various human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9672679132168872)\n",
      "- Text: \"CTS1 : p53-derived chimeric @ DiseaseTgt $ suppressor gene enhanced vitro apoptotic properties . clinical potential p53 @ DiseaseTgt $ suppressor gene evaluated currently gene therapy @ DiseaseTgt $ . built variant wild-type p53 , chimeric tumor suppressor 1 ( CTS1 ) , replaced domains mediate inactivation . CTS1 presents interesting properties : ( ) enhanced transcriptional activity ; ( b ) resistance inactivation oncogenic forms p53 ; ( c ) resistance inactivation @ GeneSrc $ ; ( ) lower sensitivity E6-induced degradation ; ( e ) ability suppress cell growth ; ( f ) faster induction apoptosis . Thus , CTS1 improved @ DiseaseTgt $ suppressor alternative treatment wild-type p53-resistant human @ DiseaseTgt $ gene therapy .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0080452565389281)\n",
      "- Text: \"NUMB controls p53 @ DiseaseTgt $ suppressor activity . NUMB cell fate determinant , , asymmetrically partitioning mitosis , controls cell fate choices antagonising activity plasma membrane receptor NOTCH family . NUMB also endocytic protein , NOTCH-NUMB counteraction linked function . might , however , additional functions NUMB , witnessed proposed role @ DiseaseTgt $ suppressor breast cancer . describe previously unknown function human NUMB regulator @ DiseaseTgt $ protein p53 ( also known TP53 ) . NUMB enters tricomplex p53 E3 ubiquitin ligase @ GeneSrc $ ( also known @ GeneSrc $ ) , thereby preventing ubiquitination degradation p53 . results increased p53 protein levels activity , regulation p53-dependent phenotypes . breast cancers frequent loss NUMB expression . show , primary breast tumour cells , event causes decreased p53 levels increased chemoresistance . breast cancers , loss NUMB expression causes increased activity receptor NOTCH . Thus , @ DiseaseTgt $ , single event-loss NUMB expression-determines activation oncogene ( NOTCH ) attenuation p53 @ DiseaseTgt $ suppressor pathway . Biologically , results aggressive @ DiseaseTgt $ phenotype , witnessed findings NUMB-defective breast tumours display poor prognosis . results uncover previously unknown @ DiseaseTgt $ suppressor circuitry .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5618679873142043)\n",
      "- Text: \"Polyubiquitination p53 ubiquitin ligase activity p300 . Rapid turnover @ DiseaseTgt $ suppressor protein p53 requires @ GeneSrc $ ubiquitin ligase , interact p300-CREB-binding protein transcriptional coactivator proteins . p53 stabilized binding p300 oncoprotein E1A , suggesting p300 regulates p53 degradation . Purified p300 exhibited intrinsic ubiquitin ligase activity inhibited E1A . vitro , p300 @ GeneSrc $ catalyzed p53 polyubiquitination , whereas @ GeneSrc $ catalyzed p53 monoubiquitination . E1A expression caused decrease polyubiquitinated monoubiquitinated p53 cells . Thus , generation polyubiquitinated forms p53 targeted proteasome degradation requires intrinsic ubiquitin ligase activities @ GeneSrc $ p300 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0279813408002821)\n",
      "- Text: \"ZNF668 functions @ DiseaseTgt $ suppressor regulating p53 stability function breast cancer . Genome-wide sequencing studies breast cancer recently identified frequent mutations zinc finger protein 668 ( ZNF668 ) , function undefined . , report ZNF668 nucleolar protein physically interacts regulates p53 negative regulator @ GeneSrc $ . @ GeneSrc $ binding , ZNF668 regulated autoubiquitination @ GeneSrc $ ability mediate p53 ubiquitination degradation . ZNF668 deficiency also impaired DNA damage-induced stabilization p53 . RNA interference-mediated knockdown ZNF668 sufficient transform normal mammary epithelial cells . ZNF668 effectively suppressed breast cancer cell proliferation vitro tumorigenicity vivo . Taken together , studies identify ZNF668 novel breast tumor suppressor gene functions regulating p53 stability .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0163359385475926)\n",
      "- Text: \"Reciprocal regulation p53 malic enzymes modulates metabolism senescence . Cellular senescence protects multicellular organisms @ DiseaseTgt $ contributes ageing . pre-eminent @ DiseaseTgt $ suppressor p53 important role induction maintenance senescence , carries function remains poorly understood . addition , although increasing evidence supports idea metabolic changes underlie many cell-fate decisions p53-mediated @ DiseaseTgt $ suppression , connections metabolic enzymes senescence established . describe new mechanism p53 links functions . show p53 represses expression tricarboxylic-acid-cycle-associated malic enzymes ME1 ME2 human mouse cells . malic enzymes important NADPH production , lipogenesis glutamine metabolism , ME2 profound effect . inhibition malic enzymes , p53 regulates cell metabolism proliferation . Downregulation ME1 ME2 reciprocally activates p53 distinct @ GeneSrc $ AMP-activated protein kinase-mediated mechanisms feed-forward manner , bolstering pathway enhancing p53 activation . Downregulation ME1 ME2 also modulates outcome p53 activation , leading strong induction senescence , apoptosis , whereas enforced expression either malic enzyme suppresses senescence . findings define physiological functions malic enzymes , demonstrate positive-feedback mechanism sustains p53 activation , reveal connection metabolism senescence mediated p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024883030052405)\n",
      "- Text: \"p53QS transactivation-deficient mutant shows stress-specific apoptotic activity induces embryonic lethality . role transcriptional activation p53 function highly controversial . define role vivo , generated Trp53 knock-in construct encoding protein carrying mutations two residues crucial transactivation ( L25Q , W26S ) . show mutations selective effects biological functions p53 . Although ability activate various p53 target genes largely compromised , p53 ( QS ) protein retains ability transactivate gene Bax . ability p53 ( QS ) mutant protein elicit DNA damage-induced G1 cell cycle-arrest response also partially impaired . p53 ( QS ) selective defects ability induce apoptosis : completely unable activate apoptosis response DNA damage , partially unable subjected serum deprivation retains substantial apoptotic activity upon exposure hypoxia . findings suggest p53 acts distinct , stimulus-specific pathways induce apoptosis . importance biological activity p53 ( QS ) vivo underscored finding expression p53 ( QS ) , bind @ GeneSrc $ , induces embryonic lethality . Taken together , results suggest p53 different mechanisms action depending specific contextual cues , may help clarify function p53 preventing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.094716830664736e-06)\n",
      "- Text: \"Inactivation p53 pathway retinoblastoma . human @ DiseaseTgt $ genetic mutations Rb p53 pathways , retinoblastoma thought exception . Studies suggest retinoblastomas , initiate mutations gene retinoblastoma 1 ( RB1 ) , bypass p53 pathway arise intrinsically death-resistant cells retinal development . contrast prevailing theory , show @ DiseaseTgt $ surveillance pathway mediated Arf , @ GeneSrc $ , MDMX p53 activated loss RB1 retinogenesis . RB1-deficient retinoblasts undergo p53-mediated apoptosis exit cell cycle . Subsequently , amplification MDMX gene increased expression MDMX protein strongly selected @ DiseaseTgt $ progression mechanism suppress p53 response RB1-deficient retinal cells . data provide evidence p53 pathway inactivated retinoblastoma @ DiseaseTgt $ originate intrinsically death-resistant cells previously thought . addition , support idea MDMX specific chemotherapeutic target treating retinoblastoma .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.936190005899078)\n",
      "- Text: \"Deubiquitination p53 HAUSP important pathway p53 stabilization . p53 @ DiseaseTgt $ short-lived protein maintained low levels normal cells @ GeneSrc $ ubiquitination subsequent proteolysis . Stabilization p53 crucial @ DiseaseTgt $ function . However , precise mechanism ubiquitinated p53 levels regulated vivo completely understood . mass spectrometry affinity-purified p53-associated factors , identified herpesvirus-associated ubiquitin-specific protease ( HAUSP ) novel p53-interacting protein . HAUSP strongly stabilizes p53 even presence excess @ GeneSrc $ , also induces p53-dependent cell growth repression apoptosis . Significantly , HAUSP intrinsic enzymatic activity specifically deubiquitinates p53 vitro vivo . contrast , expression catalytically inactive point mutant HAUSP cells increases levels p53 ubiquitination destabilizes p53 . findings reveal important mechanism p53 stabilized direct deubiquitination also imply HAUSP might function @ DiseaseTgt $ vivo stabilization p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3988805823390556)\n",
      "- Text: \"p53 regulation ammonia metabolism urea cycle controls polyamine biosynthesis . @ DiseaseTgt $ cells exhibit altered usually increased metabolic processes meet high biogenetic demands1,2 . conditions , ammonia concomitantly produced increased metabolic processing . However , unclear @ DiseaseTgt $ cells dispose excess ammonia outcomes might caused accumulation ammonia . report @ DiseaseTgt $ suppressor p53 , frequently mutated gene human @ DiseaseTgt $ , regulates ammonia metabolism repressing urea cycle . transcriptional downregulation CPS1 , OTC ARG1 , p53 suppresses ureagenesis elimination ammonia vitro vivo , leading inhibition @ DiseaseTgt $ growth . Conversely , downregulation genes reciprocally activates p53 @ GeneSrc $ mechanism ( ) . Furthermore , accumulation ammonia causes significant decline mRNA translation polyamine biosynthetic rate-limiting enzyme ODC , thereby inhibiting biosynthesis polyamine cell proliferation . Together , findings link p53 ureagenesis ammonia metabolism , reveal role ammonia controlling polyamine biosynthesis cell proliferation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0823871343504985)\n",
      "- Text: \"Acetylation indispensable p53 activation . activation @ DiseaseTgt $ suppressor p53 facilitates cellular response genotoxic stress ; however , p53 response executed interaction inhibitor @ GeneSrc $ abolished . conflicting reports question whether p53 posttranslational modifications , phosphorylation acetylation , essential play subtle , fine-tuning role p53 response . Thus , remains unclear whether p53 modification absolutely required activation . identified major acetylation sites p53 . Although unacetylated p53 retains ability induce @ GeneSrc $ feedback loop , loss acetylation completely abolishes p53-dependent growth arrest apoptosis . Notably , acetylation p53 abrogates @ GeneSrc $ repression blocking recruitment @ GeneSrc $ p53-responsive promoters , leads p53 activation independent phosphorylation status . study identifies p53 acetylation indispensable event destabilizes @ GeneSrc $ interaction enables p53-mediated stress response .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3160549704563648)\n",
      "- Text: \"Regulating p53 pathway : vitro hypotheses , vivo veritas . Mutations TP53 , gene encodes @ DiseaseTgt $ suppressor p53 , found 50 % human @ DiseaseTgt $ , increased levels negative regulators @ GeneSrc $ MDM4 ( also known MDMX ) downregulate p53 function many rest . Understanding p53 regulation remains crucial goal design broadly applicable anticancer strategies based pathway . Review vitro studies , human @ DiseaseTgt $ data recent mouse models shows p53 post-translational modifications modulatory roles , @ GeneSrc $ MDM4 profound roles regulating p53 . Importantly , MDM4 emerges independent target drug development , inactivation crucial full p53 activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.938118365750738)\n",
      "- Text: \"UBE4B promotes @ GeneSrc $ degradation @ DiseaseTgt $ suppressor p53 . TP53 gene ( encoding p53 @ DiseaseTgt $ suppressor ) rarely mutated , although frequently inactivated , medulloblastoma ependymoma . Recent work mouse models showed loss p53 accelerated development medulloblastoma . mechanism underlying p53 inactivation human brain tumors completely understood . show ubiquitination factor E4B ( UBE4B ) , E3 E4 ubiquitin ligase , physically interacts p53 @ GeneSrc $ ( also known Mdm2 mice ) . UBE4B promotes p53 polyubiquitination degradation inhibits p53-dependent transactivation apoptosis . Notably , silencing UBE4B expression impairs xenotransplanted @ DiseaseTgt $ growth p53-dependent manner overexpression UBE4B correlates decreased expression p53 @ DiseaseTgt $ . also show UBE4B overexpression often associated amplification gene human brain tumors . data indicate amplification overexpression UBE4B represent previously undescribed molecular mechanisms inactivation p53 brain tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3038479278755794)\n",
      "- Text: \"p53 Stability activity regulated @ GeneSrc $ induction alternative p53 translation products . Activation p53 @ DiseaseTgt $ suppressor protein lead cell-cycle arrest apoptosis . p53 function controlled @ GeneSrc $ oncogene product , targets p53 proteasomal degradation . report demonstrate @ GeneSrc $ induces translation p53 mRNA two alternative initiation sites , giving full-length p53 another protein relative molecular mass ( ( r ) ) approximately 47 K ; designate protein p53/47 . translation induction requires @ GeneSrc $ interact directly nascent p53 polypeptide . alternatively translated p53/47 contain @ GeneSrc $ site lacks amino-terminal transcriptional-activation domain p53 . Increased expression p53/47 stabilizes p53 presence @ GeneSrc $ , alters expression levels p53-induced gene products . results show interaction @ GeneSrc $ p53 leads change ratio full-length p53 p53/47 inducing translation p53 proteins subsequent selective degradation full-length p53 . Thus , @ GeneSrc $ controls expression levels p53 dual mechanism involves induction synthesis targeting degradation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9530013768147938)\n",
      "- Text: \"prolyl isomerase Pin1 reveals mechanism control p53 functions genotoxic insults . @ DiseaseTgt $ suppressor p53 important cell decision either arrest cell cycle progression induce apoptosis response variety stimuli . p53 post-translational modifications association proteins implicated regulation stability transcriptional activities . report , DNA damage , p53 interacts Pin1 , peptidyl-prolyl isomerase , regulates function many proteins involved cell cycle control apoptosis . interaction strictly dependent p53 phosphorylation , requires Ser 33 , Thr 81 Ser 315 . binding , Pin1 generates conformational changes p53 , enhancing transactivation activity . Stabilization p53 impaired UV-treated Pin1 ( -/- ) cells owing inability efficiently dissociate @ GeneSrc $ . consequence , reduced p53-dependent response detected Pin1 ( -/- ) cells , correlates diminished transcriptional activation p53-regulated genes . results suggest , following stress-induced phosphorylation , p53 needs form complex Pin1 undergo conformational change fulfil biological roles .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.605495632259918e-05)\n",
      "- Text: \"human long non-coding RNA-RoR p53 repressor response DNA damage . well known upon stress , level @ DiseaseTgt $ suppressor p53 remarkably elevated . However , despite extensive studies , underlying mechanism involving important inter-players stress-induced p53 regulation still fully understood . present evidence human lincRNA-RoR ( RoR ) strong negative regulator p53 . Unlike @ GeneSrc $ causes p53 degradation ubiquitin-proteasome pathway , RoR suppresses p53 translation direct interaction heterogeneous nuclear ribonucleoprotein ( hnRNP ) . Importantly , 28-base RoR sequence carrying hnRNP binding motifs essential sufficient p53 repression . show RoR inhibits p53-mediated cell cycle arrest apoptosis . Finally , demonstrate RoR-p53 autoregulatory feedback loop p53 transcriptionally induces RoR expression . Together , results suggest RoR-hnRNP I-p53 axis may constitute additional surveillance network cell better respond various stresses .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.172030867994751e-06)\n",
      "- Text: \"Inactivation p53 pathway retinoblastoma . human @ DiseaseTgt $ genetic mutations Rb p53 pathways , retinoblastoma thought exception . Studies suggest retinoblastomas , initiate mutations gene retinoblastoma 1 ( RB1 ) , bypass p53 pathway arise intrinsically death-resistant cells retinal development . contrast prevailing theory , show @ DiseaseTgt $ surveillance pathway mediated Arf , MDM2 , @ GeneSrc $ p53 activated loss RB1 retinogenesis . RB1-deficient retinoblasts undergo p53-mediated apoptosis exit cell cycle . Subsequently , amplification @ GeneSrc $ gene increased expression @ GeneSrc $ protein strongly selected @ DiseaseTgt $ progression mechanism suppress p53 response RB1-deficient retinal cells . data provide evidence p53 pathway inactivated retinoblastoma @ DiseaseTgt $ originate intrinsically death-resistant cells previously thought . addition , support idea @ GeneSrc $ specific chemotherapeutic target treating retinoblastoma .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.990256084819648)\n",
      "- Text: \"Regulating p53 pathway : vitro hypotheses , vivo veritas . Mutations TP53 , gene encodes @ DiseaseTgt $ suppressor p53 , found 50 % human @ DiseaseTgt $ , increased levels negative regulators MDM2 @ GeneSrc $ ( also known @ GeneSrc $ ) downregulate p53 function many rest . Understanding p53 regulation remains crucial goal design broadly applicable anticancer strategies based pathway . Review vitro studies , human @ DiseaseTgt $ data recent mouse models shows p53 post-translational modifications modulatory roles , MDM2 @ GeneSrc $ profound roles regulating p53 . Importantly , @ GeneSrc $ emerges independent target drug development , inactivation crucial full p53 activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8336215698056351)\n",
      "- Text: \"MiR-766 induces p53 accumulation G2/M arrest directly targeting @ GeneSrc $ . p53 , transcription factor participates multiple cellular functions , considered important @ DiseaseTgt $ suppressor . Previous evidence suggests post-transcriptional deregulation p53 microRNAs contributes tumorigenesis , @ DiseaseTgt $ progression therapeutic resistance . present study , found microRNA miR-766 aberrantly expressed breast cancer , over-expression miR-766 caused accumulation wild-type p53 protein multiple @ DiseaseTgt $ cell lines . Supporting role p53 signalling pathway , miR-766 decreased cell proliferation colony formation several @ DiseaseTgt $ cell lines , cell cycle analyses revealed miR-766 causes G2 arrest . mechanistic level , demonstrate miR-766 enhances p53 signalling directly targeting @ GeneSrc $ , oncogene negative regulator p53 . Analysis clinical genomic data multiple @ DiseaseTgt $ types supports relevance miR-766 p53 signalling . Collectively , study demonstrates miR-766 function novel @ DiseaseTgt $ suppressor enhancing p53 signalling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0070028892361946)\n",
      "- Text: \"Exome sequencing identifies rare variants multiple genes atrioventricular septal defect . PURPOSE : genetic etiology atrioventricular septal defect ( AVSD ) unknown 40 % cases . Conventional sequencing arrays identified etiology minority nonsyndromic individuals AVSD . METHODS : Whole-exome sequencing performed 81 unrelated probands AVSD identify potentially causal variants comprehensive set 112 genes strong biological relevance AVSD . RESULTS : significant enrichment rare rare damaging variants identified gene set , compared controls ( odds ratio ( ) : 1.52 ; 95 % confidence interval ( CI ) : 1.35 - 1.71 ; P = 4.8 x 10 ( -11 ) ) . enrichment specific AVSD probands , compared cohort without AVSD @ DiseaseTgt $ ( : 2.25 ; 95 % CI : 1.84 - 2.76 ; P = 2.2 x 10 ( -16 ) ) . Six genes ( NIPBL , CHD7 , CEP152 , BMPR1a , ZFPM2 , @ GeneSrc $ ) enriched rare variants AVSD compared controls , including three syndrome-associated genes ( NIPBL , CHD7 , CEP152 ) . findings confirmed replication cohort 81 AVSD probands . CONCLUSION : Mutations genes strong biological relevance AVSD , including syndrome-associated genes , contribute AVSD , even isolated heart disease . identification gene set associated AVSD facilitate targeted genetic screening cohort .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.0126283761928697e-07)\n",
      "- Text: \"@ GeneSrc $ regulates growth directly phosphorylating Tsc2 . direct mechanism serine/threonine kinase @ GeneSrc $ ( also known @ GeneSrc $ ( @ GeneSrc $ ) ) regulates cell growth unknown . , report Drosophila melanogaster @ GeneSrc $ stimulates growth phosphorylating tuberous sclerosis complex 2 ( Tsc2 ) @ DiseaseTgt $ suppressor inhibiting formation Tsc1-Tsc2 complex . show @ GeneSrc $ directly phosphorylates Drosophila Tsc2 vitro conserved residues , Ser 924 Thr 1518 . Mutation sites renders Tsc2 insensitive @ GeneSrc $ signalling , increasing stability Tsc1-Tsc2 complex within cell . Stimulating @ GeneSrc $ signalling vivo markedly increases cell growth/size , disrupts Tsc1-Tsc2 complex disturbs distinct subcellular localization Tsc1 Tsc2 . Furthermore , @ GeneSrc $ growth signals blocked expression Tsc2 mutant lacking @ GeneSrc $ phosphorylation sites . Thus , Tsc2 seems critical target @ GeneSrc $ mediating growth signals insulin signalling pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0343143516382522)\n",
      "- Text: \"Phosphorylation regulation @ GeneSrc $ rictor-mTOR complex . Deregulation @ GeneSrc $ kinase B ( PKB ) implicated pathogenesis @ DiseaseTgt $ diabetes . @ GeneSrc $ activation requires phosphorylation Thr308 activation loop phosphoinositide-dependent kinase 1 ( PDK1 ) Ser473 within carboxyl-terminal hydrophobic motif unknown kinase . show Drosophila human cells target rapamycin ( TOR ) kinase associated protein rictor necessary Ser473 phosphorylation reduction rictor mammalian TOR ( mTOR ) expression inhibited @ GeneSrc $ effector . rictor-mTOR complex directly phosphorylated @ GeneSrc $ Ser473 vitro facilitated Thr308 phosphorylation PDK1 . Rictor-mTOR may serve drug target @ DiseaseTgt $ lost expression PTEN , @ DiseaseTgt $ suppressor opposes @ GeneSrc $ activation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7047269516191468)\n",
      "- Text: \"Reciprocal regulation p53 malic enzymes modulates metabolism senescence . Cellular senescence protects multicellular organisms @ DiseaseTgt $ contributes ageing . pre-eminent @ DiseaseTgt $ suppressor p53 important role induction maintenance senescence , carries function remains poorly understood . addition , although increasing evidence supports idea metabolic changes underlie many cell-fate decisions p53-mediated @ DiseaseTgt $ suppression , connections metabolic enzymes senescence established . describe new mechanism p53 links functions . show p53 represses expression tricarboxylic-acid-cycle-associated malic enzymes @ GeneSrc $ ME2 human mouse cells . malic enzymes important NADPH production , lipogenesis glutamine metabolism , ME2 profound effect . inhibition malic enzymes , p53 regulates cell metabolism proliferation . Downregulation @ GeneSrc $ ME2 reciprocally activates p53 distinct MDM2- AMP-activated protein kinase-mediated mechanisms feed-forward manner , bolstering pathway enhancing p53 activation . Downregulation @ GeneSrc $ ME2 also modulates outcome p53 activation , leading strong induction senescence , apoptosis , whereas enforced expression either malic enzyme suppresses senescence . findings define physiological functions malic enzymes , demonstrate positive-feedback mechanism sustains p53 activation , reveal connection metabolism senescence mediated p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5600732883894918)\n",
      "- Text: \"Reciprocal regulation p53 malic enzymes modulates metabolism senescence . Cellular senescence protects multicellular organisms @ DiseaseTgt $ contributes ageing . pre-eminent @ DiseaseTgt $ suppressor p53 important role induction maintenance senescence , carries function remains poorly understood . addition , although increasing evidence supports idea metabolic changes underlie many cell-fate decisions p53-mediated @ DiseaseTgt $ suppression , connections metabolic enzymes senescence established . describe new mechanism p53 links functions . show p53 represses expression tricarboxylic-acid-cycle-associated malic enzymes ME1 ME2 human mouse cells . malic enzymes important NADPH production , lipogenesis glutamine metabolism , @ GeneSrc $ profound effect . inhibition malic enzymes , p53 regulates cell metabolism proliferation . Downregulation ME1 @ GeneSrc $ reciprocally activates p53 distinct MDM2- AMP-activated protein kinase-mediated mechanisms feed-forward manner , bolstering pathway enhancing p53 activation . Downregulation ME1 @ GeneSrc $ also modulates outcome p53 activation , leading strong induction senescence , apoptosis , whereas enforced expression either malic enzyme suppresses senescence . findings define physiological functions malic enzymes , demonstrate positive-feedback mechanism sustains p53 activation , reveal connection metabolism senescence mediated p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1274026799944758)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated nucleophosmin . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying NPM1 mutations cytoplasmic nucleophosmin ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status NPM1 FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( NPM1 unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 @ GeneSrc $ , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0017582982774423)\n",
      "- Text: \"Mutations LRRK2 cause autosomal-dominant parkinsonism pleomorphic pathology . previously linked families autosomal-dominant , late-onset parkinsonism chromosome 12p11.2-q13.1 ( PARK8 ) . high-resolution recombination mapping candidate gene sequencing 46 families , found six disease-segregating mutations ( five missense one putative splice site mutation ) gene encoding large , multifunctional protein , LRRK2 ( leucine-rich repeat kinase 2 ) . belongs ROCO protein family includes protein kinase domain @ GeneSrc $ class several major functional domains . Within affected carriers families , six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied strikingly diverse pathologies . include abnormalities consistent @ DiseaseTgt $ , diffuse Lewy body disease , nigral degeneration without distinctive histopathology , progressive supranuclear palsy-like pathology . Clinical diagnoses Parkinsonism dementia amyotrophy , associated pathologies , also noted . Hence , LRRK2 may central pathogenesis several major neurodegenerative disorders associated parkinsonism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.922668941029058e-05)\n",
      "- Text: \"Roc domain leucine-rich repeat kinase 2 sufficient interaction microtubules . Mutations leucine-rich repeat kinase 2 ( LRRK2 ) gene leading cause genetically inherited @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although multidomain protein shown GTPase kinase activities Roc @ GeneSrc $ domains , respectively , protein-protein interactions pathways involved LRRK2-mediated signaling remain elusive . Utilizing combination protein pull-down assays , mass spectrometry , Western blotting , immunofluorescence microscopy , study identifies describes interaction LRRK2 microtubules . Roc GTPase-like domain LRRK2 sufficient interaction alpha/beta-tubulin heterodimers . interaction occurs guanine nucleotide-independent manner , suggesting tubulin might effector LRRK2 GTPase domain . R1441C pathogenic mutation , located within Roc domain , retains interaction alpha/beta-tubulin heterodimers , suggesting disruption interaction likely mechanism whereby R1441C mutation leads disease . subcellular level , endogenous LRRK2 protein found colocalize alpha/beta-tubulin primary hippocampal neurons . findings significant link LRRK2 microtubules , structural component cell critically involved pathogenesis several neurodegenerative diseases , including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3053171413773627)\n",
      "- Text: \"Interaction DJ-1 Daxx inhibits @ GeneSrc $ activity cell death . Investigations cellular molecular biology genes cause inherited forms @ DiseaseTgt $ , well downstream pathways trigger , shed considerable light understanding fundamental determinants life death dopaminergic neurons . Homozygous deletion missense mutation DJ-1 results autosomal recessively inherited @ DiseaseTgt $ , suggesting wild-type DJ-1 favorable role maintaining neurons . , show DJ-1 protects oxidative stress-induced cell death , relatively modest ability quench reactive oxygen species insufficient account robust cytoprotective effect . elucidate mechanism cell-preserving function , screened death protein Daxx DJ-1-interacting partner . demonstrate wild-type DJ-1 sequesters Daxx nucleus , prevents gaining access cytoplasm , binding activating effector kinase @ GeneSrc $ , therefore , triggering ensuing death pathway . steps impaired disease-causing L166P mutant isoform DJ-1 . findings suggest regulated sequestration Daxx nucleus keeping @ GeneSrc $ activation check critical mechanism DJ-1 exerts cytoprotective function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0553493349817695)\n",
      "- Text: \"Leucine-Rich Repeat Kinase 2 interacts Parkin , DJ-1 PINK-1 Drosophila melanogaster model @ DiseaseTgt $ . Mutations LRRK2 gene common genetic cause familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , physiological pathological functions unknown . Therefore , generated several independent Drosophila lines carrying WT mutant human LRRK2 ( mutations kinase , COR LRR domains , resp . ) . Ectopic expression WT mutant LRRK2 dopaminergic neurons caused significant loss accompanied complex age-dependent changes locomotor activity . Overall , ubiquitous expression LRRK2 increased lifespan fertility flies . However , flies sensitive rotenone . @ GeneSrc $ expression eye exacerbated retinal degeneration . Importantly , double transgenic flies , various indices eye dopaminergic survival modified complex fashion concomitant expression PINK1 , DJ-1 Parkin . evidence suggests genetic interaction @ DiseaseTgt $ genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0051814434969516)\n",
      "- Text: \"Pathogenic @ GeneSrc $ negatively regulates microRNA-mediated translational repression . Gain-of-function mutations @ GeneSrc $ ( @ GeneSrc $ ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism @ GeneSrc $ action known . show @ GeneSrc $ interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila e2f1 dp messenger RNAs translationally repressed let-7 miR-184 * , respectively . Pathogenic @ GeneSrc $ antagonizes miRNAs , leading overproduction E2F1/DP , previously implicated cell cycle survival control shown critical @ GeneSrc $ pathogenesis . Genetic deletion let-7 , antagomir-mediated blockage let-7 miR-184 * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive let-7 toxic effects similar pathogenic @ GeneSrc $ . Conversely , increasing level let-7 miR-184 * attenuated pathogenic @ GeneSrc $ effects . @ GeneSrc $ associated Drosophila Argonaute-1 ( dAgo1 ) human Argonaute-2 ( hAgo2 ) RNA-induced silencing complex ( RISC ) . aged fly brain , dAgo1 protein level negatively regulated @ GeneSrc $ . , pathogenic @ GeneSrc $ promoted association phospho-4E-BP1 hAgo2 . results implicate deregulated synthesis E2F1/DP caused miRNA pathway impairment key event @ GeneSrc $ pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8584656069058436)\n",
      "- Text: \"Dopaminergic expression @ DiseaseTgt $ gene @ GeneSrc $ leads non-autonomous visual neurodegeneration , accelerated increased neural demands energy . @ DiseaseTgt $ ( @ DiseaseTgt $ ) associated loss dopaminergic signalling , affects movement , also vision . mammalian fly visual systems contain dopaminergic neurons , investigated effect @ GeneSrc $ mutations ( common cause inherited @ DiseaseTgt $ ) Drosophila electroretinograms ( ERGs ) . reveal progressive loss photoreceptor function flies expressing @ GeneSrc $ dopaminergic neurons . photoreceptors showed elevated autophagy , apoptosis mitochondrial disorganization . Head sections confirmed extensive neurodegeneration throughout visual system , including regions directly innervated dopaminergic neurons . @ DiseaseTgt $ mutations affect photoreceptor function , loss vision seen kinase-dead transgenics . Manipulations level Drosophila @ GeneSrc $ suggest G2019S acting gain-of-function , rather dominant negative mutation . Increasing activity visual system , dopaminergic neurons , accelerated G2019S-induced deterioration vision . fly visual system provides excellent , tractable model non-autonomous deficit reminiscent seen @ DiseaseTgt $ , suggests increased energy demand may contribute mechanism @ GeneSrc $ causes neurodegeneration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0724757194877591)\n",
      "- Text: \"Activation FoxO @ GeneSrc $ induces expression proapoptotic proteins alters survival postmitotic dopaminergic neuron Drosophila . Missense mutations @ GeneSrc $ @ GeneSrc $ gene , product encodes kinase multiple domains , known cause autosomal dominant late onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . current study , report gene product @ GeneSrc $ directly phosphorylates forkhead box transcription factor FoxO1 enhances transcriptional activity . pathway found conserved Drosophila , Drosophila @ GeneSrc $ homolog ( dLRRK ) enhanced neuronal toxicity FoxO . Importantly , FoxO mutants resistant @ GeneSrc $ phosphorylation suppressed neurotoxicity . Moreover , determined FoxO targets hid bim Drosophila human , respectively , responsible @ GeneSrc $ cell death . data suggest cell death molecules regulated FoxO key factors neurodegeneration @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3730852579316236)\n",
      "- Text: \"Rare @ DiseaseTgt $ mutations @ GeneSrc $ show gain function . Fifteen rare @ DiseaseTgt $ mutants @ GeneSrc $ , gene coding catalytic subunit p110alpha phosphatidylinositol 3-kinase ( PI3 K ) , examined biological biochemical properties . Fourteen mutants show gain function : induce rapamycin-sensitive oncogenic transformation chicken embryo fibroblasts , constitutively activate Akt TOR-mediated signaling , show enhanced lipid kinase activity . Mapping mutants partial structural model p110alpha suggests three groups mutants , defined location distinct functional domains protein . hypothesize three groups induces gain PI3 K function different molecular mechanism . Mutants C2 domain increase positive surface charge domain therefore may enhance recruitment p110alpha cellular membranes . Mutants helical domain map contiguous surface protein may affect interaction protein ( ) . Mutants kinase domain located near hinge activation loop . may alter position mobility activation loop . Arbitrarily introduced mutations detectable phenotype map either interior protein positioned surface region lies opposite exposed surfaces containing gain-of-function mutants . Engineered mutants exchange acidic neutral residues basic residues critical surfaces show gain function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.286283553559377)\n",
      "- Text: \"FBXO11 promotes Neddylation p53 inhibits transcriptional activity . p53 @ DiseaseTgt $ suppressor regulated post-translational modification , including ubiquitination , phosphorylation acetylation . previously shown ubiquitin ligase Mdm2 also promotes conjugation Nedd8 , ubiquitin-like protein , p53 , inhibiting transcriptional activity . report identification FBXO11 , member F-box protein family component Skp1.Cullin1.F-box ( @ GeneSrc $ ) complex , new p53-interacting protein . show FBXO11 promotes neddylation p53 vitro vivo . addition C-terminal lysine residues , FBXO11 also promote Nedd8 conjugation Lys-320 Lys-321 , neddylation p53 leads suppression p53 function . consistent recent studies showing lysine arginine mutation Lys-320 significantly enhances p53 function , although Lys-320 originally identified acetylation site involving PCAF-mediated activation p53 . study provides example F-box protein acting adaptor protein mediate neddylation non-cullin substrate .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.0052528998845686e-05)\n",
      "- Text: \"CRD-BP mediates stabilization betaTrCP1 c-myc mRNA response beta-catenin signalling . Although constitutive activation beta-catenin/Tcf signalling implicated development human cancers , mechanisms beta-catenin/Tcf pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show beta-catenin stabilizes mRNA encoding F-box protein betaTrCP1 , identify RNA-binding protein CRD-BP ( coding region determinant-binding protein ) previously unknown target beta-catenin/Tcf transcription factor . CRD-BP binds coding region betaTrCP1 mRNA . Overexpression CRD-BP stabilizes betaTrCP1 mRNA elevates betaTrCP1 levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein @ GeneSrc $ ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB beta-catenin . CRD-BP essential induction betaTrCP1 c-Myc beta-catenin signalling @ DiseaseTgt $ cells . High levels CRD-BP found primary human @ DiseaseTgt $ exhibiting active beta-catenin/Tcf signalling implicates CRD-BP induction upregulation betaTrCP1 , activation dimeric transcription factor NF-kappaB suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 9.057164822319966e-07)\n",
      "- Text: \"Akt regulates growth directly phosphorylating Tsc2 . direct mechanism serine/threonine kinase Akt ( also known protein kinase B ( PKB ) ) regulates cell growth unknown . , report Drosophila melanogaster Akt/PKB stimulates growth phosphorylating tuberous sclerosis complex 2 ( Tsc2 ) @ DiseaseTgt $ suppressor inhibiting formation Tsc1-Tsc2 complex . show Akt/PKB directly phosphorylates Drosophila Tsc2 vitro conserved residues , Ser 924 Thr 1518 . Mutation sites renders Tsc2 insensitive Akt/PKB signalling , increasing stability Tsc1-Tsc2 complex within cell . Stimulating Akt/PKB signalling vivo markedly increases cell growth/size , disrupts Tsc1-Tsc2 complex disturbs distinct subcellular localization Tsc1 Tsc2 . Furthermore , Akt/PKB growth signals blocked expression Tsc2 mutant lacking Akt phosphorylation sites . Thus , Tsc2 seems critical target Akt mediating growth signals @ GeneSrc $ signalling pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0021230832409712)\n",
      "- Text: \"FBXO11 promotes Neddylation p53 inhibits transcriptional activity . p53 @ DiseaseTgt $ suppressor regulated post-translational modification , including ubiquitination , phosphorylation acetylation . previously shown ubiquitin ligase Mdm2 also promotes conjugation Nedd8 , ubiquitin-like protein , p53 , inhibiting transcriptional activity . report identification FBXO11 , member F-box protein family component @ GeneSrc $ ( SCF ) complex , new p53-interacting protein . show FBXO11 promotes neddylation p53 vitro vivo . addition C-terminal lysine residues , FBXO11 also promote Nedd8 conjugation Lys-320 Lys-321 , neddylation p53 leads suppression p53 function . consistent recent studies showing lysine arginine mutation Lys-320 significantly enhances p53 function , although Lys-320 originally identified acetylation site involving PCAF-mediated activation p53 . study provides example F-box protein acting adaptor protein mediate neddylation non-cullin substrate .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0006362593689538)\n",
      "- Text: \"Comprehensive genomic characterization defines human glioblastoma genes core pathways . Human @ DiseaseTgt $ cells typically harbour multiple chromosomal aberrations , nucleotide substitutions epigenetic modifications drive malignant transformation . @ DiseaseTgt $ Genome Atlas ( TCGA ) pilot project aims assess value large-scale multi-dimensional analysis molecular characteristics human @ DiseaseTgt $ provide data rapidly research community . report interim integrative analysis DNA copy number , gene expression DNA methylation aberrations 206 glioblastomas -- common type adult brain cancer -- nucleotide sequence aberrations 91 206 glioblastomas . analysis provides new insights roles ERBB2 , NF1 TP53 , uncovers frequent mutations phosphatidylinositol-3-OH kinase regulatory subunit gene PIK3R1 , provides network view pathways altered development glioblastoma . Furthermore , integration mutation , DNA methylation clinical treatment data reveals link @ GeneSrc $ promoter methylation hypermutator phenotype consequent mismatch repair deficiency treated glioblastomas , observation potential clinical implications . Together , findings establish feasibility power TCGA , demonstrating rapidly expand knowledge molecular basis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0406503194727296)\n",
      "- Text: \"Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression . Gain-of-function mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause familial well sporadic @ DiseaseTgt $ characterized age-dependent degeneration dopaminergic neurons . molecular mechanism LRRK2 action known . show LRRK2 interacts microRNA ( miRNA ) pathway regulate protein synthesis . Drosophila @ GeneSrc $ dp messenger RNAs translationally repressed let-7 miR-184 * , respectively . Pathogenic LRRK2 antagonizes miRNAs , leading overproduction @ GeneSrc $ , previously implicated cell cycle survival control shown critical LRRK2 pathogenesis . Genetic deletion let-7 , antagomir-mediated blockage let-7 miR-184 * action , transgenic expression dp target protector , replacement endogenous dp dp transgene non-responsive let-7 toxic effects similar pathogenic LRRK2 . Conversely , increasing level let-7 miR-184 * attenuated pathogenic LRRK2 effects . LRRK2 associated Drosophila Argonaute-1 ( dAgo1 ) human Argonaute-2 ( hAgo2 ) RNA-induced silencing complex ( RISC ) . aged fly brain , dAgo1 protein level negatively regulated LRRK2 . , pathogenic LRRK2 promoted association phospho-4E-BP1 hAgo2 . results implicate deregulated synthesis @ GeneSrc $ caused miRNA pathway impairment key event LRRK2 pathogenesis suggest novel miRNA-based therapeutic strategies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0066268128043636)\n",
      "- Text: \"PINK1 loss-of-function mutations affect mitochondrial complex activity via NdufA10 ubiquinone uncoupling . resting conditions , Pink1 knockout cells cells derived patients PINK1 mutations display loss mitochondrial complex reductive activity , causing decrease mitochondrial membrane potential . Analyzing phosphoproteome complex liver brain Pink1 ( -/- ) mice , found specific loss phosphorylation serine-250 complex subunit NdufA10 . Phosphorylation serine-250 needed ubiquinone reduction complex I. Phosphomimetic @ GeneSrc $ reversed Pink1 deficits mouse knockout cells rescued mitochondrial depolarization synaptic transmission defects pink ( B9 ) -null mutant Drosophila . Complex deficits adenosine triphosphate synthesis also rescued cells derived PINK1 patients . Thus , evolutionary conserved pathway may contribute pathogenic cascade eventually leads @ DiseaseTgt $ patients PINK1 mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0140740952680973)\n",
      "- Text: \"Identification 46 novel SNPs 130-kb region containing myocardial infarction susceptibility gene chromosomal band 6p21 . identified total 187 single-nucleotide polymorphisms ( SNPs ) 11 gene loci 130-kb region chromosome 6p21 containing gene strongly associated @ DiseaseTgt $ ( MI ) . comparing data SNPs deposited dbSNP database National Center Biotechnology Information , 46 SNPs ( 24.6 % ) considered novel : four identified P5 - 1 locus , 14 @ GeneSrc $ locus , nine BAT1 locus , one ATP6V1G2 locus , six NFKBIL1 locus , one LTA locus , one TNF locus , five LST1 locus , four LY117a locus , one AIF-1 locus . SNP map presented provide useful resource examining relationships genotypes susceptibility MI phenotype , also scanning complex diseases mapped local segment chromosome 6 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.2750302635823752e-06)\n",
      "- Text: \"Akt regulates growth directly phosphorylating Tsc2 . direct mechanism serine/threonine kinase Akt ( also known protein kinase B ( PKB ) ) regulates cell growth unknown . , report Drosophila melanogaster Akt/PKB stimulates growth phosphorylating tuberous sclerosis complex 2 ( Tsc2 ) @ DiseaseTgt $ suppressor inhibiting formation @ GeneSrc $ complex . show Akt/PKB directly phosphorylates Drosophila Tsc2 vitro conserved residues , Ser 924 Thr 1518 . Mutation sites renders Tsc2 insensitive Akt/PKB signalling , increasing stability @ GeneSrc $ complex within cell . Stimulating Akt/PKB signalling vivo markedly increases cell growth/size , disrupts @ GeneSrc $ complex disturbs distinct subcellular localization @ GeneSrc $ Tsc2 . Furthermore , Akt/PKB growth signals blocked expression Tsc2 mutant lacking Akt phosphorylation sites . Thus , Tsc2 seems critical target Akt mediating growth signals insulin signalling pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0416875176624272)\n",
      "- Text: \"Parkin facilitates elimination expanded polyglutamine proteins leads preservation proteasome function . Parkin , commonly mutated gene familial @ DiseaseTgt $ , encodes E3 ubiquitin ligase . number candidate substrates identified parkin ubiquitin ligase action including CDCrel-1 , o-glycosylated alpha-synuclein , Pael-R , synphilin-1 . show parkin promotes ubiquitination degradation expanded polyglutamine protein . Overexpression parkin reduces aggregation cytotoxicity expanded polyglutamine @ GeneSrc $ fragment . Using cellular proteasome indicator system based destabilized form green fluorescent protein , demonstrate parkin reduces proteasome impairment caspase-12 activation induced expanded polyglutamine protein . Parkin forms complex expanded polyglutamine protein , heat shock protein 70 ( Hsp70 ) proteasome , may important elimination expanded polyglutamine protein . Hsp70 enhances parkin binding ubiquitination expanded polyglutamine protein vitro suggesting Hsp70 may help recruit misfolded proteins substrates parkin E3 ubiquitin ligase activity . speculate parkin may function relieve endoplasmic reticulum stress preserving proteasome activity presence misfolded proteins . Loss parkin function resulting proteasomal impairment may contribute accumulation toxic aberrant proteins neurodegenerative diseases including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.870446630202508e-07)\n",
      "- Text: \"Autosomal dominant dopa-responsive parkinsonism multigenerational Swiss family . AIM : describe large family autosomal dominant parkinsonism . BACKGROUND : Seven genes directly implicated autosomally inherited parkinsonism . However , several multigenerational large families known identifiable mutation . MATERIAL METHODS : Family members evaluated clinically , history chart review . Genetic investigation included SCA2 , @ GeneSrc $ , UCHL1 , SNCA , LRRK2 , PINK1 , PRKN , PGRN , FMR1 premutation , MAPT . proband underwent brain fluorodopa PET ( FD-PET ) scan , one autopsy available . RESULTS : Eleven patients diagnosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , nine women . Mean age onset 52 tremor-predominant dopa-responsive parkinsonism . Disease progression slow severe motor fluctuations occurred . One patient required subthalamic nucleus deep-brain stimulation good motor outcome . One patient mental retardation , schizophrenia became demented , another patient demented . Three patients also two unaffected subjects mild learning difficulties . genetic tests yielded negative results . FD-PET showed marked asymmetric striatal tracer uptake deficiency , consistent @ DiseaseTgt $ . Pathological examination demonstrated Lewy bodies immunostaining negative alpha-synuclein . CONCLUSION : Apart younger age onset female predominance , phenotype indistinguishable @ DiseaseTgt $ , including FD-PET scan results . known genetic causes autosomal dominant @ DiseaseTgt $ excluded , family harbors novel genetic defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0296345870304209)\n",
      "- Text: \"Genetic testing spinocerebellar ataxia Taiwan : expansions trinucleotide repeats SCA8 SCA17 associated typical @ DiseaseTgt $ . DNA tests normal subjects patients ataxia @ DiseaseTgt $ ( @ DiseaseTgt $ ) carried assess frequency spinocerebellar ataxia ( SCA ) document distribution SCA mutations underlying ethnic Chinese Taiwan . @ GeneSrc $ ( 46 % ) common autosomal dominant SCA Taiwanese cohort , followed SCA6 ( 18 % ) SCA1 ( 3 % ) . expansions SCA types 2 , 10 , 12 , dentatorubropallidoluysian atrophy ( DRPLA ) detected . clinical phenotypes affected SCA patients heterogeneous . showed clinical symptoms cerebellar ataxia , without associated features . frequencies large normal alleles closely associated prevalence SCA1 , SCA2 , @ GeneSrc $ , SCA6 , DRPLA among Taiwanese , Japanese , Caucasians . Interestingly , abnormal expansions SCA8 SCA17 genes detected patients @ DiseaseTgt $ . clinical presentation patients typical @ DiseaseTgt $ following characteristics : late onset disease , resting tremor limbs , rigidity , bradykinesia , good response levodopa . study appears first report describing @ DiseaseTgt $ phenotype association expanded allele TATA-binding protein gene suggests SCA8 may also cause typical @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0065051827254236)\n",
      "- Text: \"Distinct patterns KRAS mutations colorectal carcinomas according germline mismatch repair defects @ GeneSrc $ methylation status . sporadic colorectal tumours BRAFV600E associated microsatellite instability ( MSI-H ) inversely associated KRAS mutations . @ DiseaseTgt $ hereditary non-polyposis colorectal cancer ( HNPCC ) patients carrying germline mutations hMSH2 @ GeneSrc $ show BRAFV600E , however consistent data exist regarding KRAS mutation frequency spectrum HNPCC tumours . investigated KRAS 158 HNPCC tumours patients germline @ GeneSrc $ , hMSH2 hMSH6 mutations , 166 MSI-H 688 microsatellite stable ( MSS ) @ DiseaseTgt $ . @ DiseaseTgt $ characterized MSI 81 166 sporadic MSI-H colorectal cancer ( CRCs ) analysed @ GeneSrc $ promoter hypermethylation . KRAS mutations observed 40 % HNPCC tumours , mutation frequency varied upon mismatch repair gene affected : 48 % ( 29/61 ) hMSH2 , 32 % ( 29/91 ) @ GeneSrc $ 83 % ( 5/6 ) hMSH6 ( P = 0.01 ) . KRAS mutation frequency different HNPCC , MSS MSI-H CRCs ( P = 0.002 ) , MSI-H @ GeneSrc $ hypermethylation ( P = 0.005 ) . Furthermore , HNPCC CRCs G13D mutations MSS ( P < 0.0001 ) , MSI-H ( P = 0.02 ) @ DiseaseTgt $ @ GeneSrc $ hypermethylation ( P = 0.03 ) . HNPCC colorectal sporadic MSI-H tumours without @ GeneSrc $ hypermethylation shared similar KRAS mutation frequency , particular G13D . conclusion , show depending genetic/epigenetic mechanism leading MSI-H , outcome terms oncogenic activation may different , reinforcing idea HNPCC , sporadic MSI-H ( depending @ GeneSrc $ status ) MSS CRCs , may target distinct kinases within RAS/RAF/MAPK pathway .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6402213978113995)\n",
      "- Text: \"p53 codon 72 variation associated age onset hereditary non-polyposis colorectal cancer ( HNPCC ) . polymorphic variants codon 72 p53 gene shown functionally distinct vitro , whereby arginine ( arg ) variant induces apoptosis efficiently proline ( pro ) variant . evidence DNA mismatch repair system p53 interact maintain genomic integrity , hypothesized codon 72 variation may influence age onset disease HNPCC patients . tested 538 patients p53 codon 72 variants , including 167 unrelated patients pathogenic germline mutations MSH2 @ GeneSrc $ colorectal carcinoma first @ DiseaseTgt $ , 126 patients sporadic microsatellite stable colorectal cancers , 245 healthy controls . median age onset 41 , 36 , 32 years MSH2 @ GeneSrc $ mutation carriers arg/arg , arg/pro , pro/pro genotypes , respectively . log rank test revealed significant differences age onset arg/arg pro/pro individuals ( p = 0.0002 ) arg/pro versus arg/arg pro/pro individuals ( p = 0.0026 p = 0.0217 , respectively ) . Cox regression model indicated additive mode inheritance . significant differences age onset observed among different genotype carriers @ DiseaseTgt $ . results suggest p53 codon 72 genotypes associated age onset colorectal carcinoma mismatch repair deficient background dose dependent manner . findings may relevant preventive strategies HNPCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1182940389851305)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway colorectal cancer well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) adenomatous polyposis coli ( APC ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies @ GeneSrc $ , hMSH2 , beta-catenin , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One @ DiseaseTgt $ ( 5 % ) found RER+ , @ DiseaseTgt $ stained positive @ GeneSrc $ hMSH2 . mutations detected MCR APC gene . beta-Catenin showed increased nuclear expression loss membranous staining 10 @ DiseaseTgt $ ( 48 % ) . Absent decreased membrane expression E-cadherin found eight @ DiseaseTgt $ ( 38 % ) . Strong staining p53 found nucleus five @ DiseaseTgt $ ( 24 % ) . CONCLUSION : detect mutations MCR APC gene , suggests adenocarcinoma small intestine may follow different genetic pathway colorectal cancer . Abnormal expression E-cadherin beta-catenin common reflects early alternative APC pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1545486698589261)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway @ DiseaseTgt $ well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) adenomatous polyposis coli ( APC ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies @ GeneSrc $ , hMSH2 , beta-catenin , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One cancer ( 5 % ) found RER+ , tumours stained positive @ GeneSrc $ hMSH2 . mutations detected MCR APC gene . beta-Catenin showed increased nuclear expression loss membranous staining 10 cancers ( 48 % ) . Absent decreased membrane expression E-cadherin found eight cancers ( 38 % ) . Strong staining p53 found nucleus five cancers ( 24 % ) . CONCLUSION : detect mutations MCR APC gene , suggests adenocarcinoma small intestine may follow different genetic pathway @ DiseaseTgt $ . Abnormal expression E-cadherin beta-catenin common reflects early alternative APC pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005720333021906)\n",
      "- Text: \"molecular basis Turcot 's syndrome . BACKGROUND : Turcot 's syndrome characterized clinically concurrence primary brain tumor multiple colorectal adenomas . attempted define syndrome molecular level . METHODS : Fourteen families Turcot 's syndrome identified two registries family originally described Turcot colleagues studied . Germ-line mutations adenomatous polyposis coli ( APC ) gene characteristic familial adenomatous polyposis evaluated , well DNA replication errors germline mutations nucleotide mismatch-repair genes characteristic hereditary nonpolyposis colorectal cancer . addition , formal risk analysis brain tumors familial adenomatous polyposis performed registry data base . RESULTS : Genetic abnormalities identified 13 14 registry families . Germ-line APC mutations detected 10 . predominant brain tumor 10 families medulloblastoma ( 11 14 patients , 79 percent ) , relative risk cerebellar medulloblastoma patients familial adenomatous polyposis 92 times general population ( 95 percent confidence interval , 29 269 ; P < 0.001 ) . contrast , type brain tumor four families glioblastoma multiforme . glioblastomas @ DiseaseTgt $ three families original family studied Turcot replication errors characteristic hereditary nonpolyposis colorectal cancer . addition , germ-line mutations mismatch-repair genes @ GeneSrc $ hPMS2 found two families . CONCLUSIONS : association brain tumors multiple colorectal adenomas result two distinct types germ-line defects : mutation APC gene mutation mismatch-repair gene . Molecular diagnosis may contribute appropriate care affected patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0676638025590033)\n",
      "- Text: \"I1307 K APC @ GeneSrc $ mutations non-Jewish family @ DiseaseTgt $ . describe French Canadian @ DiseaseTgt $ ( @ DiseaseTgt $ ) kindred carries novel truncating mutation @ GeneSrc $ . Interestingly , I1307 K APC polymorphism , associated increased risk @ DiseaseTgt $ , also present family . I1307 K polymorphism previously identified individuals self-reported Ashkenazi Jewish origins . addition , family , appears relationship I1307 K polymorphism presence absence cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0067248680378691)\n",
      "- Text: \"BRAF screening low-cost effective strategy simplifying @ DiseaseTgt $ genetic testing . BACKGROUND : According international criteria @ DiseaseTgt $ ( @ DiseaseTgt $ ) diagnostics , cancer patients family history early onset @ DiseaseTgt $ showing high microsatellite instability ( MSI-H ) receive genetic counselling offered testing germline mutations DNA repair genes , mainly @ GeneSrc $ MSH2 . Recently , oncogenic V600E hotspot mutation within BRAF , kinase encoding gene RAS/RAF/MAPK pathway , found associated sporadic MSI-H @ DiseaseTgt $ , association @ DiseaseTgt $ remains clarified . METHODS : BRAF-V600E mutations analysed automatic sequencing @ DiseaseTgt $ 206 sporadic cases MSI-H 111 @ DiseaseTgt $ cases known germline mutations @ GeneSrc $ MSH2 . addition , 45 @ DiseaseTgt $ cases showing abnormal immunostaining MSH2 also analysed . RESULTS : BRAF-V600E hotspot mutation found 40 % ( 82/206 ) sporadic MSI-H tumours analysed none 111 tested @ DiseaseTgt $ 45 cases showing abnormal MSH2 immunostaining . CONCLUSIONS : Detection V600E mutation @ DiseaseTgt $ MSI-H tumour argues presence germline mutation either @ GeneSrc $ MSH2 gene . Therefore , screening mismatch repair ( MMR ) genes avoided cases positive V600E significant evidence , fulfilment strict Amsterdam criteria , suggests MMR associated @ DiseaseTgt $ . context , mutation analysis BRAF hotspot reliable , fast , low cost strategy simplifies genetic testing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8010081574642332)\n",
      "- Text: \"BRAF mutations @ DiseaseTgt $ suggest two entities microsatellite-unstable tumors . BACKGROUND : Alterations BRAF implicated carcinogenesis @ DiseaseTgt $ microsatellite instability ( MSI ) . alterations attributed defective DNA mismatch repair , underlies MSI . objective study clarify role BRAF @ DiseaseTgt $ MSI . METHODS : sequencing BRAF KRAS 82 @ DiseaseTgt $ samples without MSI , mismatch repair protein expression analyzed immunohistochemistry , promoter methylation @ GeneSrc $ analyzed methylation-specific polymerase chain reaction . Results correlated germline status @ GeneSrc $ hMSH2 clinical characteristics . RESULTS : BRAF mutated often tumors MSI tumors without MSI ( 27 % vs. 5 % ; P = 0.016 ) . prevalent BRAF alteration , V599E , occurred tumors MSI . BRAF V599E associated frequent @ GeneSrc $ promoter methylation ( P = 0.07 ) loss @ GeneSrc $ ( P = 0.02 ) . median age patients BRAF V599E older compared median age patients without mutation ( P = 0.001 ; 78 vs. 49 yrs ) . BRAF alterations occurred patients germline mutations mismatch repair genes . Five novel BRAF mutations identified . CONCLUSIONS : Although BRAF V599E common @ DiseaseTgt $ MSI , consequence deficient mismatch repair . current data showed instead BRAF V599E mutation associated subgroup @ DiseaseTgt $ MSI obtained older patients without hereditary nonpolyposis colorectal carcinoma showed epigenetic silencing @ GeneSrc $ . results indicated tumors MSI caused epigenetic @ GeneSrc $ silencing distinct mutational background tumors genetic loss mismatch repair , suggesting two genetically distinct entities microsatellite-instable tumors .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6851619850944214)\n",
      "- Text: \"CpG island methylator phenotype @ DiseaseTgt $ . Aberrant methylation promoter region CpG islands associated transcriptional inactivation tumor-suppressor genes neoplasia . understand global patterns CpG island methylation @ DiseaseTgt $ , used recently developed technique called methylated CpG island amplification examine 30 newly cloned differentially methylated DNA sequences . 30 clones , 19 ( 63 % ) progressively methylated age-dependent manner normal colon , 7 ( 23 % ) methylated cancer-specific manner , 4 ( 13 % ) methylated cell lines . Thus , majority CpG islands methylated @ DiseaseTgt $ also methylated subset normal colonic cells process aging . contrast , methylation cancer-specific clones found exclusively subset @ DiseaseTgt $ , appear display CpG island methylator phenotype ( CIMP ) . CIMP+ tumors also high incidence p16 THBS1 methylation , include majority sporadic @ DiseaseTgt $ microsatellite instability related @ GeneSrc $ methylation . thus define pathway @ DiseaseTgt $ appears responsible majority sporadic tumors mismatch repair deficiency .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9471251256337015)\n",
      "- Text: \"CpG island methylator phenotype underlies sporadic microsatellite instability tightly associated BRAF mutation @ DiseaseTgt $ . Aberrant DNA methylation CpG islands widely observed human @ DiseaseTgt $ associated gene silencing occurs promoter areas . subset @ DiseaseTgt $ exceptionally high frequency methylation CpG islands , leading suggestion distinct trait referred ' CpG island methylator phenotype ' , ' CIMP ' . However , existence CIMP challenged . resolve continuing controversy , conducted systematic , stepwise screen 195 CpG island methylation markers using MethyLight technology , involving 295 primary human @ DiseaseTgt $ 16,785 separate quantitative analyses . found CIMP-positive ( CIMP+ ) tumors convincingly represent distinct subset , encompassing almost cases tumors BRAF mutation ( odds ratio = 203 ) . Sporadic cases mismatch repair deficiency occur almost exclusively consequence CIMP-associated methylation @ GeneSrc $ . propose robust new marker panel classify CIMP+ tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010404515660599)\n",
      "- Text: \"MLH3 : DNA mismatch repair gene associated mammalian microsatellite instability . DNA mismatch repair important role maintaining genomic integrity association hereditary non-polyposis colon cancer ( HNPCC ) . identify new human mismatch repair proteins , probed nuclear extracts conserved carboxy-terminal @ GeneSrc $ interaction domain . describe cloning complete genomic sequence MLH3 , encodes new DNA mismatch repair protein interacts @ GeneSrc $ . MLH3 similar mismatch repair proteins yeast , plants , worms bacteria known mammalian protein , suggesting conserved sequence may confer unique functions mice humans . Cells culture stably expressing dominant-negative MLH3 protein exhibit microsatellite instability . Mlh3 highly expressed gastrointestinal epithelium physically maps mouse complex trait locus colon cancer susceptibility ( Ccs1 ) . Although unable identify mutation protein-coding region Mlh3 susceptible mouse strain , colon tumours congenic Ccs1 mice exhibit microsatellite instability . Functional redundancy among Mlh3 , Pms1 Pms2 may explain neither Pms1 Pms2 mutant mice develop @ DiseaseTgt $ , PMS1 PMS2 mutations rarely found HNPCC families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025306533618655)\n",
      "- Text: \"Germline somatic mutation analyses DNA mismatch repair gene MLH3 : Evidence somatic mutation @ DiseaseTgt $ . DNA mismatch repair considerable scientific medical importance essential role maintaining genomic integrity , association hereditary non-polyposis colon cancer ( HNPCC ) . Germline mutations five mismatch repair genes ( @ GeneSrc $ , MSH2 , PMS1 , PMS2 , MSH6 ) associated HNPCC susceptibility . laboratory recently identified MLH3 , novel DNA mismatch repair gene . screened MLH3 coding sequence 60 probands increased genetic risk factors @ DiseaseTgt $ susceptibility mutations candidate genes . definite MLH3 germline mutations found . subsequently screened 36 colon tumors , discovered appreciable frequency somatic MLH3 coding mutations MSI-H tumors ( 25 % ) . four six tumors , evidence biallelic inactivation noted . Furthermore , MLH3 nonsense mutations identified two 12 microsatellite stable ( MSS ) tumors 14q24 loss heterozygosity . analyses exclude existence germline MLH3 mutations patients increased genetic risk factors @ DiseaseTgt $ susceptibility , suggest mutations uncommon patient population . finding appreciable frequency somatic MLH3 mutations consistent possible role gene progression @ DiseaseTgt $ tumorigenesis . Hum Mutat 17:389 - 396 , 2001 . Published 2001 Wiley-Liss , Inc .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1475108744407668)\n",
      "- Text: \"role hMLH3 familial @ DiseaseTgt $ . Hereditary nonpolyposis colorectal cancer ( HNPCC ) commonly associated least three currently known DNA mismatch repair genes : ( ) hMSH2 ; ( b ) @ GeneSrc $ ; ( c ) hMSH6 . majority HNPCC families identifiable mutations @ GeneSrc $ hMSH2 . mutations cause inherited risk @ DiseaseTgt $ , also often associated microsatellite instability tumors . Recently , hMLH3 suggested causative HNPCC . screened 70 index patients suggestive genetic predisposition germ-line mutations hMLH3 denaturing high-performance liquid chromatography . One frameshift mutation 11 missense mutations identified 16 index patients ( 23 % ) . families presented evidence hMLH3 high risk factor familial @ DiseaseTgt $ , mutations found low risk patients , suggesting hMLH3 low risk gene @ DiseaseTgt $ . demonstrate one family hMLH3 mutation segregated disease together missense mutation hMSH2 , makes us hypothesize mutations work together additive manner result elevated risk @ DiseaseTgt $ family . None tumors hMLH3 mutations showed microsatellite instability , demonstrates hMLH3 make contribution carcinogenesis impaired DNA mismatch repair function .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.588167260665401)\n",
      "- Text: \"first functional study MLH3 mutations found cancer patients . MLH3 gene one five mismatch repair ( MMR ) genes associated hereditary nonpolyposis colorectal cancer ( HNPCC ) . Eighteen different inherited MLH3 mutations reported pathogenic international mutation database . several cases , mutation found patient without family history suggestive inherited cancer susceptibility . cases , similar mutation also found sporadic patients and/or healthy controls . Four patients carried MLH3 mutation together another inherited MMR gene variation . functional analyses performed assess pathogenicity 18 mutations . MLH3 assumed less important MMR HNPCC susceptibility genes MSH2 , MSH6 , @ GeneSrc $ , PMS2 , accordingly low-risk gene @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assess significance inherited sequence variations MLH3 , functionally characterized seven missense mutations ( Q24E , R647C , S817 G , G933C , W1276R , A1394 , E1451 K ) scattered throughout MLH3 polypeptide . mutations found @ DiseaseTgt $ endometrial cancer patients reported pathogenic . study showed seven mutated MLH3 proteins , complex counterpart @ GeneSrc $ ( MutLgamma ) , repaired mismatches wild type MutLgamma worse heterodimer @ GeneSrc $ PMS2 ( MutLalpha ) . results confirm MutLgamma less efficient MMR complex MutLalpha show MLH3 mutations alone interfere MMR . studies needed evaluate pathogenicity MLH3 mutations compound MMR mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.893077377340533)\n",
      "- Text: \"Biochemical characterization MLH3 missense mutations reveal apparent role MLH3 Lynch syndrome . far 18 MLH3 germline mutations/variants identified familial @ DiseaseTgt $ cases . Sixteen variants amino acid substitutions pathogenic nature still unclear . substitutions known unclassified variants UVs . clarify possible role eight MLH3 UVs identified suspected Lynch syndrome patients , performed several biochemical tests . determined protein expression stability , protein localization interaction mutant MLH3 proteins wildtype @ GeneSrc $ . eight MLH3 UVs gave protein expression levels comparable wildtype MLH3 . Furthermore , UV-containing proteins , contrast previous studies , localized normally nucleus interacted normally wildtype @ GeneSrc $ . different biochemical assays yielded evidence eight MLH3 UVs tested cause @ DiseaseTgt $ , including Lynch syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0465745809184053)\n",
      "- Text: \"MLH3 mutation endometrial cancer . MLH3 recently described member DNA mismatch repair gene family . Based interaction MutL homologue @ GeneSrc $ , postulated MLH3 might play role tumorigenesis . Germ line somatic mutations MLH3 identified small fraction @ DiseaseTgt $ , role MLH3 @ DiseaseTgt $ tumorigenesis remains controversial . investigated MLH3 's role endometrial tumorigenesis analysis tumor germ line DNA 57 endometrial cancer patients increased risk inherited cancer susceptibility . Patients known MSH2 MSH6 mutations excluded well @ GeneSrc $ tumors . Sixteen different variants identified single-strand conformational variant analysis . 12 missense changes identified , three somatic mutations . One patient germ line missense variant loss heterozygosity ( LOH ) tumor specimen . evidence MLH3 promoter methylation based combined bisulfite restriction analysis . identification inherited missense variants , somatic missense mutations ( present 3 57 tumors ) , LOH tumor patient germ line missense change suggest role MLH3 endometrial tumorigenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6875506681843585)\n",
      "- Text: \"role presenilin cofactors gamma-secretase complex . Mutations presenilin genes account majority cases familial form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Presenilin essential gamma-secretase activity , proteolytic activity involved intramembrane cleavage Notch beta-amyloid precursor protein ( betaAPP ) . Cleavage betaAPP @ DiseaseTgt $ mutant presenilin results overproduction highly amyloidogenic amyloid beta42 peptides . gamma-Secretase activity requires formation stable , high-molecular-mass protein complex , addition endoproteolysed fragmented form presenilin , contains essential cofactors including @ GeneSrc $ , APH-1 ( refs 15 - 18 ) PEN-2 ( refs 16 , 19 ) . However , role protein complex formation generation enzymatic activity unclear . show Drosophila APH-1 ( Aph-1 ) increases stability Drosophila presenilin ( Psn ) holoprotein complex . Depletion PEN-2 RNA interference prevents endoproteolysis presenilin promotes stabilization holoprotein Drosophila mammalian cells , including primary neurons . Co-expression Drosophila Pen-2 Aph-1 @ GeneSrc $ increases formation Psn fragments well gamma-secretase activity . Thus , APH-1 stabilizes presenilin holoprotein complex , whereas PEN-2 required endoproteolytic processing presenilin conferring gamma-secretase activity complex .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2559831512976582)\n",
      "- Text: \"reporter amyloid precursor protein gamma-secretase activity Drosophila . key event pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) deposition senile plaques consisting largely peptide known beta-amyloid ( Abeta ) derived amyloid precursor protein ( APP ) . proteolytic activity called gamma-secretase cleaves APP transmembrane domain required Abeta generation . Aberrant gamma-secretase cleavage APP underlies majority early onset , familial @ DiseaseTgt $ . gamma-Secretase resides large multi-protein complex , Presenilin , @ GeneSrc $ , APH-1 PEN-2 four essential components . Thus , identifying components pathways gamma-secretase activity regulated crucial understanding mechanisms underlying @ DiseaseTgt $ pathogenesis , may provide new diagnostic tools therapeutic targets . describe generation Drosophila act living reporters gamma-secretase activity fly eye . reporter flies size eye correlates level endogenous gamma-secretase activity , sensitive levels three genes required APP gamma-secretase activity , presenilin , @ GeneSrc $ aph-1 . Thus , flies provide sensitized system identify components gamma-secretase complex regulators activity . used flies carry screen mutations suppress gamma-secretase activity identified small chromosomal region contains gene genes whose products may promote gamma-secretase activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1263736581784666)\n",
      "- Text: \"Gain-of-function p53 mutants co-opt chromatin pathways drive @ DiseaseTgt $ growth . TP53 ( encodes p53 protein ) frequently mutated gene among human @ DiseaseTgt $ . Prevalent p53 missense mutations abrogate @ DiseaseTgt $ suppressive function lead ' gain-of-function ' ( GOF ) promotes @ DiseaseTgt $ . show p53 GOF mutants bind upregulate chromatin regulatory genes , including methyltransferases @ GeneSrc $ ( also known @ GeneSrc $ ) , MLL2 ( also known KMT2D ) , acetyltransferase MOZ ( also known KAT6A MYST3 ) , resulting genome-wide increases histone methylation acetylation . Analysis @ DiseaseTgt $ Genome Atlas shows specific upregulation @ GeneSrc $ , MLL2 , MOZ p53 GOF patient-derived @ DiseaseTgt $ , wild-type p53 p53 null @ DiseaseTgt $ . @ DiseaseTgt $ cell proliferation markedly lowered genetic knockdown @ GeneSrc $ pharmacological inhibition MLL1 methyltransferase complex . study reveals novel chromatin mechanism underlying progression @ DiseaseTgt $ GOF p53 , suggests new possibilities designing combinatorial chromatin-based therapies treating individual @ DiseaseTgt $ driven prevalent GOF p53 mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.376891892202809)\n",
      "- Text: \"Mutations truncating EP300 acetylase human cancers . EP300 protein histone acetyltransferase regulates transcription via chromatin remodelling important processes cell proliferation differentiation . EP300 acetylation TP53 response DNA damage regulates DNA-binding transcription functions . role EP300 cancer implied fact targeted viral oncoproteins , fused @ GeneSrc $ Leukaemia two missense sequence alterations EP300 identified epithelial malignancies . Nevertheless , direct demonstration role EP300 tumorigenesis inactivating mutations human cancers lacking . describe EP300 mutations , predict truncated protein , 6 ( 3 % ) 193 epithelial cancers analysed . six mutations , two primary tumours ( @ DiseaseTgt $ breast cancer ) four cancer cell lines ( @ DiseaseTgt $ , breast pancreatic ) . addition , identified somatic in-frame insertion primary breast cancer missense alterations primary @ DiseaseTgt $ two cell lines ( breast pancreatic ) . Inactivation second allele demonstrated five six cases truncating mutations two cases . data show EP300 mutated epithelial cancers provide first evidence behaves classical tumour-suppressor gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2005060055279824)\n",
      "- Text: \"( 10 ; 11 ) ( p13 ; q14 ) U937 cell line results fusion AF10 gene CALM , encoding new member AP-3 clathrin assembly protein family . translocation ( 10 ; 11 ) ( p13 ; q14 ) recurring chromosomal abnormality observed patients acute lymphoblastic leukemia well @ DiseaseTgt $ . recently reported monocytic cell line U937 ( 10 ; 11 ) ( p13 ; q14 ) translocation . Using combination positional cloning candidate gene approach , cloned breakpoint able show AF10 fused novel gene named CALM ( Clathrin Assembly Lymphoid Myeloid leukemia gene ) located 11q14 . AF10 , putative transcription factor , recently cloned one fusion partners @ GeneSrc $ . CALM high homology N-terminal third murine ap-3 gene one clathrin assembly proteins . N-terminal region ap-3 shown bind clathrin high-affinity binding site phosphoinositols . identification CALM/AF10 fusion gene widely used U937 cell line contribute understanding malignant phenotype line .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.928516029832139e-05)\n",
      "- Text: \"@ GeneSrc $ CALM fused AF10 morphologically distinct subsets @ DiseaseTgt $ translocation ( 10 ; 11 ) : rearrangements associated poor prognosis . translocation ( 10 ; 11 ) ( p13 ; q14 ) observed acute lymphoblastic leukemia ( ) well @ DiseaseTgt $ ( @ DiseaseTgt $ ) . recent study showed @ GeneSrc $ fusion cases @ DiseaseTgt $ ( 10 ; 11 ) various breakpoints chromosome 11 ranging q13 q23 . recently cloned CALM ( Clathrin Assembly Lymphoid Myeloid leukemia gene ) , fusion partner AF10 11q14 monocytic cell line U937 . define role genes @ DiseaseTgt $ , 10 cases ( 9 @ DiseaseTgt $ 1 ) cytogenetically proven ( 10 ; 11 ) ( p12 - 14 ; q13 - 21 ) well-characterized morphology , immunophenotype , clinical course analyzed . Interphase fluorescence situ hybridization ( FISH ) performed 2 YACs flanking CALM region , YAC contig @ GeneSrc $ region , YAC spanning AF10 breakpoint . Rearrangement least one genes detected cases balanced ( 10 ; 11 ) . 4 cases , including 3 @ DiseaseTgt $ immature morphology ( 1 @ DiseaseTgt $ 2 @ DiseaseTgt $ ) 1 , signals CALM YACS separated interphase cells , indicating translocation breakpoint within CALM region . @ GeneSrc $ rearranged 3 @ DiseaseTgt $ myelomonocytic differentiation ( 2 @ DiseaseTgt $ 1 @ DiseaseTgt $ ) , including 1 secondary @ DiseaseTgt $ . 3 cases , characteristic immunophenotype identified ( CD4 + , CD13- , CD33 + , CD65s+ ) . AF-10 involved 5 6 evaluable cases , including 1 case without detectable CALM @ GeneSrc $ rearrangement . 2 complex translocations , none three genes rearranged . cases remarkably poor prognosis , mean survival 9.6 + /- 6.6 months . 7 @ DiseaseTgt $ cases uniformly treated according AMLCG86/92 protocols , disease-free overall survival significantly worse overall study group ( P = .03 P = .01 , respectively ) . conclude ( 10 ; 11 ) ( p13 ; q14 ) indicates CALM @ GeneSrc $ rearrangements morphologically distinct subsets @ DiseaseTgt $ may associated poor prognosis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9082316078791832)\n",
      "- Text: \"Identification molecular characterization CALM/AF10fusion products cell acute lymphoblastic leukemia @ DiseaseTgt $ . ( 10 ; 11 ) ( p12-p13 ; q14-q21 ) observed subset patients either acute lymphoblastic leukemia @ DiseaseTgt $ shown result fusion AF10 chromosome 10 CALM ( also named CLTH ) chromosome 11 . AF10 originally identified fusion partner @ GeneSrc $ ( 10 ; 11 ) ( p12-p13 ; q23 ) observed myeloid leukemia . CALM newly isolated gene , cloned fusion partner AF10 monocytoid cell line , U937 . order understand relationship @ GeneSrc $ , AF10 , CALM leukemic process , fluorescence situ hybridization reverse transcriptase polymerase chain reaction used study series nine leukemia patients ( 10 ; 11 ) . Six myeloid leukemia ( @ DiseaseTgt $ , @ DiseaseTgt $ , @ DiseaseTgt $ @ DiseaseTgt $ ) three cell lymphoblastic leukemia . identified four different CALM/AF10 fusion products five patients AF10/CALM reciprocal message one . conclude fusion CALM AF10 recurring abnormality lymphoid myeloid leukemias various types including @ DiseaseTgt $ , breakpoints two types leukemia differ . data indicate CALM/AF10 fusion product der ( 10 ) chromosome critical leukemogenesis . Leukemia ( 2000 ) 14 , 100 - 104 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0327445814265994)\n",
      "- Text: \"FLT3 mutations childhood acute lymphoblastic leukemia . Activating mutations FLT3 receptor tyrosine kinase common @ DiseaseTgt $ ( @ DiseaseTgt $ ) rare adult acute lymphoblastic leukemia ( ) . recently shown FLT3 highly expressed often mutated ALLs rearrangement @ GeneSrc $ ( @ GeneSrc $ ) gene chromosome 11q23 . hyperdiploid samples also show high-level expression FLT3 , searched presence FLT3 mutations leukemic blasts 71 patients . data show approximately 25 % ( 6 25 ) hyperdiploid samples possess FLT3 mutations , whereas 1 29 TEL/AML1-rearranged samples harbored mutations ( P = .04 , Fisher exact test ) . Three mutations novel in-frame deletions within 7-amino acid region receptor juxtamembrane domain . Finally , 3 samples patients whose disease would relapse harbored FLT3 mutations . data suggest patients hyperdiploid relapsed might considered candidates therapy newly described small-molecule FLT3 inhibitors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1750003676644897)\n",
      "- Text: \"Somatostatin regulates brain amyloid beta peptide Abeta42 modulation proteolytic degradation . Expression somatostatin brain declines aging various mammals including apes humans . prominent decrease neuropeptide also represents pathological characteristic @ DiseaseTgt $ . Using vitro vivo paradigms , show somatostatin regulates metabolism amyloid beta peptide ( Abeta ) , primary pathogenic agent @ DiseaseTgt $ , brain modulating proteolytic degradation catalyzed @ GeneSrc $ . Among various effector candidates , somatostatin upregulated @ GeneSrc $ activity primary cortical neurons . genetic deficiency somatostatin altered hippocampal @ GeneSrc $ activity localization , increased quantity hydrophobic 42-mer form Abeta , Abeta ( 42 ) , manner similar presenilin gene mutations cause @ DiseaseTgt $ . results indicate aging-induced downregulation somatostatin expression may trigger Abeta accumulation leading late-onset sporadic @ DiseaseTgt $ , suggest somatostatin receptors may pharmacological-target candidates prevention treatment @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1378307857019931)\n",
      "- Text: \"@ GeneSrc $ APOEepsilon4 polymorphisms interact increase risk @ DiseaseTgt $ Finnish males . BACKGROUND : @ GeneSrc $ ( @ GeneSrc $ ) present senile plaques surrounding reactive microglia , normal brain parenchyma . @ GeneSrc $ plaques highest APOE epsilon4 carriers , suggesting functional interaction . @ GeneSrc $ promoter polymorphism ( -463G/A ) linked increased @ GeneSrc $ expression associated increased risk @ DiseaseTgt $ . METHODS : define possible interaction @ GeneSrc $ APOE epsilon4 , examined 127 patients @ DiseaseTgt $ 174 controls genetically homogeneous Finnish population . RESULTS : significantly higher percentage male patients @ DiseaseTgt $ carried @ GeneSrc $ APOE epsilon4 alleles relative men carrying neither allele ( p < 0.001 ; , 11.4 ; 95 % CI , 3.6 6.7 ) . Male APOE epsilon4 carriers lacking @ GeneSrc $ allele 3.0 ( p = 0.01 ; 95 % CI , 1.3 6.9 ) , indicating @ GeneSrc $ enhances @ DiseaseTgt $ risk 3.8-fold . Age onset lower men carrying @ GeneSrc $ APOE epsilon4 alleles ( Kaplan-Meier survival analysis ; p = 0.01 ) . Also , @ GeneSrc $ AA genotype associated selective mortality men , women . AA genotypes absent 159 male patients @ DiseaseTgt $ controls , representing expected 5 % 6 % women male controls younger age 20 . -463A creates estrogen receptor binding site may contribute gender differences . CONCLUSIONS : @ GeneSrc $ APOE epsilon4 alleles interact increase risk @ DiseaseTgt $ men women Finnish cohort .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6481294127967181)\n",
      "- Text: \"Increased risk @ DiseaseTgt $ interaction @ GeneSrc $ A2 polymorphisms . BACKGROUND : genes encoding @ GeneSrc $ ( @ GeneSrc $ ) alpha ( 2 ) -macroglobulin ( A2 ) involved molecular pathways leading beta-amyloid deposition . Two polymorphic sites genes ( @ GeneSrc $ A2M-Ile/Val ) associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , conflicting findings reported populations different ethnic backgrounds . OBJECTIVES : study association @ GeneSrc $ A2M-Ile/Val polymorphisms sporadic @ DiseaseTgt $ investigate interactions among @ GeneSrc $ , A2 , apolipoprotein E ( APOE ) gene polymorphisms determining risk development @ DiseaseTgt $ . DESIGN : Case-control study . SETTING : Referral center @ DiseaseTgt $ Calabria , southern Italy . PARTICIPANTS : One hundred forty-eight patients sporadic @ DiseaseTgt $ 158 healthy control subjects . RESULTS : @ GeneSrc $ A2M-Val alleles found frequently cases controls , @ GeneSrc $ A2M-Val/Val genotypes . odds ratio ( ) @ GeneSrc $ genotype 1.78 ( 95 % confidence interval [ CI ] , 1.13 - 2.80 ) ; A2M-Val/Val genotype , 3.81 ( 95 % CI , 1.66 - 8.75 ) . presence @ GeneSrc $ A2M-Val/Val genotypes synergistically increased risk @ DiseaseTgt $ ( , 25.5 ; 95 % CI , 4.65 - 139.75 ) . Stratification cases sex , age onset @ DiseaseTgt $ , APOE-epsilon 4 status show significant differences distribution @ GeneSrc $ A2 polymorphisms . CONCLUSIONS : @ GeneSrc $ A2 polymorphisms associated sporadic @ DiseaseTgt $ southern Italy . Moreover , genomic interaction polymorphisms increases risk development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6655773618602618)\n",
      "- Text: \"APC tumour suppressor nuclear export function . adenomatous polpyposis coli ( APC ) protein mutated @ DiseaseTgt $ . Nearly APC mutations truncations , many terminate mutation cluster region located halfway protein . cancer cells expressing mutant APC , beta-catenin stabilized translocates nucleus act transcriptional co-activator T-cell factor . normal development , APC also promotes destabilization beta-catenin Drosophila Armadillo . binding @ GeneSrc $ complex earmarks beta-catenin/Armadillo degradation proteasome pathway . APC regulatory role process , poorly understood . show APC contains highly conserved nuclear export signals 3 ' adjacent mutation cluster region enable exit nucleus . ability lost APC mutant cancer cells , provide evidence beta-catenin accumulates nucleus result . Thus , ability APC exit nucleus appears critical tumour suppressor function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0021612566349362)\n",
      "- Text: \"Dual positive negative regulation wingless signaling adenomatous polyposis coli . evolutionarily conserved Wnt/Wingless signal transduction pathway directs cell proliferation , cell fate , cell death development metazoans inappropriately activated several types cancer . majority @ DiseaseTgt $ contain truncating mutations adenomatous polyposis coli ( APC ) tumor suppressor , negative regulator Wnt/Wingless signaling . , demonstrate Drosophila Apc homologs also activating role physiological ectopic Wingless signaling . Apc amino terminus important activating function , whereas beta-catenin binding sites dispensable . Apc likely promotes Wingless transduction down-regulation @ GeneSrc $ , negative regulator Wingless signaling . Given evolutionary conservation APC Wnt signal transduction , activating role may also present vertebrates relevance development cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.081218759152892e-06)\n",
      "- Text: \"Mitochondrial pathology muscle dopaminergic neuron degeneration caused inactivation Drosophila Pink1 rescued Parkin . Mutations Pink1 , gene encoding Ser/Thr kinase mitochondrial-targeting signal , associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) , common movement disorder characterized selective loss dopaminergic neurons . mechanism loss Pink1 leads neurodegeneration understood . show inhibition Drosophila Pink1 ( dPink1 ) function results energy depletion , shortened lifespan , degeneration select indirect flight muscles dopaminergic neurons . muscle pathology preceded mitochondrial enlargement disintegration . phenotypes could rescued wild type pathogenic C-terminal deleted form human Pink1 ( hPink1 ) . muscle dopaminergic phenotypes associated dPink1 inactivation show similarity seen parkin mutant flies could suppressed overexpression Parkin @ GeneSrc $ . Consistent genetic rescue results , find , dPink1 RNA interference ( RNAi ) animals , level Parkin protein significantly reduced . Together , results implicate Pink1 Parkin common pathway regulates mitochondrial physiology cell survival Drosophila .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.284630068427907e-05)\n",
      "- Text: \"Leucine-Rich Repeat Kinase 2 interacts Parkin , @ GeneSrc $ PINK-1 Drosophila melanogaster model @ DiseaseTgt $ . Mutations LRRK2 gene common genetic cause familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , physiological pathological functions unknown . Therefore , generated several independent Drosophila lines carrying WT mutant human LRRK2 ( mutations kinase , COR LRR domains , resp . ) . Ectopic expression WT mutant LRRK2 dopaminergic neurons caused significant loss accompanied complex age-dependent changes locomotor activity . Overall , ubiquitous expression LRRK2 increased lifespan fertility flies . However , flies sensitive rotenone . LRRK2 expression eye exacerbated retinal degeneration . Importantly , double transgenic flies , various indices eye dopaminergic survival modified complex fashion concomitant expression PINK1 , @ GeneSrc $ Parkin . evidence suggests genetic interaction @ DiseaseTgt $ genes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018979109004317)\n",
      "- Text: \"Mutational analysis @ GeneSrc $ Drosophila implicates functional inactivation oxidative damage aging . Inherited mutations PARK7 , gene encoding @ GeneSrc $ , associated loss protein function early-onset parkinsonism . Like human DJ-1 ( hDJ-1 ) , Drosophila @ GeneSrc $ protects oxidative insult modified oxidation . demonstrate hDJ-1 rescues flies mutant @ GeneSrc $ , conserved cysteine residue fly protein ( C104 , analogous C106 hDJ-1 ) critical biological antioxidant function vivo . Targeted mutagenesis suggests modification @ GeneSrc $ residue inactivates protective activity protein oxidative stress . studies show DJ-1 modification increases dramatically age flies , mice , humans , aged flies showing strikingly increased susceptibility oxidative stress markedly enhanced @ GeneSrc $ modification upon oxidative challenge . Overoxidation @ GeneSrc $ age exposure oxidative toxins may lead inactivation @ GeneSrc $ function , suggesting role susceptibility sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3545004997287329)\n",
      "- Text: \"APC tumour suppressor nuclear export function . adenomatous polpyposis coli ( APC ) protein mutated @ DiseaseTgt $ . Nearly APC mutations truncations , many terminate mutation cluster region located halfway protein . cancer cells expressing mutant APC , beta-catenin stabilized translocates nucleus act transcriptional co-activator @ GeneSrc $ . normal development , APC also promotes destabilization beta-catenin Drosophila Armadillo . binding Axin complex earmarks beta-catenin/Armadillo degradation proteasome pathway . APC regulatory role process , poorly understood . show APC contains highly conserved nuclear export signals 3 ' adjacent mutation cluster region enable exit nucleus . ability lost APC mutant cancer cells , provide evidence beta-catenin accumulates nucleus result . Thus , ability APC exit nucleus appears critical tumour suppressor function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0978119657913957)\n",
      "- Text: \"Identification novel non-coding RNA , @ GeneSrc $ , confers risk @ DiseaseTgt $ . large-scale case-control association study using 52,608 haplotype-based single nucleotide polymorphism ( SNP ) markers , identified susceptible locus @ DiseaseTgt $ ( MI ) chromosome 22q12.1 . Following linkage disequilibrium ( LD ) mapping , haplotype analyses revealed six SNPs locus , complete LD , showed markedly significant association MI ( chi2=25.27 , P=0.0000005 ; comparison allele frequency , 3,435 affected individuals versus 3,774 controls , case intron 1 5,338 C > ; rs2331291 ) . Within locus , isolated complete cDNA novel gene , designated @ GeneSrc $ ( @ GeneSrc $ ) . @ GeneSrc $ five exons , vitro translation assay showed @ GeneSrc $ encode translational product , indicating likely functional RNA . vitro functional analyses revealed minor variant one SNP exon 5 increased transcriptional level novel gene . Moreover , unidentified nuclear protein ( ) bound intensely risk allele non-risk allele . results indicate altered expression @ GeneSrc $ SNP may play role pathogenesis MI .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1222847301017557)\n",
      "- Text: \"Mutated APC Asef involved migration @ DiseaseTgt $ cells . tumour suppressor adenomatous polyposis coli ( APC ) mutated @ DiseaseTgt $ . APC binds beta-catenin , key component Wnt signalling pathway , induces degradation . APC interacts microtubules accumulates plus ends membrane protrusions , associates plasma membrane actin-dependent manner . addition , APC interacts Rac-specific guanine nucleotide exchange factor Asef stimulates activity , thereby regulating actin cytoskeletal network cell morphology . show overexpression Asef decreases @ GeneSrc $ cell-cell adhesion promotes migration epithelial Madin-Darby canine kidney cells . activities stimulated truncated APC proteins expressed @ DiseaseTgt $ cells . Experiments based RNA interference dominant-negative mutants show Asef mutated APC required migration @ DiseaseTgt $ cells expressing truncated APC . results suggest APC-Asef complex functions cell migration well @ GeneSrc $ cell-cell adhesion , truncated APC present @ DiseaseTgt $ cells contributes aberrant migratory properties .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5106811814062295)\n",
      "- Text: \"DNA mismatch repair gene @ GeneSrc $ potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( @ GeneSrc $ ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta @ GeneSrc $ . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha @ GeneSrc $ interacted ligand-dependent manner , whereas ER beta @ GeneSrc $ interacted ligand-independent manner . Oestrogen receptor alpha/beta bound @ GeneSrc $ hMSH3/hMSH6 interaction domain @ GeneSrc $ . transient expression assay , @ GeneSrc $ potentiated transactivation function liganded ER alpha , ER beta . results suggest @ GeneSrc $ may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.217570380050002)\n",
      "- Text: \"Distinct patterns KRAS mutations colorectal carcinomas according germline mismatch repair defects hMLH1 methylation status . sporadic colorectal tumours BRAFV600E associated microsatellite instability ( MSI-H ) inversely associated KRAS mutations . @ DiseaseTgt $ hereditary non-polyposis colorectal cancer ( HNPCC ) patients carrying germline mutations @ GeneSrc $ hMLH1 show BRAFV600E , however consistent data exist regarding KRAS mutation frequency spectrum HNPCC tumours . investigated KRAS 158 HNPCC tumours patients germline hMLH1 , @ GeneSrc $ hMSH6 mutations , 166 MSI-H 688 microsatellite stable ( MSS ) @ DiseaseTgt $ . @ DiseaseTgt $ characterized MSI 81 166 sporadic MSI-H colorectal cancer ( CRCs ) analysed hMLH1 promoter hypermethylation . KRAS mutations observed 40 % HNPCC tumours , mutation frequency varied upon mismatch repair gene affected : 48 % ( 29/61 ) @ GeneSrc $ , 32 % ( 29/91 ) hMLH1 83 % ( 5/6 ) hMSH6 ( P = 0.01 ) . KRAS mutation frequency different HNPCC , MSS MSI-H CRCs ( P = 0.002 ) , MSI-H hMLH1 hypermethylation ( P = 0.005 ) . Furthermore , HNPCC CRCs G13D mutations MSS ( P < 0.0001 ) , MSI-H ( P = 0.02 ) @ DiseaseTgt $ hMLH1 hypermethylation ( P = 0.03 ) . HNPCC colorectal sporadic MSI-H tumours without hMLH1 hypermethylation shared similar KRAS mutation frequency , particular G13D . conclusion , show depending genetic/epigenetic mechanism leading MSI-H , outcome terms oncogenic activation may different , reinforcing idea HNPCC , sporadic MSI-H ( depending hMLH1 status ) MSS CRCs , may target distinct kinases within RAS/RAF/MAPK pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1269505439126852)\n",
      "- Text: \"p53 codon 72 variation associated age onset hereditary non-polyposis colorectal cancer ( HNPCC ) . polymorphic variants codon 72 p53 gene shown functionally distinct vitro , whereby arginine ( arg ) variant induces apoptosis efficiently proline ( pro ) variant . evidence DNA mismatch repair system p53 interact maintain genomic integrity , hypothesized codon 72 variation may influence age onset disease HNPCC patients . tested 538 patients p53 codon 72 variants , including 167 unrelated patients pathogenic germline mutations @ GeneSrc $ MLH1 colorectal carcinoma first @ DiseaseTgt $ , 126 patients sporadic microsatellite stable colorectal cancers , 245 healthy controls . median age onset 41 , 36 , 32 years @ GeneSrc $ MLH1 mutation carriers arg/arg , arg/pro , pro/pro genotypes , respectively . log rank test revealed significant differences age onset arg/arg pro/pro individuals ( p = 0.0002 ) arg/pro versus arg/arg pro/pro individuals ( p = 0.0026 p = 0.0217 , respectively ) . Cox regression model indicated additive mode inheritance . significant differences age onset observed among different genotype carriers @ DiseaseTgt $ . results suggest p53 codon 72 genotypes associated age onset colorectal carcinoma mismatch repair deficient background dose dependent manner . findings may relevant preventive strategies HNPCC .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4040405112061882)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway colorectal cancer well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) adenomatous polyposis coli ( APC ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies hMLH1 , @ GeneSrc $ , beta-catenin , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One @ DiseaseTgt $ ( 5 % ) found RER+ , @ DiseaseTgt $ stained positive hMLH1 @ GeneSrc $ . mutations detected MCR APC gene . beta-Catenin showed increased nuclear expression loss membranous staining 10 @ DiseaseTgt $ ( 48 % ) . Absent decreased membrane expression E-cadherin found eight @ DiseaseTgt $ ( 38 % ) . Strong staining p53 found nucleus five @ DiseaseTgt $ ( 24 % ) . CONCLUSION : detect mutations MCR APC gene , suggests adenocarcinoma small intestine may follow different genetic pathway colorectal cancer . Abnormal expression E-cadherin beta-catenin common reflects early alternative APC pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1859790012534037)\n",
      "- Text: \"insight genetic pathway adenocarcinoma small intestine . BACKGROUND : Although adenoma carcinoma pathway @ DiseaseTgt $ well described , mechanisms carcinogenesis small intestine remain unclear . AIMS : aim study investigate candidate genes genetic pathway adenocarcinoma small intestine . SUBJECTS METHODS : total 21 non-familial , non-ampullary adenocarcinomas small intestine analysed . DNA extracted formalin fixed paraffin wax embedded tissue using standard techniques . replication error ( RER ) status determined amplification BAT26 . mutation cluster region ( MCR ) adenomatous polyposis coli ( APC ) gene screened using polymerase chain reaction single strand conformational polymorphism direct sequencing . Immunohistochemistry performed formalin fixed paraffin wax embedded tissue using monoclonal antibodies hMLH1 , @ GeneSrc $ , beta-catenin , E-cadherin , p53 . RESULTS : Fourteen male seven female patients median age 64 years ( range 21 - 85 ) presented adenocarcinoma duodenum ( 10 ) , jejunum ( 7 ) , ileum ( 4 ) . One cancer ( 5 % ) found RER+ , tumours stained positive hMLH1 @ GeneSrc $ . mutations detected MCR APC gene . beta-Catenin showed increased nuclear expression loss membranous staining 10 cancers ( 48 % ) . Absent decreased membrane expression E-cadherin found eight cancers ( 38 % ) . Strong staining p53 found nucleus five cancers ( 24 % ) . CONCLUSION : detect mutations MCR APC gene , suggests adenocarcinoma small intestine may follow different genetic pathway @ DiseaseTgt $ . Abnormal expression E-cadherin beta-catenin common reflects early alternative APC pathway mutations may found adenocarcinoma small intestine .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0009694535355704)\n",
      "- Text: \"BRAF screening low-cost effective strategy simplifying @ DiseaseTgt $ genetic testing . BACKGROUND : According international criteria @ DiseaseTgt $ ( @ DiseaseTgt $ ) diagnostics , cancer patients family history early onset @ DiseaseTgt $ showing high microsatellite instability ( MSI-H ) receive genetic counselling offered testing germline mutations DNA repair genes , mainly MLH1 @ GeneSrc $ . Recently , oncogenic V600E hotspot mutation within BRAF , kinase encoding gene RAS/RAF/MAPK pathway , found associated sporadic MSI-H @ DiseaseTgt $ , association @ DiseaseTgt $ remains clarified . METHODS : BRAF-V600E mutations analysed automatic sequencing @ DiseaseTgt $ 206 sporadic cases MSI-H 111 @ DiseaseTgt $ cases known germline mutations MLH1 @ GeneSrc $ . addition , 45 @ DiseaseTgt $ cases showing abnormal immunostaining @ GeneSrc $ also analysed . RESULTS : BRAF-V600E hotspot mutation found 40 % ( 82/206 ) sporadic MSI-H tumours analysed none 111 tested @ DiseaseTgt $ 45 cases showing abnormal @ GeneSrc $ immunostaining . CONCLUSIONS : Detection V600E mutation @ DiseaseTgt $ MSI-H tumour argues presence germline mutation either MLH1 @ GeneSrc $ gene . Therefore , screening mismatch repair ( MMR ) genes avoided cases positive V600E significant evidence , fulfilment strict Amsterdam criteria , suggests MMR associated @ DiseaseTgt $ . context , mutation analysis BRAF hotspot reliable , fast , low cost strategy simplifies genetic testing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6642399292164182)\n",
      "- Text: \"BRAF mutations @ DiseaseTgt $ suggest two entities microsatellite-unstable tumors . BACKGROUND : Alterations BRAF implicated carcinogenesis @ DiseaseTgt $ microsatellite instability ( MSI ) . alterations attributed defective DNA mismatch repair , underlies MSI . objective study clarify role BRAF @ DiseaseTgt $ MSI . METHODS : sequencing BRAF KRAS 82 @ DiseaseTgt $ samples without MSI , mismatch repair protein expression analyzed immunohistochemistry , promoter methylation hMLH1 analyzed methylation-specific polymerase chain reaction . Results correlated germline status hMLH1 @ GeneSrc $ clinical characteristics . RESULTS : BRAF mutated often tumors MSI tumors without MSI ( 27 % vs. 5 % ; P = 0.016 ) . prevalent BRAF alteration , V599E , occurred tumors MSI . BRAF V599E associated frequent hMLH1 promoter methylation ( P = 0.07 ) loss hMLH1 ( P = 0.02 ) . median age patients BRAF V599E older compared median age patients without mutation ( P = 0.001 ; 78 vs. 49 yrs ) . BRAF alterations occurred patients germline mutations mismatch repair genes . Five novel BRAF mutations identified . CONCLUSIONS : Although BRAF V599E common @ DiseaseTgt $ MSI , consequence deficient mismatch repair . current data showed instead BRAF V599E mutation associated subgroup @ DiseaseTgt $ MSI obtained older patients without hereditary nonpolyposis colorectal carcinoma showed epigenetic silencing hMLH1 . results indicated tumors MSI caused epigenetic MLH1 silencing distinct mutational background tumors genetic loss mismatch repair , suggesting two genetically distinct entities microsatellite-instable tumors .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0206786081423738)\n",
      "- Text: \"Germline somatic mutation analyses DNA mismatch repair gene MLH3 : Evidence somatic mutation @ DiseaseTgt $ . DNA mismatch repair considerable scientific medical importance essential role maintaining genomic integrity , association hereditary non-polyposis colon cancer ( HNPCC ) . Germline mutations five mismatch repair genes ( MLH1 , @ GeneSrc $ , PMS1 , PMS2 , MSH6 ) associated HNPCC susceptibility . laboratory recently identified MLH3 , novel DNA mismatch repair gene . screened MLH3 coding sequence 60 probands increased genetic risk factors @ DiseaseTgt $ susceptibility mutations candidate genes . definite MLH3 germline mutations found . subsequently screened 36 colon tumors , discovered appreciable frequency somatic MLH3 coding mutations MSI-H tumors ( 25 % ) . four six tumors , evidence biallelic inactivation noted . Furthermore , MLH3 nonsense mutations identified two 12 microsatellite stable ( MSS ) tumors 14q24 loss heterozygosity . analyses exclude existence germline MLH3 mutations patients increased genetic risk factors @ DiseaseTgt $ susceptibility , suggest mutations uncommon patient population . finding appreciable frequency somatic MLH3 mutations consistent possible role gene progression @ DiseaseTgt $ tumorigenesis . Hum Mutat 17:389 - 396 , 2001 . Published 2001 Wiley-Liss , Inc .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3784066845641158)\n",
      "- Text: \"role hMLH3 familial @ DiseaseTgt $ . Hereditary nonpolyposis colorectal cancer ( HNPCC ) commonly associated least three currently known DNA mismatch repair genes : ( ) @ GeneSrc $ ; ( b ) hMLH1 ; ( c ) hMSH6 . majority HNPCC families identifiable mutations hMLH1 @ GeneSrc $ . mutations cause inherited risk @ DiseaseTgt $ , also often associated microsatellite instability tumors . Recently , hMLH3 suggested causative HNPCC . screened 70 index patients suggestive genetic predisposition germ-line mutations hMLH3 denaturing high-performance liquid chromatography . One frameshift mutation 11 missense mutations identified 16 index patients ( 23 % ) . families presented evidence hMLH3 high risk factor familial @ DiseaseTgt $ , mutations found low risk patients , suggesting hMLH3 low risk gene @ DiseaseTgt $ . demonstrate one family hMLH3 mutation segregated disease together missense mutation @ GeneSrc $ , makes us hypothesize mutations work together additive manner result elevated risk @ DiseaseTgt $ family . None tumors hMLH3 mutations showed microsatellite instability , demonstrates hMLH3 make contribution carcinogenesis impaired DNA mismatch repair function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2465149019213919)\n",
      "- Text: \"first functional study MLH3 mutations found cancer patients . MLH3 gene one five mismatch repair ( MMR ) genes associated hereditary nonpolyposis colorectal cancer ( HNPCC ) . Eighteen different inherited MLH3 mutations reported pathogenic international mutation database . several cases , mutation found patient without family history suggestive inherited cancer susceptibility . cases , similar mutation also found sporadic patients and/or healthy controls . Four patients carried MLH3 mutation together another inherited MMR gene variation . functional analyses performed assess pathogenicity 18 mutations . MLH3 assumed less important MMR HNPCC susceptibility genes @ GeneSrc $ , MSH6 , MLH1 , PMS2 , accordingly low-risk gene @ DiseaseTgt $ ( @ DiseaseTgt $ ) . assess significance inherited sequence variations MLH3 , functionally characterized seven missense mutations ( Q24E , R647C , S817 G , G933C , W1276R , A1394 , E1451 K ) scattered throughout MLH3 polypeptide . mutations found @ DiseaseTgt $ endometrial cancer patients reported pathogenic . study showed seven mutated MLH3 proteins , complex counterpart MLH1 ( MutLgamma ) , repaired mismatches wild type MutLgamma worse heterodimer MLH1 PMS2 ( MutLalpha ) . results confirm MutLgamma less efficient MMR complex MutLalpha show MLH3 mutations alone interfere MMR . studies needed evaluate pathogenicity MLH3 mutations compound MMR mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0546351707390322)\n",
      "- Text: \"MLH3 mutation endometrial cancer . MLH3 recently described member DNA mismatch repair gene family . Based interaction MutL homologue MLH1 , postulated MLH3 might play role tumorigenesis . Germ line somatic mutations MLH3 identified small fraction @ DiseaseTgt $ , role MLH3 @ DiseaseTgt $ tumorigenesis remains controversial . investigated MLH3 's role endometrial tumorigenesis analysis tumor germ line DNA 57 endometrial cancer patients increased risk inherited cancer susceptibility . Patients known @ GeneSrc $ MSH6 mutations excluded well MLH1-methylated tumors . Sixteen different variants identified single-strand conformational variant analysis . 12 missense changes identified , three somatic mutations . One patient germ line missense variant loss heterozygosity ( LOH ) tumor specimen . evidence MLH3 promoter methylation based combined bisulfite restriction analysis . identification inherited missense variants , somatic missense mutations ( present 3 57 tumors ) , LOH tumor patient germ line missense change suggest role MLH3 endometrial tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0088904809527853)\n",
      "- Text: \"DNA mismatch repair gene hMSH2 potent coactivator oestrogen receptor alpha . DNA mismatch repair gene key regulator elimination base-base mismatches insertion/deletion loops ( IDLs ) . Human MutS homologue 2 ( hMSH2 ) , originally identified human homologue bacterial MutS , @ DiseaseTgt $ suppressor gene frequently mutated hereditary non-polyposis colorectal cancer . Hereditary non-polyposis colorectal cancer characterised early onset colorectal cancer development @ DiseaseTgt $ endometrial , ovarian , urological cancers . Oestrogen receptor ( ER ) alpha beta members nuclear receptor ( NR ) superfamily . Ligand-dependent transcription ER regulated p160 steroid receptor coactivator family , thyroid hormone receptor-associated proteins/the vitamin receptor-interacting proteins ( TRAP/DRIP ) mediator complex , TATA box-binding protein ( TBP ) -free TBP associated factor complex ( TFTC ) type histone acetyltransferase complex . , report interaction ER alpha/beta hMSH2 . Immunoprecipitation glutathione-S-transferase pull-down assay revealed ER alpha hMSH2 interacted ligand-dependent manner , whereas ER beta hMSH2 interacted ligand-independent manner . Oestrogen receptor alpha/beta bound hMSH2 @ GeneSrc $ interaction domain hMSH2 . transient expression assay , hMSH2 potentiated transactivation function liganded ER alpha , ER beta . results suggest hMSH2 may play important role putative coactivator ER alpha dependent gene expression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.991419694438683e-05)\n",
      "- Text: \"Interaction Ras ( V12 ) @ GeneSrc $ clones induces @ DiseaseTgt $ growth invasion . Human @ DiseaseTgt $ large degree cellular genetic heterogeneity . Complex cell interactions @ DiseaseTgt $ microenvironment thought important role tumorigenesis @ DiseaseTgt $ progression . Furthermore , cooperation oncogenic genetic lesions required @ DiseaseTgt $ development ; however , known cell interactions contribute oncogenic cooperation . genetic techniques available fruitfly Drosophila melanogaster allow analysis behaviour cells distinct mutations , making ideal model organism study cell interactions oncogenic cooperation . Drosophila eye-antennal discs , cooperation oncogenic protein Ras ( V12 ) ( ref . 5 ) loss-of-function mutations conserved @ DiseaseTgt $ suppressor @ GeneSrc $ ( @ GeneSrc $ ) gives rise @ DiseaseTgt $ display many characteristics observed human @ DiseaseTgt $ . show clones cells bearing different mutations cooperate promote @ DiseaseTgt $ growth invasion Drosophila . found Ras ( V12 ) @ GeneSrc $ ) mutations also cause @ DiseaseTgt $ affect different adjacent epithelial cells . show interaction Ras ( V12 ) scrib ( - ) clones involves JNK signalling propagation JNK-induced upregulation JAK/STAT-activating cytokines , compensatory growth mechanism tissue homeostasis . development Ras ( V12 ) tumours also triggered tissue damage , stress condition activates JNK signalling . Given conservation pathways examined , similar cooperative mechanisms could role development human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.683966421346491)\n",
      "- Text: \"APC tumour suppressor nuclear export function . @ GeneSrc $ ( @ GeneSrc $ ) protein mutated @ DiseaseTgt $ . Nearly @ GeneSrc $ mutations truncations , many terminate mutation cluster region located halfway protein . cancer cells expressing mutant @ GeneSrc $ , beta-catenin stabilized translocates nucleus act transcriptional co-activator T-cell factor . normal development , @ GeneSrc $ also promotes destabilization beta-catenin Drosophila Armadillo . binding Axin complex earmarks beta-catenin/Armadillo degradation proteasome pathway . @ GeneSrc $ regulatory role process , poorly understood . show @ GeneSrc $ contains highly conserved nuclear export signals 3 ' adjacent mutation cluster region enable exit nucleus . ability lost @ GeneSrc $ mutant cancer cells , provide evidence beta-catenin accumulates nucleus result . Thus , ability @ GeneSrc $ exit nucleus appears critical tumour suppressor function .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0739790109183805)\n",
      "- Text: \"Dual positive negative regulation wingless signaling adenomatous polyposis coli . evolutionarily conserved Wnt/Wingless signal transduction pathway directs cell proliferation , cell fate , cell death development metazoans inappropriately activated several types cancer . majority @ DiseaseTgt $ contain truncating mutations adenomatous polyposis coli ( APC ) tumor suppressor , negative regulator Wnt/Wingless signaling . , demonstrate Drosophila @ GeneSrc $ homologs also activating role physiological ectopic Wingless signaling . @ GeneSrc $ amino terminus important activating function , whereas beta-catenin binding sites dispensable . @ GeneSrc $ likely promotes Wingless transduction down-regulation Axin , negative regulator Wingless signaling . Given evolutionary conservation @ GeneSrc $ Wnt signal transduction , activating role may also present vertebrates relevance development cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.3042774411409031)\n",
      "- Text: \"Axis inhibition protein 2 ( AXIN2 ) polymorphisms tooth agenesis . Tooth agenesis common congenital disorder affects almost 20 % world 's population . number different genes shown associated cases tooth agenesis including AXIN2 , IRF6 , FGFR1 , @ GeneSrc $ , PAX9 , TGFA . particular interest AXIN2 , linked two families segregating oligodontia @ DiseaseTgt $ . studied two collections families affected tooth agenesis tested association AXIN2 . Significant association tooth agenesis AXIN2 found ( p=0.02 ) cases least one missing incisor . work supports role AXIN2 human tooth agenesis first time suggests AXIN2 involved sporadic forms common incisor agenesis . Future studies identify specific tooth agenesis sub-phenotypes consequence AXIN2 genetic variations . sub-set cases could increased susceptibility @ DiseaseTgt $ types tumours knowledge would significant clinical implications .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0350684976852295)\n",
      "- Text: \"Chaperone suppression alpha-synuclein toxicity Drosophila model @ DiseaseTgt $ . @ DiseaseTgt $ movement disorder characterized degeneration dopaminergic neurons substantia nigra pars compacta . Dopaminergic neuronal loss also occurs Drosophila melanogaster upon directed expression alpha-synuclein , protein implicated pathogenesis @ DiseaseTgt $ major component proteinaceous Lewy bodies . report directed expression molecular chaperone @ GeneSrc $ prevented dopaminergic neuronal loss associated alpha-synuclein Drosophila interference endogenous chaperone activity accelerated alpha-synuclein toxicity . Furthermore , Lewy bodies human postmortem tissue immunostained molecular chaperones , also suggesting chaperones may play role @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.022128504294694)\n",
      "- Text: \"Cyclooxygenase-2 overexpression tumor formation blocked sulindac murine model familial adenomatous polyposis . Inducible cyclooxygenase ( Cox-2 ) , also known prostaglandin H synthase 2 ( PGH-2 ) key enzyme formation prostaglandins thromboxanes . @ GeneSrc $ product immediate-early gene expressed response growth factors , tumor promoters , cytokines . Overexpression @ GeneSrc $ associated human @ DiseaseTgt $ suppression apoptosis cultured epithelia ] cells , activity reversed nonsteroidal anti-inflammatory drug , sulindac sulfide . address relationship Cox-2 , apoptosis , tumor development vivo , studied C57BL/6J-Min/+ ( Min ) mice , strain containing fully penetrant dominant mutation Apc gene , leading development gastrointestinal adenomas 110 days age . Min mice fed AIN-76A chow diet given sulindac ( 0.5 + /- 0.1 mg/day ) drinking water . Control Min mice homozygous C57BL/6J-+/+ normal littermates lacking Apc mutation ( + /+ ) fed AIN-76A diet given tap water drink . 110 days age , mice sacrificed , intestinal tracts examined . Control Min mice 11.9 + /- 7.8 tumors per mouse compared 0.1 + /- 0.1 tumors sulindac-treated Min mice . expected , + /+ littermates macroscopic tumors . Examination histologically normal-appearing small bowel Min animals revealed increased amounts Cox-2 prostaglandin E ( 2 ) compared + /+ littermates . Using two different situ techniques , terminal transferase-mediated dUTP nick end labeling direct immunoperoxidase method , Min animals also demonstrated 27 - 47 % decrease enterocyte apoptosis compared + /+ animals . Treatment sulindac inhibited tumor formation decreased small bowel Cox-2 prostaglandin E ( 2 ) baseline restored normal levels apoptosis . data suggest overexpression Cox-2 associated tumorigenesis gastrointestinal epithelium , inhibited sulindac administration .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001843929754833)\n",
      "- Text: \"Coexistence mutations PINK1 mitochondrial DNA early onset parkinsonism . AIMS BACKGROUND : Various genes identified monogenic disorders resembling @ DiseaseTgt $ . products genes associated mitochondria implicated cellular protection oxidative damage . present study analysed fibroblasts patient carrying homozygous mutation p. W437X PTEN-induced kinase 1 ( PINK1 ) , manifested early onset parkinsonism . RESULTS : Patient 's fibroblasts show variation mtDNA copy number expression oxidative phosphorylation complexes . Sequence analysis patient 's mtDNA presented two new missense mutations @ GeneSrc $ ( m.12397A > G , p. T21A ) ND6 ( m. 14319T > C , p. N119D ) genes coding two subunits complex . two mutations homoplasmic patient patient 's mother . Patient 's fibroblasts resulted enhanced constitutive production superoxide anion radical abrogated inhibitor complex . Moreover enzyme kinetic analysis NADH : ubiquinone oxidoreductase showed changes substrates affinity . CONCLUSION : knowledge , first report showing co-segregation @ DiseaseTgt $ related nuclear gene mutation mtDNA mutation ( ) . observation might shed light clinical heterogeneity hereditary cases @ DiseaseTgt $ , highlighting hitherto unappreciated impact coexisting mtDNA mutations determining development clinical course disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0419696841527492)\n",
      "- Text: \"Coexistence mutations PINK1 mitochondrial DNA early onset parkinsonism . AIMS BACKGROUND : Various genes identified monogenic disorders resembling @ DiseaseTgt $ . products genes associated mitochondria implicated cellular protection oxidative damage . present study analysed fibroblasts patient carrying homozygous mutation p. W437X PTEN-induced kinase 1 ( PINK1 ) , manifested early onset parkinsonism . RESULTS : Patient 's fibroblasts show variation mtDNA copy number expression oxidative phosphorylation complexes . Sequence analysis patient 's mtDNA presented two new missense mutations ND5 ( m.12397A > G , p. T21A ) @ GeneSrc $ ( m. 14319T > C , p. N119D ) genes coding two subunits complex . two mutations homoplasmic patient patient 's mother . Patient 's fibroblasts resulted enhanced constitutive production superoxide anion radical abrogated inhibitor complex . Moreover enzyme kinetic analysis NADH : ubiquinone oxidoreductase showed changes substrates affinity . CONCLUSION : knowledge , first report showing co-segregation @ DiseaseTgt $ related nuclear gene mutation mtDNA mutation ( ) . observation might shed light clinical heterogeneity hereditary cases @ DiseaseTgt $ , highlighting hitherto unappreciated impact coexisting mtDNA mutations determining development clinical course disease .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0142304341541733)\n",
      "- Text: \"Organization human orphan nuclear receptor Nurr1 gene . Recent reports revealed Nurr1 ( also known @ GeneSrc $ ) , member steroid/thyroid hormone nuclear receptor superfamily , predominantly expressed midbrain ; substantia nigra ( SN ) ventral tegmental area ( VTA ) . Nurr1 null mice born lethal , lacking midbrain dopamine ( DA ) neurons , suggesting Nurr1 essential development differentiation midbrain DA neurons . Human Nurr1 gene mapped chromosome 2q22 - 23 , reported associate weakly schizophrenia . cloned sequenced human Nurr1 gene , approximately 8.3 kb long , consisting eight exons seven introns . Comparisons human Nurr1 mouse Nurr1 , mouse Nur77 human NOR-1 revealed genomic structures highly conserved . 5'-flanking region human Nurr1 included three transcriptional regulatory elements , cAMP-response element ( CRE ) , CArG-like element Sp-1 site , surrounded CpG island , showed strong homology mouse Nurr1 . performed primer extension analysis using mRNA HeLa S3 cells stimulated phorbol 12-myristate 13-acetate ( PMA ) , Ca2 + ionophore A23187 cycloheximide ( CHX ) order induce Nurr1 mRNA expression , determined one transcription initiation site within CRE . transient transfection assay indicates regulatory elements 5'-flanking region robust mitogen-induced expression human Nurr1 . analysis polymorphism human Nurr1 gene may reveal association diseases characterized changes DA system , @ DiseaseTgt $ schizophrenia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Genetic alterations @ GeneSrc $ gene @ DiseaseTgt $ . Increased oxygen free radicals produced gastric mucosa H. pylori induce DNA damage lead dyspalsia @ DiseaseTgt $ . However , small percentage individuals carry H. pylori develop @ DiseaseTgt $ , indicating factors involved . screened set 95 sporadic @ DiseaseTgt $ mutations allele loss DNA glycosylase @ GeneSrc $ gene , excises adenine misincorporated opposite unrepaired 8-oxoG . Two 95 cancers bi-allelic mutations @ GeneSrc $ gene somatic missense mutation one allele loss remaining allele . mutations missense mutations , P391S Q400R , exon 13 encoding NUDIX hydrolase domain gene . patients H. pylori-positive tumors advanced @ DiseaseTgt $ lymph node metastasis . addition , 4 ( 17.4 % ) 23 informative cases showed allele loss @ GeneSrc $ locus . Therefore , data suggest somatic mutations base excision repair gene @ GeneSrc $ contribute development sub-set sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4535961340850651)\n",
      "- Text: \"Regional chromosomal localization N-ras , K-ras-1 , K-ras-2 @ GeneSrc $ oncogenes human cells . identification transforming genes human @ DiseaseTgt $ cells made possible DNA mediated gene transfer techniques . date , possible show transforming genes activated cellular analogues ras oncogene family . better understand relationship oncogenes human genes , determined chromosomal localization analyzing human rodent somatic cell hybrids molecularly cloned human proto-oncogene probes . possible assign N-ras chromosome 1 regionally localize c-K-ras-1 c-K-ras-2 human chromosomes 6pter-q13 12q , respectively . results along previous studies demonstrate highly dispersed nature ras genes human genome . Previous reports indicated @ GeneSrc $ gene also resides chromosome 6 . possible sublocalize @ GeneSrc $ long arm chromosome 6 ( q15-q21 ) . non-random aberrations chromosomes 1 , 6 12 occur certain human @ DiseaseTgt $ suggest possible etiologic involvement ras and/or @ GeneSrc $ oncogenes @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.575353241774767)\n",
      "- Text: \"Glutathione s-transferase omega 1 activity sufficient suppress neurodegeneration Drosophila model @ DiseaseTgt $ . loss-of-function mutation gene parkin causes common neurodegenerative disease may caused mitochondrial dysfunction . Glutathione S-transferase Omega ( GSTO ) involved cell defense mechanisms , little known role GSTO progression @ DiseaseTgt $ . , report restoration Drosophila GSTO1 ( DmGSTO1 ) , down-regulated parkin mutants , alleviates parkin pathogenic phenotypes loss DmGSTO1 function enhances parkin mutant phenotypes . identified ATP synthase beta subunit novel vivo target DmGSTO1 . found glutathionylation ATP synthase beta subunit rescued DmGSTO1 expression DmGSTO1 partially restores activity assembly mitochondrial F ( 1 ) F ( 0 ) -ATP synthase parkin mutants . results suggest novel mechanism protective role DmGSTO1 parkin mutants , regulation @ GeneSrc $ activity , provide insight potential therapies @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.10079795365305e-05)\n",
      "- Text: \"@ GeneSrc $ suppression p21 ( Cip1 ) Cdk inhibitor influences outcome p53 response DNA damage . Activation @ DiseaseTgt $ suppressor p53 DNA damage induces either cell cycle arrest apoptotic cell death . cytostatic effect p53 mediated transcriptional activation cyclin-dependent kinase ( CDK ) inhibitor p21 ( Cip1 ) , whereas apoptotic effect mediated transcriptional activation mediators including PUMA PIG3 ( ref . 2 ) . determines choice cytostasis apoptosis clear . show transcription factor @ GeneSrc $ principal determinant choice . @ GeneSrc $ directly recruited p21 ( Cip1 ) promoter DNA-binding protein Miz-1 . interaction blocks p21 ( Cip1 ) induction p53 activators . result @ GeneSrc $ switches , cytostatic apoptotic , p53-dependent response colon cancer cells DNA damage . @ GeneSrc $ modify ability p53 bind p21 ( Cip1 ) PUMA promoters , selectively inhibits bound p53 activating p21 ( Cip1 ) transcription . inhibiting p21 ( Cip1 ) expression @ GeneSrc $ favours initiation apoptosis , thereby influencing outcome p53 response favour cell death .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3871187590099939)\n",
      "- Text: \"Restoration p53 function leads @ DiseaseTgt $ regression vivo . Tumorigenesis multi-step process requires activation oncogenes inactivation @ DiseaseTgt $ suppressor genes . Mouse models human @ DiseaseTgt $ recently demonstrated continuous expression dominantly acting oncogene ( example , Hras , Kras @ GeneSrc $ ) often required @ DiseaseTgt $ maintenance ; phenotype referred oncogene addiction . concept received clinical validation development active anticancer drugs specifically inhibit function oncoproteins BCR-ABL , c-KIT EGFR . Identifying additional gene mutations required @ DiseaseTgt $ maintenance may therefore yield clinically useful targets new @ DiseaseTgt $ therapies . Although loss p53 function common feature human @ DiseaseTgt $ , known whether sustained inactivation @ DiseaseTgt $ suppressor pathways required @ DiseaseTgt $ maintenance . explore issue , developed Cre-loxP-based strategy temporally control @ DiseaseTgt $ suppressor gene expression vivo . show restoring endogenous p53 expression leads regression autochthonous lymphomas sarcomas mice without affecting normal tissues . mechanism responsible @ DiseaseTgt $ regression dependent @ DiseaseTgt $ type , main consequence p53 restoration apoptosis lymphomas suppression cell growth features cellular senescence sarcomas . results support efforts treat human @ DiseaseTgt $ way pharmacological reactivation p53 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.987941482064522)\n",
      "- Text: \"p53 Pten control neural glioma stem/progenitor cell renewal differentiation . Glioblastoma ( GBM ) highly lethal brain tumour presenting one two subtypes distinct clinical histories molecular profiles . primary GBM subtype presents acutely high-grade disease typically harbours mutations EGFR , PTEN INK4A/ARF ( also known CDKN2A ) , secondary GBM subtype evolves slow progression low-grade disease classically possesses PDGF TP53 events . show concomitant central nervous system ( CNS ) -specific deletion p53 Pten mouse CNS generates penetrant acute-onset high-grade malignant glioma phenotype notable clinical , pathological molecular resemblance primary GBM humans . genetic observation prompted TP53 PTEN mutational analysis human primary GBM , demonstrating unexpectedly frequent inactivating mutations TP53 well expected PTEN mutations . Integrated transcriptomic profiling , silico promoter analysis functional studies murine neural stem cells ( NSCs ) established dual , singular , inactivation p53 Pten promotes undifferentiated state high renewal potential drives increased Myc protein levels associated signature . Functional studies validated increased Myc activity potent contributor impaired differentiation enhanced renewal NSCs doubly null p53 Pten ( p53 ( -/- ) Pten ( -/- ) ) well @ DiseaseTgt $ neurospheres ( TNSs ) derived model . Myc also serves maintain robust tumorigenic potential p53 ( -/- ) Pten ( -/- ) TNSs . murine modelling studies , together confirmatory transcriptomic/promoter studies human primary GBM , validate pathogenetic role common @ DiseaseTgt $ suppressor mutation profile human primary GBM establish @ GeneSrc $ important target cooperative actions p53 Pten regulation normal malignant stem/progenitor cell differentiation , self-renewal tumorigenic potential .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 4.382004608031157e-05)\n",
      "- Text: \"common human skin tumour caused activating mutations beta-catenin . WNT signalling orchestrates number developmental programs . response stimulus , cytoplasmic beta-catenin ( encoded CTNNB1 ) stabilized , enabling downstream transcriptional activation members LEF/TCF family . One target genes beta-catenin/TCF encodes @ GeneSrc $ , explaining constitutive activation WNT pathway lead cancer , particularly colon . @ DiseaseTgt $ arise mutations gene encoding adenomatous polyposis coli ( APC ) , protein required ubiquitin-mediated degradation beta-catenin , small percentage colon cancers harbour beta-catenin-stabilizing mutations . Recently , discovered transgenic mice expressing activated beta-catenin predisposed developing skin tumours resembling pilomatricomas . Given skin adult mice also exhibits signs de novo hair-follicle morphogenesis , wondered whether human pilomatricomas might originate hair matrix cells whether might possess beta-catenin-stabilizing mutations . , explore cell origin aetiology common human skin tumour . found nuclear LEF-1 dividing tumour cells , providing biochemical evidence pilomatricomas derived hair matrix cells . least 75 % tumours possess mutations affecting amino-terminal segment , normally involved phosphorylation-dependent , ubiquitin-mediated degradation protein . percentage CTNNB1 mutations greater human tumours examined thus far , directly implicates beta-catenin/LEF misregulation major cause hair matrix cell tumorigenesis humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0012636668046804)\n",
      "- Text: \"E2F1 represses beta-catenin transcription antagonized pRB CDK8 . E2F1 transcription factor promote proliferation apoptosis activated , key downstream target retinoblastoma tumour suppressor protein ( pRB ) . show E2F1 potent specific inhibitor beta-catenin/T-cell factor ( TCF ) -dependent transcription , function contributes E2F1-induced apoptosis . E2F1 deregulation suppresses beta-catenin activity adenomatous polyposis coli ( APC ) /glycogen synthase kinase-3 ( GSK3 ) -independent manner , reducing expression key beta-catenin targets including @ GeneSrc $ . interaction explains @ DiseaseTgt $ , depend beta-catenin transcription abnormal proliferation , keep RB1 intact . Remarkably , E2F1 activity also repressed cyclin-dependent kinase-8 ( CDK8 ) , colorectal oncoprotein . Elevated levels CDK8 protect beta-catenin/TCF-dependent transcription inhibition E2F1 . Thus , retaining RB1 amplifying CDK8 , @ DiseaseTgt $ cells select conditions collectively suppress E2F1 enhance activity beta-catenin .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0336721405478996)\n",
      "- Text: \"CRD-BP mediates stabilization betaTrCP1 @ GeneSrc $ mRNA response beta-catenin signalling . Although constitutive activation beta-catenin/Tcf signalling implicated development human cancers , mechanisms beta-catenin/Tcf pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show beta-catenin stabilizes mRNA encoding F-box protein betaTrCP1 , identify RNA-binding protein CRD-BP ( coding region determinant-binding protein ) previously unknown target beta-catenin/Tcf transcription factor . CRD-BP binds coding region betaTrCP1 mRNA . Overexpression CRD-BP stabilizes betaTrCP1 mRNA elevates betaTrCP1 levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein ( SCF ) ( betaTrCP ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB beta-catenin . CRD-BP essential induction betaTrCP1 @ GeneSrc $ beta-catenin signalling @ DiseaseTgt $ cells . High levels CRD-BP found primary human @ DiseaseTgt $ exhibiting active beta-catenin/Tcf signalling implicates CRD-BP induction upregulation betaTrCP1 , activation dimeric transcription factor NF-kappaB suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001296787628281)\n",
      "- Text: \"beta-catenin/TCF-4 complex imposes crypt progenitor phenotype @ DiseaseTgt $ cells . transactivation TCF target genes induced Wnt pathway mutations constitutes primary transforming event @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show disruption beta-catenin/TCF-4 activity @ DiseaseTgt $ cells induces rapid G1 arrest blocks genetic program physiologically active proliferative compartment colon crypts . Coincidently , intestinal differentiation program induced . TCF-4 target gene @ GeneSrc $ plays central role switch direct repression p21 ( CIP1/WAF1 ) promoter . Following disruption beta-catenin/TCF-4 activity , decreased expression @ GeneSrc $ releases p21 ( CIP1/WAF1 ) transcription , turn mediates G1 arrest differentiation . Thus , beta-catenin/TCF-4 complex constitutes master switch controls proliferation versus differentiation healthy malignant intestinal epithelial cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1268316749550674)\n",
      "- Text: \"Identification @ GeneSrc $ target APC pathway . adenomatous polyposis coli gene ( APC ) tumor suppressor gene inactivated @ DiseaseTgt $ . Mutations APC cause aberrant accumulation beta-catenin , binds cell factor-4 ( Tcf-4 ) , causing increased transcriptional activation unknown genes . , @ GeneSrc $ oncogene identified target gene signaling pathway . Expression @ GeneSrc $ shown repressed wild-type APC activated beta-catenin , effects mediated Tcf-4 binding sites @ GeneSrc $ promoter . results provide molecular framework understanding previously enigmatic overexpression @ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0053831243766022)\n",
      "- Text: \"Chemoprevention @ DiseaseTgt $ targeting APC-deficient cells apoptosis . Cancer chemoprevention uses natural , synthetic , biological substances reverse , suppress , prevent either initial phase carcinogenesis progression neoplastic cells cancer . holds promise overcoming problems associated treatment late-stage cancers . However , broad application chemoprevention compromised present limited effectiveness potential toxicity . overcome challenges , developed new chemoprevention approach specifically targets premalignant tumour cells apoptosis . show deficiency adenomatous polyposis coli ( APC ) gene subsequent activation beta-catenin lead repression cellular caspase-8 inhibitor c-FLIP ( also known CFLAR ) expression activation @ GeneSrc $ , all-trans-retinyl acetate ( RAc ) independently upregulates tumour necrosis factor-related apoptosis-inducing ligand ( TRAIL ) death receptors suppresses decoy receptors . Thus , combination TRAIL RAc induces apoptosis APC-deficient premalignant cells without affecting normal cells vitro . addition , show short-term non-continuous TRAIL RAc treatment induce apoptosis specifically intestinal polyps , strongly inhibit tumour growth , prolong survival multiple intestinal neoplasms C57BL/6J-Apc ( Min ) /J ( Apc ( Min ) ) mice . approach , demonstrate TRAIL RAc induce significant cell death human colon polyps , providing potentially selective approach @ DiseaseTgt $ chemoprevention targeting APC-deficient cells apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0173493989606737)\n",
      "- Text: \"Apolipoprotein E-promoter single-nucleotide polymorphisms affect phenotype primary open-angle glaucoma demonstrate interaction @ GeneSrc $ gene . Primary open-angle glaucoma ( POAG ) optic neuropathy high worldwide prevalence shows strong evidence complex inheritance . @ GeneSrc $ ( @ GeneSrc $ ) gene one thus far shown mutations patients POAG . Apolipoprotein E ( APOE ) plays essential role lipid metabolism , APOE gene involved neuronal degeneration occurs @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , report two APOE-promoter single-nucleotide polymorphisms ( SNPs ) previously associated @ DiseaseTgt $ also modify POAG phenotype . APOE ( -219 G ) associated increased optic nerve damage , reflected increased cup : disk ratio visual field alteration . addition , APOE ( -491 ) , interacting highly significant level SNP @ GeneSrc $ promoter , @ GeneSrc $ G ) , associated increased intraocular pressure ( IOP ) limited effectiveness IOP-lowering treatments patients POAG . Together , findings establish APOE potent modifier POAG , could explain linkage chromosome 19q previously observed use genome scan condition increased frequency glaucoma patients @ DiseaseTgt $ . findings also shed new light potential mechanisms optic nerve damage IOP regulation POAG .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0358086793921679)\n",
      "- Text: \"Identification rescue alpha-synuclein toxicity Parkinson patient-derived neurons . induced pluripotent stem ( iPS ) cell field holds promise vitro disease modeling . However , identifying innate cellular pathologies , particularly age-related neurodegenerative diseases , challenging . , exploited mutation correction iPS cells conserved proteotoxic mechanisms yeast humans discover reverse phenotypic responses alpha-synuclein ( alphasyn ) , key protein involved @ DiseaseTgt $ ( @ DiseaseTgt $ ) . generated cortical neurons iPS cells patients harboring alphasyn mutations , high risk developing @ DiseaseTgt $ . Genetic modifiers unbiased screens yeast model alphasyn toxicity led identification early pathogenic phenotypes patient neurons . included nitrosative stress , accumulation endoplasmic reticulum ( ER ) -associated degradation substrates , ER stress . small molecule identified yeast screen ( @ GeneSrc $ ) , ubiquitin ligase Nedd4 affects , reversed pathologic phenotypes neurons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0301929163714247)\n",
      "- Text: \"Transcriptional map 170-kb region chromosome 11p15.5 : identification mutational analysis BWR1A gene reveals presence mutations @ DiseaseTgt $ samples . Chromosome region 11p15.5 harbors unidentified genes involved @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome . genetic analysis 170-kb region 11p15.5 loci D11S601 D11S679 resulted identification six transcriptional units . Three genes , @ GeneSrc $ , CDKN1C , KVLQT1 , well characterized , whereas three genes novel . three additional genes designated BWR1A , BWR1B , BWR1C . Full-length cDNAs three genes cloned nucleotide sequences determined . work progress , BWR1C cDNA described IPL [ Qian , N. , Franck , D. , O'Keefe , D. , Dao , D. , Zhao , L. , Yuan , L. , Wang , Q. , Keating , M. , Walsh , C. & Tycko , B . ( 1997 ) Hum . Mol . Genet . 6 , 2021 - 2029 ] . cloning mapping genes together fine mapping three known genes indicates transcriptional map region likely complete . region frequently altered @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome , carried mutational analysis @ DiseaseTgt $ cell lines Beckwith-Wiedemann syndrome samples resulted identification genetic alterations BWR1A gene : insertion introduced stop codon breast cancer cell line BT549 point mutation rhabdomyosarcoma cell line TE125-T . results indicate BWR1A may play role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.975423826007316e-05)\n",
      "- Text: \"Chromosome 11q22.3-q25 LOH @ DiseaseTgt $ : association aggressive disease course involved subregions . Chromosome 11q deletions common various malignancies , including @ DiseaseTgt $ . However , clinical significance genetic lesions well precise chromosomal location largely unknown . examined epithelial ovarian cancer material 49 patients loss heterozygosity ( LOH ) using nine microsatellite markers 11q22.3-q25 evaluated effect observed deletions regard different clinicopathological variables . LOH detected 61 % patients . Interestingly , LOH D11S1340 marker locus 11q23 . 3 seemed associated significantly reduced survival times ( P = 0.005 ) serous tumor histology ( P = 0.036 ) . LOH D11S912 distal 11q24-q25 location correlated higher tumor stage ( P = 0.003 ) , serous tumor histology ( P = 0.015 ) , finding residual tumor ( P = 0.047 ) , directly survival times ( P = 0.320 ) . majority analyzed tumors simultaneously displayed deletions two distinct 11q regions , B , proximal distal @ GeneSrc $ ( 11q23.2-q23.3 ) , respectively . LOH two markers ( D11S1340 D11S912 ) B region seemed directly associated aggressive disease course . Therefore , appears deletions ataxia telangectasia gene region would crucial determining outcome @ DiseaseTgt $ . present results indicate survival factor gene @ DiseaseTgt $ would located close D11S1340 11q23.3 . corresponds well earlier observation breast cancer , suggesting involvement shared survival factor gene diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000143023605666)\n",
      "- Text: \"DCC gene : structural analysis mutations @ DiseaseTgt $ . DCC candidate tumor-suppressor gene encoding protein sequence similarity cell adhesion molecules @ GeneSrc $ . set overlapping YAC clones contains entire DCC coding region isolated . Studies YAC contig showed DCC gene spans approximately 1.4 Mb . elucidation exon-intron structure , lambda phage clones containing known coding sequences isolated genomic library . clones used demonstrate existence 29 DCC exons , sequences exon-intron boundaries determined . Twenty-three polymorphic markers chromosome 18 studied panel primary @ DiseaseTgt $ lost , , chromosome 18 . tumors , region lost included DCC . Finally , Southern blot PCR-based approaches used search subtle mutations several DCC exons . One tumor point mutation exon 28 found , resulting proline histidine substitution . second tumor point mutation intron 13 also found . regional map genomic structure DCC provide means extensively study DCC gene alterations protein function normal neoplastic cells .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0029418836191257)\n",
      "- Text: \"DNA damage response candidate @ DiseaseTgt $ barrier early human tumorigenesis . evolution @ DiseaseTgt $ , incipient @ DiseaseTgt $ experiences ' oncogenic stress ' , evokes counter-response eliminate hazardous cells . However , nature stress remains elusive , inducible @ DiseaseTgt $ barrier elicits growth arrest cell death . show clinical specimens different stages human tumours urinary bladder , breast , lung colon , early precursor lesions ( normal tissues ) commonly express markers activated DNA damage response . include phosphorylated kinases @ GeneSrc $ Chk2 , phosphorylated histone H2AX p53 . Similar checkpoint responses induced cultured cells upon expression different oncogenes deregulate DNA replication . Together genetic analyses , including genome-wide assessment allelic imbalances , data indicate early tumorigenesis ( genomic instability malignant conversion ) , human cells activate @ GeneSrc $ DNA damage response network delays prevents @ DiseaseTgt $ . Mutations compromising checkpoint , including defects @ GeneSrc $ pathway , might allow cell proliferation , survival , increased genomic instability @ DiseaseTgt $ progression .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9388264135206138)\n",
      "- Text: \"PPM1D dephosphorylates Chk1 p53 abrogates cell cycle checkpoints . @ GeneSrc $ ( @ GeneSrc $ ) ATR ( ataxia-telangiectasia Rad3-related ) kinases respond DNA damage phosphorylating cellular target proteins activate DNA repair pathways cell cycle checkpoints order maintain genomic integrity . show oncogenic p53-induced serine/threonine phosphatase , PPM1D ( Wip1 ) , dephosphorylates two @ GeneSrc $ targets , Chk1 p53 . PPM1D binds Chk1 dephosphorylates ATR-targeted phospho-Ser 345 , leading decreased Chk1 kinase activity . PPM1D also dephosphorylates p53 phospho-Ser 15 . PPM1D dephosphorylations correlated reduced cellular intra-S G2/M checkpoint activity response DNA damage induced ultraviolet ionizing radiation . Thus , primary function PPM1D may reverse p53 Chk1-induced DNA damage cell cycle checkpoint responses return cell homeostatic state following completion DNA repair . homeostatic functions may partially responsible oncogenic effects PPM1D amplified overexpressed human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0105710934646103)\n",
      "- Text: \"Identification rescue alpha-synuclein toxicity Parkinson patient-derived neurons . induced pluripotent stem ( iPS ) cell field holds promise vitro disease modeling . However , identifying innate cellular pathologies , particularly age-related neurodegenerative diseases , challenging . , exploited mutation correction iPS cells conserved proteotoxic mechanisms yeast humans discover reverse phenotypic responses alpha-synuclein ( alphasyn ) , key protein involved @ DiseaseTgt $ ( @ DiseaseTgt $ ) . generated cortical neurons iPS cells patients harboring alphasyn mutations , high risk developing @ DiseaseTgt $ . Genetic modifiers unbiased screens yeast model alphasyn toxicity led identification early pathogenic phenotypes patient neurons . included nitrosative stress , accumulation endoplasmic reticulum ( ER ) -associated degradation substrates , ER stress . small molecule identified yeast screen ( NAB2 ) , ubiquitin ligase @ GeneSrc $ affects , reversed pathologic phenotypes neurons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0042927272059113)\n",
      "- Text: \"FBXO11 promotes Neddylation p53 inhibits transcriptional activity . p53 @ DiseaseTgt $ suppressor regulated post-translational modification , including ubiquitination , phosphorylation acetylation . previously shown ubiquitin ligase Mdm2 also promotes conjugation @ GeneSrc $ , ubiquitin-like protein , p53 , inhibiting transcriptional activity . report identification FBXO11 , member F-box protein family component Skp1.Cullin1.F-box ( SCF ) complex , new p53-interacting protein . show FBXO11 promotes neddylation p53 vitro vivo . addition C-terminal lysine residues , FBXO11 also promote @ GeneSrc $ conjugation Lys-320 Lys-321 , neddylation p53 leads suppression p53 function . consistent recent studies showing lysine arginine mutation Lys-320 significantly enhances p53 function , although Lys-320 originally identified acetylation site involving PCAF-mediated activation p53 . study provides example F-box protein acting adaptor protein mediate neddylation non-cullin substrate .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0005533782044911)\n",
      "- Text: \"DEC1 , @ GeneSrc $ novel target gene p53 family , mediates p53-dependent premature senescence . Cellular senescence plays important role @ DiseaseTgt $ suppression . p53 tumor suppressor reported crucial cellular senescence . However , underlying mechanism poorly understood . regard , cDNA microarray assay performed identify p53 targets involved senescence . Among many candidates DEC1 , @ GeneSrc $ recently shown up-regulated K-ras-induced premature senescence . However , clear whether DEC1 capable inducing senescence . , found DEC1 novel target gene p53 family mediates p53-dependent premature senescence . Specifically , showed DEC1 induced p53 family DNA damage p53-dependent manner . also found p53 family proteins bind , activate , promoter DEC1 gene . addition , showed overexpression DEC1 induces G ( 1 ) arrest promotes senescence . Moreover , found targeting endogenous DEC1 attenuates p53-mediated premature senescence response DNA damage . Furthermore , overexpression DEC1 induces cellular senescence p53-knockdown cells , albeit lesser extent . Finally , showed DEC1-induced senescence p21-independent . Taken together , data provided strong evidence DEC1 one effectors downstream p53 promote premature senescence .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 5.571877730703056e-07)\n",
      "- Text: \"Comprehensive genomic characterization defines human glioblastoma genes core pathways . Human @ DiseaseTgt $ cells typically harbour multiple chromosomal aberrations , nucleotide substitutions epigenetic modifications drive malignant transformation . @ DiseaseTgt $ Genome Atlas ( TCGA ) pilot project aims assess value large-scale multi-dimensional analysis molecular characteristics human @ DiseaseTgt $ provide data rapidly research community . report interim integrative analysis DNA copy number , gene expression DNA methylation aberrations 206 glioblastomas -- common type adult brain cancer -- nucleotide sequence aberrations 91 206 glioblastomas . analysis provides new insights roles ERBB2 , @ GeneSrc $ TP53 , uncovers frequent mutations phosphatidylinositol-3-OH kinase regulatory subunit gene PIK3R1 , provides network view pathways altered development glioblastoma . Furthermore , integration mutation , DNA methylation clinical treatment data reveals link MGMT promoter methylation hypermutator phenotype consequent mismatch repair deficiency treated glioblastomas , observation potential clinical implications . Together , findings establish feasibility power TCGA , demonstrating rapidly expand knowledge molecular basis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2866138754087036)\n",
      "- Text: \"Nf1 ; Trp53 mutant mice develop glioblastoma evidence strain-specific effects . Astrocytomas leading cause brain cancer humans . @ DiseaseTgt $ highly infiltrative , current treatments rely targeting @ DiseaseTgt $ mass often ineffective . mouse model astrocytoma would powerful tool dissecting @ DiseaseTgt $ progression testing therapeutics . Mouse models astrocytoma designed express oncogenic proteins astrocytes , limited success due low @ DiseaseTgt $ penetrance limited @ DiseaseTgt $ progression . present mouse model astrocytomas involving mutation two @ DiseaseTgt $ genes , Nf1 Trp53 . Humans mutations @ GeneSrc $ develop neurofibromatosis type ( @ GeneSrc $ ) increased risk optic gliomas , astrocytomas glioblastomas . TP53 @ DiseaseTgt $ suppressor often mutated subset astrocytomas develop young age progress slowly glioblastoma ( termed secondary glioblastomas , contrast primary glioblastomas develop rapidly de novo ) . mouse model shows range astrocytoma stages , low-grade astrocytoma glioblastoma multiforme , may accurately model human secondary glioblastoma involving TP53 loss . first reported mouse model astrocytoma initiated loss @ DiseaseTgt $ suppressors , rather overexpression transgenic oncogenes .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3490583665887928)\n",
      "- Text: \"Tumours class 3 BRAF mutants sensitive inhibition activated RAS . Approximately 200 BRAF mutant alleles identified human tumours . Activating BRAF mutants cause feedback inhibition GTP-bound RAS , RAS-independent signal either active monomers ( class 1 ) constitutively active dimers ( class 2 ) . characterize third class BRAF mutants-those impaired kinase activity kinase-dead . mutants sensitive ERK-mediated feedback activation signalling RAS-dependent . mutants bind tightly wild-type BRAF RAS-GTP , binding activation wild-type CRAF enhanced , leading increased ERK signalling . model suggests dysregulation signalling mutants tumours requires coexistent mechanisms maintaining RAS activation despite ERK-dependent feedback . Consistent hypothesis , melanomas class 3 BRAF mutations also harbour RAS mutations @ GeneSrc $ deletions . contrast , @ DiseaseTgt $ class 3 BRAF mutants , RAS typically activated receptor tyrosine kinase signalling . tumours sensitive inhibition RAS activation inhibitors receptor tyrosine kinases . thus defined three distinct functional classes BRAF mutants human tumours . mutants activate ERK signalling different mechanisms dictate sensitivity therapeutic inhibitors pathway .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0020370937984665)\n",
      "- Text: \"Mutated APC Asef involved migration @ DiseaseTgt $ cells . tumour suppressor adenomatous polyposis coli ( APC ) mutated @ DiseaseTgt $ . APC binds @ GeneSrc $ , key component Wnt signalling pathway , induces degradation . APC interacts microtubules accumulates plus ends membrane protrusions , associates plasma membrane actin-dependent manner . addition , APC interacts Rac-specific guanine nucleotide exchange factor Asef stimulates activity , thereby regulating actin cytoskeletal network cell morphology . show overexpression Asef decreases E-cadherin-mediated cell-cell adhesion promotes migration epithelial Madin-Darby canine kidney cells . activities stimulated truncated APC proteins expressed @ DiseaseTgt $ cells . Experiments based RNA interference dominant-negative mutants show Asef mutated APC required migration @ DiseaseTgt $ cells expressing truncated APC . results suggest APC-Asef complex functions cell migration well E-cadherin-mediated cell-cell adhesion , truncated APC present @ DiseaseTgt $ cells contributes aberrant migratory properties .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6561864536311235)\n",
      "- Text: \"p300 gene alterations @ DiseaseTgt $ . @ DiseaseTgt $ frequently loss heterozygosity chromosome 22q , suggesting inactivation tumor suppressor gene ( ) 22q participates tumor development . @ GeneSrc $ ( @ GeneSrc $ ) gene E1A binding protein p300 gene , recently identified 22q , thought candidates tumor suppressor genes . study , mutation @ GeneSrc $ gene 59 @ DiseaseTgt $ , mutation p300 gene 27 @ DiseaseTgt $ two gastric carcinomas , analysed using PCR-SSCP , RT-PCR-SSCP direct sequencing methods . Missense mutations p300 gene detected @ DiseaseTgt $ , gastric carcinoma , though mutation @ GeneSrc $ gene detected . p300 mutations somatic coupled deletion second allele gene , suggests inactivation p300 gene , carcinomas . mutations located within Cys/His-rich regions , assumed play important roles function p300 . first cases p300 gene found altered alleles , suggesting inactivation p300 gene may involved development carcinomas , gene may target loss 22q carcinomas digestive tract .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4867332326469893)\n",
      "- Text: \"DJ-1 , cancer- @ DiseaseTgt $ protein , stabilizes antioxidant transcriptional master regulator @ GeneSrc $ . DJ-1/PARK7 , cancer- @ DiseaseTgt $ @ DiseaseTgt $ protein , protects cells toxic stresses . However , functional basis protection remained elusive . found loss DJ-1 leads deficits NQO1 [ NAD ( P ) H quinone oxidoreductase 1 ] , detoxification enzyme . deficit attributed loss @ GeneSrc $ ( @ GeneSrc $ ) , master regulator antioxidant transcriptional responses . DJ-1 stabilizes @ GeneSrc $ preventing association inhibitor protein , Keap1 , @ GeneSrc $ 's subsequent ubiquitination . Without intact DJ-1 , @ GeneSrc $ protein unstable , transcriptional responses thereby decreased basally induction . effect DJ-1 @ GeneSrc $ present transformed lines primary cells across human mouse species . DJ-1 's effect @ GeneSrc $ subsequent effects antioxidant responses may explain DJ-1 affects etiology cancer @ DiseaseTgt $ , seemingly disparate disorders . Furthermore , @ GeneSrc $ functional axis presents therapeutic target cancer treatment justifies DJ-1 tumor biomarker .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0706477632294364)\n",
      "- Text: \"DJ-1 induces thioredoxin 1 expression @ GeneSrc $ pathway . DJ-1 , linked recessively inherited @ DiseaseTgt $ mutated , multi-functional protein anti-oxidant transcription regulatory activities . However , mechanism ( ) DJ-1 genes regulates provide neuroprotection fully understood . , show wild-type DJ-1 induces expression thioredoxin 1 ( Trx1 ) , protein disulfide oxidoreductase , whereas pathogenic mutant isoforms L166P M26I . Conversely , DJ-1 knockdown SH-SY5Y cells DJ-1 knockout mice result significant decrease Trx1 protein mRNA expression levels . importance Trx1 cytoprotective function DJ-1 confirmed using pharmacological inhibitor Trx reductase , 1-chloro-2,4-dinitrobenzene , Trx1 siRNA . approaches result partial loss DJ-1-mediated protection . Additionally , knockdown Trx1 significantly abrogates DJ-1-dependent , hydrogen peroxide-induced activation pro-survival factor AKT . Promoter analysis human Trx1 gene identified antioxidant response element ( ) required DJ-1-dependent induction Trx1 expression . transcription factor @ GeneSrc $ ( @ GeneSrc $ ) , critical inducer ARE-mediated expression , regulated DJ-1 . Overexpression DJ-1 results increased @ GeneSrc $ protein levels , promotes translocation nucleus enhances recruitment onto site Trx1 promoter . , @ GeneSrc $ knockdown abolishes DJ-1-mediated Trx1 induction cytoprotection hydrogen peroxide , indicating critical role @ GeneSrc $ carrying protective functions DJ-1 oxidative stress . findings provide new mechanism support antioxidant function DJ-1 increasing Trx1 expression via @ GeneSrc $ transcriptional induction .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.014326328868399)\n",
      "- Text: \"functional SNP PSMA6 confers risk @ DiseaseTgt $ Japanese population . Inflammation considered critical pathogenesis @ DiseaseTgt $ . One mechanisms regulating inflammatory process ubiquitin-proteasome system . investigated whether variants 20S proteasome associated susceptibility @ DiseaseTgt $ found common SNP ( minor allele frequency 0.35 ) proteasome subunit alpha type 6 gene ( PSMA6 ) conferring risk @ DiseaseTgt $ Japanese population ( chi ( 2 ) = 21.1 , P = 0.0000044 , 2,592 affected individuals versus 2,851 controls ) . replicated association another panel @ DiseaseTgt $ control subjects , although relevance ethnic groups remains clarified . SNP , located 5 ' untranslated region exon 1 gene , enhanced transcription PSMA6 . Moreover , suppression PSMA6 expression using short interfering RNA cultured cells reduced activation transcription factor @ GeneSrc $ stabilizing phosphorylated IkappaB . results implicate PSMA6 SNP previously unknown genetic risk factor @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0025433842768229)\n",
      "- Text: \"Systematic RNA interference reveals oncogenic KRAS-driven @ DiseaseTgt $ require TBK1 . proto-oncogene KRAS mutated wide array human @ DiseaseTgt $ , aggressive respond poorly standard therapies . Although identification specific oncogenes led development clinically effective , molecularly targeted therapies cases , KRAS remained refractory approach . complementary strategy targeting KRAS identify gene products , inhibited , result cell death presence oncogenic allele . used systematic RNA interference detect synthetic lethal partners oncogenic KRAS found non-canonical IkappaB kinase TBK1 selectively essential cells contain mutant KRAS . Suppression TBK1 induced apoptosis specifically human cancer cell lines depend oncogenic KRAS expression . cells , TBK1 activated @ GeneSrc $ anti-apoptotic signals involving c-Rel BCL-XL ( also known BCL2L1 ) essential survival , providing mechanistic insights synthetic lethal interaction . observations indicate TBK1 @ GeneSrc $ signalling essential KRAS mutant @ DiseaseTgt $ , establish general approach rational identification co-dependent pathways @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.311320479083123)\n",
      "- Text: \"Requirement NF-kappaB signalling mouse model lung adenocarcinoma . NF-kappaB transcription factors function crucial regulators inflammatory immune responses well cell survival . also implicated cellular transformation tumorigenesis . However , despite extensive biochemical characterization NF-kappaB signalling past twenty years , requirement NF-kappaB @ DiseaseTgt $ development vivo , particularly @ DiseaseTgt $ , completely understood . show NF-kappaB pathway required development @ DiseaseTgt $ mouse model lung adenocarcinoma . Concomitant loss p53 ( also known Trp53 ) expression oncogenic Kras ( G12D ) resulted NF-kappaB activation primary mouse embryonic fibroblasts . Conversely , lung tumour cell lines expressing Kras ( G12D ) lacking p53 , p53 restoration led NF-kappaB inhibition . Furthermore , inhibition NF-kappaB signalling induced apoptosis p53-null lung cancer cell lines . Inhibition pathway lung tumours vivo , time @ DiseaseTgt $ initiation @ DiseaseTgt $ progression , resulted significantly reduced @ DiseaseTgt $ development . Together , results indicate critical function NF-kappaB signalling lung tumour development , , requirement depends p53 status . findings also provide support development @ GeneSrc $ inhibitory drugs targeted therapies treatment patients defined mutations Kras p53 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1424853201254848)\n",
      "- Text: \"novel transcript encoded within 10-kb first intron human p53 @ DiseaseTgt $ suppressor gene ( D17S2179E ) induced differentiation myeloid leukemia cells . Two promoters previously shown map 5'-end human p53 gene . p53p1 located upstream first exon responsible transcription major p53 mRNA species . p53p2 stronger promoter p53p1 located within 10 , 738-bp first intron , approximately 1000 bp downstream exon 1 . mRNA transcripts initiated p53p2 previously identified HL-60 cells primer extension analysis observed increase abundance differentiation HL-60 cells granulocytes . screening cDNA library probe derived sequences downstream p53p2 start site , cloned characterized cDNA represents mRNA appears initiated p53p2 promoter . designated gene encoding transcript Hp53int1 ( GDB designation D17S2179E ) . cDNA 1125 bp polyadenylated downstream consensus poly ( ) addition site . entire 1125 bp derived intron 1 p53 gene , introns removed . cDNA contains major open reading frame although reading frame + 1 contains relatively low abundance stop codons compared two reading frames could possibly encode protein 119 amino acids . Analysis + 1 reading frame shows region high homology portion DNA-binding domain @ GeneSrc $ results indicate novel polyadenylated transcript encoded first intron human p53 gene . Hp53int1 may pseudogene gene may encoded DNA-binding protein . Alternatively , transcript may function , since RNA transcripts gene present number human cells levels induced terminal differentiation myeloid leukemia cells HL-60 U937 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0002376448767208)\n",
      "- Text: \"Role @ GeneSrc $ p53-mediated programmed cell death . @ DiseaseTgt $ suppressor p53 inhibits cell growth activation cell-cycle arrest apoptosis , @ DiseaseTgt $ either mutation within p53 gene defects ability induce p53 . Activation re-introduction p53 induces apoptosis many @ DiseaseTgt $ cells may provide effective @ DiseaseTgt $ therapy . One key proteins modulates apoptotic response @ GeneSrc $ , transcription factor protect contribute apoptosis . show induction p53 causes activation @ GeneSrc $ correlates ability p53 induce apoptosis . Inhibition loss @ GeneSrc $ activity abrogated p53-induced apoptosis , indicating @ GeneSrc $ essential p53-mediated cell death . Activation @ GeneSrc $ p53 distinct mediated tumour-necrosis factor-alpha involved MEK1 activation pp90rsk . Inhibition MEK1 blocked activation @ GeneSrc $ p53 completely abrogated p53-induced cell death . conclude inhibition @ GeneSrc $ @ DiseaseTgt $ retain wild-type p53 may diminish , rather augment , therapeutic response .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9393879581961784)\n",
      "- Text: \"Nurr1/CoREST pathway microglia astrocytes protects dopaminergic neurons inflammation-induced death . Nurr1 , orphan nuclear receptor , plays essential role generation maintenance dopaminergic neurons brain . Rare mutations Nurr1 associated familial @ DiseaseTgt $ , underlying basis relationship established . , demonstrate Nurr1 unexpectedly functions inhibit expression pro-inflammatory neurotoxic mediators microglia astrocytes . Reduced Nurr1 expression results exaggerated inflammatory responses microglia amplified astrocytes , leading production factors cause death tyrosine hydroxylase-expressing neurons . Nurr1 exerts anti-inflammatory effects docking @ GeneSrc $ target inflammatory gene promoters signal-dependent manner . Subsequently , Nurr1 recruits CoREST corepressor complex , resulting clearance @ GeneSrc $ transcriptional repression . studies suggest Nurr1 protects loss dopaminergic neurons @ DiseaseTgt $ part limiting production neurotoxic mediators microglia astrocytes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0010080911529194)\n",
      "- Text: \"Fyn kinase regulates misfolded alpha-synuclein uptake NLRP3 inflammasome activation microglia . Persistent microglia-mediated neuroinflammation major pathophysiological contributor progression @ DiseaseTgt $ ( @ DiseaseTgt $ ) , cell-signaling mechanisms governing chronic neuroinflammation well understood . , show Fyn kinase , conjunction class B scavenger receptor CD36 , regulates microglial uptake aggregated human alpha-synuclein ( alphaSyn ) , major component @ DiseaseTgt $ . alphaSyn effectively mediate LPS-independent priming activation microglial NLRP3 inflammasome . Fyn kinase regulates processes ; mediates PKCdelta-dependent @ GeneSrc $ nuclear translocation , leading inflammasome priming , facilitates alphaSyn import microglia , contributing generation mitochondrial reactive oxygen species consequently inflammasome activation . vivo experiments using A53 viral-alphaSyn overexpression mouse models well human @ DiseaseTgt $ neuropathological results confirm role Fyn NLRP3 inflammasome activation . Collectively , study identifies novel Fyn-mediated signaling mechanism amplifies neuroinflammation @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0613086484330933)\n",
      "- Text: \"Phosphorylation parkin Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function @ GeneSrc $ signaling . Mutations PTEN-induced putative kinase 1 ( PINK1 ) parkin cause autosomal recessive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , mutations trigger neurodegeneration poorly understood exact functional relationship PINK1 parkin remains unclear . , report PINK1 regulates E3 ubiquitin-protein ligase function parkin direct phosphorylation . find phosphorylation parkin PINK1 activates parkin E3 ligase function catalyzing K63-linked polyubiquitination enhances parkin-mediated ubiquitin signaling IkappaB kinase/nuclear factor kappaB ( @ GeneSrc $ ) pathway . Furthermore , ability PINK1 promote parkin phosphorylation activate parkin-mediated ubiquitin signaling impaired @ DiseaseTgt $ pathogenic PINK1 mutations . findings support direct link PINK1-mediated phosphorylation parkin-mediated ubiquitin signaling implicate deregulation @ GeneSrc $ neuroprotective signaling pathway pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5148151173369253)\n",
      "- Text: \"Molecular cloning human Nurr1 gene : characterization human gene cDNAs . Nurr1 member nuclear receptor superfamily transcription factors expressed predominantly central nervous system , including developing dopaminergic neurons . Recently , demonstrated Nurr1 critical midbrain dopaminergic cell differentiation . order investigate possible relation Nurr1 pathogenesis @ DiseaseTgt $ neuropsychiatric disorders , cloned characterized human Nurr1 gene . gene exists single copy human genome comprises eight exons spanning 8 kb . determined complete nucleotide sequence flanking regions gene . Potential regulatory regions included consensus binding sites @ GeneSrc $ , CREB , Sp1 . Isolation human Nurr1 cDNAs fetal brain suggested presence new splicing variant Nurr1 human brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.1230696324098373e-07)\n",
      "- Text: \"CRD-BP mediates stabilization betaTrCP1 c-myc mRNA response beta-catenin signalling . Although constitutive activation beta-catenin/Tcf signalling implicated development human cancers , mechanisms beta-catenin/Tcf pathway promotes tumorigenesis incompletely understood . Messenger RNA turnover major function regulating gene expression responsive developmental environmental signals . mRNA decay rates dictated cis-acting elements within mRNA trans-acting factors , RNA-binding proteins ( reviewed refs 2 , 3 ) . show beta-catenin stabilizes mRNA encoding F-box protein betaTrCP1 , identify RNA-binding protein CRD-BP ( coding region determinant-binding protein ) previously unknown target beta-catenin/Tcf transcription factor . CRD-BP binds coding region betaTrCP1 mRNA . Overexpression CRD-BP stabilizes betaTrCP1 mRNA elevates betaTrCP1 levels ( cells vivo ) , resulting activation Skp1-Cullin1-F-box protein ( SCF ) ( betaTrCP ) E3 ubiquitin ligase accelerated turnover substrates including IkappaB beta-catenin . CRD-BP essential induction betaTrCP1 c-Myc beta-catenin signalling @ DiseaseTgt $ cells . High levels CRD-BP found primary human @ DiseaseTgt $ exhibiting active beta-catenin/Tcf signalling implicates CRD-BP induction upregulation betaTrCP1 , activation dimeric transcription factor @ GeneSrc $ suppression apoptosis cancers .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 6.280130014278932e-07)\n",
      "- Text: \"Mutated @ GeneSrc $ Asef involved migration @ DiseaseTgt $ cells . tumour suppressor @ GeneSrc $ ( @ GeneSrc $ ) mutated @ DiseaseTgt $ . @ GeneSrc $ binds beta-catenin , key component Wnt signalling pathway , induces degradation . @ GeneSrc $ interacts microtubules accumulates plus ends membrane protrusions , associates plasma membrane actin-dependent manner . addition , @ GeneSrc $ interacts Rac-specific guanine nucleotide exchange factor Asef stimulates activity , thereby regulating actin cytoskeletal network cell morphology . show overexpression Asef decreases E-cadherin-mediated cell-cell adhesion promotes migration epithelial Madin-Darby canine kidney cells . activities stimulated truncated @ GeneSrc $ proteins expressed @ DiseaseTgt $ cells . Experiments based RNA interference dominant-negative mutants show Asef mutated @ GeneSrc $ required migration @ DiseaseTgt $ cells expressing truncated @ GeneSrc $ . results suggest @ GeneSrc $ complex functions cell migration well E-cadherin-mediated cell-cell adhesion , truncated @ GeneSrc $ present @ DiseaseTgt $ cells contributes aberrant migratory properties .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9609934597944378)\n",
      "- Text: \"Identification 46 novel SNPs 130-kb region containing myocardial infarction susceptibility gene chromosomal band 6p21 . identified total 187 single-nucleotide polymorphisms ( SNPs ) 11 gene loci 130-kb region chromosome 6p21 containing gene strongly associated @ DiseaseTgt $ ( MI ) . comparing data SNPs deposited dbSNP database National Center Biotechnology Information , 46 SNPs ( 24.6 % ) considered novel : four identified P5 - 1 locus , 14 MICB locus , nine BAT1 locus , one ATP6V1G2 locus , six @ GeneSrc $ locus , one LTA locus , one TNF locus , five LST1 locus , four LY117a locus , one AIF-1 locus . SNP map presented provide useful resource examining relationships genotypes susceptibility MI phenotype , also scanning complex diseases mapped local segment chromosome 6 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0000000994736041e-07)\n",
      "- Text: \"Functional SNPs lymphotoxin-alpha gene associated susceptibility @ DiseaseTgt $ . means large-scale , case-control association study using 92,788 gene-based single-nucleotide polymorphism ( SNP ) markers , identified candidate locus chromosome 6p21 associated susceptibility @ DiseaseTgt $ . Subsequent linkage-disequilibrium ( LD ) mapping analyses haplotype structure showed significant associations @ DiseaseTgt $ single 50 kb halpotype comprised five SNPs LTA ( encoding lymphotoxin-alpha ) , @ GeneSrc $ ( encoding @ GeneSrc $ ) BAT1 ( encoding HLA-B associated transcript 1 ) . Homozygosity respect two SNPs LTA significantly associated increased risk @ DiseaseTgt $ ( odds ratio = 1.78 , chi ( 2 ) = 21.6 , P = 0.00000033 ; 1,133 affected individuals versus 1,006 controls ) . vitro functional analyses indicated one SNP coding region LTA , changed amino-acid residue threonine asparagine ( Thr26Asn ) , effected twofold increase induction several cell-adhesion molecules , including VCAM1 , vascular smooth-muscle cells human coronary artery . Moreover , SNP , intron 1 LTA , enhanced transcriptional level LTA . results indicate variants LTA risk factors myocardial infraction implicate LTA pathogenesis disorder .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1011048111580884)\n",
      "- Text: \"@ DiseaseTgt $ DJ-1 protein transcriptional co-activator protects neuronal apoptosis . Mutations DJ-1 gene cause early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) , although role DJ-1 degeneration dopaminergic neurons unresolved . show major interacting-proteins DJ-1 dopaminergic neuronal cells nuclear proteins @ GeneSrc $ pyrimidine tract-binding protein-associated splicing factor ( PSF ) , two multifunctional regulators transcription RNA metabolism . @ DiseaseTgt $ DJ-1 mutants exhibit decreased nuclear distribution increased mitochondrial localization , resulting diminished co-localization co-activator @ GeneSrc $ repressor PSF . Unlike pathogenic DJ-1 mutants , wild-type DJ-1 acts inhibit transcriptional silencing activity PSF . addition , transcriptional silencer PSF induces neuronal apoptosis , reversed wild-type DJ-1 lesser extent @ DiseaseTgt $ DJ-1 mutants . DJ-1-specific small interfering RNA sensitizes cells PSF-induced apoptosis . DJ-1 @ GeneSrc $ block oxidative stress mutant alpha-synuclein-induced cell death . Thus , DJ-1 neuroprotective transcriptional co-activator may act concert @ GeneSrc $ PSF regulate expression neuroprotective genetic program . Mutations impair transcriptional co-activator function DJ-1 render dopaminergic neurons vulnerable apoptosis may contribute pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9178099851912348)\n",
      "- Text: \"Association @ DiseaseTgt $ @ GeneSrc $ gene . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common form neurodegenerative disorder later life . Genetic studies demonstrated apolipoprotein E ( ApoE ) gene important susceptibility locus ; however , environmental genetic factors operating alone combination ApoE must also involved . Among candidate genes may contribute residual risk @ GeneSrc $ ( @ GeneSrc $ ) gene . release vascular endothelium accounts large part endothelium-derived relaxing factor bioactivity . Abnormalities cerebral small vessels occur early @ DiseaseTgt $ , demonstrated recently beta-amyloid interacts endothelial cells blood vessels produce excess superoxide radicals . genotyped 122 cases early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) 317 cases late-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) well 392 controls common structural polymorphism Glu/Asp codon 298 @ GeneSrc $ gene . find highly significant enrichment Glu/Glu homozygotes @ DiseaseTgt $ compared controls . effect appears independent ApoE status . @ GeneSrc $ may new genetic risk factor @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9877882567704376)\n",
      "- Text: \"@ GeneSrc $ polymorphism associated @ DiseaseTgt $ Japanese .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.106292231084449)\n",
      "- Text: \"Genetic association @ GeneSrc $ @ DiseaseTgt $ . Evidence suggests vascular inflammatory factors may important etiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Glu/Glu genotype Glu298Asp variant @ GeneSrc $ ( @ GeneSrc $ ) gene tested association @ DiseaseTgt $ several Caucasian Asian populations , conflicting results . tested Glu298Asp variant association African American Caucasian @ DiseaseTgt $ patients , unaffected siblings , unrelated controls MIRAGE Study . explore whether inconsistent results previous studies might due linkage disequilibrium polymorphism haplotype previously tested , genotyped 10 additional @ GeneSrc $ single nucleotide polymorphisms ( SNPs ) spanning 25.3 kb . Finally , compiled results previous studies Glu298Asp using meta-analysis , determine whether aggregate studies support association Glu298Asp @ DiseaseTgt $ . found Glu298 allele associated higher risk @ DiseaseTgt $ MIRAGE African American ( p = 0.002 ) Caucasian ( p = 0.9 ) groups . None additional SNPs associated @ DiseaseTgt $ Caucasians , whereas two showed evidence association African Americans . meta-analysis showed small effect Glu298Asp GG genotype @ DiseaseTgt $ risk across studies ( summary odds ratio = 1.15 , 95 % confidence interval : 0.97 - 1.35 ) significant heterogeneity association among studies ( p = 0.02 ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0015579240160678)\n",
      "- Text: \"Age-related remodelling oesophageal epithelia mutated @ DiseaseTgt $ drivers . Clonal expansion aged normal tissues implicated development @ DiseaseTgt $ . However , chronology risk dependence expansion poorly understood . intensively sequence 682 micro-scale oesophageal samples show , physiologically normal oesophageal epithelia , progressive age-related expansion clones carry mutations driver genes ( predominantly @ GeneSrc $ ) , substantially accelerated alcohol consumption smoking . Driver-mutated clones emerge multifocally early childhood increase number size ageing , ultimately replace almost entire oesophageal epithelium extremely elderly . Compared mutations @ DiseaseTgt $ , marked overrepresentation @ GeneSrc $ PPM1D mutations physiologically normal oesophageal epithelia ; mutations acquired late adolescence ( early early infancy ) significantly increase number heavy smoking drinking . remodelling oesophageal epithelium driver-mutated clones inevitable consequence normal ageing , which-depending lifestyle risks-may affect @ DiseaseTgt $ development .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9593354069828982)\n",
      "- Text: \"Genomic epigenomic landscapes adult de novo acute myeloid leukemia . BACKGROUND : Many mutations contribute pathogenesis acute myeloid leukemia ( AML ) undefined . relationships patterns mutations epigenetic phenotypes yet clear . METHODS : analyzed genomes 200 clinically annotated adult cases de novo AML , using either whole-genome sequencing ( 50 cases ) whole-exome sequencing ( 150 cases ) , along RNA microRNA sequencing DNA-methylation analysis . RESULTS : AML genomes fewer mutations adult @ DiseaseTgt $ , average 13 mutations found genes . , average 5 genes recurrently mutated AML . total 23 genes significantly mutated , another 237 mutated two samples . Nearly samples least 1 nonsynonymous mutation one nine categories genes almost certainly relevant pathogenesis , including transcription-factor fusions ( 18 % cases ) , gene encoding @ GeneSrc $ ( @ GeneSrc $ ) ( 27 % ) , @ DiseaseTgt $ genes ( 16 % ) , DNA-methylation-related genes ( 44 % ) , signaling genes ( 59 % ) , chromatin-modifying genes ( 30 % ) , myeloid transcription-factor genes ( 22 % ) , cohesin-complex genes ( 13 % ) , spliceosome-complex genes ( 14 % ) . Patterns cooperation mutual exclusivity suggested strong biologic relationships among several genes categories . CONCLUSIONS : identified least one potential driver mutation nearly AML samples found complex interplay genetic events contributes AML pathogenesis individual patients . databases study widely available serve foundation investigations AML pathogenesis , classification , risk stratification . ( Funded National Institutes Health . ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0945170832138894)\n",
      "- Text: \"Proteomics analysis identifies ribosome associated coiled-coil domain-containing protein-124 novel interaction partner Nucleophosmin-1 . Coiled-coil domain-containing protein-124 ( Ccdc124 ) conserved eukaryotic ribosome-associated RNA-binding protein involved resuming ribosome activity stress-related translational shutdown . Ccdc124 protein also detected cellular localizations devoid ribosomes , centrosome , cytokinetic midbody , translation-independent cellular function currently unknown . using unbiased LC-MS/MS-based proteomics approach human embryonic kidney ( HEK293 ) cells , identified novel Ccdc124 partners mapped cellular organization interacting proteins , subset known involved nucleoli biogenesis function . identified novel interaction cancer-associated multifunctional nucleolar marker @ GeneSrc $ ( @ GeneSrc $ ) Ccdc124 , characterized interaction HEK293 ( human embryonic kidney ) U2OS ( osteosarcoma ) cells . expected , types cells , @ GeneSrc $ Ccdc124 proteins colocalized within nucleolus assayed immunocytochemical methods , monitoring localization green fluorescent protein-tagged Ccdc124 . nucleolar localization Ccdc124 impaired @ GeneSrc $ translocates nucleolus nucleoplasm response treatment DNA-intercalator Topo2 inhibitor chemotherapeutic drug doxorubicin . @ GeneSrc $ critically involved maintaining genomic stability mediating various DNA-repair pathways , over-expression @ GeneSrc $ specific @ GeneSrc $ mutations previously associated proliferative diseases , @ DiseaseTgt $ , anaplastic large-cell lymphoma , solid cancers originating different tissues . Identification Ccdc124 novel interaction partner Nmp1 within frame molecular mechanisms involving nucleolar stress-sensing DNA-damage response expected provide novel insights biology cancers associated aberrations @ GeneSrc $ . article protected copyright . rights reserved .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0236066660787814)\n",
      "- Text: \"Cytoplasmic @ GeneSrc $ @ DiseaseTgt $ normal karyotype . BACKGROUND : @ GeneSrc $ ( @ GeneSrc $ ) , nucleocytoplasmic shuttling protein prominent nucleolar localization , regulates ARF-p53 tumor-suppressor pathway . Translocations involving @ GeneSrc $ gene cause cytoplasmic dislocation @ GeneSrc $ protein . METHODS : used immunohistochemical methods study subcellular localization @ GeneSrc $ bone marrow-biopsy specimens 591 patients primary @ DiseaseTgt $ ( @ DiseaseTgt $ ) . correlated presence cytoplasmic @ GeneSrc $ clinical biologic features disease . RESULTS : Cytoplasmic @ GeneSrc $ detected 208 ( 35.2 percent ) 591 specimens patients primary @ DiseaseTgt $ 135 secondary @ DiseaseTgt $ specimens 980 hematopoietic extrahematopoietic neoplasms @ DiseaseTgt $ . associated wide spectrum morphologic subtypes disease , normal karyotype , responsiveness induction chemotherapy , recurrent genetic abnormalities . high frequency FLT3 internal tandem duplications absence CD34 CD133 @ DiseaseTgt $ specimens normal karyotype cytoplasmic dislocation @ GeneSrc $ , protein restricted nucleus . @ DiseaseTgt $ specimens cytoplasmic @ GeneSrc $ carried mutations @ GeneSrc $ gene predicted alter protein C-terminal ; mutant gene caused cytoplasmic localization @ GeneSrc $ transfected cells . CONCLUSIONS : Cytoplasmic @ GeneSrc $ characteristic feature large subgroup patients @ DiseaseTgt $ normal karyotype , @ GeneSrc $ gene mutations , responsiveness induction chemotherapy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9306465950459324)\n",
      "- Text: \"impact FLT3 internal tandem duplication mutant level , number , size , interaction @ GeneSrc $ mutations large cohort young adult patients @ DiseaseTgt $ . internal tandem duplication fms-like tyrosine kinase 3 gene ( FLT3/ITD ) associated poor prognosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , impact mutant level , size , interaction @ GeneSrc $ ( @ GeneSrc $ ) mutations remains controversial . evaluated characteristics large cohort young adult @ DiseaseTgt $ patients . highly significant trend worsening relapse risk ( RR ) overall survival ( OS ) increasing FLT3/ITD mutant level ( P < .001 ) , even low level mutant group ( 1 % -24 % total FLT3 alleles ) , RR significantly worse FLT3 wild-type ( WT ) group ( P < .001 ) . multivariate analysis , mutant level powerful prognostic factor RR . Mutant size number significant impact outcome . beneficial impact @ GeneSrc $ mutation RR OS seen FLT3/ITD ( + ) well FLT3/WT patients ; markers highly significant independent predictors outcome ( P < .001 ) . Stratification using markers identified 3 prognostic groups : good ( @ GeneSrc $ ) ) , intermediate ( @ GeneSrc $ ) @ GeneSrc $ ) ) , poor ( @ GeneSrc $ ) ) . Patients high FLT3/ITD mutant level ( greater 50 % ) FLT3/ITD ( + ) absence @ GeneSrc $ mutation may good candidates experimental therapeutic approaches .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4334689396144186)\n",
      "- Text: \"Distinctive microRNA signature @ DiseaseTgt $ bearing cytoplasmic mutated @ GeneSrc $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) carrying @ GeneSrc $ mutations cytoplasmic @ GeneSrc $ ( NPMc+ @ DiseaseTgt $ ) accounts one-third adult @ DiseaseTgt $ shows distinct features , including unique gene expression profile . MicroRNAs ( miRNAs ) small noncoding RNAs 19 - 25 nucleotides length linked development cancer . , investigated role miRNAs biology NPMc+ @ DiseaseTgt $ . miRNA expression evaluated 85 adult de novo @ DiseaseTgt $ patients characterized subcellular localization/mutation status @ GeneSrc $ FLT3 mutations using custom microarray platform . Data analyzed using univariate test within BRB tools . identified strong miRNA signature distinguishes NPMc+ mutated ( n = 55 ) cytoplasmic-negative ( @ GeneSrc $ unmutated ) cases ( n = 30 ) includes up-regulation miR-10a , miR-10b , several let-7 miR-29 family members . Many down-regulated miRNAs including miR-204 miR-128a predicted target several HOX genes . Indeed , confirmed miR-204 targets HOXA10 MEIS1 , suggesting HOX up-regulation observed NPMc+ @ DiseaseTgt $ may due part loss HOX regulators-miRNAs . FLT3-ITD+ samples characterized up-regulation miR-155 . experiments demonstrated up-regulation miR-155 independent FLT3 signaling . results identify unique miRNA signature associated NPMc+ @ DiseaseTgt $ provide evidence support role miRNAs regulation HOX genes leukemia subtype . Moreover , found miR-155 strongly independently associated FLT3-ITD mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2631883944945821)\n",
      "- Text: \"Genomic epigenomic landscapes adult de novo @ DiseaseTgt $ . BACKGROUND : Many mutations contribute pathogenesis @ DiseaseTgt $ ( @ DiseaseTgt $ ) undefined . relationships patterns mutations epigenetic phenotypes yet clear . METHODS : analyzed genomes 200 clinically annotated adult cases de novo @ DiseaseTgt $ , using either whole-genome sequencing ( 50 cases ) whole-exome sequencing ( 150 cases ) , along RNA microRNA sequencing DNA-methylation analysis . RESULTS : @ DiseaseTgt $ genomes fewer mutations adult cancers , average 13 mutations found genes . , average 5 genes recurrently mutated @ DiseaseTgt $ . total 23 genes significantly mutated , another 237 mutated two samples . Nearly samples least 1 nonsynonymous mutation one nine categories genes almost certainly relevant pathogenesis , including transcription-factor fusions ( 18 % cases ) , gene encoding @ GeneSrc $ ( @ GeneSrc $ ) ( 27 % ) , tumor-suppressor genes ( 16 % ) , DNA-methylation-related genes ( 44 % ) , signaling genes ( 59 % ) , chromatin-modifying genes ( 30 % ) , myeloid transcription-factor genes ( 22 % ) , cohesin-complex genes ( 13 % ) , spliceosome-complex genes ( 14 % ) . Patterns cooperation mutual exclusivity suggested strong biologic relationships among several genes categories . CONCLUSIONS : identified least one potential driver mutation nearly @ DiseaseTgt $ samples found complex interplay genetic events contributes @ DiseaseTgt $ pathogenesis individual patients . databases study widely available serve foundation investigations @ DiseaseTgt $ pathogenesis , classification , risk stratification . ( Funded National Institutes Health . ) .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6729818100131039)\n",
      "- Text: \"@ GeneSrc $ mutations @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0296801746582555)\n",
      "- Text: \"Assessment Minimal Residual Disease Standard-Risk @ DiseaseTgt $ . BACKGROUND : Despite molecular heterogeneity standard-risk @ DiseaseTgt $ ( @ DiseaseTgt $ ) , treatment decisions based limited number molecular genetic markers morphology-based assessment remission . Sensitive detection leukemia-specific marker ( e.g . , mutation gene encoding @ GeneSrc $ [ @ GeneSrc $ ] ) could improve prognostication identifying submicroscopic disease remission . METHODS : used reverse-transcriptase quantitative polymerase-chain-reaction assay detect minimal residual disease 2569 samples obtained 346 patients @ GeneSrc $ @ DiseaseTgt $ undergone intensive treatment National Cancer Research Institute AML17 trial . used custom 51-gene panel perform targeted sequencing 223 samples obtained time diagnosis 49 samples obtained time relapse . Mutations associated preleukemic clones tracked means digital polymerase chain reaction . RESULTS : Molecular profiling highlighted complexity @ GeneSrc $ @ DiseaseTgt $ , segregation patients 150 subgroups , thus precluding reliable outcome prediction . determination minimal-residual-disease status informative . Persistence @ GeneSrc $ transcripts blood present 15 % patients second chemotherapy cycle associated greater risk relapse 3 years follow-up absence transcripts ( 82 % vs. 30 % ; hazard ratio , 4.80 ; 95 % confidence interval [ CI ] , 2.95 7.80 ; P < 0.001 ) lower rate survival ( 24 % vs. 75 % ; hazard ratio death , 4.38 ; 95 % CI , 2.57 7.47 ; P < 0.001 ) . presence minimal residual disease independent prognostic factor death multivariate analysis ( hazard ratio , 4.84 ; 95 % CI , 2.57 9.15 ; P < 0.001 ) . results validated independent cohort . sequential monitoring minimal residual disease , relapse reliably predicted rising level @ GeneSrc $ transcripts . Although mutations associated preleukemic clones remained detectable ongoing remission chemotherapy , @ GeneSrc $ mutations detected 69 70 patients time relapse provided better marker disease status . CONCLUSIONS : presence minimal residual disease , determined quantitation @ GeneSrc $ transcripts , provided powerful prognostic information independent risk factors . ( Funded Bloodwise National Institute Health Research ; Current Controlled Trials number , ISRCTN55675535 . ) .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0078019302633969)\n",
      "- Text: \"Detection rare point mutation Ki-ras human bladder cancer xenograft polymerase chain reaction direct sequencing . paper represents first report codon 59 mutation Ki-ras spontaneous human transitional cell carcinoma bladder . Point mutations potential activate ras genes occur critical coding regions . include sequences codons 12 , 13 , 59 , 61 63 . Mutations codons 12 , 13 61 reported wide variety human @ DiseaseTgt $ , including transitional cell carcinoma bladder . However mutations codon 59 reported retroviral Ki-ras result vitro mutagenesis experiments . used polymerase chain reaction direct sequencing detect mutations Ki-ras , allele-specific restriction analysis detect mutations @ GeneSrc $ xenografts continuous cell lines established bladder cancer biopsies ten different patients well direct biopsy specimens five human bladder tumours . studies Ki-ras , 139 bp fragment spanned critical codons 12 13 128 bp fragment spanned sequences codon 59 , 61 63 enzymatically amplified sequenced . @ GeneSrc $ mutations detected . heterozygous mutation Ki-ras codon 59 GCA -- -- G/ACA detected one line . mutation expressed appears stable detected several xenograft passages present paraffin-embedded tissue primary @ DiseaseTgt $ patient . biological significance mutation bladder cancer currently study .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.0079723758281215e-05)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation @ DiseaseTgt $ progression colon . Kras commonly mutated colon cancers , mutations @ GeneSrc $ rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within @ DiseaseTgt $ epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human colon cancer cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024344525052747)\n",
      "- Text: \"Somatic activation K-ras oncogene causes early onset lung cancer mice . 30 % human @ DiseaseTgt $ carry ras gene mutations . three genes family ( composed K-ras , @ GeneSrc $ H-ras ) , K-ras frequently mutated member human @ DiseaseTgt $ , including adenocarcinomas pancreas ( approximately 70 - 90 % incidence ) , colon ( approximately 50 % ) lung ( approximately 25 - 50 % ) . construct mouse @ DiseaseTgt $ models involving K-ras , used new gene targeting procedure create mouse strains carrying oncogenic alleles K-ras activated spontaneous recombination event whole animal . show mice carrying mutations highly predisposed range @ DiseaseTgt $ types , predominantly early onset lung cancer . model characterized examining effects germline mutations @ DiseaseTgt $ suppressor gene p53 , known mutated along K-ras human @ DiseaseTgt $ . approach several advantages traditional transgenic strategies , including closely recapitulates spontaneous oncogene activation seen human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7794220490161221)\n",
      "- Text: \"Regional chromosomal localization @ GeneSrc $ , K-ras-1 , K-ras-2 myb oncogenes human cells . identification transforming genes human @ DiseaseTgt $ cells made possible DNA mediated gene transfer techniques . date , possible show transforming genes activated cellular analogues ras oncogene family . better understand relationship oncogenes human genes , determined chromosomal localization analyzing human rodent somatic cell hybrids molecularly cloned human proto-oncogene probes . possible assign @ GeneSrc $ chromosome 1 regionally localize c-K-ras-1 c-K-ras-2 human chromosomes 6pter-q13 12q , respectively . results along previous studies demonstrate highly dispersed nature ras genes human genome . Previous reports indicated c-myb gene also resides chromosome 6 . possible sublocalize c-myb long arm chromosome 6 ( q15-q21 ) . non-random aberrations chromosomes 1 , 6 12 occur certain human @ DiseaseTgt $ suggest possible etiologic involvement ras and/or myb oncogenes @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5845144005912551)\n",
      "- Text: \"Somatic KRAS mutations associated human nonmalignant syndrome autoimmunity abnormal leukocyte homeostasis . Somatic gain-of-function mutations members RAS subfamily small guanosine triphosphatases found > 30 % human @ DiseaseTgt $ . recently described syndrome chronic nonmalignant lymphadenopathy , splenomegaly , autoimmunity associated mutation @ GeneSrc $ affecting hematopoietic cells , initially classified disease variant autoimmune lymphoproliferative syndrome . , demonstrate somatic mutations related KRAS gene also associated nonmalignant syndrome autoimmunity breakdown leukocyte homeostasis . activating KRAS mutation impaired cytokine withdrawal-induced T-cell apoptosis suppression proapoptotic protein BCL-2 interacting mediator cell death facilitated proliferation p27 ( kip1 ) down-regulation . defects could corrected vitro mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 phosphatidyl inositol-3 kinase inhibition . suggest use term RAS-associated autoimmune leukoproliferative disease differentiate disorder autoimmune lymphoproliferative syndrome .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003022869705358)\n",
      "- Text: \"Mutational activation K-ras oncogene . possible pathogenetic factor adenocarcinoma lung . define role cellular oncogenes human @ DiseaseTgt $ , studied prevalence mutational activation ras oncogenes untreated non-small-cell lung cancer . Genomic DNA extracted 39 @ DiseaseTgt $ specimens obtained thoracotomy examined activating point mutations codons 12 , 13 , 61 H-ras , K-ras , @ GeneSrc $ genes . novel , highly sensitive assay based oligonucleotide hybridization following vitro amplification step employed . K-ras gene found activated point mutations codon 12 5 10 adenocarcinomas . Two @ DiseaseTgt $ less 2 cm size metastasized . ras gene mutations observed 15 squamous-cell carcinomas , 10 large-cell carcinomas , 1 carcinoid , 2 metastatic adenocarcinomas primary @ DiseaseTgt $ outside lung , 1 small-cell carcinoma . approximately 20-fold amplification unmutated K-ras gene observed @ DiseaseTgt $ proved solitary lung metastasis rectal carcinoma . conclude mutational K-ras activation may important early event pathogenesis adenocarcinoma lung amplification ras genes mutational activation H-ras @ GeneSrc $ play major part non-small-cell lung cancer .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7371445300421077)\n",
      "- Text: \"Chromosomal localization three human ras genes situ molecular hybridization . Three human ras family protooncogenes , c-Ki-ras-1 , c-Ki-ras-2 , @ GeneSrc $ , mapped chromosome bands 6p11 - 12 , 12p11.1 - 12.1 , 1p11 - 13 , respectively situ molecular hybridization . Certain human @ DiseaseTgt $ display consistent specific alterations involving chromosomes 1 , 6 , 12 . precise chromosomal localization ras genes permit evaluation possible effect chromosome changes structure activities ras protooncogenes human @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0312749435180895)\n",
      "- Text: \"KRAS codon 12 mutations occur frequently pancreatic adenocarcinomas . DNAs human pancreatic adenocarcinomas analyzed presence mutations codons 12 , 13 61 @ GeneSrc $ , KRAS HRAS gene . Formalin-fixed paraffin-embedded tissue used directly vitro amplification reaction expand relevant RAS sequences . mutations detected selective hybridization using mutation-specific synthetic oligonucleotides . 28 30 patients found mutation codon 12 KRAS gene . result confirms findings Almoguera et al . [ Cell 53 ( 1988 ) 549 - 554 ] KRAS mutations occur frequently adenocarcinomas exocrine pancreas . mutations predominantly G-T transversions , contrast KRAS mutations colon tumors mainly G-A transitions . Furthermore , portion @ DiseaseTgt $ mutation appears homozygous .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8342553368416468)\n",
      "- Text: \"Specific pattern RAS oncogene mutations follicular thyroid tumors . prevalence H-RAS , K-RAS , @ GeneSrc $ gene mutations thyroid tumors according @ DiseaseTgt $ histology controversial . Differences methodology histological classifications may explain discrepant results . address issue , first performed pooled analysis 269 mutations garnered 39 previous studies . Mutations proved significantly less frequent detected direct sequencing without ( 12.3 % vs. 17 % ) . rate mutation involving @ GeneSrc $ exon 1 ( N1 ) K-RAS exon 2 ( K2 ) less 1 % . Mutations codon 61 @ GeneSrc $ ( N2 ) significantly frequent @ DiseaseTgt $ ( 19 % ) papillary cancers ( 5 % ) significantly frequent malignant ( 25 % ) @ DiseaseTgt $ ( 14 % ) @ DiseaseTgt $ . H-RAS mutations codons 12/13 ( H1 ) found 2 - 3 % types @ DiseaseTgt $ , H-RAS mutations codon 61 ( H2 ) observed 1.4 % @ DiseaseTgt $ , almost malignant . K-RAS mutations exon 1 found often papillary follicular cancers ( 2.7 % vs. 1.6 % ) sometimes correlated special epidemiological circumstances . second part study involved analysis 80 @ DiseaseTgt $ patients living Marseille ( France ) Kiev ( Ukraine ) . used direct sequencing PCR amplification exons 1 2 three RAS genes . Common atypical adenomas separated using strict cytological criteria . Mutations H1-RAS found 12.5 % common adenomas one follicular carcinoma ( 2.9 % ) . Mutations N2-RAS occurred 23.3 % 17.6 % atypical adenomas follicular carcinomas , respectively . results confirm predominance N2-RAS mutations thyroid follicular tumors correlation @ DiseaseTgt $ . support implication N2-RAS mutations malignant progression thyroid follicular tumors assumption atypical adenomas precursors follicular carcinomas .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6386157280792195)\n",
      "- Text: \"Differential effects oncogenic K-Ras N-Ras proliferation , differentiation tumor progression colon . Kras commonly mutated @ DiseaseTgt $ , mutations @ GeneSrc $ rare . used genetically engineered mice determine whether related oncogenes regulate homeostasis tumorigenesis colon . Expression K-Ras ( G12D ) colonic epithelium stimulated hyperproliferation Mek-dependent manner . N-Ras ( G12D ) alter growth properties epithelium , able confer resistance apoptosis . context Apc-mutant colonic tumor , activation K-Ras led defects terminal differentiation expansion putative stem cells within tumor epithelium . K-Ras tumor phenotype associated attenuated signaling MAPK pathway , human @ DiseaseTgt $ cells expressing mutant K-Ras hypersensitive inhibition Raf , Mek . studies demonstrate clear phenotypic differences mutant Kras Nras , suggest oncogenic phenotype mutant K-Ras might mediated noncanonical signaling Ras effector pathways .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.368836353468804)\n",
      "- Text: \"Amino-acid substitution codon 13 @ GeneSrc $ oncogene rectal cancer Japanese patient . activation proto-oncogenes @ DiseaseTgt $ Japanese patients studied using mouse NIH3T3 cell transfection assay system . thirty-five @ DiseaseTgt $ examined , one rectal cancer showed unusually high transformation efficiency , rectal cancer , @ GeneSrc $ oncogene found activated . Nucleotide sequence analysis activated @ GeneSrc $ showed single G -- -- C point mutation first letter codon 13 , resulting coding arginine instead glycine . amino-acid substitution codon 13 may responsible efficient induction transformants NIH3T3 cells vitro .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0049001406263043)\n",
      "- Text: \"new recurrent activating length mutation exon 20 FLT3 gene @ DiseaseTgt $ . Activating length mutations juxtamembrane ( JM ) domain FLT3 gene ( FLT3-LM ) mutations catalytic domain ( FLT3D835/836 ) receptor tyrosine kinase represent frequent genetic alterations @ DiseaseTgt $ ( @ DiseaseTgt $ ) . , describe 6-bp insertion activation loop FLT3 codons 840 841 FLT3 ( FLT3 - 840GS ) 2 unrelated patients @ DiseaseTgt $ . Screening activating mutations FLT3 , KIT , @ GeneSrc $ showed genetic alterations patients carrying FLT3 - 840GS . functional analyses could show mutant hyperphosphorylated tyrosine confers interleukin 3-independent growth Ba/F3 cells , inhibited specific FLT3 protein tyrosine kinase ( PTK ) inhibitor . results show first time addition known mutations JM catalytic domain , activating length mutations exist FLT3 gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1955676722095648)\n",
      "- Text: \"Alpha-synuclein phosphorylation controls neurotoxicity inclusion formation Drosophila model @ DiseaseTgt $ . Alpha-synuclein phosphorylated serine 129 ( Ser129 ) intracellular protein aggregates called Lewy bodies . inclusion bodies characteristic pathologic lesions @ DiseaseTgt $ . define role phosphorylation Ser129 alpha-synuclein toxicity inclusion formation using Drosophila model @ DiseaseTgt $ . Mutation Ser129 alanine prevent phosphorylation completely suppresses dopaminergic neuronal loss produced expression human alpha-synuclein . contrast , altering Ser129 negatively charged residue aspartate , mimic phosphorylation , significantly enhances alpha-synuclein toxicity . @ GeneSrc $ ( @ GeneSrc $ ) phosphorylates Ser129 vivo enhances alpha-synuclein toxicity . Blocking phosphorylation Ser129 substantially increases aggregate formation . Thus Ser129 phosphorylation status crucial mediating alpha-synuclein neurotoxicity inclusion formation . increased number inclusion bodies correlates reduced toxicity , inclusion bodies may protect neurons alpha-synuclein toxicity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.559480921160706e-05)\n",
      "- Text: \"High prevalence BRAF mutations thyroid cancer : genetic evidence constitutive activation RET/PTC-RAS-BRAF signaling pathway papillary thyroid carcinoma . Thyroid papillary cancers ( PTCs ) associated activating mutations genes coding RET @ GeneSrc $ tyrosine kinase receptors , well RAS genes . Activating mutations BRAF reported recently melanomas small proportion @ DiseaseTgt $ . show somatic mutation BRAF , V599E , common genetic change PTCs ( 28 78 ; 35.8 % ) . BRAF ( V599E ) mutations unique PTCs , found types differentiated follicular neoplasms arising cell type ( 0 46 ) . Moreover , overlap PTC RET/PTC , BRAF , RAS mutations , altogether present 66 % cases . lack concordance mutations highly unlikely chance occurrence . signaling proteins function along pathway thyroid cells , represents unique paradigm human tumorigenesis mutation three signaling effectors lying tandem .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0368253429533018)\n",
      "- Text: \"Organization human orphan nuclear receptor @ GeneSrc $ gene . Recent reports revealed @ GeneSrc $ ( also known @ GeneSrc $ ) , member steroid/thyroid hormone nuclear receptor superfamily , predominantly expressed midbrain ; substantia nigra ( SN ) ventral tegmental area ( VTA ) . Nurr1 null mice born lethal , lacking midbrain dopamine ( DA ) neurons , suggesting @ GeneSrc $ essential development differentiation midbrain DA neurons . Human @ GeneSrc $ gene mapped chromosome 2q22 - 23 , reported associate weakly schizophrenia . cloned sequenced human @ GeneSrc $ gene , approximately 8.3 kb long , consisting eight exons seven introns . Comparisons human @ GeneSrc $ mouse Nurr1 , mouse Nur77 human NOR-1 revealed genomic structures highly conserved . 5'-flanking region human @ GeneSrc $ included three transcriptional regulatory elements , cAMP-response element ( CRE ) , CArG-like element Sp-1 site , surrounded CpG island , showed strong homology mouse Nurr1 . performed primer extension analysis using mRNA HeLa S3 cells stimulated phorbol 12-myristate 13-acetate ( PMA ) , Ca2 + ionophore A23187 cycloheximide ( CHX ) order induce @ GeneSrc $ mRNA expression , determined one transcription initiation site within CRE . transient transfection assay indicates regulatory elements 5'-flanking region robust mitogen-induced expression human @ GeneSrc $ . analysis polymorphism human @ GeneSrc $ gene may reveal association diseases characterized changes DA system , @ DiseaseTgt $ schizophrenia .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0018777793340477)\n",
      "- Text: \"Point mutations exon 1 @ GeneSrc $ gene major cause familial @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0156950929102476)\n",
      "- Text: \"@ GeneSrc $ pathway microglia astrocytes protects dopaminergic neurons inflammation-induced death . @ GeneSrc $ , orphan nuclear receptor , plays essential role generation maintenance dopaminergic neurons brain . Rare mutations @ GeneSrc $ associated familial @ DiseaseTgt $ , underlying basis relationship established . , demonstrate @ GeneSrc $ unexpectedly functions inhibit expression pro-inflammatory neurotoxic mediators microglia astrocytes . Reduced @ GeneSrc $ expression results exaggerated inflammatory responses microglia amplified astrocytes , leading production factors cause death tyrosine hydroxylase-expressing neurons . @ GeneSrc $ exerts anti-inflammatory effects docking NF-kappaB-p65 target inflammatory gene promoters signal-dependent manner . Subsequently , @ GeneSrc $ recruits CoREST corepressor complex , resulting clearance NF-kappaB-p65 transcriptional repression . studies suggest @ GeneSrc $ protects loss dopaminergic neurons @ DiseaseTgt $ part limiting production neurotoxic mediators microglia astrocytes .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1098132029723657)\n",
      "- Text: \"Association homozygous 7048G7049 variant intron six @ GeneSrc $ gene @ DiseaseTgt $ . OBJECTIVE : determine whether @ GeneSrc $ gene , critical development maintenance nigral dopaminergic neurons , risk factor associated @ DiseaseTgt $ . BACKGROUND : Nurrl gene highly expressed dopaminergic neurons midbrain . Knockout gene results agenesis nigral dopaminergic neurons heterozygous knockout mice increases 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) -induced neurotoxicity . METHODS : study included 105 patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) 120 patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) 221 age-matched healthy control subjects . polymorphisms mutations @ GeneSrc $ gene patients @ DiseaseTgt $ initially examined heteroduplex analysis sequencing analysis PCR-amplified @ GeneSrc $ gene fragments . polymorphism BseRI restriction site identified , relatively large-scale analysis conducted three independent investigators blinded clinical status subjects . RESULTS : homozygous 7048G7049 polymorphism found intron 6 @ GeneSrc $ gene , significantly higher @ DiseaseTgt $ ( 10/105 ; 9.5 % ) @ DiseaseTgt $ ( 5/120 ; 4.2 % ) compared healthy control subjects ( 2/221 ; 0.9 % ) . mean age SD onset homozygote patients @ DiseaseTgt $ 52 + /- 15 years @ DiseaseTgt $ 46 + /- 7 years @ DiseaseTgt $ . clinical features homozygote patients @ DiseaseTgt $ differ typical @ DiseaseTgt $ . CONCLUSIONS : homozygote polymorphism 7048G7049 intron 6 @ GeneSrc $ gene associated typical @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0105036110659976)\n",
      "- Text: \"Extended mutation analysis association studies @ GeneSrc $ ( @ GeneSrc $ ) @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5352031257831678)\n",
      "- Text: \"@ GeneSrc $ mutations rare among European patients familial @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.925085100133794)\n",
      "- Text: \"Absence @ GeneSrc $ exon 1 mutations 108 families autosomal dominant @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1805547753700467)\n",
      "- Text: \"Molecular cloning human @ GeneSrc $ gene : characterization human gene cDNAs . @ GeneSrc $ member nuclear receptor superfamily transcription factors expressed predominantly central nervous system , including developing dopaminergic neurons . Recently , demonstrated @ GeneSrc $ critical midbrain dopaminergic cell differentiation . order investigate possible relation @ GeneSrc $ pathogenesis @ DiseaseTgt $ neuropsychiatric disorders , cloned characterized human @ GeneSrc $ gene . gene exists single copy human genome comprises eight exons spanning 8 kb . determined complete nucleotide sequence flanking regions gene . Potential regulatory regions included consensus binding sites NF-kappaB , CREB , Sp1 . Isolation human @ GeneSrc $ cDNAs fetal brain suggested presence new splicing variant @ GeneSrc $ human brain .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035244828668048)\n",
      "- Text: \"common @ GeneSrc $ polymorphism associated @ DiseaseTgt $ diffuse Lewy body disease . BACKGROUND : @ GeneSrc $ plays key role mesencephalic dopaminergic neuron development survival . homozygous @ GeneSrc $ polymorphism ( single base-pair insertion intron 6 ) ( NI6P ) reported associated @ DiseaseTgt $ ( @ DiseaseTgt $ ) . OBJECTIVE : assess association NI6P @ DiseaseTgt $ diffuse Lewy body disease . DESIGN : Case-control study . SETTING : Movement disorders clinic tissue provided brain banks . PATIENTS : Patients pathologically proven @ DiseaseTgt $ ( n = 37 ) diffuse Lewy body disease ( n = 35 ) , neuropathologically normal control subjects ( n = 59 ) , clinically diagnosed @ DiseaseTgt $ ( n = 66 ) , spousal controls ( n = 29 ) . METHODS : Determining frequency heterozygotes homozygotes NI6P DNA sequencing restriction endonuclease analyses . RESULTS : Overall , 41 ( 39.8 % ) 103 patients @ DiseaseTgt $ heterozygotes compared 22 ( 25.0 % ) 88 controls ( P = .03 ) , relative risk ( estimated odds ratio ) @ DiseaseTgt $ 2.03 ( 95 % confidence interval , 1.08 - 3.81 ) heterozygotes vs wild type subjects . Heterozygotes frequent subgroup patients pathologically confirmed @ DiseaseTgt $ ( 18 [ 48.6 % ] 37 ) vs controls ( 14 [ 23.7 % ] 59 ) ( P = .01 ) , relative risk @ DiseaseTgt $ 2.84 ( 95 % confidence interval , 1.17 - 6.88 ) heterozygotes vs wild type subjects . patients clinically diagnosed @ DiseaseTgt $ , heterozygotes frequent early-onset cases ( onset < = 45 years ) ( 10 [ 55.6 % ] 18 ) compared late-onset cases ( onset > 45 years ) ( 10 [ 23.8 % ] 42 ) ( P = .02 ) spousal controls ( 8 [ 27.6 % ] 29 ) ( P = .06 ) , relative risk early-onset @ DiseaseTgt $ 4.17 ( 95 % confidence interval , 1.13 - 15.33 ) heterozygotes vs subjects 2 wild type alleles . homozygous NI6P associated @ DiseaseTgt $ , present 6 ( 17.1 % ) 35 patients diffuse Lewy body disease compared 3 ( 5.1 % ) 59 controls ( P = .06 ) . CONCLUSIONS : common heterozygous NI6P associated increased risk @ DiseaseTgt $ . association borderline significance found homozygous NI6P diffuse Lewy body disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.836999261183652)\n",
      "- Text: \"@ GeneSrc $ genetic variation @ DiseaseTgt $ : Evidence systematic review meta-analysis . INTRODUCTION : homo sapiens nuclear receptor subfamily 4 , group ( @ GeneSrc $ ) genetic variation implicated risk factor @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Nevertheless , results inconclusive . conducted comprehensive systematic review meta-analysis quantify impact @ GeneSrc $ variation risk @ DiseaseTgt $ . METHODS : eligible case-control studies published June 2016 searching Pubmed , OVID , EBSCO , PsycINFO , ISI Web Knowledge , Chinese Biomedical Literature Database China Academic Journals Database identified . Pooled odds ratio ( ) 95 % confidence interval ( CI ) used access strength association fixed- random-effects model . RESULTS : Eighteen studies reported 24 genetic variants total 6150 cases 5919 controls included . Twelve studies @ GeneSrc $ rs35479735 polymorphism 4 studies rs12803 available meta-analysis . significant association observed rs35479735 homozygous model ( OR=1.31 , 95 % CI : 1.10 - 1.56 , P=0.003 ) , whereas significant association rs12803 detected . subgroup analysis stratified ethnicity , age onset familial history , found significant association except one sporadic @ DiseaseTgt $ subgroup recessive ( OR=3.30 , 95 % CI : 1.23 - 8.84 , P=0.02 ) homozygous model ( OR=3.43 , 95 % CI : 1.26 - 9.33 , P=0.02 ) rs35479735 . CONCLUSION : study comprehensively evaluated association @ GeneSrc $ variation @ DiseaseTgt $ , results failed demonstrate @ GeneSrc $ polymorphisms significantly associated @ DiseaseTgt $ except rs35479735 , suggesting studies needed elucidate @ GeneSrc $ risk @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1680836282569125)\n",
      "- Text: \"Direct generation functional dopaminergic neurons mouse human fibroblasts . Transplantation dopaminergic neurons potentially improve clinical outcome @ DiseaseTgt $ , neurological disorder resulting degeneration mesencephalic dopaminergic neurons . particular , transplantation embryonic-stem-cell-derived dopaminergic neurons shown efficient restoring motor symptoms conditions dopamine deficiency . However , use pluripotent-derived cells might lead development tumours properly controlled . identified minimal set three transcription factors -- Mash1 ( also known Ascl1 ) , @ GeneSrc $ ( also known @ GeneSrc $ ) Lmx1a -- able generate directly functional dopaminergic neurons mouse human fibroblasts without reverting progenitor cell stage . Induced dopaminergic ( iDA ) cells release dopamine show spontaneous electrical activity organized regular spikes consistent pacemaker activity featured brain dopaminergic neurons . three factors able elicit dopaminergic neuronal conversion prenatal adult fibroblasts healthy donors @ DiseaseTgt $ patients . Direct generation iDA cells somatic cells might significant implications understanding critical processes neuronal development , vitro disease modelling cell replacement therapies .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.2713809928956223e-05)\n",
      "- Text: \"p53 regulation ammonia metabolism urea cycle controls polyamine biosynthesis . @ DiseaseTgt $ cells exhibit altered usually increased metabolic processes meet high biogenetic demands1,2 . conditions , ammonia concomitantly produced increased metabolic processing . However , unclear @ DiseaseTgt $ cells dispose excess ammonia outcomes might caused accumulation ammonia . report @ DiseaseTgt $ suppressor p53 , frequently mutated gene human @ DiseaseTgt $ , regulates ammonia metabolism repressing urea cycle . transcriptional downregulation CPS1 , OTC ARG1 , p53 suppresses ureagenesis elimination ammonia vitro vivo , leading inhibition @ DiseaseTgt $ growth . Conversely , downregulation genes reciprocally activates p53 MDM2-mediated mechanism ( ) . Furthermore , accumulation ammonia causes significant decline mRNA translation polyamine biosynthetic rate-limiting enzyme @ GeneSrc $ , thereby inhibiting biosynthesis polyamine cell proliferation . Together , findings link p53 ureagenesis ammonia metabolism , reveal role ammonia controlling polyamine biosynthesis cell proliferation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0447833506231071)\n",
      "- Text: \"Association single nucleotide polymorphisms @ GeneSrc $ ( @ GeneSrc $ ) gene patients @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.126462657836408)\n",
      "- Text: \"Oxidized LDL receptor gene ( @ GeneSrc $ ) associated risk @ DiseaseTgt $ . Lectin-like oxidized low-density lipoprotein receptor ( @ GeneSrc $ ) suggested play role progression atherogenesis . analyzed @ GeneSrc $ gene found single nucleotide polymorphism ( SNP ) , G501C , patients ischemic heart disease single family , resulted missense mutation K167N @ GeneSrc $ protein . compared group patients @ DiseaseTgt $ ( MI ) ( n=102 ) group clinically healthy subjects ( n=102 ) , found MI group significantly high frequency 501G/C+501C/C ( 38.2 % ) compared healthy group ( 17.6 % ; p < 0.002 ) . odds ratio risk MI associated 501G/C+501C/C genotype 2.89 ( 95 % CI , 1.51 - 5.53 ) . findings suggest @ GeneSrc $ neighboring gene linked G501C SNP important incidence MI . Manipulating @ GeneSrc $ activity might useful therapeutic preventative approach coronary artery disease , especially individuals G501C genotype @ GeneSrc $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003645636649001)\n",
      "- Text: \"@ GeneSrc $ 11q25 epigenetically inactivated tumor-suppressor function epithelial ovarian cancer . Epithelial ovarian cancer ( EOC ) , leading cause death gynecological malignancy , poorly understood disease . typically advanced presentation EOC loco-regional dissemination peritoneal cavity rare incidence visceral metastases hallmarks disease . features relate biology disease , principal determinant outcome . EOC arises result genetic alterations sustained ovarian surface epithelium ( OSE ; ref . 3 ) . causes changes unknown manifest activation oncogenes inactivation tumor-suppressor genes ( TSGs ) . analysis loss heterozygosity 11q25 identified @ GeneSrc $ ( also called @ GeneSrc $ ) , member IgLON family immunoglobulin ( Ig ) domain-containing glycosylphosphatidylinositol ( GPI ) -anchored cell adhesion molecules , candidate TSG EOC . @ GeneSrc $ frequently somatically inactivated EOC allele loss CpG island methylation . @ GeneSrc $ functional characteristics consistent TSG properties vitro vivo . somatic missense mutation individual EOC shows clear evidence loss function . findings suggest @ GeneSrc $ excellent candidate 11q25 @ DiseaseTgt $ TSG . first description knowledge involvement IgLON family cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0140675570118259)\n",
      "- Text: \"Divergently transcribed overlapping genes expressed liver kidney located 11p15.5 imprinted domain . Human chromosomal band 11p15.5 shown contain genes involved development several pediatric adult @ DiseaseTgt $ Beckwith-Wiedemann syndrome ( BWS ) . Overlapping P1 artificial chromosome clones region used templates genomic sequencing effort identify candidate genes disorders . PowerBLAST identified several matches expressed sequence tags ( ESTs ) fetal brain liver cDNA libraries . Northern blot analysis indicated two genes identified ESTs encode transcripts 1 - 1.5 kb predominant expression fetal adult liver kidney . RT-PCR RACE , full-length transcripts isolated two genes , largest open reading frames encoding putative proteins 253 424 amino acids . Database comparison predicted amino acid sequence larger transcript indicated homology integral membrane organic cation transporters ; hence , designate gene @ GeneSrc $ ( @ GeneSrc $ ) . expressed sequence polymorphism provided evidence @ GeneSrc $ gene exhibits `` leaky `` imprinting human fetal kidney human fetal liver . mouse orthologue ( Orctl2 ) identified , similar polymorphism used demonstrate maternal-specific expression gene fetal liver interspecific F1 mice . predicted protein smaller gene showed significant similarity database . Northern RACE analyses suggest gene may multiple transcription start sites . Determination genomic structure humans indicated 5'-end transcript overlaps divergent orientation first two exons @ GeneSrc $ , suggesting possible role antisense regulation one gene . , therefore , provisionally name second transcript ORCTL2S ( @ GeneSrc $ ) . expression patterns genes imprinted expression @ GeneSrc $ suggestive possible role development Wilms tumor ( WT ) hepatoblastoma . Although SSCP analysis 62 WT samples 10 BWS patients result identification mutations @ GeneSrc $ ORCTL2S , important examine expression pattern @ DiseaseTgt $ BWS patients , since epigenetic alteration loci may play role etiology diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1311993205220211)\n",
      "- Text: \"Transcriptional map 170-kb region chromosome 11p15.5 : identification mutational analysis @ GeneSrc $ gene reveals presence mutations @ DiseaseTgt $ samples . Chromosome region 11p15.5 harbors unidentified genes involved @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome . genetic analysis 170-kb region 11p15.5 loci D11S601 D11S679 resulted identification six transcriptional units . Three genes , hNAP2 , CDKN1C , KVLQT1 , well characterized , whereas three genes novel . three additional genes designated @ GeneSrc $ , BWR1B , BWR1C . Full-length cDNAs three genes cloned nucleotide sequences determined . work progress , BWR1C cDNA described IPL [ Qian , N. , Franck , D. , O'Keefe , D. , Dao , D. , Zhao , L. , Yuan , L. , Wang , Q. , Keating , M. , Walsh , C. & Tycko , B . ( 1997 ) Hum . Mol . Genet . 6 , 2021 - 2029 ] . cloning mapping genes together fine mapping three known genes indicates transcriptional map region likely complete . region frequently altered @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome , carried mutational analysis @ DiseaseTgt $ cell lines Beckwith-Wiedemann syndrome samples resulted identification genetic alterations @ GeneSrc $ gene : insertion introduced stop codon breast cancer cell line BT549 point mutation rhabdomyosarcoma cell line TE125-T . results indicate @ GeneSrc $ may play role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001261689973754)\n",
      "- Text: \"Somatic mutation @ GeneSrc $ , novel imprinted gene human chromosome 11p15.5 . previously reported isolation 2.5 Mb @ DiseaseTgt $ subchromosomal transferable fragment ( STF ) 11p15.5 identification nine known genes four novel genes within STF . report isolation fifth novel cDNA , tumor-suppressing STF cDNA 5 , designated @ GeneSrc $ , located within STF . @ GeneSrc $ encodes predicted protein 424 amino acids . Sequence analysis suggests @ GeneSrc $ membrane protein 10 transmembrane segments , located two imprinted genes , p57KIP2 TSSC3 . Northern blot hybridization revealed 1.6-kb transcript multiple adult tissues fetal liver kidney , consistent potential role embryonal tumors . also found @ GeneSrc $ imprinted preferential expression maternal chromosome . Reverse transcription-PCR analysis @ GeneSrc $ revealed frequent occurrence aberrant RNA splicing , deleted exons 4 , 5 , 6 Wilms ' tumors . Mutational analysis @ GeneSrc $ direct DNA sequencing exons revealed base substitution G1120A Wilms ' tumor , matched normal kidney , patient 's mother , changed Arg codon 309 Gln . G1120A substitution thus represents either rare polymorphism @ DiseaseTgt $ mutation , mutant allele maternal origin preferentially expressed patient 's tissue . second base substitution , C892 , found lung cancer , changing Ser codon 233 Phe . substitution absent matched normal tissue thus represented somatic mutation . also found loss heterozygosity lung cancer , suggesting @ GeneSrc $ may conventional @ DiseaseTgt $ suppressor gene adult human lung imprinted @ DiseaseTgt $ suppressor gene fetal kidney .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2580356585537993)\n",
      "- Text: \"Tumor suppressor candidate @ GeneSrc $ regulated UbcH6 novel ubiquitin ligase RING105 . region human chromosome 11p15.5 linked Beckwith-Wiedemann syndrome associated susceptibility Wilms ' tumor , rhabdomyosarcoma hepatoblastoma . @ GeneSrc $ ( @ DiseaseTgt $ subchromosomal transferable fragment cDNA ; also known @ GeneSrc $ ) located region . expression @ GeneSrc $ genes region regulated paternal imprinting . Mutations and/or reduced expression @ GeneSrc $ found certain @ DiseaseTgt $ . @ GeneSrc $ encodes efflux transporter-like protein 10 transmembrane domains , whose regulation may affect drug sensitivity , cellular metabolism growth . , present evidences indicating RING105 , novel conserved RING-finger protein PA ( protease-associated ) domain PEST sequence , ubiquitin ligase @ GeneSrc $ function concert ubiquitin-conjugating enzyme UbcH6 . polyubiquitin target site @ GeneSrc $ mapped region 6th hydrophilic loop . Ectopic expression RING105 HeLa cells caused accumulation cells G1 observed expression form RING105 residue within RING finger mutated inactivate ligase activity . UbcH6-RING105 may define novel ubiquitin-proteasome pathway targets @ GeneSrc $ mammalian cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7453963479225363)\n",
      "- Text: \"Divergently transcribed overlapping genes expressed liver kidney located 11p15.5 imprinted domain . Human chromosomal band 11p15.5 shown contain genes involved development several pediatric adult @ DiseaseTgt $ Beckwith-Wiedemann syndrome ( BWS ) . Overlapping P1 artificial chromosome clones region used templates genomic sequencing effort identify candidate genes disorders . PowerBLAST identified several matches expressed sequence tags ( ESTs ) fetal brain liver cDNA libraries . Northern blot analysis indicated two genes identified ESTs encode transcripts 1 - 1.5 kb predominant expression fetal adult liver kidney . RT-PCR RACE , full-length transcripts isolated two genes , largest open reading frames encoding putative proteins 253 424 amino acids . Database comparison predicted amino acid sequence larger transcript indicated homology integral membrane organic cation transporters ; hence , designate gene ORCTL2 ( organic cation transporter-like 2 ) . expressed sequence polymorphism provided evidence ORCTL2 gene exhibits `` leaky `` imprinting human fetal kidney human fetal liver . mouse orthologue ( Orctl2 ) identified , similar polymorphism used demonstrate maternal-specific expression gene fetal liver interspecific F1 mice . predicted protein smaller gene showed significant similarity database . Northern RACE analyses suggest gene may multiple transcription start sites . Determination genomic structure humans indicated 5'-end transcript overlaps divergent orientation first two exons ORCTL2 , suggesting possible role antisense regulation one gene . , therefore , provisionally name second transcript @ GeneSrc $ ( ORCTL2-antisense ) . expression patterns genes imprinted expression ORCTL2 suggestive possible role development Wilms tumor ( WT ) hepatoblastoma . Although SSCP analysis 62 WT samples 10 BWS patients result identification mutations ORCTL2 @ GeneSrc $ , important examine expression pattern @ DiseaseTgt $ BWS patients , since epigenetic alteration loci may play role etiology diseases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0125856381922633)\n",
      "- Text: \"Transcriptional map 170-kb region chromosome 11p15.5 : identification mutational analysis BWR1A gene reveals presence mutations @ DiseaseTgt $ samples . Chromosome region 11p15.5 harbors unidentified genes involved @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome . genetic analysis 170-kb region 11p15.5 loci D11S601 D11S679 resulted identification six transcriptional units . Three genes , hNAP2 , CDKN1C , KVLQT1 , well characterized , whereas three genes novel . three additional genes designated BWR1A , @ GeneSrc $ , BWR1C . Full-length cDNAs three genes cloned nucleotide sequences determined . work progress , BWR1C cDNA described IPL [ Qian , N. , Franck , D. , O'Keefe , D. , Dao , D. , Zhao , L. , Yuan , L. , Wang , Q. , Keating , M. , Walsh , C. & Tycko , B . ( 1997 ) Hum . Mol . Genet . 6 , 2021 - 2029 ] . cloning mapping genes together fine mapping three known genes indicates transcriptional map region likely complete . region frequently altered @ DiseaseTgt $ genetic disease Beckwith-Wiedemann syndrome , carried mutational analysis @ DiseaseTgt $ cell lines Beckwith-Wiedemann syndrome samples resulted identification genetic alterations BWR1A gene : insertion introduced stop codon breast cancer cell line BT549 point mutation rhabdomyosarcoma cell line TE125-T . results indicate BWR1A may play role tumorigenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.096264201603242e-05)\n",
      "- Text: \"p53 regulation ammonia metabolism urea cycle controls polyamine biosynthesis . @ DiseaseTgt $ cells exhibit altered usually increased metabolic processes meet high biogenetic demands1,2 . conditions , ammonia concomitantly produced increased metabolic processing . However , unclear @ DiseaseTgt $ cells dispose excess ammonia outcomes might caused accumulation ammonia . report @ DiseaseTgt $ suppressor p53 , frequently mutated gene human @ DiseaseTgt $ , regulates ammonia metabolism repressing urea cycle . transcriptional downregulation CPS1 , @ GeneSrc $ ARG1 , p53 suppresses ureagenesis elimination ammonia vitro vivo , leading inhibition @ DiseaseTgt $ growth . Conversely , downregulation genes reciprocally activates p53 MDM2-mediated mechanism ( ) . Furthermore , accumulation ammonia causes significant decline mRNA translation polyamine biosynthetic rate-limiting enzyme ODC , thereby inhibiting biosynthesis polyamine cell proliferation . Together , findings link p53 ureagenesis ammonia metabolism , reveal role ammonia controlling polyamine biosynthesis cell proliferation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.288097185003107)\n",
      "- Text: \"@ GeneSrc $ , gene implicated autosomal recessive juvenile parkinsonism , candidate tumor suppressor gene chromosome 6q25-q27 . effort identify tumor suppressor gene ( ) associated frequent loss heterozygosity observed chromosome 6q25-q27 , constructed contig derived sequences bacterial artificial chromosomeP1 bacteriophage artificial chromosome clones defined genetic interval D6S1581-D6S1579-D6S305-D6S1599-D6S1008 . Sequence analysis contig found contain eight known genes , including complete genomic structure @ GeneSrc $ gene . Loss heterozygosity ( LOH ) analysis 40 malignant @ DiseaseTgt $ identified common minimal region loss , including markers D6S305 ( 50 % ) D6S1599 ( 32 % ) . loci exhibited highest frequencies LOH study located within @ GeneSrc $ genomic structure . Whereas mutation analysis revealed missense substitutions , expression @ GeneSrc $ gene appeared down-regulated absent tumor biopsies tumor cell lines examined . addition , identification two truncating deletions 3 20 @ DiseaseTgt $ samples , well homozygous deletion exon 2 lung adenocarcinoma cell lines Calu-3 H-1573 , supports hypothesis hemizygous homozygous deletions responsible abnormal expression @ GeneSrc $ samples . data suggest LOH observed chromosome 6q25-q26 may contribute initiation andor progression cancer inactivating reducing expression @ GeneSrc $ gene . @ GeneSrc $ maps FRA6E , one active common fragile sites human genome , represents another example large tumor suppressor gene , like FHIT WWOX , located common fragile site .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0567044585839685)\n",
      "- Text: \"Alterations common fragile site gene @ GeneSrc $ @ DiseaseTgt $ . cloning characterization common fragile site ( CFS ) FRA6E ( 6q26 ) identified @ GeneSrc $ , gene involved pathogenesis many cases juvenile , early-onset , rarely , late-onset Parkinson 's disease , third large gene localized within large CFS . Initial analyses @ GeneSrc $ indicated addition playing role Parkinson 's disease , might also involved development and/or progression @ DiseaseTgt $ . analyses also indicated striking similarities among large CFS-locus genes : fragile histidine triad gene ( FHIT ; 3p14.2 ) , WW domain-containing oxidoreductase gene ( WWOX ; 16q23 ) , @ GeneSrc $ ( 6q26 ) . Analyses FHIT WWOX variety different cancer types identified presence alternative transcripts whole exon deletions . Interestingly , various whole exon duplications deletions identified @ GeneSrc $ juvenile early-onset Parkinson 's patients . Therefore , performed mutational/exon rearrangement analysis @ GeneSrc $ @ DiseaseTgt $ cell lines primary tumors . Four ( 66.7 % ) cell lines four ( 18.2 % ) primary tumors identified heterozygous duplication deletion @ GeneSrc $ exon . Additionally , three 23 ( 13.0 % ) nonovarian tumor-derived cell lines also identified duplication deletion one @ GeneSrc $ exons . Analysis @ GeneSrc $ protein expression antibodies revealed @ DiseaseTgt $ cell lines primary tumors diminished absent @ GeneSrc $ expression . functional analyses yet performed @ GeneSrc $ , data suggest like FHIT WWOX , @ GeneSrc $ may represent tumor suppressor gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0911789545989668)\n",
      "- Text: \"Evaluation 50 probands early-onset @ DiseaseTgt $ @ GeneSrc $ mutations . BACKGROUND : Early onset @ DiseaseTgt $ associated different mutations @ GeneSrc $ gene , including exon deletions duplications . METHODS : authors performed extensive mutational analysis 50 probands onset @ DiseaseTgt $ younger 50 years age . Thirteen probands ascertained registry familial @ DiseaseTgt $ 37 probands age onset younger 50 years , blind family history . Mutational analysis undertaken probands available family members included conventional techniques ( single strand conformation polymorphism analysis sequencing ) newly developed method quantitative duplex PCR detect alterations gene dosage ( exon deletions duplications ) @ GeneSrc $ : RESULTS : Using new technique , authors detected eight alterations gene dosage probands , whereas 12 mutations found conventional methods among probands another different mutation affected family member . total , authors identified compound heterozygous mutations 14 % , heterozygous mutations 12 % , @ GeneSrc $ mutation 74 % 50 probands . expanded occurrence @ GeneSrc $ mutations another ethnic group ( African-American ) . CONCLUSION : authors systematically screened 12 @ GeneSrc $ exons quantitative PCR conventional methods 50 probands . Eight mutations newly reported , 2 localized exon 1 , 38 % mutations gene dosage alterations . results underline need screen exons undertake gene dosage studies . Furthermore , study reveals frequency heterozygous mutation carriers may signify unique mode inheritance expression @ GeneSrc $ gene .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8405632875119118)\n",
      "- Text: \"Ubiquitination new form alpha-synuclein @ GeneSrc $ human brain : implications @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative disorder characterized progressive accumulation selected neurons protein inclusions containing alpha-synuclein ubiquitin . Rare inherited forms @ DiseaseTgt $ caused autosomal dominant mutations alpha-synuclein autosomal recessive mutations @ GeneSrc $ , E3 ubiquitin ligase . hypothesized two gene products interact functionally , namely , @ GeneSrc $ ubiquitinates alpha-synuclein normally process altered @ DiseaseTgt $ . identified protein complex normal human brain includes @ GeneSrc $ E3 ubiquitin ligase , UbcH7 associated E2 ubiquitin conjugating enzyme , new 22-kilodalton glycosylated form alpha-synuclein ( alphaSp22 ) substrate . contrast normal @ GeneSrc $ , mutant @ GeneSrc $ associated @ DiseaseTgt $ failed bind alphaSp22 . vitro ubiquitination assay , alphaSp22 modified normal mutant @ GeneSrc $ polyubiquitinated , high molecular weight species . Accordingly , alphaSp22 accumulated non-ubiquitinated form @ GeneSrc $ @ DiseaseTgt $ brains . conclude alphaSp22 substrate @ GeneSrc $ 's ubiquitin ligase activity normal human brain loss @ GeneSrc $ function causes pathological alphaSp22 accumulation . findings demonstrate critical biochemical reaction two @ DiseaseTgt $ gene products suggest reaction underlies accumulation ubiquitinated alpha-synuclein conventional @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8110017915282451)\n",
      "- Text: \"Caenorhabditis elegans @ GeneSrc $ mutant altered solubility couples alpha-synuclein aggregation proteotoxic stress . Mutations human @ GeneSrc $ gene encoding E3 ubiquitin ligase associated early-onset recessive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , molecular mechanisms mutations @ GeneSrc $ gene cause @ DiseaseTgt $ still debate . , identified characterized Caenorhabditis elegans @ GeneSrc $ homolog , pdr-1 . PDR-1 protein physically associates cooperates conserved degradation machinery mediate ubiquitin conjugation . Strikingly , contrast pdr-1 loss-of-function mutants , in-frame deletion variant altered solubility intracellular localization properties hypersensitive toward different proteotoxic stress conditions . endoplasmic reticulum-derived folding stress cytosolic stress conferred expression mutant human alpha-synuclein resulted severe developmental defects lethality pdr-1 ( lg103 ) mutant background . Furthermore , show corresponding truncated protein PDR-1 ( Deltaaa24 - 247 ) aggregates cell culture , still interacts ubiquitylation co-enzymes . Thus , might block cellular degradation/detoxification machinery therefore renders worms highly vulnerable protein folding stress . contrast complete gene knockouts RNAi models @ GeneSrc $ function , C. elegans model recapitulates @ GeneSrc $ insolubility aggregation similar several autosomal recessive juvenile parkinsonism ( AR-JP ) -linked @ GeneSrc $ mutations . suggest @ GeneSrc $ variants either confer neomorphic function partial loss-of-function may help elucidate biological function @ GeneSrc $ vivo pathogenic mechanisms resulting AR-JP . Due high-throughput capacity C. elegans , model particularly well suited identify genetic chemical modifiers toxicity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3818793435479175)\n",
      "- Text: \"Mutation analysis PINK1 gene 391 patients @ DiseaseTgt $ . OBJECTIVES : determine frequency , distribution , clinical features @ DiseaseTgt $ ( @ DiseaseTgt $ ) PINK1 mutations . DESIGN : Retrospective clinical genetic review . SETTING : University hospital . PATIENTS : performed extensive mutation analyses PINK1 414 @ DiseaseTgt $ patients negative @ GeneSrc $ mutations ( mean [ SD ] age onset , 42.8 [ 14.3 ] years ) , including 391 unrelated patients ( 190 patients sporadic @ DiseaseTgt $ 201 probands patients familial PD ) 13 countries . RESULTS : found 10 patients @ DiseaseTgt $ 9 families PINK1 mutations identified 7 novel mutations ( 2 homozygous mutations [ p. D297MfsX22 p. W437R ] 5 single heterozygous mutations [ p. A78V , p. P196QfsX25 , p. M342V , p. W437R , p. N542S ] ) . compound heterozygous mutations found . frequency homozygous mutations 4.26 % ( 2 47 ) families autosomal recessive @ DiseaseTgt $ 0.53 % ( 1 190 ) patients sporadic @ DiseaseTgt $ . frequency heterozygous mutations 1.89 % ( 2 106 ) families potential autosomal dominant @ DiseaseTgt $ 1.05 % ( 2 190 ) patients sporadic @ DiseaseTgt $ . mean ( SD ) age onset patients single heterozygous mutations ( 53.6 [ 11.1 ] years ; range , 39 - 69 years ) higher patients homozygous mutations ( 34.0 [ 20.3 ] years ; range , 10 - 55 years ) . Myocardial iodine-123 metaiodobenzylguanidine uptake low patients heterozygous mutations homozygous mutations . CONCLUSIONS : results suggest homozygous PINK1 mutations tend diagnosed early-onset autosomal recessive form @ DiseaseTgt $ . Single heterozygous mutations may contribute development sporadic @ DiseaseTgt $ also could additional genetic predisposition developing familial PD . reduced myocardial iodine-123 metaiodobenzylguanidine uptake observed patients single heterozygous PINK1 mutations similar seen patients sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8247102511920597)\n",
      "- Text: \"Structure @ GeneSrc $ in-between-ring domain provides insights E3-ligase dysfunction @ DiseaseTgt $ . Mutations @ GeneSrc $ one predominant hereditary factors found patients suffering autosomal recessive juvenile Parkinsonism . @ GeneSrc $ member E3 ubiquitin ligase family defined tripartite RING1-in-between-ring ( IBR ) -RING2 motif . @ GeneSrc $ , IBR domain shown augment binding E2 proteins UbcH7 UbcH8 , subsequent ubiquitination proteins synphilin-1 , Sept5 , SIM2 . facilitate understanding @ GeneSrc $ function , solution structure @ GeneSrc $ IBR domain solved using NMR spectroscopy . Folding IBR domain ( residues M327-S378 ) found zinc dependent , structure reveals domain forms unique pair scissor-like GAG knuckle-like zinc-binding sites , different zinc-binding motifs RING , LIM , PHD , B-box motifs . N terminus IBR domain , residues E307-E322 , unstructured . disease causing mutation T351P causes global unfolding , whereas mutation R334C causes structural rearrangement domain . contrast , protein containing mutation G328E appears properly folded . structure @ GeneSrc $ IBR domain , combination mutational data , allows model proposed IBR domain facilitates close arrangement adjacent RING1 RING2 domains facilitate protein interactions subsequent ubiquitination .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6180333739291624)\n",
      "- Text: \"Familial-associated mutations differentially disrupt solubility , localization , binding ubiquitination properties @ GeneSrc $ . Mutations @ GeneSrc $ largely associated autosomal recessive juvenile parkinsonism . underlying mechanism pathogenesis @ GeneSrc $ @ DiseaseTgt $ ( @ DiseaseTgt $ ) thought due loss @ GeneSrc $ 's E3 ubiquitin ligase activity . subset missense nonsense point mutations @ GeneSrc $ span entire gene represent numerous inheritance patterns associated @ GeneSrc $ @ DiseaseTgt $ investigated E3 ligase activity , localization ability bind , ubiquitinate effect degradation two substrates , synphilin-1 aminoacyl-tRNA synthetase complex cofactor , p38 . @ GeneSrc $ mutants vary intracellular localization , binding substrates enzymatic activity , yet ultimately deficient ability degrade substrate . results suggest @ GeneSrc $ mutations result loss @ GeneSrc $ 's E3 ligase activity , appear manifest loss-of-function mutants due defects solubility , aggregation , enzymatic activity targeting proteins proteasome degradation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.975755933569151)\n",
      "- Text: \"@ GeneSrc $ recruited aggresomes stress-specific manner : over-expression @ GeneSrc $ reduces aggresome formation dissociated @ GeneSrc $ 's effect neuronal survival . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized loss dopamine neurons substantia nigra presence cytoplasmic inclusions known Lewy bodies ( LBs ) . Mutations @ GeneSrc $ cause autosomal recessive juvenile parkinsonism ( AR-JP ) distinct @ DiseaseTgt $ general absence LBs . Several studies reported @ GeneSrc $ present LBs @ DiseaseTgt $ role @ GeneSrc $ LB formation unclear . Aggresomes perinuclear aggregates representing intracellular deposition misfolded protein . LBs aggresomes reported share common biogenesis . investigated role @ GeneSrc $ aggresome formation . human SH-SY5Y neuroblastoma cells observe endogenous @ GeneSrc $ present aggresomes induced variety stresses including dopamine , proteosome inhibition pro-apoptopic stimulus . show vimentin invariably collapsed around aggresome detection ubiquitin variable depending stress . show cells stably over-express human wild-type @ GeneSrc $ form fewer aggresomes upon stress compared cells express vector alone whereas over-expression AR-JP causing mutants @ GeneSrc $ effect stress-induced aggresome formation . Finally , show prevention aggresome formation over-expression wild-type @ GeneSrc $ always associated beneficial effect neuronal survival . findings suggest @ GeneSrc $ important aggresome formation human neuronal cells may lead better understanding biogenesis LBs @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4883535095726746)\n",
      "- Text: \"Heterogeneous phenotype family compound heterozygous @ GeneSrc $ gene mutations . BACKGROUND : Mutations @ GeneSrc $ gene ( PRKN ) cause autosomal recessive early-onset @ DiseaseTgt $ ( EOPD ) . OBJECTIVE : investigate presence mutations PRKN gene white family EOPD genotype-phenotype correlations . DESIGN : Twenty members belonging 3 generations EOPD family 4 affected subjects underwent genetic analysis . Direct genomic DNA sequencing , semiquantitative polymerase chain reaction , real-time quantitative polymerase chain reaction , reverse-transcriptase polymerase chain reaction analyses performed identify PRKN mutation . RESULTS : Compound heterozygous mutations ( T240 EX 5_6 del ) PRKN gene identified 4 patients early onset ( ages 30 - 38 years ) . Although heterozygous T240 homozygous EX 5_6 del mutations PRKN gene previously described , , knowledge , first report mutations compound heterozygotes . phenotype patients classic autosomal recessive EOPD characterized beneficial response levodopa , relatively slow progression , motor complications . heterozygous mutation carriers ( T240 EX 5_6 del ) 56-year-old woman compound heterozygous mutation carrier ( T240 EX 5_6 del ) free neurological symptoms . CONCLUSIONS : Compound heterozygous mutations ( T240 EX 5_6 del ) PRKN gene found cause autosomal recessive EOPD 4 members large white family . One additional member mutation , 10 years older mean age onset 4 affected individuals , clinical manifestation disease . incomplete penetrance implications genetic counseling , suggests complex gene-environment interactions may play role pathogenesis PRKN EOPD .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9156109666647718)\n",
      "- Text: \"Influence heterozygosity @ GeneSrc $ mutation onset age familial @ DiseaseTgt $ : GenePD study . BACKGROUND : @ GeneSrc $ gene 6q26 encodes @ GeneSrc $ , whose inactivation implicated early-onset autosomal recessive form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . OBJECTIVE : evaluate influence heterozygosity @ GeneSrc $ mutation onset age sample families least 2 @ DiseaseTgt $ members . DESIGN : Clinical genetic study . SETTING : Twenty collaborative clinical sites . PATIENTS : Patients familial @ DiseaseTgt $ collected GenePD study . Studied families selected ( 1 ) affected sibling pairs sharing 2 alleles identical state @ GeneSrc $ ( D6S305 ) ( 2 ) 1 family members onset age younger 54 years , regardless D6S305 status . least 1 member 183 families underwent comprehensive screening deletion/insertion variants point mutations @ GeneSrc $ . MAIN OUTCOME MEASURES : Mutations @ GeneSrc $ gene screened means single-stranded conformation polymorphism sequencing 12 coding exons flanking intronic sequences point mutations duplex quantitative polymerase chain reaction exons rearrangement , duplication , deletion . RESULTS : Mutations found 23 families ( 12.6 % screened ) . Among mutation-positive families , 10 ( 43 % ) contained compound heterozygotes ; 3 ( 13 % ) , homozygotes ; 10 ( 43 % ) , heterozygotes . onset age patients @ GeneSrc $ gene mutations ranged 20 76 years . Patients 1 @ GeneSrc $ mutation 11.7-year age onset patients none ( P = .04 ) , patients 2 @ GeneSrc $ mutations 13.2-year decrease age onset compared patients 1 mutation ( P = .04 ) . CONCLUSIONS : data indicate @ GeneSrc $ mutations rare multiply affected sibships , heterozygous mutation carrier status @ GeneSrc $ significantly influences age onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8125371549493471)\n",
      "- Text: \"@ GeneSrc $ promotes intracellular Abeta1 - 42 clearance . Alzheimer 's disease @ DiseaseTgt $ common neurodegenerative diseases may share underlying mechanisms pathogenesis . Abeta ( 1 - 42 ) fragments found intracellularly , extracellularly amyloid plaques , Alzheimer 's disease dementia Lewy Bodies . @ GeneSrc $ E3-ubiquitin ligase involved proteasomal degradation intracellular proteins . Mutations @ GeneSrc $ , result loss @ GeneSrc $ function , lead early onset Parkinsonism . tested whether ubiquitin ligase activity @ GeneSrc $ could lead reduction intracellular human Abeta ( 1 - 42 ) . Lentiviral constructs encoding either human @ GeneSrc $ human Abeta ( 1 - 42 ) used infect M17 neuroblastoma cells . @ GeneSrc $ expression resulted reduction intracellular human Abeta ( 1 - 42 ) levels protected toxicity M17 cells . Co-injection lentiviral constructs control rat primary motor cortex demonstrated @ GeneSrc $ co-expression reduced human Abeta ( 1 - 42 ) levels Abeta ( 1 - 42 ) -induced neuronal degeneration vivo . @ GeneSrc $ increased proteasomal activity , proteasomal inhibition blocked effects @ GeneSrc $ reducing Abeta ( 1 - 42 ) levels . Incubation Abeta ( 1 - 42 ) cell lysates ubiquitin , presence @ GeneSrc $ , demonstrated generation Abeta-ubiquitin complexes . data indicate @ GeneSrc $ promotes ubiquitination proteasomal degradation intracellular Abeta ( 1 - 42 ) demonstrate protective effect neurodegenerative diseases Abeta deposits .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0321680713488436)\n",
      "- Text: \"Association DJ-1 @ GeneSrc $ mediated pathogenic DJ-1 mutations oxidative stress . identification rare monogenic forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) provided tremendous insight molecular pathogenesis disorder . Heritable mutations alpha-synuclein , @ GeneSrc $ , DJ-1 PINK1 cause familial forms @ DiseaseTgt $ . common sporadic form @ DiseaseTgt $ , oxidative stress derangements mitochondrial complex-I function considered play prominent role disease pathogenesis . However , relationship DJ-1 @ DiseaseTgt $ genes oxidative stress explored . , show pathogenic mutant forms DJ-1 specifically differentially associate @ GeneSrc $ , E3 ubiquitin ligase . Chemical cross-linking shows pathogenic DJ-1 mutants exhibit impairments homo-dimer formation , suggesting @ GeneSrc $ may bind monomeric DJ-1 . @ GeneSrc $ fails specifically ubiquitinate enhance degradation L166P M26I mutant DJ-1 , instead promotes stability cultured cells . interaction @ GeneSrc $ L166P DJ-1 may involve larger protein complex contains CHIP Hsp70 , perhaps accounting lack @ GeneSrc $ ubiquitination . Oxidative stress also promotes interaction DJ-1 @ GeneSrc $ , result ubiquitination degradation DJ-1 . @ GeneSrc $ alterations DJ-1 protein stability may pathogenically relevant DJ-1 levels dramatically increased detergent-insoluble fraction sporadic @ DiseaseTgt $ brains , reduced insoluble fraction @ GeneSrc $ autosomal recessive juvenile-onset @ DiseaseTgt $ brains . data potentially link DJ-1 @ GeneSrc $ common molecular pathway multiple levels may important implications understanding pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9935388890776966)\n",
      "- Text: \"heterozygous effect PINK1 mutations @ DiseaseTgt $ ? OBJECTIVE : investigate significance PINK1 mutations sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . METHODS : determined frequency PINK1 mutations direct sequencing large series @ DiseaseTgt $ patients apparently sporadic disease ( n = 768 ) . RESULTS : Twelve heterozygous mutations identified , nine @ DiseaseTgt $ patients three control subjects . INTERPRETATION : Given difficulty interpreting pathogenic significance heterozygous mutations already reported @ GeneSrc $ DJ-1 , first determined frequency heterozygous PINK1 mutations general population sequencing large number control subjects ( n = 768 ) , subsequently assessed functional significance examining effects stress-induced alterations mitochondrial membrane potential ( DeltaPsim ) . demonstrate enrichment heterozygous mutations sporadic @ DiseaseTgt $ patients compared matched control subjects ( 1.2 % @ DiseaseTgt $ vs 0.4 % control subjects ) . Furthermore , show adversely affect DeltaPsim similar way familial G309D mutation . Although remains difficult conclusively demonstrate pathogenicity heterozygous mutations , results study previously reported subclinical nigrostriatal dysfunction carriers heterozygous PINK1 mutations suggest possibility heterozygous mutations significant risk factor development later onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2658207865329676)\n",
      "- Text: \"SH3 domains subset BAR proteins define Ubl-binding domain implicate @ GeneSrc $ synaptic ubiquitination . Mutations @ GeneSrc $ gene responsible common inherited form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ RING-type E3 ubiquitin ligase N-terminal ubiquitin-like domain ( Ubl ) . report @ GeneSrc $ Ubl binds SH3 domains endocytic BAR proteins endophilin-A affinity comparable proline-rich domains ( PRDs ) well-established SH3 partners . NMR structure Ubl-SH3 complex identifies PaRK extension , unique C-terminal motif @ GeneSrc $ Ubl required SH3 binding @ GeneSrc $ ubiquitination endophilin-A vitro . nerve terminals , conditions promote phosphorylation enhance interaction @ GeneSrc $ endophilin-A increase levels ubiquitinated proteins within PRD-associated synaptic protein complexes wild-type @ GeneSrc $ knockout brain . findings identify pathway recruitment synaptic substrates @ GeneSrc $ potential explain defects synaptic transmission observed recessive forms @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7152274647920742)\n",
      "- Text: \"Heterozygous @ GeneSrc $ point mutations common control subjects @ DiseaseTgt $ patients . OBJECTIVE : Homozygous compound heterozygous @ GeneSrc $ mutations cause juvenile parkinsonism . Heterozygous @ GeneSrc $ mutations also found patients typical @ DiseaseTgt $ ( @ DiseaseTgt $ ) , unclear whether single `` mutation `` patient related disease coincidental , mutation frequency control subjects unknown . present comprehensive sequence analysis @ GeneSrc $ control subjects . METHODS : total 302 patients 301 control subjects sequenced , findings replicated 1,260 additional patients 1,657 control subjects . RESULTS : Thirty-four variants detected , 21 novel ; 12 polymorphisms 22 rare variants . Patients control subjects differ frequency , type , functional location variants . Even P437L , common mutation thought pathogenic , present unaffected control subjects . INTERPRETATION : @ GeneSrc $ point mutations exclusive @ DiseaseTgt $ . mere presence single point mutation patient , absence second mutation , taken cause disease unless corroborated family data functional studies . study support notion heterozygous @ GeneSrc $ sequence variants ( mutations polymorphisms ) risk factors @ DiseaseTgt $ . Whether heterozygous dosage anomalies associated @ DiseaseTgt $ remains determined .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0471622493819643)\n",
      "- Text: \"@ GeneSrc $ facilitates elimination expanded polyglutamine proteins leads preservation proteasome function . @ GeneSrc $ , commonly mutated gene familial @ DiseaseTgt $ , encodes E3 ubiquitin ligase . number candidate substrates identified @ GeneSrc $ ubiquitin ligase action including CDCrel-1 , o-glycosylated alpha-synuclein , Pael-R , synphilin-1 . show @ GeneSrc $ promotes ubiquitination degradation expanded polyglutamine protein . Overexpression @ GeneSrc $ reduces aggregation cytotoxicity expanded polyglutamine ataxin-3 fragment . Using cellular proteasome indicator system based destabilized form green fluorescent protein , demonstrate @ GeneSrc $ reduces proteasome impairment caspase-12 activation induced expanded polyglutamine protein . @ GeneSrc $ forms complex expanded polyglutamine protein , heat shock protein 70 ( Hsp70 ) proteasome , may important elimination expanded polyglutamine protein . Hsp70 enhances @ GeneSrc $ binding ubiquitination expanded polyglutamine protein vitro suggesting Hsp70 may help recruit misfolded proteins substrates @ GeneSrc $ E3 ubiquitin ligase activity . speculate @ GeneSrc $ may function relieve endoplasmic reticulum stress preserving proteasome activity presence misfolded proteins . Loss @ GeneSrc $ function resulting proteasomal impairment may contribute accumulation toxic aberrant proteins neurodegenerative diseases including @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.267387410521262)\n",
      "- Text: \"Lack association cancer history @ GeneSrc $ genotype : family based study @ DiseaseTgt $ families . number publications attributed tumor suppressive ( TS ) function @ GeneSrc $ , gene associated recessive familial early onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Discoveries @ GeneSrc $ deletions point mutations tumors , functional studies , data mouse models presented support hypothesis . asked whether @ GeneSrc $ mutations associated history cancer humans . interviewed 431 participants screened @ GeneSrc $ mutations , including 149 @ DiseaseTgt $ cases family members , unaware mutation status . found significant difference self-reported history cancer among carriers one two @ GeneSrc $ mutations noncarriers , odds ratio 0.75 ( 95 % confidence interval 0.27 - 1.83 ) . particular , increase cancer history seen among homozygous compound heterozygous mutation carriers compared noncarriers . Therefore , hypothesize published studies attributing TS capability @ GeneSrc $ merit exploration present reevaluation data respect patterns mutation frequencies normal cancer cells . conclude although @ GeneSrc $ may exert suppressive effect mice , studies required prior assigning TS function @ GeneSrc $ humans .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3104082544490645)\n",
      "- Text: \"Oxidation cysteine-rich regions @ GeneSrc $ perturbs E3 ligase activity contributes protein aggregation . BACKGROUND : Accumulation aberrant proteins form Lewy bodies ( LBs ) hallmark @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Ubiquitination-mediated degradation aberrant , misfolded proteins critical maintaining normal cell function . Emerging evidence suggests oxidative/nitrosative stress compromises precisely-regulated network ubiquitination @ DiseaseTgt $ , particularly affecting @ GeneSrc $ E3 ligase activity , contributes accumulation toxic proteins neuronal cell death . RESULTS : gain insight mechanism whereby cell stress alters @ GeneSrc $ ubiquitination LB formation , investigated effect oxidative stress . found significant increases oxidation ( sulfonation ) subsequent aggregation @ GeneSrc $ SH-SY5Y cells exposed mitochondrial complex inhibitor 1-methyl-4-phenlypyridinium ( MPP+ ) , representing vitro cell-based @ DiseaseTgt $ model . Exposure cells direct oxidation via pathological doses H2O2 induced vicious cycle increased followed decreased @ GeneSrc $ E3 ligase activity , similar previously reported following S-nitrosylation @ GeneSrc $ . Pre-incubation catalase attenuated H2O2 accumulation , @ GeneSrc $ sulfonation , @ GeneSrc $ aggregation . Mass spectrometry ( MS ) analysis revealed H2O2 reacted specific cysteine residues @ GeneSrc $ , resulting sulfination/sulfonation regions protein similar affected @ GeneSrc $ mutations hereditary forms @ DiseaseTgt $ . Immunohistochemistry gel electrophoresis revealed increase aggregated @ GeneSrc $ rats primates exposed mitochondrial complex inhibitors , well postmortem human brain patients @ DiseaseTgt $ LBs . CONCLUSION : findings show oxidative stress alters @ GeneSrc $ E3 ligase activity , leading dysfunction ubiquitin-proteasome system potentially contributing LB formation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6454907286634846)\n",
      "- Text: \"Early-onset @ DiseaseTgt $ caused novel @ GeneSrc $ mutation genetic isolate north-eastern Brazil . describe clinical molecular findings genetic isolate north-eastern Brazil early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) novel mutation @ GeneSrc $ gene . Genealogical studies could connect 255 individuals , 15 @ DiseaseTgt $ . Geographic isolation multiple consanguineous marriages initially suggested autosomal recessive inheritance @ DiseaseTgt $ patients . available individuals personally examined , DNA obtained 26 members : ten early-onset @ DiseaseTgt $ patients , one case likely neuroleptic-induced parkinsonism 15 unaffected relatives . average age onset @ DiseaseTgt $ symptoms 30.8 years ( range 12 - 46 ) . Haplotype analysis revealed homozygosity @ DiseaseTgt $ patients markers across @ GeneSrc $ locus . Genomic sequencing identified novel homozygous splice-site @ GeneSrc $ mutation ( IVS1 + 1G/T ) , completely co-segregated early-onset @ DiseaseTgt $ phenotype . cDNA analysis confirmed total loss @ GeneSrc $ transcript homozygous mutation carriers , delineating loss-of-function mutation . case neuroleptic-induced parkinsonism 13 15 healthy relatives heterozygous carriers mutation . absence @ DiseaseTgt $ heterozygous carriers indicates genuinely recessive nature mutation , suggesting @ GeneSrc $ haploinsufficiency relevant risk factor early- late-onset @ DiseaseTgt $ . However , @ GeneSrc $ haploinsufficiency could facilitate emergence neuroleptic-induced parkinsonism . cluster reported , knowledge largest described date early-onset @ DiseaseTgt $ @ GeneSrc $ mutations , also offers unique opportunity search modifiers @ GeneSrc $ disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8293438089872472)\n",
      "- Text: \"Transcriptional repression p53 @ GeneSrc $ impairment mutations associated autosomal recessive @ DiseaseTgt $ . Mutations ubiquitin ligase @ GeneSrc $ account autosomal recessive forms @ DiseaseTgt $ ( AR-JP ) . Several studies suggested @ GeneSrc $ possesses DNA-binding transcriptional activity . report @ GeneSrc $ p53 transcriptional repressor . First , @ GeneSrc $ prevented 6-hydroxydopamine-induced caspase-3 activation p53-dependent manner . Concomitantly , @ GeneSrc $ reduced p53 expression activity , effect abrogated familial @ GeneSrc $ mutations known either abolish preserve ligase activity . ChIP experiments indicate overexpressed endogenous @ GeneSrc $ interact physically p53 promoter pathogenic mutations abolish DNA binding promoter transactivation p53 . @ GeneSrc $ lowered p53 mRNA levels repressed p53 promoter transactivation Ring1 domain . Conversely , @ GeneSrc $ depletion enhanced p53 expression mRNA levels fibroblasts mouse brains , increased cellular p53 activity promoter transactivation cells . Finally , familial @ GeneSrc $ missense deletion mutations enhanced p53 expression human brains affected AR-JP . study reveals ubiquitin ligase-independent function @ GeneSrc $ control transcription functional link @ GeneSrc $ p53 altered AR-JP mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9253617583940384)\n",
      "- Text: \"@ GeneSrc $ , PINK1 , DJ-1 form ubiquitin E3 ligase complex promoting unfolded protein degradation . Mutations @ GeneSrc $ , pten-induced putative kinase 1 ( PINK1 ) , DJ-1 individually linked autosomal recessive early-onset familial forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although mutations genes lead disease state , functional relationships respective disease-associated mutations cause @ DiseaseTgt $ largely unknown . , show @ GeneSrc $ , PINK1 , DJ-1 formed complex ( termed PPD complex ) promote ubiquitination degradation @ GeneSrc $ substrates , including @ GeneSrc $ Synphilin-1 neuroblastoma cells human brain lysates . Genetic ablation either Pink1 Dj-1 resulted reduced ubiquitination endogenous @ GeneSrc $ well decreased degradation increased accumulation aberrantly expressed @ GeneSrc $ substrates . Expression PINK1 enhanced @ GeneSrc $ degradation heat shock-induced misfolded protein . contrast , @ DiseaseTgt $ @ GeneSrc $ PINK1 mutations showed reduced ability promote degradation @ GeneSrc $ substrates . study identified functional ubiquitin E3 ligase complex consisting @ DiseaseTgt $ @ GeneSrc $ , PINK1 , DJ-1 promote degradation un-/misfolded proteins suggests @ DiseaseTgt $ mutations impair E3 ligase activity complex , may constitute mechanism underlying @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9753075709488498)\n",
      "- Text: \"Lewy bodies parkinsonism families @ GeneSrc $ mutations . Previous work established compound mutations homozygous loss function @ GeneSrc $ gene cause early-onset , autosomal recessive parkinsonism . Classically , disease associated loss dopaminergic neurons substantia nigra pars compacta locus ceruleus , without Lewy body pathology . sequenced @ GeneSrc $ gene 38 patients early-onset @ DiseaseTgt $ ( < 41 years ) . Two probands mutations followed . Clinical evaluation families performed , blinded genetic pathological findings . Chromosome 6q25.2 - 27 haplotype analysis carried independently trait ; @ GeneSrc $ gene expression examined RNA protein levels . Haplotype analysis families revealed common chromosome 6 , novel 40 bp exon 3 deletion cosegregated disease . proband smaller kindred , exon 7 R275W substitution identified addition exon 3 deletion ; RNA analysis demonstrated mutations alternate transcripts . However , Lewy body pathology typical @ DiseaseTgt $ found autopsy proband smaller kindred . data suggest compound heterozygous @ GeneSrc $ mutations loss @ GeneSrc $ protein may lead early-onset parkinsonism Lewy body pathology , hemizygous mutation may confer increased susceptibility typical @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8808849589030437)\n",
      "- Text: \"Functional association @ GeneSrc $ gene promoter @ DiseaseTgt $ . Loss-of-function mutations @ GeneSrc $ gene first identified autosomal recessive juvenile parkinsonism ( AR-JP ) . Subsequently , @ GeneSrc $ mutations found many early-onset patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( < 45 years onset ) . hypothesized @ GeneSrc $ gene expression also may contribute age-associated risk idiopathic @ DiseaseTgt $ ( > 50 years onset ) . Two single-nucleotide polymorphisms within @ GeneSrc $ core promoter identified assessed . show one variants , -258 T/G , located region DNA binds nuclear protein human substantia nigra vitro functionally affects gene transcription . Furthermore , -258 T/G polymorphism genetically associated idiopathic @ DiseaseTgt $ , assessed large population-based series cases controls . results implicate @ GeneSrc $ gene development @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8036252230197786)\n",
      "- Text: \"@ GeneSrc $ PINK1 mitigate STING-induced inflammation . Although serum patients @ DiseaseTgt $ contains elevated levels numerous pro-inflammatory cytokines including IL-6 , TNF , IL-1beta , IFNgamma , whether inflammation contributes consequence neuronal loss remains unknown1 . Mutations @ GeneSrc $ , E3 ubiquitin ligase , PINK1 , ubiquitin kinase , cause early onset Parkinson 's disease2,3 . PINK1 @ GeneSrc $ function within biochemical pathway remove damaged mitochondria cells culture animal models via mitophagy , selective form autophagy4 . vivo role mitophagy , however , unclear , partly mice lack either PINK1 @ GeneSrc $ substantial @ DiseaseTgt $ phenotypes5 - 7 . Mitochondrial stress lead release damage-associated molecular patterns ( DAMPs ) activate innate immunity8 - 12 , suggesting mitophagy may mitigate inflammation . report strong inflammatory phenotype Prkn-/- Pink1-/- mice following exhaustive exercise Prkn-/- ; mutator mice , accumulate mutations mitochondrial DNA ( mtDNA ) 13,14 . Inflammation resulting either exhaustive exercise mtDNA mutation completely rescued concurrent loss STING , central regulator type interferon response cytosolic DNA15,16 . loss dopaminergic neurons substantia nigra pars compacta motor defect observed aged Prkn-/- ; mutator mice also rescued loss STING , suggesting inflammation facilitates phenotype . Humans mono- biallelic @ GeneSrc $ mutations also display elevated cytokines . results support role PINK1- @ GeneSrc $ mitophagy restraining innate immunity .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.656767633115838)\n",
      "- Text: \"Familial Parkinson disease gene product , @ GeneSrc $ , ubiquitin-protein ligase . Autosomal recessive juvenile parkinsonism ( AR-JP ) , one common familial forms @ DiseaseTgt $ , characterized selective dopaminergic neural cell death absence Lewy body , cytoplasmic inclusion body consisting aggregates abnormally accumulated proteins . previously cloned @ GeneSrc $ , mutations cause AR-JP ( ref . 2 ) , function gene product , @ GeneSrc $ , remains unknown . report @ GeneSrc $ involved protein degradation ubiquitin-protein ligase collaborating ubiquitin-conjugating enzyme UbcH7 , mutant parkins AR-JP patients show loss ubiquitin-protein ligase activity . findings indicate accumulation proteins yet identified causes selective neural cell death without formation Lewy bodies . findings enhance exploration molecular mechanisms neurodegeneration @ DiseaseTgt $ well neurodegenerative diseases characterized involvement abnormal protein ubiquitination , including Alzheimer disease , tauopathies , CAG triplet repeat disorders amyotrophic lateral sclerosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0844767081407661)\n",
      "- Text: \"Loss VPS13C Function Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction Increases @ GeneSrc $ Mitophagy . Autosomal-recessive early-onset parkinsonism clinically genetically heterogeneous . genetic causes approximately 50 % autosomal-recessive early-onset forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) remain elucidated . Homozygozity mapping exome sequencing 62 isolated individuals early-onset parkinsonism confirmed consanguinity followed data mining exomes 1,348 @ DiseaseTgt $ individuals identified , three isolated subjects , homozygous compound heterozygous truncating mutations vacuolar protein sorting 13C ( VPS13C ) . VPS13C mutations associated distinct form early-onset parkinsonism characterized rapid severe disease progression early cognitive decline ; pathological features striking reminiscent diffuse Lewy body disease . cell models , VPS13C partly localized outer membrane mitochondria . Silencing VPS13C associated lower mitochondrial membrane potential , mitochondrial fragmentation , increased respiration rates , exacerbated @ GeneSrc $ mitophagy , transcriptional upregulation @ GeneSrc $ response mitochondrial damage . work suggests loss function VPS13C cause autosomal-recessive early-onset parkinsonism distinctive phenotype rapid severe progression .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0158609400906164)\n",
      "- Text: \"CHIP associated @ GeneSrc $ , gene responsible familial @ DiseaseTgt $ , enhances ubiquitin ligase activity . Unfolded Pael receptor ( Pael-R ) substrate E3 ubiquitin ligase @ GeneSrc $ . Accumulation Pael-R endoplasmic reticulum ( ER ) dopaminergic neurons induces ER stress leading neurodegeneration . , show CHIP , Hsp70 , @ GeneSrc $ , Pael-R formed complex vitro vivo . amount CHIP complex increased ER stress . CHIP promoted dissociation Hsp70 @ GeneSrc $ Pael-R , thus facilitating @ GeneSrc $ Pael-R ubiquitination . Moreover , CHIP enhanced @ GeneSrc $ vitro ubiquitination Pael-R absence Hsp70 . Furthermore , CHIP enhanced ability @ GeneSrc $ inhibit cell death induced Pael-R. Taken together , results indicate CHIP mammalian E4-like molecule positively regulates Parkin E3 activity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0128003305951957)\n",
      "- Text: \"@ GeneSrc $ protects human dopaminergic neuroblastoma cells dopamine-induced apoptosis . @ DiseaseTgt $ ( @ DiseaseTgt $ ) characterized selective degeneration dopaminergic ( DA ) neurons substantia nigra pars compacta ( SNpc ) . combination genetic environmental factors contributes specific loss . Among five @ DiseaseTgt $ genes identified far , @ GeneSrc $ , protein-ubiquitin E3 ligase , appears prevalent genetic factor @ DiseaseTgt $ . Although variety substrates identified @ GeneSrc $ , none selectively expressed nigral DA neurons . remains unclear accumulation substrates absence functional @ GeneSrc $ may cause selective death DA neurons SNpc . , show overexpression @ GeneSrc $ protected human DA neuroblastoma cell line ( SH-SY5Y ) apoptosis induced DA 6-OHDA , H ( 2 ) ( 2 ) rotenone . @ GeneSrc $ significantly attenuated dopamine-induced activation c-Jun N-terminal kinase ( JNK ) caspase-3 . also decreased level reactive oxygen species ( ROS ) protein carbonyls cell . Inhibiting DA uptake dopamine transporter treating cell antioxidants significantly reduced oxidative stress dopamine toxicity . Furthermore , @ DiseaseTgt $ mutations @ GeneSrc $ significantly abrogated protective effect wild-type @ GeneSrc $ , well ability suppress ROS protein carbonylation . results suggest @ GeneSrc $ protects dopamine toxicity decreasing oxidative stress ensuing activation apoptotic programs JNK/caspase pathway . protective function @ GeneSrc $ , greatly attenuated @ DiseaseTgt $ mutations , may uniquely important survival DA neurons , constantly threatened oxyradicals produced dopamine oxidation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4338158006855783)\n",
      "- Text: \"Autosomal dominant dopa-responsive parkinsonism multigenerational Swiss family . AIM : describe large family autosomal dominant parkinsonism . BACKGROUND : Seven genes directly implicated autosomally inherited parkinsonism . However , several multigenerational large families known identifiable mutation . MATERIAL METHODS : Family members evaluated clinically , history chart review . Genetic investigation included SCA2 , SCA3 , UCHL1 , SNCA , LRRK2 , PINK1 , @ GeneSrc $ , PGRN , FMR1 premutation , MAPT . proband underwent brain fluorodopa PET ( FD-PET ) scan , one autopsy available . RESULTS : Eleven patients diagnosis @ DiseaseTgt $ ( @ DiseaseTgt $ ) , nine women . Mean age onset 52 tremor-predominant dopa-responsive parkinsonism . Disease progression slow severe motor fluctuations occurred . One patient required subthalamic nucleus deep-brain stimulation good motor outcome . One patient mental retardation , schizophrenia became demented , another patient demented . Three patients also two unaffected subjects mild learning difficulties . genetic tests yielded negative results . FD-PET showed marked asymmetric striatal tracer uptake deficiency , consistent @ DiseaseTgt $ . Pathological examination demonstrated Lewy bodies immunostaining negative alpha-synuclein . CONCLUSION : Apart younger age onset female predominance , phenotype indistinguishable @ DiseaseTgt $ , including FD-PET scan results . known genetic causes autosomal dominant @ DiseaseTgt $ excluded , family harbors novel genetic defect .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.020824594148675)\n",
      "- Text: \"@ GeneSrc $ deletions family adult-onset , tremor-dominant parkinsonism : expanding phenotype . gene autosomal recessive parkinsonism , @ GeneSrc $ ( @ GeneSrc $ ) , recently identified chromosome 6q shown mutated Japanese European families , mostly early-onset parkinsonism . present large pedigree South Tyrol ( region northern Italy ) adult-onset , clinically typical tremor-dominant parkinsonism apparently autosomal dominant inheritance . Haplotype analysis excluded linkage chromosome 2p , 4p , 4q regions harbor genes associated autosomal dominant parkinsonism , implicated @ GeneSrc $ locus chromosome 6q . Compound heterozygous deletions @ GeneSrc $ gene ( one large one truncating ) identified 4 affected male siblings . patients clinically indistinguishable patients @ DiseaseTgt $ . None displayed clinical hallmarks described patients previously reported @ GeneSrc $ mutations , including diurnal fluctuations , benefit sleep , foot dystonia , hyperreflexia , early susceptibility levodopa-induced dyskinesias . Two affected female individuals carried one ( truncating ) two deletions heterozygous state apparently normal allele . conclude phenotypic spectrum associated mutations @ GeneSrc $ gene broader previously reported , suggesting gene may important etiology frequent late-onset typical @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.911324821120024)\n",
      "- Text: \"@ GeneSrc $ selectively alters intrinsic threshold mitochondrial cytochrome c release . Autosomal-recessive mutations @ GeneSrc $ gene second common cause familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Parkin deficiency leads premature demise catecholaminergic neurons ventral midbrain familial @ DiseaseTgt $ . Thus , better understanding @ GeneSrc $ function may elucidate molecular aspects selective vulnerability idiopathic @ DiseaseTgt $ . Numerous lines evidence suggest mitochondrial function @ GeneSrc $ protective effect ectopic @ GeneSrc $ expression . Since mitochondria play critical role cell survival/cell death regulated cytochrome c release control apoptosis , sought direct evidence @ GeneSrc $ function pathway . Mitochondria isolated cells expressing either excess levels human @ GeneSrc $ shRNA directed endogenous @ GeneSrc $ treated peptides corresponding active Bcl-2 homology 3 ( BH3 ) domains pro-apoptotic proteins threshold cytochrome c release analyzed . Data obtained rodent human neuroblastoma cell lines showed expression levels @ GeneSrc $ inversely correlated cytochrome c release . @ GeneSrc $ found associated isolated mitochondria , binding per se sufficient inhibit cytochrome c release . addition , pathogenic @ GeneSrc $ mutants failed influence cytochrome c release . Furthermore , PINK1 expression effect cytochrome c release , suggesting divergent function autosomal recessive @ DiseaseTgt $ gene . summary , data demonstrate specific autonomous effect @ GeneSrc $ mitochondrial mechanisms governing cytochrome c release apoptosis , may relevant selective vulnerability certain neuronal populations @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9412136458536036)\n",
      "- Text: \"PINK1 mutations parkinsonism . BACKGROUND : PINK1 loss-of-function causes recessive , early-onset parkinsonism . Tunisia high rate consanguineous marriage PINK1 carrier frequency disease prevalence yet assessed . OBJECTIVES : frequency PINK1 mutations familial parkinsonism , community-based patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( non-familial @ DiseaseTgt $ ) , control subjects determined . Demographic clinical characteristics individuals PINK1 homozygous heterozygous variants , without PINK1 mutations , compared . METHODS : total 92 kindreds ( 208 affected 340 unaffected subjects ) , 240 nonfamilial @ DiseaseTgt $ , 368 control participants recruited Institut National de Neurologie , Tunis . Clinical examinations included Hoehn & Yahr , UPDRS , Epworth scales . PINK1 sequencing dosage analysis performed familial index patients , variants identified screened subjects . @ GeneSrc $ LRRK2 genes also examined . RESULTS : Four PINK1 homozygous mutations , three novel ( Q129X , Q129fsX157 , G440E , one previously reported ; Q456X ) , segregate parkinsonism 46 individuals 14 92 families ( 15 % ) . Six 240 patients nonfamilial @ DiseaseTgt $ found either homozygous Q456X Q129X ( 2.5 % ) substitutions . patients familial disease , PINK1 homozygotes younger disease onset ( 36 + /- 12 years ) noncarriers ( 57 + /- 15 years ) often akinetic-rigid presentation examination slow progression . CONCLUSIONS : Segregation PINK1 mutations parkinsonism within families , frequency estimates within population controls , suggested four PINK1 mutations pathogenic . Several PINK1 sequence variants potentially benign evidence PINK1 heterozygosity increases susceptibility @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0698762012990625)\n",
      "- Text: \"Clinicogenetic study PINK1 mutations autosomal recessive early-onset parkinsonism . authors performed PINK1 mutation analysis 51 families autosomal recessive Parkinson disease ( ARPD ) . found two novel PINK1 mutations : one homozygous deletion ( 13516 - 18118del ) homozygous missense mutation ( C388R ) . Clinically , patients deletion dementia . Thus , early-onset @ DiseaseTgt $ dementia may considered PINK1-linked parkinsonism . Furthermore , patients PINK1 mutations form 8.9 % @ GeneSrc $ DJ-1-negative ARPD families .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0024380587607718)\n",
      "- Text: \"@ GeneSrc $ gene involved late-onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1212193940154461)\n",
      "- Text: \"Landscape @ GeneSrc $ ubiquitylome response mitochondrial depolarization . PARKIN ubiquitin ligase ( also known @ GeneSrc $ ) regulatory kinase PINK1 ( also known PARK6 ) , often mutated familial early-onset @ DiseaseTgt $ , central roles mitochondrial homeostasis mitophagy . Whereas @ GeneSrc $ recruited mitochondrial outer membrane ( MOM ) upon depolarization via PINK1 action ubiquitylate porin , mitofusin Miro proteins MOM , full repertoire @ GeneSrc $ substrates -- @ GeneSrc $ ubiquitylome -- remains poorly defined . use quantitative diGly capture proteomics ( diGly ) elucidate ubiquitylation site specificity topology @ GeneSrc $ target modification response mitochondrial depolarization . Hundreds dynamically regulated ubiquitylation sites dozens proteins identified , strong enrichment MOM proteins , indicating @ GeneSrc $ dramatically alters ubiquitylation status mitochondrial proteome . Using complementary interaction proteomics , found depolarization-dependent @ GeneSrc $ association numerous MOM targets , autophagy receptors , proteasome . Mutation @ GeneSrc $ active site residue C431 , found mutated @ DiseaseTgt $ patients , largely disrupts associations . Structural topological analysis revealed extensive conservation @ GeneSrc $ ubiquitylation sites cytoplasmic domains vertebrate Drosophila melanogaster MOM proteins . studies provide resource understanding @ GeneSrc $ pathway re-sculpts proteome support mitochondrial homeostasis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.677665046337758)\n",
      "- Text: \"@ GeneSrc $ ubiquitinates alpha-synuclein-interacting protein , synphilin-1 : implications Lewy-body formation @ DiseaseTgt $ . @ DiseaseTgt $ common neurodegenerative disorder characterized loss dopaminergic neurons presence intracytoplasmic-ubiquitinated inclusions ( Lewy bodies ) . Mutations alpha-synuclein ( A53 , A30P ) @ GeneSrc $ cause familial Parkinson disease . proteins found Lewy bodies . absence Lewy bodies patients @ GeneSrc $ mutations suggests @ GeneSrc $ might required formation Lewy bodies . show @ GeneSrc $ interacts ubiquitinates alpha-synuclein-interacting protein , synphilin-1 . Co-expression alpha-synuclein , synphilin-1 @ GeneSrc $ result formation Lewy-body-like ubiquitin-positive cytosolic inclusions . show familial-linked mutations @ GeneSrc $ disrupt ubiquitination synphilin-1 formation ubiquitin-positive inclusions . results provide molecular basis ubiquitination Lewy-body-associated proteins link @ GeneSrc $ alpha-synuclein common pathogenic mechanism interaction synphilin-1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0711485897967196)\n",
      "- Text: \"@ GeneSrc $ mutation analysis clinic patients early-onset @ DiseaseTgt $ . @ GeneSrc $ Mutations common identified cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . suggested patients young-onset @ DiseaseTgt $ screened @ GeneSrc $ mutations part clinical work-up . aim study assess @ GeneSrc $ mutation frequency clinical setting , correlate genotype phenotype , evaluate current justification clinical @ GeneSrc $ testing . Patients selected movement disorder clinic based diagnosis @ DiseaseTgt $ onset age < /=40 years . @ GeneSrc $ genotyped sequence dosage analysis 12 exons . Key relatives controls screened identified mutations . Mutations found 7/39 patients . Two patients compound heterozygous ; five heterozygous . Mutations included deletions exons 2 , 3 , 8 , duplications exons 2 - 4 , 9 , P437L substitution . Seventy-eight percent mutations deletions/multiplications . novel substitution ( R402W ) found one patient one control . None point mutations found patients detected 96 controls . @ GeneSrc $ phenotypes consistent idiopathic @ DiseaseTgt $ . conclusion , @ GeneSrc $ mutations common clinic setting : 10 % @ DiseaseTgt $ patients early-onset 18 % @ GeneSrc $ mutations . However , @ GeneSrc $ recessive , 5 % early-onset cases compound mutations could attributed locus . Mutation frequency 0.12 ( 95 % CI 0.04 - 0.19 ) . @ GeneSrc $ cases present typical idiopathic @ DiseaseTgt $ , distinguishable molecular testing . Seventy percent @ GeneSrc $ cases heterozygous . unclear whether heterozygous mutations pathogenic . @ GeneSrc $ diagnosis counseling require better understanding mode inheritance , penetrance , carrier frequencies .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6911457725997807)\n",
      "- Text: \"Alterations common fragile site gene @ GeneSrc $ ovarian cancers . cloning characterization common fragile site ( CFS ) FRA6E ( 6q26 ) identified @ GeneSrc $ , gene involved pathogenesis many cases juvenile , early-onset , rarely , late-onset @ DiseaseTgt $ , third large gene localized within large CFS . Initial analyses @ GeneSrc $ indicated addition playing role @ DiseaseTgt $ , might also involved development and/or progression ovarian cancer . analyses also indicated striking similarities among large CFS-locus genes : fragile histidine triad gene ( FHIT ; 3p14.2 ) , WW domain-containing oxidoreductase gene ( WWOX ; 16q23 ) , @ GeneSrc $ ( 6q26 ) . Analyses FHIT WWOX variety different cancer types identified presence alternative transcripts whole exon deletions . Interestingly , various whole exon duplications deletions identified @ GeneSrc $ juvenile early-onset @ DiseaseTgt $ patients . Therefore , performed mutational/exon rearrangement analysis @ GeneSrc $ ovarian cancer cell lines primary tumors . Four ( 66.7 % ) cell lines four ( 18.2 % ) primary tumors identified heterozygous duplication deletion @ GeneSrc $ exon . Additionally , three 23 ( 13.0 % ) nonovarian tumor-derived cell lines also identified duplication deletion one @ GeneSrc $ exons . Analysis @ GeneSrc $ protein expression antibodies revealed ovarian cancer cell lines primary tumors diminished absent @ GeneSrc $ expression . functional analyses yet performed @ GeneSrc $ , data suggest like FHIT WWOX , @ GeneSrc $ may represent tumor suppressor gene .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0514323044034166)\n",
      "- Text: \"Somatic mutations @ DiseaseTgt $ gene @ GeneSrc $ glioblastoma human malignancies . Mutation gene @ GeneSrc $ , encodes E3 ubiquitin ligase , common cause early-onset @ DiseaseTgt $ . search multisite tumor suppressors , identified @ GeneSrc $ frequently targeted gene chromosome 6q25.2-q27 cancer . describe inactivating somatic mutations frequent intragenic deletions @ GeneSrc $ human malignancies . @ GeneSrc $ mutations cancer occur domains , sometimes residues , germline mutations causing familial @ DiseaseTgt $ . Cancer-specific mutations abrogate growth-suppressive effects @ GeneSrc $ protein . @ GeneSrc $ mutations cancer decrease @ GeneSrc $ 's E3 ligase activity , compromising ability ubiquitinate cyclin E resulting mitotic instability . data strongly point @ GeneSrc $ tumor suppressor 6q25.2-q27 . Thus , @ GeneSrc $ , gene causes neuronal dysfunction mutated germline , may instead contribute oncogenesis altered non-neuronal somatic cells .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9522034489158118)\n",
      "- Text: \"Mutations @ GeneSrc $ gene cause autosomal recessive juvenile parkinsonism . @ DiseaseTgt $ common neurodegenerative disease complex clinical features . Autosomal recessive juvenile parkinsonism ( AR-JP ) maps long arm chromosome 6 ( 6q25.2-q27 ) linked strongly markers D6S305 D6S253 ; former deleted one Japanese AR-JP patient . positional cloning within microdeletion , isolated complementary DNA done 2,960 base pairs 1,395-base-pair open reading frame , encoding protein 465 amino acids moderate similarity ubiquitin amino terminus RING-finger motif carboxy terminus . gene spans 500 kilobases 12 exons , five ( exons 3 - 7 ) deleted patient . Four AR-JP patients three unrelated families deletion affecting exon 4 alone . 4.5-kilobase transcript expressed many human tissues abundant brain , including substantia nigra , shorter brain tissue one groups exon-4-deleted patients . Mutations newly identified gene appear responsible pathogenesis AR-JP , therefore named protein product ' @ GeneSrc $ ' .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7915050636435521)\n",
      "- Text: \"Combined kinase inhibition modulates @ GeneSrc $ inactivation . Mutations @ GeneSrc $ gene cause autosomal-recessive , juvenile-onset parkinsonism , parkin dysfunction may also play role pathogenesis sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Although precise function remains largely unknown , @ GeneSrc $ seems play neuroprotective role . Several studies indicate changes @ GeneSrc $ solubility induced post-translational modifications , S-nitrosylation dopamine modification , comprise one mechanism @ GeneSrc $ inactivation associated disease . Protein phosphorylation events recently linked molecular mechanism ( ) underlying @ DiseaseTgt $ , role post-translational modification @ GeneSrc $ function remained unclear . report compound phosphorylation @ GeneSrc $ casein kinase cyclin-dependent kinase 5 ( cdk5 ) decreases @ GeneSrc $ solubility , leading aggregation inactivation . Combined kinase inhibition partially reverses aggregative properties several pathogenic point mutants cultured cells . Enhanced @ GeneSrc $ phosphorylation detected distinct brain areas individuals sporadic @ DiseaseTgt $ correlates increases levels p25 , activator cdk5 . findings indicate casein kinase cdk5 may represent novel combinatorial therapeutic targets treating @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4148424925041653)\n",
      "- Text: \"@ GeneSrc $ mutations early-onset parkinsonism Taiwanese cohort . BACKGROUND : Loss function @ GeneSrc $ gene ( PRKN ) predominant genetic cause juvenile early-onset parkinsonism Japan , Europe , United States . OBJECTIVES : evaluate frequency PRKN mutations Taiwanese ( ethnic Chinese ) patients early-onset parkinsonism explore genotype-phenotype correlations . DESIGN : Clinical assessment included medical , neurologic , psychiatric evaluation . Genomic DNA sequencing quantitative polymerase chain reaction performed identify PRKN mutations . Gene expression examined patient lymphoblastoid cell lines , PRKN mutations identified . PATIENTS : Forty-one Taiwanese patients early-onset parkinsonism ( aged < 50 years onset ) . RESULTS : Four 41 probands PRKN mutations . One proband compound heterozygous mutations , PRKN exon 2 deletion exon 7 G284R substitution . phenotype resembled typical @ DiseaseTgt $ . Three patients mutation carriers . One proband PRKN exon 2 exon 3 deletions allele . However , patient 's phenotype classic `` @ GeneSrc $ `` autosomal recessive juvenile parkinsonism , characterized symmetrical foot dystonia onset , gait disturbance , diurnal change , slow progression . 2 remaining carriers novel heterozygous exon 11 R396 G substitutions . Patients PRKN mutations younger onset without mutations , required lower dose levodopa despite longer disease duration . CONCLUSIONS : Mutations PRKN rare cause early-onset parkinsonism Taiwanese individuals . overall mutation frequency , adjusted age onset , comparable reported white cohorts ; however , point mutations identified seem population specific .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.398769779071131)\n",
      "- Text: \"Phosphorylation @ GeneSrc $ Parkinson disease-linked kinase PINK1 activates @ GeneSrc $ E3 ligase function NF-kappaB signaling . Mutations PTEN-induced putative kinase 1 ( PINK1 ) @ GeneSrc $ cause autosomal recessive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , mutations trigger neurodegeneration poorly understood exact functional relationship PINK1 @ GeneSrc $ remains unclear . , report PINK1 regulates E3 ubiquitin-protein ligase function @ GeneSrc $ direct phosphorylation . find phosphorylation @ GeneSrc $ PINK1 activates @ GeneSrc $ E3 ligase function catalyzing K63-linked polyubiquitination enhances @ GeneSrc $ ubiquitin signaling IkappaB kinase/nuclear factor kappaB ( NF-kappaB ) pathway . Furthermore , ability PINK1 promote @ GeneSrc $ phosphorylation activate @ GeneSrc $ ubiquitin signaling impaired @ DiseaseTgt $ pathogenic PINK1 mutations . findings support direct link PINK1-mediated phosphorylation @ GeneSrc $ ubiquitin signaling implicate deregulation @ GeneSrc $ neuroprotective signaling pathway pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8204290195273801)\n",
      "- Text: \"Nitrosative stress linked sporadic @ DiseaseTgt $ : S-nitrosylation @ GeneSrc $ regulates E3 ubiquitin ligase activity . Many hereditary sporadic neurodegenerative disorders characterized accumulation aberrant proteins . sporadic @ DiseaseTgt $ , representing prevalent movement disorder , oxidative nitrosative stress believed contribute disease pathogenesis , exact molecular basis protein aggregation remains unclear . case autosomal recessive-juvenile Parkinsonism , mutation E3 ubiquitin ligase protein @ GeneSrc $ linked death dopaminergic neurons . show vitro vivo nitrosative stress leads S-nitrosylation wild-type @ GeneSrc $ , initially , dramatic increase followed decrease E3 ligase-ubiquitin-proteasome degradative pathway . initial increase @ GeneSrc $ 's E3 ubiquitin ligase activity leads autoubiquitination @ GeneSrc $ subsequent inhibition activity , would impair ubiquitination clearance @ GeneSrc $ substrates . findings may thus provide molecular link free radical toxicity protein accumulation sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2081231415641301)\n",
      "- Text: \"apparently sporadic case @ GeneSrc $ gene mutation Korean woman . OBJECTIVE : report clinical features results iodine 123 - 2beta-carbomethoxy-3beta- ( 4-iodophenyl ) -tropane ( CIT ) single photon emission computed tomography molecular genetic analysis Korean woman juvenile Parkinson disease deletion exon 4 @ GeneSrc $ gene . DESIGN : Case report molecular genetic analysis . PATIENT RESULTS : patient bradykinesia , postural imbalance , postural tremor since age 12 years . developed wearing early disease course . [ ( 123 ) ] -2beta-carbomethoxy-3beta- ( 4-iodophenyl ) -tropane single photon emission computed tomography showed severe reduction specific striatal CIT binding , comparable @ DiseaseTgt $ . polymerase chain reaction products @ GeneSrc $ gene showed homozygous exon 4 deletion . CONCLUSION : sporadic juvenile Parkinson disease case , severe nigrostriatal dopaminergic damage homozygous exon 4 deletion @ GeneSrc $ gene demonstrated .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.7477461867937954e-05)\n",
      "- Text: \"p38 subunit aminoacyl-tRNA synthetase complex @ GeneSrc $ substrate : linking protein biosynthesis neurodegeneration . @ DiseaseTgt $ ( @ DiseaseTgt $ ) severe neurological disorder , characterized progressive degeneration dopaminergic nigrostriatal pathway presence Lewy bodies ( LBs ) . discovery genes responsible familial forms disease provided insights pathogenesis . Mutations @ GeneSrc $ gene , encodes E3 ubiquitin-protein ligase involved ubiquitylation proteasomal degradation specific protein substrates , found nearly 50 % patients autosomal-recessive early-onset parkinsonism . abnormal accumulation substrates due loss @ GeneSrc $ function may cause neurodegeneration @ GeneSrc $ parkinsonism . , demonstrate @ GeneSrc $ interacts , ubiquitylates promotes degradation p38 , key structural component mammalian aminoacyl-tRNA synthetase complex . found ubiquitylation p38 abrogated truncated variants @ GeneSrc $ lacking essential functional domains , pathogenic Lys161Asn point mutant . Expression p38 COS7 cells resulted formation aggresome-like inclusions @ GeneSrc $ systematically sequestered . human dopaminergic neuroblastoma-derived SH-SY5Y cell line , @ GeneSrc $ promoted formation ubiquitylated p38-positive inclusions . Moreover , overexpression p38 SH-SY5Y cells caused significant cell death @ GeneSrc $ provided protection . Analysis p38 expression human adult midbrain revealed strong immunoreactivity normal dopaminergic neurons labeling LBs idiopathic @ DiseaseTgt $ . suggests p38 plays role pathogenesis @ DiseaseTgt $ , opening way detailed examination potential non-canonical role neurodegeneration .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.999994014944942)\n",
      "- Text: \"Mitochondrial function morphology impaired @ GeneSrc $ fibroblasts . OBJECTIVE : marked mitochondrial abnormalities @ GeneSrc $ Drosophila model systems . aim study determine mitochondrial function morphology @ GeneSrc $ patients . also investigated whether pharmacological rescue impaired mitochondrial function may possible @ GeneSrc $ human tissue . METHODS : used three sets techniques , namely , biochemical measurements mitochondrial function , quantitative morphology , live cell imaging functional connectivity assess mitochondrial respiratory chain , outer shape connectivity mitochondria , functional inner connectivity fibroblasts patients homozygous compound heterozygous @ GeneSrc $ mutations . RESULTS : @ GeneSrc $ cells lower mitochondrial complex activity complex I-linked adenosine triphosphate production , correlated greater degree mitochondrial branching , suggesting functional morphological effects @ GeneSrc $ related . Knockdown @ GeneSrc $ control fibroblasts confirmed parkin deficiency sufficient explain mitochondrial effects . contrast , 50 % knockdown @ GeneSrc $ , mimicking haploinsufficiency human patient tissue , result impaired mitochondrial function morphology . Fluorescence recovery photobleaching assays demonstrated lower level functional connectivity mitochondrial matrix , worsened rotenone exposure . Treatment experimental neuroprotective compounds resulted rescue mitochondrial membrane potential . INTERPRETATION : study demonstrates marked abnormalities mitochondrial function morphology @ GeneSrc $ patients provides proof-of-principle data potential usefulness new model system tool screen disease-modifying compounds genetically homogenous @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0166788560023084)\n",
      "- Text: \"BAG5 inhibits @ GeneSrc $ enhances dopaminergic neuron degeneration . Loss-of-function mutations @ GeneSrc $ gene , encodes E3 ubiquitin ligase , major cause early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Decreases @ GeneSrc $ activity may also contribute neurodegeneration sporadic forms @ DiseaseTgt $ . , show bcl-2-associated athanogene 5 ( BAG5 ) , BAG family member , directly interacts @ GeneSrc $ chaperone Hsp70 . Within complex , BAG5 inhibits @ GeneSrc $ E3 ubiquitin ligase activity Hsp70-mediated refolding misfolded proteins . BAG5 enhances @ GeneSrc $ sequestration within protein aggregates mitigates @ GeneSrc $ preservation proteasome function . Finally , BAG5 enhances dopamine neuron death vivo model @ DiseaseTgt $ , whereas mutant inhibits BAG5 activity attenuates dopaminergic neurodegeneration . contrasts antideath functions ascribed BAG family members suggests potential role BAG5 promoting neurodegeneration sporadic @ DiseaseTgt $ functional interactions @ GeneSrc $ Hsp70 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9739047146209472)\n",
      "- Text: \"Loss @ DiseaseTgt $ gene DJ-1 perturbs mitochondrial dynamics . Growing evidence highlights role mitochondrial dysfunction oxidative stress underlying contributors @ DiseaseTgt $ ( @ DiseaseTgt $ ) pathogenesis . DJ-1 ( PARK7 ) recently identified recessive familial @ DiseaseTgt $ gene . loss leads increased susceptibility neurons oxidative stress death . However , mechanism action fully understood . Presently , report DJ-1 deficiency cell lines , cultured neurons , mouse brain lymphoblast cells derived DJ-1 patients display aberrant mitochondrial morphology . also show DJ-1-dependent mitochondrial defects contribute oxidative stress-induced sensitivity cell death since reversal fragmented mitochondrial phenotype abrogates neuronal cell death . Reactive oxygen species ( ROS ) appear play critical role observed defects , ROS scavengers rescue phenotype mitochondria isolated DJ-1 deficient animals produce ROS compared control . Importantly , aberrant mitochondrial phenotype rescued expression Pink1 @ GeneSrc $ , two @ DiseaseTgt $ genes involved regulating mitochondrial dynamics quality control . Finally , show DJ-1 deficiency leads altered autophagy murine human cells . findings define mechanism DJ-1-dependent mitochondrial defects contribute increased sensitivity oxidative stress-induced cell death previously reported .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007107344789802)\n",
      "- Text: \"Stress-induced alterations @ GeneSrc $ solubility promote @ GeneSrc $ aggregation compromise @ GeneSrc $ 's protective function . Mutations @ GeneSrc $ currently recognized common cause familial Parkinsonism . Emerging evidence also suggests @ GeneSrc $ expression variability may confer risk development common , sporadic form @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Supporting , recently demonstrated @ GeneSrc $ solubility human brain becomes altered age . @ GeneSrc $ apparently functions broad-spectrum neuroprotectant , resulting decrease availability soluble @ GeneSrc $ age may underlie progressive susceptibility brain stress . Interestingly , also observed many @ DiseaseTgt $ mutations @ GeneSrc $ alter solubility manner highly reminiscent observations aged brain . converging effects @ GeneSrc $ brought aging @ DiseaseTgt $ mutations probably trivial suggest environmental modulators affecting @ GeneSrc $ solubility would increase individual 's risk developing @ DiseaseTgt $ . Using cell culture vivo models , demonstrate several @ DiseaseTgt $ stressors , including neurotoxins ( MPP+ , rotenone , 6-hydroxydopamine ) , paraquat , , dopamine iron , induce alterations @ GeneSrc $ solubility result intracellular aggregation . Furthermore , depletion soluble , functional forms @ GeneSrc $ associated reduced proteasomal activities increased cell death . results suggest exogenously introduced stress well endogenous dopamine could affect native structure @ GeneSrc $ , promote misfolding , concomitantly compromise protective functions . Mechanistically , results provide link influence environmental intrinsic factors genetic susceptibilities @ DiseaseTgt $ pathogenesis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1579018932764389)\n",
      "- Text: \"LRRK2 impairs @ GeneSrc $ mitophagy via kinase activity : pathologic insights @ DiseaseTgt $ . Mutations LRRK2 , encoding leucine-rich repeat kinase 2 ( LRRK2 ) , leading cause @ DiseaseTgt $ ( @ DiseaseTgt $ ) . frequent mutations , G2019S substitution , increases kinase activity , remains unclear causes @ DiseaseTgt $ . Recent studies suggest LRRK2 modulates mitochondrial homeostasis . Mitochondrial dysfunction plays key role pathogenesis @ DiseaseTgt $ forms linked @ GeneSrc $ PINK1 , encoding cytosolic E3 ubiquitin-protein ligase @ GeneSrc $ mitochondrial kinase PINK1 , jointly regulate mitophagy . explored role LRRK2 kinase activity @ GeneSrc $ mitophagy . LRRK2 increased mitochondrial aggregation attenuated mitochondrial clearance cells coexpressing @ GeneSrc $ exposed protonophore carbonylcyanide m-chlorophenylhydrazone . Forster resonance energy transfer imaging microscopy showed LRRK2 impaired interactions @ GeneSrc $ Drp1 mitochondrial targets early mitophagy . inhibition LRRK2 kinase activity ' kinase-dead ' LRRK2 mutation pharmacological inhibitor ( LRRK2-IN-1 ) restored interactions . monitoring mitophagy human primary fibroblasts novel dual-fluorescence mtRosella reporter new hypothermic shock paradigm revealed similar defects @ DiseaseTgt $ patients G2019S LRRK2 substitution @ GeneSrc $ mutations relative healthy subjects . defect restored LRRK2-IN-1 treatment LRRK2 patients . results suggest @ DiseaseTgt $ forms due LRRK2 @ GeneSrc $ mutations involve pathogenic mechanisms converging @ GeneSrc $ mitophagy .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9926955990269084)\n",
      "- Text: \"@ GeneSrc $ disease : common founders divergent phenotypes . OBJECTIVE : compare contrast clinical genetic findings six probands parkinsonism @ GeneSrc $ exon 3 438- 477-bp deletion ( Ex3Delta40 ) search evidence common founder . METHOD : Clinical review , @ GeneSrc $ gene sequencing , dosage studies , high-resolution genotype/haplotype analysis performed . RESULTS : subjects two signs consistent diagnosis possible probable @ DiseaseTgt $ age onset younger 45 years ( mean + /- SD 29.3 + /- 10.2 years , range 16 42 years ) . Affected individuals either homozygotes , compound heterozygotes , Ex3Delta40 carriers one normal @ GeneSrc $ allele . Haplotype analysis revealed Ex3Delta40 Ex7 924 C -- > ( R275W ) mutations originated common founders , former probably Irish descent . Although three cases Ex7 924 C -- > ( R275W ) Ex3Delta40 mutations , clinical presentation mode inheritance variable . CONCLUSION : @ GeneSrc $ mutations common @ GeneSrc $ haplotypes provide testable hypotheses @ GeneSrc $ function genetically defined parkinsonism .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0187358712727309)\n",
      "- Text: \"Analysis PARK genes Korean cohort early-onset @ DiseaseTgt $ . Mutations five PARK genes ( SNCA , @ GeneSrc $ , DJ-1 , PINK1 , LRRK2 ) well-established genetic causes @ DiseaseTgt $ ( @ DiseaseTgt $ ) . Recently , G2385R substitution LRRK2 determined susceptibility allele Asian @ DiseaseTgt $ . objective study determine frequency mutations PARK genes Korean early-onset @ DiseaseTgt $ ( EOPD ) cohort . authors sequenced 35 exons SNCA , @ GeneSrc $ , DJ-1 , PINK1 , LRRK2 72 unrelated EOPD ( age-at-onset < or=50 ) recruited ten movement disorders clinics South Korea . Gene dosage change aforementioned genes studied using multiple ligation-dependent probe amplification . found four patients @ GeneSrc $ mutations , homozygous deletion exon 4 , compound heterozygous deletion exon 2 exon 4 , heterozygous deletion exon 4 , heterozygous nonsense mutation ( Q40X ) . Four patients PINK1 mutations ; compound heterozygous mutation ( N367S K520RfsX522 ) three heterozygous mutations ( G32R , R279H , F385L ) . missense mutation SNCA ( A53 ) found familial @ DiseaseTgt $ autosomal dominant inheritance . Nine patients ( 12.5 % ) heterozygous G2385R polymorphism LRRK2 , whereas none G2019S mutation . However , mutations detected DJ-1 UCHL1 series . identified genetic variants @ GeneSrc $ , PINK1 , LRRK2 , SNCA cause genetic risk factors @ DiseaseTgt $ 25 % Korean EOPD , mutation @ GeneSrc $ common genetic cause .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0458106705430028)\n",
      "- Text: \"@ GeneSrc $ protects mitochondrial genome integrity supports mitochondrial DNA repair . Mutations @ GeneSrc $ gene common cause recessive familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) . @ GeneSrc $ initially characterized ubiquitin E3 ligase , pathological relevance activity remains uncertain . Recently , impressive amount evidence accumulated @ GeneSrc $ involved maintenance mitochondrial function biogenesis . used human neuroblastoma cell line model study influence endogenous @ GeneSrc $ mitochondrial genomic integrity . Using unbiased chromatin immunoprecipitation approach , found @ GeneSrc $ associated physically mitochondrial DNA ( mtDNA ) proliferating well differentiated SH-SY5Y cells . vivo , association @ GeneSrc $ mtDNA could confirmed brain tissue mouse human origin . Replication transcription mtDNA enhanced SH-SY5Y cells over-expressing @ GeneSrc $ gene . ability @ GeneSrc $ support mtDNA-metabolism impaired pathogenic @ GeneSrc $ point mutations . importantly , show @ GeneSrc $ protects mtDNA oxidative damage stimulates mtDNA repair . Moreover , higher susceptibility mtDNA reactive oxygen species reduced mtDNA repair capacity observed @ GeneSrc $ fibroblasts @ DiseaseTgt $ patient . data indicate novel role @ GeneSrc $ directly supporting mitochondrial function protecting mitochondrial genomic integrity oxidative stress .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3499354383748046)\n",
      "- Text: \"T313 PINK1 mutation extended highly consanguineous Saudi family early-onset @ DiseaseTgt $ . BACKGROUND : date , 5 well-confirmed genes @ DiseaseTgt $ ( @ DiseaseTgt $ ) identified , including 3 autosomal recessive genes : PTEN-induced putative kinase 1 ( PINK1 ) , @ GeneSrc $ , DJ-1 . Almost nothing known genetics @ DiseaseTgt $ Saudi Arabia ; however , consanguineous families , infrequent population , could important evaluation known @ DiseaseTgt $ genes search new @ DiseaseTgt $ factors future . OBJECTIVE : investigate known recessive @ DiseaseTgt $ genes 5 consanguineous Saudi families @ DiseaseTgt $ . DESIGN : entire open frame well untranslated region 5 ' 3 ' intron-exon boundaries PINK1 , @ GeneSrc $ , DJ-1 genes sequenced 5 probands Saudi families . RESULTS : Four 5 probands tested negative PINK1 , @ GeneSrc $ , DJ-1 mutations . However , large Saudi family @ DiseaseTgt $ least 3 consanguineous marriages first cousins , detected threonine methionine substitution codon 313 ( T313 ) PINK1 mutation affected kinase domain . Manifestations disease family included early onset ( age , 28 - 38 years ) , tremulous movement , slow progression , diurnal fluctuations , bradykinesia , good response levodopa therapy , mild dyskinesias . neurologist blinded genetic status clinically evaluated 15 family members , older 20 years , diagnosed @ DiseaseTgt $ individuals later found homozygous T313 mutation . None 13 heterozygotes demonstrated sign @ DiseaseTgt $ . CONCLUSION : homozygous T313 mutation responsible @ DiseaseTgt $ large Saudi family . However , heterozygous T313 mutation act @ DiseaseTgt $ susceptibility factor , contrast several reports mutations affecting 1 PINK1 allele discovered sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.7050519244979601)\n",
      "- Text: \"Heterozygosity mutation @ GeneSrc $ gene leads later onset @ DiseaseTgt $ . BACKGROUND : vast majority @ GeneSrc $ mutations previously identified found individuals juvenile early onset @ DiseaseTgt $ . Previous screening later onset @ DiseaseTgt $ cohorts identified substantial numbers @ GeneSrc $ mutations . METHODS : Families least two siblings @ DiseaseTgt $ ascertained identify genes contributing @ DiseaseTgt $ susceptibility . Screening @ GeneSrc $ gene , quantitative PCR exon sequencing , performed families either early onset @ DiseaseTgt $ ( age onset < = 50 years ) positive lod score marker intron 7 @ GeneSrc $ gene . RESULTS : total 25 different mutations @ GeneSrc $ gene identified 103 individuals 47 families . Mutations found @ GeneSrc $ alleles 41 individuals , whereas single mutation one two @ GeneSrc $ alleles observed 62 individuals . Thirty-five subjects ( 34 % ) @ GeneSrc $ mutation age onset 60 years 30 35 ( 86 % ) detectable mutation one @ GeneSrc $ allele . significant clinical differences observed among individuals two , one , mutated copies @ GeneSrc $ gene . CONCLUSION : Mutations @ GeneSrc $ gene occur among individuals @ DiseaseTgt $ older age onset ( > = 60 years ) positive family history disease . addition , clinical findings @ GeneSrc $ individuals remarkably similar without mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9504237515779548)\n",
      "- Text: \"Impaired transcriptional upregulation @ GeneSrc $ promoter variant oxidative stress proteasomal inhibition : clinical association . provided data show transcriptional activity wildtype -258 @ GeneSrc $ promoter region significantly higher -258 G variant human cell lines . transcriptional activity wildtype -258 significantly increased oxidative stress hydrogen peroxide , observed -258 G variant . transcriptional upregulation significantly higher wildtype -258 compared -258 G variant 0.1 , 0.2 0.4 mM hydrogen peroxide . Similar results obtained cells treated proteasome inhibitor , MG132.Furthermore , case control study involving 753 subjects , demonstrated @ GeneSrc $ promoter -258 G variant associated increased risk sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) elderly ethnic Chinese population . clinical laboratory data provide corroborative evidence older individuals -258 G variant may higher risk developing @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0245326504827291)\n",
      "- Text: \"mitochondrial deubiquitinase USP30 opposes @ GeneSrc $ mitophagy . Cells maintain healthy mitochondria degrading damaged mitochondria mitophagy ; defective mitophagy linked @ DiseaseTgt $ . report USP30 , deubiquitinase localized mitochondria , antagonizes mitophagy driven ubiquitin ligase @ GeneSrc $ ( also known @ GeneSrc $ ) protein kinase PINK1 , encoded two genes associated @ DiseaseTgt $ . @ GeneSrc $ ubiquitinates tags damaged mitochondria clearance . Overexpression USP30 removes ubiquitin attached @ GeneSrc $ onto damaged mitochondria blocks @ GeneSrc $ 's ability drive mitophagy , whereas reducing USP30 activity enhances mitochondrial degradation neurons . Global ubiquitination site profiling identified multiple mitochondrial substrates oppositely regulated @ GeneSrc $ USP30 . Knockdown USP30 rescues defective mitophagy caused pathogenic mutations @ GeneSrc $ improves mitochondrial integrity @ GeneSrc $ PINK1-deficient flies . Knockdown USP30 dopaminergic neurons protects flies paraquat toxicity vivo , ameliorating defects dopamine levels , motor function organismal survival . Thus USP30 inhibition potentially beneficial @ DiseaseTgt $ promoting mitochondrial clearance quality control .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1436593378003344)\n",
      "- Text: \"Leucine-rich repeat kinase 2 ( LRRK2 ) interacts @ GeneSrc $ , mutant LRRK2 induces neuronal degeneration . @ DiseaseTgt $ ( @ DiseaseTgt $ ) disorder movement , cognition , emotion , characterized pathologically neuronal degeneration Lewy bodies , cytoplasmic inclusion bodies containing deposits aggregated proteins . @ DiseaseTgt $ cases appear sporadic , genetic forms disease , caused mutations alpha-synuclein , @ GeneSrc $ , genes , helped elucidate pathogenesis . Mutations leucine-rich repeat kinase 2 ( LRRK2 ) cause autosomal-dominant Parkinsonism clinical features @ DiseaseTgt $ pleomorphic pathology including deposits aggregated protein . study expression interactions LRRK2 , synthesized cDNAs generated expression constructs coding human WT mutant LRRK2 proteins . Expression full-length LRRK2 cells culture suggests protein predominately cytoplasmic , endogenous protein subcellular fractionation . Using coimmunoprecipitation , find LRRK2 , expressed cells culture , interacts @ GeneSrc $ alpha-synuclein , DJ-1 , tau . small proportion cells overexpressing LRRK2 contain protein aggregates , proportion greatly increased coexpression @ GeneSrc $ . addition , @ GeneSrc $ increases ubiquitination aggregated protein . Also , mutant LRRK2 causes neuronal degeneration SH-SY5Y cells primary neurons . cell model may useful studies @ DiseaseTgt $ cellular pathogenesis therapeutics . findings suggest gain-of-function mechanism pathogenesis LRRK2-linked @ DiseaseTgt $ suggest LRRK2 may involved pathogenic pathway @ DiseaseTgt $ proteins @ GeneSrc $ , may help illuminate familial sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9059779974441468)\n",
      "- Text: \"@ GeneSrc $ component SCF-like ubiquitin ligase complex protects postmitotic neurons kainate excitotoxicity . Mutations @ GeneSrc $ , encodes RING domain protein associated ubiquitin ligase activity , lead @ DiseaseTgt $ characterized midbrain dopamine neuron loss . show @ GeneSrc $ functions multiprotein ubiquitin ligase complex includes F-box/WD repeat protein hSel-10 Cullin-1 . HSel-10 serves target @ GeneSrc $ ubiquitin ligase activity cyclin E , hSel-10-interacting protein previously implicated regulation neuronal apoptosis . Consistent notion cyclin E substrate @ GeneSrc $ ubiquitin ligase complex , @ GeneSrc $ deficiency potentiates accumulation cyclin E cultured postmitotic neurons exposed glutamatergic excitotoxin kainate promotes apoptosis . Furthermore , @ GeneSrc $ overexpression attenuates accumulation cyclin E toxin-treated primary neurons , including midbrain dopamine neurons , protects apoptosis .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0384620825083146)\n",
      "- Text: \"@ GeneSrc $ interacts proteasome subunit alpha4 . Mutations @ GeneSrc $ gene encoding E3 ligase responsible autosomal recessive @ DiseaseTgt $ . Putative @ GeneSrc $ substrates interacting partners identified , molecular mechanism underlying @ GeneSrc $ neurodegeneration still unclear . identified 20S proteasomal subunit alpha4 ( synonyms : PSMA7 , XAPC7 , subunit alpha type 7 ) new interacting partner @ GeneSrc $ . C-terminal IBR-RING domain @ GeneSrc $ C-terminal part alpha4 essential interaction . Biochemical studies revealed alpha4 substrate @ GeneSrc $ ubiquitylation . Putative functions interaction might therefore substrate presentation proteasome regulation proteasomal activity . Full-length @ GeneSrc $ @ GeneSrc $ lacking N-terminal ubiquitin-like domain slightly increased proteasomal activity HEK 293 cells , line latter hypothesis .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4130429697046048)\n",
      "- Text: \"Accumulation @ GeneSrc $ substrate , FAF1 , plays key role dopaminergic neurodegeneration . study reports physical functional interplay Fas-associated factor 1 ( FAF1 ) , death-promoting protein , @ GeneSrc $ , key susceptibility protein @ DiseaseTgt $ ( @ DiseaseTgt $ ) . found @ GeneSrc $ acts E3 ubiquitin ligase ubiquitinate FAF1 vitro cellular level , identifying FAF1 direct substrate @ GeneSrc $ . loss @ GeneSrc $ function due @ DiseaseTgt $ mutations found disrupt ubiquitination degradation FAF1 , resulting elevated FAF1 expression SH-SY5Y cells . Moreover , FAF1-mediated cell death abolished wild-type @ GeneSrc $ , @ DiseaseTgt $ @ GeneSrc $ mutants , implying @ GeneSrc $ antagonizes death potential FAF1 . led us investigate whether FAF1 participates pathogenesis @ DiseaseTgt $ . address , used gene trap mutagenesis approach generate mutant mice diminished levels FAF1 ( Faf1 ( gt/gt ) ) . Using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP ) -treated mouse model @ DiseaseTgt $ , found FAF1 accumulated substantia nigra pars compacta ( SNc ) MPTP-treated @ DiseaseTgt $ mice , MPTP-induced dopaminergic cell loss SNc significantly attenuated Faf1 ( gt/gt ) mice versus Faf1 ( +/+ ) mice . MPTP-induced reduction locomotor activity also lessened Faf1 ( gt/gt ) mice versus Faf1 ( +/+ ) mice . Furthermore , found FAF1 deficiency blocked @ DiseaseTgt $ biochemical events , including caspase activation , ROS generation , JNK activation cell death . Taken together , results suggest new role FAF1 : positive modulator @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8881484525605238)\n",
      "- Text: \"Dopamine covalently modifies functionally inactivates @ GeneSrc $ . Inherited mutations @ GeneSrc $ , gene encoding @ GeneSrc $ , cause selective degeneration catecholaminergic neurons substantia nigra locus coeruleus brainstem , resulting early-onset parkinsonism . role @ GeneSrc $ common , sporadic forms @ DiseaseTgt $ remains unclear . report neurotransmitter dopamine covalently modifies @ GeneSrc $ living dopaminergic cells , process increases @ GeneSrc $ insolubility inactivates E3 ubiquitin ligase function . brains individuals sporadic @ DiseaseTgt $ , observed decreases @ GeneSrc $ solubility consistent functional inactivation . Using new biochemical method , detected catechol-modified @ GeneSrc $ substantia nigra regions normal human brain . findings show vulnerability @ GeneSrc $ modification dopamine , principal transmitter lost @ DiseaseTgt $ , suggesting mechanism progressive loss @ GeneSrc $ function dopaminergic neurons aging sporadic @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6796931301061518)\n",
      "- Text: \"@ GeneSrc $ mitophagy dependent VDAC1 p62/SQSTM1 . @ DiseaseTgt $ common neurodegenerative movement disorder . Mutations PINK1 @ GeneSrc $ frequent causes recessive @ DiseaseTgt $ . However , molecular contribution pathogenesis remains unclear . , reveal important mechanistic steps @ GeneSrc $ pathway linking mitochondrial damage , ubiquitylation autophagy non-neuronal neuronal cells . PINK1 kinase activity mitochondrial localization sequence prerequisites induce translocation E3 ligase @ GeneSrc $ depolarized mitochondria . Subsequently , @ GeneSrc $ mediates formation two distinct poly-ubiquitin chains , linked Lys 63 Lys 27 . addition , autophagic adaptor p62/SQSTM1 recruited mitochondrial clusters essential clearance mitochondria . Strikingly , identified VDAC1 ( voltage-dependent anion channel 1 ) target @ GeneSrc $ Lys 27 poly-ubiquitylation mitophagy . Moreover , pathogenic @ GeneSrc $ mutations interfere distinct steps mitochondrial translocation , ubiquitylation and/or final clearance mitophagy . Thus , data provide functional links PINK1 , @ GeneSrc $ selective autophagy mitochondria , implicated pathogenesis @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5417589315983927)\n",
      "- Text: \"RING finger 1 mutations @ GeneSrc $ produce altered localization protein . @ GeneSrc $ gene ( PRKN ) encodes E3 protein-ubiquitin ligase loss function associated autosomal-recessive juvenile ( < 20 years ) early-onset Parkinsonism ( < 45 years ) . Although detailed pathological reports scarce , brains patients homozygous exonic deletions demonstrate neuronal loss substantia nigra , albeit without Lewy body pathology characteristic @ DiseaseTgt $ . However , rare descriptions florid pathology , including Lewy bodies tau positive astrocytes individuals compound heterozygous mutations . present study examined whether PRKN point mutations , leading amino acid substitutions , may alter cellular distribution protein produced . Wild-type @ GeneSrc $ homogeneously distributed throughout cytoplasm small amount protein nucleus transfection human embryonic kidney cells . Mutant isoforms A82E , G328E C431F amino acid substitutions also normally distributed . However , two mutant isoforms , R256C R275W , within RING finger 1 @ GeneSrc $ protein ( 238 - 293 amino acids ) , produced unusual distribution protein , large cytoplasmic nuclear inclusions . replicated observation primary cultured neurons demonstrate , accumulation/co-localization cytoskeletal protein vimentin , inclusion bodies aggresomes , cellular response misfolded protein .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0073013076001274)\n",
      "- Text: \"LRRK2 gene @ DiseaseTgt $ : mutation analysis case control association study . BACKGROUND : addition four well-confirmed genes linked early-onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) ( SNCA , @ GeneSrc $ , DJ-1 , PINK1 ) , mutations leucine-rich repeat kinase 2 gene ( LRRK2 ) recently identified families autosomal dominant late-onset @ DiseaseTgt $ . OBJECTIVE : perform mutation analysis LRRK2 probands families showing dominant inheritance @ DiseaseTgt $ conduct case control association study test hypothesis common coding variations might associated increased susceptibility @ DiseaseTgt $ . METHODS : 51 LRRK2 coding exons sequenced 23 probands mutation frequencies evaluated 180 neurologically normal control subjects . association study authors genotyped four coding LRRK2 polymorphisms 250 normal control subjects 121 patients @ DiseaseTgt $ ( predominantly white patients Canadian origin ) , 84 % age onset 50 years 42 % positive family history . RESULTS : authors identified three probands heterozygous LRRK2 mutations : two known G2019S substitution one proband novel I1371V substitution . Mutation analysis large family demonstrated complete segregation G2019S @ DiseaseTgt $ . However , association @ DiseaseTgt $ four polymorphisms allelic genotypic levels ( p > 0.17 ) . Furthermore , authors detect modifying effect genotype APOE genotypes upon age onset @ DiseaseTgt $ group ( p > 0.20 ) . CONCLUSIONS : results support prior suggestion LRRK2 mutations cause @ DiseaseTgt $ . disease families reported presents phenotype indistinguishable typical @ DiseaseTgt $ . three families demonstrate variable age onset explained APOE genotypes . common coding variations LRRK2 gene neither constitute strong @ DiseaseTgt $ risk factors modify age onset ; however , possibility modest risk effect remains assessed large datasets .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9697996029770736)\n",
      "- Text: \"Effect endogenous mutant wild-type PINK1 @ GeneSrc $ fibroblasts @ DiseaseTgt $ patients . Mutations PTEN-induced putative kinase 1 ( PINK1 ) , mitochondrial serine-threonine kinase , @ GeneSrc $ , E3 ubiquitin ligase , associated autosomal-recessive forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) . involved maintenance mitochondrial integrity protection multiple stressors . Recently , @ GeneSrc $ demonstrated recruited impaired mitochondria PINK1-dependent manner , triggers mitophagy . Using primary human dermal fibroblasts originating @ DiseaseTgt $ patients various PINK1 mutations , showed endogenous level ( ) PINK1 regulates stress-induced decrease endogenous @ GeneSrc $ ; ( ii ) mitochondrially localized PINK1 mediates stress-induced mitochondrial translocation @ GeneSrc $ ; ( iii ) endogenous PINK1 stabilized depolarized mitochondria ; ( iv ) mitochondrial accumulation full-length PINK1 sufficient necessary stress-induced loss @ GeneSrc $ signal mitochondrial translocation . Furthermore , showed different stressors , depolarizing non-depolarizing , led effect detectable @ GeneSrc $ levels mitochondrial targeting . Although effect @ GeneSrc $ independent mitochondrial membrane potential , demonstrate differential effect depolarizing versus non-depolarizing stressors endogenous levels PINK1 . study shows necessity introduce environmental factor , i.e . stress , visualize differences interaction PINK1 @ GeneSrc $ mutants versus controls . Establishing human fibroblasts suitable model studying interaction , extend data animal cellular models provide experimental evidence generally held notion @ DiseaseTgt $ condition combined genetic environmental etiology .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9855385416012196)\n",
      "- Text: \"@ DiseaseTgt $ large pedigree 77 @ GeneSrc $ mutation carriers . report clinical , genetic , neuropathological findings seven generation-spanning pedigree 196 individuals , 25 levodopa-responsive parkinsonism . Genetic analyses indicated @ GeneSrc $ mutations 77 subjects . Among 25 patients , 5 carried compound heterozygous mutations met criteria definite @ DiseaseTgt $ ( @ DiseaseTgt $ ) according UK @ DiseaseTgt $ Society Brain Bank guidelines ; 8 subjects carried heterozygous @ GeneSrc $ mutation . mutational status five deceased patients unknown , seven @ DiseaseTgt $ patients @ GeneSrc $ mutation . Survival analyses showed significant difference age-at-onset distribution patients compound heterozygous mutations groups heterozygous carriers subjects without detectable @ GeneSrc $ mutations . Autopsy 73-year-old patient , carried two mutant @ GeneSrc $ alleles ( delExon7 + del1072 ) , showed @ DiseaseTgt $ cell loss , reactive gliosis , alpha-synuclein-positive Lewy bodies substantia nigra locus ceruleus . Surviving neurons reactive antibodies N terminus @ GeneSrc $ In-Between-RING ( `` IBR `` ) domain , deleted mutations . large @ GeneSrc $ pedigree represents unique opportunity prospectively study role heterozygous @ GeneSrc $ mutations @ DiseaseTgt $ risk factor , identify additional contributors expression late-onset @ DiseaseTgt $ heterozygous carriers , reexamine role @ GeneSrc $ inclusion formation .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9364218267787962)\n",
      "- Text: \"Functional alteration PARL contributes mitochondrial dysregulation @ DiseaseTgt $ . Molecular genetics linked mitochondrial dysfunction pathogenesis @ DiseaseTgt $ discovery rare , inherited mutations gene products associate mitochondria . Mutations PTEN-induced kinase-1 ( PINK1 ) , encodes mitochondrial kinase , @ GeneSrc $ , encoding E3 ubiquitin ligase , frequent causes recessive @ DiseaseTgt $ . Recent functional studies revealed PINK1 recruits @ GeneSrc $ mitochondria initiate mitophagy , important autophagic quality control mechanism rids cell damaged mitochondria . PINK1 post-translationally processed cleaved form whose levels tightly regulated , although significance processing unknown . demonstrate mitochondrial protease presenilin-associated rhomboid-like ( PARL ) affect proteolytic processing PINK1 normal PINK1 localization stability requires PARL 's catalytic activity . PARL deficiency impairs @ GeneSrc $ recruitment mitochondria , suggesting PINK1 's processing localization important determining interaction @ GeneSrc $ . sequenced PARL gene @ DiseaseTgt $ patients discovered novel missense mutation functional domain PARL 's N-terminus . PARL mutant sufficient rescue @ GeneSrc $ recruitment , suggesting impaired mitophagy may underlying mechanism disease pathogenesis patients PARL mutations .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8183827725421976)\n",
      "- Text: \"Down-regulation @ GeneSrc $ protein transient focal cerebral ischemia : link stroke degenerative disease ? Ubiquitylated protein aggregates characteristic features neurodegenerative disorders also found acute pathological states brain stroke . Many proteins connected neurodegenerative diseases play role ubiquitin-proteasomal pathway . Mutation one proteins , E3 ubiquitin ligase @ GeneSrc $ , cause autosomal recessive juvenile @ DiseaseTgt $ . show transient focal cerebral ischemia 1-h duration induces marked depletion @ GeneSrc $ protein levels , 60 % , 36 % , 33 % , 25 % controls 1 , 3 , 6 , 24 h reperfusion , ischemia cause lower protein levels E2 ubiquitin-conjugating enzymes Ubc6 , Ubc7 , Ubc9 . 3 h reperfusion , @ GeneSrc $ protein levels already reduced < 40 % control , ATP levels almost completely recovered ischemia observe DNA fragmentation , suggesting @ GeneSrc $ depletion preceded development neuronal cell death . Up-regulation expression @ GeneSrc $ shown protect cells injury induced endoplasmic reticulum ( ER ) dysfunction , form cellular stress also triggered transient cerebral ischemia . However , contrast observations neuroblastoma cells , saw up-regulation @ GeneSrc $ expression primary neuronal cell cultures induction ER dysfunction . data thus suggest ischemia-induced depletion @ GeneSrc $ protein may contribute pathological process resulting cell injury increasing sensitivity neurons ER dysfunction aggregation ubiquitylated proteins reperfusion period .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4763314336788603)\n",
      "- Text: \"wide variety mutations @ GeneSrc $ gene responsible autosomal recessive parkinsonism Europe . French @ DiseaseTgt $ Genetics Study Group European Consortium Genetic Susceptibility @ DiseaseTgt $ . Autosomal recessive juvenile parkinsonism ( AR-JP , @ GeneSrc $ ; OMIM 602544 ) , one monogenic forms @ DiseaseTgt $ ( @ DiseaseTgt $ ) , initially described Japan . characterized early onset ( age 40 ) , marked response levodopa treatment levodopa-induced dyskinesias . gene responsible AR-JP recently identified designated @ GeneSrc $ . analysed 12 coding exons @ GeneSrc $ gene 35 mostly European families early onset autosomal recessive parkinsonism . one family , homozygous deletion exon 4 could demonstrated . direct sequencing exons index patients remaining 34 families , eight previously undescribed point mutations ( homozygous heterozygous ) detected eight families included 20 patients . mutations segregated disease families detected 110 - 166 control chromosomes . Four mutations caused truncation @ GeneSrc $ protein . Three frameshifts ( 202 - 203delAG , 255delA 321 - 322insGT ) one nonsense mutation ( Trp453Stop ) . four missense mutations ( Lys161Asn , Arg256Cys , Arg275Trp Thr415Asn ) probably affect amino acids important function @ GeneSrc $ protein , since result phenotype truncating mutations homozygous exon deletions . Mean age onset 38 + /- 12 years , onset age 58 observed . Mutations @ GeneSrc $ gene therefore invariably associated early onset parkinsonism . many patients , phenotype indistinguishable idiopathic @ DiseaseTgt $ . study shown wide variety different mutations @ GeneSrc $ gene common cause autosomal recessive parkinsonism Europe different types point mutations seem frequently responsible disease phenotype deletions .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8994342185747465)\n",
      "- Text: \"Ubiquitylation synphilin-1 alpha-synuclein SIAH presence cellular inclusions Lewy bodies imply role @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) neurodegenerative disease characterized Lewy body formation death dopaminergic neurons . Mutations alpha-synuclein @ GeneSrc $ cause familial forms @ DiseaseTgt $ . Synphilin-1 shown interact alpha-synuclein promote formation cytosolic inclusions . report synphilin-1 interacts E3 ubiquitin-ligases SIAH-1 SIAH-2 . SIAH proteins ubiquitylate synphilin-1 vitro vivo , promoting degradation ubiquitin-proteasome system . Inability proteasome degrade synphilin-1/SIAH complex leads robust formation ubiquitylated cytosolic inclusions . Ubiquitylation required inclusion formation , catalytically inactive mutant SIAH-1 , still binds synphilin-1 , fails promote inclusions . Like synphilin-1 , alpha-synuclein associates SIAH intact cells , interaction SIAH-2 much stronger SIAH-1 . vitro experiments show SIAH-2 monoubiquitylates alpha-synuclein . evidence SIAH proteins may play role inclusion formation comes demonstration SIAH immunoreactivity Lewy bodies @ DiseaseTgt $ patients .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4006571979071981)\n",
      "- Text: \"Engineered alpha-synuclein prevents wild type familial @ GeneSrc $ variant fibril formation . Alpha-synuclein major component several pathological lesions diagnostic specific neurodegenerative disease @ DiseaseTgt $ . study focuses non-amyloid beta component Alzheimer 's disease amyloid , key region aggregation fibril formation alpha-synuclein . Several mutations introduced attempt repress beta-strand formation hydrophobic interaction-based aggregation . Although reducing hydrophobicity drastically decreased fibril formation , Val70Thr Val70Pro mutations resulted unstable secondary structure thereby increasing non-structural aggregation , instead fibril formation . Therefore , stabilization non-structural natively unfolded status important prevent alpha-synuclein fibril formation . Mixing Val70Thr/Val71Thr double mutant , inherently low potential , fibril forming alpha-synucleins , WT Ala53Thr , greatly reduced fibril formation aggregation . double mutant great potential therapeutic approaches .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.6978412960523516e-07)\n",
      "- Text: \"@ GeneSrc $ functions E2-dependent ubiquitin- protein ligase promotes degradation synaptic vesicle-associated protein , CDCrel-1 . @ DiseaseTgt $ common neurodegenerative disorder familial-linked genes provided novel insights pathogenesis disorder . Mutations @ GeneSrc $ , ring-finger-containing protein unknown function , implicated pathogenesis autosomal recessive familial Parkinson 's disease . , show @ GeneSrc $ binds E2 ubiquitin-conjugating human enzyme 8 ( UbcH8 ) C-terminal ring-finger . @ GeneSrc $ ubiquitin-protein ligase activity presence UbcH8 . @ GeneSrc $ also ubiquitinates promotes degradation . also identify show synaptic vesicle-associated protein , CDCrel-1 , interacts @ GeneSrc $ ring-finger domains . Furthermore , @ GeneSrc $ ubiquitinates promotes degradation CDCrel-1 . Familial-linked mutations disrupt ubiquitin-protein ligase function @ GeneSrc $ impair @ GeneSrc $ CDCrel-1 degradation . results suggest @ GeneSrc $ functions E3 ubiquitin-protein ligase ring domains may control protein levels via ubiquitination . loss Parkin 's ubiquitin-protein ligase function familial-linked mutations suggests may cause familial autosomal recessive @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.783385281321257)\n",
      "- Text: \"S-nitrosylation @ GeneSrc $ regulates ubiquitination compromises @ GeneSrc $ 's protective function . @ GeneSrc $ E3 ubiquitin ligase involved ubiquitination proteins important survival dopamine neurons @ DiseaseTgt $ ( @ DiseaseTgt $ ) . show @ GeneSrc $ S-nitrosylated vitro , well vivo mouse model @ DiseaseTgt $ brains patients @ DiseaseTgt $ diffuse Lewy body disease . Moreover , S-nitrosylation inhibits @ GeneSrc $ 's ubiquitin E3 ligase activity protective function . inhibition @ GeneSrc $ 's ubiquitin E3 ligase activity S-nitrosylation could contribute degenerative process disorders impairing ubiquitination @ GeneSrc $ substrates .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2491645560438367)\n",
      "- Text: \"Pink1 Parkinson mutations , Cdc37/Hsp90 chaperones @ GeneSrc $ influence maturation subcellular distribution Pink1 . Mutations ubiquitously expressed gene PTEN-induced kinase 1 ( Pink1 ) cause autosomal recessive @ DiseaseTgt $ . Pink1 encodes putative serine/threonine kinase N-terminal mitochondrial targeting sequence . mechanism leads selective degeneration dopaminergic neurons via Pink1 mutations unknown . full-length pre-protein ( 66 kDa ) N-terminally truncated mature form ( 55 kDa ) described human brain . , report endogenous 66 kDa 55 kDa Pink1 forms cultured cells exclusive mitochondria also occur cytosolic microsome-rich fractions . Pink1 66 kDa predominant isoform cultured cells . Using unbiased analyses immunoisolated Pink1 complexes mass spectrometry , co-immunoprecipitation Hsp90 inhibitor studies , identify Pink1 novel Cdc37/Hsp90 client kinase . chaperone system influences subcellular distribution 66/55 kDa protein ratio Pink1 . @ DiseaseTgt $ Pink1 mutations decrease whereas @ GeneSrc $ expression increases Pink1 66/55 kDa protein ratio , biochemically linking Pink1 @ GeneSrc $ highlighting potential relevance ratio @ DiseaseTgt $ pathogenesis . Finally , document influence @ GeneSrc $ Pink1 subcellular distribution , providing evidence common pathogenic pathway recessive @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3104762629747998)\n",
      "- Text: \"Novel homozygous p. E64D mutation DJ1 early onset @ DiseaseTgt $ ( PARK7 ) . Mutations @ GeneSrc $ gene identified common cause autosomal recessive inherited Parkinson disease ( @ DiseaseTgt $ ) associated early disease manifestation . However , based linkage data , mutations genes contribute genetic heterogeneity early-onset @ DiseaseTgt $ ( EOPD ) . Recently , two mutations DJ1 gene described second cause autosomal recessive EOPD ( PARK7 ) . Analyzing PARK7/DJ1 gene 104 EOPD patients , identified third mutation , c.192G > C ( p. E64D ) , associated EOPD patient Turkish ancestry characterized functional significance amino acid substitution . patient , substantial reduction dopamine uptake transporter ( DAT ) binding found striatum using [ ( 18 ) F ] FP-CIT PET , indicating serious loss presynaptic dopaminergic afferents . sister , homozygous E64D , clinically unaffected showed reduced dopamine uptake compared clinically unaffected brother , heterozygous E64D . demonstrate crystallography E64D mutation alter structure DJ1 protein , however observe tendency towards decreased levels mutant protein overexpressed HEK293 COS7 cells . Using immunocytochemistry contrast homogenous nuclear cytoplasmic staining HEK293 cells overexpressing wild-type DJ1 , 5 % cells expressing E64D 80 % cells expressing recently described L166P mutation displayed predominant nuclear localization mutant DJ1 protein .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.5951394842399771)\n",
      "- Text: \"@ GeneSrc $ mutations susceptibility alleles late-onset @ DiseaseTgt $ . @ GeneSrc $ , E2-dependent ubiquitin protein ligase , carries pathogenic mutations patients autosomal recessive juvenile parkinsonism , role late-onset form @ DiseaseTgt $ ( @ DiseaseTgt $ ) firmly established . Previously , detected linkage idiopathic @ DiseaseTgt $ region chromosome 6 containing @ GeneSrc $ gene ( D6S305 , logarithm odds score , 5.47 ) families least one subject age onset ( AAO ) younger 40 years . Mutation analysis @ GeneSrc $ gene 174 multiplex families genomic screen 133 additional @ DiseaseTgt $ families identified mutations 18 % early-onset 2 % late-onset families ( 5 % total families screened ) . AAO patients @ GeneSrc $ mutations ranged 12 71 years . Excluding exon 7 mutations , mean AAO patients @ GeneSrc $ mutations 31.5 years . However , mutations exon 7 , first RING finger ( Cys253Trp , Arg256Cys , Arg275Trp , Asp280Asn ) observed primarily heterozygous @ DiseaseTgt $ patients much later AAO ( mean AAO , 49.2 years ) found controls study several previous reports ( 920 chromosomes ) . findings suggest mutations @ GeneSrc $ contribute common form @ DiseaseTgt $ heterozygous mutations , especially lying exon 7 , act susceptibility alleles late-onset form @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9781148508782636)\n",
      "- Text: \"@ GeneSrc $ ubiquitinates promotes degradation RanBP2 . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative disorder , involves deterioration dopaminergic neurons pars compacta substantia nigra . etiology @ DiseaseTgt $ still unknown , recent identification mutations familial cases @ DiseaseTgt $ advanced understanding molecular mechanisms neurological disease . Mutations @ GeneSrc $ gene , encodes ubiquitin-protein ligase ( E3 ) , implicated autosomal recessive juvenile Parkinsonism , early onset common familial form @ DiseaseTgt $ . reported @ GeneSrc $ selectively binds RanBP2 , localized cytoplasmic filament nuclear pore complex belongs small ubiquitin-related modifier E3 ligase family . also demonstrated RanBP2 becomes target @ GeneSrc $ E3 ubiquitin-ligase processed via @ GeneSrc $ ubiquitination subsequent proteasomal degradation . Furthermore , @ GeneSrc $ controls intracellular levels sumoylated HDAC4 , result ubiquitination degradation RanBP2 . findings suggested intracellular levels RanBP2 functional activity may modulated @ GeneSrc $ ubiquitination proteasomal pathways .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.3351291785625852)\n",
      "- Text: \"High-content genome-wide RNAi screens identify regulators @ GeneSrc $ upstream mitophagy . increasing body evidence points mitochondrial dysfunction contributor molecular pathogenesis neurodegenerative diseases @ DiseaseTgt $ . Recent studies @ DiseaseTgt $ associated genes PINK1 ( ref . 2 ) @ GeneSrc $ ( @ GeneSrc $ , ref . 3 ) indicate may act quality control pathway preventing accumulation dysfunctional mitochondria . elucidate regulators impact @ GeneSrc $ translocation damaged mitochondria genome-wide small interfering RNA ( siRNA ) screens coupled high-content microscopy . Screening yielded gene candidates involved diverse cellular processes subsequently validated low-throughput assays . led characterization TOMM7 essential stabilizing PINK1 outer mitochondrial membrane following mitochondrial damage . also discovered HSPA1L ( HSP70 family member ) BAG4 mutually opposing roles regulation @ GeneSrc $ translocation . screens revealed SIAH3 , found localize mitochondria , inhibits PINK1 accumulation mitochondrial insult , reducing @ GeneSrc $ translocation . Overall , screens provide rich resource understand mitochondrial quality control .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0938451960567242)\n",
      "- Text: \"ubiquitin ligase @ GeneSrc $ mediates resistance intracellular pathogens . Ubiquitin-mediated targeting intracellular bacteria autophagy pathway key innate defence mechanism invading microbes , including important human pathogen Mycobacterium tuberculosis . However , ubiquitin ligases responsible catalysing ubiquitin chains surround intracellular bacteria poorly understood . @ GeneSrc $ protein ubiquitin ligase well-established role mitophagy , mutations @ GeneSrc $ gene ( @ GeneSrc $ ) lead increased susceptibility @ DiseaseTgt $ . Surprisingly , genetic polymorphisms @ GeneSrc $ regulatory region also associated increased susceptibility intracellular bacterial pathogens humans , including Mycobacterium leprae Salmonella enterica serovar Typhi , function @ GeneSrc $ immunity remained unexplored . show @ GeneSrc $ role ubiquitin-mediated autophagy M. tuberculosis . @ GeneSrc $ mice flies sensitive various intracellular bacterial infections , indicating @ GeneSrc $ conserved role metazoan innate defence . Moreover , work reveals unexpected functional link mitophagy infectious disease .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4190557205964881)\n",
      "- Text: \"Differential expression splice variant wild-type @ GeneSrc $ sporadic @ DiseaseTgt $ . BACKGROUND : Altered splicing @ GeneSrc $ cellular stress could lead changes gene expression altered protein activity . causative role @ GeneSrc $ sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) unknown . OBJECTIVES : described @ GeneSrc $ splice variant ( SV ) substantia nigra leukocytes sporadic @ DiseaseTgt $ patients . Using case control methodology , investigated exon 4 SV ( E4SV ) wild-type @ GeneSrc $ expression leukocytes sporadic @ DiseaseTgt $ patients healthy individuals . METHODS/RESULTS : identified @ GeneSrc $ E4SV substantia nigra leukocytes sporadic @ DiseaseTgt $ patients controls reverse transcriptase-polymerase chain reaction ( PCR ) . exon 4 ( 122 bp ) deletion resulted reading frame shift junction exons 3 - 5 stop codon ( tga ) 17 bp downstream exon 3 . translated truncated protein associated total loss two-RING finger functional domain . Utilizing TaqMan real-time PCR probes located across junction exons 3 - 4 3 - 5 , demonstrated over-expression E4SV/wild-type @ GeneSrc $ ratio leukocytes sporadic @ DiseaseTgt $ patients compared age- , gender- , race-matched controls ( p < 0.0005 ) . multivariate regression analysis demonstrated ratio E4SV/wild-type @ GeneSrc $ expression increased age @ DiseaseTgt $ patients , observed controls ( p < 0.0005 ) . CONCLUSION : relative expression E4SV/wild type @ GeneSrc $ increased sporadic @ DiseaseTgt $ compared healthy controls . Based observations , functional studies determine pathophysiologic role E4SV sporadic @ DiseaseTgt $ patients importance .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1797788841603097)\n",
      "- Text: \"Case-control study @ GeneSrc $ gene early-onset @ DiseaseTgt $ . BACKGROUND : Mutations @ GeneSrc $ estimated account much 50 % familial @ DiseaseTgt $ ( @ DiseaseTgt $ ) 18 % sporadic @ DiseaseTgt $ . Single heterozygous mutations @ GeneSrc $ familial sporadic cases may also increase susceptibility @ DiseaseTgt $ . knowledge , previous studies restricted @ DiseaseTgt $ cases ; first study systematically screen @ GeneSrc $ coding regions exon deletions duplications controls . OBJECTIVE : determine frequency spectrum @ GeneSrc $ variants early-onset @ DiseaseTgt $ cases ( aged < = 50 years ) controls participating familial aggregation study . PATIENTS METHODS : sequenced @ GeneSrc $ gene 101 cases 105 controls . cases controls also screened exon deletions duplications semiquantitative multiplex polymerase chain reaction . RESULTS : Thirteen ( 12.9 % [ 95 % confidence interval , 7 % -21 % ] ) 101 cases previously described @ GeneSrc $ mutation : 1 homozygous , 11 heterozygous , 1 compound heterozygote . mutations Arg42Pro ( exon 2 ) Arg275Trp ( exon 7 ) recurrent . previously reported synonymous substitution Leu261Leu ( c.884A > G ) identified 4 ( 3.9 % ) 101 cases 2 ( 2 % ) 105 controls ( P = .44 ) . Excluding synonymous substitution Leu261Leu ( heterozygotes ) , 10 ( 9.9 % [ 95 % confidence interval , 4.6 % -17.5 % ] ) carried mutations . CONCLUSIONS : frequency mutations among cases selected based family history @ DiseaseTgt $ similar previously reported sporadic @ DiseaseTgt $ . similar frequency Leu261Leu cases controls suggests normal variant rather disease-associated mutation . confirmed heterozygous @ GeneSrc $ mutations may increase susceptibility early-onset @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9394189829789316)\n",
      "- Text: \"Interaction @ GeneSrc $ mutant glucocerebrosidase variants : possible link @ DiseaseTgt $ Gaucher disease . Gaucher disease ( GD ) , sphingolipidosis characterized impaired activity lysosomal enzyme glucocerebrosidase ( GCase ) , results mutations GCase-encoding gene , GBA . shown mutant GCase variants present variable degrees endoplasmic reticulum ( ER ) retention undergo ER-associated degradation ( ERAD ) proteasome . Furthermore , degree ERAD mutant GCase variants correlates one factors determine GD severity . association GD @ DiseaseTgt $ ( @ DiseaseTgt $ ) demonstrated concurrence @ DiseaseTgt $ GD patients identification GCase mutations probands sporadic @ DiseaseTgt $ . One genes involved @ DiseaseTgt $ @ GeneSrc $ , encoding E3 ubiquitin ligase @ GeneSrc $ . @ GeneSrc $ functions ERAD misfolded ER proteins , upregulated unfolded protein response . Loss @ GeneSrc $ function leads accumulation substrates , deleterious dopaminergic neurons @ DiseaseTgt $ . , therefore , tested possibility association GD @ DiseaseTgt $ reflects fact @ GeneSrc $ acts E3 ligase mutant GCase variants . results showed mutant GCase variants associate @ GeneSrc $ . Normal @ GeneSrc $ , RING finger mutants , affects stability mutant GCase variants . @ GeneSrc $ also promotes accumulation mutant GCase aggresome-like structures involved K48-mediated polyubiquitination GCase mutants , indicating function E3 ligase . suggest involvement @ GeneSrc $ degradation mutant GCase explains concurrence GD @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6848240116501216)\n",
      "- Text: \"Identification novel homozygous mutation Arg459Pro SYNJ1 gene Indian family autosomal recessive juvenile Parkinsonism . BACKGROUND : novel homozygous missense mutation ( c.773 G > , p. Arg258Gln ) Synaptojanin 1 ( SYNJ1 , 21q22.2 ) recently reported two Italian one Iranian consanguineous families autosomal recessive juvenile Parkinsonism ( ARJP ) . Contribution synaptic gene related Parkinsonism phenotypes populations still remains unidentified . METHODS : ARJP family two affected siblings characterized frequent tremor bradykinesia rigidity recruited study . siblings showed intense dyskinesia dystonia administration Syndopa . family analyzed mutations exon dosage variations @ GeneSrc $ , PINK1 DJ1 . , whole exome sequencing performed two affected one unaffected sibling family . RESULTS : identified novel homozygous mutation ( c.1376C > G , p. Arg459Pro ) SYNJ1 segregating family . p. Arg459Pro mutation observed 285 additional @ DiseaseTgt $ ( @ DiseaseTgt $ ) samples ( 32 familial , 81 early onset 172 late onset ) screened PCR-Sanger-sequencing . also absent dbSNP , 1000 Genomes , ExAC , NHLBI-ESP database > 250 ethnically matched exomes available laboratory . arginine residue highly conserved across species predicted damaging several silico tools . previous mutation p. Arg258Gln , p. Arg459Pro also present Sac 1 domain SYNJ1 wherein p. Arg258Gln mutation already described impair phosphatase activity . CONCLUSIONS : report another novel mutation SYNJ1 Indian consanguineous ARJP family . Finding additional mutation gene supports involvement SYNJ1 @ DiseaseTgt $ pathogenesis across different ethnicities .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0083200111530622)\n",
      "- Text: \"@ GeneSrc $ protects toxicity associated mutant alpha-synuclein : proteasome dysfunction selectively affects catecholaminergic neurons . One hypothesis etiology @ DiseaseTgt $ ( @ DiseaseTgt $ ) subsets neurons vulnerable failure proteasome-mediated protein turnover . show overexpression mutant alpha-synuclein increases sensitivity proteasome inhibitors decreasing proteasome function . Overexpression @ GeneSrc $ decreases sensitivity proteasome inhibitors manner dependent @ GeneSrc $ 's ubiquitin-protein E3 ligase activity , antisense knockdown @ GeneSrc $ increases sensitivity proteasome inhibitors . Mutant alpha-synuclein also causes selective toxicity catecholaminergic neurons primary midbrain cultures , effect mimicked application proteasome inhibitors . @ GeneSrc $ capable rescuing toxic effects mutant alpha-synuclein proteasome inhibition cells . Therefore , @ GeneSrc $ alpha-synuclein linked common effects pathway associated selective cell death catecholaminergic neurons .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.2369356039206688)\n",
      "- Text: \"@ GeneSrc $ gene involved late-onset @ DiseaseTgt $ . Mutations @ GeneSrc $ gene reported patients early onset @ DiseaseTgt $ . authors investigated @ GeneSrc $ gene 118 patients onset @ DiseaseTgt $ age 45 years : 95 subjects sporadic patients 23 subjects 18 families probable autosomal recessive inheritance . pathogenetic mutations @ GeneSrc $ gene detected either familial sporadic patients . Moreover , differences found patients 100 age-matched normal controls allele genotype frequencies four exonic @ GeneSrc $ polymorphisms .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9450688248290342)\n",
      "- Text: \"Rare heterozygous @ GeneSrc $ variants French early-onset @ DiseaseTgt $ patients controls . BACKGROUND : Mutations @ GeneSrc $ gene cause autosomal recessive early-onset parkinsonism . effect single heterozygous mutations @ GeneSrc $ still unclear . aim study evaluate frequency exonic @ GeneSrc $ variants case-control study . METHODS : @ GeneSrc $ gene screened point mutations exon rearrangements 172 French patients @ DiseaseTgt $ ( @ DiseaseTgt $ ) 170 controls population . Patients single @ GeneSrc $ variants also screened PINK1 , DJ-1 LRRK2 exon 41 mutations . RESULTS : 10 exonic sequence variations identified , including 3 known polymorphisms 7 rare heterozygous variants , 2 novel . significantly rare heterozygous variants patients ( n = 10 ) early-onset @ DiseaseTgt $ controls ( n = 2 ) . Screening PINK1 , DJ-1 LRRK2 exon 41 10 patients heterozygous @ GeneSrc $ failed identify second causative mutation . CONCLUSION : results suggest single @ GeneSrc $ mutations increase risk early-onset @ DiseaseTgt $ , possibility second @ GeneSrc $ mutation excluded .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.886924129013417)\n",
      "- Text: \"@ GeneSrc $ mediates proteasome-dependent protein degradation rupture outer mitochondrial membrane . Upon mitochondrial depolarization , @ GeneSrc $ , @ DiseaseTgt $ E3 ubiquitin ligase , translocates cytosol mitochondria promotes degradation mitophagy , selective type autophagy . , report addition mitophagy , @ GeneSrc $ mediates proteasome-dependent degradation outer membrane proteins Tom20 , Tom40 , Tom70 , Omp25 depolarized mitochondria . contrast , degradation inner membrane matrix proteins largely depends mitophagy . Furthermore , @ GeneSrc $ induces rupture outer membrane depolarized mitochondria , also depends proteasomal activity . Upon induction mitochondrial depolarization , proteasomes recruited mitochondria perinuclear region . Neither proteasome-dependent degradation outer membrane proteins outer membrane rupture required mitophagy . results suggest @ GeneSrc $ regulates degradation outer inner mitochondrial membrane proteins differently proteasome- mitophagy-dependent pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0035611566825627)\n",
      "- Text: \"Aberrant folding pathogenic @ GeneSrc $ mutants : aggregation versus degradation . Loss-of-function mutations @ GeneSrc $ gene ( @ GeneSrc $ ) responsible majority autosomal recessive Parkinson disease . growing body evidence indicates misfolding aggregation @ GeneSrc $ major mechanism @ GeneSrc $ inactivation , accounting loss-of-function phenotype various pathogenic @ GeneSrc $ mutants . Remarkably , wild-type @ GeneSrc $ also prone misfolding certain cellular conditions , suggesting general role @ GeneSrc $ pathogenesis @ DiseaseTgt $ . show misfolding @ GeneSrc $ lead two phenotypes : formation detergent-insoluble , aggregated @ GeneSrc $ , destabilization @ GeneSrc $ resulting accelerated proteasomal degradation . combining two pathogenic @ GeneSrc $ mutations , could demonstrate destabilization @ GeneSrc $ dominant formation detergent-insoluble @ GeneSrc $ aggregates . Furthermore , comparative analysis HHARI , E3 ubiquitin ligase RBR domain highly homologous @ GeneSrc $ , revealed folding @ GeneSrc $ specifically dependent integrity C-terminal domain , presence putative PDZ-binding motif extreme C terminus .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.9799250165170796)\n",
      "- Text: \"alpha-Synuclein aggregates interfere @ GeneSrc $ solubility distribution : role pathogenesis @ DiseaseTgt $ . @ DiseaseTgt $ ( @ DiseaseTgt $ ) belongs heterogeneous group neurodegenerative disorders movement alterations , cognitive impairment , alpha-synuclein accumulation cortical subcortical regions . Jointly , disorders denominated Lewy body disease . Mutations @ GeneSrc $ gene common cause familial parkinsonism , growing number studies shown stress factors associated sporadic @ DiseaseTgt $ promote @ GeneSrc $ accumulation insoluble fraction . alpha-Synuclein @ GeneSrc $ accumulation mutations genes associated familial @ DiseaseTgt $ . investigate whether alpha-synuclein accumulation might involved pathogenesis disorders interfering @ GeneSrc $ solubility , synuclein-transfected neuronal cells transduced lentiviral vectors expressing @ GeneSrc $ . Challenging neurons proteasome inhibitors amyloid-beta resulted accumulation insoluble @ GeneSrc $ , lesser extent , alpha-tubulin . Similarly neurons brains patients Lewy body disease , co-transduced cells alpha-synuclein @ GeneSrc $ colocalized co-immunoprecipitated . effects resulted decreased @ GeneSrc $ alpha-tubulin ubiquitination , accumulation insoluble @ GeneSrc $ , cytoskeletal alterations reduced neurite outgrowth . Taken together , accumulation alpha-synuclein might contribute pathogenesis @ DiseaseTgt $ Lewy body diseases promoting alterations @ GeneSrc $ tubulin solubility , turn might compromise neural function damaging neuronal cytoskeleton . studies provide new perspective potential nature pathogenic alpha-synuclein @ GeneSrc $ interactions @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8547704257376967)\n",
      "- Text: \"LRRK2 exon 41 mutations sporadic @ DiseaseTgt $ Europeans . BACKGROUND : Mutations leucine-rich repeat kinase 2 gene ( LRRK2 ) , particularly G2019S mutation exon 41 , detected familial sporadic @ DiseaseTgt $ ( @ DiseaseTgt $ ) cases . OBJECTIVES : assess frequency LRRK2 exon 41 mutations series sporadic @ DiseaseTgt $ cases Europe determine clinical features LRRK2 mutation carriers . DESIGN : analyzed European cases sporadic @ DiseaseTgt $ presence LRRK2 exon 41 mutations . mutations screened denaturing high-performance liquid chromatography , abnormal chromatograph traces investigated direct sequencing determine exact nature variants . Early-onset sporadic @ DiseaseTgt $ cases also screened @ GeneSrc $ mutations . haplotypes associated G2019S mutation determined . clinical characteristics patients carrying LRRK2 mutations detailed . SETTING : French Network Study @ DiseaseTgt $ Genetics . Patients Three hundred twenty patients apparently sporadic @ DiseaseTgt $ Europe . MAIN OUTCOME MEASURES : Results genetic analyses . RESULTS : found G2019S mutation 6 patients identified 2 new variants ( Y2006H T2031S ) 1 patient . clinical features similar typical @ DiseaseTgt $ . G2019S mutation carriers shared common haplotype . CONCLUSIONS : G2019S mutation almost frequent sporadic cases ( 1.9 % ) previously reported familial cases ( 2.9 % ) Europe occurs common founder . identified 2 novel variants . Although phenotype LRRK2 mutation carriers closely resembles typical @ DiseaseTgt $ , age onset younger ( 29 years 1 patient ) previously described , 3 patients improved deep brain stimulation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0172360537286095)\n",
      "- Text: \"autosomal recessive juvenile Parkinson disease gene product , @ GeneSrc $ , interacts ubiquitinates synaptotagmin XI . Inactivating mutations gene encoding @ GeneSrc $ responsible forms autosomal recessive juvenile Parkinson disease . @ GeneSrc $ ubiquitin ligase ubiquitinates misfolded proteins targeted proteasome-dependent protein degradation pathway . Using yeast two-hybrid system co-immunoprecipitation methods , identified synaptotagmin XI protein interacts @ GeneSrc $ . @ GeneSrc $ binds C2A C2B domains synaptotagmin XI resulting polyubiquitination synaptotagmin XI . Truncated missense mutated parkins reduce @ GeneSrc $ binding affinity ubiquitination . @ GeneSrc $ ubiquitination also enhances turnover sytXI . sporadic @ DiseaseTgt $ brain sections , sytXI found core Lewy bodies . Since synaptotagmin XI member synaptotagmin family well characterized importance vesicle formation docking , interaction protein suggests role @ GeneSrc $ regulation synaptic vesicle pool vesicle release . Loss @ GeneSrc $ could thus affect multiple proteins controlling vesicle pools , docking release explain deficits dopaminergic function seen patients @ GeneSrc $ mutations .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0357494794122851)\n",
      "- Text: \"Regulation ERBB2 oestrogen @ GeneSrc $ determines response tamoxifen . Crosstalk oestrogen receptor ( ER ) ERBB2/HER-2 pathways long implicated breast cancer aetiology drug response , yet direct connection transcriptional level shown . show oestrogen-ER tamoxifen-ER complexes directly repress ERBB2 transcription means cis-regulatory element within ERBB2 gene human cell lines . implicate @ GeneSrc $ gene product ( @ GeneSrc $ ) , previously unrecognized role , crucial mediator ER repression ERBB2 @ DiseaseTgt $ drug tamoxifen . show @ GeneSrc $ ER co-activator AIB-1/SRC-3 compete binding regulation ERBB2 transcription , outcome determines tamoxifen response breast cancer cells . repression ERBB2 @ GeneSrc $ links two breast cancer subtypes suggests aggressive ERBB2-positive @ DiseaseTgt $ originate ER-positive @ DiseaseTgt $ circumventing repressive mechanism . data provide mechanistic insight molecular basis endocrine resistance breast cancer .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.1237009711518239)\n",
      "- Text: \"Axis inhibition protein 2 ( AXIN2 ) polymorphisms tooth agenesis . Tooth agenesis common congenital disorder affects almost 20 % world 's population . number different genes shown associated cases tooth agenesis including AXIN2 , IRF6 , FGFR1 , MSX1 , @ GeneSrc $ , TGFA . particular interest AXIN2 , linked two families segregating oligodontia @ DiseaseTgt $ . studied two collections families affected tooth agenesis tested association AXIN2 . Significant association tooth agenesis AXIN2 found ( p=0.02 ) cases least one missing incisor . work supports role AXIN2 human tooth agenesis first time suggests AXIN2 involved sporadic forms common incisor agenesis . Future studies identify specific tooth agenesis sub-phenotypes consequence AXIN2 genetic variations . sub-set cases could increased susceptibility @ DiseaseTgt $ types tumours knowledge would significant clinical implications .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0772501240235882)\n",
      "- Text: \"Parkin PINK1 mitigate STING-induced inflammation . Although serum patients @ DiseaseTgt $ contains elevated levels numerous pro-inflammatory cytokines including IL-6 , TNF , IL-1beta , IFNgamma , whether inflammation contributes consequence neuronal loss remains unknown1 . Mutations parkin , E3 ubiquitin ligase , PINK1 , ubiquitin kinase , cause early onset Parkinson 's disease2,3 . PINK1 parkin function within biochemical pathway remove damaged mitochondria cells culture animal models via mitophagy , selective form autophagy4 . vivo role mitophagy , however , unclear , partly mice lack either PINK1 parkin substantial @ DiseaseTgt $ phenotypes5 - 7 . Mitochondrial stress lead release damage-associated molecular patterns ( DAMPs ) activate innate immunity8 - 12 , suggesting mitophagy may mitigate inflammation . report strong inflammatory phenotype @ GeneSrc $ Pink1-/- mice following exhaustive exercise @ GeneSrc $ mice , accumulate mutations mitochondrial DNA ( mtDNA ) 13,14 . Inflammation resulting either exhaustive exercise mtDNA mutation completely rescued concurrent loss STING , central regulator type interferon response cytosolic DNA15,16 . loss dopaminergic neurons substantia nigra pars compacta motor defect observed aged @ GeneSrc $ mice also rescued loss STING , suggesting inflammation facilitates phenotype . Humans mono- biallelic PRKN mutations also display elevated cytokines . results support role PINK1- parkin-mediated mitophagy restraining innate immunity .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 1.3704354735713257e-06)\n",
      "- Text: \"Loss locus coeruleus neurons reduced startle parkin null mice . @ DiseaseTgt $ ( @ DiseaseTgt $ ) common neurodegenerative movement disorder characterized pathologically degeneration catecholaminergic neurons substantia nigra pars compacta locus coeruleus , among regions . Autosomal-recessive juvenile Parkinsonism ( ARJP ) caused mutations @ GeneSrc $ gene coding parkin constitutes common familial form @ DiseaseTgt $ . majority ARJP-associated parkin mutations thought loss function-mutations ; however , pathogenesis ARJP remains poorly understood . , report generation parkin null mice targeted deletion parkin exon 7 . mice show loss catecholaminergic neurons locus coeruleus accompanying loss norepinephrine discrete regions central nervous system . Moreover , dramatic reduction norepinephrine-dependent startle response . nigrostriatal dopaminergic system show impairment . mouse model help gain better understanding parkin function mechanisms underlying parkin-associated @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.6775922681707712)\n",
      "- Text: \"Intestinal infection triggers @ DiseaseTgt $ Pink1-/- mice . @ DiseaseTgt $ neurodegenerative disorder motor symptoms linked loss dopaminergic neurons substantia nigra compacta . Although mechanisms trigger loss dopaminergic neurons unclear , mitochondrial dysfunction inflammation thought key roles1,2 . early-onset form @ DiseaseTgt $ associated mutations PINK1 kinase @ GeneSrc $ ubiquitin ligase genes3 . PINK1 Parkin ( encoded @ GeneSrc $ ) involved clearance damaged mitochondria cultured cells4 , recent evidence obtained using knockout knockin mouse models led contradictory results regarding contributions PINK1 Parkin mitophagy vivo5 - 8 . previously shown PINK1 Parkin key role adaptive immunity repressing presentation mitochondrial antigens9 , suggests autoimmune mechanisms participate aetiology @ DiseaseTgt $ . show intestinal infection Gram-negative bacteria Pink1-/- mice engages mitochondrial antigen presentation autoimmune mechanisms elicit establishment cytotoxic mitochondria-specific CD8 + cells periphery brain . Notably , mice show sharp decrease density dopaminergic axonal varicosities striatum affected motor impairment reversed treatment L-DOPA . data support idea PINK1 repressor immune system , provide pathophysiological model intestinal infection acts triggering event @ DiseaseTgt $ , highlights relevance gut-brain axis disease10 .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.8991706103448794)\n",
      "- Text: \"Atg7 modulates p53 activity regulate cell cycle survival metabolic stress . Withdrawal nutrients triggers exit cell division cycle , induction autophagy , eventually activation cell death pathways . relation , , among events well characterized . found starved mouse embryonic fibroblasts lacking essential autophagy gene product Atg7 failed undergo cell cycle arrest . Independent E1-like enzymatic activity , Atg7 could bind @ DiseaseTgt $ suppressor p53 regulate transcription gene encoding cell cycle inhibitor p21 ( CDKN1A ) . prolonged metabolic stress , absence Atg7 resulted augmented DNA damage increased p53-dependent apoptosis . Inhibition DNA damage response deletion protein kinase @ GeneSrc $ partially rescued postnatal lethality Atg7 ( -/- ) mice . Thus , nutrients limited , Atg7 regulates p53-dependent cell cycle cell death pathways .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0003387997983482)\n",
      "- Text: \"Carboxyl-terminal-truncated apolipoprotein E4 causes @ DiseaseTgt $ neurodegeneration behavioral deficits transgenic mice . Apolipoprotein ( apo ) E4 increases risk accelerates onset @ DiseaseTgt $ ( @ DiseaseTgt $ ) . However , underlying mechanisms remain determined . previously found apoE undergoes proteolytic cleavage @ DiseaseTgt $ brains cultured neuronal cells , resulting accumulation carboxyl-terminal-truncated fragments apoE neurotoxic . show fragmentation caused proteolysis apoE chymotrypsin-like @ GeneSrc $ cleaves apoE4 efficiently apoE3 . Transgenic mice expressing carboxyl-terminal-cleaved product , apoE4 ( Delta272 - 299 ) , high levels brain died 2 - 4 months age . cortex hippocampus mice displayed @ DiseaseTgt $ neurodegenerative alterations , including abnormally phosphorylated tau ( p-tau ) Gallyas silver-positive neurons contained cytosolic straight filaments diameters 15 - 20 nm , resembling preneurofibrillary tangles . Transgenic mice expressing lower levels truncated apoE4 survived longer showed impaired learning memory 6 - 7 months age . Thus , carboxyl-terminal-truncated fragments apoE4 , occur @ DiseaseTgt $ brains , sufficient elicit @ DiseaseTgt $ neurodegeneration behavioral deficits vivo . Inhibiting formation might inhibit apoE4-associated neuronal deficits .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4443238892423027)\n",
      "- Text: \"Expression functional analysis @ GeneSrc $ mouse development . Mice homozygous ( 1Acrg ) deletion Ednrb locus arrest embryonic day 8.5 . determine molecular basis defect , initiated positional cloning ( 1Acrg ) minimal region . mouse @ GeneSrc $ ( @ GeneSrc $ ) gene mapped within ( 1Acrg ) minimal region . @ GeneSrc $ transcripts present embryonic structures relevant ( 1Acrg ) phenotype , created targeted mutation @ GeneSrc $ address role development possible contribution ( 1Acrg ) phenotype . Mice homozygous mutation @ GeneSrc $ - 7 ) viable , obvious developmental histological abnormalities . Although high levels @ GeneSrc $ RNA detected testes thymus , @ GeneSrc $ - 7 ) homozygotes fertile , defect intrathymic T-cell differentiation detected . conclude @ DiseaseTgt $ phenotype either complex multigenic due loss another gene within region . propose @ GeneSrc $ may functionally redundant homologue Uch-L1 .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0034626091604629)\n",
      "- Text: \"gluconeogenic enzyme @ GeneSrc $ phosphorylates INSIG1/2 lipogenesis . @ DiseaseTgt $ cells increase lipogenesis proliferation activation sterol regulatory element-binding proteins ( SREBPs ) central role process . SREBPs inhibited complex composed INSIG proteins , SREBP cleavage-activating protein ( SCAP ) sterols endoplasmic reticulum . Regulation interaction INSIG proteins SCAP sterol levels critical dissociation SCAP-SREBP complex endoplasmic reticulum activation SREBPs1,2 . However , whether protein interaction regulated mechanism abundance sterol-and particular , whether oncogenic signalling role-is unclear . show activated AKT human hepatocellular carcinoma ( HCC ) cells phosphorylates cytosolic @ GeneSrc $ ( @ GeneSrc $ ) , rate-limiting enzyme gluconeogenesis , Ser90 . Phosphorylated @ GeneSrc $ translocates endoplasmic reticulum , uses GTP phosphate donor phosphorylate INSIG1 Ser207 INSIG2 Ser151 . phosphorylation reduces binding sterols INSIG1 INSIG2 disrupts interaction INSIG proteins SCAP , leading translocation SCAP-SREBP complex Golgi apparatus , activation SREBP proteins ( SREBP1 SREBP2 ) transcription downstream lipogenesis-related genes , proliferation @ DiseaseTgt $ cells , tumorigenesis mice . addition , phosphorylation @ GeneSrc $ Ser90 , INSIG1 Ser207 INSIG2 Ser151 positively correlated nuclear accumulation SREBP1 samples patients HCC , also associated poor HCC prognosis . findings highlight importance protein kinase activity @ GeneSrc $ activation SREBPs , lipogenesis development HCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.025095877621223)\n",
      "- Text: \"Analysis lipid pathway genes indicates association sequence variation near SREBF1/TOM1L2/ATPAF2 dementia risk . conducted dense linkage disequilibrium ( LD ) mapping series 25 genes putatively involved lipid metabolism 1567 dementia cases [ including 1270 @ DiseaseTgt $ ( @ DiseaseTgt $ ) ] 2203 Swedish controls . Across total 448 tested genetic markers , strongest evidence association anticipated APOE ( rs429358 P approximately 10 ( -72 ) ) followed previously reported association ABCA1 ( rs2230805 P approximately 10 ( -8 ) ) . present study , report two additional markers near SREBF1 locus chromosome 17p also significant multiple testing correction ( best P = 3.1 x 10 ( -6 ) marker rs3183702 ) . convincing evidence association remaining genes , including candidates highlighted recent genome-wide association studies plasma lipids ( CELSR2/PSRC1/SORT1 , @ GeneSrc $ , PCSK9 , GALNT2 GCKR ) . associated markers near SREBF1 reside large LD block , extending 400 kb across seven candidate genes . Secondary analyses gene expression levels candidates spanning LD region together investigation gene network context highlighted two possible susceptibility genes including ATPAF2 TOM1L2 . Several markers strong LD ( r ( 2 ) > 0.7 ) rs3183702 found significantly associated @ DiseaseTgt $ risk recent genome-wide association studies similar effect sizes , providing independent support current findings .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000736634921272)\n",
      "- Text: \"@ GeneSrc $ , Pen-2 , Nicastrin Presenilin generate active gamma-Secretase complex . Gamma-Secretase cleaves Amyloid Precursor Protein ( APP ) transmembrane domain , releasing amyloid peptide Abeta . Abeta main constituent amyloid plaques brains patients suffering @ DiseaseTgt $ . Several type integral membrane proteins also cleaved protease . Recent work indicates gamma-Secretase multiprotein complex consisting Presenilin , Nicastrin , @ GeneSrc $ , Pen-2 four proteins necessary full proteolytic activity . Since several paralogs alternatively spliced variants least Presenilin @ GeneSrc $ identified well , anticipated gamma-Secretase homogeneous activity . Gamma-Secretase interesting complex drug target challenges classical thinking proteolytic processing intracellular signaling .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0004148290887025)\n",
      "- Text: \"Mutations immunohistochemistry p53 proliferation markers astrocytic tumors childhood . Thirty cases hemispheric astrocytic tumors childhood , consisting 11 pilocytic astrocytomas , 2 fibrillary astrocytomas , 9 anaplastic astrocytomas , 8 glioblastomas , studied presence p53 mutations immunohistochemical demonstrations p53 proliferation markers @ GeneSrc $ Ki-67 MIB-1 . study performed using polymerase chain reaction ( PCR ) -assisted single-strand conformation polymorphism analysis exons 5 - 8 direct sequence analysis PCR products . immunohistochemistry , DO1 PAb 1801 used . mutation positivity p53 protein found pilocytic astrocytomas . Mutations ( codons 144 , 202 , 245 ) found 2 8 glioblastomas 1 9 anaplastic astrocytomas , whereas positive staining found 11 17 malignant gliomas . Cases mutations showed highest p53 labeling index also @ GeneSrc $ MIB-1 labeling indices . negative results pilocytic astrocytomas line benign course @ DiseaseTgt $ , whereas malignant gliomas difference seems exist comparison adult cases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0001166653706486)\n",
      "- Text: \"Association extended tau haplotype frontotemporal dementia . BACKGROUND : Recent studies shown association extended tau haplotype ( H1 ) covers entire human tau gene progressive supranuclear palsy , inconsistently , neurodegenerative disorders , corticobasal degeneration , @ DiseaseTgt $ , Alzheimer disease , frontotemporal dementia ( FTD ) . addition , disease-causing mutations tau gene chromosome 17 detected families autosomal dominant FTD parkinsonism . FTD , pathological accumulation @ GeneSrc $ tau suggests tau gene may genetic risk factor disorder . OBJECTIVE : confirm refute association H1 haplotype H1H1 genotype tau gene FTD . DESIGN : Case-control study . SETTING : Neurology departments 12 French university hospitals . PARTICIPANTS : One hundred unrelated patients FTD 79 controls . METHODS : Tau genotype ( contiguous polymorphisms exons 1 , 7 , 13 intron 9 used reconstruct extended haplotypes H1 H2 ) . Clinical examination , psychometric testing , laboratory tests , computed tomography magnetic resonance imaging , single-photon emission computed tomography , electroencephalography patients FTD . RESULTS : H1H1 genotype significantly overrepresented patients FTD compared controls ( 62 % vs 46 % ; P=.01 , 1-sided ; odds ratio adjusted age sex , 1.95 ) . stratification according apolipoprotein E ( APOE ) genotype , found significant interaction APOE tau genotypes ( P=.03 ) . CONCLUSIONS : study largest series patients FTD confirms primary role tau FTD establishes H1 haplotype tau gene E2 allele APOE interact unknown mechanism increases risk FTD .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 2.891040987670036e-05)\n",
      "- Text: \"gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 lipogenesis . @ DiseaseTgt $ cells increase lipogenesis proliferation activation sterol regulatory element-binding proteins ( SREBPs ) central role process . SREBPs inhibited complex composed INSIG proteins , SREBP cleavage-activating protein ( SCAP ) sterols endoplasmic reticulum . Regulation interaction INSIG proteins SCAP sterol levels critical dissociation SCAP-SREBP complex endoplasmic reticulum activation SREBPs1,2 . However , whether protein interaction regulated mechanism abundance sterol-and particular , whether oncogenic signalling role-is unclear . show activated AKT human hepatocellular carcinoma ( HCC ) cells phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 ( PCK1 ) , rate-limiting enzyme gluconeogenesis , Ser90 . Phosphorylated PCK1 translocates endoplasmic reticulum , uses GTP phosphate donor phosphorylate INSIG1 Ser207 @ GeneSrc $ Ser151 . phosphorylation reduces binding sterols INSIG1 @ GeneSrc $ disrupts interaction INSIG proteins SCAP , leading translocation SCAP-SREBP complex Golgi apparatus , activation SREBP proteins ( SREBP1 SREBP2 ) transcription downstream lipogenesis-related genes , proliferation @ DiseaseTgt $ cells , tumorigenesis mice . addition , phosphorylation PCK1 Ser90 , INSIG1 Ser207 @ GeneSrc $ Ser151 positively correlated nuclear accumulation SREBP1 samples patients HCC , also associated poor HCC prognosis . findings highlight importance protein kinase activity PCK1 activation SREBPs , lipogenesis development HCC .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 3.294224795726137e-05)\n",
      "- Text: \"@ GeneSrc $ harboring @ DiseaseTgt $ T61I mutation precipitates inside mitochondria induces precipitation wild-type @ GeneSrc $ . T61I mutation @ GeneSrc $ ( @ GeneSrc $ ) , protein residing mitochondrial intermembrane space ( IMS ) , causes autosomal dominant form @ DiseaseTgt $ ( @ DiseaseTgt $ ) , underlying pathogenic mechanisms well understood . , compared subcellular localization solubility wild-type ( WT ) T61I mutant @ GeneSrc $ human cells . found mitochondrial targeting WT T61I @ GeneSrc $ depended four cysteine residues C-terminal coiled-coil-helix-coiled-coil-helix ( CHCH ) domain N-terminal predicted mitochondrial targeting sequence . T61I mutation interfere mitochondrial targeting mutant protein induced precipitation IMS . Moreover , T61I @ GeneSrc $ induced increased mitochondrial production reactive oxygen species apoptosis , prevented treatment anti-oxidants . Retention T61I @ GeneSrc $ cytosol mutation cysteine residues CHCH domain prevented precipitation well apoptosis-inducing effect . Importantly , T61I @ GeneSrc $ potently impaired solubility WT @ GeneSrc $ . conclusion , data show T61I mutation renders mutant @ GeneSrc $ insoluble inside mitochondria , suggesting loss function mutant protein . addition , T61I @ GeneSrc $ exerts dominant-negative effect solubility WT @ GeneSrc $ , explaining dominant inheritance form @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 1, Confidence: 0.4060058571898665)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ -- authors ' reply .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.036908440552222)\n",
      "- Text: \"Mutation analysis @ GeneSrc $ gene Chinese familial @ DiseaseTgt $ . Funayama et al . recently identified mutations @ GeneSrc $ gene Japanese families autosomal dominant @ DiseaseTgt $ , increasing knowledge monogenic cause disorder . However , report regarding association @ GeneSrc $ @ DiseaseTgt $ ( @ DiseaseTgt $ ) Chinese Han population . aim study obtain prevalence @ GeneSrc $ mutations Chinese familial @ DiseaseTgt $ . Genetic analysis mutations @ GeneSrc $ gene conducted cohort 92 families autosomal dominant @ DiseaseTgt $ mainland China . mutations @ GeneSrc $ gene identified , suggesting @ GeneSrc $ mutations might common cause @ DiseaseTgt $ Chinese familial cases .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0099197862533843)\n",
      "- Text: \"@ GeneSrc $ mutations autosomal dominant late-onset @ DiseaseTgt $ : genome-wide linkage sequencing study . BACKGROUND : Identification causative genes mendelian forms @ DiseaseTgt $ valuable understanding cause disease . genetic studies Japanese family @ DiseaseTgt $ identify novel causative genes . METHODS : genome-wide linkage analysis eight affected five unaffected individuals family @ DiseaseTgt $ ( family ) . Subsequently , exome sequencing three patients whole-genome sequencing one patient family A. Variants validated Sanger sequencing samples patients @ DiseaseTgt $ , patients sporadic @ DiseaseTgt $ , controls . Participants identified DNA bank Comprehensive Genetic Study @ DiseaseTgt $ ( Juntendo University School Medicine , Tokyo , Japan ) classified according clinical information obtained neurologists . Splicing abnormalities @ GeneSrc $ mutants analysed SH-SY5Y cells . used Fisher 's exact test calculate significance allele frequencies patients sporadic @ DiseaseTgt $ unaffected controls , calculated odds ratios 95 % CIs minor alleles . FINDINGS : identified missense mutation ( @ GeneSrc $ , 182C > , Thr61Ile ) family next-generation sequencing . obtained samples 340 index patients @ DiseaseTgt $ , 517 patients sporadic @ DiseaseTgt $ , 559 controls . Three @ GeneSrc $ mutations four 341 index cases independent families @ DiseaseTgt $ detected @ GeneSrc $ mutation screening : 182C > ( Thr61Ile ) , 434G > ( Arg145Gln ) , 300 + 5G > . Two single nucleotide variants ( -9T > G 5C > ) @ GeneSrc $ confirmed different frequencies sporadic @ DiseaseTgt $ controls , odds ratios 2 51 ( 95 % CI 1 48 - 4 24 ; p=0 0004 ) 4 69 ( 1 59 - 13 83 , p=0 0025 ) , respectively . One single nucleotide polymorphism ( rs816411 ) found @ GeneSrc $ previously reported genome-wide association study ; however , significant difference frequency patients @ DiseaseTgt $ controls previously reported genome-wide association study ( odds ratio 1 17 , 95 % CI 0 96 - 1 19 ; p=0 22 ) . SH-SY5Y cells , 300 + 5G > mutation two mutations caused exon 2 skipping . INTERPRETATION : @ GeneSrc $ mutations associated , might cause , @ DiseaseTgt $ . genetic studies populations needed confirm pathogenicity @ GeneSrc $ mutations @ DiseaseTgt $ susceptibility sporadic @ DiseaseTgt $ , functional studies needed understand mutant @ GeneSrc $ might play part pathophysiology @ DiseaseTgt $ . FUNDING : Japan Society Promotion Science ; Japanese Ministry Education , Culture , Sports , Science Technology ; Japanese Ministry Health , Labour Welfare ; Takeda Scientific Foundation ; Cell Science Research Foundation ; Nakajima Foundation .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0236426303165045)\n",
      "- Text: \"Mutation analysis @ GeneSrc $ Canadian patients familial @ DiseaseTgt $ . Recently , several @ GeneSrc $ mutations reported associated autosomal dominant @ DiseaseTgt $ ( @ DiseaseTgt $ ) Japanese population . However , association @ GeneSrc $ @ DiseaseTgt $ observed 2 Caucasian data sets . present study searched @ GeneSrc $ coding variants Canadian @ DiseaseTgt $ patients . Sanger sequencing @ GeneSrc $ exons revealed coding mutations 155 familial cases . Moreover , 3 coding @ GeneSrc $ polymorphisms available NeuroX array ( Pro2Leu , Pro14Ser , Ile118Met ) homozygous major allele additional 85 @ DiseaseTgt $ patients . study suggests @ GeneSrc $ mutations may account @ DiseaseTgt $ Canadian patients .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0697216710789426)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.038730543107415)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.038730543107415)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.038730543107415)\n",
      "- Text: \"@ GeneSrc $ @ DiseaseTgt $ .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.038730543107415)\n",
      "- Text: \"common human skin tumour caused activating mutations beta-catenin . WNT signalling orchestrates number developmental programs . response stimulus , cytoplasmic beta-catenin ( encoded CTNNB1 ) stabilized , enabling downstream transcriptional activation members LEF/TCF family . One target genes beta-catenin/TCF encodes c-MYC , explaining constitutive activation WNT pathway lead cancer , particularly colon . @ DiseaseTgt $ arise mutations gene encoding adenomatous polyposis coli ( APC ) , protein required ubiquitin-mediated degradation beta-catenin , small percentage colon cancers harbour beta-catenin-stabilizing mutations . Recently , discovered transgenic mice expressing activated beta-catenin predisposed developing skin tumours resembling pilomatricomas . Given skin adult mice also exhibits signs de novo hair-follicle morphogenesis , wondered whether human pilomatricomas might originate hair matrix cells whether might possess beta-catenin-stabilizing mutations . , explore cell origin aetiology common human skin tumour . found nuclear @ GeneSrc $ dividing tumour cells , providing biochemical evidence pilomatricomas derived hair matrix cells . least 75 % tumours possess mutations affecting amino-terminal segment , normally involved phosphorylation-dependent , ubiquitin-mediated degradation protein . percentage CTNNB1 mutations greater human tumours examined thus far , directly implicates beta-catenin/LEF misregulation major cause hair matrix cell tumorigenesis humans .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0037097609684547)\n",
      "- Text: \"Down-regulation parkin protein transient focal cerebral ischemia : link stroke degenerative disease ? Ubiquitylated protein aggregates characteristic features neurodegenerative disorders also found acute pathological states brain stroke . Many proteins connected neurodegenerative diseases play role ubiquitin-proteasomal pathway . Mutation one proteins , E3 ubiquitin ligase parkin , cause autosomal recessive juvenile @ DiseaseTgt $ . show transient focal cerebral ischemia 1-h duration induces marked depletion parkin protein levels , 60 % , 36 % , 33 % , 25 % controls 1 , 3 , 6 , 24 h reperfusion , ischemia cause lower protein levels E2 ubiquitin-conjugating enzymes @ GeneSrc $ , Ubc7 , Ubc9 . 3 h reperfusion , parkin protein levels already reduced < 40 % control , ATP levels almost completely recovered ischemia observe DNA fragmentation , suggesting parkin depletion preceded development neuronal cell death . Up-regulation expression parkin shown protect cells injury induced endoplasmic reticulum ( ER ) dysfunction , form cellular stress also triggered transient cerebral ischemia . However , contrast observations neuroblastoma cells , saw up-regulation parkin expression primary neuronal cell cultures induction ER dysfunction . data thus suggest ischemia-induced depletion parkin protein may contribute pathological process resulting cell injury increasing sensitivity neurons ER dysfunction aggregation ubiquitylated proteins reperfusion period .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 7.052874203108446e-05)\n",
      "- Text: \"Isolation candidate tumor suppressor gene chromosome 8p21.3-p22 homologous extracellular domain PDGF receptor beta gene . isolated candidate tumor suppressor gene 600-kb region chromosome 8p21.3-p22 commonly deleted sporadic hepatocellular carcinomas ( HCC ) , @ DiseaseTgt $ ( @ DiseaseTgt $ ) , non-small cell lung cancers ( NSCLC ) . gene encodes protein 375 amino acids bears significant sequence similarity extracellular ( ligand-binding domain platelet-derived growth factor receptor beta , designated @ GeneSrc $ ( @ GeneSrc $ ) . Structural rearrangement involving gene found sporadic NSCLC . addition , somatic missense frame-shift mutations found two HCCs one @ DiseaseTgt $ . findings indicate inactivation @ GeneSrc $ gene may play significant role development carcinomas .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0148889270316184)\n",
      "- Text: \"Reversible adaptive resistance BRAF ( V600E ) inhibition melanoma . Treatment BRAF ( V600E ) mutant melanoma small molecule drugs target BRAF MEK kinases effective , resistance develops invariably . contrast , @ DiseaseTgt $ harbour BRAF ( V600E ) mutation intrinsically resistant BRAF inhibitors , due feedback activation epidermal growth factor receptor ( EGFR ) . show 6 16 melanoma tumours analysed acquired EGFR expression development resistance BRAF MEK inhibitors . Using chromatin-regulator-focused short hairpin RNA ( shRNA ) library , find suppression sex determining region Y-box 10 ( SOX10 ) melanoma causes activation TGF-beta signalling , thus leading upregulation EGFR @ GeneSrc $ ( @ GeneSrc $ ) , confer resistance BRAF MEK inhibitors . Expression EGFR melanoma treatment TGF-beta results slow-growth phenotype cells displaying hallmarks oncogene-induced senescence . However , EGFR expression exposure TGF-beta becomes beneficial proliferation presence BRAF MEK inhibitors . heterogeneous population melanoma cells varying levels SOX10 suppression , cells low SOX10 consequently high EGFR expression rapidly enriched presence drug , reversed drug treatment discontinued . find evidence SOX10 loss and/or activation TGF-beta signalling 4 6 EGFR-positive drug-resistant melanoma patient samples . findings provide rationale BRAF MEK inhibitor-resistant melanoma patients may regain sensitivity drugs ' drug holiday ' identify patients EGFR-positive melanoma group may benefit re-treatment drug holiday .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.000739208964377)\n",
      "- Text: \"Isolation candidate tumor suppressor gene chromosome 8p21.3-p22 homologous extracellular domain PDGF receptor beta gene . isolated candidate tumor suppressor gene 600-kb region chromosome 8p21.3-p22 commonly deleted sporadic hepatocellular carcinomas ( HCC ) , @ DiseaseTgt $ ( @ DiseaseTgt $ ) , non-small cell lung cancers ( NSCLC ) . gene encodes protein 375 amino acids bears significant sequence similarity extracellular ( ligand-binding domain @ GeneSrc $ , designated PRLTS ( PDGF-receptor beta-like tumor suppressor ) . Structural rearrangement involving gene found sporadic NSCLC . addition , somatic missense frame-shift mutations found two HCCs one @ DiseaseTgt $ . findings indicate inactivation PRLTS gene may play significant role development carcinomas .\"\n",
      "  (Prior Model Prediction: 0, Confidence: 0.0007327513602484)\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "IOPub data rate exceeded.\n",
      "The Jupyter server will temporarily stop sending output\n",
      "to the client in order to avoid crashing it.\n",
      "To change this limit, set the config variable\n",
      "`--ServerApp.iopub_data_rate_limit`.\n",
      "\n",
      "Current values:\n",
      "ServerApp.iopub_data_rate_limit=1000000.0 (bytes/sec)\n",
      "ServerApp.rate_limit_window=3.0 (secs)\n",
      "\n",
      "Processing: 100%|| 1203/1203 [01:45<00:00, 11.38it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " Done! Time: 0:01:45.762653\n",
      " Causal found: 814\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from tqdm import tqdm\n",
    "from openai import AzureOpenAI\n",
    "import concurrent.futures\n",
    "import threading\n",
    "\n",
    "# ==== Azure OpenAI Config ====\n",
    "AZURE_OPENAI_API_KEY = \"CqSAIM2DLgxvf6S58h8dOYHVKPzMdumoTXLeZMtzLWZhfkKtNkN8JQQJ99BFACF24PCXJ3w3AAABACOGe0ty\"\n",
    "AZURE_OPENAI_ENDPOINT = \"https://teccspazureopenai.openai.azure.com/\"\n",
    "AZURE_DEPLOYMENT = \"gpt-4o\" \n",
    "\n",
    "# ==== Initialize Azure Client ====\n",
    "client = AzureOpenAI(\n",
    "    api_key=AZURE_OPENAI_API_KEY,\n",
    "    azure_endpoint=AZURE_OPENAI_ENDPOINT,\n",
    "    api_version=\"2024-02-01\"\n",
    ")\n",
    "\n",
    "# ==== Thread Safety & Custom JSON Encoding ====\n",
    "log_lock = threading.Lock()\n",
    "\n",
    "class NpEncoder(json.JSONEncoder):\n",
    "    \"\"\"Custom encoder to handle standard Pandas/Numpy types during JSON logging.\"\"\"\n",
    "    def default(self, obj):\n",
    "        if isinstance(obj, np.integer):\n",
    "            return int(obj)\n",
    "        if isinstance(obj, np.floating):\n",
    "            return float(obj)\n",
    "        if isinstance(obj, np.ndarray):\n",
    "            return obj.tolist()\n",
    "        if pd.isna(obj):\n",
    "            return None\n",
    "        return super(NpEncoder, self).default(obj)\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_disease\"\n",
    "\n",
    "try:\n",
    "    data = pd.read_csv(DATA_PATH, sep='\\t')\n",
    "except FileNotFoundError:\n",
    "    print(\"Warning: File not found. Creating dummy data for test.\")\n",
    "    # Added dummy pred_label and pred_proba for testing\n",
    "    data = pd.DataFrame({\n",
    "        \"id1\": [\"GeneA\"] * 5,\n",
    "        \"id2\": [f\"Disease{i}\" for i in range(5)],\n",
    "        \"sentence\": [\"This gene causes disease.\"] * 5,\n",
    "        \"label\": [1, 0, 1, 0, 1],\n",
    "        \"pred_label\": [1, 0, 1, 0, 1],\n",
    "        \"pred_proba\": [0.9, 0.2, 0.85, 0.1, 0.95]\n",
    "    })\n",
    "\n",
    "# Check for required columns\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "if not required_cols.issubset(data.columns):\n",
    "    raise ValueError(f\"Missing basic columns. Found: {data.columns}\")\n",
    "\n",
    "# Ensure prediction columns exist (fill with N/A if missing to avoid crash)\n",
    "if \"pred_label\" not in data.columns:\n",
    "    data[\"pred_label\"] = \"N/A\"\n",
    "if \"pred_proba\" not in data.columns:\n",
    "    data[\"pred_proba\"] = \"N/A\"\n",
    "\n",
    "# Find Ground Truth Label Column\n",
    "LABEL_COL = None\n",
    "for col in [\"label\", \"Label\", \"labels\", \"Labels\", \"ground_truth\", \"class\"]:\n",
    "    if col in data.columns:\n",
    "        LABEL_COL = col\n",
    "        print(f\"Found ground truth label column: '{LABEL_COL}'\")\n",
    "        break\n",
    "\n",
    "# ============================\n",
    "# ==== Grouping Logic Updated =\n",
    "# ============================\n",
    "grouped_data = []\n",
    "\n",
    "# Group by Gene and Disease\n",
    "for (id1, id2), group in data.groupby([\"id1\", \"id2\"]):\n",
    "    \n",
    "    # Construct a detailed evidence string containing Sentence + Model Preds\n",
    "    evidence_list = []\n",
    "    for index, row in group.iterrows():\n",
    "        sent = row[\"sentence\"]\n",
    "        p_label = row.get(\"pred_label\", \"N/A\")\n",
    "        p_proba = row.get(\"pred_proba\", \"N/A\")\n",
    "        \n",
    "        # Format: Text ... | Previous Model says: ...\n",
    "        evidence_entry = f\"- Text: \\\"{sent}\\\"\\n  (Prior Model Prediction: {p_label}, Confidence: {p_proba})\"\n",
    "        evidence_list.append(evidence_entry)\n",
    "        \n",
    "\n",
    "    # Join all evidence for this pair\n",
    "    full_evidence_context = \"\\n\".join(evidence_list)\n",
    "    print(full_evidence_context)\n",
    "    \n",
    "    # Get ground truth (mode or first)\n",
    "    label = None\n",
    "    if LABEL_COL:\n",
    "        unique_labels = group[LABEL_COL].dropna().unique()\n",
    "        if len(unique_labels) >= 1:\n",
    "            label = group[LABEL_COL].mode().iloc[0] if not group[LABEL_COL].mode().empty else unique_labels[0]\n",
    "    \n",
    "    grouped_data.append({\n",
    "        \"id1\": id1,\n",
    "        \"id2\": id2,\n",
    "        \"evidence_context\": full_evidence_context, # Renamed from 'sentences' to reflect richer data\n",
    "        \"original_label\": label\n",
    "    })\n",
    "\n",
    "print(f\"Processing {len(grouped_data)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_llm_results_no_cred.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_raw_responses.jsonl\")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Prompts Updated =======\n",
    "# ============================\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Your task is to determine whether a Causal relationship exists between @GeneSrc$ and @DiseaseTgt$ in overall text data provided to you, with the confidence score.\n",
    "You will be provided with abstracts from various published papers and predictions from BioBERT+SVM for each abstract, including a 'Label' (1=Causal, 0=Not Causal) and a 'Confidence Score'.\n",
    "\n",
    "**Instructions:**\n",
    "- Use the provided 'Prior Model Predictions' as supplementary signals if you want. \n",
    "- Associations are NOT causal relation, look for explicit mention of causal relation in the text. Don't use your preaquired knowledge. \n",
    "\n",
    "Respond ONLY with valid JSON in this exact format:\n",
    "{\n",
    "  \"relationship\": \"Causal\" or \"Not causal\",\n",
    "  \"score\": <float between 0 and 1>\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "def build_user_prompt(evidence_context, gene, disease):\n",
    "    return (\n",
    "        f\"Gene: {gene}\\n\"\n",
    "        f\"Disease: {disease}\\n\\n\"\n",
    "        f\"EVIDENCE & PRIOR PREDICTIONS:\\n\"\n",
    "        f\"{evidence_context}\\n\\n\"\n",
    "        f\"Task: Does {gene} cause {disease}?\\n\"\n",
    "        f\"Consider both the text semantics and the provided model confidence scores.\\n\"\n",
    "        f\"Return only valid JSON.\"\n",
    "    )\n",
    "\n",
    "# ============================\n",
    "# ==== Azure Call ============\n",
    "# ============================\n",
    "def call_azure_openai(item):\n",
    "    id1, id2 = item[\"id1\"], item[\"id2\"]\n",
    "    evidence, original_label = item[\"evidence_context\"], item[\"original_label\"]\n",
    "    \n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=AZURE_DEPLOYMENT,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": build_user_prompt(evidence, id1, id2)}\n",
    "            ],\n",
    "            max_tokens=200, # Increased slightly for reasoning\n",
    "            temperature=0.5, # Lowered slightly for more analytical consistency\n",
    "            response_format={\"type\": \"json_object\"}, \n",
    "        )\n",
    "        \n",
    "        content = resp.choices[0].message.content\n",
    "        parsed = json.loads(content)\n",
    "        \n",
    "        # Thread-safe logging\n",
    "        log_entry = {\n",
    "            \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "            \"id1\": str(id1),\n",
    "            \"id2\": str(id2),\n",
    "            \"original_label\": original_label,\n",
    "            \"evidence_snippet\": evidence[:200], # Log start of evidence for debug\n",
    "            \"response\": parsed\n",
    "        }\n",
    "        \n",
    "        with log_lock:\n",
    "            with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "                f.write(json.dumps(log_entry, cls=NpEncoder) + \"\\n\")\n",
    "        \n",
    "        return {\n",
    "            \"id1\": id1, \"id2\": id2, \"original_label\": original_label,\n",
    "            \"llm_relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "            \"llm_score\": parsed.get(\"score\", 0.0),\n",
    "            \"llm_reasoning\": parsed.get(\"reasoning\", \"\")\n",
    "        }\n",
    "    \n",
    "    except Exception as e:\n",
    "        return {\n",
    "            \"id1\": id1, \"id2\": id2, \"original_label\": original_label,\n",
    "            \"llm_relationship\": \"Error\", \"llm_score\": 0.0, \n",
    "            \"llm_reasoning\": str(e), \"error_msg\": str(e)\n",
    "        }\n",
    "\n",
    "# ============================\n",
    "# ==== Execution =============\n",
    "# ============================\n",
    "def process_all_parallel(max_workers=10):\n",
    "    results = []\n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor:\n",
    "        futures = [executor.submit(call_azure_openai, item) for item in grouped_data]\n",
    "        for future in tqdm(concurrent.futures.as_completed(futures), total=len(futures), desc=\"Processing\"):\n",
    "            results.append(future.result())\n",
    "    return results\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    start_time = datetime.datetime.now()\n",
    "    final_results = process_all_parallel(max_workers=10)\n",
    "    \n",
    "    df_results = pd.DataFrame(final_results)\n",
    "    cols_order = [\"id1\", \"id2\", \"original_label\", \"llm_relationship\", \"llm_score\", \"llm_reasoning\", \"error_msg\"]\n",
    "    \n",
    "    # Ensure all columns exist before selecting\n",
    "    for c in cols_order:\n",
    "        if c not in df_results.columns:\n",
    "            df_results[c] = None\n",
    "\n",
    "    df_results = df_results[cols_order]\n",
    "    df_results.to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    \n",
    "    print(f\"\\n Done! Time: {datetime.datetime.now() - start_time}\")\n",
    "    if not df_results.empty:\n",
    "        print(f\" Causal found: {(df_results['llm_relationship'] == 'Causal').sum()}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c394d575-9676-457b-9fb8-bbf82d955840",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import OpenAI\n",
    "import concurrent.futures\n",
    "import threading\n",
    "from pydantic import BaseModel # Added for Structured Output\n",
    "from typing import Literal     # Added for Type Safety\n",
    "\n",
    "# ==== OpenRouter Configuration ====\n",
    "OPENROUTER_API_KEY = \"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\"\n",
    "OPENROUTER_BASE_URL = \"https://openrouter.ai/api/v1\"\n",
    "\n",
    "MODELS = {\n",
    "    \"openai\": \"openai/gpt-5.2\",\n",
    "    \"google\": \"google/gemini-2.5-pro\",\n",
    "    \"anthropic\": \"anthropic/claude-4.5-opus\", \n",
    "    \"grok\": \"xai/grok-4.1-thinking\"\n",
    "}\n",
    "\n",
    "CURRENT_MODEL = MODELS[\"anthropic\"] \n",
    "\n",
    "client = OpenAI(\n",
    "    base_url=OPENROUTER_BASE_URL,\n",
    "    api_key=OPENROUTER_API_KEY,\n",
    "    default_headers={\n",
    "        \"HTTP-Referer\": \"https://research-portal.edu\", \n",
    "        \"X-Title\": \"BioNLP Causal Discovery 2025\"\n",
    "    }\n",
    ")\n",
    "\n",
    "log_lock = threading.Lock()\n",
    "\n",
    "# ============================\n",
    "# ==== Data Loading Section ==\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_disease\"\n",
    "\n",
    "try:\n",
    "    data = pd.read_csv(DATA_PATH, sep='\\t')\n",
    "except FileNotFoundError:\n",
    "    print(\"Warning: File not found. Creating dummy data.\")\n",
    "    data = pd.DataFrame({\n",
    "        \"id1\": [\"BRCA1\", \"TNF\"],\n",
    "        \"id2\": [\"Breast Cancer\", \"Inflammation\"],\n",
    "        \"sentence\": [\"Mutations in BRCA1 cause breast cancer.\", \"TNF is associated with inflammation.\"],\n",
    "        \"label\": [1, 0]\n",
    "    })\n",
    "\n",
    "LABEL_COL = next((col for col in [\"label\", \"Label\", \"ground_truth\"] if col in data.columns), None)\n",
    "grouped_data = []\n",
    "for (id1, id2), group in data.groupby([\"id1\", \"id2\"]):\n",
    "    sentences = \"\\n\".join(group[\"sentence\"].dropna().unique()[:10]) \n",
    "    label = group[LABEL_COL].iloc[0] if LABEL_COL else None\n",
    "    grouped_data.append({\"id1\": id1, \"id2\": id2, \"sentences\": sentences, \"original_label\": label})\n",
    "\n",
    "# ============================\n",
    "# ==== LLM Logic (Structured) ==\n",
    "# ============================\n",
    "\n",
    "# Define the schema for Structured Output\n",
    "class CausalAnalysis(BaseModel):\n",
    "    relationship: Literal[\"Causal\", \"Not causal\"]\n",
    "    score: float\n",
    "    reasoning_summary: str\n",
    "\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the provided text to determine if a DIRECT CAUSAL relationship exists.\n",
    "Associations or correlations are NOT causal.\"\"\"\n",
    "\n",
    "def call_llm(item):\n",
    "    try:\n",
    "        # Using beta.chat.completions.parse for native Structured Output support\n",
    "        completion = client.beta.chat.completions.parse(\n",
    "            model=CURRENT_MODEL,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": f\"Gene: {item['id1']}\\nDisease: {item['id2']}\\nSentences:\\n{item['sentences']}\"}\n",
    "            ],\n",
    "            response_format=CausalAnalysis, # This enforces the Pydantic schema\n",
    "            temperature=0.2 \n",
    "        )\n",
    "        \n",
    "        # Accessing the parsed object directly\n",
    "        parsed = completion.choices[0].message.parsed\n",
    "        \n",
    "        return {\n",
    "            \"id1\": item[\"id1\"],\n",
    "            \"id2\": item[\"id2\"],\n",
    "            \"original_label\": item[\"original_label\"],\n",
    "            \"llm_relationship\": parsed.relationship,\n",
    "            \"llm_score\": parsed.score,\n",
    "            \"llm_reasoning\": parsed.reasoning_summary\n",
    "        }\n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {item['id1']}: {e}\")\n",
    "        return {\"id1\": item[\"id1\"], \"id2\": item[\"id2\"], \"llm_relationship\": \"Error\", \"error\": str(e)}\n",
    "\n",
    "# ============================\n",
    "# ==== Runner ================\n",
    "# ============================\n",
    "if __name__ == \"__main__\":\n",
    "    print(f\" Starting inference with {CURRENT_MODEL}...\")\n",
    "    \n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=8) as executor:\n",
    "        results = list(tqdm(executor.map(call_llm, grouped_data), total=len(grouped_data)))\n",
    "\n",
    "    df_results = pd.DataFrame(results)\n",
    "    output_file = f\"llm_results_opus_{datetime.datetime.now().strftime('%Y%m%d')}.csv\"\n",
    "    df_results.to_csv(output_file, index=False)\n",
    "    \n",
    "    print(f\"\\n Completed. Results saved to {output_file}\")\n",
    "    if \"llm_relationship\" in df_results:\n",
    "        print(f\"Causal found: {len(df_results[df_results['llm_relationship'] == 'Causal'])}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "c26dba83-5bc7-4bd6-a054-8b458a6a3b58",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Found label column: 'label'\n",
      "Processing 1203 unique gene-disease pairs...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   0%|          | 2/1203 [00:01<10:48,  1.85it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.85\n",
      "0.8\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   1%|          | 7/1203 [00:01<02:28,  8.03it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   1%|          | 10/1203 [00:01<03:03,  6.49it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.8\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   1%|          | 15/1203 [00:02<01:46, 11.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.3\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   2%|         | 22/1203 [00:02<01:44, 11.27it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.2\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   2%|         | 25/1203 [00:02<01:26, 13.55it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.8\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   3%|         | 31/1203 [00:03<01:42, 11.40it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.3\n",
      "0.9\n",
      "0.2\n",
      "0.4\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   3%|         | 38/1203 [00:04<01:43, 11.21it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   4%|         | 44/1203 [00:04<01:06, 17.53it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.4\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   4%|         | 51/1203 [00:05<01:26, 13.28it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.85\n",
      "0.2\n",
      "0.85\n",
      "0.3\n",
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   5%|         | 55/1203 [00:05<01:26, 13.20it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   5%|         | 62/1203 [00:06<01:26, 13.21it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n",
      "0.3\n",
      "0.3\n",
      "0.3\n",
      "0.2\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   5%|         | 65/1203 [00:06<01:25, 13.29it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   6%|         | 69/1203 [00:06<01:45, 10.79it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   6%|         | 71/1203 [00:06<01:39, 11.34it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   6%|         | 75/1203 [00:07<01:37, 11.60it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   6%|         | 77/1203 [00:07<01:45, 10.68it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   7%|         | 79/1203 [00:07<01:51, 10.10it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   7%|         | 82/1203 [00:07<01:24, 13.26it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   7%|         | 84/1203 [00:08<01:33, 12.01it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   7%|         | 87/1203 [00:08<01:34, 11.84it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   8%|         | 92/1203 [00:08<01:19, 13.94it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.8\n",
      "0.95\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   8%|         | 94/1203 [00:08<01:29, 12.45it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   8%|         | 96/1203 [00:09<01:44, 10.62it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   8%|         | 101/1203 [00:09<01:33, 11.74it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n",
      "0.85\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   9%|         | 105/1203 [00:10<01:54,  9.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   9%|         | 110/1203 [00:10<01:20, 13.60it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.95\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:   9%|         | 112/1203 [00:10<02:05,  8.70it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  10%|         | 116/1203 [00:11<01:37, 11.19it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  10%|         | 118/1203 [00:11<01:31, 11.80it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  10%|         | 122/1203 [00:11<01:35, 11.37it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  10%|         | 124/1203 [00:11<01:23, 12.89it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.95\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  10%|         | 126/1203 [00:11<01:38, 10.99it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  11%|         | 131/1203 [00:12<01:28, 12.09it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.2\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  11%|         | 135/1203 [00:12<01:23, 12.79it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  11%|        | 137/1203 [00:12<01:33, 11.44it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  12%|        | 139/1203 [00:13<01:31, 11.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  12%|        | 144/1203 [00:13<01:29, 11.83it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  12%|        | 148/1203 [00:13<01:21, 12.99it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  13%|        | 151/1203 [00:14<01:40, 10.48it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  13%|        | 156/1203 [00:14<01:29, 11.71it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.2\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  13%|        | 160/1203 [00:14<01:22, 12.59it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  13%|        | 162/1203 [00:15<01:45,  9.88it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.2\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  14%|        | 169/1203 [00:15<01:19, 13.06it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  14%|        | 171/1203 [00:15<01:37, 10.56it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  15%|        | 178/1203 [00:16<01:14, 13.84it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.3\n",
      "0.4\n",
      "0.3\n",
      "0.6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  15%|        | 180/1203 [00:16<01:25, 11.91it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  15%|        | 182/1203 [00:16<01:19, 12.87it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  15%|        | 184/1203 [00:17<01:52,  9.06it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.4\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  16%|        | 190/1203 [00:17<01:14, 13.66it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.6\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  16%|        | 192/1203 [00:17<01:36, 10.42it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  16%|        | 194/1203 [00:17<01:32, 10.95it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  16%|        | 198/1203 [00:18<01:28, 11.30it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  17%|        | 204/1203 [00:18<01:22, 12.10it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  17%|        | 206/1203 [00:19<01:43,  9.60it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.95\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  17%|        | 210/1203 [00:19<01:39,  9.96it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  18%|        | 214/1203 [00:19<01:17, 12.80it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.3\n",
      "0.4\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  18%|        | 216/1203 [00:19<01:12, 13.62it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  18%|        | 218/1203 [00:20<01:33, 10.52it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  19%|        | 223/1203 [00:20<01:26, 11.39it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  19%|        | 225/1203 [00:20<01:28, 11.06it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.95\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  19%|        | 229/1203 [00:21<01:20, 12.14it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  19%|        | 231/1203 [00:21<01:29, 10.87it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  19%|        | 233/1203 [00:21<01:35, 10.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  20%|        | 236/1203 [00:21<01:36, 10.07it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  20%|        | 240/1203 [00:22<01:27, 10.96it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  20%|        | 244/1203 [00:22<01:10, 13.64it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  20%|        | 246/1203 [00:22<01:23, 11.45it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  21%|        | 250/1203 [00:23<01:28, 10.81it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  21%|        | 253/1203 [00:23<01:21, 11.69it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.2\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  21%|       | 258/1203 [00:23<01:18, 12.02it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  22%|       | 260/1203 [00:23<01:20, 11.77it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  22%|       | 265/1203 [00:24<01:12, 12.88it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  22%|       | 267/1203 [00:24<01:12, 12.89it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  22%|       | 269/1203 [00:24<01:28, 10.60it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  23%|       | 271/1203 [00:24<01:22, 11.25it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  23%|       | 276/1203 [00:25<01:15, 12.21it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  23%|       | 278/1203 [00:25<01:34,  9.80it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  24%|       | 283/1203 [00:25<01:11, 12.79it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  24%|       | 288/1203 [00:26<01:11, 12.88it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  24%|       | 290/1203 [00:26<01:10, 13.03it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  24%|       | 292/1203 [00:26<01:22, 11.09it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  25%|       | 297/1203 [00:27<01:23, 10.88it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  25%|       | 299/1203 [00:27<01:24, 10.64it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.2\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  25%|       | 301/1203 [00:27<01:15, 11.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  25%|       | 303/1203 [00:27<01:24, 10.68it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.9\n",
      "0.95\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  26%|       | 308/1203 [00:28<01:18, 11.35it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n",
      "0.9\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  26%|       | 313/1203 [00:28<01:13, 12.14it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  26%|       | 315/1203 [00:28<01:06, 13.34it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  27%|       | 319/1203 [00:29<01:19, 11.16it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.85\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  27%|       | 323/1203 [00:29<01:05, 13.49it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  27%|       | 327/1203 [00:29<01:17, 11.28it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.95\n",
      "0.85\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  28%|       | 331/1203 [00:30<01:15, 11.61it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.2\n",
      "0.95\n",
      "0.9\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  28%|       | 335/1203 [00:30<01:12, 11.95it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  28%|       | 339/1203 [00:30<01:18, 10.99it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.2\n",
      "0.2\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  29%|       | 343/1203 [00:31<01:14, 11.48it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  29%|       | 347/1203 [00:31<01:13, 11.60it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  29%|       | 350/1203 [00:31<00:59, 14.42it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  29%|       | 354/1203 [00:32<01:08, 12.39it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  30%|       | 358/1203 [00:32<01:00, 13.93it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  30%|       | 360/1203 [00:32<01:11, 11.75it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  30%|       | 365/1203 [00:33<01:03, 13.18it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  31%|       | 367/1203 [00:33<01:21, 10.24it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  31%|       | 371/1203 [00:33<01:17, 10.68it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  31%|       | 375/1203 [00:34<01:16, 10.80it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  31%|      | 377/1203 [00:34<01:24,  9.81it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  32%|      | 380/1203 [00:34<01:09, 11.87it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  32%|      | 385/1203 [00:34<01:10, 11.59it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  32%|      | 389/1203 [00:35<01:03, 12.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.3\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  33%|      | 393/1203 [00:35<01:15, 10.78it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  33%|      | 398/1203 [00:35<00:56, 14.35it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.8\n",
      "0.4\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  33%|      | 401/1203 [00:36<00:59, 13.56it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  33%|      | 403/1203 [00:36<01:04, 12.32it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  34%|      | 408/1203 [00:36<00:58, 13.60it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.4\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  34%|      | 410/1203 [00:36<00:59, 13.34it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  34%|      | 414/1203 [00:37<01:10, 11.20it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.95\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  35%|      | 418/1203 [00:37<01:00, 13.06it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  35%|      | 420/1203 [00:37<00:59, 13.25it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.6\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  35%|      | 422/1203 [00:38<01:07, 11.54it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  35%|      | 426/1203 [00:38<01:05, 11.94it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  36%|      | 428/1203 [00:38<00:58, 13.24it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  36%|      | 433/1203 [00:38<01:00, 12.67it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.4\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  36%|      | 435/1203 [00:39<01:18,  9.81it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  37%|      | 441/1203 [00:39<00:52, 14.53it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.3\n",
      "0.2\n",
      "0.85\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  37%|      | 443/1203 [00:39<01:05, 11.64it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  37%|      | 447/1203 [00:40<01:04, 11.69it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  37%|      | 449/1203 [00:40<00:57, 13.15it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.6\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  37%|      | 451/1203 [00:40<01:06, 11.27it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  38%|      | 457/1203 [00:40<00:53, 13.98it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.95\n",
      "0.2\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  38%|      | 459/1203 [00:41<00:49, 14.97it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  38%|      | 461/1203 [00:41<01:01, 12.12it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  39%|      | 468/1203 [00:41<00:51, 14.17it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  39%|      | 470/1203 [00:41<00:51, 14.11it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.8\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  39%|      | 474/1203 [00:42<01:11, 10.15it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.4\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  40%|      | 477/1203 [00:42<01:00, 12.07it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  40%|      | 479/1203 [00:42<01:07, 10.69it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  40%|      | 483/1203 [00:43<01:08, 10.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.2\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  40%|      | 486/1203 [00:43<00:55, 12.89it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.95\n",
      "0.2\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  41%|      | 490/1203 [00:43<00:56, 12.62it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  41%|      | 492/1203 [00:43<00:59, 12.03it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.2\n",
      "0.7\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  41%|     | 498/1203 [00:44<00:55, 12.70it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  42%|     | 502/1203 [00:44<00:53, 12.99it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  42%|     | 504/1203 [00:44<00:56, 12.28it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  42%|     | 506/1203 [00:45<00:54, 12.76it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  42%|     | 510/1203 [00:45<00:54, 12.69it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.85\n",
      "0.4\n",
      "0.85\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  43%|     | 514/1203 [00:45<00:42, 16.25it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  43%|     | 521/1203 [00:46<00:52, 12.96it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.85\n",
      "0.9\n",
      "0.2\n",
      "0.4\n",
      "0.3\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  44%|     | 525/1203 [00:46<00:51, 13.19it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  44%|     | 527/1203 [00:46<01:03, 10.73it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  44%|     | 530/1203 [00:47<01:06, 10.17it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  45%|     | 537/1203 [00:47<00:48, 13.74it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.2\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  45%|     | 539/1203 [00:47<00:47, 13.93it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  45%|     | 541/1203 [00:48<01:01, 10.75it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  45%|     | 546/1203 [00:48<00:52, 12.44it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.4\n",
      "0.4\n",
      "0.3\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  46%|     | 549/1203 [00:48<00:46, 14.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.2\n",
      "0.6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  46%|     | 553/1203 [00:49<00:58, 11.14it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.2\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  46%|     | 556/1203 [00:49<00:52, 12.35it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.4\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  46%|     | 559/1203 [00:49<00:47, 13.48it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  47%|     | 561/1203 [00:49<00:58, 10.94it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  47%|     | 564/1203 [00:49<00:53, 11.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  47%|     | 569/1203 [00:50<00:49, 12.83it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  47%|     | 571/1203 [00:50<00:46, 13.66it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.9\n",
      "0.85\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  48%|     | 577/1203 [00:51<00:54, 11.49it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.95\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  48%|     | 581/1203 [00:51<00:44, 14.05it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.4\n",
      "0.4\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  49%|     | 585/1203 [00:51<00:56, 10.99it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.6\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  49%|     | 587/1203 [00:51<00:52, 11.71it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  49%|     | 589/1203 [00:52<00:56, 10.92it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "1.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  49%|     | 594/1203 [00:52<00:48, 12.52it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.2\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  50%|     | 598/1203 [00:52<00:49, 12.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  50%|     | 601/1203 [00:53<00:45, 13.26it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.8\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  50%|     | 605/1203 [00:53<00:56, 10.62it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  51%|     | 608/1203 [00:53<00:47, 12.62it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  51%|     | 612/1203 [00:54<00:52, 11.36it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.2\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  51%|     | 614/1203 [00:54<01:00,  9.78it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  51%|    | 619/1203 [00:54<00:45, 12.85it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.3\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  52%|    | 621/1203 [00:55<01:00,  9.64it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  52%|    | 626/1203 [00:55<00:46, 12.51it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.95\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  52%|    | 628/1203 [00:55<01:15,  7.66it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  53%|    | 633/1203 [00:56<00:51, 11.15it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.95\n",
      "0.3\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  53%|    | 635/1203 [00:56<01:12,  7.83it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  53%|    | 641/1203 [00:57<00:47, 11.94it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.2\n",
      "0.4\n",
      "0.3\n",
      "0.4\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  53%|    | 643/1203 [00:57<00:52, 10.75it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  54%|    | 647/1203 [00:57<00:54, 10.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.85\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  54%|    | 651/1203 [00:58<00:56,  9.75it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n",
      "1.0\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  55%|    | 656/1203 [00:58<00:50, 10.76it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  55%|    | 658/1203 [00:58<00:51, 10.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  55%|    | 660/1203 [00:59<00:51, 10.59it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  55%|    | 665/1203 [00:59<00:42, 12.61it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.95\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  55%|    | 667/1203 [00:59<00:40, 13.11it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  56%|    | 669/1203 [00:59<00:47, 11.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  56%|    | 671/1203 [01:00<00:59,  8.91it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  56%|    | 674/1203 [01:00<00:50, 10.56it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  56%|    | 679/1203 [01:00<00:40, 13.07it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  57%|    | 683/1203 [01:01<00:39, 13.20it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  57%|    | 685/1203 [01:01<00:48, 10.78it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  57%|    | 687/1203 [01:01<01:06,  7.71it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  58%|    | 693/1203 [01:01<00:39, 12.78it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  58%|    | 696/1203 [01:02<00:48, 10.41it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  58%|    | 702/1203 [01:02<00:36, 13.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.85\n",
      "0.9\n",
      "0.9\n",
      "0.95\n",
      "0.35\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  59%|    | 707/1203 [01:03<00:45, 10.83it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  59%|    | 709/1203 [01:03<00:49,  9.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  59%|    | 712/1203 [01:03<00:46, 10.47it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  59%|    | 714/1203 [01:03<00:43, 11.27it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  60%|    | 718/1203 [01:04<00:38, 12.68it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  60%|    | 722/1203 [01:04<00:40, 11.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.4\n",
      "0.3\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  60%|    | 727/1203 [01:05<00:39, 12.05it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  61%|    | 729/1203 [01:05<00:41, 11.43it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  61%|    | 735/1203 [01:05<00:33, 14.11it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.6\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  61%|   | 737/1203 [01:05<00:35, 13.02it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  62%|   | 741/1203 [01:06<00:35, 13.14it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.2\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  62%|   | 746/1203 [01:06<00:37, 12.15it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  62%|   | 748/1203 [01:06<00:37, 12.17it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  62%|   | 750/1203 [01:06<00:36, 12.25it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  63%|   | 755/1203 [01:07<00:32, 13.95it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  63%|   | 759/1203 [01:07<00:34, 12.79it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.85\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  63%|   | 761/1203 [01:07<00:35, 12.61it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  63%|   | 763/1203 [01:08<00:44,  9.80it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  64%|   | 768/1203 [01:08<00:34, 12.53it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  64%|   | 770/1203 [01:08<00:34, 12.70it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  64%|   | 774/1203 [01:08<00:37, 11.29it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  65%|   | 776/1203 [01:09<00:34, 12.48it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  65%|   | 778/1203 [01:09<00:42,  9.92it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  65%|   | 780/1203 [01:09<00:55,  7.68it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  65%|   | 787/1203 [01:10<00:30, 13.65it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.9\n",
      "0.3\n",
      "0.3\n",
      "0.3\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  66%|   | 792/1203 [01:10<00:36, 11.31it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.8\n",
      "0.9\n",
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  66%|   | 797/1203 [01:10<00:25, 15.74it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  67%|   | 800/1203 [01:11<00:38, 10.53it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n",
      "0.85\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  67%|   | 806/1203 [01:11<00:30, 12.97it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  67%|   | 808/1203 [01:11<00:32, 12.01it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  67%|   | 810/1203 [01:12<00:34, 11.24it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  68%|   | 814/1203 [01:12<00:36, 10.54it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  68%|   | 818/1203 [01:12<00:28, 13.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  68%|   | 820/1203 [01:12<00:26, 14.26it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  68%|   | 824/1203 [01:13<00:31, 12.20it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.2\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  69%|   | 829/1203 [01:13<00:25, 14.50it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  69%|   | 831/1203 [01:13<00:27, 13.35it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  69%|   | 836/1203 [01:14<00:26, 13.72it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.85\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  70%|   | 838/1203 [01:14<00:26, 13.56it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  70%|   | 842/1203 [01:14<00:35, 10.23it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.85\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  70%|   | 847/1203 [01:15<00:24, 14.52it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.8\n",
      "0.95\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  71%|   | 849/1203 [01:15<00:31, 11.23it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  71%|   | 851/1203 [01:15<00:31, 11.34it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.85\n",
      "0.3\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  71%|   | 855/1203 [01:15<00:28, 12.30it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  71%|   | 857/1203 [01:16<00:33, 10.23it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  72%|  | 864/1203 [01:16<00:20, 16.66it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n",
      "0.3\n",
      "0.9\n",
      "0.3\n",
      "0.3\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  72%|  | 869/1203 [01:17<00:30, 11.01it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.9\n",
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  73%|  | 873/1203 [01:17<00:22, 14.79it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  73%|  | 876/1203 [01:17<00:29, 11.19it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.85\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  73%|  | 880/1203 [01:17<00:29, 11.03it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  73%|  | 882/1203 [01:18<00:32,  9.82it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  73%|  | 884/1203 [01:18<00:32,  9.89it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.8\n",
      "0.9\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  74%|  | 888/1203 [01:18<00:26, 11.86it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  74%|  | 894/1203 [01:19<00:25, 11.96it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.4\n",
      "0.9\n",
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "1.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  75%|  | 897/1203 [01:19<00:22, 13.76it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  75%|  | 899/1203 [01:19<00:27, 10.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  75%|  | 901/1203 [01:20<00:33,  8.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.85\n",
      "0.85\n",
      "0.3\n",
      "0.2\n",
      "0.9\n",
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  75%|  | 908/1203 [01:20<00:21, 13.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  76%|  | 912/1203 [01:20<00:25, 11.29it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  76%|  | 916/1203 [01:21<00:23, 12.37it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.4\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  77%|  | 921/1203 [01:21<00:25, 11.14it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.6\n",
      "0.3\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  77%|  | 923/1203 [01:21<00:23, 12.02it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  77%|  | 926/1203 [01:21<00:19, 14.31it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  77%|  | 931/1203 [01:22<00:22, 12.06it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.4\n",
      "0.3\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  78%|  | 935/1203 [01:22<00:21, 12.37it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  78%|  | 937/1203 [01:23<00:28,  9.24it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.8\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  78%|  | 943/1203 [01:23<00:18, 14.22it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.6\n",
      "0.9\n",
      "0.9\n",
      "0.85\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  79%|  | 945/1203 [01:23<00:23, 10.84it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  79%|  | 951/1203 [01:24<00:18, 13.94it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.9\n",
      "0.2\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  79%|  | 953/1203 [01:24<00:18, 13.56it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.8\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  80%|  | 958/1203 [01:24<00:22, 10.77it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n",
      "0.8\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  80%|  | 961/1203 [01:25<00:18, 13.20it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  80%|  | 965/1203 [01:25<00:22, 10.62it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.4\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  81%|  | 969/1203 [01:25<00:18, 12.54it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n",
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  81%|  | 973/1203 [01:26<00:21, 10.59it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.9\n",
      "0.2\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  81%|  | 976/1203 [01:26<00:17, 13.18it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  81%| | 978/1203 [01:26<00:17, 12.54it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  81%| | 980/1203 [01:26<00:19, 11.65it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  82%| | 984/1203 [01:27<00:20, 10.53it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.85\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  82%| | 987/1203 [01:27<00:18, 11.71it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  82%| | 989/1203 [01:27<00:16, 12.97it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  83%| | 994/1203 [01:28<00:16, 12.38it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.4\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  83%| | 998/1203 [01:28<00:16, 12.19it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  83%| | 1000/1203 [01:28<00:16, 12.12it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  83%| | 1004/1203 [01:28<00:17, 11.36it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  84%| | 1006/1203 [01:29<00:16, 12.10it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  84%| | 1010/1203 [01:29<00:16, 11.71it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  84%| | 1014/1203 [01:29<00:14, 13.10it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  85%| | 1018/1203 [01:29<00:13, 13.43it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.6\n",
      "0.9\n",
      "0.4\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  85%| | 1020/1203 [01:30<00:15, 11.51it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  85%| | 1024/1203 [01:30<00:16, 10.66it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.8\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  85%| | 1026/1203 [01:30<00:14, 12.18it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  86%| | 1030/1203 [01:31<00:13, 12.77it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n",
      "0.3\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  86%| | 1035/1203 [01:31<00:12, 13.13it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  86%| | 1040/1203 [01:31<00:13, 12.01it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.6\n",
      "0.85\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  87%| | 1042/1203 [01:32<00:13, 11.82it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.4\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  87%| | 1044/1203 [01:32<00:12, 12.58it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  87%| | 1048/1203 [01:32<00:14, 11.06it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.8\n",
      "0.4\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  87%| | 1052/1203 [01:32<00:12, 12.23it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.9\n",
      "0.8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  88%| | 1056/1203 [01:33<00:13, 10.96it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  88%| | 1058/1203 [01:33<00:14,  9.78it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  88%| | 1061/1203 [01:33<00:13, 10.75it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  89%| | 1065/1203 [01:34<00:12, 11.11it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  89%| | 1067/1203 [01:34<00:15,  8.84it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  89%| | 1071/1203 [01:34<00:12, 10.32it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.9\n",
      "0.4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  89%| | 1075/1203 [01:35<00:11, 11.40it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.0\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  90%| | 1077/1203 [01:35<00:15,  7.92it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.9\n",
      "0.3\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  90%| | 1084/1203 [01:36<00:08, 13.27it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.85\n",
      "0.4\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  90%| | 1088/1203 [01:36<00:10, 11.44it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  91%| | 1090/1203 [01:36<00:09, 11.57it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  91%| | 1092/1203 [01:36<00:10, 10.92it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  91%| | 1097/1203 [01:37<00:08, 13.15it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.9\n",
      "0.6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  91%|| 1099/1203 [01:37<00:08, 12.02it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  92%|| 1101/1203 [01:37<00:09, 10.26it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  92%|| 1106/1203 [01:38<00:07, 12.45it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.8\n",
      "0.9\n",
      "0.95\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  92%|| 1108/1203 [01:38<00:08, 11.83it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  92%|| 1110/1203 [01:38<00:10,  8.79it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.4\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  93%|| 1115/1203 [01:38<00:08, 10.64it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  93%|| 1120/1203 [01:39<00:06, 11.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.2\n",
      "0.85\n",
      "0.9\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  94%|| 1125/1203 [01:39<00:05, 13.90it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  94%|| 1127/1203 [01:39<00:05, 12.74it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.85\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  94%|| 1131/1203 [01:40<00:05, 13.71it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  94%|| 1135/1203 [01:40<00:04, 15.55it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  95%|| 1140/1203 [01:40<00:05, 11.40it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.2\n",
      "0.3\n",
      "0.6\n",
      "0.9\n",
      "0.95\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  95%|| 1145/1203 [01:41<00:03, 17.80it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.2\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  95%|| 1148/1203 [01:41<00:05, 10.32it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.2\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  96%|| 1150/1203 [01:41<00:04, 10.86it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  96%|| 1154/1203 [01:42<00:04, 11.36it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.2\n",
      "0.6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  96%|| 1157/1203 [01:42<00:03, 12.81it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.85\n",
      "0.3\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  97%|| 1162/1203 [01:42<00:03, 13.39it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.2\n",
      "0.2\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  97%|| 1167/1203 [01:43<00:03, 11.51it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.3\n",
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  97%|| 1172/1203 [01:43<00:02, 14.98it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.85\n",
      "0.2\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  98%|| 1174/1203 [01:43<00:02, 13.48it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  98%|| 1176/1203 [01:44<00:02,  9.47it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  98%|| 1179/1203 [01:44<00:02, 11.96it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.95\n",
      "0.3\n",
      "0.2\n",
      "0.9\n",
      "0.2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  98%|| 1182/1203 [01:44<00:01, 10.76it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  99%|| 1186/1203 [01:44<00:01, 10.37it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  99%|| 1190/1203 [01:45<00:00, 14.30it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.3\n",
      "0.4\n",
      "0.85\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing:  99%|| 1192/1203 [01:45<00:00, 13.02it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.4\n",
      "0.6\n",
      "0.9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing: 100%|| 1197/1203 [01:45<00:00, 11.48it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.2\n",
      "0.2\n",
      "0.9\n",
      "0.4\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing: 100%|| 1201/1203 [01:45<00:00, 14.97it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "0.6\n",
      "0.6\n",
      "0.3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing: 100%|| 1203/1203 [01:46<00:00, 11.33it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.3\n",
      "\n",
      " Done! Time: 0:01:46.220703\n",
      " Causal found: 646\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from tqdm import tqdm\n",
    "from openai import AzureOpenAI\n",
    "import concurrent.futures\n",
    "import threading\n",
    "\n",
    "# ==== Azure OpenAI Config ====\n",
    "AZURE_OPENAI_API_KEY = \"CqSAIM2DLgxvf6S58h8dOYHVKPzMdumoTXLeZMtzLWZhfkKtNkN8JQQJ99BFACF24PCXJ3w3AAABACOGe0ty\"\n",
    "AZURE_OPENAI_ENDPOINT = \"https://teccspazureopenai.openai.azure.com/\"\n",
    "AZURE_DEPLOYMENT = \"gpt-4o\" \n",
    "\n",
    "# ==== Initialize Azure Client ====\n",
    "client = AzureOpenAI(\n",
    "    api_key=AZURE_OPENAI_API_KEY,\n",
    "    azure_endpoint=AZURE_OPENAI_ENDPOINT,\n",
    "    api_version=\"2024-02-01\"\n",
    ")\n",
    "\n",
    "# ==== Thread Safety & Custom JSON Encoding ====\n",
    "log_lock = threading.Lock()\n",
    "\n",
    "class NpEncoder(json.JSONEncoder):\n",
    "    \"\"\"Custom encoder to handle standard Pandas/Numpy types during JSON logging.\"\"\"\n",
    "    def default(self, obj):\n",
    "        if isinstance(obj, np.integer):\n",
    "            return int(obj)\n",
    "        if isinstance(obj, np.floating):\n",
    "            return float(obj)\n",
    "        if isinstance(obj, np.ndarray):\n",
    "            return obj.tolist()\n",
    "        if pd.isna(obj):\n",
    "            return None\n",
    "        return super(NpEncoder, self).default(obj)\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_disease\"\n",
    "\n",
    "try:\n",
    "    data = pd.read_csv(DATA_PATH, sep='\\t')\n",
    "except FileNotFoundError:\n",
    "    print(\"Warning: File not found. Creating dummy data for test.\")\n",
    "    data = pd.DataFrame({\n",
    "        \"id1\": [\"GeneA\"] * 5,\n",
    "        \"id2\": [f\"Disease{i}\" for i in range(5)],\n",
    "        \"sentence\": [\"This gene causes disease.\"] * 5,\n",
    "        \"label\": [1, 0, 1, 0, 1]\n",
    "    })\n",
    "\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "if not required_cols.issubset(data.columns):\n",
    "    raise ValueError(f\"Missing columns. Found: {data.columns}\")\n",
    "\n",
    "# Find Label Column\n",
    "LABEL_COL = None\n",
    "for col in [\"label\", \"Label\", \"labels\", \"Labels\", \"ground_truth\", \"class\"]:\n",
    "    if col in data.columns:\n",
    "        LABEL_COL = col\n",
    "        print(f\"Found label column: '{LABEL_COL}'\")\n",
    "        break\n",
    "\n",
    "# Group data\n",
    "grouped_data = []\n",
    "for (id1, id2), group in data.groupby([\"id1\", \"id2\"]):\n",
    "    sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "    \n",
    "    label = None\n",
    "    if LABEL_COL:\n",
    "        unique_labels = group[LABEL_COL].dropna().unique()\n",
    "        if len(unique_labels) >= 1:\n",
    "            label = group[LABEL_COL].mode().iloc[0] if not group[LABEL_COL].mode().empty else unique_labels[0]\n",
    "    \n",
    "    grouped_data.append({\n",
    "        \"id1\": id1,\n",
    "        \"id2\": id2,\n",
    "        \"sentences\": sentences,\n",
    "        \"original_label\": label\n",
    "    })\n",
    "\n",
    "print(f\"Processing {len(grouped_data)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_llm_results.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_raw_responses.jsonl\")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Prompts ===============\n",
    "# ============================\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between @DiseaseTgt and the @GeneSrc.\n",
    "Predict it causal if it is explicitly mentioned in the text. Do not use your pre-acquired knowledge. Associations are not causal relations. \n",
    "\n",
    "Respond ONLY with valid JSON in this exact format:\n",
    "score should be based on strength of causality based on abstract provided .think this as probability of being causal .\n",
    "{\n",
    "  \"relationship\": \"Causal\" or \"Not causal\",\n",
    "  \"score\": <float between 0 and 1>\n",
    "}\n",
    "\"\"\"\n",
    "\n",
    "def build_user_prompt(sentences, gene, disease):\n",
    "    return f\"Gene: {gene}\\nDisease: {disease}\\n\\nSentences:\\n{sentences}\\n\\nDoes {gene} cause {disease}?\\nReturn only valid JSON.\"\n",
    "\n",
    "# ============================\n",
    "# ==== Azure Call ============\n",
    "# ============================\n",
    "def call_azure_openai(item):\n",
    "    id1, id2 = item[\"id1\"], item[\"id2\"]\n",
    "    text, original_label = item[\"sentences\"], item[\"original_label\"]\n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=AZURE_DEPLOYMENT,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": build_user_prompt(text, ' @GeneSrc', '@DiseaseTgt')}\n",
    "            ],\n",
    "            max_tokens=100,\n",
    "            temperature=0.7,\n",
    "            response_format={\"type\": \"json_object\"}, \n",
    "        )\n",
    "        \n",
    "        content = resp.choices[0].message.content\n",
    "        parsed = json.loads(content)\n",
    "        \n",
    "        # Thread-safe logging using the Custom Encoder\n",
    "        log_entry = {\n",
    "            \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "            \"id1\": str(id1),\n",
    "            \"id2\": str(id2),\n",
    "            \"original_label\": original_label,\n",
    "            \"response\": parsed\n",
    "        }\n",
    "        \n",
    "        with log_lock:\n",
    "            with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "                f.write(json.dumps(log_entry, cls=NpEncoder) + \"\\n\")\n",
    "        print(parsed.get(\"score\", 0.0))\n",
    "        \n",
    "        return {\n",
    "            \"id1\": id1, \"id2\": id2, \"original_label\": original_label,\n",
    "            \"llm_relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "            \"llm_score\": parsed.get(\"score\", 0.0)\n",
    "        }\n",
    "    \n",
    "    except Exception as e:\n",
    "        return {\n",
    "            \"id1\": id1, \"id2\": id2, \"original_label\": original_label,\n",
    "            \"llm_relationship\": \"Error\", \"llm_score\": 0.0, \"error_msg\": str(e)\n",
    "        }\n",
    "\n",
    "# ============================\n",
    "# ==== Execution =============\n",
    "# ============================\n",
    "def process_all_parallel(max_workers=10):\n",
    "    results = []\n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor:\n",
    "        futures = [executor.submit(call_azure_openai, item) for item in grouped_data]\n",
    "        for future in tqdm(concurrent.futures.as_completed(futures), total=len(futures), desc=\"Processing\"):\n",
    "            results.append(future.result())\n",
    "    return results\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    start_time = datetime.datetime.now()\n",
    "    final_results = process_all_parallel(max_workers=10)\n",
    "    \n",
    "    df_results = pd.DataFrame(final_results)\n",
    "    cols_order = [\"id1\", \"id2\", \"original_label\", \"llm_relationship\", \"llm_score\", \"error_msg\"]\n",
    "    df_results = df_results[[c for c in cols_order if c in df_results.columns]]\n",
    "    df_results.to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    \n",
    "    print(f\"\\n Done! Time: {datetime.datetime.now() - start_time}\")\n",
    "    print(f\" Causal found: {(df_results['llm_relationship'] == 'Causal').sum()}\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "328afa34-379f-4c13-9d1a-40b76baa684b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      " 1q\t\t\t\t\t     llm_training.ipynb\n",
      " bert_gt\t\t\t\t     logs\n",
      " best_causal_f1_model.pth\t\t     merged_model_for_vllm\n",
      " bharat\t\t\t\t\t     mmed_llama_finetuning.ipynb\n",
      " causal_analysis_results.csv\t\t     myfiles.zip\n",
      " causal_analysis_results_omim.csv\t     negative_data_creation.ipynb\n",
      " causal_analysis_results_omim_GPT4o_PD.csv   new_train_data\n",
      " causal_analysis_results_openai.csv\t     nltk_data\n",
      " causal_analysis_results_parallel.csv\t     nohup.out\n",
      "'Causal score OMIM vs complete AD.png'\t     openai.ipynb\n",
      "'Causal score OMIM vs complete PD.png'\t     outputs\n",
      " CRED_application\t\t\t     outputs_grpo_hf\n",
      " custom_datasets\t\t\t     outputs_grpo_pmcllama_v2\n",
      " datasets\t\t\t\t     pertub_seq_data_analysis\n",
      " environment.yml\t\t\t     phi4_finetuning.ipynb\n",
      " genomics_data\t\t\t\t     PR_curve_AD.png\n",
      " grpo_saved_lora_ohi\t\t\t     PR_curve_neg_AD.png\n",
      " grpo_saved_lora_phi_full_training_data      PR_curve_neg_PD.png\n",
      " grpo_saved_lora_phi_partial_training_data   PR_curve_PD.png\n",
      " grpo_saved_MED__partial_training_data\t     Recall_curve_AD.png\n",
      " grpo_trainer_lora_model\t\t     Recall_curve_neg_AD.png\n",
      " GT-BERT.pem\t\t\t\t     Recall_curve_neg_PD.png\n",
      " kachra\t\t\t\t\t     Recall_curve_PD.png\n",
      " llm\t\t\t\t\t     requirements.txt\n",
      " LLM_Inference_AD.ipynb\t\t\t     sunnobva.ipynb\n",
      " LLM_inference_AD_OMIM.csv\t\t     tempfile.txt\n",
      " LLM_Inference_AD_to_submit.ipynb\t     test\n",
      " LLM_Inference_All_disease.ipynb\t     test_data.txt\n",
      " LLM_inference_neg_AD_OMIM.csv\t\t     train_absa.py\n",
      " LLM_inference_neg_PD_OMIM.csv\t\t     train_data.csv\n",
      " LLM_Inference_PD.ipynb\t\t\t     truth_discovery\n",
      " LLM_inference_PD_OMIM.csv\t\t     unsloth_compiled_cache\n",
      " LLM_Inference_PD_to_submit.ipynb\t     Untitled1.ipynb\n",
      " llm_results\t\t\t\t     Untitled2.ipynb\n",
      " llm_results_20251224.csv\t\t     Untitled3.ipynb\n",
      " llm_results_gemini\t\t\t     Untitled4.ipynb\n",
      " llm_results_omim_pd_new.csv\t\t     Untitled.ipynb\n",
      " llm_sessions\t\t\t\t    'val_data (3).txt'\n",
      " llm_training_grpo.ipynb\t\t     wandb\n"
     ]
    }
   ],
   "source": [
    "!ls"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bf2c8f68-6c5c-442b-ad3a-cef833a95004",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.read_csv('llm_results_20251224.csv').rename(columns={'llm_score':'score'}).to_csv('llm_results_20251224.csv',index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "faa02a21-d161-4959-810f-e858be92466a",
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip install google-generativeai"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7a071102-1c78-4561-a9d7-95ae9ef50f31",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "import google.generativeai as genai\n",
    "from google.api_core import retry\n",
    "import concurrent.futures\n",
    "import threading\n",
    "import time\n",
    "\n",
    "# ==== Google Gemini Config ====\n",
    "# REPLACE WITH YOUR ACTUAL GOOGLE AI STUDIO KEY\n",
    "GOOGLE_API_KEY = \"AIzaSyDMm0opkyBczPqdsD1RrJtLjuvDd4r0lbo\"\n",
    "\n",
    "# Configure the SDK\n",
    "genai.configure(api_key=GOOGLE_API_KEY)\n",
    "\n",
    "# Initialize Model with System Instruction\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the provided sentences to determine whether a causal relationship exists between the Gene and the Disease.\n",
    "\n",
    "Respond ONLY with a JSON object containing two keys:\n",
    "1. \"relationship\": String, either \"Causal\" or \"Not causal\"\n",
    "2. \"confidence\": Float, between 0.0 (non-causal) and 1.0 (certainly causal)\n",
    "\n",
    "Example Output:\n",
    "{\"relationship\": \"Causal\", \"confidence\": 0.95}\n",
    "\"\"\"\n",
    "\n",
    "model = genai.GenerativeModel(\n",
    "    model_name=\"gemini-3-flash-preview\",\n",
    "    system_instruction=SYSTEM_PROMPT\n",
    ")\n",
    "\n",
    "# ==== Thread Safety ====\n",
    "log_lock = threading.Lock()\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_diseasae\"\n",
    "\n",
    "try:\n",
    "    data = pd.read_csv(DATA_PATH, sep='\\t')\n",
    "except FileNotFoundError:\n",
    "    print(\"Warning: File not found. Creating dummy data for test.\")\n",
    "    data = pd.DataFrame({\n",
    "        \"id1\": [\"GeneA\"] * 20,\n",
    "        \"id2\": [f\"Disease{i}\" for i in range(20)],\n",
    "        \"sentence\": [\"This gene has been shown to cause the disease in multiple studies.\"] * 20\n",
    "    })\n",
    "\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "if not required_cols.issubset(data.columns):\n",
    "    raise ValueError(f\"Missing columns. Found: {data.columns}\")\n",
    "\n",
    "grouped = list(data.groupby([\"id1\", \"id2\"]))\n",
    "print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "BASE_RESULTS_DIR = \"llm_results_gemini\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_gemini_results.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_gemini_raw.jsonl\")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Gemini Call ===========\n",
    "# ============================\n",
    "def call_gemini(id1, id2, text):\n",
    "    user_prompt = f\"\"\"\n",
    "    Gene: {id1}\n",
    "    Disease: {id2}\n",
    "    \n",
    "    Sentences:\n",
    "    {text}\n",
    "    \n",
    "    Does {id1} cause {id2}?\n",
    "    \"\"\"\n",
    "    \n",
    "    try:\n",
    "        # Generate content with JSON enforcement\n",
    "        response = model.generate_content(\n",
    "            user_prompt,\n",
    "            generation_config={\n",
    "                \"response_mime_type\": \"application/json\",\n",
    "                \"temperature\": 0.2, # Lower temp is usually better for classification\n",
    "            },\n",
    "            request_options={\"retry\": retry.Retry(predicate=retry.if_transient_error)} # Auto-retry on network glitches\n",
    "        )\n",
    "        \n",
    "        content = response.text\n",
    "        parsed = json.loads(content)\n",
    "        print(parsed)\n",
    "        \n",
    "        # Thread-safe logging\n",
    "        with log_lock:\n",
    "            with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "                f.write(json.dumps({\n",
    "                    \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                    \"id1\": str(id1),\n",
    "                    \"id2\": str(id2),\n",
    "                    \"response\": content\n",
    "                }) + \"\\n\")\n",
    "        \n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "            \"score\": parsed.get(\"confidence\", 0.0)\n",
    "        }\n",
    "    \n",
    "    except Exception as e:\n",
    "        # Handle \"429 Resource Exhausted\" specifically if needed, \n",
    "        # but the retry logic above handles transient errors.\n",
    "        print(e)\n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": \"Error\",\n",
    "            \"score\": 0.0,\n",
    "            \"error_msg\": str(e)\n",
    "        }\n",
    "\n",
    "# ============================\n",
    "# ==== Process All (Parallel)\n",
    "# ============================\n",
    "def process_all_parallel(max_workers=10):\n",
    "    results = []\n",
    "    \n",
    "    # Note: Gemini Free Tier has rate limits (RPM). \n",
    "    # If using Paid Tier, 10 workers is fine. \n",
    "    # If Free Tier, you might hit limits with 10 workers.\n",
    "    \n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor:\n",
    "        future_to_ids = {}\n",
    "        \n",
    "        for (id1, id2), group in grouped:\n",
    "            sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "            future = executor.submit(call_gemini, id1, id2, sentences)\n",
    "            future_to_ids[future] = (id1, id2)\n",
    "\n",
    "        for future in tqdm(concurrent.futures.as_completed(future_to_ids), \n",
    "                           total=len(grouped), \n",
    "                           desc=f\"Processing (Gemini Pro)\"):\n",
    "            try:\n",
    "                data = future.result()\n",
    "                results.append(data)\n",
    "                \n",
    "                # Optional: Sleep slightly if hitting rate limits\n",
    "                # time.sleep(0.5) \n",
    "            except Exception as exc:\n",
    "                id1, id2 = future_to_ids[future]\n",
    "                print(f\"Exception for {id1}-{id2}: {exc}\")\n",
    "\n",
    "    return results\n",
    "\n",
    "# ============================\n",
    "# ==== RUN ====================\n",
    "# ============================\n",
    "if __name__ == \"__main__\":\n",
    "    start_time = datetime.datetime.now()\n",
    "    \n",
    "    # Run\n",
    "    results = process_all_parallel(max_workers=10)\n",
    "    \n",
    "    # Save\n",
    "    df_results = pd.DataFrame(results)\n",
    "    df_results.to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    \n",
    "    print(\"\\n Completed Successfully with Gemini\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "9ebd67f5-f25b-46c2-8db6-1b6344e01554",
   "metadata": {},
   "outputs": [],
   "source": [
    "#medllama.py"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "917e8976-bc09-4dfe-bf18-04c0893f1c20",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import OpenAI\n",
    "import tiktoken\n",
    "import instructor\n",
    "from pydantic import BaseModel, Field, model_validator\n",
    "from typing import Literal, Any\n",
    "import concurrent.futures\n",
    "import threading\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM CONFIG ===========\n",
    "# ============================\n",
    "\n",
    "VLLM_ENDPOINT = \"http://localhost:8000/v1\"\n",
    "VLLM_API_KEY = \"token-abc123\"\n",
    "VLLM_MODEL = \"Henrychur/MMed-Llama-3-8B\"\n",
    "MAX_WORKERS = 10  # Number of parallel requests\n",
    "\n",
    "base_client = OpenAI(\n",
    "    base_url=VLLM_ENDPOINT,\n",
    "    api_key=VLLM_API_KEY,\n",
    "    timeout=60.0  # Add timeout to prevent hanging threads\n",
    ")\n",
    "\n",
    "client = instructor.from_openai(base_client, mode=instructor.Mode.JSON)\n",
    "\n",
    "# ============================\n",
    "# ==== Pydantic Schema =======\n",
    "# ============================\n",
    "\n",
    "class CausalAnalysis(BaseModel):\n",
    "    relationship: Literal[\"Causal\", \"Not causal\"] = Field(\n",
    "        ..., \n",
    "        description=\"Classify the relationship. Value must be exactly 'Causal' or 'Not causal'\"\n",
    "    )\n",
    "    score: float = Field(\n",
    "        ..., \n",
    "        ge=0.0, \n",
    "        le=1.0, \n",
    "        description=\"Confidence score (0.0 to 1.0).\"\n",
    "    )\n",
    "\n",
    "    @model_validator(mode='before')\n",
    "    @classmethod\n",
    "    def robust_validator(cls, data: Any) -> Any:\n",
    "        if isinstance(data, list):\n",
    "            return {\"relationship\": \"Not causal\", \"score\": 0.0}\n",
    "        \n",
    "        if isinstance(data, dict):\n",
    "            if \"data\" in data and isinstance(data[\"data\"], dict):\n",
    "                data = data[\"data\"]\n",
    "            elif \"result\" in data and isinstance(data[\"result\"], dict):\n",
    "                data = data[\"result\"]\n",
    "                \n",
    "        return data\n",
    "\n",
    "# ============================\n",
    "# ==== Global Setup ==========\n",
    "# ============================\n",
    "\n",
    "try:\n",
    "    tokenizer = tiktoken.encoding_for_model(\"gpt-3.5-turbo\")\n",
    "except:\n",
    "    tokenizer = tiktoken.get_encoding(\"cl100k_base\")\n",
    "\n",
    "# Limits\n",
    "INITIAL_MAX_TOKENS = 1200   # Start with this\n",
    "MIN_TOKENS = 400            # Don't go below this\n",
    "MAX_CHARS_HARD_LIMIT = 6000 # Hard cap for safety\n",
    "\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_diseasae\"\n",
    "MODEL_NAME = \"MMed-Llama-3-8B\"\n",
    "\n",
    "if not os.path.exists(DATA_PATH):\n",
    "    raise FileNotFoundError(f\"Could not find {DATA_PATH}\")\n",
    "\n",
    "# Output Paths\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "DATESTAMP = datetime.datetime.now().strftime(\"%Y-%m-%d\")\n",
    "\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_llm_results_{DATESTAMP}.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_raw_responses_{DATESTAMP}.jsonl\")\n",
    "\n",
    "# Clean up old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# Thread Lock for writing to files\n",
    "file_lock = threading.Lock()\n",
    "\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between two entities.\n",
    "\n",
    "Respond ONLY with one of the two relationship labels:\n",
    "  - Causal\n",
    "  - Not causal\n",
    "Then provide a confidence score between 0 and 1. Here 0 represents non causal and 1 represents causal.\n",
    "\n",
    "The response MUST follow this exact format (no extra text, no explanation):\n",
    "\n",
    "**** <relationship>: <score> ****\n",
    "\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== Core Logic ============\n",
    "# ============================\n",
    "\n",
    "def get_truncated_text(text, max_tokens):\n",
    "    \"\"\"Helper to truncate text to specific token count\"\"\"\n",
    "    if len(text) > MAX_CHARS_HARD_LIMIT:\n",
    "        text = text[:MAX_CHARS_HARD_LIMIT]\n",
    "        \n",
    "    tokens = tokenizer.encode(text)\n",
    "    if len(tokens) > max_tokens:\n",
    "        tokens = tokens[:max_tokens]\n",
    "        return tokenizer.decode(tokens)\n",
    "    return text\n",
    "\n",
    "def process_single_pair(args):\n",
    "    \"\"\"Worker function for a single ID pair\"\"\"\n",
    "    id1, id2, full_text = args\n",
    "    \n",
    "    current_token_limit = INITIAL_MAX_TOKENS\n",
    "    attempts = 0\n",
    "    max_attempts = 3  # Try: 1200 -> 900 -> 600\n",
    "    \n",
    "    while attempts < max_attempts:\n",
    "        try:\n",
    "            # 1. Prepare text with current limit\n",
    "            input_text = get_truncated_text(full_text, current_token_limit)\n",
    "            \n",
    "            # 2. Call API\n",
    "            resp = client.chat.completions.create(\n",
    "                model=VLLM_MODEL,\n",
    "                messages=[\n",
    "                    {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                    {\"role\": \"user\", \"content\": f\"Text:\\n{input_text}\"}\n",
    "                ],\n",
    "                response_model=CausalAnalysis,\n",
    "                max_tokens=500,\n",
    "                temperature=0,\n",
    "                max_retries=1 # Let our loop handle major retries\n",
    "            )\n",
    "\n",
    "            # 3. Success! Write Log\n",
    "            with file_lock:\n",
    "                with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "                    f.write(json.dumps({\n",
    "                        \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                        \"id1\": str(id1),\n",
    "                        \"id2\": str(id2),\n",
    "                        \"tokens_used\": current_token_limit,\n",
    "                        \"response\": resp.model_dump()\n",
    "                    }) + \"\\n\")\n",
    "\n",
    "            return {\n",
    "                \"id1\": id1,\n",
    "                \"id2\": id2,\n",
    "                \"relationship\": resp.relationship,\n",
    "                \"score\": resp.score\n",
    "            }\n",
    "\n",
    "        except Exception as e:\n",
    "            error_msg = str(e).lower()\n",
    "            \n",
    "            # Check if it's a context length error or similar\n",
    "            if \"context length\" in error_msg or \"maximum context\" in error_msg or \"400\" in error_msg:\n",
    "                # Reduce tokens by 25% and retry\n",
    "                new_limit = int(current_token_limit * 0.75)\n",
    "                if new_limit < MIN_TOKENS:\n",
    "                    break # Give up if too small\n",
    "                \n",
    "                # print(f\" {id1}-{id2}: Reducing tokens {current_token_limit} -> {new_limit}\")\n",
    "                current_token_limit = new_limit\n",
    "                attempts += 1\n",
    "                continue\n",
    "            else:\n",
    "                # If it's a different error (like connection), fail immediately or handle differently\n",
    "                # print(f\" Error {id1}-{id2}: {e}\")\n",
    "                break\n",
    "\n",
    "    # If all attempts fail\n",
    "    with file_lock:\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"error\": \"Max retries exceeded or fatal error\"\n",
    "            }) + \"\\n\")\n",
    "            \n",
    "    return {\"id1\": id1, \"id2\": id2, \"relationship\": \"Error\", \"score\": 0.0}\n",
    "\n",
    "# ============================\n",
    "# ==== Runner ================\n",
    "# ============================\n",
    "\n",
    "def run_parallel():\n",
    "    data = pd.read_csv(DATA_PATH,sep='\\t')\n",
    "    grouped = data.groupby([\"id1\", \"id2\"])\n",
    "    \n",
    "    # Prepare tasks list\n",
    "    tasks = []\n",
    "    for (id1, id2), group in grouped:\n",
    "        sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "        tasks.append((id1, id2, sentences))\n",
    "    \n",
    "    print(f\" Starting parallel processing for {len(tasks)} pairs with {MAX_WORKERS} workers...\")\n",
    "    \n",
    "    results = []\n",
    "    \n",
    "    # Execute in parallel\n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=MAX_WORKERS) as executor:\n",
    "        # Submit all tasks\n",
    "        futures = {executor.submit(process_single_pair, task): task for task in tasks}\n",
    "        \n",
    "        # Monitor with tqdm\n",
    "        for future in tqdm(concurrent.futures.as_completed(futures), total=len(tasks), desc=\"Processing\"):\n",
    "            try:\n",
    "                result = future.result()\n",
    "                results.append(result)\n",
    "            except Exception as exc:\n",
    "                print(f\"Generated an exception: {exc}\")\n",
    "\n",
    "    # Save final CSV\n",
    "    pd.DataFrame(results).to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    run_parallel()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f536cc27-3e31-4299-b74a-16c07489961a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import AzureOpenAI\n",
    "import concurrent.futures\n",
    "import threading\n",
    "\n",
    "# ==== Azure OpenAI Config ====\n",
    "# REPLACE WITH YOUR ACTUAL KEY IF NEEDED\n",
    "AZURE_OPENAI_API_KEY = \"CqSAIM2DLgxvf6S58h8dOYHVKPzMdumoTXLeZMtzLWZhfkKtNkN8JQQJ99BFACF24PCXJ3w3AAABACOGe0ty\"\n",
    "AZURE_OPENAI_ENDPOINT = \"https://teccspazureopenai.openai.azure.com/\"\n",
    "AZURE_DEPLOYMENT = \"gpt-4o\" \n",
    "\n",
    "# ==== Initialize Azure Client ====\n",
    "client = AzureOpenAI(\n",
    "    api_key=AZURE_OPENAI_API_KEY,\n",
    "    azure_endpoint=AZURE_OPENAI_ENDPOINT,\n",
    "    api_version=\"2024-02-01\"\n",
    ")\n",
    "\n",
    "# ==== Thread Safety ====\n",
    "# Lock is required so multiple threads don't write to the log file simultaneously\n",
    "log_lock = threading.Lock()\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_diseasae\"\n",
    "\n",
    "# Fixed syntax error: assuming tab-separated value (.tsv)\n",
    "try:\n",
    "    data = pd.read_csv(DATA_PATH, sep='\\t')\n",
    "except FileNotFoundError:\n",
    "    # Fallback for demonstration if file doesn't exist\n",
    "    print(\"Warning: File not found. Creating dummy data for test.\")\n",
    "    data = pd.DataFrame({\n",
    "        \"id1\": [\"GeneA\"] * 20,\n",
    "        \"id2\": [f\"Disease{i}\" for i in range(20)],\n",
    "        \"sentence\": [\"This gene causes disease.\"] * 20\n",
    "    })\n",
    "\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "if not required_cols.issubset(data.columns):\n",
    "    raise ValueError(f\"Missing columns. Found: {data.columns}\")\n",
    "\n",
    "grouped = list(data.groupby([\"id1\", \"id2\"])) # Convert to list for tqdm total count\n",
    "print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_llm_results.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_raw_responses.jsonl\")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Prompts ===============\n",
    "# ============================\n",
    "# UPDATED: Prompt must explicitly ask for JSON structure to match your parsing logic\n",
    " \n",
    "SYSTEM_PROMPT =  \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between @GeneSrc aand @DiseaseTgt.\n",
    "Predict it causal if it is explicitly mentioned in the text. Do not use your pre-acquired knowledge. Associations are not causal relations. \n",
    "\n",
    "\n",
    "Respond ONLY with one of the two relationship labels:\n",
    "  - Causal\n",
    "  - Not causal\n",
    "Then provide a confidence score between 0 and 1. Here 0 represents non causal and 1 represents causal.\n",
    "try to be variable in score , dont give 0 and 1 ,give confidence score based on strength\n",
    "\n",
    "The response MUST follow this exact format (no extra text, no explanation):\n",
    "\n",
    "**** <relationship>: <score> ****\n",
    "\"\"\"\n",
    "def build_user_prompt(sentences, gene, disease):\n",
    "    return f\"\"\"\n",
    "Gene: {gene}\n",
    "Disease: {disease}\n",
    "\n",
    "Sentences:\n",
    "{sentences}\n",
    "\n",
    "Does {gene} cause {disease}?\n",
    "Return only valid JSON.\n",
    "\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== Azure Call ============\n",
    "# ============================\n",
    "def call_azure_openai(id1, id2, text):\n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=AZURE_DEPLOYMENT,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": build_user_prompt(text, id1, id2)}\n",
    "            ],\n",
    "            max_tokens=100,\n",
    "            temperature=0.7,\n",
    "            response_format={\"type\": \"json_object\"}, \n",
    "        )\n",
    "        \n",
    "        content = resp.choices[0].message.content\n",
    "        parsed = json.loads(content)\n",
    "        \n",
    "        # Thread-safe logging\n",
    "        with log_lock:\n",
    "            with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "                f.write(json.dumps({\n",
    "                    \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                    \"id1\": str(id1),\n",
    "                    \"id2\": str(id2),\n",
    "                    \"response\": content\n",
    "                }) + \"\\n\")\n",
    "        \n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "            \"score\": parsed.get(\"score\", 0.0)\n",
    "        }\n",
    "    \n",
    "    except Exception as e:\n",
    "        # print(f\"Error processing {id1}-{id2}: {str(e)}\") # Optional: comment out to reduce noise\n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": \"Error\",\n",
    "            \"score\": 0.0,\n",
    "            \"error_msg\": str(e)\n",
    "        }\n",
    "\n",
    "# ============================\n",
    "# ==== Process All (Parallel)\n",
    "# ============================\n",
    "def process_all_parallel(max_workers=10):\n",
    "    results = []\n",
    "    \n",
    "    # Create the executor\n",
    "    with concurrent.futures.ThreadPoolExecutor(max_workers=max_workers) as executor:\n",
    "        # Submit all tasks\n",
    "        # We create a dictionary to map futures back to their IDs if needed\n",
    "        future_to_ids = {}\n",
    "        \n",
    "        for (id1, id2), group in grouped:\n",
    "            sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "            # Submit task\n",
    "            future = executor.submit(call_azure_openai, id1, id2, sentences)\n",
    "            future_to_ids[future] = (id1, id2)\n",
    "\n",
    "        # Process as they complete with tqdm bar\n",
    "        for future in tqdm(concurrent.futures.as_completed(future_to_ids), \n",
    "                           total=len(grouped), \n",
    "                           desc=f\"Processing (Parallel={max_workers})\"):\n",
    "            try:\n",
    "                data = future.result()\n",
    "                results.append(data)\n",
    "            except Exception as exc:\n",
    "                id1, id2 = future_to_ids[future]\n",
    "                print(f\"Generated an exception for {id1}-{id2}: {exc}\")\n",
    "\n",
    "    return results\n",
    "\n",
    "# ============================\n",
    "# ==== RUN ====================\n",
    "# ============================\n",
    "if __name__ == \"__main__\":\n",
    "    start_time = datetime.datetime.now()\n",
    "    \n",
    "    results = process_all_parallel(max_workers=10)\n",
    "    \n",
    "    # Save Final CSV\n",
    "    df_results = pd.DataFrame(results)\n",
    "    df_results.to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    \n",
    "    end_time = datetime.datetime.now()\n",
    "    duration = end_time - start_time\n",
    "    \n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(f\" Time taken: {duration}\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5d06df6d-947b-449b-94ba-f1a65ec507c8",
   "metadata": {},
   "outputs": [],
   "source": [
    "truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "578faca6-fa31-400d-88ea-39c02eccdc51",
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv('/data/users/nency/llm_results/All_diseasae_llm_results.csv',index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b2a71afc-4071-4b47-8b0d-c7a0fc2fde05",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Apply the calculation: score = 1 - score \n",
    "# Only for rows where relationship is NOT 'Causal' and score > 0.5\n",
    "df.loc[(df['relationship'] != 'Causal') & (df['score'] > 0.5), 'score'] = 1 - df['score']\n",
    "\n",
    "# Verify the update\n",
    "print(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4b6bc219-3b55-4702-9a6f-4cabbc90d20e",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import AzureOpenAI  # Changed to AzureOpenAI\n",
    "\n",
    "# ==== Azure OpenAI Config ====\n",
    "AZURE_OPENAI_API_KEY = \"CqSAIM2DLgxvf6S58h8dOYHVKPzMdumoTXLeZMtzLWZhfkKtNkN8JQQJ99BFACF24PCXJ3w3AAABACOGe0ty\"\n",
    "AZURE_OPENAI_ENDPOINT = \"https://teccspazureopenai.openai.azure.com/\"\n",
    "AZURE_DEPLOYMENT = \"gpt-4o\"  # Azure deployment name\n",
    "\n",
    "# ==== Initialize Azure Client (Correct for new SDK) ====\n",
    "client = AzureOpenAI(\n",
    "    api_key=AZURE_OPENAI_API_KEY,\n",
    "    azure_endpoint=AZURE_OPENAI_ENDPOINT,  # Use azure_endpoint instead of base_url\n",
    "    api_version=\"2024-02-01\"  # API version for Azure\n",
    ")\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"All_diseasae\"\n",
    "data = pd.read_csv(DATA_PATH,sep='\\t')\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "assert required_cols.issubset(data.columns)\n",
    "grouped = data.groupby([\"id1\", \"id2\"])\n",
    "print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_llm_results.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_raw_responses.jsonl\")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Prompts ===============\n",
    "# ============================\n",
    "SYSTEM_PROMPT =  \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between two entities.\n",
    "\n",
    "Respond ONLY with one of the two relationship labels:\n",
    "  - Causal\n",
    "  - Not causal\n",
    "Then provide a confidence score between 0 and 1. Here 0 represents non causal and 1 represents causal.\n",
    "always give scores in range try to be variable dont exactly give 0 or 1 based on strengths give scores\n",
    "\n",
    "The response MUST follow this exact format (no extra text, no explanation):\n",
    "\n",
    "**** <relationship>: <score> ****\n",
    "\"\"\"\n",
    "\n",
    "def build_user_prompt(sentences):\n",
    "    return f\"\"\"\n",
    "Sentences:\n",
    "{sentences}\n",
    "Does GeneSrc cause DiseaseTgt?\n",
    "Return only valid JSON.\n",
    "\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== Azure Call ============\n",
    "# ============================\n",
    "def call_azure_openai(id1, id2, text):\n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=AZURE_DEPLOYMENT,  # Use deployment name directly\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": build_user_prompt(text)}\n",
    "            ],\n",
    "            max_tokens=100,\n",
    "            temperature=0.7,\n",
    "            response_format={\"type\": \"json_object\"},\n",
    "            # STRICT JSON OUTPUT\n",
    "        )\n",
    "        \n",
    "        # Correct way to access content in new SDK\n",
    "        content = resp.choices[0].message.content\n",
    "        parsed = json.loads(content)\n",
    "        \n",
    "        # Save raw log\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"response\": content\n",
    "            }) + \"\\n\")\n",
    "        \n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "            \"score\": parsed.get(\"score\", 0.0)\n",
    "        }\n",
    "    \n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {id1}-{id2}: {str(e)}\")\n",
    "        # Return default values on error\n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": \"Error\",\n",
    "            \"score\": 0.0\n",
    "        }\n",
    "\n",
    "# ============================\n",
    "# ==== Process All ===========\n",
    "# ============================\n",
    "def process_all():\n",
    "    results = []\n",
    "    for (id1, id2), group in tqdm(grouped, desc=\"Processing pairs\"):\n",
    "        sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "        results.append(call_azure_openai(id1, id2, sentences))\n",
    "    return results\n",
    "\n",
    "# ============================\n",
    "# ==== RUN ====================\n",
    "# ============================\n",
    "if __name__ == \"__main__\":\n",
    "    results = process_all()\n",
    "    pd.DataFrame(results).to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)\n",
    "\n",
    "# Version: 1.99.9"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f9301935-abc8-459e-8606-40a492d4a467",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.read_csv('llm_results/All_diseasae_MMed-Llama-3-8B_llm_results_2025-12-21.csv').relationship.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2dc37a7f-917d-41a2-a449-edd75fae4d7a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import OpenAI\n",
    "import tiktoken\n",
    "import instructor\n",
    "from pydantic import BaseModel, Field, model_validator\n",
    "from typing import Literal, Any\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM CONFIG ===========\n",
    "# ============================\n",
    "\n",
    "VLLM_ENDPOINT = \"http://localhost:8000/v1\"\n",
    "VLLM_API_KEY = \"token-abc123\"\n",
    "VLLM_MODEL = \"Henrychur/MMed-Llama-3-8B\"\n",
    "\n",
    "base_client = OpenAI(\n",
    "    base_url=VLLM_ENDPOINT,\n",
    "    api_key=VLLM_API_KEY\n",
    ")\n",
    "\n",
    "client = instructor.from_openai(base_client, mode=instructor.Mode.JSON)\n",
    "\n",
    "# ============================\n",
    "# ==== Pydantic Schema =======\n",
    "# ============================\n",
    "\n",
    "class CausalAnalysis(BaseModel):\n",
    "    relationship: Literal[\"Causal\", \"Not causal\"] = Field(\n",
    "        ..., \n",
    "        description=\"Classify the relationship. Value must be exactly 'Causal' or 'Not causal'.\"\n",
    "    )\n",
    "    score: float = Field(\n",
    "        ..., \n",
    "        ge=0.0, \n",
    "        le=1.0, \n",
    "        description=\"Confidence score (0.0 to 1.0).\"\n",
    "    )\n",
    "\n",
    "    @model_validator(mode='before')\n",
    "    @classmethod\n",
    "    def robust_validator(cls, data: Any) -> Any:\n",
    "        if isinstance(data, list):\n",
    "            return {\"relationship\": \"Not causal\", \"score\": 0.0}\n",
    "            \n",
    "        if isinstance(data, dict):\n",
    "            # Unwrap \"data\" or \"result\" wrappers\n",
    "            if \"data\" in data and isinstance(data[\"data\"], dict):\n",
    "                data = data[\"data\"]\n",
    "            elif \"result\" in data and isinstance(data[\"result\"], dict):\n",
    "                data = data[\"result\"]\n",
    "                \n",
    "        return data\n",
    "\n",
    "# ============================\n",
    "# ==== Data Loading ==========\n",
    "# ============================\n",
    "\n",
    "try:\n",
    "    tokenizer = tiktoken.encoding_for_model(\"gpt-3.5-turbo\")\n",
    "except:\n",
    "    tokenizer = tiktoken.get_encoding(\"cl100k_base\")\n",
    "\n",
    "MAX_TOKENS = 7000   # Safe limit for Input\n",
    "MAX_CHARS = 25000    # Safe limit for Input\n",
    "\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"all_disease\"\n",
    "MODEL_NAME = \"MMed-Llama-3-8B\"\n",
    "\n",
    "if not os.path.exists(DATA_PATH):\n",
    "    raise FileNotFoundError(f\"Could not find {DATA_PATH}\")\n",
    "\n",
    "data = pd.read_csv(DATA_PATH,sep='\\t')\n",
    "grouped = data.groupby([\"id1\", \"id2\"])\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "DATESTAMP = datetime.datetime.now().strftime(\"%Y-%m-%d\")\n",
    "\n",
    "SUMMARY_CSV_PATH = os.path.join(\n",
    "    BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_llm_results_{DATESTAMP}.csv\"\n",
    ")\n",
    "LOG_JSONL_PATH = os.path.join(\n",
    "    BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_raw_responses_{DATESTAMP}.jsonl\"\n",
    ")\n",
    "\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# --- CRITICAL PROMPT FIX ---\n",
    "SYSTEM_PROMPT = \"\"\"You are a relationship classifier.\n",
    "1. Analyze the text for a causal link between the entities.\n",
    "2. Return ONLY the JSON object with 'relationship' and 'score'.\n",
    "3. CRITICAL: Do NOT repeat the input text in your response.\n",
    "4. CRITICAL: Do NOT include any 'code', 'status', or 'message' fields.\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM Call =============\n",
    "# ============================\n",
    "\n",
    "def call_vllm(id1, id2, text):\n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=VLLM_MODEL,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": f\"Text to analyze:\\n{text}\"}\n",
    "            ],\n",
    "            response_model=CausalAnalysis,\n",
    "            max_tokens=500,  # Increased from 150 to prevent cutoff if it ignores instructions\n",
    "            temperature=0,\n",
    "            max_retries=2\n",
    "        )\n",
    "\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"response\": resp.model_dump()\n",
    "            }) + \"\\n\")\n",
    "\n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": resp.relationship,\n",
    "            \"score\": resp.score\n",
    "        }\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"\\nError processing {id1}-{id2}: {str(e)}\")\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"error\": str(e)\n",
    "            }) + \"\\n\")\n",
    "            \n",
    "        return {\"id1\": id1, \"id2\": id2, \"relationship\": \"Error\", \"score\": 0.0}\n",
    "\n",
    "# ============================\n",
    "# ==== Process All ===========\n",
    "# ============================\n",
    "\n",
    "def process_all():\n",
    "    results = []\n",
    "    \n",
    "    for (id1, id2), group in tqdm(grouped, desc=\"Processing pairs\"):\n",
    "        sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "        \n",
    "        # 1. Hard Character Cutoff\n",
    "        if len(sentences) > MAX_CHARS:\n",
    "            sentences = sentences[:MAX_CHARS]\n",
    "            \n",
    "        # 2. Token Cutoff\n",
    "        tokens = tokenizer.encode(sentences)\n",
    "        if len(tokens) > MAX_TOKENS:\n",
    "            truncated_tokens = tokens[:MAX_TOKENS]\n",
    "            sentences = tokenizer.decode(truncated_tokens)\n",
    "        \n",
    "        results.append(call_vllm(id1, id2, sentences))\n",
    "        \n",
    "    return results\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "    print(f\"Limits: {MAX_TOKENS} tokens / {MAX_CHARS} chars\")\n",
    "    \n",
    "    results = process_all()\n",
    "    pd.DataFrame(results).to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    \n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d4d82cf6-908a-43fd-abc9-eeaf1782b7b6",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import OpenAI\n",
    "import tiktoken\n",
    "import instructor\n",
    "from pydantic import BaseModel, Field\n",
    "from typing import Literal\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM CONFIG ===========\n",
    "# ============================\n",
    "\n",
    "VLLM_ENDPOINT = \"http://localhost:8000/v1\"\n",
    "VLLM_API_KEY = \"token-abc123\"\n",
    "VLLM_MODEL = \"Henrychur/MMed-Llama-3-8B\"\n",
    "\n",
    "# 1. Initialize OpenAI Client\n",
    "base_client = OpenAI(\n",
    "    base_url=VLLM_ENDPOINT,\n",
    "    api_key=VLLM_API_KEY\n",
    ")\n",
    "\n",
    "# 2. Patch with Instructor\n",
    "client = instructor.from_openai(base_client, mode=instructor.Mode.JSON)\n",
    "\n",
    "# ============================\n",
    "# ==== Pydantic Schema =======\n",
    "# ============================\n",
    "\n",
    "class CausalAnalysis(BaseModel):\n",
    "    relationship: Literal[\"Causal\", \"Not causal\"] = Field(\n",
    "        ..., \n",
    "        description=\"The classification of the relationship between the entities.\"\n",
    "    )\n",
    "    score: float = Field(\n",
    "        ..., \n",
    "        ge=0.0, \n",
    "        le=1.0, \n",
    "        description=\"Confidence score between 0 and 1.\"\n",
    "    )\n",
    "\n",
    "# ============================\n",
    "# ==== Data Loading ==========\n",
    "# ============================\n",
    "\n",
    "# Initialize tokenizer (Approximation using GPT-3.5 or cl100k)\n",
    "try:\n",
    "    tokenizer = tiktoken.encoding_for_model(\"gpt-3.5-turbo\")\n",
    "except:\n",
    "    tokenizer = tiktoken.get_encoding(\"cl100k_base\")\n",
    "\n",
    "MAX_TOKENS = 7500\n",
    "DATA_PATH = \"truth_discovery/AD_negative_class_data.csv\"\n",
    "DATA_NAME = \"AD_neg\"\n",
    "MODEL_NAME = \"MMed-Llama-3-8B\"\n",
    "\n",
    "if not os.path.exists(DATA_PATH):\n",
    "    raise FileNotFoundError(f\"Could not find {DATA_PATH}\")\n",
    "\n",
    "data = pd.read_csv(DATA_PATH)\n",
    "grouped = data.groupby([\"id1\", \"id2\"])\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "DATESTAMP = datetime.datetime.now().strftime(\"%Y-%m-%d\")\n",
    "\n",
    "SUMMARY_CSV_PATH = os.path.join(\n",
    "    BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_llm_results_{DATESTAMP}.csv\"\n",
    ")\n",
    "LOG_JSONL_PATH = os.path.join(\n",
    "    BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_raw_responses_{DATESTAMP}.jsonl\"\n",
    ")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between two entities.\n",
    "Analyze the text deeply and provide your conclusion.\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM Call =============\n",
    "# ============================\n",
    "\n",
    "def call_vllm(id1, id2, text):\n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=VLLM_MODEL,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": f\"Sentences:\\n{text}\"}\n",
    "            ],\n",
    "            response_model=CausalAnalysis,\n",
    "            max_tokens=150,\n",
    "            temperature=0,\n",
    "        )\n",
    "\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"response\": resp.model_dump()\n",
    "            }) + \"\\n\")\n",
    "\n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": resp.relationship,\n",
    "            \"score\": resp.score\n",
    "        }\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"\\nError processing {id1}-{id2}: {str(e)}\")\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"error\": str(e)\n",
    "            }) + \"\\n\")\n",
    "            \n",
    "        return {\"id1\": id1, \"id2\": id2, \"relationship\": \"Error\", \"score\": 0.0}\n",
    "\n",
    "# ============================\n",
    "# ==== Process All ===========\n",
    "# ============================\n",
    "\n",
    "def process_all():\n",
    "    results = []\n",
    "    \n",
    "    # Iterate through groups\n",
    "    for (id1, id2), group in tqdm(grouped, desc=\"Processing pairs\"):\n",
    "        sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "        \n",
    "        # ---------------------------------------------------------\n",
    "        # TRUNCATION LOGIC (RESTORED)\n",
    "        # ---------------------------------------------------------\n",
    "        tokens = tokenizer.encode(sentences)\n",
    "        \n",
    "        if len(tokens) > MAX_TOKENS:\n",
    "            print(f\"Warning: Truncating {id1}-{id2} from {len(tokens)} to {MAX_TOKENS} tokens\")\n",
    "            \n",
    "            # Slice the tokens to the limit\n",
    "            truncated_tokens = tokens[:MAX_TOKENS]\n",
    "            \n",
    "            # Decode back to text for the prompt\n",
    "            sentences = tokenizer.decode(truncated_tokens)\n",
    "        # ---------------------------------------------------------\n",
    "        \n",
    "        results.append(call_vllm(id1, id2, sentences))\n",
    "        \n",
    "    return results\n",
    "\n",
    "# ============================\n",
    "# ==== RUN ====================\n",
    "# ============================\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "    results = process_all()\n",
    "    pd.DataFrame(results).to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "20df3c52-71b9-4aeb-b1ba-cc33346291b7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import OpenAI   # vLLM client\n",
    "import tiktoken  # For token counting\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM CONFIG ===========\n",
    "# ============================\n",
    "\n",
    "VLLM_ENDPOINT = \"http://localhost:8000/v1\"\n",
    "VLLM_API_KEY = \"token-abc123\"\n",
    "VLLM_MODEL = \"Henrychur/MMed-Llama-3-8B\"\n",
    "\n",
    "client = OpenAI(\n",
    "    base_url=VLLM_ENDPOINT,\n",
    "    api_key=VLLM_API_KEY\n",
    ")\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "# client = OpenAI(\n",
    "# \tbase_url = \"https://x2wqybxvec6wno11.us-east-1.aws.endpoints.huggingface.cloud/v1/\",\n",
    "#     # base_url = \"https://x2wqybxvec6wno11.us-east-1.aws.endpoints.huggingface.cloud\",\n",
    "# \tapi_key = \"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\"\n",
    "# )\n",
    "\n",
    "# Initialize tokenizer for Llama-3 (uses cl100k_base encoding)\n",
    "# Note: For exact Llama-3 tokenization, you might want to use transformers library instead\n",
    "try:\n",
    "    tokenizer = tiktoken.encoding_for_model(\"gpt-3.5-turbo\")  # Close approximation for token counting\n",
    "except:\n",
    "    tokenizer = tiktoken.get_encoding(\"cl100k_base\")  # Fallback encoding\n",
    "\n",
    "MAX_TOKENS = 7900  # Maximum tokens for input text\n",
    "DATA_PATH = \"truth_discovery/gene_discovery/gene_discovery/merged_correct_omim_filtered/complete_data_bibliometrics_with_all_diseases_biobert_svm_prediction_updated.tsv\"\n",
    "DATA_NAME = \"all_disease\"\n",
    "MODEL_NAME = \"MMed-Llama-3-8B\"      # <-- Add model name here\n",
    "\n",
    "data = pd.read_csv(DATA_PATH,sep='\\t')\n",
    "\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "assert required_cols.issubset(data.columns)\n",
    "\n",
    "grouped = data.groupby([\"id1\", \"id2\"])\n",
    "print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "\n",
    "DATESTAMP = datetime.datetime.now().strftime(\"%Y-%m-%d\")\n",
    "\n",
    "# ADD MODEL NAME HERE \n",
    "SUMMARY_CSV_PATH = os.path.join(\n",
    "    BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_llm_results_{DATESTAMP}.csv\"\n",
    ")\n",
    "LOG_JSONL_PATH = os.path.join(\n",
    "    BASE_RESULTS_DIR, f\"{DATA_NAME}_{MODEL_NAME}_raw_responses_{DATESTAMP}.jsonl\"\n",
    ")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Prompts ===============\n",
    "# ============================\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between two entities.\n",
    "\n",
    "Respond ONLY with one of the two relationship labels:\n",
    "  - Causal\n",
    "  - Not causal\n",
    "\n",
    "Then provide a confidence score between 0 and 1.\n",
    "\n",
    "The response MUST follow this exact format (no extra text, no explanation):\n",
    "\n",
    "**** <relationship>: <score> ****\n",
    "\"\"\"\n",
    "\n",
    "def build_user_prompt(sentences):\n",
    "    return f\"\"\"\n",
    "Sentences:\n",
    "{sentences}\n",
    "\n",
    "Return only valid JSON.\n",
    "\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== vLLM Call =============\n",
    "# ============================\n",
    "\n",
    "def call_vllm(id1, id2, text):\n",
    "    # try:\n",
    "    resp = client.chat.completions.create(\n",
    "        model=\"Henrychur/MMed-Llama-3-8B\",\n",
    "        messages=[\n",
    "            {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "            {\"role\": \"user\", \"content\": build_user_prompt(text)}\n",
    "        ],\n",
    "        max_tokens=150,\n",
    "        temperature=0,\n",
    "        response_format={\n",
    "            \"type\": \"json_schema\",\n",
    "            \"json_schema\": {\n",
    "                \"name\": \"causal_output\",\n",
    "                \"schema\": {\n",
    "                    \"type\": \"object\",\n",
    "                    \"properties\": {\n",
    "                        \"relationship\": {\n",
    "                            \"type\": \"string\"\n",
    "                        },\n",
    "                        \"score\": {\"type\": \"number\"}\n",
    "                    },\n",
    "                    \"required\": [\"relationship\", \"score\"]\n",
    "                }\n",
    "            }\n",
    "        }\n",
    "    )\n",
    "\n",
    "    content = resp.choices[0].message.content\n",
    "    parsed = json.loads(content)\n",
    "\n",
    "    print(resp)\n",
    "    \n",
    "\n",
    "    # Save raw log\n",
    "    with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "        f.write(json.dumps({\n",
    "            \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "            \"id1\": str(id1),\n",
    "            \"id2\": str(id2),\n",
    "            \"response\": content\n",
    "        }) + \"\\n\")\n",
    "\n",
    "    return {\n",
    "        \"id1\": id1,\n",
    "        \"id2\": id2,\n",
    "        \"relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "        \"score\": parsed.get(\"score\", 0.0)\n",
    "    }\n",
    "\n",
    "    # except Exception as e:\n",
    "    #     print(f\"Error processing {id1}-{id2}: {str(e)}\")\n",
    "    #     return {\"id1\": id1, \"id2\": id2, \"relationship\": \"Error\", \"score\": 0.0}\n",
    "\n",
    "# ============================\n",
    "# ==== Process All ===========\n",
    "# ============================\n",
    "\n",
    "def process_all():\n",
    "    results = []\n",
    "    for (id1, id2), group in tqdm(grouped, desc=\"Processing pairs\"):\n",
    "        sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "        \n",
    "        # Token-based truncation\n",
    "        tokens = tokenizer.encode(sentences)\n",
    "        if len(tokens) > MAX_TOKENS:\n",
    "            print(f\"Warning: Truncating {id1}-{id2} from {len(tokens)} to {MAX_TOKENS} tokens\")\n",
    "            # Truncate tokens and decode back to text\n",
    "            truncated_tokens = tokens[:MAX_TOKENS]\n",
    "            sentences = tokenizer.decode(truncated_tokens)\n",
    "        \n",
    "        results.append(call_vllm(id1, id2, sentences))\n",
    "    return results\n",
    "\n",
    "# ============================\n",
    "# ==== RUN ====================\n",
    "# ============================\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    results = process_all()\n",
    "    pd.DataFrame(results).to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c8721d4f-a4e3-45b6-a479-15a915c01ad4",
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.read_json('llm_results/AD_neg_MMed-Llama-3-8B_raw_responses_2025-11-17.jsonl',lines=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "abbdcffa-008b-4e0d-a639-5c4bd13fcb36",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "import datetime\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from openai import AzureOpenAI  # Changed to AzureOpenAI\n",
    "\n",
    "# ==== Azure OpenAI Config ====\n",
    "AZURE_OPENAI_API_KEY = \"CqSAIM2DLgxvf6S58h8dOYHVKPzMdumoTXLeZMtzLWZhfkKtNkN8JQQJ99BFACF24PCXJ3w3AAABACOGe0ty\"\n",
    "AZURE_OPENAI_ENDPOINT = \"https://teccspazureopenai.openai.azure.com/\"\n",
    "AZURE_DEPLOYMENT = \"gpt-4o\"  # Azure deployment name\n",
    "\n",
    "# ==== Initialize Azure Client (Correct for new SDK) ====\n",
    "client = AzureOpenAI(\n",
    "    api_key=AZURE_OPENAI_API_KEY,\n",
    "    azure_endpoint=AZURE_OPENAI_ENDPOINT,  # Use azure_endpoint instead of base_url\n",
    "    api_version=\"2024-02-01\"  # API version for Azure\n",
    ")\n",
    "\n",
    "# ============================\n",
    "# ==== Load dataset ==========\n",
    "# ============================\n",
    "DATA_PATH = \"truth_discovery/AD_negative_class_data.csv\"  # Added .csv extension\n",
    "DATA_NAME = \"AD_neg\"\n",
    "data = pd.read_csv(DATA_PATH)\n",
    "required_cols = {\"id1\", \"id2\", \"sentence\"}\n",
    "assert required_cols.issubset(data.columns)\n",
    "grouped = data.groupby([\"id1\", \"id2\"])\n",
    "print(f\"Processing {len(grouped)} unique gene-disease pairs...\")\n",
    "\n",
    "# ============================\n",
    "# ==== Output Folder =========\n",
    "# ============================\n",
    "BASE_RESULTS_DIR = \"llm_results\"\n",
    "os.makedirs(BASE_RESULTS_DIR, exist_ok=True)\n",
    "SUMMARY_CSV_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_llm_results.csv\")\n",
    "LOG_JSONL_PATH = os.path.join(BASE_RESULTS_DIR, f\"{DATA_NAME}_raw_responses.jsonl\")\n",
    "\n",
    "# Reset old files\n",
    "for f in [SUMMARY_CSV_PATH, LOG_JSONL_PATH]:\n",
    "    if os.path.exists(f):\n",
    "        os.remove(f)\n",
    "\n",
    "# ============================\n",
    "# ==== Prompts ===============\n",
    "# ============================\n",
    "SYSTEM_PROMPT = \"\"\"You are a biomedical expert. Analyze the following sentences to determine whether a causal relationship exists between two entities.\n",
    "\n",
    "Respond ONLY with one of the two relationship labels:\n",
    "  - Causal\n",
    "  - Not causal\n",
    "\n",
    "Then provide a confidence score between 0 and 1.\n",
    "\n",
    "\n",
    "\"\"\"\n",
    "\n",
    "def build_user_prompt(sentences):\n",
    "    return f\"\"\"\n",
    "Sentences:\n",
    "{sentences}\n",
    "Does GeneSrc cause DiseaseTgt?\n",
    "Return only valid JSON.\n",
    "\"\"\"\n",
    "\n",
    "# ============================\n",
    "# ==== Azure Call ============\n",
    "# ============================\n",
    "def call_azure_openai(id1, id2, text):\n",
    "    try:\n",
    "        resp = client.chat.completions.create(\n",
    "            model=AZURE_DEPLOYMENT,  # Use deployment name directly\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
    "                {\"role\": \"user\", \"content\": build_user_prompt(text)}\n",
    "            ],\n",
    "            max_tokens=100,\n",
    "            temperature=0.7,\n",
    "            response_format={\"type\": \"json_object\"},\n",
    "            # STRICT JSON OUTPUT\n",
    "        )\n",
    "        \n",
    "        # Correct way to access content in new SDK\n",
    "        content = resp.choices[0].message.content\n",
    "        parsed = json.loads(content)\n",
    "        \n",
    "        # Save raw log\n",
    "        with open(LOG_JSONL_PATH, \"a\", encoding=\"utf-8\") as f:\n",
    "            f.write(json.dumps({\n",
    "                \"timestamp\": datetime.datetime.now().isoformat(),\n",
    "                \"id1\": str(id1),\n",
    "                \"id2\": str(id2),\n",
    "                \"response\": content\n",
    "            }) + \"\\n\")\n",
    "        \n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": parsed.get(\"relationship\", \"Unknown\"),\n",
    "            \"score\": parsed.get(\"confidence\", 0.0)\n",
    "        }\n",
    "    \n",
    "    except Exception as e:\n",
    "        print(f\"Error processing {id1}-{id2}: {str(e)}\")\n",
    "        # Return default values on error\n",
    "        return {\n",
    "            \"id1\": id1,\n",
    "            \"id2\": id2,\n",
    "            \"relationship\": \"Error\",\n",
    "            \"score\": 0.0\n",
    "        }\n",
    "\n",
    "# ============================\n",
    "# ==== Process All ===========\n",
    "# ============================\n",
    "def process_all():\n",
    "    results = []\n",
    "    for (id1, id2), group in tqdm(grouped, desc=\"Processing pairs\"):\n",
    "        sentences = \"\\n\".join(group[\"sentence\"].dropna().unique())\n",
    "        results.append(call_azure_openai(id1, id2, sentences))\n",
    "    return results\n",
    "\n",
    "# ============================\n",
    "# ==== RUN ====================\n",
    "# ============================\n",
    "if __name__ == \"__main__\":\n",
    "    results = process_all()\n",
    "    pd.DataFrame(results).to_csv(SUMMARY_CSV_PATH, index=False)\n",
    "    print(\"\\n Completed Successfully\")\n",
    "    print(\" CSV:\", SUMMARY_CSV_PATH)\n",
    "    print(\" Logs:\", LOG_JSONL_PATH)\n",
    "\n",
    "# Version: 1.99.9"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "87ee6d8e-b07d-4110-a29c-f82bace21b2e",
   "metadata": {},
   "outputs": [],
   "source": [
    "data1=pd.read_csv('llm_results/AD_neg_llm_results.csv')\n",
    "data2=pd.read_json('llm_results/AD_neg_raw_responses.jsonl',lines=True)\n",
    "data1['openai_response']=data2['response']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6b20befe-758d-4110-8371-dfaf3ec31f19",
   "metadata": {},
   "outputs": [],
   "source": [
    "data3=pd.read_csv('llm_results/AD_neg_MMed-Llama-3-8B_llm_results_2025-11-17.csv')\n",
    "data4=pd.read_json('llm_results/AD_neg_MMed-Llama-3-8B_raw_responses_2025-11-17.jsonl',lines=True)\n",
    "data3['medllama_response']=data4['response']\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6cb06f6b-20ea-4d33-b1bd-168b0a1be9d4",
   "metadata": {},
   "outputs": [],
   "source": [
    "data1['medllama_response']=data3['medllama_response']\n",
    "data1['medllama_score']=data3['score']\n",
    "data1['medllama_relationship']=data3['relationship']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "819958ef-7244-424b-a1f8-bcd2467ff2f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "data_unique = (\n",
    "    data.dropna(subset=['id1', 'vq*'])\n",
    "    .groupby('id1')['vq*'].mean().reset_index()\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "52ce5bdc-3988-449f-9821-98061f3a8e3b",
   "metadata": {},
   "outputs": [],
   "source": [
    "id1_symbol_map = data.dropna(subset=['Symbol']).groupby('id1')['Symbol'].first().to_dict()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3af68eef-64ae-4c08-869a-c38f7629636d",
   "metadata": {},
   "outputs": [],
   "source": [
    "id1_symbol_map.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0137a55c-f1a9-4ba1-b8f6-ef66ca0822a8",
   "metadata": {},
   "outputs": [],
   "source": [
    "data1['Symbol'] = data1['id1'].map(id1_symbol_map)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "78201cf0-98f4-4b01-88a3-1fc77e75860c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# data1['id1']=data1['id1'].apply(lambda x:x.split(';')[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f89179aa-c72d-413e-9eca-f7bb9f46d409",
   "metadata": {},
   "outputs": [],
   "source": [
    "gene_symbols_table = [\n",
    "    'APP', 'APOE', 'PSEN1', 'PSEN2', 'TREM2', 'NOS3', 'PLAU', 'ADAM10', \n",
    "    'ABCA7', 'MPO']\n",
    "data1_filtered = data1[data1['Symbol'].isin(gene_symbols_table)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9f5e44d4-3410-41f6-acfb-b0104559ed38",
   "metadata": {},
   "outputs": [],
   "source": [
    "data1['vq*']=data_unique['vq*']\n",
    "gene_symbols_table = [\n",
    "    'APP', 'APOE', 'PSEN1', 'PSEN2', 'TREM2', 'NOS3', 'PLAU', 'ADAM10', \n",
    "    'ABCA7', 'MPO']\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "80fc0e0a-8019-4b83-b343-9c21fef58e30",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Your list of OMIM causal symbols\n",
    "gene_symbols_table = [\n",
    "    'APP', 'APOE', 'PSEN1', 'PSEN2', 'TREM2', \n",
    "    'NOS3', 'PLAU', 'ADAM10', 'ABCA7', 'MPO'\n",
    "]\n",
    "\n",
    "# Create omim column (True/False)\n",
    "data1['omim'] = data1['Symbol'].isin(gene_symbols_table)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2a8413ec-3984-47a0-9c5b-f35754ebc5d2",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared=pd.read_csv('LLM_inference_neg_AD_OMIM.csv')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "37bbc1ef-7994-49ff-b767-11e60c7276b0",
   "metadata": {},
   "outputs": [],
   "source": [
    "data1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "375ec34b-0b37-42e7-be8a-58c416332f5b",
   "metadata": {},
   "outputs": [],
   "source": [
    "df=data1\n",
    "mask1 = (df['relationship'].str.lower().str.contains('not causal', na=False)) & (df['score'] > 0.5)\n",
    "df.loc[mask1, 'score'] = 1 - df.loc[mask1, 'score']\n",
    "\n",
    "mask2 = (df['medllama_relationship'].str.lower().str.contains('not causal', na=False)) & (df['medllama_score'] > 0.5)\n",
    "df.loc[mask2, 'medllama_score'] = 1 - df.loc[mask2, 'medllama_score']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e8d07b1c-5832-4cf4-b873-c7e4a320209e",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.metrics import classification_report\n",
    "\n",
    "def generate_classification_reports(df, score_columns, threshold=0.9, ground_truth_col='omim_binary'):\n",
    "    \"\"\"\n",
    "    Prints the full sklearn classification report for multiple models at a specific threshold.\n",
    "    \"\"\"\n",
    "    print(f\"\\n{'='*60}\")\n",
    "    print(f\"CLASSIFICATION REPORT @ THRESHOLD {threshold}\")\n",
    "    print(f\"{'='*60}\")\n",
    "\n",
    "    valid_cols = [c for c in score_columns if c in df.columns]\n",
    "    \n",
    "    for col in valid_cols:\n",
    "        # 1. Get Data (Drop NaNs for this specific column)\n",
    "        mask = df[col].notna() & df[ground_truth_col].notna()\n",
    "        if mask.sum() == 0:\n",
    "            print(f\"Skipping {col} (No valid data)\")\n",
    "            continue\n",
    "            \n",
    "        y_true = df.loc[mask, ground_truth_col]\n",
    "        y_scores = df.loc[mask, col]\n",
    "        \n",
    "        # 2. Check Scale Warning\n",
    "        # If scores are 0-100 and threshold is 0.9, the report will be meaningless (everything becomes 1)\n",
    "        if y_scores.max() > 1.0 and threshold < 1.0:\n",
    "            print(f\"\\n[WARNING] '{col}' max value is {y_scores.max()}.\")\n",
    "            print(f\"           Threshold {threshold} might be too low. Did you mean 90?\")\n",
    "\n",
    "        # 3. Apply Threshold\n",
    "        y_pred = (y_scores >= threshold).astype(int)\n",
    "        \n",
    "        # 4. Generate Report\n",
    "        # zero_division=0 prevents errors if a model predicts only one class\n",
    "        report = classification_report(y_true, y_pred, \n",
    "                                     target_names=['Not OMIM (0)', 'OMIM (1)'],\n",
    "                                     zero_division=0)\n",
    "        display_names = {\n",
    "        'score': 'GPT-4o',\n",
    "        'medllama_score': 'MedLLama',\n",
    "        'vq*': 'CSTD'\n",
    "        }\n",
    "        print(f\"\\n--- Model: {display_names[col]} ---\")\n",
    "        print(report)\n",
    "\n",
    "# ==========================================\n",
    "# EXECUTION\n",
    "# ==========================================\n",
    "# Assuming 'df_prepared' is your dataframe\n",
    "cols_to_test = ['score', 'medllama_score', 'vq*']\n",
    "df_prepared = prepare_data(df)\n",
    "df_prepared = df_prepared.drop_duplicates(subset='id1', keep='first')\n",
    "generate_classification_reports(df_prepared, cols_to_test, threshold=0.9)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6abb97aa-cc92-4c9e-a18a-1dfb87c34ca0",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_prepared=pd.read_csv('LLM_inference_AD_OMIM.csv')\n",
    "df_new = pd.read_csv('truth_discovery/AD_OMIM_complete_data_new_td.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6bab15b2-cdca-4451-84d7-ea8dac157354",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "27e10988-98f5-4b8e-b50d-d89d108eff1c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_new.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "72476cba-1991-4e0f-9abe-0b5ec3e058dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared = df_prepared.merge(\n",
    "    df_new[['Symbol', 'vq*_stable']],\n",
    "    on='Symbol',\n",
    "    how='left',\n",
    "    suffixes=('', '_new')\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6ef0a679-c304-4966-a62d-aed7340717c6",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared['causal/total'] = df_prepared['number_of_causal'] / df_prepared['total']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "77ecac67-0566-40e6-b5ee-a71f2509fec6",
   "metadata": {},
   "outputs": [],
   "source": [
    "def plot_pr_curves(df, score_columns, ground_truth_col='omim_binary',\n",
    "                   manual_thresholds=None):\n",
    "    \"\"\"\n",
    "    Plots PrecisionRecall curves for multiple models and shows their AUCs.\n",
    "    \"\"\"\n",
    "    plt.figure(figsize=(5, 4))\n",
    "    plt.xlabel(\"Recall\")\n",
    "    plt.ylabel(\"Precision\")\n",
    "    plt.grid(True, linestyle='--', alpha=0.6)\n",
    "    \n",
    "    display_names = {\n",
    "        'score': 'GPT-4o',\n",
    "        'medllama_score': 'MMed-Llama 3',\n",
    "        'vq*': 'CSTD'\n",
    "    }\n",
    "\n",
    "    # ============================================\n",
    "    # NEW BASELINE CALCULATION\n",
    "    # ============================================\n",
    "    positive_rate = df[ground_truth_col].mean()  # prevalence\n",
    "    plt.axhline(\n",
    "        y=positive_rate,\n",
    "        linestyle='--',\n",
    "        color='black',\n",
    "        linewidth=1.5,\n",
    "        label=f'Baseline'\n",
    "    )\n",
    "    print(df[ground_truth_col].sum(), len(df[ground_truth_col]))\n",
    "    print(positive_rate)\n",
    "    # print(positive_rate)\n",
    "    # ============================================\n",
    "\n",
    "    for col in score_columns:\n",
    "        if col not in df.columns:\n",
    "            print(f\"Column {col} not in DataFrame, skipping.\")\n",
    "            continue\n",
    "\n",
    "        mask = df[col].notna() & df[ground_truth_col].notna()\n",
    "        if mask.sum() == 0:\n",
    "            print(f\"Skipping {col}  no valid data.\")\n",
    "            continue\n",
    "\n",
    "        y_true = df.loc[mask, ground_truth_col].astype(int).values\n",
    "        y_scores = df.loc[mask, col].astype(float).values\n",
    "\n",
    "        if manual_thresholds is None:\n",
    "            precision, recall, _ = precision_recall_curve(y_true, y_scores)\n",
    "        else:\n",
    "            precision, recall, _ = pr_at_thresholds_like_sklearn(\n",
    "                y_true, y_scores, manual_thresholds, add_anchor=True\n",
    "            )\n",
    "\n",
    "        pr_auc = auc(recall, precision)\n",
    "        label_name = display_names.get(col, col)\n",
    "\n",
    "        plt.plot(\n",
    "            recall,\n",
    "            precision,\n",
    "            linewidth=2,\n",
    "            label=f\"{label_name} (AUC={pr_auc:.3f})\"\n",
    "        )\n",
    "\n",
    "        if manual_thresholds is not None:\n",
    "            plt.scatter(recall, precision, s=2)\n",
    "\n",
    "    plt.legend(loc='upper right')\n",
    "    plt.tight_layout()\n",
    "    plt.savefig('PR_curve_AD')\n",
    "    \n",
    "    plt.show()\n",
    "df_prepared = df_prepared.drop_duplicates(subset='id1', keep='first')\n",
    "\n",
    "cols_to_test = ['vq*', 'score', 'medllama_score','causal/total']\n",
    "\n",
    "manual_thresholds = np.linspace(0,1,100)\n",
    "\n",
    "df_filtered = df_prepared[df_prepared['total'] >= 2].copy()\n",
    "\n",
    "plot_pr_curves(\n",
    "    df_filtered,\n",
    "    cols_to_test,\n",
    "    ground_truth_col='omim_binary'\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cd36681a-4704-4345-a9c5-49135e460ab8",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared = df_prepared.drop_duplicates(subset='id1', keep='first')\n",
    "\n",
    "cols_to_test = ['vq*', 'score', 'medllama_score','causal/total']\n",
    "\n",
    "manual_thresholds = np.linspace(0,1,100)\n",
    "\n",
    "df_filtered = df_prepared[df_prepared['total'] >= 2].copy()\n",
    "\n",
    "plot_pr_curves(\n",
    "    df_filtered,\n",
    "    cols_to_test,\n",
    "    ground_truth_col='omim_binary'\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7b535507-6714-4af6-a330-b559bd37004e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared[df_prepared['omim_binary']==1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "46fc647d-5c0e-4095-b3d2-3abe57875700",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared.to_csv('LLM_inference_neg_AD_OMIM.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "079e4b77-ad0a-4171-b264-ef063d77dca7",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "\n",
    "def recall_at_k_curve(df, score_cols, ground_truth_col='omim_binary',\n",
    "                      k_values=None, display_names=None):\n",
    "    \"\"\"\n",
    "    Compute and plot Recall@K curves for multiple model score columns.\n",
    "    \"\"\"\n",
    "    plt.figure(figsize=(6,4))\n",
    "    plt.grid(True, linestyle='--', alpha=0.6)\n",
    "    plt.xlabel(\"K\")\n",
    "    plt.ylabel(\"Recall@K\")\n",
    "\n",
    "    # default K values: 1 .. 200 or up to dataset size\n",
    "    if k_values is None:\n",
    "        k_values = np.arange(1, min(200, len(df)) + 1)\n",
    "\n",
    "    # mapping names for legend\n",
    "    if display_names is None:\n",
    "        display_names = {col: col for col in score_cols}\n",
    "\n",
    "    total_positives = df[ground_truth_col].sum()\n",
    "\n",
    "    for col in score_cols:\n",
    "        if col not in df.columns:\n",
    "            print(f\"Column {col} missing, skipping.\")\n",
    "            continue\n",
    "\n",
    "        # Drop rows with missing score or ground truth\n",
    "        mask = df[col].notna() & df[ground_truth_col].notna()\n",
    "        df_valid = df.loc[mask].copy()\n",
    "\n",
    "        # Sort by descending score\n",
    "        df_valid = df_valid.sort_values(col, ascending=False)\n",
    "\n",
    "        recalls = []\n",
    "        for k in k_values:\n",
    "            topk = df_valid.head(k)\n",
    "            tp_at_k = topk[ground_truth_col].sum()\n",
    "            recall = tp_at_k / total_positives if total_positives > 0 else 0\n",
    "            recalls.append(recall)\n",
    "\n",
    "        plt.plot(k_values, recalls, linewidth=2,\n",
    "                 label=display_names.get(col, col))\n",
    "\n",
    "    plt.legend()\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "45656058-d604-42d2-9a03-a5227f23cc14",
   "metadata": {},
   "outputs": [],
   "source": [
    "score_columns = ['score', 'medllama_score', 'vq*']\n",
    "\n",
    "display_names = {\n",
    "    'score': 'GPT-4o',\n",
    "    'medllama_score': 'MedLLama',\n",
    "    'vq*': 'CWTD'\n",
    "}\n",
    "# df_prepared=df_prepared['id1'].astype(\"int64\")\n",
    "k_values = np.arange(1, 250)  # or any range you want\n",
    "\n",
    "recall_at_k_curve(\n",
    "    df_prepared,\n",
    "    score_columns,\n",
    "    ground_truth_col='omim_binary',\n",
    "    k_values=k_values,\n",
    "    display_names=display_names\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "de486e57-a6f8-421a-9fe4-2831794a055b",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_omim_comp = pd.read_csv('truth_discovery/AD_complete_data.csv')\n",
    "df_omim_comp['id1']=df_omim_comp['id1'].apply(lambda x:x.split(';')[0])\n",
    "df_omim_comp['id1']=df_omim_comp['id1'].astype('int64')\n",
    "# df_prepared=df_prepared.astype(str)\n",
    "# Count Prediction == 1\n",
    "pred1 = (\n",
    "    df_omim_comp\n",
    "    .groupby(['id1', 'id2'])['pred_label']\n",
    "    .apply(lambda x: (x == 1).sum())\n",
    "    .reset_index(name='number_of_causal')\n",
    ")\n",
    "\n",
    "# Count total rows for each id1,id2\n",
    "total = (\n",
    "    df_omim_comp\n",
    "    .groupby(['id1', 'id2'])\n",
    "    .size()\n",
    "    .reset_index(name='total')\n",
    ")\n",
    "\n",
    "df_prepared = (\n",
    "    df_prepared\n",
    "    .merge(pred1, on=['id1', 'id2'], how='left')\n",
    "    .merge(total, on=['id1', 'id2'], how='left')\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "962952a3-180f-47eb-926f-722b4fc26c68",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "\n",
    "def recall_at_k_curve(df, score_cols, ground_truth_col='omim_binary',\n",
    "                      k_values=None, display_names=None,\n",
    "                      min_total_count=0):\n",
    "    \"\"\"\n",
    "    Compute and plot Recall@K curves for multiple model score columns.\n",
    "    Only uses rows where total_count >= min_total_count.\n",
    "    \"\"\"\n",
    "\n",
    "    # ------------------------------\n",
    "    # NEW: filter by total_count >= min_total_count\n",
    "    # ------------------------------\n",
    "    if 'total' not in df.columns:\n",
    "        raise ValueError(\"df must contain 'total_count' column\")\n",
    "\n",
    "    df = df[df['total'] >= min_total_count].copy()\n",
    "    # ------------------------------\n",
    "\n",
    "    plt.figure(figsize=(6,4))\n",
    "    plt.grid(True, linestyle='--', alpha=0.6)\n",
    "    plt.xlabel(\"K\")\n",
    "    plt.ylabel(\"Recall@K\")\n",
    "\n",
    "    if k_values is None:\n",
    "        k_values = np.arange(1, min(200, len(df)) + 1)\n",
    "\n",
    "    if display_names is None:\n",
    "        display_names = {col: col for col in score_cols}\n",
    "\n",
    "    total_positives = df[ground_truth_col].sum()\n",
    "\n",
    "    for col in score_cols:\n",
    "        if col not in df.columns:\n",
    "            print(f\"Column {col} missing, skipping.\")\n",
    "            continue\n",
    "\n",
    "        mask = df[col].notna() & df[ground_truth_col].notna()\n",
    "        df_valid = df.loc[mask].copy()\n",
    "\n",
    "        df_valid = df_valid.sort_values(col, ascending=False)\n",
    "\n",
    "        recalls = []\n",
    "        for k in k_values:\n",
    "            topk = df_valid.head(k)\n",
    "            tp_at_k = topk[ground_truth_col].sum()\n",
    "            recall = tp_at_k / total_positives if total_positives > 0 else 0\n",
    "            recalls.append(recall)\n",
    "\n",
    "        plt.plot(k_values, recalls, linewidth=2,\n",
    "                 label=display_names.get(col, col))\n",
    "\n",
    "    plt.legend()\n",
    "    plt.tight_layout()\n",
    "    plt.savefig(\"Recall_curve_AD\")\n",
    "    plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9e6b83ab-66ed-4f9c-898d-3a444e66e70e",
   "metadata": {},
   "outputs": [],
   "source": [
    "score_columns = ['vq*', 'score', 'medllama_score', 'causal/total']\n",
    "\n",
    "display_names = {\n",
    "    'score': 'GPT-4o',\n",
    "    'medllama_score': 'MMed-Llama 3',\n",
    "    'vq*': 'CSTD',\n",
    "    'causal/total': 'Majority voting'\n",
    "}\n",
    "\n",
    "k_values = np.arange(1, 40)\n",
    "\n",
    "recall_at_k_curve(\n",
    "    df_prepared,\n",
    "    score_columns,\n",
    "    ground_truth_col='omim_binary',\n",
    "    k_values=k_values,\n",
    "    display_names=display_names,\n",
    "    min_total_count=2      # <-- FILTER APPLIED HERE\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fdc1f600-7372-48df-b55a-aeb7e85988cd",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.metrics import classification_report\n",
    "\n",
    "def generate_classification_reports(df, score_columns, threshold=0.9,\n",
    "                                    ground_truth_col='omim_binary',\n",
    "                                    min_total_count=0):\n",
    "    \"\"\"\n",
    "    Prints the full sklearn classification report for multiple models at a specific threshold.\n",
    "    Evaluates ONLY rows where total_count >= min_total_count.\n",
    "    \"\"\"\n",
    "\n",
    "    # -----------------------------------------\n",
    "    # NEW: Filter by total_count >= min_total_count\n",
    "    # -----------------------------------------\n",
    "    if 'total' not in df.columns:\n",
    "        raise ValueError(\"df must contain 'total_count' column.\")\n",
    "\n",
    "    df = df[df['total'] >= min_total_count].copy()\n",
    "    # -----------------------------------------\n",
    "\n",
    "    print(f\"\\nUsing only id1,id2 pairs with total_count >= {min_total_count}\")\n",
    "    print(f\"Remaining rows = {len(df)}\")\n",
    "\n",
    "    print(f\"\\n{'='*60}\")\n",
    "    print(f\"CLASSIFICATION REPORT @ THRESHOLD {threshold}\")\n",
    "    print(f\"{'='*60}\")\n",
    "\n",
    "    valid_cols = [c for c in score_columns if c in df.columns]\n",
    "\n",
    "    for col in valid_cols:\n",
    "\n",
    "        mask = df[col].notna() & df[ground_truth_col].notna()\n",
    "        if mask.sum() == 0:\n",
    "            print(f\"Skipping {col} (No valid data)\")\n",
    "            continue\n",
    "\n",
    "        y_true = df.loc[mask, ground_truth_col]\n",
    "        y_scores = df.loc[mask, col]\n",
    "\n",
    "        if y_scores.max() > 1.0 and threshold < 1.0:\n",
    "            print(f\"\\n[WARNING] '{col}' max value is {y_scores.max()}.\")\n",
    "            print(f\"           Threshold {threshold} might be too low. Did you mean 90?\")\n",
    "\n",
    "        y_pred = (y_scores >= threshold).astype(int)\n",
    "\n",
    "        report = classification_report(\n",
    "            y_true, y_pred,\n",
    "            target_names=['Not OMIM (0)', 'OMIM (1)'],\n",
    "            zero_division=0\n",
    "        )\n",
    "\n",
    "        display_names = {\n",
    "            'score': 'GPT-4o',\n",
    "            'medllama_score': 'MedLLama',\n",
    "            'vq*': 'CSTD',\n",
    "            'causal/total': 'Majority voting'\n",
    "        }\n",
    "\n",
    "        print(f\"\\n--- Model: {display_names[col]} ---\")\n",
    "        print(report)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cee84d22-8bf2-423e-9560-10121afed1b9",
   "metadata": {},
   "outputs": [],
   "source": [
    "cols_to_test = ['score', 'medllama_score', 'vq*', 'causal/total']\n",
    "\n",
    "# df_prepared = prepare_data(df)\n",
    "# df_prepared = df_prepared.drop_duplicates(subset='id1', keep='first')\n",
    "\n",
    "# Evaluate only pairs with >= 5 supporting sentences\n",
    "generate_classification_reports(\n",
    "    df_prepared,\n",
    "    cols_to_test,\n",
    "    threshold=0.9,\n",
    "    min_total_count=2\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cd55d317-b5d5-4f67-8ad7-3afb1e1fffe8",
   "metadata": {},
   "outputs": [],
   "source": [
    "gene_symbols_table = [\n",
    "    'APP', 'APOE', 'PSEN1', 'PSEN2', 'TREM2', 'NOS3', 'PLAU', 'ADAM10', \n",
    "    'ABCA7', 'MPO'\n",
    "]\n",
    "matched_rows = df_prepared[df_prepared['Symbol'].isin(gene_symbols_table)]\n",
    "matched_rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "79f37c1b-655f-4fed-91c4-78e152957e6c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_omim_comp['pred_label'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "205fd081-eadf-4b4f-b55d-44d862fbf7db",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared['causal/total'] = df_prepared['number_of_causal'] / df_prepared['total']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "172bbbe5-bfb2-4403-be5f-609849b73d01",
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Create scatter plot: causal/total vs vq*\n",
    "plt.figure(figsize=(6, 6))\n",
    "plt.scatter(df_prepared['causal/total'], df_prepared['vq*'])\n",
    "plt.xlabel('causal/total')\n",
    "plt.ylabel('vq*')\n",
    "plt.title('Scatter plot of causal/total vs vq*')\n",
    "plt.grid(True, linestyle='--', alpha=0.6)\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e11e7d9e-5950-4245-802a-f4bddc821f3c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared[df_prepared['causal/total']>0.9]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "55e8b9a4-61ee-4052-aca0-79adc6e0c2a7",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.metrics import classification_report, precision_recall_curve, auc\n",
    "import numpy as np\n",
    "\n",
    "def classify_using_causal_ratio(df, threshold=0.5):\n",
    "    \"\"\"\n",
    "    Uses causal/total as prediction score\n",
    "    and omim_binary as ground truth.\n",
    "    Only considers rows where total > 1.\n",
    "    Also computes AUPRC.\n",
    "    \"\"\"\n",
    "\n",
    "    # -----------------------------\n",
    "    # FILTER: only rows with total > 1\n",
    "    # -----------------------------\n",
    "    df = df[df['total'] > 1].copy()\n",
    "\n",
    "    # Safely create causal/total\n",
    "    df['causal/total'] = df['number_of_causal'] / df['total']\n",
    "    df['causal/total'] = df['causal/total'].replace(\n",
    "        [np.inf, -np.inf], 0\n",
    "    ).fillna(0)\n",
    "\n",
    "    # Valid rows\n",
    "    mask = df['causal/total'].notna() & df['omim_binary'].notna()\n",
    "    df_valid = df.loc[mask]\n",
    "\n",
    "    y_true = df_valid['omim_binary'].astype(int).values\n",
    "    y_scores = df_valid['causal/total'].astype(float).values\n",
    "\n",
    "    # Binary prediction\n",
    "    y_pred = (y_scores >= threshold).astype(int)\n",
    "\n",
    "    print(f\"\\nClassification Report using causal/total @ threshold {threshold}\")\n",
    "    print(\"Using only rows where total > 1\")\n",
    "    print(\"=\" * 70)\n",
    "\n",
    "    report = classification_report(\n",
    "        y_true,\n",
    "        y_pred,\n",
    "        target_names=['Not OMIM (0)', 'OMIM (1)'],\n",
    "        zero_division=0\n",
    "    )\n",
    "    print(report)\n",
    "\n",
    "    # -----------------------------\n",
    "    # AUPRC Calculation\n",
    "    # -----------------------------\n",
    "    precision, recall, _ = precision_recall_curve(y_true, y_scores)\n",
    "    auprc = auc(recall, precision)\n",
    "\n",
    "    print(f\"AUPRC (causal/total vs OMIM): {auprc:.4f}\")\n",
    "\n",
    "    return auprc\n",
    "auprc_value = classify_using_causal_ratio(df_prepared, threshold=0.9)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "14f52006-0d24-483b-924c-cbf83179c9c6",
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "# df_omim_comp['id1']=df_omim_comp['id1'].apply(lambda x:x.split(';')[0])\n",
    "# df_omim_comp['id1']=df_omim_comp['id1'].astype('int64')\n",
    "# Merge df_prepared and df_omim_comp on id1 and id2 to align vq* values\n",
    "df = df_prepared[df_prepared['total'] > 1].copy()\n",
    "\n",
    "merged = df[['id1', 'id2', 'vq*']].merge(\n",
    "    df_omim_comp[['id1', 'id2', 'vq*']],\n",
    "    on=['id1', 'id2'],\n",
    "    how='inner',\n",
    "    suffixes=('_prepared', '_omim_comp')\n",
    ")\n",
    "\n",
    "# Create scatter plot\n",
    "plt.figure(figsize=(5, 4))\n",
    "plt.scatter(merged['vq*_prepared'], merged['vq*_omim_comp'])\n",
    "plt.xlabel('Causal score from OMIM data')\n",
    "plt.ylabel('Causal score from complete data')\n",
    "# plt.title('Scatter Plot: vq* Comparison between df_prepared and df_omim_comp')\n",
    "plt.grid(True, linestyle='--', alpha=0.6)\n",
    "plt.tight_layout()\n",
    "plt.savefig(\"Causal score OMIM vs complete AD\")\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1a50bda5-276d-40c8-814c-084422a63bd1",
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "df_prepared['causal/total'] = df_prepared['number_of_causal'] / df_prepared['total']\n",
    "# Setup the figure: 2 Rows (Linear/Log), 2 Columns (vq* / causal)\n",
    "fig, axes = plt.subplots(2, 2, figsize=(18, 10))\n",
    "# --- PLOT 1: vq* (The Stable Model) ---\n",
    "# Linear Scale\n",
    "sns.histplot(df_prepared['vq*'], bins=50, kde=False, color='skyblue', edgecolor='black', ax=axes[0, 0])\n",
    "axes[0, 0].set_title('vq*: Linear Scale (Good Spread)')\n",
    "axes[0, 0].axvline(0.829, color='red', linestyle='--', linewidth=2, label='Threshold (0.83)')\n",
    "axes[0, 0].legend()\n",
    "\n",
    "# Log Scale\n",
    "sns.histplot(df_prepared['vq*'], bins=50, kde=False, color='skyblue', edgecolor='black', ax=axes[1, 0])\n",
    "axes[1, 0].set_yscale('log')\n",
    "axes[1, 0].set_title('vq*: Log Scale')\n",
    "axes[1, 0].axvline(0.829, color='red', linestyle='--', linewidth=2)\n",
    "\n",
    "# --- PLOT 2: causal/total (The Squashed Model) ---\n",
    "# Linear Scale\n",
    "sns.histplot(df_prepared['causal/total'], bins=50, kde=False, color='salmon', edgecolor='black', ax=axes[0, 1])\n",
    "axes[0, 1].set_title('causal/total: Linear Scale (Squashed)')\n",
    "axes[0, 1].axvline(0.0625, color='red', linestyle='--', linewidth=2, label='Threshold (0.06)')\n",
    "axes[0, 1].legend()\n",
    "\n",
    "# Log Scale\n",
    "sns.histplot(df_prepared['causal/total'], bins=50, kde=False, color='salmon', edgecolor='black', ax=axes[1, 1])\n",
    "axes[1, 1].set_yscale('log')\n",
    "axes[1, 1].set_title('causal/total: Log Scale')\n",
    "axes[1, 1].axvline(0.0625, color='red', linestyle='--', linewidth=2)\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "18a32921-3ee3-4a59-9b11-9eec3895f0da",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared=pd.read_csv('LLM_inference_AD_OMIM.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "da0483b5-beef-4bb8-94fe-f101ba12fc0a",
   "metadata": {},
   "outputs": [],
   "source": [
    "!pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c6a57b5b-3166-4d02-8b99-78d48dbd722e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared['causal/total'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7463d63d-2882-4d89-93c0-78177edaf2ab",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_prepared['vq*'].describe()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3697d1cf-5139-405c-bd86-e302323e8520",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "from sklearn.metrics import precision_recall_curve, auc, f1_score, brier_score_loss\n",
    "from sklearn.calibration import calibration_curve\n",
    "\n",
    "def analyze_model_performance(df, model_cols, ground_truth_col, threshold_step=0.01):\n",
    "    \"\"\"\n",
    "    Runs comprehensive checks: PR Curve, F1 Optimization, Stability, and Calibration.\n",
    "    \"\"\"\n",
    "    \n",
    "    # Setup the plot grid: One row per model to keep it clean\n",
    "    n_models = len(model_cols)\n",
    "    fig, axes = plt.subplots(n_models, 3, figsize=(20, 5 * n_models))\n",
    "    if n_models == 1: axes = [axes] # Handle single model case\n",
    "    \n",
    "    results_summary = []\n",
    "\n",
    "    for idx, col in enumerate(model_cols):\n",
    "        y_true = df[ground_truth_col]\n",
    "        y_scores = df[col]\n",
    "        \n",
    "        # ---------------------------------------------------------\n",
    "        # Check 1: Precision-Recall Curve (Standard)\n",
    "        # ---------------------------------------------------------\n",
    "        precision, recall, thresholds = precision_recall_curve(y_true, y_scores)\n",
    "        pr_auc = auc(recall, precision)\n",
    "        \n",
    "        ax_pr = axes[idx][0]\n",
    "        ax_pr.plot(recall, precision, label=f'AUC = {pr_auc:.3f}', color='blue')\n",
    "        ax_pr.set_title(f\"{col}: PR Curve\")\n",
    "        ax_pr.set_xlabel(\"Recall\")\n",
    "        ax_pr.set_ylabel(\"Precision\")\n",
    "        ax_pr.legend()\n",
    "        ax_pr.grid(True, alpha=0.3)\n",
    "\n",
    "        # ---------------------------------------------------------\n",
    "        # Check 2: Threshold Optimization & Stability (Crucial!)\n",
    "        # ---------------------------------------------------------\n",
    "        # Calculate F1 for every threshold to find the \"Operating Point\"\n",
    "        f1_scores = 2 * (precision * recall) / (precision + recall)\n",
    "        # Handle division by zero (0 precision + 0 recall)\n",
    "        f1_scores = np.nan_to_num(f1_scores) \n",
    "        \n",
    "        # Find best threshold\n",
    "        best_idx = np.argmax(f1_scores)\n",
    "        best_thresh = thresholds[best_idx] if best_idx < len(thresholds) else 1.0\n",
    "        max_f1 = f1_scores[best_idx]\n",
    "        \n",
    "        ax_stab = axes[idx][1]\n",
    "        # We plot Precision, Recall, and F1 against Thresholds\n",
    "        # Note: thresholds array is 1 shorter than precision/recall arrays\n",
    "        ax_stab.plot(thresholds, precision[:-1], 'g--', label='Precision', alpha=0.5)\n",
    "        ax_stab.plot(thresholds, recall[:-1], 'r--', label='Recall', alpha=0.5)\n",
    "        ax_stab.plot(thresholds, f1_scores[:-1], 'k-', linewidth=2, label='F1 Score')\n",
    "        \n",
    "        # Highlight the optimal point\n",
    "        ax_stab.axvline(best_thresh, color='orange', linestyle=':', label=f'Best Thresh: {best_thresh:.2f}')\n",
    "        ax_stab.set_title(f\"{col}: Stability (Best F1: {max_f1:.3f})\")\n",
    "        ax_stab.set_xlabel(\"Threshold\")\n",
    "        ax_stab.set_ylabel(\"Score\")\n",
    "        ax_stab.legend()\n",
    "        ax_stab.grid(True, alpha=0.3)\n",
    "\n",
    "        # ---------------------------------------------------------\n",
    "        # Check 3: Calibration Curve (The \"Trust\" Check)\n",
    "        # ---------------------------------------------------------\n",
    "        # Normalize scores to 0-1 if they aren't already (simple min-max for visualization)\n",
    "        if y_scores.max() > 1 or y_scores.min() < 0:\n",
    "            y_scores_norm = (y_scores - y_scores.min()) / (y_scores.max() - y_scores.min())\n",
    "        else:\n",
    "            y_scores_norm = y_scores\n",
    "\n",
    "        prob_true, prob_pred = calibration_curve(y_true, y_scores_norm, n_bins=10)\n",
    "        brier = brier_score_loss(y_true, y_scores_norm)\n",
    "        \n",
    "        ax_cal = axes[idx][2]\n",
    "        ax_cal.plot(prob_pred, prob_true, marker='o', label=f'Brier Score: {brier:.3f}')\n",
    "        ax_cal.plot([0, 1], [0, 1], linestyle='--', color='gray', label='Perfectly Calibrated')\n",
    "        ax_cal.set_title(f\"{col}: Calibration (Trust)\")\n",
    "        ax_cal.set_xlabel(\"Predicted Probability\")\n",
    "        ax_cal.set_ylabel(\"True Probability\")\n",
    "        ax_cal.legend()\n",
    "        ax_cal.grid(True, alpha=0.3)\n",
    "\n",
    "        results_summary.append({\n",
    "            'Model': col,\n",
    "            'AUC': pr_auc,\n",
    "            'Max_F1': max_f1,\n",
    "            'Best_Threshold': best_thresh,\n",
    "            'Brier_Score': brier\n",
    "        })\n",
    "\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "    \n",
    "    return pd.DataFrame(results_summary)\n",
    "\n",
    "# --- EXECUTION ---\n",
    "\n",
    "# Prepare your data\n",
    "df_prepared = df_prepared.drop_duplicates(subset='id1', keep='first')\n",
    "df_filtered = df_prepared[df_prepared['total'] >= 2].copy()\n",
    "\n",
    "cols_to_test = ['vq*','vq*_stable', 'score', 'medllama_score', 'causal/total']\n",
    "\n",
    "# Run the new comprehensive analysis\n",
    "metrics_df = analyze_model_performance(\n",
    "    df_filtered,\n",
    "    cols_to_test,\n",
    "    ground_truth_col='omim_binary'\n",
    ")\n",
    "\n",
    "print(metrics_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "67a1d94c-65ad-49b3-bcff-242acaa2f90c",
   "metadata": {},
   "outputs": [],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "837de373-beeb-426f-9ea3-456dd39500cc",
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "# Ensure 'Year difference' is the raw value (e.g., 2024 - 1990 = 34 years old)\n",
    "# If it was normalized, try to use the original raw column if possible.\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "\n",
    "# Boxplot: Distribution of \"Age\" for True vs False claims\n",
    "sns.boxplot(x='omim_binary', y='Year difference', data=df_filtered, palette={0: \"salmon\", 1: \"skyblue\"})\n",
    "\n",
    "plt.title('Does Paper Age Predict Truth?')\n",
    "plt.xlabel('Ground Truth (0 = False, 1 = True)')\n",
    "plt.ylabel('Year Difference (Age of Paper)')\n",
    "plt.xticks([0, 1], ['False Claims', 'True Claims'])\n",
    "plt.grid(True, alpha=0.3)\n",
    "plt.show()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
